PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Mookerjee, I; Hewitson, TD; Halls, ML; Summers, RJ; Mathai, ML; Bathgate, RAD; Tregear, GW; Samuel, CS				Mookerjee, Ishanee; Hewitson, Tim D.; Halls, Michelle L.; Summers, Roger J.; Mathai, Michael L.; Bathgate, Ross A. D.; Tregear, Geoffrey W.; Samuel, Chrishan S.			Relaxin inhibits renal myofibroblast differentiation via RXFP1, the nitric oxide pathway, and Smad2	FASEB JOURNAL			English	Article						tubulointerstitial fibrosis; transforming growth factor-beta 1; alpha-smooth muscle actin; cell signaling	INTERSTITIAL FIBROSIS; MEDIATED MECHANISM; ENDOTHELIAL-CELLS; IN-VITRO; TUBULOINTERSTITIAL FIBROSIS; FIBROBLAST PROLIFERATION; ENDOGENOUS RELAXIN; FAMILY PEPTIDES; GROWTH-FACTOR; COLLAGEN	The hormone relaxin inhibits renal myofibroblast differentiation by interfering with TGF-beta 1/Smad2 signaling. However, the pathways involved in the relaxin-TGF-beta 1/Smad2 interaction remain unknown. This study investigated the signaling mechanisms by which human gene-2 (H2) relaxin regulates myofibroblast differentiation in vitro by examining its effects on mixed populations of fibroblasts and myofibroblasts propagated from injured rat kidneys. Cultures containing similar to 60-70% myofibroblasts were used to determine which relaxin receptors, G-proteins, and signaling pathways were involved in the H2 relaxin-mediated regulation of alpha-smooth muscle actin (alpha-SMA; a marker of myofibroblast differentiation). H2 relaxin only inhibited alpha-SMA immunostaining and collagen concentration in the presence of relaxin family peptide receptor 1 (RXFP1). H2 relaxin also induced a transient rise in cAMP in the presence of G(i/o) inhibition, and a sustained increase in extracellular signal-regulated kinase (ERK)-1/2 phosphorylation. Furthermore, inhibition of neuronal nitric oxide synthase (nNOS), NO, and cGMP significantly blocked the inhibitory effects of relaxin on alpha-SMA and Smad2 phosphorylation, while the NO inhibitor, L-nitroarginine methyl ester (hydrochloride) (L-NAME) significantly blocked the inhibitory actions of relaxin on collagen concentration in vivo. These findings suggest that relaxin signals through RXFP1, and a nNOS-NO-cGMP-dependent pathway to inhibit Smad2 phosphorylation and interfere with TGF-beta 1-mediated renal myofibroblast differentiation and collagen production.- Mookerjee, I., Hewitson, T. D., Halls, M. L., Summers, R. J., Mathai, M. L., Bathgate, R. A. D., Tregear, G. W., Samuel, C. S. Relaxin inhibits renal myofibroblast differentiation via RXFP1, the nitric oxide pathway, and Smad2. FASEB J. 23, 1219-1229 (2009)	[Mookerjee, Ishanee; Mathai, Michael L.; Bathgate, Ross A. D.; Tregear, Geoffrey W.; Samuel, Chrishan S.] Univ Melbourne, Howard Florey Inst, Parkville, Vic 3010, Australia; [Mookerjee, Ishanee; Bathgate, Ross A. D.; Tregear, Geoffrey W.; Samuel, Chrishan S.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; [Hewitson, Tim D.] Univ Melbourne, Dept Nephrol, Royal Melbourne Hosp, Parkville, Vic 3010, Australia; [Hewitson, Tim D.] Univ Melbourne, Dept Med, Royal Melbourne Hosp, Parkville, Vic 3010, Australia; [Halls, Michelle L.; Summers, Roger J.] Monash Univ, Dept Pharmacol, Clayton, Vic 3800, Australia; [Mathai, Michael L.] Victoria Univ, Sch Biomed & Hlth Sci, Melbourne, Vic 8001, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; Monash University; Victoria University	Samuel, CS (corresponding author), Univ Melbourne, Howard Florey Inst, Parkville, Vic 3010, Australia.	chrishan.samuel@florey.edu.au	Bathgate, Ross/ABE-6471-2020; Summers, Roger J/F-6351-2011	Bathgate, Ross/0000-0001-6301-861X; Summers, Roger J/0000-0002-8367-4056; Hewitson, Tim/0000-0002-1994-2423; Halls, Michelle/0000-0001-8555-8959				Baccari MC, 2007, AM J PHYSIOL-REG I, V293, pR662, DOI 10.1152/ajpregu.00214.2007; Bani D, 1997, GEN PHARMACOL-VASC S, V28, P13, DOI 10.1016/S0306-3623(96)00171-1; BANISACCHI T, 1995, BRIT J PHARMACOL, V116, P1589, DOI 10.1111/j.1476-5381.1995.tb16377.x; Bathgate RA, 2006, PHARMACOL REV, V58, P7, DOI 10.1124/pr.58.1.9; Boffa JJ, 1999, CIRCULATION, V100, P1901, DOI 10.1161/01.CIR.100.18.1901; Conrad KP, 2004, J SOC GYNECOL INVEST, V11, P438, DOI 10.1016/j.jsgi.2004.05.002; Danielson LA, 2000, AM J PHYSIOL-REG I, V279, pR1298, DOI 10.1152/ajpregu.2000.279.4.R1298; Darby IA, 2007, INT REV CYTOL, V257, P143, DOI 10.1016/S0074-7696(07)57004-X; Diamond JR, 1998, SEMIN NEPHROL, V18, P594; Eddy AA, 2000, PEDIATR NEPHROL, V15, P290, DOI 10.1007/s004670000461; Erikson MS, 2001, RELAXIN 2000, P373; Fu P, 2006, J ENDOCRINOL, V189, P397, DOI 10.1677/joe.1.06697; GALLOP PM, 1975, PHYSIOL REV, V55, P418, DOI 10.1152/physrev.1975.55.3.418; Garber SL, 2003, AM J NEPHROL, V23, P8, DOI 10.1159/000066302; Garber SL, 2001, KIDNEY INT, V59, P876, DOI 10.1046/j.1523-1755.2001.059003876.x; Halls ML, 2006, MOL PHARMACOL, V70, P214, DOI 10.1124/mol.105.021691; Halls ML, 2005, J PHARMACOL EXP THER, V313, P677, DOI 10.1124/jpet.104.080655; Heeg MHJ, 2005, KIDNEY INT, V68, P96, DOI 10.1111/j.1523-1755.2005.00384.x; Hewitson TD, 2002, J LAB CLIN MED, V140, P199, DOI 10.1067/mlc.2002.126828; Hewitson TD, 1998, J AM SOC NEPHROL, V9, P632; Hewitson TD, 2007, ENDOCRINOLOGY, V148, P660, DOI 10.1210/en.2006-0814; Krotova K, 2006, BRIT J PHARMACOL, V148, P732, DOI 10.1038/sj.bjp.0706777; Lekgabe ED, 2005, HYPERTENSION, V46, P412, DOI 10.1161/01.HYP.0000171930.00697.2f; Liu YH, 2004, AM J PHYSIOL-RENAL, V287, pF7, DOI 10.1152/ajprenal.00451.2003; Masini E, 1997, ENDOCRINOLOGY, V138, P4713, DOI 10.1210/en.138.11.4713; Masini E, 2004, ENDOCRINOLOGY, V145, P1106, DOI 10.1210/en.2003-0833; Masterson R, 2004, NEPHROL DIAL TRANSPL, V19, P544, DOI 10.1093/ndt/gfg598; Mineo C, 2003, J BIOL CHEM, V278, P9142, DOI 10.1074/jbc.M211394200; Mookerjee I, 2006, ENDOCRINOLOGY, V147, P754, DOI 10.1210/en.2005-1006; Naqvi T, 2005, ARTHRITIS RES THER, V7, pR1, DOI 10.1186/ar1451; Nistri S, 2003, FASEB J, V17, P2109, DOI 10.1096/fj.03-0216fje; Nistri Silvia, 2007, Cardiovascular & Hematological Agents in Medicinal Chemistry, V5, P101, DOI 10.2174/187152507780363179; Ortiz PA, 2003, AM J PHYSIOL-REG I, V284, pR628, DOI 10.1152/ajpregu.00401.2002; Palejwala S, 1998, ENDOCRINOLOGY, V139, P1208, DOI 10.1210/en.139.3.1208; Parsell DA, 1996, J BIOL CHEM, V271, P27936, DOI 10.1074/jbc.271.44.27936; RODEMANN HP, 1990, P SOC EXP BIOL MED, V195, P57; Samuel CS, 2007, CELL MOL LIFE SCI, V64, P1539, DOI 10.1007/s00018-007-6543-y; Samuel CS, 2006, PHARMACOL THERAPEUT, V112, P529, DOI 10.1016/j.pharmthera.2005.05.012; Samuel CS, 2004, ENDOCRINOLOGY, V145, P4125, DOI 10.1210/en.2004-0209; Samuel CS, 2005, ANN NY ACAD SCI, V1041, P173, DOI 10.1196/annals.1282.025; Samuel CS, 1996, ENDOCRINOLOGY, V137, P3884, DOI 10.1210/en.137.9.3884; Saura M, 2005, CIRC RES, V97, P1115, DOI 10.1161/01.RES.0000191538.76771.66; Szabo AJ, 2003, KIDNEY INT, V64, P1765, DOI 10.1046/j.1523-1755.2003.00260.x; Taguchi M, 2000, MOL HUM REPROD, V6, P185, DOI 10.1093/molehr/6.2.185; UNEMORI EN, 1990, J BIOL CHEM, V265, P10681; Unemori EN, 1996, J CLIN INVEST, V98, P2739, DOI 10.1172/JCI119099; Winbanks CE, 2007, INT J BIOCHEM CELL B, V39, P206, DOI 10.1016/j.biocel.2006.08.004; Zeisberg M, 2004, NEPHROL DIAL TRANSPL, V19, P759, DOI 10.1093/ndt/gfh060	48	109	112	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2009	23	4					1219	1229		10.1096/fj.08-120857	http://dx.doi.org/10.1096/fj.08-120857			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZO	19073841				2022-12-25	WOS:000266651600026
J	Wendler, CC; Busovsky-McNeal, M; Ghatpande, S; Kalinowski, A; Russell, KS; Rivkees, SA				Wendler, Christopher C.; Busovsky-McNeal, Melissa; Ghatpande, Satish; Kalinowski, April; Russell, Kerry S.; Rivkees, Scott A.			Embryonic caffeine exposure induces adverse effects in adulthood	FASEB JOURNAL			English	Article						hypoxia-inducible factor 1 alpha; cardiac; heart development; echocardiography	PLASMA ADENOSINE CONCENTRATION; ENDOTHELIAL GROWTH-FACTOR; RECEPTOR EXPRESSION; HEART; RISK; PROTECTION; ONTOGENY	The purpose of this study was to determine both the short-term effects on cardiac development and embryo growth and the long-term effects on cardiac function and body composition of in utero caffeine exposure. Pregnant mice (C57BL/6) were exposed to hypoxia (10% O-2) or room air from embryonic days (E) 8.5-10.5, and treated with caffeine (20 mg/kg, i.p.) or vehicle (normal saline, 0.9% NaCl). This caffeine dose results in a circulating level that is equivalent to 2 cups of coffee in humans. Hypoxic exposure acutely reduced embryonic growth by 30%. Exposure to a single dose of caffeine inhibited cardiac ventricular development by 53% in hypoxia and 37% in room air. Caffeine exposure resulted in inhibition of hypoxia-induced HIF1 alpha protein expression in embryos by 40%. When offspring from dams treated with a single dose of caffeine were studied in adulthood, we observed that caffeine treatment alone resulted in a decrease in cardiac function of 38%, as assessed by echocardiography. We also observed a 20% increase in body fat with male mice exposed to caffeine. Caffeine was dissolved in normal saline, so it was used as a control. Room air controls were used to compare to the hypoxic mice. Exposure to a single dose of caffeine during embryogenesis results in both short-term effects on cardiac development and long-term effects on cardiac function.-Wendler, C. C., Busovsky-McNeal, M., Ghatpande, S., Kalinowski, A., Russell, K. S., Rivkees, S. A. Embryonic caffeine exposure induces adverse effects in adulthood. FASEB J. 23, 1272-1278 (2009)	[Wendler, Christopher C.; Busovsky-McNeal, Melissa; Ghatpande, Satish; Rivkees, Scott A.] Yale Univ, Sch Med, Dept Pediat, Yale Child Hlth Res Ctr,Sect Dev Endocrinol & Bio, New Haven, CT 06520 USA; [Kalinowski, April; Russell, Kerry S.] Yale Univ, Sch Med, Div Cardiovasc Med, New Haven, CT 06520 USA	Yale University; Yale University	Wendler, CC (corresponding author), Yale Univ, Sch Med, Dept Pediat, Yale Child Hlth Res Ctr,Sect Dev Endocrinol & Bio, 464 Congress Ave, New Haven, CT 06520 USA.	christopher.wendler@yale.edu			U. S. National Institutes of Health (NIH) [R01HL58442, U24 DK-76169]; March of Dimes; Charles H. Hood Foundation; Yale Diabetes Endocrinology Research Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK076169] Funding Source: NIH RePORTER	U. S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); Charles H. Hood Foundation; Yale Diabetes Endocrinology Research Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U. S. National Institutes of Health (NIH) grant R01HL58442 (S. A. R), the March of Dimes (S. A. R.), the Charles H. Hood Foundation (S. G.) and the Yale Diabetes Endocrinology Research Center (C. C. W.). We thank Dr. Gerald Shulman, Varman Samuel, and David Frederick of the Yale Mouse Metabolic Phenotyping Center, which is supported by NIH grant U24 DK-76169. We also thank Sarah Renzi and Ryan Poulsen for their technical assistance.	Browne ML, 2006, EPIDEMIOLOGY, V17, P324, DOI 10.1097/01.ede.0000208476.36988.44; Cline GW, 2001, J BIOL CHEM, V276, P20240, DOI 10.1074/jbc.M102540200; Cnattingius S, 2003, FOOD CHEM TOXICOL, V41, P1202, DOI 10.1016/S0278-6915(03)00103-0; Cnattingius S, 2000, NEW ENGL J MED, V343, P1839, DOI 10.1056/NEJM200012213432503; Daly JW, 2007, CELL MOL LIFE SCI, V64, P2153, DOI 10.1007/s00018-007-7051-9; De Ponti C, 2007, J LEUKOCYTE BIOL, V82, P392, DOI 10.1189/jlb.0107060; FREDHOLM BB, 1994, PHARMACOL REV, V46, P143; FREDHOLM BB, 1995, PHARMACOL TOXICOL, V76, P93, DOI 10.1111/j.1600-0773.1995.tb00111.x; GOLDING J, 1995, EARLY HUM DEV, V43, P1, DOI 10.1016/0378-3782(95)01660-U; Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009; Ijzerman A. P., 1997, P129; Jacoby JJ, 2003, P NATL ACAD SCI USA, V100, P12929, DOI 10.1073/pnas.2134694100; KOOS BJ, 1994, AM J PHYSIOL, V266, pR215, DOI 10.1152/ajpregu.1994.266.1.R215; KOOS BJ, 1994, J APPL PHYSIOL, V77, P2734, DOI 10.1152/jappl.1994.77.6.2734; Lankford AR, 2006, AM J PHYSIOL-HEART C, V290, pH1469, DOI 10.1152/ajpheart.00181.2005; Lukac R, 2006, J VIS COMMUN IMAGE R, V17, P1, DOI 10.1016/j.jvcir.2005.08.007; Merighi S, 2005, NEOPLASIA, V7, P894, DOI 10.1593/neo.05334; Merighi S, 2007, MOL PHARMACOL, V72, P395, DOI 10.1124/mol.106.032920; Merighi S, 2006, BIOCHEM PHARMACOL, V72, P19, DOI 10.1016/j.bcp.2006.03.020; Ohta A, 2006, P NATL ACAD SCI USA, V103, P13132, DOI 10.1073/pnas.0605251103; Porter GA, 2001, AM J PHYSIOL-REG I, V281, pR401, DOI 10.1152/ajpregu.2001.281.2.R401; Rivkees SA, 1999, J BIOL CHEM, V274, P14204, DOI 10.1074/jbc.274.20.14204; RIVKEES SA, 1995, DEV BRAIN RES, V89, P202, DOI 10.1016/0165-3806(95)00120-3; Schulte G, 2004, ACTA PHYSIOL SCAND, V182, P133, DOI 10.1111/j.1365-201X.2004.01350.x; SEMENIUK C, 2007, WETLANDS ECOL CONSER, V1, P1; Signorello LB, 2001, OBSTET GYNECOL, V98, P1059, DOI 10.1016/S0029-7844(01)01575-7; Simon DK, 2008, CLIN NEUROPHARMACOL, V31, P189, DOI 10.1097/WNF.0b013e31815a3f03; Simon MC, 2008, ANNU REV PHYSIOL, V70, P51, DOI 10.1146/annurev.physiol.70.113006.100526; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Turner CP, 2003, P NATL ACAD SCI USA, V100, P11718, DOI 10.1073/pnas.1931975100; Wendler CC, 2007, P NATL ACAD SCI USA, V104, P9697, DOI 10.1073/pnas.0703557104; Weng XP, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.10.803; YONEYAMA Y, 1994, AM J OBSTET GYNECOL, V170, P684, DOI 10.1016/S0002-9378(94)70248-9; YONEYAMA Y, 1994, AM J OBSTET GYNECOL, V171, P701, DOI 10.1016/0002-9378(94)90085-X	35	30	34	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2009	23	4					1272	1278		10.1096/fj.08-124941	http://dx.doi.org/10.1096/fj.08-124941			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZO	19088180	Green Published			2022-12-25	WOS:000266651600031
J	Dietzel, U; Kuper, J; Doebbler, JA; Schulte, A; Truglio, JJ; Leimkuhler, S; Kisker, C				Dietzel, Uwe; Kuper, Jochen; Doebbler, Jennifer A.; Schulte, Antje; Truglio, James J.; Leimkuehler, Silke; Kisker, Caroline			Mechanism of Substrate and Inhibitor Binding of Rhodobacter capsulatus Xanthine Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ACTIVE-SITE; OXIDASE; CATALYSIS; PTERIN-6-ALDEHYDE; IDENTIFICATION; SPECIFICITY; INSERTION; RESIDUES; ENZYME	Rhodobacter capsulatus xanthine dehydrogenase (XDH) is an (alpha beta)(2) heterotetrameric cytoplasmic enzyme that resembles eukaryotic xanthine oxidoreductases in respect to both amino acid sequence and structural fold. To obtain a detailed understanding of the mechanism of substrate and inhibitor binding at the active site, we solved crystal structures of R. capsulatus XDH in the presence of its substrates hypoxanthine, xanthine, and the inhibitor pterin-6-aldehyde using either the inactive desulfo form of the enzyme or an active site mutant (E(B)232Q) to prevent substrate turnover. The hypoxanthine-and xanthine-bound structures reveal the orientation of both substrates at the active site and show the importance of residue GluB-232 for substrate positioning. The oxygen atom at the C-6 position of both substrates is oriented toward Arg(B)-310 in the active site. Thus the substrates bind in an orientation opposite to the one seen in the structure of the reduced enzyme with the inhibitor oxypurinol. The tightness of the substrates in the active site suggests that the intermediate products must exit the binding pocket to allow first the attack of the C-2, followed by oxidation of the C-8 atom to form the final product uric acid. Structural studies of pterin-6-aldehyde, a potent inhibitor of R. capsulatus XDH, contribute further to the understanding of the relative positioning of inhibitors and substrates in the binding pocket. Steady state kinetics reveal a competitive inhibition pattern with a K-i of 103.57 +/- 18.96 nM for pterin-6-aldehyde.	[Leimkuehler, Silke] Univ Potsdam, Inst Biochem & Biol, D-14476 Potsdam, Germany; [Kisker, Caroline] Univ Wurzburg, Inst Biol Struct, Rudolf Virchow Ctr Expt Biomed, D-97078 Wurzburg, Germany; [Doebbler, Jennifer A.] SUNY Stony Brook, Dept Phys, Stony Brook, NY 11794 USA; [Doebbler, Jennifer A.; Schulte, Antje; Truglio, James J.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA	University of Potsdam; University of Wurzburg; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Leimkuhler, S (corresponding author), Univ Potsdam, Inst Biochem & Biol, D-14476 Potsdam, Germany.	sleim@uni-potsdam.de; caroline.kisker@virchow.uni-wuerzburg.de	Kisker, Caroline/T-1724-2019	Leimkuhler, Silke/0000-0003-3238-2122; Kisker, Caroline/0000-0002-0216-6026; Strauss, Jennifer/0000-0002-8832-0265	National Institutes of Health [GM070873]; Deutsche Forschungsgemeinschaft [LE1171/3]; Forschungszentrum [FZ-82]; State University of New York and its Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070873] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Forschungszentrum; State University of New York and its Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM070873. This work was also supported by Deutsche Forschungsgemeinschaft Grant LE1171/3 (to S. L.), Forschungszentrum Grant FZ-82 (to C. K.), and in part by the State University of New York and its Research Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; BOSS GR, 1980, J LAB CLIN MED, V96, P783; Brunger A. T., 1992, XPLOR VERSION 3 1 SY; Dixon M, 1924, BIOCHEM J, V18, P976, DOI 10.1042/bj0180976; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HALPERN R, 1977, P NATL ACAD SCI USA, V74, P587, DOI 10.1073/pnas.74.2.587; HOFSTEE BHJ, 1955, J BIOL CHEM, V216, P235; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KALCKAR HM, 1950, BIOCHIM BIOPHYS ACTA, V5, P586, DOI 10.1016/0006-3002(50)90204-6; Leimkuhler S, 1998, MOL MICROBIOL, V27, P853, DOI 10.1046/j.1365-2958.1998.00733.x; Leimkuhler S, 1999, J BACTERIOL, V181, P2745; Leimkuhler S, 2004, J BIOL CHEM, V279, P40437, DOI 10.1074/jbc.M405778200; LOWRY OH, 1949, J BIOL CHEM, V180, P399; LOWRY OH, 1949, J BIOL CHEM, V180, P389; MASSEY V, 1970, J BIOL CHEM, V245, P2837; Neumann M, 2006, J BIOL CHEM, V281, P15701, DOI 10.1074/jbc.M601617200; Nishino T, 2005, J BIOL CHEM, V280, P24888, DOI 10.1074/jbc.M501830200; Okamoto K, 2004, P NATL ACAD SCI USA, V101, P7931, DOI 10.1073/pnas.0400973101; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palmer T, 1996, MOL MICROBIOL, V20, P875, DOI 10.1111/j.1365-2958.1996.tb02525.x; Pauff JM, 2008, J BIOL CHEM, V283, P4818, DOI 10.1074/jbc.M707918200; Pauff JM, 2007, J BIOL CHEM, V282, P12785, DOI 10.1074/jbc.M700364200; Reginato AJ, 2005, HARRISONS PRINCIPLES, P2046; SPECTOR T, 1970, J BIOL CHEM, V245, P5079; Takano Y, 2005, LIFE SCI, V76, P1835, DOI 10.1016/j.lfs.2004.10.031; Truglio JJ, 2002, STRUCTURE, V10, P115, DOI 10.1016/S0969-2126(01)00697-9; Watanabe K, 1997, BIOCHEM BIOPH RES CO, V233, P447, DOI 10.1006/bbrc.1997.6479; WILLIAMS JW, 1981, BIOCHEM J, V195, P753, DOI 10.1042/bj1950753; Yamaguchi Y, 2007, J BIOCHEM, V141, P513, DOI 10.1093/jb/mvm053	30	38	38	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8759	8767		10.1074/jbc.M808114200	http://dx.doi.org/10.1074/jbc.M808114200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19109249	Green Published, hybrid			2022-12-25	WOS:000264397800060
J	Mascioni, A; Bentley, BE; Camarda, R; Dilts, DA; Fink, P; Gusarova, V; Hoiseth, SK; Jacob, J; Lin, SL; Malakian, K; McNeil, LK; Mininni, T; Moy, F; Murphy, E; Novikova, E; Sigethy, S; Wen, YX; Zlotnick, GW; Tsao, DHH				Mascioni, Alessandro; Bentley, Breagh E.; Camarda, Rosaria; Dilts, Deborah A.; Fink, Pamela; Gusarova, Viktoria; Hoiseth, Susan K.; Jacob, Jaison; Lin, Shuo L.; Malakian, Karl; McNeil, Lisa K.; Mininni, Terri; Moy, Franklin; Murphy, Ellen; Novikova, Elena; Sigethy, Scott; Wen, Yingxia; Zlotnick, Gary W.; Tsao, Desiree H. H.			Structural Basis for the Immunogenic Properties of the Meningococcal Vaccine Candidate LP2086	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR MAGNETIC-RESONANCE; B NEISSERIA-MENINGITIDIS; ALTERNATIVE CONFORMATIONS; ANTIBODY COMPLEXES; NMR-SPECTROSCOPY; CHEMICAL-SHIFT; SEROGROUP-B; PROTEIN; LIPOPROTEIN; ANTIGEN	LP2086 is a family of outer membrane lipoproteins from Neisseria meningitidis, which elicits bactericidal antibodies and are currently undergoing human clinical trials in a bivalent formulation where each antigen represents one of the two known LP2086 subfamilies. Here we report the NMR structure of the recombinant LP2086 variant B01, a representative of the LP2086 subfamily B. The structure reveals a novel fold composed of two domains: a "taco-shaped" N-terminal beta-sheet and a C-terminal beta-barrel connected by a linker. The structure in micellar solution is consistent with a model of LP2086 anchored to the outer membrane bilayer through its lipidated N terminus. A long flexible chain connects the folded part of the protein to the lipid anchor and acts as spacer, making both domains accessible to the host immune system. Antibodies broadly reactive against members from both subfamilies have been mapped to the N terminus. A surface of subfamily-defining residues was identified on one face of the protein, offering an explanation for the induction of subfamily-specific bactericidal antibodies.	[Jacob, Jaison; Malakian, Karl; Moy, Franklin; Tsao, Desiree H. H.] Wyeth Res, Struct Biol & Computat Chem, Cambridge, MA 02140 USA; [Bentley, Breagh E.; Camarda, Rosaria; Dilts, Deborah A.; Fink, Pamela; Gusarova, Viktoria; Hoiseth, Susan K.; Lin, Shuo L.; McNeil, Lisa K.; Mininni, Terri; Murphy, Ellen; Novikova, Elena; Sigethy, Scott; Zlotnick, Gary W.] Wyeth Vaccines Res, Pearl River, NY 10965 USA	Pfizer; Pfizer	Tsao, DHH (corresponding author), Wyeth Res, Struct Biol & Computat Chem, 200 Cambridge Pk Dr, Cambridge, MA 02140 USA.	dtsao@wyeth.com						BENTLEY AT, 1988, J BACTERIOL, V170, P1063, DOI 10.1128/jb.170.3.1063-1068.1988; Buck-Koehntop BA, 2005, J MOL BIOL, V354, P652, DOI 10.1016/j.jmb.2005.09.038; Cantini F, 2006, J BIOL CHEM, V281, P7220, DOI 10.1074/jbc.M508595200; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; CRESPI HL, 1968, SCIENCE, V161, P796, DOI 10.1126/science.161.3843.795; Decanniere K, 2001, J MOL BIOL, V313, P473, DOI 10.1006/jmbi.2001.5075; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2000, PYMOL; Deschamps ML, 2005, J BIOMOL NMR, V31, P155, DOI 10.1007/s10858-004-7912-6; Fletcher LD, 2004, INFECT IMMUN, V72, P2088, DOI 10.1128/IAI.72.4.2088-2100.2004; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Hilty C, 2004, CHEMBIOCHEM, V5, P467, DOI 10.1002/cbic.200300815; Hwang PM, 2002, P NATL ACAD SCI USA, V99, P13560, DOI 10.1073/pnas.212344499; Jodar L, 2002, LANCET, V359, P1499, DOI 10.1016/S0140-6736(02)08416-7; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LEX A, 1986, J IMMUNOL, V137, P2676; Li YL, 2003, BIOCHEMISTRY-US, V42, P11, DOI 10.1021/bi020589+; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; MARKLEY JL, 1968, SCIENCE, V161, P1249, DOI 10.1126/science.161.3847.1249; Masignani V, 2003, J EXP MED, V197, P789, DOI 10.1084/jem.20021911; Matsuo H, 1999, J AM CHEM SOC, V121, P9903, DOI 10.1021/ja991881g; Metzler WJ, 1996, J AM CHEM SOC, V118, P6800, DOI 10.1021/ja9604875; Morley SL, 2001, VACCINE, V20, P666, DOI 10.1016/S0264-410X(01)00410-8; Nassif X, 2000, SCIENCE, V287, P1767, DOI 10.1126/science.287.5459.1767; Nietlispach D, 2005, J BIOMOL NMR, V31, P161, DOI 10.1007/s10858-004-8195-7; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Pillai S, 2005, VACCINE, V23, P2206, DOI 10.1016/j.vaccine.2005.01.056; POOLMAN JT, 1995, INFECT AGENT DIS, V4, P13; Rosen O, 2005, BIOCHEMISTRY-US, V44, P7250, DOI 10.1021/bi047387t; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sharon M, 2003, STRUCTURE, V11, P225, DOI 10.1016/S0969-2126(03)00011-X; Sundberg EJ, 2003, ADV PROTEIN CHEM, V61, P119; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; Walters KJ, 1999, P NATL ACAD SCI USA, V96, P7877, DOI 10.1073/pnas.96.14.7877; WUTHRICH K, 1983, J MOL BIOL, V169, P949, DOI 10.1016/S0022-2836(83)80144-2; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhu DZ, 2006, VACCINE, V24, P5420, DOI 10.1016/j.vaccine.2006.03.051; Zhu DZ, 2005, INFECT IMMUN, V73, P6838, DOI 10.1128/IAI.73.10.6838-6845.2005	39	62	92	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8729	8737		10.1074/jbc.M808831200	http://dx.doi.org/10.1074/jbc.M808831200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19103601	Green Published, hybrid			2022-12-25	WOS:000264397800057
J	Yamnik, RL; Digilova, A; Davis, DC; Brodt, ZN; Murphy, CJ; Holz, MK				Yamnik, Rachel L.; Digilova, Alla; Davis, Daphne C.; Brodt, Z. Nilly; Murphy, Christopher J.; Holz, Marina K.			S6 Kinase 1 Regulates Estrogen Receptor alpha in Control of Breast Cancer Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN TARGET; CYCLE PROGRESSION; 17Q23 AMPLICON; MTOR; PROTEIN; PHOSPHORYLATION; GROWTH; TRANSLATION; LYMPHANGIOLEIOMYOMATOSIS; IDENTIFICATION	The 40 S ribosomal S6 kinase 1 (S6K1) acts downstream of mTOR (mammalian target of rapamycin) and is sensitive to inhibition by rapamycin. The chromosomal region 17q23 containing the RPS6KB1 gene is frequently amplified in breast cancer cells, leading to S6K1 overexpression. The role of S6K1 in disease development and progression is supported by the observation that S6K1 overexpression is associated with poor prognosis in breast cancer patients. However, the identity of mammary cell-specific S6K1 targets is not well understood. In this study, we report that overexpression of S6K1 endows breast cancer cells with a proliferative advantage in low serum conditions and enhanced sensitivity to rapamycin. We investigate the molecular mechanism behind this observation to show that S6K1 regulates estrogen receptor alpha (ER alpha) by phosphorylating it on serine 167, leading to transcriptional activation of ER alpha. By contributing to the activation of ER alpha, S6K1 promotes ER alpha-mediated cell proliferation and may be a target of therapeutic intervention in breast cancer.	[Yamnik, Rachel L.; Digilova, Alla; Davis, Daphne C.; Brodt, Z. Nilly; Murphy, Christopher J.; Holz, Marina K.] Yeshiva Univ, Stern Coll Women, Dept Biol, New York, NY 10016 USA; [Holz, Marina K.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	Yeshiva University; Yeshiva University; Albert Einstein College of Medicine	Holz, MK (corresponding author), Yeshiva Univ, Stern Coll Women, Dept Biol, 245 Lexington Ave, New York, NY 10016 USA.	mholz@yu.edu			Atol Charitable Trust; Yeshiva University graduate research fellowship; S. Daniel Abraham Honors Program	Atol Charitable Trust; Yeshiva University graduate research fellowship; S. Daniel Abraham Honors Program	This work was supported by a grant from the Atol Charitable Trust (to M. K. H.), a Yeshiva University graduate research fellowship (to R. L.Y.), and the S. Daniel Abraham Honors Program (to A. D. and Z.N.B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barlund M, 2000, J NATL CANCER I, V92, P1252, DOI 10.1093/jnci/92.15.1252; BORENFREUND E, 1990, IN VITRO CELL DEV B, V26, P1030; Boulay A, 2005, CLIN CANCER RES, V11, P5319, DOI 10.1158/1078-0432.CCR-04-2402; Brugge J, 2007, CANCER CELL, V12, P104, DOI 10.1016/j.ccr.2007.07.014; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; CHEATHAM L, 1995, P NATL ACAD SCI USA, V92, P11696, DOI 10.1073/pnas.92.25.11696; Chorianopoulos D, 2008, LUNG, V186, P197, DOI 10.1007/s00408-008-9087-5; Cohen EEW, 2008, J CLIN ONCOL, V26, P348, DOI 10.1200/JCO.2007.14.3164; Couch FJ, 1999, CANCER RES, V59, P1408; DeGraffenried LA, 2004, CLIN CANCER RES, V10, P8059, DOI 10.1158/1078-0432.CCR-04-0035; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hohman DW, 2008, EUR J INTERN MED, V19, P319, DOI 10.1016/j.ejim.2007.10.015; Holz MK, 2005, J BIOL CHEM, V280, P26089, DOI 10.1074/jbc.M504045200; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; JENO P, 1988, P NATL ACAD SCI USA, V85, P406, DOI 10.1073/pnas.85.2.406; Joel PB, 1998, MOL CELL BIOL, V18, P1978, DOI 10.1128/MCB.18.4.1978; Johnston SRD, 2005, CLIN CANCER RES, V11, p889S; Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031; Monni O, 2001, P NATL ACAD SCI USA, V98, P5711, DOI 10.1073/pnas.091582298; Nicholson RI, 1999, ENDOCR-RELAT CANCER, V6, P373, DOI 10.1677/erc.0.0060373; Noh WC, 2004, CLIN CANCER RES, V10, P1013, DOI 10.1158/1078-0432.CCR-03-0043; Raught B, 2004, EMBO J, V23, P1761, DOI 10.1038/sj.emboj.7600193; Richardson CJ, 2004, CURR BIOL, V14, P1540, DOI 10.1016/j.cub.2004.08.061; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Schalm SS, 2005, J BIOL CHEM, V280, P11101, DOI 10.1074/jbc.M413995200; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Sehgal SN, 2003, TRANSPLANT P, V35, p7S, DOI 10.1016/S0041-1345(03)00211-2; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; Sinclair CS, 2003, BREAST CANCER RES TR, V78, P313, DOI 10.1023/A:1023081624133; van der Hage JA, 2004, BRIT J CANCER, V90, P1543, DOI 10.1038/sj.bjc.6601741; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370; Wu GJ, 2000, CANCER RES, V60, P5371; Zhang HH, 2006, MOL CELL, V24, P185, DOI 10.1016/j.molcel.2006.09.019	38	186	190	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6361	6369		10.1074/jbc.M807532200	http://dx.doi.org/10.1074/jbc.M807532200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19112174	hybrid			2022-12-25	WOS:000263742700039
J	Gubern, A; Barcelo-Torns, M; Casas, J; Barneda, D; Masgrau, R; Picatoste, F; Balsinde, J; Balboa, MA; Claro, E				Gubern, Albert; Barcelo-Torns, Miquel; Casas, Javier; Barneda, David; Masgrau, Roser; Picatoste, Fernando; Balsinde, Jesus; Balboa, Maria A.; Claro, Enrique			Lipid Droplet Biogenesis Induced by Stress Involves Triacylglycerol Synthesis That Depends on Group VIA Phospholipase A(2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID RELEASE; ENDOPLASMIC-RETICULUM STRESS; CELL-DEATH; PHOSPHATIDATE PHOSPHOHYDROLASE; INHIBITION; APOPTOSIS; PHOSPHATIDYLCHOLINE; ACCUMULATION; MECHANISM; PROTECTS	This work investigates the metabolic origin of triacylglycerol (TAG) formed during lipid droplet (LD) biogenesis induced by stress. Cytotoxic inhibitors of fatty acid synthase induced TAG synthesis and LD biogenesis in CHO-K1 cells, in the absence of external sources of fatty acids. TAG synthesis was required for LD biogenesis and was sensitive to inhibition and down-regulation of the expression of group VIA phospholipase A(2) (iPLA(2)-VIA). Induction of stress with acidic pH, C-2-ceramide, tunicamycin, or deprivation of glucose also stimulated TAG synthesis and LD formation in a manner dependent on iPLA(2)-VIA. Overexpression of the enzyme enhanced TAG synthesis from endogenous fatty acids and LD occurrence. During stress, LD biogenesis but not TAG synthesis required phosphorylation and activation of group IVA PLA(2) (cPLA(2)alpha). The results demonstrate that iPLA(2)-VIA provides fatty acids for TAG synthesis while cPLA(2)alpha allows LD biogenesis. LD biogenesis during stress may be a survival strategy, recycling structural phospholipids into energy-generating substrates.	[Gubern, Albert; Barcelo-Torns, Miquel; Barneda, David; Masgrau, Roser; Picatoste, Fernando; Claro, Enrique] Univ Autonoma Barcelona, Inst Neurosci, E-08193 Barcelona, Spain; [Gubern, Albert; Barcelo-Torns, Miquel; Barneda, David; Masgrau, Roser; Picatoste, Fernando; Claro, Enrique] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain; [Casas, Javier; Balsinde, Jesus; Balboa, Maria A.] CSIC, Inst Biol & Genet Mol, E-47003 Valladolid, Spain; [Casas, Javier; Balsinde, Jesus; Balboa, Maria A.] Ctr Invest Biomed Red Diabet & Enfermedades Metab, E-47003 Valladolid, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM	Claro, E (corresponding author), Univ Autonoma Barcelona, Inst Neurosci, Edifici M2,Campus UAB, E-08193 Barcelona, Spain.	enrique.claro@uab.es	Claro, Enrique/D-5612-2009; Masgrau, Roser/D-3047-2011; Balboa, María A./V-9493-2018; Gubern, Albert/C-9902-2011; Casas, Javier/K-7190-2015; Balsinde, Jesús/C-7833-2018	Claro, Enrique/0000-0002-7592-7906; Masgrau, Roser/0000-0002-6722-5939; Balboa, María A./0000-0002-2130-5298; Gubern, Albert/0000-0001-6458-1498; Casas, Javier/0000-0002-6413-8127; Balsinde, Jesús/0000-0002-4157-6714; Barneda, David/0000-0002-4436-4100	Spanish Ministry of Education and Science [SAF 2004-01698, SAF 2007-60055, BFU 2007-67154/BMC]; Spanish Ministry of Health	Spanish Ministry of Education and Science(Spanish Government); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government)	This work was supported in part by Grants SAF 2004-01698, SAF 2007-60055, and BFU 2007-67154/BMC from the Spanish Ministry of Education and Science and PI03/0528 from the Spanish Ministry of Health. The Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas is an initiative of the Instituto de Salud Carlos III.	Aki T, 2003, ONCOGENE, V22, P8529, DOI 10.1038/sj.onc.1207197; Al-Saffar NMS, 2002, BRIT J CANCER, V86, P963, DOI 10.1038/sj/bjc/6600188; Atsumi G, 2000, J BIOL CHEM, V275, P18248, DOI 10.1074/jbc.M000271200; Atsumi G, 1998, J BIOL CHEM, V273, P13870, DOI 10.1074/jbc.273.22.13870; Baburina I, 1999, J BIOL CHEM, V274, P9400, DOI 10.1074/jbc.274.14.9400; Baburina I, 1998, J BIOL CHEM, V273, P2169, DOI 10.1074/jbc.273.4.2169; Balboa MA, 1998, J BIOL CHEM, V273, P7684, DOI 10.1074/jbc.273.13.7684; Balsinde J, 2005, CELL SIGNAL, V17, P1052, DOI 10.1016/j.cellsig.2005.03.002; Balsinde J, 1996, J BIOL CHEM, V271, P31937, DOI 10.1074/jbc.271.50.31937; Balsinde J, 1997, J BIOL CHEM, V272, P29317, DOI 10.1074/jbc.272.46.29317; Balsinde J, 2006, BBA-MOL CELL BIOL L, V1761, P1344, DOI 10.1016/j.bbalip.2006.07.013; Barba I, 1999, CANCER RES, V59, P1861; Barba I, 2001, NMR BIOMED, V14, P33, DOI 10.1002/nbm.688; Barbour SE, 1999, BBA-MOL CELL BIOL L, V1439, P77, DOI 10.1016/S1388-1981(99)00078-5; BLEASDALE JE, 1990, J PHARMACOL EXP THER, V255, P756; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boggs K, 1998, BBA-LIPID LIPID MET, V1389, P1, DOI 10.1016/S0005-2760(97)00145-8; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Casas J, 2006, J BIOL CHEM, V281, P6106, DOI 10.1074/jbc.M505230200; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Cui Z, 2002, BBA-MOL CELL BIOL L, V1585, P87, DOI 10.1016/S1388-1981(02)00328-1; Dricu A, 1997, CANCER RES, V57, P543; Du L, 2009, J BIOL CHEM, V284, P2383, DOI 10.1074/jbc.M804396200; Ducharme NA, 2008, ENDOCRINOLOGY, V149, P942, DOI 10.1210/en.2007-1713; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Finn PF, 2006, NUTRITION, V22, P830, DOI 10.1016/j.nut.2006.04.008; Fuentes L, 2003, J BIOL CHEM, V278, P44683, DOI 10.1074/jbc.M307209200; Gubern A, 2008, J BIOL CHEM, V283, P27369, DOI 10.1074/jbc.M800696200; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Iorio E, 2003, BBA-MOL CELL BIOL L, V1634, P1, DOI 10.1016/j.bbalip.2003.07.001; Jackowski S, 2000, BBA-MOL CELL BIOL L, V1483, P301, DOI 10.1016/S1388-1981(99)00203-6; Jenkins CM, 2002, J BIOL CHEM, V277, P32807, DOI 10.1074/jbc.M202568200; Kim SJ, 2002, J EXP MED, V196, P655, DOI 10.1084/jem.20020542; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Mancuso DJ, 2007, J BIOL CHEM, V282, P9216, DOI 10.1074/jbc.M607307200; Manguikian AD, 2004, J BIOL CHEM, V279, P52881, DOI 10.1074/jbc.M410659200; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; Okoshi R, 2008, J BIOL CHEM, V283, P3979, DOI 10.1074/jbc.M705232200; Perez R, 2006, J IMMUNOL, V176, P2555, DOI 10.4049/jimmunol.176.4.2555; Perez R, 2004, J BIOL CHEM, V279, P40385, DOI 10.1074/jbc.M402562200; Ramos B, 2003, MOL PHARMACOL, V64, P502, DOI 10.1124/mol.64.2.502; Ramos B, 2002, MOL PHARMACOL, V62, P1068, DOI 10.1124/mol.62.5.1068; Seleznev K, 2006, J BIOL CHEM, V281, P22275, DOI 10.1074/jbc.M604330200; Servitja JM, 1999, J NEUROCHEM, V72, P1441, DOI 10.1046/j.1471-4159.1999.721441.x; Tang J, 1997, J BIOL CHEM, V272, P8567, DOI 10.1074/jbc.272.13.8567; Unger RH, 2002, BBA-MOL CELL BIOL L, V1585, P202, DOI 10.1016/S1388-1981(02)00342-6; Winstead MV, 2000, BBA-MOL CELL BIOL L, V1488, P28, DOI 10.1016/S1388-1981(00)00107-4; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040; Zhang XH, 2006, J CELL SCI, V119, P1005, DOI 10.1242/jcs.02821	55	67	67	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5697	5708		10.1074/jbc.M806173200	http://dx.doi.org/10.1074/jbc.M806173200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19117952	hybrid, Green Published			2022-12-25	WOS:000263560600033
J	Lowry, JA; Gamsjaeger, R; Thong, SY; Hung, W; Kwan, AH; Broitman-Maduro, G; Matthews, JM; Maduro, M; Mackay, JP				Lowry, Jason A.; Gamsjaeger, Roland; Thong, Sock Yue; Hung, Wendy; Kwan, Ann H.; Broitman-Maduro, Gina; Matthews, Jacqueline M.; Maduro, Morris; Mackay, Joel P.			Structural Analysis of MED-1 Reveals Unexpected Diversity in the Mechanism of DNA Recognition by GATA- type Zinc Finger Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-1; BINDING DOMAIN; PROTEIN SECONDARY; DEVELOPING HEART; J-COUPLINGS; FAMILY; PREDICTION; COMPLEX; SPECIFICITY; MESENDODERM	MED-1 is a member of a group of divergent GATA-type zinc finger proteins recently identified in several species of Caenorhabditis. The med genes are transcriptional regulators that are involved in the specification of the mesoderm and endoderm precursor cells in nematodes. Unlike other GATA-type zinc fingers that recognize the consensus sequence (A/C/ T) GATA (A/G), the MED-1 zinc finger (MED1zf) binds the larger and atypical site GTATACT(T/C)(3). We have examined the basis for this unusual DNA specificity using a range of biochemical and biophysical approaches. Most strikingly, we show that although the core of the MED1zf structure is similar to that of GATA-1, the basic tail C-terminal to the zinc finger unexpectedly adopts an alpha-helical structure upon binding DNA. This additional helix appears to contact the major groove of the DNA, making contacts that explain the extended DNA consensus sequence observed for MED1zf. Our data expand the versatility of DNA recognition by GATA-type zinc fingers and perhaps shed new light on the DNA-binding properties of mammalian GATA factors.	[Lowry, Jason A.; Gamsjaeger, Roland; Thong, Sock Yue; Kwan, Ann H.; Matthews, Jacqueline M.; Mackay, Joel P.] Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia; [Hung, Wendy; Broitman-Maduro, Gina; Maduro, Morris] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA	University of Sydney; University of California System; University of California Riverside	Mackay, JP (corresponding author), Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia.	j.mackay@usyd.edu.au	Mackay, Joel P/D-6834-2011; Matthews, Jacqueline/A-7322-2013	Mackay, Joel P/0000-0001-7508-8033; Kwan, Ann/0000-0002-1506-2226; Matthews, Jacqueline/0000-0001-8518-3472; Broitman-Maduro, Gina/0000-0002-8059-8246; Gamsjaeger, Roland/0000-0003-1095-2569	Australian National Health and Medical Research Council	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a program grant and a senior research fellowship (to J.P.M.) from the Australian National Health and Medical Research Council.	ARCECI RJ, 1993, MOL CELL BIOL, V13, P2235, DOI 10.1128/MCB.13.4.2235; Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756; Bates DL, 2008, J MOL BIOL, V381, P1292, DOI 10.1016/j.jmb.2008.06.072; BAX A, 1994, METHOD ENZYMOL, V239, P79; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; Broitman-Maduro G, 2005, DEV CELL, V8, P427, DOI 10.1016/j.devcel.2005.01.014; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cai ML, 1998, J BIOMOL NMR, V11, P97, DOI 10.1023/A:1008222131470; Cordier F, 1999, J BIOMOL NMR, V13, P175, DOI 10.1023/A:1008301415843; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Coroian C, 2006, DEV BIOL, V289, P444, DOI 10.1016/j.ydbio.2005.10.024; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Deane JE, 2003, EMBO J, V22, P2224, DOI 10.1093/emboj/cdg196; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; EVANS T, 1989, CELL, V58, P877, DOI 10.1016/0092-8674(89)90940-9; FENG B, 1993, NUCLEIC ACIDS RES, V21, P3989, DOI 10.1093/nar/21.17.3989; Gamsjaeger R, 2008, J BIOL CHEM, V283, P5158, DOI 10.1074/jbc.M703772200; Ghirlando R, 2003, J BIOL CHEM, V278, P45620, DOI 10.1074/jbc.M306410200; Goddard T. D., 2006, SPARKY 3; Hung HL, 1999, MOL CELL BIOL, V19, P3496; Kamphuis MB, 2006, J MOL BIOL, V357, P115, DOI 10.1016/j.jmb.2005.12.033; KELLEY C, 1993, DEVELOPMENT, V118, P817; KO LJ, 1993, MOL CELL BIOL, V13, P4011, DOI 10.1128/MCB.13.7.4011; KUDLA B, 1990, EMBO J, V9, P1355, DOI 10.1002/j.1460-2075.1990.tb08250.x; LAVERRIERE AC, 1994, J BIOL CHEM, V269, P23177; Lejeune D, 2005, PROTEINS, V61, P258, DOI 10.1002/prot.20607; Liew CK, 2005, P NATL ACAD SCI USA, V102, P583, DOI 10.1073/pnas.0407511102; Liew CK, 2000, STRUCTURE, V8, P1157, DOI 10.1016/S0969-2126(00)00527-X; Lowry JA, 2000, J MOL EVOL, V50, P103, DOI 10.1007/s002399910012; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Manfield IW, 2000, BBA-GENE STRUCT EXPR, V1493, P325, DOI 10.1016/S0167-4781(00)00197-4; Meiler J, 2003, P NATL ACAD SCI USA, V100, P12105, DOI 10.1073/pnas.1831973100; MERIKA M, 1993, MOL CELL BIOL, V13, P3999, DOI 10.1128/MCB.13.7.3999; OMICHINSKI JG, 1993, P NATL ACAD SCI USA, V90, P1676, DOI 10.1073/pnas.90.5.1676; OMICHINSKI JG, 1993, SCIENCE, V261, P438, DOI 10.1126/science.8332909; Page BD, 1997, GENE DEV, V11, P1651, DOI 10.1101/gad.11.13.1651; Pollastri G, 2005, BIOINFORMATICS, V21, P1719, DOI 10.1093/bioinformatics/bti203; Starich MR, 1998, J MOL BIOL, V277, P605, DOI 10.1006/jmbi.1998.1625; Teakle GR, 1998, TRENDS BIOCHEM SCI, V23, P100, DOI 10.1016/S0968-0004(98)01174-8; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; Wuthrich K, 1986, NMR PROTEINS NUCL AC; YAMAMOTO M, 1990, GENE DEV, V4, P1650, DOI 10.1101/gad.4.10.1650; Zweckstetter M, 2004, BIOPHYS J, V86, P3444, DOI 10.1529/biophysj.103.035790	43	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5827	5835		10.1074/jbc.M808712200	http://dx.doi.org/10.1074/jbc.M808712200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19095651	hybrid			2022-12-25	WOS:000263560600046
J	Sako, K; Fukuhara, S; Minami, T; Hamakubo, T; Song, HH; Kodama, T; Fukamizu, A; Gutkind, JS; Koh, GY; Mochizuki, N				Sako, Keisuke; Fukuhara, Shigetomo; Minami, Takashi; Hamakubo, Takao; Song, Haihua; Kodama, Tatsuhiko; Fukamizu, Akiyoshi; Gutkind, J. Silvio; Koh, Gou Young; Mochizuki, Naoki			Angiopoietin-1 Induces Kruppel-like Factor 2 Expression through a Phosphoinositide 3-Kinase/AKT-dependent Activation of Myocyte Enhancer Factor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; TRANSCRIPTION FACTOR MEF2C; CELL-CELL CONTACT; C-JUN PROMOTER; GENE-EXPRESSION; MUSCLE DIFFERENTIATION; INDEPENDENT PATHWAY; ENDOTHELIAL-CELLS; SIGNALING PATHWAY; ADULT VASCULATURE	Angiopoietin-1 (Ang1) regulates both vascular quiescence and angiogenesis through the receptor tyrosine kinase Tie2. We and another group have recently shown that Ang1 and Tie2 form distinct signaling complexes at cell-cell and cell-matrix contacts and further demonstrated that the former selectively induces expression of Kruppel-like factor 2 (KLF2), a transcription factor involved in vascular quiescence. Here, we investigated the mechanism of how Ang1/Tie2 signal induces KLF2 expression to clarify the role of KLF2 in Ang1/Tie2 signal-mediated vascular quiescence. Ang1 stimulated KLF2 promoter driven reporter gene expression in endothelial cells, whereas it failed when a myocyte enhancer factor 2 (MEF2)-binding site of KLF2 promoter was mutated. Depletion of MEF2 by siRNAs abolished Ang1-induced KLF2 expression, indicating the requirement of MEF2 in KLF2 induction by Ang1. Constitutive active phosphoinositide 3-kinase (PI3K)and AKT increased the MEF2-dependent reporter gene expression by enhancing its transcriptional activity and stimulated the KLF2 promoter activity cooperatively with MEF2. Consistently, inhibition of either PI3K or AKT and depletion of AKT abrogated Ang1-induced KLF2 expression. In addition, we confirmed the dispensability of extracellular signal-regulated kinase 5 (ERK5) for Ang1-induced KLF2 expression. Furthermore, depletion of KLF2 resulted in the loss of the inhibitory effect of Ang1 on vascular endothelial growth factor (VEGF)-mediated expression of vascular cell adhesion molecule-1 in endothelial cells and VEGF-mediated monocyte adhesion to endothelial cells. Collectively, these findings indicate that Ang1/Tie2 signal stimulates transcriptional activity of MEF2 through a PI3K/AKT pathway to induce KLF2 expression, which may counteract VEGF-mediated inflammatory responses.	[Sako, Keisuke; Fukuhara, Shigetomo; Mochizuki, Naoki] Natl Cardiovasc Ctr, Res Inst, Dept Struct Anal, Osaka 5658565, Japan; [Minami, Takashi; Hamakubo, Takao; Song, Haihua; Kodama, Tatsuhiko] Univ Tokyo, Adv Sci & Technol Res Ctr, Lab Syst Biol & Med, Meguro Ku, Tokyo 1538904, Japan; [Fukamizu, Akiyoshi] Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058577, Japan; [Gutkind, J. Silvio] NIDCR, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA; [Koh, Gou Young] Korea Adv Inst Sci & Technol, Biomed Res Ctr, Taejon 305701, South Korea; [Koh, Gou Young] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea	National Cerebral & Cardiovascular Center - Japan; University of Tokyo; University of Tsukuba; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Fukuhara, S (corresponding author), Natl Cardiovasc Ctr, Res Inst, Dept Struct Anal, 5-7-1 Fujishirodai, Osaka 5658565, Japan.	fuku@ri.ncvc.go.jp	Gutkind, J. Silvio/A-1053-2009; Gutkind, J. Silvio/J-1201-2016; fukamizu, akiyoshi/J-5350-2012; Koh, Gou Young/C-1615-2011	Gutkind, J. Silvio/0000-0002-5150-4482; fukamizu, akiyoshi/0000-0002-8786-6020; sako, keisuke/0000-0002-6453-8075	Ministry of Education, Science, Sports and Culture of Japan; Ministry of Health, Labour, and Welfare of Japan; Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation; Naito Foundation; Takeda Science Foundation; Sagawa Foundation for Promotion of Cancer Research; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kowa Life Science Foundation; Kanae Foundation for the Promotion of Medical Science; Takeda Medical Research Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000551] Funding Source: NIH RePORTER	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Naito Foundation(Naito Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Sagawa Foundation for Promotion of Cancer Research; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kowa Life Science Foundation; Kanae Foundation for the Promotion of Medical Science; Takeda Medical Research Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grants from the Ministry of Education, Science, Sports and Culture of Japan ( to K. S., S. F., and N. M.); the Ministry of Health, Labour, and Welfare of Japan ( to N. M.); and the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation ( to S. F., T. M., T. K., and N. M.); the Naito Foundation ( to S. F.); Takeda Science Foundation ( to S. F.); the Sagawa Foundation for Promotion of Cancer Research ( to S. F.), Mochida Memorial Foundation for Medical and Pharmaceutical Research ( to S. F.), Kowa Life Science Foundation ( to S. F.), Kanae Foundation for the Promotion of Medical Science ( to S. F.), and Takeda Medical Research Foundation ( to N. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Asahara T, 1998, CIRC RES, V83, P233, DOI 10.1161/01.RES.83.3.233; Atkins GB, 2007, CIRC RES, V100, P1686, DOI 10.1161/01.RES.0000267856.00713.0a; Bhattacharya R, 2005, J BIOL CHEM, V280, P28848, DOI 10.1074/jbc.C500200200; Bi WZ, 1999, DEV BIOL, V211, P255, DOI 10.1006/dbio.1999.9307; Brindle NPJ, 2006, CIRC RES, V98, P1014, DOI 10.1161/01.RES.0000218275.54089.12; Cho CH, 2004, P NATL ACAD SCI USA, V101, P5547, DOI 10.1073/pnas.0307574101; Coso OA, 1997, J BIOL CHEM, V272, P20691, DOI 10.1074/jbc.272.33.20691; Dekker RJ, 2002, BLOOD, V100, P1689, DOI 10.1182/blood-2002-01-0046; Dekker RJ, 2005, AM J PATHOL, V167, P609, DOI 10.1016/S0002-9440(10)63002-7; Dekker RJ, 2006, BLOOD, V107, P4354, DOI 10.1182/blood-2005-08-3465; Deng Y, 2007, AM J PHYSIOL-CELL PH, V293, pC1404, DOI 10.1152/ajpcell.00058.2007; DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897; Eklund L, 2006, EXP CELL RES, V312, P630, DOI 10.1016/j.yexcr.2005.09.002; Fukuhara S, 2000, J BIOL CHEM, V275, P21730, DOI 10.1074/jbc.M002410200; Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; Gamble JR, 2000, CIRC RES, V87, P603, DOI 10.1161/01.RES.87.7.603; Gavard J, 2008, DEV CELL, V14, P25, DOI 10.1016/j.devcel.2007.10.019; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Hayashi M, 2004, J CLIN INVEST, V113, P1138, DOI 10.1172/JCI200419890; Huddleson JP, 2005, J BIOL CHEM, V280, P23371, DOI 10.1074/jbc.M413839200; Huddleson JP, 2004, BIOL CHEM, V385, P723, DOI 10.1515/BC.2004.088; Kato Y, 2000, J BIOL CHEM, V275, P18534, DOI 10.1074/jbc.M001573200; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kim I, 2001, J BIOL CHEM, V276, P7614, DOI 10.1074/jbc.M009705200; Kumar A, 2005, MOL CELL BIOL, V25, P5893, DOI 10.1128/MCB.25.14.5893-5903.2005; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; Lee JS, 2006, DEV CELL, V11, P845, DOI 10.1016/j.devcel.2006.09.006; Lin PN, 1997, J CLIN INVEST, V100, P2072, DOI 10.1172/JCI119740; Lin ZY, 2006, ARTERIOSCL THROM VAS, V26, P1185, DOI 10.1161/01.ATV.0000215638.53414.99; Ma KW, 2005, MOL CELL BIOL, V25, P3575, DOI 10.1128/MCB.25.9.3575-3582.2005; Marinissen MJ, 1999, MOL CELL BIOL, V19, P4289; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2002, CURR OPIN CELL BIOL, V14, P763, DOI 10.1016/S0955-0674(02)00389-7; Murga C, 2000, J BIOL CHEM, V275, P12069, DOI 10.1074/jbc.275.16.12069; Olson EN, 2004, J CLIN INVEST, V113, P1110, DOI 10.1172/JCI200421497; Parmar KM, 2006, J CLIN INVEST, V116, P49, DOI 10.1172/JCI24787; Peters KG, 2004, RECENT PROG HORM RES, V59, P51, DOI 10.1210/rp.59.1.51; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Saharinen P, 2008, NAT CELL BIOL, V10, P527, DOI 10.1038/ncb1715; Sakurai A, 2006, MOL BIOL CELL, V17, P966, DOI 10.1091/mbc.E05-07-0647; Sartorelli V, 1997, MOL CELL BIOL, V17, P1010, DOI 10.1128/MCB.17.2.1010; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Sen-Banerjee S, 2005, CIRCULATION, V112, P720, DOI 10.1161/CIRCULATIONAHA.104.525774; SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132; Serra C, 2007, MOL CELL, V28, P200, DOI 10.1016/j.molcel.2007.08.021; Sohn SJ, 2005, MOL CELL BIOL, V25, P8553, DOI 10.1128/MCB.25.19.8553-8566.2005; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Wang LJ, 2003, SCIENCE, V302, P1578, DOI 10.1126/science.1088477; Wong AL, 1997, CIRC RES, V81, P567, DOI 10.1161/01.RES.81.4.567; Wu JH, 2008, J BIOL CHEM, V283, P3942, DOI 10.1074/jbc.M707882200; Xu Q, 2000, J BIOL CHEM, V275, P36750, DOI 10.1074/jbc.M005030200	55	57	63	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5592	5601		10.1074/jbc.M806928200	http://dx.doi.org/10.1074/jbc.M806928200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19106103	hybrid			2022-12-25	WOS:000263560600022
J	Cullen, SP; Afonina, IS; Donadini, R; Luthi, AU; Medema, JP; Bird, PI; Martin, SJ				Cullen, Sean P.; Afonina, Inna S.; Donadini, Roberta; Luethi, Alexander U.; Medema, Jan Paul; Bird, Phillip I.; Martin, Seamus J.			Nucleophosmin Is Cleaved and Inactivated by the Cytotoxic Granule Protease Granzyme M during Natural Killer Cell-mediated Killing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOLAR PHOSPHOPROTEIN B23; ACUTE MYELOGENOUS LEUKEMIA; CYTOCHROME-C RELEASE; MONOCLONAL-ANTIBODY; RIBOSOME BIOGENESIS; SERINE-PROTEASE; ACTIVATION; APOPTOSIS; CYTOMEGALOVIRUS; EXPRESSION	Natural killer (NK) cells kill virus-infected or transformed target cells by delivering cytotoxic proteases called granzymes to the target cell cytosol. One of these proteases, granzyme M, is specifically expressed in NK cells and is thought to instigate a form of cell death distinct from that mediated by granzyme A or granzyme B. However, the mechanism of granzyme M-induced cell death is unclear at present, and few substrates for this granzyme have been reported to date. Here we show that the abundant nucleolar phosphoprotein, nucleophosmin (NPM), is cleaved and inactivated by granzyme M. NPMis essential for cell viability as RNA interference-mediated ablation of NPM expression in human cells resulted in spontaneous apoptosis. Significantly, overexpression of wild-type NPM rescued cells treated with NPM small interference RNA, whereas overexpression of the granzyme M-cleaved form of NPM did not. Because NPMis essential for cell viability, these data suggest that targeting of NPM by granzyme M may contribute to tumor cell eradication by abolishing NPM function.	[Cullen, Sean P.; Afonina, Inna S.; Luethi, Alexander U.; Martin, Seamus J.] Trinity Coll Dublin, Smurfit Inst, Dept Genet, Mol Cell Biol Lab, Dublin 2, Ireland; [Donadini, Roberta; Bird, Phillip I.] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3800, Australia; [Medema, Jan Paul] Acad Med Ctr, Ctr Expt Mol Med, Lab Expt Oncol & Radiobiol, NL-11005 AZ Amsterdam, Netherlands	Trinity College Dublin; Monash University	Martin, SJ (corresponding author), Trinity Coll Dublin, Smurfit Inst, Dept Genet, Mol Cell Biol Lab, Dublin 2, Ireland.	martinsj@tcd.ie	Afonina, Inna/AAM-8978-2020; Lüthi, Alexander U/B-4398-2009	Afonina, Inna/0000-0001-8894-5305; Martin, Seamus/0000-0002-8539-3143; Medema, Jan Paul/0000-0003-3045-2924; Bird, Phillip/0000-0002-6695-606X	Science Foundation Ireland [PI/B038]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported in part by Science Foundation Ireland Grant PI/B038. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Adrain C, 2005, J BIOL CHEM, V280, P4663, DOI 10.1074/jbc.M410915200; Alimonti JB, 2001, J BIOL CHEM, V276, P6974, DOI 10.1074/jbc.M008444200; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Beresford PJ, 1999, IMMUNITY, V10, P585, DOI 10.1016/S1074-7613(00)80058-8; BIRON CA, 1989, NEW ENGL J MED, V320, P1731, DOI 10.1056/NEJM198906293202605; Boon K, 2001, EMBO J, V20, P1383, DOI 10.1093/emboj/20.6.1383; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; Cazzaniga G, 2005, BLOOD, V106, P1419, DOI 10.1182/blood-2005-03-0899; Colombo E, 2005, MOL CELL BIOL, V25, P8874, DOI 10.1128/MCB.25.20.8874-8886.2005; Cullen SP, 2008, CELL DEATH DIFFER, V15, P251, DOI 10.1038/sj.cdd.4402244; Cullen SP, 2007, J CELL BIOL, V176, P435, DOI 10.1083/jcb.200612025; Daniels KA, 2001, J EXP MED, V194, P29, DOI 10.1084/jem.194.1.29; DARMON AJ, 1995, NATURE, V377, P446, DOI 10.1038/377446a0; Dergunova NN, 2002, IMMUNOL LETT, V83, P67, DOI 10.1016/S0165-2478(02)00085-8; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Fan ZS, 2003, NAT IMMUNOL, V4, P145, DOI 10.1038/ni885; Grimwade D, 2000, BLOOD, V96, P1297; Grisendi S, 2005, NATURE, V437, P147, DOI 10.1038/nature03915; Grossman WJ, 2003, CURR OPIN IMMUNOL, V15, P544, DOI 10.1016/S0952-7915(03)00099-2; Gubin AN, 1999, GENOMICS, V59, P168, DOI 10.1006/geno.1999.5855; Heibein JA, 2000, J EXP MED, V192, P1391, DOI 10.1084/jem.192.10.1391; Hill MM, 2004, EMBO J, V23, P2134, DOI 10.1038/sj.emboj.7600210; Hua GQ, 2007, J BIOL CHEM, V282, P20553, DOI 10.1074/jbc.M703196200; Huang WH, 2001, J BIOL CHEM, V276, P25166, DOI 10.1074/jbc.M010087200; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Kelly JM, 2004, J BIOL CHEM, V279, P22236, DOI 10.1074/jbc.M401670200; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Kim S, 2000, P NATL ACAD SCI USA, V97, P2731, DOI 10.1073/pnas.050588297; Lee SH, 2001, NAT GENET, V28, P42, DOI 10.1038/ng0501-42; Li J, 2004, J BIOL CHEM, V279, P41275, DOI 10.1074/jbc.C400297200; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Li YP, 1997, J VIROL, V71, P4098, DOI 10.1128/JVI.71.5.4098-4102.1997; Lieberman J, 2003, CURR OPIN IMMUNOL, V15, P553, DOI 10.1016/S0952-7915(03)00108-0; Lu HX, 2006, J IMMUNOL, V177, P1171, DOI 10.4049/jimmunol.177.2.1171; Mahrus S, 2004, J BIOL CHEM, V279, P54275, DOI 10.1074/jbc.M411482200; Mai RT, 2006, ONCOGENE, V25, P448, DOI 10.1038/sj.onc.1209052; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Martin SJ, 1996, EMBO J, V15, P2407, DOI 10.1002/j.1460-2075.1996.tb00598.x; Medema JP, 1997, EUR J IMMUNOL, V27, P3492, DOI 10.1002/eji.1830271250; Moretta A, 2008, CELL DEATH DIFFER, V15, P226, DOI 10.1038/sj.cdd.4402170; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Nozawa Y, 1996, J PATHOL, V178, P48; Okuda M, 2002, ONCOGENE, V21, P6170, DOI 10.1038/sj.onc.1205708; Okuwaki M, 2001, J MOL BIOL, V311, P41, DOI 10.1006/jmbi.2001.4812; OLSON MOJ, 1986, BIOCHEMISTRY-US, V25, P484, DOI 10.1021/bi00350a031; Pao LI, 2005, J IMMUNOL, V175, P3235, DOI 10.4049/jimmunol.175.5.3235; Pinkoski MJ, 2001, J BIOL CHEM, V276, P12060, DOI 10.1074/jbc.M009038200; Redner RL, 2002, LEUKEMIA, V16, P1927, DOI 10.1038/sj.leu.2402720; Rukamp BJ, 2004, ARCH BIOCHEM BIOPHYS, V422, P9, DOI 10.1016/j.abb.2003.12.005; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; Shields LBE, 1997, J SOC GYNECOL INVEST, V4, P298, DOI 10.1016/S1071-5576(97)00068-3; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; SMYTH MJ, 1992, J BIOL CHEM, V267, P24418; SMYTH MJ, 1993, J IMMUNOL, V151, P6195; Street SEA, 2004, J EXP MED, V199, P879, DOI 10.1084/jem.20031981; Subong ENP, 1999, PROSTATE, V39, P298; Sutton VR, 2000, J EXP MED, V192, P1403, DOI 10.1084/jem.192.10.1403; TANAKA M, 1992, CANCER RES, V52, P3372; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Ulanet DB, 2003, P NATL ACAD SCI USA, V100, P12361, DOI 10.1073/pnas.2035245100; Wu MH, 2002, INT J CANCER, V97, P297, DOI 10.1002/ijc.1606; Wu MH, 2002, CARCINOGENESIS, V23, P93, DOI 10.1093/carcin/23.1.93; YonedaKato N, 1996, ONCOGENE, V12, P265; Yun JP, 2003, J CELL BIOCHEM, V90, P1140, DOI 10.1002/jcb.10706; Zeller KI, 2001, J BIOL CHEM, V276, P48285, DOI 10.1074/jbc.M108506200	66	32	36	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5137	5147		10.1074/jbc.M807913200	http://dx.doi.org/10.1074/jbc.M807913200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19103589	hybrid			2022-12-25	WOS:000263416600044
J	Hendriks, J; Hellingwerf, KJ				Hendriks, Johnny; Hellingwerf, Klaas J.			pH Dependence of the Photoactive Yellow Protein Photocycle Recovery Reaction Reveals a New Late Photocycle Intermediate with a Deprotonated Chromophore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ECTOTHIORHODOSPIRA-HALOPHILA; ACTIVE-SITE; STRUCTURAL-CHANGES; COUMARIC ACID; PHOTORECEPTOR; ACTIVATION; DYNAMICS; KINETICS; SPECTROSCOPY; MUTANTS	The recovery reaction of the signaling state of photoactive yellow protein includes the following: (i) deprotonation of the p-coumaryl chromophore, (ii) refolding of the protein, and (iii) chromophore re-isomerization from the cis to the trans configuration. Through analysis of the pH dependence of this recovery reaction, we were able to provide proof for the existence of an additional photocycle intermediate. The spectral similarity between this new intermediate and the dark state indicates that the new intermediate has a deprotonated chromophore, which may facilitate chromophore re-isomerization. This spectral similarity also explains why this new intermediate has not been noticed in earlier studies. For our data analysis we introduce a photocycle model that takes into account the effect of the specific light regime selected, a model that was also used for simulations.	Univ Amsterdam, Swammerdam Inst Life Sci, Microbiol Lab, NL-1018 WV Amsterdam, Netherlands; Univ Amsterdam, Netherlands Inst Syst Biol, NL-1018 WV Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam	Hellingwerf, KJ (corresponding author), Nieuwe Achtergracht 166, NL-1018 WV Amsterdam, Netherlands.	K.J.Hellingwerf@uva.nl						Anderson S, 2004, STRUCTURE, V12, P1039, DOI 10.1016/j.str.2004.04.008; BACA M, 1994, BIOCHEMISTRY-US, V33, P14369, DOI 10.1021/bi00252a001; BORGSTAHL GEO, 1995, BIOCHEMISTRY-US, V34, P6278, DOI 10.1021/bi00019a004; Borucki B, 2006, BIOPHYS J, V91, P2991, DOI 10.1529/biophysj.106.086645; Chen EF, 2003, BIOCHEMISTRY-US, V42, P2062, DOI 10.1021/bi020577o; Dux P, 1998, BIOCHEMISTRY-US, V37, P12689, DOI 10.1021/bi9806652; Genick UK, 1997, BIOCHEMISTRY-US, V36, P8, DOI 10.1021/bi9622884; Getzoff ED, 2003, NAT STRUCT BIOL, V10, P663, DOI 10.1038/nsb958; Hellingwerf KJ, 2003, J PHYS CHEM A, V107, P1082, DOI 10.1021/jp027005y; HENDLER RW, 1994, J BIOCHEM BIOPH METH, V28, P1, DOI 10.1016/0165-022X(94)90061-2; Hendriks J, 1999, FEBS LETT, V458, P252, DOI 10.1016/S0014-5793(99)01136-9; Hendriks J, 1999, J BIOL CHEM, V274, P17655, DOI 10.1074/jbc.274.25.17655; Hendriks J, 2003, BIOPHYS J, V84, P1180, DOI 10.1016/S0006-3495(03)74932-7; Hendriks J, 2002, BIOPHYS J, V82, P1632, DOI 10.1016/S0006-3495(02)75514-8; HENDRIKS J, 2007, COMPUTATIONAL BIOPHY, P149; Hoersch D, 2007, BIOPHYS J, V93, P1687, DOI 10.1529/biophysj.107.106633; Hoff WD, 1996, BIOCHEMISTRY-US, V35, P1274, DOI 10.1021/bi951755z; HOFF WD, 1994, BIOCHEMISTRY-US, V33, P13959, DOI 10.1021/bi00251a001; Holiday ER, 1936, BIOCHEM J, V30, P1795, DOI 10.1042/bj0301795; Ihee H, 2005, P NATL ACAD SCI USA, V102, P7145, DOI 10.1073/pnas.0409035102; Joshi CP, 2005, BIOCHEMISTRY-US, V44, P656, DOI 10.1021/bi0481141; Kort R, 1996, EMBO J, V15, P3209, DOI 10.1002/j.1460-2075.1996.tb00685.x; KRAAYENHOF R, 1982, ANAL BIOCHEM, V127, P93, DOI 10.1016/0003-2697(82)90149-X; Kumauchi M, 2002, J BIOCHEM, V132, P205, DOI 10.1093/oxfordjournals.jbchem.a003211; Lee BC, 2008, PROTEIN SCI, V17, P2101, DOI 10.1110/ps.037655.108; Meyer TE, 2003, BIOCHEMISTRY-US, V42, P3319, DOI 10.1021/bi020702w; Schmidt M, 2004, P NATL ACAD SCI USA, V101, P4799, DOI 10.1073/pnas.0305983101; Sergi A, 2001, J PHYS CHEM B, V105, P4386, DOI 10.1021/jp002270+; Shimizu N, 2006, BIOCHEMISTRY-US, V45, P3542, DOI 10.1021/bi051430a; Shimizu N, 2006, J BIOL CHEM, V281, P4318, DOI 10.1074/jbc.M506403200; Shimizu N, 2002, J BIOCHEM, V132, P257, DOI 10.1093/oxfordjournals.jbchem.a003219; Takeshita K, 2002, BIOCHEMISTRY-US, V41, P3037, DOI 10.1021/bi0110600; Takeshita K, 2002, BIOPHYS J, V83, P1567, DOI 10.1016/S0006-3495(02)73926-X; van Wilderen LJGW, 2006, P NATL ACAD SCI USA, V103, P15050, DOI 10.1073/pnas.0603476103; VANBREDERODE ME, 1995, BIOPHYS J, V68, P1101, DOI 10.1016/S0006-3495(95)80284-5; VanBrederode ME, 1996, BIOPHYS J, V71, P365, DOI 10.1016/S0006-3495(96)79234-2; Vreede J, 2008, PROTEINS, V72, P136, DOI 10.1002/prot.21902; Xie AH, 2001, BIOCHEMISTRY-US, V40, P1510, DOI 10.1021/bi002449a	38	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5277	5288		10.1074/jbc.M805904200	http://dx.doi.org/10.1074/jbc.M805904200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19091750	hybrid			2022-12-25	WOS:000263416600058
J	Mori, K; Amano, M; Takefuji, M; Kato, K; Morita, Y; Nishioka, T; Matsuura, Y; Murohara, T; Kaibuchi, K				Mori, Kazutaka; Amano, Mutsuki; Takefuji, Mikito; Kato, Katsuhiro; Morita, Yasuhiro; Nishioka, Tomoki; Matsuura, Yoshiharu; Murohara, Toyoaki; Kaibuchi, Kozo			Rho-kinase Contributes to Sustained RhoA Activation through Phosphorylation of p190A RhoGAP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR SMOOTH-MUSCLE; MYOSIN LIGHT-CHAIN; G-PROTEINS; CELL-ADHESION; RND PROTEINS; PHOSPHATASE; GTPASE; INHIBITION; FAMILY; PATHOPHYSIOLOGY	RhoA is transiently activated by specific extracellular signals such as endothelin-1 (ET-1) in vascular smooth muscle cells. RhoGAP negatively regulates RhoA activity: thus, RhoA becomes the GDP-bound inactive form afterward. Sustained activation of RhoA is induced with high doses of the extracellular signals and is implicated in certain diseases such as vasospasms. However, it remains largely unknown how prolonged activation of RhoA is induced. Here we show that Rho-kinase, an effector of RhoA, phosphorylated p190A RhoGAP at Ser(1150) and attenuated p190A RhoGAP activity in COS7 cells. Binding of Rnd to p190A RhoGAP is thought to enhance its activation. Phosphorylation of p190A RhoGAP by Rho-kinase impaired Rnd binding. Stimulation of vascular smooth muscle cells with a high dose of ET-1 provoked sustained RhoA activation and p190A RhoGAP phosphorylation, both of which were prohibited by a Rho-kinase inhibitor. The phosphomimic mutation of p190A RhoGAP weakened Rnd binding and RhoGAP activities. Taken together, these results suggest that ET-1 induces Rho-kinase activation and subsequent phosphorylation of p190A RhoGAP, leading to prolonged RhoA activation.	[Mori, Kazutaka; Amano, Mutsuki; Takefuji, Mikito; Kato, Katsuhiro; Morita, Yasuhiro; Nishioka, Tomoki; Kaibuchi, Kozo] Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Mori, Kazutaka; Takefuji, Mikito; Kato, Katsuhiro; Morita, Yasuhiro; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Nishioka, Tomoki] Kurume Univ, Sch Med, Dept Forens Med & Human Genet, Kurume, Fukuoka 830001, Japan; [Matsuura, Yoshiharu] Osaka Univ, Dept Mol Virol, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan	Nagoya University; Nagoya University; Kurume University; Osaka University	Kaibuchi, K (corresponding author), Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	kaibuchi@med.nagoya-u.ac.jp	Murohara, Toyoaki/M-4958-2014; Kato, Katsuhiro/AAV-8356-2020; Nishioka, Tomoki/M-4976-2014; Takefuji, Mikito/GXG-5982-2022; Amano, Mutsuki/M-4820-2014	Amano, Mutsuki/0000-0002-0662-1524	Ministry of Education, Culture, Sports, Science, and Technology of Japan [S: 20227006, C: 20590308]; National Institute of Biomedical Innovation [02-3]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation)	This work was supported by grants-in-aid for creative science research and a grant-in-aid for scientific research (S: 20227006; C: 20590308), by the Global Centers of Excellence Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (Grant 02-3). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agapitov AV, 2002, J RENIN-ANGIO-ALDO S, V3, P1, DOI 10.3317/jraas.2002.001; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Chardin P, 2006, NAT REV MOL CELL BIO, V7, P54, DOI 10.1038/nrm1788; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Gohla A, 2000, CIRC RES, V87, P221, DOI 10.1161/01.RES.87.3.221; Guilluy C, 2005, BRIT J PHARMACOL, V146, P1010, DOI 10.1038/sj.bjp.0706408; Harada A, 2005, J BIOL CHEM, V280, P18418, DOI 10.1074/jbc.M411356200; Hartshorne DJ, 2004, J BIOL CHEM, V279, P37211, DOI 10.1074/jbc.R400018200; Hersch E, 2004, AM J PHYSIOL-CELL PH, V287, pC1209, DOI 10.1152/ajpcell.00198.2004; Hynynen Meri M, 2006, Recent Pat Cardiovasc Drug Discov, V1, P95; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kandabashi T, 2000, CIRCULATION, V101, P1319, DOI 10.1161/01.CIR.101.11.1319; Kimura K, 1998, J BIOL CHEM, V273, P5542, DOI 10.1074/jbc.273.10.5542; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Ligeti E, 2006, METHOD ENZYMOL, V406, P104, DOI 10.1016/S0076-6879(06)06009-5; Loirand G, 2006, CIRC RES, V98, P322, DOI 10.1161/01.RES.0000201960.04223.3c; Mammoto A, 2007, J CELL SCI, V120, P456, DOI 10.1242/jcs.03353; Matsumura F, 2008, BIOCHEM BIOPH RES CO, V369, P149, DOI 10.1016/j.bbrc.2007.12.090; Moriki N, 2004, HYPERTENS RES, V27, P263, DOI 10.1291/hypres.27.263; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; RIDLEY AJ, 1993, EMBO J, V12, P5151, DOI 10.1002/j.1460-2075.1993.tb06210.x; Rossman KL, 2003, J BIOL CHEM, V278, P18393, DOI 10.1074/jbc.M300127200; Sakurada S, 2001, AM J PHYSIOL-CELL PH, V281, pC571, DOI 10.1152/ajpcell.2001.281.2.C571; Sato M, 2000, CIRC RES, V87, P195, DOI 10.1161/01.RES.87.3.195; SETTLEMAN J, 1992, CELL, V69, P539, DOI 10.1016/0092-8674(92)90454-K; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Sternweis PC, 2007, ADV PROTEIN CHEM, V74, P189, DOI 10.1016/S0065-3233(07)74006-8; Suzuki N, 2003, P NATL ACAD SCI USA, V100, P733, DOI 10.1073/pnas.0234057100; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; Vincent S, 1999, EUR J CELL BIOL, V78, P539, DOI 10.1016/S0171-9335(99)80019-3; Wennerberg K, 2003, CURR BIOL, V13, P1106, DOI 10.1016/S0960-9822(03)00418-4; Wettschureck N, 2002, J MOL MED, V80, P629, DOI 10.1007/s00109-002-0370-2; Woodsome TP, 2006, J CELL SCI, V119, P1769, DOI 10.1242/jcs.02805; Worth NF, 2004, CELL MOTIL CYTOSKEL, V59, P189, DOI 10.1002/cm.20036	40	48	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5067	5076		10.1074/jbc.M806853200	http://dx.doi.org/10.1074/jbc.M806853200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19103606	hybrid			2022-12-25	WOS:000263416600037
J	Wu, CH; Yeh, SH; Tsay, YG; Shieh, YH; Kao, CL; Chen, YS; Wang, SH; Kuo, TJ; Chen, DS; Chen, PJ				Wu, Chia-Hsin; Yeh, Shiou-Hwei; Tsay, Yeou-Guang; Shieh, Ya-Hsiung; Kao, Chuan-Liang; Chen, Yen-Shun; Wang, Sheng-Han; Kuo, Ti-Jung; Chen, Ding-Shinn; Chen, Pei-Jer			Glycogen Synthase Kinase-3 Regulates the Phosphorylation of Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Protein and Viral Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE HEPATITIS-VIRUS; INFECTIOUS-BRONCHITIS VIRUS; SARS-CORONAVIRUS; RNA-BINDING; SUBCELLULAR-LOCALIZATION; RICH MOTIF; B-VIRUS; MULTIMERIZATION; GENOME; DOMAIN	Coronavirus (CoV) nucleocapsid (N) protein is a highly phosphorylated protein required for viral replication, but whether its phosphorylation and the related kinases are involved in the viral life cycle is unknown. We found the severe acute respiratory syndrome CoVNprotein to be an appropriate system to address this issue. Using high resolution PAGE analysis, this protein could be separated into phosphorylated and unphosphorylated isoforms. Mass spectrometric analysis and deletion mapping showed that the major phosphorylation sites were located at the central serine-arginine (SR)-rich motif that contains several glycogen synthase kinase (GSK)-3 substrate consensus sequences. GSK-3-specific inhibitor treatment dephosphorylated the N protein, and this could be recovered by the constitutively active GSK-3 kinase. Immunoprecipitation brought down both N and GSK-3 proteins in the same complex, and the N protein could be phosphorylated directly at its SR-rich motif by GSK-3 using an in vitro kinase assay. Mutation of the two priming sites critical for GSK-3 phosphorylation in the SR-rich motif abolished N protein phosphorylation. Finally, GSK-3 inhibitor was found to reduce N phosphorylation in the severe acute respiratory syndrome CoV-infected VeroE6 cells and decrease the viral titer and cytopathic effects. The effect of GSK-3 inhibitor was reproduced in another coronavirus, the neurotropic JHM strain of mouse hepatitis virus. Our results indicate that GSK-3 is critical for CoV N protein phosphorylation and suggest that it plays a role in regulating the viral life cycle. This study, thus, provides new avenues to further investigate the specific role of N protein phosphorylation in CoV replication.	[Wu, Chia-Hsin; Yeh, Shiou-Hwei; Shieh, Ya-Hsiung; Chen, Yen-Shun; Wang, Sheng-Han; Chen, Ding-Shinn; Chen, Pei-Jer] Natl Taiwan Univ, Coll Med, Dept Microbiol, Taipei 100, Taiwan; [Yeh, Shiou-Hwei; Kuo, Ti-Jung; Chen, Pei-Jer] Natl Taiwan Univ, Coll Med, Ctr Genom Med, Taipei 100, Taiwan; [Kao, Chuan-Liang] Natl Taiwan Univ, Coll Med, Dept Med Technol, Taipei 100, Taiwan; [Chen, Ding-Shinn; Chen, Pei-Jer] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 100, Taiwan; [Chen, Ding-Shinn; Chen, Pei-Jer] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei 100, Taiwan; [Tsay, Yeou-Guang] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Yang Ming Chiao Tung University	Yeh, SH (corresponding author), Natl Taiwan Univ, Coll Med, Dept Microbiol, 1 Jen Ai Rd,Sect 1, Taipei 100, Taiwan.	shyeh@ntu.edu.tw	Tsay, Yeou-Guang/HGE-2076-2022; CHEN, DING-SHINN/T-4395-2019	CHEN, DING-SHINN/0000-0001-7791-6154; KAO, CHUAN-LIANG/0000-0002-1020-2605; /0000-0003-4509-180X	National Science Council, Taiwan [NSC93-2751-B-002-008-Y, NSC95-3112-B-002-013]; Department of Health, Executive Yuan, Taiwan [DOH96-TD-O-113-101]; European Commission [SP22-CT-2004-511064]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Department of Health, Executive Yuan, Taiwan; European Commission(European CommissionEuropean Commission Joint Research Centre)	The study was supported by National Science Council, Taiwan ( Grants NSC93-2751-B-002-008-Y and NSC95-3112-B-002-013), by Department of Health, Executive Yuan, Taiwan ( DOH96-TD-O-113-101), and also in part by the European Commission in the context of the activities of the Euro-Asian SARS-DTV Network Grant SP22-CT-2004-511064.	Almazan F, 2004, J VIROL, V78, P12683, DOI 10.1128/JVI.78.22.12683-12688.2004; Calvo E, 2005, J GEN VIROL, V86, P2255, DOI 10.1099/vir.0.80975-0; Chen HY, 2005, J VIROL, V79, P1164, DOI 10.1128/JVI.79.2.1164-1179.2005; Chiu CM, 2007, P NATL ACAD SCI USA, V104, P2571, DOI 10.1073/pnas.0609498104; Darnell MER, 2006, TRANSFUSION, V46, P1770, DOI 10.1111/j.1537-2995.2006.00976.x; Denison MR, 1999, J VIROL, V73, P6862, DOI 10.1128/JVI.73.8.6862-6871.1999; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Fan H, 2005, STRUCTURE, V13, P1859, DOI 10.1016/j.str.2005.08.021; Fang XN, 2005, J BIOCHEM MOL BIOL, V38, P381; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; He RT, 2003, BIOCHEM BIOPH RES CO, V311, P870, DOI 10.1016/j.bbrc.2003.10.075; Huang LR, 2004, J MED VIROL, V73, P338, DOI 10.1002/jmv.20096; Huang QL, 2004, BIOCHEMISTRY-US, V43, P6059, DOI 10.1021/bi036155b; Jayaram H, 2006, J VIROL, V80, P6612, DOI 10.1128/JVI.00157-06; Kopecky-Bromberg SA, 2007, J VIROL, V81, P548, DOI 10.1128/JVI.01782-06; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Lai MMC, 1997, ADV VIRUS RES, V48, P1, DOI 10.1016/S0065-3527(08)60286-9; Law LMJ, 2003, J VIROL, V77, P1764, DOI 10.1128/JVI.77.3.1764-1771.2003; Law LJ, 2006, J VIROL, V80, P6917, DOI 10.1128/JVI.01152-05; Lin L, 2007, INT J MASS SPECTROM, V268, P296, DOI 10.1016/j.ijms.2007.05.009; Luo HB, 2006, BIOCHEMISTRY-US, V45, P11827, DOI 10.1021/bi0609319; Luo HB, 2005, BIOCHEMISTRY-US, V44, P15351, DOI 10.1021/bi051122c; Mizutani T, 2004, BIOCHEM BIOPH RES CO, V319, P1228, DOI 10.1016/j.bbrc.2004.05.107; MOHANDAS DV, 1991, FEBS LETT, V282, P419, DOI 10.1016/0014-5793(91)80528-B; Nelson GW, 2000, J GEN VIROL, V81, P181, DOI 10.1099/0022-1317-81-1-181; Peng TY, 2008, FEBS J, V275, P4152, DOI 10.1111/j.1742-4658.2008.06564.x; Schelle B, 2005, J VIROL, V79, P6620, DOI 10.1128/JVI.79.11.6620-6630.2005; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; Snijder EJ, 2006, J VIROL, V80, P5927, DOI 10.1128/JVI.02501-05; Spencer KA, 2008, VIROLOGY, V370, P373, DOI 10.1016/j.virol.2007.08.016; STOHLMAN SA, 1982, J GEN VIROL, V63, P265, DOI 10.1099/0022-1317-63-2-265; STOHLMAN SA, 1983, VIROLOGY, V130, P527, DOI 10.1016/0042-6822(83)90106-X; Surjit M, 2006, J BIOL CHEM, V281, P10669, DOI 10.1074/jbc.M509233200; Surjit M, 2005, J VIROL, V79, P11476, DOI 10.1128/JVI.79.17.11476-11486.2005; Tahara SM, 1998, ADV EXP MED BIOL, V440, P313; van der Meer Y, 1999, J VIROL, V73, P7641, DOI 10.1128/JVI.73.9.7641-7657.1999; White TC, 2007, VIRUS RES, V126, P139, DOI 10.1016/j.virusres.2007.02.008; Ye Y, 2007, J VIROL, V81, P2554, DOI 10.1128/JVI.01634-06; Yeh SH, 2004, P NATL ACAD SCI USA, V101, P2542, DOI 10.1073/pnas.0307904100; Yeh SH, 2004, J HEPATOL, V41, P659, DOI 10.1016/j.jhep.2004.06.031	40	106	114	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5229	5239		10.1074/jbc.M805747200	http://dx.doi.org/10.1074/jbc.M805747200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19106108	hybrid, Green Published			2022-12-25	WOS:000263416600053
J	Zitomer, NC; Mitchell, T; Voss, KA; Bondy, GS; Pruett, ST; Garnier-Amblard, EC; Liebeskind, LS; Park, H; Wang, E; Sullards, MC; Merrill, AH; Riley, RT				Zitomer, Nicholas C.; Mitchell, Trevor; Voss, Kenneth A.; Bondy, Genevieve S.; Pruett, Sarah T.; Garnier-Amblard, Ethel C.; Liebeskind, Lanny S.; Park, Hyejung; Wang, Elaine; Sullards, M. Cameron; Merrill, Alfred H., Jr.; Riley, Ronald T.			Ceramide Synthase Inhibition by Fumonisin B-1 Causes Accumulation of 1-Deoxysphinganine A NOVEL CATEGORY OF BIOACTIVE 1-DEOXYSPHINGOID BASES AND 1-DEOXYDIHYDROCERAMIDES BIOSYNTHESIZED BY MAMMALIAN CELL LINES AND ANIMALS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISRUPTED SPHINGOLIPID METABOLISM; RENAL EPITHELIAL-CELLS; SERINE PALMITOYLTRANSFERASE; MASS-SPECTROMETRY; CYTOTOXICITY; SPHINGANINE; APOPTOSIS; LLC-PK1; KIDNEY; PURIFICATION	Fumonisin B-1 (FB1) is a mycotoxin that inhibits ceramide synthases (CerS) and causes kidney and liver toxicity and other disease. Inhibition of CerS by FB1 increases sphinganine (Sa), Sa 1-phosphate, and a previously unidentified metabolite. Analysis of the latter by quadrupole-time-of-flight mass spectrometry assigned an m/z = 286.3123 in positive ionization mode, consistent with the molecular formula for deoxysphinganine (C18H40NO). Comparison with a synthetic standard using liquid chromatography, electrospray tandem mass spectrometry identified the metabolite as 1-deoxysphinganine (1-deoxySa) based on LC mobility and production of a distinctive fragment ion (m/z 44, CH3CH = NH2+) upon collision-induced dissociation. This novel sphingoid base arises from condensation of alanine with palmitoyl-CoA via serine palmitoyltransferase (SPT), as indicated by incorporation of L-[U-C-13] alanine into 1-deoxySa by Vero cells; inhibition of its production in LLC-PK1 cells by myriocin, an SPT inhibitor; and the absence of incorporation of [U-C-13] palmitate into 1-[C-13] deoxySa in LY-B cells, which lack SPT activity. LY-B-LCB1 cells, in which SPT has been restored by stable transfection, however, produce large amounts of 1-[C-13] deoxySa. 1-DeoxySa was elevated in FB1-treated cells and mouse liver and kidney, and its cytotoxicity was greater than or equal to that of Sa for LLC-PK1 and DU-145 cells. Therefore, this compound is likely to contribute to pathologies associated with fumonisins. In the absence of FB1, substantial amounts of 1-deoxySa are made and acylated to N-acyl-1-deoxySa (i.e. 1-deoxydihydroceramides). Thus, these compounds are an underappreciated category of bioactive sphingoid bases and "ceramides" that might play important roles in cell regulation.	[Zitomer, Nicholas C.; Mitchell, Trevor; Voss, Kenneth A.; Riley, Ronald T.] USDA ARS, Toxicol & Mycotoxin Res Unit, Athens, GA 30604 USA; [Bondy, Genevieve S.] Hlth Canada, Food Directorate, Hlth Prod & Food Branch, Ottawa, ON K1A 0L2, Canada; [Pruett, Sarah T.] Emory Univ, Biomarkers Core Lab, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Garnier-Amblard, Ethel C.; Liebeskind, Lanny S.] Emory Univ, Dept Chem, Atlanta, GA 30322 USA; [Park, Hyejung; Wang, Elaine; Sullards, M. Cameron; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Sullards, M. Cameron; Merrill, Alfred H., Jr.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Dept Chem, Atlanta, GA 30332 USA	United States Department of Agriculture (USDA); Health Canada; Emory University; Emory University; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Riley, RT (corresponding author), USDA ARS, Toxicol & Mycotoxin Res Unit, POB 5677, Athens, GA 30604 USA.	ron.riley@ars.usda.gov	Pruett, Sarah/C-7433-2009	Zitomer, Nicholas/0000-0002-3900-4282; Merrill, Alfred/0000-0002-6673-968X	National Institutes of Health [GM76217, GM69338, GM066153]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338, R01GM066153, R01GM076217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM76217 and GM69338 (LIPID MAPS) (to A. H. M., H. P., and M. C. S.) and GM066153 (to E. C. G.- A. and L. S. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Delongchamp RR, 2001, FOOD ADDIT CONTAM, V18, P255, DOI 10.1080/02652030118953; Enongene EN, 2002, TOXICOL SCI, V67, P173, DOI 10.1093/toxsci/67.2.173; Fyrst H, 2008, BBA-MOL CELL BIOL L, V1781, P448, DOI 10.1016/j.bbalip.2008.05.005; GELDERBLOM WCA, 1994, CARCINOGENESIS, V15, P209, DOI 10.1093/carcin/15.2.209; Hanada K, 1998, J BIOL CHEM, V273, P33787, DOI 10.1074/jbc.273.50.33787; He QR, 2002, PHARMACOL TOXICOL, V90, P268, DOI 10.1034/j.1600-0773.2002.900507.x; Hornemann T, 2008, CHEM PHYS LIPIDS, V154, pS62, DOI 10.1016/j.chemphyslip.2008.05.170; Humpf HU, 1998, J BIOL CHEM, V273, P19060, DOI 10.1074/jbc.273.30.19060; Kim MS, 2001, TOXICOL APPL PHARM, V176, P118, DOI 10.1006/taap.2001.9188; Lanny HY, 2007, ORG LETT, V9, P2993, DOI 10.1021/ol070991m; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marasas WFO, 2004, J NUTR, V134, P711, DOI 10.1093/jn/134.4.711; Marasas WFO, 2001, ENVIRON HEALTH PERSP, V109, P239, DOI 10.2307/3435014; Meredith FI, 1996, J AGR FOOD CHEM, V44, P195, DOI 10.1021/jf950294l; Merrill AH, 2001, ENVIRON HEALTH PERSP, V109, P283, DOI 10.2307/3435020; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; MIYAKE Y, 1995, BIOCHEM BIOPH RES CO, V211, P396, DOI 10.1006/bbrc.1995.1827; National cholesterol education program National heart lung and blood institute National institutes of health, 2002, 3 REP NAT CHOL ED PR; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Pruett ST, 2008, J LIPID RES, V49, P1621, DOI 10.1194/jlr.R800012-JLR200; Quesney S, 2003, CYTOTECHNOLOGY, V42, P1, DOI 10.1023/A:1026185615650; Riley RT, 2006, TOXICOL SCI, V92, P335, DOI 10.1093/toxsci/kfj198; Riley RT, 1999, NAT TOXINS, V7, P407, DOI 10.1002/1522-7189(199911/12)7:6<407::AID-NT84>3.0.CO;2-0; Riley RT, 2001, ENVIRON HEALTH PERSP, V109, P301, DOI 10.2307/3435022; Riley RT, 1999, ENVIRON TOXICOL PHAR, V7, P109, DOI 10.1016/S1382-6689(98)00047-7; Riley RT, 1998, REV MED VET-TOULOUSE, V149, P617; Riley RT, 2000, METHOD ENZYMOL, V311, P348; Sanchez AM, 2008, EUR J PHARMACOL, V584, P237, DOI 10.1016/j.ejphar.2008.02.011; Schmelz EM, 1998, TOXICOL APPL PHARM, V148, P252, DOI 10.1006/taap.1997.8356; SCHROEDER JJ, 1994, J BIOL CHEM, V269, P3475; STEVENS VL, 1990, BIOCHIM BIOPHYS ACTA, V1051, P37, DOI 10.1016/0167-4889(90)90171-9; Sullards MC, 2007, METHOD ENZYMOL, V432, P83, DOI 10.1016/S0076-6879(07)32004-1; Tolleson WH, 1999, INT J ONCOL, V14, P833; Tsunoda M, 1998, J BIOCHEM MOL TOXIC, V12, P281, DOI 10.1002/(SICI)1099-0461(1998)12:5<281::AID-JBT4>3.0.CO;2-H; Urs AN, 2007, MOL CELL ENDOCRINOL, V265, P174, DOI 10.1016/j.mce.2006.12.016; Voss KA, 2001, ENVIRON HEALTH PERSP, V109, P259, DOI 10.2307/3435017; WANG E, 1991, J BIOL CHEM, V266, P14486; YOO HS, 1992, TOXICOL APPL PHARM, V114, P9, DOI 10.1016/0041-008X(92)90090-F; Yoo HS, 1996, TOXICOL APPL PHARM, V138, P211, DOI 10.1006/taap.1996.0119; Yu CH, 2001, ARCH PHARM RES, V24, P136, DOI 10.1007/BF02976481; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009; Zitomer NC, 2008, ANAL BIOANAL CHEM, V391, P2257, DOI 10.1007/s00216-008-2166-x	42	153	158	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4786	4795		10.1074/jbc.M808798200	http://dx.doi.org/10.1074/jbc.M808798200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19095642	Green Published, hybrid			2022-12-25	WOS:000263416600006
J	Leferink, NGH; Fraaije, MW; Joosten, HJ; Schaap, PJ; Mattevi, A; van Berkel, WJH				Leferink, Nicole G. H.; Fraaije, Marco W.; Joosten, Henk-Jan; Schaap, Peter J.; Mattevi, Andrea; van Berkel, Willem J. H.			Identification of a Gatekeeper Residue That Prevents Dehydrogenases from Acting as Oxidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-LACTONE DEHYDROGENASE; MONOMERIC SARCOSINE OXIDASE; L-GALACTONO-1,4-LACTONE DEHYDROGENASE; OXYGEN REACTIVITY; ENZYME; PLANT; SITE; BINDING; ACTIVATION; DISCOVERY	The oxygen reactivity of flavoproteins is poorly understood. Here we show that a single Ala to Gly substitution in L-galactono-gamma-lactone dehydrogenase (GALDH) turns the enzyme into a catalytically competent oxidase. GALDH is an aldonolactone oxidoreductase with a vanillyl-alcohol oxidase (VAO) fold. We found that nearly all oxidases in the VAO family contain either a Gly or a Pro at a structurally conserved position near the C4a locus of the isoalloxazine moiety of the flavin, whereas dehydrogenases prefer another residue at this position. Mutation of the corresponding residue in GALDH (Ala-133 -> Gly) resulted in a striking 400-fold increase in oxygen reactivity, whereas the cytochrome c reductase activity is retained. The activity of the A113G variant shows a linear dependence on oxygen concentration (k(ox) = 3.5 x 10(5) M-1 s(-1)), similar to most other flavoprotein oxidases. The Ala-133 -> Gly replacement does not change the reduction potential of the flavin but creates space for molecular oxygen to react with the reduced flavin. In the wild-type enzyme, Ala-113 acts as a gatekeeper, preventing oxygen from accessing the isoalloxazine nucleus. The presence of such an oxygen access gate seems to be a key factor for the prevention of oxidase activity within the VAO family and is absent in members that act as oxidases.	[Leferink, Nicole G. H.; van Berkel, Willem J. H.] Wageningen Univ, Biochem Lab, NL-6703 HA Wageningen, Netherlands; [Fraaije, Marco W.] Univ Groningen, Biomol Sci & Biotechnol Inst, Biochem Lab, NL-9747 AG Groningen, Netherlands; [Joosten, Henk-Jan; Schaap, Peter J.] Wageningen Univ, Microbiol Lab, NL-6703 HB Wageningen, Netherlands; [Mattevi, Andrea] Univ Pavia, Dept Genet & Microbiol, I-27100 Pavia, Italy	Wageningen University & Research; University of Groningen; Wageningen University & Research; University of Pavia	van Berkel, WJH (corresponding author), Wageningen Univ, Biochem Lab, Dreijenlaan 3, NL-6703 HA Wageningen, Netherlands.	willem.vanberkel@wur.nl	van Berkel, Willem J.H./O-2431-2014; Leferink, Nicole G H/I-6867-2012; Fraaije, Marco/E-8421-2014; mattevi, andrea/K-5464-2012; Leferink, Nicole/C-6273-2011; Mattevi, Andrea/R-4469-2019	van Berkel, Willem J.H./0000-0002-6551-2782; Leferink, Nicole G H/0000-0003-4134-4339; mattevi, andrea/0000-0002-9523-7128; Mattevi, Andrea/0000-0002-9523-7128; Fraaije, Marco/0000-0001-6346-5014; Schaap, Peter/0000-0002-4346-6084	Carbohydrate Research Centre Wageningen	Carbohydrate Research Centre Wageningen	This work was supported by a grant from the Carbohydrate Research Centre Wageningen.	Alhagdow M, 2007, PLANT PHYSIOL, V145, P1408, DOI 10.1104/pp.107.106500; Arent S, 2008, PLANT PHYSIOL BIOCH, V46, P292, DOI 10.1016/j.plaphy.2007.12.014; Chen L, 2008, BIOCHEMISTRY-US, V47, P5368, DOI 10.1021/bi800228w; Coulombe R, 2001, J BIOL CHEM, V276, P30435, DOI 10.1074/jbc.M104103200; Dewanti AR, 2004, BIOCHEMISTRY-US, V43, P10692, DOI 10.1021/bi049005p; Forneris F, 2008, BIOCHEMISTRY-US, V47, P978, DOI 10.1021/bi701886t; Fraaije MW, 1999, J BIOL CHEM, V274, P35514, DOI 10.1074/jbc.274.50.35514; Fraaije MW, 1998, TRENDS BIOCHEM SCI, V23, P206, DOI 10.1016/S0968-0004(98)01210-9; Frebortova J, 2004, BIOCHEM J, V380, P121, DOI 10.1042/BJ20031813; Heuts DPHM, 2007, J BIOL CHEM, V282, P20283, DOI 10.1074/jbc.M610849200; Huh WK, 1998, MOL MICROBIOL, V30, P895, DOI 10.1046/j.1365-2958.1998.01133.x; Jin JF, 2007, FEBS J, V274, P2311, DOI 10.1111/j.1742-4658.2007.05767.x; Joosten HJ, 2008, PROTEINS, V70, P157, DOI 10.1002/prot.21622; Joosten V, 2007, CURR OPIN CHEM BIOL, V11, P195, DOI 10.1016/j.cbpa.2007.01.010; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEFERINK NGH, 2008, FLAVINS FLAVOPROTEIN, P75; Leferink NGH, 2008, ARCH BIOCHEM BIOPHYS, V474, P292, DOI 10.1016/j.abb.2008.01.027; Leferink NGH, 2008, FEBS J, V275, P713, DOI 10.1111/j.1742-4658.2007.06233.x; Mackenzie J, 2006, J BIOL CHEM, V281, P31012, DOI 10.1074/jbc.M603405200; Massey V, 1990, FLAVINS FLAVOPROTEIN, P59; Mattevi A, 2006, TRENDS BIOCHEM SCI, V31, P276, DOI 10.1016/j.tibs.2006.03.003; Mattevi A, 1997, STRUCTURE, V5, P907, DOI 10.1016/S0969-2126(97)00245-1; Navrot N, 2007, PHYSIOL PLANTARUM, V129, P185, DOI 10.1111/j.1399-3054.2006.00777.x; Nishikimi M, 1979, Methods Enzymol, V62, P24; Noctor G, 2007, TRENDS PLANT SCI, V12, P125, DOI 10.1016/j.tplants.2007.01.005; OBA K, 1995, J BIOCHEM, V117, P120, DOI 10.1093/oxfordjournals.jbchem.a124697; Pineau B, 2008, J BIOL CHEM, V283, P32500, DOI 10.1074/jbc.M805320200; Piubelli L, 2008, J BIOL CHEM, V283, P24738, DOI 10.1074/jbc.M802321200; POLLEGIONI L, 2008, FLAVINS FLAVOPROTEIN, P497; Roth JP, 2003, P NATL ACAD SCI USA, V100, P62, DOI 10.1073/pnas.252644599; STANKOVICH MT, 1991, CHEM BIOCH FLAVOENZY, P401; Sucharitakul J, 2008, BIOCHEMISTRY-US, V47, P8485, DOI 10.1021/bi801039d; Sun WM, 1996, J BIOL CHEM, V271, P17226, DOI 10.1074/jbc.271.29.17226; Trickey P, 1999, STRUCTURE, V7, P331, DOI 10.1016/S0969-2126(99)80043-4; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; van Berkel WJH, 1999, METH MOL B, V131, P61; Winkler A, 2007, J BIOL CHEM, V282, P24437, DOI 10.1074/jbc.M703642200; WINTER RT, 2008, FLAVINS FLAVOPROTEIN, P237; Zeng J, 2007, BBA-PROTEINS PROTEOM, V1774, P1628, DOI 10.1016/j.bbapap.2007.08.018; Zhao GH, 2008, BIOCHEMISTRY-US, V47, P9124, DOI 10.1021/bi8008642	40	73	73	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4392	4397		10.1074/jbc.M808202200	http://dx.doi.org/10.1074/jbc.M808202200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19088070	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000263134400038
J	Minhajuddin, M; Bijli, KM; Fazal, F; Sassano, A; Nakayama, KI; Hay, N; Platanias, LC; Rahman, A				Minhajuddin, Mohd; Bijli, Kaiser M.; Fazal, Fabeha; Sassano, Antonella; Nakayama, Keiichi I.; Hay, Nissim; Platanias, Leonidas C.; Rahman, Arshad			Protein Kinase C-delta and Phosphatidylinositol 3-Kinase/Akt Activate Mammalian Target of Rapamycin to Modulate NF-kappa B Activation and Intercellular Adhesion Molecule-1 (ICAM-1) Expression in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; MICE LACKING; PHOSPHATASE 2A; PHOSPHORYLATION; MTOR; AKT; COMPLEX; ISOFORMS; SIGNALS; PATHWAY	We have shown that the mammalian target of rapamycin (mTOR) down-regulates thrombin-induced ICAM-1 expression in endothelial cells by suppressing the activation of NF-kappa B. However, the mechanisms by which mTOR is activated to modulate these responses remain to be addressed. Here, we show that thrombin engages protein kinase C (PKC)-delta and phosphattidylinositol 3-kinase (PI3K)/Akt pathways to activate mTOR and thereby dampens NF-kappa B activation and intercellular adhesion molecule 1 (ICAM-1) expression. Stimulation of human vascular endothelial cells with thrombin induced the phosphorylation of mTOR and its downstream target p70 S6 kinase in a PKC-delta- and PI3K/Akt-dependent manner. Consistent with this, thrombin-induced phosphorylation of p70 S6 kinase was defective in embryonic fibroblasts from mice with targeted disruption of PKC-delta (Pkc-delta(-/-)), p85 alpha and p85 beta subunits of the PI3K (p85 alpha(-/-)beta(-/-)), or Akt1 and Akt2 (Akt1(-/-)2(-/-)). Furthermore, we observed that expression of the constitutively active form of PKC-delta or Akt was sufficient to induce NF-kappa B activation and ICAM-1 expression, and that co-expression of mTOR suppressed these responses. In reciprocal experiments, inhibition/depletion of mTOR augmented NF-kappa B activation and ICAM-1 expression induced by PKC-delta or Akt. In control experiments, increasing or impairing mTOR signaling by the above approaches produced similar effects on NF-kappa B activation and ICAM-1 expression induced by thrombin. Thus, these data reveal an important role of PKC-delta and PI3K/Akt pathways in activating mTOR as an endogenous modulator to ensure a tight regulation of NF-kappa B signaling of ICAM-1 expression in endothelial cells.	[Minhajuddin, Mohd; Bijli, Kaiser M.; Fazal, Fabeha; Rahman, Arshad] Univ Rochester, Sch Med & Dent, Lung Biol & Dis Program, Dept Pediat Neonatol, Rochester, NY 14642 USA; [Sassano, Antonella; Platanias, Leonidas C.] Northwestern Univ, Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Fukuoka 8128582, Japan; [Hay, Nissim] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60612 USA	University of Rochester; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Kyushu University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Rahman, A (corresponding author), Box 850,601 Elmwood Ave, Rochester, NY 14642 USA.	Arshad_Rahman@urmc.rochester.edu			National Institutes of Health [CA77816, CA121192, CA100579]; NHLBI [HL67424]; NIEHSC [ES-01247]; American Lung Association; NATIONAL CANCER INSTITUTE [R01CA100579, R01CA077816, R01CA121192] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067424] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHSC; American Lung Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA77816, CA121192, and CA100579 ( to L. C. P.), NHLBI Grant HL67424 ( to A. R.), and NIEHSC Grant ES-01247. This work was also supported by a Biomedical Research grant from the American Lung Association ( to F. F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be here by marked" advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; Aird WC, 2005, CRIT CARE CLIN, V21, P417, DOI 10.1016/j.ccc.2005.04.004; Anwar KN, 2004, J IMMUNOL, V173, P6965, DOI 10.4049/jimmunol.173.11.6965; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bharti A, 1998, MOL CELL BIOL, V18, P6719, DOI 10.1128/MCB.18.11.6719; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Bijli KM, 2007, AM J PHYSIOL-LUNG C, V292, pL396, DOI 10.1152/ajplung.00163.2006; Brachmann SA, 2005, MOL CELL BIOL, V25, P2593, DOI 10.1128/MCB.25.7.2593-2606.2005; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Dan HC, 2008, J IMMUNOL, V180, P7582, DOI 10.4049/jimmunol.180.11.7582; Dan HC, 2008, GENE DEV, V22, P1490, DOI 10.1101/gad.1662308; DICKNEITE G, 1993, THROMB HAEMOSTASIS, V69, P98; Doerschuk CM, 2000, AM J RESP CELL MOL, V23, P133, DOI 10.1165/ajrcmb.23.2.f193; Fenton J W 2nd, 1981, Ann N Y Acad Sci, V370, P468, DOI 10.1111/j.1749-6632.1981.tb29757.x; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fruman DA, 2000, NAT GENET, V26, P379, DOI 10.1038/81715; Fu DX, 2003, J BIOL CHEM, V278, P1487, DOI 10.1074/jbc.M210631200; GIMBRONE MA, 1974, J CELL BIOL, V60, P673, DOI 10.1083/jcb.60.3.673; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Huang SL, 2004, J BIOL CHEM, V279, P36490, DOI 10.1074/jbc.M401208200; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; KEITH CT, 1995, SCIENCE, V270, P50, DOI 10.1126/science.270.5233.50; Kumar V, 2000, EMBO J, V19, P1087, DOI 10.1093/emboj/19.5.1087; Lekmine F, 2003, J BIOL CHEM, V278, P27772, DOI 10.1074/jbc.M301364200; LOPATA MA, 1984, NUCLEIC ACIDS RES, V12, P5707, DOI 10.1093/nar/12.14.5707; Marinov M, 2007, CRIT REV ONCOL HEMAT, V63, P172, DOI 10.1016/j.critrevonc.2007.04.002; Mehta D, 2001, J BIOL CHEM, V276, P22614, DOI 10.1074/jbc.M101927200; Mingo-Sion AM, 2005, BREAST CANCER RES TR, V91, P259, DOI 10.1007/s10549-005-0669-0; Minhajuddin M, 2005, J IMMUNOL, V174, P5823, DOI 10.4049/jimmunol.174.9.5823; Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a; Nien WL, 2007, MOL CELL ENDOCRINOL, V263, P10, DOI 10.1016/j.mce.2006.08.015; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Phung TL, 2006, CANCER CELL, V10, P159, DOI 10.1016/j.ccr.2006.07.003; Pons S, 2000, J BIOL CHEM, V275, P38620, DOI 10.1074/jbc.M004531200; Prajapati S, 2004, J BIOL CHEM, V279, P1739, DOI 10.1074/jbc.M306273200; Rahman A, 1999, J IMMUNOL, V162, P5466; Rahman A, 2002, CIRC RES, V91, P398, DOI 10.1161/01.RES.0000033520.95242.A2; Rahman A, 2001, MOL CELL BIOL, V21, P5554, DOI 10.1128/MCB.21.16.5554-5565.2001; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schouten M, 2008, J LEUKOCYTE BIOL, V83, P536, DOI 10.1189/jlb.0607373; SMITH CW, 1989, J CLIN INVEST, V83, P2008, DOI 10.1172/JCI114111; Soh JW, 1999, MOL CELL BIOL, V19, P1313; Song JS, 1998, ONCOGENE, V16, P3357, DOI 10.1038/sj.onc.1201886; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; WAGNER DD, 1982, J CELL BIOL, V95, P355, DOI 10.1083/jcb.95.1.355	53	60	64	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4052	4061		10.1074/jbc.M805032200	http://dx.doi.org/10.1074/jbc.M805032200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19074768	Green Published, hybrid			2022-12-25	WOS:000263134400003
J	Vempati, UD; Han, XL; Moraes, CT				Vempati, Uma D.; Han, Xianlin; Moraes, Carlos T.			Lack of Cytochrome c in Mouse Fibroblasts Disrupts Assembly/Stability of Respiratory Complexes I and IV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN MITOCHONDRIA; SHOTGUN LIPIDOMICS; YEAST MITOCHONDRIA; OXIDATIVE-PHOSPHORYLATION; SEQUENTIAL STABILIZATION; SACCHAROMYCES-CEREVISIAE; BIOLOGICAL SAMPLES; HEME-A; MEMBRANE; OXIDASE	Cytochrome c (cyt c) is a heme-containing protein that participates in electron transport in the respiratory chain and as a signaling molecule in the apoptotic cascade. Here we addressed the effect of removing mammalian cyt c on the integrity of the respiratory complexes in mammalian cells. Mitochondria from cyt c knockout mouse cells lacked fully assembled complexes I and IV and had reduced levels of complex III. A redox-deficient mutant of cyt c was unable to rescue the levels of complexes I and IV. We found that cyt c is associated with both complex IV and respiratory supercomplexes, providing a potential mechanism for the requirement for cyt c in the assembly/stability of complex IV.	[Vempati, Uma D.; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Vempati, Uma D.; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Cell Biol & Anat, Miami, FL 33136 USA; [Han, Xianlin] Washington Univ, Dept Internal Med, Div Bioorgan Chem & Mol Pharmacol, St Louis, MO 63110 USA	University of Miami; University of Miami; Washington University (WUSTL)	Moraes, CT (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, 1095 NW,14th Terrace, Miami, FL 33136 USA.	cmoraes@med.miami.edu	Moraes, Carlos/AAT-3818-2021		National Institutes of Health [R01-CA85700, R01-NS41777]; NATIONAL CANCER INSTITUTE [R01CA085700] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY010804] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041777] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-CA85700 and R01-NS41777 (to C. T. M.) and P01 HL57278 (to X. H.).	Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Barrientos A, 1998, J BIOL CHEM, V273, P14210, DOI 10.1074/jbc.273.23.14210; Barrientos A, 2003, J BIOL CHEM, V278, P8881, DOI 10.1074/jbc.M212427200; Barros MH, 2002, FEBS LETT, V516, P119, DOI 10.1016/S0014-5793(02)02514-0; Bernard DG, 2003, J BIOL CHEM, V278, P49732, DOI 10.1074/jbc.M308881200; Buchet K, 1998, J BIOL CHEM, V273, P22983, DOI 10.1074/jbc.273.36.22983; Cheng H, 2008, BIOCHEMISTRY-US, V47, P5869, DOI 10.1021/bi7023282; Dey R, 2000, J BIOL CHEM, V275, P7087, DOI 10.1074/jbc.275.10.7087; Diaz F, 2006, MOL CELL BIOL, V26, P4872, DOI 10.1128/MCB.01767-05; Diekert K, 2001, EMBO J, V20, P5626, DOI 10.1093/emboj/20.20.5626; DOWNIE JA, 1977, J MOL BIOL, V113, P369, DOI 10.1016/0022-2836(77)90147-4; DUMONT ME, 1991, MOL CELL BIOL, V11, P5487, DOI 10.1128/MCB.11.11.5487; DUTTA C, 1990, ANAL BIOCHEM, V184, P96, DOI 10.1016/0003-2697(90)90018-5; Gohil VM, 2004, J BIOL CHEM, V279, P42612, DOI 10.1074/jbc.M402545200; Gottlieb RA, 2000, METHOD ENZYMOL, V322, P213; Han XL, 2006, J LIPID RES, V47, P864, DOI 10.1194/jlr.D500044-JLR200; Han XL, 2005, MASS SPECTROM REV, V24, P367, DOI 10.1002/mas.20023; Koshkin V, 2002, BIOCHEM J, V364, P317, DOI 10.1042/bj3640317; Koshkin V, 2000, BIOCHEM J, V347, P687, DOI 10.1042/0264-6021:3470687; Krishna MMG, 2006, J MOL BIOL, V359, P1410, DOI 10.1016/j.jmb.2006.04.035; Li YF, 2007, J BIOL CHEM, V282, P17557, DOI 10.1074/jbc.M701056200; Maity H, 2004, J MOL BIOL, V343, P223, DOI 10.1016/j.jmb.2004.08.005; Mancuso DJ, 2007, J BIOL CHEM, V282, P34611, DOI 10.1074/jbc.M707795200; Mansfield KD, 2005, CELL METAB, V1, P393, DOI 10.1016/j.cmet.2005.05.003; Mayer A, 1995, METHOD ENZYMOL, V260, P252, DOI 10.1016/0076-6879(95)60143-0; Moraes CT, 2004, BBA-BIOENERGETICS, V1659, P153, DOI 10.1016/j.bbabio.2004.09.002; PEARCE DA, 1995, J BIOL CHEM, V270, P20879, DOI 10.1074/jbc.270.36.20879; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Plant GW, 2002, J NEUROSCI, V22, P6083; Robinson BH, 2000, PEDIATR RES, V48, P581, DOI 10.1203/00006450-200011000-00004; Rumbley J, 2001, P NATL ACAD SCI USA, V98, P105, DOI 10.1073/pnas.98.1.105; Schagger H, 2004, J BIOL CHEM, V279, P36349, DOI 10.1074/jbc.M404033200; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; SCHWEINGRUBER ME, 1979, J BIOL CHEM, V254, P4132; Vempati UD, 2007, MOL CELL BIOL, V27, P1771, DOI 10.1128/MCB.00287-06; Zhao M, 1998, J BIOL CHEM, V273, P2402, DOI 10.1074/jbc.273.4.2402	37	56	58	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4383	4391		10.1074/jbc.M805972200	http://dx.doi.org/10.1074/jbc.M805972200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19075019	hybrid, Green Published			2022-12-25	WOS:000263134400037
J	Hamiaux, C; Stanley, D; Greenwood, DR; Baker, EN; Newcomb, RD				Hamiaux, Cyril; Stanley, Duncan; Greenwood, Dave R.; Baker, Edward N.; Newcomb, Richard D.			Crystal Structure of Epiphyas postvittana Takeout 1 with Bound Ubiquinone Supports a Role as Ligand Carriers for Takeout Proteins in Insects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-BINDING-PROTEIN; JUVENILE-HORMONE; MANDUCA-SEXTA; MACROMOLECULAR STRUCTURES; FEEDING-BEHAVIOR; GENE; DROSOPHILA; IDENTIFICATION; EXPRESSION; GENOMICS	Takeout (To) proteins are found exclusively in insects and have been proposed to have important roles in various aspects of their physiology and behavior. Limited sequence similarity with juvenile hormone-binding proteins (JHBPs), which specifically bind and transport juvenile hormones in Lepidoptera, suggested a role for To proteins in binding hydrophobic ligands. We present the first crystal structure of a To protein, EpTo1 from the light brown apple moth Epiphyas postvittana, solved in-house by the single-wavelength anomalous diffraction technique using sulfur anomalous dispersion, and refined to 1.3 angstrom resolution. EpTo1 adopts the unusual alpha/beta-wrap fold, seen only for JHBP and several mammalian lipid carrier proteins, a scaffold tailored for the binding and/or transport of hydrophobic ligands. EpTo1 has a 45 angstrom long, purely hydrophobic, internal tunnel that extends for the full length of the protein and accommodates a bound ligand. The latter was shown by mass spectrometry to be ubiquinone-8 and is probably derived from Escherichia coli. The structure provides the first direct experimental evidence that To proteins are ligand carriers; gives insights into the nature of endogenous ligand(s) of EpTo1; shows, by comparison with JHBP, a basis for different ligand specificities; and suggests a mechanism for the binding/release of ligands.	[Hamiaux, Cyril; Baker, Edward N.] Univ Auckland, Sch Biol Sci, Struct Biol Lab, Auckland 1142, New Zealand; [Hamiaux, Cyril; Stanley, Duncan; Greenwood, Dave R.; Newcomb, Richard D.] Hort & Food Res Inst New Zealand Ltd, Auckland 1142, New Zealand	University of Auckland; New Zealand Institute for Plant & Food Research Ltd	Baker, EN (corresponding author), Univ Auckland, Sch Biol Sci, Struct Biol Lab, Private Bag 92019, Auckland 1142, New Zealand.	en.baker@auckland.ac.nz; rnewcomb@hortresearch.co.nz	Greenwood, David R/D-2375-2016; Hamiaux, Cyril/U-9978-2017; Newcomb, Richard/C-2067-2009	Greenwood, David R/0000-0001-5280-042X; Hamiaux, Cyril/0000-0001-9198-3441; Newcomb, Richard/0000-0002-7307-9755; Baker, Edward/0000-0003-2456-7661	New Zealand's Foundation for Research Science and Technology [UOAX0301, CO6X0301]	New Zealand's Foundation for Research Science and Technology(New Zealand Foundation for Research, Science and Technology)	This work was supported by New Zealand's Foundation for Research Science and Technology (contract IDs UOAX0301 and CO6X0301). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beamer LJ, 1997, SCIENCE, V276, P1861, DOI 10.1126/science.276.5320.1861; Bohbot J, 2005, INSECT BIOCHEM MOLEC, V35, P961, DOI 10.1016/j.ibmb.2005.03.010; Charles JP, 1996, ARCH INSECT BIOCHEM, V31, P371, DOI 10.1002/(SICI)1520-6327(1996)31:4&lt;371::AID-ARCH2&gt;3.0.CO;2-Z; Dauwalder B, 2002, GENE DEV, V16, P2879, DOI 10.1101/gad.1010302; Du JG, 2003, INSECT BIOCHEM MOLEC, V33, P803, DOI 10.1016/S0965-1748(03)00079-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fujikawa K, 2006, FEBS J, V273, P4311, DOI 10.1111/j.1742-4658.2006.05422.x; Gao MC, 2004, J BASIC MICROB, V44, P424, DOI 10.1002/jobm.200410436; Hagai T, 2007, INSECT BIOCHEM MOLEC, V37, P689, DOI 10.1016/j.ibmb.2007.04.002; Hojo M, 2005, INSECT BIOCHEM MOLEC, V35, P347, DOI 10.1016/j.ibmb.2005.01.007; Jordan MD, 2008, INSECT MOL BIOL, V17, P361, DOI 10.1111/j.1365-2583.2008.00812.x; Justice RW, 2003, INSECT MOL BIOL, V12, P581, DOI 10.1046/j.1365-2583.2003.00443.x; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Kolodziejczyk R, 2008, J MOL BIOL, V377, P870, DOI 10.1016/j.jmb.2008.01.026; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lazareva AA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030016; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li H, 1998, INSECT BIOCHEM MOLEC, V28, P69, DOI 10.1016/S0965-1748(97)00098-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meunier N, 2007, J EXP BIOL, V210, P1424, DOI 10.1242/jeb.02755; Meyer P, 2004, EMBO J, V23, P511, DOI 10.1038/sj.emboj.7600060; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Noriega FG, 2006, INSECT BIOCHEM MOLEC, V36, P366, DOI 10.1016/j.ibmb.2006.01.013; PALLI SR, 1994, P NATL ACAD SCI USA, V91, P6191, DOI 10.1073/pnas.91.13.6191; Papanicolaou A, 2008, NUCLEIC ACIDS RES, V36, pD582, DOI 10.1093/nar/gkm853; Qiu XY, 2007, NAT STRUCT MOL BIOL, V14, P106, DOI 10.1038/nsmb1197; Saito K, 2006, INSECT MOL BIOL, V15, P245, DOI 10.1111/j.1365-2583.2006.00612.x; Sarov-Blat L, 2000, CELL, V101, P647, DOI 10.1016/S0092-8674(00)80876-4; So WV, 2000, MOL CELL BIOL, V20, P6935, DOI 10.1128/MCB.20.18.6935-6944.2000; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Zhu HS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001345	34	38	41	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3496	3503		10.1074/jbc.M807467200	http://dx.doi.org/10.1074/jbc.M807467200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19073605	hybrid			2022-12-25	WOS:000262872500016
J	Liu, Y; Hao, WL; Dawson, A; Liu, SR; Fassbender, K				Liu, Yang; Hao, Wenlin; Dawson, Alik; Liu, Shirong; Fassbender, Klaus			Expression of Amyotrophic Lateral Sclerosis-linked SOD1 Mutant Increases the Neurotoxic Potential of Microglia via TLR2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOTOR-NEURON DEGENERATION; NECROSIS-FACTOR-ALPHA; TOLL-LIKE RECEPTOR-4; MOUSE MODEL; OXIDATIVE STRESS; EXTEND SURVIVAL; NADPH OXIDASE; DISMUTASE; ACTIVATION; CELLS	Amyotrophic lateral sclerosis (ALS) is a progressive motor neuron disease, in which activated microglia overexpressing ALS-linked SOD1 mutants (mSOD1) are known to contribute to neuronal death. However, it is unclear how mSOD1 expression affects micoglial activation and subsequently damages neurons. In this study, we created mSOD1-overexpressing BV-2 microglial cell lines. Following TLR2, but not TLR4 stimulation, we observed that overexpression of human SOD1 G93A, L8Q, or G10V mutant, as compared with the wild-type SOD1 or a mock control, significantly enhanced microglial secretion of a neurotoxic cytokine, tumor necrosis factor-alpha (TNF-alpha), which was dependent on the NADPH-oxidase-mediated increased generation of reactive oxygen species (ROS). In further experiments, we demonstrated that mSOD1 expression regulated TNF-alpha secretion at a post-transcriptional level and involved ROS-sensitive TNF-alpha-converting enzymes, e. g. ADAM10 and -17, which shed TNF-alpha from its membrane-anchored precursor. Together with a recent report that the function of SOD1, as a self-regulating redox sensor in NADPH oxidase-dependent ROS production, is lost due to its genetic mutations, we conclude that mSOD1 expression in ALS facilitates microglial neurotoxic inflammatory responses via TLR2, which is mediated by an uncontrolled ROS generation. The link, between mSOD1, innate immunity and NADPH oxidase, offers new opportunities in ALS therapies.	[Liu, Yang; Hao, Wenlin; Dawson, Alik; Liu, Shirong; Fassbender, Klaus] Univ Saarland, Dept Neurol, D-66421 Homburg, Germany	Saarland University	Liu, Y (corresponding author), Univ Saarland, Dept Neurol, Kirrberger Str, D-66421 Homburg, Germany.	a.liu@mx.uni-saarland.de	Liu, Yang/GSD-5476-2022; Liu, Shirong/AAB-7300-2021	Liu, Shirong/0000-0002-3821-9134; Fassbender, Klaus/0000-0003-3596-868X; , Shirong/0000-0001-9475-6236; Liu, Yang/0000-0002-7614-4233	Fritz Thyssen Stiftung; Homburger Forschungsforderungsprogramm [HOMFOR2008]; Forschungspreis2007 der Freunde des Universitatsklinikums des Saarlandes	Fritz Thyssen Stiftung; Homburger Forschungsforderungsprogramm; Forschungspreis2007 der Freunde des Universitatsklinikums des Saarlandes	This work was supported by Fritz Thyssen Stiftung (to Y. L. and K. F.), Homburger Forschungsforderungsprogramm (HOMFOR2008) (to Y. L.), and Forschungspreis2007 der Freunde des Universitatsklinikums des Saarlandes (to Y. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ascherio A, 2005, ANN NEUROL, V57, P104, DOI 10.1002/ana.20316; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; BAZAN JF, 1991, NEURON, V7, P197, DOI 10.1016/0896-6273(91)90258-2; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Bigini P, 2008, NEUROBIOL DIS, V29, P465, DOI 10.1016/j.nbd.2007.11.005; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Bsibsi M, 2002, J NEUROPATH EXP NEUR, V61, P1013, DOI 10.1093/jnen/61.11.1013; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Fassbender K, 2004, FASEB J, V18, P203, DOI 10.1096/fj.03-0364fje; Frantz S, 2001, J BIOL CHEM, V276, P5197, DOI 10.1074/jbc.M009160200; Gordon PH, 2007, LANCET NEUROL, V6, P1045, DOI 10.1016/S1474-4422(07)70270-3; Gowing G, 2008, J NEUROSCI, V28, P10234, DOI 10.1523/JNEUROSCI.3494-08.2008; Graves MC, 2004, AMYOTROPH LATERAL SC, V5, P213, DOI 10.1080/14660820410020286; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Harraz MM, 2008, J CLIN INVEST, V118, P659, DOI 10.1172/JCI34060; Hirota H, 1996, J EXP MED, V183, P2627, DOI 10.1084/jem.183.6.2627; Holvoet P, 2006, ARTERIOSCL THROM VAS, V26, P1558, DOI 10.1161/01.ATV.0000226553.01555.02; Ikeda K, 1996, J NEUROL SCI, V135, P109, DOI 10.1016/0022-510X(95)00263-2; Ischiropoulos H, 2003, J CLIN INVEST, V111, P163, DOI 10.1172/JCI200317638; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Kang J, 2007, J CELL BIOL, V179, P1219, DOI 10.1083/jcb.200705046; Kiaei M, 2006, J NEUROSCI, V26, P2467, DOI 10.1523/JNEUROSCI.5253-05.2006; Konat GW, 2006, J NEUROCHEM, V99, P1, DOI 10.1111/j.1471-4159.2006.04076.x; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; LAMPSON LA, 1990, ANN NEUROL, V28, P365, DOI 10.1002/ana.410280311; Leichsenring A, 2006, BRAIN RES, V1096, P180, DOI 10.1016/j.brainres.2006.04.029; LETIEMBRE M, 2007, NEUROBIOL A IN PRESS; Liu Y, 2005, BRAIN, V128, P1778, DOI 10.1093/brain/awh531; Liu Y, 2006, J NEUROSCI, V26, P12904, DOI 10.1523/JNEUROSCI.2531-06.2006; Lunn CA, 1997, FEBS LETT, V400, P333, DOI 10.1016/S0014-5793(96)01410-X; Marden JJ, 2007, J CLIN INVEST, V117, P2913, DOI 10.1172/JCI31265; Nguyen MD, 2004, J NEUROSCI, V24, P1340, DOI 10.1523/JNEUROSCI.4786-03.2004; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Orrell RW, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002829.pub4; PINEAU I, 2008, IN PRESS; Riener CK, 2002, ANAL BIOANAL CHEM, V373, P266, DOI 10.1007/s00216-002-1347-2; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; Simpson EP, 2003, CURR OPIN RHEUMATOL, V15, P730, DOI 10.1097/00002281-200311000-00008; TROOST D, 1990, NEUROPATH APPL NEURO, V16, P401, DOI 10.1111/j.1365-2990.1990.tb01276.x; Turner MR, 2004, NEUROBIOL DIS, V15, P601, DOI 10.1016/j.nbd.2003.12.012; Udan MLD, 2008, J NEUROCHEM, V104, P524, DOI 10.1111/j.1471-4159.2007.05001.x; Urushitani M, 2006, NAT NEUROSCI, V9, P108, DOI 10.1038/nn1603; Veldink JH, 2007, J NEUROL NEUROSUR PS, V78, P367, DOI 10.1136/jnnp.2005.083378; Walter S, 2007, CELL PHYSIOL BIOCHEM, V20, P947, DOI 10.1159/000110455; Walton KA, 2003, J BIOL CHEM, V278, P29661, DOI 10.1074/jbc.M300738200; Walton KA, 2003, ARTERIOSCL THROM VAS, V23, P1197, DOI 10.1161/01.ATV.0000079340.80744.B8; Weydt P, 2004, GLIA, V48, P179, DOI 10.1002/glia.20062; Wu DC, 2006, P NATL ACAD SCI USA, V103, P12132, DOI 10.1073/pnas.0603670103; Zhang ZL, 2001, FASEB J, V15, P303; Zhong J, 1999, J NEUROSCI, V19, P4305	55	89	92	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3691	3699		10.1074/jbc.M804446200	http://dx.doi.org/10.1074/jbc.M804446200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19091752	hybrid			2022-12-25	WOS:000262872500037
J	Ohlendorf, S; Sprenger, A; Speck, O; Haller, S; Kimmig, H				Ohlendorf, Sabine; Sprenger, Andreas; Speck, Oliver; Haller, Sven; Kimmig, Hubert			Optic Flow Stimuli in and Near the Visual Field Centre: A Group fMRI Study of Motion Sensitive Regions	PLOS ONE			English	Article								Motion stimuli in one visual hemifield activate human primary visual areas of the contralateral side, but suppress activity of the corresponding ipsilateral regions. While hemifield motion is rare in everyday life, motion in both hemifields occurs regularly whenever we move. Consequently, during motion primary visual regions should simultaneously receive excitatory and inhibitory inputs. A comparison of primary and higher visual cortex activations induced by bilateral and unilateral motion stimuli is missing up to now. Many motion studies focused on the MT+ complex in the parieto-occipito-temporal cortex. In single human subjects MT+ has been subdivided in area MT, which was activated by motion stimuli in the contralateral visual field, and area MST, which responded to motion in both the contra and ipsilateral field. In this study we investigated the cortical activation when excitatory and inhibitory inputs interfere with each other in primary visual regions and we present for the first time group results of the MT+ subregions, allowing for comparisons with the group results of other motion processing studies. Using functional magnetic resonance imaging (fMRI), we investigated whole brain activations in a large group of healthy humans by applying optic flow stimuli in and near the visual field centre and performed a second level analysis. Primary visual areas were activated exclusively by motion in the contralateral field but to our surprise not by central flow fields. Inhibitory inputs to primary visual regions appear to cancel simultaneously occurring excitatory inputs during central flow field stimulation. Within MT+ we identified two subregions. Putative area MST (pMST) was activated by ipsi- and contralateral stimulation and located in the anterior part of MT+. The second subregion was located in the more posterior part of MT+ (putative area MT, pMT).	Univ Freiburg Klinikum, Neurol Klin, Freiburg, Germany; [Sprenger, Andreas; Kimmig, Hubert] Universitatsklin Schleswig Holstein, Klin Neurol, Lubeck, Germany; [Ohlendorf, Sabine; Speck, Oliver] Universitatsklin, Abt Rontgendiagnost, Freiburg, Germany; [Speck, Oliver] Univ Magdeburg, Inst Expt Phys, Abt Biomedizin Magnetresonanz, Magdeburg, Germany; [Haller, Sven] Universitatssp, Abt Neuroradiol, Basel, Switzerland; [Ohlendorf, Sabine] Univ Freiburg, Fak Biol, Freiburg, Germany; [Kimmig, Hubert] Univ Freiburg, Acad Teaching Hosp, Schwarzwald Baar Klin, Villingen Schwenningen, Germany	University of Freiburg; University of Kiel; Schleswig Holstein University Hospital; Otto von Guericke University; University of Freiburg; University of Freiburg	Ohlendorf, S (corresponding author), Univ Freiburg Klinikum, Neurol Klin, Freiburg, Germany.	hubert.kimmig@neuro.uni-luebeck.de	Speck, Oliver/F-1406-2013; Sprenger, Andreas/C-7612-2009; Haller, Sven/AAY-2564-2020	Speck, Oliver/0000-0002-6019-5597; Sprenger, Andreas/0000-0001-9255-7911; Haller, Sven/0000-0001-7433-0203; Issa, Naoum Pierre/0000-0001-9247-1341	DFG [SFB654-A4]	DFG(German Research Foundation (DFG))	This study was performed as part of the binational PhD project of author SO (Universities of Freiburg, Germany and Basel, Switzerland) within the Eltem program of Neurex, the 13 Neuroscience network in the upper Rhine Valley. Author HK is currently supported by a grant from DFG (SFB654-A4).	Brandt T, 2000, NEUROREPORT, V11, P2803, DOI 10.1097/00001756-200008210-00039; Brandt T, 2003, ANN NY ACAD SCI, V1004, P283, DOI 10.1196/annals.1303.025; CLARKE S, 1990, J COMP NEUROL, V298, P188, DOI 10.1002/cne.902980205; d'Avossa G, 2007, NAT NEUROSCI, V10, P249, DOI 10.1038/nn1824; DESIMONE R, 1986, J COMP NEUROL, V248, P164, DOI 10.1002/cne.902480203; Dukelow SP, 2001, J NEUROPHYSIOL, V86, P1991, DOI 10.1152/jn.2001.86.4.1991; Dumoulin SO, 2000, CEREB CORTEX, V10, P454, DOI 10.1093/cercor/10.5.454; DUPONT P, 1994, J NEUROPHYSIOL, V72, P1420, DOI 10.1152/jn.1994.72.3.1420; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; GATTASS R, 1981, J NEUROPHYSIOL, V46, P621, DOI 10.1152/jn.1981.46.3.621; Goossens J, 2006, J NEUROSCI, V26, P5616, DOI 10.1523/JNEUROSCI.0730-06.2006; Huk AC, 2002, J NEUROSCI, V22, P7195; Kimmig H, 1999, EXP BRAIN RES, V126, P443, DOI 10.1007/s002210050751; KOMATSU H, 1988, J NEUROPHYSIOL, V60, P580, DOI 10.1152/jn.1988.60.2.580; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; MARUYAMA M, 2007, HUM BRAIN MAPP; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; Morrone MC, 2000, NAT NEUROSCI, V3, P1322, DOI 10.1038/81860; Nelles G, 2002, STROKE, V33, P1286, DOI 10.1161/01.STR.0000013685.76973.67; Orban GA, 2003, NEUROPSYCHOLOGIA, V41, P1757, DOI 10.1016/S0028-3932(03)00177-5; Orban GA, 1999, NEURON, V24, P929, DOI 10.1016/S0896-6273(00)81040-5; Orban GA, 2004, TRENDS COGN SCI, V8, P315, DOI 10.1016/j.tics.2004.05.009; Raiguel S, 1997, NEUROREPORT, V8, P2803, DOI 10.1097/00001756-199708180-00030; Sincich LC, 2004, NAT NEUROSCI, V7, P1123, DOI 10.1038/nn1318; Smith AT, 2006, EUR J NEUROSCI, V23, P561, DOI 10.1111/j.1460-9568.2005.04526.x; Smith SM, 2004, BRIT J RADIOL, V77, pS167, DOI 10.1259/bjr/33553595; Stepniewska I, 1999, EUR J NEUROSCI, V11, P469, DOI 10.1046/j.1460-9568.1999.00461.x; TOOTELL RBH, 1995, CEREB CORTEX, V5, P39, DOI 10.1093/cercor/5.1.39; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P818, DOI 10.1073/pnas.95.3.818; Tootell RBH, 1997, J NEUROSCI, V17, P7060; UNGERLEIDER LG, 1986, J COMP NEUROL, V248, P190, DOI 10.1002/cne.902480204; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Van Essen DC, 2004, NEUROIMAGE, V23, pS97, DOI 10.1016/j.neuroimage.2004.07.024; Van Essen DC, 2002, CURR OPIN NEUROBIOL, V12, P574, DOI 10.1016/S0959-4388(02)00361-6; Van Essen DC, 2001, VISION RES, V41, P1359, DOI 10.1016/S0042-6989(01)00045-1; VANESSEN DC, 1986, J COMP NEUROL, V244, P451, DOI 10.1002/cne.902440405; VANESSEN DC, 1981, J COMP NEUROL, V199, P293, DOI 10.1002/cne.901990302; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; Weiskrantz L, 1996, CURR OPIN NEUROBIOL, V6, P215, DOI 10.1016/S0959-4388(96)80075-4; Zaitsev M, 2004, MAGNET RESON MED, V52, P1156, DOI 10.1002/mrm.20261; ZEKI S, 1991, J NEUROSCI, V11, P641	42	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2008	3	12							e4043	10.1371/journal.pone.0004043	http://dx.doi.org/10.1371/journal.pone.0004043			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DI	19112507	Green Submitted, Green Published, gold			2022-12-25	WOS:000265466000010
J	Vukojevic, V; Ming, Y; D'Addario, C; Rigler, R; Johansson, B; Terenius, L				Vukojevic, Vladana; Ming, Yu; D'Addario, Claudio; Rigler, Rudolf; Johansson, Bjorn; Terenius, Lars			Ethanol/Naltrexone Interactions at the mu-Opioid Receptor. CLSM/FCS Study in Live Cells	PLOS ONE			English	Article							LIPID-PROTEIN INTERACTIONS; PLASMA-MEMBRANE; ETHANOL; ALCOHOL; NALTREXONE; CHOLESTEROL; ANESTHETICS; SYSTEM; RAFTS; OLIGOMERIZATION	Background: Alcoholism is a widespread chronic disorder of complex aetiology with a significant negative impact on the individual and the society. Mechanisms of ethanol action are not sufficiently well understood at the molecular level and the pharmacotherapy of alcoholism is still in its infancy. Our study focuses at the cellular and molecular level on ethanol-induced effects that are mediated through the mu-opioid receptor ( MOP) and on the effects of naltrexone, a well-known antagonist at MOP that is used clinically to prevent relapse in alcoholism. Methodology/Principal Findings: Advanced fluorescence imaging by Confocal Laser Scanning Microscopy (CLSM) and Fluorescence Correlation Spectroscopy (FCS) are used to study ethanol effects on MOP and plasma membrane lipid dynamics in live PC12 cells. We observed that relevant concentrations of ethanol (10-40 mM) alter MOP mobility and surface density, and affect the dynamics of plasma membrane lipids. Compared to the action of specific ligands at MOP, ethanol-induced effects show complex kinetics and point to a biphasic underlying mechanism. Pretreatment with naloxone or naltrexone considerably mitigates the effects of ethanol. Conclusions/Significance: We suggest that ethanol acts by affecting the sorting of MOP at the plasma membrane of PC12 cells. Naltrexone exerts opposite effects on MOP sorting at the plasma membrane, thereby countering the effects of ethanol. Our experimental findings give new insight on MOP-mediated ethanol action at the cellular and molecular level. We suggest a new hypothesis to explain the well established ethanol-induced increase in the activity of the endogenous opioid system.	[Vukojevic, Vladana; Ming, Yu; D'Addario, Claudio; Johansson, Bjorn; Terenius, Lars] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Rigler, Rudolf] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Rigler, Rudolf] Swiss Fed Inst Technol, Lab Biomed Opt, Lausanne, Switzerland	Karolinska Institutet; Karolinska Institutet; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Vukojevic, V (corresponding author), Karolinska Inst, Dept Clin Neurosci, CMM L8 01, Stockholm, Sweden.	vladana.vukojevic@ki.se	DAddario, Claudio/A-5970-2010; Vukojevic, Vladana B/AAY-3144-2021	Vukojevic, Vladana/0000-0003-0873-5653; d'addario, claudio/0000-0002-1275-098X	Swedish Research Council; AFA Insurance; Cancerdegradome; The Brain foundation; The Knut and Alice Wallenberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); AFA Insurance; Cancerdegradome; The Brain foundation; The Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	Financial support from the Swedish Research Council, AFA Insurance, Cancerdegradome, The Brain foundation and The Knut and Alice Wallenberg Foundation is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Arispe N, 2002, FASEB J, V16, P1526, DOI 10.1096/fj.02-0829com; Bacia K, 2007, NAT PROTOC, V2, P2842, DOI 10.1038/nprot.2007.410; Bacia Kirsten, 2007, V398, P73, DOI 10.1007/978-1-59745-513-8_7; CHIOU JS, 1990, SCIENCE, V248, P583, DOI 10.1126/science.2159183; Coonfield DL, 2002, ALCOHOL, V26, P43, DOI 10.1016/S0741-8329(01)00180-X; D'Addario C, 2008, FASEB J, V22, P662, DOI 10.1096/fj.07-8346com; Dai Q, 2005, BIOCHEM BIOPH RES CO, V332, P37, DOI 10.1016/j.bbrc.2005.04.088; Dai Q, 2006, ALCOHOL CLIN EXP RES, V30, P1436, DOI 10.1111/j.1530-0277.2006.00172.x; EHRENBER.M, 1974, CHEM PHYS, V4, P390, DOI 10.1016/0301-0104(74)85005-6; ELSON EL, 1974, BIOPOLYMERS, V13, P1, DOI 10.1002/bip.1974.360130102; Forman Stuart A., 1998, P5; FRASER DM, 1990, BIOCHEMISTRY-US, V29, P2664, DOI 10.1021/bi00463a007; Ghozland S, 2005, NEUROPHARMACOLOGY, V49, P493, DOI 10.1016/j.neuropharm.2005.04.006; Gomes I, 2002, METHODS, V27, P358, DOI 10.1016/S1046-2023(02)00094-4; Grahame NJ, 1998, ALCOHOL CLIN EXP RES, V22, P1093, DOI 10.1111/j.1530-0277.1998.tb03706.x; GREENBERG ML, 1993, J MEMBRANE BIOL, V131, P115, DOI 10.1007/BF02791320; Griepernau B, 2007, BBA-BIOMEMBRANES, V1768, P2899, DOI 10.1016/j.bbamem.2007.08.002; Grisel JE, 1999, BRAIN RES, V835, P62, DOI 10.1016/S0006-8993(99)01384-0; Guizzetti M, 2007, HUM EXP TOXICOL, V26, P355, DOI 10.1177/0960327107078412; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Herz A, 1998, CAN J PHYSIOL PHARM, V76, P252, DOI 10.1139/cjpp-76-3-252; Herz A, 1997, PSYCHOPHARMACOLOGY, V129, P99, DOI 10.1007/s002130050169; Jung SW, 2005, J BIOL CHEM, V280, P308, DOI 10.1074/jbc.M409871200; Koenig HN, 2002, NEUROSCI LETT, V325, P75, DOI 10.1016/S0304-3940(02)00242-2; Lerner RA, 1997, P NATL ACAD SCI USA, V94, P13375, DOI 10.1073/pnas.94.25.13375; Levac BAR, 2002, CURR OPIN PHARMACOL, V2, P76, DOI 10.1016/S1471-4892(02)00124-8; Loura LMS, 2000, BBA-BIOMEMBRANES, V1467, P101, DOI 10.1016/S0005-2736(00)00211-X; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; Muller JD, 2000, BIOPHYS J, V78, P474, DOI 10.1016/S0006-3495(00)76610-0; Nourissat P, 2008, HEPATOLOGY, V47, P59, DOI 10.1002/hep.21958; OMALLEY SS, 1992, ARCH GEN PSYCHIAT, V49, P881; Oswald LM, 2004, PHYSIOL BEHAV, V81, P339, DOI 10.1016/j.physbeh.2004.02.008; Peoples RW, 1996, ANNU REV PHARMACOL, V36, P185, DOI 10.1146/annurev.pa.36.040196.001153; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Pucadyil TJ, 2006, PROG LIPID RES, V45, P295, DOI 10.1016/j.plipres.2006.02.002; Roberts AJ, 2000, J PHARMACOL EXP THER, V293, P1002; Saland LC, 2005, NEUROSCI LETT, V381, P163, DOI 10.1016/j.neulet.2005.02.016; SEEMAN P, 1972, PHARMACOL REV, V24, P583; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Slater SJ, 1997, J BIOL CHEM, V272, P6167, DOI 10.1074/jbc.272.10.6167; SWIFT RM, 1995, J CLIN PSYCHIAT, V56, P24; Szabo G, 2007, J IMMUNOL, V178, P1243, DOI 10.4049/jimmunol.178.3.1243; Terama E, 2008, J PHYS CHEM B, V112, P4131, DOI 10.1021/jp0750811; TOCANNE JF, 1994, CHEM PHYS LIPIDS, V73, P139, DOI 10.1016/0009-3084(94)90179-1; VOLPICELLI JR, 1992, ARCH GEN PSYCHIAT, V49, P876; Vukojevic V, 2005, CELL MOL LIFE SCI, V62, P535, DOI 10.1007/s00018-004-4305-7; Vukojevic V, 2008, FASEB J, V22, P3537, DOI 10.1096/fj.08-108894; Wallner M, 2006, PHARMACOL THERAPEUT, V112, P513, DOI 10.1016/j.pharmthera.2006.05.004	49	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2008	3	12							e4008	10.1371/journal.pone.0004008	http://dx.doi.org/10.1371/journal.pone.0004008			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CB	19104662	gold, Green Published, Green Submitted			2022-12-25	WOS:000265462400009
J	Egeland, T; Salas, A				Egeland, Thore; Salas, Antonio			Estimating Haplotype Frequency and Coverage of Databases	PLOS ONE			English	Article							INTERNATIONAL-SOCIETY; FORENSIC-GENETICS; DNA COMMISSION; MTDNA; NUMBER; POPULATION; DIVERSITY; SAMPLE; ORIGIN; INDIVIDUALS	A variety of forensic, population, and disease studies are based on haploid DNA (e. g. mitochondrial DNA or Y-chromosome data). For any set of genetic markers databases of conventional size will normally contain only a fraction of all haplotypes. For several applications, reliable estimates of haplotype frequencies, the total number of haplotypes and coverage of the database (the probability that the next random haplotype is contained in the database) will be useful. We propose different approaches to the problem based on classical methods as well as new applications of Principal Component Analysis (PCA). We also discuss previous proposals based on saturation curves. Several conclusions can be inferred from simulated and real data. First, classical estimates of the fraction of unseen haplotypes can be seriously biased. Second, there is no obvious way to decide on required sample size based on traditional approaches. Methods based on testing of hypotheses or length of confidence intervals may appear artificial since no single test or parameter stands out as particularly relevant. Rather the coverage may be more relevant since it indicates the percentage of different haplotypes that are contained in a database; if the coverage is low, there is a considerable chance that the next haplotype to be observed does not appear in the database and this indicates that the database needs to be expanded. Finally, freeware and example data sets accompany the methods discussed in this paper: http://folk.uio.no/thoree/nhap/.	Univ Oslo, Inst Forens Med, Oslo, Norway; [Egeland, Thore] Oslo Univ Coll, Oslo, Norway; [Salas, Antonio] Univ Santiago Compostela, Fac Med, Inst Med Legal, Unidade Xenet, Galicia, Spain	University of Oslo; Oslo Metropolitan University (OsloMet); Universidade de Santiago de Compostela	Egeland, T (corresponding author), Univ Oslo, Inst Forens Med, Oslo, Norway.	thore.egeland@medisin.uio.no	Salas, Antonio/U-2029-2019; Salas, Antonio/E-3977-2012	Salas, Antonio/0000-0002-2336-702X; Salas, Antonio/0000-0002-2336-702X	Fundacion de Investigacion Medica Mutua Madrilena	Fundacion de Investigacion Medica Mutua Madrilena	Two grants from the Fundacion de Investigacion Medica Mutua Madrilena awarded to AS partially supported this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balding DJ, 2005, STAT PRACT; Bandelt HJ, 2005, J MED GENET, V42, P957, DOI 10.1136/jmg.2005.033589; BERTRANPETIT J, 1995, ANN HUM GENET, V59, P63, DOI 10.1111/j.1469-1809.1995.tb01606.x; BUNGE J, 1993, J AM STAT ASSOC, V88, P364, DOI 10.2307/2290733; Carracedo A, 2000, FORENSIC SCI INT, V110, P79, DOI 10.1016/S0379-0738(00)00161-4; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Chao A, 2005, SPECIES RICHNESS EST; CorteReal HBSM, 1996, ANN HUM GENET, V60, P331, DOI 10.1111/j.1469-1809.1996.tb01196.x; Crawford DC, 2005, ANNU REV MED, V56, P303, DOI 10.1146/annurev.med.56.082103.104540; Crespillo M, 2000, INT J LEGAL MED, V114, P130, DOI 10.1007/s004140000158; Curran JM, 2002, SCI JUSTICE, V42, P29, DOI 10.1016/S1355-0306(02)71794-2; EFRON B, 1976, BIOMETRIKA, V63, P435, DOI 10.1093/biomet/63.3.435; Egeland T, 2004, ANN HUM GENET, V68, P461, DOI 10.1046/j.1529-8817.2004.00109.x; ESTY WW, 1983, ANN STAT, V11, P905, DOI 10.1214/aos/1176346256; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Gill P, 2001, FORENSIC SCI INT, V124, P5, DOI 10.1016/S0379-0738(01)00498-4; Gonzalez AM, 2003, AM J PHYS ANTHROPOL, V120, P391, DOI 10.1002/ajpa.10168; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; HAAS P, 1998, JASA, V63, P837; Haas PJ, 1998, J AM STAT ASSOC, V93, P1475, DOI 10.2307/2670061; Helgason A, 2000, AM J HUM GENET, V66, P999, DOI 10.1086/302816; Huang SP, 2001, GENETICS, V159, P1365; Krawczak M, 2001, FORENSIC SCI INT, V118, P114, DOI 10.1016/S0379-0738(00)00479-5; Mao CX, 2004, J AM STAT ASSOC, V99, P1108, DOI 10.1198/016214504000001709; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; NORDBORG M, 2001, COALESCENT THEORY; Pereira L, 2004, INT J LEGAL MED, V118, P132, DOI 10.1007/s00414-003-0424-1; Pereira L, 2000, ANN HUM GENET, V64, P491, DOI 10.1046/j.1469-1809.2000.6460491.x; Pfeiffer H, 1999, INT J LEGAL MED, V112, P291, DOI 10.1007/s004140050252; Pfeiffer H, 2001, INT J LEGAL MED, V114, P169, DOI 10.1007/s004140000165; Plaza S, 2004, HUM GENET, V115, P439, DOI 10.1007/s00439-004-1164-0; Richards M, 1996, AM J HUM GENET, V59, P185; ROBBINS H, 1956, EMPIRICAL BAYES APPR, P92; Roewer L, 2001, FORENSIC SCI INT, V118, P106, DOI 10.1016/S0379-0738(00)00478-3; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Salas A, 2017, EUR J HUM GENET, V25, pS33, DOI 10.1038/sj.ejhg.5200202; STARR N, 1979, ANN STAT, V7, P644, DOI 10.1214/aos/1176344684; Wilson IJ, 2003, J R STAT SOC A STAT, V166, P155, DOI 10.1111/1467-985X.00264	38	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2008	3	12							e3988	10.1371/journal.pone.0003988	http://dx.doi.org/10.1371/journal.pone.0003988			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CA	19098988	gold, Green Published, Green Submitted			2022-12-25	WOS:000265462300001
J	Beaufays, J; Adam, B; Menten-Dedoyart, C; Fievez, L; Grosjean, A; Decrem, Y; Prevot, PP; Santini, S; Brasseur, R; Brossard, M; Vanhaeverbeek, M; Bureau, F; Heinen, E; Lins, L; Vanhamme, L; Godfroid, E				Beaufays, Jerome; Adam, Benoit; Menten-Dedoyart, Catherine; Fievez, Laurence; Grosjean, Amelie; Decrem, Yves; Prevot, Pierre-Paul; Santini, Sebastien; Brasseur, Robert; Brossard, Michel; Vanhaeverbeek, Michel; Bureau, Fabrice; Heinen, Ernst; Lins, Laurence; Vanhamme, Luc; Godfroid, Edmond			Ir-LBP, an Ixodes ricinus Tick Salivary LTB4-Binding Lipocalin, Interferes with Host Neutrophil Function	PLOS ONE			English	Article							LEUKOTRIENE B-4 RECEPTOR; ENDOTHELIAL-CELLS; CHEMOTACTIC FACTOR; BINDING PROTEINS; MECHANISM; RELEASE; BLT1; HYPERADHESIVENESS; ACTIVATION; EVOLUTION	Background: During their blood meal, ticks secrete a wide variety of proteins that can interfere with their host's defense mechanisms. Among these proteins, lipocalins play a major role in the modulation of the inflammatory response. Methodology/Principal Findings: We previously identified 14 new lipocalin genes in the tick Ixodes ricinus. One of them codes for a protein that specifically binds leukotriene B4 with a very high affinity (Kd: +/- 1 nM), similar to that of the neutrophil transmembrane receptor BLT1. By in silico approaches, we modeled the 3D structure of the protein and the binding of LTB4 into the ligand pocket. This protein, called Ir-LBP, inhibits neutrophil chemotaxis in vitro and delays LTB4-induced apoptosis. Ir-LBP also inhibits the host inflammatory response in vivo by decreasing the number and activation of neutrophils located at the tick bite site. Thus, Ir-LBP participates in the tick's ability to interfere with proper neutrophil function in inflammation. Conclusions/Significance: These elements suggest that Ir-LBP is a "scavenger" of LTB4, which, in combination with other factors, such as histamine-binding proteins or proteins inhibiting the classical or alternative complement pathways, permits the tick to properly manage its blood meal. Moreover, with regard to its properties, Ir-LBP could possibly be used as a therapeutic tool for illnesses associated with an increased LTB4 production.	[Decrem, Yves; Prevot, Pierre-Paul; Vanhamme, Luc; Godfroid, Edmond] Free Univ Brussels, IBMM, Lab Mol Biol Ectoparasites, Gosselies, Belgium; [Adam, Benoit; Santini, Sebastien; Brasseur, Robert; Lins, Laurence] Gembloux Agr Univ, Ctr Biophys Mol Numer, Gembloux, Belgium; [Menten-Dedoyart, Catherine; Heinen, Ernst] Univ Liege, Fac Med, Dept Morphol & Immunol, Inst Human Histol, B-4000 Liege, Belgium; [Fievez, Laurence; Bureau, Fabrice] Univ Liege, GIGA Res, Lab Cellular & Mol Physiol, B-4000 Liege, Belgium; [Grosjean, Amelie; Vanhaeverbeek, Michel] ISPPC Hop Andre Vesale, Lab Med Expt, Montignies le Tilleul, Belgium; [Brossard, Michel] Univ Neuchatel, Inst Zool, CH-2000 Neuchatel, Switzerland; [Vanhamme, Luc] Free Univ Brussels, IBMM, Lab Mol Parasitol, B-1050 Brussels, Belgium	Universite Libre de Bruxelles; University of Liege; University of Liege; University of Liege; University of Neuchatel; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Beaufays, J (corresponding author), Free Univ Brussels, IBMM, Lab Mol Biol Ectoparasites, Gosselies, Belgium.	edmond.godfroid@ulb.ac.be	LINS, LAURENCE/Y-1661-2019	LINS, LAURENCE/0000-0001-7772-6748; Santini, Sebastien/0000-0001-7087-1950	Belgian National Fund for Scientific Research [Senior Research Associate]; Ministere de la Region Wallonne in Belgium [215107, 415702]	Belgian National Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS); Ministere de la Region Wallonne in Belgium	LVH is a Senior Research Associate at the Belgian National Fund for Scientific Research. This work was supported by contracts 215107 and 415702 from the Ministere de la Region Wallonne in Belgium.	Adam B, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-1; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BOMALASKI JS, 1987, PROSTAGLANDINS, V33, P855, DOI 10.1016/0090-6980(87)90114-6; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Couvreur B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001400; Daix V, 2007, INSECT MOL BIOL, V16, P155, DOI 10.1111/j.1365-2583.2006.00710.x; Dibbert B, 1999, P NATL ACAD SCI USA, V96, P13330, DOI 10.1073/pnas.96.23.13330; Edwards SW, 2003, CHEM IMMUNOL, V83, P204; FORDHUTCHINSON AW, 1980, NATURE, V286, P264, DOI 10.1038/286264a0; GOETZL EJ, 1980, BIOCHEM BIOPH RES CO, V94, P881, DOI 10.1016/0006-291X(80)91317-0; GOETZL EJ, 1980, J IMMUNOL, V125, P1789; GOLDMAN DW, 1984, J EXP MED, V159, P1027, DOI 10.1084/jem.159.4.1027; GOLDSTEIN I, 1973, P NATL ACAD SCI USA, V70, P2916, DOI 10.1073/pnas.70.10.2916; Goodarzi K, 2003, NAT IMMUNOL, V4, P965, DOI 10.1038/ni972; Hajnicka V, 2001, PARASITE IMMUNOL, V23, P483, DOI 10.1046/j.1365-3024.2001.00403.x; Hebert MJ, 1996, J IMMUNOL, V157, P3105; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Jozefowski S, 2005, IMMUNOLOGY, V116, P418, DOI 10.1111/j.1365-2567.2005.02241.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee E, 1999, AM J RESP CRIT CARE, V160, P2079, DOI 10.1164/ajrccm.160.6.9903136; LIN AH, 1984, PROSTAGLANDINS, V28, P837, DOI 10.1016/0090-6980(84)90038-8; Lundeen KA, 2006, J IMMUNOL, V177, P3439, DOI 10.4049/jimmunol.177.5.3439; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P862, DOI 10.1016/j.ibmb.2008.06.002; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P841, DOI 10.1016/j.ibmb.2008.06.007; Mans BJ, 2008, J BIOL CHEM, V283, P18721, DOI 10.1074/jbc.M800188200; Murray J, 2003, BRIT J PHARMACOL, V139, P388, DOI 10.1038/sj.bjp.0705265; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; NG CF, 1991, J IMMUNOL, V147, P3096; Nohgawa M, 1997, J LEUKOCYTE BIOL, V62, P203, DOI 10.1002/jlb.62.2.203; Ott VL, 2003, NAT IMMUNOL, V4, P974, DOI 10.1038/ni971; Paesen GC, 1999, MOL CELL, V3, P661, DOI 10.1016/S1097-2765(00)80359-7; PALMBLAD J, 1984, J IMMUNOL, V132, P3041; PALMBLAD J, 1994, J IMMUNOL, V152, P262; PALMBLAD JEW, 1992, CLIN EXP IMMUNOL, V90, P300; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; RIBEIRO JMC, 1990, EXP PARASITOL, V70, P382, DOI 10.1016/0014-4894(90)90121-R; ROLAPLESZCZYNSKI M, 1985, J IMMUNOL, V135, P3958; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sangamnatdej S, 2002, INSECT MOL BIOL, V11, P79, DOI 10.1046/j.0962-1075.2001.00311.x; SCHRODER JM, 1989, J EXP MED, V170, P847, DOI 10.1084/jem.170.3.847; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SHAW JO, 1981, J IMMUNOL, V127, P1250; SHOWELL HJ, 1976, J EXP MED, V143, P1154, DOI 10.1084/jem.143.5.1154; SNYDERMAN R, 1969, J IMMUNOL, V103, P413; Tager AM, 2003, NAT IMMUNOL, V4, P982, DOI 10.1038/ni970; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; WARLOW RS, 1987, MOL IMMUNOL, V24, P27, DOI 10.1016/0161-5890(87)90108-8; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506; YOSHIMURA T, 1987, P NATL ACAD SCI USA, V84, P9233, DOI 10.1073/pnas.84.24.9233	52	57	59	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2008	3	12							e3987	10.1371/journal.pone.0003987	http://dx.doi.org/10.1371/journal.pone.0003987			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AV	19096526	Green Published, gold			2022-12-25	WOS:000265458800009
J	Rafii, A; Mirshahi, P; Poupot, M; Faussat, AM; Simon, A; Ducros, E; Mery, E; Couderc, B; Lis, R; Capdet, J; Bergalet, J; Querleu, D; Dagonnet, F; Fournie, JJ; Marie, JP; Pujade-Lauraine, E; Favre, G; Soria, J; Mirshahi, M				Rafii, Arash; Mirshahi, Pejman; Poupot, Mary; Faussat, Anne-Marie; Simon, Anne; Ducros, Elodie; Mery, Eliane; Couderc, Bettina; Lis, Raphael; Capdet, Jerome; Bergalet, Julie; Querleu, Denis; Dagonnet, Francoise; Fournie, Jean-Jacques; Marie, Jean-Pierre; Pujade-Lauraine, Eric; Favre, Gilles; Soria, Jeanine; Mirshahi, Massoud			Oncologic Trogocytosis of an Original Stromal Cells Induces Chemoresistance of Ovarian Tumours	PLOS ONE			English	Article							PERITONEAL MESOTHELIAL CELLS; MULTIDRUG-RESISTANCE; STEM-CELLS; INTERCELLULAR TRANSFER; MOLECULAR PREDICTOR; ADHESION MOLECULE; IN-VITRO; CANCER; GROWTH; EXPRESSION	Background: The microenvironment plays a major role in the onset and progression of metastasis. Epithelial ovarian cancer (EOC) tends to metastasize to the peritoneal cavity where interactions within the microenvironment might lead to chemoresistance. Mesothelial cells are important actors of the peritoneal homeostasis; we determined their role in the acquisition of chemoresistance of ovarian tumours. Methodology/Principal Findings: We isolated an original type of stromal cells, referred to as "Hospicells'' from ascitis of patients with ovarian carcinosis using limiting dilution. We studied their ability to confer chemoresistance through heterocellular interactions. These stromal cells displayed a new phenotype with positive immunostaining for CD9, CD10, CD29, CD146, CD166 and Multi drug resistance protein. They preferentially interacted with epithelial ovarian cancer cells. This interaction induced chemoresistance to platin and taxans with the implication of multi-drug resistance proteins. This contact enabled EOC cells to capture patches of the Hospicells membrane through oncologic trogocytosis, therefore acquiring their functional P-gp proteins and thus developing chemoresistance. Presence of Hospicells on ovarian cancer tissue micro-array from patients with neo-adjuvant chemotherapy was also significantly associated to chemoresistance. Conclusions/Significance: This is the first report of trogocytosis occurring between a cancer cell and an original type of stromal cell. This interaction induced autonomous acquisition of chemoresistance. The presence of stromal cells within patient's tumour might be predictive of chemoresistance. The specific interaction between cancer cells and stromal cells might be targeted during chemotherapy.	[Mirshahi, Pejman; Faussat, Anne-Marie; Simon, Anne; Ducros, Elodie; Dagonnet, Francoise; Marie, Jean-Pierre; Pujade-Lauraine, Eric; Soria, Jeanine; Mirshahi, Massoud] Univ Paris 06, INSERM, UMR 872, Paris, France; [Mirshahi, Pejman; Faussat, Anne-Marie; Simon, Anne; Ducros, Elodie; Dagonnet, Francoise; Marie, Jean-Pierre; Pujade-Lauraine, Eric; Soria, Jeanine; Mirshahi, Massoud] Univ Paris 05, Ctr Rech Cordeliers, Equipe 18, Paris, France; [Rafii, Arash; Mery, Eliane; Querleu, Denis] Inst Claudius Regaud, IFR 31, LFR 44, Toulouse, France; [Couderc, Bettina; Lis, Raphael; Capdet, Jerome; Bergalet, Julie; Favre, Gilles] Inst Claudius Regaud, Fac Sci Pharm, Dept Innovat Therapeut Oncol Mol, INSERM U563, Toulouse, France; [Poupot, Mary; Fournie, Jean-Jacques] CHU Purpan, Ctr Physiopathol Toulouse Purpan, INSERM U563, BP3028, Toulouse, France; [Rafii, Arash] Qatar Fdn, WCMC Qatar, Dept Genet Med & Obstet & Gynecol, Doha, Qatar	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UNICANCER; Institut Claudius Regaud; UNICANCER; Institut Claudius Regaud; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Qatar Foundation (QF); Weill Cornell Medical College Qatar	Rafii, A (corresponding author), Univ Paris 06, INSERM, UMR 872, Paris, France.	hospicells@gmail.com	Fournie, Jean-Jacques/J-7805-2013; FAVRE, Gilles/K-9189-2014; Couderc, Bettina/P-1576-2014; Rafii, Arash/E-4106-2013; Poupot, Mary/F-8570-2013; Mery-Lamarche, Eliane/P-2795-2014	Fournie, Jean-Jacques/0000-0001-6542-6908; FAVRE, Gilles/0000-0002-2344-1883; Couderc, Bettina/0000-0002-4530-5508; Mery-Lamarche, Eliane/0000-0002-0354-4519; Poupot, Mary/0000-0002-2688-1091; jerome, capdet/0000-0001-8340-4921				Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; BENDAYAN M, 1987, J HISTOCHEM CYTOCHEM, V35, P983, DOI 10.1177/35.9.3302022; BETJES MGH, 1993, J INFECT DIS, V168, P1202, DOI 10.1093/infdis/168.5.1202; Bhoola S, 2006, OBSTET GYNECOL, V107, P1399, DOI 10.1097/01.AOG.0000220516.34053.48; Boucheix C, 2001, CELL MOL LIFE SCI, V58, P1189, DOI 10.1007/PL00000933; Burleson KM, 2004, CLIN EXP METASTAS, V21, P685, DOI 10.1007/s10585-004-5768-5; Burleson KM, 2004, GYNECOL ONCOL, V93, P170, DOI 10.1016/j.ygyno.2003.12.034; Casey RC, 2001, AM J PATHOL, V159, P2071, DOI 10.1016/S0002-9440(10)63058-1; Darland DC, 2001, CURR TOP DEV BIOL, V52, P107, DOI 10.1016/S0070-2153(01)52010-4; Davis DM, 2007, NAT REV IMMUNOL, V7, P238, DOI 10.1038/nri2020; Di Nicolantonio F, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-78; Eisenkop SM, 2006, GYNECOL ONCOL, V103, P329, DOI 10.1016/j.ygyno.2006.07.004; ESPINOSA E, 2001, J IMMUNOL, V166, P3645; Galon J, 2007, CANCER RES, V67, P1883, DOI 10.1158/0008-5472.CAN-06-4806; GARDNER MJ, 1995, CANCER LETT, V91, P229, DOI 10.1016/0304-3835(95)03743-G; Guezguez B, 2007, J IMMUNOL, V179, P6673, DOI 10.4049/jimmunol.179.10.6673; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Houle CD, 2002, GYNECOL ONCOL, V86, P69, DOI 10.1006/gyno.2002.6729; Jayne DG, 2000, BRIT J CANCER, V82, P1233; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; JONES LMH, 1995, CLIN EXP METASTAS, V13, P373; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Khin EE, 2003, INT J GYNECOL PATHOL, V22, P175, DOI 10.1097/00004347-200304000-00010; KISHIKAWA T, 1995, INVAS METAST, V15, P11; Levchenko A, 2005, P NATL ACAD SCI USA, V102, P1933, DOI 10.1073/pnas.0401851102; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; MECHETNER EB, 1992, P NATL ACAD SCI USA, V89, P5824, DOI 10.1073/pnas.89.13.5824; Mezzanzanica D, 2008, CLIN CANCER RES, V14, P1726, DOI 10.1158/1078-0432.CCR-07-0428; MUIJSKEN MA, 1991, J CLIN PATHOL, V44, P600, DOI 10.1136/jcp.44.7.600; Naniwa J, 2007, INT J GYNECOL CANCER, V17, P76, DOI 10.1111/j.1525-1438.2006.00752.x; Pfisterer J, 2006, SEMIN ONCOL, V33, pS12, DOI 10.1053/j.seminoncol.2006.03.012; Poupot M, 2005, J IMMUNOL, V174, P1717, DOI 10.4049/jimmunol.174.3.1717; Poupot M, 2003, J IMMUNOL, V171, P2517, DOI 10.4049/jimmunol.171.5.2517; Rodriguez GC, 2001, GYNECOL ONCOL, V80, P245, DOI 10.1006/gyno.2000.6042; Rodriguez-Rodriguez L, 2003, MED ONCOL, V20, P255, DOI 10.1385/MO:20:3:255; Sako A, 2006, J SURG RES, V130, P94, DOI 10.1016/j.jss.2005.08.007; Sako A, 2003, J SURG RES, V115, P113, DOI 10.1016/S0022-4804(03)00307-X; Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589; Seshi B, 2000, BLOOD CELL MOL DIS, V26, P234, DOI 10.1006/bcmd.2000.0301; Shih IM, 1996, CLIN CANCER RES, V2, P569; SHOSTAK A, 1988, KIDNEY INT, V34, P786, DOI 10.1038/ki.1988.250; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Smith JA, 2005, GYNECOL ONCOL, V98, P141, DOI 10.1016/j.ygyno.2005.02.006; Trimble E L, 2001, Expert Opin Pharmacother, V2, P1299, DOI 10.1517/14656566.2.8.1299; Velazquez EF, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-2; Wang E, 2005, CLIN CANCER RES, V11, P113; Wels J, 2008, GENE DEV, V22, P559, DOI 10.1101/gad.1636908; WILSON AP, 1989, BRIT J CANCER, V59, P876, DOI 10.1038/bjc.1989.186; Yakirevich E, 2006, GYNECOL ONCOL, V100, P152, DOI 10.1016/j.ygyno.2005.08.050; Zannettino ACW, 2008, J CELL PHYSIOL, V214, P413, DOI 10.1002/jcp.21210; Zhang XY, 1999, J SOC GYNECOL INVEST, V6, P333, DOI 10.1016/S1071-5576(99)00040-4; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	54	78	79	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2008	3	12							e3894	10.1371/journal.pone.0003894	http://dx.doi.org/10.1371/journal.pone.0003894			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AR	19079610	gold, Green Published			2022-12-25	WOS:000265458400001
J	Kaito, C; Omae, Y; Matsumoto, Y; Nagata, M; Yamaguchi, H; Aoto, T; Ito, T; Hiramatsu, K; Sekimizu, K				Kaito, Chikara; Omae, Yosuke; Matsumoto, Yasuhiko; Nagata, Makiko; Yamaguchi, Hiroki; Aoto, Taiji; Ito, Teruyo; Hiramatsu, Keiichi; Sekimizu, Kazuhisa			A Novel Gene, fudoh, in the SCCmec Region Suppresses the Colony Spreading Ability and Virulence of Staphylococcus aureus	PLOS ONE			English	Article								Staphylococcus aureus colonies can spread on soft agar plates. We compared colony spreading of clinically isolated methicillin-sensitive S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA). All MSSA strains showed colony spreading, but most MRSA strains (73%) carrying SCCmec type-II showed little colony spreading. Deletion of the entire SCCmec type-II region from these MRSA strains restored colony spreading. Introduction of a novel gene, fudoh, carried by SCCmec type-II into Newman strain suppressed colony spreading. MRSA strains with high spreading ability (27%) had no fudoh or a point-mutated fudoh that did not suppress colony spreading. The fudoh-transformed Newman strain had decreased exotoxin production and attenuated virulence in mice. Most community-acquired MRSA strains carried SCCmec type-IV, which does not include fudoh, and showed high colony spreading ability. These findings suggest that fudoh in the SCCmec type-II region suppresses colony spreading and exotoxin production, and is involved in S. aureus pathogenesis.	[Kaito, Chikara; Omae, Yosuke; Matsumoto, Yasuhiko; Nagata, Makiko; Sekimizu, Kazuhisa] Univ Tokyo, Microbiol Lab, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo, Japan; [Yamaguchi, Hiroki] Nippon Med Sch, Dept Internal Med, Div Hematol, Tokyo, Japan; [Aoto, Taiji] Nippon Med Sch, Dept Cent Lab, Tokyo, Japan; [Ito, Teruyo; Hiramatsu, Keiichi] Juntendo Univ, Fac Med, Dept Infect Control Sci, Tokyo, Japan	University of Tokyo; Nippon Medical School; Nippon Medical School; Juntendo University	Kaito, C (corresponding author), Univ Tokyo, Microbiol Lab, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo, Japan.	sekimizu@mol.f.u-tokyo.ac.jp	Kaito, Chikara/W-1815-2019; Kaito, Chikara/G-1248-2017; Matsumoto, Yasuhiko/H-5767-2019	Kaito, Chikara/0000-0002-2895-3386; Kaito, Chikara/0000-0002-2895-3386; Matsumoto, Yasuhiko/0000-0002-0796-2304	Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO); Genome Pharmaceuticals Institute;  [19041022];  [20790057];  [20390021]	Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Genome Pharmaceuticals Institute; ; ; 	This work was supported by Grants-in-Aid for Scientific Research (19041022, 20790057, 20390021). This study was supported in part by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) and Genome Pharmaceuticals Institute.	Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Chambers HF, 2005, NEW ENGL J MED, V352, P1485, DOI 10.1056/NEJMe058023; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Daum RS, 2002, J INFECT DIS, V186, P1344, DOI 10.1086/344326; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Hanssen AM, 2007, ANTIMICROB AGENTS CH, V51, P1671, DOI 10.1128/AAC.00978-06; Higashide M, 2008, ANTIMICROB AGENTS CH, V52, P2061, DOI 10.1128/AAC.01150-07; Hiramatsu K, 2001, Lancet Infect Dis, V1, P147, DOI 10.1016/S1473-3099(01)00091-3; Hiramatsu K, 2001, TRENDS MICROBIOL, V9, P486, DOI 10.1016/S0966-842X(01)02175-8; Ichihashi N, 2003, J BIOL CHEM, V278, P28778, DOI 10.1074/jbc.M212202200; Josenhans C, 2002, INT J MED MICROBIOL, V291, P605, DOI 10.1078/1438-4221-00173; Kaito C, 2005, MOL MICROBIOL, V56, P934, DOI 10.1111/j.1365-2958.2005.04596.x; Kaito C, 2007, J BACTERIOL, V189, P2553, DOI 10.1128/JB.01635-06; Kaito C, 2006, MOL MICROBIOL, V62, P1601, DOI 10.1111/j.1365-2958.2006.05480.x; Katayama Y, 2000, ANTIMICROB AGENTS CH, V44, P1549, DOI 10.1128/AAC.44.6.1549-1555.2000; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Krukonis ES, 2003, CURR OPIN MICROBIOL, V6, P186, DOI 10.1016/S1369-5274(03)00032-8; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; MIZOBUCHI S, 1994, MICROBIOL IMMUNOL, V38, P599, DOI 10.1111/j.1348-0421.1994.tb01829.x; Naimi TS, 2001, CLIN INFECT DIS, V33, P990, DOI 10.1086/322693; Noto MJ, 2008, J BACTERIOL, V190, P1276, DOI 10.1128/JB.01128-07; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; Rozgonyi F, 2007, CLIN MICROBIOL INFEC, V13, P843, DOI 10.1111/j.1469-0691.2007.01780.x; Sambrook J., 1989, MOL CLONING LAB MANU, p3 v; SUZUKI E, 1993, ANTIMICROB AGENTS CH, V37, P1219, DOI 10.1128/AAC.37.6.1219; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656	29	35	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2008	3	12							e3921	10.1371/journal.pone.0003921	http://dx.doi.org/10.1371/journal.pone.0003921			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZU	19079549	gold, Green Published, Green Submitted			2022-12-25	WOS:000265455900007
J	Akerboom, J; Rivera, JDV; Guilbe, MMR; Malave, ECA; Hernandez, HH; Tian, L; Hires, SA; Marvin, JS; Looger, LL; Schreiter, ER				Akerboom, Jasper; Rivera, Jonathan D. Velez; Guilbe, Maria M. Rodriguez; Malave, Elisa C. Alfaro; Hernandez, Hector H.; Tian, Lin; Hires, S. Andrew; Marvin, Jonathan S.; Looger, Loren L.; Schreiter, Eric R.			Crystal Structures of the GCaMP Calcium Sensor Reveal the Mechanism of Fluorescence Signal Change and Aid Rational Design	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; INDICATOR PROTEIN; DENDRITIC SPINES; CALMODULIN	The genetically encoded calcium indicator GCaMP2 shows promise for neural network activity imaging, but is currently limited by low signal-to-noise ratio. We describe x-ray crystal structures as well as solution biophysical and spectroscopic characterization of GCaMP2 in the calcium-free dark state, and in two calcium-bound bright states: a monomeric form that dominates at intracellular concentrations observed during imaging experiments and an unexpected domain-swapped dimer with decreased fluorescence. This series of structures provides insight into the mechanism of Ca2+-induced fluorescence change. Upon calcium binding, the calmodulin (CaM) domain wraps around the M13 peptide, creating a new domain interface between CaM and the circularly permuted enhanced green fluorescent protein domain. Residues from CaM alter the chemical environment of the circularly permuted enhanced green fluorescent protein chromophore and, together with flexible inter-domain linkers, block solvent access to the chromophore. Guided by the crystal structures, we engineered a series of GCaMP2 point mutants to probe the mechanism of GCaMP2 function and characterized one mutant with significantly improved signal-to-noise. The mutation is located at a domain interface and its effect on sensor function could not have been predicted in the absence of structural data.	[Rivera, Jonathan D. Velez; Malave, Elisa C. Alfaro; Schreiter, Eric R.] Univ Puerto Rico, Dept Chem, San Juan, PR 00931 USA; [Akerboom, Jasper; Tian, Lin; Hires, S. Andrew; Marvin, Jonathan S.; Looger, Loren L.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Guilbe, Maria M. Rodriguez] Univ Puerto Rico, Dept Biochem, San Juan, PR 00936 USA; [Hernandez, Hector H.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02142 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; Howard Hughes Medical Institute; University of Puerto Rico; Massachusetts Institute of Technology (MIT)	Schreiter, ER (corresponding author), Univ Puerto Rico, Dept Chem, San Juan, PR 00931 USA.	eschreiter@vmail.uprrp.edu	Hernandez, Hector H./Q-4234-2019; Schreiter, Eric/B-2641-2009; Hires, Samuel/E-4717-2015	Hernandez, Hector H./0000-0001-7173-1829; Marvin, Jonathan/0000-0003-2294-4515; Schreiter, Eric/0000-0002-2864-7469; Tian, Lin/0000-0001-7012-6926	National Institutes of Health [5P20RR016439-05]; University of Puerto Rico, Rio Piedras Campus; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061838] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Puerto Rico, Rio Piedras Campus; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5P20RR016439-05 to the UPR Protein Research Center. This work was also supported by the University of Puerto Rico, Rio Piedras Campus. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Brejc K, 1997, P NATL ACAD SCI USA, V94, P2306, DOI 10.1073/pnas.94.6.2306; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Diez-Garcia J, 2005, EUR J NEUROSCI, V22, P627, DOI 10.1111/j.1460-9568.2005.04250.x; Elsliger MA, 1999, BIOCHEMISTRY-US, V38, P5296, DOI 10.1021/bi9902182; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Guilbe MMR, 2008, ACTA CRYSTALLOGR F, V64, P629, DOI 10.1107/S1744309108016059; Hires SA, 2008, BRAIN CELL BIOL, V36, P69, DOI 10.1007/s11068-008-9029-4; JAFFE DB, 1992, NATURE, V357, P244, DOI 10.1038/357244a0; Jung G, 2005, BIOPHYS J, V88, P1932, DOI 10.1529/biophysj.104.044412; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; Kummer AD, 2000, J PHYS CHEM B, V104, P4791, DOI 10.1021/jp9942522; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Mank M, 2008, CHEM REV, V108, P1550, DOI 10.1021/cr078213v; Mao T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001796; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; NAUMANN EA, 2005, THESIS U KONSTANZ KO; Ohkura M, 2005, ANAL CHEM, V77, P5861, DOI 10.1021/ac0506837; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Souslova EA, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-37; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Wallace DJ, 2008, NAT METHODS, V5, P797, DOI 10.1038/NMETH.1242; Wang YL, 2004, J NEUROSCI, V24, P6507, DOI 10.1523/JNEUROSCI.3727-03.2004; Word JM, 1999, J MOL BIOL, V285, P1711, DOI 10.1006/jmbi.1998.2400; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; YASUDA R, 2004, SCI STKE, P15; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758	37	173	182	1	60	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6455	6464		10.1074/jbc.M807657200	http://dx.doi.org/10.1074/jbc.M807657200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19098007	Green Published, hybrid			2022-12-25	WOS:000263742700048
J	Lamb, D; Mirsaliotis, A; Kelly, SM; Brighty, DW				Lamb, Daniel; Mirsaliotis, Antonis; Kelly, Sharon M.; Brighty, David W.			Basic Residues Are Critical to the Activity of Peptide Inhibitors of Human T Cell Leukemia Virus Type 1 Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENVELOPE GLYCOPROTEIN; MEMBRANE-FUSION; HIV-1 GP41; HTLV-I; TRANSMEMBRANE GLYCOPROTEIN; CIRCULAR-DICHROISM; SYNTHETIC PEPTIDES; PROTEIN EXPRESSION; COILED-COIL; IDENTIFICATION	A synthetic peptide based on the leash and alpha-helical region (LHR) of human T cell leukemia virus type 1 envelope is a potent inhibitor of viral entry into cells. The inhibitory peptide targets a triple-stranded coiled-coil motif of the fusion-active transmembrane glycoprotein and in a trans-dominant negative manner blocks resolution to the trimer-of-hairpins form. The LHR-mimetic is, therefore, functionally analogous to the C34/T20-type inhibitors of human immunodeficiency virus. Previous attempts to shorten the bioactive peptide produced peptides with severely attenuated activity. We now demonstrate that truncated peptides often suffer from poor solubility and impaired coiled coil binding properties, and we identify features that are critical to peptide function. In particular, the alpha-helical region of the LHR-mimetic is necessary but not sufficient for inhibitory activity. Moreover, two basic residues are crucial for coiled-coil binding and efficient inhibition of membrane fusion. By retaining these basic residues and a region of main chain peptide contacts with the coiled coil, a core LHR-mimetic was obtained that retains both the inhibitory properties and solubility profile of the parental peptide. Variants of the core peptide inhibit both membrane fusion and infection of cells by free viral particles, but unexpectedly, infection by virions was more susceptible to inhibition by low activity inhibitors than syncytium formation. The core inhibitor provides a valuable lead in the search for smaller more bio-available peptides and peptido-mimetics that possess anti-viral activity. Such molecules may be attractive candidates for therapeutic intervention in human T cell leukemia virus type 1 infections.	[Lamb, Daniel; Mirsaliotis, Antonis; Brighty, David W.] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Dundee DD1 9SY, Scotland; [Kelly, Sharon M.] Univ Glasgow, Inst Biomed & Life Sci, Prot Characterizat Facil, Glasgow G12 8QQ, Lanark, Scotland	University of Dundee; University of Glasgow	Brighty, DW (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Dundee DD1 9SY, Scotland.	d.w.brighty@dundee.ac.uk	Kelly, Sharon/K-4611-2013	Kelly, Sharon/0000-0002-3516-1387	The Leukemia Research Fund [LRF-354, LRF-05062]	The Leukemia Research Fund	The Leukemia Research Fund generously supported this work through Project Grants LRF-354 and LRF-05062 ( to D. W. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bangham CRM, 2003, J GEN VIROL, V84, P3177, DOI 10.1099/vir.0.19334-0; BLACKLOW SC, 1995, BIOCHEMISTRY-US, V34, P14955, DOI 10.1021/bi00046a001; Bossart KN, 2002, J VIROL, V76, P11186, DOI 10.1128/JVI.76.22.11186-11198.2002; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; DOKHELAR MC, 1989, J ACQ IMMUN DEF SYND, V2, P431; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; GESSAIN A, 1985, LANCET, V2, P407; Hanon E, 2000, AIDS RES HUM RETROV, V16, P1711, DOI 10.1089/08892220050193191; Igakura T, 2003, SCIENCE, V299, P1713, DOI 10.1126/science.1080115; Jassal SR, 2001, J VIROL, V75, P8317, DOI 10.1128/JVI.75.17.8317-8328.2001; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; Jones KS, 2008, NAT MED, V14, P429, DOI 10.1038/nm1745; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kobe B, 1999, P NATL ACAD SCI USA, V96, P4319, DOI 10.1073/pnas.96.8.4319; Lamb D, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-70; Liu SW, 2004, LANCET, V363, P938, DOI 10.1016/S0140-6736(04)15788-7; Lombardi S, 1996, VIROLOGY, V220, P274, DOI 10.1006/viro.1996.0315; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Maerz AL, 2000, J VIROL, V74, P6614, DOI 10.1128/JVI.74.14.6614-6621.2000; Majorovits E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002251; Markosyan RM, 2003, MOL BIOL CELL, V14, P926, DOI 10.1091/mbc.E02-09-0573; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Mirsaliotis A, 2008, J VIROL, V82, P4965, DOI 10.1128/JVI.02458-07; Mirsaliotis A, 2007, J GEN VIROL, V88, P660, DOI 10.1099/vir.0.82390-0; Munoz-Barroso I, 1998, J CELL BIOL, V140, P315, DOI 10.1083/jcb.140.2.315; OSAME M, 1986, LANCET, V1, P1031; Pinon JD, 2003, J VIROL, V77, P3281, DOI 10.1128/JVI.77.5.3281-3290.2003; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; PRICE NC, 1996, DETERMINATION PROTEI, P34; Sagara Y, 1996, J VIROL, V70, P1564, DOI 10.1128/JVI.70.3.1564-1569.1996; Sjoberg M, 2008, J VIROL, V82, P2358, DOI 10.1128/JVI.01931-07; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; WILD C, 1993, AIDS RES HUM RETROV, V9, P1051, DOI 10.1089/aid.1993.9.1051; Yamano Y, 2002, BLOOD, V99, P88, DOI 10.1182/blood.V99.1.88	37	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6575	6584		10.1074/jbc.M806725200	http://dx.doi.org/10.1074/jbc.M806725200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19114713	hybrid			2022-12-25	WOS:000263742700060
J	Kongsuphol, P; Cassidy, D; Hieke, B; Treharne, KJ; Schreiber, R; Mehta, A; Kunzelmann, K				Kongsuphol, Patthara; Cassidy, Diane; Hieke, Bernhard; Treharne, Kate J.; Schreiber, Rainer; Mehta, Anil; Kunzelmann, Karl			Mechanistic Insight into Control of CFTR by AMPK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; TRANSMEMBRANE-CONDUCTANCE-REGULATOR; AIRWAY EPITHELIAL-CELLS; CYSTIC-FIBROSIS; APICAL MEMBRANE; R-DOMAIN; CHANNEL; CAMP; PHOSPHORYLATION; TRANSPORT	The cystic fibrosis transmembrane conductance regulator (CFTR) is a cAMP and protein kinase A (PKA)-regulated Cl- channel in the apical membrane of epithelial cells. The metabolically regulated and adenosine monophosphate-stimulated kinase (AMPK) is colocalized with CFTR and attenuates its function. However, the sites for CFTR phosphorylation and the precise mechanism of inhibition of CFTR by AMPK remain obscure. We demonstrate that CFTR normally remains closed at baseline, but nevertheless, opens after inhibition of AMPK. AMPK phosphorylates CFTR in vitro at two essential serines (Ser(737) and Ser(768)) in the R domain, formerly identified as "inhibitory" PKA sites. Replacement of both serines by alanines (i) reduced phosphorylation of the R domain, with Ser768 having dramatically greater impact, (ii) produced CFTR channels that were partially open in the absence of any stimulation, (iii) significantly augmented their activation by IBMX/forskolin, and (iv) eliminated CFTR inhibition post AMPK activation. Attenuation of CFTR by AMPK activation was detectable in the absence of cAMP-dependent stimulation but disappeared in maximally stimulated oocytes. Our data also suggest that AMP is produced by local phosphodiesterases in close proximity to CFTR. Thus we propose that CFTR channels are kept closed in nonstimulated epithelia with high baseline AMPK activity but CFTR may be basally active in tissues with lowered endogenous AMPK activity.	[Kongsuphol, Patthara; Hieke, Bernhard; Schreiber, Rainer; Kunzelmann, Karl] Univ Regensburg, Dept Physiol, D-93053 Regensburg, Germany; [Cassidy, Diane; Treharne, Kate J.; Mehta, Anil] Univ Dundee, TICH, Dundee DD195Y, Scotland	University of Regensburg; University of Dundee	Kunzelmann, K (corresponding author), Univ Regensburg, Dept Physiol, D-93053 Regensburg, Germany.	Karl.Kunzelmann@vkl.uni-regensburg.de		Kunzelmann, Karl/0000-0002-4583-7037	Deutsche Forschungsgemeinschaft [SFB699 A6, DFG KU756/8-1]; Wellcome Trust [079965/z/06/z, 075237/z/04/z]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB699 A6 and DFG KU756/8-1 and Wellcome Trust Grants 079965/z/06/z (to K.J.T.) and 075237/z/04/z (to D.C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Aleksandrov AA, 2007, PFLUG ARCH EUR J PHY, V453, P693, DOI 10.1007/s00424-006-0140-z; Barnes AP, 2005, J BIOL CHEM, V280, P7997, DOI 10.1074/jbc.M407521200; Bhalla V, 2006, J BIOL CHEM, V281, P26159, DOI 10.1074/jbc.M606045200; Carattino MD, 2005, J BIOL CHEM, V280, P17608, DOI 10.1074/jbc.M501770200; Cooper DMF, 2005, BIOCHEM SOC T, V33, P1319, DOI 10.1042/BST0331319; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Csanady L, 2005, J GEN PHYSIOL, V125, P171, DOI 10.1085/jgp.200409076; Dahan D, 2001, PFLUG ARCH EUR J PHY, V443, pS92, DOI 10.1007/s004240100652; Fraser S, 2005, AM J PHYSIOL-RENAL, V288, pF578, DOI 10.1152/ajprenal.00190.2004; Fraser SA, 2007, BIOCHEM J, V405, P85, DOI 10.1042/BJ20061850; Gadsby David C., 1999, Physiological Reviews, V79, pS77; Guerra L, 2005, J BIOL CHEM, V280, P40925, DOI 10.1074/jbc.M505103200; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Guo X, 1997, J MEMBRANE BIOL, V155, P239, DOI 10.1007/s002329900176; Hallows KR, 2003, AM J PHYSIOL-CELL PH, V284, pC1297, DOI 10.1152/ajpcell.00227.2002; Hallows KR, 2006, J BIOL CHEM, V281, P4231, DOI 10.1074/jbc.M511029200; Hallows KR, 2005, CURR OPIN NEPHROL HY, V14, P464, DOI 10.1097/01.mnh.0000174145.14798.64; Hallows KR, 2003, J BIOL CHEM, V278, P998, DOI 10.1074/jbc.M210621200; Hallows KR, 2000, J CLIN INVEST, V105, P1711, DOI 10.1172/JCI9622; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Huang PB, 2001, P NATL ACAD SCI USA, V98, P14120, DOI 10.1073/pnas.241318498; Hurley RL, 2006, J BIOL CHEM, V281, P36662, DOI 10.1074/jbc.M606676200; Jarnaess E, 2007, BIOCHEM SOC T, V35, P931, DOI 10.1042/BST0350931; Kunzelmann K, 2002, PHYSIOL REV, V82, P245, DOI 10.1152/physrev.00026.2001; Lee JH, 2007, J BIOL CHEM, V282, P10414, DOI 10.1074/jbc.M610857200; Li CY, 2007, CELL, V131, P940, DOI 10.1016/j.cell.2007.09.037; Li CY, 2005, J EXP MED, V202, P975, DOI 10.1084/jem.20050421; Li CY, 2005, PHARMACOL THERAPEUT, V108, P208, DOI 10.1016/j.pharmthera.2005.04.004; McAlroy HL, 2000, BRIT J PHARMACOL, V131, P1651, DOI 10.1038/sj.bjp.0703743; Mehta A, 2007, PFLUG ARCH EUR J PHY, V455, P215, DOI 10.1007/s00424-007-0290-7; Motoshima H, 2006, J PHYSIOL-LONDON, V574, P63, DOI 10.1113/jphysiol.2006.108324; Naren AP, 2003, P NATL ACAD SCI USA, V100, P342, DOI 10.1073/pnas.0135434100; Quinton PM, 2007, PHYSIOLOGY, V22, P212, DOI 10.1152/physiol.00041.2006; Riordan JR, 2005, ANNU REV PHYSIOL, V67, P701, DOI 10.1146/annurev.physiol.67.032003.154107; RIORDAN JR, 1989, SCIENCE, V245, P1066; Sheppard David N., 1999, Physiological Reviews, V79, pS23; Steinberg SF, 2001, ANNU REV PHARMACOL, V41, P751, DOI 10.1146/annurev.pharmtox.41.1.751; Sun F, 2000, J BIOL CHEM, V275, P29539, DOI 10.1074/jbc.M004961200; Treharne KJ, 2001, PFLUG ARCH EUR J PHY, V443, pS97; Walker J, 2003, AM J PHYSIOL-GASTR L, V285, pG850, DOI 10.1152/ajpgi.00077.2003; Wilkinson DJ, 1997, AM J PHYSIOL-LUNG C, V273, pL127, DOI 10.1152/ajplung.1997.273.1.L127; Wine JJ, 2007, AUTON NEUROSCI-BASIC, V133, P35, DOI 10.1016/j.autneu.2007.01.008; Woollhead AM, 2005, J PHYSIOL-LONDON, V566, P781, DOI 10.1113/jphysiol.2005.088674	44	66	66	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5645	5653		10.1074/jbc.M806780200	http://dx.doi.org/10.1074/jbc.M806780200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19095655	Green Published, hybrid			2022-12-25	WOS:000263560600028
J	Chen, X; Wang, KH; Chen, JN; Guo, JG; Yin, Y; Cai, X; Guo, X; Wang, GQ; Yang, R; Zhu, LY; Zhang, Y; Wang, J; Xiang, Y; Weng, CY; Zen, K; Zhang, JF; Zhang, CY				Chen, Xi; Wang, Kehui; Chen, Jiangning; Guo, Jigang; Yin, Yuan; Cai, Xing; Guo, Xing; Wang, Guoqiang; Yang, Rong; Zhu, Lingyun; Zhang, Yan; Wang, Jin; Xiang, Yang; Weng, Chunyue; Zen, Ke; Zhang, Junfeng; Zhang, Chen-Yu			In Vitro Evidence Suggests That miR-133a-mediated Regulation of Uncoupling Protein 2 (UCP2) Is an Indispensable Step in Myogenic Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC-HYPERTROPHY; ENERGY-METABOLISM; REDOX-REGULATION; MUSCLE-CELLS; MICRORNAS; TRANSCRIPTION; EXPRESSION; HEART; MODULATE; STRESS	UCP2 and UCP3, two novel uncoupling proteins, are important regulators of energy expenditure and thermogenesis in various organisms. The striking disparity between UCP2 mRNA and protein levels in muscle tissues prompted initial speculation that microRNAs are implicated in the regulatory pathway of UCP2. We found, for the first time, that the repression of UCP2 expression in cardiac and skeletal muscle resulted from its targeting by a muscle-specific microRNA, miR-133a. Moreover, our findings illustrate a novel function of UCP2 as a brake for muscle development. We also show that MyoD can remove the braking role of UCP2 via direct up-regulation of miR-133a during myogenic differentiation. Taken together, our current work delineates a novel regulatory network employing MyoD, microRNA, and uncoupling proteins to fine-tune the balance between muscle differentiation and proliferation during myogenesis.	[Chen, Xi; Wang, Kehui; Chen, Jiangning; Guo, Jigang; Yin, Yuan; Cai, Xing; Guo, Xing; Wang, Guoqiang; Yang, Rong; Zhu, Lingyun; Zhang, Yan; Wang, Jin; Xiang, Yang; Weng, Chunyue; Zen, Ke; Zhang, Junfeng; Zhang, Chen-Yu] Nanjing Univ, Sch Life Sci, Jiangsu Diabet Ctr, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China	Nanjing University	Zen, K (corresponding author), Nanjing Univ, Sch Life Sci, Jiangsu Diabet Ctr, State Key Lab Pharmaceut Biotechnol, 22 Hankou Rd, Nanjing 210093, Jiangsu, Peoples R China.	kzen@nju.edu.cn; jfzhang@nju.edu.cn; cyzhang@nju.edu.cn	Yin, Yuan/AAG-1707-2020; 殷, 媛/GSE-4523-2022	/0000-0002-0420-4508	National Natural Science Foundation of China [90813035, 30890044, 30570731, 30771036]; National Basic Research Program of China [2006CB503908, 2006CB503909, 2004CB518603, 2003CB715905]; Natural Science Foundation of Jiangsu Province [BK2004082, BK2006714]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by grants from the National Natural Science Foundation of China ( Grants 90813035, 30890044, 30570731, and 30771036), the National Basic Research Program of China ( 973 Program) ( Grants 2006CB503908, 2006CB503909, 2004CB518603, and 2003CB715905), the "111" Project, and the Natural Science Foundation of Jiangsu Province ( Grants BK2004082 and BK2006714).	Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Bodyak N, 2007, AM J PHYSIOL-HEART C, V293, pH829, DOI 10.1152/ajpheart.01409.2006; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Clempus RE, 2006, CARDIOVASC RES, V71, P216, DOI 10.1016/j.cardiores.2006.02.033; Duval C, 2007, FEBS LETT, V581, P955, DOI 10.1016/j.febslet.2007.01.085; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Krauss S, 2003, J CLIN INVEST, V112, P1831, DOI 10.1172/JCI200319774; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Laloi C, 2004, CURR OPIN PLANT BIOL, V7, P323, DOI 10.1016/j.pbi.2004.03.005; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Murakami K, 2002, HYPERTENSION, V40, P251, DOI 10.1161/01.HYP.0000029094.85023.01; Murray AJ, 2004, LANCET, V364, P1786, DOI 10.1016/S0140-6736(04)17402-3; Neubauer S, 1997, CIRCULATION, V96, P2190; Noma T, 2001, FASEB J, V15, P1206, DOI 10.1096/fj.000569fje; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; OLSON EN, 1993, CIRC RES, V72, P1, DOI 10.1161/01.RES.72.1.1; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; Piao YJ, 2005, FREE RADICAL BIO MED, V38, P989, DOI 10.1016/j.freeradbiomed.2004.11.011; Puceat M, 2005, ANTIOXID REDOX SIGN, V7, P1435, DOI 10.1089/ars.2005.7.1435; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Rhee SG, 1999, EXP MOL MED, V31, P53, DOI 10.1038/emm.1999.9; Schrauwen P, 2002, J EXP BIOL, V205, P2275; Soulez M, 1996, MOL CELL BIOL, V16, P6065; Su B, 2001, CIRC RES, V89, P39, DOI 10.1161/hh1301.093615; Torres M, 2003, BIOFACTORS, V17, P287, DOI 10.1002/biof.5520170128; Tsatmali M, 2006, MOL CELL NEUROSCI, V33, P345, DOI 10.1016/j.mcn.2006.08.005; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103	33	74	81	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5362	5369		10.1074/jbc.M807523200	http://dx.doi.org/10.1074/jbc.M807523200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19073597	hybrid			2022-12-25	WOS:000263416600066
J	Gould, CM; Kannan, N; Taylor, SS; Newton, AC				Gould, Christine M.; Kannan, Natarajan; Taylor, Susan S.; Newton, Alexandra C.			The Chaperones Hsp90 and Cdc37 Mediate the Maturation and Stabilization of Protein Kinase C through a Conserved PXXP Motif in the C-terminal Tail	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOINOSITIDE-DEPENDENT KINASE; PROLINE-RICH MOTIF; HYDROPHOBIC-MOTIF; TURN MOTIF; MOLECULAR CHAPERONES; PHOSPHORYLATION; AKT; PKC; DOMAIN; STABILITY	The life cycle of protein kinase C (PKC) is tightly controlled by mechanisms that mature the enzyme, sustain the activation-competent enzyme, and degrade the enzyme. Here we show that a conserved PXXP motif (Kannan, N., Haste, N., Taylor, S. S., and Neuwald, A. F. (2007) Proc. Natl. Acad. Sci. U. S. A. 104, 1272-1277), in the C-terminal tail of AGC (c-AMP-dependent protein kinase/protein kinase G/protein kinase C) kinases, controls the processing phosphorylation of conventional and novel PKC isozymes, a required step in the maturation of the enzyme into a signaling-competent species. Mutation of both Pro-616 and Pro-619 to Ala in the conventional PKC beta II abolishes the phosphorylation and activity of the kinase. Co-immunoprecipitation studies reveal that conventional and novel, but not atypical, PKC isozymes bind the chaperones Hsp90 and Cdc37 through a PXXP-dependent mechanism. Inhibitors of Hsp90 and Cdc37 significantly reduce the rate of processing phosphorylation of PKC. Of the two C-terminal sites processed by phosphorylation, the hydrophobic motif, but not the turn motif, is regulated by Hsp90. Overlay of purified Hsp90 onto a peptide array containing peptides covering the catalytic domain of PKC beta II identified regions surrounding the PXXP segment, but not the PXXP motif itself, as major binding determinants for Hsp90. These Hsp90-binding regions, however, are tethered to the C-terminal tail via a "molecular clamp" formed between the PXXP motif and a conserved Tyr (Tyr-446) in the alpha E-helix. Disruption of the clamp by mutation of the Tyr to Ala recapitulates the phosphorylation defect of mutating the PXXP motif. These data are consistent with a model in which a molecular clamp created by the PXXP motif in the C-terminal tail and determinants in the alpha E-helix of the catalytic domain allows the chaperones Hsp90 and Cdc37 to bind newly synthesized PKC, a required event in the processing of PKC by phosphorylation.	[Gould, Christine M.; Kannan, Natarajan; Taylor, Susan S.; Newton, Alexandra C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92039 USA; [Gould, Christine M.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92039 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Newton, AC (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92039 USA.	anewton@ucsd.edu			National Institutes of Health [2T32 GM-07752, GM-43154, P01 DK54441]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752, R01GM043154, R37GM043154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant Grants 2T32 GM-07752 (to C. G.) and by National Institutes of Health Grants GM-43154 and P01 DK54441. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Behn-Krappa A, 1999, CURR BIOL, V9, P728, DOI 10.1016/S0960-9822(99)80332-7; Bornancin F, 1997, J BIOL CHEM, V272, P3544, DOI 10.1074/jbc.272.6.3544; Cameron AJ, 2008, INT J CANCER, V123, P769, DOI 10.1002/ijc.23560; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Caplan AJ, 2007, TRENDS CELL BIOL, V17, P87, DOI 10.1016/j.tcb.2006.12.002; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200; Dries DR, 2007, J BIOL CHEM, V282, P826, DOI 10.1074/jbc.C600268200; Dutil EM, 2000, J BIOL CHEM, V275, P10697, DOI 10.1074/jbc.275.14.10697; Dutil EM, 1998, CURR BIOL, V8, P1366, DOI 10.1016/S0960-9822(98)00017-7; Edwards AS, 1997, J BIOL CHEM, V272, P18382, DOI 10.1074/jbc.272.29.18382; Edwards AS, 1999, J BIOL CHEM, V274, P6461, DOI 10.1074/jbc.274.10.6461; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Fields Alan P, 2003, Methods Mol Biol, V233, P519; Freeley M, 2005, BIOCHEM BIOPH RES CO, V334, P619, DOI 10.1016/j.bbrc.2005.06.136; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; Fujita N, 2002, J BIOL CHEM, V277, P10346, DOI 10.1074/jbc.M106736200; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Gao TY, 2006, J BIOL CHEM, V281, P32461, DOI 10.1074/jbc.M604076200; Gao TY, 2002, J BIOL CHEM, V277, P31585, DOI 10.1074/jbc.M204335200; Gao TY, 2001, J BIOL CHEM, V276, P19588, DOI 10.1074/jbc.M101357200; Gould CM, 2008, CURR DRUG TARGETS, V9, P614, DOI 10.2174/138945008785132411; Gray PJ, 2008, NAT REV CANCER, V8, P491, DOI 10.1038/nrc2420; Gray PJ, 2007, CANCER RES, V67, P11942, DOI 10.1158/0008-5472.CAN-07-3162; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Grodsky N, 2006, BIOCHEMISTRY-US, V45, P13970, DOI 10.1021/bi061128h; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Jane EP, 2008, CANCER LETT, V268, P46, DOI 10.1016/j.canlet.2008.03.039; Jiang TY, 2003, J BIOL CHEM, V278, P15789, DOI 10.1074/jbc.M212525200; Kamal A, 2004, TRENDS MOL MED, V10, P283, DOI 10.1016/j.molmed.2004.04.006; Kane LP, 2004, J IMMUNOL, V172, P5441, DOI 10.4049/jimmunol.172.9.5441; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; KARNITZ LM, 2007, SCI STKE 2007, pE22; Keranen LM, 1995, CURR BIOL, V5, P1394, DOI 10.1016/S0960-9822(95)00277-6; MacLean M, 2003, CELL STRESS CHAPERON, V8, P114, DOI 10.1379/1466-1268(2003)008<0114:CGBHAK>2.0.CO;2; Majumder PK, 2005, ONCOGENE, V24, P7465, DOI 10.1038/sj.onc.1209096; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; McCarthy MM, 2008, ANN ONCOL, V19, P590, DOI 10.1093/annonc/mdm545; Moriwaki Y, 2008, NEUROSCI RES, V61, P43, DOI 10.1016/j.neures.2008.01.006; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; ORR JW, 1992, J BIOL CHEM, V267, P15263; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Pearl LH, 2005, CURR OPIN GENET DEV, V15, P55, DOI 10.1016/j.gde.2004.12.011; Pick E, 2007, CANCER RES, V67, P2932, DOI 10.1158/0008-5472.CAN-06-4511; REED SI, 1980, GENETICS, V95, P561; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Sonnenburg ED, 2001, J BIOL CHEM, V276, P45289, DOI 10.1074/jbc.M107416200; Standaert ML, 2001, BIOCHEMISTRY-US, V40, P249, DOI 10.1021/bi0018234; Torkamani A, 2008, CANCER RES, V68, P1675, DOI 10.1158/0008-5472.CAN-07-5283; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Xu WP, 2002, CELL STRESS CHAPERON, V7, P91, DOI 10.1379/1466-1268(2002)007<0091:HNGRTI>2.0.CO;2; Xu WP, 2001, J BIOL CHEM, V276, P3702, DOI 10.1074/jbc.M006864200; Xu Y, 1999, P NATL ACAD SCI USA, V96, P109, DOI 10.1073/pnas.96.1.109; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Yeong SS, 2006, J BIOL CHEM, V281, P30768, DOI 10.1074/jbc.M511278200; Zhang T, 2008, MOL CANCER THER, V7, P162, DOI 10.1158/1535-7163.MCT-07-0484; Ziegler WH, 1999, CURR BIOL, V9, P522, DOI 10.1016/S0960-9822(99)80236-X	62	87	89	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4921	4935		10.1074/jbc.M808436200	http://dx.doi.org/10.1074/jbc.M808436200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19091746	Green Published, hybrid			2022-12-25	WOS:000263416600022
J	Ren, B; Duan, XW; Ding, HG				Ren, Binbin; Duan, Xuewu; Ding, Huangen			Redox Control of the DNA Damage-inducible Protein DinG Helicase Activity via Its Iron-Sulfur Cluster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE PRODUCTION; ESCHERICHIA-COLI; TRANSCRIPTION FACTOR; ENDONUCLEASE-III; REPAIR; DOMAIN; BACH1; SOXR; GENE; RNA	The Escherichia coli DNA damage-inducible protein DinG, a member of the superfamily 2 DNA helicases, has been implicated in the nucleotide excision repair and recombinational DNA repair pathways. Combining UV-visible absorption, EPR, and enzyme activity measurements, we demonstrate here that E. coli DinG contains a redox-active [4Fe-S-4] cluster with a midpoint redox potential (E-m) of -390 +/- 23 mV (pH 8.0) and that reduction of the [4Fe-4S] cluster reversibly switches off the DinG helicase activity. Unlike the [4Fe-4S] cluster in E. coli dihydroxyacid dehydratase, the DinG [4Fe-4S] cluster is stable, and the enzyme remains fully active after exposure to 100-fold excess of hydrogen peroxide, indicating that DinG could be functional under oxidative stress conditions. However, the DinG [4Fe-4S] cluster can be efficiently modified by nitric oxide (NO), forming the DinG-bound dinitrosyl iron complex with the concomitant inactivation of helicase activity in vitro and in vivo. Reassembly of the [4Fe-4S] cluster in NO-modified DinG restores helicase activity, indicating that the iron-sulfur cluster in DinG is the primary target of NO cytotoxicity. The results led us to propose that the iron-sulfur cluster in DinG may act as a sensor of intracellular redox potential to modulate its helicase activity and that modification of the iron-sulfur cluster in DinG and likely in other DNA repair enzymes by NO may contribute to NO-mediated genomic instability.	[Ren, Binbin; Duan, Xuewu; Ding, Huangen] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Ding, HG (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	hding@lsu.edu	Ding, Huangen/AAJ-8550-2020	Ding, Huangen/0000-0002-4815-7336	United States Public Health Service [RO1 CA107494]; National Science Foundation [MCB-0416537]; NATIONAL CANCER INSTITUTE [R01CA107494] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA107494 from the United States Public Health Service. This work was also supported by National Science Foundation Grant MCB-0416537 (to H. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agarwalla S, 2004, J BIOL CHEM, V279, P34123, DOI 10.1074/jbc.M405702200; Boal AK, 2005, BIOCHEMISTRY-US, V44, P8397, DOI 10.1021/bi047494n; Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; CIOFFI EA, 1980, ANAL BIOCHEM, V104, P485, DOI 10.1016/0003-2697(80)90104-9; Coin F, 2007, MOL CELL, V26, P245, DOI 10.1016/j.molcel.2007.03.009; COWART RE, 1993, ANAL BIOCHEM, V211, P151, DOI 10.1006/abio.1993.1246; Cruz-Ramos H, 2002, EMBO J, V21, P3235, DOI 10.1093/emboj/cdf339; CUNNINGHAM RP, 1989, BIOCHEMISTRY-US, V28, P4450, DOI 10.1021/bi00436a049; Ding HG, 2000, P NATL ACAD SCI USA, V97, P5146, DOI 10.1073/pnas.97.10.5146; Ding HG, 1996, J BIOL CHEM, V271, P33173, DOI 10.1074/jbc.271.52.33173; Drapier JC, 1997, METHODS, V11, P319, DOI 10.1006/meth.1996.0426; Dutton P L, 1978, Methods Enzymol, V54, P411; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Fernandez de Henestrosa AR, 2000, MOL MICROBIOL, V35, P1560, DOI 10.1046/j.1365-2958.2000.01826.x; FLINT DH, 1993, J BIOL CHEM, V268, P14732; Foster HW, 1999, J AM CHEM SOC, V121, P4093; Gal A, 1996, P NATL ACAD SCI USA, V93, P15102, DOI 10.1073/pnas.93.26.15102; Gaudu P, 1996, P NATL ACAD SCI USA, V93, P10094, DOI 10.1073/pnas.93.19.10094; Gobert AP, 2001, P NATL ACAD SCI USA, V98, P13844, DOI 10.1073/pnas.241443798; Hernandez HL, 2007, BIOCHEMISTRY-US, V46, P5140, DOI 10.1021/bi7000449; Hinks JA, 2002, J BIOL CHEM, V277, P16936, DOI 10.1074/jbc.M200668200; Ignarro LJ, 1999, BIOSCIENCE REP, V19, P51, DOI 10.1023/A:1020150124721; Kennedy MC, 1997, J BIOL CHEM, V272, P20340, DOI 10.1074/jbc.272.33.20340; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; KOONIN EV, 1993, NUCLEIC ACIDS RES, V21, P1497, DOI 10.1093/nar/21.6.1497; Krieglstein CF, 2001, J EXP MED, V194, P1207, DOI 10.1084/jem.194.9.1207; Lehmann AR, 2001, GENE DEV, V15, P15, DOI 10.1101/gad.859501; LEWIS LK, 1992, J BACTERIOL, V174, P3377, DOI 10.1128/jb.174.10.3377-3385.1992; Li CQ, 2002, P NATL ACAD SCI USA, V99, P10364, DOI 10.1073/pnas.162356399; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; Liu H, 2008, CELL, V133, P801, DOI 10.1016/j.cell.2008.04.029; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; McDevitt CA, 2002, BIOCHEMISTRY-US, V41, P15234, DOI 10.1021/bi026221u; Mettert EL, 2007, J BACTERIOL, V189, P3036, DOI 10.1128/JB.00052-07; Paraskeva E, 1996, FEBS LETT, V389, P40, DOI 10.1016/0014-5793(96)00574-1; Porello SL, 1998, BIOCHEMISTRY-US, V37, P6465, DOI 10.1021/bi972433t; Pugh RA, 2008, J BIOL CHEM, V283, P1732, DOI 10.1074/jbc.M707064200; Ren BB, 2008, MOL MICROBIOL, V70, P953, DOI 10.1111/j.1365-2958.2008.06464.x; Rogers PA, 2003, DNA REPAIR, V2, P809, DOI 10.1016/S1568-7864(03)00065-X; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Schwartz CJ, 2001, P NATL ACAD SCI USA, V98, P14895, DOI 10.1073/pnas.251550898; SIEGEL LM, 1965, ANAL BIOCHEM, V11, P126, DOI 10.1016/0003-2697(65)90051-5; Spiro S, 2007, FEMS MICROBIOL REV, V31, P193, DOI 10.1111/j.1574-6976.2006.00061.x; TAMIR S, 1993, CHEM RES TOXICOL, V6, P895, DOI 10.1021/tx00036a021; Van Dyk TK, 2001, J BACTERIOL, V183, P5496, DOI 10.1128/JB.183.19.5496-5505.2001; Voloshin ON, 2007, J BIOL CHEM, V282, P18437, DOI 10.1074/jbc.M700376200; Voloshin ON, 2003, J BIOL CHEM, V278, P28284, DOI 10.1074/jbc.M301188200; Weiner BE, 2007, J BIOL CHEM, V282, P33444, DOI 10.1074/jbc.M705826200; Wolski SC, 2008, PLOS BIOL, V6, P1332, DOI 10.1371/journal.pbio.0060149; Yang JJ, 2006, J BIOL CHEM, V281, P27956, DOI 10.1074/jbc.M601356200; Yang WY, 2002, J BIOL CHEM, V277, P12868, DOI 10.1074/jbc.M109485200	52	62	65	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4829	4835		10.1074/jbc.M807943200	http://dx.doi.org/10.1074/jbc.M807943200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19074432	Green Published, hybrid			2022-12-25	WOS:000263416600011
J	Csibi, A; Leibovitch, MP; Cornille, K; Tintignac, LA; Leibovitch, SA				Csibi, Alfredo; Leibovitch, Marie Pierre; Cornille, Karen; Tintignac, Lionel A.; Leibovitch, Serge A.			MAFbx/Atrogin-1 Controls the Activity of the Initiation Factor eIF3-f in Skeletal Muscle Atrophy by Targeting Multiple C-terminal Lysines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEASOME PATHWAY; FACTOR 3F; TRANSLATION; MTOR; EXPRESSION; ATROGIN-1; LIGASES; GROWTH; EIF4G	We recently presented evidence that the subunit eIF3-f of the eukaryotic initiation translation factor eIF3 that interacts with the E3-ligase Atrogin-1/muscle atrophy F-box (MAFbx) for polyubiquitination and proteasome-mediated degradation is a key target that accounts for MAFbx function during muscle atrophy. To understand this process, deletion analysis was used to identify the region of eIF3-f that is required for its proteolysis. Here, we report that the highly conserved C-terminal domain of eIF3-f is implicated for MAFbx-directed polyubiquitination and proteasomal degradation. Site-directed mutagenesis of eIF3-f revealed that the six lysine residues within this domain are required for full polyubiquitination and degradation by the proteasome. In addition, mutation of these six lysines (mutant K5-10R) displayed hypertrophic activity in cellulo and in vivo and was able to protect against starvation-induced muscle atrophy. Taken together, our data demonstrate that the C-terminal modifications, believed to be critical for proper eIF3-f regulation, are essential and contribute to a fine-tuning mechanism that plays an important role for eIF3-f function in skeletal muscle.	[Csibi, Alfredo; Leibovitch, Marie Pierre; Cornille, Karen; Tintignac, Lionel A.; Leibovitch, Serge A.] SupAgro Inst Natl Rech Agron, Lab Genom Fonct & Myogenese, Differenciat Cellulaire & Croissance UMR866, F-34060 Montpellier 1, France; [Csibi, Alfredo] Univ Montpellier Sud France, F-34060 Montpellier 1, France	INRAE; Institut Agro; Montpellier SupAgro	Leibovitch, SA (corresponding author), SupAgro Inst Natl Rech Agron, Lab Genom Fonct & Myogenese, Differenciat Cellulaire & Croissance UMR866, 2 Pl Pierre Viala, F-34060 Montpellier 1, France.	leibovs@supagro.inra.fr			"Association Francaise contre les Myopathies" (AFM); INRA; INSERM	"Association Francaise contre les Myopathies" (AFM)(Association Francaise contre les Myopathies); INRA; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by grants from the "Association Francaise contre les Myopathies" (AFM), the department PHASE from INRA, and INSERM.	Acharyya S, 2004, J CLIN INVEST, V114, P370, DOI 10.1172/jci200420174; Avruch J, 2001, Prog Mol Subcell Biol, V26, P115; Beugnet A, 2003, BIOCHEM J, V372, P555, DOI 10.1042/BJ20021266; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Ciechanover A, 1998, P NATL ACAD SCI USA, V95, P2727, DOI 10.1073/pnas.95.6.2727; Csibi A, 2008, CELL CYCLE, V7, P1698, DOI 10.4161/cc.7.12.6090; Doldan A, 2008, MOL CARCINOGEN, V47, P806, DOI 10.1002/mc.20436; Doldan A, 2008, MOL CARCINOGEN, V47, P235, DOI 10.1002/mc.20379; Fraser CS, 2004, J BIOL CHEM, V279, P8946, DOI 10.1074/jbc.M312745200; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; GOLDSPINK DF, 1983, BIOCHEM J, V210, P89, DOI 10.1042/bj2100089; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Harris TE, 2006, EMBO J, V25, P1659, DOI 10.1038/sj.emboj.7601047; Hofmann K, 1998, TRENDS BIOCHEM SCI, V23, P204, DOI 10.1016/S0968-0004(98)01217-1; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Jagoe RT, 2001, CURR OPIN CLIN NUTR, V4, P183, DOI 10.1097/00075197-200105000-00003; Lagirand-Cantaloube J, 2008, EMBO J, V27, P1266, DOI 10.1038/emboj.2008.52; LAMPHEAR BJ, 1995, J BIOL CHEM, V270, P21975, DOI 10.1074/jbc.270.37.21975; Latres E, 2005, J BIOL CHEM, V280, P2737, DOI 10.1074/jbc.M407517200; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Shi J, 2006, ONCOGENE, V25, P4923, DOI 10.1038/sj.onc.1209495; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200; Tisdale Michael J, 2005, J Support Oncol, V3, P209; Xiao H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001494; Zhou CS, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-14	28	68	72	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4413	4421		10.1074/jbc.M807641200	http://dx.doi.org/10.1074/jbc.M807641200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19073596	Green Published, hybrid			2022-12-25	WOS:000263134400041
J	Tsai, CM; Jankowska-Stephens, E; Mizanur, RM; Cipollo, JF				Tsai, Chao-Ming; Jankowska-Stephens, Ewa; Mizanur, Rahman M.; Cipollo, John F.			The Fine Structure of Neisseria meningitidis Lipooligosaccharide from the M986 Strain and Three of Its Variants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNER-CORE LIPOPOLYSACCHARIDE; OUTER-MEMBRANE PROTEINS; GROUP-B; IMMUNOTYPE EPITOPES; SECONDARY RESPONSE; GROUP-A; OLIGOSACCHARIDE; PHOSPHOETHANOLAMINE; IMMUNORESPONSES; IDENTIFICATION	Neisseria meningitidis is a cause of fatal sepsis and epidemic meningitis. A major virulence factor is cell wall lipooligosaccharide (LOS). The M986 strain has been used extensively in immunological and vaccine research. Yet, the LOS repertoire of this strain is not known. Here we have investigated the LOS structures of M986 and three of its variants OP1, OP2-, and OP2+. This strain and its variants present a series of related LOS families that are increasingly truncated in their listed order. The major structural differences are seen in the lacto-N-neotetraose alpha-chain. The gamma-chain Hep II contains two phosphoethanolamine (PEA) substitutions at C3 and C6/7. These substitutions were seen in all strains except OP2+ where the canonical core Hep II is missing. The PEA disubstitution was present in nearly stoichiometric amounts with only minor amounts of monosubstitution observed, and no glycomers devoid of PEA were seen. This was also the case in LOS with a complete lacto-N-neotetraosyl alpha-chain even though previous reports suggested that the presence of an extended alpha-chain hinders C3 PEA substitution of Hep II. Approximately 50% of gamma-chain GlcNAc was present in its 3-OAc-substituted form. Because Hep II C3 PEA substitution and gamma-chain GlcNAc OAc addition have been reported to negatively interact, the co-existence of these two modifications in these strains is unique. The LOS structures of M986 and three of its variants have been determined, which better defines these strains as tools for immunological and vaccine research.	[Cipollo, John F.] NIH, Ctr Biol Evaluat & Res, US FDA, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; US Food & Drug Administration (FDA)	Cipollo, JF (corresponding author), NIH, Ctr Biol Evaluat & Res, US FDA, Bldg 29,Rm 126,8800 Rockville Pike, Bethesda, MD 20892 USA.	john.cipollo@fda.hhs.gov			Department of Energy [DE-FG09-93ER-20097]	Department of Energy(United States Department of Energy (DOE))	This work was supported by the Department of Energy-funded (Grant DE-FG09-93ER-20097) Center for Plant and Microbial Complex Carbohydrates. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ASHTON FE, 1983, J MED MICROBIOL, V16, P443, DOI 10.1099/00222615-16-4-443; BANERJEEBHATNAGAR N, 1990, INFECT IMMUN, V58, P2875, DOI 10.1128/IAI.58.9.2875-2881.1990; Bayliss CD, 2008, INFECT IMMUN, V76, P5038, DOI 10.1128/IAI.00395-08; Cartwright Keith, 2001, Vaccine, V19, P4347, DOI 10.1016/S0264-410X(01)00205-5; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Cox AD, 2003, EUR J BIOCHEM, V270, P1759, DOI 10.1046/j.1432-1033.2003.03535.x; Cox AD, 2002, CARBOHYD RES, V337, P1435, DOI 10.1016/S0008-6215(02)00161-1; Cox AD, 2002, EUR J BIOCHEM, V269, P4169, DOI 10.1046/j.1432-1033.2002.03131.x; DEVI SJN, 1991, P NATL ACAD SCI USA, V88, P7175, DOI 10.1073/pnas.88.16.7175; DIFABIO JL, 1990, CAN J CHEM, V68, P1029, DOI 10.1139/v90-160; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; DYER DW, 1988, INFECT IMMUN, V56, P977, DOI 10.1128/IAI.56.4.977-983.1988; FARO J, 1987, MED MICROBIOL IMMUN, V176, P289; FARO J, 1986, INFECT IMMUN, V51, P224, DOI 10.1128/IAI.51.1.224-232.1986; FARO J, 1987, MED MICROBIOL IMMUN, V176, P131; FARO J, 1985, INFECT IMMUN, V48, P428, DOI 10.1128/IAI.48.2.428-432.1985; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; GAMIAN A, 1992, J BIOL CHEM, V267, P922; GIBSON BW, 1993, J BACTERIOL, V175, P2702, DOI 10.1128/JB.175.9.2702-2712.1993; GU XX, 1991, ANAL BIOCHEM, V196, P311, DOI 10.1016/0003-2697(91)90472-6; HARDY MR, 1988, ANAL BIOCHEM, V170, P54, DOI 10.1016/0003-2697(88)90089-9; JENNINGS HJ, 1981, J IMMUNOL, V127, P1011; JENNINGS HJ, 1983, CARBOHYD RES, V121, P233, DOI 10.1016/0008-6215(83)84020-8; Kahler CM, 2006, J BIOL CHEM, V281, P19939, DOI 10.1074/jbc.M601308200; Kahler CM, 2005, GLYCOBIOLOGY, V15, P409, DOI 10.1093/glycob/cwi018; KAHLER CM, 2004, GLYCOBIOLOGY; KIM JJ, 1994, INFECT IMMUN, V62, P1566, DOI 10.1128/IAI.62.5.1566-1575.1994; Kogan G, 1997, CARBOHYD RES, V298, P191, DOI 10.1016/S0008-6215(96)00305-9; Mackinnon FG, 2002, MOL MICROBIOL, V43, P931, DOI 10.1046/j.1365-2958.2002.02754.x; MICHON F, 1990, J BIOL CHEM, V265, P7243; Minetti CASA, 1997, J BIOL CHEM, V272, P10710; O'Connor ET, 2006, J BACTERIOL, V188, P1039, DOI 10.1128/JB.188.3.1039-1048.2006; PAVLIAK V, 1993, J BIOL CHEM, V268, P14146; Plested JS, 2003, J INFECT DIS, V187, P1223, DOI 10.1086/368360; Quakyi EK, 1997, PATHOBIOLOGY, V65, P26, DOI 10.1159/000164100; Quakyi EK, 1999, J INFECT DIS, V180, P747, DOI 10.1086/314927; Quakyi EK, 1997, INFECT IMMUN, V65, P1972, DOI 10.1128/IAI.65.5.1972-1979.1997; Ram S, 2007, INFECT IMMUN, V75, P4071, DOI 10.1128/IAI.01109-06; SCHOLTEN RJPM, 1994, J MED MICROBIOL, V41, P236, DOI 10.1099/00222615-41-4-236; TSAI CM, 1980, J BACTERIOL, V141, P169, DOI 10.1128/JB.141.1.169-176.1980; Tsai CM, 2002, INFECT IMMUN, V70, P407, DOI 10.1128/IAI.70.1.407-411.2002; TSAI CM, 1987, INFECT IMMUN, V55, P1652, DOI 10.1128/IAI.55.7.1652-1656.1987; TSAI CM, 1983, J BACTERIOL, V155, P498, DOI 10.1128/JB.155.2.498-504.1983; Wright JC, 2004, J BACTERIOL, V186, P6970, DOI 10.1128/JB.186.20.6970-6982.2004	44	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4616	4625		10.1074/jbc.M808209200	http://dx.doi.org/10.1074/jbc.M808209200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19095648	hybrid			2022-12-25	WOS:000263134400061
J	Sampathi, S; Bhusari, A; Shen, BH; Chai, WH				Sampathi, Shilpa; Bhusari, Amruta; Shen, Binghui; Chai, Weihang			Human Flap Endonuclease I Is in Complex with Telomerase and Is Required for Telomerase-mediated Telomere Maintenance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; HOMOLOGOUS RECOMBINATION; SACCHAROMYCES-CEREVISIAE; CELLULAR SENESCENCE; CATALYTIC SUBUNIT; HUMAN-CHROMOSOMES; POLYMERASE ALPHA; END REPLICATION; STEM-CELLS; LENGTH	Studies from budding yeast and ciliates have suggested that telomerase extension of telomeres requires the conventional DNA replication machinery, yet little is known about how DNA replication proteins regulate telomerase action in higher eukaryotic cells. Here we investigate the role of one of the DNA replication factors, flap endonuclease I (FEN1), in regulating telomerase activity in mammalian cells. FEN1 is a nuclease that plays an important role in DNA replication, repair, and recombination. We show that FEN1 is in complex with telomerase in vivo via telomeric DNA. We further demonstrate that FEN1 deficiency in mouse embryonic fibroblasts leads to an increase in telomere end-to-end fusions. In cancer cells, FEN1 deficiency induces gradual shortening of telomeres but does not alter the single-stranded G-overhangs. This is, to our knowledge, the first evidence that FEN1 and telomerase physically co-exist as a complex and that FEN1 can regulate telomerase activity at telomeres in mammalian cells.	[Sampathi, Shilpa; Chai, Weihang] Washington State Univ, WWAMI Med Educ Program, Spokane, WA 99210 USA; [Sampathi, Shilpa; Chai, Weihang] Washington State Univ, Sch Mol Biosci, Spokane, WA 99210 USA; [Bhusari, Amruta] Texas Womans Univ, Dept Biol, Denton, TX 76204 USA; [Shen, Binghui] City Hope Natl Med Ctr, Dept Radiat Biol, Duarte, CA 91010 USA; [Shen, Binghui] Beckman Res Inst, Duarte, CA 91010 USA	Washington State University; Washington State University; Texas Womans University; City of Hope; City of Hope; Beckman Research Institute of City of Hope	Chai, WH (corresponding author), Washington State Univ, WWAMI Med Educ Program, Hlth Sci Bldg 320L,POB 1495, Spokane, WA 99210 USA.	wchai@wsu.edu	Chai, Weihang/AAG-5194-2021	Shen, Binghui/0000-0002-4408-407X	National Institutes of Health [R15CA132090, R01CA073764]; Texas Woman's University Research Enhancement Program; NATIONAL CANCER INSTITUTE [R01CA073764, R15CA132090] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Woman's University Research Enhancement Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R15CA132090 (to W. C.) and R01CA073764 (to B. H. S.). This work was also supported by Texas Woman's University Research Enhancement Program (to W. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams AK, 1996, MOL CELL BIOL, V16, P4614; BLACKBURN EH, 1989, GENOME, V31, P553, DOI 10.1139/g89-104; Blasco MA, 2007, NAT CHEM BIOL, V3, P640, DOI 10.1038/nchembio.2007.38; Campisi J, 2001, EXP GERONTOL, V36, P1619, DOI 10.1016/S0531-5565(01)00160-7; CARSON MJ, 1985, CELL, V42, P249, DOI 10.1016/S0092-8674(85)80120-3; Chai WH, 2006, MOL CELL, V21, P427, DOI 10.1016/j.molcel.2005.12.004; Chai WH, 2005, MOL CELL BIOL, V25, P2158, DOI 10.1128/MCB.25.6.2158-2168.2005; Chai WH, 2002, J BIOL CHEM, V277, P47242, DOI 10.1074/jbc.M208542200; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [10.1038/nature02118, DOI 10.1038/NATURE02118]; Dahlen M, 2003, MOL CELL BIOL, V23, P3031, DOI 10.1128/MCB.23.9.3031-3042.2003; de Lange T, 2006, COLD SPRING HARB MON, V45, P387; Deng Z, 2007, CURR BIOL, V17, P1989, DOI 10.1016/j.cub.2007.10.054; di Fagagna FD, 2004, GENE DEV, V18, P1781, DOI 10.1101/gad.1214504; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; Dionne I, 1996, P NATL ACAD SCI USA, V93, P13902, DOI 10.1073/pnas.93.24.13902; Fan XQ, 1997, MOL BIOL CELL, V8, P2145, DOI 10.1091/mbc.8.11.2145; Flores I, 2006, CURR OPIN CELL BIOL, V18, P254, DOI 10.1016/j.ceb.2006.03.003; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; Herbert B-S, 2003, ANAL TELOMERES TELOM; Hiyama E, 2007, BRIT J CANCER, V96, P1020, DOI 10.1038/sj.bjc.6603671; Hockemeyer D, 2005, EMBO J, V24, P2667, DOI 10.1038/sj.emboj.7600733; Hug N, 2006, CHROMOSOMA, V115, P413, DOI 10.1007/s00412-006-0067-3; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Kikuchi K, 2005, MOL CELL BIOL, V25, P6948, DOI 10.1128/MCB.25.16.6948-6955.2005; Kucherlapati M, 2002, P NATL ACAD SCI USA, V99, P9924, DOI 10.1073/pnas.152321699; LINGNER J, 1995, SCIENCE, V269, P1533, DOI 10.1126/science.7545310; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Longhese MP, 2008, GENE DEV, V22, P125, DOI 10.1101/gad.1626908; Martin AD, 2000, MOL CELL BIOL, V20, P786, DOI 10.1128/MCB.20.3.786-796.2000; Muftuoglu M, 2006, CANCER RES, V66, P113, DOI 10.1158/0008-5472.CAN-05-2742; Ohki R, 2001, MOL CELL BIOL, V21, P5753, DOI 10.1128/MCB.21.17.5753-5766.2001; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Parenteau J, 2002, GENETICS, V162, P1583; Parenteau J, 1999, MOL CELL BIOL, V19, P4143; Parrish JZ, 2003, EMBO J, V22, P3451, DOI 10.1093/emboj/cdg320; Qi HY, 2000, GENE DEV, V14, P1777; Ray S, 2002, MOL CELL BIOL, V22, P5859, DOI 10.1128/MCB.22.16.5859-5868.2002; Saharia A, 2008, CURR BIOL, V18, P496, DOI 10.1016/j.cub.2008.02.071; Sfeir AJ, 2005, MOL CELL, V18, P131, DOI 10.1016/j.molcel.2005.02.035; Sharma S, 2004, J BIOL CHEM, V279, P9847, DOI 10.1074/jbc.M309898200; Shay JW, 2006, NAT REV DRUG DISCOV, V5, P577, DOI 10.1038/nrd2081; Shay Jerry W., 1996, Current Opinion in Oncology, V8, P66, DOI 10.1097/00001622-199601000-00012; Shay JW, 2001, RADIAT RES, V155, P188, DOI 10.1667/0033-7587(2001)155[0188:TATIFC]2.0.CO;2; Shen BH, 2005, BIOESSAYS, V27, P717, DOI 10.1002/bies.20255; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; WRIGHT WE, 1989, MOL CELL BIOL, V9, P3088, DOI 10.1128/MCB.9.7.3088; Yago M, 2002, FEBS LETT, V520, P40, DOI 10.1016/S0014-5793(02)02757-6; Zheng L, 2005, EMBO REP, V6, P83, DOI 10.1038/sj.embor.7400313; Zheng L, 2007, NAT MED, V13, P812, DOI 10.1038/nm1599; Zou Y, 2004, P NATL ACAD SCI USA, V101, P12928, DOI 10.1073/pnas.0404106101; Zou Y, 2004, MOL BIOL CELL, V15, P3709, DOI 10.1091/mbc.E04-03-0207	53	26	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3682	3690		10.1074/jbc.M805362200	http://dx.doi.org/10.1074/jbc.M805362200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19068479	hybrid, Green Published			2022-12-25	WOS:000262872500036
J	Chen, CTL; Gottlieb, DI; Cohen, BA				Chen, Christina T. L.; Gottlieb, David I.; Cohen, Barak A.			Ultraconserved Elements in the Olig2 Promoter	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; GENE-EXPRESSION; OLIGODENDROCYTE DEVELOPMENT; TRANSCRIPTION FACTOR; NEURONAL PROPERTIES; SPINAL-CORD; DIFFERENTIATION; IDENTIFICATION; SEQUENCES; PATTERNS	Background: Oligodendrocytes are specialized cells of the nervous system that produce the myelin sheaths surrounding the axons of neurons. Myelinating the axons increases the speed of nerve conduction and demyelination contributes to the pathology of neurodegenerative diseases such as multiple sclerosis. Oligodendrocyte differentiation is specified early in development by the expression of the basic-helix-loop-helix transcription factor Olig2 in the ventral region of the neural tube. Understanding how Olig2 expression is controlled is therefore essential for elucidating the mechanisms governing oligodendrocyte differentiation. A method is needed to identify potential regulatory sequences in the long stretches of adjacent non-coding DNA that flank Olig2. Methodology/Principal Findings: We identified ten potential regulatory regions upstream of Olig2 based on a combination of bioinformatics metrics that included evolutionary conservation across multiple vertebrate genomes, the presence of potential transcription factor binding sites and the existence of ultraconserved elements. One of our computational predictions includes a region previously identified as the Olig2 basal promoter, suggesting that our criterion represented characteristics of known regulatory regions. In this study, we tested one candidate regulatory region for its ability to modulate the Olig2 basal promoter and found that it represses expression in undifferentiated embryonic stem cells. Conclusions/Significance: The regulatory region we identified modifies the expression regulated by the Olig2 basal promoter in a manner consistent with our current understanding of Olig2 expression during oligodendrocyte differentiation. Our results support a model in which constitutive activation of Olig2 by its basal promoter is repressed in undifferentiated cells by upstream repressive elements until that repression is relieved during differentiation. We conclude that the potential regulatory elements presented in this study provide a good starting point for unraveling the cis-regulatory logic that governs Olig2 expression. Future studies of the functionality of the potential regulatory elements we present will help reveal the interactions that govern Olig2 expression during development.	[Cohen, Barak A.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Gottlieb, David I.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL)	Chen, CTL (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.	cohen@genetics.wustl.edu			National Science Foundation [MCB-0543156]	National Science Foundation(National Science Foundation (NSF))	This work was supported by a grant from the National Science Foundation (MCB-0543156). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bain G, 1996, BIOCHEM BIOPH RES CO, V223, P691, DOI 10.1006/bbrc.1996.0957; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Bauer DC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-220; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Billon N, 2002, J CELL SCI, V115, P3657, DOI 10.1242/jcs.00049; Bronchain OJ, 2007, DEV GENES EVOL, V217, P485, DOI 10.1007/s00427-007-0158-z; Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754; Chen CTL, 2007, AM J HUM GENET, V80, P692, DOI 10.1086/513149; Donaldson IJ, 2005, HUM MOL GENET, V14, P595, DOI 10.1093/hmg/ddi056; Du ZW, 2004, STEM CELLS DEV, V13, P372, DOI 10.1089/scd.2004.13.372; Georgieva L, 2006, P NATL ACAD SCI USA, V103, P12469, DOI 10.1073/pnas.0603029103; Girault JA, 2003, BIOL CELL, V95, P447, DOI 10.1016/S0248-4900(03)00073-X; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; HERTZ GZ, 1990, COMPUT APPL BIOSCI, V6, P81; HILDEBRAND C, 1993, PROG NEUROBIOL, V40, P319, DOI 10.1016/0301-0082(93)90015-K; Hu B, 2007, AM J RESP CELL MOL, V36, P78, DOI 10.1165/rcmb.2006-0043OC; Huang K, 2008, HUM GENET, V122, P659, DOI 10.1007/s00439-007-0434-z; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; KUHLMANN T, 2008, BRAIN; Kyo S, 2000, NUCLEIC ACIDS RES, V28, P669, DOI 10.1093/nar/28.3.669; Li HL, 2007, J NEUROSCI, V27, P14375, DOI 10.1523/JNEUROSCI.4456-07.2007; Ligon KL, 2006, GLIA, V54, P1, DOI 10.1002/glia.20273; Liu S, 2000, P NATL ACAD SCI USA, V97, P6126, DOI 10.1073/pnas.97.11.6126; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Lu QR, 2001, P NATL ACAD SCI USA, V98, P10851, DOI 10.1073/pnas.181340798; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; MEISSNER A, 2008, NATURE; Murakami K, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-16; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Park HC, 2007, DEV DYNAM, V236, P3402, DOI 10.1002/dvdy.21365; Rosmarin AG, 1998, J BIOL CHEM, V273, P13097, DOI 10.1074/jbc.273.21.13097; Sandelin A, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-99; Sugimori M, 2008, DEVELOPMENT, V135, P1271, DOI 10.1242/dev.015370; Sun T, 2006, DEV BIOL, V292, P152, DOI 10.1016/j.ydbio.2005.12.047; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takebayashi H, 2002, MECH DEVELOP, V113, P169, DOI 10.1016/S0925-4773(02)00021-7; Takebayashi H, 2000, MECH DEVELOP, V99, P143, DOI 10.1016/S0925-4773(00)00466-4; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858; Uchida Y, 2007, J BIOL CHEM, V282, P19700, DOI 10.1074/jbc.M703099200; Vavouri T, 2006, TRENDS GENET, V22, P5, DOI 10.1016/j.tig.2005.10.005; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Xian HQ, 2005, BIOCHEM BIOPH RES CO, V327, P155, DOI 10.1016/j.bbrc.2004.11.149; Xian HQ, 2003, STEM CELLS, V21, P41, DOI 10.1634/stemcells.21-1-41; YAO M, 1995, J NEUROSCI RES, V41, P792, DOI 10.1002/jnr.490410610; ZHANG X, 2008, STEM CELLS	49	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2008	3	12							e3946	10.1371/journal.pone.0003946	http://dx.doi.org/10.1371/journal.pone.0003946			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AR	19079603	Green Published, gold			2022-12-25	WOS:000265458400005
J	Yamanaka, S; Zahanich, I; Wersto, RP; Boheler, KR				Yamanaka, Satoshi; Zahanich, Ihor; Wersto, Robert P.; Boheler, Kenneth R.			Enhanced Proliferation of Monolayer Cultures of Embryonic Stem (ES) Cell-Derived Cardiomyocytes Following Acute Loss of Retinoblastoma	PLOS ONE			English	Article							CARDIAC PRECURSOR CELLS; SMOOTH MUSCLE ACTIN; DNA-SYNTHESIS; CYCLE PROGRESSION; SARCOMERIC ACTIN; FAMILY-MEMBERS; TROPONIN-I; RAT-HEART; B-MYB; EXPRESSION	Background: Cardiomyocyte (CM) cell cycle analysis has been impeded because of a reliance on primary neonatal cultures of poorly proliferating cells or chronic transgenic animal models with innate compensatory mechanisms. Methodology/Principal Findings: We describe an in vitro model consisting of monolayer cultures of highly proliferative embryonic stem (ES) cell-derived CM. Following induction with ascorbate and selection with puromycin, early CM cultures are >98% pure, and at least 85% of the cells actively proliferate. During the proliferative stage, cells express high levels of E2F3a, B-Myb and phosphorylated forms of retinoblastoma (Rb), but with continued cultivation, cells stop dividing and mature functionally. This developmental transition is characterized by a switch from slow skeletal to cardiac TnI, an increase in binucleation, cardiac calsequestrin and hypophosphorylated Rb, a decrease in E2F3, B-Myb and atrial natriuretic factor, and the establishment of a more negative resting membrane potential. Although previous publications suggested that Rb was not necessary for cell cycle control in heart, we find following acute knockdown of Rb that this factor actively regulates progression through the G1 checkpoint and that its loss promotes proliferation at the expense of CM maturation. Conclusions/Significance: We have established a unique model system for studying cardiac cell cycle progression, and show in contrast to previous reports that Rb actively regulates both cell cycle progression through the G1 checkpoint and maturation of heart cells. We conclude that this in vitro model will facilitate the analysis of cell cycle control mechanisms of CMs.	[Yamanaka, Satoshi; Zahanich, Ihor; Boheler, Kenneth R.] NIA, Cardiovasc Sci Lab, Baltimore, MD 21224 USA; [Wersto, Robert P.] NIA, NIH, Resource Res Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Yamanaka, S (corresponding author), NIA, Cardiovasc Sci Lab, Baltimore, MD 21224 USA.	bohelerk@grc.nia.nih.gov			Intramural Research Program of the NIH, National Institute on Aging; NATIONAL INSTITUTE ON AGING [ZICAG000618, Z01AG000618, Z01AG000849, ZIAAG000849] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Intramural Research Program of the NIH, National Institute on Aging (KRB, RPW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agah R, 1997, J CLIN INVEST, V100, P2722, DOI 10.1172/JCI119817; Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Anversa P, 2002, J MOL CELL CARDIOL, V34, P91, DOI 10.1006/jmcc.2001.1506; BABAI F, 1990, DIFFERENTIATION, V44, P132, DOI 10.1111/j.1432-0436.1990.tb00546.x; Baker JE, 1999, CIRCULATION, V99, P1249, DOI 10.1161/01.CIR.99.9.1249; Barth AS, 2008, MOL THER, V16, P957, DOI 10.1038/mt.2008.30; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bicknell KA, 2007, J MOL CELL CARDIOL, V42, P706, DOI 10.1016/j.yjmcc.2007.01.006; Boheler KR, 2003, METHOD ENZYMOL, V365, P228; Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32; Busk PK, 2005, EXP CELL RES, V304, P149, DOI 10.1016/j.yexcr.2004.10.022; CARRIER L, 1992, CIRC RES, V70, P999, DOI 10.1161/01.RES.70.5.999; Christoffels VM, 2000, DEV BIOL, V223, P266, DOI 10.1006/dbio.2000.9753; Christoforou N, 2008, J CLIN INVEST, V118, P894, DOI 10.1172/JCI33942; Cloud JE, 2002, MOL CELL BIOL, V22, P2663, DOI 10.1128/MCB.22.8.2663-2672.2002; Ebelt H, 2005, CIRC RES, V96, P509, DOI 10.1161/01.RES.0000159705.17322.57; EPPENBERGEREBERHARDT M, 1990, DEV BIOL, V139, P269, DOI 10.1016/0012-1606(90)90296-U; Fan JS, 1998, PFLUG ARCH EUR J PHY, V436, P1021, DOI 10.1007/PL00008086; Fijnvandraat AC, 2003, J MOL CELL CARDIOL, V35, P1461, DOI 10.1016/j.yjmcc.2003.09.011; Fijnvandraat AC, 2003, CARDIOVASC RES, V58, P399, DOI 10.1016/S0008-6363(03)00282-7; Flink IL, 1998, J MOL CELL CARDIOL, V30, P563, DOI 10.1006/jmcc.1997.0620; Franco D, 1998, CARDIOVASC RES, V38, P25, DOI 10.1016/S0008-6363(97)00321-0; Hassink RJ, 2008, CARDIOVASC RES, V78, P18, DOI 10.1093/cvr/cvm101; Houweling AC, 2005, CARDIOVASC RES, V67, P583, DOI 10.1016/j.cardiores.2005.06.013; Jiang Z, 1997, ONCOGENE, V14, P1789, DOI 10.1038/sj.onc.1201014; Kirshenbaum LA, 1996, DEV BIOL, V179, P402, DOI 10.1006/dbio.1996.0270; Klug MG, 1995, AM J PHYSIOL-HEART C, V269, pH1913, DOI 10.1152/ajpheart.1995.269.6.H1913; Koban MU, 1998, CARDIOVASC RES, V37, P405, DOI 10.1016/S0008-6363(97)00276-9; Koban MU, 2001, MECH DEVELOP, V109, P267, DOI 10.1016/S0925-4773(01)00548-2; KOH GY, 1995, J CLIN INVEST, V96, P2034, DOI 10.1172/JCI118251; KOH GY, 1995, J INTERV CARDIOL, V8, P387, DOI 10.1111/j.1540-8183.1995.tb00564.x; Kolossov E, 2005, FASEB J, V19, P577, DOI 10.1096/fj.03-1451fje; Kolossov E, 1998, J CELL BIOL, V143, P2045, DOI 10.1083/jcb.143.7.2045; LAM EWF, 1993, EMBO J, V12, P2705, DOI 10.1002/j.1460-2075.1993.tb05932.x; Li JL, 2007, J BIOL CHEM, V282, P34984, DOI 10.1074/jbc.M703513200; Liu Y, 1996, J CELL BIOL, V133, P325, DOI 10.1083/jcb.133.2.325; MacLellan WR, 2005, MOL CELL BIOL, V25, P2486, DOI 10.1128/MCB.25.6.2486-2497.2005; MacPherson D, 2003, MOL CELL BIOL, V23, P1044, DOI 10.1128/MCB.23.3.1044-1053.2003; McClellan KA, 2007, CELL CYCLE, V6, P2917, DOI 10.4161/cc.6.23.4997; MILLERHANCE WC, 1993, J BIOL CHEM, V268, P25244; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Muhlfeld C, 2006, ANAT REC PART A, V288A, P297, DOI 10.1002/ar.a.20315; Muhlfeld C, 2005, COMP BIOCHEM PHYS A, V141, P310, DOI 10.1016/j.cbpb.2005.06.001; Murry CE, 2005, CIRCULATION, V112, P3174, DOI 10.1161/CIRCULATIONAHA.105.546218; Papadimou E, 2005, EMBO J, V24, P1750, DOI 10.1038/sj.emboj.7600652; Park KW, 1998, GENE, V217, P25, DOI 10.1016/S0378-1119(98)00372-2; Perino MG, 2008, J MOL CELL CARDIOL, V45, P475, DOI 10.1016/j.yjmcc.2008.05.002; Puceat M, 2005, CELL CYCLE, V4, P1030, DOI 10.4161/cc.4.8.1905; Rubart M, 2006, ANNU REV PHYSIOL, V68, P29, DOI 10.1146/annurev.physiol.68.040104.124530; Rubart M, 2006, ANN NY ACAD SCI, V1080, P34, DOI 10.1196/annals.1380.004; SABRY MA, 1989, J MUSCLE RES CELL M, V10, P85, DOI 10.1007/BF01739858; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; SAGGIN L, 1989, J BIOL CHEM, V264, P16299; Shackney SE, 1999, CYTOMETRY, V35, P97, DOI 10.1002/(SICI)1097-0320(19990201)35:2<97::AID-CYTO1>3.3.CO;2-X; Soonpaa MH, 1996, AM J PHYSIOL-HEART C, V271, pH2183; Soonpaa MH, 1997, J CLIN INVEST, V99, P2644, DOI 10.1172/JCI119453; Sun A, 2007, J CELL BIOCHEM, V102, P1400, DOI 10.1002/jcb.21609; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takahashi T, 2003, CIRCULATION, V107, P1912, DOI 10.1161/01.CIR.0000064899.53876.A3; Tamamori-Adachi M, 2003, CIRC RES, V92, pE12, DOI 10.1161/01.RES.0000049105.15329.1C; Tarasov KV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002478; Tarasova YS, 2006, EMBRYONIC STEM CELLS, P130; von Harsdorf R, 1999, CIRC RES, V85, P128, DOI 10.1161/01.RES.85.2.128; Wersto RP, 1998, J VIROL, V72, P9491, DOI 10.1128/JVI.72.12.9491-9502.1998; Wobus A M, 2002, Methods Mol Biol, V185, P127; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Yutzey KE, 2007, CIRCULATION, V115, P792, DOI 10.1161/CIRCULATIONAHA.106.682534; Zandstra PW, 2003, TISSUE ENG, V9, P767, DOI 10.1089/107632703768247449	70	23	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2008	3	12							e3896	10.1371/journal.pone.0003896	http://dx.doi.org/10.1371/journal.pone.0003896			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZS	19066628	Green Published, Green Submitted, gold			2022-12-25	WOS:000265455700006
J	Keely, S; Glover, LE; MacManus, CF; Campbell, EL; Scully, MM; Furuta, GT; Colgan, SP				Keely, Simon; Glover, Louise E.; MacManus, Christopher F.; Campbell, Eric L.; Scully, Melanie M.; Furuta, Glenn T.; Colgan, Sean P.			Selective induction of integrin beta 1 by hypoxia-inducible factor: implications for wound healing	FASEB JOURNAL			English	Article						inflammation; Crohn's disease; restitution; transcription; gene promoter	COLLAGEN GEL CONTRACTION; INTESTINAL EPITHELIUM; EXTRACELLULAR-MATRIX; MURINE MODEL; FACTOR-I; EXPRESSION; OXYGEN; INFLAMMATION; ANGIOGENESIS; HIF-1	Because of localized vascular damage and increased tissue oxygen demand, wound healing occurs in a relatively hypoxic microenvironment. These features are particularly relevant to wound healing and fibrosis in chronic inflammatory conditions, such as Crohn's disease and ulcerative colitis. In these studies, we sought to identify the contribution of hypoxia to mechanisms of wound repair in a model of the intestinal submucosa. Initial studies revealed that hypoxia promotes wound healing, as modeled by an increase in intestinal fibroblast-mediated collagen gel contraction. Guided by results from transcriptional profiling, we identified the selective induction of fibroblast integrin beta 1 (ITGB1) by hypoxia. Further analysis revealed that hypoxia, as well as pharmacological activators of hypoxia-inducible factor (HIF), induce fibroblast beta 1 integrin mRNA, protein, and function by as much as 4-fold. Cloning and analysis of the beta 1 integrin gene promoter revealed a 10 +/- 0.8-fold increase in promoter activity in response to hypoxia, and subsequent studies identified a functional DNA binding region for HIF in the ITGB1 gene promoter. Mutational analysis of the HIF binding site within the ITGB1 promoter resulted in a significant loss of ITGB1 hypoxia-inducibility. As proof of principle, studies in a murine model of colitis revealed a correlation between colitic disease severity and tissue ITGB1 expression (R-2=0.80). Taken together, these results demonstrate that hypoxia induces fibroblast ITGB1 expression and function by transcriptional mechanisms dependent on HIF.-Keely, S., Glover, L. E., MacManus, C. F., Campbell, E. L., Scully, M. M., Furuta, G. T., Colgan, S. P. Selective induction of integrin beta 1 by hypoxia-inducible factor: implications for wound healing. FASEB J. 23, 1338-1346 (2009)	[Colgan, Sean P.] Univ Colorado Denver, Mucosal Inflammat Program, Div Gastroenterol & Hepatol, Dept Med,Hlth Sci Ctr,Sch Med, Aurora, CO 80045 USA; [Furuta, Glenn T.] Univ Colorado Denver, Sch Med, Dept Pediat Gastroenterol Hepatol & Nutr, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Colgan, SP (corresponding author), Univ Colorado Denver, Mucosal Inflammat Program, Div Gastroenterol & Hepatol, Dept Med,Hlth Sci Ctr,Sch Med, 12700 E 19th Ave,MS B-146, Aurora, CO 80045 USA.	sean.colgan@uchsc.edu	Campbell, Eric/N-5357-2015; Keely, Simon/AAV-9973-2020	Campbell, Eric/0000-0003-0744-6577; Keely, Simon/0000-0002-1248-9590; Glover, Louise/0000-0001-9056-1810	U.S. National Institutes of Health [HL60569, DK50189, DE DE13499]; Crohn's and Colitis Foundation of America; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060569] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P01DE013499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK050189, R01DK050189, R29DK050189] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. National Institutes of Health grants HL60569, DK50189, and DE DE13499 and by a grant and research fellowship from the Crohn's and Colitis Foundation of America. The authors acknowledge the generous gift of FG4497 from Fibrogen Corp.	Albina JE, 2001, AM J PHYSIOL-CELL PH, V281, pC1971, DOI 10.1152/ajpcell.2001.281.6.C1971; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Benson DA, 1999, NUCLEIC ACIDS RES, V27, P12, DOI 10.1093/nar/27.1.12; Boirivant M, 1998, J EXP MED, V188, P1929, DOI 10.1084/jem.188.10.1929; Carlson TR, 2008, DEVELOPMENT, V135, P2193, DOI 10.1242/dev.016378; Chen CP, 2005, J CLIN ENDOCR METAB, V90, P1083, DOI 10.1210/jc.2004-0803; Colgan SP, 1996, J EXP MED, V184, P1003, DOI 10.1084/jem.184.3.1003; Comerford KM, 2002, CANCER RES, V62, P3387; Cummins EP, 2008, GASTROENTEROLOGY, V134, P156, DOI 10.1053/j.gastro.2007.10.012; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Eckes B, 2006, J INVEST DERM SYMP P, V11, P66, DOI 10.1038/sj.jidsymp.5650003; Elson DA, 2000, CANCER RES, V60, P6189; Furuta GT, 2001, J EXP MED, V193, P1027, DOI 10.1084/jem.193.9.1027; Grinnell F, 2002, EXP CELL RES, V273, P248, DOI 10.1006/excr.2001.5445; Grinnell F, 1999, J BIOL CHEM, V274, P918, DOI 10.1074/jbc.274.2.918; Haddad JJ, 2003, CRIT CARE, V7, P47, DOI 10.1186/cc1840; HEMLER ME, 1990, ANNU REV IMMUNOL, V8, P365, DOI 10.1146/annurev.iy.08.040190.002053; Imaizumi F, 2004, TISSUE ENG, V10, P657, DOI 10.1089/1076327041348329; Jones RG, 2006, J CELL BIOL, V175, P505, DOI 10.1083/jcb.200602160; Kan C, 2003, J DERMATOL SCI, V32, P75, DOI 10.1016/S0923-1811(03)00032-X; Karhausen J, 2005, CELL CYCLE, V4, P256; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; Kong TQ, 2004, P NATL ACAD SCI USA, V101, P10440, DOI 10.1073/pnas.0401339101; Krieglstein CF, 2002, J CLIN INVEST, V110, P1773, DOI 10.1172/JCI200215256; Laughlin KM, 1996, J PHARMACOL EXP THER, V277, P1049; Lawrance IC, 2001, INFLAMM BOWEL DIS, V7, P226, DOI 10.1097/00054725-200108000-00008; Lotz MM, 1997, AM J PATHOL, V150, P747; Louis NA, 2005, FASEB J, V19, P950, DOI 10.1096/fj.04-3251com; Louis NA, 2008, J IMMUNOL, V180, P4246, DOI 10.4049/jimmunol.180.6.4246; Louis NA, 2006, J CELL BIOCHEM, V99, P1616, DOI 10.1002/jcb.20947; Mace KA, 2007, WOUND REPAIR REGEN, V15, P636, DOI 10.1111/j.1524-475X.2007.00278.x; Maclachlan T, 2005, INT J RADIAT BIOL, V81, P567, DOI 10.1080/09553000500211091; Maxwell PH, 2002, SEMIN CELL DEV BIOL, V13, P29, DOI 10.1006/scdb.2001.0287; Meissner U, 2003, PHARMACOLOGY, V69, P74, DOI 10.1159/000072359; Montandon D, 1977, Clin Plast Surg, V4, P325; MOORE R, 1989, AM J PHYSIOL, V257, pG274, DOI 10.1152/ajpgi.1989.257.2.G274; MORRIS GP, 1989, GASTROENTEROLOGY, V96, P795, DOI 10.1016/0016-5085(89)90904-9; Ngo P, 2006, METH MOL B, V341, P103; OLSON AD, 1993, DIGEST DIS SCI, V38, P388, DOI 10.1007/BF01316489; Papakonstantinou E, 2003, CYTOKINE, V24, P25, DOI 10.1016/S1043-4666(03)00253-9; Phillips JA, 2005, EXP CELL RES, V310, P79, DOI 10.1016/j.yexcr.2005.03.039; RIIKONEN T, 1995, J BIOL CHEM, V270, P376, DOI 10.1074/jbc.270.1.376; Robinson A, 2008, GASTROENTEROLOGY, V134, P145, DOI 10.1053/j.gastro.2007.09.033; Saadi S, 2002, FASEB J, V16, DOI 10.1096/fj.01-0690hyp; SEMENIUK C, 2007, WETLANDS ECOL CONSER, V1, P1; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Semenza GL, 2000, ADV EXP MED BIOL, V475, P123; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Steinbrech DS, 1999, J SURG RES, V84, P127, DOI 10.1006/jsre.1999.5627; STEMME S, 1992, ARTERIOSCLER THROMB, V12, P206, DOI 10.1161/01.ATV.12.2.206; Synnestvedt K, 2002, J CLIN INVEST, V110, P993, DOI 10.1172/JCI200215337; Tandara AA, 2004, WORLD J SURG, V28, P294, DOI 10.1007/s00268-003-7400-2; Taylor CT, 2007, J MOL MED, V85, P1295, DOI 10.1007/s00109-007-0277-z; Turner CE, 2000, J CELL SCI, V113, P4139; Van Assche G, 2004, INFLAMM BOWEL DIS, V10, P55, DOI 10.1097/00054725-200401000-00009; Zhang QX, 2008, J INVEST DERMATOL, V128, P2102, DOI 10.1038/jid.2008.53; Zinkernagel AS, 2007, J MOL MED, V85, P1339, DOI 10.1007/s00109-007-0282-2; ZUTTER MM, 1990, AM J PATHOL, V137, P113	59	77	78	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2009	23	5					1338	1346		10.1096/fj.08-125344	http://dx.doi.org/10.1096/fj.08-125344			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZP	19103643	Green Published			2022-12-25	WOS:000266651700010
J	Piconi, S; Trabattoni, D; Luraghi, C; Perilli, E; Borelli, M; Pacei, M; Rizzardini, G; Lattuada, A; Bray, DH; Catalano, M; Sparaco, A; Clerici, M				Piconi, Stefania; Trabattoni, Daria; Luraghi, Cristina; Perilli, Edoardo; Borelli, Manuela; Pacei, Michela; Rizzardini, Giuliano; Lattuada, Antonella; Bray, Dorothy H.; Catalano, Mariella; Sparaco, Antonella; Clerici, Mario			Treatment of periodontal disease results in improvements in endothelial dysfunction and reduction of the carotid intima-media thickness	FASEB JOURNAL			English	Article						leukocyte activation; inflammation; T lymphocytes; ultrasound measurement	TOLL-LIKE RECEPTOR-4; ATHEROSCLEROTIC LESIONS; MONOCYTE ADHESION; INFLAMMATION; MACROPHAGES; PROGRESSION; CD36; IDENTIFICATION; POLYMORPHISMS; MECHANISMS	Several cohort studies reported a relation of cardiovascular events and periodontal disease. In particular, Porphyromonas gingivalis is associated with the development of atherosclerotic plaques. We verified in a longitudinal study whether inflammation biomarkers, endothelial adhesion molecules, leukocyte activation markers, and intima-media thickness could be beneficially modified by periodontal treatment alone. Thirty-five otherwise healthy individuals affected by mild to moderate parodontopathy were enrolled in the study. Echo-Doppler cardiography of the carotid artery, fluorescence-activated cell sorting analyses on lymphocytes and monocytes, and plasma inflammatory indices were evaluated at baseline and at multiple time points after the periodontal treatment. Results showed that inflammation biomarkers were abnormally increased at baseline. Periodontal treatment resulted in a significant reduction of the total oral bacterial load that was associated with a significant amelioration of inflammation biomarkers and of adhesion and activation proteins. Notably, intima-media thickness was significantly diminished after treatment. Inflammatory alterations associated with the genesis of atherosclerotic plaques are detected in otherwise healthy individuals affected by parodontopathy and are positively influenced by periodontal treatment. Reduction of oral bacterial load results in a modification of an anatomical parameter directly responsible for atherosclerosis. These results shed light on the pathogenesis of atherosclerosis and could have practical implications for public health.-Piconi, S., Trabattoni, D., Luraghi, C., Perilli, E., Borelli, M., Pacei, M., Rizzardini, G., Lattuada, A., Bray, D. H., Catalano, M., Sparaco, A., Clerici, M. Treatment of periodontal disease results in improvements of endothelial dysfunction and reduction of the carotid intima-media thickness. FASEB J. 23, 1196-1204 (2009)	[Clerici, Mario] Univ Milan, Dept Biomed Sci & Technol, I-20090 Milan, Italy; [Piconi, Stefania; Rizzardini, Giuliano] Hosp Luigi Sacco, Infect Dis Unit, Milan, Italy; [Luraghi, Cristina; Sparaco, Antonella] Hosp Luigi Sacco, Odontoiatr Unit, Milan, Italy; [Perilli, Edoardo; Catalano, Mariella] Hosp Luigi Sacco, Res Ctr Vasc Dis & Angiol Unit, Milan, Italy; [Lattuada, Antonella] Hosp Luigi Sacco, Haematol Unit, Milan, Italy; [Bray, Dorothy H.] Immunoclin Ltd, London, England; [Clerici, Mario] Ist Ricovero & Cura Carattere Sci, Don C Gnocchi Fdn, Milan, Italy	University of Milan; University of Milan; Luigi Sacco Hospital; University of Milan; Luigi Sacco Hospital; University of Milan; Luigi Sacco Hospital; University of Milan; Luigi Sacco Hospital; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Fondazione Don Carlo Gnocchi Onlus	Clerici, M (corresponding author), Univ Milan, Dept Biomed Sci & Technol, Via Flli Cervi 93, I-20090 Milan, Italy.	mario.clerici@unimi.it	Catalano, Mariella/F-2708-2017; Trabattoni, Daria/G-7424-2012	Catalano, Mariella/0000-0002-8355-0344; Trabattoni, Daria/0000-0001-9535-3359; Clerici, Mario/0000-0001-5920-6191	Istituto Superiore di Sanita'; European Commission (EC); Japan Health Science Foundation,; Italian Ministry of Health; progetto Fondo Italiano Ricerca di Base RETI; Rete Italiana Chimica Farmaceutica CHEM-PRO-FARMA-NET	Istituto Superiore di Sanita'; European Commission (EC)(European CommissionEuropean Commission Joint Research Centre); Japan Health Science Foundation,; Italian Ministry of Health(Ministry of Health, Italy); progetto Fondo Italiano Ricerca di Base RETI; Rete Italiana Chimica Farmaceutica CHEM-PRO-FARMA-NET	This study was supported by grants from the Istituto Superiore di Sanita' "Programma Nazionale di Ricerca sull' AIDS," the AIDS Vaccine Integrated Project European Commission (EC) WP6 Projects, the nGIN EC FP7 Project, the Japan Health Science Foundation, 2007 Ricerca Finalizzata (Italian Ministry of Health), 2007 Ricerca Corrente (Italian Ministry of Health) and progetto Fondo Italiano Ricerca di Base RETI, Rete Italiana Chimica Farmaceutica CHEM-PRO-FARMA-NET (RBPR05NWWC). We are grateful to Gaba International AG and to Nadia Berto, RN, and Simona Pranzo for excellent technical support.	Agnese DM, 2002, J INFECT DIS, V186, P1522, DOI 10.1086/344893; Armitage G C, 2000, Oral Dis, V6, P335, DOI 10.1111/j.1601-0825.2000.tb00126.x; Binder CJ, 2002, NAT MED, V8, P1218, DOI 10.1038/nm1102-1218; Blankenberg S, 2003, ATHEROSCLEROSIS, V170, P191, DOI 10.1016/S0021-9150(03)00097-2; Bulut Y, 2002, J IMMUNOL, V168, P1435, DOI 10.4049/jimmunol.168.3.1435; Cuff CA, 2001, J CLIN INVEST, V108, P1031, DOI 10.1172/JCI12455; D'Aiuto F, 2005, J DENT RES, V84, P269, DOI 10.1177/154405910508400312; DeGrendele HC, 1996, J EXP MED, V183, P1119, DOI 10.1084/jem.183.3.1119; Edfeldt K, 2002, CIRCULATION, V105, P1158, DOI 10.1161/circ.105.10.1158; Elkind MSV, 2006, SEMIN NEUROL, V26, P88, DOI 10.1055/s-2006-933312; Elter JR, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2005.10.002; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Fiehn NE, 2005, J PERIODONTOL, V76, P731, DOI 10.1902/jop.2005.76.5.731; FURBERG CD, 1994, CIRCULATION, V90, P1679, DOI 10.1161/01.CIR.90.4.1679; Giacona MB, 2004, FEMS MICROBIOL LETT, V241, P95, DOI 10.1016/j.femsle.2004.10.009; Giuffre L, 1997, J CELL BIOL, V136, P945, DOI 10.1083/jcb.136.4.945; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Haase R, 2003, J IMMUNOL, V171, P4294, DOI 10.4049/jimmunol.171.8.4294; Hajishengallis George, 2002, Ann Periodontol, V7, P72, DOI 10.1902/annals.2002.7.1.72; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hansson GK, 2001, ARTERIOSCL THROM VAS, V21, P1876, DOI 10.1161/hq1201.100220; Haraszthy VI, 2000, J PERIODONTOL, V71, P1554, DOI 10.1902/jop.2000.71.10.1554; Harokopakis E, 2006, J IMMUNOL, V176, P7645, DOI 10.4049/jimmunol.176.12.7645; Harris N, 1997, J EXP MED, V185, P177, DOI 10.1084/jem.185.1.177; Jain A, 2003, INFECT IMMUN, V71, P6012, DOI 10.1128/IAI.71.10.6012-6018.2003; KANE JP, 1990, JAMA-J AM MED ASSOC, V264, P3007, DOI 10.1001/jama.264.23.3007; Kiechl S, 2002, NEW ENGL J MED, V347, P185, DOI 10.1056/NEJMoa012673; Kozarov EV, 2005, ARTERIOSCL THROM VAS, V25, pE17, DOI 10.1161/01.ATV.0000155018.67835.1a; Kuchibhotla S, 2008, CARDIOVASC RES, V78, P185, DOI 10.1093/cvr/cvm093; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; Lalla E, 2003, ARTERIOSCL THROM VAS, V23, P1405, DOI 10.1161/01.ATV.0000082462.26258.FE; Libby P, 2001, CIRCULATION, V104, P365, DOI 10.1161/01.CIR.104.3.365; Libby P, 1996, CURR OPIN LIPIDOL, V7, P330, DOI 10.1097/00041433-199610000-00012; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Mercanoglu F, 2004, J PERIODONTOL, V75, P1694, DOI 10.1902/jop.2004.75.12.1694; Merched AJ, 2008, FASEB J, V22, P3595, DOI 10.1096/fj.08-112201; Papapanou P N, 1996, Ann Periodontol, V1, P1, DOI 10.1902/annals.1996.1.1.1; Papapanou PN, 2007, J CLIN PERIODONTOL, V34, P736, DOI 10.1111/j.1600-051X.2007.01113.x; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Ramos CL, 1999, CIRC RES, V84, P1237, DOI 10.1161/01.RES.84.11.1237; Roth GA, 2007, ATHEROSCLEROSIS, V190, P271, DOI 10.1016/j.atherosclerosis.2006.03.018; SALONEN R, 1995, CIRCULATION, V92, P1758, DOI 10.1161/01.CIR.92.7.1758; Schillinger T, 2006, STROKE, V37, P2271, DOI 10.1161/01.STR.0000236495.82545.2e; Stelzel M, 2002, J PERIODONTOL, V73, P868, DOI 10.1902/jop.2002.73.8.868; Tonetti MS, 2007, NEW ENGL J MED, V356, P911, DOI 10.1056/NEJMoa063186; Triantafilou M, 2007, CELL MICROBIOL, V9, P2030, DOI 10.1111/j.1462-5822.2007.00935.x; Xu XH, 2001, CIRCULATION, V104, P3103, DOI 10.1161/hc5001.100631	47	108	117	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2009	23	4					1196	1204		10.1096/fj.08-119578	http://dx.doi.org/10.1096/fj.08-119578			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZO	19074511				2022-12-25	WOS:000266651600024
J	Unhavaithaya, Y; Hao, Y; Beyret, E; Yin, H; Kuramochi-Miyagawa, S; Nakano, T; Lin, HF				Unhavaithaya, Yingdee; Hao, Yi; Beyret, Ergin; Yin, Hang; Kuramochi-Miyagawa, Satomi; Nakano, Toru; Lin, Haifan			MILI, a PIWI-interacting RNA-binding Protein, Is Required for Germ Line Stem Cell Self-renewal and Appears to Positively Regulate Translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPERMATOGONIAL-DEPLETION JSD; UNDIFFERENTIATED SPERMATOGONIA; CAENORHABDITIS-ELEGANS; MESSENGER-RNAS; PIRNA COMPLEX; GENE ENCODES; DROSOPHILA; DIFFERENTIATION; INITIATION; MICRORNA	The Argonaute/PIWI protein family consists of Argonaute and PIWI subfamilies. Argonautes function in RNA interference and micro-RNA pathways; whereas PIWIs bind to PIWI-interacting RNAs and regulate germ line development, stem cell maintenance, epigenetic regulation, and transposition. However, the role of PIWIs in mammalian stem cells has not been demonstrated, and molecular mechanisms mediated by PIWIs remain elusive. Here we show that MILI, a murine PIWI protein, is expressed in the cytoplasm of testicular germ line stem cells, spermatogonia, and early spermatocytes, where it is enriched in chromatoid bodies. MILI is essential for the self-renewing division and differentiation of germ line stem cells but does not affect initial establishment of the germ line stem cell population at 7 days postpartum. Furthermore, MILI forms a stable RNA-independent complex with eIF3a and associates with the eIF4E- and eIF4G-containing m(7)G cap-binding complex. In isolated 7 days postpartum seminiferous tubules containing mostly germ line stem cells, the mili mutation has no effect on the cellular mRNA level yet significantly reduces the rate of protein synthesis. These observations indicate that MILI may positively regulate translation and that such regulation is required for germ line stem cell self-renewal.	[Unhavaithaya, Yingdee; Hao, Yi; Beyret, Ergin; Yin, Hang; Lin, Haifan] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Beyret, Ergin; Yin, Hang; Lin, Haifan] Yale Univ, Sch Med, Yale Stem Cell Ctr, New Haven, CT 06511 USA; [Kuramochi-Miyagawa, Satomi; Nakano, Toru] Osaka Univ, Dept Mol Cell Biol, Suita, Osaka 5650871, Japan	Duke University; Yale University; Osaka University	Lin, HF (corresponding author), Yale Stem Cell Ctr, 10 Amistad St, New Haven, CT 06509 USA.	haifan.lin@yale.edu	Yin, Hang/J-3613-2019	Yin, Hang/0000-0002-9621-0138; BEYRET, ERGIN/0000-0003-1980-532X	National Institutes of Health [HD42012]; Connecticut Stem Cell Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042012] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Connecticut Stem Cell Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant HD42012. This work was also supported by a grant from the Connecticut Stem Cell Research Foundation ( to H. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; BEAMER WG, 1988, BIOL REPROD, V38, P899, DOI 10.1095/biolreprod38.4.899; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; BELLVE AR, 1977, J HISTOCHEM CYTOCHEM, V25, P480, DOI 10.1177/25.7.893996; Beyret E, 2008, MICRORNAS: FROM BASIC SCIENCE TO DISEASE BIOLOGY, P497; Bloch DB, 2006, RNA, V12, P707, DOI 10.1261/rna.17406; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Cataldo L, 1997, EXP CELL RES, V231, P206, DOI 10.1006/excr.1996.3447; Ciosk R, 2004, DEVELOPMENT, V131, P4831, DOI 10.1242/dev.01352; Collier B, 2005, EMBO J, V24, P2656, DOI 10.1038/sj.emboj.7600738; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; de Rooij DG, 1999, BIOL REPROD, V61, P842, DOI 10.1095/biolreprod61.3.842; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Gilboa L, 2004, CURR BIOL, V14, P981, DOI 10.1016/j.cub.2004.05.049; Giorgini F, 2002, DEVELOPMENT, V129, P3669; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; GODCHAUX W, 1967, J MOL BIOL, V27, P57, DOI 10.1016/0022-2836(67)90351-8; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Grivna ST, 2006, P NATL ACAD SCI USA, V103, P13415, DOI 10.1073/pnas.0605506103; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Groisman I, 2002, CELL, V109, P473, DOI 10.1016/S0092-8674(02)00733-X; Harris AN, 2001, DEVELOPMENT, V128, P2823; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Jakymiw A, 2005, NAT CELL BIOL, V7, P1267, DOI 10.1038/ncb1334; Johnson KR, 1997, J BIOL CHEM, V272, P7106, DOI 10.1074/jbc.272.11.7106; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; KLEENE KC, 1993, DEV BIOL, V159, P720, DOI 10.1006/dbio.1993.1277; KOSHIMIZU U, 1995, MOL REPROD DEV, V40, P221, DOI 10.1002/mrd.1080400211; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Kotaja N, 2006, J CELL SCI, V119, P2819, DOI 10.1242/jcs.03022; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; LIN H, 2004, STEM CELLS HDB, P57; Lin HF, 2007, SCIENCE, V316, P397, DOI 10.1126/science.1137543; Lin HF, 1997, DEVELOPMENT, V124, P2463; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Megosh HB, 2006, CURR BIOL, V16, P1884, DOI 10.1016/j.cub.2006.08.051; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Morita S, 2007, GENOMICS, V89, P687, DOI 10.1016/j.ygeno.2007.01.004; Nelson PT, 2004, RNA, V10, P387, DOI 10.1261/rna.5181104; Ohta H, 2003, BIOL REPROD, V69, P1815, DOI 10.1095/biolreprod.103.019323; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Parisi M, 1999, GENETICS, V153, P235; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Raverot G, 2005, DEV BIOL, V283, P215, DOI 10.1016/j.ydbio.2005.04.013; Reddien PW, 2005, SCIENCE, V310, P1327, DOI 10.1126/science.1116110; Rehwinkel J, 2005, RNA, V11, P1640, DOI 10.1261/rna.2191905; Reynolds N, 2005, HUM MOL GENET, V14, P3899, DOI 10.1093/hmg/ddi414; Rohozinski J, 2004, P NATL ACAD SCI USA, V101, P11695, DOI 10.1073/pnas.0401130101; Ross AJ, 2005, TRENDS ENDOCRIN MET, V16, P19, DOI 10.1016/j.tem.2004.11.004; Ruggiu M, 1997, NATURE, V389, P73, DOI 10.1038/37987; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; Shi HF, 2004, J BIOL CHEM, V279, P49889, DOI 10.1074/jbc.M409280200; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Wang G, 2008, CURR BIOL, V18, P861, DOI 10.1016/j.cub.2008.05.009; Wang Z, 2004, SCIENCE, V303, P2016, DOI 10.1126/science.1093983; Watanabe T, 2006, GENE DEV, V20, P1732, DOI 10.1101/gad.1425706; Wilson JE, 1996, DEVELOPMENT, V122, P1631; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263	69	160	176	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6507	6519		10.1074/jbc.M809104200	http://dx.doi.org/10.1074/jbc.M809104200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19114715	Green Published, hybrid			2022-12-25	WOS:000263742700053
J	Oresic, K; Ng, CL; Tortorella, D				Oresic, Kristina; Ng, Caroline L.; Tortorella, Domenico			TRAM1 Participates in Human Cytomegalovirus US2-and US11-mediated Dislocation of an Endoplasmic Reticulum Membrane Glycoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I HEAVY-CHAINS; PROTEIN INTEGRATION; MISFOLDED PROTEINS; SECRETORY PROTEIN; LIPID-BILAYER; DEGRADATION; ER; CYTOSOL; TRANSLOCATION; COMPLEX	The human cytomegalovirus proteins US2 and US11 have co-opted endoplasmic reticulum (ER) quality control to facilitate the destruction of major histocompatibility complex class I heavy chains. The class I heavy chains are dislocated from the ER to the cytosol, where they are deglycosylated and subsequently degraded by the proteasome. We examined the role of TRAM1 (translocating chain-associated membrane protein-1) in the dislocation of class I molecules using US2- and US11-expressing cells. TRAM1 is an ER protein initially characterized for its role in processing nascent polypeptides. Co-immunoprecipitation studies demonstrated that TRAM1 can complex with the wild type US2 and US11 proteins as well as deglycosylated and polyubiquitinated class I degradation intermediates. In studies using US2- and US11-TRAM1 knockdown cells, we observed an increase in levels of class I heavy chains. Strikingly, increased levels of glycosylated heavy chains were observed in TRAM1 knockdown cells when compared with control cells in a pulse-chase experiment. In fact, US11-mediated class I dislocation was more sensitive to the lack of TRAM1 than US2. These results provide further evidence that these viral proteins may utilize distinct complexes to facilitate class I dislocation. For example, US11-mediated class I heavy chain degradation requires Derlin-1 and SEL1L, whereas signal peptide peptidase is critical for US2-induced class I destabilization. In addition, TRAM1 can complex with the dislocation factors Derlin-1 and signal peptide peptidase. Collectively, the data support a model in which TRAM1 functions as a cofactor to promote efficient US2- and US11-dependent dislocation of major histocompatibility complex class I heavy chains.	[Oresic, Kristina; Ng, Caroline L.; Tortorella, Domenico] Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Tortorella, D (corresponding author), Mt Sinai Sch Med, Dept Microbiol, 1 Gustave L Levy Pl,Box 1124, New York, NY 10029 USA.	Domenico.Tortorella@mssm.edu		Tortorella, Domenico/0000-0003-0961-3535	National Institutes of Health [AI060905, U19 AI062623]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI062623, R01AI060905] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI060905 and U19 AI062623. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported in part by the Irma T. Hirschl Trust. To whom correspondence should be addressed: Dept. of Microbiology, Mount Sinai School of Medicine, One Gustave L. Levy Pl., Box 1124, New York, NY 10029. Tel.: 212-241-5447; Fax: 212-241-7336; E-mail:Domenico.Tortorella@mssm.edu.	Bays NW, 2002, CURR BIOL, V12, pR366, DOI 10.1016/S0960-9822(02)00862-X; BEERSMA MFC, 1993, J IMMUNOL, V151, P4455; Blom D, 2004, EMBO J, V23, P650, DOI 10.1038/sj.emboj.7600090; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Do H, 1996, CELL, V85, P369, DOI 10.1016/S0092-8674(00)81115-0; Furman MH, 2003, J BIOL CHEM, V278, P34804, DOI 10.1074/jbc.M300913200; GORLICH D, 1992, NATURE, V357, P47, DOI 10.1038/357047a0; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; HIGH S, 1993, J CELL BIOL, V121, P743, DOI 10.1083/jcb.121.4.743; HOCHSTENBACH F, 1992, P NATL ACAD SCI USA, V89, P4734, DOI 10.1073/pnas.89.10.4734; JONES TR, 1995, J VIROL, V69, P4830, DOI 10.1128/JVI.69.8.4830-4841.1995; Kislauskis EH, 1997, J CELL BIOL, V136, P1263, DOI 10.1083/jcb.136.6.1263; Knight BC, 1998, BIOCHEM J, V331, P161, DOI 10.1042/bj3310161; Knop M, 1996, EMBO J, V15, P753, DOI 10.1002/j.1460-2075.1996.tb00411.x; Kreft SG, 2006, J BIOL CHEM, V281, P4646, DOI 10.1074/jbc.M512215200; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Lilley BN, 2003, MOL BIOL CELL, V14, P3690, DOI 10.1091/mbc.E03-03-0192; Loureiro J, 2006, ADV IMMUNOL, V92, P225, DOI 10.1016/S0065-2776(06)92006-9; Loureiro J, 2006, NATURE, V441, P894, DOI 10.1038/nature04830; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; MARTOGLIO B, 1995, CELL, V81, P207, DOI 10.1016/0092-8674(95)90330-5; McCormick PJ, 2003, MOL CELL, V12, P329, DOI 10.1016/S1097-2765(03)00304-6; Meacock SL, 2002, MOL BIOL CELL, V13, P4114, DOI 10.1091/mbc.E02-04-0198; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Noriega VM, 2008, J BIOL CHEM, V283, P4031, DOI 10.1074/jbc.M706283200; Oresic K, 2008, J GEN VIROL, V89, P1122, DOI 10.1099/vir.0.83516-0; Oresic K, 2006, J BIOL CHEM, V281, P19395, DOI 10.1074/jbc.M601026200; PARHAM P, 1979, J IMMUNOL, V123, P342; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; Qu DF, 1996, J BIOL CHEM, V271, P22791, DOI 10.1074/jbc.271.37.22791; Rapoport TA, 2004, TRENDS CELL BIOL, V14, P568, DOI 10.1016/j.tcb.2004.09.002; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Shamu CE, 1999, J CELL BIOL, V147, P45, DOI 10.1083/jcb.147.1.45; Shamu CE, 2001, MOL BIOL CELL, V12, P2546, DOI 10.1091/mbc.12.8.2546; STAM NJ, 1986, J IMMUNOL, V137, P2299; Tortorella D, 1998, J CELL BIOL, V142, P365, DOI 10.1083/jcb.142.2.365; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Voigt S, 1996, J CELL BIOL, V134, P25, DOI 10.1083/jcb.134.1.25; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; WILSON IA, 1984, CELL, V37, P767, DOI 10.1016/0092-8674(84)90412-4; Winter E, 2002, TRENDS BIOCHEM SCI, V27, P381, DOI 10.1016/S0968-0004(02)02154-0; Wurmbach E, 2001, J BIOL CHEM, V276, P47195, DOI 10.1074/jbc.M108716200; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Yuen T, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e48	49	14	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5905	5914		10.1074/jbc.M807568200	http://dx.doi.org/10.1074/jbc.M807568200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19121997	Green Published, hybrid			2022-12-25	WOS:000263560600054
J	Pittman, YR; Kandl, K; Lewis, M; Valente, L; Kinzy, TG				Pittman, Yvette R.; Kandl, Kimberly; Lewis, Marcus; Valente, Louis; Kinzy, Terri Goss			Coordination of Eukaryotic Translation Elongation Factor 1A (eEF1A) Function in Actin Organization and Translation Elongation by the Guanine Nucleotide Exchange Factor eEF1B alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; AMINOACYL-TRANSFER-RNA; PROTEIN-SYNTHESIS; CRYSTAL-STRUCTURE; BINDING SITE; FACTOR-I; F-ACTIN; EF-TU; COMPLEX; CYTOSKELETON	Eukaryotic translation elongation factor 1A (eEF1A) both shuttles aminoacyl-tRNA (aa-tRNA) to the ribosome and binds and bundles actin. A single domain of eEF1A is proposed to bind actin, aa-tRNA and the guanine nucleotide exchange factor eEF1B alpha. We show that eEF1B alpha has the ability to disrupt eEF1A-induced actin organization. Mutational analysis of eEF1B alpha F163, which binds in this domain, demonstrates effects on growth, eEF1A binding, nucleotide exchange activity, and cell morphology. These phenotypes can be partially restored by an intragenic W130A mutation. Furthermore, the combination of F163A with the lethal K205A mutation restores viability by drastically reducing eEF1B alpha affinity for eEF1A. This also results in a consistent increase in actin bundling and partially corrected morphology. The consequences of the overlapping functions in this eEF1A domain and its unique differences from the bacterial homologs provide a novel function for eEF1B alpha to balance the dual roles in actin bundling and protein synthesis.	[Pittman, Yvette R.; Lewis, Marcus; Valente, Louis; Kinzy, Terri Goss] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Microbiol Mol Genet & Immunol, Piscataway, NJ 08854 USA; [Kandl, Kimberly] St Olaf Coll, Dept Biol, Northfield, MN 55057 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Saint Olaf College	Kinzy, TG (corresponding author), 675 Hoes Lane, Piscataway, NJ 08854 USA.	kinzytg@umdnj.edu			National Institutes of Health [R01 GM57483, F31 A126530]; NATIONAL CANCER INSTITUTE [F31CA126530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057483] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM57483 (to T. G. K.) and F31 A126530 (to Y. R. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anand M, 2001, COLD SPRING HARB SYM, V66, P439, DOI 10.1101/sqb.2001.66.439; Andersen GR, 2000, MOL CELL, V6, P1261, DOI 10.1016/S1097-2765(00)00122-2; Andersen GR, 2001, NAT STRUCT BIOL, V8, P531, DOI 10.1038/88598; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Burke D., 2000, METHODS YEAST GENETI; Carr-Schmid A, 1999, MOL CELL BIOL, V19, P5257; CARVALHO MDD, 1984, ARCH BIOCHEM BIOPHYS, V234, P603, DOI 10.1016/0003-9861(84)90310-2; DeLano WL, 2002, PYMOL USERS MANUAL; Dinman JD, 1997, RNA, V3, P870; Edmonds BT, 1998, J BIOL CHEM, V273, P10288, DOI 10.1074/jbc.273.17.10288; Gross SR, 2005, NAT STRUCT MOL BIOL, V12, P772, DOI 10.1038/nsmb979; Gross SR, 2007, MOL CELL BIOL, V27, P1974, DOI 10.1128/MCB.00832-06; HONTS JE, 1994, J CELL BIOL, V126, P413, DOI 10.1083/jcb.126.2.413; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JANSSEN GMC, 1988, J BIOL CHEM, V263, P1773; Jeppesen MG, 2005, J BIOL CHEM, V280, P5071, DOI 10.1074/jbc.M411782200; JONES E W, 1991, P428; Kawashima T, 1996, NATURE, V379, P511, DOI 10.1038/379511a0; KINZY TG, 1992, J BIOL CHEM, V267, P1623; KINZY TG, 1994, NUCLEIC ACIDS RES, V22, P2703, DOI 10.1093/nar/22.13.2703; Liu G, 1996, J CELL BIOL, V135, P953, DOI 10.1083/jcb.135.4.953; Munshi R, 2001, GENETICS, V157, P1425; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Pittman YR, 2006, J BIOL CHEM, V281, P19457, DOI 10.1074/jbc.M601076200; SAHA SK, 1986, J BIOL CHEM, V261, P2599; SLOBIN LI, 1978, EUR J BIOCHEM, V84, P69, DOI 10.1111/j.1432-1033.1978.tb12142.x; YANG F, 1990, NATURE, V347, P494, DOI 10.1038/347494a0	28	38	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4739	4747		10.1074/jbc.M807945200	http://dx.doi.org/10.1074/jbc.M807945200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19095653	Green Published, hybrid			2022-12-25	WOS:000263134400073
J	Nakano, T; Homae, F; Watanabe, H; Taga, G				Nakano, Tamami; Homae, Fumitaka; Watanabe, Hama; Taga, Gentaro			Anticipatory Cortical Activation Precedes Auditory Events in Sleeping Infants	PLOS ONE			English	Article							HUMAN PREFRONTAL CORTEX; FALSE DISCOVERY RATE; VISUAL-STIMULATION; AWAKE INFANTS; HUMAN BRAIN; HEMODYNAMIC-RESPONSES; PRENATAL DEVELOPMENT; MISMATCH NEGATIVITY; OPTICAL TOPOGRAPHY; FRONTAL-CORTEX	Background: Behavioral studies have shown that infants can form associations between environmental events and produce anticipatory actions for the predictable event, but the neural mechanisms for the learning and anticipation of events in infants are not known. Recent neuroimaging studies revealed that the association cortices of infants show activation related to auditory-stimulus discrimination and novelty detection during sleep. In the present study, we expected that when an auditory cue (beeps) predicted an auditory event (a female voice), specific regions of the infant cortex would show anticipatory activation before the event onset even while sleeping. Methodology/Principal Findings: We examined the cortical activation of 3-month-old infants during delays between the cue and the event by using multi-channel near-infrared spectroscopy. To investigate spatiotemporal changes in cortical activation over the experimental session, we divided the session into two phases (early and late phase) and analyzed each phase separately. In the early phase, the frontal regions showed activation in response to the cue that was followed by the event compared with another cue that was not followed by any event. In the late phase, the temporoparietal region, in addition to the frontal region, showed prominent activation in response to the cue followed by the event. In contrast, when the cue was followed by an event and no-event in equal proportions, cortical activation in response to the cue was not observed in any phase. Conclusions: Sleeping 3-month-old infants showed anticipatory cortical activation in the temporoparietal and frontal regions only in response to the cue predicting the event, suggesting that infants can implicitly form associations between temporally separated events and generate the anticipatory activation before the predictable event. Furthermore, the different time evolution of activation in the temporoparietal and frontal regions suggests that these regions may be involved in different aspects of learning and predicting future events.	[Homae, Fumitaka; Watanabe, Hama; Taga, Gentaro] Univ Tokyo, Grad Sch Educ, Bunkyo Ku, Tokyo, Japan; [Nakano, Tamami] Japan Soc Promot Sci, Tokyo, Japan; [Homae, Fumitaka; Watanabe, Hama; Taga, Gentaro] CREST, Japan Sci & Technol Agcy, Saitama, Japan	University of Tokyo; Japan Society for the Promotion of Science; Japan Science & Technology Agency (JST)	Nakano, T (corresponding author), Univ Tokyo, Grad Sch Educ, Bunkyo Ku, Tokyo, Japan.	tamami@p.u-tokyo.ac.jp		Lauwereyns, Jan/0000-0003-0551-2550	Core Research for Evolution Science and Technology (CREST); Japan Science and Technology Agency	Core Research for Evolution Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This study was supported by Core Research for Evolution Science and Technology (CREST), Japan Science and Technology Agency. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bruce D J, 1970, Nature, V225, P873, DOI 10.1038/225873a0; CANFIELD RL, 1991, DEV PSYCHOL, V27, P198, DOI 10.1037/0012-1649.27.2.198; Carlsson K, 2000, J COGNITIVE NEUROSCI, V12, P691, DOI 10.1162/089892900562318; Cheour M, 2002, NATURE, V415, P599, DOI 10.1038/415599b; Cheour M, 2000, CLIN NEUROPHYSIOL, V111, P4, DOI 10.1016/S1388-2457(99)00191-1; Coenen AML, 2002, INT J PSYCHOPHYSIOL, V46, P163, DOI 10.1016/S0167-8760(02)00110-1; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Csibra G, 2001, INFANCY, V2, P159, DOI 10.1207/S15327078IN0202_3; Davis MH, 2007, P NATL ACAD SCI USA, V104, P16032, DOI 10.1073/pnas.0701309104; DIAMOND A, 1985, CHILD DEV, V56, P868, DOI 10.1111/j.1467-8624.1985.tb00160.x; Dubois J, 2006, NEUROIMAGE, V30, P1121, DOI 10.1016/j.neuroimage.2005.11.022; Gibson Eleanor Jack, 1969, PRINCIPLES PERCEPTUA; GILMORE RO, 1995, J EXP CHILD PSYCHOL, V59, P70418; GREENFIELD PM, 1991, BEHAV BRAIN SCI, V14, P531, DOI 10.1017/S0140525X00071235; Griffiths TD, 2002, TRENDS NEUROSCI, V25, P348, DOI 10.1016/S0166-2236(02)02191-4; HAITH MM, 1988, CHILD DEV, V59, P467, DOI 10.2307/1130325; HENNEVIN E, 1992, PSYCHOBIOLOGY, V20, P166; Homae F, 2006, NEUROSCI RES, V54, P276, DOI 10.1016/j.neures.2005.12.006; Homae F, 2007, NEUROSCI RES, V59, P29, DOI 10.1016/j.neures.2007.05.005; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; Kanwisher N, 2000, NAT REV NEUROSCI, V1, P91, DOI 10.1038/35039043; KAPLAN PS, 1992, DEV PSYCHOBIOL, V25, P299, DOI 10.1002/dev.420250407; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Knight DC, 2003, P NATL ACAD SCI USA, V100, P15280, DOI 10.1073/pnas.2535780100; Knudsen EI, 2007, ANNU REV NEUROSCI, V30, P57, DOI 10.1146/annurev.neuro.30.051606.094256; Kotilahti K, 2005, NEUROREPORT, V16, P1373, DOI 10.1097/01.wnr.0000175247.35837.15; MAHO C, 1992, BRAIN RES, V581, P115, DOI 10.1016/0006-8993(92)90350-I; Maki A, 1995, MED PHYS, V22, P1997, DOI 10.1118/1.597496; Martynova O, 2003, NEUROSCI LETT, V340, P75, DOI 10.1016/S0304-3940(02)01401-5; Maurer D., 1988, WORLD NEWBORN; Meek JH, 1998, PEDIATR RES, V43, P840, DOI 10.1203/00006450-199806000-00019; Minagawa-Kawai Y, 2007, J NEUROSCI, V27, P315, DOI 10.1523/JNEUROSCI.1984-06.2007; MRZLJAK L, 1992, J COMP NEUROL, V316, P485, DOI 10.1002/cne.903160408; MRZLJAK L, 1988, J COMP NEUROL, V271, P355, DOI 10.1002/cne.902710306; NAKANO T, CEREB CORTEX, DOI DOI 10.1092/CERCOR/BHN096; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Obrig H, 2003, J CEREBR BLOOD F MET, V23, P1, DOI 10.1097/01.WCB.0000043472.45775.29; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; Peirano P, 2003, J PEDIATR-US, V143, pS70, DOI 10.1067/S0022-3476(03)00404-9; Pena M, 2003, P NATL ACAD SCI USA, V100, P11702, DOI 10.1073/pnas.1934290100; Pessiglione M, 2008, NEURON, V59, P561, DOI 10.1016/j.neuron.2008.07.005; Petanjek Z, 2008, CEREB CORTEX, V18, P915, DOI 10.1093/cercor/bhm124; Portas CM, 2000, NEURON, V28, P991, DOI 10.1016/S0896-6273(00)00169-0; REEVE L, 1993, J EXP ANAL BEHAV, V60, P515, DOI 10.1901/jeab.1993.60-515; Singh AK, 2006, NEUROIMAGE, V33, P542, DOI 10.1016/j.neuroimage.2006.06.047; Taga G, 2003, P NATL ACAD SCI USA, V100, P10722, DOI 10.1073/pnas.1932552100; Taga G, 2007, NEUROIMAGE, V38, P452, DOI 10.1016/j.neuroimage.2007.07.050; Taga G, 2007, NEUROIMAGE, V36, P1246, DOI 10.1016/j.neuroimage.2007.04.037; Villringer A, 1997, TRENDS NEUROSCI, V20, P435, DOI 10.1016/S0166-2236(97)01132-6; Voisin J, 2006, J NEUROSCI, V26, P273, DOI 10.1523/JNEUROSCI.2967-05.2006; Watanabe H, 2008, NEUROIMAGE, V43, P346, DOI 10.1016/j.neuroimage.2008.07.014; WENTWORTH N, 1992, DEV PSYCHOL, V28, P842, DOI 10.1037/0012-1649.28.5.842; Wilcox T, 2008, DEVELOPMENTAL SCI, V11, P361, DOI 10.1111/j.1467-7687.2008.00681.x	56	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2008	3	12							e3912	10.1371/journal.pone.0003912	http://dx.doi.org/10.1371/journal.pone.0003912			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436ZS	19066629	Green Published, Green Submitted, gold			2022-12-25	WOS:000265455700009
J	Hershko, A				Hershko, Avram			Some Lessons from My Work on the Biochemistry of the Ubiquitin System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							DEPENDENT PROTEOLYTIC SYSTEM; PROTEIN LIGASE SYSTEM; DEGRADATION; ATP; RETICULOCYTES; POLYPEPTIDE; CONJUGATION; BREAKDOWN; P27		[Hershko, Avram] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Biochem Unit, IL-31096 Haifa, Israel; [Hershko, Avram] Technion Israel Inst Technol, Rappaport Family Inst Res Med Sci, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Hershko, A (corresponding author), Technion Israel Inst Technol, Bruce Rappaport Fac Med, Biochem Unit, POB 9649, IL-31096 Haifa, Israel.	hershko@tx.technion.ac.il						Braunstein I, 2007, P NATL ACAD SCI USA, V104, P4870, DOI 10.1073/pnas.0700523104; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; CIECHANOVER A, 1980, P NATL ACAD SCI-BIOL, V77, P1365, DOI 10.1073/pnas.77.3.1365; CIECHANOVER A, 1978, BIOCHEM BIOPH RES CO, V81, P1100, DOI 10.1016/0006-291X(78)91249-4; ETLINGER JD, 1977, P NATL ACAD SCI USA, V74, P54, DOI 10.1073/pnas.74.1.54; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; Hershko A, 1996, TRENDS BIOCHEM SCI, V21, P445, DOI 10.1016/S0968-0004(96)10054-2; HERSHKO A, 1971, J BIOL CHEM, V246, P710; HERSHKO A, 1986, J BIOL CHEM, V261, P1992; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; HERSHKO A, 1988, J BIOL CHEM, V263, P15237; HERSHKO A, 1980, P NATL ACAD SCI-BIOL, V77, P1783, DOI 10.1073/pnas.77.4.1783; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; HERSHKO A, 2005, LES PRIX NOBEL 2004, P187; PERUTZ MF, 2003, I WISH I D MADE YOU, P412; SCHIMKE RT, 1970, ANNU REV BIOCHEM, V39, P929, DOI 10.1146/annurev.bi.39.070170.004433; SIMPSON MV, 1953, J BIOL CHEM, V201, P143; SUDAKIN V, 1995, MOL BIOL CELL, V6, P185, DOI 10.1091/mbc.6.2.185; WILKINSON KD, 1980, J BIOL CHEM, V255, P7529	19	6	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10291	10295		10.1074/jbc.X800016200	http://dx.doi.org/10.1074/jbc.X800016200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19075010	hybrid, Green Published			2022-12-25	WOS:000265104600002
J	Kleerekoper, QK; Putkey, JA				Kleerekoper, Quinn K.; Putkey, John A.			PEP-19, an Intrinsically Disordered Regulator of Calmodulin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; TARGET RECOGNITION; NMR CHARACTERIZATION; BINDING-PROTEIN; FOLDING PROBLEM; DYNAMICS; KINASE; EXPRESSION; SECONDARY; COMPLEX	PEP-19 is a small calmodulin (CaM)-binding protein that greatly increases the rates of association and dissociation of Ca2+ from the C-domain of CaM, an effect that is mediated by an acidic/IQ sequence in PEP-19. We show here using NMR that PEP-19 is an intrinsically disordered protein, but with residual structure localized to its acidic/IQ motif. We also show that the k(on) and k(off) rates for binding PEP-19 to apo-CaM are at least 50-fold slower than for binding to Ca2+-CaM. These data indicate that intrinsic disorder confers plasticity that allows PEP-19 to bind to either apo- or Ca2+-CaM via different structural modes, and that complex formation may be facilitated by conformational selection of residual structure in the acidic/IQ sequence.	[Putkey, John A.] Univ Texas, Houston Med Sch, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Univ Texas, Houston Med Sch, Struct Biol Ctr, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Putkey, JA (corresponding author), Univ Texas, Houston Med Sch, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	john.putkey@uth.tmc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS038310] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM069611] Funding Source: Medline; NINDS NIH HHS [NS038310] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Chen YG, 2007, J AM CHEM SOC, V129, P2414, DOI 10.1021/ja067791a; Chou JJ, 2001, NAT STRUCT BIOL, V8, P990, DOI 10.1038/nsb1101-990; CRAESCU CT, 1995, J BIOL CHEM, V270, P7088, DOI 10.1074/jbc.270.13.7088; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dyson HJ, 2001, METHOD ENZYMOL, V339, P258; Erhardt JA, 2000, NEUROREPORT, V11, P3719, DOI 10.1097/00001756-200011270-00026; Evenas J, 2001, STRUCTURE, V9, P185, DOI 10.1016/S0969-2126(01)00575-5; Fallon JL, 2005, STRUCTURE, V13, P1881, DOI 10.1016/j.str.2005.09.021; Gaertner TR, 2004, J BIOL CHEM, V279, P39374, DOI 10.1074/jbc.M405352200; Gerendasy D, 1999, J NEUROSCI RES, V58, P107, DOI 10.1002/(SICI)1097-4547(19991001)58:1<107::AID-JNR11>3.0.CO;2-G; GERENDASY DD, 1995, J BIOL CHEM, V270, P6741, DOI 10.1074/jbc.270.12.6741; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; IKURA M, 1990, FEBS LETT, V266, P155, DOI 10.1016/0014-5793(90)81528-V; Jurado LA, 1999, PHYSIOL REV, V79, P661, DOI 10.1152/physrev.1999.79.3.661; Kanazawa Y, 2008, NEUROSCIENCE, V154, P473, DOI 10.1016/j.neuroscience.2008.03.044; Kranz JK, 2002, BIOCHEMISTRY-US, V41, P2599, DOI 10.1021/bi011818f; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; Lacroix E, 1998, J MOL BIOL, V284, P173, DOI 10.1006/jmbi.1998.2145; LOGAN TM, 1994, J MOL BIOL, V236, P637, DOI 10.1006/jmbi.1994.1173; Lundstrom P, 2005, P NATL ACAD SCI USA, V102, P16984, DOI 10.1073/pnas.0504361102; MUNOZ V, 1994, NAT STRUCT BIOL, V1, P399, DOI 10.1038/nsb0694-399; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Pelton JT, 2000, ANAL BIOCHEM, V277, P167, DOI 10.1006/abio.1999.4320; Permyakov SE, 2003, PROTEINS, V53, P855, DOI 10.1002/prot.10481; PRECHEUR B, 1992, BIOCHEMISTRY-US, V31, P229, DOI 10.1021/bi00116a032; PUTKEY JA, 1985, J BIOL CHEM, V260, P4704; Putkey JA, 1996, J BIOL CHEM, V271, P29619, DOI 10.1074/jbc.271.47.29619; Putkey JA, 2003, J BIOL CHEM, V278, P49667, DOI 10.1074/jbc.C300372200; Putkey JA, 2008, J BIOL CHEM, V283, P1401, DOI 10.1074/jbc.M703831200; Rabl CR, 2002, BIOPHYS CHEM, V101, P553, DOI 10.1016/S0301-4622(02)00150-3; Radivojac P, 2006, PROTEINS, V63, P398, DOI 10.1002/prot.20873; Ran XY, 2003, BIOCHEMISTRY-US, V42, P5143, DOI 10.1021/bi0271751; Reck-Peterson SL, 2000, BBA-MOL CELL RES, V1496, P36, DOI 10.1016/S0167-4889(00)00007-0; Rudolph MC, 2007, PHYSIOL GENOMICS, V28, P323, DOI 10.1152/physiolgenomics.00020.2006; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; SEEHOLZER SH, 1986, P NATL ACAD SCI USA, V83, P3634, DOI 10.1073/pnas.83.11.3634; Shmukler BE, 2001, BBA-GENE STRUCT EXPR, V1518, P36, DOI 10.1016/S0167-4781(01)00166-X; Slemmon JR, 2000, MOL NEUROBIOL, V22, P99, DOI 10.1385/MN:22:1-3:099; Slemmon JR, 1996, J BIOL CHEM, V271, P15911, DOI 10.1074/jbc.271.27.15911; Song J, 2008, P NATL ACAD SCI USA, V105, P1505, DOI 10.1073/pnas.0709558105; Tapp H, 2005, J BIOL CHEM, V280, P9946, DOI 10.1074/jbc.M414614200; TSALKOVA TN, 1985, J MOL BIOL, V181, P533, DOI 10.1016/0022-2836(85)90425-5; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; Waxham MN, 1998, J BIOL CHEM, V273, P17579, DOI 10.1074/jbc.273.28.17579; Wishart DS, 2001, METHOD ENZYMOL, V338, P3; Xiao JG, 2008, MOL CELL BIOCHEM, V309, P143, DOI 10.1007/s11010-007-9652-x; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758; Zhou N, 1997, BIOCHEMISTRY-US, V36, P2817, DOI 10.1021/bi9625713	56	41	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7455	7464		10.1074/jbc.M808067200	http://dx.doi.org/10.1074/jbc.M808067200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19106096	hybrid, Green Published			2022-12-25	WOS:000264195600009
J	Lapaque, N; Jahnke, M; Trowsdale, J; Kelly, AP				Lapaque, Nicolas; Jahnke, Martin; Trowsdale, John; Kelly, Adrian P.			The HLA-DR alpha Chain Is Modified by Polyubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-II; COMPLEX CLASS-II; DENDRITIC CELLS; ANTIGEN PRESENTATION; PLASMA-MEMBRANE; DOWN-REGULATION; PROTEIN; UBIQUITINATION; MOLECULES; PATHWAY	Ubiquitination plays a major role in regulating cell surface and intracellular localization of major histocompatibility complex class II molecules. Two E3 ligases, MARCH I and MARCH VIII, have been shown to polyubiquitinate lysine residue 225 in the cytoplasmic tail of I-A beta and HLA-DR beta. We show that lysine residue 219 in the cytoplasmic tail of DR alpha is also subject to polyubiquitination. Each chain of the HLA-DR heterodimer is independently recognized and ubiquitinated, but DR beta is more extensively modified. In the cytoplasmic tail of DR beta lysine, residue 225 is the only residue that is absolutely required for ubiquitination; all other residues can be deleted or substituted without loss of function. In contrast, although lysine 219 is absolutely required for modification of DR beta, other features of the DR beta tail act to limit the extent of ubiquitination.	[Lapaque, Nicolas; Jahnke, Martin; Trowsdale, John; Kelly, Adrian P.] Univ Cambridge, Dept Pathol, Div Immunol, Cambridge CB2 1QP, England	University of Cambridge	Kelly, AP (corresponding author), Univ Cambridge, Dept Pathol, Div Immunol, Tennis Court Rd, Cambridge CB2 1QP, England.	apk23@mole.bio.cam.ac.uk	Lapaque, Nicolas/D-5377-2014; Lapaque, Nicolas/AAB-4530-2021	Lapaque, Nicolas/0000-0003-0824-0108; Lapaque, Nicolas/0000-0003-0824-0108	Medical Research Council [G9800943] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G9800943] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; CRESSWELL P, 1992, CURR OPIN IMMUNOL, V4, P87, DOI 10.1016/0952-7915(92)90131-W; De Gassart A, 2008, P NATL ACAD SCI USA, V105, P3491, DOI 10.1073/pnas.0708874105; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; Duncan LM, 2006, EMBO J, V25, P1635, DOI 10.1038/sj.emboj.7601056; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Goto E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001490; Hiltbold EM, 2002, CURR OPIN IMMUNOL, V14, P30, DOI 10.1016/S0952-7915(01)00295-3; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Komada M, 2005, J BIOCHEM, V137, P1, DOI 10.1093/jb/mvi001; Matsuki Y, 2007, EMBO J, V26, P846, DOI 10.1038/sj.emboj.7601556; Mukherjee K, 2000, J CELL BIOL, V148, P741, DOI 10.1083/jcb.148.4.741; Nakatsu F, 2000, J BIOL CHEM, V275, P26213, DOI 10.1074/jbc.M907720199; Neefjes J, 1999, EUR J IMMUNOL, V29, P1421, DOI 10.1002/(SICI)1521-4141(199905)29:05<1421::AID-IMMU1421>3.3.CO;2-3; Ohmura-Hoshino M, 2006, J IMMUNOL, V177, P341, DOI 10.4049/jimmunol.177.1.341; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; PETERS PJ, 1991, NATURE, V349, P669, DOI 10.1038/349669a0; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Shin JS, 2006, NATURE, V444, P115, DOI 10.1038/nature05261; van Lith M, 2001, J IMMUNOL, V167, P884, DOI 10.4049/jimmunol.167.2.884; van Niel G, 2006, IMMUNITY, V25, P885, DOI 10.1016/j.immuni.2006.11.001; Watts C, 2004, NAT IMMUNOL, V5, P685, DOI 10.1038/ni1088; Zhong GM, 1997, J EXP MED, V185, P429, DOI 10.1084/jem.185.3.429; Zwart W, 2005, IMMUNITY, V22, P221, DOI 10.1016/j.immuni.2005.01.006	26	34	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7007	7016		10.1074/jbc.M805736200	http://dx.doi.org/10.1074/jbc.M805736200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19117940	hybrid, Green Published			2022-12-25	WOS:000263919000049
J	Oertel, BG; Kettner, M; Scholich, K; Renne, C; Roskam, B; Geisslinger, G; Schmidt, PH; Lotsch, J				Oertel, Bruno Georg; Kettner, Mattias; Scholich, Klaus; Renne, Christoph; Roskam, Bianca; Geisslinger, Gerd; Schmidt, Peter Harald; Loetsch, Joern			A Common Human mu-Opioid Receptor Genetic Variant Diminishes the Receptor Signaling Efficacy in Brain Regions Processing the Sensory Information of Pain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; G-PROTEIN ACTIVATION; POSTMORTEM HUMAN BRAIN; RESPIRATORY DEPRESSION; MORPHINE CONSUMPTION; HEALTHY-VOLUNTEERS; GENOTYPE AFFECTS; BINDING; A118G; ANALGESIA	The single nucleotide polymorphism 118A > G of the human mu-opioid receptor gene OPRM1, which leads to an exchange of the amino acid asparagine (N) to aspartic acid (D) at position 40 of the extracellular receptor region, alters the in vivo effects of opioids to different degrees in pain-processing brain regions. The most pronounced N40D effects were found in brain regions involved in the sensory processing of pain intensity. Using the mu-opioid receptor-specific agonist DAMGO, we analyzed the mu-opioid receptor signaling, expression, and binding affinity in human brain tissue sampled postmortem from the secondary somatosensory area (S-II) and from the ventral posterior part of the lateral thalamus, two regions involved in the sensory processing and transmission of nociceptive information. We show that the main effect of the N40D mu-opioid receptor variant is a reduction of the agonist-induced receptor signaling efficacy. In the S-II region of homo- and heterozygous carriers of the variant 118G allele (n = 18), DAMGO was only 62% as efficient (p = 0.002) as in homozygous carriers of the wild-type 118A allele (n = 15). In contrast, the number of [H-3] DAMGO binding sites was unaffected. Hence, the mu-opioid receptor G-protein coupling efficacy in SII of carriers of the 118G variant was only 58% as efficient as in homozygous carriers of the 118A allele (p < 0.001). The thalamus was unaffected by the OPRM1 118A > G SNP. In conclusion, we provide a molecular basis for the reduced clinical effects of opioid analgesics in carriers of mu-opioid receptor variant N40D.	[Oertel, Bruno Georg; Scholich, Klaus; Roskam, Bianca; Geisslinger, Gerd; Loetsch, Joern] Goethe Univ Frankfurt, Inst Clin Pharmacol, Pharmazentrum Frankfurt ZAFES, D-60590 Frankfurt, Germany; [Kettner, Mattias; Schmidt, Peter Harald] Goethe Univ Frankfurt, Inst Forens Med, Frankfurt, Germany; [Renne, Christoph] Goethe Univ Frankfurt, Senckenberg Inst Pathol, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt	Lotsch, J (corresponding author), Goethe Univ Frankfurt, Inst Clin Pharmacol, Pharmazentrum Frankfurt ZAFES, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	j.loetsch@em.uni-frankfurt.de		Lotsch, Jorn/0000-0002-5818-6958				Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Baumgartner U, 2006, NEUROIMAGE, V30, P692, DOI 10.1016/j.neuroimage.2005.10.033; Befort K, 2001, J BIOL CHEM, V276, P3130, DOI 10.1074/jbc.M006352200; Berthele A, 2005, NEUROIMAGE, V28, P185, DOI 10.1016/j.neuroimage.2005.05.030; Beyer A, 2004, J NEUROCHEM, V89, P553, DOI 10.1111/j.1471-4159.2004.02340.x; Bond C, 1998, P NATL ACAD SCI USA, V95, P9608, DOI 10.1073/pnas.95.16.9608; Bornhovd K, 2002, BRAIN, V125, P1326, DOI 10.1093/brain/awf137; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Campa D, 2008, CLIN PHARMACOL THER, V83, P559, DOI 10.1038/sj.clpt.6100385; CHAKRABARTI S, 1995, J NEUROCHEM, V64, P2534; Chou WY, 2006, ANESTHESIOLOGY, V105, P334, DOI 10.1097/00000542-200608000-00016; Coghill RC, 1999, J NEUROPHYSIOL, V82, P1934, DOI 10.1152/jn.1999.82.4.1934; Gonzalez-Maeso J, 2000, EUR J PHARMACOL, V390, P25, DOI 10.1016/S0014-2999(99)00827-4; Klepstad P, 2004, ACTA ANAESTH SCAND, V48, P1232, DOI 10.1111/j.1399-6576.2004.00517.x; KLEUSS C, 1992, NATURE, V358, P424, DOI 10.1038/358424a0; Ko MCH, 2003, J PHARMACOL EXP THER, V306, P179, DOI 10.1124/jpet.103.050625; Kroslak T, 2007, J NEUROCHEM, V103, P77, DOI 10.1111/j.1471-4159.2007.04738.x; Lotsch J, 2002, PHARMACOGENETICS, V12, P3, DOI 10.1097/00008571-200201000-00002; Maher CE, 2000, BIOCHEM PHARMACOL, V59, P1395, DOI 10.1016/S0006-2952(00)00272-0; Margas W, 2007, J NEUROPHYSIOL, V97, P1058, DOI 10.1152/jn.01007.2006; Neilan CL, 2003, J PHARMACOL EXP THER, V306, P430, DOI 10.1124/jpet.103.049742; Oertel BG, 2008, CLIN PHARMACOL THER, V83, P577, DOI 10.1038/sj.clpt.6100441; Oertel BG, 2006, PHARMACOGENET GENOM, V16, P625, DOI 10.1097/01.fpc.0000220566.90466.a2; Pan L, 2005, NEUROSCIENCE, V133, P209, DOI 10.1016/j.neuroscience.2004.12.033; Pan YX, 2003, BIOCHEM BIOPH RES CO, V301, P1057, DOI 10.1016/S0006-291X(03)00089-5; PILAPIL C, 1987, BRAIN RES BULL, V19, P611, DOI 10.1016/0361-9230(87)90080-3; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Rodriguez-Puertas R, 2000, NEUROSCIENCE, V96, P169, DOI 10.1016/S0306-4522(99)00527-8; Romberg R, 2004, ANESTHESIOLOGY, V100, P120, DOI 10.1097/00000542-200401000-00021; Romberg RR, 2005, ANESTHESIOLOGY, V102, P522, DOI 10.1097/00000542-200503000-00008; Sia AT, 2008, ANESTHESIOLOGY, V109, P520, DOI 10.1097/ALN.0b013e318182af21; Sim LJ, 1996, EUR J PHARMACOL, V307, P97, DOI 10.1016/0014-2999(96)00211-7; Skarke C, 2003, CLIN PHARMACOL THER, V73, P107, DOI 10.1067/mcp.2003.5; Skarke C, 2004, CLIN CHEM, V50, P640, DOI 10.1373/clinchem.2003.027607; Zhang Y, 2005, J BIOL CHEM, V280, P32618, DOI 10.1074/jbc.M504942200; Zubieta JK, 2003, SCIENCE, V299, P1240, DOI 10.1126/science.1078546	36	120	126	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6530	6535		10.1074/jbc.M807030200	http://dx.doi.org/10.1074/jbc.M807030200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19116204	hybrid			2022-12-25	WOS:000263742700055
J	Strachan, RT; Sheffler, DJ; Willard, B; Kinter, M; Kiselar, JG; Roth, BL				Strachan, Ryan T.; Sheffler, Douglas J.; Willard, Belinda; Kinter, Michael; Kiselar, Janna G.; Roth, Bryan L.			Ribosomal S6 Kinase 2 Directly Phosphorylates the 5-Hydroxytryptamine 2A (5-HT2A) Serotonin Receptor, Thereby Modulating 5-HT2A Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; 3RD INTRACELLULAR LOOP; IN-VIVO; CRYSTAL-STRUCTURE; PHOSPHOLIPASE-C; MESANGIAL CELLS; DESENSITIZATION; ACTIVATION; RHODOPSIN; AGONIST	The 5-hydroxytryptamine 2A (5-HT2A) receptor is a member of the G protein-coupled receptor superfamily (GPCR) and plays a key role in transducing a variety of cellular signals elicited by 5-hydroxytryptamine in both peripheral and central tissues. Despite its broad physiological importance, our current understanding of 5-HT2A receptor regulation is incomplete. We recently reported the novel finding that the multifunctional ERK effector ribosomal S6 kinase 2 (RSK2) physically interacts with the 5-HT2A receptor third intracellular (i3) loop and modulates receptor signaling (Sheffler, D.J., Kroeze, W.K., Garcia, B.G., Deutch, A.Y., Hufeisen, S.J., Leahy, P., Bruning, J.C., and Roth, B.L. (2006) Proc.Natl.Acad.Sci.U.S.A. 103, 4717-4722). We report here that RSK2 directly phosphorylates the 5-HT2A receptor i3 loop at the conserved residue Ser-314, thereby modulating 5-HT2A receptor signaling. Furthermore, these studies led to the discovery that RSK2 is required for epidermal growth factor-mediated heterologous desensitization of the 5-HT2A receptor. We arrived at these conclusions via multiple lines of evidence, including in vitro kinase experiments, tandem mass spectrometry, and site-directed mutagenesis. Our findings were further validated using phospho-specific Western blot analysis, metabolic labeling studies, and whole-cell signaling experiments. These results support a novel regulatory mechanism in which a downstream effector of the ERK/MAPK pathway directly interacts with, phosphorylates, and modulates signaling of the 5-HT2A serotonin receptor. To our knowledge, these findings are the first to demonstrate that a downstream member of the ERK/MAPK cascade phosphorylates a GPCR as well as mediates cross-talk between a growth factor and a GPCR.	[Roth, Bryan L.] Univ N Carolina, Dept Pharmacol, Sch Med, Chapel Hill, NC 27599 USA; [Strachan, Ryan T.; Roth, Bryan L.] Case Western Reserve Univ, Dept Biochem, Sch Med, Cleveland, OH 44106 USA; [Sheffler, Douglas J.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Willard, Belinda; Kinter, Michael] Cleveland Clin Lerner Res Inst, Cleveland, OH 44195 USA; [Kiselar, Janna G.] Case Western Reserve Univ, Ctr Prote, Cleveland, OH 44106 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Case Western Reserve University; Vanderbilt University; Cleveland Clinic Foundation; Case Western Reserve University	Roth, BL (corresponding author), Univ N Carolina, Dept Pharmacol, Sch Med, 4009 Genet Med CB 7365, Chapel Hill, NC 27599 USA.	bryan_roth@med.unc.edu	Roth, Bryan/ABE-7032-2020; Roth, Bryan L/F-3928-2010	Roth, Bryan/0000-0002-0561-6520; Kinter, Michael/0000-0001-7409-8918	National Institutes of Health [RO1MH61887, NO1MH32004, U19MH82441]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061887, U19MH082441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1MH61887, NO1MH32004, and U19MH82441 (to B. L. R.).	Aghajanian GK, 1997, NEUROPHARMACOLOGY, V36, P589, DOI 10.1016/S0028-3908(97)00051-8; Allen JA, 2008, NEUROPHARMACOLOGY, V55, P961, DOI 10.1016/j.neuropharm.2008.06.048; Backstrom JR, 1997, J NEUROSCI METH, V77, P109, DOI 10.1016/S0165-0270(97)00102-7; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Berg KA, 2001, J PHARMACOL EXP THER, V299, P593; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Bourdon DM, 2006, METHOD ENZYMOL, V406, P489, DOI 10.1016/S0076-6879(06)06037-X; BOUVIER M, 1988, NATURE, V333, P370, DOI 10.1038/333370a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruning JC, 2000, P NATL ACAD SCI USA, V97, P2462, DOI 10.1073/pnas.97.6.2462; Chrestensen CA, 2002, J BIOL CHEM, V277, P27733, DOI 10.1074/jbc.M202663200; Cohen MS, 2005, SCIENCE, V308, P1318, DOI 10.1126/science1108367; DECLERCK F, 1982, AGENTS ACTIONS, V12, P388; Delcourt N, 2007, TRENDS PHARMACOL SCI, V28, P602, DOI 10.1016/j.tips.2007.09.007; DUERSON K, 1993, FEBS LETT, V324, P103, DOI 10.1016/0014-5793(93)81541-7; El Kouhen R, 2001, J BIOL CHEM, V276, P12774, DOI 10.1074/jbc.M009571200; Ferguson SSG, 1996, CAN J PHYSIOL PHARM, V74, P1095, DOI 10.1139/y96-124; Fisher TL, 1996, MOL CELL BIOL, V16, P1212; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Gavi S, 2006, TRENDS ENDOCRIN MET, V17, P46, DOI 10.1016/j.tem.2006.01.006; Gavi S, 2007, ENDOCRINOLOGY, V148, P2653, DOI 10.1210/en.2006-1569; Gelber EI, 1999, J NEUROCHEM, V72, P2206, DOI 10.1046/j.1471-4159.1999.0722206.x; Gooz M, 2006, J BIOL CHEM, V281, P21004, DOI 10.1074/jbc.M512096200; Gray JA, 2003, BIOCHEMISTRY-US, V42, P10853, DOI 10.1021/bi035061z; Gray JA, 2001, MOL PHARMACOL, V60, P1020, DOI 10.1124/mol.60.5.1020; Greene EL, 2000, AM J PHYSIOL-RENAL, V278, pF650, DOI 10.1152/ajprenal.2000.278.4.F650; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; Hanauer A, 2002, J MED GENET, V39, P705, DOI 10.1136/jmg.39.10.705; Hanley NRS, 2002, J PHARMACOL EXP THER, V300, P468, DOI 10.1124/jpet.300.2.468; Hanlon M, 2001, J BIOL CHEM, V276, P38449, DOI 10.1074/jbc.M102165200; January B, 1997, J BIOL CHEM, V272, P23871, DOI 10.1074/jbc.272.38.23871; KAGAYA A, 1990, J PHARMACOL EXP THER, V255, P305; Kang S, 2008, J BIOL CHEM, V283, P4652, DOI 10.1074/jbc.M709673200; Karoor V, 1996, J BIOL CHEM, V271, P29347, DOI 10.1074/jbc.271.46.29347; Kelly E, 2008, BRIT J PHARMACOL, V153, pS379, DOI 10.1038/sj.bjp.0707604; Kroeze WK, 2003, J CELL SCI, V116, P4867, DOI 10.1242/jcs.00902; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; LEIGHTON IA, 1995, FEBS LETT, V375, P289, DOI 10.1016/0014-5793(95)01170-J; Maestri-El Kouhen O, 2000, J BIOL CHEM, V275, P36659, DOI 10.1074/jbc.M006788200; MAREK GJ, 1995, SYNAPSE, V21, P123, DOI 10.1002/syn.890210205; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P1068, DOI 10.1093/nar/18.4.1068; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Nichols DE, 2004, PHARMACOL THERAPEUT, V101, P131, DOI 10.1016/j.pharmthera.2003.11.002; OHGURO H, 1993, BIOCHEMISTRY-US, V32, P5718, DOI 10.1021/bi00072a030; OHGURO H, 1995, J BIOL CHEM, V270, P14259, DOI 10.1074/jbc.270.24.14259; OKSENBERG D, 1995, J NEUROCHEM, V64, P1440; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pierce KL, 2001, ONCOGENE, V20, P1532, DOI 10.1038/sj.onc.1204184; Poteet-Smith CE, 1999, J BIOL CHEM, V274, P22135, DOI 10.1074/jbc.274.32.22135; Rahimian R, 1995, CAN J PHYSIOL PHARM, V73, P1686, DOI 10.1139/y95-731; RAHMAN S, 1995, NEUROSCIENCE, V66, P891, DOI 10.1016/0306-4522(95)00002-Z; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Roth B L, 1994, Ann Clin Psychiatry, V6, P67, DOI 10.3109/10401239409148985; ROTH BL, 1986, J PHARMACOL EXP THER, V238, P480; Roth BL, 1995, J PHARMACOL EXP THER, V275, P1638; Roth BL, 1998, PHARMACOL THERAPEUT, V79, P231, DOI 10.1016/S0163-7258(98)00019-9; Roth BL, 2002, P NATL ACAD SCI USA, V99, P11934, DOI 10.1073/pnas.182234399; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Shapiro DA, 2002, J BIOL CHEM, V277, P11441, DOI 10.1074/jbc.M111675200; Sheffler DJ, 2006, P NATL ACAD SCI USA, V103, P4717, DOI 10.1073/pnas.0600585103; SIBLEY DR, 1986, P NATL ACAD SCI USA, V83, P9408, DOI 10.1073/pnas.83.24.9408; Smith JA, 2005, CANCER RES, V65, P1027; Soskic V, 1999, J BIOL CHEM, V274, P8539, DOI 10.1074/jbc.274.13.8539; STURGILL TW, 1988, NATURE, V334, P715, DOI 10.1038/334715a0; Tobin AB, 2008, BRIT J PHARMACOL, V153, pS167, DOI 10.1038/sj.bjp.0707662; Turner JH, 2004, J BIOL CHEM, V279, P17027, DOI 10.1074/jbc.M313919200; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; VOURETCRAVIARI V, 1995, J BIOL CHEM, V270, P4813, DOI 10.1074/jbc.270.9.4813; Williams GV, 2002, J NEUROSCI, V22, P2843, DOI 10.1523/JNEUROSCI.22-07-02843.2002; Xia ZQ, 2003, J BIOL CHEM, V278, P21901, DOI 10.1074/jbc.M301905200; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Zhao Y, 1996, J BIOL CHEM, V271, P29773, DOI 10.1074/jbc.271.47.29773	75	32	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5557	5573		10.1074/jbc.M805705200	http://dx.doi.org/10.1074/jbc.M805705200			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19103592	Green Published, hybrid			2022-12-25	WOS:000263560600019
J	Ackermann, S; Hiller, S; Osswald, H; Losle, M; Grenz, A; Hambrock, A				Ackermann, Stefanie; Hiller, Sabrina; Osswald, Hartmut; Loesle, Martina; Grenz, Almut; Hambrock, Annette			17 beta-Estradiol Modulates Apoptosis in Pancreatic beta-Cells by Specific Involvement of the Sulfonylurea Receptor (SUR) Isoform SUR1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM CHANNEL OPENERS; PLASMA-LEVELS; INSULIN-RESISTANCE; ENDOCRINE PANCREAS; DIABETES-MELLITUS; ATP; ESTROGEN; ESTRADIOL; BINDING; MECHANISMS	Apoptosis of pancreatic beta-cells is an important factor in the pathophysiology of diabetes. Previously, we have shown that the "phytoestrogen" resveratrol can induce beta-cell apoptosis dependent on the expression of sulfonylurea receptor (SUR) 1, the regulatory subunit of pancreatic ATP-sensitive K+ channels. Here, we investigate whether 17 beta-estradiol also influences beta-cell apoptosis in a SUR1-dependent manner. Therefore, islets from wild type or SUR1 knock-out mice, clonal beta-cells, or HEK293 cells expressing different SUR forms were treated with 17 beta-estradiol or estrone. Different apoptotic parameters were determined and estrogen binding to SUR was analyzed. In murine islets, 17 beta-estradiol treatment resulted in significant apoptotic changes, which in their nature (either apoptotic or anti-apoptotic) were dependent on the age of the animal. These effects were not observed in SUR1 knock-out mice. Furthermore, 17 beta-estradiol, which specifically binds to SUR, induced enhanced apoptosis in SUR1-expressing HEK293 cells and clonal beta-cells, whereas apoptosis in recombinant cells expressing SUR2A or SUR2B (cardiac or vascular SUR-isoforms) or sham-transfected control cells was significantly lower. The apoptotic potency of 17 beta-estradiol was much higher than that of resveratrol or estrone. SUR1-specific 17 beta-estradiol-induced apoptosis was either abolished by the mutation M1289T in transmembrane helix 17 of SUR1 or clearly enhanced by two mutations in nucleotide binding fold 2 (R1379C, R1379L). In conclusion, 17 beta-estradiol treatment modulates beta-cell apoptosis under specific involvement of SUR1 in an age-dependent manner. 17 beta-Estradiol-induced apoptosis can be influenced by certain SUR1 mutations. These findings may contribute to the understanding of pathophysiological changes in beta-cell mass and could, for instance, provide interesting aspects concerning the etiology of gestational diabetes.	[Ackermann, Stefanie; Hiller, Sabrina; Osswald, Hartmut; Loesle, Martina; Grenz, Almut; Hambrock, Annette] Univ Tubingen, Fac Med, Dept Pharmacol & Toxicol, D-72074 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Hambrock, A (corresponding author), Wilhelmstr 56, D-72074 Tubingen, Germany.	annette.hambrock@uni-tuebingen.de			Deutsche Forschungsgemeinschaft [Ha 2711/2-1, Ha 2711/2-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants Ha 2711/2-1 and Ha 2711/2-2 (to A. H. and S. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ABRAHAM GE, 1972, J CLIN ENDOCR METAB, V34, P312, DOI 10.1210/jcem-34-2-312; Al-Majed HT, 2005, PANCREAS, V30, P307, DOI 10.1097/01.mpa.0000161886.17492.22; Ashcroft FM, 2007, AM J PHYSIOL-ENDOC M, V293, pE880, DOI 10.1152/ajpendo.00348.2007; Babenko AP, 2006, NEW ENGL J MED, V355, P456, DOI 10.1056/NEJMoa055068; Baggio LL, 2006, ANNU REV MED, V57, P265, DOI 10.1146/annurev.med.57.110104.115624; Bryan J, 2007, PFLUG ARCH EUR J PHY, V453, P703, DOI 10.1007/s00424-006-0116-z; Buchanan TA, 2007, DIABETES CARE, V30, pS105, DOI 10.2337/dc07-s201; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Butler PC, 2007, NAT CLIN PRACT ENDOC, V3, P758, DOI 10.1038/ncpendmet0647; Choi SB, 2005, ENDOCRINOLOGY, V146, P4786, DOI 10.1210/en.2004-1653; Contreras JL, 2002, TRANSPLANTATION, V74, P1252, DOI 10.1097/00007890-200211150-00010; de Koning EJP, 2008, TRENDS PHARMACOL SCI, V29, P218, DOI 10.1016/j.tips.2008.02.001; de Wet H, 2007, P NATL ACAD SCI USA, V104, P18988, DOI 10.1073/pnas.0707428104; DEHERTOGH R, 1975, J CLIN ENDOCR METAB, V40, P93, DOI 10.1210/jcem-40-1-93; Eckhoff DE, 2004, SURGERY, V136, P336, DOI 10.1016/j.surg.2004.05.009; Godsland IF, 2005, DIABETOLOGIA, V48, P2213, DOI 10.1007/s00125-005-1930-0; Gonzalez-Arenas A, 2006, MOL PHARMACOL, V70, P154, DOI 10.1124/mol.106.025064; Hambrock A, 2006, J PHARMACOL EXP THER, V316, P1031, DOI 10.1124/jpet.105.097501; Hambrock A, 2004, DIABETES, V53, pS128, DOI 10.2337/diabetes.53.suppl_3.S128; Hambrock A, 1999, MOL PHARMACOL, V55, P832; Hambrock A, 2001, MOL PHARMACOL, V60, P190, DOI 10.1124/mol.60.1.190; Hambrock A, 2007, J BIOL CHEM, V282, P3347, DOI 10.1074/jbc.M608216200; Hollander MH, 2007, OBSTET GYNECOL SURV, V62, P125, DOI 10.1097/01.ogx.0000253303.92229.59; Ito K, 2001, J BIOL CHEM, V276, P15616, DOI 10.1074/jbc.M011246200; Kahlert S, 2000, J BIOL CHEM, V275, P18447, DOI 10.1074/jbc.M910345199; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kassem SA, 2000, DIABETES, V49, P1325, DOI 10.2337/diabetes.49.8.1325; Kim C, 2007, DIABETES CARE, V30, P1314, DOI 10.2337/dc06-2517; Le May C, 2006, P NATL ACAD SCI USA, V103, P9232, DOI 10.1073/pnas.0602956103; LINDBERG BS, 1974, ACTA OBSTET GYN SCAN, P21; LORIAUX DL, 1972, J CLIN ENDOCR METAB, V35, P887, DOI 10.1210/jcem-35-6-887; Luo Y, 2008, CELL BIOL INT, V32, P899, DOI 10.1016/j.cellbi.2008.03.023; Maedler K, 2006, DIABETES, V55, P2455, DOI 10.2337/db05-1586; MANLEY PW, 1993, J MED CHEM, V36, P2004, DOI 10.1021/jm00066a009; Moreau C, 2000, EMBO J, V19, P6644, DOI 10.1093/emboj/19.24.6644; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Nadal A, 1998, FASEB J, V12, P1341, DOI 10.1096/fasebj.12.13.1341; Negulescu O, 2002, KIDNEY INT, V62, P1989, DOI 10.1046/j.1523-1755.2002.00679.x; Ripoll Cristina, 2008, Infectious Disorders - Drug Targets, V8, P61; Ropero AB, 2006, J STEROID BIOCHEM, V102, P163, DOI 10.1016/j.jsbmb.2006.09.019; Santen RJ, 2007, NAT CLIN PRACT ENDOC, V3, P496, DOI 10.1038/ncpendmet0535; Schwanstecher M, 1998, EMBO J, V17, P5529, DOI 10.1093/emboj/17.19.5529; Seghers V, 2000, J BIOL CHEM, V275, P9270, DOI 10.1074/jbc.275.13.9270; Soria B, 2004, DIABETES, V53, pS86, DOI 10.2337/diabetes.53.2007.S86; Stephan D, 2005, BRIT J PHARMACOL, V144, P1078, DOI 10.1038/sj.bjp.0706142; Tang WJ, 2006, J STEROID BIOCHEM, V100, P42, DOI 10.1016/j.jsbmb.2006.02.005; Van Pelt RE, 2008, J CLIN ENDOCR METAB, V93, P484, DOI 10.1210/jc.2007-1657; VANASSCHE FA, 1980, DIABETOLOGIA, V18, P487, DOI 10.1007/BF00261705; VANASSCHE FA, 1978, BRIT J OBSTET GYNAEC, V85, P818; Vaxillaire M, 2007, DIABETES, V56, P1737, DOI 10.2337/db06-1540; Zhang DW, 2003, BIOCHEMISTRY-US, V42, P9989, DOI 10.1021/bi034462b	51	23	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4905	4913		10.1074/jbc.M807638200	http://dx.doi.org/10.1074/jbc.M807638200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19095654	hybrid			2022-12-25	WOS:000263416600020
J	Bonner, A; Almogren, A; Furtado, PB; Kerr, MA; Perkins, SJ				Bonner, Alexandra; Almogren, Adel; Furtado, Patricia B.; Kerr, Michael A.; Perkins, Stephen J.			The Nonplanar Secretory IgA2 and Near Planar Secretory IgA1 Solution Structures Rationalize Their Different Mucosal Immune Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PNEUMOCOCCAL POLYSACCHARIDE VACCINE; IMMUNOGLOBULIN-A IGA; AMINO-ACID-SEQUENCE; SUBCLASS DISTRIBUTION; NEUTRON-SCATTERING; X-RAY; ANALYTICAL ULTRACENTRIFUGATION; FC FRAGMENTS; COMPONENT; ANTIBODIES	Secretory IgA (SIgA) is the most prevalent human antibody and is central to mucosal immunity. It exists as two subclasses, SIgA1 and SIgA2, where SIgA2 has a shorter hinge joining the Fab and Fc regions. Both forms of SIgA are predominantly dimeric and contain an additional protein called the secretory component (SC) that is attached during the secretory process and is believed to protect SIgA in harsh mucosal conditions. Here we locate the five SC domains relative to dimeric IgA2 within SIgA2 using constrained scattering modeling. The x-ray and sedimentation parameters showed that SIgA2 has an extended solution structure. The constrained modeling of SIgA2 was initiated using two IgA2 monomers that were positioned according to our best fit solution structure for dimeric IgA1. SC was best located along the convex edge of the Fc-Fc region. The best fit models showed that SIgA2 is significantly nonplanar in its structure, in distinction to our previous near planar SIgA1 structure. Both the shorter IgA2 hinges and the presence of SC appear to displace the four Fab regions out of the Fc plane in SIgA2. This may explain the noncovalent binding of SC in some SIgA2 molecules. This nonplanar structure is predicted to result in specific immune properties for SIgA2 and SIgA1. It may explain differences observed between the SIgA1 and SIgA2 subclasses in terms of their interactions with antigens, susceptibility to proteases, effects on receptors, and distribution in different tissues. The different structures account for the prevalence of both forms in mucosal secretions.	[Bonner, Alexandra; Furtado, Patricia B.; Perkins, Stephen J.] UCL, Div Biosci, Inst Struct & Mol Biol, London WC1E 6BT, England; [Almogren, Adel] King Saud Univ, King Khalid Univ Hosp, Riyadh 11461, Saudi Arabia; [Almogren, Adel] King Saud Univ, Dept Pathol, Coll Med, Riyadh 11461, Saudi Arabia; [Kerr, Michael A.] Gen Infirm, Dept Clin Biochem & Immunol, Leeds LS1 3EX, W Yorkshire, England	University of London; Birkbeck University London; University College London; King Saud University; King Khalid University Hospital; King Saud University; Leeds General Infirmary	Perkins, SJ (corresponding author), UCL, Div Biosci, Inst Struct & Mol Biol, Darwin Bldg,Gower St, London WC1E 6BT, England.	s.perkins@medsch.ucl.ac.uk		Almogren, Ahmad/0000-0002-8253-9709	Biological and Biotechnology Sciences Research Council; Wellcome Trust; Biotechnology and Biological Sciences Research Council [BB/E013104/1] Funding Source: researchfish; BBSRC [BB/E013104/1] Funding Source: UKRI	Biological and Biotechnology Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biological and Biotechnology Sciences Research Council and the Wellcome Trust. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Almogren A, 2003, INFECT IMMUN, V71, P3349, DOI 10.1128/IAI.71.6.3349-3356.2003; Almogren A, 2008, MOL IMMUNOL, V45, P87, DOI 10.1016/j.molimm.2007.05.002; Almogren A, 2007, IMMUNOLOGY, V120, P273, DOI 10.1111/j.1365-2567.2006.02498.x; Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; BEALE D, 1985, BIOCHEM J, V229, P759, DOI 10.1042/bj2290759; BLOTH B, 1971, J EXP MED, V133, P1035, DOI 10.1084/jem.133.5.1035; Boehm MK, 1999, J MOL BIOL, V286, P1421, DOI 10.1006/jmbi.1998.2556; Bonner A, 2009, MUCOSAL IMMUNOL, V2, P74, DOI 10.1038/mi.2008.68; Bonner A, 2008, J IMMUNOL, V180, P1008, DOI 10.4049/jimmunol.180.2.1008; Bonner A, 2007, J BIOL CHEM, V282, P16969, DOI 10.1074/jbc.M701281200; Brandtzaeg P, 2007, VACCINE, V25, P5467, DOI 10.1016/j.vaccine.2006.12.001; BROWN TA, 1985, INFECT IMMUN, V49, P459, DOI 10.1128/IAI.49.2.459-462.1985; CHILDERS NK, 1989, ANNU REV MICROBIOL, V43, P503, DOI 10.1146/annurev.mi.43.100189.002443; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Crottet P, 1998, J IMMUNOL, V161, P5445; Crottet P, 1999, J BIOL CHEM, V274, P31456, DOI 10.1074/jbc.274.44.31456; FALLGREENGEBAUER E, 1993, BIOL CHEM H-S, V374, P1023, DOI 10.1515/bchm3.1993.374.7-12.1023; FITZSIMMONS SP, 1994, J PEDIATR-US, V124, P566, DOI 10.1016/S0022-3476(05)83135-X; Furtado PB, 2004, J MOL BIOL, V338, P921, DOI 10.1016/j.jmb.2004.03.007; GREY HM, 1968, J EXP MED, V128, P1223, DOI 10.1084/jem.128.6.1223; Hacsek G, 1996, J PEDIATR GASTR NUTR, V22, P307, DOI 10.1097/00005176-199604000-00014; HEREMANS JF, 1974, ANTIGENS, V2, P365; Herr AB, 2003, NATURE, V423, P614, DOI 10.1038/nature01685; KETT K, 1986, J IMMUNOL, V136, P3631; Kilian M, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P291, DOI 10.1016/B978-012491543-5/50019-X; LADJEVA I, 1989, CLIN EXP IMMUNOL, V78, P85; LINDH E, 1975, J IMMUNOL, V114, P284; LUE C, 1988, J IMMUNOL, V140, P3793; MAZENGERA RL, 1990, BIOCHEM J, V272, P159, DOI 10.1042/bj2720159; MESTECKY J, 1987, ADV IMMUNOL, V40, P153, DOI 10.1016/S0065-2776(08)60240-0; Mestecky J, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P153, DOI 10.1016/B978-012491543-5/50013-9; Monteiro RC, 2003, ANNU REV IMMUNOL, V21, P177, DOI 10.1146/annurev.immunol.21.120601.141011; Obaro SK, 2004, PEDIATR INFECT DIS J, V23, P1023, DOI 10.1097/01.inf.0000143651.54880.09; Osman AA, 1996, CLIN CHIM ACTA, V255, P145, DOI 10.1016/0009-8981(96)06401-7; Perkins SJ, 2001, BIOPHYS CHEM, V93, P129, DOI 10.1016/S0301-4622(01)00216-2; Perkins SJ, 2008, METHOD CELL BIOL, V84, P375, DOI 10.1016/S0091-679X(07)84013-1; Pilette C, 2007, J IMMUNOL, V178, P4658, DOI 10.4049/jimmunol.178.7.4658; PRIGENTDELECOURT L, 1995, CLIN EXP IMMUNOL, V99, P221; PUTNAM FW, 1979, J BIOL CHEM, V254, P2865; Roux KH, 1998, J IMMUNOL, V161, P4083; Russell MW, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P267, DOI 10.1016/B978-012491543-5/50018-8; Schilling J, 2005, SCAND J IMMUNOL, V61, P207, DOI 10.1111/j.0300-9475.2005.01549.x; Simell B, 2006, CLIN EXP IMMUNOL, V143, P543, DOI 10.1111/j.1365-2249.2006.03009.x; STEWART WW, 1990, IMMUNOLOGY, V71, P328; Sumiyama K, 2002, MOL BIOL EVOL, V19, P1093, DOI 10.1093/oxfordjournals.molbev.a004167; SYKULEV YK, 1984, BIOFIZIKA+, V29, P744; Takeshita S, 2002, PEDIATR INT, V44, P5, DOI 10.1046/j.1442-200X.2002.01506.x; TORANO A, 1978, P NATL ACAD SCI USA, V75, P966, DOI 10.1073/pnas.75.2.966; Tregoat V, 2001, J CLIN LAB ANAL, V15, P55, DOI 10.1002/jcla.1; Woof JM, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P251, DOI 10.1016/B978-012491543-5/50017-6	51	41	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5077	5087		10.1074/jbc.M807529200	http://dx.doi.org/10.1074/jbc.M807529200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19109255	hybrid, Green Published			2022-12-25	WOS:000263416600038
J	Sharma, G; First, EA				Sharma, Gyanesh; First, Eric A.			Thermodynamic Analysis Reveals a Temperature-dependent Change in the Catalytic Mechanism of Bacillus stearothermophilus Tyrosyl-tRNA Synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTHALPY-ENTROPY COMPENSATION; RIBONUCLEIC-ACID SYNTHETASE; SITE-DIRECTED MUTAGENESIS; COGNATE TRANSFER-RNA; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; THERMUS-THERMOPHILUS; ADENYLATE FORMATION; TRANSITION-STATE; SIGNIFICANT DISCREPANCIES	Catalysis of tRNA(Tyr) aminoacylation by tyrosyl-tRNA synthetase can be divided into two steps. In the first step, tyrosine is activated by ATP to form the tyrosyl-adenylate intermediate. In the second step, the tyrosyl moiety is transferred to the 3' end of tRNA. To investigate the roles that enthalpic and entropic contributions play in catalysis by Bacillus stearothermophilus tyrosyl-tRNA synthetase (TyrRS), the temperature dependence for the activation of tyrosine and subsequent transfer to tRNA(Tyr) has been determined using single turnover kinetic methods. A van't Hoff plot for binding of ATP to the TyrRS center dot Tyr complex reveals three distinct regions. Particularly striking is the change occurring at 25 degrees C, where the values of Delta H-0 and Delta S-0 go from - 144 kJ/mol and - 438 J/mol K below 25 degrees C to + 137.9 kJ/mol and +507 J/mol K above 25 degrees C. Nonlinear Eyring and van't Hoff plots are also observed for formation of the TyrRS center dot[Tyr-ATP](double dagger) and TyrRS center dot Tyr- AMP complexes. Comparing the van't Hoff plots for the binding of ATP to tyrosyl-tRNA synthetase in the absence and presence of saturating tyrosine concentrations indicates that the temperature-dependent changes in Delta H-0 and Delta S-0 for the binding of ATP only occur when tyrosine is bound to the enzyme. Previous investigations revealed a similar synergistic interaction between the tyrosine and ATP substrates when the "KMSKS" signature sequence is deleted or replaced by a nonfunctional sequence. We propose that the temperature-dependent changes in Delta H0 and Delta S0 are because of the KMSKS signature sequence being conformationally constrained and unable to disrupt this synergistic interaction below 25 degrees C.	[Sharma, Gyanesh; First, Eric A.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71130 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	First, EA (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, 1501 Kings Highway, Shreveport, LA 71130 USA.	efirst@lsuhsc.edu	Sharma, Gyanesh/G-1210-2012		National Institutes of Health [GM68070]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068070] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM68070 (NIGMS). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ARNEZ JG, 1995, EMBO J, V14, P4143, DOI 10.1002/j.1460-2075.1995.tb00088.x; Austin J, 2002, J BIOL CHEM, V277, P14812, DOI 10.1074/jbc.M103396200; AVIS JM, 1993, BIOCHEMISTRY-US, V32, P5312, DOI 10.1021/bi00071a005; BELRHALI H, 1995, STRUCTURE, V3, P341, DOI 10.1016/S0969-2126(01)00166-6; Berthet-Colominas C, 1998, EMBO J, V17, P2947, DOI 10.1093/emboj/17.10.2947; BHAT TN, 1982, J MOL BIOL, V158, P699, DOI 10.1016/0022-2836(82)90255-8; BIOU V, 1994, SCIENCE, V263, P1404, DOI 10.1126/science.8128220; BRICK P, 1987, J MOL BIOL, V194, P287, DOI 10.1016/0022-2836(87)90376-7; BRUNIE S, 1990, J MOL BIOL, V216, P411, DOI 10.1016/S0022-2836(05)80331-6; Caprara MG, 1996, CELL, V87, P1135, DOI 10.1016/S0092-8674(00)81807-3; Caprara MG, 2001, J MOL BIOL, V308, P165, DOI 10.1006/jmbi.2001.4581; CAREY J, 1983, BIOCHEMISTRY-US, V22, P2610, DOI 10.1021/bi00280a003; Case A, 2003, BIOCHEMISTRY-US, V42, P3335, DOI 10.1021/bi020668l; CHAN KW, 1995, FEBS LETT, V363, P33, DOI 10.1016/0014-5793(95)00274-D; Cooper A, 2001, BIOPHYS CHEM, V93, P215, DOI 10.1016/S0301-4622(01)00222-8; CUSACK S, 1990, NATURE, V347, P249, DOI 10.1038/347249a0; DELARUE M, 1993, BIOESSAYS, V15, P675, DOI 10.1002/bies.950151007; Demchenko A, 1997, COMMENTS MOL CELL BI, V9, P87; DUNITZ JD, 1995, CHEM BIOL, V2, P709, DOI 10.1016/1074-5521(95)90097-7; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P5, DOI 10.1021/bi00672a002; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P3350, DOI 10.1021/bi00686a010; FERSHT AR, 1988, BIOCHEMISTRY-US, V27, P1581, DOI 10.1021/bi00405a028; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P13, DOI 10.1021/bi00672a003; FERSHT AR, 1987, BIOCHEMISTRY-US, V26, P8031, DOI 10.1021/bi00399a001; FIRST EA, 1993, BIOCHEMISTRY-US, V32, P13644, DOI 10.1021/bi00212a032; FIRST EA, 1993, BIOCHEMISTRY-US, V32, P13651, DOI 10.1021/bi00212a033; FIRST EA, 1995, BIOCHEMISTRY-US, V34, P5030, DOI 10.1021/bi00015a014; FIRST EA, 1993, BIOCHEMISTRY-US, V32, P13658, DOI 10.1021/bi00212a034; FREIST W, 1988, EUR J BIOCHEM, V177, P425, DOI 10.1111/j.1432-1033.1988.tb14392.x; Haldane JBS, 1930, ENZYMES, P74; Hall KB, 1995, METHOD ENZYMOL, V259, P261; HOUNTONDJI C, 1986, BIOCHEMISTRY-US, V25, P16, DOI 10.1021/bi00349a003; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Ibba M, 1999, P NATL ACAD SCI USA, V96, P418, DOI 10.1073/pnas.96.2.418; JAKES R, 1975, BIOCHEMISTRY-US, V14, P3344, DOI 10.1021/bi00686a009; KERN D, 1979, BIOCHEMISTRY-US, V18, P5809, DOI 10.1021/bi00593a010; Kobayashi T, 2005, J MOL BIOL, V346, P105, DOI 10.1016/j.jmb.2004.11.034; KORNELYUK AI, 1995, BIOCHEM MOL BIOL INT, V35, P317; Kuratani M, 2006, J MOL BIOL, V355, P395, DOI 10.1016/j.jmb.2005.10.073; LANDES C, 1995, BIOCHIMIE, V77, P194, DOI 10.1016/0300-9084(96)88125-9; LEATHERBARROW RJ, 1987, BIOCHEMISTRY-US, V26, P8524, DOI 10.1021/bi00400a005; Li LW, 2008, CHEM BIOL DRUG DES, V71, P529, DOI 10.1111/j.1747-0285.2008.00661.x; Li T, 2008, EUR BIOPHYS J BIOPHY, V38, P25, DOI 10.1007/s00249-008-0350-8; Liu L, 2001, CHEM REV, V101, P673, DOI 10.1021/cr990416z; LIU YF, 1995, PROTEIN SCI, V4, P2559, DOI 10.1002/pro.5560041212; LOGAN DT, 1995, EMBO J, V14, P4156, DOI 10.1002/j.1460-2075.1995.tb00089.x; MECHULAM Y, 1991, J MOL BIOL, V217, P465, DOI 10.1016/0022-2836(91)90750-Z; MEHLER AH, 1967, J BIOL CHEM, V242, P5495; MOSYAK L, 1995, NAT STRUCT BIOL, V2, P537, DOI 10.1038/nsb0795-537; NAGHIBI H, 1995, P NATL ACAD SCI USA, V92, P5597, DOI 10.1073/pnas.92.12.5597; ONESTI S, 1995, STRUCTURE, V3, P163, DOI 10.1016/S0969-2126(01)00147-2; Perozzo R, 2004, J RECEPT SIG TRANSD, V24, P1, DOI 10.1081/RRS-120037896; Prabhu NV, 2005, ANNU REV PHYS CHEM, V56, P521, DOI 10.1146/annurev.physchem.56.092503.141202; RAVEL JM, 1965, J BIOL CHEM, V240, P432; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; Retailleau P, 2003, J MOL BIOL, V325, P39, DOI 10.1016/S0022-2836(02)01156-7; ROULD MA, 1989, SCIENCE, V246, P1135, DOI 10.1126/science.2479982; Sankaranarayanan R, 1999, CELL, V97, P371, DOI 10.1016/S0092-8674(00)80746-1; SANTI DV, 1971, FEBS LETT, V13, P157, DOI 10.1016/0014-5793(71)80224-7; SCHIMMEL PR, 1979, ANNU REV BIOCHEM, V48, P601, DOI 10.1146/annurev.bi.48.070179.003125; SCHMITT E, 1994, J MOL BIOL, V242, P566, DOI 10.1006/jmbi.1994.1601; Segal I. H., 1976, BIOCH CALCULATIONS, P193; TINOCO IJ, 1978, PHYS CHEM PRINCIPLES, P253; Tsunoda M, 2007, NUCLEIC ACIDS RES, V35, P4289, DOI 10.1093/nar/gkm417; Uter NT, 2005, J BIOL CHEM, V280, P23966, DOI 10.1074/jbc.M414259200; WEBSTER T, 1984, SCIENCE, V226, P1315, DOI 10.1126/science.6390679; WELLS TNC, 1991, BIOCHEMISTRY-US, V30, P5151, DOI 10.1021/bi00235a006; WELLS TNC, 1986, BIOCHEMISTRY-US, V25, P1881, DOI 10.1021/bi00356a007; WIESINGER H, 1980, H-S Z PHYSIOL CHEM, V361, P201; Xin Y, 2000, BIOCHEMISTRY-US, V39, P340, DOI 10.1021/bi991675l; Xin Y, 2000, J MOL BIOL, V303, P299, DOI 10.1006/jmbi.2000.4126; Yaremchuk A, 2000, EMBO J, V19, P4745, DOI 10.1093/emboj/19.17.4745; Yaremchuk A, 2002, EMBO J, V21, P3829, DOI 10.1093/emboj/cdf373; ZELWER C, 1982, J MOL BIOL, V155, P63, DOI 10.1016/0022-2836(82)90492-2; Zhang Y, 2005, PROTEIN SCI, V14, P1340, DOI 10.1110/ps.041239305	75	14	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4179	4190		10.1074/jbc.M808500200	http://dx.doi.org/10.1074/jbc.M808500200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19098308	hybrid, Green Published			2022-12-25	WOS:000263134400015
J	Heyes, DJ; Sakuma, M; de Visser, SP; Scrutton, NS				Heyes, Derren J.; Sakuma, Michiyo; de Visser, Sam P.; Scrutton, Nigel S.			Nuclear Quantum Tunneling in the Light-activated Enzyme Protochlorophyllide Oxidoreductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRODUCT RELEASE STEPS; DRIVEN ENZYME; CATALYTIC CYCLE; DYNAMICS; PROTEIN; PROTON; IDENTIFICATION; DEHYDROGENASE; PERSPECTIVE; MUTAGENESIS	In chlorophyll biosynthesis, the light-activated enzyme protochlorophyllide oxidoreductase catalyzes trans addition of hydrogen across the C-17-C-18 double bond of the chlorophyll precursor protochlorophyllide ( Pchlide). This unique light-driven reaction plays a key role in the assembly of the photosynthetic apparatus, but despite its biological importance, the mechanism of light-activated catalysis is unknown. In this study, we show that Pchlide reduction occurs by dynamically coupled nuclear quantum tunneling of a hydride anion followed by a proton on the microsecond time scale in the Pchlide excited and ground states, respectively. We demonstrate the need for fast dynamic searches to form degenerate "tunneling-ready" configurations within the lifetime of the Pchlide excited state from which hydride transfer occurs. Moreover, we have found a breakpoint at -27 degrees C in the temperature dependence of the hydride transfer rate, which suggests that motions/vibrations that are important for promoting light-activated hydride tunneling are quenched below -27 degrees C. We observed no such breakpoint for the proton-tunneling reaction, indicating a reliance on different promoting modes for this reaction in the enzyme-substrate complex. Our studies indicate that the overall photoreduction of Pchlide is endothermic and that rapid dynamic searches are required to form distinct tunneling-ready configurations within the lifetime of the photoexcited state. Consequently, we have established the first important link between photochemical and nuclear quantum tunneling reactions, linked to protein dynamics, in a biologically significant system.	[Heyes, Derren J.; Sakuma, Michiyo; Scrutton, Nigel S.] Univ Manchester, Manchester Interdisciplinary Bioctr, Fac Life Sci, Manchester M1 7DN, Lancs, England; [de Visser, Sam P.] Univ Manchester, Sch Chem Engn & Analyt Sci, Manchester M1 7DN, Lancs, England	University of Manchester; University of Manchester	Heyes, DJ (corresponding author), Univ Manchester, Manchester Interdisciplinary Bioctr, Fac Life Sci, 131 Princess St, Manchester M1 7DN, Lancs, England.	derren.heyes@manchester.ac.uk; sam.devisser@manchester.ac.uk; nigel.scrutton@manchester.ac.uk	de Visser, Samuel P/A-6960-2008	de Visser, Samuel P/0000-0002-2620-8788; Heyes, Derren/0000-0002-7453-1571	Biotechnology and Biological Sciences Research Council, United Kingdom; BBSRC [BB/D01963X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D01963X/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council, United Kingdom. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aronsson H, 2003, PLANT MOL BIOL, V51, P1, DOI 10.1023/A:1020795415631; Basran J, 1999, BIOCHEMISTRY-US, V38, P3218, DOI 10.1021/bi982719d; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BEGLEY TP, 1989, J AM CHEM SOC, V111, P3095, DOI 10.1021/ja00190a071; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Benkovic SJ, 2006, SCIENCE, V312, P208, DOI 10.1126/science.1127654; Blomberg LM, 2004, J BIOL INORG CHEM, V9, P923, DOI 10.1007/s00775-004-0585-5; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Brocker MJ, 2008, J BIOL CHEM, V283, P10559, DOI 10.1074/jbc.M708010200; de Visser SP, 2007, INORG CHEM, V46, P4632, DOI 10.1021/ic700462h; de Visser SP, 2006, J AM CHEM SOC, V128, P9813, DOI 10.1021/ja061581g; de Visser SP, 2006, INORG CHEM, V45, P9551, DOI 10.1021/ic061019r; Dietzek B, 2006, J PHYS CHEM B, V110, P4399, DOI 10.1021/jp0556456; Frisch M., 2016, GAUSSIAN 16 REVISION; Garcia-Viloca M, 2004, SCIENCE, V303, P186, DOI 10.1126/science.1088172; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; HEHRE WJ, 1972, J CHEM PHYS, V56, P2257, DOI 10.1063/1.1677527; Heyes DJ, 2007, J BIOL CHEM, V282, P32015, DOI 10.1074/jbc.M706098200; Heyes DJ, 2006, J BIOL CHEM, V281, P26847, DOI 10.1074/jbc.M602943200; Heyes DJ, 2005, TRENDS BIOCHEM SCI, V30, P642, DOI 10.1016/j.tibs.2005.09.001; Heyes DJ, 2004, BIOCHEMISTRY-US, V43, P8265, DOI 10.1021/bi049576h; Heyes DJ, 2003, NAT STRUCT BIOL, V10, P491, DOI 10.1038/nsb929; Heyes DJ, 2003, BIOCHEMISTRY-US, V42, P523, DOI 10.1021/bi0268448; Heyes DJ, 2002, P NATL ACAD SCI USA, V99, P11145, DOI 10.1073/pnas.182274199; Johannissen LO, 2007, J PHYS CHEM B, V111, P2631, DOI 10.1021/jp066276w; Knapp MJ, 2002, J AM CHEM SOC, V124, P3865, DOI 10.1021/ja012205t; Knapp MJ, 2002, EUR J BIOCHEM, V269, P3113, DOI 10.1046/j.1432-1033.2002.03022.x; Kohen A, 1999, NATURE, V399, P496, DOI 10.1038/20981; Kuznetsov AM, 1999, CAN J CHEM, V77, P1085, DOI 10.1139/cjc-77-5-6-1085; Lebedev N, 1998, PHOTOSYNTH RES, V58, P5, DOI 10.1023/A:1006082119102; Masgrau L, 2004, ARCH BIOCHEM BIOPHYS, V428, P41, DOI 10.1016/j.abb.2004.03.013; Masgrau L, 2006, SCIENCE, V312, P237, DOI 10.1126/science.1126002; Pudney CR, 2006, J AM CHEM SOC, V128, P14053, DOI 10.1021/ja0614619; *SCHR LLC, 2007, JAG 7 0; Shaik S, 2005, CHEM REV, V105, P2279, DOI 10.1021/cr030722j; Sytina OA, 2008, NATURE, V456, P1001, DOI 10.1038/nature07354; Townley HE, 2001, PROTEINS, V44, P329, DOI 10.1002/prot.1098; WILKS HM, 1995, P NATL ACAD SCI USA, V92, P724, DOI 10.1073/pnas.92.3.724; Zhao GJ, 2008, BIOPHYS J, V94, P38, DOI 10.1529/biophysj.107.113738	39	66	66	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3762	3767		10.1074/jbc.M808548200	http://dx.doi.org/10.1074/jbc.M808548200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19073603	hybrid			2022-12-25	WOS:000262872500044
J	Shen, H; Tesar, BM; Du, W; Goldstein, DR				Shen, Hua; Tesar, Bethany M.; Du, Wei; Goldstein, Daniel R.			Aging Impairs Recipient T Cell Intrinsic and Extrinsic Factors in Response to Transplantation	PLOS ONE			English	Article								Background: As increasing numbers of older people are listed for solid organ transplantation, there is an urgent need to better understand how aging modifies alloimmune responses. Here, we investigated whether aging impairs the ability of donor dendritic cells or recipient immunity to prime alloimmune responses to organ transplantation. Principal Findings: Using murine experimental models, we found that aging impaired the host environment to expand and activate antigen specific CD8(+) T cells. Additionally, aging impaired the ability of polyclonal T cells to induce acute allograft rejection. However, the alloimmune priming capability of donor dendritic cells was preserved with aging. Conclusion: Aging impairs recipient responses, both T cell intrinsic and extrinsic, in response to organ transplantation.	[Shen, Hua; Tesar, Bethany M.; Du, Wei; Goldstein, Daniel R.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA	Yale University	Shen, H (corresponding author), Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.	daniel.goldstein@yale.edu	Shen, Hua/F-5678-2010	Goldstein, Daniel/0000-0001-6695-979X	NIH [AI064660, AG028082]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064660, R56AI064660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028082] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grants AI064660 and AG028082 to DRG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron O, 1999, TRANSPLANT P, V31, P75, DOI 10.1016/S0041-1345(98)01444-4; Crespo-Leiro MG, 1999, TRANSPLANT P, V31, P2537, DOI 10.1016/S0041-1345(99)00453-4; Curtis JJ, 2006, AM J TRANSPLANT, V6, P1264, DOI 10.1111/j.1600-6143.2006.01318.x; Danovitch GM, 2006, AM J TRANSPLANT, V6, P1267, DOI 10.1111/j.1600-6143.2006.01311.x; Ehst BD, 2003, AM J TRANSPLANT, V3, P1355, DOI 10.1046/j.1600-6135.2003.00246.x; Fry AM, 2005, JAMA-J AM MED ASSOC, V294, P2712, DOI 10.1001/jama.294.21.2712; Krieger NR, 1996, J EXP MED, V184, P2013, DOI 10.1084/jem.184.5.2013; Lechler R, 2001, IMMUNITY, V14, P357, DOI 10.1016/S1074-7613(01)00116-9; Lechler RI, 2005, NAT MED, V11, P605, DOI 10.1038/nm1251; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Martins PNA, 2005, TRANSPLANTATION, V79, P127, DOI 10.1097/01.TP.0000146258.79425.04; Meier-Kriesche HU, 2002, J AM GERIATR SOC, V50, P14, DOI 10.1046/j.1532-5415.2002.50002.x; Miller RA, 1996, SCIENCE, V273, P70, DOI 10.1126/science.273.5271.70; Ordemann R, 2002, J CLIN INVEST, V109, P1249, DOI 10.1172/JCI200214793; PIRSCH JD, 1989, TRANSPLANTATION, V47, P259, DOI 10.1097/00007890-198902000-00012; ROSENBERG AS, 1994, EUR J IMMUNOL, V24, P1312, DOI 10.1002/eji.1830240611; Tesar BM, 2006, AM J TRANSPLANT, V6, P2622, DOI 10.1111/j.1600-6143.2006.01537.x; Tesar BM, 2006, AGING CELL, V5, P473, DOI 10.1111/j.1474-9726.2006.00245.x; Tesar BM, 2004, AM J TRANSPLANT, V4, P1429, DOI 10.1111/j.1600-6143.2004.00544.x; THOMAN ML, 1982, J IMMUNOL, V128, P2358; TIELEN FJ, 1993, TRANSPL P, V25, P2872; Tullius SG, 2000, J AM SOC NEPHROL, V11, P1317, DOI 10.1681/ASN.V1171317; Walker WE, 2006, J IMMUNOL, V177, P5307, DOI 10.4049/jimmunol.177.8.5307; Wang ZL, 2004, J IMMUNOL, V172, P5924, DOI 10.4049/jimmunol.172.10.5924; Yung RL, 2000, RHEUM DIS CLIN N AM, V26, P455, DOI 10.1016/S0889-857X(05)70151-4; Zhang XH, 2002, J EXP MED, V195, P283, DOI 10.1084/jem.20011267; 2000, ANN REPORT US SCI RE	27	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2009	4	1							e4097	10.1371/journal.pone.0004097	http://dx.doi.org/10.1371/journal.pone.0004097			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FR	19119314	gold, Green Published, Green Submitted			2022-12-25	WOS:000265472600005
J	Chang, Q; Tang, WX; Ahmad, S; Zhou, BF; Lin, X				Chang, Qing; Tang, Wenxue; Ahmad, Shoeb; Zhou, Binfei; Lin, Xi			Gap Junction Mediated Intercellular Metabolite Transfer in the Cochlea Is Compromised in Connexin30 Null Mice	PLOS ONE			English	Article								Connexin26 (Cx26) and connexin30 (Cx30) are two major protein subunits that co-assemble to form gap junctions (GJs) in the cochlea. Mutations in either one of them are the major cause of non-syndromic prelingual deafness in humans. Because the mechanisms of cochlear pathogenesis caused by Cx mutations are unclear, we investigated effects of Cx30 null mutation on GJ-mediated ionic and metabolic coupling in the cochlea of mice. A novel flattened cochlear preparation was used to directly assess intercellular coupling in the sensory epithelium of the cochlea. Double-electrode patch clamp recordings revealed that the absence of Cx30 did not significantly change GJ conductance among the cochlear supporting cells. The preserved electrical coupling is consistent with immunolabeling data showing extensive Cx26 GJs in the cochlea of the mutant mice. In contrast, dye diffusion assays showed that the rate and extent of intercellular transfer of multiple fluorescent dyes (including a non-metabolizable D-glucose analogue, 2-NBDG) among cochlear supporting cells were severely reduced in Cx30 null mice. Since the sensory epithelium in the cochlea is an avascular organ, GJ-facilitated intercellular transfer of nutrient and signaling molecules may play essential roles in cellular homeostasis. To test this possibility, NBDG was used as a tracer to study the contribution of GJs in transporting glucose into the cochlear sensory epithelium when delivered systemically. NBDG uptake in cochlear supporting cells was significantly reduced in Cx30 null mice. The decrease was also observed with GJ blockers or glucose competition, supporting the specificity of our tests. These data indicate that GJs facilitate efficient uptake of glucose in the supporting cells. This study provides the first direct experimental evidence showing that the transfer of metabolically-important molecules in cochlear supporting cells is dependent on the normal function of GJs, thereby suggesting a novel pathogenesis process in the cochlea for Cx-mutation-linked deafness.	[Chang, Qing; Tang, Wenxue; Ahmad, Shoeb; Zhou, Binfei; Lin, Xi] Emory Univ, Sch Med, Dept Otolaryngol, Atlanta, GA 30322 USA; [Lin, Xi] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA	Emory University; Emory University	Chang, Q (corresponding author), Emory Univ, Sch Med, Dept Otolaryngol, Atlanta, GA 30322 USA.	xlin2@emory.edu	lin, xi/GZL-4959-2022	Tang, Wenxue/0000-0001-8087-0900	National Institute on Deafness and other Communication Disorders NIDCD [RO1-DC006483, R21-DC008353, R21 DC008672, R03-DC008693]; Woodruff Foundation; Deafness Research Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC008693, R21DC008353, R21DC008672, R01DC006483] Funding Source: NIH RePORTER	National Institute on Deafness and other Communication Disorders NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Woodruff Foundation; Deafness Research Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by grants to X.Lin from National Institute on Deafness and other Communication Disorders (NIDCD, RO1-DC006483 and R21-DC008353) and Woodruff Foundation. W.Tang received grant supports from NIDCD (R21 DC008672) and the Deafness Research Foundation. S.Ahmad is a recipient of NIDCD RO3 (R03-DC008693). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2003, BIOCHEM BIOPH RES CO, V307, P362, DOI 10.1016/S0006-291X(03)01166-5; Ahmad S, 2007, P NATL ACAD SCI USA, V104, P1337, DOI 10.1073/pnas.0606855104; Axelsson A, 1968, ACTA OTOLARYNGOL S, V243, P3; Beltramello M, 2005, NAT CELL BIOL, V7, P63, DOI 10.1038/ncb1205; Cohen-Salmon M, 2002, CURR BIOL, V12, P1106, DOI 10.1016/S0960-9822(02)00904-1; Cohen-Salmon M, 2007, P NATL ACAD SCI USA, V104, P6229, DOI 10.1073/pnas.0605108104; Forge A, 2003, J COMP NEUROL, V467, P207, DOI 10.1002/cne.10916; Gabriel HD, 1998, J CELL BIOL, V140, P1453, DOI 10.1083/jcb.140.6.1453; Grifa A, 1999, NAT GENET, V23, P16, DOI 10.1038/12612; GUILFORD P, 1994, NAT GENET, V6, P24, DOI 10.1038/ng0194-24; Jagger DJ, 2006, J NEUROSCI, V26, P1260, DOI 10.1523/JNEUROSCI.4278-05.2006; Kameritsch P, 2005, J CELL PHYSIOL, V203, P233, DOI 10.1002/jcp.20218; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; KIKUCHI T, 1995, ANAT EMBRYOL, V191, P101, DOI 10.1007/BF00186783; Kikuchi T, 2000, BRAIN RES REV, V32, P163, DOI 10.1016/S0165-0173(99)00076-4; Kirkland RA, 2001, J NEUROSCI, V21, P1949, DOI 10.1523/JNEUROSCI.21-06-01949.2001; KONISHI T, 1978, ACTA OTO-LARYNGOL, V86, P22, DOI 10.3109/00016487809124717; Martinez-Wittinghan FJ, 2003, J CELL BIOL, V161, P969, DOI 10.1083/jcb.200303068; Matsunami T, 2006, CELL COMMUN ADHES, V13, P93, DOI 10.1080/15419060600631805; Moley KH, 2000, APOPTOSIS, V5, P99, DOI 10.1023/A:1009697908332; Qu Y, 2002, P NATL ACAD SCI USA, V99, P697, DOI 10.1073/pnas.022324499; ROYALL JA, 1993, ARCH BIOCHEM BIOPHYS, V302, P348, DOI 10.1006/abbi.1993.1222; SANTOS-SACCHI J, 1983, HEARING RES, V9, P317, DOI 10.1016/0378-5955(83)90034-5; SCHULTE BA, 1989, J HISTOCHEM CYTOCHEM, V37, P127, DOI 10.1177/37.2.2536055; Spicer SS, 1996, HEARING RES, V100, P80, DOI 10.1016/0378-5955(96)00106-2; STERKERS O, 1982, AM J PHYSIOL, V243, pF173, DOI 10.1152/ajprenal.1982.243.2.F173; Sun JJ, 2005, AM J PHYSIOL-CELL PH, V288, pC613, DOI 10.1152/ajpcell.00341.2004; SUZUKI T, 2008, HISTOCHEM CELL BIOL; Teubner B, 2003, HUM MOL GENET, V12, P13, DOI 10.1093/hmg/ddg001; Wangemann P, 2002, HEARING RES, V165, P1, DOI 10.1016/S0378-5955(02)00279-4; Wangemann P, 2006, J PHYSIOL-LONDON, V576, P11, DOI 10.1113/jphysiol.2006.112888; White TW, 2002, SCIENCE, V295, P319, DOI 10.1126/science.1067582; White TW, 1999, ANNU REV PHYSIOL, V61, P283, DOI 10.1146/annurev.physiol.61.1.283; Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076; Yamada K, 2007, NAT PROTOC, V2, P753, DOI 10.1038/nprot.2007.76; Zelante L, 1997, HUM MOL GENET, V6, P1605, DOI 10.1093/hmg/6.9.1605; Zhang YP, 2005, P NATL ACAD SCI USA, V102, P15201, DOI 10.1073/pnas.0501859102; ZIDANIC M, 1990, BIOPHYS J, V57, P1253, DOI 10.1016/S0006-3495(90)82644-8	38	75	76	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4088	10.1371/journal.pone.0004088	http://dx.doi.org/10.1371/journal.pone.0004088			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DO	19116647	Green Published, gold, Green Submitted			2022-12-25	WOS:000265466600009
J	Fischer, T; Nagel, F; Jacobs, S; Stumm, R; Schulz, S				Fischer, Thomas; Nagel, Falko; Jacobs, Stefan; Stumm, Ralf; Schulz, Stefan			Reassessment of CXCR4 Chemokine Receptor Expression in Human Normal and Neoplastic Tissues Using the Novel Rabbit Monoclonal Antibody UMB-2	PLOS ONE			English	Article								Background: The CXCR4 chemokine receptor regulates migration and homing of cancer cells to specific metastatic sites. Determination of the CXCR4 receptor status will provide predictive information for disease prognosis and possible therapeutic intervention. However, previous attempts to localize CXCR4 using poorly characterized mouse monoclonal or rabbit polyclonal antibodies have produced predominant nuclear and occasional cytoplasmic staining but did not result in the identification of bona fide cell surface receptors. Methodology/Principal Findings: In the present study, we extensively characterized the novel rabbit monoclonal anti-CXCR4 antibody (clone UMB-2) using transfected cells and tissues from CXCR4-deficient mice. Specificity of UMB-2 was demonstrated by cell surface staining of CXCR4-transfected cells; translocation of CXCR4 immunostaining after agonist exposure; detection of a broad band migrating at M(r) 38,000-43,000 in Western blots of homogenates from CXCR4-expressing cells; selective detection of the receptor in tissues from CXCR4+/+ but not from CXCR4-/- mice; and abolition of tissue immunostaining by preadsorption of UMB-2 with its immunizing peptide. In formalin-fixed, paraffin-embedded human tumor tissues, UMB-2 yielded highly effective plasma membrane staining of a subpopulation of tumor cells, which were often heterogeneously distributed throughout the tumor. A comparative analysis of the mouse monoclonal antibody 12G5 and other frequently used commercially available antibodies revealed that none of these was able to detect CXCR4 under otherwise identical conditions. Conclusions/Significance: Thus, the rabbit monoclonal antibody UMB-2 may prove of great value in the assessment of the CXCR4 receptor status in a variety of human tumors during routine histopathological examination.	[Fischer, Thomas; Nagel, Falko; Jacobs, Stefan; Schulz, Stefan] Univ Wurzburg, Dept Pharmacol, Wurzburg, Germany; [Nagel, Falko; Schulz, Stefan] Univ Jena, Dept Pharmacol & Toxicol, Jena, Germany; [Stumm, Ralf] Otto von Guericke Univ, Dept Pharmacol & Toxicol, Magdeburg, Germany	University of Wurzburg; Friedrich Schiller University of Jena; Otto von Guericke University	Fischer, T (corresponding author), Univ Wurzburg, Dept Pharmacol, Wurzburg, Germany.	Stefan.Schulz@mti.uni-jena.de	Schulz, Stefan/A-6928-2017	Schulz, Stefan/0000-0002-5997-8885; Fischer, Thomas/0000-0003-4711-645X				Baribaud F, 2001, J VIROL, V75, P8957, DOI 10.1128/JVI.75.19.8957-8967.2001; Bertolini F, 2002, CANCER RES, V62, P3106; Blot E, 2008, BREAST J, V14, P268, DOI 10.1111/j.1524-4741.2008.00573.x; Cabioglu N, 2005, CLIN CANCER RES, V11, P5686, DOI 10.1158/1078-0432.CCR-05-0014; Endres MJ, 1996, CELL, V87, P745, DOI 10.1016/S0092-8674(00)81393-8; Fischer T, 2008, J CLIN ENDOCRINOL ME; Kim J, 2005, J CLIN ONCOL, V23, P2744, DOI 10.1200/JCO.2005.07.078; Kolodziej A, 2008, J NEUROSCI, V28, P4488, DOI 10.1523/JNEUROSCI.4721-07.2008; Kryczek I, 2007, AM J PHYSIOL-CELL PH, V292, pC987, DOI 10.1152/ajpcell.00406.2006; Lee BC, 2004, MOL CANCER RES, V2, P327; Liang ZX, 2005, CANCER RES, V65, P967; Mori T, 2004, MOL CANCER THER, V3, P29; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Ottaiano A, 2006, CLIN CANCER RES, V12, P2795, DOI 10.1158/1078-0432.CCR-05-2142; Rempel SA, 2000, CLIN CANCER RES, V6, P102; Robledo MM, 2001, J BIOL CHEM, V276, P45098, DOI 10.1074/jbc.M106912200; Salvucci O, 2006, BREAST CANCER RES TR, V97, P275, DOI 10.1007/s10549-005-9121-8; Scala S, 2005, CLIN CANCER RES, V11, P1835, DOI 10.1158/1078-0432.CCR-04-1887; Schmid BC, 2004, BREAST CANCER RES TR, V84, P247, DOI 10.1023/B:BREA.0000019962.18922.87; Spano JP, 2004, ANN ONCOL, V15, P613, DOI 10.1093/annonc/mdh136; Stumm R, 2007, J COMP NEUROL, V502, P382, DOI 10.1002/cne.21336; Stumm RK, 2003, J NEUROSCI, V23, P5123; Stumm RK, 2002, J NEUROSCI, V22, P5865; Vaday GG, 2004, CLIN CANCER RES, V10, P5630, DOI 10.1158/1078-0432.CCR-03-0633; Vasyutina E, 2005, GENE DEV, V19, P2187, DOI 10.1101/gad.346205; Woerner BM, 2005, CANCER RES, V65, P11392, DOI 10.1158/0008-5472.CAN-05-0847; Xu FY, 2007, CLIN CANCER RES, V13, P5082, DOI 10.1158/1078-0432.CCR-07-0597; Yang YC, 2007, INT J GYNECOL CANCER, V17, P676, DOI 10.1111/j.1525-1438.2007.00841.x; Yoshitake N, 2008, BRIT J CANCER, V98, P1682, DOI 10.1038/sj.bjc.6604363; Zagzag D, 2008, AM J PATHOL, V173, P545, DOI 10.2353/ajpath.2008.071197	30	58	62	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4069	10.1371/journal.pone.0004069	http://dx.doi.org/10.1371/journal.pone.0004069			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DO	19116653	Green Submitted, Green Published, gold			2022-12-25	WOS:000265466600003
J	Eichorst, JP; Lu, SY; Xu, J; Wang, YX				Eichorst, John Paul; Lu, Shaoying; Xu, Jing; Wang, Yingxiao			Differential RhoA Dynamics in Migratory and Stationary Cells Measured by FRET and Automated Image Analysis	PLOS ONE			English	Article								Genetically-encoded biosensors based on fluorescence resonance energy transfer (FRET) have been widely applied to study the spatiotemporal regulation of molecular activity in live cells with high resolution. The efficient and accurate quantification of the large amount of imaging data from these single-cell FRET measurements demands robust and automated data analysis. However, the nonlinear movement of live cells presents tremendous challenge for this task. Based on image registration of the single-cell movement, we have developed automated image analysis methods to track and quantify the FRET signals within user-defined subcellular regions. In addition, the subcellular pixels were classified according to their associated FRET signals and the dynamics of the clusters analyzed. The results revealed that the EGF-induced reduction of RhoA activity in migratory HeLa cells is significantly less than that in stationary cells. Furthermore, the RhoA activity is polarized in the migratory cells, with the gradient of polarity oriented toward the opposite direction of cell migration. In contrast, there is a lack of consistent preference in RhoA polarity among stationary cells. Therefore, our image analysis methods can provide powerful tools for high-throughput and systematic investigation of the spatiotemporal molecular activities in regulating functions of live cells with their shapes and positions continuously changing in time.	[Wang, Yingxiao] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Lu, Shaoying; Xu, Jing; Wang, Yingxiao] Univ Illinois, Dept Bioengn, Urbana, IL USA; [Wang, Yingxiao] Univ Illinois, Beckman Inst Advanced Sci & Technol, Dept Mol & Integrat Physiol, Urbana, IL USA; [Wang, Yingxiao] Univ Illinois, Neurosci Program, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Eichorst, JP (corresponding author), Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA.	yingxiao@uiuc.edu			Bioengineering Department of the University of Illinois, Urbana-Champaign; Wallace H. Coulter Foundation; Beckman Laser Institute Inc; NSF [08-00870]; NIH [NS-063405]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063405] Funding Source: NIH RePORTER	Bioengineering Department of the University of Illinois, Urbana-Champaign; Wallace H. Coulter Foundation; Beckman Laser Institute Inc; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the Bioengineering Department of the University of Illinois, Urbana-Champaign, the Wallace H. Coulter Foundation, Beckman Laser Institute Inc., NSF grant 08-00870, and NIH grant NS-063405. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber CB, 1996, ACM T MATH SOFTWARE, V22, P469, DOI 10.1145/235815.235821; Chamberlain CE, 2000, METHOD ENZYMOL, V325, P389; Dormann D, 2002, CELL MOTIL CYTOSKEL, V52, P221, DOI 10.1002/cm.10048; Dubin-Thaler BJ, 2004, BIOPHYS J, V86, P1794, DOI 10.1016/S0006-3495(04)74246-0; El-Sibai M, 2008, EXP CELL RES, V314, P1540, DOI 10.1016/j.yexcr.2008.01.016; GEORGE PL, 1991, AUTOMATIC MESH GENER, P333; GOSHTASBY A, 1986, PATTERN RECOGN, V19, P459, DOI 10.1016/0031-3203(86)90044-0; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hodgson L, 2006, METHOD ENZYMOL, V406, P140, DOI 10.1016/S0076-6879(06)06012-5; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jagalur M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S10-S5; Kurokawa K, 2005, MOL BIOL CELL, V16, P4294, DOI 10.1091/mbc.E04-12-1076; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; LEE J, 1993, NATURE, V362, P167, DOI 10.1038/362167a0; Matula P, 2006, IEEE T IMAGE PROCESS, V15, P2388, DOI 10.1109/TIP.2006.875209; Mott RE, 2007, AM J PHYSIOL-CELL PH, V293, pC1616, DOI 10.1152/ajpcell.00457.2006; Nakamura T, 2005, MOL BRAIN RES, V139, P277, DOI 10.1016/j.molbrainres.2005.05.030; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rieger B, 2004, MICROSC RES TECHNIQ, V64, P142, DOI 10.1002/jemt.20069; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Salmon WC, 2002, J CELL BIOL, V158, P31, DOI 10.1083/jcb.200203022; SEBER GAF, 1984, MULTIVARIATE OBSERVA; Shen FM, 2006, CYTOM PART A, V69A, P563, DOI 10.1002/cyto.a.20283; Shi LZ, 2008, BIOMED MICRODEVICES, V10, P573, DOI 10.1007/s10544-008-9169-4; Shi LZ, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2357735; SPATH H, 1985, CLUSTER DISSECTION A; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Vielkind S, 2005, J IMMUNOL, V175, P350, DOI 10.4049/jimmunol.175.1.350; WANG Y, 2008, ANN REV BIO IN PRESS, V10; Wang YT, 2008, J COMMUN NETW-S KOR, V10, P38, DOI 10.1109/JCN.2008.6388326; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Wischgoll T, 2008, ANN BIOMED ENG, V36, P356, DOI 10.1007/s10439-008-9443-x; Wong K, 2006, P NATL ACAD SCI USA, V103, P3639, DOI 10.1073/pnas.0600092103; Yamana N, 2006, MOL CELL BIOL, V26, P6844, DOI 10.1128/MCB.00283-06; Yoshizaki H, 2004, J BIOL CHEM, V279, P44756, DOI 10.1074/jbc.M402292200; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976; Zitova B, 2003, IMAGE VISION COMPUT, V21, P977, DOI 10.1016/S0262-8856(03)00137-9	43	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2008	3	12							e4082	10.1371/journal.pone.0004082	http://dx.doi.org/10.1371/journal.pone.0004082			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DL	19114999	gold, Green Submitted, Green Published			2022-12-25	WOS:000265466300019
J	Eldin, NS; Ismail, S; Mansour, H; Rekacewicz, C; El-Houssinie, M; El-Kafrawy, S; El Aidi, S; Abdel-Hamid, M; Esmat, G; Pol, S; Fontanet, A; Mohamed, MK				Eldin, Noha Sharaf; Ismail, Soheir; Mansour, Hala; Rekacewicz, Claire; El-Houssinie, Moustafa; El-Kafrawy, Sherif; El Aidi, Saeed; Abdel-Hamid, Mohamed; Esmat, Gamal; Pol, Stanislas; Fontanet, Arnaud; Mohamed, Mostafa K.			Symptomatic Acute Hepatitis C in Egypt: Diagnosis, Spontaneous Viral Clearance, and Delayed Treatment with 12 Weeks of Pegylated Interferon Alfa-2a	PLOS ONE			English	Article							INFECTION; THERAPY; VIRUS; MONOTHERAPY; SPREAD	Background and Objectives: The aim of this study was to estimate the proportion of spontaneous viral clearance (SVC) after symptomatic acute hepatitis C and to evaluate the efficacy of 12 weeks of pegylated interferon alfa-2a in patients who did not clear the virus spontaneously. Methods: Patients with symptomatic acute hepatitis C were recruited from two "fever hospitals'' in Cairo, Egypt. Patients still viremic three months after the onset of symptoms were considered for treatment with 12 weeks of pegylated interferon alfa-2a (180 mu g/week). Results: Between May 2002 and February 2006, 2243 adult patients with acute hepatitis were enrolled in the study. The SVC rate among 117 patients with acute hepatitis C was 33.8% (95%CI [25.9%-43.2%]) at three months and 41.5% (95%CI [33.0%-51.2%]) at six months. The sustained virological response (SVR) rate among the 17 patients who started treatment 4-6 months after onset of symptoms was 15/17=88.2% (95%CI [63.6%-98.5%]). Conclusion: Spontaneous viral clearance was high (41.5% six months after the onset of symptoms) in this population with symptomatic acute hepatitis C. Allowing time for spontaneous clearance should be considered before treatment is initiated for symptomatic acute hepatitis C.	[El-Houssinie, Moustafa; Mohamed, Mostafa K.] Ain Shams Univ, Dept Community Med, Cairo, Egypt; [Ismail, Soheir; Mansour, Hala] Natl Hepatol & Trop Med Res Inst, Cairo, Egypt; [Rekacewicz, Claire; Fontanet, Arnaud] Inst Pasteur, Emerging Dis Epidemiol Unit, Paris, France; [El-Kafrawy, Sherif] Menoufia Univ, Natl Liver Inst, Menoufia, Egypt; [El Aidi, Saeed] Imbaba Fever Hosp, Cairo, Egypt; [Abdel-Hamid, Mohamed] Menia Univ, Fac Med, Al Minya, Egypt; [Esmat, Gamal] Cairo Univ, Fac Med, Dept Trop Med & Hepatol, Cairo, Egypt; [Pol, Stanislas] AP HP, Hop Cochin, Unite Hepatol, Paris, France	Egyptian Knowledge Bank (EKB); Ain Shams University; Egyptian Knowledge Bank (EKB); National Hepatology & Tropical Medicine Research Institute (NHTMRI); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Egyptian Knowledge Bank (EKB); Menofia University; Egyptian Knowledge Bank (EKB); Minia University; Egyptian Knowledge Bank (EKB); Cairo University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Eldin, NS (corresponding author), Ain Shams Univ, Dept Community Med, Cairo, Egypt.	fontanet@pasteur.fr	Sharafeldin, Noha/K-5040-2014; mohamed, mostafa/AFE-7371-2022	mohamed, mostafa/0000-0002-1421-2667; , arnaud/0000-0002-5239-6110; Esmat, Gamal/0000-0001-8614-1629	Agence Nationale de Recherche contre le SIDA et les hepatites virales [1213]	Agence Nationale de Recherche contre le SIDA et les hepatites virales(French National Research Agency (ANR))	This study was funded by the Agence Nationale de Recherche contre le SIDA et les hepatites virales (ANRS 1213). We would like to thank the Roche laboratories for supplying Pegylated Interferon (PEG-IFNalpha-2a) PEGASYS 180 mg free of charge to study participants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hamid M, 1997, J Hum Virol, V1, P58; Arafa N, 2005, J HEPATOL, V43, P418, DOI 10.1016/j.jhep.2005.03.021; Busch MP, 2005, CLIN INFECT DIS, V40, P959, DOI 10.1086/428583; Calleri G, 2007, J VIRAL HEPATITIS, V14, P116, DOI 10.1111/j.1365-2893.2006.00802.x; De Rosa F, 2006, HEPATOLOGY, V44, P511, DOI 10.1002/hep.21273; De Rosa FG, 2007, CLIN INFECT DIS, V45, P583, DOI 10.1086/520660; El Gaafary MM, 2005, J MED VIROL, V76, P520, DOI 10.1002/jmv.20392; Frank C, 2000, LANCET, V355, P887, DOI 10.1016/S0140-6736(99)06527-7; Gerlach JT, 2003, GASTROENTEROLOGY, V125, P80, DOI 10.1016/S0016-5085(03)00668-1; Jaeckel E, 2001, NEW ENGL J MED, V345, P1452, DOI 10.1056/NEJMoa011232; Kamal SM, 2006, HEPATOLOGY, V43, P923, DOI 10.1002/hep.21197; Kamal SM, 2006, GASTROENTEROLOGY, V130, P632, DOI 10.1053/j.gastro.2006.01.034; Licata A, 2003, J HEPATOL, V39, P1056, DOI 10.1016/S0168-8278(03)00461-6; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Nomura H, 2004, HEPATOLOGY, V39, P1213, DOI 10.1002/hep.20196; Ray SC, 2000, J INFECT DIS, V182, P698, DOI 10.1086/315786; Santantonio T, 2006, CLIN INFECT DIS, V43, P1154, DOI 10.1086/507640; Santantonio T, 2005, J HEPATOL, V42, P329, DOI 10.1016/j.jhep.2004.11.021; Wedemeyer H, 2004, HEPATOLOGY, V39, P1201, DOI 10.1002/hep.20221; Wiegand J, 2006, HEPATOLOGY, V43, P250, DOI 10.1002/hep.21043; Zekry A, 2005, J HEPATOL, V42, P293, DOI 10.1016/j.jhep.2004.12.012	21	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2008	3	12							e4085	10.1371/journal.pone.0004085	http://dx.doi.org/10.1371/journal.pone.0004085			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DL	19115010	Green Published, gold, Green Submitted			2022-12-25	WOS:000265466300021
J	Mine, S; Fortunel, NO; Pageon, H; Asselineau, D				Mine, Solene; Fortunel, Nicolas O.; Pageon, Herve; Asselineau, Daniel			Aging Alters Functionally Human Dermal Papillary Fibroblasts but Not Reticular Fibroblasts: A New View of Skin Morphogenesis and Aging	PLOS ONE			English	Article							AGE-RELATED-CHANGES; IN-VITRO; GROWTH-FACTOR; REPLICATIVE SENESCENCE; HUMAN KERATINOCYTES; MATRIX METALLOPROTEINASES; EPIDERMAL-KERATINOCYTES; SERIAL CULTIVATION; BASEMENT-MEMBRANE; GENE-EXPRESSION	Understanding the contribution of the dermis in skin aging is a key question, since this tissue is particularly important for skin integrity, and because its properties can affect the epidermis. Characteristics of matched pairs of dermal papillary and reticular fibroblasts (Fp and Fr) were investigated throughout aging, comparing morphology, secretion of cytokines, MMPs/TIMPs, growth potential, and interaction with epidermal keratinocytes. We observed that Fp populations were characterized by a higher proportion of small cells with low granularity and a higher growth potential than Fr populations. However, these differences became less marked with increasing age of donors. Aging was also associated with changes in the secretion activity of both Fp and Fr. Using a reconstructed skin model, we evidenced that Fp and Fr cells do not possess equivalent capacities to sustain keratinopoiesis. Comparing Fp and Fr from young donors, we noticed that dermal equivalents containing Fp were more potent to promote epidermal morphogenesis than those containing Fr. These data emphasize the complexity of dermal fibroblast biology and document the specific functional properties of Fp and Fr. Our results suggest a new model of skin aging in which marked alterations of Fp may affect the histological characteristics of skin.	[Mine, Solene; Fortunel, Nicolas O.; Pageon, Herve; Asselineau, Daniel] LOreal, Sci Vivant, Clichy, France	L'Oreal Group	Mine, S (corresponding author), LOreal, Sci Vivant, Clichy, France.	dasselineau@rd.loreal.com		FORTUNEL, Nicolas/0000-0001-8702-247X				Andreadis ST, 2001, FASEB J, V15, P898, DOI 10.1096/fj.00-0324com; ANGELLO JC, 1987, J CELL PHYSIOL, V132, P125, DOI 10.1002/jcp.1041320117; Ashcroft GS, 2002, BIOGERONTOLOGY, V3, P337, DOI 10.1023/A:1021399228395; Ashcroft GS, 1997, J INVEST DERMATOL, V108, P430, DOI 10.1111/1523-1747.ep12289705; ASSELINEAU D, 1985, EXP CELL RES, V159, P536, DOI 10.1016/S0014-4827(85)80027-6; AZZARONE B, 1982, J CELL SCI, V57, P177; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Bartsch G, 2005, STEM CELLS DEV, V14, P337, DOI 10.1089/scd.2005.14.337; BAYREUTHER K, 1988, P NATL ACAD SCI USA, V85, P5112, DOI 10.1073/pnas.85.14.5112; BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274; BELL E, 1978, SCIENCE, V202, P1158, DOI 10.1126/science.725592; Bernerd F, 1998, CELL DEATH DIFFER, V5, P792, DOI 10.1038/sj.cdd.4400413; Boehnke K, 2007, EUR J CELL BIOL, V86, P731, DOI 10.1016/j.ejcb.2006.12.005; Brash DE, 1997, TRENDS GENET, V13, P410, DOI 10.1016/S0168-9525(97)01246-8; Buckley CD, 2004, ANN RHEUM DIS, V63, P92, DOI 10.1136/ard.2004.028332; Campisi J, 2001, EXP GERONTOL, V36, P1619, DOI 10.1016/S0531-5565(01)00160-7; Capri M, 2006, ANN NY ACAD SCI, V1067, P252, DOI 10.1196/annals.1354.033; Carrino DA, 2003, J BIOL CHEM, V278, P17566, DOI 10.1074/jbc.M300124200; Chen FG, 2007, J CELL SCI, V120, P2875, DOI 10.1242/jcs.03478; Chung JH, 2001, J INVEST DERMATOL, V117, P1218, DOI 10.1046/j.0022-202x.2001.01544.x; Chuttani Anjali, 1995, P309; CRISTOFALO VJ, 1993, PHYSIOL REV, V73, P617, DOI 10.1152/physrev.1993.73.3.617; DALY CH, 1979, J INVEST DERMATOL, V73, P84, DOI 10.1111/1523-1747.ep12532770; DEMARCHEZ M, 1992, TRANSPLANTATION, V54, P317, DOI 10.1097/00007890-199208000-00023; El Ghalbzouri A, 2002, CELL TISSUE RES, V310, P189, DOI 10.1007/s00441-002-0621-0; FELDMAN SR, 1993, AM J MED SCI, V305, P203, DOI 10.1097/00000441-199304000-00002; Finch CE, 1997, SCIENCE, V278, P407, DOI 10.1126/science.278.5337.407; Fisher GJ, 1996, FASEB J, V10, P1002, DOI 10.1096/fasebj.10.9.8801161; Fortunel NO, 2003, J CELL SCI, V116, P4043, DOI 10.1242/jcs.00702; GARMYN M, 1992, J INVEST DERMATOL, V99, P743, DOI 10.1111/1523-1747.ep12614470; GOLDSTEIN S, 1990, SCIENCE, V249, P1129, DOI 10.1126/science.2204114; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; HARPER RA, 1979, SCIENCE, V204, P526, DOI 10.1126/science.432659; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; HAYFLICK L, 1979, J INVEST DERMATOL, V73, P8, DOI 10.1111/1523-1747.ep12532752; IRWIN CR, 1994, J CELL SCI, V107, P1333; IZUMI T, 1995, J BIOCHEM-TOKYO, V117, P1004, DOI 10.1093/oxfordjournals.jbchem.a124798; Jahoda CAB, 2003, EXP DERMATOL, V12, P849, DOI 10.1111/j.0906-6705.2003.00161.x; JONES PH, 1995, CELL, V80, P83, DOI 10.1016/0092-8674(95)90453-0; Kahari VM, 1997, EXP DERMATOL, V6, P199, DOI 10.1111/j.1600-0625.1997.tb00164.x; Larderet G, 2006, STEM CELLS, V24, P965, DOI 10.1634/stemcells.2005-0196; LAVKER RM, 1987, J INVEST DERMATOL, V88, pS44, DOI 10.1111/1523-1747.ep12468934; Lee DY, 2005, ARCH DERMATOL RES, V296, P296, DOI 10.1007/s00403-004-0529-5; Li A, 1998, P NATL ACAD SCI USA, V95, P3902, DOI 10.1073/pnas.95.7.3902; Marionnet C, 2006, J INVEST DERMATOL, V126, P971, DOI 10.1038/sj.jid.5700230; Martin GM, 2000, NATURE, V408, P263, DOI 10.1038/35041705; MONTAGNA W, 1979, J INVEST DERMATOL, V73, P47, DOI 10.1111/1523-1747.ep12532761; Moulin V, 2000, BURNS, V26, P3, DOI 10.1016/S0305-4179(99)00091-1; Odorisio T, 2002, EUR J DERMATOL, V12, pVII; POSTLETHWAITE AE, 1999, INFLAMMATION BASIC P, P227; Quan TH, 2004, AM J PATHOL, V165, P741, DOI 10.1016/S0002-9440(10)63337-8; REENSTRA WR, 1993, EXP CELL RES, V209, P118, DOI 10.1006/excr.1993.1291; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Rittie L, 2005, METH MOLEC MED, V117, P83; SCHAFER IA, 1989, EXP CELL RES, V183, P112, DOI 10.1016/0014-4827(89)90422-9; SCHAFER IA, 1985, MECH AGEING DEV, V31, P275, DOI 10.1016/0047-6374(85)90095-8; SCHNEIDER EL, 1979, J INVEST DERMATOL, V73, P15, DOI 10.1111/1523-1747.ep12532753; SCHNEIDER EL, 1976, P NATL ACAD SCI USA, V73, P3584, DOI 10.1073/pnas.73.10.3584; SCHONHERR E, 1993, BIOCHEM J, V290, P893, DOI 10.1042/bj2900893; SMITH JR, 1974, J CELL BIOL, V62, P48, DOI 10.1083/jcb.62.1.48; SMITH JR, 1978, P NATL ACAD SCI USA, V75, P1353, DOI 10.1073/pnas.75.3.1353; Smith RS, 1997, AM J PATHOL, V151, P317; Sorrell JM, 2004, J CELL PHYSIOL, V200, P134, DOI 10.1002/jcp.10474; TAJIMA S, 1981, J INVEST DERMATOL, V77, P410, DOI 10.1111/1523-1747.ep12494614; Tajima S, 1996, ARCH DERMATOL RES, V288, P753, DOI 10.1007/BF02505292; Toma JG, 2005, STEM CELLS, V23, P727, DOI 10.1634/stemcells.2004-0134; Uitto J, 2000, J DERMATOL SCI, V24, pS60, DOI 10.1016/S0923-1811(00)00143-2; Varani J, 2006, AM J PATHOL, V168, P1861, DOI 10.2353/ajpath.2006.051302; Varani J, 2000, J INVEST DERMATOL, V114, P480, DOI 10.1046/j.1523-1747.2000.00902.x; Vazquez F, 1996, MATURITAS, V25, P209, DOI 10.1016/S0378-5122(96)01066-3; WERNER S, 1994, SCIENCE, V266, P819, DOI 10.1126/science.7973639; WEST MD, 1989, EXP CELL RES, V184, P138, DOI 10.1016/0014-4827(89)90372-8; Yaar M, 2002, ARCH DERMATOL, V138, P1429, DOI 10.1001/archderm.138.11.1429	74	132	140	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2008	3	12							e4066	10.1371/journal.pone.0004066	http://dx.doi.org/10.1371/journal.pone.0004066			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DL	19115004	gold, Green Submitted, Green Published			2022-12-25	WOS:000265466300008
J	Saaf, AM; Tengvall-Linder, M; Chang, HY; Adler, AS; Wahlgren, CF; Scheynius, A; Nordenskjold, M; Bradley, M				Saaf, Annika M.; Tengvall-Linder, Maria; Chang, Howard Y.; Adler, Adam S.; Wahlgren, Carl-Fredrik; Scheynius, Annika; Nordenskjold, Magnus; Bradley, Maria			Global Expression Profiling in Atopic Eczema Reveals Reciprocal Expression of Inflammatory and Lipid Genes	PLOS ONE			English	Article							PITYROSPORUM-ORBICULARE; MALASSEZIA-SYMPODIALIS; BARRIER FUNCTION; STRATUM-CORNEUM; SKIN-LESIONS; FATTY-ACIDS; DERMATITIS; ASSOCIATION; LINKAGE; PROTEIN	Background: Atopic eczema (AE) is a common chronic inflammatory skin disorder. In order to dissect the genetic background several linkage and genetic association studies have been performed. Yet very little is known about specific genes involved in this complex skin disease, and the underlying molecular mechanisms are not fully understood. Methodology/Findings: We used human DNA microarrays to identify a molecular picture of the programmed responses of the human genome to AE. The transcriptional program was analyzed in skin biopsy samples from lesional and patch-tested skin from AE patients sensitized to Malassezia sympodialis (M. sympodialis), and corresponding biopsies from healthy individuals. The most notable feature of the global gene-expression pattern observed in AE skin was a reciprocal expression of induced inflammatory genes and repressed lipid metabolism genes. The overall transcriptional response in M. sympodialis patch-tested AE skin was similar to the gene-expression signature identified in lesional AE skin. In the constellation of genes differentially expressed in AE skin compared to healthy control skin, we have identified several potential susceptibility genes that may play a critical role in the pathological condition of AE. Many of these genes, including genes with a role in immune responses, lipid homeostasis, and epidermal differentiation, are localized on chromosomal regions previously linked to AE. Conclusions/Significance: Through genome-wide expression profiling, we were able to discover a distinct reciprocal expression pattern of induced inflammatory genes and repressed lipid metabolism genes in skin from AE patients. We found a significant enrichment of differentially expressed genes in AE with cytobands associated to the disease, and furthermore new chromosomal regions were found that could potentially guide future region-specific linkage mapping in AE. The full data set is available at http://microarray-pubs.stanford.edu/eczema.	[Nordenskjold, Magnus; Bradley, Maria] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Tengvall-Linder, Maria; Scheynius, Annika] Karolinska Inst, Dept Med Solna, Clin Allergy Res Unit, Stockholm, Sweden; [Chang, Howard Y.; Adler, Adam S.] Stanford Univ, Sch Med, Programs Epithelial Biol & Canc Biol, Stanford, CA 94305 USA; [Wahlgren, Carl-Fredrik; Bradley, Maria] Karolinska Inst, Dept Med Solna, Dermatol Unit, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Stanford University; Karolinska Institutet	Saaf, AM (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.	annika.saaf@ki.se		Nordenskjold, Magnus/0000-0002-4974-425X; Adler, Adam/0000-0001-9301-0037	Swedish Research Council Vetenskapsradet; U.S. National Eczema Association for Science and Education; Edward Welander-Finsen Foundation; Swedish Asthma and Allergy Association; Stockholm County Council; Karolinska Institutet	Swedish Research Council Vetenskapsradet(Swedish Research Council); U.S. National Eczema Association for Science and Education; Edward Welander-Finsen Foundation; Swedish Asthma and Allergy Association; Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet)	This work was supported by the Swedish Research Council Vetenskapsradet (A.S), the U.S. National Eczema Association for Science and Education, the Edward Welander-Finsen Foundation, the Swedish Asthma and Allergy Association and through the regional agreement on medical training and clinical research (ALF) between the Stockholm County Council and Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis CA, 2006, ALLERGY, V61, P969, DOI 10.1111/j.1398-9995.2006.01153.x; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beyer K, 2000, J INVEST DERMATOL, V115, P906, DOI 10.1046/j.1523-1747.2000.00096.x; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Bradley M, 2002, HUM MOL GENET, V11, P1539, DOI 10.1093/hmg/11.13.1539; Calder PC, 2006, CLIN EXP ALLERGY, V36, P138, DOI 10.1111/j.1365-2222.2006.02433.x; Calder PC, 2000, PEDIAT ALLERG IMM-UK, V11, P29, DOI 10.1034/j.1399-3038.2000.00508.x; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Casagrande BF, 2006, J INVEST DERMATOL, V126, P2414, DOI 10.1038/sj.jid.5700431; Cassidy AJ, 2005, AM J HUM GENET, V77, P909, DOI 10.1086/497707; Choi MJ, 2005, AM J CLIN DERMATOL, V6, P215, DOI 10.2165/00128071-200506040-00002; Christensen U, 2006, EUR J HUM GENET, V14, P227, DOI 10.1038/sj.ejhg.5201541; Colgan J, 2007, CURR OPIN ALLERGY CL, V7, P51, DOI 10.1097/ACI.0b013e32801297e6; Cookson WOCM, 2001, NAT GENET, V27, P372, DOI 10.1038/86867; Ekelund E, 2006, AM J HUM GENET, V78, P1060, DOI 10.1086/504272; Elias PM, 2008, J INVEST DERMATOL, V128, P1067, DOI 10.1038/jid.2008.88; Enomoto H, 2007, BMC DERMATOL, V7, DOI 10.1186/1471-5945-7-5; Goren I, 2006, J INVEST DERMATOL, V126, P477, DOI 10.1038/sj.jid.5700063; Haagerup A, 2004, ALLERGY, V59, P88, DOI 10.1111/j.1398-9995.2004.00294.x; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; HUBER M, 1995, SCIENCE, V267, P525, DOI 10.1126/science.7824952; Irvine AD, 2007, J INVEST DERMATOL, V127, P504, DOI 10.1038/sj.jid.5700695; Jarvikallio A, 1997, BRIT J DERMATOL, V136, P871, DOI 10.1046/j.1365-2133.1997.01831.x; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Jump DB, 2002, CURR OPIN LIPIDOL, V13, P155, DOI 10.1097/00041433-200204000-00007; Kalinin AE, 2002, BIOESSAYS, V24, P789, DOI 10.1002/bies.10144; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kere J, 2005, PHILOS T R SOC B, V360, P1551, DOI 10.1098/rstb.2005.1684; Komatsu N, 2007, EXP DERMATOL, V16, P513, DOI 10.1111/j.1600-0625.2007.00562.x; Laitinen K, 2006, CLIN EXP ALLERGY, V36, P166, DOI 10.1111/j.1365-2222.2006.02417.x; LARSEN FS, 1993, J AM ACAD DERMATOL, V28, P719, DOI 10.1016/0190-9622(93)70099-F; LARSEN FS, 1986, J AM ACAD DERMATOL, V15, P487; Lee YA, 2000, NAT GENET, V26, P470, DOI 10.1038/82625; Leung DYM, 2004, J CLIN INVEST, V113, P651, DOI 10.1172/JCI200421060; Lin YT, 2007, CLIN REV ALLERG IMMU, V33, P167, DOI 10.1007/s12016-007-0044-5; Linder MT, 2000, CLIN EXP ALLERGY, V30, P122, DOI 10.1046/j.1365-2222.2000.00702.x; Mehul B, 2000, J BIOL CHEM, V275, P12841, DOI 10.1074/jbc.275.17.12841; Mizuno M, 2006, CURR MED CHEM, V13, P1707, DOI 10.2174/092986706777441959; Morar N, 2006, J ALLERGY CLIN IMMUN, V118, P24, DOI 10.1016/j.jaci.2006.03.037; Nomura I, 2003, J IMMUNOL, V171, P3262, DOI 10.4049/jimmunol.171.6.3262; Nomura L, 2003, J ALLERGY CLIN IMMUN, V112, P1195, DOI 10.1016/j.jaci.2003.08.049; Ogawa K, 2005, J DERMATOL SCI, V40, P35, DOI 10.1016/j.jdermsci.2005.06.001; Oiso N, 2000, BRIT J DERMATOL, V142, P1003, DOI 10.1046/j.1365-2133.2000.03485.x; Olsson M, 2006, ALLERGY, V61, P1132, DOI 10.1111/j.1398-9995.2006.01151.x; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Pivarcsi A, 2005, CURR ALLERGY ASTHM R, V5, P284, DOI 10.1007/s11882-005-0068-y; Pivarcsi A, 2004, J IMMUNOL, V173, P5810, DOI 10.4049/jimmunol.173.9.5810; Reue K, 2008, FEBS LETT, V582, P90, DOI 10.1016/j.febslet.2007.11.014; RUSSELL LJ, 1995, NAT GENET, V9, P279, DOI 10.1038/ng0395-279; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Scheynius A, 2002, INT ARCH ALLERGY IMM, V127, P161, DOI 10.1159/000053860; Schmid-Grendelmeier P, 2006, CHEM IMMUNOL ALLERGY, V91, P98; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Seki Y, 2003, NAT MED, V9, P1047, DOI 10.1038/nm896; Simon M, 1997, J BIOL CHEM, V272, P31770, DOI 10.1074/jbc.272.50.31770; Soderhall C, 2001, HUM GENET, V109, P129, DOI 10.1007/s004390100556; Soderhall C, 2007, PLOS BIOL, V5, P1952, DOI 10.1371/journal.pbio.0050242; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; STALDER JF, 1993, DERMATOLOGY, V186, P23, DOI 10.1159/000247298; Sugiura H, 2005, BRIT J DERMATOL, V152, P146, DOI 10.1111/J.1365-2133.2005.06352.X; Takahashi N, 2005, HUM MOL GENET, V14, P3149, DOI 10.1093/hmg/ddi347; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; Vasilopoulos Y, 2004, J INVEST DERMATOL, V123, P62, DOI 10.1111/j.0022-202X.2004.22708.x; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P406, DOI 10.1111/j.1365-2133.1994.tb08532.x; Yen CH, 2008, ANN ALLERG ASTHMA IM, V100, P66, DOI 10.1016/S1081-1206(10)60407-3; ZARGARI A, 1994, ALLERGY, V49, P50, DOI 10.1111/j.1398-9995.1994.tb00773.x	70	64	66	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4017	10.1371/journal.pone.0004017	http://dx.doi.org/10.1371/journal.pone.0004017			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107207	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000265463000012
J	Suryan, RM; Anderson, DJ; Shaffer, SA; Roby, DD; Tremblay, Y; Costa, DP; Sievert, PR; Sato, F; Ozaki, K; Balogh, GR; Nakamura, N				Suryan, Robert M.; Anderson, David J.; Shaffer, Scott A.; Roby, Daniel D.; Tremblay, Yann; Costa, Daniel P.; Sievert, Paul R.; Sato, Fumio; Ozaki, Kiyoaki; Balogh, Gregory R.; Nakamura, Noboru			Wind, Waves, and Wing Loading: Morphological Specialization May Limit Range Expansion of Endangered Albatrosses	PLOS ONE			English	Article							FORAGING DESTINATIONS; WANDERING ALBATROSSES; PHOEBASTRIA-ALBATRUS; NORTH PACIFIC; TRACKING; PROCELLARIIFORMES; HABITAT; FLIGHT	Among the varied adaptations for avian flight, the morphological traits allowing large-bodied albatrosses to capitalize on wind and wave energy for efficient long-distance flight are unparalleled. Consequently, the biogeographic distribution of most albatrosses is limited to the windiest oceanic regions on earth; however, exceptions exist. Species breeding in the North and Central Pacific Ocean (Phoebastria spp.) inhabit regions of lower wind speed and wave height than southern hemisphere genera, and have large intrageneric variation in body size and aerodynamic performance. Here, we test the hypothesis that regional wind and wave regimes explain observed differences in Phoebastria albatross morphology and we compare their aerodynamic performance to representatives from the other three genera of this globally distributed avian family. In the North and Central Pacific, two species (short-tailed P. albatrus and waved P. irrorata) are markedly larger, yet have the smallest breeding ranges near highly productive coastal upwelling systems. Short-tailed albatrosses, however, have 60% higher wing loading (weight per area of lift) compared to waved albatrosses. Indeed, calculated aerodynamic performance of waved albatrosses, the only tropical albatross species, is more similar to those of their smaller congeners (black-footed P. nigripes and Laysan P. immutabilis), which have relatively low wing loading and much larger foraging ranges that include central oceanic gyres of relatively low productivity. Globally, the aerodynamic performance of short-tailed and waved albatrosses are most anomalous for their body sizes, yet consistent with wind regimes within their breeding season foraging ranges. Our results are the first to integrate global wind and wave patterns with albatross aerodynamics, thereby identifying morphological specialization that may explain limited breeding ranges of two endangered albatross species. These results are further relevant to understanding past and potentially predicting future distributional limits of albatrosses globally, particularly with respect to climate change effects on basin-scale and regional wind fields.	Oregon State Univ, Hatfield Marine Sci Ctr, Newport, OR 97365 USA; [Anderson, David J.] Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA; [Shaffer, Scott A.; Tremblay, Yann; Costa, Daniel P.] Univ Calif Santa Cruz, Dept Ecol & Evolut Biol, Long Marine Lab, Santa Cruz, CA 95064 USA; [Roby, Daniel D.] Oregon State Univ, Dept Fisheries & Wildlife, USGS, Oregon Cooperat Fish & Wildlife Res Unit, Corvallis, OR 97331 USA; [Sievert, Paul R.] Univ Massachusetts, Dept Nat Resources Conservat, USGS, Massachusetts Cooperat Fish & Wildlife Res Unit, Amherst, MA 01003 USA; [Sato, Fumio; Ozaki, Kiyoaki; Nakamura, Noboru] Yamashina Inst Ornithol, Abiko, Chiba, Japan; [Balogh, Gregory R.] US Fish & Wildlife Serv, Ecol Serv, Anchorage, AK USA	Oregon State University; Wake Forest University; University of California System; University of California Santa Cruz; Oregon State University; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; University of Massachusetts System; University of Massachusetts Amherst; United States Department of the Interior; US Fish & Wildlife Service	Suryan, RM (corresponding author), Oregon State Univ, Hatfield Marine Sci Ctr, Newport, OR 97365 USA.	rob.suryan@oregonstate.edu	Shaffer, Scott A/D-5015-2009; Costa, Daniel/E-2616-2013	Shaffer, Scott A/0000-0002-7751-5059; Suryan, Robert/0000-0003-0755-8317; Tremblay, Yann/0000-0002-4653-9269; Costa, Daniel/0000-0002-0233-5782	U.S. Fish and Wildlife Service; Ministry of Environment, Japan; North Pacific Research Board; U.S. National Science Foundation [DEB 98-06606, DEB 0235818]; National Ocean Partnership Program [N00014-02-1-1012]; Office of Naval Research [N00014-00-1-0880, N00014-03-1-0651]; Alfred P. Sloan Foundation; David and Lucille Packard Foundation; Gordon and Betty Moore Foundation; NOAA [Fisheries Oceanography Fellowship]	U.S. Fish and Wildlife Service(US Fish & Wildlife Service); Ministry of Environment, Japan(Ministry of the Environment, Japan); North Pacific Research Board; U.S. National Science Foundation(National Science Foundation (NSF)); National Ocean Partnership Program; Office of Naval Research(Office of Naval Research); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); David and Lucille Packard Foundation(The David & Lucile Packard Foundation); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA)	Financial support was provided by the U.S. Fish and Wildlife Service, Ministry of Environment, Japan, the North Pacific Research Board, U.S. National Science Foundation (awards DEB 98-06606 and DEB 0235818), and through the Tagging of Pacific Predators (TOPP) program, which is funded by the National Ocean Partnership Program (N00014-02-1-1012), the Office of Naval Research (N00014-00-1-0880 & N00014-03-1-0651) and the Alfred P. Sloan, David and Lucille Packard, and Gordon and Betty Moore foundations. R. Suryan was supported, in part, by the Cooperative Institute for Marine Resource Studies, Oregon State University, through a NOAA Fisheries Oceanography Fellowship. The funders had no role in study design, data collection and analysis, or decision to publish.	Anderson DJ, 2003, BIOL CONSERV, V110, P367, DOI 10.1016/S0006-3207(02)00238-0; ANDERSON DJ, 2008, ENDANGERED SPECIES R, DOI DOI 10.3354/ESR0089; Baker J.D., 2006, ENDANGER SPECIES RES, V2, P21, DOI DOI 10.3354/ESR002021; Burger AE, 2008, AUK, V125, P253, DOI 10.1525/auk.2008.1408; COSTA DP, 1987, IBIS, V129, P149, DOI 10.1111/j.1474-919X.1987.tb03196.x; Croxall JP, 2005, SCIENCE, V307, P249, DOI 10.1126/science.1106042; Fernandez P, 2001, J ZOOL, V254, P391, DOI 10.1017/S0952836901000899; HASEGAWA H, 1982, American Birds, V36, P806; Hyrenbach KD, 2002, MAR ECOL PROG SER, V233, P283, DOI 10.3354/meps233283; JOUVENTIN P, 1990, NATURE, V343, P746, DOI 10.1038/343746a0; Murray MD, 2003, EMU, V103, P59, DOI 10.1071/MU01011; Nunn GB, 1996, AUK, V113, P784; Olson SL, 2003, P NATL ACAD SCI USA, V100, P12825, DOI 10.1073/pnas.1934576100; Pennycuick C.J., 1989, BIRD FLIGHT PERFORMA; PENNYCUICK CJ, 1982, PHILOS T ROY SOC B, V300, P75, DOI 10.1098/rstb.1982.0158; PENNYCUICK CJ, 2002, AVIAN SCI, V1, P1; PENNYCUICK CJ, 1998, BIRD FLIGHT PERFORMA; Phillips RA, 2005, ECOLOGY, V86, P2386, DOI 10.1890/04-1885; Phillips RA, 2004, P ROY SOC B-BIOL SCI, V271, P1283, DOI 10.1098/rspb.2004.2718; Piatt JF, 2006, DEEP-SEA RES PT II, V53, P387, DOI 10.1016/j.dsr2.2006.01.008; Rayleigh L., 1883, NATURE, V27, P534, DOI DOI 10.1038/027388A0; Shaffer SA, 2001, FUNCT ECOL, V15, P203, DOI 10.1046/j.1365-2435.2001.00514.x; Shaffer SA, 2001, J ANIM ECOL, V70, P864, DOI 10.1046/j.0021-8790.2001.00548.x; Spear LB, 1997, IBIS, V139, P234, DOI 10.1111/j.1474-919X.1997.tb04621.x; Suryan RM, 2006, DEEP-SEA RES PT II, V53, P370, DOI 10.1016/j.dsr2.2006.01.012; TICKELL, 2000, ALBATROSSES; Walkden SL, 1925, NATURE, V116, P132, DOI 10.1038/116132b0; Weimerskirch H, 2000, P ROY SOC B-BIOL SCI, V267, P1869, DOI 10.1098/rspb.2000.1223; Weimerskirch H, 2002, SCIENCE, V295, P1259, DOI 10.1126/science.1068034	29	54	55	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4016	10.1371/journal.pone.0004016	http://dx.doi.org/10.1371/journal.pone.0004016			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107200	Green Submitted, Green Published, gold			2022-12-25	WOS:000265463000011
J	Lehmann, MB; Funston, PJ; Owen, CR; Slotow, R				Lehmann, Monika B.; Funston, Paul J.; Owen, Cailey R.; Slotow, Rob			Home Range Utilisation and Territorial Behaviour of Lions (Panthera leo) on Karongwe Game Reserve, South Africa	PLOS ONE			English	Article								Interventionist conservation management of territorial large carnivores has increased in recent years, especially in South Africa. Understanding of spatial ecology is an important component of predator conservation and management. Spatial patterns are influenced by many, often interacting, factors making elucidation of key drivers difficult. We had the opportunity to study a simplified system, a single pride of lions (Panthera leo) after reintroduction onto the 85 km(2) Karongwe Game Reserve, from 1999-2005, using radio-telemetry. In 2002 one male was removed from the paired coalition which had been present for the first three years. A second pride and male were in a fenced reserve adjacent of them to the east. This made it possible to separate social and resource factors in both a coalition and single male scenario, and the driving factors these seem to have on spatial ecology. Male ranging behaviour was not affected by coalition size, being driven more by resource rather than social factors. The females responded to the lions on the adjacent reserve by avoiding the area closest to them, therefore females may be more driven by social factors. Home range size and the resource response to water are important factors to consider when reintroducing lions to a small reserve, and it is hoped that these findings lead to other similar studies which will contribute to sound decisions regarding the management of lions on small reserves.	[Funston, Paul J.] Tshwane Univ Technol, Nat Conservat Dept, Pretoria, South Africa; [Lehmann, Monika B.; Owen, Cailey R.] Ecol Inst Res, Schagen, South Africa; [Owen, Cailey R.; Slotow, Rob] Univ KwaZulu Natal, Sch Biol & Conservat Sci, Durban, South Africa	Tshwane University of Technology; University of Kwazulu Natal	Lehmann, MB (corresponding author), Tshwane Univ Technol, Nat Conservat Dept, Pretoria, South Africa.	FunstonPJ@TUT.ac.za	Slotow, Rob/AAM-9053-2020	Slotow, Rob/0000-0001-9469-1508	Tshwane University of Technology [scholarship]; NRF [FA2004050400038]	Tshwane University of Technology; NRF	The author was funded by a Tshwane University of Technology scholarship as well as an NRF grant-holder linked bursary (grant: FA2004050400038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPS CD, 1999, USDA FOREST SERVICE, P1; BERTRAM B, 1973, E AFR WILDL J, V2, P215; Borger L, 2006, J ANIM ECOL, V75, P1393, DOI 10.1111/j.1365-2656.2006.01164.x; BRADBURY JW, 1976, BEHAV ECOL SOCIOBIOL, V1, P337, DOI 10.1007/BF00299399; Burt W. H., 1943, Journal of Mammalogy, V24, P346, DOI 10.2307/1374834; Druce D., 2004, Koedoe, V47, P103; Funston P.J, 1999, THESIS U PRETORIA PR; Funston PJ, 1998, ANIM BEHAV, V56, P1333, DOI 10.1006/anbe.1998.0884; Funston PJ, 2001, J ZOOL, V253, P419, DOI 10.1017/S0952836901000395; FUNSTON PJ, 1997, 597 SCI SERV; Garai Marion E., 2004, Pachyderm, V37, P28; GITTLEMAN JL, 1982, BEHAV ECOL SOCIOBIOL, V10, P57, DOI 10.1007/BF00296396; GRINNEL J, 1996, BEHAV ECOL, V1, P55; Grinnell J, 2001, ANIM BEHAV, V62, P93, DOI 10.1006/anbe.2001.1735; Gusset M, 2008, J APPL ECOL, V45, P100, DOI 10.1111/j.1365-2664.2007.01357.x; HANBY JP, 1987, ANIM BEHAV, V35, P161, DOI 10.1016/S0003-3472(87)80221-X; Hayward Matt W., 2007, Open Conservation Biology Journal, V1, P1, DOI 10.2174/1874839200701010001; HOOGE PN, 1999, ANIMAL MOVEMENT ANAL; Hopcraft JGC, 2005, J ANIM ECOL, V74, P559, DOI 10.1111/j.1365-2656.2005.00955.x; HUNTER L, 1999, SOCIOECOLOGY REINTRO; Hunter LTB, 2007, ORYX, V41, P196, DOI 10.1017/S003060530700172X; Lehmann MB, 2008, S AFR J WILDL RES, V38, P66, DOI 10.3957/0379-4369-38.1.66; Low A. B., 1998, VEGETATION S AFRICA; MACDONALD DW, 1983, NATURE, V301, P379, DOI 10.1038/301379a0; Mills M. G. L., 1996, P223; Mizutani F, 1998, J ZOOL, V244, P269, DOI 10.1111/j.1469-7998.1998.tb00031.x; PACKER C, 1983, AM NAT, V121, P716, DOI 10.1086/284097; PACKER C, 1990, AM NAT, V136, P1, DOI 10.1086/285079; Packer C, 2000, AM ANTHROPOL, V102, P829, DOI 10.1525/aa.2000.102.4.829; PACKER C, 1991, NATURE, V351, P562, DOI 10.1038/351562a0; PACKER C, 1997, DIVIDED WE FALL COOP, P32; PUSEY AE, 1987, BEHAVIOUR, V101, P275, DOI 10.1163/156853987X00026; RUTHERFORD MC, 2003, BIOMES SO AFRICA OBJ; Schaller G. B., 1972, SERENGETI LION STUDY; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Slotow R., 2008, REINTRODUCTION TOP O; Spong G, 2002, BEHAV ECOL SOCIOBIOL, V52, P303, DOI 10.1007/s00265-002-0515-x; STANDER P E, 1991, Madoqua, V18, P1; Starfield A.M., 1981, P121; VANORSDOL KG, 1985, J ZOOL, V206, P97; WHYTE J, 1985, THESIS U NATAL	41	21	21	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2008	3	12							e3998	10.1371/journal.pone.0003998	http://dx.doi.org/10.1371/journal.pone.0003998			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CA	19098987	Green Published, gold, Green Submitted			2022-12-25	WOS:000265462300009
J	Rao, KN; Burley, SK; Swaminathan, S				Rao, Krishnamurthy N.; Burley, Stephen K.; Swaminathan, Subramanyam			UPF201 Archaeal Specific Family Members Reveal Structural Similarity to RNA-Binding Proteins but Low Likelihood for RNA-Binding Function	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; LARGE RIBOSOMAL-SUBUNIT; CRYSTAL-STRUCTURE; THERMOTOGA-MARITIMA; RECOGNITION; DOMAIN; THERMOSTABILITY; EVOLUTION; SERVER; RESOLUTION	We have determined X-ray crystal structures of four members of an archaeal specific family of proteins of unknown function (UPF0201; Pfam classification: DUF54) to advance our understanding of the genetic repertoire of archaea. Despite low pairwise amino acid sequence identities (10-40%) and the absence of conserved sequence motifs, the three-dimensional structures of these proteins are remarkably similar to one another. Their common polypeptide chain fold, encompassing a five-stranded antiparallel beta-sheet and five alpha-helices, proved to be quite unexpectedly similar to that of the RRM-type RNA-binding domain of the ribosomal L5 protein, which is responsible for binding the 5S- rRNA. Structure-based sequence alignments enabled construction of a phylogenetic tree relating UPF0201 family members to L5 ribosomal proteins and other structurally similar RNA binding proteins, thereby expanding our understanding of the evolutionary purview of the RRM superfamily. Analyses of the surfaces of these newly determined UPF0201 structures suggest that they probably do not function as RNA binding proteins, and that this domain specific family of proteins has acquired a novel function in archaebacteria, which awaits experimental elucidation.	[Swaminathan, Subramanyam] Brookhaven Natl Lab, Dept Biol, New York, NY USA; [Burley, Stephen K.] Eli Lilly & Co, San Diego, CA USA	United States Department of Energy (DOE); Brookhaven National Laboratory; Eli Lilly	Rao, KN (corresponding author), Brookhaven Natl Lab, Dept Biol, New York, NY USA.	swami@bnl.gov		Burley, Stephen K./0000-0002-2487-9713	National Institute of General Medical Sciences [GM074945]; DOE [DEAC02- 98CH10886]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074945] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research was supported by a U54 award from the National Institute of General Medical Sciences to the NYSGXRC (GM074945; PI: Stephen K. Burley) under DOE Prime Contract No. DEAC02- 98CH10886 with Brookhaven National Laboratory. Financial support for X12C beamline comes principally from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the US Department of Energy, and from the National Center for Research Resources of the National Institutes of Health.	Allain FHT, 2000, EMBO J, V19, P6870, DOI 10.1093/emboj/19.24.6870; Allers T, 2005, NAT REV GENET, V6, P58, DOI 10.1038/nrg1504; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Atomi H, 2005, CURR OPIN CHEM BIOL, V9, P166, DOI 10.1016/j.cbpa.2005.02.013; BAJAJ M, 1984, ANNU REV BIOPHYS BIO, V13, P453; Balaji S, 2007, J BIOSCIENCES, V32, P83, DOI 10.1007/s12038-007-0008-1; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Beeby M, 2005, PLOS BIOL, V3, P1549, DOI 10.1371/journal.pbio.0030309; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bult CJ, 1996, SCIENCE, V273, P1058, DOI 10.1126/science.273.5278.1058; Canaves JM, 2004, J MOL BIOL, V344, P977, DOI 10.1016/j.jmb.2004.09.076; Chaban B, 2006, CAN J MICROBIOL, V52, P73, DOI [10.1139/WDS-147, 10.1139/w05-147]; Chakravarty S, 2002, BIOCHEMISTRY-US, V41, P8152, DOI 10.1021/bi025523t; Charlebois RL, 2000, GENOME, V43, P116, DOI 10.1139/gen-43-1-116; Chivers PT, 2005, J MOL BIOL, V348, P597, DOI 10.1016/j.jmb.2005.03.017; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Deo RC, 1999, CELL, V98, P835, DOI 10.1016/S0092-8674(00)81517-2; Dian C, 2006, J MOL BIOL, V361, P715, DOI 10.1016/j.jmb.2006.06.058; Egorova K, 2005, CURR OPIN MICROBIOL, V8, P649, DOI 10.1016/j.mib.2005.10.015; Eijsink VGH, 2004, J BIOTECHNOL, V113, P105, DOI 10.1016/j.jbiotec.2004.03.026; Elcock AH, 1998, J MOL BIOL, V284, P489, DOI 10.1006/jmbi.1998.2159; Galperin MY, 2007, ENVIRON MICROBIOL, V9, P279, DOI 10.1111/j.1462-2920.2006.01223.x; Garcia JL, 2000, ANAEROBE, V6, P205, DOI 10.1006/anae.2000.0345; GODZIK A, 1995, PROTEIN SCI, V4, P2107, DOI 10.1002/pro.5560041016; Goyal K, 2007, NUCLEIC ACIDS RES, V35, pW503, DOI 10.1093/nar/gkm252; Gribaldo S, 2006, PHILOS T R SOC B, V361, P1007, DOI 10.1098/rstb.2006.1841; Halic M, 2006, NATURE, V444, P507, DOI 10.1038/nature05326; Handa N, 1999, NATURE, V398, P579, DOI 10.1038/19242; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Holm L, 1997, NUCLEIC ACIDS RES, V25, P231, DOI 10.1093/nar/25.1.231; Huber H, 2003, RES MICROBIOL, V154, P165, DOI 10.1016/S0923-2508(03)00035-4; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kielkopf CL, 2004, GENE DEV, V18, P1513, DOI 10.1101/gad.1206204; Kim OTP, 2006, NUCLEIC ACIDS RES, V34, P6450, DOI 10.1093/nar/gkl819; Klenk HP, 1997, NATURE, V390, P364, DOI 10.1038/37052; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Meinel T, 2005, NUCLEIC ACIDS RES, V33, pD226; NAGAI K, 1990, NATURE, V348, P515, DOI 10.1038/348515a0; Nakashima T, 2001, RNA, V7, P692, DOI 10.1017/S1355838201002345; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; Olsen GJ, 1997, CELL, V89, P991, DOI 10.1016/S0092-8674(00)80284-6; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OUBRIDGE C, 1994, NATURE, V372, P432, DOI 10.1038/372432a0; Perederina A, 2002, RNA, V8, P1548, DOI 10.1017/S1355838202029953; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Petsko GA, 2001, METHOD ENZYMOL, V334, P469; Podar M, 2006, CURR OPIN BIOTECH, V17, P250, DOI 10.1016/j.copbio.2006.05.002; Price SR, 1998, NATURE, V394, P645, DOI 10.1038/29234; RAO KN, 2007, PROTEINS; Robinson-Rechavi M, 2006, J MOL BIOL, V356, P547, DOI 10.1016/j.jmb.2005.11.065; Robinson-Rechavi M, 2005, STRUCTURE, V13, P857, DOI 10.1016/j.str.2005.03.011; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schutze Norbert, 2005, Cell Commun Signal, V3, P5, DOI 10.1186/1478-811X-3-5; She Q, 2001, P NATL ACAD SCI USA, V98, P7835, DOI 10.1073/pnas.141222098; SPASSOV VZ, 1995, PROTEIN SCI, V4, P1516, DOI 10.1002/pro.5560040809; Sterner R, 2001, CRIT REV BIOCHEM MOL, V36, P39, DOI 10.1080/20014091074174; Stetter KO, 2006, EXTREMOPHILES, V10, P357, DOI 10.1007/s00792-006-0012-7; Suhre K, 2003, J BIOL CHEM, V278, P17198, DOI 10.1074/jbc.M301327200; Szilagyi A, 2000, STRUCTURE, V8, P493, DOI 10.1016/S0969-2126(00)00133-7; Terribilini M, 2007, NUCLEIC ACIDS RES, V35, pW578, DOI 10.1093/nar/gkm294; Thauer RK, 1998, MICROBIOL-UK, V144, P2377, DOI 10.1099/00221287-144-9-2377; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Valentine DL, 2007, NAT REV MICROBIOL, V5, P316, DOI 10.1038/nrmicro1619; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Wang LJ, 2006, NUCLEIC ACIDS RES, V34, pW243, DOI 10.1093/nar/gkl298; Wang SY, 2006, RNA, V12, P959, DOI 10.1261/rna.5906; Wang XQ, 2001, NAT STRUCT BIOL, V8, P141, DOI 10.1038/84131; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; WOESE CR, 1978, J MOL EVOL, V11, P245, DOI 10.1007/BF01734485; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088	75	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2008	3	12							e3903	10.1371/journal.pone.0003903	http://dx.doi.org/10.1371/journal.pone.0003903			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZU	19079550	Green Published, gold			2022-12-25	WOS:000265455900001
J	Resa-Infante, P; Jorba, N; Zamarreno, N; Fernandez, Y; Juarez, S; Ortin, J				Resa-Infante, Patricia; Jorba, Nuria; Zamarreno, Noelia; Fernandez, Yolanda; Juarez, Silvia; Ortin, Juan			The Host-Dependent Interaction of alpha-Importins with Influenza PB2 Polymerase Subunit Is Required for Virus RNA Replication	PLOS ONE			English	Article								The influenza virus polymerase is formed by the PB1, PB2 and PA subunits and is required for virus transcription and replication in the nucleus of infected cells. As PB2 is a relevant host-range determinant we expressed a TAP-tagged PB2 in human cells and isolated intracellular complexes. Alpha-importin was identified as a PB2-associated factor by proteomic analyses. To study the relevance of this interaction for virus replication we mutated the PB2 NLS and analysed the phenotype of mutant subunits, polymerase complexes and RNPs. While mutant PB2 proteins showed reduced nuclear accumulation, they formed polymerase complexes normally when co expressed with PB1 and PA. However, mutant RNPs generated with a viral CAT replicon showed up to hundred-fold reduced CAT accumulation. Rescue of nuclear localisation of mutant PB2 by insertion of an additional SV40 TAg-derived NLS did not revert the mutant phenotype of RNPs. Furthermore, determination of recombinant RNP accumulation in vivo indicated that PB2 NLS mutations drastically reduced virus RNA replication. These results indicate that, above and beyond its role in nuclear accumulation, PB2 interaction with alpha-importins is required for virus RNA replication. To ascertain whether PB2-alpha-importin binding could contribute to the adaptation of H5N1 avian viruses to man, their association in vivo was determined. Human alpha importin isoforms associated efficiently to PB2 protein of an H3N2 human virus but bound to diminished and variable extents to PB2 from H5N1 avian or human strains, suggesting that the function of alpha importin during RNA replication is important for the adaptation of avian viruses to the human host.	[Resa-Infante, Patricia; Jorba, Nuria; Zamarreno, Noelia; Fernandez, Yolanda; Juarez, Silvia; Ortin, Juan] CSIC, Ctr Nacl Biotecnol, Madrid, Spain; [Resa-Infante, Patricia; Jorba, Nuria; Zamarreno, Noelia; Fernandez, Yolanda; Juarez, Silvia; Ortin, Juan] CIBER Enfermedades Resp, Palma de Mallorca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Resa-Infante, P (corresponding author), CSIC, Ctr Nacl Biotecnol, Darwin 3 Campus Cantoblanco, Madrid, Spain.	jortin@cnb.csic.es	Resa-Infante, Patricia/D-3843-2018; Ortin, Juan/L-3622-2013	Resa-Infante, Patricia/0000-0002-1727-592X; Zamarreno, Noelia/0000-0002-7968-9458; Moron, Yolanda Fernandez/0000-0002-2256-163X; Ortin, Juan/0000-0002-6200-4678	Ministerio de Educacion y Ciencia [fellows, BFU2004-491, BFU2007-60046]; Consejo Superior de Investigaciones Cientificas [fellows]; European Union; VIRGIL [FP6-503359]; FLUPOL [SP5B-CT-2007-044263]; Comunidad de Madrid (VIRHOST) [S-SAL-0815-2006]	Ministerio de Educacion y Ciencia(Spanish Government); Consejo Superior de Investigaciones Cientificas; European Union(European Commission); VIRGIL; FLUPOL; Comunidad de Madrid (VIRHOST)(Comunidad de Madrid)	N.J. and P.R-I were fellows from Ministerio de Educacion y Ciencia and Consejo Superior de Investigaciones Cientificas, respectively. This work was funded by Ministerio de Educacion y Ciencia (BFU2004-491 and BFU2007-60046), European Union. (VIRGIL)( FP6-503359) and (FLUPOL) (SP5B-CT-2007-044263) and Comunidad de Madrid (VIRHOST) (S-SAL-0815-2006).	ALMOND JW, 1977, NATURE, V270, P617, DOI 10.1038/270617a0; Area E, 2004, P NATL ACAD SCI USA, V101, P308, DOI 10.1073/pnas.0307127101; BARCENA J, 1994, J VIROL, V68, P6900; Deng T, 2005, J VIROL, V79, P8669, DOI 10.1128/JVI.79.13.8669-8674.2005; Deng T, 2006, J VIROL, V80, P11911, DOI 10.1128/JVI.01565-06; Elton D, 2005, CURRENT TOPICS INFLU, P1; Falcon AM, 2004, J VIROL, V78, P3880, DOI 10.1128/JVI.78.8.3880-3888.2004; Finkelstein DB, 2007, J VIROL, V81, P10292, DOI 10.1128/JVI.00921-07; Fodor E, 2004, J VIROL, V78, P9144, DOI 10.1128/JVI.78.17.9144-9153.2004; FUERST TR, 1987, MOL CELL BIOL, V7, P2538, DOI 10.1128/MCB.7.7.2538; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Gastaminza P, 2003, J VIROL, V77, P5098, DOI 10.1128/JVI.77.9.5098-5108.2003; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Jorba N, 2008, PROTEOMICS, V8, P2077, DOI 10.1002/pmic.200700508; Jorba N, 2008, J GEN VIROL, V89, P520, DOI 10.1099/vir.0.83387-0; Labadie K, 2007, VIROLOGY, V362, P271, DOI 10.1016/j.virol.2006.12.027; Lee MTM, 2002, NUCLEIC ACIDS RES, V30, P429, DOI 10.1093/nar/30.2.429; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Marion RM, 1997, J GEN VIROL, V78, P2447, DOI 10.1099/0022-1317-78-10-2447; Martin-Benito J, 2001, EMBO REP, V2, P313, DOI 10.1093/embo-reports/kve063; MENA I, 1994, J GEN VIROL, V75, P2109, DOI 10.1099/0022-1317-75-8-2109; Momose F, 2002, J BIOL CHEM, V277, P45306, DOI 10.1074/jbc.M206822200; MUKAIGAWA J, 1991, J VIROL, V65, P245, DOI 10.1128/JVI.65.1.245-253.1991; Naffakh N, 2008, ANNU REV MICROBIOL, V62, P403, DOI 10.1146/annurev.micro.62.081307.162746; Naito T, 2007, J VIROL, V81, P1339, DOI 10.1128/JVI.01917-06; NATH ST, 1990, MOL CELL BIOL, V10, P4139, DOI 10.1128/MCB.10.8.4139; Neumann G, 2004, CURR TOP MICROBIOL, V283, P121; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; NIETO A, 1994, J GEN VIROL, V75, P29, DOI 10.1099/0022-1317-75-1-29; OCHOA M, 1995, VIRUS RES, V37, P305, DOI 10.1016/0168-1702(95)00039-S; Ortega J, 2000, J VIROL, V74, P156, DOI 10.1128/JVI.74.1.156-163.2000; ORTIN J, 1980, GENE, V11, P319, DOI 10.1016/0378-1119(80)90072-4; Palese P, 2006, FIELDS VIROLOGY, P1647; Perales B, 1997, J VIROL, V71, P1381, DOI 10.1128/JVI.71.2.1381-1385.1997; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Torreira E, 2007, NUCLEIC ACIDS RES, V35, P3774, DOI 10.1093/nar/gkm336; Villace P, 2004, NUCLEIC ACIDS RES, V32, P2411, DOI 10.1093/nar/gkh552; WIGLER M, 1979, P NATL ACAD SCI USA, V76, P1373, DOI 10.1073/pnas.76.3.1373; Zhang J, 2004, J MASS SPECTROM, V39, P808, DOI 10.1002/jms.657	42	85	89	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2008	3	12							e3904	10.1371/journal.pone.0003904	http://dx.doi.org/10.1371/journal.pone.0003904			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZS	19066626	Green Published, gold, Green Submitted			2022-12-25	WOS:000265455700008
J	Telgmann, R; Dordelmann, C; Brand, E; Nicaud, V; Hagedorn, C; Pavenstadt, H; Cambien, F; Tiret, L; Paul, M; Brand-Herrmann, SM				Telgmann, Ralph; Doerdelmann, Corinna; Brand, Eva; Nicaud, Viviane; Hagedorn, Claudia; Pavenstaedt, Hermann; Cambien, Francois; Tiret, Laurence; Paul, Martin; Brand-Herrmann, Stefan-Martin			Molecular genetic analysis of a human insulin-like growth factor 1 promoter P1 variation	FASEB JOURNAL			English	Article						gene expression; hypertension; bandshift assay; reporter gene; transcription factor; functional analysis	SMOOTH-MUSCLE-CELLS; POSTNATAL BODY GROWTH; FACTOR-I; BINDING-PROTEIN; IGF-I; MYOCARDIAL-INFARCTION; BLOOD-PRESSURE; MESSENGER-RNA; RECEPTOR GENE; EXPRESSION	Insulin-like growth factor 1 (IGF1) exerts important endocrine and paracrine functions in the cardiovascular system. We identified the common variant -1411C>T in the IGF1 upstream promoter P1, located within several overlapping transcription factor binding sites. Using transient transfection assays, we identified this site as a functional enhancer. The T allele-carrying enhancer, compared with the C allelic portion, exerts significantly reduced or even abrogated activity, respectively, in SaOs-2 and HepG2 (all P<0.0001) as well as in differentiated THP-1 macrophages. Electrophoretic mobility shift assay and subsequent supershift experiments in HepG2 identified c-Jun as the binding partner exclusively to the T allele, whereas CCAAT/enhancer-binding protein delta and interferon consensus site-binding protein/interferon-regulating factor 8 interacted only with the C allelic promoter portion. Furthermore, genotyping in a case-control study for essential hypertension (n=745 hypertensive patients; n=769 normotensive control subjects) for this variant revealed an odds ratio for hypertension of 0.73 (95% confidence interval 0.58-0.91, P=0.006) associated with the T allele, and normotensive subjects carrying the protective T allele displayed a significant decrease in diastolic (P=0.036) and systolic (P=0.024) blood pressure levels. We here report detection of a functional enhancer module in the upstream IGF1 promoter region, which might play a key role in local IGF1 bioavailability. Whether -1411C>T is also associated with other IGF1-related disease phenotypes should be evaluated further in population studies.-Telgmann, R., Dordelmann, C., Brand, E., Nicaud, V., Hagedorn, C., Pavenstadt, H., Cambien, F., Tiret, L., Paul, M., Brand-Herrmann, S.-M. Molecular genetic analysis of a human insulin growth factor 1 promoter P1 variation. FASEB J. 23, 1303-1313 (2009)	[Telgmann, Ralph; Doerdelmann, Corinna; Hagedorn, Claudia; Brand-Herrmann, Stefan-Martin] Univ Munster, Leibniz Inst Arteriosclerosis Res, Dept Mol Genet Cardiovasc Dis, D-48149 Munster, Germany; [Brand, Eva; Pavenstaedt, Hermann] Univ Hosp Munster, Munster, Germany; [Nicaud, Viviane; Cambien, Francois; Tiret, Laurence] INSERM, UMR S 525, Paris, France; [Paul, Martin] Maastricht Univ, Fac Hlth Med & Life Sci, Maastricht, Netherlands	University of Munster; University of Munster; Institut National de la Sante et de la Recherche Medicale (Inserm); Maastricht University	Brand-Herrmann, SM (corresponding author), Univ Munster, Leibniz Inst Arteriosclerosis Res, Dept Mol Genet Cardiovasc Dis, Domagkstr 3, D-48149 Munster, Germany.	brandher@uni-muenster.de	Paul, Martin/K-5425-2015; Cambien, Francois/AAP-9751-2020	Hagedorn, Claudia/0000-0001-7010-4807	German Ministry for Education and Science (BMBF); BMBF [0313040C]; Deutsche Forschungsgemeinschaft [Br1589/8-1]; European Union [FP6-2005-LIFESCIHEALTH-6]; Integrating Genomics; Clinical Research and Care in Hypertension; InGenious HyperCare proposal [037093]; ICT [FP7-ICT-2007-2, 224635]; VPH2-Virtual Pathological Heart of the Virtual Physiological Human	German Ministry for Education and Science (BMBF)(Federal Ministry of Education & Research (BMBF)); BMBF(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission); Integrating Genomics; Clinical Research and Care in Hypertension; InGenious HyperCare proposal(European Commission); ICT; VPH2-Virtual Pathological Heart of the Virtual Physiological Human	This work was supported by grants from the German Ministry for Education and Science (BMBF) to M. P. in the context of the National Genome Research Network (NGFN) for Cardiovascular Disease and to E. B., S. M. B. H., and R. T. in the context of the BioProfile-Project BMBF 0313040C. S. M. B. H. and M. P. are participants in Deutsche Forschungsgemeinschaft grant "Graduierten-Kolleg 754, Myokardiale Genexpression und Funktion, Myokardhypertrophie." E. B. was supported by a Heisenberg professorship from the Deutsche Forschungsgemeinschaft (Br1589/8-1). This study was also supported by grants from the European Union Project Network of Excellence, FP6-2005-LIFESCIHEALTH-6, Integrating Genomics, Clinical Research and Care in Hypertension, InGenious HyperCare proposal 037093 to E. B. and S. M. B. H. (supported R. T.), an ICT in the FP7-ICT-2007-2, project 224635, and VPH2-Virtual Pathological Heart of the Virtual Physiological Human to S. M. B.	BENNETT MR, 1995, J CLIN INVEST, V95, P2266, DOI 10.1172/JCI117917; BORNFELDT KE, 1994, J CLIN INVEST, V93, P1266, DOI 10.1172/JCI117081; BOULUKOS KE, 1990, GENE DEV, V4, P401, DOI 10.1101/gad.4.3.401; BRISSENDEN JE, 1984, NATURE, V310, P781, DOI 10.1038/310781a0; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Conti E, 2004, CIRCULATION, V110, P2260, DOI 10.1161/01.CIR.0000144309.87183.FB; Dehoux M, 2007, AM J PHYSIOL-ENDOC M, V292, pE145, DOI 10.1152/ajpendo.00085.2006; Dordelmann C, 2008, J BIOL CHEM, V283, P24382, DOI 10.1074/jbc.M802198200; DU J, 1995, CIRC RES, V76, P963, DOI 10.1161/01.RES.76.6.963; Egecioglu E, 2007, AM J PHYSIOL-ENDOC M, V292, pE1418, DOI 10.1152/ajpendo.00335.2006; Gillespie CM, 1997, J ENDOCRINOL, V155, P351, DOI 10.1677/joe.0.1550351; Grabe Niels, 2002, In Silico Biology, V2, pS1; Herrmann SM, 1998, HUM MOL GENET, V7, P1277, DOI 10.1093/hmg/7.8.1277; HIGASHINO F, 1993, NUCLEIC ACIDS RES, V21, P547, DOI 10.1093/nar/21.3.547; Izhar U, 2000, CORONARY ARTERY DIS, V11, P69, DOI 10.1097/00019501-200002000-00012; JANSEN M, 1983, NATURE, V306, P609, DOI 10.1038/306609a0; Katoh M, 2002, INT J MOL MED, V10, P221; KLAMPFER L, 1994, MOL CELL BIOL, V14, P6561, DOI 10.1128/MCB.14.10.6561; Klover P, 2007, ENDOCRINOLOGY, V148, P1489, DOI 10.1210/en.2006-1431; Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53; Mittanck DW, 1997, MOL CELL ENDOCRINOL, V126, P153, DOI 10.1016/S0303-7207(96)03979-2; Muller C, 2000, J Renin Angiotensin Aldosterone Syst, V1, P273, DOI 10.3317/jraas.2000.042; Nagy Z, 1999, J AM SOC NEPHROL, V10, P1709; Okura Y, 2001, J MOL CELL CARDIOL, V33, P1777, DOI 10.1006/jmcc.2001.1441; Patel VA, 2001, CIRC RES, V88, P895, DOI 10.1161/hh0901.090305; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SHARF R, 1995, J BIOL CHEM, V270, P13063, DOI 10.1074/jbc.270.22.13063; Sjogren K, 1999, P NATL ACAD SCI USA, V96, P7088, DOI 10.1073/pnas.96.12.7088; Telgmann R, 2003, BIOL REPROD, V68, P1015, DOI 10.1095/biolreprod.102.008961; Tiret L, 1998, J HYPERTENS, V16, P37, DOI 10.1097/00004872-199816010-00007; TOBIN G, 1990, MOL ENDOCRINOL, V4, P1914, DOI 10.1210/mend-4-12-1914; TRICOLI JV, 1984, NATURE, V310, P784, DOI 10.1038/310784a0; TSUKAHARA H, 1994, KIDNEY INT, V45, P598, DOI 10.1038/ki.1994.78; Umayahara Y, 2002, J BIOL CHEM, V277, P15261, DOI 10.1074/jbc.M110827200; WU HY, 1994, DIABETES, V43, P1027, DOI 10.2337/diabetes.43.8.1027; Wynes MW, 2005, AM J PHYSIOL-LUNG C, V288, pL1089, DOI 10.1152/ajplung.00352.2004	36	17	17	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2009	23	5					1303	1313		10.1096/fj.08-116863	http://dx.doi.org/10.1096/fj.08-116863			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZP	19103645				2022-12-25	WOS:000266651700007
J	French, CJ; Spees, JL; Zaman, AKMT; Taatjes, DJ; Sobel, BE				French, Christopher J.; Spees, Jeffrey L.; Zaman, A. K. M. Tarikuz; Taatjes, Douglas J.; Sobel, Burton E.			The magnitude and temporal dependence of apoptosis early after myocardial ischemia with or without reperfusion	FASEB JOURNAL			English	Article						multiple assays; infarction; TUNEL; caspase 3; ssDNA	INTERNUCLEOSOMAL DNA CLEAVAGE; DEXAMETHASONE-TREATED RATS; CELL-DEATH; HEART-FAILURE; CARDIOMYOCYTE APOPTOSIS; INFARCT SIZE; TUNEL; END; MYOCYTES; DISEASE	In view of the conventional wisdom in the cardiology literature that apoptosis is extensive early after myocardial ischemia, predicated largely from results with the TUNEL assay known to be nonspecific, this study was performed to delineate its extent with multiple assays and at multiple intervals. Coronary occlusion with and without subsequent revascularization was induced in 10-wk-old C57BL6 mice subjected to 1 or 4 h of transient ligation followed by 24 h of reperfusion, or 24 h persistent ligation. Apoptosis was quantified throughout the left ventricle immunohistochemically by assay of TUNEL, single-stranded DNA (ssDNA), and cleaved caspase 3; electron microscopy (EM); and activity assays of caspase 3 and 8. TUNEL staining was marked, but ssDNA and cleaved caspase 3 staining were significantly less (P<0.001 compared with TUNEL), and apoptosis defined by EM was virtually absent in all groups. Caspase 3 and caspase 8 activities per milligram protein were not significantly different from those in normal hearts. Only rare, potentially apoptotic cells were seen by EM in hearts from any group. Thus, the results with TUNEL were not specific, and the extent of apoptosis was markedly less than that predicated on the results with the TUNEL procedure. Apoptosis is de minimus early after transitory or persistent ischemia, though it is overestimated by TUNEL assays. Thus, antiapoptotic interventions per se are not likely to preserve substantial amounts of myocardium early after ischemic insults.-French, C. J., Spees, J. L., Tarikuz Zaman, A. K. M., Taatjes, D. J., Sobel, B. E. The magnitude and temporal dependence of apoptosis early after myocardial ischemia with or without reperfusion. FASEB J. 23, 1177-1185 (2009)	[Sobel, Burton E.] Univ Vermont, Cardiovasc Res Inst, Colchester Res Facil, Dept Med, Colchester, VT 05446 USA; [Taatjes, Douglas J.] Univ Vermont, Cardiovasc Res Inst, Dept Pathol, Colchester, VT 05446 USA	University of Vermont; University of Vermont	Sobel, BE (corresponding author), Univ Vermont, Cardiovasc Res Inst, Colchester Res Facil, Dept Med, 208 S Pk Dr, Colchester, VT 05446 USA.	burton.sobel@uvm.edu			U.S. National Institutes of Health [RO1 HL085210]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085210] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by U.S. National Institutes of Health grant NIH RO1 HL085210 (J. L. S.). We appreciate the expert technical assistance of Ms. Patricia Baumann, Ms. Keara McElroy-Yaggy, Ms. Dagnija Neimane, and Ms. Marilyn Wadsworth and preparation of the manuscript by Ms. Lori Dales. We appreciate also helpful discussions during the course of our study with Drs. Ralph Budd and David Schneider.	Abbate A, 2007, INT J CARDIOL, V114, P118, DOI 10.1016/j.ijcard.2005.11.025; Abbate A, 2007, INT J CARDIOL, V121, P109, DOI 10.1016/j.ijcard.2006.08.077; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRYANT RE, 1958, CIRC RES, V6, P699, DOI 10.1161/01.RES.6.6.699; Buja LM, 1998, CIRCULATION, V98, P1355, DOI 10.1161/01.CIR.98.14.1355; CAULFIELD J, 1959, AM J PATHOL, V35, P489; CharriautMarlangue C, 1995, NEUROREPORT, V7, P61, DOI 10.1097/00001756-199512290-00014; COLLINS RJ, 1992, INT J RADIAT BIOL, V61, P451, DOI 10.1080/09553009214551201; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; Dong Z, 1997, AM J PATHOL, V151, P1205; Doukas J, 2006, P NATL ACAD SCI USA, V103, P19866, DOI 10.1073/pnas.0606956103; Frankfurt OS, 1996, EXP CELL RES, V226, P387, DOI 10.1006/excr.1996.0240; Freude B, 2000, J MOL CELL CARDIOL, V32, P197, DOI 10.1006/jmcc.1999.1066; Galluzzi L, 2007, CELL DEATH DIFFER, V14, P1237, DOI 10.1038/sj.cdd.4402148; Hayakawa K, 2002, CIRCULATION, V105, P3039, DOI 10.1161/01.CIR.0000018651.89208.69; Hikoso S, 2007, J AM COLL CARDIOL, V50, P453, DOI 10.1016/j.jacc.2007.03.053; Ito Y, 2006, J HISTOCHEM CYTOCHEM, V54, P683, DOI 10.1369/jhc.5A6799.2006; Kajstura J, 1996, LAB INVEST, V74, P86; Kang PM, 2000, J CARD FAIL, V6, P43, DOI 10.1016/S1071-9164(00)80005-6; Kanoh M, 1999, CIRCULATION, V99, P2757, DOI 10.1161/01.CIR.99.21.2757; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Kockx MM, 1996, AM J PATHOL, V148, P1771; Kockx MM, 1998, AM J PATHOL, V152, P885; Kumar D, 2003, J LAB CLIN MED, V142, P288, DOI 10.1016/S0022-2143(03)00148-3; Lipsic E, 2006, CARDIOVASC DRUG THER, V20, P135, DOI 10.1007/s10557-006-7680-5; Moon C, 2003, P NATL ACAD SCI USA, V100, P11612, DOI 10.1073/pnas.1930406100; Narula J, 1996, NEW ENGL J MED, V335, P1182, DOI 10.1056/NEJM199610173351603; Ohno M, 1998, CIRCULATION, V98, P1422, DOI 10.1161/01.CIR.98.14.1422; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; Rao KNS, 2008, FUTUR CARDIOL, V4, P57, DOI 10.2217/14796678.4.1.57; Sakahira H, 1999, CURR BIOL, V9, P543, DOI 10.1016/S0960-9822(99)80240-1; Saraste A, 1997, CIRCULATION, V95, P320; Sloop GD, 1999, ARCH PATHOL LAB MED, V123, P529; Sobel BE, 2005, PHARMACOINVASIVE THE, P3; Sobel BE, 2006, BIOCHEM BIOPH RES CO, V346, P102, DOI 10.1016/j.bbrc.2006.05.078; SUN XM, 1992, BIOCHEM PHARMACOL, V44, P2131; Taatjes DJ, 2008, HISTOCHEM CELL BIOL, V129, P33, DOI 10.1007/s00418-007-0356-9; Taatjes DJ, 2007, HISTOCHEM CELL BIOL, V128, P275, DOI 10.1007/s00418-007-0323-5; Takernura G, 2006, J CELL MOL MED, V10, P56, DOI 10.1111/j.1582-4934.2006.tb00291.x; Veinot JP, 1997, HUM PATHOL, V28, P485, DOI 10.1016/S0046-8177(97)90039-3; Walker JA, 2001, J PATHOL, V195, P275; Watanabe M, 2002, MICROSC MICROANAL, V8, P375, DOI 10.1017/S1431927602010346; Xiang GS, 2005, J AM COLL CARDIOL, V46, P536, DOI 10.1016/j.jacc.2005.04.047; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Zaman AKMT, 2007, HISTOCHEM CELL BIOL, V128, P135, DOI 10.1007/s00418-007-0300-z; Zavitsanou K, 2007, J MOL HISTOL, V38, P313, DOI 10.1007/s10735-007-9104-7; Zhao ZQ, 2000, CARDIOVASC RES, V45, P651, DOI 10.1016/S0008-6363(99)00354-5; Zhao ZQ, 2000, J SURG RES, V94, P133, DOI 10.1006/jsre.2000.6029	48	16	16	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2009	23	4					1177	1185		10.1096/fj.08-116509	http://dx.doi.org/10.1096/fj.08-116509			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZO	19095733	Green Published			2022-12-25	WOS:000266651600022
J	Baron, RA; Tavare, R; Figueiredo, AC; Blazewska, KM; Kashemirov, BA; McKenna, CE; Ebetino, FH; Taylor, A; Rogers, MJ; Coxon, FP; Seabra, MC				Baron, Rudi A.; Tavare, Richard; Figueiredo, Ana C.; Blazewska, Katarzyna M.; Kashemirov, Boris A.; McKenna, Charles E.; Ebetino, Frank H.; Taylor, Adam; Rogers, Michael J.; Coxon, Fraser P.; Seabra, Miguel C.			Phosphonocarboxylates Inhibit the Second Geranylgeranyl Addition by Rab Geranylgeranyl Transferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN FARNESYLTRANSFERASE; ESCORT PROTEIN; SMALL GTPASES; IN-VITRO; PRENYLATION; BISPHOSPHONATES; OSTEOCLASTS; RESOLUTION; COMPLEX; MOTIF	Rab geranylgeranyl transferase (RGGT) catalyzes the post-translational geranylgeranyl (GG) modification of (usually) two C-terminal cysteines in Rab GTPases. Here we studied the mechanism of the Rab geranylgeranylation reaction by bisphosphonate analogs in which one phosphonate group is replaced by a carboxylate (phosphonocarboxylate, PC). The phosphonocarboxylates used were 3-PEHPC, which was previously reported, and2-hydroxy-3-imidazo[1,2-a] pyridin-3-yl-2-phosphonopropionic acid ((+)-3-IPEHPC), a >25-fold more potent related compound as measured by both IC50 and Ki. (+)-3-IPEHPC behaves as a mixed-type inhibitor with respect to GG pyrophosphate ( GGPP) and an uncompetitive inhibitor with respect to Rab substrates. We propose that phosphonocarboxylates prevent only the second GG transfer onto Rabs based on the following evidence. First, geranylgeranylation of Rab proteins ending with a single cysteine motif such as CAAX, is not affected by the inhibitors, either in vitro or in vivo. Second, the addition of an -AAX sequence onto Rab-CC proteins protects the substrate from inhibition by the inhibitors. Third, we demonstrate directly that in the presence of (+)-3-IPEHPC, Rab-CC and Rab-CXC proteins are modified by only a single GG addition. The presence of (+)-3-IPEHPC resulted in a preference for the Rab N-terminal cysteine to be modified first, suggesting an order of cysteine geranylgeranylation in RGGT catalysis. Our results further suggest that the inhibitor binds to a site distinct from the GGPP-binding site on RGGT. We suggest that phosphonocarboxylate inhibitors bind to a GG-cysteine binding site adjacent to the active site, which is necessary to align the mono-GG-Rab for the second GG addition. These inhibitors may represent a novel therapeutic approach in Rab-mediated diseases.	[Baron, Rudi A.; Tavare, Richard; Figueiredo, Ana C.; Seabra, Miguel C.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England; [Blazewska, Katarzyna M.; Kashemirov, Boris A.; McKenna, Charles E.] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; [Ebetino, Frank H.] Procter & Gamble Pharmaceut, Cincinnati, OH 45040 USA; [Taylor, Adam; Rogers, Michael J.; Coxon, Fraser P.] Univ Aberdeen, Inst Med Sci, Bone & Musculoskeletal Programme, Aberdeen AB25 2ZD, Scotland; [Seabra, Miguel C.] Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal; [Seabra, Miguel C.] Univ Nova Lisboa, Fac Ciencias Med, P-1169056 Lisbon, Portugal	Imperial College London; University of Southern California; Procter & Gamble; University of Aberdeen; Instituto Gulbenkian de Ciencia; Universidade Nova de Lisboa	Seabra, MC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England.	m.seabra@imperial.ac.uk	Seabra, Miguel/AAC-3099-2019; Seabra, Miguel C/M-3280-2013; Figueiredo, Ana/K-1384-2013; Błażewska, Katarzyna/M-3722-2018	Seabra, Miguel C/0000-0002-6404-4892; Figueiredo, Ana/0000-0001-8386-8216; Błażewska, Katarzyna/0000-0002-1218-7111; Tavare, Richard/0000-0001-5150-5963; Rogers, Michael/0000-0002-1818-9249	Arthritis Research UK [17285] Funding Source: Medline; Versus Arthritis [17285] Funding Source: Medline; Wellcome Trust [075498] Funding Source: Medline	Arthritis Research UK(Versus Arthritis); Versus Arthritis(Versus Arthritis); Wellcome Trust(Wellcome TrustEuropean Commission)		ANDRES DA, 1993, CELL, V73, P1091, DOI 10.1016/0092-8674(93)90639-8; ARMSTRONG SA, 1995, METHOD ENZYMOL, V257, P30; Basso AD, 2006, J LIPID RES, V47, P15, DOI 10.1194/jlr.R500012-JLR200; Bergo MO, 2001, J BIOL CHEM, V276, P5841, DOI 10.1074/jbc.C000831200; Coxon FP, 2001, J BIOL CHEM, V276, P48213, DOI 10.1074/jbc.M106473200; Coxon FP, 2005, BONE, V37, P349, DOI 10.1016/j.bone.2005.04.021; Desnoyers L, 1998, P NATL ACAD SCI USA, V95, P12266, DOI 10.1073/pnas.95.21.12266; FARNSWORTH CC, 1994, P NATL ACAD SCI USA, V91, P11963, DOI 10.1073/pnas.91.25.11963; Gomes AQ, 2003, MOL BIOL CELL, V14, P1882, DOI 10.1091/mbc.E02-10-0639; Lane KT, 2006, J LIPID RES, V47, P681, DOI 10.1194/jlr.R600002-JLR200; Leung KF, 2007, J BIOL CHEM, V282, P1487, DOI 10.1074/jbc.M605557200; Leung KF, 2006, J LIPID RES, V47, P467, DOI 10.1194/jlr.R500017-JLR200; Long SB, 2002, NATURE, V419, P645, DOI 10.1038/nature00986; Mazieres J, 2004, CANCER LETT, V206, P159, DOI 10.1016/j.canlet.2003.08.033; Pylypenko O, 2003, MOL CELL, V11, P483, DOI 10.1016/S1097-2765(03)00044-3; Russell RGG, 2007, ANN NY ACAD SCI, V1117, P209, DOI 10.1196/annals.1402.089; SEABRA MC, 1995, J BIOL CHEM, V270, P24420, DOI 10.1074/jbc.270.41.24420; SEABRA MC, 1992, J BIOL CHEM, V267, P14497; Seabra MC, 1998, CELL SIGNAL, V10, P167, DOI 10.1016/S0898-6568(97)00120-4; Seabra MC, 1998, METH MOL B, V84, P251; Shen F, 1996, J BIOL CHEM, V271, P3692; Taylor JS, 2003, EMBO J, V22, P5963, DOI 10.1093/emboj/cdg571; Thoma NH, 2000, BIOCHEMISTRY-US, V39, P12043, DOI 10.1021/bi000835m; van Beek E, 1999, BIOCHEM BIOPH RES CO, V255, P491, DOI 10.1006/bbrc.1999.0224; Watanabe M, 2008, J BIOL CHEM, V283, P9571, DOI 10.1074/jbc.M706229200; Wu YW, 2006, CHEMBIOCHEM, V7, P1859, DOI 10.1002/cbic.200600377; Zhang H, 2000, STRUCTURE, V8, P241, DOI 10.1016/S0969-2126(00)00102-7	27	47	47	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6861	6868		10.1074/jbc.M806952200	http://dx.doi.org/10.1074/jbc.M806952200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19074143	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000263919000033
J	Morales, J; Mogi, T; Mineki, S; Takashima, E; Mineki, R; Hirawake, H; Sakamoto, K; Omura, S; Kita, K				Morales, Jorge; Mogi, Tatsushi; Mineki, Shigeru; Takashima, Eizo; Mineki, Reiko; Hirawake, Hiroko; Sakamoto, Kimitoshi; Omura, Satoshi; Kita, Kiyoshi			Novel Mitochondrial Complex II Isolated from Trypanosoma cruzi Is Composed of 12 Peptides Including a Heterodimeric Ip Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUCCINATE-UBIQUINONE OXIDOREDUCTASE; QUINONE-BINDING-SITE; ELECTRON-TRANSFER COMPLEXES; FUMARATE REDUCTASE; ESCHERICHIA-COLI; PARASITIC NEMATODE; ENERGY-METABOLISM; AMINO-ACIDS; DEHYDROGENASE; HEME	Mitochondrial respiratory enzymes play a central role in energy production in aerobic organisms. They differentiated from the alpha-proteobacteria-derived ancestors by adding noncatalytic subunits. An exception is Complex II (succinate: ubiquinone reductase), which is composed of four alpha-proteobacteria-derived catalytic subunits (SDH1-SDH4). Complex II often plays a pivotal role in adaptation of parasites in host organisms and would be a potential target for new drugs. We purified Complex II from the parasitic protist Trypanosoma cruzi and obtained the unexpected result that it consists of six hydrophilic (SDH1, SDH2(N), SDH2(C), and SDH5-SDH7) and six hydrophobic (SDH3, SDH4, and SDH8-SDH11) nucleus-encoded subunits. Orthologous genes for each subunit were identified in Trypanosoma brucei and Leishmania major. Notably, the iron-sulfur subunit was heterodimeric; SDH2(N) and SDH2(C) contain the plant-type ferredoxin domain in the N-terminal half and the bacterial ferredoxin domain in the C-terminal half, respectively. Catalytic subunits (SDH1, SDH2(N) plus SDH2(C), SDH3, and SDH4) contain all key residues for binding of dicarboxylates and quinones, but the enzyme showed the lower affinity for both substrates and inhibitors than mammalian enzymes. In addition, the enzyme binds protoheme IX, but SDH3 lacks a ligand histidine. These unusual features are unique in the Trypanosomatida and make their Complex II a target for new chemotherapeutic agents.	[Morales, Jorge; Mogi, Tatsushi; Takashima, Eizo; Hirawake, Hiroko; Sakamoto, Kimitoshi; Kita, Kiyoshi] Univ Tokyo, Grad Sch Med, Dept Biomed Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Omura, Satoshi] Kitasato Univ, Grad Sch Infect Control Sci, Minato Ku, Tokyo 1088641, Japan; [Omura, Satoshi] Kitasato Univ, Kitasato Inst Life Sci, Minato Ku, Tokyo 1088641, Japan; [Mineki, Reiko] Juntendo Univ, Grad Sch Med, Div Proteom & Biomol Sci, Bunkyo Ku, Tokyo 1138421, Japan; [Mineki, Shigeru] Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, Chiba 2788510, Japan	University of Tokyo; Kitasato University; Kitasato University; Juntendo University; Tokyo University of Science	Mogi, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Biomed Chem, Bunkyo Ku, Tokyo 1130033, Japan.	tmogi@m.u-tokyo.ac.jp; kitak@m.u-tokyo.ac.jp	Morales, Jorge/E-9916-2013; Morales, Jorge/AAJ-9381-2020; Sakamoto, Kimitoshi/G-4539-2014	Morales, Jorge/0000-0002-2828-1567; Kita, Kiyoshi/0000-0002-0426-4308; Takashima, Eizo/0000-0001-9070-8499	Japanese Society for the Promotion of Science [20570124, 18GS0314, 18073004]; Japanese Ministry of Education, Science, Culture, Sports and Technology (MEXT)	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Education, Science, Culture, Sports and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-aid for Scientific Research 20570124 (to T. M.), Creative Scientific Research Grant 18GS0314 (to K. K.), Grant-in-aid for Scientific Research on Priority Areas 18073004 (to K. K.) from the Japanese Society for the Promotion of Science, and Targeted Proteins Research Program (to K. K.) from the Japanese Ministry of Education, Science, Culture, Sports and Technology (MEXT).	Adams KL, 2001, GENETICS, V158, P1289; Allen JWA, 2004, BIOCHEM J, V383, P537, DOI 10.1042/BJ20040832; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Besteiro S, 2005, TRENDS PARASITOL, V21, P185, DOI 10.1016/j.pt.2005.02.008; Bourguignon SC, 2006, ACTA TROP, V98, P103, DOI 10.1016/j.actatropica.2006.02.006; Bringaud F, 2006, MOL BIOCHEM PARASIT, V149, P1, DOI 10.1016/j.molbiopara.2006.03.017; BRUSCA JS, 1994, METHOD ENZYMOL, V228, P182; CAZZULO JJ, 1994, J BIOENERG BIOMEMBR, V26, P157, DOI 10.1007/BF00763064; Cecchini G, 2003, ANNU REV BIOCHEM, V72, P77, DOI 10.1146/annurev.biochem.72.121801.161700; Concepcion JL, 1999, COMP BIOCHEM PHYS B, V122, P211, DOI 10.1016/S0305-0491(99)00002-4; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Eubel H, 2004, PLANT PHYSIOL, V134, P1450, DOI 10.1104/pp.103.038018; Eubel H, 2004, PLANT PHYSIOL BIOCH, V42, P937, DOI 10.1016/j.plaphy.2004.09.010; Funes S, 2002, SCIENCE, V298, P2155, DOI 10.1126/science.1076003; GRIVENNIKOVA VG, 1993, BIOCHIM BIOPHYS ACTA, V1140, P282, DOI 10.1016/0005-2728(93)90067-P; HARINGTON JS, 1961, PARASITOLOGY, V51, P309, DOI 10.1017/S0031182000070554; Horsefield R, 2006, J BIOL CHEM, V281, P7309, DOI 10.1074/jbc.M508173200; Huang LS, 2006, J BIOL CHEM, V281, P5965, DOI 10.1074/jbc.M511270200; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; KITA K, 1989, J BIOL CHEM, V264, P2672; Kita K, 2002, ADV PARASIT, V51, P95, DOI 10.1016/S0065-308X(02)51004-6; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Maklashina E, 1999, ARCH BIOCHEM BIOPHYS, V369, P223, DOI 10.1006/abbi.1999.1359; Maklashina E, 2001, J BIOL CHEM, V276, P18968, DOI 10.1074/jbc.M011270200; Marande W, 2007, SCIENCE, V318, P415, DOI 10.1126/science.1148033; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Millar AH, 2004, PLANT MOL BIOL, V56, P77, DOI 10.1007/s11103-004-2316-2; Mitaku S, 2002, BIOINFORMATICS, V18, P608, DOI 10.1093/bioinformatics/18.4.608; Miyadera H, 2003, EUR J BIOCHEM, V270, P1863, DOI 10.1046/j.1432-1033.2003.03553.x; Miyadera H, 2003, P NATL ACAD SCI USA, V100, P473, DOI 10.1073/pnas.0237315100; Nelson RE, 2004, MOL BIOCHEM PARASIT, V135, P219, DOI 10.1016/j.molbiopara.2004.02.003; Oyedotun KS, 2007, BBA-BIOENERGETICS, V1767, P1436, DOI 10.1016/j.bbabio.2007.09.008; ROOS MH, 1994, MOL BIOCHEM PARASIT, V66, P273, DOI 10.1016/0166-6851(94)90154-6; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Sabar M, 2005, PLANT J, V44, P893, DOI 10.1111/j.1365-313X.2005.02577.x; SARUTA F, 1995, J BIOL CHEM, V270, P928, DOI 10.1074/jbc.270.2.928; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; TAKAMIYA S, 1986, BIOCHIM BIOPHYS ACTA, V848, P99, DOI 10.1016/0005-2728(86)90165-9; Takashima E, 2002, MOL BIOCHEM PARASIT, V122, P189, DOI 10.1016/S0166-6851(02)00100-7; Tielens AGM, 2002, TRENDS BIOCHEM SCI, V27, P564, DOI 10.1016/S0968-0004(02)02193-X; Tran QM, 2007, P NATL ACAD SCI USA, V104, P18007, DOI 10.1073/pnas.0707732104; Tran QM, 2006, J BIOL CHEM, V281, P32310, DOI 10.1074/jbc.M607476200; TUSHURASHVILI PR, 1985, BIOCHIM BIOPHYS ACTA, V809, P145, DOI 10.1016/0005-2728(85)90057-X; Van Hellemond JJ, 1998, P NATL ACAD SCI USA, V95, P3036, DOI 10.1073/pnas.95.6.3036; Waller RF, 2006, GENE, V383, P33, DOI 10.1016/j.gene.2006.07.003; WHO Expert Committee on Problems Related to Alcohol Consumption, 2007, World Health Organ Tech Rep Ser, P1; WILLIAMS N, 1990, MOL BIOCHEM PARASIT, V43, P125, DOI 10.1016/0166-6851(90)90137-B; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Yang XD, 1998, J BIOL CHEM, V273, P31916, DOI 10.1074/jbc.273.48.31916; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605	53	44	44	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7255	7263		10.1074/jbc.M806623200	http://dx.doi.org/10.1074/jbc.M806623200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19122194	Green Published, hybrid			2022-12-25	WOS:000263919000072
J	Wu, WH; Wu, CH; Ladurner, A; Mizuguchi, G; Wei, D; Xiao, H; Luk, E; Ranjan, A; Wu, C				Wu, Wei-Hua; Wu, Chwen-Huey; Ladurner, Andreas; Mizuguchi, Gaku; Wei, Debbie; Xiao, Hua; Luk, Ed; Ranjan, Anand; Wu, Carl			N Terminus of Swr1 Binds to Histone H2AZ and Provides a Platform for Subunit Assembly in the Chromatin Remodeling Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE GENOME; ACTIN-RELATED PROTEINS; VARIANT H2A.Z; HETEROCHROMATIN BOUNDARIES; H4 ACETYLATION; HSA DOMAIN; NUA4; HTZ1; NUCLEOSOME; EXCHANGE	Variant histone H2AZ-containing nucleosomes are involved in the regulation of gene expression. In Saccharomyces cerevisiae, chromatin deposition of histone H2AZ is mediated by the fourteen-subunit SWR1 complex, which catalyzes ATP-dependent exchange of nucleosomal histone H2A for H2AZ. Previous work defined the role of seven SWR1 subunits (Swr1 ATPase, Swc2, Swc3, Arp6, Swc5, Yaf9, and Swc6) in maintaining complex integrity and H2AZ histone replacement activity. Here we examined the function of three additional SWR1 subunits, bromodomain containing Bdf1, actin-related protein Arp4 and Swc7, by analyzing affinity-purified mutant SWR1 complexes. We observed that depletion of Arp4 (arp4-td) substantially impaired the association of Bdf1, Yaf9, and Swc4. In contrast, loss of either Bdf1 or Swc7 had minimal effects on overall complex integrity. Furthermore, the basic H2AZ histone replacement activity of SWR1 in vitro required Arp4, but not Bdf1 or Swc7. Thus, three out of fourteen SWR1 subunits, Bdf1, Swc7, and previously noted Swc3, appear to have roles auxiliary to the basic histone replacement activity. The N-terminal region of the Swr1 ATPase subunit is necessary and sufficient to direct association of Bdf1 and Swc7, as well as Arp4, Act1, Yaf9 and Swc4. This same region contains an additional H2AZ-H2B specific binding site, distinct from the previously identified Swc2 subunit. These findings suggest that one SWR1 enzyme might be capable of binding two H2AZ-H2B dimers, and provide further insight on the hierarchy and interdependency of molecular interactions within the SWR1 complex.	[Wu, Wei-Hua; Wu, Chwen-Huey; Mizuguchi, Gaku; Wei, Debbie; Xiao, Hua; Luk, Ed; Ranjan, Anand; Wu, Carl] NCI, Biochem & Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Ladurner, Andreas] European Mol Biol Lab, Gene Express Unit, D-69117 Heidelberg, Germany	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); European Molecular Biology Laboratory (EMBL)	Wu, WH (corresponding author), NCI, Biochem & Mol Biol Lab, NIH, Bldg 37,Rm 6066, Bethesda, MD 20892 USA.	wuwe@mail.nih.gov; carlwu@helix.nih.gov		Luk, Ed/0000-0002-6619-2258; Ladurner, Andreas/0000-0003-3835-232X	NCI; National Institutes of Health; NATIONAL CANCER INSTITUTE [Z01BC005263, ZIABC005263] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the intramural research program of the NCI, National Institutes of Health.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Auger A, 2008, MOL CELL BIOL, V28, P2257, DOI 10.1128/MCB.01755-07; Babiarz JE, 2006, GENE DEV, V20, P700, DOI 10.1101/gad.1386306; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bittner CB, 2004, EUKARYOT CELL, V3, P976, DOI 10.1128/EC.3.4.976-983.2004; Boyer LA, 2004, NAT REV MOL CELL BIO, V5, P158, DOI 10.1038/nrm1314; Cai Y, 2005, J BIOL CHEM, V280, P13665, DOI 10.1074/jbc.M500001200; Carey M, 2006, MOL CELL, V24, P481, DOI 10.1016/j.molcel.2006.09.012; Choi K, 2007, DEVELOPMENT, V134, P1931, DOI 10.1242/dev.001891; Doerks T, 2002, GENOME RES, V12, P47, DOI 10.1101/gr.203201; Dohmen RJ, 2005, METHOD ENZYMOL, V399, P799, DOI 10.1016/S0076-6879(05)99052-6; Downs JA, 2004, MOL CELL, V16, P979, DOI 10.1016/j.molcel.2004.12.003; Doyon Y, 2004, CURR OPIN GENET DEV, V14, P147, DOI 10.1016/j.gde.2004.02.009; Durant M, 2007, MOL CELL BIOL, V27, P5327, DOI 10.1128/MCB.00468-07; Eirin-Lopez JM, 2007, CURR GENOMICS, V8, P59, DOI 10.2174/138920207780076965; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Galarneau L, 2000, MOL CELL, V5, P927, DOI 10.1016/S1097-2765(00)80258-0; Gangaraju VK, 2007, MUTAT RES-FUND MOL M, V618, P3, DOI 10.1016/j.mrfmmm.2006.08.015; Gevry N, 2007, GENE DEV, V21, P1869, DOI 10.1101/gad.1545707; Gligoris T, 2007, MOL CELL BIOL, V27, P4198, DOI 10.1128/MCB.00238-07; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Guillemette B, 2006, BIOCHEM CELL BIOL, V84, P528, DOI 10.1139/O06-077; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Kasten M, 2004, EMBO J, V23, P1348, DOI 10.1038/sj.emboj.7600143; Keogh MC, 2006, GENE DEV, V20, P660, DOI 10.1101/gad.1388106; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Krogan NJ, 2004, P NATL ACAD SCI USA, V101, P13513, DOI 10.1073/pnas.0405753101; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Kusch Thomas, 2007, Subcell Biochem, V41, P91; Ladurner AG, 2003, MOL CELL, V11, P365, DOI 10.1016/S1097-2765(03)00035-2; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luk E, 2007, MOL CELL, V25, P357, DOI 10.1016/j.molcel.2006.12.015; Matangkasombut O, 2000, GENE DEV, V14, P951; Matangkasombut O, 2003, MOL CELL, V11, P353, DOI 10.1016/S1097-2765(03)00033-9; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Mizuguchi G, 2007, CELL, V129, P1153, DOI 10.1016/j.cell.2007.04.026; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Shen XT, 2004, METHOD ENZYMOL, V377, P401; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; Shia WJ, 2006, GENE DEV, V20, P2507, DOI 10.1101/gad.1439206; Sunada R, 2005, YEAST, V22, P753, DOI 10.1002/yea.1239; Szerlong H, 2008, NAT STRUCT MOL BIOL, V15, P469, DOI 10.1038/nsmb.1403; Trotter KW, 2008, MOL CELL BIOL, V28, P1413, DOI 10.1128/MCB.01301-07; Wong MM, 2007, J BIOL CHEM, V282, P26132, DOI 10.1074/jbc.M703418200; Wu WH, 2005, NAT STRUCT MOL BIOL, V12, P1064, DOI 10.1038/nsmb1023; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; Zhang HY, 2004, MOL CELL BIOL, V24, P9424, DOI 10.1128/MCB.24.21.9424-9436.2004	53	78	79	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6200	6207		10.1074/jbc.M808830200	http://dx.doi.org/10.1074/jbc.M808830200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19088068	Green Published, hybrid			2022-12-25	WOS:000263742700023
J	Yang, J; Kennedy, EJ; Wu, J; Deal, MS; Pennypacker, J; Ghosh, G; Taylor, SS				Yang, Jie; Kennedy, Eileen J.; Wu, Jian; Deal, Michael S.; Pennypacker, Juniper; Ghosh, Gourisankar; Taylor, Susan S.			Contribution of Non-catalytic Core Residues to Activity and Regulation in Protein Kinase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC SUBUNIT; CRYSTAL-STRUCTURE; NUCLEOTIDE-BINDING; PKA; ADENOSINE; COMPLEX; COMMUNICATION; SPECIFICITY; MECHANISM; NETWORKS	Protein kinase A holoenzyme is comprised of two catalytic (C) and two regulatory (R) subunits which keep the enzyme in an inhibited state before activation by cyclic-AMP. The C-subunit folds into a conserved bi-lobal core flanked by N- and C-terminal tails. We report here characterization of a C-tail loss-of-function mutant, C-F327A, and a related suppressor mutant, C-F327A/K285P. Phe-327 is the only residue outside the kinase core that binds to the adenine ring of ATP, whereas Lys-285 is similar to 45 angstrom away and lies in an AGC kinase-specific insert. The two mutations were previously identified from a yeast genetic screen, where the F327A mutation was unable to complement cell growth but mutation of K285P in the same allele rescued cell viability. We show that C-F327A exhibits significant reduction in catalytic efficiency, which likely explains the observed loss-of-function phenotype. Interestingly, the additional K285P mutation does not restore kinase activity but reduces the inhibitory interaction of the double mutant with RII subunits. The additional K285P mutation, thus, helps to keep a low but uninhibited PKA activity that is sufficient for cell viability. The crystal structure of C-F327A/K285P further reveals that recruitment of Phe-327 to the ATP binding pocket not only contributes to the hydrophobic pocket, as previously thought, but also recruits its flanking C-tail region to the kinase core, thereby concertedly positioning the glycine-rich loop and ATP for phosphoryl transfer. The study exemplifies two different ways for regulating cAMP-dependent protein kinase activity through non-conserved residues and sheds light on the structural and functional diversity of the kinase family.	[Yang, Jie; Kennedy, Eileen J.; Wu, Jian; Deal, Michael S.; Pennypacker, Juniper; Ghosh, Gourisankar; Taylor, Susan S.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Taylor, Susan S.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Taylor, SS (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA.			Kennedy, Eileen/0000-0001-5610-1677	National Institutes of Health [GM19301]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM019301, R01GM019301] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM19301. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Akamine P, 2003, J MOL BIOL, V327, P159, DOI 10.1016/S0022-2836(02)01446-8; Anand GS, 2007, J MOL BIOL, V374, P487, DOI 10.1016/j.jmb.2007.09.035; Andersen MD, 2001, J BIOL CHEM, V276, P14204, DOI 10.1074/jbc.M011543200; Biondi RM, 2003, BIOCHEM J, V372, P1, DOI 10.1042/BJ20021641; BOSSEMEYER D, 1993, EMBO J, V12, P849, DOI 10.1002/j.1460-2075.1993.tb05725.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CANNON JF, 1987, MOL CELL BIOL, V7, P2653, DOI 10.1128/MCB.7.8.2653; Deminoff SJ, 2006, GENETICS, V173, P1909, DOI 10.1534/genetics.106.059238; Grant BD, 1996, PROTEIN SCI, V5, P1316, DOI 10.1002/pro.5560050710; Hatley ME, 2003, P NATL ACAD SCI USA, V100, P14445, DOI 10.1073/pnas.1835919100; Johnson DA, 2001, CHEM REV, V101, P2243, DOI 10.1021/cr000226k; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; Kennedy EJ, 2008, J BIOL CHEM, V283, P1084, DOI 10.1074/jbc.M704028200; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; Kornev AP, 2008, P NATL ACAD SCI USA, V105, P14377, DOI 10.1073/pnas.0807988105; Laskowski RA, 1998, CURR OPIN STRUC BIOL, V8, P631, DOI 10.1016/S0959-440X(98)80156-5; MADHUSUDAN, 1994, PROTEIN SCI, V3, P176; Madhusudan, 2002, NAT STRUCT BIOL, V9, P273, DOI 10.1038/nsb780; Narayana N, 1997, STRUCTURE, V5, P921, DOI 10.1016/S0969-2126(97)00246-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Prowse CN, 2001, J BIOL CHEM, V276, P40817, DOI 10.1074/jbc.M105860200; Shi ZS, 2006, CURR OPIN STRUC BIOL, V16, P686, DOI 10.1016/j.sbi.2006.10.011; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Taylor SS, 2004, BBA-PROTEINS PROTEOM, V1697, P259, DOI 10.1016/j.bbapap.2003.11.029; TAYLOR SS, 1994, STRUCTURE, V2, P345, DOI 10.1016/S0969-2126(00)00036-8; TODA T, 1987, CELL, V50, P277, DOI 10.1016/0092-8674(87)90223-6; Torkamani A, 2008, P NATL ACAD SCI USA, V105, P9011, DOI 10.1073/pnas.0802403105; Wong L, 2004, ACCOUNTS CHEM RES, V37, P304, DOI 10.1021/ar020128g; Wu J, 2007, SCIENCE, V318, P274, DOI 10.1126/science.1146447; Yang J, 2004, J MOL BIOL, V336, P473, DOI 10.1016/j.jmb.2003.11.044; Yang J, 2005, J MOL BIOL, V346, P191, DOI 10.1016/j.jmb.2004.11.030; ZHENG JH, 1993, BIOCHEMISTRY-US, V32, P2154, DOI 10.1021/bi00060a005; ZOLLER MJ, 1991, GENE, V99, P171, DOI 10.1016/0378-1119(91)90124-T	37	39	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6241	6248		10.1074/jbc.M805862200	http://dx.doi.org/10.1074/jbc.M805862200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19122195	Green Published, hybrid			2022-12-25	WOS:000263742700027
J	Zhang, LJ; Liu, X; Gafken, PR; Kioussi, C; Leid, M				Zhang, Ling-juan; Liu, Xiao; Gafken, Philip R.; Kioussi, Chrissa; Leid, Mark			A Chicken Ovalbumin Upstream Promoter Transcription Factor I (COUP-TFI) Complex Represses Expression of the Gene Encoding Tumor Necrosis Factor alpha-induced Protein 8 (TNFAIP8)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR COREPRESSOR COMPLEX; DEATH EFFECTOR DOMAIN; NUCLEAR RECEPTORS; N-COR; DEACETYLASE SIRT1; PURIFICATION; ACTIVATION; INTERACTS; MEMBERS; DIFFERENTIATION	The orphan nuclear receptor chicken ovalbumin upstream promoter transcription factor I (COUP-TFI) plays key roles in development and homeostasis. A tandem affinity purification procedure revealed that COUP-TFI associated with a number of transcriptional regulatory proteins in HeLa S3 cells, including the nuclear receptor corepressor (NCoR), TIF1 beta/KAP-1, HDAC1, and the SWI/SNF family member Brahma. The proapoptotic protein DBC1 was also identified in COUP-TFI complexes. In vitro experiments revealed that COUP-TFI interacted directly with NCoR but in a manner different from that of other nuclear receptors. DBC1 stabilized the interaction between COUP-TFI and NCoR by interacting directly with both proteins. The gene encoding the anti-apoptotic protein TNFAIP8 (tumor necrosis factor alpha(TNF alpha)-induced protein 8) was identified as being repressed by COUP-TFI in a manner that required several of the component proteins of the COUP-TFI complex. Finally, our studies highlight a central role for COUP-TFI in the induction of the TNFAIP8 promoter by TNF alpha. Together, these studies identify a novel COUP-TFI complex that functions as a repressor of transcription and may play a role in the TNF alpha signaling pathways.	[Zhang, Ling-juan; Liu, Xiao; Kioussi, Chrissa; Leid, Mark] Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA; [Gafken, Philip R.] Fred Hutchinson Canc Res Ctr, Prote Facil, Seattle, WA 98109 USA	Oregon State University; Fred Hutchinson Cancer Center	Leid, M (corresponding author), Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA.	Mark.Leid@oregonstate.edu	Zhang, Lingjuan/K-3080-2017; Zhang, Ling-juan/V-6141-2019	Zhang, Lingjuan/0000-0001-6937-4578; Zhang, Ling-juan/0000-0001-6937-4578; Kioussi, Chrissa/0000-0001-8226-9908	National Institutes of Health [GM60852]; Oregon State University College of Pharmacy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060852] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oregon State University College of Pharmacy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM60852 to M. L.). This work was also supported by the Oregon State University College of Pharmacy.	Avram D, 1999, J BIOL CHEM, V274, P14331, DOI 10.1074/jbc.274.20.14331; Avram D, 2000, J BIOL CHEM, V275, P10315, DOI 10.1074/jbc.275.14.10315; Dowell P, 1997, J BIOL CHEM, V272, P33435, DOI 10.1074/jbc.272.52.33435; Dressel U, 1999, MOL CELL BIOL, V19, P3383; Gaur U, 2003, BIOCHEM PHARMACOL, V66, P1403, DOI 10.1016/S0006-2952(03)00490-8; Gay F, 2002, MOL ENDOCRINOL, V16, P1332, DOI 10.1210/me.16.6.1332; Glass CK, 2000, GENE DEV, V14, P121; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Hamaguchi M, 2002, P NATL ACAD SCI USA, V99, P13647, DOI 10.1073/pnas.212516099; Harikrishnan KN, 2005, NAT GENET, V37, P254, DOI 10.1038/ng1516; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Huggins GS, 2001, J BIOL CHEM, V276, P28029, DOI 10.1074/jbc.M103577200; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Kadonaga JT, 1998, CELL, V92, P307, DOI 10.1016/S0092-8674(00)80924-1; Kane CD, 2000, EMBO J, V19, P691, DOI 10.1093/emboj/19.4.691; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; Kobayashi S, 2004, J MOL ENDOCRINOL, V32, P69, DOI 10.1677/jme.0.0320069; Kumar D, 2004, ONCOGENE, V23, P612, DOI 10.1038/sj.onc.1207123; Kumar D, 2000, J BIOL CHEM, V275, P2973, DOI 10.1074/jbc.275.4.2973; Kurihara I, 2005, J BIOL CHEM, V280, P6721, DOI 10.1074/jbc.M411820200; Kurihara I, 2002, ENDOCR RES, V28, P581, DOI 10.1081/ERC-120016845; Lee CT, 2004, MOL CELL BIOL, V24, P10835, DOI 10.1128/MCB.24.24.10835-10843.2004; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Marcus SL, 1996, J BIOL CHEM, V271, P27197, DOI 10.1074/jbc.271.44.27197; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Pal S, 2003, MOL CELL BIOL, V23, P7475, DOI 10.1128/MCB.23.21.7475-7487.2003; Pereira FA, 2000, CELL MOL LIFE SCI, V57, P1388, DOI 10.1007/PL00000624; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Qiu YH, 1997, GENE DEV, V11, P1925, DOI 10.1101/gad.11.15.1925; Robinson-Rechavi M, 2003, J CELL SCI, V116, P585, DOI 10.1242/jcs.00247; Rohr O, 2000, J BIOL CHEM, V275, P2654, DOI 10.1074/jbc.275.4.2654; Rohr O, 1997, J BIOL CHEM, V272, P31149, DOI 10.1074/jbc.272.49.31149; SAGAMI I, 1986, MOL CELL BIOL, V6, P4259, DOI 10.1128/MCB.6.12.4259; Senawong T, 2003, J BIOL CHEM, V278, P43041, DOI 10.1074/jbc.M307477200; Seol W, 1996, MOL ENDOCRINOL, V10, P1646, DOI 10.1210/me.10.12.1646; SHAPIRO DJ, 1988, DNA-J MOLEC CELL BIO, V7, P47, DOI 10.1089/dna.1988.7.47; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Shibata H, 2003, HORM RES, V59, P85, DOI 10.1159/000067830; Shibata H, 1997, MOL ENDOCRINOL, V11, P714, DOI 10.1210/me.11.6.714; Sif S, 2001, GENE DEV, V15, P603, DOI 10.1101/gad.872801; Stroup D, 1997, J BIOL CHEM, V272, P9833; Studer M, 2005, BRAIN RES BULL, V66, P394, DOI 10.1016/j.brainresbull.2004.11.027; Sundararajan R, 2005, ONCOGENE, V24, P4908, DOI 10.1038/sj.onc.1208681; Topark-Ngarm A, 2006, J BIOL CHEM, V281, P32272, DOI 10.1074/jbc.M602776200; Toulouse A, 2003, GENOMICS, V82, P162, DOI 10.1016/S0888-7543(03)00101-0; Underhill C, 2000, J BIOL CHEM, V275, P40463, DOI 10.1074/jbc.M007864200; WANG LH, 1987, J BIOL CHEM, V262, P16080; WANG LH, 1989, NATURE, V340, P163, DOI 10.1038/340163a0; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Warnecke M, 2005, GENE DEV, V19, P614, DOI 10.1101/gad.317905; Yi EC, 2003, RAPID COMMUN MASS SP, V17, P2093, DOI 10.1002/rcm.1150; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; You ZB, 2001, J BIOL CHEM, V276, P26398, DOI 10.1074/jbc.M102464200; Zamir I, 1996, MOL CELL BIOL, V16, P5458; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9; Zhang Y, 2003, MOL CELL BIOL, V23, P6958, DOI 10.1128/MCB.23.19.6958-6972.2003; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515; Zhou C, 1999, NEURON, V24, P847, DOI 10.1016/S0896-6273(00)81032-6; Zhu NL, 2007, GENE, V393, P70, DOI 10.1016/j.gene.2007.01.016	65	35	38	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6156	6168		10.1074/jbc.M807713200	http://dx.doi.org/10.1074/jbc.M807713200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19112178	Green Published, hybrid			2022-12-25	WOS:000263742700018
J	Wu, JJ; Weis, MA; Kim, LS; Carter, BG; Eyre, DR				Wu, Jiann-Jiu; Weis, Mary Ann; Kim, Lammy S.; Carter, Bryan G.; Eyre, David R.			Differences in Chain Usage and Cross-linking Specificities of Cartilage Type V/XI Collagen Isoforms with Age and Tissue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IX COLLAGEN; XI COLLAGEN; EXTRACELLULAR-MATRIX; INTERVERTEBRAL DISC; II COLLAGEN; V COLLAGEN; IDENTIFICATION; FIBRILS; HETEROGENEITY; DOMAINS	Collagen type V/XI is a minor but essential component of collagen fibrils in vertebrates. We here report on age-and tissue-related variations in isoform usage in cartilages. With maturation of articular cartilage, the alpha 1(V) chain progressively replaced the alpha 2(XI) chain. A mix of the molecular isoforms, alpha 1(XI) alpha 1(V) alpha 3(XI) and alpha 1(XI) alpha 2(XI) alpha 3(XI), best explained this finding. A prominence of alpha 1(V) chains is therefore characteristic and a potential biomarker of mature mammalian articular cartilage. Analysis of cross-linked peptides showed that the alpha 1(V) chains were primarily cross-linked to alpha 1(XI) chains in the tissue and hence an integral component of the V/XI polymer. From nucleus pulposus of the intervertebral disc (in which the bulk collagen monomer is type II as in articular cartilage), type V/XI collagen consisted of a mix of five genetically distinct chains, alpha 1(XI), alpha 2(XI), alpha 3(XI), alpha 1(V), and alpha 2(V). These presumably were derived from several different molecular isoforms, including alpha 1(XI) alpha 2(XI) alpha 3(XI), (alpha 1(XI))(2) alpha 2(V), and others. Meniscal fibrocartilage shows yet another V/XI phenotype. The findings support and extend the concept that the clade B subfamily of COL5 and COL11 gene products should be considered members of the same collagen subfamily, from which, in combination with clade A gene products (COL2A1 or COL5A2), a range of molecular isoforms has evolved into tissue-dependent usage. We propose an evolving role for collagen V/XI isoforms as an adaptable polymeric template of fibril macro-architecture.	[Wu, Jiann-Jiu; Weis, Mary Ann; Kim, Lammy S.; Carter, Bryan G.; Eyre, David R.] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Wu, JJ (corresponding author), 1959 NE Pacific St,HSB BB1052, Seattle, WA 98195 USA.	wujj@u.washington.edu			National Institutes of Health [AR37318, AR36794]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR037318, R37AR037318, R37AR036794, R01AR036794] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR37318 and AR36794.	AYAD S, 1989, BIOCHEM J, V262, P753, DOI 10.1042/bj2620753; BISHOP PN, 1994, BIOCHEM J, V299, P497, DOI 10.1042/bj2990497; Boot-Handford RP, 2003, J BIOL CHEM, V278, P31067, DOI 10.1074/jbc.M212889200; BURGESON RE, 1979, BIOCHEM BIOPH RES CO, V87, P1124, DOI 10.1016/S0006-291X(79)80024-8; Eyre D, 1987, STRUCTURE FUNCTION C, P261; EYRE D R, 1990, P188; Eyre DR, 2008, METHODS, V45, P65, DOI 10.1016/j.ymeth.2008.01.002; Eyre DR, 2004, J BIOL CHEM, V279, P2568, DOI 10.1074/jbc.M311653200; EYRE DR, 1987, FEBS LETT, V220, P337, DOI 10.1016/0014-5793(87)80842-6; Eyre DR, 2002, BIOCHEM SOC T, V30, P844; EYRE DR, 1976, BIOCHEM J, V157, P267, DOI 10.1042/bj1570267; EYRE DR, 1983, FEBS LETT, V158, P265, DOI 10.1016/0014-5793(83)80592-4; Huxley-Jones J, 2007, MATRIX BIOL, V26, P2, DOI 10.1016/j.matbio.2006.09.008; Kinter M, 2000, PROTEIN SEQUENCING I, V1st, P152; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANE JM, 1975, ARTHRITIS RHEUM-US, V18, P553, DOI 10.1002/art.1780180605; Malone JP, 2005, BIOCHEMISTRY-US, V44, P15269, DOI 10.1021/bi0508338; MAYNE R, 1993, J BIOL CHEM, V268, P9381; MENDLER M, 1989, J CELL BIOL, V108, P191, DOI 10.1083/jcb.108.1.191; MORRIS NP, 1987, J BIOL CHEM, V262, P11345; MULLERGLAUSER W, 1986, J CELL BIOL, V102, P1931, DOI 10.1083/jcb.102.5.1931; NIYIBIZI C, 1994, EUR J BIOCHEM, V224, P943, DOI 10.1111/j.1432-1033.1994.00943.x; NIYIBIZI C, 1989, FEBS LETT, V242, P314, DOI 10.1016/0014-5793(89)80492-2; Oegema TR, 2002, BIOCHEM SOC T, V30, P839, DOI 10.1042/bst0300839; Poole CA, 1997, OSTEOARTHR CARTILAGE, V5, P191, DOI 10.1016/S1063-4584(97)80014-3; SNOWDEN JM, 1980, INVEST OPHTH VIS SCI, V19, P610; VAUGHAN L, 1988, J CELL BIOL, V106, P991, DOI 10.1083/jcb.106.3.991; WU JJ, 1995, J BIOL CHEM, V270, P18865, DOI 10.1074/jbc.270.32.18865; WU JJ, 1992, J BIOL CHEM, V267, P23007; Wu JJ, 2003, J BIOL CHEM, V278, P24521, DOI 10.1074/jbc.M302431200; WU JJ, 1984, BIOCHEM BIOPH RES CO, V123, P1033, DOI 10.1016/S0006-291X(84)80237-5	31	30	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5539	5545		10.1074/jbc.M806369200	http://dx.doi.org/10.1074/jbc.M806369200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19103590	Green Published, hybrid			2022-12-25	WOS:000263560600017
J	Cen, B; Li, HY; Weinstein, IB				Cen, Bo; Li, Haiyang; Weinstein, I. Bernard			Histidine Triad Nucleotide-binding Protein 1 Up-regulates Cellular Levels of p27(KIP1) by Targeting Scf(SKP2) Ubiquitin Ligase and Src	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT KINASE INHIBITOR; ACTIVATED MAST-CELLS; TUMOR-SUPPRESSOR; TRANSCRIPTIONAL ACTIVITY; PROGNOSTIC-SIGNIFICANCE; TYROSINE KINASE; CDK INHIBITORS; HUMAN CANCER; CYCLIN; P27	The one or more underlying mechanisms of the tumor suppressing activity of the histidine triad nucleotide-binding protein 1 (HINT1) are not well defined. In this study we found that HINT1 regulates cellular levels of the cyclin-dependent kinase inhibitor p27(KIP1) through multiple mechanisms. Increased expression of HINT1 increases cellular levels of p27(KIP1), and HINT1 knockdown with small hairpin RNA leads to decreased cellular levels of p27(KIP1). HINT1 does not affect the transcription of p27(KIP1), but it does inhibit proteasomal degradation of the p27(KIP1) protein. HINT1 directly interacts with the SCFSKP2 ubiquitin ligase complex and inhibits the ubiquitylation of p27(KIP1). Src has been shown to phosphorylate p27(KIP1) and thus decrease its stability. We found that HINT1 is a negative regulator of Src transcription apparently by forming a complex with the transcription factor Sp1 on the promoter of Src. Taken together, our findings indicate that HINT1 up-regulates cellular levels of p27(KIP1) by two mechanisms: 1) it inhibits its ubiquitylation by targeting the SCFSKP2 ubiquitin ligase complex, and 2) it inhibits the phosphorylation of p27(KIP1) by Src via inhibiting Src expression.	[Cen, Bo; Li, Haiyang; Weinstein, I. Bernard] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Weinstein, I. Bernard] Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA	Columbia University; Columbia University	Cen, B (corresponding author), Med Univ S Carolina, Hollings Canc Ctr, Dept Med, 86 Jonathan Lucas St, Charleston, SC 29425 USA.	cen@musc.edu			Environmental Protection Agency [X97279801-0]; T. J. Martell Foundation; National Foundation for Cancer Research; Entertainment Industry Foundation	Environmental Protection Agency(United States Environmental Protection Agency); T. J. Martell Foundation; National Foundation for Cancer Research; Entertainment Industry Foundation	This work was supported by the Environmental Protection Agency ( Grant X97279801-0 to H. L.), the T. J. Martell Foundation, the National Foundation for Cancer Research, and the Entertainment Industry Foundation ( to I.B.W.).	Ajit SK, 2007, CELL SIGNAL, V19, P723, DOI 10.1016/j.cellsig.2006.09.008; Avizienyte E, 2004, MOL BIOL CELL, V15, P2794, DOI 10.1091/mbc.E03-12-0879; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Biscardi JS, 2000, BREAST CANCER RES, V2, P203, DOI 10.1186/bcr55; Bloom J, 2003, SEMIN CANCER BIOL, V13, P41, DOI 10.1016/S1044-579X(02)00098-6; BONHAM K, 1993, ONCOGENE, V8, P1973; Brenner C, 2002, BIOCHEMISTRY-US, V41, P9003, DOI 10.1021/bi025942q; Brenner C, 1999, J CELL PHYSIOL, V181, P179, DOI 10.1002/(SICI)1097-4652(199911)181:2<179::AID-JCP1>3.0.CO;2-8; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; BRZOSKA PM, 1995, P NATL ACAD SCI USA, V92, P7824, DOI 10.1073/pnas.92.17.7824; Chen T, 2006, ANTI-CANCER DRUG, V17, P123, DOI 10.1097/00001813-200602000-00002; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Clurman BE, 1998, P NATL ACAD SCI USA, V95, P15158, DOI 10.1073/pnas.95.26.15158; Courtneidge SA, 2003, BIOCHEM SOC T, V31, P25, DOI 10.1042/bst0310025; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; Guang W, 2004, MOL PHARMACOL, V66, P1285, DOI 10.1124/mol.66.5.; GUPTA SK, 1992, J BIOL CHEM, V267, P7987; Harper JW, 1999, NAT CELL BIOL, V1, pE5, DOI 10.1038/8952; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; Inoue T, 1999, J BIOL CHEM, V274, P32309, DOI 10.1074/jbc.274.45.32309; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Klein MG, 1998, EXP CELL RES, V244, P26, DOI 10.1006/excr.1998.4153; Koepp DM, 1999, CELL, V97, P431, DOI 10.1016/S0092-8674(00)80753-9; Korsisaari N, 2000, J BIOL CHEM, V275, P34837, DOI 10.1074/jbc.C000505200; LEE MH, 1995, GENE DEV, V9, P639, DOI 10.1101/gad.9.6.639; Lee YN, 2005, MOL CELL BIOL, V25, P8904, DOI 10.1128/MCB.25.20.8904-8912.2005; Lee YN, 2004, IMMUNITY, V20, P145, DOI 10.1016/S1074-7613(04)00020-2; Li H, 2006, ONCOGENE, V25, P713, DOI 10.1038/sj.onc.1209111; Lloyd RV, 1999, AM J PATHOL, V154, P313, DOI 10.1016/S0002-9440(10)65277-7; MATSUOKA S, 1995, GENE DEV, V9, P650, DOI 10.1101/gad.9.6.650; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Pagano M, 1997, FASEB J, V11, P1067, DOI 10.1096/fasebj.11.13.9367342; Philipp-Staheli J, 2001, EXP CELL RES, V264, P148, DOI 10.1006/excr.2000.5143; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Razin E, 1999, J BIOL CHEM, V274, P34272, DOI 10.1074/jbc.274.48.34272; Ritchie S, 2000, J BIOL CHEM, V275, P847, DOI 10.1074/jbc.275.2.847; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Su T, 2003, P NATL ACAD SCI USA, V100, P7824, DOI 10.1073/pnas.1332160100; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Tsihlias J, 1999, ANNU REV MED, V50, P401; Wang L, 2007, CANCER RES, V67, P4700, DOI 10.1158/0008-5472.CAN-06-4645; Weiske J, 2006, J BIOL CHEM, V281, P27356, DOI 10.1074/jbc.M513452200; Zhou P, 1999, ANTICANCER RES, V19, P4935	51	23	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5265	5276		10.1074/jbc.M804531200	http://dx.doi.org/10.1074/jbc.M804531200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19112177	hybrid			2022-12-25	WOS:000263416600057
J	Izumi, K; Kodama, E; Shimura, K; Sakagami, Y; Watanabe, K; Ito, S; Watabe, T; Terakawa, Y; Nishikawa, H; Sarafianos, SG; Kitaura, K; Oishi, S; Fujii, N; Matsuoka, M				Izumi, Kazuki; Kodama, Eiichi; Shimura, Kazuya; Sakagami, Yasuko; Watanabe, Kentaro; Ito, Saori; Watabe, Tsuyoshi; Terakawa, Yukihiro; Nishikawa, Hiroki; Sarafianos, Stefan G.; Kitaura, Kazuo; Oishi, Shinya; Fujii, Nobutaka; Matsuoka, Masao			Design of Peptide-based Inhibitors for Human Immunodeficiency Virus Type 1 Strains Resistant to T-20	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 FUSION INHIBITOR; ENFUVIRTIDE RESISTANCE; ENVELOPE GLYCOPROTEIN; BH3 HELIX; GP41; MUTATIONS; EVOLUTION; VARIANT; BINDING; SENSITIVITY	Enfuvirtide (T-20) is a fusion inhibitor that suppresses replication of human immunodeficiency virus (HIV) variants with multi-drug resistance to reverse transcriptase and protease inhibitors. It is a peptide derived from the C-terminal heptad repeat (C-HR) of HIV-1 gp41, and it prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion. However, prolonged therapies with T-20 result in the emergence of T-20-resistant strains that contain primary mutations such as N43D in the N-HR of gp41 (where T-20 and C-HR bind) that help the virus escape at a fitness cost. Such variants often go on to acquire a secondary mutation, S138A, in the C-HR of gp41 region that corresponds to the sequence of T-20. We demonstrate here that the role of S138A is to compensate for the impaired fusion kinetics of HIV-1s carrying primary mutations that abrogate binding of T-20. To preempt this escape strategy, we designed a modified T-20 variant containing the S138A substitution and showed that it is a potent inhibitor of both T-20-sensitive and T-20-resistant viruses. Circular dichroism analysis revealed that the S138A provided increased stability of the 6-helix bundle. We validated our approach on another fusion inhibitor, C34. In this case, we designed a variant of C34 with the secondary escape mutation N126K and showed that it can effectively inhibit replication of C34-resistant HIV-1. These results prove that it is possible to design improved peptide-based fusion inhibitors that are efficient against a major mechanism of drug resistance.	[Izumi, Kazuki; Kodama, Eiichi; Shimura, Kazuya; Sakagami, Yasuko; Matsuoka, Masao] Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan; [Watanabe, Kentaro; Ito, Saori; Watabe, Tsuyoshi; Terakawa, Yukihiro; Nishikawa, Hiroki; Kitaura, Kazuo; Oishi, Shinya; Fujii, Nobutaka] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan; [Sarafianos, Stefan G.] Univ Missouri, Sch Med, Christopher S Bond Life Sci Ctr, Columbia, MO 65211 USA; [Sarafianos, Stefan G.] Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA	Kyoto University; Kyoto University; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Kodama, E (corresponding author), Kyoto Univ, Inst Virus Res, 53 Kawaramachi, Kyoto 6068507, Japan.	ekodama@virus.kyoto-u.ac.jp	Oishi, Shinya/C-1350-2011; Kodama, Eiichi N/C-4032-2009	Oishi, Shinya/0000-0002-2833-2539; Kodama, Eiichi N/0000-0002-6622-2752; Sarafianos, Stefan G/0000-0002-5840-154X; Matsuoka, Masao/0000-0002-0473-754X; SHIMURA, Kazuya/0000-0001-7819-5184	National Institutes of Health [AI076119, AI079801, AI074389]; Ministry of Health and Welfare and the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Health Sciences Foundation; 21st Century COE program; Japan Society for the Promotion of Science research fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079801, R01AI076119, R33AI079801, R01AI074389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Health and Welfare and the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Health Sciences Foundation; 21st Century COE program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science research fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in part, by National Institutes of Health Grants AI076119, AI079801, and AI074389 (to S. G. S.). This work was also supported in part by grants from the Ministry of Health and Welfare and the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to E. K., S. O., and N. F.), the Japan Health Sciences Foundation (to E. K., S. O., N. F., and M. M.), the 21st Century COE program (to K. I., S. I., and H. N.), and a Japan Society for the Promotion of Science research fellowship (to H. N.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Armand-Ugon M, 2003, ANTIVIR RES, V59, P137, DOI 10.1016/S0166-3542(03)00071-8; Bai XF, 2008, BIOCHEMISTRY-US, V47, P6662, DOI 10.1021/bi702509d; Baldwin CE, 2004, J VIROL, V78, P12428, DOI 10.1128/JVI.78.22.12428-12437.2004; Baldwin C, 2008, J VIROL, V82, P7735, DOI 10.1128/JVI.02524-07; Baldwin CE, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-84; Cabrera C, 2006, AIDS, V20, P2075, DOI 10.1097/QAD.0b013e3280102377; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chinnadurai R, 2007, J VIROL, V81, P6563, DOI 10.1128/JVI.02546-06; Dwyer JJ, 2007, P NATL ACAD SCI USA, V104, P12772, DOI 10.1073/pnas.0701478104; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Eggink D, 2008, J VIROL, V82, P6678, DOI 10.1128/JVI.00352-08; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; Hachiya A, 2008, J VIROL, V82, P3261, DOI 10.1128/JVI.01154-07; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Labrosse B, 2006, J VIROL, V80, P8807, DOI 10.1128/JVI.02706-05; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Lazzarin A, 2003, NEW ENGL J MED, V348, P2186, DOI 10.1056/NEJMoa035211; Maeda Y, 1998, J INFECT DIS, V177, P1207, DOI 10.1086/515282; Mink M, 2005, J VIROL, V79, P12447, DOI 10.1128/JVI.79.19.12447-12454.2005; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Nameki D, 2005, J VIROL, V79, P764, DOI 10.1128/JVI.79.2.764-770.2005; Nilsson I, 1998, J MOL BIOL, V284, P1165, DOI 10.1006/jmbi.1998.2217; Nishikawa H, 2009, INT J BIOCHEM CELL B, V41, P891, DOI 10.1016/j.biocel.2008.08.039; Nishitsuji H, 2006, J VIROL, V80, P7658, DOI 10.1128/JVI.00078-06; Oishi S, 2008, J MED CHEM, V51, P388, DOI 10.1021/jm701109d; Otaka A, 2002, ANGEW CHEM INT EDIT, V41, P2938, DOI 10.1002/1521-3773(20020816)41:16<2937::AID-ANIE2937>3.0.CO;2-J; Perez-Alvarez L, 2006, J MED VIROL, V78, P141, DOI 10.1002/jmv.20520; Takeuchi T, 2006, ACS CHEM BIOL, V1, P299, DOI 10.1021/cb600127m; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; WATABE T, 2009, PEPTIDE SCI IN PRESS; Weiss Carol D, 2003, AIDS Rev, V5, P214; Xu L, 2005, ANTIMICROB AGENTS CH, V49, P1113, DOI 10.1128/AAC.49.3.1113-1119.2005	38	38	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4914	4920		10.1074/jbc.M807169200	http://dx.doi.org/10.1074/jbc.M807169200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19073606	Green Published, hybrid			2022-12-25	WOS:000263416600021
J	Ramadan, O; Qu, YX; Wadgaonkar, R; Baroudi, G; Karnabi, E; Chahine, M; Boutjdir, M				Ramadan, Omar; Qu, Yongxia; Wadgaonkar, Raj; Baroudi, Ghayath; Karnabi, Eddy; Chahine, Mohamed; Boutjdir, Mohamed			Phosphorylation of the Consensus Sites of Protein Kinase A on alpha(1D) L-type Calcium Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NULL MUTANT MICE; CA2+ CHANNELS; ATRIOVENTRICULAR-CONDUCTION; PACEMAKER ACTIVITY; CARDIAC MYOCYTES; FUNCTIONAL ROLES; SINOATRIAL NODE; EXPRESSION; ATRIAL; PHARMACOLOGY	The novel alpha(1D) L-type Ca2+ channel is expressed in supraventricular tissue and has been implicated in the pacemaker activity of the heart and in atrial fibrillation. We recently demonstrated that PKA activation led to increased alpha(1D) Ca2+ channel activity in tsA201 cells by phosphorylation of the channel protein. Here we sought to identify the phosphorylated PKA consensus sites on the alpha(1) subunit of the alpha(1D) Ca2+ channel by generating GST fusion proteins of the intracellular loops, N terminus, proximal and distal C termini of the alpha(1) subunit of alpha(1D) Ca2+ channel. An in vitro PKA kinase assay was performed for the GST fusion proteins, and their phosphorylation was assessed by Western blotting using either anti-PKA substrate or anti-phosphoserine antibodies. Western blotting showed that the N terminus and C terminus were phosphorylated. Serines 1743 and 1816, two PKA consensus sites, were phosphorylated by PKA and identified by mass spectrometry. Site directed mutagenesis and patch clamp studies revealed that serines 1743 and 1816 were major functional PKA consensus sites. Altogether, biochemical and functional data revealed that serines 1743 and 1816 are major functional PKA consensus sites on the alpha(1) subunit of alpha(1D) Ca2+ channel. These novel findings provide new insights into the autonomic regulation of the alpha(1D) Ca2+ channel in the heart.	[Ramadan, Omar; Qu, Yongxia; Wadgaonkar, Raj; Karnabi, Eddy; Boutjdir, Mohamed] VA New York Harbor Healthcare Syst, Brooklyn, NY 11209 USA; [Ramadan, Omar; Qu, Yongxia; Wadgaonkar, Raj; Karnabi, Eddy; Boutjdir, Mohamed] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA; [Baroudi, Ghayath] Univ Montreal, Montreal, PQ H3C 3J7, Canada; [Chahine, Mohamed] Univ Laval Robert Giffard, Quebec City, PQ G1J 2G3, Canada; [Boutjdir, Mohamed] NYU, Sch Med, New York, NY 10016 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Universite de Montreal; Laval University; New York University	Boutjdir, M (corresponding author), VA New York Harbor Healthcare Syst, Res & Dev 151,800 Poly Pl, Brooklyn, NY 11209 USA.	Mohamed.boutjdir@med.va.gov		Boutjdir, Mohamed/0000-0002-6068-223X	NHLBI [HL 077494]; Veterans Administration Merit Grant Award; Veterans Administration MREP; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077494] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Administration Merit Grant Award; Veterans Administration MREP; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL 077494 from the NHLBI. This work was also supported by Veterans Administration Merit Grant Award (to M. B.) and the Veterans Administration MREP Grant (to Y. Q.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Baroudi G, 2006, AM J PHYSIOL-HEART C, V291, pH1614, DOI 10.1152/ajpheart.00095.2006; Bell DC, 2001, J NEUROPHYSIOL, V85, P816, DOI 10.1152/jn.2001.85.2.816; Brette F, 2006, PROG BIOPHYS MOL BIO, V91, P1, DOI 10.1016/j.pbiomolbio.2005.01.001; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; DeJongh KS, 1996, BIOCHEMISTRY-US, V35, P10392, DOI 10.1021/bi953023c; Dolphin AC, 2006, BRIT J PHARMACOL, V147, pS56, DOI 10.1038/sj.bjp.0706442; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Ganesan AN, 2006, CIRC RES, V98, pE11, DOI 10.1161/01.RES.0000202692.23001.e2; Hockerman GH, 1997, ANNU REV PHARMACOL, V37, P361, DOI 10.1146/annurev.pharmtox.37.1.361; Mangoni ME, 2006, CIRC RES, V98, P1422, DOI 10.1161/01.RES.0000225862.14314.49; Mangoni ME, 2003, P NATL ACAD SCI USA, V100, P5543, DOI 10.1073/pnas.0935295100; Marionneau C, 2005, J PHYSIOL-LONDON, V562, P223, DOI 10.1113/jphysiol.2004.074047; Matthes J, 2004, N-S ARCH PHARMACOL, V369, P554, DOI 10.1007/s00210-004-0940-7; Moosmang S, 2005, PHARMACOL THERAPEUT, V106, P347, DOI 10.1016/j.pharmthera.2004.12.003; Nargeot J, 1997, EUR HEART J, V18, pA15; OUADID H, 1992, MOL PHARMACOL, V41, P346; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Qu YX, 2005, CIRCULATION, V111, P3034, DOI 10.1161/CIRCULATIONAHA.104.517326; Qu YX, 2005, AM J PHYSIOL-HEART C, V288, pH2123, DOI 10.1152/ajpheart.01023.2004; RANDALL WC, 1984, J AUTONOM NERV SYST, V11, P145, DOI 10.1016/0165-1838(84)90072-9; REUTER H, 1984, ANNU REV PHYSIOL, V46, P473; STILES GL, 1984, ANNU REV MED, V35, P149, DOI 10.1146/annurev.me.35.020184.001053; Striessnig J, 1999, CELL PHYSIOL BIOCHEM, V9, P242, DOI 10.1159/000016320; Takimoto K, 1997, J MOL CELL CARDIOL, V29, P3035, DOI 10.1006/jmcc.1997.0532; Tellez JO, 2006, CIRC RES, V99, P1384, DOI 10.1161/01.RES.0000251717.98379.69; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; Yang L, 2005, J BIOL CHEM, V280, P207, DOI 10.1074/jbc.M410509200; ZAMPONI G, 2005, VOLTAGE GATED CALCIU, P61; Zhang Z, 2005, CIRCULATION, V112, P1936, DOI 10.1161/CIRCULATIONAHA.105.540070; Zhang Z, 2002, CIRC RES, V90, P981, DOI 10.1161/01.RES.0000018003.14304.E2	30	15	16	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5042	5049		10.1074/jbc.M809132200	http://dx.doi.org/10.1074/jbc.M809132200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19074150	Green Published, hybrid			2022-12-25	WOS:000263416600034
J	Fahling, M; Mrowka, R; Steege, A; Kirschner, KM; Benko, E; Forstera, B; Persson, PB; Thiele, BJ; Meier, JC; Scholz, H				Faehling, Michael; Mrowka, Ralf; Steege, Andreas; Kirschner, Karin M.; Benko, Edgar; Foerstera, Benjamin; Persson, Pontus B.; Thiele, Bernd J.; Meier, Jochen C.; Scholz, Holger			Translational Regulation of the Human Achaete-scute Homologue-1 by Fragile X Mental Retardation Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; HIPPOCAMPAL-NEURONS; CGG REPEAT; FMR1 GENE; CELL DIFFERENTIATION; BINDING PROTEIN; MASH1; BRAIN; EXPRESSION; POLYRIBOSOMES	Fragile X syndrome is a common inherited cause of mental retardation that results from loss or mutation of the fragile X mental retardation protein (FMRP). In this study, we identified the mRNA of the basic helix-loop-helix transcription factor human achaete-scute homologue-1 (hASH1 or ASCL1), which is required for normal development of the nervous system and has been implicated in the formation of neuroendocrine tumors, as a new FMRP target. Using a double-immunofluorescent staining technique we detected an overlapping pattern of both proteins in the hippocampus, temporal cortex, subventricular zone, and cerebellum of newborn rats. Forced expression of FMRP and gene silencing by small interference RNA transfection revealed a positive correlation between the cellular protein levels of FMRP and hASH1. A luciferase reporter construct containing the 5 '-untranslated region of hASH1 mRNA was activated by the full-length FMRP, but not by naturally occurring truncated FMR proteins, in transient co-transfections. The responsible cis-element was mapped by UV-cross-linking experiments and reporter mutagenesis assays to a (U) 10 sequence located in the 5 '-untranslated region of the hASH1 mRNA. Sucrose density gradient centrifugation revealed that hASH1 transcripts were translocated into a translationally active polysomal fraction upon transient transfection of HEK293 cells with FMRP, thus indicating translational activation of hASH1 mRNA. In conclusion, we identified hASH1 as a novel downstream target of FMRP. Improved translation efficiency of hASH1 mRNA by FMRP may represent an important regulatory switch in neuronal differentiation.	[Faehling, Michael; Mrowka, Ralf; Steege, Andreas; Kirschner, Karin M.; Benko, Edgar; Persson, Pontus B.; Thiele, Bernd J.; Scholz, Holger] Univ Med Berlin, Inst Vegetat Physiol, Charite, D-10117 Berlin, Germany; [Benko, Edgar] Tech Univ Berlin, Inst Biotechnol, D-13355 Berlin, Germany; [Foerstera, Benjamin; Meier, Jochen C.] Max Delbruck Ctr Mol Med, RNA Editing & Hyperexcitabil Disorders Helmholtz, D-13092 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technical University of Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Fahling, M (corresponding author), Univ Med Berlin, Inst Vegetat Physiol, Charite, Tucholskystr 2, D-10117 Berlin, Germany.	michael.faehling@charite.de	Fähling, Michael/E-5018-2011; Mrowka, Ralf/AAW-1480-2021; Steege, Andreas/F-3885-2010	Mrowka, Ralf/0000-0002-0991-3418; Meier, Jochen/0000-0001-5574-3336; Fahling, Michael/0000-0003-1079-5049; Kirschner, Karin/0000-0003-0226-8636; Persson, Pontus/0000-0003-0926-2878	Deutsche Forschungsgemeinschaft [FA845/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by the Deutsche Forschungsgemeinschaft (DFG, Grant FA845/2-1). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Antar LN, 2005, GENES BRAIN BEHAV, V4, P350, DOI 10.1111/j.1601-183X.2005.00128.x; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Bakker CE, 2000, EXP CELL RES, V258, P162, DOI 10.1006/excr.2000.4932; BAKKER CE, 1994, CELL, V78, P23; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bittel DC, 2007, GENET MED, V9, P464, DOI 10.1097/GIM.0b013e3180ca9a9a; Borges M, 1997, NATURE, V386, P852, DOI 10.1038/386852a0; BREWER GJ, 1989, BRAIN RES, V494, P65, DOI 10.1016/0006-8993(89)90144-3; Brown V, 1998, J BIOL CHEM, V273, P15521, DOI 10.1074/jbc.273.25.15521; Casarosa S, 1999, DEVELOPMENT, V126, P525; Castella P, 1999, J NEUROSCI RES, V56, P229, DOI 10.1002/(SICI)1097-4547(19990501)56:3<229::AID-JNR2>3.0.CO;2-Z; Ceman S, 2003, HUM MOL GENET, V12, P3295, DOI 10.1093/hmg/ddg350; Corbin F, 1997, HUM MOL GENET, V6, P1465, DOI 10.1093/hmg/6.9.1465; Darnell JC, 2005, GENES BRAIN BEHAV, V4, P341, DOI 10.1111/j.1601-183X.2005.00144.x; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; Eberhart DE, 1996, HUM MOL GENET, V5, P1083, DOI 10.1093/hmg/5.8.1083; EICHLER EE, 1993, HUM MOL GENET, V2, P1147, DOI 10.1093/hmg/2.8.1147; Eichler SA, 2008, J CELL MOL MED, V12, P2848, DOI 10.1111/j.1582-4934.2008.00357.x; Fahling M, 2009, ACTA PHYSIOL, V195, P205, DOI 10.1111/j.1748-1716.2008.01894.x; Fahling M, 2006, J BIOL CHEM, V281, P26089, DOI 10.1074/jbc.M604939200; Fahling M, 2006, J BIOL CHEM, V281, P9279, DOI 10.1074/jbc.M510925200; Feng Y, 1997, J NEUROSCI, V17, P1539; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; Gabus C, 2004, NUCLEIC ACIDS RES, V32, P2129, DOI 10.1093/nar/gkh535; GEDEON AK, 1992, NAT GENET, V1, P341, DOI 10.1038/ng0892-341; Grynfeld A, 2000, INT J CANCER, V88, P401, DOI 10.1002/1097-0215(20001101)88:3<401::AID-IJC12>3.3.CO;2-M; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; HIRST M, 1995, AM J HUM GENET, V56, P67; Horton S, 1999, MOL CELL NEUROSCI, V14, P355, DOI 10.1006/mcne.1999.0791; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Jessberger S, 2008, NAT NEUROSCI, V11, P888, DOI 10.1038/nn.2148; Jin P, 2004, NAT CELL BIOL, V6, P1048, DOI 10.1038/ncb1104-1048; Jin P, 2003, TRENDS BIOCHEM SCI, V28, P152, DOI 10.1016/S0968-0004(03)00033-1; Jo AY, 2007, EXP CELL RES, V313, P4066, DOI 10.1016/j.yexcr.2007.08.026; Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015; Khandjian EW, 2004, P NATL ACAD SCI USA, V101, P13357, DOI 10.1073/pnas.0405398101; Kim EJ, 2008, MOL CELL NEUROSCI, V38, P595, DOI 10.1016/j.mcn.2008.05.008; Kokubu H, 2008, GENES CELLS, V13, P41, DOI 10.1111/j.1365-2443.2007.01146.x; Koukoui SD, 2007, BRAIN RES REV, V53, P27, DOI 10.1016/j.brainresrev.2006.06.001; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; Kuersten S, 2003, NAT REV GENET, V4, P626, DOI 10.1038/nrg1125; Lim JH, 2005, J CELL PHYSIOL, V205, P170, DOI 10.1002/jcp.20401; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; MEIJER H, 1994, HUM MOL GENET, V3, P615; Menon RP, 2004, J MOL BIOL, V343, P43, DOI 10.1016/j.jmb.2004.08.024; Miyashiro KY, 2003, NEURON, V37, P417, DOI 10.1016/S0896-6273(03)00034-5; Mrowka R, 2007, NUCLEIC ACIDS RES, V35, P5120, DOI 10.1093/nar/gkm535; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Penagarikano O, 2007, ANNU REV GENOM HUM G, V8, P109, DOI 10.1146/annurev.genom.8.080706.092249; Sang LY, 2008, SCIENCE, V321, P1095, DOI 10.1126/science.1155998; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; SIOMI H, 1994, CELL, V77, P33, DOI 10.1016/0092-8674(94)90232-1; Sugimori M, 2008, DEVELOPMENT, V135, P1271, DOI 10.1242/dev.015370; Sung YJ, 2000, BIOCHEM BIOPH RES CO, V275, P973, DOI 10.1006/bbrc.2000.3405; Torii MA, 1999, DEVELOPMENT, V126, P443; Ufer C, 2008, GENE DEV, V22, P1838, DOI 10.1101/gad.466308; VERKERK AJMH, 1993, HUM MOL GENET, V2, P399, DOI 10.1093/hmg/2.4.399; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wagner N, 2005, DEVELOPMENT, V132, P1327, DOI 10.1242/dev.01682; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; Willemsen R, 2004, MENT RETARD DEV D R, V10, P60, DOI 10.1002/mrdd.20010; Willemsen R, 2003, HUM MOL GENET, V12, P949, DOI 10.1093/hmg/ddg114; Yung SY, 2002, P NATL ACAD SCI USA, V99, P16273, DOI 10.1073/pnas.232586699; Zalfa F, 2007, NAT NEUROSCI, V10, P578, DOI 10.1038/nn1893; Zalfa F, 2006, CURR OPIN NEUROBIOL, V16, P265, DOI 10.1016/j.conb.2006.05.010; Zhong N, 1999, AM J MED GENET, V84, P268, DOI 10.1002/(SICI)1096-8628(19990528)84:3<268::AID-AJMG20>3.0.CO;2-#	70	49	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4255	4266		10.1074/jbc.M807354200	http://dx.doi.org/10.1074/jbc.M807354200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19097999	hybrid			2022-12-25	WOS:000263134400023
J	Ithychanda, SS; Das, M; Ma, YQ; Ding, KY; Wang, XX; Gupta, S; Wu, CY; Plow, EF; Qin, J				Ithychanda, Sujay Subbayya; Das, Mitali; Ma, Yan-Qing; Ding, Keyang; Wang, Xiaoxia; Gupta, Sudhiranjan; Wu, Chuanyue; Plow, Edward F.; Qin, Jun			Migfilin, a Molecular Switch in Regulation of Integrin Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; FILAMIN BINDING; PEPTIDES; ALPHA(IIB)BETA(3); LOCALIZATION; COMPETITION; MECHANICS; TRANSPORT; ADHESIONS; DOMAINS	The linkage of heterodimeric (alpha/beta) integrin receptors with their extracellular matrix ligands and intracellular actin cytoskeleton is a fundamental step for controlling cell adhesion and migration. Binding of the actin-linking protein, talin, to integrin beta cytoplasmic tails (CTs) induces high affinity ligand binding (integrin activation), whereas binding of another actin-linking protein, filamin, to the integrin beta CTs negatively regulates this process by blocking the talin-integrin interaction. Here we show structurally that migfilin, a novel cytoskeletal adaptor highly enriched in the integrin adhesion sites, strongly interacts with the same region in filamin where integrin beta CTs bind. We further demonstrate that the migfilin interaction dissociates filamin from integrin and promotes the talin/integrin binding and integrin activation. Migfilin thus acts as a molecular switch to disconnect filamin from integrin for regulating integrin activation and dynamics of extracellular matrix-actin linkage.	[Ithychanda, Sujay Subbayya; Das, Mitali; Ma, Yan-Qing; Ding, Keyang; Wang, Xiaoxia; Gupta, Sudhiranjan; Plow, Edward F.; Qin, Jun] Cleveland Clin, Dept Mol Cardiol, Lerner Res Inst, Cleveland, OH 44195 USA; [Wu, Chuanyue] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA	Cleveland Clinic Foundation; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Plow, EF (corresponding author), Cleveland Clin, Dept Mol Cardiol, Lerner Res Inst, NB20,9500 Euclid Ave, Cleveland, OH 44195 USA.	plowe@ccf.org; qinj@ccf.org	Qin, Jun/D-5559-2009; Ithychanda, Sujay Subbayya/C-7792-2011	Ithychanda, Sujay Subbayya/0000-0001-8979-246X; Qin, Jun/0000-0002-2647-9270	National Institutes of Health [GM62823, P01HL073311]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL073311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM62823 (to J. Q.) and P01HL073311 (to J. Q. and E. F. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akazawa H, 2004, J CELL BIOL, V164, P395, DOI 10.1083/jcb.200309159; Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; Chen L, 2001, CHEM BIOL, V8, P1123, DOI 10.1016/S1074-5521(01)00076-X; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; David T, 2006, J THROMB HAEMOST, V4, P2645, DOI 10.1111/j.1538-7836.2006.02198.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FAULL RJ, 1993, J CELL BIOL, V121, P155, DOI 10.1083/jcb.121.1.155; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Flanagan LA, 2001, J CELL BIOL, V155, P511, DOI 10.1083/jcb.200105148; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Goldmann WH, 2000, BIOCHEM BIOPH RES CO, V271, P553, DOI 10.1006/bbrc.2000.2653; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Klaile E, 2005, J CELL SCI, V118, P5513, DOI 10.1242/jcs.02660; Lad Y, 2008, J BIOL CHEM, V283, P35154, DOI 10.1074/jbc.M802592200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li W, 2005, P NATL ACAD SCI USA, V102, P1424, DOI 10.1073/pnas.0409334102; Luo BH, 2004, PLOS BIOL, V2, P776, DOI 10.1371/journal.pbio.0020153; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Ma YQ, 2007, J THROMB HAEMOST, V5, P1345, DOI 10.1111/j.1538-7836.2007.02537.x; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Ma YQ, 2006, BIOCHEMISTRY-US, V45, P6656, DOI 10.1021/bi060279h; Martel V, 2001, J BIOL CHEM, V276, P21217, DOI 10.1074/jbc.M102373200; Martin K, 2003, J THROMB HAEMOST, V1, P2643, DOI 10.1046/j.1538-7836.2003.00478.x; Millon-Fremillon A, 2008, J CELL BIOL, V180, P427, DOI 10.1083/jcb.200707142; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Nakamura F, 2006, BLOOD, V107, P1925, DOI 10.1182/blood-2005-10-3964; Nelson AR, 2007, BIOCHEMISTRY-US, V46, P14771, DOI 10.1021/bi701295k; Partridge AW, 2005, J BIOL CHEM, V280, P7294, DOI 10.1074/jbc.M412701200; Pudas R, 2005, STRUCTURE, V13, P111, DOI 10.1016/j.str.2004.10.014; Qin J, 2004, PLOS BIOL, V2, P726, DOI 10.1371/journal.pbio.0020169; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Sjekloca L, 2007, J MOL BIOL, V368, P1011, DOI 10.1016/j.jmb.2007.02.018; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Takafuta T, 2003, J BIOL CHEM, V278, P12175, DOI 10.1074/jbc.M209339200; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takala H, 2008, BLOOD, V112, P1853, DOI 10.1182/blood-2007-12-127795; Trehin R, 2004, EUR J PHARM BIOPHARM, V58, P209, DOI 10.1016/j.ejpb.2004.02.018; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; UGAROVA TP, 1993, J BIOL CHEM, V268, P21080; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Watanabe N, 2008, J CELL BIOL, V181, P1211, DOI 10.1083/jcb.200803094; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Wu CY, 2005, J CELL SCI, V118, P659, DOI 10.1242/jcs.01639; Xu YZ, 2006, J BIOMOL NMR, V34, P41, DOI 10.1007/s10858-005-5358-0; Ye YP, 2006, J MED CHEM, V49, P2268, DOI 10.1021/jm050947h; Zhang Y, 2006, J BIOL CHEM, V281, P39897, DOI 10.1074/jbc.M608657200; ZHANG ZH, 1993, J CELL BIOL, V122, P235, DOI 10.1083/jcb.122.1.235	56	89	92	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4713	4722		10.1074/jbc.M807719200	http://dx.doi.org/10.1074/jbc.M807719200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19074766	Green Published, hybrid			2022-12-25	WOS:000263134400071
J	Verselis, VK; Trelles, MP; Rubinos, C; Bargiello, TA; Srinivas, M				Verselis, Vytas K.; Trelles, Maria P.; Rubinos, Clio; Bargiello, Thaddeus A.; Srinivas, Miduturu			Loop Gating of Connexin Hemichannels Involves Movement of Pore-lining Residues in the First Extracellular Loop Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION HEMICHANNELS; SINGLE-CHANNEL SCAM; ATP RELEASE; METABOLIC INHIBITION; CX46 HEMICHANNELS; AMINO-TERMINUS; HEAVY-METALS; ION-CHANNEL; HELA-CELLS; SELECTIVITY	Unapposed connexin hemichannels exhibit robust closure in response to membrane hyperpolarization and extracellular calcium. This form of gating, termed "loop gating," is largely responsible for regulating hemichannel opening, thereby preventing cell damage through excessive flux of ions and metabolites. The molecular components and structural rearrangements underlying loop gating remain unknown. Here, using cysteine mutagenesis in Cx50, we demonstrate that residues at the TM1/E1 border undergo movement during loop gating. Replacement of Phe(43) in Cx50 with a cysteine resulted in small or no appreciable membrane currents. Bath application of dithiothreitol or TPEN (N,N,N',N'-tetrakis(2-pyridylmethyl) ethylenediamine), reagents that exhibit strong transition metal chelating activity, led to robust currents indicating that the F43C substitution impaired hemichannel function, producing "lock-up" in a closed or poorly functional state due to formation of metal bridges. In support, Cd2+ at submicromolar concentrations (50-100 nM) enhanced lock-up of F43C hemichannels. Moreover, lock-up occurred under conditions that favored closure, indicating that the sulfhydryl groups come close enough to each other or to other residues to coordinate metal ions with high affinity. In addition to F43C, metal binding was also found for G46C, and to a lesser extent, D51C substitutions, positions found to be pore-lining in the open state using the substituted-cysteine accessibility method, but not for A40C and A41C substitutions, which were not found to reside in the open pore. These results indicate that metal ions access the cysteine side chains through the open pore and that closure of the loop gate involves movement of the TM1/E1 region that results in local narrowing of the large aqueous connexin pore.	[Verselis, Vytas K.; Bargiello, Thaddeus A.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; [Trelles, Maria P.; Rubinos, Clio; Srinivas, Miduturu] SUNY Coll Optometry, Dept Biol Sci, New York, NY 10036 USA	Yeshiva University; Albert Einstein College of Medicine; State University of New York (SUNY) System; SUNY Optometry	Verselis, VK (corresponding author), 1300 Morris Pk Ave, Bronx, NY 10461 USA.	verselis@aecom.yu.edu; msrinivas@sunyopt.edu		Rubinos, Clio/0000-0002-1680-2302	National Institutes of Health Grants [GM54179, EY13869]; NATIONAL EYE INSTITUTE [R01EY013869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054179] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM54179 (to V. K. V.) and EY13869 (to M. S.).	ARSLAN P, 1985, J BIOL CHEM, V260, P2719; Bao L, 2004, AM J PHYSIOL-CELL PH, V287, pC1389, DOI 10.1152/ajpcell.00220.2004; Beahm DL, 2002, BIOPHYS J, V82, P2016, DOI 10.1016/S0006-3495(02)75550-1; Bukauskas FF, 2004, BBA-BIOMEMBRANES, V1662, P42, DOI 10.1016/j.bbamem.2004.01.008; BUKAUSKAS FF, 1995, BIOPHYS J, V68, P2289, DOI 10.1016/S0006-3495(95)80411-X; Bukauskas FF, 2001, METH MOL B, V154, P379; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Contreras JE, 2002, P NATL ACAD SCI USA, V99, P495, DOI 10.1073/pnas.012589799; Doyle DA, 2004, TRENDS NEUROSCI, V27, P298, DOI 10.1016/j.tins.2004.04.004; Ebihara L, 2003, BIOPHYS J, V84, P277, DOI 10.1016/S0006-3495(03)74848-6; EBIHARA L, 1993, J GEN PHYSIOL, V102, P59, DOI 10.1085/jgp.102.1.59; Genetos DC, 2007, J CELL PHYSIOL, V212, P207, DOI 10.1002/jcp.21021; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; John SA, 1999, J BIOL CHEM, V274, P236, DOI 10.1074/jbc.274.1.236; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Krezel A, 2001, J INORG BIOCHEM, V84, P77, DOI 10.1016/S0162-0134(00)00212-9; Kronengold J, 2003, CELL COMMUN ADHES, V10, P193, DOI 10.1080/15419060390264325; Kronengold J, 2003, J GEN PHYSIOL, V122, P389, DOI 10.1085/jgp.200308861; Oh S, 2000, J GEN PHYSIOL, V116, P13, DOI 10.1085/jgp.116.1.13; OSHIMA A, 2007, P NATL ACAD SCI US; Pfahnl A, 1998, BIOPHYS J, V75, P2323, DOI 10.1016/S0006-3495(98)77676-3; Puljung MC, 2004, J GEN PHYSIOL, V124, P587, DOI 10.1085/jgp.200409023; Purnick PEM, 2000, ARCH BIOCHEM BIOPHYS, V381, P181, DOI 10.1006/abbi.2000.1989; Purnick PEM, 2000, BIOPHYS J, V79, P2403, DOI 10.1016/S0006-3495(00)76485-X; Retamal MA, 2006, P NATL ACAD SCI USA, V103, P4475, DOI 10.1073/pnas.0511118103; Ri Y, 1999, BIOPHYS J, V76, P2887, DOI 10.1016/S0006-3495(99)77444-8; Schock SC, 2008, BIOCHEM BIOPH RES CO, V368, P138, DOI 10.1016/j.bbrc.2008.01.054; Srinivas M, 2006, J GEN PHYSIOL, V127, P67, DOI 10.1085/jgp.200509397; Srinivas M, 2005, BIOPHYS J, V88, P1725, DOI 10.1529/biophysj.104.054023; Srinivas M, 2001, P NATL ACAD SCI USA, V98, P10942, DOI 10.1073/pnas.191206198; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Sukharev S, 2001, NATURE, V409, P720, DOI 10.1038/35055559; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Tong JJ, 2006, BIOPHYS J, V91, P2142, DOI 10.1529/biophysj.106.082859; Trexler EB, 2000, BIOPHYS J, V79, P3036, DOI 10.1016/S0006-3495(00)76539-8; Trexler EB, 1996, P NATL ACAD SCI USA, V93, P5836, DOI 10.1073/pnas.93.12.5836; Unger VM, 1999, SCIENCE, V283, P1176, DOI 10.1126/science.283.5405.1176; Valiunas V, 2000, PFLUG ARCH EUR J PHY, V440, P366, DOI 10.1007/s004240000294; Valiunas V, 2002, CIRC RES, V91, P104, DOI 10.1161/01.RES.0000025638.24255.AA; Verselis V.K., 2000, ADV MOL CEL, V30, P129; VERSELIS VK, 1994, NATURE, V368, P348, DOI 10.1038/368348a0; Verselis VK, 2008, J GEN PHYSIOL, V132, P315, DOI 10.1085/jgp.200810029; Verselis Vytas K., 2009, P77, DOI 10.1007/978-1-59745-489-6_3; Wang HZ, 1997, J GEN PHYSIOL, V109, P491, DOI 10.1085/jgp.109.4.491; Zampighi GA, 1999, J GEN PHYSIOL, V113, P507, DOI 10.1085/jgp.113.4.507; Zhao HB, 2005, P NATL ACAD SCI USA, V102, P18724, DOI 10.1073/pnas.0506481102	46	70	71	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4484	4493		10.1074/jbc.M807430200	http://dx.doi.org/10.1074/jbc.M807430200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19074140	Green Published, hybrid			2022-12-25	WOS:000263134400048
J	Jeong, YI; Kim, SW; Jung, ID; Lee, JS; Chang, JH; Lee, CM; Chun, SH; Yoon, MS; Kim, GT; Ryu, SW; Kim, JS; Shin, YK; Lee, WS; Shin, HK; Lee, JD; Park, YM				Jeong, Young-Il; Kim, Sang Woo; Jung, In Duk; Lee, Jun Sik; Chang, Jeong Hyun; Lee, Chang-Min; Chun, Sung Hak; Yoon, Man-Soo; Kim, Geun Tae; Ryu, Seok Woo; Kim, Jong-Suk; Shin, Yong Kyoo; Lee, Won Suk; Shin, Hwa Kyoung; Lee, Jae-Dong; Park, Yeong-Min			Curcumin Suppresses the Induction of Indoleamine 2,3-Dioxygenase by Blocking the Janus-activated Kinase-Protein Kinase C delta-STAT1 Signaling Pathway in Interferon-gamma-stimulated Murine Dendritic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TRYPTOPHAN CATABOLISM; IN-VIVO; SERINE PHOSPHORYLATION; POTENTIAL TARGETS; GENE PROMOTER; COLON-CANCER; EXPRESSION; TOLERANCE; IDO	Indoleamine 2,3-dioxygenase (IDO) catalyzes the initial and rate-limiting step in the degradation of tryptophan and is strongly induced in interferon-gamma (IFN gamma)-stimulated dendritic cells (DCs). IDO has recently been established as a key enzyme in T-cell suppression-mediated immune tolerance to tumors. STAT1 phosphorylation appears to play an important role in the control of IDO expression by IFN gamma, but the precise regulatory mechanism remains obscure. Here we present a novel mechanism of IFN gamma-induced IDO expression in bone marrow-derived dendritic cells. In addition, we demonstrate that curcumin, an active component of turmeric, significantly inhibited the induction of IDO expression and activity by IFN gamma. We found that curcumin suppressed STAT1 activation by directly inhibiting Janus-activated kinase 1/2 and protein kinase C delta phosphorylation in bone marrow-derived DCs, suppressing the subsequent translocation and binding of STAT1 to the GAS element of the IRF-1 promoter. Coincident with these inhibitory effects on IFN gamma-induced IDO expression, curcumin reversed IDO-mediated suppression of T-cell responses. Our results, thus, suggest that down-regulation of IDO in DCs is an important immunomodulatory property of curcumin that may be exploited therapeutically in the control of cancers.	[Jung, In Duk; Lee, Jun Sik; Lee, Chang-Min; Chun, Sung Hak; Park, Yeong-Min] Pusan Natl Univ, Dept Microbiol & Immunol, Pusan 602739, South Korea; [Jeong, Young-Il; Lee, Jae-Dong] Pusan Natl Univ, Coll Nat Sci, Dept Microbiol, Pusan 609735, South Korea; [Kim, Sang Woo; Yoon, Man-Soo] Pusan Natl Univ, Dept Obstet & Gynecol, Pusan 602739, South Korea; [Jung, In Duk; Lee, Jun Sik; Lee, Chang-Min; Chun, Sung Hak; Park, Yeong-Min] Pusan Natl Univ, Natl Res Lab Dendrit Cell Differentiat & Regulat, Med Res Inst, Pusan 602739, South Korea; [Lee, Won Suk; Shin, Hwa Kyoung] Pusan Natl Univ, Dept Pharmacol, Coll Med, Pusan 602739, South Korea; [Chang, Jeong Hyun] Daegu Haany Univ, Coll Hlth & Therapy, Dept Clin Lab Sci, Gyeongsangbuk Do 712715, Gyeongsan, South Korea; [Kim, Geun Tae] Busan Med Ctr, Dept Internal Med, Pusan 611072, South Korea; [Ryu, Seok Woo] Busan Med Ctr, Dept Family Med, Pusan 611072, South Korea; [Kim, Jong-Suk] Chonbuk Natl Univ, Sch Med, Dept Biochem, Jeonju 561180, South Korea; [Shin, Yong Kyoo] Chung Ang Univ, Coll Med, Dept Pharmacol, Seoul 156756, South Korea	Pusan National University; Pusan National University; Pusan National University; Pusan National University; Pusan National University; Daegu Haany University; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Jeonbuk National University; Chung Ang University; Chung Ang University Hospital	Park, YM (corresponding author), Pusan Natl Univ, Dept Microbiol & Immunol, Ami Dong 1-10, Pusan 602739, South Korea.	immunpym@pusan.ac.kr			Korea Science and Engineering Foundation [R0A-2005-000-10008-0]	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported by the Korea Science and Engineering Foundation through National Research Laboratory Program Grant R0A-2005-000-10008-0. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aggarwal BB, 2005, CLIN CANCER RES, V11, P7490, DOI 10.1158/1078-0432.CCR-05-1192; Belz GT, 2002, J EXP MED, V196, P1099, DOI 10.1084/jem.20020861; Braun D, 2005, BLOOD, V106, P2375, DOI 10.1182/blood-2005-03-0979; BURKE F, 1995, INT J CANCER, V60, P115, DOI 10.1002/ijc.2910600117; Chon SY, 1996, J BIOL CHEM, V271, P17247, DOI 10.1074/jbc.271.29.17247; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Fallarino I, 2002, CELL DEATH DIFFER, V9, P1069, DOI 10.1038/sj.cdd.4401073; Granucci F, 2003, EMBO J, V22, P2546, DOI 10.1093/emboj/cdg261; Grohmann U, 2000, J IMMUNOL, V165, P1357, DOI 10.4049/jimmunol.165.3.1357; Grohmann U, 2001, J IMMUNOL, V167, P708, DOI 10.4049/jimmunol.167.2.708; Grohmann U, 2001, J IMMUNOL, V166, P277, DOI 10.4049/jimmunol.166.1.277; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hou DY, 2007, CANCER RES, V67, P792, DOI 10.1158/0008-5472.CAN-06-2925; Hwu P, 2000, J IMMUNOL, V164, P3596, DOI 10.4049/jimmunol.164.7.3596; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Ireson C, 2001, CANCER RES, V61, P1058; Jeong YI, 2007, BIOCHEM BIOPH RES CO, V354, P1004, DOI 10.1016/j.bbrc.2007.01.076; Johnson JJ, 2007, CANCER LETT, V255, P170, DOI 10.1016/j.canlet.2007.03.005; Jung ID, 2007, FEBS LETT, V581, P1449, DOI 10.1016/j.febslet.2007.02.073; Kawamori T, 1999, CANCER RES, V59, P597; Kim GY, 2005, J IMMUNOL, V174, P8116, DOI 10.4049/jimmunol.174.12.8116; Kim SI, 2007, INT IMMUNOPHARMACOL, V7, P805, DOI 10.1016/j.intimp.2007.01.020; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Lee HJ, 2007, BIOCHEM PHARMACOL, V73, P1412, DOI 10.1016/j.bcp.2006.12.018; LEW DJ, 1991, MOL CELL BIOL, V11, P182, DOI 10.1128/MCB.11.1.182; Ma XJ, 1996, J EXP MED, V183, P147, DOI 10.1084/jem.183.1.147; MARTIN E, 1994, J EXP MED, V180, P977, DOI 10.1084/jem.180.3.977; Matthews SA, 2006, CURR OPIN IMMUNOL, V18, P314, DOI 10.1016/j.coi.2006.03.006; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Mellor AL, 1999, IMMUNOL TODAY, V20, P469, DOI 10.1016/S0167-5699(99)01520-0; Mellor AL, 2004, INT IMMUNOL, V16, P1391, DOI 10.1093/intimm/dxh140; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Muller AJ, 2005, NAT MED, V11, P312, DOI 10.1038/nm1196; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; Munn DH, 2004, J CLIN INVEST, V114, P280, DOI 10.1172/JCI200421583; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Orabona C, 2006, BLOOD, V107, P2846, DOI 10.1182/blood-2005-10-4077; Ozawa H, 1996, EUR J IMMUNOL, V26, P648, DOI 10.1002/eji.1830260321; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Ramsauer K, 2007, P NATL ACAD SCI USA, V104, P2849, DOI 10.1073/pnas.0610944104; RUBY AJ, 1995, CANCER LETT, V94, P79, DOI 10.1016/0304-3835(95)03827-J; Stan SD, 2008, J CELL BIOCHEM, V104, P339, DOI 10.1002/jcb.21623; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Tas SW, 2007, BLOOD, V110, P1540, DOI 10.1182/blood-2006-11-056010; Thomas SR, 2001, J IMMUNOL, V166, P6332, DOI 10.4049/jimmunol.166.10.6332; Wakkach A, 2003, IMMUNITY, V18, P605, DOI 10.1016/S1074-7613(03)00113-4; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Williams CA, 2008, IMMUNOLOGY, V124, P89, DOI 10.1111/j.1365-2567.2007.02743.x; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	50	86	91	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3700	3708		10.1074/jbc.M807328200	http://dx.doi.org/10.1074/jbc.M807328200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19075017	hybrid			2022-12-25	WOS:000262872500038
J	Steirer, LM; Park, EI; Townsend, RR; Baenziger, JU				Steirer, Lindsay M.; Park, Eric I.; Townsend, R. Reid; Baenziger, Jacques U.			The Asialoglycoprotein Receptor Regulates Levels of Plasma Glycoproteins Terminating with Sialic Acid alpha 2,6-Galactose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOLATED RAT HEPATOCYTES; MICE LACKING; SUBUNIT; LECTIN; CELL; OLIGOSACCHARIDES; DETERMINANTS; SPECIFICITY; DEFICIENCY; EXPRESSION	The asialoglycoprotein receptor (ASGP-R) is an abundant, carbohydrate-specific, endocytic receptor expressed by parenchymal cells of the liver. We recently demonstrated that the ASGP-R mediates the clearance of glycoproteins bearing Sia alpha 2,6GalNAc as well as those bearing terminal Gal or GalNAc. We now report that glycoproteins such as haptoglobin, serum amyloid protein (SAP), and carboxylesterase that bear oligosaccharides with terminal Sia alpha 2,6Gal are elevated in the plasma of ASGP-R-deficient mice. Because of their abundance in plasma, glycoproteins bearing terminal Sia alpha 2,6Gal will saturate the ASGP-R and compete with each other on the basis of their relative affinities for the ASGP-R and their relative abundance. We propose that the ASGP-R mediates the clearance of glycoproteins that bear oligosaccharides terminating with Sia alpha 2,6Gal and thereby helps maintain the relative concentrations of these glycoproteins in the blood.	[Steirer, Lindsay M.; Park, Eric I.; Baenziger, Jacques U.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Townsend, R. Reid] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Steirer, Lindsay M.; Townsend, R. Reid; Baenziger, Jacques U.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Baenziger, JU (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	Baenziger@wustl.edu	Baenziger, Jacques U/E-9430-2012		National Institutes of Health [R37-CA21923]; National Centers of Research Resources [P41-RR00954]; Siteman Cancer Center; institutional resources to the Proteomics Center; NATIONAL CANCER INSTITUTE [R01CA021923, R37CA021923] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Centers of Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Siteman Cancer Center; institutional resources to the Proteomics Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant R37-CA21923 (to J. U. B.). This work was also supported by the National Centers of Research Resources P41-RR00954, the Siteman Cancer Center, and institutional resources to the Proteomics Center. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531; BAENZIGER JU, 1979, J BIOL CHEM, V254, P9795; BAENZIGER JU, 1980, CELL, V22, P611, DOI 10.1016/0092-8674(80)90371-2; BERGWERFF AA, 1995, EUR J BIOCHEM, V228, P1009; Braun JR, 1996, J BIOL CHEM, V271, P21160, DOI 10.1074/jbc.271.35.21160; Bredemeyer AJ, 2004, P NATL ACAD SCI USA, V101, P11785, DOI 10.1073/pnas.0402353101; Dalziel M, 1999, GLYCOBIOLOGY, V9, P1003, DOI 10.1093/glycob/9.10.1003; DELL A, 1995, J BIOL CHEM, V270, P24116, DOI 10.1074/jbc.270.41.24116; Grewal PK, 2008, NAT MED, V14, P648, DOI 10.1038/nm1760; HARTREE AS, 1992, BIOCHEM J, V287, P665, DOI 10.1042/bj2870665; HOOPER LV, 1995, J BIOL CHEM, V270, P5985, DOI 10.1074/jbc.270.11.5985; ISHIBASHI S, 1994, J BIOL CHEM, V269, P27803; Kawada N, 1997, HISTOL HISTOPATHOL, V12, P1069; Kedderis GL, 1996, TOXICOL APPL PHARM, V140, P124, DOI 10.1006/taap.1996.0205; Manzella SM, 1997, J BIOL CHEM, V272, P4775, DOI 10.1074/jbc.272.8.4775; MENGELING BJ, 1991, ANAL BIOCHEM, V199, P286, DOI 10.1016/0003-2697(91)90103-Z; Mi YL, 2008, J CLIN INVEST, V118, P1815, DOI 10.1172/JCI32467; MORELL AG, 1971, J BIOL CHEM, V246, P1461; Nyame AK, 1999, GLYCOBIOLOGY, V9, P1029, DOI 10.1093/glycob/9.10.1029; Park EI, 2005, P NATL ACAD SCI USA, V102, P17125, DOI 10.1073/pnas.0508537102; Park EI, 2003, J BIOL CHEM, V278, P4597, DOI 10.1074/jbc.M210612200; SCHWARTZ AL, 1980, J BIOL CHEM, V255, P9033; SCHWARTZ AL, 1982, J BIOL CHEM, V257, P4230; SHIBUYA N, 1987, J BIOL CHEM, V262, P1596; TOLLESHAUG H, 1977, BIOCHIM BIOPHYS ACTA, V499, P73, DOI 10.1016/0304-4165(77)90230-6; Tozawa R, 2001, J BIOL CHEM, V276, P12624, DOI 10.1074/jbc.M011063200; Unverzagt C, 2002, J MED CHEM, V45, P478, DOI 10.1021/jm0110237; VanDamme EJM, 1996, EUR J BIOCHEM, V235, P128, DOI 10.1111/j.1432-1033.1996.00128.x; WEIGEL PH, 1980, J BIOL CHEM, V255, P6111	29	72	73	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3777	3783		10.1074/jbc.M808689200	http://dx.doi.org/10.1074/jbc.M808689200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19075021	Green Published, hybrid			2022-12-25	WOS:000262872500046
J	Dyer, AG; Vuong, QC				Dyer, Adrian G.; Vuong, Quoc C.			Insect Brains Use Image Interpolation Mechanisms to Recognise Rotated Objects	PLOS ONE			English	Article							FACE RECOGNITION; HONEYBEES; REPRESENTATION; VIEWPOINT; MONKEYS; VISION; WASP	Recognising complex three-dimensional objects presents significant challenges to visual systems when these objects are rotated in depth. The image processing requirements for reliable individual recognition under these circumstances are computationally intensive since local features and their spatial relationships may significantly change as an object is rotated in the horizontal plane. Visual experience is known to be important in primate brains learning to recognise rotated objects, but currently it is unknown how animals with comparatively simple brains deal with the problem of reliably recognising objects when seen from different viewpoints. We show that the miniature brain of honeybees initially demonstrate a low tolerance for novel views of complex shapes (e. g. human faces), but can learn to recognise novel views of stimuli by interpolating between or 'averaging' views they have experienced. The finding that visual experience is also important for bees has important implications for understanding how three dimensional biologically relevant objects like flowers are recognised in complex environments, and for how machine vision might be taught to solve related visual problems.	Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia; [Dyer, Adrian G.] Johannes Gutenberg Univ Mainz, Inst Zool III, D-6500 Mainz, Germany; [Vuong, Quoc C.] Univ Newcastle, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England	Monash University; Johannes Gutenberg University of Mainz; Newcastle University - UK	Dyer, AG (corresponding author), Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia.	adrian.dyer@med.monash.edu.au		Vuong, Quoc/0000-0002-5983-964X	Alexander von Humboldt Foundation; USAF AOARD [064038, 074080]; Monash-Newcastle University Neuroscience Initiative	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); USAF AOARD; Monash-Newcastle University Neuroscience Initiative	The study was completed with the financial assistance of Alexander von Humboldt Foundation (for experiments in Germany), the USAF AOARD (064038 and 074080; provided salary support and equipment for AGD), and the Monash-Newcastle University Neuroscience Initiative (facilitated meetings and data sharing between AGD and QCV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNARD J, 2007, ANIM COGN, V9, P257; Bruce V, 1999, J EXP PSYCHOL-APPL, V5, P339, DOI 10.1037/1076-898X.5.4.339; BULTHOFF HH, 1992, P NATL ACAD SCI USA, V89, P60, DOI 10.1073/pnas.89.1.60; Chittka L, 2003, NATURE, V424, P388, DOI 10.1038/424388a; COLLETT TS, 1995, J COMP PHYSIOL A, V177, P287, DOI 10.1007/BF00192418; Dafni A, 1997, BIOL REV, V72, P239, DOI 10.1017/S0006323196005002; Dyer AG, 2008, J EXP BIOL, V211, P1180, DOI 10.1242/jeb.016683; Dyer AG, 2005, J EXP BIOL, V208, P4709, DOI 10.1242/jeb.01929; DYER AG, 2007, WORLD C NEUR; Frisch K. v., 1967, DANCE LANGUAGE ORIEN; Giurfa M, 1999, ANIM BEHAV, V57, P315, DOI 10.1006/anbe.1998.0957; Giurfa M, 2001, NATURE, V410, P930, DOI 10.1038/35073582; Hill H, 1997, COGNITION, V62, P201, DOI 10.1016/S0010-0277(96)00785-8; Kendrick KM, 2001, NATURE, V414, P165, DOI 10.1038/35102669; Kourtzi Z, 2006, CURR OPIN NEUROBIOL, V16, P152, DOI 10.1016/j.conb.2006.03.012; Liu CH, 2002, COGNITION, V83, P31, DOI 10.1016/S0010-0277(01)00164-0; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; LOGOTHETIS NK, 1994, CURR BIOL, V4, P401, DOI 10.1016/S0960-9822(00)00089-0; MARR D, 1978, PROC R SOC SER B-BIO, V200, P269, DOI 10.1098/rspb.1978.0020; Perrett DI, 1998, COGNITION, V67, P111, DOI 10.1016/S0010-0277(98)00015-8; POGGIO T, 1990, NATURE, V343, P263, DOI 10.1038/343263a0; RIND FC, 2004, METHODS INSECT SENSO, P213; SLATER A, 1985, PERCEPTION, V14, P337, DOI 10.1068/p140337; Spetch ML, 2003, PSYCHON B REV, V10, P135, DOI 10.3758/BF03196477; Stach S, 2004, NATURE, V429, P758, DOI 10.1038/nature02594; Stach S, 2005, BEHAV BRAIN RES, V161, P8, DOI 10.1016/j.bbr.2005.02.008; Tibbetts EA, 2004, NATURE, V432, P218, DOI 10.1038/nature02949; Tibbetts EA, 2002, P ROY SOC B-BIOL SCI, V269, P1423, DOI 10.1098/rspb.2002.2031; Turati C, 2008, COGNITION, V106, P1300, DOI 10.1016/j.cognition.2007.06.005; Vuong QC, 2004, VISION RES, V44, P1717, DOI 10.1016/j.visres.2004.02.002; Zhang Shaowu, 2004, P41	31	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4086	10.1371/journal.pone.0004086	http://dx.doi.org/10.1371/journal.pone.0004086			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437DO	19116650	Green Published, gold, Green Submitted			2022-12-25	WOS:000265466600007
J	Gray, DJ; Williams, GM; Li, YS; McManus, DP				Gray, Darren J.; Williams, Gail M.; Li, Yuesheng; McManus, Donald P.			Transmission Dynamics of Schistosoma japonicum in the Lakes and Marshlands of China	PLOS ONE			English	Article							REPUBLIC-OF-CHINA; YANGTZE-RIVER VALLEY; SAMAR PROVINCE; POYANG LAKE; BASE-LINE; ANHUI PROVINCE; WATER-BUFFALOS; WESTERN SAMAR; INFECTION; INTERVENTION	Background: Schistosoma japonicum is a major public health concern in China, with over one million people infected and another 40 million living in areas at risk of infection. Unlike the disease caused by S. mansoni and S. haematobium, schistosomiasis japonica is a zoonosis, involving a number of different mammalian species as reservoir hosts. As a result of a number of published reports from China, it has long been considered that bovines, particularly water buffaloes, play a major role in human S. japonicum transmission there, and a drug-based intervention study (1998-2003) around the Poyang Lake in Jiangxi Province provided proof of concept that water buffaloes are, indeed, major reservoirs of human infection in this setting. Methods and Findings: In this study we incorporated recently obtained epidemiological information to model the steady-state S. japonicum transmission as well as the impact of the removal of S. japonicum transmission attributable to water buffaloes on human infection rates across six different endemic scenarios within three villages in the Dongting (Hunan) and Poyang (Jiangxi) lakes of southern China. Similar results were obtained for all scenarios. Steady-state S. japonicum infection rates remained constant and human prevalence and incidence were predicted to fall considerably over time. The model showed that the contribution of S. japonicum water buffalo transmission to human infection ranged from 39.1% to 99.1% and predicted that the removal of water buffalo transmission would reduce parasite reproductive rates below 1. This indicates that without the contribution of water buffaloes, S. japonicum transmission is interrupted and unsustainable. These scenarios are generalizable to other endemic villages in the lake and marshland areas of China where a similar cycle of snail infection and infection/reinfection of humans and bovines occurs. Conclusions: Along with previous epidemiological data, our findings strongly support water buffaloes as an important component of the transmission cycle that affects humans in the lake and marshlands region of China, a feature which appears to differ from the situation prevalent in the Philippines where their contribution is less pronounced. Our conclusions underscore the rationale for removal, replacement or treatment of water buffaloes, and for the development and deployment of a transmission blocking buffalo vaccine against S. japonicum for this setting to achieve the goal of transmission control. The Chinese Government has recently commenced a new integrated national strategy to improve on existing approaches to control schistosomiasis in the lake and marshlands region by reducing bovines and humans as a source of S. japonicum infection to Oncomelania snails.	[Li, Yuesheng; McManus, Donald P.] Queensland Inst Med Res, Mol Parasitol Lab, Herston, Qld 4006, Australia; [Gray, Darren J.; Williams, Gail M.] Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia; [Li, Yuesheng] WHO, Collaborating Ctr Res & Control Schistosomiasis, Hunan Inst Parasit Dis, Yueyang, Peoples R China	QIMR Berghofer Medical Research Institute; University of Queensland; World Health Organization	Gray, DJ (corresponding author), Queensland Inst Med Res, Mol Parasitol Lab, Bramston Terrace, Herston, Qld 4006, Australia.	donM@qimr.edu.au	Gray, Darren/A-8455-2011; McManus, Don/AAC-5394-2020; McManus, Donald P./G-2678-2013; Williams, Gail/S-8833-2019; LI, Yue/GRS-8071-2022	McManus, Don/0000-0001-6443-1449; Williams, Gail/0000-0002-4822-5263; Gray, Darren/0000-0003-3525-1339	Wellcome Trust (UK); National Health and Medical Research Council of Australia	Wellcome Trust (UK)(Wellcome Trust); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Wellcome Trust (UK) and National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balen J, 2007, B WORLD HEALTH ORGAN, V85, P519, DOI 10.2471/BLT.06.034033; Barbour AD, 1996, AM J TROP MED HYG, V55, P135, DOI 10.4269/ajtmh.1996.55.135; Carabin H, 2005, INT J PARASITOL, V35, P1517, DOI 10.1016/j.ijpara.2005.06.010; *COMM NEA, 1998, CHIN J PARASITOL PAR, V16, P84; Da'Dara AA, 2008, VACCINE, V26, P3617, DOI 10.1016/j.vaccine.2008.04.080; Davis GM, 2002, AM J TROP MED HYG, V66, P359, DOI 10.4269/ajtmh.2002.66.359; DeBont J, 1997, PARASITOL TODAY, V13, P255, DOI 10.1016/S0169-4758(97)01057-0; Fedorko James M., 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P343; Fernandez TJ, 2007, VECTOR-BORNE ZOONOT, V7, P147, DOI 10.1089/vbz.2006.0565; Finkelstein JL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000158; Gray DJ, 2007, AM J TROP MED HYG, V77, P866, DOI 10.4269/ajtmh.2007.77.866; Guo JG, 2006, AM J TROP MED HYG, V74, P335, DOI 10.4269/ajtmh.2006.74.335; Guo JG, 2001, AM J TROP MED HYG, V65, P272, DOI 10.4269/ajtmh.2001.65.272; He YX, 2001, TRENDS PARASITOL, V17, P320, DOI 10.1016/S1471-4922(01)01904-3; Ho Yi-HsuN, 1963, Chinese Medical Journal, V82, P403; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Johansen MV, 2000, ACTA TROP, V76, P85, DOI 10.1016/S0001-706X(00)00103-0; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; LU YL, 1980, SELECTION SCHISTOSOM, P453; LUO XF, 1988, CHIN J VET SCI TECHN, V8, P42; *MATHS ENG ED INC, 2004, MATHC VERS 14; McGarvey ST, 2006, B WORLD HEALTH ORGAN, V84, P446, DOI 10.2471/BLT.05.026427; McManus DP, 2006, PARASITOLOGY, V133, pS43, DOI 10.1017/S0031182006001806; Minggang Chen, 1999, Parasitology International, V48, P11, DOI 10.1016/S1383-5769(99)00004-5; MITCHELL GF, 1990, PARASITOLOGY, V101, P27, DOI 10.1017/S0031182000079713; Riley S, 2008, PLOS MED, V5, P70, DOI 10.1371/journal.pmed.0050018; Ross AGP, 2002, NEW ENGL J MED, V346, P1212, DOI 10.1056/NEJMra012396; Ross AGP, 2001, CLIN MICROBIOL REV, V14, P270, DOI 10.1128/CMR.14.2.270-295.2001; Utzinger J, 2005, ACTA TROP, V96, P69, DOI 10.1016/j.actatropica.2005.08.004; van der Werf MJ, 2003, ACTA TROP, V86, P125, DOI 10.1016/S0001-706X(03)00029-9; WANG LD, 2006, EPIDEMIC STATUS SCHI; Wang LK, 2007, INT SER DEV HEAT TRA, P11; Wang TP, 2006, INT J PARASITOL, V36, P1317, DOI 10.1016/j.ijpara.2006.06.011; Wang TP, 2006, J PARASITOL, V92, P1088, DOI 10.1645/GE-806R.1; Wang TP, 2005, ACTA TROP, V96, P198, DOI 10.1016/j.actatropica.2005.07.017; *WHO, 1993, CONTR SCH; Williams GM, 2002, ACTA TROP, V82, P253, DOI 10.1016/S0001-706X(02)00017-7; Willingham A. L., 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P128; Zhou XN, 2007, EMERG INFECT DIS, V13, P1470, DOI 10.3201/eid1310.061423; Zhou XN, 2005, ACTA TROP, V96, P97, DOI 10.1016/j.actatropica.2005.07.005	40	77	85	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2008	3	12							e4058	10.1371/journal.pone.0004058	http://dx.doi.org/10.1371/journal.pone.0004058			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DL	19115007	Green Published, gold			2022-12-25	WOS:000265466300004
J	Gilge, JL; Fisher, M; Chai, YC				Gilge, Jasen Lee; Fisher, Michael; Chai, Yuh-Cherng			The Effect of Oxidant and the Non-Oxidant Alteration of Cellular Thiol Concentration on the Formation of Protein Mixed-Disulfides in HEK 293 Cells	PLOS ONE			English	Article							S-GLUTATHIONYLATION; REDOX REGULATION; OXIDATION; CHROMATOGRAPHY; STRESS	Cellular molecules possess various mechanisms in responding to oxidant stress. In terms of protein responses, protein S-glutathionylation is a unique post-translational modification of protein reactive cysteines forming disulfides with glutathione molecules. This modification has been proposed to play roles in antioxidant, regulatory and signaling in cells under oxidant stress. Recently, the increased level of protein S-glutathionylation has been linked with the development of diseases. In this report, specific S-glutathionylated proteins were demonstrated in human embryonic kidney 293 cells treated with two different oxidative reagents: diamide and hydrogen peroxide. Diamide is a chemical oxidizing agent whereas hydrogen peroxide is a physiological oxidant. Under the experimental conditions, these two oxidants decreased glutathione concentration without toxicity. S-glutathionylated proteins were detected by immunoblotting and glutathione concentrations were determined by high performance liquid chromatography. We further show the effect of alteration of the cellular thiol pool on the amount of protein S-glutathionylation in oxidant-treated cells. Cellular thiol concentrations were altered either by a specific way using buthionine sulfoximine, a specific inhibitor of glutathione biosynthesis or by a non-specific way, incubating cells in cystine-methionine deficient media. Cells only treated with either buthionine sulfoximine or cystine-methionine deficient media did not induce protein S-glutathionylation, even though both conditions decreased 65% of cellular glutathione. Moreover, the amount of protein S-glutathionylation under both conditions in the presence of oxidants was not altered when compared to the amount observed in regular media with oxidants present. Protein S-glutathionylation is a dynamic reaction which depends on the rate of adding and removing glutathione. Phenylarsine oxide, which specifically forms a covalent adduct with vicinal thiols, was used to determine the possible role of vicinal thiols in the amount of glutathionylation. Our data shows phenylarsine oxide did not change glutathione concentrations, but it did enhance the amount of glutathionylation in oxidant-treated cells.	[Gilge, Jasen Lee; Fisher, Michael; Chai, Yuh-Cherng] John Carroll Univ, Dept Chem, University Hts, OH USA	John Carroll University	Gilge, JL (corresponding author), John Carroll Univ, Dept Chem, University Hts, OH USA.	ychai@jcu.edu			Cottrell College [CC 6143]; Research Corporation	Cottrell College; Research Corporation(Research Corporation for Science Advancement)	This work was financially supported by a Cottrell College Science Grant (CC 6143) from the Research Corporation to Y-C Chai. Jasen Gilge was supported by the same grant to Y-C Chai for an undergraduate student. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON ME, 1998, CHEM BIOL INTERACT; Anselmo Anthony N, 2004, Biochem J, V381, pe1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHAI YC, 1994, ARCH BIOCHEM BIOPHYS, V310, P264, DOI 10.1006/abbi.1994.1166; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014; Di Simplicio P, 2005, ANTIOXID REDOX SIGN, V7, P951; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Ghezzi P, 2005, BIOCHEM SOC T, V33, P1378, DOI 10.1042/BST0331378; Ghezzi P, 2003, PROTEOMICS, V3, P1145, DOI 10.1002/pmic.200300435; Giustarini D, 2004, J CELL MOL MED, V8, P201, DOI 10.1111/j.1582-4934.2004.tb00275.x; ISHII T, 2007, SUBCELL BIOCH, V44; KALEF E, 1993, ANAL BIOCHEM, V212, P325, DOI 10.1006/abio.1993.1337; KOSOWER NS, 1995, METHODS ENZYMOL, V251; Leonberg AK, 2007, MOL CELL BIOCHEM, V304, P207, DOI 10.1007/s11010-007-9501-y; Oktyabrsky ON, 2007, BIOCHEMISTRY-MOSCOW+, V72, P132, DOI 10.1134/S0006297907020022; REED DJ, 1990, ANNU REV PHARMACOL, V30, P603, DOI 10.1146/annurev.pa.30.040190.003131; REED DJ, 1980, ANAL BIOCHEM, V106, P55, DOI 10.1016/0003-2697(80)90118-9; Reinhardt C, 2008, J CLIN INVEST, V118, P1110, DOI 10.1172/JCI32376; Shackelford RE, 2005, ANTIOXID REDOX SIGN, V7, P940, DOI 10.1089/ars.2005.7.940; Shelton MD, 2005, ANTIOXID REDOX SIGN, V7, P348, DOI 10.1089/ars.2005.7.348; SIES H, 1991, OXIDATIVE STRESS, V2; Thomas JA, 2001, EXP GERONTOL, V36, P1519, DOI 10.1016/S0531-5565(01)00137-1; Townsend DM, 2007, MOL INTERV, V7, P313, DOI 10.1124/mi.7.6.7; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200; WANG J, 2001, J BIOL CHEM, V276; Ying J, 2007, FREE RADICAL BIO MED, V43, P1099, DOI 10.1016/j.freeradbiomed.2007.07.014; Yu J, 2008, PROTEINS, V72, P1077, DOI 10.1002/prot.22096; ZIEGLER DM, 1985, ANNU REV BIOCHEM, V54, P305, DOI 10.1146/annurev.bi.54.070185.001513	28	23	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4015	10.1371/journal.pone.0004015	http://dx.doi.org/10.1371/journal.pone.0004015			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107210	Green Published, Green Submitted, gold			2022-12-25	WOS:000265463000010
J	Quintana, FJ; Mimran, A; Carmi, P; Mor, F; Cohen, IR				Quintana, Francisco J.; Mimran, Avishai; Carmi, Pnina; Mor, Felix; Cohen, Irun R.			HSP60 as a Target of Anti-Ergotypic Regulatory T Cells	PLOS ONE			English	Article							JUVENILE CHRONIC ARTHRITIS; HEAT-SHOCK PROTEINS; ADJUVANT ARTHRITIS; DNA VACCINATION; AUTOIMMUNE-DISEASE; GROWTH-FACTOR; HEAT-SHOCK-PROTEIN-60; INHIBITION; RESPONSES; RATS	The 60 kDa heat shock protein (HSP60) has been reported to influence T-cell responses in two ways: as a ligand of toll-like receptor 2 signalling and as an antigen. Here we describe a new mechanism of T-cell immuno-regulation focused on HSP60: HSP60 is up-regulated and presented by activated T cells ( HSP60 is an ergotope) to regulatory (anti-ergotypic) T cells. Presentation of HSP60 by activated T cells was found to be MHC-restricted and dependent on accessory molecules - CD28, CD80 and CD86. Anti-ergotypic T cells responded to T-cell HSP60 by proliferation and secreted IFN gamma and TGF beta 1. In vitro, the anti-ergotypic T cells inhibited IFN gamma production by their activated T-cell targets. In vivo, adoptive transfer of an anti-ergotypic HSP60-specific T-cell line led to decreased secretion of IFN gamma by arthritogenic T cells and ameliorated adjuvant arthritis ( AA). Thus, the presentation of HSP60 by activated T cells turns them into targets for anti-ergotypic regulatory T cells specific for HSP60. However, the direct interaction between the anti-ergotypic T regulators (anti-HSP60) and the activated T cells also down-regulated the regulators. Thus, by functioning as an ergotope, HSP60 can control both the effector T cells and the regulatory HSP60-specific T cells that control them.	Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Quintana, Francisco J.; Mimran, Avishai; Carmi, Pnina; Mor, Felix; Cohen, Irun R.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA USA	Weizmann Institute of Science; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Quintana, FJ (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	fquintana@rics.bwh.harvard.edu	Mor, Felix/K-1093-2012; Quintana, Francisco Javier/AAB-6915-2020		Center for the Study of Emerging Diseases; EU	Center for the Study of Emerging Diseases; EU(European Commission)	This work was partially supported by grants from the Center for the Study of Emerging Diseases and by the EU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERTON SM, 1994, J IMMUNOL, V152, P3656; AZUMA M, 1993, J EXP MED, V177, P845, DOI 10.1084/jem.177.3.845; Chen GJ, 2007, ARTHRITIS RHEUM-US, V56, P453, DOI 10.1002/art.22316; Cohen I. R., 2000, TENDING ADAMS GARDEN; COHEN IR, 1992, IMMUNOL TODAY, V13, P490, DOI 10.1016/0167-5699(92)90024-2; Cohen IR, 2004, J CLIN INVEST, V114, P1227, DOI 10.1172/JCI200422396; Cohen IR, 2003, PROG INFLAM RES, P1; Cohen IR, 2001, VACCINE, V20, P706, DOI 10.1016/S0264-410X(01)00419-4; Cohen IR, 2007, NAT REV IMMUNOL, V7, P569, DOI 10.1038/nri2102; Correale J, 1997, J NEUROIMMUNOL, V80, P47, DOI 10.1016/S0926-9851(97)00020-7; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; de Kleer IM, 2004, J IMMUNOL, V172, P6435, DOI 10.4049/jimmunol.172.10.6435; de Kleer IM, 2003, ARTHRITIS RHEUM, V48, P2001, DOI 10.1002/art.11174; DEGRAEFFMEEDER ER, 1995, J CLIN INVEST, V95, P934, DOI 10.1172/JCI117801; Delaleu N, 2008, ARTHRITIS RHEUM-US, V58, P2318, DOI 10.1002/art.23656; ELIAS D, 1991, P NATL ACAD SCI USA, V88, P3088, DOI 10.1073/pnas.88.8.3088; Elias D, 1997, DIABETES, V46, P758, DOI 10.2337/diabetes.46.5.758; ELIAS D, 1990, P NATL ACAD SCI USA, V87, P1576, DOI 10.1073/pnas.87.4.1576; Elias D, 1996, DIABETES, V45, P1168, DOI 10.2337/diabetes.45.9.1168; FERRIS DK, 1988, P NATL ACAD SCI USA, V85, P3850, DOI 10.1073/pnas.85.11.3850; Hakamada-Taguchi R, 1998, EUR J IMMUNOL, V28, P865, DOI 10.1002/(SICI)1521-4141(199803)28:03<865::AID-IMMU865>3.0.CO;2-T; HOLOSHITZ J, 1984, J CLIN INVEST, V73, P211, DOI 10.1172/JCI111193; Hong J, 2006, P NATL ACAD SCI USA, V103, P5024, DOI 10.1073/pnas.0508784103; Huurman VAL, 2008, CLIN EXP IMMUNOL, V152, P488, DOI 10.1111/j.1365-2249.2008.03656.x; Jiang H, 1998, P NATL ACAD SCI USA, V95, P4533, DOI 10.1073/pnas.95.8.4533; Jiang H, 2000, ANNU REV IMMUNOL, V18, P185, DOI 10.1146/annurev.immunol.18.1.185; LASALLE JM, 1992, J EXP MED, V176, P177, DOI 10.1084/jem.176.1.177; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; LOHSE AW, 1989, SCIENCE, V244, P820, DOI 10.1126/science.2471264; LOPEZGUERRERO JA, 1993, INFECT IMMUN, V61, P4225; Merbl Y, 2007, J CLIN INVEST, V117, P712, DOI 10.1172/JCI29943; Mimran A, 2005, INT REV IMMUNOL, V24, P159, DOI 10.1080/08830180590934949; Mimran A, 2005, J AUTOIMMUN, V24, P191, DOI 10.1016/j.jaut.2004.12.002; Mimran A, 2004, J CLIN INVEST, V113, P924, DOI 10.1172/JCI200417772; Mor F, 2004, J IMMUNOL, V172, P4618, DOI 10.4049/jimmunol.172.7.4618; Mor F, 1996, J IMMUNOL, V157, P4855; Panoutsakopoulou V, 2004, J CLIN INVEST, V113, P1218, DOI 10.1172/JCI200420772; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Pockley AG, 1999, CELL STRESS CHAPERON, V4, P29, DOI 10.1054/csac.1998.0121; Prakken ABJ, 1997, IMMUNOL LETT, V57, P139, DOI 10.1016/S0165-2478(97)00090-4; Prakken ABJ, 1996, ARTHRITIS RHEUM-US, V39, P1826, DOI 10.1002/art.1780391108; Quintana FJ, 2004, P NATL ACAD SCI USA, V101, P14615, DOI 10.1073/pnas.0404848101; Quintana FJ, 2005, J CLIN INVEST, V115, P2149, DOI 10.1172/JCI23956; Quintana FJ, 2004, ARTHRITIS RHEUM-US, V50, P3712, DOI 10.1002/art.20635; Quintana FJ, 2003, J IMMUNOL, V171, P3533, DOI 10.4049/jimmunol.171.7.3533; Quintana FJ, 2003, J AUTOIMMUN, V21, P65, DOI 10.1016/S0896-8411(03)00064-7; Quintana FJ, 2002, J IMMUNOL, V169, P6030, DOI 10.4049/jimmunol.169.10.6030; Quintana FJ, 2002, J IMMUNOL, V169, P3422, DOI 10.4049/jimmunol.169.6.3422; Quintana FJ, 2005, J IMMUNOL, V175, P2777, DOI 10.4049/jimmunol.175.5.2777; Ragno S, 1997, ARTHRITIS RHEUM-US, V40, P277, DOI 10.1002/art.1780400212; Ramage JM, 1999, J IMMUNOL, V162, P704; Raz I, 2001, LANCET, V358, P1749, DOI 10.1016/S0140-6736(01)06801-5; Reizis B, 1996, INT IMMUNOL, V8, P1825, DOI 10.1093/intimm/8.12.1825; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Stinissen P, 1998, J NEUROIMMUNOL, V87, P94, DOI 10.1016/S0165-5728(98)00060-5; Strawbridge AB, 2007, CURR OPIN IMMUNOL, V19, P87, DOI 10.1016/j.coi.2006.11.009; Taams LS, 1999, EUR J IMMUNOL, V29, P1543, DOI 10.1002/(SICI)1521-4141(199905)29:05<1543::AID-IMMU1543>3.0.CO;2-R; VANEDEN W, 1988, NATURE, V331, P171, DOI 10.1038/331171a0; Zang YCQ, 2000, EUR J IMMUNOL, V30, P908, DOI 10.1002/1521-4141(200003)30:3<908::AID-IMMU908>3.0.CO;2-1; Zanin-Zhorov A, 2005, J IMMUNOL, V174, P3227, DOI 10.4049/jimmunol.174.6.3227; Zanin-Zhorov A, 2003, FASEB J, V17, P1567, DOI 10.1096/fj.02-1139fje; Zanin-Zhorov A, 2006, J CLIN INVEST, V116, P2022, DOI 10.1172/JCI28423; ZHANG JW, 1993, SCIENCE, V261, P1451, DOI 10.1126/science.7690157	64	28	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4026	10.1371/journal.pone.0004026	http://dx.doi.org/10.1371/journal.pone.0004026			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107191	Green Submitted, Green Published, gold			2022-12-25	WOS:000265463000020
J	Swoap, SJ; Weinshenker, D				Swoap, Steven J.; Weinshenker, David			Norepinephrine Controls Both Torpor Initiation and Emergence via Distinct Mechanisms in the Mouse	PLOS ONE			English	Article								Some mammals, including laboratory mice, enter torpor in response to food deprivation, and leptin can attenuate these bouts of torpor. We previously showed that dopamine beta-hydroxylase knockout (Dbh -/-) mice, which lack norepinephrine (NE), do not reduce circulating leptin upon fasting nor do they enter torpor. To test whether the onset of torpor in mice during a fast requires a NE-mediated reduction in circulating leptin, double mutant mice deficient in both leptin (ob/ob) and DBH (DBL MUT) were generated. Upon fasting, control and ob/ob mice entered torpor as assessed by telemetric core T(b) acquisition. While fasting failed to induce torpor in Dbh -/- mice, leptin deficiency bypassed the requirement for NE, as DBL MUT mice readily entered torpor upon fasting. These data indicate that sympathetic activation of white fat and suppression of leptin is required for the onset of torpor in the mouse. Emergence from torpor was severely retarded in DBL MUT mice, revealing a novel, leptin-independent role for NE in torpor recovery. This phenotype was mimicked by administration of a beta 3 adrenergic receptor antagonist to control mice during a torpor bout. Hence, NE signaling via b3 adrenergic receptors presumably in brown fat is the first neurotransmitter-receptor system identified that is required for normal recovery from torpor.	Williams Coll, Dept Biol, Williamstown, MA 01267 USA; [Weinshenker, David] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA	Williams College; Emory University	Swoap, SJ (corresponding author), Williams Coll, Dept Biol, Williamstown, MA 01267 USA.	sswoap@williams.edu	Weinshenker, David/V-3998-2019		NIH [R15 HL081101-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL081101] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grant R15 HL081101-01 (to SJS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartness TJ, 2007, PHYSIOL BEHAV, V91, P343, DOI 10.1016/j.physbeh.2007.04.002; Bartness TJ, 1998, AM J PHYSIOL-REG I, V275, pR1399, DOI 10.1152/ajpregu.1998.275.5.R1399; Bouthegourd JC, 2004, APPETITE, V42, P91, DOI 10.1016/j.appet.2003.07.003; Brito MN, 2007, ENDOCRINOLOGY, V148, P5339, DOI 10.1210/en.2007-0621; Brito NA, 2008, AM J PHYSIOL-REG I, V294, pR1445, DOI 10.1152/ajpregu.00068.2008; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cariou B, 2007, FEBS LETT, V581, P5191, DOI 10.1016/j.febslet.2007.09.064; COLEMAN DL, 1982, DIABETOLOGIA, V22, P205, DOI 10.1007/BF00283754; Doring H, 1998, INT J OBESITY, V22, P83, DOI 10.1038/sj.ijo.0800547; Gavrilova O, 1999, P NATL ACAD SCI USA, V96, P14623, DOI 10.1073/pnas.96.25.14623; Geiser F, 1998, AM J PHYSIOL-REG I, V275, pR1627, DOI 10.1152/ajpregu.1998.275.5.R1627; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Gluck EF, 2006, AM J PHYSIOL-REG I, V291, pR1303, DOI 10.1152/ajpregu.00232.2006; Golozoubova V, 2001, FASEB J, V15, P2048, DOI 10.1096/fj.00-0536fje; HAYWARD JS, 1992, CAN J ZOOL, V70, P171, DOI 10.1139/z92-025; HIMMSHAGEN J, 1985, ANNU REV NUTR, V5, P69, DOI 10.1146/annurev.nu.05.070185.000441; HIMMSHAGEN J, 1985, AM J PHYSIOL, V248, pE531, DOI 10.1152/ajpendo.1985.248.5.E531; HOGAN S, 1980, AM J PHYSIOL-ENDOC M, V239, pR301; HORWITZ BA, 1985, AM J PHYSIOL, V249, pR689, DOI 10.1152/ajpregu.1985.249.6.R689; HUDSON JW, 1979, PHYSIOL ZOOL, V52, P205, DOI 10.1086/physzool.52.2.30152564; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Mantzoros CS, 1996, DIABETES, V45, P909, DOI 10.2337/diabetes.45.7.909; MORY G, 1984, FEBS LETT, V166, P393, DOI 10.1016/0014-5793(84)80120-9; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; NIZIELSKI SE, 1989, AM J PHYSIOL, V257, pR536, DOI 10.1152/ajpregu.1989.257.3.R536; Rasmussen AT, 1923, J MORPHOL, V38, P147, DOI 10.1002/jmor.1050380106; Rayner DV, 2001, P NUTR SOC, V60, P357, DOI 10.1079/PNS2001101; Sato M, 2007, MOL PHARMACOL, V72, P1359, DOI 10.1124/mol.107.035337; SEYDOUX J, 1982, ENDOCRINOLOGY, V110, P432, DOI 10.1210/endo-110-2-432; SMITH RE, 1963, SCIENCE, V140, P199, DOI 10.1126/science.140.3563.199; Swoap SJ, 2006, J NEUROSCI, V26, P241, DOI 10.1523/JNEUROSCI.3721-05.2006; Thomas SA, 1998, J NEUROCHEM, V70, P2468; Thomas SA, 1997, NATURE, V387, P94, DOI 10.1038/387094a0; Williams TD, 2002, AM J PHYSIOL-REG I, V282, pR1459, DOI 10.1152/ajpregu.00612.2001; YOUNG JB, 1977, SCIENCE, V196, P1473, DOI 10.1126/science.867049	35	42	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4038	10.1371/journal.pone.0004038	http://dx.doi.org/10.1371/journal.pone.0004038			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107190	Green Submitted, Green Published, gold			2022-12-25	WOS:000265463000027
J	Wu, MM; Sato, TN				Wu, Mingming; Sato, Thomas N.			On the Mechanics of Cardiac Function of Drosophila Embryo	PLOS ONE			English	Article								The heart is a vital organ that provides essential circulation throughout the body. Malfunction of cardiac pumping, thus, leads to serious and most of the times, to fatal diseases. Mechanics of cardiac pumping is a complex process, and many experimental and theoretical approaches have been undertaken to understand this process. We have taken advantage of the simplicity of the embryonic heart of an invertebrate, Drosophila melanogaster, to understand the fundamental mechanics of the beating heart. We applied a live imaging technique to the beating embryonic heart combined with analytical imaging tools to study the dynamic mechanics of the pumping. Furthermore, we have identified one mutant line that exhibits aberrant pumping mechanics. The Drosophila embryonic heart consists of only 104 cardiac cells forming a simple straight tube that can be easily accessed for real-time imaging. Therefore, combined with the wealth of available genetic tools, the embryonic Drosophila heart may serve as a powerful model system for studies of human heart diseases, such as arrhythmia and congenital heart diseases. We, furthermore, believe our mechanistic data provides important information that is useful for our further understanding of the design of biological structure and function and for engineering the pumps for medical uses.	Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA; [Wu, Mingming] Cornell Univ, Dept Chem & Biomol Engn, Ithaca, NY 14853 USA; [Sato, Thomas N.] Cornell Univ, Weill Med Coll, Dept Cell & Dev Biol, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University	Wu, MM (corresponding author), Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA.	island1005@aol.com	wu, mingming/GXN-1864-2022		Joseph C. Hinsey Chair, National Science Foundation [CBET-0619626]	Joseph C. Hinsey Chair, National Science Foundation(National Science Foundation (NSF))	Joseph C. Hinsey Chair, National Science Foundation (CBET-0619626). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianco A, 2007, NATURE, V448, P362, DOI 10.1038/nature05965; Bier E, 2004, GENE, V342, P1, DOI 10.1016/j.gene.2004.07.018; Bodmer R, 1998, DEV GENET, V22, P181, DOI 10.1002/(SICI)1520-6408(1998)22:3<181::AID-DVG1>3.0.CO;2-2; Bruckner K, 2004, DEV CELL, V7, P73, DOI 10.1016/j.devcel.2004.06.007; Cho NK, 2002, CELL, V108, P865, DOI 10.1016/S0092-8674(02)00676-1; Cripps RM, 2002, DEV BIOL, V246, P14, DOI 10.1006/dbio.2002.0666; Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5; Dulcis D, 2003, J COMP NEUROL, V465, P560, DOI 10.1002/cne.10869; Evans CJ, 2003, DEV CELL, V5, P673, DOI 10.1016/S1534-5807(03)00335-6; FISHMAN MC, 1994, CIRC RES, V74, P757, DOI 10.1161/01.RES.74.5.757; Forouhar AS, 2006, SCIENCE, V312, P751, DOI 10.1126/science.1123775; Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043; Glass L, 1991, THEORY HEART BIOMECH; Heino TI, 2001, MECH DEVELOP, V109, P69, DOI 10.1016/S0925-4773(01)00510-X; Helenius IT, 2008, J CELL BIOL, V182, P221, DOI 10.1083/jcb.200806186; Hove JR, 2003, NATURE, V421, P172, DOI 10.1038/nature01282; Ishimaru S, 2004, EMBO J, V23, P3984, DOI 10.1038/sj.emboj.7600417; Karma A, 2007, PHYS TODAY, V60, P51, DOI 10.1063/1.2718757; Krasnow NA, 1997, COLD SPRING HARB SYM, V62, P235; Macias A, 2004, INT J DEV BIOL, V48, P1087, DOI 10.1387/ijdb.041859am; Mankad R, 2001, J CARDIOVASC MAGN R, V3, P257, DOI 10.1081/JCMR-100107474; Medioni C, 2008, J CELL BIOL, V182, P249, DOI 10.1083/jcb.200801100; Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635; Molina MR, 2001, MECH DEVELOP, V109, P51, DOI 10.1016/S0925-4773(01)00509-3; Olofsson B, 2005, DEV BIOL, V279, P233, DOI 10.1016/j.ydbio.2004.12.020; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; POULSON EF, 1950, BIOL DROSOPHILA, P168; Rosin D, 2004, DEVELOPMENT, V131, P1939, DOI 10.1242/dev.01101; Rubin GM, 1996, GENOME RES, V6, P71, DOI 10.1101/gr.6.2.71; RUBIN GM, 1988, SCIENCE, V240, P1453, DOI 10.1126/science.3131880; Santiago-Martinez E, 2008, J CELL BIOL, V182, P241, DOI 10.1083/jcb.200804120; Sellin J, 2006, GENE EXPR PATTERNS, V6, P360, DOI 10.1016/j.modgep.2005.09.012; Stainier DYR, 2001, NAT REV GENET, V2, P39, DOI 10.1038/35047564; Tao Y, 2007, SEMIN CELL DEV BIOL, V18, P3, DOI 10.1016/j.semcdb.2006.12.001; Wang JB, 2005, MOL CELL BIOL, V25, P4200, DOI 10.1128/MCB.25.10.4200-4210.2005; Warren KS, 2000, PHILOS T R SOC B, V355, P939, DOI 10.1098/rstb.2000.0629	36	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4045	10.1371/journal.pone.0004045	http://dx.doi.org/10.1371/journal.pone.0004045			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107195	Green Published, gold, Green Submitted			2022-12-25	WOS:000265463000031
J	Kawakita, A; Sato, K; Makino, H; Ikegami, H; Takayama, S; Toyama, Y; Umezawa, A				Kawakita, Atsuo; Sato, Kazuki; Makino, Hatsune; Ikegami, Hiroyasu; Takayama, Shinichiro; Toyama, Yoshiaki; Umezawa, Akihiro			Nicotine Acts on Growth Plate Chondrocytes to Delay Skeletal Growth through the alpha 7 Neuronal Nicotinic Acetylcholine Receptor	PLOS ONE			English	Article								Background: Cigarette smoking adversely affects endochondral ossification during the course of skeletal growth. Among a plethora of cigarette chemicals, nicotine is one of the primary candidate compounds responsible for the cause of smoking-induced delayed skeletal growth. However, the possible mechanism of delayed skeletal growth caused by nicotine remains unclarified. In the last decade, localization of neuronal nicotinic acetylcholine receptor (nAChR), a specific receptor of nicotine, has been widely detected in non-excitable cells. Therefore, we hypothesized that nicotine affect growth plate chondrocytes directly and specifically through nAChR to delay skeletal growth. Methodology/Principal Findings: We investigated the effect of nicotine on human growth plate chondrocytes, a major component of endochondral ossification. The chondrocytes were derived from extra human fingers. Nicotine inhibited matrix synthesis and hypertrophic differentiation in human growth plate chondrocytes in suspension culture in a concentration-dependent manner. Both human and murine growth plate chondrocytes expressed alpha7 nAChR, which constitutes functional homopentameric receptors. Methyllycaconitine (MLA), a specific antagonist of alpha7 nAChR, reversed the inhibition of matrix synthesis and functional calcium signal by nicotine in human growth plate chondrocytes in vitro. To study the effect of nicotine on growth plate in vivo, ovulation-controlled pregnant alpha7 nAChR +/- mice were given drinking water with or without nicotine during pregnancy, and skeletal growth of their fetuses was observed. Maternal nicotine exposure resulted in delayed skeletal growth of alpha7 nAChR +/+ fetuses but not in alpha7 nAChR -/- fetuses, implying that skeletal growth retardation by nicotine is specifically mediated via fetal alpha7 nAChR. Conclusions/Significance: These results suggest that nicotine, from cigarette smoking, acts directly on growth plate chondrocytes to decrease matrix synthesis, suppress hypertrophic differentiation via alpha7 nAChR, leading to delayed skeletal growth.	[Makino, Hatsune; Umezawa, Akihiro] NICHD, Dept Reprod Biol, Tokyo, Japan; [Kawakita, Atsuo; Sato, Kazuki; Ikegami, Hiroyasu; Toyama, Yoshiaki] Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo 108, Japan; [Takayama, Shinichiro] Natl Ctr Child Hlth & Dev, Dept Orthopaed Surg, Tokyo, Japan	National Center for Child Health & Development - Japan; Keio University; National Center for Child Health & Development - Japan	Kawakita, A (corresponding author), NICHD, Dept Reprod Biol, Tokyo, Japan.	umezawa@1985.jukuin.keio.ac.jp	Toyama, Yoshiaki/K-5743-2013; Sato, Kazuki/AAL-2166-2021		Smoking Research Foundation; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Ministry of Health, Labour and Welfare (MHLW); Japan Health Science Foundation; program for promotion of Fundamental Studies in Health Science of the Pharmaceuticals and Medical Devices Agency	Smoking Research Foundation; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare (MHLW)(Ministry of Health, Labour and Welfare, Japan); Japan Health Science Foundation; program for promotion of Fundamental Studies in Health Science of the Pharmaceuticals and Medical Devices Agency	This study was supported by a grant from the Smoking Research Foundation; by grants from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; by the Ministry of Health, Labour and Welfare (MHLW) Sciences Research Grants; by a Research Grant on Health Science focusing on Drug Innovation from the Japan Health Science Foundation; by the program for promotion of Fundamental Studies in Health Science of the Pharmaceuticals and Medical Devices Agency; by a Research Grant for Cardiovascular Disease from the MHLW; and by a Grant for Child Health and Development from the MHLW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNERIC SP, 1999, NEURONAL NICOTINIC R, pR12; Arredondo J, 2002, J CELL BIOL, V159, P325, DOI 10.1083/jcb.200206096; BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7; DAVIES DP, 1976, LANCET, V1, P385; Dempsey D, 2000, CLIN PHARMACOL THER, V67, P458, DOI 10.1067/mcp.2000.106129; El-Zawawy HB, 2006, J ORTHOP RES, V24, P2150, DOI 10.1002/jor.20263; Gullahorn L, 2005, OSTEOARTHR CARTILAGE, V13, P942, DOI 10.1016/j.joca.2005.03.001; HADDON W, 1961, OBSTET GYNECOL, V18, P262; HARDY JB, 1972, LANCET, V2, P1332; HAUSELMANN HJ, 1994, J CELL SCI, V107, P17; Karatza AA, 2003, CLIN PEDIATR, V42, P533, DOI 10.1177/000992280304200608; Kurtoglu S, 2007, EXP BIOL MED, V232, P398; LUCK W, 1985, DEV PHARMACOL THERAP, V8, P384, DOI 10.1159/000457063; MAU G, 1976, LANCET, V1, P972; MOCHIZUKI M, 1985, ACTA PHYSIOL HUNG, V65, P295; Nelson E, 1999, HUM EXP TOXICOL, V18, P252, DOI 10.1191/096032799678840002; Nordstrom ML, 1996, SCAND J SOC MED, V24, P55, DOI 10.1177/140349489602400109; OLSEN J, 1991, AM J PUBLIC HEALTH, V81, P69, DOI 10.2105/AJPH.81.1.69; OLSEN J, 1992, INT J EPIDEMIOL, V21, P279, DOI 10.1093/ije/21.2.279; OrrUrtreger A, 1997, J NEUROSCI, V17, P9165; Sano M, 2000, EXP CELL RES, V259, P127, DOI 10.1006/excr.2000.4977; Sano M, 2001, EXP CELL RES, V266, P114, DOI 10.1006/excr.2001.5203; SEXTON M, 1984, JAMA-J AM MED ASSOC, V251, P911, DOI 10.1001/jama.251.7.911; Sharma G, 2002, J NEUROBIOL, V53, P524, DOI 10.1002/neu.10114; TACCHETTI C, 1987, J CELL BIOL, V105, P999, DOI 10.1083/jcb.105.2.999; TRYGG K, 1995, PAEDIATR PERINAT EP, V9, P307, DOI 10.1111/j.1365-3016.1995.tb00147.x; WINGERD J, 1974, PEDIATRICS, V53, P737; YERUSHALMY J, 1971, AM J EPIDEMIOL, V93, P443, DOI 10.1093/oxfordjournals.aje.a121278	28	47	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2008	3	12							e3945	10.1371/journal.pone.0003945	http://dx.doi.org/10.1371/journal.pone.0003945			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AR	19079602	gold, Green Published, Green Submitted			2022-12-25	WOS:000265458400004
J	Stiefel, KM; Gutkin, BS; Sejnowski, TJ				Stiefel, Klaus M.; Gutkin, Boris S.; Sejnowski, Terrence J.			Cholinergic Neuromodulation Changes Phase Response Curve Shape and Type in Cortical Pyramidal Neurons	PLOS ONE			English	Article								Spike generation in cortical neurons depends on the interplay between diverse intrinsic conductances. The phase response curve (PRC) is a measure of the spike time shift caused by perturbations of the membrane potential as a function of the phase of the spike cycle of a neuron. Near the rheobase, purely positive (type I) phase-response curves are associated with an onset of repetitive firing through a saddle-node bifurcation, whereas biphasic (type II) phase-response curves point towards a transition based on a Hopf-Andronov bifurcation. In recordings from layer 2/3 pyramidal neurons in cortical slices, cholinergic action, consistent with down-regulation of slow voltage-dependent potassium currents such as the M-current, switched the PRC from type II to type I. This is the first report showing that cholinergic neuromodulation may cause a qualitative switch in the PRCs type implying a change in the fundamental dynamical mechanism of spike generation.	[Stiefel, Klaus M.; Sejnowski, Terrence J.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA USA; [Gutkin, Boris S.] CNRS, Coll France, ENS, DEC, Grp Neural Theory, Paris, France; [Sejnowski, Terrence J.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; Salk Institute; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; College de France; Ecole Normale Superieure (ENS); University of California System; University of California San Diego	Stiefel, KM (corresponding author), Okinawa Inst Sci & Technol, Theoret & Expt Neurobiol Unit, Okinawa, Japan.	Boris.Gutkin@ens.fr	Gutkin, Boris/A-7420-2014; Gutkin, Boris/ABC-5754-2020; Sejnowski, Terrence/AAV-5558-2021	Gutkin, Boris/0000-0001-6409-979X; 	Deutsche Forschungsgemeinschaft; Gatsby Foundation; CNRS; College de France; MEXT "BIND"; Howard Hughes Medical Institute	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Gatsby Foundation; CNRS(Centre National de la Recherche Scientifique (CNRS)); College de France; MEXT "BIND"(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by the Deutsche Forschungsgemeinschaft (K.M.S.), the Gatsby Foundation, CNRS, College de France and MEXT "BIND" (B.S.G.) and the Howard Hughes Medical Institute (T.J.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROCHER S, 1992, BRAIN RES, V573, P27, DOI 10.1016/0006-8993(92)90110-U; Buhl EH, 1998, J PHYSIOL-LONDON, V513, P117, DOI 10.1111/j.1469-7793.1998.117by.x; DODT HU, 1990, BRAIN RES, V537, P333, DOI 10.1016/0006-8993(90)90380-T; Ermentrout B, 2001, NEURAL COMPUT, V13, P1285, DOI 10.1162/08997660152002861; Ermentrout GB, 1996, NEURAL COMPUT, V8, P979, DOI DOI 10.1162/NECO.1996.8.5.979; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Galan RF, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.158101; Gutkin BS, 2005, J NEUROPHYSIOL, V94, P1623, DOI 10.1152/jn.00359.2004; HANSEL D, 1995, NEURAL COMPUT, V7, P307, DOI 10.1162/neco.1995.7.2.307; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Lengyel M, 2005, NAT NEUROSCI, V8, P1677, DOI 10.1038/nn1561; MCCORMICK DA, 1993, PROG BRAIN RES, V98, P303; Netoff TI, 2005, J NEUROPHYSIOL, V93, P1197, DOI 10.1152/jn.00982.2004; REYES AD, 1993, J NEUROPHYSIOL, V69, P1661, DOI 10.1152/jn.1993.69.5.1661; Rodriguez R, 2004, J NEUROSCI, V24, P10369, DOI 10.1523/JNEUROSCI.1839-04.2004; Schobesberger H, 2000, J NEUROPHYSIOL, V83, P1912, DOI 10.1152/jn.2000.83.4.1912; Steriade M, 2004, PROG BRAIN RES, V145, P179, DOI 10.1016/S0079-6123(03)45013-9; Stiefel KM, 2005, EUR J NEUROSCI, V21, P2605, DOI 10.1111/j.1460-9568.2005.04094.x; STIEFEL KM, 2008, J COMPUT NEUROSCI; Tiesinga PHE, 2001, HIPPOCAMPUS, V11, P251, DOI 10.1002/hipo.1041; Tsubo Y, 2007, EUR J NEUROSCI, V25, P3429, DOI 10.1111/j.1460-9568.2007.05579.x	23	89	90	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2008	3	12							e3947	10.1371/journal.pone.0003947	http://dx.doi.org/10.1371/journal.pone.0003947			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AR	19079601	gold, Green Published, Green Submitted			2022-12-25	WOS:000265458400006
J	Magalhaes, ES; Paiva, CN; Souza, HSP; Pyrrho, AS; Mourao-Sa, D; Figueiredo, RT; Vieira-De-Abreu, A; Dutra, HS; Silveira, MS; Gaspar-Elsas, MIC; Xavier-Elsas, P; Bozza, PT; Bozza, MT				Magalhaes, Elizabeth S.; Paiva, Claudia N.; Souza, Heitor S. P.; Pyrrho, Alexandre S.; Mourao-Sa, Diego; Figueiredo, Rodrigo T.; Vieira-de-Abreu, Adriana; Dutra, Helio S.; Silveira, Mariana S.; Gaspar-Elsas, Maria Ignez C.; Xavier-Elsas, Pedro; Bozza, Patricia T.; Bozza, Marcelo T.			Macrophage migration inhibitory factor is critical to interleukin-5-driven eosinophilopoiesis and tissue eosinophilia triggered by Schistosoma mansoni infection	FASEB JOURNAL			English	Article						Th2 response; apoptosis; inflammation; granuloma; MIF	FACTOR MIF; GRANULOMA-FORMATION; REGULATORY ROLE; ASTHMA; MICE; APOPTOSIS; SURVIVAL; INFLAMMATION; RECRUITMENT; ACTIVATION	Macrophage migration inhibitory factor (MIF) participates in the pathogenesis of inflammatory diseases, including asthma, in which it enhances airway hypersensitivity and tissue eosinophilia. Herein, we investigated the role of MIF in eosinophilopoiesis and tissue eosinophilia using Schistosoma mansoni infection. MIF-deficient (Mif(-/-)) mice had similar numbers of adult worms, eggs, and granulomas compared to wildtype mice, but the size of granulomas was strikingly reduced due to smaller numbers of eosinophils. MIF did not affect the acquired response to infection, as Mif(-/-) mice produced normal amounts of Th2 cytokines and IgE. Nevertheless, recombinant MIF (rMIF) behaved as a chemoattractant for eosinophils, what could partially explain the reduced eosinophilia in infected Mif(-/-) mice. Moreover, the percentage of eosinophils was reduced in bone marrows of Mif(-/-) mice chronically infected with S. mansoni compared to wild type. Mif(-/-) had impaired eosinophilopoiesis in response to interleukin (IL)-5 and addition of rMIF to bone marrow cultures from IL-5 transgenic mice enhanced the generation of eosinophils. In the absence of MIF, eosinophil precursors were unable to survive the IL-5-supplemented cell culture, and were ingested by macrophages. Treatment with pancaspase inhibitor z-VAD or rMIF promoted the survival of eosinophil progenitors. Together, these results indicate that MIF participates in IL-5-driven maturation of eosinophils and in tissue eosinophilia associated with S. mansoni infection.-Magalhaes, E. S., Paiva, C. N., Souza, H. S. P., Pyrrho, A. S., Mourao-Sa, D., Figueiredo, R. T., Vieira-de-Abreu, A., Dutra, H. S., Silveira, M. S., Gaspar-Elsas, M. I. C., Xavier-Elsas, P., Bozza, P. T., Bozza, M. T. Macrophage migration inhibitory factor is critical to IL-5-driven eosinophilopoiesis and tissue eosinophilia triggered by Schistosoma mansoni infection. FASEB J. 23, 1262-1271 (2009)	[Magalhaes, Elizabeth S.; Paiva, Claudia N.; Mourao-Sa, Diego; Figueiredo, Rodrigo T.; Xavier-Elsas, Pedro; Bozza, Marcelo T.] Univ Fed Rio de Janeiro, Dept Immunol, Inst Microbiol, BR-21941902 Rio De Janeiro, Brazil; [Souza, Heitor S. P.] Univ Fed Rio de Janeiro, Dept Clin Med, Fac Med, BR-21941902 Rio De Janeiro, Brazil; [Pyrrho, Alexandre S.] Univ Fed Rio de Janeiro, Dept Farm, Inst Biol, BR-21941902 Rio De Janeiro, Brazil; [Dutra, Helio S.] Univ Fed Rio de Janeiro, Dept Histol & Embriol, Inst Ciencias Biomed, BR-21941902 Rio De Janeiro, Brazil; [Silveira, Mariana S.] Univ Fed Rio de Janeiro, Lab Neurogenese, Inst Biofisca, BR-21941902 Rio De Janeiro, Brazil; [Vieira-de-Abreu, Adriana] Inst Oswaldo Cruz, Lab Imunofarmacol, BR-20001 Rio De Janeiro, Brazil; [Gaspar-Elsas, Maria Ignez C.] Fiocruz MS, Dept Pediat, Inst Fernandes Figueira, BR-21045900 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Bozza, MT (corresponding author), Univ Fed Rio de Janeiro, Dept Immunol, Inst Microbiol, CCS Bloco 1,UFRJ Ave Carlos Chagas Filho,373 Cida, BR-21941902 Rio De Janeiro, Brazil.	mbozza@micro.ufrj.br	Xavier-Elsas, Pedro/Q-9070-2019; Mourao-Sa, Diego/C-5977-2009; Bozza, Patricia T./AAM-4537-2021; de Souza, Heitor Siffert Pereira/G-3297-2012; Silveira, Mariana/M-4865-2013; Bozza, Patricia T./AAE-2933-2021; Figueiredo, Rodrigo/F-5176-2016	Xavier-Elsas, Pedro/0000-0003-3057-6062; Bozza, Patricia T./0000-0001-8349-9529; de Souza, Heitor Siffert Pereira/0000-0002-3647-7324; Silveira, Mariana/0000-0002-0496-1517; Figueiredo, Rodrigo/0000-0002-7551-8782; Mourao, Diego/0000-0001-6618-6969; Bozza, Marcelo/0000-0003-3683-7550	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Amano T, 2007, INFLAMM RES, V56, P24, DOI 10.1007/s00011-007-5184-9; Bacher M, 1996, P NATL ACAD SCI USA, V93, P7849, DOI 10.1073/pnas.93.15.7849; Baumann R, 2003, FASEB J, V17, P2221, DOI 10.1096/fj.03-0110com; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Borchers MT, 2002, J LEUKOCYTE BIOL, V71, P1033; Bozza FA, 2004, SHOCK, V22, P309, DOI 10.1097/01.shk.0000140305.01641.c8; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; Chiaramonte MG, 1999, J CLIN INVEST, V104, P777, DOI 10.1172/JCI7325; DAVID JR, 1980, AM J TROP MED HYG, V29, P842, DOI 10.4269/ajtmh.1980.29.842; Davies SJ, 2005, INT J PARASITOL, V35, P851, DOI 10.1016/j.ijpara.2005.02.017; Davies SJ, 2004, INT J PARASITOL, V34, P27, DOI 10.1016/j.ijpara.2003.10.010; Denkinger CM, 2004, ARCH IMMUNOL THER EX, V52, P389; DOLBER PC, 1993, J HISTOCHEM CYTOCHEM, V41, P465, DOI 10.1177/41.3.7679127; Elsas MICG, 1997, AM J RESP CELL MOL, V17, P404, DOI 10.1165/ajrcmb.17.4.2691; Falcone FH, 2001, J IMMUNOL, V167, P5348, DOI 10.4049/jimmunol.167.9.5348; Fallon PG, 2000, J IMMUNOL, V164, P2585, DOI 10.4049/jimmunol.164.5.2585; Farahi N, 2007, J IMMUNOL, V179, P1264, DOI 10.4049/jimmunol.179.2.1264; Flaster H, 2007, MOL ENDOCRINOL, V21, P1267, DOI 10.1210/me.2007-0065; Heath H, 1997, J CLIN INVEST, V99, P178, DOI 10.1172/JCI119145; HER E, 1991, J CLIN INVEST, V88, P1982, DOI 10.1172/JCI115524; Hoontrakoon R, 2002, AM J RESP CELL MOL, V26, P404, DOI 10.1165/ajrcmb.26.4.4517; Hu JS, 2006, AM J PATHOL, V169, P424, DOI 10.2353/ajpath.2006.051234; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; KARIYAWASAM HH, 2007, CURR OPIN IMMUNOL; Lee JJ, 2004, SCIENCE, V305, P1773, DOI 10.1126/science.1099472; Leeto M, 2006, AM J PATHOL, V169, P1701, DOI 10.2353/ajpath.2006.060346; LENZI H L, 1987, Memorias do Instituto Oswaldo Cruz, V82, P67, DOI 10.1590/S0074-02761987000800011; Lukacs NW, 2002, AM J PATHOL, V160, P1353, DOI 10.1016/S0002-9440(10)62562-X; Magalhaes ES, 2007, EUR J IMMUNOL, V37, P1097, DOI 10.1002/eji.200635968; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; Mizue Y, 2005, P NATL ACAD SCI USA, V102, P14410, DOI 10.1073/pnas.0507189102; Nagase H, 2001, INT ARCH ALLERGY IMM, V125, P29, DOI 10.1159/000053849; Nakamaru Y, 2005, CYTOKINE, V31, P103, DOI 10.1016/j.cyto.2005.04.002; Ohnmacht C, 2007, J IMMUNOL, V179, P4766, DOI 10.4049/jimmunol.179.7.4766; Padigel UM, 2006, INFECT IMMUN, V74, P3232, DOI 10.1128/IAI.02067-05; Petering H, 1999, BLOOD, V93, P694, DOI 10.1182/blood.V93.2.694.402k31_694_702; Powell ND, 2005, J IMMUNOL, V175, P5611, DOI 10.4049/jimmunol.175.9.5611; Reiman RM, 2006, INFECT IMMUN, V74, P1471, DOI 10.1128/IAI.74.3.1471-1479.2006; Rodriguez-Sosa M, 2003, INFECT IMMUN, V71, P1247, DOI 10.1128/IAI.71.3.1247-1254.2003; Rossi AG, 1998, J CLIN INVEST, V101, P2869, DOI 10.1172/JCI1524; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Sabroe I, 2000, CLIN EXP ALLERGY, V30, P1194; Satoskar AR, 2001, INFECT IMMUN, V69, P906, DOI 10.1128/IAI.69.2.906-911.2001; SHER A, 1990, P NATL ACAD SCI USA, V87, P61, DOI 10.1073/pnas.87.1.61; Stavitsky AB, 2003, PARASITE IMMUNOL, V25, P369, DOI 10.1046/j.1365-3024.2003.00641.x; Swartz JM, 2006, BLOOD, V108, P2420, DOI 10.1182/blood-2006-04-015933; Vermeire JJ, 2008, TRENDS PARASITOL, V24, P355, DOI 10.1016/j.pt.2008.04.007; Wang FZ, 2005, MED HYPOTHESES, V65, P1082, DOI 10.1016/j.mehy.2005.05.047; Wilson MS, 2007, IMMUNOL CELL BIOL, V85, P148, DOI 10.1038/sj.icb.7100014; Yamaguchi E, 2000, CLIN EXP ALLERGY, V30, P1244; YAMAGUCHI Y, 1991, BLOOD, V78, P2542; Yousefi S, 1997, INT ARCH ALLERGY IMM, V112, P9, DOI 10.1159/000237424	53	35	37	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2009	23	4					1262	1271		10.1096/fj.08-124248	http://dx.doi.org/10.1096/fj.08-124248			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZO	19088181				2022-12-25	WOS:000266651600030
J	Beazely, MA; Lim, AN; Li, HB; Trepanier, C; Chen, XM; Sidhu, B; MacDonald, JF				Beazely, Michael A.; Lim, Aeni; Li, Hongbin; Trepanier, Catherine; Chen, XuanMao; Sidhu, Bikram; MacDonald, John F.			Platelet-derived Growth Factor Selectively Inhibits NR2B-containing N-Methyl-D-aspartate Receptors in CA1 Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRASYNAPTIC NMDA RECEPTORS; MEDIATED SYNAPTIC-TRANSMISSION; FACTOR-B-CHAIN; SUBUNIT COMPOSITION; DIFFERENTIAL ROLES; KAINATE RECEPTORS; AMPA RECEPTORS; PROTEIN-KINASE; CREB SHUTOFF; CELL-DEATH	Platelet-derived growth factor (PDGF) beta receptor activation inhibits N-methyl-D-aspartate (NMDA)-evoked currents in hippocampal and cortical neurons via the activation of phospholipase C gamma, PKC, the release of intracellular calcium, and a rearrangement of the actin cytoskeleton. In the hippocampus, the majority of NMDA receptors are heteromeric; most are composed of 2 NR1 subunits and 2 NR2A or 2 NR2B subunits. Using NR2B- and NR2A-specific antagonists, we demonstrate that PDGF-BB treatment preferentially inhibits NR2B-containing NMDA receptor currents in CA1 hippocampal neurons and enhances long-term depression in an NR2B subunit-dependent manner. Furthermore, treatment of hippocampal slices or cultures with PDGF-BB decreases the surface localization of NR2B but not of NR2A subunits. PDGF beta receptors colocalize to a higher degree with NR2B subunits than with NR2A subunits. After neuronal injury, PDGF beta receptors and PDGF-BB are upregulated and PDGF beta receptor activation is neuroprotective against glutamate-induced neuronal damage in cultured neurons. We demonstrate that the neuroprotective effects of PDGF-BB are occluded by the NR2B antagonist, Ro25-6981, and that PDGF-BB promotes NMDA signaling to CREB and ERK1/2. We conclude that PDGF beta R signaling, by preferentially targeting NR2B receptors, provides an important mechanism for neuroprotection by growth factors in the central nervous system.	[Beazely, Michael A.; Lim, Aeni; Li, Hongbin; Chen, XuanMao; Sidhu, Bikram; MacDonald, John F.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Trepanier, Catherine; MacDonald, John F.] Univ Toronto, Dept Pharmacol, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	MacDonald, JF (corresponding author), Univ Toronto, Dept Physiol, Med Sci Bldg,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	j.macdonald@utoronto.ca	chen, xuanmao/I-7576-2013; Sidhu, Bikrampal/ABB-1367-2020	Beazely, Michael/0000-0002-8722-460X; Chen, Xuanmao/0000-0002-0057-8510	Canadian Institutes of Health Research [15514]; postdoctoral award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); postdoctoral award	This work was supported by Canadian Institutes of Health Research Grant 15514 (to J. F. M.) and a postdoctoral award (to M. A. B.).	Al-Hallaq RA, 2007, J NEUROSCI, V27, P8334, DOI 10.1523/JNEUROSCI.2155-07.2007; Arancio O, 2007, CURR OPIN NEUROBIOL, V17, P325, DOI 10.1016/j.conb.2007.03.013; Auberson YP, 2002, BIOORG MED CHEM LETT, V12, P1099, DOI 10.1016/S0960-894X(02)00074-4; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; Bartlett TE, 2007, NEUROPHARMACOLOGY, V52, P60, DOI 10.1016/j.neuropharm.2006.07.013; Bear MF, 2003, PHILOS T ROY SOC B, V358, P649, DOI 10.1098/rstb.2002.1255; Beazely MA, 2006, J NEUROCHEM, V98, P1657, DOI 10.1111/j.1471-4159.2006.04064.x; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; Carrier RL, 2006, J NEUROSCI METH, V154, P239, DOI 10.1016/j.jneumeth.2005.12.030; Chen WS, 2007, NEUROPHARMACOLOGY, V52, P200, DOI 10.1016/j.neuropharm.2006.07.003; Egawa-Tsuzuki T, 2004, EXP NEUROL, V186, P89, DOI 10.1016/j.expneurol.2003.11.001; Fischer G, 1997, J PHARMACOL EXP THER, V283, P1285; Grabs D, 1997, J BIOL CHEM, V272, P13419, DOI 10.1074/jbc.272.20.13419; Groc L, 2007, J NEUROSCI, V27, P10165, DOI 10.1523/JNEUROSCI.1772-07.2007; Groc L, 2006, P NATL ACAD SCI USA, V103, P18769, DOI 10.1073/pnas.0605238103; Hardingham GE, 2006, BIOCHEM SOC T, V34, P936, DOI 10.1042/BST0340936; Hardingham GE, 2002, BBA-PROTEINS PROTEOM, V1600, P148, DOI 10.1016/S1570-9639(02)00455-7; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Harris AZ, 2007, J PHYSIOL-LONDON, V584, P509, DOI 10.1113/jphysiol.2007.137679; Heldin CH, 1998, BBA-REV CANCER, V1378, pF79, DOI 10.1016/S0304-419X(98)00015-8; Hendricson AW, 2002, J PHARMACOL EXP THER, V301, P938, DOI 10.1124/jpet.301.3.938; IIHARA K, 1994, J CEREBR BLOOD F MET, V14, P818, DOI 10.1038/jcbfm.1994.102; Ishii Y, 2006, J NEUROCHEM, V98, P588, DOI 10.1111/j.1471-4159.2006.03922.x; Ivanov A, 2006, J PHYSIOL-LONDON, V572, P789, DOI 10.1113/jphysiol.2006.105510; Jackson MF, 2003, MOL PHARMACOL, V64, P395, DOI 10.1124/mol.64.2.395; Kohr G, 2006, CELL TISSUE RES, V326, P439, DOI 10.1007/s00441-006-0273-6; Kotecha SA, 2002, NEURON, V35, P1111, DOI 10.1016/S0896-6273(02)00859-0; Lauterborn JC, 2007, J NEUROSCI, V27, P10685, DOI 10.1523/JNEUROSCI.2624-07.2007; Lavezzari G, 2003, NEUROPHARMACOLOGY, V45, P729, DOI 10.1016/S0028-3908(03)00308-3; Lei SB, 1999, J BIOL CHEM, V274, P30617, DOI 10.1074/jbc.274.43.30617; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; MANDERS EMM, 1992, J CELL SCI, V103, P857; Marini AM, 2007, AMINO ACIDS, V32, P299, DOI 10.1007/s00726-006-0414-y; Morishita W, 2005, NAT NEUROSCI, V8, P1043, DOI 10.1038/nn1506; Morishita W, 2007, NEUROPHARMACOLOGY, V52, P71, DOI 10.1016/j.neuropharm.2006.07.005; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; Ohi Y, 2007, BRAIN RES, V1159, P77, DOI 10.1016/j.brainres.2007.05.037; Ohno M, 1999, NEUROSCIENCE, V90, P643, DOI 10.1016/S0306-4522(98)00593-4; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; Philpot BD, 2003, J NEUROSCI, V23, P5583; Pokorska A, 2003, J NEUROCHEM, V84, P447, DOI 10.1046/j.1471-4159.2003.01504.x; SASAHARA M, 1991, CELL, V64, P217, DOI 10.1016/0092-8674(91)90223-L; SMITS A, 1991, P NATL ACAD SCI USA, V88, P8159, DOI 10.1073/pnas.88.18.8159; Tovar KR, 2002, NEURON, V34, P253; Tseng HC, 2005, NEUROBIOL DIS, V19, P77, DOI 10.1016/j.nbd.2004.11.007; Turrigiano G, 2007, CURR OPIN NEUROBIOL, V17, P318, DOI 10.1016/j.conb.2007.04.004; Valenzuela CF, 1997, BRAIN RES REV, V24, P77; Valenzuela CF, 1996, J BIOL CHEM, V271, P16151, DOI 10.1074/jbc.271.27.16151; Vanhoutte P, 2003, CURR OPIN NEUROBIOL, V13, P366, DOI 10.1016/S0959-4388(03)00073-4; von Engelhardt J, 2007, NEUROPHARMACOLOGY, V53, P10, DOI 10.1016/j.neuropharm.2007.04.015; WANG LY, 1995, J PHYSIOL-LONDON, V486, P83, DOI 10.1113/jphysiol.1995.sp020792; WANG LY, 1993, SCIENCE, V259, P1173, DOI 10.1126/science.8382377; WANG LY, 1991, SCIENCE, V253, P1132, DOI 10.1126/science.1653455; WANG LY, 1994, J PHYSIOL-LONDON, V475, P431, DOI 10.1113/jphysiol.1994.sp020083; Wu HY, 2007, J BIOL CHEM, V282, P20075, DOI 10.1074/jbc.M700624200; Xu F, 2006, BRAIN RES, V1121, P22, DOI 10.1016/j.brainres.2006.08.129; YEH HJ, 1993, P NATL ACAD SCI USA, V90, P1952, DOI 10.1073/pnas.90.5.1952; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025; Zhang S, 2008, J NEUROSCI, V28, P415, DOI 10.1523/JNEUROSCI.1900-07.2008; Zhou MJ, 1997, ANAL BIOCHEM, V253, P169, DOI 10.1006/abio.1997.2392; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	66	34	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					8054	8063		10.1074/jbc.M805384200	http://dx.doi.org/10.1074/jbc.M805384200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19106110	hybrid, Green Published			2022-12-25	WOS:000264195600068
J	Dubini, A; Mus, F; Seibert, M; Grossman, AR; Posewitz, MC				Dubini, Alexandra; Mus, Florence; Seibert, Michael; Grossman, Arthur R.; Posewitz, Matthew C.			Flexibility in Anaerobic Metabolism as Revealed in a Mutant of Chlamydomonas reinhardtii Lacking Hydrogenase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE FORMATE-LYASE; GENE-EXPRESSION; SUCCINIC ACID; SULFATE RESPIRATION; H-2 PRODUCTION; ATP SYNTHESIS; GREEN-ALGAE; EVOLUTION; PATHWAYS; INSIGHTS	The green alga Chlamydomonas reinhardtii has a network of fermentation pathways that become active when cells acclimate to anoxia. Hydrogenase activity is an important component of this metabolism, and we have compared metabolic and regulatory responses that accompany anaerobiosis in wild-type C. reinhardtii cells and a null mutant strain for the HYDEF gene (hydEF-1 mutant), which encodes an [FeFe] hydrogenase maturation protein. This mutant has no hydrogenase activity and exhibits elevated accumulation of succinate and diminished production of CO2 relative to the parental strain during dark, anaerobic metabolism. In the absence of hydrogenase activity, increased succinate accumulation suggests that the cells activate alternative pathways for pyruvate metabolism, which contribute to NAD(P)H reoxidation, and continued glycolysis and fermentation in the absence of O-2. Fermentative succinate production potentially proceeds via the formation of malate, and increases in the abundance of mRNAs encoding two malate-forming enzymes, pyruvate carboxylase and malic enzyme, are observed in the mutant relative to the parental strain following transfer of cells from oxic to anoxic conditions. Although C. reinhardtii has a single gene encoding pyruvate carboxylase, it has six genes encoding putative malic enzymes. Only one of the malic enzyme genes, MME4, shows a dramatic increase in expression (mRNA abundance) in the hydEF-1 mutant during anaerobiosis. Furthermore, there are marked increases in transcripts encoding fumarase and fumarate reductase, enzymes putatively required to convert malate to succinate. These results illustrate the marked metabolic flexibility of C. reinhardtii and contribute to the development of an informed model of anaerobic metabolism in this and potentially other algae.	[Dubini, Alexandra; Seibert, Michael; Posewitz, Matthew C.] Natl Renewable Energy Lab, Golden, CO 80401 USA; [Dubini, Alexandra] Colorado Sch Mines, Environm Sci & Engn Div, Golden, CO 80401 USA; [Posewitz, Matthew C.] Colorado Sch Mines, Dept Chem & Geochem, Golden, CO 80401 USA; [Mus, Florence; Grossman, Arthur R.] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Colorado School of Mines; Colorado School of Mines; Carnegie Institution for Science	Posewitz, MC (corresponding author), Natl Renewable Energy Lab, Golden, CO 80401 USA.	matthew_posewitz@nrel.gov	dubini, alexandra/A-7252-2016; dubini, alexandra/Q-6277-2019	dubini, alexandra/0000-0001-8825-3915; dubini, alexandra/0000-0001-8825-3915; Mus, Florence/0000-0002-1655-1267	Office of Biological and Environmental Research; GTL; Office of Science; United States Department of Energy; National Science Foundation [MCB 0235878]; Air Force Office of Scientific Research [FA9550-05-1-0365]	Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); GTL; Office of Science(United States Department of Energy (DOE)); United States Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was supported by the Office of Biological and Environmental Research, GTL Program, Office of Science, United States Department of Energy (to A. R. G., M. C. P., and M. S.), by National Science Foundation Grant MCB 0235878 (to A. R. G.), and by Air Force Office of Scientific Research Grant FA9550-05-1-0365 (to M. C. P.).	Allmer J, 2006, PROTEOMICS, V6, P6207, DOI 10.1002/pmic.200600208; APARICIO PJ, 1985, PLANT PHYSIOL, V78, P803, DOI 10.1104/pp.78.4.803; Arp DJ, 2007, ANNU REV MICROBIOL, V61, P503, DOI 10.1146/annurev.micro.61.080706.093449; Atteia A, 2006, J BIOL CHEM, V281, P9909, DOI 10.1074/jbc.M507862200; BHANDARI B, 1984, FEBS LETT, V168, P321, DOI 10.1016/0014-5793(84)80271-9; Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; Bologna FP, 2007, J BACTERIOL, V189, P5937, DOI 10.1128/JB.00428-07; Eberhard S, 2006, CURR GENET, V49, P106, DOI 10.1007/s00294-005-0041-2; Forestier M, 2003, EUR J BIOCHEM, V270, P2750, DOI 10.1046/j.1432-1033.2003.03656; GFELLER RP, 1984, PLANT PHYSIOL, V75, P212, DOI 10.1104/pp.75.1.212; Ghirardi ML, 2007, ANNU REV PLANT BIOL, V58, P71, DOI 10.1146/annurev.arplant.58.032806.103848; Ghirardi ML, 2005, BIOCHEM SOC T, V33, P70, DOI 10.1042/BST0330070; Ghirardi ML, 1997, APPL BIOCHEM BIOTECH, V63-5, P141, DOI 10.1007/BF02920420; Grossman AR, 2007, CURR OPIN PLANT BIOL, V10, P190, DOI 10.1016/j.pbi.2007.01.012; Hankamer B, 2007, PHYSIOL PLANTARUM, V131, P10, DOI 10.1111/j.1399-3054.2007.00924.x; HAPPE T, 1994, EUR J BIOCHEM, V222, P769, DOI 10.1111/j.1432-1033.1994.tb18923.x; Happe T, 2002, EUR J BIOCHEM, V269, P1022, DOI 10.1046/j.0014-2956.2001.02743.x; Harris EH, 2001, ANNU REV PLANT PHYS, V52, P363, DOI 10.1146/annurev.arplant.52.1.363; Harris EH, 1989, CHLAMYDOMONAS SOURCE, P780; Hemschemeier A, 2005, BIOCHEM SOC T, V33, P39, DOI 10.1042/BST0330039; Hemschemeier A, 2008, EUKARYOT CELL, V7, P518, DOI 10.1128/EC.00368-07; HODSON RC, 1971, PLANT PHYSIOL, V47, P296, DOI 10.1104/pp.47.2.296; Im CS, 2003, PHOTOSYNTH RES, V75, P111, DOI 10.1023/A:1022800630430; Kosourov S, 2003, PLANT CELL PHYSIOL, V44, P146, DOI 10.1093/pcp/pcg020; KREUZBERG K, 1984, PHYSIOL PLANTARUM, V61, P87, DOI 10.1111/j.1399-3054.1984.tb06105.x; Kruse O, 2005, PHOTOCH PHOTOBIO SCI, V4, P957, DOI 10.1039/b506923h; Kruse O, 2005, J BIOL CHEM, V280, P34170, DOI 10.1074/jbc.M503840200; Lee SJ, 2006, APPL ENVIRON MICROB, V72, P1939, DOI 10.1128/AEM.72.3.1939-1948.2006; Lemaire SD, 2004, P NATL ACAD SCI USA, V101, P7475, DOI 10.1073/pnas.0402221101; Li Y, 2008, BIOTECHNOL PROGR, V24, P815, DOI 10.1021/bp070371k; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matias PM, 2005, PROG BIOPHYS MOL BIO, V89, P292, DOI 10.1016/j.pbiomolbio.2004.11.003; McGlynn SE, 2007, J BIOL INORG CHEM, V12, P443, DOI 10.1007/s00775-007-0224-z; Melis A, 2001, PLANT PHYSIOL, V127, P740, DOI 10.1104/pp.127.3.740; Melis A, 2000, PLANT PHYSIOL, V122, P127, DOI 10.1104/pp.122.1.127; Melis A, 2007, ADV EXP MED BIOL, V616, P108; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Millard CS, 1996, APPL ENVIRON MICROB, V62, P1808, DOI 10.1128/AEM.62.5.1808-1810.1996; Moseley J, 2000, EMBO J, V19, P2139, DOI 10.1093/emboj/19.10.2139; Mus F, 2007, J BIOL CHEM, V282, P25475, DOI 10.1074/jbc.M701415200; Nagy LE, 2007, BIOTECHNOL LETT, V29, P421, DOI 10.1007/s10529-006-9254-9; OHTA S, 1987, PLANT PHYSIOL, V83, P1022, DOI 10.1104/pp.83.4.1022; Ozawa K, 2000, J BACTERIOL, V182, P2200, DOI 10.1128/JB.182.8.2200-2206.2000; Posewitz M., 2008, CURR CHEM BIOL, V2, P178, DOI DOI 10.2174/187231308784220527; Posewitz MC, 2004, J BIOL CHEM, V279, P25711, DOI 10.1074/jbc.M403206200; Posewitz MC, 2005, BIOCHEM SOC T, V33, P102, DOI 10.1042/BST0330102; Quinn JM, 2002, PLANT PHYSIOL, V128, P463, DOI 10.1104/pp.010694; Richardson DJ, 2001, CELL MOL LIFE SCI, V58, P165, DOI 10.1007/PL00000845; Rochaix JD, 2002, FEBS LETT, V529, P34, DOI 10.1016/S0014-5793(02)03181-2; ROESSLER PG, 1984, PLANT PHYSIOL, V75, P705, DOI 10.1104/pp.75.3.705; Seibert M, 2008, BIOENERGY, P273; Steunou AS, 2006, P NATL ACAD SCI USA, V103, P2398, DOI 10.1073/pnas.0507513103; Stoimenova M, 2007, PLANTA, V226, P465, DOI 10.1007/s00425-007-0496-0; Stols L, 1997, APPL ENVIRON MICROB, V63, P2695, DOI 10.1128/AEM.63.7.2695-2701.1997; Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0; Wagner V, 2006, EUKARYOT CELL, V5, P457, DOI 10.1128/EC.5.3.457-468.2006; WEAVER PF, 1980, SOL ENERGY, V24, P3, DOI 10.1016/0038-092X(80)90018-3	57	85	86	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7201	7213		10.1074/jbc.M803917200	http://dx.doi.org/10.1074/jbc.M803917200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19117946	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000263919000067
J	Pascreau, G; Eckerdt, F; Lewellyn, AL; Prigent, C; Maller, JL				Pascreau, Gaetan; Eckerdt, Frank; Lewellyn, Andrea L.; Prigent, Claude; Maller, James L.			Phosphorylation of p53 Is Regulated by TPX2-Aurora A in Xenopus Oocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AURORA-A KINASE; CENTROSOME AMPLIFICATION; MITOTIC KINASE; GENETIC INSTABILITY; SIGNALING PATHWAY; TARGETING PROTEIN; STRUCTURAL BASIS; CELL-LINES; ACTIVATION; SPINDLE	p53 is an important tumor suppressor regulating the cell cycle at multiple stages in higher vertebrates. The p53 gene is frequently deleted or mutated in human cancers, resulting in loss of p53 activity. This leads to centrosome amplification, aneuploidy, and tumorigenesis, three phenotypes also observed after overexpression of the oncogenic kinase Aurora A. Accordingly, recent studies have focused on the relationship between these two proteins. p53 and Aurora A have been reported to interact in mammalian cells, but the function of this interaction remains unclear. We recently reported that Xenopus p53 can inhibit Aurora A activity in vitro but only in the absence of TPX2. Here we investigate the interplay between Xenopus Aurora A, TPX2, and p53 and show that newly synthesized TPX2 is required for nearly all Aurora A activation and for full p53 synthesis and phosphorylation in vivo during oocyte maturation. In vitro, phosphorylation mediated by Aurora A targets serines 129 and 190 within the DNA binding domain of p53. Glutathione S-transferase pull-down studies indicate that the interaction occurs via the p53 transactivation domain and the Aurora A catalytic domain around the T-loop. Our studies suggest that targeting of TPX2 might be an effective strategy for specifically inhibiting the phosphorylation of Aurora A substrates, including p53.	[Pascreau, Gaetan; Eckerdt, Frank; Lewellyn, Andrea L.; Maller, James L.] Univ Colorado, Sch Med, Howard Hughes Med Inst, Aurora, CO 80045 USA; [Pascreau, Gaetan; Eckerdt, Frank; Lewellyn, Andrea L.; Maller, James L.] Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA; [Prigent, Claude] Univ Rennes 1, CNRS, F-35043 Rennes, France	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Maller, JL (corresponding author), 12801 E 17th Ave,POB 6511,MS 8303, Aurora, CO 80045 USA.	jim.maller@ucdenver.edu		Pascreau, Gaetan/0000-0002-1654-4032	Howard Hughes Medical Institute; CNRS; Union Internationale Contre le Cancer	Howard Hughes Medical Institute(Howard Hughes Medical Institute); CNRS(Centre National de la Recherche Scientifique (CNRS)); Union Internationale Contre le Cancer	This work was supported by the Howard Hughes Medical Institute and by grants from the CNRS and the Union Internationale Contre le Cancer (to C. P.).	Amariglio F, 1997, ONCOGENE, V15, P2191, DOI 10.1038/sj.onc.1201395; Anderson JA, 1997, MOL BIOL CELL, V8, P1195, DOI 10.1091/mbc.8.7.1195; Anderson K, 2007, BIOCHEMISTRY-US, V46, P10287, DOI 10.1021/bi7011355; Andresson T, 1998, EMBO J, V17, P5627, DOI 10.1093/emboj/17.19.5627; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Bayliss R, 2004, CELL CYCLE, V3, P404; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; BROWN CR, 1994, J CELL PHYSIOL, V160, P47, DOI 10.1002/jcp.1041600107; Castro A, 2003, J BIOL CHEM, V278, P2236, DOI 10.1074/jbc.M207894200; Chen SS, 2002, EMBO J, V21, P4491, DOI 10.1093/emboj/cdf409; Eckerdt F, 2008, CURR BIOL, V18, P519, DOI 10.1016/j.cub.2008.02.077; Eyers PA, 2003, CURR BIOL, V13, P691, DOI 10.1016/S0960-9822(03)00166-0; Eyers PA, 2004, J BIOL CHEM, V279, P9008, DOI 10.1074/jbc.M312424200; Frank-Vaillant M, 2000, J CELL SCI, V113, P1127; Fu JY, 2007, MOL CANCER RES, V5, P1, DOI 10.1158/1541-7786.MCR-06-0208; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; Gadea BB, 2005, MOL BIOL CELL, V16, P1305, DOI 10.1091/mbc.E04-10-0891; Gautschi O, 2008, CLIN CANCER RES, V14, P1639, DOI 10.1158/1078-0432.CCR-07-2179; Ghadimi BM, 2000, GENE CHROMOSOME CANC, V27, P183, DOI 10.1002/(SICI)1098-2264(200002)27:2<183::AID-GCC10>3.0.CO;2-P; Giet R, 1999, J CELL SCI, V112, P3591; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Hensey C, 1997, MECH DEVELOP, V69, P183, DOI 10.1016/S0925-4773(97)00191-3; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Holmberg CI, 2002, TRENDS BIOCHEM SCI, V27, P619, DOI 10.1016/S0968-0004(02)02207-7; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Katayama H, 2004, NAT GENET, V36, P55, DOI 10.1038/ng1279; Katayama H, 2001, J BIOL CHEM, V276, P46219, DOI 10.1074/jbc.M107540200; Kaustov L, 2006, CELL CYCLE, V5, P489, DOI 10.4161/cc.5.5.2489; Keady BT, 2007, J CELL SCI, V120, P1093, DOI 10.1242/jcs.03416; Kiat LS, 2002, J BIOL CHEM, V277, P45558, DOI 10.1074/jbc.M206820200; Krams M, 2003, J CLIN ONCOL, V21, P1810, DOI 10.1200/JCO.2003.05.076; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Littlepage LE, 2002, P NATL ACAD SCI USA, V99, P15440, DOI 10.1073/pnas.202606599; Liu Q, 2004, J BIOL CHEM, V279, P18210, DOI 10.1074/jbc.M400678200; Ma Y, 2006, CLIN CANCER RES, V12, P1121, DOI 10.1158/1078-0432.CCR-05-1766; Mendez R, 2000, NATURE, V404, P302, DOI 10.1038/35005126; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Morgan-Lappe SE, 2007, CANCER RES, V67, P4390, DOI 10.1158/0008-5472.CAN-06-4132; Morris VB, 2000, EXP CELL RES, V256, P122, DOI 10.1006/excr.2000.4800; Ohashi S, 2006, ONCOGENE, V25, P7691, DOI 10.1038/sj.onc.1209754; Pascreau G, 2005, J BIOL CHEM, V280, P13415, DOI 10.1074/jbc.M410584200; Pascreau G, 2008, DEV BIOL, V317, P523, DOI 10.1016/j.ydbio.2008.02.053; Pihan GA, 1998, CANCER RES, V58, P3974; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Qian YW, 1998, MOL CELL BIOL, V18, P4262, DOI 10.1128/MCB.18.7.4262; Radford HE, 2008, BBA-GENE REGUL MECH, V1779, P217, DOI 10.1016/j.bbagrm.2008.02.002; REMPEL RE, 1995, J BIOL CHEM, V270, P6843, DOI 10.1074/jbc.270.12.6843; Satinover DL, 2004, P NATL ACAD SCI USA, V101, P8625, DOI 10.1073/pnas.0402966101; SAWIN KE, 1991, J CELL BIOL, V112, P925, DOI 10.1083/jcb.112.5.925; Scoumanne A, 2005, CANCER BIOL THER, V4, P1178, DOI 10.4161/cbt.4.11.2254; Shinmura K, 2007, ONCOGENE, V26, P2939, DOI 10.1038/sj.onc.1210085; Tarapore P, 2002, ONCOGENE, V21, P6234, DOI 10.1038/sj.onc.1205707; Tarapore P, 2001, ONCOGENE, V20, P3173, DOI 10.1038/sj.onc.1204424; Tatsuka M, 1998, CANCER RES, V58, P4811; Tchang F, 1999, EXP CELL RES, V251, P46, DOI 10.1006/excr.1999.4570; TCHANG F, 1993, DEV BIOL, V159, P163, DOI 10.1006/dbio.1993.1230; Terada Y, 1998, EMBO J, V17, P667, DOI 10.1093/emboj/17.3.667; Tritarelli A, 2004, MOL BIOL CELL, V15, P3751, DOI 10.1091/mbc.E03-12-0900; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; VERNOS I, 1995, TRENDS CELL BIOL, V5, P297, DOI 10.1016/S0962-8924(00)89045-5; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Xu Y, 2008, ONCOGENE, V27, P3501, DOI 10.1038/sj.onc.1211023; Yamamoto TM, 2008, MOL CELL BIOL, V28, P4196, DOI 10.1128/MCB.00169-08; Yang YL, 2004, ONCOGENE, V23, P2096, DOI 10.1038/sj.onc.1207411; ZAJDEL MEB, 1988, ONCOGENE, V2, P579; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	68	23	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5497	5505		10.1074/jbc.M805959200	http://dx.doi.org/10.1074/jbc.M805959200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19121998	hybrid, Green Published			2022-12-25	WOS:000263560600012
J	Dancho, B; McKenzie, MO; Connor, JH; Lyles, DS				Dancho, Brooke; McKenzie, Margie O.; Connor, John H.; Lyles, Douglas S.			Vesicular Stomatitis Virus Matrix Protein Mutations That Affect Association with Host Membranes and Viral Nucleocapsids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; INFECTED-CELLS; MUTANTS; COMPLEMENTATION; MICRODOMAINS; LIPOSOMES; SEQUENCES; SEPARATE; VIRIONS; DOMAINS	Viral matrix (M) proteins bind the nucleoprotein core (nucleocapsid) to host membranes during the process of virus assembly by budding. Previous studies using truncated M proteins had implicated the N-terminal 50 amino acids of the vesicular stomatitis virus M protein in binding both membranes and nucleocapsids and a sequence from amino acids 75-106 as an additional membrane binding region. Structure-based mutations were introduced into these two regions, and their effects on membrane association and incorporation into nucleocapsid-M protein complexes were determined using quantitative assays. The results confirmed that the N terminus of M protein is involved in association with plasma membranes as well as nucleocapsids, although these two activities were differentially affected by individual mutations. Mutations in the 75-106 region affected incorporation into nucleocapsid-M complexes but had only minor effects on association with membranes. The ability of site-specific mutant M proteins to complement growth of temperature-sensitive M mutant virus did not correlate well with the ability to associate with membranes or nucleocapsids, suggesting that complementation involves an additional activity of M protein. Mutants with similar abilities to associate with membranes and nucleocapsids but differing in complementation activity were incorporated into infectious cDNA clones. Infectious virus was repeatedly recovered containing mutant M proteins capable of complementation but was never recovered with mutant M proteins that lacked complementation activity, providing further evidence for a separate activity of M protein that is essential for virus replication.	[Dancho, Brooke; McKenzie, Margie O.; Lyles, Douglas S.] Wake Forest Univ, Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; [Connor, John H.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA	Wake Forest University; Boston University	Lyles, DS (corresponding author), Wake Forest Univ, Sch Med, Dept Biochem, Winston Salem, NC 27157 USA.	dlyles@wfubmc.edu		Connor, John/0000-0002-8867-7256; Lyles, Douglas/0000-0002-8401-3073	National Institutes of Health [AI15892]; NIAID; NATIONAL CANCER INSTITUTE [P30CA012197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015892, R55AI015892] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI15892 (a Public Health Service grant from the NIAID).	Armbruster BN, 2001, MOL CELL BIOL, V21, P7775, DOI 10.1128/MCB.21.22.7775-7786.2001; BARGE A, 1993, J VIROL, V67, P7246, DOI 10.1128/JVI.67.12.7246-7253.1993; BLACK BL, 1993, J VIROL, V67, P4814, DOI 10.1128/JVI.67.8.4814-4821.1993; Brown EL, 2003, J VIROL, V77, P3985, DOI 10.1128/JVI.77.7.3985-3992.2003; CHONG LD, 1993, J VIROL, V67, P407, DOI 10.1128/JVI.67.1.407-414.1993; Connor JH, 2006, J VIROL, V80, P3701, DOI 10.1128/JVI.80.8.3701-3711.2006; Flood EA, 2000, VIROLOGY, V278, P520, DOI 10.1006/viro.2000.0675; Flood EA, 1999, VIROLOGY, V261, P295, DOI 10.1006/viro.1999.9856; Gaudier M, 2002, EMBO J, V21, P2886, DOI 10.1093/emboj/cdf284; Gaudier M, 2001, VIROLOGY, V288, P308, DOI 10.1006/viro.2001.1062; GOPALAKRISHNA Y, 1985, J VIROL, V56, P655, DOI 10.1128/JVI.56.3.655-659.1985; Irie T, 2004, J VIROL, V78, P7823, DOI 10.1128/JVI.78.14.7823-7827.2004; Jayakar HR, 2004, VIRUS RES, V106, P117, DOI 10.1016/j.virusres.2004.08.009; KAPTUR PE, 1991, J VIROL, V65, P1057, DOI 10.1128/JVI.65.3.1057-1065.1991; KNIPE DM, 1977, J VIROL, V21, P1128, DOI 10.1128/JVI.21.3.1128-1139.1977; Kopecky SA, 2001, J VIROL, V75, P12169, DOI 10.1128/JVI.75.24.12169-12181.2001; LENARD J, 1990, J VIROL, V64, P3486, DOI 10.1128/JVI.64.7.3486-3491.1990; Lenard J, 1996, VIROLOGY, V216, P289, DOI 10.1006/viro.1996.0064; LI Y, 1993, J VIROL, V67, P4415, DOI 10.1128/JVI.67.7.4415-4420.1993; LYLES DS, 1988, J VIROL, V62, P4387, DOI 10.1128/JVI.62.11.4387-4392.1988; Lyles DS, 1996, VIROLOGY, V217, P76, DOI 10.1006/viro.1996.0095; Lyles DS, 1998, BIOCHEMISTRY-US, V37, P439, DOI 10.1021/bi971812j; MCCREEDY BJ, 1989, VIRUS RES, V14, P189, DOI 10.1016/0168-1702(89)90001-4; MCCREEDY BJ, 1990, J VIROL, V64, P902, DOI 10.1128/JVI.64.2.902-906.1990; MORITA K, 1987, J VIROL, V61, P256, DOI 10.1128/JVI.61.2.256-263.1987; NEWCOMB WW, 1982, J VIROL, V41, P1055, DOI 10.1128/JVI.41.3.1055-1062.1982; NEWCOMB WW, 1981, J VIROL, V39, P295, DOI 10.1128/JVI.39.1.295-299.1981; OGDEN JR, 1986, J VIROL, V58, P860, DOI 10.1128/JVI.58.3.860-868.1986; ONO K, 1987, J VIROL, V61, P1332, DOI 10.1128/JVI.61.5.1332-1341.1987; Pornillos O, 2002, TRENDS CELL BIOL, V12, P569, DOI 10.1016/S0962-8924(02)02402-9; Swinteck BD, 2008, J VIROL, V82, P5536, DOI 10.1128/JVI.02407-07; THOMAS D, 1985, J VIROL, V54, P598, DOI 10.1128/JVI.54.2.598-607.1985; Timmins J, 2004, FEMS MICROBIOL LETT, V233, P179, DOI [10.1111/j.1574-6968.2004.tb09480.x, 10.1016/j.femsle.2004.03.002]; WILSON IA, 1985, P NATL ACAD SCI USA, V82, P5255, DOI 10.1073/pnas.82.16.5255; YE ZP, 1994, J VIROL, V68, P7386, DOI 10.1128/JVI.68.11.7386-7396.1994	35	22	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4500	4509		10.1074/jbc.M808136200	http://dx.doi.org/10.1074/jbc.M808136200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19088071	hybrid, Green Published			2022-12-25	WOS:000263134400050
J	Mitra, S; Tsvetkov, AS; Finkbeiner, S				Mitra, Siddhartha; Tsvetkov, Andrey S.; Finkbeiner, Steven			Single Neuron Ubiquitin-Proteasome Dynamics Accompanying Inclusion Body Formation in Huntington Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYGLUTAMINE PROTEINS; FLUORESCENT PROTEIN; POLYUBIQUITIN GENE; MUTANT HUNTINGTIN; SYSTEM; DEGRADATION; AUTOPHAGY; CELLS; MICE; NEURODEGENERATION	The accumulation of mutant protein in intracellular aggregates is a common feature of neurodegenerative disease. In Huntington disease, mutant huntingtin leads to inclusion body (IB) formation and neuronal toxicity. Impairment of the ubiquitin-proteasome system (UPS) has been implicated in IB formation and Huntington disease pathogenesis. However, IBs form asynchronously in only a subset of cells with mutant huntingtin, and the relationship between IB formation and UPS function has been difficult to elucidate. Here, we applied single-cell longitudinal acquisition and analysis to monitor mutant huntingtin IB formation, UPS function, and neuronal toxicity. We found that proteasome inhibition is toxic to striatal neurons in a dose-dependent fashion. Before IB formation, the UPS is more impaired in neurons that go on to form IBs than in those that do not. After forming IBs, impairment is lower in neurons with IBs than in those without. These findings suggest IBs are a protective cellular response to mutant protein mediated in part by improving intracellular protein degradation.	[Mitra, Siddhartha; Tsvetkov, Andrey S.; Finkbeiner, Steven] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Mitra, Siddhartha; Finkbeiner, Steven] Univ Calif San Francisco, Program Biomed Sci, Med Scientist Training Program, San Francisco, CA 94143 USA; [Tsvetkov, Andrey S.; Finkbeiner, Steven] Univ Calif San Francisco, Neurosci Program, Dept Neurol, San Francisco, CA 94143 USA; [Tsvetkov, Andrey S.; Finkbeiner, Steven] Univ Calif San Francisco, Neurosci Program, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Finkbeiner, S (corresponding author), Gladstone Inst Neurol Dis, 1650 Owens St, San Francisco, CA 94158 USA.	sfinkbeiner@gladstone.ucsf.edu			National Institutes of Health [R01 2NS039074, R01 NS045191]; NINDS; NIA [P01 AG022074]; Taube Family Foundation Program in Huntington Disease; Gladstone Institutes; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045191, R01NS039074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG022074] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Taube Family Foundation Program in Huntington Disease; Gladstone Institutes(University of California System); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 2NS039074 and R01 NS045191 from the NINDS (to S. F.) and Grant P01 AG022074 from the NIA. This work was also supported by the Taube Family Foundation Program in Huntington Disease, and the Gladstone Institutes (to S. F.).	Almeida CG, 2006, J NEUROSCI, V26, P4277, DOI 10.1523/JNEUROSCI.5078-05.2006; Arrasate M, 2005, P NATL ACAD SCI USA, V102, P3840, DOI 10.1073/pnas.0409777102; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Bett JS, 2006, HUM MOL GENET, V15, P33, DOI 10.1093/hmg/ddi423; Bowman AB, 2005, HUM MOL GENET, V14, P679, DOI 10.1093/hmg/ddi064; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chai YH, 2002, P NATL ACAD SCI USA, V99, P9310, DOI 10.1073/pnas.152101299; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Ding QX, 2002, J BIOL CHEM, V277, P13935, DOI 10.1074/jbc.M107706200; Gilon T, 1998, EMBO J, V17, P2759, DOI 10.1093/emboj/17.10.2759; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Holmberg CI, 2004, EMBO J, V23, P4307, DOI 10.1038/sj.emboj.7600426; Iwata A, 2005, P NATL ACAD SCI USA, V102, P13135, DOI 10.1073/pnas.0505801102; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Keller JN, 2002, AGEING RES REV, V1, P279, DOI 10.1016/S1568-1637(01)00006-X; Khan LA, 2006, J NEUROCHEM, V98, P576, DOI 10.1111/j.1471-4159.2006.03895.x; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Lindsten K, 2003, NAT BIOTECHNOL, V21, P897, DOI 10.1038/nbt851; Massey AC, 2006, CURR TOP DEV BIOL, V73, P205, DOI 10.1016/S0070-2153(05)73007-6; Matsumoto G, 2006, J BIOL CHEM, V281, P4477, DOI 10.1074/jbc.M509201200; Michalik A, 2004, NEUROBIOL DIS, V16, P202, DOI 10.1016/j.nbd.2003.12.020; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Rusmini P, 2007, NEUROBIOL AGING, V28, P1099, DOI 10.1016/j.neurobiolaging.2006.05.015; Ryu KY, 2008, P NATL ACAD SCI USA, V105, P4016, DOI 10.1073/pnas.0800096105; Ryu KY, 2008, MOL CELL BIOL, V28, P1136, DOI 10.1128/MCB.01566-07; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Stangl K, 2002, BIOCHEM BIOPH RES CO, V291, P542, DOI 10.1006/bbrc.2002.6476; Stenoien DL, 2002, NAT CELL BIOL, V4, P806, DOI 10.1038/ncb859; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Verhoef LGGC, 2002, HUM MOL GENET, V11, P2689, DOI 10.1093/hmg/11.22.2689; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33	41	74	75	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4398	4403		10.1074/jbc.M806269200	http://dx.doi.org/10.1074/jbc.M806269200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19074152	Green Published, hybrid			2022-12-25	WOS:000263134400039
J	Sum, CS; Tikhonova, IG; Costanzi, S; Gershengorn, MC				Sum, Chi Shing; Tikhonova, Irina G.; Costanzi, Stefano; Gershengorn, Marvin C.			Two Arginine-Glutamate Ionic Locks Near the Extracellular Surface of FFAR1 Gate Receptor Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; THYROTROPIN-RELEASING-HORMONE; A(2A) ADENOSINE RECEPTOR; BETA(2)-ADRENERGIC RECEPTOR; DRUG DISCOVERY; AGONIST RECOGNITION; LIGAND RECOGNITION; INSULIN-SECRETION; CRYSTAL-STRUCTURE; BINDING	Activation of a number of class A G protein-coupled receptors (GPCRs) is thought to involve two molecular switches, a rotamer toggle switch within the transmembrane domain and an ionic lock at the cytoplasmic surface of the receptor; however, the mechanism by which agonist binding changes these molecular interactions is not understood. Importantly, 80% of GPCRs including free fatty acid receptor 1 (FFAR1) lack the complement of amino acid residues implicated in either or both of these two switches; the mechanism of activation of these GPCRs is therefore less clear. By homology modeling, we identified two Glu residues (Glu-145 and Glu-172) in the second extracellular loop of FFAR1 that form putative interactions individually with two transmembrane Arg residues (Arg-183(5.39) and Arg-258(7.35)) to create two ionic locks. Molecular dynamics simulations showed that binding of agonists to FFAR1 leads to breakage of these Glu-Arg interactions. In mutagenesis experiments, breakage of these two putative interactions by substituting Ala for Glu-145 and Glu-172 caused constitutive receptor activation. Our results therefore reveal a molecular switch for receptor activation present on the extracellular surface of FFAR1 that is broken by agonist binding. Similar ionic locks between the transmembrane domains and the extracellular loops may constitute a mechanism common to other class A GPCRs also.	[Sum, Chi Shing; Gershengorn, Marvin C.] NIDDK, Clin Endocrinol Branch, NIH, Bethesda, MD 20892 USA; [Tikhonova, Irina G.; Costanzi, Stefano] NIDDK, Lab Biol Modeling, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Gershengorn, MC (corresponding author), 50 South Dr,Rm 4134, Bethesda, MD 20892 USA.	marving@intra.niddk.nih.gov	Costanzi, Stefano/G-8990-2013	Costanzi, Stefano/0000-0003-3183-7332	Intramural Research Program; NIDDK; National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK013025, ZIADK013025, ZIADK011006, Z01DK011006] Funding Source: NIH RePORTER	Intramural Research Program; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the Intramural Research Program, NIDDK, National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; Ballesteros J.A., 1995, METHODS NEUROSCIENCE; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Baneres JL, 2005, J BIOL CHEM, V280, P20253, DOI 10.1074/jbc.M412009200; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brown AJ, 2005, DNA CELL BIOL, V24, P54, DOI 10.1089/dna.2005.24.54; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Colson AO, 1998, BIOPHYS J, V74, P1087, DOI 10.1016/S0006-3495(98)77827-0; Conner M, 2007, J BIOL CHEM, V282, P17405, DOI 10.1074/jbc.M702151200; Costanzi S, 2005, J MED CHEM, V48, P8108, DOI 10.1021/jm050911p; Costanzi S, 2004, J MED CHEM, V47, P5393, DOI 10.1021/jm049914c; Costanzi S, 2008, J BIOL CHEM, V283, P16269, DOI 10.1074/jbc.R800014200; Costanzi S, 2008, J MED CHEM, V51, P2907, DOI 10.1021/jm800044k; Cristalli G, 2008, CURR PHARM DESIGN, V14, P1525, DOI 10.2174/138161208784480081; Foucaud M, 2006, MOL PHARMACOL, V69, P680, DOI 10.1124/mol.105.019992; Garrido DM, 2006, BIOORG MED CHEM LETT, V16, P1840, DOI 10.1016/j.bmcl.2006.01.007; Greasley PJ, 2002, MOL PHARMACOL, V61, P1025, DOI 10.1124/mol.61.5.1025; Huang W, 2005, BIOCHEMISTRY-US, V44, P2419, DOI 10.1021/bi048808+; Im W, 2003, BIOPHYS J, V85, P2900, DOI 10.1016/S0006-3495(03)74712-2; Im WP, 2003, J COMPUT CHEM, V24, P1691, DOI 10.1002/jcc.10321; Kim JH, 1996, MOL PHARMACOL, V49, P683; Klco JM, 2005, NAT STRUCT MOL BIOL, V12, P320, DOI 10.1038/nsmb913; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Moro S, 1999, BIOCHEMISTRY-US, V38, P3498, DOI 10.1021/bi982369v; OLAH ME, 1994, J BIOL CHEM, V269, P24692; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Perlman JH, 1997, BIOCHEMISTRY-US, V36, P15670, DOI 10.1021/bi9713310; Robbins AK, 1998, BIOTECHNIQUES, V25, P240, DOI 10.2144/98252st04; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scarselli M, 2007, J BIOL CHEM, V282, P7385, DOI 10.1074/jbc.M610394200; Shapiro DA, 2002, J BIOL CHEM, V277, P11441, DOI 10.1074/jbc.M111675200; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Song FB, 2007, J MED CHEM, V50, P2807, DOI 10.1021/jm070130j; Stoddart LA, 2007, MOL PHARMACOL, V71, P994, DOI 10.1124/mol.106.031534; Sum CS, 2007, J BIOL CHEM, V282, P29248, DOI 10.1074/jbc.M705077200; Surgand JS, 2006, PROTEINS, V62, P509, DOI 10.1002/prot.20768; Tan CP, 2008, DIABETES, V57, P2211, DOI 10.2337/db08-0130; Tan ES, 2008, CHEM BIOL, V15, P343, DOI 10.1016/j.chembiol.2008.03.004; Tikhonova IG, 2008, J MED CHEM, V51, P625, DOI 10.1021/jm7012425; Tikhonova IG, 2007, J MED CHEM, V50, P2981, DOI 10.1021/jm0614782; Winzell MS, 2007, PHARMACOL THERAPEUT, V116, P437, DOI 10.1016/j.pharmthera.2007.08.002	44	51	52	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3529	3536		10.1074/jbc.M806987200	http://dx.doi.org/10.1074/jbc.M806987200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19068482	Green Published, hybrid			2022-12-25	WOS:000262872500020
J	Hausmann, S; Marq, JB; Tapparel, C; Kolakofsky, D; Garcin, D				Hausmann, Stephane; Marq, Jean-Baptiste; Tapparel, Caroline; Kolakofsky, Daniel; Garcin, Dominique			RIG-I and dsRNA-Induced IFN beta Activation	PLOS ONE			English	Article							INNATE IMMUNITY; ANTIVIRAL RESPONSES; INTERFERON-BETA; RNA HELICASE; RECOGNITION; VIRUSES; ACID; INDUCTION; PROMOTER; DOMAIN	Except for viruses that initiate RNA synthesis with a protein primer (e. g., picornaviruses), most RNA viruses initiate RNA synthesis with an NTP, and at least some of their viral (ppp)RNAs remain unblocked during the infection. Consistent with this, most viruses require RIG-I to mount an innate immune response, whereas picornaviruses require mda-5. We have examined a SeV infection whose ability to induce interferon depends on the generation of capped dsRNA (without free 5' triphosphate ends), and found that this infection as well requires RIG-I and not mda-5. We also provide evidence that RIG-I interacts with poly-I/C in vivo, and that heteropolymeric dsRNA and poly-I/C interact directly with RIG-I in vitro, but in different ways; i.e., poly-I/C has the unique ability to stimulate the helicase ATPase of RIG-I variants which lack the C-terminal regulatory domain.	[Hausmann, Stephane; Marq, Jean-Baptiste; Tapparel, Caroline; Kolakofsky, Daniel; Garcin, Dominique] Univ Geneva, Sch Med, Dept Microbiol & Mol Med, CH-1211 Geneva, Switzerland; [Tapparel, Caroline] Univ Geneva Hosp, Fac Med, Div Infect Dis, Lab Virol, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva	Hausmann, S (corresponding author), Univ Geneva, Sch Med, Dept Microbiol & Mol Med, CH-1211 Geneva, Switzerland.	daniel.kolakofsky@medecine.unige.ch		Tapparel Vu, Caroline/0000-0002-0411-6567	Swiss National Science Fund; Canton of Geneva	Swiss National Science Fund(Swiss National Science Foundation (SNSF)); Canton of Geneva	The work was funded by the Swiss National Science Fund, plus the Canton of Geneva. Neither had any role in the study or the decision to submit the manuscript, or its preparation.	Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; CHILDS K, 2006, VIROLOGY; COLBY C, 1969, P NATL ACAD SCI USA, V63, P160, DOI 10.1073/pnas.63.1.160; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Flint S.J., 2004, PRINCIPLES VIROLOGY, VSecond; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Hopfner KP, 2007, CURR OPIN STRUC BIOL, V17, P87, DOI 10.1016/j.sbi.2006.11.003; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; KING P, 1994, J BIOL CHEM, V269, P30609; KOLAKOFSKY D, 1976, CELL, V8, P547, DOI 10.1016/0092-8674(76)90223-3; LAMB R., 2001, FIELDS VIROLOGY, V1, P1305; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Plumet S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000279; Poast J, 2002, J INTERF CYTOK RES, V22, P1035, DOI 10.1089/107999002760624260; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Strahle L, 2003, J VIROL, V77, P7903, DOI 10.1128/JVI.77.14.7903-7913.2003; STRAHLE L, 2007, J VIROL; Strahle L, 2006, VIROLOGY, V351, P101, DOI 10.1016/j.virol.2006.03.022; TAKAHASI K, 2008, MOL CELL; Takeuchi O, 2007, IMMUNOL REV, V220, P214, DOI 10.1111/j.1600-065X.2007.00562.x; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2007, J BIOL CHEM, V282, P15315, DOI 10.1074/jbc.R700007200	30	39	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2008	3	12							e3965	10.1371/journal.pone.0003965	http://dx.doi.org/10.1371/journal.pone.0003965			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DL	19115016	Green Published, gold, Green Submitted			2022-12-25	WOS:000265466300001
J	Xiao, QZ; Ye, S; Oberhollenzer, F; Mayr, A; Jahangiri, M; Willeit, J; Kiechl, S; Xu, QB				Xiao, Qingzhong; Ye, Shu; Oberhollenzer, Friedrich; Mayr, Agnes; Jahangiri, Marjan; Willeit, Johann; Kiechl, Stefan; Xu, Qingbo			SDF1 Gene Variation Is Associated with Circulating SDF1 alpha Level and Endothelial Progenitor Cell Number-The Bruneck Study	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CHEMOKINE RECEPTOR CXCR4; PERIPHERAL-BLOOD; HEMATOPOIETIC PROGENITOR; MOLECULAR-CLONING; RISK-FACTORS; TOPCARE-AMI; MOBILIZATION; STEM; RECRUITMENT	Background: Stromal cell-derived factor-1 (SDF1) and its receptor CXC chemokine receptor 4 (CXCR4) play a critical role in progenitor cell homing, mobilization and differentiation. It would be interesting to assess the predictive value of SDF-1alpha level for EPC number, and to ascertain whether there is a relationship between SDF1 gene variation, plasma SDF-1alpha level, and the number and function of circulating EPCs. We also tested whether EPC number and function was related to CXCR4 gene variation. Methodology and Principal Findings: We genotyped a cohort of individuals who participated in the Bruneck Study for single nucleotide polymorphisms (SNPs) in the SDF1 and CXCR4 genes, and measured blood SDF1 alpha level as well as EPC number and function. SDF1 alpha levels were correlated with age, gender, alcohol consumption, circulating reticulocyte numbers, and concentrations of matrix metalloproteinase-9, C-reactive protein, cystatin C, fibrinogen and homocytein. In blood samples taken in 2005, EPC number was inversely associated with SDF1a level (p<0.001). EPC number in 2005 was also inversely associated with SDF1 alpha level in 2000 (p = 0.009), suggesting a predictive value of plasma SDF1 alpha level for EPC number. There was an association between the SDF1 gene rs2297630 SNP A/A genotype, increased SDF1 alpha level (p=0.002) and lower EPC number (p=0.006). Conclusions: Our data indicate that a SDF1 gene variation (rs2297630) has an influence on SDF1 alpha level and circulating EPC number, and that plasma SDF1 alpha level is a predictor of EPC number.	[Xu, Qingbo] Kings Coll London, Div Cardiovasc, BHF Ctr, London WC2R 2LS, England; [Ye, Shu] Queen Marys Univ London, Barts & London Sch Med & Dentist, London, England; [Oberhollenzer, Friedrich; Mayr, Agnes] Bruneck Hosp, Dept Internal & Lab Med, Brunico, Italy; [Jahangiri, Marjan] St George Hosp, Dept Cardiothorac Surg, London, England; [Willeit, Johann; Kiechl, Stefan] Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria	University of London; King's College London; University of London; Queen Mary University London; St Georges University London; Medical University of Innsbruck	Xiao, QZ (corresponding author), Kings Coll London, Div Cardiovasc, BHF Ctr, London WC2R 2LS, England.	qingbo.xu@kcl.ac.uk	Ye, Shu/R-6384-2017; Ye, Shu/C-4067-2009	Ye, Shu/0000-0002-4126-4278; 	British Heart Foundation; Oak Foundation	British Heart Foundation(British Heart Foundation); Oak Foundation	QX thanks support from the British Heart Foundation and Oak Foundation, and SY thanks support from the British Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Arya SK, 1999, J HUMAN VIROL, V2, P133; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Benboubker L, 2001, BRIT J HAEMATOL, V113, P247, DOI 10.1046/j.1365-2141.2001.02717.x; Brambilla A, 2000, J INFECT DIS, V182, P311, DOI 10.1086/315650; Britten MB, 2003, CIRCULATION, V108, P2212, DOI 10.1161/01.CIR.0000095788.78169.AF; Choi JH, 2004, ARTERIOSCL THROM VAS, V24, P1246, DOI 10.1161/01.ATV.0000133488.56221.4a; de Oliveira CEC, 2007, J CLIN LAB ANAL, V21, P49, DOI 10.1002/jcla.20142; De Falco E, 2004, BLOOD, V104, P3472, DOI 10.1182/blood-2003-12-4423; Dimberg J, 2007, INT J MOL MED, V19, P11; Dommange F, 2006, FASEB J, V20, P1913, DOI 10.1096/fj.05-5667fje; Fadini GP, 2005, J AM COLL CARDIOL, V45, P1449, DOI 10.1016/j.jacc.2004.11.067; Foresta C, 2005, INT J IMPOT RES, V17, P288, DOI 10.1038/sj.ijir.3901311; Ghani U, 2005, STROKE, V36, P151, DOI 10.1161/01.STR.0000149944.15406.16; Ghilardi G, 2008, CYTOKINE, V41, P24, DOI 10.1016/j.cyto.2007.10.007; Grisar J, 2005, CIRCULATION, V111, P204, DOI 10.1161/01.CIR.0000151875.21836.AE; Hattori K, 2001, BLOOD, V97, P3354, DOI 10.1182/blood.V97.11.3354; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Hiasa K, 2004, CIRCULATION, V109, P2454, DOI 10.1161/01.CIR.0000128213.96779.61; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Ide A, 2003, HUM IMMUNOL, V64, P973, DOI 10.1016/S0198-8859(03)00176-9; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kawamoto A, 2001, CIRCULATION, V103, P634; Kimura R, 2005, HUM MOL GENET, V14, P1579, DOI 10.1093/hmg/ddi166; Kondo T, 2004, ARTERIOSCL THROM VAS, V24, P1442, DOI 10.1161/01.ATV.0000135655.52088.c5; Lima G, 2007, HUM IMMUNOL, V68, P980, DOI 10.1016/j.humimm.2007.10.007; Moore MAS, 2001, ANN NY ACAD SCI, V938, P36; Mummidi S, 1998, NAT MED, V4, P786, DOI 10.1038/nm0798-786; NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305; Nagasawa T, 1996, P NATL ACAD SCI USA, V93, P14726, DOI 10.1073/pnas.93.25.14726; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Prater DN, 2007, LEUKEMIA, V21, P1141, DOI 10.1038/sj.leu.2404676; Rafii S, 2002, GENE THER, V9, P631, DOI 10.1038/sj.gt.3301723; Schachinger V, 2004, J AM COLL CARDIOL, V44, P1690, DOI 10.1016/j.jacc.2004.08.014; SHIROZU M, 1995, GENOMICS, V28, P495, DOI 10.1006/geno.1995.1180; Soriano A, 2002, J INFECT DIS, V186, P922, DOI 10.1086/343741; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Vasa M, 2001, CIRCULATION, V103, P2885, DOI 10.1161/hc2401.092816; Whittaker A, 2008, EUR HEART J, V29, P332, DOI 10.1093/eurheartj/ehm602; Winkler C, 1998, SCIENCE, V279, P389, DOI 10.1126/science.279.5349.389; Xiao QZ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000975; Xu QB, 2000, CIRCULATION, V102, P14, DOI 10.1161/01.CIR.102.1.14; XU QB, 1993, LANCET, V341, P255, DOI 10.1016/0140-6736(93)92613-X; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22; Zafiropoulos A, 2004, J MED GENET, V41, DOI 10.1136/JMG.2003.013649; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	51	52	56	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2008	3	12							e4061	10.1371/journal.pone.0004061	http://dx.doi.org/10.1371/journal.pone.0004061			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DL	19115008	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000265466300005
J	Zhang, B; Ma, JX				Zhang, Bin; Ma, Jian-xing			SERPINA3K Prevents Oxidative Stress Induced Necrotic Cell Death by Inhibiting Calcium Overload	PLOS ONE			English	Article								Background: SERPINA3K, an extracellular serine proteinase inhibitor (serpin), has been shown to have decreased levels in the retinas of diabetic rats, which may contribute to diabetic retinopathy. The function of SERPINA3K in the retina has not been investigated. Methodology/Principal Findings: The present study identified a novel function of SERPINA3K, i.e. it protects retinal cells against oxidative stress-induced cell death including retinal neuronal cells and Muller cells. Flow-cytometry showed that the protective effect of SERPINA3K on Muller cells is via reducing oxidation-induced necrosis. Measurements of intracellular calcium concentration showed that SERPINA3K prevented the intracellular calcium overload induced by H(2)O(2). A similar protective effect was observed using a calcium chelator (BAPTA/AM). Further, SERPINA3K inhibited the phosphorylation of phospholipase C (PLC)-gamma1 induced by H(2)O(2). Likewise, a specific PLC inhibitor showed similar protective effects on Muller cells exposed to H(2)O(2). Furthermore, the protective effect of SERPINA3K was attenuated by a specific PLC activator (m-3M3FBS). Finally, in a binding assay, SERPINA3K displayed saturable and specific binding on Muller cells. Conclusion/Significance: These results for the first time demonstrate that SERPINA3K is an endogenous serpin which protects cells from oxidative stress-induced cells death, and its protective effect is via blocking the calcium overload through the PLC pathway. The decreased retinal levels of SERPINA3K may represent a new pathogenic mechanism for the retinal Muller cell dysfunction and neuron loss in diabetes.	[Zhang, Bin; Ma, Jian-xing] Univ Oklahoma, Dept Cell Biol, Dept Med, Hlth Sci Ctr, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Zhang, B (corresponding author), Univ Oklahoma, Dept Cell Biol, Dept Med, Hlth Sci Ctr, Oklahoma City, OK USA.	jian-xing-ma@ouhsc.edu			NIH [EY012231, EY015650, EY004939, P20RR024215]; National Center for Research Resources; OCAST; Foundation fighting Blindness and Research for Prevention of Blindness; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024215] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R21EY015650, R01EY004939, R33EY015650, R01EY012231] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OCAST; Foundation fighting Blindness and Research for Prevention of Blindness; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by NIH grants EY012231, EY015650, EY004939, and P20RR024215 from the National Center for Research Resources, and grants from OCAST, Foundation fighting Blindness and Research for Prevention of Blindness. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health.	Abraham MC, 2007, DEV CELL, V13, P464, DOI 10.1016/j.devcel.2007.09.008; Altomare E, 1997, EUR J CLIN INVEST, V27, P141, DOI 10.1046/j.1365-2362.1997.780629.x; ANDERSON RE, 1994, ADV EXP MED BIOL, V366, P73; BHOOLA KD, 1992, PHARMACOL REV, V44, P1; Canelles M, 1997, ONCOGENE, V14, P1315, DOI 10.1038/sj.onc.1200948; Cao W, 1999, J NEUROSCI RES, V57, P789, DOI 10.1002/(SICI)1097-4547(19990915)57:6<789::AID-JNR4>3.3.CO;2-D; CHAO J, 1990, J BIOL CHEM, V265, P16394; CHAO J, 1986, BIOCHEM J, V239, P325, DOI 10.1042/bj2390325; Clement MV, 1998, FEBS LETT, V440, P13, DOI 10.1016/S0014-5793(98)01410-0; CLEMENTS JA, 1989, ENDOCR REV, V10, P393, DOI 10.1210/edrv-10-4-393; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Dubois-Dauphin M, 2000, NEUROSCIENCE, V95, P9; Gao G, 2003, DIABETOLOGIA, V46, P689, DOI 10.1007/s00125-003-1085-9; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gosbell AD, 2006, INVEST OPHTH VIS SCI, V47, P2613, DOI 10.1167/iovs.05-0962; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Hatcher HC, 1997, INVEST OPHTH VIS SCI, V38, P658; Hong JH, 2006, J BIOL CHEM, V281, P13057, DOI 10.1074/jbc.M601726200; Kowluru RA, 2001, NEUROCHEM INT, V38, P385, DOI 10.1016/S0197-0186(00)00112-1; Kowluru RA, 2007, EXP DIABETES RES, DOI 10.1155/2007/43603; Luke CJ, 2007, CELL, V130, P1108, DOI 10.1016/j.cell.2007.07.013; MA JX, 1995, J BIOL CHEM, V270, P451, DOI 10.1074/jbc.270.1.451; Miao RQ, 2002, BLOOD, V100, P3245, DOI 10.1182/blood-2002-01-0185; MUALLEM S, 1989, ANNU REV PHYSIOL, V51, P83; MURRAY SR, 1990, J CARDIOVASC PHARM, V15, pS7, DOI 10.1097/00005344-199000156-00003; Newman E, 1996, TRENDS NEUROSCI, V19, P307, DOI 10.1016/0166-2236(96)10040-0; NEWMAN EA, 1993, J NEUROSCI, V13, P3333; Ohira A, 2003, INVEST OPHTH VIS SCI, V44, P1230, DOI 10.1167/iovs.02-0191; Poitry S, 2000, J NEUROSCI, V20, P1809; Puro Donald G, 2002, Trans Am Ophthalmol Soc, V100, P339; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Rothstein EC, 2002, AM J PHYSIOL-HEART C, V283, pH598, DOI 10.1152/ajpheart.00198.2002; Sarthy VP, 1998, INVEST OPHTH VIS SCI, V39, P212; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Syntichaki P, 2002, EMBO REP, V3, P604, DOI 10.1093/embo-reports/kvf138; Tkaczyk C, 2003, J BIOL CHEM, V278, P48474, DOI 10.1074/jbc.M301350200; Viard P, 2004, NAT NEUROSCI, V7, P939, DOI 10.1038/nn1300; Wang X, 2003, J BIOL CHEM, V278, P29184, DOI 10.1074/jbc.M301624200; Willbold E, 1997, J BRAIN RES, V38, P383; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	40	38	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2008	3	12							e4077	10.1371/journal.pone.0004077	http://dx.doi.org/10.1371/journal.pone.0004077			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DL	19115003	gold, Green Published, Green Submitted			2022-12-25	WOS:000265466300016
J	Gingras, Y; Lariviere, V; Macaluso, B; Robitaille, JP				Gingras, Yves; Lariviere, Vincent; Macaluso, Benoit; Robitaille, Jean-Pierre			The Effects of Aging on Researchers' Publication and Citation Patterns	PLOS ONE			English	Article							RESEARCH PERFORMANCE; AGE; SCIENCE; PRODUCTIVITY; INDICATORS; SCIENTISTS; IMPACT; OUTPUT	The average age at which U. S. researchers receive their first grant from NIH has increased from 34.3 in 1970, to 41.7 in 2004. These data raise the crucial question of the effects of aging on the scientific productivity and impact of researchers. Drawing on a sizeable sample of 6,388 university professors in Quebec who have published at least one paper between 2000 and 2007, our results identify two turning points in the professors' careers. A first turning point is visible at age 40 years, where researchers start to rely on older literature and where their productivity increases at a slower pace-after having increased sharply since the beginning of their career. A second turning point can be seen around age 50, when researchers are the most productive whereas their average scientific impact is at its lowest. Our results also show that older professors publish fewer first-authored papers and move closer to the end of the list of co-authors. Although average scientific impact per paper decreases linearly until about age 50, the average number of papers in highly cited journals and among highly cited papers rises continuously until retirement. Our results show clearly that productivity and impact are not a simple and declining function of age and that we must take into account the collaborative aspects of scientific research. Science is a collective endeavor and, as our data shows, researchers of all ages play a significant role in its dynamic.	[Gingras, Yves; Lariviere, Vincent; Macaluso, Benoit; Robitaille, Jean-Pierre] Univ Quebec, OST, CIRST, Montreal, PQ H3C 3P8, Canada	University of Quebec; University of Quebec Montreal	Gingras, Y (corresponding author), Univ Quebec, OST, CIRST, Succursale Ctr Ville, Montreal, PQ H3C 3P8, Canada.	gingras.yves@uqam.ca	Lariviere, Vincent/AAF-3179-2019; GIngras, Yves/AAQ-7556-2020		Quebec's Ministere de la recherche, du developpement economique, de l'innovation et de l'exportation; Fonds de la recherche en sante du Quebec; Fonds quebecois de la recherche sur la societe et la culture; Fonds quebecois de la recherche sur la nature et les technologies	Quebec's Ministere de la recherche, du developpement economique, de l'innovation et de l'exportation; Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); Fonds quebecois de la recherche sur la societe et la culture(FQRNT); Fonds quebecois de la recherche sur la nature et les technologies(FQRNT)	This research was made possible by research contracts with Quebec's Ministere de la recherche, du developpement economique, de l'innovation et de l'exportation, Fonds de la recherche en sante du Quebec, Fonds quebecois de la recherche sur la societe et la culture and the Fonds quebecois de la recherche sur la nature et les technologies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS C W, 1946, Isis, V36, P166, DOI 10.1086/347941; ALLISON PD, 1974, AM SOCIOL REV, V39, P596, DOI 10.2307/2094424; ARCHAMBAULT E, 2009, SCIENTOMETR IN PRESS, V79; Archambault E, 2006, SCIENTOMETRICS, V68, P329, DOI 10.1007/s11192-006-0115-z; *ASS U COLL CAN, 2007, TRENDS HIGH ED, V2; Barnett GA, 2008, J AM SOC INF SCI TEC, V59, P526, DOI 10.1002/asi.20706; Biagioli Mario, 2003, SCI AUTHORSHIP CREDI; Birnholtz JP, 2006, J AM SOC INF SCI TEC, V57, P1758, DOI 10.1002/asi.20380; BOURDIEU P, 1975, SOC SCI INFORM, V14, P19, DOI 10.1177/053901847501400602; COLE S, 1979, AM J SOCIOL, V84, P958, DOI 10.1086/226868; *CREPUQ, 2006, SYST U QUEB DONN IND; DENNIS W, 1956, SCIENCE, V123, P724, DOI 10.1126/science.123.3200.724; Dietrich A, 2007, J CREATIVE BEHAV, V41, P54, DOI 10.1002/j.2162-6057.2007.tb01281.x; Feist G., 2006, PSYCHOL SCI ORIGINS; GARFIELD E, 1990, J AM SOC INF SCI TEC, V57, P997; GIERYN TF, 1981, SCIENTOMETRICS, V3, P325, DOI 10.1007/BF02021125; HOLDEN C, 2008, SCIENCE, V31, P391; Horner K L, 1986, Psychol Aging, V1, P319, DOI 10.1037/0882-7974.1.4.319; Kaiser J, 2008, SCIENCE, V322, P848, DOI 10.1126/science.322.5903.848; Kuhn, 1962, STRUCTURE SCI REVOLU, P148; Kyvik S, 2008, SCIENTOMETRICS, V76, P439, DOI 10.1007/s11192-007-1767-z; Lariviere V, 2008, J AM SOC INF SCI TEC, V59, P288, DOI 10.1002/asi.20744; Lehman H., 1953, AGE ACHIEVEMENT; Liang LM, 2001, SCIENTOMETRICS, V52, P471, DOI 10.1023/A:1014252017971; Merton R. K., 1957, SOCIAL THEORY SOCIAL; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; MERTON Robert King., 1973, THEORETICAL SOCIOLOG; MOED HF, 1995, SCIENTOMETRICS, V33, P381, DOI 10.1007/BF02017338; Moed HF, 1996, SCIENTOMETRICS, V35, P177, DOI 10.1007/BF02018476; OVER R, 1988, SCIENTOMETRICS, V13, P215, DOI 10.1007/BF02019959; Pontille D., 2004, SIGNATURE SCI SOCIOL; PRICE DJD, 1970, COMMUNICATION SCI EN, P155; SCHUBERT A, 1986, SCIENTOMETRICS, V9, P281, DOI 10.1007/BF02017249; Shinn Terry, 1988, ACTES RECHERCHE SCI, V74, P2, DOI DOI 10.3406/ARSS.1988.2430; Sigogneau A, 2000, SCIENTOMETRICS, V47, P589, DOI 10.1023/A:1005628218890; Simonton D.K., 1994, GREATNESS WHO MAKES; SIMONTON DK, 1984, DEV REV, V4, P77, DOI 10.1016/0273-2297(84)90020-0; SIMONTON DK, 1997, PSYCHO REV, V104, P251; STERN N, 1978, SOC STUD SCI, V8, P127, DOI 10.1177/030631277800800105; Wray KB, 2004, SCIENTOMETRICS, V61, P117, DOI 10.1023/B:SCIE.0000037367.99073.bb; Wray KB, 2003, SOC STUD SCI, V33, P137, DOI 10.1177/0306312703033001961; Zuckerman H., 1977, SCI ELITE NOBEL LAUR; Zuckerman H., 1973, SOCIOL SCI, P493	43	119	128	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2008	3	12							e4048	10.1371/journal.pone.0004048	http://dx.doi.org/10.1371/journal.pone.0004048			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437DI	19112502	gold, Green Published, Green Submitted			2022-12-25	WOS:000265466000012
J	Klyubin, AS; Polani, D; Nehaniv, CL				Klyubin, Alexander S.; Polani, Daniel; Nehaniv, Chrystopher L.			Keep Your Options Open: An Information-Based Driving Principle for Sensorimotor Systems	PLOS ONE			English	Article							THEORETIC APPROACH; INTEGRATION; COMPLEXITY; ENERGY; BACK	The central resource processed by the sensorimotor system of an organism is information. We propose an information-based quantity that allows one to characterize the efficiency of the perception-action loop of an abstract organism model. It measures the potential of the organism to imprint information on the environment via its actuators in a way that can be recaptured by its sensors, essentially quantifying the options available and visible to the organism. Various scenarios suggest that such a quantity could identify the preferred direction of evolution or adaptation of the sensorimotor loop of organisms.	[Klyubin, Alexander S.; Polani, Daniel; Nehaniv, Chrystopher L.] Univ Hertfordshire, Sch Comp Sci, Adapt Syst Res Grp, Hatfield AL10 9AB, Herts, England; [Polani, Daniel; Nehaniv, Chrystopher L.] Univ Hertfordshire, Sch Comp Sci, Algorithms Res Grp, Hatfield AL10 9AB, Herts, England	University of Hertfordshire; University of Hertfordshire	Klyubin, AS (corresponding author), Univ Hertfordshire, Sch Comp Sci, Adapt Syst Res Grp, Hatfield AL10 9AB, Herts, England.	D.Polani@herts.ac.uk	Polani, Daniel/AAJ-9529-2020	Nehaniv, Chrystopher L./0000-0002-7807-1875	University of Hertfordshire [PhD studentship]	University of Hertfordshire	Alexander Klyubin was funded by a PhD studentship of the University of Hertfordshire. Daniel Polani and Chrystopher Nehaniv are staff members of the University of Hertfordshire. The funders played no role in the study design and execution.	Anthony T., 2008, P ARTIFICIAL LIFE, P25; Ashby W. R., 1956, INTRO CYBERNETICS; Aticky JJ, 2011, NETWORK-COMP NEURAL, V22, P4, DOI [10.1088/0954-898X/3/2/009, 10.3109/0954898X.2011.638888]; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Ay N, 2008, EUR PHYS J B, V63, P329, DOI 10.1140/epjb/e2008-00175-0; Ay N, 2008, ADV COMPLEX SYST, V11, P17, DOI 10.1142/S0219525908001465; Barlow H, 2001, NETWORK-COMP NEURAL, V12, P241, DOI 10.1088/0954-898X/12/3/301; Barlow H. B., 1959, SENS COMMUN, P217; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bergstrom CT, 2004, 2004 IEEE INFORMATION THEORY WORKSHOP, PROCEEDINGS, P50; BERTSCHINGER N, 2006, P WORKSH ART AUT AL, P7; Bialek W, 2001, NEURAL COMPUT, V13, P2409, DOI 10.1162/089976601753195969; BLAHUT RE, 1972, IEEE T INFORM THEORY, V18, P460, DOI 10.1109/TIT.1972.1054855; BLANK D, 2005, CYBERNETICS SYSTEMS, V36; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; CARIANI P, 1992, PRACTICE AUTONOMOUS, P484; Cover T. M, 2006, ELEMENTS INFORM THEO, V2nd, DOI 10.1002/0471200611; CRUTCHFIELD JP, 1989, PHYS REV LETT, V63, P105, DOI 10.1103/PhysRevLett.63.105; Csikszentmihalyi M, 1978, BOREDOM ANXIETY EXPE; Der R, 1999, CONCUR SYST ENGN SER, V55, P43; Der R, 2000, P WORKSH SOAVE 2000, V643, P39; Emmeche C, 2001, SEMIOTICA, V134, P653; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Friston KJ, 2006, J PHYSIOL-PARIS, V100, P70, DOI 10.1016/j.jphysparis.2006.10.001; GIBSON James J., 1979, ECOLOGICAL APPROACH; Harvey I, 2004, Artificial Life IX, P309; Kaplan F, 2004, LECT NOTES ARTIF INT, V3139, P259; Kauffman Stuart A., 1993; Klyubin AS, 2007, NEURAL COMPUT, V19, P2387, DOI 10.1162/neco.2007.19.9.2387; Klyubin AS, 2004, ARTIFICIAL LIFE IX, P563; Klyubin AS, 2005, LECT NOTES ARTIF INT, V3630, P744, DOI 10.1007/11553090_75; Klyubin AS, 2004, 2004 NASA/DOD CONFERENCE ON EVOLVABLE HARDWARE, PROCEEDINGS, P177; Laughlin SB, 2001, CURR OPIN NEUROBIOL, V11, P475, DOI 10.1016/S0959-4388(00)00237-3; Laughlin SB, 1998, NAT NEUROSCI, V1, P36, DOI 10.1038/236; LAUGHLIN SB, 2000, INFORMATION THEORY B, P41; LINSKER R, 1988, COMPUTER, V21, P105, DOI 10.1109/2.36; Lungarella M, 2005, NEUROINFORMATICS, V3, P243, DOI 10.1385/NI:3:3:243; Lungarella M, 2003, CONNECT SCI, V15, P151, DOI 10.1080/09540090310001655110; LUNGARELLA M, 2006, PLOS COMPUTATIONAL B, V2; MORISSET J, 1995, CELL SIGNAL, V7, P195, DOI 10.1016/0898-6568(94)00081-L; Nadal JP, 1995, INTERNATIONAL JOURNAL OF NEURAL SYSTEMS, SUPPLEMENTARY ISSUE, 1995, P153; Nehaniv C. L., 1999, Proceedings of the 1999 IEEE International Symposium on Intelligent Control Intelligent Systems and Semiotics (Cat. No.99CH37014), P435, DOI 10.1109/ISIC.1999.796694; NEHANIV CL, 2002, ARTIF LIFE, V8, P345; Pearl J., 2000, CAUSALITY MODELS REA, DOI DOI 10.1017/CBO9780511803161; Pfeifer R, 2001, LECT NOTES COMPUT SC, V2000, P294; PHILIPONA D, 2004, ADV NEURAL INFORM PR, V16; Polani D., 2006, P ARTIFICIAL LIFE, VX, P337; Polani D, 2001, LECT NOTES ARTIF INT, V2159, P704; Porr B, 2003, NEURAL COMPUT, V15, P865, DOI 10.1162/08997660360581930; Press W.H., 1996, NUMERICAL RECIPES C; Prokopenko M, 2006, LECT NOTES COMPUT SC, V4095, P558; RIEKE F, 1999, SPIKES BRADFORD BOOK; ROCHA LM, 2006, P ARTIFICIAL LIFE, V10; SCHMIDHUBER J, 2002, ADV EVOLUTIONARY COM, P579; Shalizi CR, 2001, J STAT PHYS, V104, P817, DOI 10.1023/A:1010388907793; SHANNON CE, 1958, IBM J RES DEV, V2, P289, DOI 10.1147/rd.24.0289; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; SINGH S, 2005, P 18 ANN C NEUR INF; SPORNS O, 2006, P ARTIFICIAL LIFE, V10, P323; Steels L, 2004, LECT NOTES ARTIF INT, V3139, P231; Sutton RS, 2018, ADAPT COMPUT MACH LE, P1; TAYLOR SF, 2007, ARXIVORG07124382QBIO; Tishby Naftali, 1999, P ANN ALL C COMM CON; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; Tononi G, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-31; Touchette H, 2004, PHYSICA A, V331, P140, DOI 10.1016/j.physa.2003.09.007; Touchette H, 2000, PHYS REV LETT, V84, P1156, DOI 10.1103/PhysRevLett.84.1156; vanSteveninck RRD, 1996, NATURE, V379, P642, DOI 10.1038/379642a0; VARELA F G, 1974, Biosystems, V5, P187, DOI 10.1016/0303-2647(74)90031-8; Vergassola M, 2007, NATURE, V445, P406, DOI 10.1038/nature05464	71	52	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4018	10.1371/journal.pone.0004018	http://dx.doi.org/10.1371/journal.pone.0004018			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107219	gold, Green Published, Green Submitted			2022-12-25	WOS:000265463000013
J	Wang, FY; Xiao, JF; Pan, LL; Yang, M; Zhang, G; Jin, SG; Yu, J				Wang, Fengyu; Xiao, Jingfa; Pan, Linlin; Yang, Ming; Zhang, Guoqiang; Jin, Shouguang; Yu, Jun			A Systematic Survey of Mini-Proteins in Bacteria and Archaea	PLOS ONE			English	Article								Background: Mini-proteins, defined as polypeptides containing no more than 100 amino acids, are ubiquitous in prokaryotes and eukaryotes. They play significant roles in various biological processes, and their regulatory functions gradually attract the attentions of scientists. However, the functions of the majority of mini-proteins are still largely unknown due to the constraints of experimental methods and bioinformatic analysis. Methodology/Principal Findings: In this article, we extracted a total of 180,879 mini-proteins from the annotations of 532 sequenced genomes, including 491 strains of Bacteria and 41 strains of Archaea. The average proportion of mini-proteins among all genomic proteins is approximately 10.99%, but different strains exhibit remarkable fluctuations. These mini-proteins display two notable characteristics. First, the majority are species-specific proteins with an average proportion of 58.79% among six representative phyla. Second, an even larger proportion (70.03% among all strains) is hypothetical proteins. However, a fraction of highly conserved hypothetical proteins potentially play crucial roles in organisms. Among mini-proteins with known functions, it seems that regulatory and metabolic proteins are more abundant than essential structural proteins. Furthermore, domains in mini-proteins seem to have greater distributions in Bacteria than Eukarya. Analysis of the evolutionary progression of these domains reveals that they have diverged to new patterns from a single ancestor. Conclusions/Significance: Mini-proteins are ubiquitous in bacterial and archaeal species and play significant roles in various functions. The number of mini-proteins in each genome displays remarkable fluctuation, likely resulting from the differential selective pressures that reflect the respective life-styles of the organisms. The answers to many questions surrounding mini-proteins remain elusive and need to be resolved experimentally.	[Wang, Fengyu; Xiao, Jingfa; Yang, Ming; Zhang, Guoqiang; Yu, Jun] Chinese Acad Sci, CAS Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing, Peoples R China; [Wang, Fengyu; Xiao, Jingfa; Yang, Ming; Zhang, Guoqiang; Yu, Jun] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Pan, Linlin] Zhejiang Univ, James D Watson Inst Genome Sci, Hangzhou, Peoples R China; [Jin, Shouguang] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32611 USA	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Zhejiang University; State University System of Florida; University of Florida	Wang, FY (corresponding author), Chinese Acad Sci, CAS Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing, Peoples R China.	xiaojingfa@big.ac.cn; junyu56@gmail.com	郑, 征/C-8514-2011; Jin, Shouguang/N-5548-2016		Chinese Academy of Science [100 Talents]	Chinese Academy of Science(Chinese Academy of Sciences)	The work was supported by "100 Talents" grant from the Chinese Academy of Science awarded to JY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiri H, 2003, MOL BIOL EVOL, V20, P1575, DOI 10.1093/molbev/msg175; [Anonymous], NCBI GEN; [Anonymous], INTERPROSCAN SEQUENC; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Brayton KA, 2005, P NATL ACAD SCI USA, V102, P844, DOI 10.1073/pnas.0406656102; Brocchieri L, 2005, NUCLEIC ACIDS RES, V33, P3390, DOI 10.1093/nar/gki615; de la Pena-Moctezuma A, 1999, FEMS MICROBIOL LETT, V177, P319, DOI 10.1111/j.1574-6968.1999.tb13749.x; Hotopp JCD, 2006, PLOS GENET, V2, P208, DOI 10.1371/journal.pgen.0020021; Ebedes J, 2004, BIOINFORMATICS, V20, P1193, DOI 10.1093/bioinformatics/bth055; *FAB POLT GR MAPA, 2001, BIOCH MOL BIOL ED, V29, P16; Gellman SH, 2002, NAT STRUCT BIOL, V9, P408, DOI 10.1038/nsb0602-408; Gribaldo S, 2006, PHILOS T R SOC B, V361, P1007, DOI 10.1098/rstb.2006.1841; Ha UH, 2004, MOL MICROBIOL, V54, P307, DOI 10.1111/j.1365-2958.2004.04282.x; Imperiali B, 1999, J PEPT RES, V54, P177, DOI 10.1034/j.1399-3011.1999.00121.x; Kastenmayer JP, 2006, GENOME RES, V16, P365, DOI 10.1101/gr.4355406; KRIEGER DT, 1983, SCIENCE, V222, P975, DOI 10.1126/science.6139875; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lipman DJ, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-20; Martin L, 2000, CURR PROTEIN PEPT SC, V1, P403, DOI 10.2174/1389203003381306; Seligmann H, 2003, J MOL EVOL, V56, P151, DOI 10.1007/s00239-002-2388-z; Setlow P, 2007, TRENDS MICROBIOL, V15, P172, DOI 10.1016/j.tim.2007.02.004; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Wheelan SJ, 2000, BIOINFORMATICS, V16, P613, DOI 10.1093/bioinformatics/16.7.613; Wu WH, 2005, J BACTERIOL, V187, P6058, DOI 10.1128/JB.187.17.6058-6068.2005	24	34	37	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4027	10.1371/journal.pone.0004027	http://dx.doi.org/10.1371/journal.pone.0004027			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107199	Green Published, Green Submitted, gold			2022-12-25	WOS:000265463000021
J	Rits, MAN; van Dort, KA; Kootstra, NA				Rits, Maarten A. N.; van Dort, Karel A.; Kootstra, Neeltje A.			Polymorphisms in the Regulatory Region of the Cyclophilin A Gene Influence the Susceptibility for HIV-1 Infection	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; OLD-WORLD MONKEY; CLINICAL-COURSE; LIFE-CYCLE; RESTRICTION; VARIANTS; TRANSDUCTION; PROGRESSION; RESISTANCE; MUTATIONS	Background: Previous studies have demonstrated an association between polymorphisms in the regulatory regions of Cyclophilin A (CypA) and susceptibility to both HIV-1 infection and disease progression. Here we studied whether these polymorphisms are associated with susceptibility to HIV-1 infection and disease progression in the Amsterdam Cohort on HIV-1 infection and AIDS (ACS) in a group of men having sex with men (MSM) and drug users (DU). Methodology/Principal Findings: We screened participants of the ACS for the C1604G and A1650G polymorphisms in the regulatory regions of CypA. The prevalence of the 1650G allele was significantly higher in high risk seronegative MSM than in HIV-1 infected MSM. However, C1604G or A1650G were not associated with the clinical course of infection in MSM of the ACS. Interestingly, participants of the ACS-DU who carried the 1604G allele showed a significantly accelerated progression when viral RNA load above 10(4.5) copies per ml plasma was used as an endpoint in survival analysis. Conclusion/Significance: The results obtained in this study suggest that the A1650G polymorphism in the regulatory region of the CypA gene may be associated with protection from HIV-1 infection, while the 1604G allele may have a weak association with the clinical course of infection in DU.	[Rits, Maarten A. N.; van Dort, Karel A.; Kootstra, Neeltje A.] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Rits, Maarten A. N.; van Dort, Karel A.; Kootstra, Neeltje A.] Univ Amsterdam, Acad Med Ctr, CINIMA, NL-1012 WX Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Rits, MAN (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Landsteiner Lab, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	N.A.Kootstra@amc.uva.nl		Kootstra, Neeltje A./0000-0001-9429-7754	Netherlands Organization for scientific Research [96.36.024]; Dutch AIDS fund [2004062]; Landsteiner Foundation for Blood Transfusion Research [0435]	Netherlands Organization for scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch AIDS fund; Landsteiner Foundation for Blood Transfusion Research	Netherlands Organization for scientific Research (NWO grant number 96.36.024); the Dutch AIDS fund (grant 2004062) and the Landsteiner Foundation for Blood Transfusion Research (grant 0435). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An P, 2004, J VIROL, V78, P11070, DOI 10.1128/JVI.78.20.11070-11076.2004; An P, 2007, PLOS PATHOG, V3, P849, DOI 10.1371/journal.ppat.0030088; An P, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030019; Berthoux L, 2005, P NATL ACAD SCI USA, V102, P14849, DOI 10.1073/pnas.0505659102; Bleiber G, 2005, J VIROL, V79, P12674, DOI 10.1128/JVI.79.20.12674-12680.2005; Bosco DA, 2002, P NATL ACAD SCI USA, V99, P5247, DOI 10.1073/pnas.082100499; Braaten D, 1996, J VIROL, V70, P3551, DOI 10.1128/JVI.70.6.3551-3560.1996; Braaten D, 1997, J VIROL, V71, P2107, DOI 10.1128/JVI.71.3.2107-2113.1997; CDC, 1993, MMWR-MORBID MORTAL W, V41, P1; Centers for Disease Control, 1987, MMWR-MORBID MORTAL W, V21, p1S; FRANKE EK, 1994, NATURE, V372, P359, DOI 10.1038/372359a0; Gamble TR, 1996, CELL, V87, P1285, DOI 10.1016/S0092-8674(00)81823-1; Geskus RB, 2000, STAT MED, V19, P1753, DOI 10.1002/1097-0258(20000715)19:13&lt;1753::AID-SIM487&gt;3.0.CO;2-F; Hatziioannou T, 2005, J VIROL, V79, P176, DOI 10.1128/JVI.79.1.176-183.2005; Husman AMD, 1997, ANN INTERN MED, V127, P882, DOI 10.7326/0003-4819-127-10-199711150-00004; Keckesova Z, 2006, J VIROL, V80, P4683, DOI 10.1128/JVI.80.10.4683-4690.2006; Kootstra NA, 2003, P NATL ACAD SCI USA, V100, P1298, DOI 10.1073/pnas.0337541100; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; Nisole S, 2004, P NATL ACAD SCI USA, V101, P13324, DOI 10.1073/pnas.0404640101; Palacin M, 2008, INT J IMMUNOGENET, V35, P159, DOI 10.1111/j.1744-313X.2008.00755.x; Rits MAN, 2007, MOL THER, V15, P930, DOI 10.1038/mt.sj.6300091; Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777; Schinkel J, 1999, J INFECT DIS, V179, P825, DOI 10.1086/314658; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; Sokolskaja E, 2004, J VIROL, V78, P12800, DOI 10.1128/JVI.78.23.12800-12808.2004; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Stremlau M, 2006, VIROLOGY, V351, P112, DOI 10.1016/j.virol.2006.03.015; TERSMETTE M, 1989, VIROLOGY, V171, P149, DOI 10.1016/0042-6822(89)90521-7; Towers GJ, 2003, NAT MED, V9, P1138, DOI 10.1038/nm910; Van Manen D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040018; van Rij RP, 1998, AIDS, V12, pF85, DOI 10.1097/00002030-199809000-00001; Winkler C, 1998, SCIENCE, V279, P389, DOI 10.1126/science.279.5349.389	32	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2008	3	12							e3975	10.1371/journal.pone.0003975	http://dx.doi.org/10.1371/journal.pone.0003975			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AT	19092998	Green Submitted, gold, Green Published			2022-12-25	WOS:000265458600010
J	Humbert, M; Rasmussen, RA; Ong, H; Kaiser, FMP; Hu, SL; Ruprecht, RM				Humbert, Michael; Rasmussen, Robert A.; Ong, Helena; Kaiser, Fabian M. P.; Hu, Shiu-Lok; Ruprecht, Ruth M.			Inducing Cross-Clade Neutralizing Antibodies against HIV-1 by Immunofocusing	PLOS ONE			English	Article								Background: Although vaccines are important in preventing viral infections by inducing neutralizing antibodies (nAbs), HIV-1 has proven to be a difficult target and escapes humoral immunity through various mechanisms. We sought to test whether HIV-1 Env mimics may serve as immunogens. Methodology/Principal Findings: Using random peptide phage display libraries, we identified the epitopes recognized by polyclonal antibodies of a rhesus monkey that had developed high-titer, broadly reactive nAbs after infection with a simian-human immunodeficiency virus (SHIV) encoding env of a recently transmitted HIV-1 clade C (HIV-C). Phage peptide inserts were analyzed for conformational and linear homology using computational analysis; some peptides mimicked various domains of the original HIV-C Env, such as conformational V3 loop epitopes and the conserved linear region of the gp120 C-terminus. Next, we devised a novel prime/boost strategy to test the immunogenicity of such phage-displayed peptides and primed mice only once with HIV-C gp160 DNA followed by boosting with mixtures of recombinant phages. Conclusions/Significance: This strategy, which was designed to focus the immune system on a few Env epitopes (immunofocusing), not only induced HIV-C gp160 binding antibodies andcross-clade nAbs, but also linked a conserved HIV Env region for the first time to the induction of nAbs: the C-terminus of gp120. The identification of conserved antigen mimics may lead to novel immunogens capable of inducing broadly reactive nAbs.	[Rasmussen, Robert A.; Ong, Helena; Kaiser, Fabian M. P.; Ruprecht, Ruth M.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Humbert, Michael; Rasmussen, Robert A.; Ruprecht, Ruth M.] Harvard Univ, Sch Med, Boston, MA USA; [Hu, Shiu-Lok] Univ Washington, Natl Primate Res Ctr, Seattle, WA 98195 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle	Humbert, M (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.	ruth_ruprecht@dfci.harvard.edu			NIH [PO1 AI048240, R37 AI034266]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI048240, R37AI034266] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH Grant PO1 AI048240 to RMR, RAR, and SLH and R37 AI034266 to RMR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Bublil EM, 2007, PROTEINS, V68, P294, DOI 10.1002/prot.21387; Bublil EM, 2006, FASEB J, V20, P1762, DOI 10.1096/fj.05-5509rev; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Calarese DA, 2005, P NATL ACAD SCI USA, V102, P13372, DOI 10.1073/pnas.0505763102; Cleveland SM, 2000, VIROLOGY, V266, P66, DOI 10.1006/viro.1999.0041; Coeffier E, 2000, VACCINE, V19, P684, DOI 10.1016/S0264-410X(00)00267-X; Conley AJ, 1996, J VIROL, V70, P6751, DOI 10.1128/JVI.70.10.6751-6758.1996; Davis D, 1997, VACCINE, V15, P1661, DOI 10.1016/S0264-410X(97)00084-4; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Enshell-Seijffers D, 2001, FASEB J, V15, P2112, DOI 10.1096/fj.00-0898com; Felici F, 1996, METHOD ENZYMOL, V267, P116; Ferrantelli F, 2004, J INFECT DIS, V189, P2167, DOI 10.1086/420833; Ferrantelli F, 2004, J INFECT DIS, V189, P71, DOI 10.1086/380102; Ferrantelli F, 2003, AIDS, V17, P301, DOI 10.1097/00002030-200302140-00003; Galfre G, 1996, METHOD ENZYMOL, V267, P109; Gorny MK, 2006, J VIROL, V80, P6865, DOI 10.1128/JVI.02202-05; Gorny MK, 2004, J VIROL, V78, P2394, DOI 10.1128/JVI.78.5.2394-2404.2004; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hioe CE, 1997, INT IMMUNOL, V9, P1281, DOI 10.1093/intimm/9.9.1281; Hofmann-Lehmann R, 2001, J VIROL, V75, P7470, DOI 10.1128/JVI.75.16.7470-7480.2001; Holl V, 2006, J VIROL, V80, P6177, DOI 10.1128/JVI.02625-05; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-451; Humbert M, 2007, EUR J IMMUNOL, V37, P501, DOI 10.1002/eji.200636560; Humbert M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-94; KELLER PM, 1993, VIROLOGY, V193, P709, DOI 10.1006/viro.1993.1179; Kitabwalla M, 2003, AIDS RES HUM RETROV, V19, P125, DOI 10.1089/088922203762688630; Konigs C, 2000, EUR J IMMUNOL, V30, P1162, DOI 10.1002/(SICI)1521-4141(200004)30:4<1162::AID-IMMU1162>3.0.CO;2-L; Kramer VG, 2007, CURR HIV RES, V5, P642, DOI 10.2174/157016207782418506; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Li B, 2006, J VIROL, V80, P5211, DOI 10.1128/JVI.00201-06; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Mayrose I, 2007, BIOINFORMATICS, V23, P3244, DOI 10.1093/bioinformatics/btm493; McGaughey GB, 2003, BIOCHEMISTRY-US, V42, P3214, DOI 10.1021/bi026952u; McMichael AJ, 2006, ANNU REV IMMUNOL, V24, P227, DOI 10.1146/annurev.immunol.24.021605.090605; MEOLA A, 1995, J IMMUNOL, V154, P3162; Moreau V, 2006, BIOINFORMATICS, V22, P1088, DOI 10.1093/bioinformatics/btl012; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POSNER MR, 1991, J IMMUNOL, V146, P4325; Prezzi C, 1996, J IMMUNOL, V156, P4504; Rasmussen RA, 2006, VACCINE, V24, P2324, DOI 10.1016/j.vaccine.2005.11.063; Riemer AB, 2006, EUR J IMMUNOL, V36, P1267, DOI 10.1002/eji.200535279; Roccasecca R, 2001, MOL IMMUNOL, V38, P485, DOI 10.1016/S0161-5890(01)00084-0; Rosen O, 2005, BIOCHEMISTRY-US, V44, P7250, DOI 10.1021/bi047387t; Rowland-Jones S, 2008, EUR J IMMUNOL, V38, P13, DOI 10.1002/eji.200790061; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Saphire EO, 2007, J MOL BIOL, V369, P696, DOI 10.1016/j.jmb.2007.01.060; Scala G, 1999, J IMMUNOL, V162, P6155; Schreiber A, 2005, J COMPUT CHEM, V26, P879, DOI 10.1002/jcc.20229; Sharon M, 2003, STRUCTURE, V11, P225, DOI 10.1016/S0969-2126(03)00011-X; SIDDAPPA NB, J VIROL IN PRESS; Smith GP, 1997, CHEM REV, V97, P391, DOI 10.1021/cr960065d; Song RJ, 2006, J VIROL, V80, P8729, DOI 10.1128/JVI.00558-06; Sticht J, 2005, NAT STRUCT MOL BIOL, V12, P671, DOI 10.1038/nsmb964; *UNAIDS, 2007, AIDS EP UPD; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Xu WD, 2001, J HUMAN VIROL, V4, P55; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307; Zolla-Pazner S, 2008, VIROLOGY, V372, P233, DOI 10.1016/j.virol.2007.09.024; Zuercher AW, 2000, EUR J IMMUNOL, V30, P128, DOI 10.1002/1521-4141(200001)30:1<128::AID-IMMU128>3.3.CO;2-O; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005; Zwick MB, 2001, J VIROL, V75, P6692, DOI 10.1128/JVI.75.14.6692-6699.2001	71	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2008	3	12							e3937	10.1371/journal.pone.0003937	http://dx.doi.org/10.1371/journal.pone.0003937			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AP	19081789	Green Submitted, Green Published, gold			2022-12-25	WOS:000265458200004
J	Tachikawa, M				Tachikawa, Masashi			Fluctuation Induces Evolutionary Branching in a Mathematical Model of Ecosystems	PLOS ONE			English	Article								Ecological systems are always subjected to various environmental fluctuations. They evolve under these fluctuations and the resulting systems are robust against them. The diversity in ecological systems is also acquired through the evolution. How do the fluctuations affect the evolutionary processes? Do the fluctuations have direct impact on the species diversity in ecological systems? In the present paper, we investigate the relation between the environmental fluctuation and the evolution of species diversity with a mathematical model of evolutionary ecology. In the model, individual organisms compete for a single restricted resource and the temporal fluctuation in the resource supply is introduced as the environmental fluctuation. The evolutionary process is represented by the mutational change of genotypes which determines their resource utilization strategies. We found that when the environmental state is switched form static to fluctuating conditions, the initial closely related population distributed around the genotype adapted for the static environment is destabilized and divided into two groups in the genotype space; i.e., the evolutionary branching is induced by the environmental fluctuation. The consequent multiple species structures is evolutionary stable at the presence of the fluctuation. We perform the evolutionary invasion analysis for the phenomena and illustrate the mechanisms of the branchings. The results indicate a novel process of increasing the species diversity via evolutionary branching, and the analysis reveals the mechanisims of the branching preocess as the response to the environmental fluctuation. The robustness of the evolutionary process is also discussed.	Japan Sci & Technol Agcy JST, Exploratory Res Adv Technol ERATO, Complex Syst Biol Project, Tokyo, Japan	Japan Science & Technology Agency (JST)	Tachikawa, M (corresponding author), Japan Sci & Technol Agcy JST, Exploratory Res Adv Technol ERATO, Complex Syst Biol Project, Tokyo, Japan.	mtach@complex.c.u-tokyo.ac.jp						ARMSTRONG R, 1980, AM NAT, V15, P151; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; CUSHING JM, 1984, SIAM J APPL MATH, V44, P392, DOI 10.1137/0144026; Dieckmann U, 2007, BIOL MED PHYS BIOMED, P145, DOI 10.1007/978-3-540-34428-5_8; Eigen M, 1979, THE HYPERCYCLE, P60; Gause G. F., 1934, STRUGGLE EXISTENCE; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; Geritz SAH, 2007, THEOR POPUL BIOL, V71, P424, DOI 10.1016/j.tpb.2007.03.006; Holling C.S., 1965, MEM ENTOMOL SOC CAN, V45, P3; Huisman J, 1999, NATURE, V402, P407, DOI 10.1038/46540; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; KANEKO K, 1992, PHYSICA D, V56, P406, DOI 10.1016/0167-2789(92)90179-Q; Kaneko K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000434; Kovarova-Kovar K, 1998, MICROBIOL MOL BIOL R, V62, P646; Litchman E, 2001, AM NAT, V157, P170, DOI 10.1086/318628; MACARTHUR RH, 1964, P NATL ACAD SCI USA, V51, P1207, DOI 10.1073/pnas.51.6.1207; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Shibata T, 2005, P NATL ACAD SCI USA, V102, P331, DOI 10.1073/pnas.0403350102; Smith H.L., 1996, J AM CHEM SOC, V117, P11616, DOI [10.1021/ja9654387, DOI 10.1021/JA9654387]; TILMAN D, 1987, RESOURCE COMPETITION; White A, 2006, EVOL ECOL RES, V8, P387; Yanagida T, 2007, BIOSYSTEMS, V88, P228, DOI 10.1016/j.biosystems.2006.08.012	25	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2008	3	12							e3925	10.1371/journal.pone.0003925	http://dx.doi.org/10.1371/journal.pone.0003925			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZW	19081842	Green Published, Green Submitted, gold			2022-12-25	WOS:000265456300004
J	Nomura, M				Nomura, Masayasu			Switching from Prokaryotic Molecular Biology to Eukaryotic Molecular Biology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL-PROTEIN GENES; RNA-POLYMERASE-I; E-COLI RIBOSOMES; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; RIBONUCLEIC-ACID; MESSENGER-RNA; POSTTRANSCRIPTIONAL REGULATION; CONDITIONAL EXPRESSION; FEEDBACK-REGULATION		Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA	University of California System; University of California Irvine	Nomura, M (corresponding author), Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA.	mnomura@uci.edu			National Institutes of Health [GM35949]; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM035949, R01GM035949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	I acknowledge continued grant support from the National Institutes of Health ( from 1961 to the present; the current grant is GM35949) and the National Science Foundation ( from 1964 to 1995). Quite a few of the early-day molecular biologists, whose names I have given in this article, are gone by now. They include my postdoctoral-time mentors, Sol Spiegelman and Seymour Benzer, and other teachers, colleagues, and friends: Francis Crick, Max Delbruck, Salvador Luria, George Streisinger, Ole Maaloe, Niels Ole Kjeldgaard, Rudy Planta, and Gunther Stent. Other notable early-day molecular biologists mentioned, Jacques Monod, John Kendrew, and Max Perutz, also have passed away. I miss them and cherish my memories of these early-day molecular biologists. Ira Herskowitz, who was much younger than I, also passed away prematurely. I dedicate this article to these people. I would also like to thank my former graduate students, postdoctoral fellows, and other staff scientists for their dedicated participation in research in my laboratory throughout my career. Finally, I thank James F. Crow, Melanie Oakes, Suzanne Sandmeyer, Robert Steele, Millard Susman, and Marian Waterman for their reading of the drafts of this article and for their useful suggestions and comments and Melanie Oakes and Catherine Cao for their help in the preparation of this article.	BEGGS JD, 1978, NATURE, V275, P104, DOI 10.1038/275104a0; Botstein David, 1993, P361; BRENNER S, 1961, NATURE, V190, P576, DOI 10.1038/190576a0; Cote CA, 2002, RNA, V8, P786, DOI 10.1017/S1355838202023063; ELBARADI TTAL, 1986, CURR GENET, V10, P733, DOI 10.1007/BF00405095; ELLWOOD M, 1980, J BACTERIOL, V143, P1077, DOI 10.1128/JB.143.2.1077-1080.1980; FALLON AM, 1979, P NATL ACAD SCI USA, V76, P3411, DOI 10.1073/pnas.76.7.3411; GOURSE RL, 1985, P NATL ACAD SCI USA, V82, P1069, DOI 10.1073/pnas.82.4.1069; GROS F, 1961, NATURE, V190, P581, DOI 10.1038/190581a0; GUTHRIE C, 1969, P NATL ACAD SCI USA, V63, P384, DOI 10.1073/pnas.63.2.384; GUTHRIE C, 1968, NATURE, V219, P232, DOI 10.1038/219232a0; HARTWELL LH, 1970, MOL GEN GENET, V109, P42, DOI 10.1007/BF00334045; HENRY Y, 1994, EMBO J, V13, P2452, DOI 10.1002/j.1460-2075.1994.tb06530.x; HERSKOWITZ I, 1989, NATURE, V342, P749, DOI 10.1038/342749a0; HINNEN A, 1978, P NATL ACAD SCI USA, V75, P1929, DOI 10.1073/pnas.75.4.1929; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; JASKUNAS SR, 1975, NATURE, V256, P183, DOI 10.1038/256183a0; JASKUNAS SR, 1975, P NATL ACAD SCI USA, V72, P6, DOI 10.1073/pnas.72.1.6; JINKSROBERTSON S, 1983, CELL, V33, P865, DOI 10.1016/0092-8674(83)90029-6; Keener J, 1998, J BIOL CHEM, V273, P33795, DOI 10.1074/jbc.273.50.33795; KENERLEY ME, 1977, J BACTERIOL, V132, P931, DOI 10.1128/JB.132.3.931-949.1977; KRANZ JE, 1990, P NATL ACAD SCI USA, V87, P6629, DOI 10.1073/pnas.87.17.6629; LURIA SE, 1984, SLOT MACHINE BROKEN, P103; MaalOe O, 1966, CONTROL MACROMOLECUL; Maaloe O, 1969, DEVELOP BIOL       S, V3, P33; MAICAS E, 1988, MOL CELL BIOL, V8, P169, DOI 10.1128/MCB.8.1.169; MARCKER K, 1964, J MOL BIOL, V8, P835, DOI 10.1016/S0022-2836(64)80164-9; NOGI Y, 1991, P NATL ACAD SCI USA, V88, P7026, DOI 10.1073/pnas.88.16.7026; NOGI Y, 1991, P NATL ACAD SCI USA, V88, P3962, DOI 10.1073/pnas.88.9.3962; NOMURA M, 1967, P NATL ACAD SCI USA, V58, P946, DOI 10.1073/pnas.58.3.946; NOMURA M, 1961, J MOL BIOL, V3, P684, DOI 10.1016/S0022-2836(61)80031-4; NOMURA M, 1970, NATURE, V228, P744, DOI 10.1038/228744a0; NOMURA M, 1960, J MOL BIOL, V2, P306, DOI 10.1016/S0022-2836(60)80027-7; Nomura M, 2004, MOL BIOL INTELL UNIT, P128; NOMURA M, 1963, COLD SPRING HARB SYM, V28, P315, DOI 10.1101/SQB.1963.028.01.046; NOMURA M, 1988, TRANSCRIPTION RIBOSO, P155; NOMURA M, 1981, SCI SCI ESSAYS BIOCH, P133; NOMURA M, 1953, J AGR CHEM SOC JPN, V27, P46; Oakes M, 1998, J CELL BIOL, V143, P23, DOI 10.1083/jcb.143.1.23; Oakes ML, 2006, MOL CELL BIOL, V26, P3889, DOI 10.1128/MCB.26.10.3889-3901.2006; OZAKI M, 1969, NATURE, V222, P333, DOI 10.1038/222333a0; PETES TD, 1977, P NATL ACAD SCI USA, V74, P5091, DOI 10.1073/pnas.74.11.5091; RIGGS DL, 1990, J BIOL CHEM, V265, P7596; ROSBASH M, 1981, CELL, V24, P679, DOI 10.1016/0092-8674(81)90094-5; SAITO K, 1994, J MOL BIOL, V235, P125, DOI 10.1016/S0022-2836(05)80021-X; SAITO K, 1994, J MOL BIOL, V235, P111, DOI 10.1016/S0022-2836(05)80020-8; Schneider DA, 2007, MOL CELL, V26, P217, DOI 10.1016/j.molcel.2007.04.007; SMITH AE, 1970, NATURE, V226, P607, DOI 10.1038/226607a0; Stent G. S., 1969, COMING GOLDEN AGE VI; STENT GS, 1968, SCIENCE, V160, P390, DOI 10.1126/science.160.3826.390; STREISINGER G, 1992, PHAGES ORIGINS MOL B, P335; TRAUB P, 1968, P NATL ACAD SCI USA, V59, P777, DOI 10.1073/pnas.59.3.777; TSAY YF, 1988, GENE DEV, V2, P664, DOI 10.1101/gad.2.6.664; VOLKIN E, 1956, VIROLOGY, V2, P149, DOI 10.1016/0042-6822(56)90016-2; WARNER JR, 1985, MOL CELL BIOL, V5, P1512, DOI 10.1128/MCB.5.6.1512; WITTEKIND M, 1990, MOL CELL BIOL, V10, P2049, DOI 10.1128/MCB.10.5.2049; YAMAGISHI M, 1988, CURR GENET, V13, P305, DOI 10.1007/BF00424424; YATES JL, 1980, P NATL ACAD SCI-BIOL, V77, P1837, DOI 10.1073/pnas.77.4.1837; [No title captured]	59	2	2	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9625	9635		10.1074/jbc.X800014200	http://dx.doi.org/10.1074/jbc.X800014200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19074426	Green Published, hybrid			2022-12-25	WOS:000264892900001
J	Raj, DK; Mu, JB; Jiang, HY; Kabat, J; Singh, S; Sullivan, M; Fay, MP; McCutchan, TF; Su, XZ				Raj, Dipak Kumar; Mu, Jianbing; Jiang, Hongying; Kabat, Juraj; Singh, Subash; Sullivan, Margery; Fay, Michael P.; McCutchan, Thomas F.; Su, Xin-zhuan			Disruption of a Plasmodium falciparum Multidrug Resistance-associated Protein (PfMRP) Alters Its Fitness and Transport of Antimalarial Drugs and Glutathione	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING CASSETTE TRANSPORTERS; CHLOROQUINE RESISTANCE; MALARIA PARASITES; ABC TRANSPORTERS; QUININE RESISTANCE; DIGESTIVE VACUOLE; P-GLYCOPROTEIN; PFMDR1 GENE; SENSITIVITY; MEFLOQUINE	ATP-binding cassette transporters play an important role in drug resistance and nutrient transport. In the human malaria parasite Plasmodium falciparum, a homolog of the human p-glycoprotein (PfPgh-1) was shown to be involved in resistance to several drugs. More recently, many transporters were associated with higher IC50 levels in responses to chloroquine (CQ) and quinine (QN) in field isolates. Subsequent studies, however, could not confirm the associations, although inaccuracy in drug tests in the later studies could contribute to the lack of associations. Here we disrupted a gene encoding a putative multidrug resistance-associated protein (PfMRP) that was previously shown to be associated with P. falciparum responses to CQ and QN. Parasites with disrupted PfMRP (W2/MRP Delta) could not grow to a parasitemia higher than 5% under normal culture conditions, possibly because of lower efficiency in removing toxic metabolites. The W2/MRP Delta parasite also accumulated more radioactive glutathione, CQ, and QN and became more sensitive to multiple antimalarial drugs, including CQ, QN, artemisinin, piperaquine, and primaquine. PfMRP was localized on the parasite surface membrane, within membrane-bound vesicles, and along the straight side of the D-shaped stage II gametocytes. The results suggest that PfMRP plays a role in the efflux of glutathione, CQ, and QN and contributes to parasite responses to multiple antimalarial drugs, possibly by pumping drugs outside the parasite.	[Raj, Dipak Kumar; Mu, Jianbing; Jiang, Hongying; Singh, Subash; Sullivan, Margery; McCutchan, Thomas F.; Su, Xin-zhuan] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA; [Kabat, Juraj] NIAID, Res Technol Branch, NIH, Rockville, MD 20852 USA; [Fay, Michael P.] NIAID, Biostat Res Branch, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Su, XZ (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, 12735 Twinbrook Pkwy,Rm 3E-24B, Rockville, MD 20852 USA.	xsu@niaid.nih.gov	Fay, Michael P/A-2974-2008	Fay, Michael P/0000-0002-8643-9625; Su, Xinzhuan/0000-0003-3246-3248	Division of Intramural Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000892, Z01AI000892, Z01AI000208, ZIAAI000208] Funding Source: NIH RePORTER	Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the Division of Intramural Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Allen JD, 2000, CANCER RES, V60, P5761; Anderson TJC, 2005, ANTIMICROB AGENTS CH, V49, P2180, DOI 10.1128/AAC.49.6.2180-2188.2005; Borst P, 2000, JNCI-J NATL CANCER I, V92, P1295, DOI 10.1093/jnci/92.16.1295; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Cervenak J, 2006, CANCER LETT, V234, P62, DOI 10.1016/j.canlet.2005.01.061; Chakraborti PK, 1999, BIOSCIENCE REP, V19, P293, DOI 10.1023/A:1020598324663; Cojean S, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-24; Cooper RA, 2002, MOL PHARMACOL, V61, P35, DOI 10.1124/mol.61.1.35; COWMAN AF, 1991, J CELL BIOL, V113, P1033, DOI 10.1083/jcb.113.5.1033; Dean M, 2005, ANNU REV GENOM HUM G, V6, P123, DOI 10.1146/annurev.genom.6.080604.162122; Dean M, 2005, METHOD ENZYMOL, V400, P409, DOI 10.1016/S0076-6879(05)00024-8; Dent JA, 2000, P NATL ACAD SCI USA, V97, P2674, DOI 10.1073/pnas.97.6.2674; Duraisingh MT, 2000, MOL MICROBIOL, V36, P955, DOI 10.1046/j.1365-2958.2000.01914.x; Duraisingh MT, 2000, PARASITOLOGY, V121, P1, DOI 10.1017/S0031182099006022; Dyer M, 2000, PARASITOL TODAY, V16, P102, DOI 10.1016/S0169-4758(99)01608-7; Ernst R, 2005, METHOD ENZYMOL, V400, P460, DOI 10.1016/S0076-6879(05)00026-1; Ferdig MT, 2004, MOL MICROBIOL, V52, P985, DOI 10.1111/j.1365-2958.2004.04035.x; Fernandez V, 1998, INFECT IMMUN, V66, P2969, DOI 10.1128/IAI.66.6.2969-2975.1998; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; FOOTE SJ, 1990, NATURE, V345, P255, DOI 10.1038/345255a0; FOOTE SJ, 1989, CELL, V57, P921, DOI 10.1016/0092-8674(89)90330-9; Furuya T, 2005, P NATL ACAD SCI USA, V102, P16813, DOI 10.1073/pnas.0501858102; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Ginsburg H, 2003, REDOX REP, V8, P276, DOI 10.1179/135100003225002907; Ginsburg H, 1998, BIOCHEM PHARMACOL, V56, P1305, DOI 10.1016/S0006-2952(98)00184-1; Igarashi Y, 2004, MOL BIOL EVOL, V21, P2149, DOI 10.1093/molbev/msh226; Jungwirth H, 2006, FEBS LETT, V580, P1131, DOI 10.1016/j.febslet.2005.12.050; Kawazu SI, 2008, PARASITOL INT, V57, P1, DOI 10.1016/j.parint.2007.08.001; Klokouzas A, 2004, BIOCHEM BIOPH RES CO, V321, P197, DOI 10.1016/j.bbrc.2004.06.135; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Liang XJ, 2006, CURR DRUG TARGETS, V7, P911, DOI 10.2174/138945006778019264; Mu JB, 2005, PLOS BIOL, V3, P1734, DOI 10.1371/journal.pbio.0030335; Mu JB, 2003, MOL MICROBIOL, V49, P977, DOI 10.1046/j.1365-2958.2003.03627.x; Oliveira F, 2006, VACCINE, V24, P374, DOI 10.1016/j.vaccine.2005.07.085; Ouellette Marc, 1994, Trends in Microbiology, V2, P407, DOI 10.1016/0966-842X(94)90620-3; Peklak-Scott C, 2005, BIOCHEMISTRY-US, V44, P4426, DOI 10.1021/bi047810y; Price RN, 2004, LANCET, V364, P438, DOI 10.1016/S0140-6736(04)16767-6; R Core Team, 2022, R LANG ENV STAT COMP; Rebbeor JF, 2002, BBA-BIOMEMBRANES, V1559, P171, DOI 10.1016/S0005-2736(01)00454-0; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; Rosenberg E, 2006, J BIOL CHEM, V281, P27039, DOI 10.1074/jbc.M601686200; RUBIO JP, 1994, EXP PARASITOL, V79, P137, DOI 10.1006/expr.1994.1073; Rychlik B, 2000, ACTA BIOCHIM POL, V47, P763, DOI 10.18388/abp.2000_3994; Sanchez CP, 2008, MOL MICROBIOL, V70, P786, DOI 10.1111/j.1365-2958.2008.06413.x; Sidhu ABS, 2005, MOL MICROBIOL, V57, P913, DOI 10.1111/j.1365-2958.2005.04729.x; Sinden RE, 1998, MALARIA PARASITE BIO; Singh S, 2007, P NATL ACAD SCI USA, V104, P20043, DOI 10.1073/pnas.0709999104; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Stefkova J, 2004, PHYSIOL RES, V53, P235; Su XZ, 2007, NAT REV GENET, V8, P497, DOI 10.1038/nrg2126; Su XZ, 1998, EXP PARASITOL, V89, P262, DOI 10.1006/expr.1998.4299; Su XZ, 1999, SCIENCE, V286, P1351, DOI 10.1126/science.286.5443.1351; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; WILSON CM, 1989, SCIENCE, V244, P1184, DOI 10.1126/science.2658061; Wongsrichanalai C, 2008, EMERG INFECT DIS, V14, P716, DOI 10.3201/eid1405.071601; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813; Wu YM, 1996, P NATL ACAD SCI USA, V93, P1130, DOI 10.1073/pnas.93.3.1130; Yazaki K, 2006, FEBS LETT, V580, P1183, DOI 10.1016/j.febslet.2005.12.009; Young JA, 2005, MOL BIOCHEM PARASIT, V143, P67, DOI 10.1016/j.molbiopara.2005.05.007	61	107	112	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7687	7696		10.1074/jbc.M806944200	http://dx.doi.org/10.1074/jbc.M806944200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19117944	Green Published, hybrid			2022-12-25	WOS:000264195600031
J	Davis, L; Abdi, K; Machius, M; Brautigam, C; Tomchick, DR; Bennett, V; Michaely, P				Davis, Lydia; Abdi, Khadar; Machius, Mischa; Brautigam, Chad; Tomchick, Diana R.; Bennett, Vann; Michaely, Peter			Localization and Structure of the Ankyrin-binding Site on beta(2)-Spectrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYTHROCYTE SPECTRIN; MOLECULAR-STRUCTURE; MEMBRANE; PROTEINS; PATHWAYS; REPEATS; MODEL; DEFECTS; CELLS; HELIX	Spectrins are tetrameric actin-cross-linking proteins that form an elastic network, termed the membrane skeleton, on the cytoplasmic surface of cellular membranes. At the plasma membrane, the membrane skeleton provides essential support, preventing loss of membrane material to environmental shear stresses. The skeleton also controls the location, abundance, and activity of membrane proteins that are critical to cell and tissue function. The ability of the skeleton to modulate membrane stability and function requires adaptor proteins that bind the skeleton to membranes. The principal adaptors are the ankyrin proteins, which bind to the beta-subunit of spectrin and to the cytoplasmic domains of numerous integral membrane proteins. Here, we present the crystal structure of the ankyrin-binding domain of human beta(2)-spectrin at 1.95 A resolution together with mutagenesis data identifying the binding surface for ankyrins on beta(2)-spectrin.	[Michaely, Peter] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Davis, Lydia; Abdi, Khadar; Bennett, Vann] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Davis, Lydia; Abdi, Khadar; Bennett, Vann] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Machius, Mischa; Brautigam, Chad; Tomchick, Diana R.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Duke University; Duke University; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Michaely, P (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Peter.Michaely@utsouthwestern.edu	Tomchick, Diana/HGV-2018-2022	Brautigam, Chad/0000-0001-6563-1338; Tomchick, Diana/0000-0002-7529-4643	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085218] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [HL085218, R01 HL085218] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Altmann SM, 2002, STRUCTURE, V10, P1085, DOI 10.1016/S0969-2126(02)00808-0; Beck K, 1998, J STRUCT BIOL, V122, P17, DOI 10.1006/jsbi.1998.3965; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; BENNETT V, 1982, NATURE, V299, P126, DOI 10.1038/299126a0; Bennett V, 2008, TRENDS MOL MED, V14, P28, DOI 10.1016/j.molmed.2007.11.005; BURRIDGE K, 1982, J CELL BIOL, V95, P478, DOI 10.1083/jcb.95.2.478; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DISCHER DE, 1994, SCIENCE, V266, P1032, DOI 10.1126/science.7973655; Dubreuil RR, 2006, J MEMBRANE BIOL, V211, P151, DOI 10.1007/s00232-006-0863-y; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gallagher PG, 1998, BLOOD CELL MOL DIS, V24, P539, DOI 10.1006/bcmd.1998.0217; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HARTWIG JH, 1995, PROTEIN PROFILE, V2, P703; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KENNEDY SP, 1991, J CELL BIOL, V115, P267, DOI 10.1083/jcb.115.1.267; Kusunoki H, 2004, J MOL BIOL, V344, P495, DOI 10.1016/j.jmb.2004.09.019; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; MOHANDAS N, 1983, SEMIN HEMATOL, V20, P225; MOHANDAS N, 1994, ANNU REV BIOPH BIOM, V23, P787, DOI 10.1146/annurev.bb.23.060194.004035; Mohler PJ, 2005, FRONT BIOSCI, V10, P2832, DOI 10.2741/1739; Morris RJ, 2004, J SYNCHROTRON RADIAT, V11, P56, DOI 10.1107/S090904950302394X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1991, P CCP4 STUD WEEK IS, P80; Rief M, 1999, J MOL BIOL, V286, P553, DOI 10.1006/jmbi.1998.2466; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; SHOTTON DM, 1979, J MOL BIOL, V131, P303, DOI 10.1016/0022-2836(79)90078-0; Stabach PR, 2000, J BIOL CHEM, V275, P21385, DOI 10.1074/jbc.C000159200	29	54	55	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6982	6987		10.1074/jbc.M809245200	http://dx.doi.org/10.1074/jbc.M809245200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19098307	Green Published, hybrid			2022-12-25	WOS:000263919000046
J	Bederman, IR; Foy, S; Chandramouli, V; Alexander, JC; Previs, SF				Bederman, Ilya R.; Foy, Steven; Chandramouli, Visvanathan; Alexander, James C.; Previs, Stephen F.			Triglyceride Synthesis in Epididymal Adipose Tissue CONTRIBUTION OF GLUCOSE AND NON-GLUCOSE CARBON SOURCES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS ISOTOPOMER ANALYSIS; CARBOHYDRATE-FREE DIET; IN-VIVO; FATTY-ACIDS; PHOSPHOENOLPYRUVATE CARBOXYKINASE; CHOLESTEROL-SYNTHESIS; GLYCERIDE-GLYCEROL; PLASMA-GLUCOSE; HIGH-PROTEIN; GLYCERONEOGENESIS	The obesity epidemic has generated interest in determining the contribution of various pathways to triglyceride synthesis, including an elucidation of the origin of triglyceride fatty acids and triglyceride glycerol. We hypothesized that a dietary intervention would demonstrate the importance of using glucose versus non-glucose carbon sources to synthesize triglycerides in white adipose tissue. C57BL/6J mice were fed either a low fat, high carbohydrate (HC) diet or a high fat, carbohydrate-free (CF) diet and maintained on (H2O)-H-2 (to determine total triglyceride dynamics) or infused with [6,6-H-2] glucose (to quantify the contribution of glucose to triglyceride glycerol). The (H2O)-H-2 labeling data demonstrate that although de novo lipogenesis contributed similar to 80% versus similar to 5% to the pool of triglyceride palmitate in HC-versus CF-fed mice, the epididymal adipose tissue synthesized similar to 1.5-fold more triglyceride in CF-versus HC-fed mice, i.e. 37 +/- 5 versus 25 +/- 3 mu mol x day(-1). The [6,6-H-2] glucose labeling data demonstrate that similar to 69 and similar to 28% of triglyceride glycerol is synthesized from glucose in HC-versus CF-fed mice, respectively. Although these data are consistent with the notion that non-glucose carbon sources (e. g. glyceroneogenesis) can make substantial contributions to the synthesis of triglyceride glycerol (i.e. the absolute synthesis of triglyceride glycerol from non-glucose substrates increased from similar to 8 to similar to 26 mu mol x day(-1) in HC-versus CF-fed mice), these observations suggest (i) the importance of nutritional status in affecting flux rates and (ii) the operation of a glycerol-glucose cycle.	[Previs, Stephen F.] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA; [Chandramouli, Visvanathan; Previs, Stephen F.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Alexander, James C.] Case Western Reserve Univ, Dept Math, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Previs, SF (corresponding author), Case Western Reserve Univ, Sch Med, Dept Nutr, Rm WG 48,10900 Euclid Ave, Cleveland, OH 44106 USA.	stephen.previs@case.edu			National Institutes of Health Metabolomics Roadmap Initiative [R33DK070291]; American Diabetes Association [1-04-JF-40]; Mt. Sinai Health Care Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R33DK070291] Funding Source: NIH RePORTER	National Institutes of Health Metabolomics Roadmap Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Mt. Sinai Health Care Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Metabolomics Roadmap Initiative Grant R33DK070291. This work was also supported by grants from the American Diabetes Association (Grant 1-04-JF-40) and the Mt. Sinai Health Care Foundation (Cleveland, OH).	BAKER N, 1972, J LIPID RES, V13, P716; BALLARD FJ, 1967, J BIOL CHEM, V242, P2746; BEALE EG, 2003, BIOCHEM SOC T, V31, P1125; Bederman IR, 2006, AM J PHYSIOL-ENDOC M, V290, pE1048, DOI 10.1152/ajpendo.00340.2005; Behn A, 2006, CURR OPIN CARDIOL, V21, P353, DOI 10.1097/01.hco.0000231406.84554.96; Bessesen DH, 2000, AM J PHYSIOL-ENDOC M, V278, pE1124, DOI 10.1152/ajpendo.2000.278.6.E1124; Botion LM, 1998, METABOLISM, V47, P1217, DOI 10.1016/S0026-0495(98)90326-2; Bray GA, 2006, ENDOCRINE, V29, P109, DOI 10.1385/ENDO:29:1:109; Brito SC, 2006, METABOLISM, V55, P84, DOI 10.1016/j.metabol.2005.07.010; Brunengraber DZ, 2003, AM J PHYSIOL-ENDOC M, V285, pE917, DOI 10.1152/ajpendo.00128.2003; Burgess SC, 2003, ANAL BIOCHEM, V318, P321, DOI 10.1016/S0003-2697(03)00158-1; Burgess SC, 2008, J APPL PHYSIOL, V104, P1852, DOI 10.1152/japplphysiol.90406.2008; Cadoudal T, 2008, DIABETES, V57, P2272, DOI 10.2337/db08-0477; Chacko SK, 2008, J APPL PHYSIOL, V104, P944, DOI 10.1152/japplphysiol.00752.2007; Chen JL, 2005, J BIOL CHEM, V280, P25396, DOI 10.1074/jbc.M413948200; Daniels SR, 2006, FUTURE CHILD, V16, P47, DOI 10.1353/foc.2006.0004; Dietz WH, 2004, NEW ENGL J MED, V350, P855, DOI 10.1056/NEJMp048008; Diraison F, 1997, J MASS SPECTROM, V32, P81, DOI 10.1002/(SICI)1096-9888(199701)32:1<81::AID-JMS454>3.0.CO;2-2; Forest C, 2003, BIOCHEM SOC T, V31, P1125; Hanson RW, 2003, BIOCHIMIE, V85, P1199, DOI 10.1016/j.biochi.2003.10.022; Jones JG, 2002, MAGNET RESON MED, V48, P535, DOI 10.1002/mrm.10234; KNEER P, 1968, J BIOL CHEM, V243, P2863; LEE WNP, 1994, AM J PHYSIOL, V266, pE699, DOI 10.1152/ajpendo.1994.266.5.E699; LEE WNP, 1994, AM J PHYSIOL, V266, pE372, DOI 10.1152/ajpendo.1994.266.3.E372; Leroyer SN, 2006, J BIOL CHEM, V281, P13141, DOI 10.1074/jbc.M512943200; NURJHAN N, 1986, DIABETES, V35, P1326, DOI 10.2337/diabetes.35.12.1326; Nye CK, 2008, J BIOL CHEM, V283, P27565, DOI 10.1074/jbc.M804393200; Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200; ROGNSTAD R, 1974, EUR J BIOCHEM, V47, P383, DOI 10.1111/j.1432-1033.1974.tb03703.x; Schoenheimer R, 1936, J BIOL CHEM, V114, P381; Siler SQ, 1998, AM J PHYSIOL-ENDOC M, V275, pE897, DOI 10.1152/ajpendo.1998.275.5.E897; Summers LKM, 2000, AM J CLIN NUTR, V71, P1470; Tordjman J, 2003, J BIOL CHEM, V278, P18785, DOI 10.1074/jbc.M206999200; Turner SM, 2003, AM J PHYSIOL-ENDOC M, V285, pE790, DOI 10.1152/ajpendo.00402.2002; WHITE LW, 1968, ARCH BIOCHEM BIOPHYS, V126, P552, DOI 10.1016/0003-9861(68)90441-4; Wolfe RR, 2004, ISOTOPE TRACERS META; Xu J, 2002, J BIOL CHEM, V277, P50237, DOI 10.1074/jbc.M201208200; Yang DW, 1998, ANAL BIOCHEM, V258, P315, DOI 10.1006/abio.1998.2632	38	67	67	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6101	6108		10.1074/jbc.M808668200	http://dx.doi.org/10.1074/jbc.M808668200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19114707	Green Published, hybrid			2022-12-25	WOS:000263742700012
J	Veyron-Churlet, R; Molle, V; Taylor, RC; Brown, AK; Besra, GS; Zanella-Cleon, I; Futterer, K; Kremer, L				Veyron-Churlet, Romain; Molle, Virginie; Taylor, Rebecca C.; Brown, Alistair K.; Besra, Gurdyal S.; Zanella-Cleon, Isabelle; Fuetterer, Klaus; Kremer, Laurent			The Mycobacterium tuberculosis beta-Ketoacyl-Acyl Carrier Protein Synthase III Activity Is Inhibited by Phosphorylation on a Single Threonine Residue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHASE; SERINE/THREONINE KINASE; CELL-DIVISION; CRYSTAL-STRUCTURE; FAS-II; SUBSTRATE-SPECIFICITY; SER/THR KINASE; IN-VIVO; BIOSYNTHESIS; IDENTIFICATION	Mycolic acids are hallmark features of the Mycobacterium tuberculosis cell wall. They are synthesized by the condensation of two fatty acids, a C56-64-meromycolyl chain and a C24-26-fatty acyl chain. Meromycolates are produced via the combination of type I and type II fatty acid synthases (FAS-I and FAS-II). The beta-ketoacyl-acyl carrier protein (ACP) synthase III ( mtFabH) links FAS-I and FAS-II, catalyzing the condensation of FAS-I-derived acyl-CoAs with malonyl-ACP. Because mtFabH represents a potential regulatory key point of the mycolic acid pathway, we investigated the hypothesis that phosphorylation of mtFabH controls its activity. Phosphorylation of proteins by Ser/Thr protein kinases (STPKs) has recently emerged as a major physiological mechanism of regulation in prokaryotes. We demonstrate here that mtFabH was efficiently phosphorylated in vitro by several mycobacterial STPKs, particularly by PknF and PknA, as well as in vivo in mycobacteria. Analysis of the phosphoamino acid content indicated that mtFabH was phosphorylated exclusively on threonine residues. Mass spectrometry analyses using liquid chromatography-electrospray ionization/tandem mass spectrometry identified Thr(45) as the unique phosphoacceptor. This was further supported by complete loss of PknF- or PknA-dependent phosphorylation of a mtFabH mutant. Mapping Thr(45) on the crystal structure of mtFabH illustrates that this residue is located at the entrance of the substrate channel, suggesting that the phosphate group may alter accessibility of the substrate and thus affect mtFabH enzymatic activity. A T45D mutant of mtFabH, designed to mimic constitutive phosphorylation, exhibited markedly decreased transacylation, malonyl-AcpM decarboxylation, and condensing activities compared with the wild-type protein or the T45A mutant. Together, these findings not only represent the first demonstration of phosphorylation of a beta-ketoacyl-ACP synthase III enzyme but also indicate that phosphorylation of mtFabH inhibits its enzymatic activity, which may have important consequences in regulating mycolic acid biosynthesis.	[Molle, Virginie; Zanella-Cleon, Isabelle] Univ Lyon 1, CNRS, IBCP, UMR 5086,IFR128 BioSci, F-69367 Lyon 07, France; [Veyron-Churlet, Romain; Kremer, Laurent] Univ Montpellier 2, Lab Dynam Interact Membranaires Normales & Pathol, CNRS, UMR 5235, F-34095 Montpellier 05, France; [Veyron-Churlet, Romain; Kremer, Laurent] Univ Montpellier I, Lab Dynam Interact Membranaires Normales & Pathol, CNRS, UMR 5235, F-34095 Montpellier 05, France; [Kremer, Laurent] INSERM, F-34095 Montpellier 05, France; [Taylor, Rebecca C.; Brown, Alistair K.; Besra, Gurdyal S.; Fuetterer, Klaus] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of Birmingham	Molle, V (corresponding author), Univ Lyon 1, CNRS, IBCP, UMR 5086,IFR128 BioSci, 7 Passage Vercors, F-69367 Lyon 07, France.	vmolle@ibcp.fr; laurent.kremer@univ-montp2.fr	MOLLE, Virginie/D-4050-2019; Kremer, Laurent/M-4935-2017; Veyron-Churlet, Romain/J-4254-2019	MOLLE, Virginie/0000-0002-6573-3411; Kremer, Laurent/0000-0002-6604-4458; Veyron-Churlet, Romain/0000-0001-6902-5917; Brown, Alistair/0000-0003-0479-8294; Futterer, Klaus/0000-0001-7445-5372; Besra, Gurdyal/0000-0002-5605-0395	National Research Agency [ANR-06-MIME-027-01]; MRC [G0500590] Funding Source: UKRI; Medical Research Council [G0500590] Funding Source: researchfish	National Research Agency(French National Research Agency (ANR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by National Research Agency Grant ANR-06-MIME-027-01 (to V. M. and L. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alhamadsheh MM, 2007, CHEM BIOL, V14, P513, DOI 10.1016/j.chembiol.2007.03.013; Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Banerjee A, 1998, MICROBIOL-SGM, V144, P2697, DOI 10.1099/00221287-144-10-2697; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Bhatt A, 2008, CHEM BIOL, V15, P930, DOI 10.1016/j.chembiol.2008.07.007; Bhatt A, 2007, MOL MICROBIOL, V64, P1442, DOI 10.1111/j.1365-2958.2007.05761.x; Bhatt A, 2007, P NATL ACAD SCI USA, V104, P5157, DOI 10.1073/pnas.0608654104; Briken V, 2004, MOL MICROBIOL, V53, P391, DOI 10.1111/j.1365-2958.2004.04183.x; Brown AK, 2005, J BIOL CHEM, V280, P32539, DOI 10.1074/jbc.M413216200; Brown AK, 2007, MICROBIOL-SGM, V153, P4166, DOI 10.1099/mic.0.2007/012419-0; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; Camacho LR, 2001, J BIOL CHEM, V276, P19845, DOI 10.1074/jbc.M100662200; Canova MJ, 2008, PROTEOMICS, V8, P521, DOI 10.1002/pmic.200700442; Choi KH, 2000, J BIOL CHEM, V275, P28201; Cohen-Gonsaud M, 2004, J BIOMOL NMR, V30, P373, DOI 10.1007/s10858-004-3466-x; Cohen-Gonsaud M, 2002, J MOL BIOL, V320, P249, DOI 10.1016/S0022-2836(02)00463-1; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cottin V, 1999, J BIOL CHEM, V274, P32975, DOI 10.1074/jbc.274.46.32975; Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Dasgupta A, 2006, MICROBIOL-SGM, V152, P493, DOI 10.1099/mic.0.28630-0; Deol P, 2005, J BACTERIOL, V187, P3415, DOI 10.1128/JB.187.10.3415-3420.2005; Fernandez P, 2006, J BACTERIOL, V188, P7778, DOI 10.1128/JB.00963-06; Fiuza M, 2008, J BIOL CHEM, V283, P18099, DOI 10.1074/jbc.M802615200; Glickman MS, 2001, CELL, V104, P477, DOI 10.1016/S0092-8674(01)00236-7; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Jackson M, 2000, J BIOL CHEM, V275, P30092, DOI 10.1074/jbc.M004658200; Jayakumar D, 2008, CELL MICROBIOL, V10, P365, DOI 10.1111/j.1462-5822.2007.01049.x; Kang CM, 2008, MICROBIOL-SGM, V154, P725, DOI 10.1099/mic.0.2007/014076-0; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Kolattukudy PE, 1997, MOL MICROBIOL, V24, P263, DOI 10.1046/j.1365-2958.1997.3361705.x; Kremer L, 2002, BIOCHEM J, V364, P423, DOI 10.1042/BJ20011628; Kremer L, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P173; Kruh NA, 2008, J BIOL CHEM, V283, P31719, DOI 10.1074/jbc.M802169200; Marrakchi H, 2002, MICROBIOL-SGM, V148, P951, DOI 10.1099/00221287-148-4-951; Molle V, 2003, BIOCHEMISTRY-US, V42, P15300, DOI 10.1021/bi035150b; Molle V, 2003, BIOCHEM BIOPH RES CO, V308, P820, DOI 10.1016/S0006-291X(03)01476-1; Molle V, 2006, J BIOL CHEM, V281, P30094, DOI 10.1074/jbc.M601691200; Musayev F, 2005, J MOL BIOL, V346, P1313, DOI 10.1016/j.jmb.2004.12.044; Papavinasasundaram KG, 2005, J BACTERIOL, V187, P5751, DOI 10.1128/JB.187.16.5751-5760.2005; Peirs P, 1997, EUR J BIOCHEM, V244, P604, DOI 10.1111/j.1432-1033.1997.00604.x; Perez J, 2006, BIOCHEM BIOPH RES CO, V348, P6, DOI 10.1016/j.bbrc.2006.06.164; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; Qiu XY, 2001, J MOL BIOL, V307, P341, DOI 10.1006/jmbi.2000.4457; Sacco E, 2007, P NATL ACAD SCI USA, V104, P14628, DOI 10.1073/pnas.0704132104; Scarsdale JN, 2001, J BIOL CHEM, V276, P20516, DOI 10.1074/jbc.M010762200; Schaeffer ML, 2001, J BIOL CHEM, V276, P47029, DOI 10.1074/jbc.M108903200; Sharma K, 2006, J BACTERIOL, V188, P2936, DOI 10.1128/JB.188.8.2936-2944.2006; Shorrosh BS, 1996, PLANT J, V10, P261, DOI 10.1046/j.1365-313X.1996.10020261.x; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Veyron-Churlet R, 2004, MOL MICROBIOL, V54, P1161, DOI 10.1111/j.1365-2958.2004.04334.x; Vilcheze C, 2006, NAT MED, V12, P1027, DOI 10.1038/nm1466; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Wehenkel A, 2008, BBA-PROTEINS PROTEOM, V1784, P193, DOI 10.1016/j.bbapap.2007.08.006; Zheng XJ, 2007, BIOCHEM BIOPH RES CO, V355, P162, DOI 10.1016/j.bbrc.2007.01.122	58	57	58	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6414	6424		10.1074/jbc.M806537200	http://dx.doi.org/10.1074/jbc.M806537200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19074144	Green Published, hybrid			2022-12-25	WOS:000263742700044
J	Tisdale, EJ; Azizi, F; Artalejo, CR				Tisdale, Ellen J.; Azizi, Fouad; Artalejo, Cristina R.			Rab2 Utilizes Glyceraldehyde-3-phosphate Dehydrogenase and Protein Kinase C iota to Associate with Microtubules and to Recruit Dynein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; ENDOPLASMIC-RETICULUM; VESICULAR TRANSPORT; APKC-IOTA/LAMBDA; PKC-IOTA/LAMBDA; CARGO TRANSPORT; GOLGI; TUBULIN; ER; KINESIN	Rab2 requires glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and atypical protein kinase C iota(aPKC iota) for retrograde vesicle formation from vesicular tubular clusters that sort secretory cargo from recycling proteins returned to the endoplasmic reticulum. However, the precise role of GAPDH and aPKC iota in the early secretory pathway is unclear. GAPDH was the first glycolytic enzyme reported to co-purify with microtubules (MTs). Similarly, aPKC associates directly with MTs. To learn whether Rab2 also binds directly to MTs, a MT binding assay was performed. Purified Rab2 was found in a MT-enriched pellet only when both GAPDH and aPKC iota were present, and Rab2-MT binding could be prevented by a recombinant fragment made to the Rab2 amino terminus (residues 2-70), which directly interacts with GAPDH and aPKC iota. Because GAPDH binds to the carboxyl terminus of alpha-tubulin, we characterized the distribution of tyrosinated/detyrosinated alpha-tubulin that is recruited by Rab2 in a quantitative membrane binding assay. Rab2-treated membranes contained predominantly tyrosinated alpha-tubulin; however, aPKC iota was the limiting and essential factor. Tyrosination/detyrosination influences MT motor protein binding; therefore, we determined whether Rab2 stimulated kinesin or dynein membrane binding. Although kinesin was not detected on membranes incubated with Rab2, dynein was recruited in a dose-dependent manner, and binding was aPKC iota-dependent. These combined results suggest a mechanism by which Rab2 controls MT and motor recruitment to vesicular tubular clusters.	[Tisdale, Ellen J.; Azizi, Fouad; Artalejo, Cristina R.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA	Wayne State University	Tisdale, EJ (corresponding author), Wayne State Univ, Sch Med, Dept Pharmacol, 540 E Canfield Ave,6374 Scott Hall, Detroit, MI 48201 USA.	etisdale@med.wayne.edu			National Institutes of Health [GM068813]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068813] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM068813 (to E. J. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Altan-Bonnet N, 2004, CURR OPIN CELL BIOL, V16, P364, DOI 10.1016/j.ceb.2004.06.011; Andrade J, 2004, BIOCHEM J, V384, P327, DOI 10.1042/BJ20040622; Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019; ARCE CA, 1985, BIOCHEM J, V226, P311, DOI 10.1042/bj2260311; BALCH WE, 1994, CELL, V76, P841, DOI 10.1016/0092-8674(94)90359-X; Barroso MR, 1996, J BIOL CHEM, V271, P10183, DOI 10.1074/jbc.271.17.10183; Ben-Tekaya H, 2005, J CELL SCI, V118, P357, DOI 10.1242/jcs.01615; Bielli A, 2001, BIOCHEM BIOPH RES CO, V281, P1141, DOI 10.1006/bbrc.2001.4468; Caviston JP, 2006, TRENDS CELL BIOL, V16, P530, DOI 10.1016/j.tcb.2006.08.002; Cueille N, 2007, J PROTEOME RES, V6, P2640, DOI 10.1021/pr070081z; Echard A, 1998, SCIENCE, V279, P580, DOI 10.1126/science.279.5350.580; Etienne-Manneville S, 2003, CURR OPIN CELL BIOL, V15, P67, DOI 10.1016/S0955-0674(02)00005-4; Fan SL, 2004, CURR BIOL, V14, P1451, DOI 10.1016/j.cub.2004.08.025; GarciaRocha M, 1997, EXP CELL RES, V230, P1, DOI 10.1006/excr.1996.3364; Glaser PE, 2002, P NATL ACAD SCI USA, V99, P14104, DOI 10.1073/pnas.222542999; Gross SP, 2007, CURR BIOL, V17, pR478, DOI 10.1016/j.cub.2007.04.025; HAMMOND J, 2007, CURR OPIN CELL BIOL, V19, P1; Harris TJC, 2007, DEV CELL, V12, P727, DOI 10.1016/j.devcel.2007.02.011; Hoepfner S, 2005, CELL, V121, P437, DOI 10.1016/j.cell.2005.02.017; Honnappa S, 2006, MOL CELL, V23, P663, DOI 10.1016/j.molcel.2006.07.013; Hook P, 2006, J CELL SCI, V119, P4369, DOI 10.1242/jcs.03176; Idriss HT, 2000, CELL MOTIL CYTOSKEL, V45, P173, DOI 10.1002/(SICI)1097-0169(200003)45:3<173::AID-CM1>3.0.CO;2-O; KREIS TE, 1987, EMBO J, V6, P2597, DOI 10.1002/j.1460-2075.1987.tb02550.x; KUMAGAI H, 1983, J BIOCHEM-TOKYO, V93, P1259, DOI 10.1093/oxfordjournals.jbchem.a134260; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Liao GJ, 1998, J BIOL CHEM, V273, P9797, DOI 10.1074/jbc.273.16.9797; Lin SX, 2002, MOL BIOL CELL, V13, P96, DOI 10.1091/mbc.01-05-0224; LIPPINCOTTSCHWARTZ J, 1995, J CELL BIOL, V128, P293, DOI 10.1083/jcb.128.3.293; MACRAE TH, 1992, BIOCHIM BIOPHYS ACTA, V1160, P145, DOI 10.1016/0167-4838(92)90001-T; McCaffrey MW, 2001, FEBS LETT, V495, P21, DOI 10.1016/S0014-5793(01)02359-6; Pereira-Leal JB, 2000, J MOL BIOL, V301, P1077, DOI 10.1006/jmbi.2000.4010; Peris L, 2006, J CELL BIOL, V174, P839, DOI 10.1083/jcb.200512058; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Roghi C, 1999, J CELL SCI, V112, P4673; Ross JL, 2008, CURR OPIN CELL BIOL, V20, P41, DOI 10.1016/j.ceb.2007.11.006; Ruiz-Canada C, 2004, NEURON, V42, P567, DOI 10.1016/S0896-6273(04)00255-7; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Seibenhener M L, 1999, Mol Cell Biol Res Commun, V2, P28, DOI 10.1006/mcbr.1999.0140; Shao CY, 2006, J NEUROPATH EXP NEUR, V65, P327, DOI 10.1097/01.jnen.0000218441.00040.82; Short B, 2002, CURR BIOL, V12, P1792, DOI 10.1016/S0960-9822(02)01221-6; Sironi JJ, 1997, MOL CELL BIOCHEM, V170, P9, DOI 10.1023/A:1006846828547; SOMERS M, 1990, EUR J BIOCHEM, V193, P437, DOI 10.1111/j.1432-1033.1990.tb19357.x; Stauber T, 2006, CURR BIOL, V16, P2245, DOI 10.1016/j.cub.2006.09.060; Tisdale EJ, 2006, J BIOL CHEM, V281, P8436, DOI 10.1074/jbc.M513031200; Tisdale EJ, 1999, MOL BIOL CELL, V10, P1837, DOI 10.1091/mbc.10.6.1837; Tisdale EJ, 2000, TRAFFIC, V1, P702, DOI 10.1034/j.1600-0854.2000.010903.x; Tisdale EJ, 1996, J BIOL CHEM, V271, P29372, DOI 10.1074/jbc.271.46.29372; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; Tisdale EJ, 2002, J BIOL CHEM, V277, P3334, DOI 10.1074/jbc.M109744200; Tisdale EJ, 2004, J BIOL CHEM, V279, P54046, DOI 10.1074/jbc.M409472200; Tisdale EJ, 2003, J BIOL CHEM, V278, P52524, DOI 10.1074/jbc.M309343200; Tisdale EJ, 1997, J CELL BIOL, V137, P581, DOI 10.1083/jcb.137.3.581; Tisdale EJ, 2001, J BIOL CHEM, V276, P2480, DOI 10.1074/jbc.M007567200; Tisdale EJ, 1998, J BIOL CHEM, V273, P17269, DOI 10.1074/jbc.273.27.17269; Tisdale EJ, 2007, TRAFFIC, V8, P733, DOI 10.1111/j.1600-0854.2007.00569.x; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; Volker KW, 1997, ARCH BIOCHEM BIOPHYS, V338, P237, DOI 10.1006/abbi.1996.9819; VOLKER KW, 1995, COMP BIOCHEM PHYS B, V112, P503, DOI 10.1016/0305-0491(95)00096-8; Wade Richard H, 2007, Methods Mol Med, V137, P1, DOI 10.1007/978-1-59745-442-1_1; Wang Q, 2005, FASEB J, V19, P869, DOI 10.1096/fj.04-3210fje; Wanschers B, 2008, CELL MOTIL CYTOSKEL, V65, P183, DOI 10.1002/cm.20254; Watson P, 2005, NAT CELL BIOL, V7, P48, DOI 10.1038/ncb1206; WEBSTER DR, 1987, P NATL ACAD SCI USA, V84, P9040, DOI 10.1073/pnas.84.24.9040; Weisbrich A, 2007, NAT STRUCT MOL BIOL, V14, P959, DOI 10.1038/nsmb1291; White J, 1999, J CELL BIOL, V147, P743, DOI 10.1083/jcb.147.4.743; Yoshiyama Y, 2003, J NEUROSCI, V23, P10662	66	55	57	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5876	5884		10.1074/jbc.M807756200	http://dx.doi.org/10.1074/jbc.M807756200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19106097	Green Published, hybrid			2022-12-25	WOS:000263560600051
J	Wei, HJ; Gan, BY; Wu, XY; Guan, JL				Wei, Huijun; Gan, Boyi; Wu, Xiaoyang; Guan, Jun-Lin			Inactivation of FIP200 Leads to Inflammatory Skin Disorder, but Not Tumorigenesis, in Conditional Knock-out Mouse Models	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; FOCAL ADHESION KINASE; CELL-CYCLE REGULATION; HUMAN BREAST-CANCER; TRANSGENIC MICE; TRANSCRIPTIONAL ACTIVITY; SIGNALING PATHWAYS; IMMUNE-SYSTEM; IFN-GAMMA; TNF-ALPHA	FIP200 (focal adhesion kinase family interacting protein of 200 kDa) has been shown to interact with other proteins to regulate several intracellular signaling pathways. To study a potential role of FIP200 in tumorigenesis and possibly other disease processes in vivo, we created and analyzed murine mammary tumor virus-Cre-mediated FIP200 conditional knock-out (CKO) mice. We found that deletion of FIP200 in mammary epithelial cells did not result in spontaneous development of breast cancer. Moreover, deletion of FIP200 did not further accelerate or inhibit lymphomagenesis induced by inactivation of p53 in mice. Interestingly, however, FIP200 and p53 double conditional knock-out (dCKO) mice exhibited significant hyperplasia of epidermis (acanthosis), thickening of the cornified layer (hyperkeratosis), and increased vascularity in the dermis. FIP200 CKO mice also showed similar, although less severe, skin defects as dCKO mice. Analyses of primary keratinocytes isolated from dCKO mice did not detect increased proliferation of these cells in vitro, suggesting that epidermis hyperproliferation is not epidermal cell-autonomous but may be a consequence of increased inflammation triggered by immune cells in vivo. Consistent with this possibility, we found infiltration of leukocytes including T cells, macrophages, and granulocytes into the dermis and epidermis, associated with activation of NF-kappa B and increased expression of several proinflammatory cytokines and chemokines in skin of the dCKO mice. We further found that cultured FIP200 KO keratinocytes showed reduced NF-kappa B phosphorylation in response to tumor necrosis factor alpha stimulation, suggesting a paracrine regulation of aberrant NF-kappa B activation in the skin microenviroment of dCKO and FIP200 CKO mice. Together, these results demonstrate that ablation of FIP200, although not promoting tumorigenesis, can lead to skin inflammatory disorders, suggesting a novel function of FIP200 in the maintenance of normal skin homeostasis in vivo.	[Wei, Huijun; Gan, Boyi; Wu, Xiaoyang; Guan, Jun-Lin] Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA; [Guan, Jun-Lin] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Guan, JL (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA.	jlguan@umich.edu	Gan, Boyi/HDM-4206-2022		National Institutes of Health [GM52890]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052890] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM52890 (to J.-L.G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abbi S, 2002, MOL BIOL CELL, V13, P3178, DOI 10.1091/mbc.E02-05-0295; Arican O, 2005, MEDIAT INFLAMM, P273, DOI 10.1155/MI.2005.273; Austin LM, 1999, J INVEST DERMATOL, V113, P752, DOI 10.1046/j.1523-1747.1999.00749.x; Bamba N, 2004, INT J MOL MED, V14, P583; Carroll JM, 1997, J INVEST DERMATOL, V108, P412, DOI 10.1111/1523-1747.ep12289702; CARROLL JM, 1995, CELL, V83, P957, DOI 10.1016/0092-8674(95)90211-2; Chano T, 2002, NAT GENET, V31, P285, DOI 10.1038/ng911; Chano T, 2002, ONCOGENE, V21, P1295, DOI 10.1038/sj.onc.1205178; Chano T, 2006, INT J MOL MED, V18, P425; Gan B, 2008, CELL SIGNAL, V20, P787, DOI 10.1016/j.cellsig.2007.10.021; Gan BY, 2006, J CELL BIOL, V175, P121, DOI 10.1083/jcb.200604129; Gan BY, 2005, J CELL BIOL, V170, P379, DOI 10.1083/jcb.200411106; Gudjonsson JE, 2007, J INVEST DERMATOL, V127, P1292, DOI 10.1038/sj.jid.5700807; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Klement JF, 1996, MOL CELL BIOL, V16, P2341; Leung DYM, 1999, J ALLERGY CLIN IMMUN, V104, pS99, DOI 10.1016/S0091-6749(99)70051-5; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Martin N, 2008, MOL CELL BIOL, V28, P2771, DOI 10.1128/MCB.01210-07; Melkoumian ZK, 2005, CANCER RES, V65, P6676, DOI 10.1158/0008-5472.CAN-04-4142; Nickoloff BJ, 1999, J CLIN INVEST, V104, P1161, DOI 10.1172/JCI8633; Nickoloff BJ, 1997, NAT MED, V3, P475, DOI 10.1038/nm0597-475b; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Peng X, 2006, J CLIN INVEST, V116, P217, DOI 10.1172/JCI24497; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Rebholz B, 2007, IMMUNITY, V27, P296, DOI 10.1016/j.immuni.2007.05.024; Robert C, 1999, NEW ENGL J MED, V341, P1817, DOI 10.1056/NEJM199912093412407; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stratis A, 2006, J CLIN INVEST, V116, P2094, DOI 10.1172/JCI27179; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; Ueda H, 2000, J CELL BIOL, V149, P423, DOI 10.1083/jcb.149.2.423; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007; Wei HJ, 2006, J BIOL CHEM, V281, P16664, DOI 10.1074/jbc.M513135200; Werner S, 2001, TRENDS CELL BIOL, V11, P143, DOI 10.1016/S0962-8924(01)01955-9; Whiteside ST, 1997, EMBO J, V16, P1413, DOI 10.1093/emboj/16.6.1413; Zhang JY, 2004, GENE DEV, V18, P17, DOI 10.1101/gad.1160904	43	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					6004	6013		10.1074/jbc.M806375200	http://dx.doi.org/10.1074/jbc.M806375200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19106106	Green Published, hybrid			2022-12-25	WOS:000263560600064
J	Mukherjee, S; Partch, CL; Lehotzky, RE; Whitham, CV; Chu, HT; Bevins, CL; Gardner, KH; Hooper, LV				Mukherjee, Sohini; Partch, Carrie L.; Lehotzky, Rebecca E.; Whitham, Cecilia V.; Chu, Hiutung; Bevins, Charles L.; Gardner, Kevin H.; Hooper, Lora V.			Regulation of C-type Lectin Antimicrobial Activity by a Flexible N-terminal Prosegment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERICIDAL LECTIN; ALPHA-DEFENSINS; ACTIVATION; PROTEINS; EXPRESSION; BINDING; HIP/PAP; ENZYME; DOMAIN; MICE	Members of the RegIII family of intestinal C-type lectins are directly antibacterial proteins that play a vital role in maintaining host-bacterial homeostasis in the mammalian gut, yet little is known about the mechanisms that regulate their biological activity. Here we show that the antibacterial activities of mouse RegIII gamma and its human ortholog, HIP/PAP, are tightly controlled by an inhibitory N-terminal prosegment that is removed by trypsin in vivo. NMR spectroscopy revealed a high degree of conformational flexibility in the HIP/PAP inhibitory prosegment, and mutation of either acidic prosegment residues or basic core protein residues disrupted prosegment inhibitory activity. NMR analyses of pro-HIP/PAP variants revealed distinctive colinear backbone amide chemical shift changes that correlated with antibacterial activity, suggesting that prosegment-HIP/PAP interactions are linked to a two-state conformational switch between biologically active and inactive protein states. These findings reveal a novel regulatory mechanism governing C-type lectin biological function and yield new insight into the control of intestinal innate immunity.	[Hooper, Lora V.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Mukherjee, Sohini; Lehotzky, Rebecca E.; Whitham, Cecilia V.; Hooper, Lora V.] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Hooper, Lora V.] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Partch, Carrie L.; Gardner, Kevin H.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Chu, Hiutung; Bevins, Charles L.] Univ Calif Davis, Sch Med, Dept Microbiol & Immunol, Davis, CA 95616 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California Davis	Gardner, KH (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	kevin.gardner@utsouthwestern.edu; lora.hooper@utsouthwestern.edu	Gardner, Kevin H./K-7802-2012; Gardner, Kevin/K-5493-2019; Bevins, Charles L/P-4438-2015	Gardner, Kevin H./0000-0002-8671-2556; Bevins, Charles L/0000-0003-2725-2622; Chu, Hiutung/0000-0001-7489-0446	National Institutes of Health [DK070855, GM081875, CA130441]; Burroughs Wellcome Foundation; Robert A. Welch Foundation [1-1659]; NATIONAL CANCER INSTITUTE [F32CA130441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI032738, R01AI050843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081875] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); Robert A. Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK070855 (to L. V. H.), GM081875 (to K. H. G.), and CA130441 (to C. L. P.). This work was also supported by the Burroughs Wellcome Foundation (New Investigators in the Pathogenesis of Infectious Diseases Award (to L. V. H.), and the Robert A. Welch Foundation (1-1659, to L. V. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abergel C, 1999, ACTA CRYSTALLOGR D, V55, P1487, DOI 10.1107/S0907444999007969; Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563; Cash HL, 2006, PROTEIN EXPRES PURIF, V48, P151, DOI 10.1016/j.pep.2006.01.014; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Christa L, 1996, AM J PHYSIOL-GASTR L, V271, pG993, DOI 10.1152/ajpgi.1996.271.6.G993; Clayberger C, 2003, CURR OPIN IMMUNOL, V15, P560, DOI 10.1016/S0952-7915(03)00097-9; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Farmer BT, 1996, NAT STRUCT BIOL, V3, P995, DOI 10.1038/nsb1296-995; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; Graf R, 2001, J BIOL CHEM, V276, P21028, DOI 10.1074/jbc.M010717200; Hadders MA, 2007, SCIENCE, V317, P1552, DOI 10.1126/science.1147103; Hoover DM, 2000, J BIOL CHEM, V275, P32911, DOI 10.1074/jbc.M006098200; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Li PL, 2008, NAT STRUCT MOL BIOL, V15, P613, DOI 10.1038/nsmb.1428; Mukherjee S, 2008, CELL MOL LIFE SCI, V65, P3019, DOI 10.1007/s00018-008-8182-3; Ogawa H, 2000, AM J PHYSIOL-GASTR L, V279, pG492, DOI 10.1152/ajpgi.2000.279.3.G492; Ogawa H, 2003, INFLAMM BOWEL DIS, V9, P162, DOI 10.1097/00054725-200305000-00003; Pufall MA, 2005, SCIENCE, V309, P142, DOI 10.1126/science.1111915; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Salzman NH, 2007, SEMIN IMMUNOL, V19, P70, DOI 10.1016/j.smim.2007.04.002; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Tanabe H, 2004, J BIOL CHEM, V279, P11976, DOI 10.1074/jbc.M310251200; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; Weeks CS, 2006, J BIOL CHEM, V281, P28932, DOI 10.1074/jbc.M602041200; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113	27	59	63	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4881	4888		10.1074/jbc.M808077200	http://dx.doi.org/10.1074/jbc.M808077200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19095652	Green Published, hybrid			2022-12-25	WOS:000263416600017
J	Li, YD; Ye, BQ; Zheng, SX; Wang, JT; Wang, JG; Chen, M; Liu, JG; Pei, XH; Wang, LJ; Lin, ZX; Gupta, K; Mackman, N; Slungaard, A; Key, NS; Geng, JG				Li, Yi-Dan; Ye, Bu-Qing; Zheng, Sheng-Xi; Wang, Jin-Tao; Wang, Jian-Guo; Chen, Ming; Liu, Ji-Guo; Pei, Xin-Hui; Wang, Li-Jing; Lin, Zhi-Xin; Gupta, Kalpna; Mackman, Nigel; Slungaard, Arne; Key, Nigel S.; Geng, Jian-Guo			NF-kappa B Transcription Factor p50 Critically Regulates Tissue Factor in Deep Vein Thrombosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-SELECTIN; CELL-ADHESION; VENOUS THROMBOSIS; FACTOR GENE; ENDOTHELIAL-CELLS; MONOCYTIC CELLS; DEFICIENT MICE; CANCER GROWTH; BONE-MARROW; ACTIVATION	NF-kappa B transcription factors regulate the expression of tissue factor (TF), a principal initiator of the coagulation cascade. Dominant among them is the p50/p65 heterodimer. Here we report that Andrographolide (Andro; a p50 inhibitor) and genetic deletion of p50 attenuated TF activity in stimulated endothelial cells and monocytes/macrophages. Results of the electrophoretic mobility "supershift" assay and chromatin immunoprecipitation demonstrated the direct interaction of the p50/p65 heterodimer with the NF-kappa B site of the human TF promoter. Andro-treated and p50 null mice both exhibited blunted TF expression and reduced venous thrombosis, which were recapitulated by an anti-murine TF antibody in vivo. Our findings thus indicate that regulation of TF by NF-kappa B transcription factor p50 is essential for the pathogenesis of deep vein thrombosis and suggest that specific inhibitors of p50, such as Andro, may be therapeutically valuable for preventing and perhaps treating venous thrombosis.	[Li, Yi-Dan; Ye, Bu-Qing; Zheng, Sheng-Xi; Wang, Jin-Tao; Chen, Ming; Liu, Ji-Guo; Pei, Xin-Hui; Geng, Jian-Guo] Chinese Acad Sci, Grad Sch, Mol Cell Biol Lab, Inst Biochem & Cell Biol,Shangai Inst Biol Sci, Shanghai 200031, Peoples R China; [Wang, Jian-Guo; Mackman, Nigel; Key, Nigel S.] Univ N Carolina, Div Hematol Oncol, Chapel Hill, NC 27599 USA; [Pei, Xin-Hui; Lin, Zhi-Xin] Shanghai Jiao Tong Univ, Coll Life Sci & Biotechnol, Shanghai 200240, Peoples R China; [Wang, Li-Jing] Guangdong Pharmaceut Univ, Inst Basic Med Sci, Guangzhou 510006, Guangdong, Peoples R China; [Gupta, Kalpna; Slungaard, Arne; Geng, Jian-Guo] Univ Minnesota, Sch Med, Vasc Biol Ctr, Minneapolis, MN 55455 USA; [Gupta, Kalpna; Slungaard, Arne; Geng, Jian-Guo] Univ Minnesota, Sch Med, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of North Carolina; University of North Carolina Chapel Hill; Shanghai Jiao Tong University; Guangdong Pharmaceutical University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Geng, JG (corresponding author), MMC 480,420 Delaware St SE, Minneapolis, MN 55455 USA.	genglab@gmail.com	Xiao, Yang/B-5668-2012		Asia-Pacific International Molecular Biology Network and Institute of Biochemistry and Cell Biology professorship; National Science Foundation of China [30721065, 30623003, 30700409, 30771960, 30630036]; Ministry of Science and Technology of China [2006CB943902, 2006AA02Z169, 2007CB947102, 2007CB914501]; Chinese Academy of Sciences [KSCX2-YW-R-67, KJCX2-YW-H08]; Shanghai Municipal Commission for Science and Technology [06DZ22032, 058014578]; Shanghai Institutes for Biological Sciences [2007KIP203]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064743] Funding Source: NIH RePORTER	Asia-Pacific International Molecular Biology Network and Institute of Biochemistry and Cell Biology professorship; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Municipal Commission for Science and Technology; Shanghai Institutes for Biological Sciences(Chinese Academy of Sciences); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1AI064743. This work was also supported by an Asia-Pacific International Molecular Biology Network and Institute of Biochemistry and Cell Biology professorship, National Science Foundation of China Grants 30721065, 30623003, 30700409, 30771960, and 30630036, Ministry of Science and Technology of China Grants 2006CB943902, 2006AA02Z169, 2007CB947102, and 2007CB914501, Chinese Academy of Sciences Grants KSCX2-YW-R-67 and KJCX2-YW-H08, Shanghai Municipal Commission for Science and Technology Grants 06DZ22032 and 058014578, Shanghai Institutes for Biological Sciences Grant 2007KIP203.	ANDREWS BS, 1991, GENE, V98, P265, DOI 10.1016/0378-1119(91)90184-D; Atarashi K, 2005, J IMMUNOL, V174, P1424, DOI 10.4049/jimmunol.174.3.1424; Campbell IK, 2000, J CLIN INVEST, V105, P1799, DOI 10.1172/JCI8298; del Conde I, 2005, BLOOD, V106, P1604, DOI 10.1182/blood-2004-03-1095; Furie B, 2001, THROMB HAEMOSTASIS, V86, P214, DOI 10.1055/s-0037-1616219; Geng JG, 2004, CURR MED CHEM, V11, P2153, DOI 10.2174/0929867043364720; GENG JG, 1990, NATURE, V343, P757, DOI 10.1038/343757a0; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Henke PK, 2001, J SURG RES, V99, P84, DOI 10.1006/jsre.2001.6122; Hilliard B, 1999, J IMMUNOL, V163, P2937; JANSON TL, 1984, HAEMOSTASIS, V14, P440; Key NS, 2001, THROMB HAEMOSTASIS, V85, P375; Laudanna C, 2002, IMMUNOL REV, V186, P37, DOI 10.1034/j.1600-065X.2002.18604.x; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Ma YQ, 2004, BLOOD, V104, P2549, DOI 10.1182/blood-2004-03-1108; Mack KD, 1998, J IMMUNOL METHODS, V211, P79, DOI 10.1016/S0022-1759(97)00194-4; Mackman N, 1997, THROMB HAEMOSTASIS, V78, P747; Marelli-Berg FM, 2000, J IMMUNOL METHODS, V244, P205, DOI 10.1016/S0022-1759(00)00258-1; McEver RP, 2002, CURR OPIN CELL BIOL, V14, P581, DOI 10.1016/S0955-0674(02)00367-8; MERCURIO AM, 1984, J EXP MED, V160, P1114, DOI 10.1084/jem.160.4.1114; Modarai B, 2005, THROMB HAEMOSTASIS, V93, P801, DOI 10.1160/TH04-09-0596; Modarai B, 2005, CIRCULATION, V111, P2645, DOI 10.1161/CIRCULATIONAHA.104.492678; Morrissey JH, 2003, J THROMB HAEMOST, V1, P878, DOI 10.1046/j.1538-7836.2003.00219.x; Myers D, 2002, J SURG RES, V108, P212, DOI 10.1006/jsre.2002.6552; Myers DD, 2003, J VASC SURG, V38, P1075, DOI 10.1016/S0741-5214(03)01033-4; Nandiwada SL, 2006, J IMMUNOL, V177, P401, DOI 10.4049/jimmunol.177.1.401; NEISH AS, 1992, J EXP MED, V176, P1583, DOI 10.1084/jem.176.6.1583; Oeth P, 1997, ARTERIOSCL THROM VAS, V17, P365, DOI 10.1161/01.ATV.17.2.365; OETH PA, 1994, MOL CELL BIOL, V14, P3772, DOI 10.1128/MCB.14.6.3772; Ozcan M, 2001, THROMB HAEMOSTASIS, V85, P250, DOI 10.1055/s-0037-1615705; PARRY GCN, 1994, J BIOL CHEM, V269, P20823; Polgar J, 2005, J THROMB HAEMOST, V3, P1590, DOI 10.1111/j.1538-7836.2005.01373.x; SHU HB, 1993, MOL CELL BIOL, V13, P6283, DOI 10.1128/MCB.13.10.6283; Singh I, 2003, CIRCULATION, V107, P869, DOI 10.1161/01.CIR.0000050149.22928.39; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Steffel J, 2006, CIRCULATION, V113, P722, DOI 10.1161/CIRCULATIONAHA.105.567297; Sullivan VV, 2003, J SURG RES, V109, P1, DOI 10.1016/S0022-4804(02)00041-0; Tilley R, 2006, SEMIN THROMB HEMOST, V32, P5, DOI 10.1055/s-2006-933335; Viles-Gonzalez JF, 2005, AM HEART J, V149, pS19, DOI 10.1016/j.ahj.2004.10.019; Wakefield T W, 1997, Cardiovasc Surg, V5, P6, DOI 10.1016/S0967-2109(96)00083-X; Wakefield Thomas W, 2005, Semin Vasc Surg, V18, P118, DOI 10.1053/j.semvascsurg.2005.05.003; Wakefield TW, 1999, J VASC SURG, V30, P885, DOI 10.1016/S0741-5214(99)70013-3; Wang B, 2003, CANCER CELL, V4, P19, DOI 10.1016/S1535-6108(03)00164-8; Wang JG, 2006, BLOOD, V107, P558, DOI 10.1182/blood-2005-05-2152; Wang YJ, 2007, CELL RES, V17, P933, DOI 10.1038/cr.2007.89; WHITLEY MZ, 1994, MOL CELL BIOL, V14, P6464, DOI 10.1128/MCB.14.10.6464; Woollard KJ, 2006, CIRC RES, V98, P149, DOI 10.1161/01.RES.0000199295.14073.69; Xia YF, 2004, J IMMUNOL, V173, P4207, DOI 10.4049/jimmunol.173.6.4207; Yang LY, 1998, J EXP MED, V188, P1739, DOI 10.1084/jem.188.9.1739	50	72	86	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4473	4483		10.1074/jbc.M806010200	http://dx.doi.org/10.1074/jbc.M806010200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19095643	Green Published, hybrid			2022-12-25	WOS:000263134400047
J	van Brummelen, AC; Olszewski, KL; Wilinski, D; Llinas, M; Louw, AI; Birkholtz, LM				van Brummelen, Anna C.; Olszewski, Kellen L.; Wilinski, Daniel; Llinas, Manuel; Louw, Abraham I.; Birkholtz, Lyn-Marie			Co-inhibition of Plasmodium falciparum S-Adenosylmethionine Decarboxylase/Ornithine Decarboxylase Reveals Perturbation-specific Compensatory Mechanisms by Transcriptome, Proteome, and Metabolome Analyses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRUCEI-RHODESIENSE INFECTIONS; HUMAN MALARIA; GENE-EXPRESSION; ORNITHINE-DECARBOXYLASE; LYSINE DECARBOXYLASE; BIOSYNTHETIC-ENZYMES; HUMAN-ERYTHROCYTES; CELL-GROWTH; IN-VITRO; POLYAMINES	Polyamines are ubiquitous components of all living cells, and their depletion usually causes cytostasis, a strategy employed for treatment of West African trypanosomiasis. To evaluate polyamine depletion as an anti-malarial strategy, cytostasis caused by the co-inhibition of S-adenosylmethionine decarboxylase/ ornithine decarboxylase in Plasmodium falciparum was studied with a comprehensive transcriptome, proteome, and metabolome investigation. Highly synchronized cultures were sampled just before and during cytostasis, and a novel zero time point definition was used to enable interpretation of results in lieu of the developmentally regulated control of gene expression in P. falciparum. Transcriptome analysis revealed the occurrence of a generalized transcriptional arrest just prior to the growth arrest due to polyamine depletion. However, the abundance of 538 transcripts was differentially affected and included three perturbation-specific compensatory transcriptional responses as follows: the increased abundance of the transcripts for lysine decarboxylase and ornithine aminotransferase and the decreased abundance of that for S-adenosylmethionine synthetase. Moreover, the latter two compensatory mechanisms were confirmed on both protein and metabolite levels confirming their biological relevance. In contrast with previous reports, the results provide evidence that P. falciparum responds to alleviate the detrimental effects of polyamine depletion via regulation of its transcriptome and subsequently the proteome and metabolome.	[van Brummelen, Anna C.; Louw, Abraham I.; Birkholtz, Lyn-Marie] Univ Pretoria, Dept Biochem, ZA-0002 Gauteng, South Africa; [Olszewski, Kellen L.; Wilinski, Daniel; Llinas, Manuel] Princeton Univ, Dept Mol Biol, Lewis Sigler Inst Integrat Gen, Princeton, NJ 08544 USA	University of Pretoria; Princeton University	Birkholtz, LM (corresponding author), Univ Pretoria, Dept Biochem, Lynwood Rd, ZA-0002 Pretoria, South Africa.	lbirkholtz@up.ac.za	Louw, Abraham I/A-5726-2008; Birkholtz, Lyn-Marie/E-2939-2010; Birkholtz, Lyn-Marie/AAF-8481-2019	Birkholtz, Lyn-Marie/0000-0001-5888-2905; Birkholtz, Lyn-Marie/0000-0001-5888-2905; Louw, Abraham/0000-0002-8036-1513	National Research Foundation [FA2004051300055, TTK2006061500031]; Prestigious Bursary; South African Malaria Initiative; University of Pretoria; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER	National Research Foundation; Prestigious Bursary; South African Malaria Initiative; University of Pretoria; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Research Foundation Grant FA2004051300055, Thuthuka TTK2006061500031, and Prestigious Bursary (to A. C. v. B.), the South African Malaria Initiative, and the University of Pretoria. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alm K, 1999, J CELL BIOCHEM, V75, P46, DOI 10.1002/(SICI)1097-4644(19991001)75:1<46::AID-JCB5>3.3.CO;2-E; ASSARAF YG, 1984, BIOCHEM J, V222, P815, DOI 10.1042/bj2220815; ASSARAF YG, 1987, PARASITOL RES, V73, P313, DOI 10.1007/BF00531084; BACCHI CJ, 1992, ANTIMICROB AGENTS CH, V36, P2736, DOI 10.1128/AAC.36.12.2736; Bajad SU, 2006, J CHROMATOGR A, V1125, P76, DOI 10.1016/j.chroma.2006.05.019; Birkholtz L, 2008, ACTA TROP, V105, P113, DOI 10.1016/j.actatropica.2007.10.013; BITONTI AJ, 1987, EXP PARASITOL, V64, P237, DOI 10.1016/0014-4894(87)90148-2; BITONTI AJ, 1989, P NATL ACAD SCI USA, V86, P651, DOI 10.1073/pnas.86.2.651; BITONTI AJ, 1990, ANTIMICROB AGENTS CH, V34, P1485, DOI 10.1128/AAC.34.8.1485; Boshoff HIM, 2006, MICROBES INFECT, V8, P1654, DOI 10.1016/j.micinf.2005.11.018; Boshoff HIM, 2004, J BIOL CHEM, V279, P40174, DOI 10.1074/jbc.M406796200; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Bozdech Z, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r9; BYERS TL, 1991, BIOCHEM J, V274, P527, DOI 10.1042/bj2740527; Clark K, 2008, BIOL CHEM, V389, P111, DOI 10.1515/BC.2008.014; Coulson RMR, 2004, GENOME RES, V14, P1548, DOI 10.1101/gr.2218604; Cui L, 2008, EUKARYOT CELL, V7, P1200, DOI 10.1128/EC.00063-08; Dahl EL, 2006, ANTIMICROB AGENTS CH, V50, P3124, DOI 10.1128/AAC.00394-06; Das Gupta R, 2005, ANTIMICROB AGENTS CH, V49, P2857, DOI 10.1128/AAC.49.7.2857-2864.2005; Date SV, 2006, GENOME RES, V16, P542, DOI 10.1101/gr.4573206; De Silva EK, 2008, P NATL ACAD SCI USA, V105, P8393, DOI 10.1073/pnas.0801993105; Deitsch K, 2007, AM J TROP MED HYG, V77, P201; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Efferth T, 2006, MOL CANCER THER, V5, P1986, DOI 10.1158/1535-7163.MCT-06-0086; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fang J, 2004, MOL BIOCHEM PARASIT, V133, P125, DOI 10.1016/j.molbiopara.2003.09.004; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gunasekera AM, 2003, MOL MICROBIOL, V50, P1229, DOI 10.1046/j.1365-2958.2003.03787.x; Gunasekera AM, 2007, EXP PARASITOL, V117, P87, DOI 10.1016/j.exppara.2007.03.001; Haider N, 2005, MOL BIOCHEM PARASIT, V142, P224, DOI 10.1016/j.molbiopara.2005.04.004; HEBY O, 1981, DIFFERENTIATION, V19, P1, DOI 10.1111/j.1432-0436.1981.tb01123.x; ICEKSON I, 1986, PLANT PHYSIOL, V82, P607, DOI 10.1104/pp.82.2.607; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; Johnsson A, 2005, ANTICANCER RES, V25, P2661; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Le Roch K, 2005, MOLECULAR APPROACHES TO MALARIA, P68; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517; Lu WY, 2006, J AM SOC MASS SPECTR, V17, P37, DOI 10.1016/j.jasms.2005.09.001; Mair GR, 2006, SCIENCE, V313, P667, DOI 10.1126/science.1125129; Makanga M, 2005, PROTEOMICS, V5, P1849, DOI 10.1002/pmic.200401076; Muller IB, 2008, MOL BIOCHEM PARASIT, V160, P1, DOI 10.1016/j.molbiopara.2008.03.008; Muller S, 2000, J BIOL CHEM, V275, P8097, DOI 10.1074/jbc.275.11.8097; MUSCARI C, 1995, MOL CELL BIOCHEM, V144, P125, DOI 10.1007/BF00944391; Natalang O, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-388; Nemoto T, 2001, BIOCHEM BIOPH RES CO, V280, P848, DOI 10.1006/bbrc.2000.4227; Nirmalan N, 2004, MOL MICROBIOL, V52, P1187, DOI 10.1111/j.1365-2958.2004.04049.x; Nirmalan N, 2002, MOL MICROBIOL, V46, P179, DOI 10.1046/j.1365-2958.2002.03148.x; Oakley MSM, 2007, INFECT IMMUN, V75, P2012, DOI 10.1128/IAI.01236-06; ODEN KL, 1983, BIOCHEMISTRY-US, V22, P2978, DOI 10.1021/bi00281a030; Reguera RM, 2005, COMP BIOCHEM PHYS C, V140, P151, DOI 10.1016/j.cca.2005.02.006; SANDMEIER E, 1994, EUR J BIOCHEM, V221, P997, DOI 10.1111/j.1432-1033.1994.tb18816.x; Seiler N, 2005, J CELL MOL MED, V9, P623, DOI 10.1111/j.1582-4934.2005.tb00493.x; Seiler N, 2003, CURR DRUG TARGETS, V4, P537, DOI 10.2174/1389450033490885; SHAPIRO T, 2006, GOODMAN GILMANS PHAR, P1053; Shock JL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r134; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stoeckert CJ, 2006, TRENDS PARASITOL, V22, P543, DOI 10.1016/j.pt.2006.09.005; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; TADOLINI B, 1988, BIOCHEM J, V249, P33, DOI 10.1042/bj2490033; Takatsuka Y, 2000, J BACTERIOL, V182, P6732, DOI 10.1128/JB.182.23.6732-6741.2000; Teng RW, 2009, NMR BIOMED, V22, P292, DOI 10.1002/nbm.1323; Thomas T, 2001, CELL MOL LIFE SCI, V58, P244, DOI 10.1007/PL00000852; Tkachenko AG, 2003, BIOCHEMISTRY-MOSCOW+, V68, P850, DOI 10.1023/A:1025790729797; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Ueda M, 1998, INVEST OPHTH VIS SCI, V39, P820; Wallace HM, 2003, BIOCHEM J, V376, P1, DOI 10.1042/BJ20031327; WRIGHT PS, 1991, BIOCHEM PHARMACOL, V41, P1713, DOI 10.1016/0006-2952(91)90174-4; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Yang YH, 2005, STAT BIOL HEALTH, P49; Yeh I, 2006, MINI-REV MED CHEM, V6, P177, DOI 10.2174/138955706775475957; Yoshida M, 2004, J BIOL CHEM, V279, P46008, DOI 10.1074/jbc.M404393200; Young JA, 2005, PHARMACOGENOMICS, V6, P17, DOI 10.1517/14622416.6.1.17	75	53	53	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4635	4646		10.1074/jbc.M807085200	http://dx.doi.org/10.1074/jbc.M807085200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19073607	Green Published, hybrid			2022-12-25	WOS:000263134400063
J	Takahashi, K; Yoshina, S; Masashi, M; Ito, W; Inoue, T; Shiwaku, H; Arai, H; Mitani, S; Okazawa, H				Takahashi, Keiko; Yoshina, Sawako; Masashi, Maekawa; Ito, Wakana; Inoue, Takao; Shiwaku, Hiroki; Arai, Hiroyuki; Mitani, Shohei; Okazawa, Hitoshi			Nematode Homologue of PQBP1, a Mental Retardation Causative Gene, Is Involved in Lipid Metabolism	PLOS ONE			English	Article							POLYGLUTAMINE TRACT-BINDING; RENPENNING SYNDROME; MUTATIONS; ELEGANS; PROTEIN; TRANSCRIPTION; PGC-1-ALPHA; HUNTINGTIN; FAMILIES; SYSTEM	Background: PQBP1 is a causative gene for X-linked mental retardation (MR) whose patients frequently show lean body. C. elegans has a strictly conserved homologue gene of PQBP1, T21D12.3. Methodology and Principal Findings: We generated Venus-transgenic and T21D12.3-mutant nematodes to analyze developmental expression patterns and in vivo functions of the nematode PQBP1 homologue protein (pqbp-1.1). During development, pqbp-1.1 is expressed from cell proliferation stage to larva stage. In larva, intestinal cells show the highest expression of pqbp-1.1, while it decreases in adult worms. The mutants of pqbp-1.1 show a decrease of the lipid content in intestinal cells. Especially, incorporation of fatty acid into triglyceride is impaired. ShRNA-mediated repression of PQBP1 also leads to reduction of lipid content in mammalian primary white adipocytes. Conclusion/Significance: These results suggest that pqbp-1.1 is involved in lipid metabolism of intestinal cells. Dysfunction of lipid metabolism might underlie lean body, one of the most frequent symptoms associating with PQBP1-linked MR patients.	[Ito, Wakana; Shiwaku, Hiroki; Okazawa, Hitoshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Neuropathol, Tokyo, Japan; [Takahashi, Keiko; Yoshina, Sawako; Mitani, Shohei] Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo, Japan; [Masashi, Maekawa; Inoue, Takao; Arai, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Hlth Chem, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Women's Medical University; University of Tokyo	Takahashi, K (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Neuropathol, Tokyo, Japan.	okazawa-tky@umin.ac.jp		Shiwaku, Hiroki/0000-0001-7503-8044	Japan Science Technology Agency (PRESTO, JST, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan [16390249, 16650076, 18390254, 18650097, 17025017, 18023014, 20023011]	Japan Science Technology Agency (PRESTO, JST, Japan)(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants to H.O. from Japan Science Technology Agency (PRESTO, JST, Japan) and from Ministry of Education, Culture, Sports, Science and Technology of Japan (16390249, 16650076, 18390254, 18650097, Research on Pathomechanisms of Brain Disorders: 17025017, 18023014, 20023011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Ashrafi Kaveh, 2007, WormBook, P1; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Busch A, 2003, J BIOL CHEM, V278, P41452, DOI 10.1074/jbc.M303354200; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; de Brouwer APM, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9482; Gengyo-Ando K, 2000, BIOCHEM BIOPH RES CO, V269, P64, DOI 10.1006/bbrc.2000.2260; Gengyo-Ando K, 2006, BIOCHEM BIOPH RES CO, V349, P1345, DOI 10.1016/j.bbrc.2006.08.183; Kalscheuer VM, 2003, NAT GENET, V35, P313, DOI 10.1038/ng1264; Kleefstra T, 2004, CLIN GENET, V66, P318, DOI 10.1111/j.1399-0004.2004.00308.x; Komuro A, 1999, J BIOL CHEM, V274, P36513, DOI 10.1074/jbc.274.51.36513; Lee HC, 2008, MOL BIOL CELL, V19, P1174, DOI 10.1091/mbc.E07-09-0893; Lenski C, 2004, AM J HUM GENET, V74, P777, DOI 10.1086/383205; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; NISHINO N, 2008, J CLIN INVEST; Okazawa H, 2001, BRAIN RES BULL, V56, P273, DOI 10.1016/S0361-9230(01)00579-2; Okazawa H, 2002, NEURON, V34, P701, DOI 10.1016/S0896-6273(02)00697-9; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Puri V, 2008, P NATL ACAD SCI USA, V105, P7833, DOI 10.1073/pnas.0802063105; Qi YL, 2005, EUR J NEUROSCI, V22, P1277, DOI 10.1111/j.1460-9568.2005.04339.x; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Stevenson RE, 2005, AM J MED GENET A, V134A, P415, DOI 10.1002/ajmg.a.30664; Waragai M, 1999, HUM MOL GENET, V8, P977, DOI 10.1093/hmg/8.6.977; Waragai M, 2000, BIOCHEM BIOPH RES CO, V273, P592, DOI 10.1006/bbrc.2000.2992; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Yoshimura N, 2006, FEBS LETT, V580, P2335, DOI 10.1016/j.febslet.2006.03.056; Zhang YZ, 2000, GENE, V257, P33, DOI 10.1016/S0378-1119(00)00372-3	29	17	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2009	4	1							e4104	10.1371/journal.pone.0004104	http://dx.doi.org/10.1371/journal.pone.0004104			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FR	19119319	Green Submitted, gold, Green Published			2022-12-25	WOS:000265472600006
J	Al Mahmud, A; Amore, G; Bernardi, G				Al Mahmud, Abdullah; Amore, Gabriele; Bernardi, Giorgio			Compositional Genome Contexts Affect Gene Expression Control in Sea Urchin Embryo	PLOS ONE			English	Article							INTEGRATION; VIRUS	Gene expression is widely perceived as exclusively controlled by the information contained in cis-regulatory regions. These are built in a modular way, each module being a cluster of binding sites for the transcription factors that control the level, the location and the time at which gene transcription takes place. On the other hand, results from our laboratory have shown that gene expression is affected by the compositional properties (GC levels) of the isochores in which genes are embedded, i.e. the genome context. To clarify how compositional genomic properties affect the way cis-regulatory information is utilized, we have changed the genome context of a GFP-reporter gene containing the complete cis-regulatory region of the gene spdeadringer (spdri), expressed during sea urchin embryogenesis. We have observed that GC levels higher or lower than those found in the natural genome context can alter the reporter expression pattern. We explain this as the result of an interference with the functionality of specific modules in the gene's cis-regulatory region. From these observations we derive the notion that the compositional properties of the genome context can affect cis-regulatory control of gene expression. Therefore although the way a gene works depends on the information contained in its cis-regulatory region, availability of such information depends on the compositional properties of the genomic context.	[Al Mahmud, Abdullah; Amore, Gabriele; Bernardi, Giorgio] Stn Zool A Dohrn, I-80121 Naples, Italy	Stazione Zoologica Anton Dohrn di Napoli	Al Mahmud, A (corresponding author), Stn Zool A Dohrn, I-80121 Naples, Italy.	gabriele.amore@szn.it	Bernardi, Giorgio/G-1639-2011		MIRG [036543]	MIRG	This work was funded in part with a MIRG 036543 Grant, FP6th. The funders had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Amore G, 2006, DEV BIOL, V293, P555, DOI 10.1016/j.ydbio.2006.02.024; Arhondakis S, 2008, BIOCHEM BIOPH RES CO, V367, P542, DOI 10.1016/j.bbrc.2007.12.155; Bernardi G., 2004, STRUCTURAL EVOLUTION; Bernardi G, 2007, P NATL ACAD SCI USA, V104, P8385, DOI 10.1073/pnas.0701652104; Cameron RA, 2004, GENE EXPR PATTERNS, V4, P205, DOI 10.1016/j.modgep.2003.08.007; Davidson EH, 2006, REG GEN GEN REG; DESARIO A, 1995, NUCLEIC ACIDS RES, V23, P4013, DOI 10.1093/nar/23.19.4013; MAHMUD A, 2008, DEV BIOL; MCMAHON AP, 1985, DEV BIOL, V108, P420, DOI 10.1016/0012-1606(85)90045-4; OHNO S, 1972, BROOKHAVEN SYM BIOL, P366; Rizzo F, 2006, DEV BIOL, V300, P35, DOI 10.1016/j.ydbio.2006.08.012; RYNDITCH A, 1991, GENE, V106, P165, DOI 10.1016/0378-1119(91)90196-I; Rynditch AV, 1998, GENE, V222, P1, DOI 10.1016/S0378-1119(98)00451-X; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; ZERIAL M, 1986, NUCLEIC ACIDS RES, V14, P8373, DOI 10.1093/nar/14.21.8373; ZOUBAK B, 1994, GENE, V143, P155	16	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2008	3	12							e4025	10.1371/journal.pone.0004025	http://dx.doi.org/10.1371/journal.pone.0004025			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DI	19112499	Green Published, gold, Green Submitted			2022-12-25	WOS:000265466000002
J	Zarse, K; Ristow, M				Zarse, Kim; Ristow, Michael			Antidepressants of the Serotonin-Antagonist Type Increase Body Fat and Decrease Lifespan of Adult Caenorhabditis elegans	PLOS ONE			English	Article							DIETARY RESTRICTION; STRESS RESISTANCE; OXIDATIVE STRESS; BACTERIAL DEPRIVATION; EXTENDS; RESVERATROL; LONGEVITY; SURVIVAL; GENES; ACID	It was recently suggested that specific antidepressants of the serotonin-antagonist type, namely mianserin and methiothepin, may exert anti-aging properties and specifically extend lifespan of the nematode C. elegans by causing a state of perceived calorie restriction (Petrascheck M, Ye X, Buck LB: An antidepressant that extends lifespan in adult Caenorhabditis elegans; Nature, Nov 22, 2007; 450( 7169): 553-6, PMID 18033297). Using the same model organism, we instead observe a reduction of life expectancy when employing the commonly used, standardized agar-based solid-phase assay while applying the same or lower concentrations of the same antidepressants. Consistent with a well-known sideeffect of these compounds in humans, antidepressants not only reduced lifespan but also increased body fat accumulation in C. elegans reflecting the mammalian phenotype. Taken together and in conflict with previously published findings, we find that antidepressants of the serotonin-antagonist type not only promote obesity, but also decrease nematode lifespan.	[Ristow, Michael] Univ Jena, Inst Nutr, Jena, Germany; [Ristow, Michael] German Inst Human Nutr, Potsdam, Germany	Friedrich Schiller University of Jena; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Zarse, K (corresponding author), Univ Jena, Inst Nutr, Jena, Germany.	mristow@mristow.org	Sanguansri, Luz/B-6630-2011; Ristow, Michael/O-9858-2014; Zarse, Kim/D-2133-2016	Sanguansri, Luz/0000-0003-1908-7604; Ristow, Michael/0000-0003-2109-2453; Zarse, Kim/0000-0003-2542-6123				Adachi H, 2000, J GERONTOL A-BIOL, V55, pB280, DOI 10.1093/gerona/55.6.B280; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Bakaev V., 2002, BIOGERONTOLOGY S1, V3, P23; Bakaev V. V., 2002, BIOGERONTOLOGY S1, V3, P12; Bass TM, 2007, MECH AGEING DEV, V128, P546, DOI 10.1016/j.mad.2007.07.007; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Benedetti MG, 2008, EXP GERONTOL, V43, P882, DOI 10.1016/j.exger.2008.08.049; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNER S, 1974, GENETICS, V77, P71; Broue F, 2007, AGING CELL, V6, P87, DOI 10.1111/j.1474-9726.2006.00268.x; Brown MK, 2006, PHARMACOL BIOCHEM BE, V85, P620, DOI 10.1016/j.pbb.2006.10.017; Castelein Natascha, 2008, Biotechnology Journal, V3, P803, DOI 10.1002/biot.200800003; CROLL N A, 1977, Experimental Aging Research, V3, P175, DOI 10.1080/03610737708257101; Cypser JR, 2002, J GERONTOL A-BIOL, V57, pB109, DOI 10.1093/gerona/57.3.B109; Evason K, 2005, SCIENCE, V307, P258, DOI 10.1126/science.1105299; Evason K, 2008, AGING CELL, V7, P305, DOI 10.1111/j.1474-9726.2008.00375.x; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Gerisch B, 2007, P NATL ACAD SCI USA, V104, P5014, DOI 10.1073/pnas.0700847104; Gruber J, 2007, ANN NY ACAD SCI, V1100, P530, DOI 10.1196/annals.1395.059; HARRINGTON LA, 1988, MECH AGEING DEV, V43, P71, DOI 10.1016/0047-6374(88)90098-X; HARRIS B, 1980, LANCET, V1, P590; Houthoofd K, 2002, EXP GERONTOL, V37, P1371, DOI 10.1016/S0531-5565(02)00173-0; Ishii N, 2004, MECH AGEING DEV, V125, P41, DOI 10.1016/j.mad.2003.10.002; Johnson TE, 2001, EXP GERONTOL, V36, P1609, DOI 10.1016/S0531-5565(01)00144-9; Kampkotter A, 2007, ARCH TOXICOL, V81, P849, DOI 10.1007/s00204-007-0215-4; Kampkotter A, 2008, COMP BIOCHEM PHYS B, V149, P314, DOI 10.1016/j.cbpb.2007.10.004; Keaney M, 2003, FREE RADICAL BIO MED, V34, P277, DOI 10.1016/S0891-5849(02)01290-X; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kim J, 2008, MECH AGEING DEV, V129, P322, DOI 10.1016/j.mad.2008.02.011; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kornfeld K, 2006, ARCH NEUROL-CHICAGO, V63, P491, DOI 10.1001/archneur.63.4.491; Lenaerts I, 2008, J GERONTOL A-BIOL, V63, P242, DOI 10.1093/gerona/63.3.242; Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567; Miller DL, 2007, P NATL ACAD SCI USA, V104, P20618, DOI 10.1073/pnas.0710191104; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Petrascheck M, 2007, NATURE, V450, P553, DOI 10.1038/nature05991; PINDER RM, 1980, INT PHARMACOPSYCHIAT, V15, P218, DOI 10.1159/000468441; Ristow M, 2000, P NATL ACAD SCI USA, V97, P12239, DOI 10.1073/pnas.220403797; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Shook DR, 1999, GENETICS, V153, P1233; Smith ED, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-49; Strayer A, 2003, FASEB J, V17, P2305, DOI 10.1096/fj.03-0376fje; Sutphin GL, 2008, EXP GERONTOL, V43, P130, DOI 10.1016/j.exger.2007.10.019; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017; WIEGANT FA, 2008, BIOGERONTOL IN PRESS; Wilson MA, 2006, AGING CELL, V5, P59, DOI 10.1111/j.1474-9726.2006.00192.x; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Wu ZX, 2002, CELL MOL BIOL, V48, P725; Zarse K, 2007, FASEB J, V21, P1271, DOI 10.1096/fj.06-6994com; Zou SG, 2007, MECH AGEING DEV, V128, P222, DOI 10.1016/j.mad.2006.11.026	51	26	27	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2008	3	12							e4062	10.1371/journal.pone.0004062	http://dx.doi.org/10.1371/journal.pone.0004062			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437DI	19112515	Green Submitted, Green Published, gold			2022-12-25	WOS:000265466000019
J	Staiger, H; Machicao, F; Schafer, SA; Kirchhoff, K; Kantartzis, K; Guthoff, M; Silbernagel, G; Stefan, N; Haring, HU; Fritsche, A				Staiger, Harald; Machicao, Fausto; Schaefer, Silke A.; Kirchhoff, Kerstin; Kantartzis, Konstantinos; Guthoff, Martina; Silbernagel, Guenther; Stefan, Norbert; Haering, Hans-Ulrich; Fritsche, Andreas			Polymorphisms within the Novel Type 2 Diabetes Risk Locus MTNR1B Determine beta-Cell Function	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INSULIN-SECRETION; COMMON VARIANTS; SUSCEPTIBILITY LOCI; FASTING GLUCOSE; MELATONIN; RELEASE; HHEX; GENE; RECEPTOR	Background: Very recently, a novel type 2 diabetes risk gene, i.e., MTNR1B, was identified and reported to affect fasting glycemia. Using our thoroughly phenotyped cohort of subjects at an increased risk for type 2 diabetes, we assessed the association of common genetic variation within the MTNR1B locus with obesity and prediabetes traits, namely impaired insulin secretion and insulin resistance. Methodology/Principal Findings: We genotyped 1,578 non-diabetic subjects, metabolically characterized by oral glucose tolerance test, for five tagging single nucleotide polymorphisms (SNPs) covering 100% of common genetic variation (minor allele frequency >0.05) within the MTNR1B locus (rs10830962, rs4753426, rs12804291, rs10830963, rs3781638). In a subgroup (N = 513), insulin sensitivity was assessed by hyperinsulinemic-euglycemic clamp, and in a further subgroup (N = 301), glucose-stimulated insulin secretion was determined by intravenous glucose tolerance test. After appropriate adjustment for confounding variables and Bonferroni correction for multiple comparisons, none of the tagging SNPs was reliably associated with measures of adiposity. SNPs rs10830962, rs4753426, and rs10830963 were significantly associated with higher fasting plasma glucose concentrations (p<0.0001) and reduced OGTT- and IVGTT-induced insulin release (p <= 0.0007 and p <= 0.01, respectively). By contrast, SNP rs3781638 displayed significant association with lower fasting plasma glucose levels and increased OGTT-induced insulin release (p<0.0001 and p <= 0.0002, respectively). Moreover, SNP rs3781638 revealed significant association with elevated fasting-and OGTT-derived insulin sensitivity (p <= 0.0021). None of the MTNR1B tagging SNPs altered proinsulin-to-insulin conversion. Conclusions/Significance: In conclusion, common genetic variation within MTNR1B determines glucose-stimulated insulin secretion and plasma glucose concentrations. Their impact on beta-cell function might represent the prevailing pathomechanism how MTNR1B variants increase the type 2 diabetes risk.	[Staiger, Harald; Machicao, Fausto; Schaefer, Silke A.; Kirchhoff, Kerstin; Kantartzis, Konstantinos; Guthoff, Martina; Silbernagel, Guenther; Stefan, Norbert; Haering, Hans-Ulrich; Fritsche, Andreas] Univ Tubingen Hosp, Div Endocrinol Diabetol Angiol Nephrol & Clin Che, Dept Internal Med, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Staiger, H (corresponding author), Univ Tubingen Hosp, Div Endocrinol Diabetol Angiol Nephrol & Clin Che, Dept Internal Med, Tubingen, Germany.	hans-ulrich.haering@med.uni-tuebingen.de	Kantartzis, Konstantinos/AAC-3999-2019; Staiger, Harald/N-5871-2014; Guthoff, Martina/D-3960-2018	Guthoff, Martina/0000-0002-4294-980X; Staiger, Harald/0000-0002-9507-5333; Silbernagel, Guenther/0000-0001-9323-329X; Stefan, Norbert/0000-0002-2186-9595; Kantartzis, Konstantinos/0000-0002-0584-1138	German Research Foundation [KFO 114/2]	German Research Foundation(German Research Foundation (DFG))	The study was supported by a grant from the German Research Foundation (KFO 114/2). The funding organisation is a non-profit organisation and was not involved in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Boesgaard TW, 2008, DIABETOLOGIA, V51, P816, DOI 10.1007/s00125-008-0955-6; Carter KW, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-60; de Sousa AGP, 2008, OBES REV, V9, P340, DOI 10.1111/j.1467-789X.2008.00478.x; Duesing K, 2008, DIABETOLOGIA, V51, P821, DOI 10.1007/s00125-008-0973-4; Furukawa Y, 2008, J CLIN ENDOCR METAB, V93, P310, DOI 10.1210/jc.2007-1029; Grarup N, 2007, DIABETES, V56, P3105, DOI 10.2337/db07-0856; Hertel JK, 2008, DIABETOLOGIA, V51, P971, DOI 10.1007/s00125-008-0982-3; Horikoshi M, 2007, DIABETOLOGIA, V50, P2461, DOI 10.1007/s00125-007-0827-5; *INT HAPMAP PROJ, NATURE, V426, P789; Kashyap Sangeeta R, 2007, Diab Vasc Dis Res, V4, P13, DOI 10.3132/dvdr.2007.001; Kemp DM, 2002, MOL CELL ENDOCRINOL, V191, P157, DOI 10.1016/S0303-7207(02)00064-3; Kirchhoff K, 2008, DIABETOLOGIA, V51, P597, DOI 10.1007/s00125-008-0926-y; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Mori S, 2008, DIABETES, V57, P791, DOI 10.2337/db07-0979; Muhlbauer E, 2007, J PINEAL RES, V42, P105, DOI 10.1111/j.1600-079X.2006.00399.x; Palmer ND, 2008, DIABETES, V57, P1093, DOI 10.2337/db07-1169; Pascoe L, 2007, DIABETES, V56, P3101, DOI 10.2337/db07-0634; Peschke E, 2002, J PINEAL RES, V33, P63, DOI 10.1034/j.1600-079X.2002.02919.x; Picinato MC, 2002, J PINEAL RES, V33, P156, DOI 10.1034/j.1600-079X.2002.02903.x; Prokopenko I, 2008, DIABETOLOGIA, V51, pS11; REPPERT SM, 1995, P NATL ACAD SCI USA, V92, P8734, DOI 10.1073/pnas.92.19.8734; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schafer SA, 2007, DIABETOLOGIA, V50, P2443, DOI 10.1007/s00125-007-0753-6; Schulze MB, 2007, DIABETOLOGIA, V50, P2405, DOI 10.1007/s00125-007-0766-1; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Staiger H, 2008, DIABETES, V57, P514, DOI 10.2337/db07-1254; Staiger H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000832; Staiger H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003019; Stancakova A, 2008, J CLIN ENDOCR METAB, V93, P1924, DOI 10.1210/jc.2007-2218; Stumpf I, 2008, J PINEAL RES, V45, P318, DOI 10.1111/j.1600-079X.2008.00593.x; Stumvoll M, 2000, DIABETES CARE, V23, P295, DOI 10.2337/diacare.23.3.295; Tripathy D, 2003, DIABETES CARE, V26, P1395, DOI 10.2337/diacare.26.5.1395; van Vliet-Ostaptchouk JV, 2008, EUR J HUM GENET, V16, P652, DOI 10.1038/sj.ejhg.5202008; Watanabe RM, 2008, DIABETES, V57, pA42; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	38	93	97	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2008	3	12							e3962	10.1371/journal.pone.0003962	http://dx.doi.org/10.1371/journal.pone.0003962			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AS	19088850	gold, Green Submitted, Green Published			2022-12-25	WOS:000265458500008
J	Kempa, S; Krasensky, J; Dal Santo, S; Kopka, J; Jonak, C				Kempa, Stefan; Krasensky, Julia; Dal Santo, Silvia; Kopka, Joachim; Jonak, Claudia			A Central Role of Abscisic Acid in Stress-Regulated Carbohydrate Metabolism	PLOS ONE			English	Article								Background: Abiotic stresses adversely affect plant growth and development. The hormone abscisic acid (ABA) plays a central role in the response and adaptation to environmental constraints. However, apart from the well established role of ABA in regulating gene expression programmes, little is known about its function in plant stress metabolism. Principal Findings: Using an integrative multiparallel approach of metabolome and transcriptome analyses, we studied the dynamic response of the model glyophyte Arabidopsis thaliana to ABA and high salt conditions. Our work shows that salt stress induces complex re-adjustment of carbohydrate metabolism and that ABA triggers the initial steps of carbon mobilisation. Significance: These findings open new perspectives on how high salinity and ABA impact on central carbohydrate metabolism and highlight the power of iterative combinatorial approaches of non-targeted and hypothesis-driven experiments in stress biology.	[Kempa, Stefan; Krasensky, Julia; Dal Santo, Silvia; Jonak, Claudia] Austrian Acad Sci, Gregor Mendel Inst Mol Plant Biol, A-1010 Vienna, Austria; [Kopka, Joachim] Max Plank Inst Mol Plant Physiol, Golm, Germany	Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI); Max Planck Society	Kempa, S (corresponding author), Max Plank Inst Mol Plant Physiol, Golm, Germany.	claudia.jonak@gmi.oeaw.ac.at	Jonak, Claudia/G-1362-2016; kempa, stefan/C-5213-2008	kempa, stefan/0000-0002-0696-9299; Krasensky-Wrzaczek, Julia/0000-0002-5989-9984; Dal Santo, Silvia/0000-0001-5012-1140; Kopka, Joachim/0000-0001-9675-4883; Jonak, Claudia/0000-0001-9605-6751	Austrian Science Fund; Vienna Science and Technology Fund; GEN-AU	Austrian Science Fund(Austrian Science Fund (FWF)); Vienna Science and Technology Fund; GEN-AU	This work was supported by the Austrian Science Fund (FWF), the Vienna Science and Technology Fund (WWTF) and GEN-AU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2003, PLANT MOL BIOL, V51, P363, DOI 10.1023/A:1022043000516; Bouche N, 2004, TRENDS PLANT SCI, V9, P110, DOI 10.1016/j.tplants.2004.01.006; Bown AW, 2006, TRENDS PLANT SCI, V11, P424, DOI 10.1016/j.tplants.2006.07.002; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; BRANCOPRICE C, 2008, PLANT J; Brosche M, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r101; Bruzzone S, 2007, P NATL ACAD SCI USA, V104, P5759, DOI 10.1073/pnas.0609379104; Chen THH, 2002, CURR OPIN PLANT BIOL, V5, P250, DOI 10.1016/S1369-5266(02)00255-8; Christmann A, 2006, PLANT BIOLOGY, V8, P314, DOI 10.1055/s-2006-924120; Cook D, 2004, P NATL ACAD SCI USA, V101, P15243, DOI 10.1073/pnas.0406069101; De Smet I, 2006, TRENDS PLANT SCI, V11, P434, DOI 10.1016/j.tplants.2006.07.003; Fait A, 2008, TRENDS PLANT SCI, V13, P14, DOI 10.1016/j.tplants.2007.10.005; Geigenberger P, 1997, PLANTA, V201, P502, DOI 10.1007/s004250050095; Gibon Y, 2004, PLANT CELL, V16, P3304, DOI 10.1105/tpc.104.025973; Goda H, 2008, PLANT J, V55, P526, DOI [10.1111/j.1365-313X.2008.03510.x, 10.1111/j.0960-7412.2008.03510.x]; Gong QQ, 2005, PLANT J, V44, P826, DOI 10.1111/j.1365-313X.2005.02587.x; HANDA S, 1986, PLANT PHYSIOL, V80, P938, DOI 10.1104/pp.80.4.938; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Hirayama T, 2007, TRENDS PLANT SCI, V12, P343, DOI 10.1016/j.tplants.2007.06.013; Kaplan F, 2005, PLANT J, V44, P730, DOI 10.1111/j.1365-313X.2005.02565.x; Kaplan F, 2004, PLANT PHYSIOL, V136, P4159, DOI 10.1104/pp.104.052142; Kaplan F, 2004, PLANT PHYSIOL, V135, P1674, DOI 10.1104/pp.104.040808; Kaplan F, 2007, PLANT J, V50, P967, DOI 10.1111/j.1365-313X.2007.03100.x; Kawasaki S, 2001, PLANT CELL, V13, P889, DOI 10.1105/tpc.13.4.889; Kempa S, 2007, PLANT J, V49, P1076, DOI 10.1111/j.1365-313X.2006.03025.x; Khelil A, 2007, PLANT PHYSIOL BIOCH, V45, P551, DOI 10.1016/j.plaphy.2007.05.003; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Kim JK, 2007, J EXP BOT, V58, P415, DOI 10.1093/jxb/erl216; Kopka J, 2005, BIOINFORMATICS, V21, P1635, DOI 10.1093/bioinformatics/bti236; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Leung J, 1998, ANNU REV PLANT PHYS, V49, P199, DOI 10.1146/annurev.arplant.49.1.199; Liu XG, 2007, SCIENCE, V315, P1712, DOI 10.1126/science.1135882; Lloyd JR, 2005, TRENDS PLANT SCI, V10, P130, DOI 10.1016/j.tplants.2005.01.001; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Nagamune K, 2008, NATURE, V451, P207, DOI 10.1038/nature06478; OPARKA KJ, 1988, PLANTA, V174, P123, DOI 10.1007/BF00394884; Puce S, 2004, J BIOL CHEM, V279, P39783, DOI 10.1074/jbc.M405348200; Razem FA, 2006, NATURE, V439, P290, DOI 10.1038/nature04373; Ruggiero B, 2004, PLANT PHYSIOL, V136, P3134, DOI 10.1104/pp.104.046169; Sanchez DH, 2008, PLANT J, V53, P973, DOI 10.1111/j.1365-313X.2007.03381.x; Scholz M, 2004, BIOINFORMATICS, V20, P2447, DOI 10.1093/bioinformatics/bth270; SCHOLZ M, 2005, NONLINEAR PCA MISSIN; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Shen YY, 2006, NATURE, V443, P823, DOI 10.1038/nature05176; Smith AM, 2005, ANNU REV PLANT BIOL, V56, P73, DOI 10.1146/annurev.arplant.56.032604.144257; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; Tetlow IJ, 2004, J EXP BOT, V55, P2131, DOI 10.1093/jxb/erh248; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Todaka D, 2000, J EXP BOT, V51, P739, DOI 10.1093/jexbot/51.345.739; Usadel B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-535; Valderrama R, 2006, PLANT CELL ENVIRON, V29, P1449, DOI 10.1111/j.1365-3040.2006.01530.x; Wagner C, 2003, PHYTOCHEMISTRY, V62, P887, DOI 10.1016/S0031-9422(02)00703-3; Wasilewska A, 2008, MOL PLANT, V1, P198, DOI 10.1093/mp/ssm022; Weise SE, 2005, PLANT PHYSIOL, V137, P756, DOI 10.1104/pp.104.055996; Xiong LM, 2002, J BIOL CHEM, V277, P8588, DOI 10.1074/jbc.M109275200; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Xiong LM, 2001, PLANT CELL, V13, P2063, DOI 10.1105/tpc.13.9.2063; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730; Yano R, 2005, PLANT PHYSIOL, V138, P837, DOI 10.1104/pp.104.056374; ZENNER R, 1991, PLANT CELL ENVIRON, V14, P939; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0; Zocchi E, 2001, P NATL ACAD SCI USA, V98, P14859, DOI 10.1073/pnas.261448698	63	141	146	8	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2008	3	12							e3935	10.1371/journal.pone.0003935	http://dx.doi.org/10.1371/journal.pone.0003935			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZW	19081841	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000265456300010
J	Sernandez, IV; de Yebenes, VG; Dorsett, Y; Ramiro, AR				Sernandez, Isora V.; de Yebenes, Virginia G.; Dorsett, Yair; Ramiro, Almudena R.			Haploinsufficiency of Activation-Induced Deaminase for Antibody Diversification and Chromosome Translocations both In Vitro and In Vivo	PLOS ONE			English	Article								The humoral immune response critically relies on the secondary diversification of antibodies. This diversification takes places through somatic remodelling of the antibody genes by two molecular mechanisms, Class Switch Recombination (CSR) and Somatic Hypermutation (SHM). The enzyme Activation Induced Cytidine Deaminase (AID) initiates both SHM and CSR by deaminating cytosine residues on the DNA of immunoglobulin genes. While crucial for immunity, AID-catalysed deamination is also the triggering event for the generation of lymphomagenic chromosome translocations. To address whether restricting the levels of AID expression in vivo contributes to the regulation of its function, we analysed mice harbouring a single copy of the AID gene (AID(+/-)). AID(+/-) mice express roughly 50% of normal AID levels, and display a mild hyperplasia, reminiscent of AID deficient mice and humans. Moreover, we found that AID(+/-) cells have an impaired competence for CSR and SHM, which indicates that AID gene dose is limiting for its physiologic function. We next evaluated the impact of AID reduction in AID(+/-) mice on the generation of chromosome translocations. Our results show that the frequency of AID-promoted c-myc/IgH translocations is reduced in AID(+/-) mice, both in vivo and in vitro. Therefore, AID is haploinsufficient for antibody diversification and chromosome translocations. These findings suggest that limiting the physiologic levels of AID expression can be a regulatory mechanism that ensures an optimal balance between immune proficiency and genome integrity.	[Sernandez, Isora V.; de Yebenes, Virginia G.; Ramiro, Almudena R.] Spanish Natl Canc Res Ctr CNIO, DNA Hypermutat & Canc Grp, Madrid, Spain; [Dorsett, Yair] Rockefeller Univ, New York, NY USA	Centro Nacional de Investigaciones Oncologicas (CNIO); Rockefeller University	Sernandez, IV (corresponding author), Spanish Natl Canc Res Ctr CNIO, DNA Hypermutat & Canc Grp, Madrid, Spain.	aramiro@cnio.es	de Yébenes, Virginia/F-3156-2016; Ramiro, Almudena R/H-6037-2015	de Yébenes, Virginia/0000-0002-3785-5868; Ramiro, Almudena R/0000-0002-7539-3844	Comunidad Autonoma de Madrid; CNIO investigator; Ramon y Cajal programe from the Ministerio de Educacion y Ciencia [SAF2007-63130]; European Research Council [BCLYM-207844]	Comunidad Autonoma de Madrid(Comunidad de Madrid); CNIO investigator; Ramon y Cajal programe from the Ministerio de Educacion y Ciencia(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission)	IVS is funded by Comunidad Autonoma de Madrid, VGY is a CNIO investigator and ARR is supported by the Ramon y Cajal programe from the Ministerio de Educacion y Ciencia. This work has been funded by grants from Ministerio de Educacion y Ciencia (SAF2007-63130), Comunidad Autonoma de Madrid (DIFHEMAT-CM) and European Research Council (BCLYM-207844). They have not had any role in the design, implementation, analysis, etc of the analysis.	Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chesi M, 2008, CANCER CELL, V13, P167, DOI 10.1016/j.ccr.2008.01.007; de Yebenes VG, 2008, J EXP MED, V205, P2199, DOI 10.1084/jem.20080579; de Yebenes VG, 2006, TRENDS MOL MED, V12, P432, DOI 10.1016/j.molmed.2006.07.001; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; Dorsett Y, 2008, IMMUNITY, V28, P630, DOI 10.1016/j.immuni.2008.04.002; Dorsett Y, 2007, J EXP MED, V204, P2225, DOI 10.1084/jem.20070884; Durandy A, 2005, IMMUNOL REV, V203, P67, DOI 10.1111/j.0105-2896.2005.00222.x; Imai K, 2005, CLIN IMMUNOL, V115, P277, DOI 10.1016/j.clim.2005.02.003; Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101; Kasahara Y, 2003, J ALLERGY CLIN IMMUN, V112, P755, DOI 10.1016/S0091-6749(03)01860-8; Kotani A, 2007, P NATL ACAD SCI USA, V104, P1616, DOI 10.1073/pnas.0610732104; Kovalchuk AL, 1997, ONCOGENE, V15, P2369, DOI 10.1038/sj.onc.1201409; Kovalchuk AL, 2002, P NATL ACAD SCI USA, V99, P1509, DOI 10.1073/pnas.022643999; Kovalchuk AL, 2007, J EXP MED, V204, P2989, DOI 10.1084/jem.20070882; Kuppers R, 2005, NAT REV CANCER, V5, P251, DOI 10.1038/nrc1589; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; McBride KM, 2008, J EXP MED, V205, P2585, DOI 10.1084/jem.20081319; McBride KM, 2004, J EXP MED, V199, P1235, DOI 10.1084/jem.20040373; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Odegard VH, 2006, NAT REV IMMUNOL, V6, P573, DOI 10.1038/nri1896; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pasqualucci L, 2008, NAT GENET, V40, P108, DOI 10.1038/ng.2007.35; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Petersen-Mahrt SK, 2003, J BIOL CHEM, V278, P19583, DOI 10.1074/jbc.C300114200; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Quartier P, 2004, CLIN IMMUNOL, V110, P22, DOI 10.1016/j.clim.2003.10.007; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Schatz DG, 2004, IMMUNOL REV, V200, P5, DOI 10.1111/j.0105-2896.2004.00173.x; Stavnezer J, 2000, CURR TOP MICROBIOL, V245, P127; Stavnezer J, 1996, ADV IMMUNOL, V61, P79, DOI 10.1016/S0065-2776(08)60866-4; Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964; Takizawa M, 2008, J EXP MED, V205, P1949, DOI 10.1084/jem.20081007; Teng G, 2008, IMMUNITY, V28, P621, DOI 10.1016/j.immuni.2008.03.015; Xue KM, 2006, J EXP MED, V203, P2085, DOI 10.1084/jem.20061067; Zhu Yi, 2003, Journal of Medical and Dental Sciences, V50, P41	46	39	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2008	3	12							e3927	10.1371/journal.pone.0003927	http://dx.doi.org/10.1371/journal.pone.0003927			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZW	19079594	gold, Green Submitted, Green Published			2022-12-25	WOS:000265456300006
J	Field, CB; Johnston, K; Gati, JS; Menon, RS; Everling, S				Field, Courtney B.; Johnston, Kevin; Gati, Joseph S.; Menon, Ravi S.; Everling, Stefan			Connectivity of the Primate Superior Colliculus Mapped by Concurrent Microstimulation and Event-Related fMRI	PLOS ONE			English	Article								Background: Neuroanatomical studies investigating the connectivity of brain areas have heretofore employed procedures in which chemical or viral tracers are injected into an area of interest, and connected areas are subsequently identified using histological techniques. Such experiments require the sacrifice of the animals and do not allow for subsequent electrophysiological studies in the same subjects, rendering a direct investigation of the functional properties of anatomically identified areas impossible. Methodology/Principal Findings: Here, we used a combination of microstimulation and fMRI in an anesthetized monkey preparation to study the connectivity of the superior colliculus (SC). Microstimulation of the SC resulted in changes in the blood oxygenation level-dependent (BOLD) signals in the SC and in several cortical and subcortical areas consistent with the known connectivity of the SC in primates. Conclusions/Significance: These findings demonstrates that the concurrent use of microstimulation and fMRI can be used to identify brain networks for further electrophysiological or fMRI investigation.	[Field, Courtney B.; Everling, Stefan] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Johnston, Kevin; Gati, Joseph S.; Menon, Ravi S.; Everling, Stefan] Robarts Res Inst, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Field, CB (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada.	severlin@uwo.ca	Menon, Ravi S/K-5500-2013; Everling, Stefan/K-5208-2013; Menon, Ravi/ABA-8654-2020; Gati, Joseph S/K-5476-2013; Johnston, Kevin/U-4453-2018; Everling, Stefan/AAR-8687-2020	Menon, Ravi S/0000-0002-7916-0263; Menon, Ravi/0000-0002-7916-0263; Everling, Stefan/0000-0001-9714-9757; Johnston, Kevin/0000-0001-9481-6251	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was funded by the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin VC, 2003, MAGNET RESON MED, V49, P838, DOI 10.1002/mrm.10428; Baker JT, 2006, CEREB CORTEX, V16, P447, DOI 10.1093/cercor/bhi124; Barry RL, 2005, MAGN RESON MED, V54, P411, DOI 10.1002/mrm.20591; Biswal BB, 1997, NMR BIOMED, V10, P165, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<165::AID-NBM454>3.0.CO;2-7; Bohning DE, 1998, INVEST RADIOL, V33, P336, DOI 10.1097/00004424-199806000-00004; Boldogkoi Z, 2004, PROG NEUROBIOL, V72, P417, DOI 10.1016/j.pneurobio.2004.03.010; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; Chouinard PA, 2003, J NEUROPHYSIOL, V90, P1071, DOI 10.1152/jn.01105.2002; CRAPSE TB, 2006, NEUR CONTR MOV M KEY; Dueck MH, 2005, ACTA ANAESTH SCAND, V49, P784, DOI 10.1111/j.1399-6576.2005.00703.x; Ekstrom LB, 2008, SCIENCE, V321, P414, DOI 10.1126/science.1153276; Everling S, 2000, J NEUROSCI, V20, P387, DOI 10.1523/JNEUROSCI.20-01-00387.2000; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Ford KA, 2005, J NEUROPHYSIOL, V94, P429, DOI 10.1152/jn.00471.2004; FRIES W, 1984, J COMP NEUROL, V230, P55, DOI 10.1002/cne.902300106; Funahashi M, 2001, NEUROSCI LETT, V311, P177, DOI 10.1016/S0304-3940(01)02169-3; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Goebel R, 1998, NEUROREPORT, V9, P713, DOI 10.1097/00001756-199803090-00028; Hampson M, 2004, NEUROREPORT, V15, P1315, DOI 10.1097/01.wnr.0000129997.95055.15; Harrison RV, 2002, CEREB CORTEX, V12, P225, DOI 10.1093/cercor/12.3.225; Heeger DJ, 2002, NAT REV NEUROSCI, V3, P142, DOI 10.1038/nrn730; Jech R, 2001, MOVEMENT DISORD, V16, P1126, DOI 10.1002/mds.1217; Johnston K, 2006, J NEUROSCI, V26, P12471, DOI 10.1523/JNEUROSCI.4101-06.2006; Kashiwagi M, 2004, ANESTH ANALG, V99, P49, DOI 10.1213/01.ANE.0000117226.45704.65; Kelly RM, 2000, J NEUROSCI METH, V103, P63, DOI 10.1016/S0165-0270(00)00296-X; Klassen LM, 2004, MAGN RESON MED, V51, P881, DOI 10.1002/mrm.20094; Kobbert C, 2000, PROG NEUROBIOL, V62, P327, DOI 10.1016/S0301-0082(00)00019-8; Koyama M, 2004, NEURON, V41, P795, DOI 10.1016/S0896-6273(04)00047-9; LEICHNETZ GR, 1981, NEUROSCIENCE, V6, P1023, DOI 10.1016/0306-4522(81)90068-3; LIPSKI J, 1981, J NEUROSCI METH, V4, P1, DOI 10.1016/0165-0270(81)90015-7; Lock TM, 2003, EXP BRAIN RES, V151, P455, DOI 10.1007/s00221-003-1500-y; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; LYNCH JC, 1985, J COMP NEUROL, V235, P241, DOI 10.1002/cne.902350207; LYNCH JC, 1994, EXP BRAIN RES, V100, P181; MALACH R, 1993, P NATL ACAD SCI USA, V90, P10469, DOI 10.1073/pnas.90.22.10469; MESULAM MM, 1976, J HISTOCHEM CYTOCHEM, V24, P1281, DOI 10.1177/24.12.826585; Moeller S, 2008, SCIENCE, V320, P1355, DOI 10.1126/science.1157436; Moschovakis AK, 1996, PROG NEUROBIOL, V50, P133, DOI 10.1016/S0301-0082(96)00034-2; Munoz DP, 1998, J NEUROPHYSIOL, V79, P1193, DOI 10.1152/jn.1998.79.3.1193; MUNOZ DP, 1995, J NEUROPHYSIOL, V73, P2313, DOI 10.1152/jn.1995.73.6.2313; MUNOZ DP, 1993, J NEUROPHYSIOL, V70, P576, DOI 10.1152/jn.1993.70.2.576; MUNOZ DP, 1993, J NEUROPHYSIOL, V70, P559, DOI 10.1152/jn.1993.70.2.559; OHSHIMA K, 1981, INVEST UROL, V19, P79; Pare M, 2001, J NEUROPHYSIOL, V85, P2545, DOI 10.1152/jn.2001.85.6.2545; Paus T, 1997, J NEUROSCI, V17, P3178; Paus T, 2001, EUR J NEUROSCI, V14, P1405, DOI 10.1046/j.0953-816x.2001.01757.x; Paxinos G., 2000, RHESUS MONKEY BRAIN; Payne BR, 1999, J NEUROSCI METH, V86, P195, DOI 10.1016/S0165-0270(98)00166-6; Ramnani N, 2004, BIOL PSYCHIAT, V56, P613, DOI 10.1016/j.biopsych.2004.02.004; Robinson D L, 1989, Rev Oculomot Res, V3, P337; Saleem KS, 2002, NEURON, V34, P685, DOI 10.1016/S0896-6273(02)00718-3; Schall JD, 1997, CEREBR CORT, V12, P527; SCHLAG J, 1987, J NEUROPHYSIOL, V57, P179, DOI 10.1152/jn.1987.57.1.179; Schlag J, 1998, J NEUROPHYSIOL, V79, P64, DOI 10.1152/jn.1998.79.1.64; SEGRAVES MA, 1987, J NEUROPHYSIOL, V58, P1387, DOI 10.1152/jn.1987.58.6.1387; Silva AC, 2004, NMR BIOMED, V17, P532, DOI 10.1002/nbm.945; Sommer MA, 2004, J NEUROPHYSIOL, V91, P1381, DOI 10.1152/jn.00738.2003; Steinhausen M, 1997, J PHYSIOL-LONDON, V505, P493, DOI 10.1111/j.1469-7793.1997.493bb.x; Tolias AS, 2005, NEURON, V48, P901, DOI 10.1016/j.neuron.2005.11.034; UNGERLEIDER LG, 1986, J COMP NEUROL, V248, P190, DOI 10.1002/cne.902480204; Vanduffel W, 1997, P NATL ACAD SCI USA, V94, P7617, DOI 10.1073/pnas.94.14.7617; Wang X, 2004, ANESTHESIOLOGY, V100, P1198, DOI 10.1097/00000542-200405000-00023; Wang Y, 2004, NEUROREPORT, V15, P1559, DOI 10.1097/01.wnr.0000133300.62031.9b; Wurtz R. H, 1989, NEUROBIOLOGY SACCADI; Xiong JH, 1999, HUM BRAIN MAPP, V8, P151, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<151::AID-HBM13>3.0.CO;2-5	66	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2008	3	12							e3928	10.1371/journal.pone.0003928	http://dx.doi.org/10.1371/journal.pone.0003928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZU	19079541	Green Published, Green Submitted, gold			2022-12-25	WOS:000265455900009
J	Hromada, M; Antczak, M; Valone, TJ; Tryjanowski, P				Hromada, Martin; Antczak, Marcin; Valone, Thomas J.; Tryjanowski, Piotr			Settling Decisions and Heterospecific Social Information Use in Shrikes	PLOS ONE			English	Article							PUBLIC INFORMATION; CONSPECIFIC ATTRACTION; HABITAT SELECTION; LANIUS-EXCUBITOR; FITNESS CONSEQUENCES; MIGRANT; BIRDS; SIZE; FOOD; AGGREGATION	Animals often settle near competitors, a behavior known as social attraction, which belies standard habitat selection theory. Two hypotheses account for these observations: individuals obtain Allee benefits mediated by the physical presence of a competitor, or they use successfully settled individual as a source of information indicating the location of high quality habitat. We evaluated these hypotheses experimentally in two species of shrikes. These passerine birds with a raptor-like mode of life impale prey to create larders that serve as an indicator of male/habitat quality. Thus, two forms of indirect information are available in our system: a successfully settled shrike and its larder. Typically these two cues are associated with each other, however, our experimental treatment created an unnatural situation by disassociating them. We manipulated the presence of larders of great grey shrikes and examined the settling decisions of red-backed shrikes within and outside the great grey shrike territories. Male red-backed shrikes did not settle sooner on plots with great grey shrikes compared to plots that only contained artificial larders indicating that red-backed shrikes do not use the physical presence of a great grey shrike when making settling decisions which is inconsistent with the Allee effect hypothesis. In contrast, for all plots without great grey shrikes, red-backed shrikes settled, paired and laid clutches sooner on plots with larders compared to plots without larders. We conclude that red-backed shrikes use larders of great grey shrikes as a cue to rapidly assess habitat quality.	[Antczak, Marcin] Univ S Bohemia, Fac Sci, Dept Zool, Ceske Budejovice, Czech Republic; [Hromada, Martin; Antczak, Marcin; Tryjanowski, Piotr] Adam Mickiewicz Univ, Dept Behav Ecol, PL-61712 Poznan, Poland; [Valone, Thomas J.] St Louis Univ, Dept Biol, St Louis, MO USA	University of South Bohemia Ceske Budejovice; Adam Mickiewicz University; Saint Louis University	Hromada, M (corresponding author), Univ S Bohemia, Fac Sci, Dept Zool, Ceske Budejovice, Czech Republic.	hromada.martin@gmail.com	Antczak, Marcin/F-1204-2011; Hromada, Martin/I-7409-2019	Hromada, Martin/0000-0002-5626-1205; Valone, Thomas/0000-0002-7657-3126; Tryjanowski, Piotr/0000-0002-8358-0797	University of South Bohemia Ceske Budejovice [MSMT600766580MH]; Foundation Kasa im. Mianowskiego; SGA 2003; GACR [206/05/H012]; NSF; Scientific Grant of Ministry of Science of Poland [N N 303 317 433];  [VEGA 1/0139/08]	University of South Bohemia Ceske Budejovice; Foundation Kasa im. Mianowskiego; SGA 2003; GACR(Grant Agency of the Czech Republic); NSF(National Science Foundation (NSF)); Scientific Grant of Ministry of Science of Poland; 	The work was supported by University of South Bohemia Ceske Budejovice, MSMT600766580MH to MH and MA, Foundation Kasa im. Mianowskiego and VEGA 1/0139/08 to MH, SGA 2003 and GACR no.206/05/H012 to MA, NSF grant to TJV and by Scientific Grant of Ministry of Science of Poland No.N N 303 317 433.	Allee W. C, 1951, SOCIAL LIFE ANIMALS; Antczak M, 2004, ACTA ORNITHOL, V39, P9, DOI 10.3161/068.039.0105; Cade Tom J., 1995, Proceedings of the Western Foundation of Vertebrate Zoology, V6, P1; Coolen I, 2003, P ROY SOC B-BIOL SCI, V270, P2413, DOI 10.1098/rspb.2003.2525; Cramp S, 1993, BIRDS W PALEARTIC, VVII; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; Danchin E, 1998, ECOLOGY, V79, P2415, DOI 10.2307/176832; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Doligez B, 2002, SCIENCE, V297, P1168, DOI 10.1126/science.1072838; Fletcher RJ, 2007, J ANIM ECOL, V76, P598, DOI 10.1111/j.1365-2656.2007.01230.x; Forsman JT, 2002, P ROY SOC B-BIOL SCI, V269, P1619, DOI 10.1098/rspb.2002.2065; Forsman JT, 1998, OECOLOGIA, V115, P278, DOI 10.1007/s004420050517; Forsman JT, 2007, BEHAV ECOL, V18, P888, DOI 10.1093/beheco/arm048; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; GETTY T, 1981, AM NAT, V118, P426, DOI 10.1086/283834; Greene CM, 2001, ECOLOGY, V82, P2091; Harris T., 2000, SHRIKES BUSH SHRIKES; HERNANDEZ A, 1995, CONDOR, V97, P1002, DOI 10.2307/1369539; Hodge MA, 1997, ETHOLOGY, V103, P815; Holmes RT, 2001, AUK, V118, P589, DOI 10.1642/0004-8038(2001)118[0589:TYBPTI]2.0.CO;2; Hromada M, 1996, BIOLOGIA, V51, P227; Hromada M, 2002, ANN ZOOL FENN, V39, P125; Karban R, 2002, ECOLOGY, V83, P1209, DOI 10.1890/0012-9658(2002)083[1209:TFCOIE]2.0.CO;2; Kuzniak S., 2003, RED BACKED SHRIKE; Lefranc N., 1997, SHRIKES GUIDE SHRIKE; Marcin A, 2005, ARDEA, V93, P101; Monkkonen M, 1996, OIKOS, V77, P127, DOI 10.2307/3545592; Monkkonen M, 1997, CAN J ZOOL, V75, P2077, DOI 10.1139/z97-842; MONKKONEN M, 1990, OECOLOGIA, V85, P218, DOI 10.1007/BF00319404; Muller KL, 1997, AM NAT, V150, P650, DOI 10.1086/286087; OLIVEIRA RF, 1998, P ROY SOC LOND B BIO, V268, P1183; Parejo D, 2005, BEHAV ECOL, V16, P96, DOI 10.1093/beheco/arh136; Ryttman Hans, 1996, Ornis Svecica, V6, P122; Simek J, 2001, ORNIS FENNICA, V78, P61; SLOANE SA, 1991, NAT HIST, P32; SMITH AT, 1990, CONSERV BIOL, V4, P320, DOI 10.1111/j.1523-1739.1990.tb00294.x; STAMPS JA, 1991, BEHAV ECOL SOCIOBIOL, V28, P29; STAMPS JA, 1988, AM NAT, V131, P329, DOI 10.1086/284793; Stamps Judy A., 2001, P230; TEMPLETON JJ, 1995, BEHAV ECOL, V6, P65, DOI 10.1093/beheco/6.1.65; Thomson RL, 2003, OECOLOGIA, V134, P431, DOI 10.1007/s00442-002-1140-0; Tryjanowski P, 2004, J ORNITHOL, V145, P264, DOI 10.1007/s10336-004-0035-8; Tryjanowski P, 2001, INT J BIOMETEOROL, V45, P217, DOI 10.1007/s00484-001-0112-0; Tryjanowski Piotr, 1999, Acta Ornithologica (Warsaw), V34, P59; Valone TJ, 2007, BEHAV ECOL SOCIOBIOL, V62, P1, DOI 10.1007/s00265-007-0439-6; VALONE TJ, 1989, OIKOS, V56, P357, DOI 10.2307/3565621; Valone TJ, 2002, PHILOS T R SOC B, V357, P1549, DOI 10.1098/rstb.2002.1064; Votypka J, 2003, ANN ZOOL FENN, V40, P431; YOSEF R, 1989, AUK, V106, P418; Yosef Reuven, 1995, Proceedings of the Western Foundation of Vertebrate Zoology, V6, P251	50	36	37	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2008	3	12							e3930	10.1371/journal.pone.0003930	http://dx.doi.org/10.1371/journal.pone.0003930			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZU	19079540	Green Published, Green Submitted, gold			2022-12-25	WOS:000265455900010
J	Argellati, F; Domenicotti, C; Passalacqua, M; Janda, E; Melloni, E; Marinari, UM; Pronzato, MA; Ricciarelli, R				Argellati, Francesca; Domenicotti, Cinzia; Passalacqua, Mario; Janda, Elzbieta; Melloni, Edon; Marinari, Umberto M.; Pronzato, Maria A.; Ricciarelli, Roberta			Protein kinase C-dependent alpha-secretory processing of the amyloid precursor protein is mediated by phosphorylation of myosin II-B	FASEB JOURNAL			English	Article						Alzheimer's disease; neurodegeneration; signaling	HEAVY-CHAIN ISOFORMS; LOCALIZATION; IDENTIFICATION; VESICLES; CLEAVAGE; PEPTIDE; BINDING; MICE	A substantial body of evidence indicates that protein kinase C (PKC) is involved in the alpha-secretory processing of the amyloid precursor protein (APP), an event that reduces the formation of the pathogenic amyloid-beta peptide. Recently, we have shown that trafficking and processing of APP are both impaired by knockdown of myosin II-B, one of the major neuronal motor proteins. Here, we provide evidence that the alpha-secretory processing of APP is mediated by PKC-dependent phosphorylation of myosin II-B. This signaling pathway provides an important link between APP and the neuronal cytoskeleton and might be crucial for the understanding of the biological and pathological roles of APP.-Argellati, F., Domenicotti, C., Passalacqua, M., Janda, E., Melloni, E., Marinari, U. M., Pronzato, M. A., Ricciarelli, R. Protein kinase C-dependent alpha-secretory processing of the amyloid precursor protein is mediated by phosphorylation of myosin II-B. FASEB J. 23, 1246-1251 (2009)	[Argellati, Francesca; Domenicotti, Cinzia; Passalacqua, Mario; Melloni, Edon; Marinari, Umberto M.; Pronzato, Maria A.; Ricciarelli, Roberta] Univ Genoa, Dept Expt Med, Genoa, Italy; [Janda, Elzbieta] Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy	University of Genoa; Magna Graecia University of Catanzaro	Ricciarelli, R (corresponding author), Via LB Alberti 2, I-16132 Genoa, Italy.	ricciarelli@medicina.unige.it	Janda, Elzbieta/AAD-5126-2022; Ricciarelli, Roberta/AAE-8063-2019; Domenicotti, Cinzia/C-7786-2011; Janda, Elzbieta/AFQ-7061-2022; Passalacqua, Mario/W-1973-2019	Janda, Elzbieta/0000-0002-6787-7291; Janda, Elzbieta/0000-0002-6787-7291; Passalacqua, Mario/0000-0003-2779-6259; Ricciarelli, Roberta/0000-0002-2053-2501	Fondazione CARIGE; Genoa University [2006065711_002]	Fondazione CARIGE(Fondazione Carige); Genoa University	We thank Prof. S. Ravid and Drs. S. Massone and L. Vattuone for their productive suggestions. This work was supported by grants from Fondazione CARIGE, Genoa University, PRIN (2006065711_002).	Ben-Ya'acov A, 2003, J BIOL CHEM, V278, P40032, DOI 10.1074/jbc.M306948200; BUXBAUM JD, 1993, P NATL ACAD SCI USA, V90, P9195, DOI 10.1073/pnas.90.19.9195; CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P3055, DOI 10.1073/pnas.89.7.3055; CONTI MA, 1991, BIOCHEMISTRY-US, V30, P966, DOI 10.1021/bi00218a012; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; De Strooper B, 2000, J CELL SCI, V113, P1857; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Even-Faitelson L, 2006, MOL BIOL CELL, V17, P2869, DOI 10.1091/mbc.e05-11-1001; Furukawa K, 1996, J NEUROCHEM, V67, P1882, DOI 10.1046/j.1471-4159.1996.67051882.x; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; HAASS C, 1993, CELL, V75, P1039, DOI 10.1016/0092-8674(93)90312-E; HUNG AY, 1993, J BIOL CHEM, V268, P22959; Ikezu T, 1998, J BIOL CHEM, V273, P10485, DOI 10.1074/jbc.273.17.10485; Koike H, 1999, BIOCHEM J, V343, P371, DOI 10.1042/0264-6021:3430371; LEE RKK, 1995, P NATL ACAD SCI USA, V92, P8083, DOI 10.1073/pnas.92.17.8083; Liu WS, 1998, CELL SIGNAL, V10, P529, DOI 10.1016/S0898-6568(98)00012-6; Ma XF, 2007, MOL BIOL CELL, V18, P2305, DOI 10.1091/mbc.E07-01-0073; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Massone S, 2007, BIOCHEM BIOPH RES CO, V362, P633, DOI 10.1016/j.bbrc.2007.08.061; Meziane H, 1998, P NATL ACAD SCI USA, V95, P12683, DOI 10.1073/pnas.95.21.12683; Murakami N, 1998, BIOCHEMISTRY-US, V37, P1989, DOI 10.1021/bi971959a; MURAKAMI N, 1994, J BIOL CHEM, V269, P16082; Neco P, 2008, J BIOL CHEM, V283, P10949, DOI 10.1074/jbc.M709058200; ROCHLIN MW, 1995, J CELL SCI, V108, P3661; Rosenberg M, 2006, MOL BIOL CELL, V17, P1364, DOI 10.1091/mbc.e05-07-0597; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; Skovronsky DM, 2000, J BIOL CHEM, V275, P2568, DOI 10.1074/jbc.275.4.2568; Straussman R, 2001, J CELL SCI, V114, P3047; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; XU HX, 1995, J BIOL CHEM, V270, P23243, DOI 10.1074/jbc.270.40.23243	31	6	7	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2009	23	4					1246	1251		10.1096/fj.08-119263	http://dx.doi.org/10.1096/fj.08-119263			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZO	19103644				2022-12-25	WOS:000266651600028
J	Berdyshev, EV; Gorshkova, I; Skobeleva, A; Bittman, R; Lu, XQ; Dudek, SM; Mirzapoiazova, T; Garcia, JGN; Natarajan, V				Berdyshev, Evgeny V.; Gorshkova, Irina; Skobeleva, Anastasia; Bittman, Robert; Lu, Xuequan; Dudek, Steven M.; Mirzapoiazova, Tamara; Garcia, Joe G. N.; Natarajan, Viswanathan			FTY720 Inhibits Ceramide Synthases and Up-regulates Dihydrosphingosine 1-Phosphate Formation in Human Lung Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPHINGOSINE KINASE; IMMUNOSUPPRESSANT FTY720; DRUG FTY720; SPHINGOSINE-1-PHOSPHATE; APOPTOSIS; MODULATION; GENERATION; PHOSPHORYLATION; HEPATOTOXICITY; ACCUMULATION	Novel immunomodulatory molecule FTY720 is a synthetic analog of myriocin, but unlike myriocin FTY720 does not inhibit serine palmitoyltransferase. Although many of the effects of FTY720 are ascribed to its phosphorylation and subsequent sphingosine 1-phosphate (S1P)-like action through S1P(1,3-5) receptors, studies on modulation of intracellular balance of signaling sphingolipids by FTY720 are limited. In this study, we used stable isotope pulse labeling of human pulmonary artery endothelial cells with L-[U-C-13,N-15] serine as well as in vitro enzymatic assays and liquid chromatography-tandem mass spectrometry methodology to characterize FTY720 interference with sphingolipid de novo biosynthesis. In human pulmonary artery endothelial cells, FTY720 inhibited ceramide synthases, resulting in decreased cellular levels of dihydroceramides, ceramides, sphingosine, and S1P but increased levels of dihydrosphingosine and dihydrosphingosine 1-phosphate (DHS1P). The FTY720-induced modulation of sphingolipid de novo biosynthesis was similar to that of fumonisin B1, a classical inhibitor of ceramide synthases, but differed in the efficiency to inhibit biosynthesis of short-chain versus long-chain ceramides. In vitro kinetic studies revealed that FTY720 is a competitive inhibitor of ceramide synthase 2 toward dihydrosphingosine with an apparent K-i of 2.15 mu M. FTY720-induced up-regulation of DHS1P level was mediated by sphingosine kinase (SphK) 1, but not SphK2, as confirmed by experiments using SphK1/2 silencing with small interfering RNA. Our data demonstrate for the first time the ability of FTY720 to inhibit ceramide synthases and modulate the intracellular balance of signaling sphingolipids. These findings open a novel direction for therapeutic applications of FTY720 that focuses on inhibition of ceramide biosynthesis, ceramide-dependent signaling, and the up-regulation of DHS1P generation in cells.	[Natarajan, Viswanathan] Univ Chicago, Dept Med, Div Biol Sci, GCIS, Chicago, IL 60637 USA; [Bittman, Robert; Lu, Xuequan] CUNY Queens Coll, Dept Chem & Biochem, Flushing, NY 11367 USA	University of Chicago; City University of New York (CUNY) System; Queens College NY (CUNY)	Natarajan, V (corresponding author), Univ Chicago, Dept Med, Div Biol Sci, GCIS, 929 E 57th St, Chicago, IL 60637 USA.	eberdysh@medicine.bsd.uchicago.edu	Garcia, Joe GN/E-8862-2010		National Institutes of Health [HL-079396, HL-083187]; Lipidomics Facility of the Department of Medicine at the University of Chicago; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R24HL083187, R37HL079396, R01HL079396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lipidomics Facility of the Department of Medicine at the University of Chicago(University of Chicago); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-079396 (to V. N.) and HL-083187 (to R. B.). This work was also supported by the Lipidomics Facility of the Department of Medicine at the University of Chicago.	Bandhuvula P, 2005, J BIOL CHEM, V280, P33697, DOI 10.1074/jbc.C500294200; Baran Y, 2007, J BIOL CHEM, V282, P10922, DOI 10.1074/jbc.M610157200; Berdyshev EV, 2005, ANAL BIOCHEM, V339, P129, DOI 10.1016/j.ab.2004.12.006; Berdyshev EV, 2006, CELL SIGNAL, V18, P1779, DOI 10.1016/j.cellsig.2006.01.018; Billich A, 2003, J BIOL CHEM, V278, P47408, DOI 10.1074/jbc.M307687200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Desai K, 2002, BBA-MOL CELL BIOL L, V1585, P188, DOI 10.1016/S1388-1981(02)00340-2; Eto M, 2006, INT J UROL, V13, P148, DOI 10.1111/j.1442-2042.2006.01249.x; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; He QR, 2006, TOXICOL SCI, V94, P388, DOI 10.1093/toxsci/kfl102; Hiestand Peter C., 2008, V66; Huwiler A, 2006, CURR PHARM DESIGN, V12, P4625, DOI 10.2174/138161206779010422; Kharel Y, 2005, J BIOL CHEM, V280, P36865, DOI 10.1074/jbc.M506293200; Kim DH, 2007, ARCH PHARM RES, V30, P962, DOI 10.1007/BF02993964; Kim DH, 2006, J TOXICOL ENV HEAL A, V69, P2071, DOI 10.1080/15287390600746215; Kiuchi M, 2000, J MED CHEM, V43, P2946, DOI 10.1021/jm000173z; LaMontagne K, 2006, CANCER RES, V66, P221, DOI 10.1158/0008-5472.CAN-05-2001; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Le Stunff H, 2002, J BIOL CHEM, V277, P8920, DOI 10.1074/jbc.M109968200; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Lu XQ, 2006, TETRAHEDRON LETT, V47, P825, DOI 10.1016/j.tetlet.2005.11.092; Mansoor M, 2008, REV RECENT CLIN TRIA, V3, P62, DOI 10.2174/157488708783330486; Merrill AH, 1996, ADV EXP MED BIOL, V392, P297; Merrill AH, 2000, METHOD ENZYMOL, V312, P3; Morales A, 2007, MINI-REV MED CHEM, V7, P371, DOI 10.2174/138955707780363792; Murphy RC, 2001, CHEM REV, V101, P479, DOI 10.1021/cr9900883; Oo ML, 2007, J BIOL CHEM, V282, P9082, DOI 10.1074/jbc.M610318200; Panjarian S, 2008, PROSTAG OTH LIPID M, V86, P41, DOI 10.1016/j.prostaglandins.2008.02.004; Paugh SW, 2006, MOL PHARMACOL, V70, P41, DOI 10.1124/mol.105.020552; Paugh SW, 2003, FEBS LETT, V554, P189, DOI 10.1016/S0014-5793(03)01168-2; Payne SG, 2007, BLOOD, V109, P1077, DOI 10.1182/blood-2006-03-011437; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Pettus BJ, 2005, MOL PHARMACOL, V68, P330, DOI 10.1124/mol.104.008722; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Salm P, 2006, J CHROMATOGR B, V843, P157, DOI 10.1016/j.jchromb.2006.05.026; Sanchez T, 2003, J BIOL CHEM, V278, P47281, DOI 10.1074/jbc.M306896200; Schmid G, 2005, TRANSPL P, V37, P110, DOI 10.1016/j.transproceed.2004.12.278; Schmid G, 2007, J CELL BIOCHEM, V101, P259, DOI 10.1002/jcb.21181; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Seumois G, 2007, J LEUKOCYTE BIOL, V81, P1477, DOI 10.1189/jlb.0806529; Siskind LJ, 2005, J BIOENERG BIOMEMBR, V37, P143, DOI 10.1007/s10863-005-6567-7; Stahelin RV, 2007, J BIOL CHEM, V282, P20467, DOI 10.1074/jbc.M701396200; Subramanian P, 2005, J BIOL CHEM, V280, P17601, DOI 10.1074/jbc.M414173200; Suzuki H, 2007, TOXICOLOGY, V229, P42, DOI 10.1016/j.tox.2006.09.010; Taha TA, 2006, BBA-BIOMEMBRANES, V1758, P2027, DOI 10.1016/j.bbamem.2006.10.018; Thevissen K, 2006, MINI-REV MED CHEM, V6, P699, DOI 10.2174/138955706777435643; VASKOVSKY VE, 1975, J CHROMATOGR, V114, P129, DOI 10.1016/S0021-9673(00)85249-8; Vessey DA, 2007, J BIOCHEM MOL TOXIC, V21, P273, DOI 10.1002/jbt.20193; Yamaji-Hasegawa A, 2005, BIOCHEMISTRY-US, V44, P268, DOI 10.1021/bi048605l; Yu J, 2007, J BIOL CHEM, V282, P25940, DOI 10.1074/jbc.M701812200; Zemann B, 2006, BLOOD, V107, P1454, DOI 10.1182/blood-2005-07-2628; Zhang Z, 2007, MINI-REV MED CHEM, V7, P845; Zhao YT, 2007, J BIOL CHEM, V282, P14165, DOI 10.1074/jbc.M701279200	53	128	131	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5467	5477		10.1074/jbc.M805186200	http://dx.doi.org/10.1074/jbc.M805186200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19119142	Green Published, hybrid			2022-12-25	WOS:000263560600009
J	Shaik, SS; Soltau, TD; Chaturvedi, G; Totapally, B; Hagood, JS; Andrews, WW; Athar, M; Voitenok, NN; Killingsworth, CR; Patel, RP; Fallon, MB; Maheshwari, A				Shaik, Sadiq S.; Soltau, Thomas D.; Chaturvedi, Gaurav; Totapally, Balagangadhar; Hagood, James S.; Andrews, William W.; Athar, Mohammad; Voitenok, Nikolai N.; Killingsworth, Cheryl R.; Patel, Rakesh P.; Fallon, Michael B.; Maheshwari, Akhil			Low Intensity Shear Stress Increases Endothelial ELR+ CXC Chemokine Production via a Focal Adhesion Kinase-p38 beta MAPK-NF-kappa B Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPRESSION; NITRIC-OXIDE SYNTHASE; POLYMORPHONUCLEAR LEUKOCYTES; TRANSCRIPTIONAL ACTIVATION; SIGNALING PATHWAY; SKELETAL-MUSCLE; GENE-EXPRESSION; MOLECULAR-BASIS; CELLS; FLOW	CXC chemokines with a glutamate-leucine-arginine (ELR) tripeptide motif (ELR+ CXC chemokines) play an important role in leukocyte trafficking into the tissues. For reasons that are not well elucidated, circulating leukocytes are recruited into the tissues mainly in small vessels such as capillaries and venules. Because ELR+ CXC chemokines are important mediators of endothelial-leukocyte interaction, we compared chemokine expression by microvascular and aortic endothelium to investigate whether differences in chemokine expression by various endothelial types could, at least partially, explain the microvascular localization of endothelial-leukocyte interaction. Both in vitro and in vivo models indicate that ELR+ CXC chemokine expression is higher in microvascular endothelium than in aortic endothelial cells. These differences can be explained on the basis of the preferential activation of endothelial chemokine production by low intensity shear stress. Low shear activated endothelial ELR+ CXC chemokine production via cell surface heparan sulfates, beta(3)-integrins, focal adhesion kinase, the mitogen-activated protein kinase p38 beta, mitogen-and stress-associated protein kinase-1, and the transcription factor.	[Hagood, James S.; Maheshwari, Akhil] Univ Alabama, Dept Pediat, Translat Res Normal & Disordered Dev Program, Birmingham, AL 35233 USA; [Hagood, James S.; Maheshwari, Akhil] Univ Alabama, Dept Cell Biol, Birmingham, AL 35233 USA; [Andrews, William W.] Univ Alabama, Dept Obstet & Gynecol, Birmingham, AL 35233 USA; [Athar, Mohammad] Univ Alabama, Dept Dermatol, Birmingham, AL 35233 USA; [Killingsworth, Cheryl R.] Univ Alabama, Dept Internal Med, Birmingham, AL 35233 USA; [Patel, Rakesh P.; Maheshwari, Akhil] Univ Alabama, Dept Pathol, Birmingham, AL 35233 USA; [Fallon, Michael B.] Vet Affairs Hosp, Birmingham, AL 35233 USA; [Voitenok, Nikolai N.; Fallon, Michael B.] Fund Mol Hematol & Immunol, Moscow, Russia; [Chaturvedi, Gaurav] Univ Kansas, Med Ctr, Ctr Reprod Sci, Kansas City, KS 66160 USA; [Totapally, Balagangadhar] Miami Childrens Hosp, Dept Pediat, Miami, FL 33155 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Kansas; University of Kansas Medical Center	Maheshwari, A (corresponding author), NHB 525,619 19th St S, Birmingham, AL 35233 USA.	akhil@peds.uab.edu		Patel, Rakesh/0000-0002-1526-4303	National Institutes of Health [K12HD043397, RHD059142, HL082818, ES015323, DK056804]; American Heart Association [0665155B]; American Gastroenterological Association Research Scholar Award; American Heart Association Award [0655312B]; National Center for Research Resources [C06 RR 15490]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059142, K12HD043397] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015490] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056804] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Gastroenterological Association Research Scholar Award; American Heart Association Award(American Heart Association); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K12HD043397 and RHD059142 (to A. M.), HL082818 (to J. S. H.), ES015323 (to M. A.), and DK056804 (to M. B. F.). This work was also supported by American Heart Association Grant 0665155B, an American Gastroenterological Association Research Scholar Award, American Heart Association Award 0655312B (to R. P. P.). The work was made possible in part by Research Facilities Improvement Program Grant C06 RR 15490 from the National Center for Research Resources. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ATHERTON A, 1972, J PHYSIOL-LONDON, V222, P447, DOI 10.1113/jphysiol.1972.sp009808; Baeza-Raja B, 2004, MOL BIOL CELL, V15, P2013, DOI 10.1091/mbc.E03-08-0585; Benjamin JT, 2007, AM J PHYSIOL-LUNG C, V292, pL550, DOI 10.1152/ajplung.00329.2006; BOYLE J, 1988, J THEOR BIOL, V131, P223, DOI 10.1016/S0022-5193(88)80238-8; Chen HQ, 2003, BIORHEOLOGY, V40, P53; Chen ZY, 2001, PROSTAG LEUKOTR ESS, V64, P67, DOI 10.1054/plef.2000.0239; Cheng C, 2007, J CLIN INVEST, V117, P616, DOI 10.1172/JCI28180; Cheng M, 2007, ENDOTHELIUM-J ENDOTH, V14, P265, DOI 10.1080/10623320701678169; Chung BJ, 2003, COMPUT STRUCT, V81, P535, DOI 10.1016/S0045-7949(02)00416-9; Dimmeler S, 1999, ARTERIOSCL THROM VAS, V19, P656, DOI 10.1161/01.ATV.19.3.656; Doerschuk CM, 1999, AM J RESP CRIT CARE, V159, P1693; Fox SE, 2005, CYTOKINE, V29, P135, DOI 10.1016/j.cyto.2004.10.007; Garofalo R, 1996, J VIROL, V70, P8773, DOI 10.1128/JVI.70.12.8773-8781.1996; Gerna G, 2000, J VIROL, V74, P5629, DOI 10.1128/JVI.74.12.5629-5638.2000; Gilmore TD, 2006, ONCOGENE, V25, P6887, DOI 10.1038/sj.onc.1209982; GRANGER DN, 1994, J LEUKOCYTE BIOL, V55, P662, DOI 10.1002/jlb.55.5.662; Hale KK, 1999, J IMMUNOL, V162, P4246; Hay DC, 2003, BBA-MOL CELL RES, V1642, P33, DOI 10.1016/S0167-4889(03)00084-3; Hippenstiel S, 2000, BLOOD, V95, P3044; Ho RC, 2005, AM J PHYSIOL-CELL PH, V289, pC794, DOI 10.1152/ajpcell.00632.2004; Huang S, 1997, IMMUNITY, V6, P739, DOI 10.1016/S1074-7613(00)80449-5; Iivanainen E, 2003, MICROSC RES TECHNIQ, V60, P13, DOI 10.1002/jemt.10238; Illi B, 2003, CIRC RES, V93, P155, DOI 10.1161/01.RES.0000080933.82105.29; Jana M, 2005, FREE RADICAL BIO MED, V38, P655, DOI 10.1016/j.freeradbiomed.2004.11.021; Johnston B, 2002, SEMIN IMMUNOL, V14, P83, DOI 10.1006/smim.2001.0345; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kato H, 2001, BIORHEOLOGY, V38, P347; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Li YSJ, 2005, J BIOMECH, V38, P1949, DOI 10.1016/j.jbiomech.2004.09.030; Luscinskas FW, 2002, SEMIN IMMUNOL, V14, P105, DOI 10.1006/smim.2001.0347; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Maheshwari A, 2005, PEDIATR RES, V57, P438, DOI 10.1203/01.PDR.0000151317.08180.7E; Maheshwari A, 2003, CYTOKINE, V24, P91, DOI 10.1016/j.cyto.2003.07.002; Maheshwari A, 2006, J LEUKOCYTE BIOL, V80, P1111, DOI 10.1189/jlb.0306230; McCoy CE, 2005, BIOCHEM J, V387, P507, DOI 10.1042/BJ20041501; Meyer T, 1998, BRIT J CANCER, V77, P530, DOI 10.1038/bjc.1998.86; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; Mohan S, 2007, AM J PHYSIOL-CELL PH, V292, pC362, DOI 10.1152/ajpcell.00535.2005; Moon JJ, 2005, J CELL PHYSIOL, V203, P166, DOI 10.1002/jcp.20220; Mukaida N, 1995, Cancer Treat Res, V80, P261; Nolan K, 1999, MOL CELL BIOL, V19, P6120; Partridge J, 2007, FASEB J, V21, P3553, DOI 10.1096/fj.06-8059com; Pries AR, 2003, CLIN HEMORHEOL MICRO, V29, P143; RESNICK N, 1995, FASEB J, V9, P874, DOI 10.1096/fasebj.9.10.7615157; SDOUGOS HP, 1984, J FLUID MECH, V138, P379, DOI 10.1017/S0022112084000161; Sheikh S, 2003, BLOOD, V102, P2828, DOI 10.1182/blood-2003-01-0080; Shin WS, 2002, ATHEROSCLEROSIS, V160, P91, DOI 10.1016/S0021-9150(01)00571-8; SKALAK R, 1989, ANNU REV FLUID MECH, V21, P167; Smythies LE, 2006, J LEUKOCYTE BIOL, V80, P492, DOI 10.1189/jlb.1005566; SPRINGER TA, 1995, ANNU REV PHYSIOL, V57, P827, DOI 10.1146/annurev.ph.57.030195.004143; SRIRAMARAO P, 1993, J BIOL CHEM, V268, P22036; Surapisitchat J, 2001, P NATL ACAD SCI USA, V98, P6476, DOI 10.1073/pnas.101134098; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959; WIGGS BR, 1994, J APPL PHYSIOL, V77, P463, DOI 10.1152/jappl.1994.77.1.463; Wootton DM, 1999, ANNU REV BIOMED ENG, V1, P299, DOI 10.1146/annurev.bioeng.1.1.299; Zhang SS, 2003, J CLIN INVEST, V111, P833, DOI 10.1172/JCI200316290	58	37	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5945	5955		10.1074/jbc.M807205200	http://dx.doi.org/10.1074/jbc.M807205200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19117939	Green Published, hybrid			2022-12-25	WOS:000263560600058
J	Wang, YQ; Liao, MX; Hoe, N; Acharya, P; Deng, CH; Krutchinsky, AN; Correia, MA				Wang, YongQiang; Liao, Mingxiang; Hoe, Nicholas; Acharya, Poulomi; Deng, Changhui; Krutchinsky, Andrew N.; Correia, Maria Almira			A Role for Protein Phosphorylation in Cytochrome P450 3A4 Ubiquitin-dependent Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B-ALPHA; ETHANOL-INDUCIBLE CYTOCHROME-P-450; RETICULUM-ASSOCIATED DEGRADATION; SITE-SPECIFIC PHOSPHORYLATION; METAL-CATALYZED OXIDATION; ER-ASSOCIATED DEGRADATION; ISOLATED RAT HEPATOCYTES; SACCHAROMYCES-CEREVISIAE; POSTTRANSLATIONAL MODIFICATION; MICROSOMAL CYTOCHROME-P-450	Cytochromes P450 (P450s) incur phosphorylation. Although the precise role of this post-translational modification is unclear, marking P450s for degradation is plausible. Indeed, we have found that after structural inactivation, CYP3A4, the major human liver P450, and its rat orthologs are phosphorylated during their ubiquitin-dependent proteasomal degradation. Peptide mapping coupled with mass spectrometric analyses of CYP3A4 phosphorylated in vitro by protein kinase C (PKC) previously identified two target sites, Thr264 and Ser420. We now document that liver cytosolic kinases additionally target Ser478 as a major site. To determine whether such phosphorylation is relevant to in vivo CYP3A4 degradation, wild type and CYP3A4 with single, double, or triple Ala mutations of these residues were heterologously expressed in Saccharomyces cerevisiae pep4 Delta strains. We found that relative to CYP3A4wt, its S478A mutant was significantly stabilized in these yeast, and this was greatly to markedly enhanced for its S478A/T264A, S478A/S420A, and S478A/T264A/S420A double and triple mutants. Similar relative S478A/T264A/S420A mutant stabilization was also observed in HEK293T cells. To determine whether phosphorylation enhances CYP3A4 degradation by enhancing its ubiquitination, CYP3A4 ubiquitination was examined in an in vitro UBC7/gp78-reconstituted system with and without cAMP-dependent protein kinase A and PKC, two liver cytosolic kinases involved in CYP3A4 phosphorylation. cAMP-dependent protein kinase A/PKC-mediated phosphorylation of CYP3A4wt but not its S478A/T264A/S420A mutant enhanced its ubiquitination in this system. Together, these findings indicate that phosphorylation of CYP3A4 Ser478, Thr264, and Ser420 residues by cytosolic kinases is important both for its ubiquitination and proteasomal degradation and suggest a direct link between P450 phosphorylation, ubiquitination, and degradation.	[Wang, YongQiang; Liao, Mingxiang; Hoe, Nicholas; Acharya, Poulomi; Correia, Maria Almira] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Deng, Changhui; Krutchinsky, Andrew N.; Correia, Maria Almira] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Correia, Maria Almira] Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94158 USA; [Correia, Maria Almira] Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Correia, MA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Mission Bay Campus,Genentech Hall,N572F,Box 2280,, San Francisco, CA 94158 USA.	almira.correia@ucsf.edu	Deng, Changhui/A-1010-2012		National Institutes of Health [GM44037, DK26506, R21 RR023120]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR023120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026506, R56DK026506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants GM44037 and DK26506 (to M.A.C.) and R21 RR023120 (to A.N.K.). The costs of publication of this article were defrayed in part by the payment of page charges.	Aguiar M, 2005, DRUG METAB REV, V37, P379, DOI 10.1081/DMR-200046136; Ahner A, 2004, TRENDS CELL BIOL, V14, P474, DOI 10.1016/j.tcb.2004.07.013; AMICI A, 1989, J BIOL CHEM, V264, P3341; Annan RS, 1996, ANAL CHEM, V68, P3413, DOI 10.1021/ac960221g; Ballar P, 2006, J BIOL CHEM, V281, P35359, DOI 10.1074/jbc.M603355200; Bardag-Gorce F, 2002, FREE RADICAL BIO MED, V32, P17, DOI 10.1016/S0891-5849(01)00768-7; Blethrow JD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000358; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Butler MP, 2007, J BIOL CHEM, V282, P29729, DOI 10.1074/jbc.M704558200; CALLEN DF, 1977, MUTAT RES, V45, P309, DOI 10.1016/0027-5107(77)90141-5; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Choi BK, 2003, PROTEOMICS, V3, P1955, DOI 10.1002/pmic.200300558; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Correia MA, 2007, EXPERT OPIN DRUG MET, V3, P33, DOI 10.1517/17425255.3.1.33; Correia MA, 2005, ANNU REV PHARMACOL, V45, P439, DOI 10.1146/annurev.pharmtox.45.120403.100127; CORREIA MA, 1987, ARCH BIOCHEM BIOPHYS, V258, P436, DOI 10.1016/0003-9861(87)90365-1; CORREIA MA, 1992, ARCH BIOCHEM BIOPHYS, V297, P228, DOI 10.1016/0003-9861(92)90666-K; CORREIA MA, 1989, DRUG METAB REV, V20, P615, DOI 10.3109/03602538909103565; Dai RM, 1998, J BIOL CHEM, V273, P3562, DOI 10.1074/jbc.273.6.3562; DAI Y, 1993, BIOCHEMISTRY-US, V32, P6928, DOI 10.1021/bi00078a017; Denisov IG, 2007, J BIOL CHEM, V282, P26865, DOI 10.1074/jbc.M704747200; Doolman R, 2004, J BIOL CHEM, V279, P38184, DOI 10.1074/jbc.M405935200; EKSTROM G, 1989, BIOCHEM PHARMACOL, V38, P1313, DOI 10.1016/0006-2952(89)90338-9; ELIASSON E, 1990, P NATL ACAD SCI USA, V87, P3225, DOI 10.1073/pnas.87.8.3225; ELIASSON E, 1988, BIOCHEM BIOPH RES CO, V150, P436, DOI 10.1016/0006-291X(88)90539-6; ELIASSON E, 1992, J BIOL CHEM, V267, P15765; ELIASSON E, 1994, J BIOL CHEM, V269, P18378; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Faouzi S, 2007, BIOCHEMISTRY-US, V46, P7793, DOI 10.1021/bi700340n; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; FREEMAN JE, 1994, BIOCHEMISTRY-US, V33, P13963, DOI 10.1021/bi00251a002; Goasduff T, 1999, ARCH BIOCHEM BIOPHYS, V370, P258, DOI 10.1006/abbi.1999.1399; GORSKY LD, 1984, J BIOL CHEM, V259, P6812; Guengerich F.P., 2005, CYTOCHROME P450 STRU, V3rd ed., P377, DOI [10.1007/0-387-27447-2_10, DOI 10.1007/0-387-27447-2_10]; Guengerich FP, 1997, BIOCHEMISTRY-US, V36, P14741, DOI 10.1021/bi9719399; GUENGERICH FP, 1986, BIOCHEM BIOPH RES CO, V138, P193, DOI 10.1016/0006-291X(86)90265-2; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; He K, 1998, BIOCHEMISTRY-US, V37, P17448, DOI 10.1021/bi9808464; Henderson CJ, 2003, J BIOL CHEM, V278, P13480, DOI 10.1074/jbc.M212087200; JANSSON I, 1990, ARCH BIOCHEM BIOPHYS, V283, P285, DOI 10.1016/0003-9861(90)90644-E; Kaplan KB, 1997, CELL, V91, P491, DOI 10.1016/S0092-8674(00)80435-3; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; KOCH JA, 1989, BIOCHEMISTRY-US, V28, P3145, DOI 10.1021/bi00434a005; Kornitzer D, 2002, METHOD ENZYMOL, V351, P639; Korsmeyer KK, 1999, ARCH BIOCHEM BIOPHYS, V365, P31, DOI 10.1006/abbi.1999.1138; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Liao M, 2006, MOL PHARMACOL, V69, P1897, DOI 10.1124/mol.105.021816; Lohr JB, 1997, BIOCHEM BIOPH RES CO, V231, P403, DOI 10.1006/bbrc.1997.6113; MENEZ JF, 1993, ALCOHOL ALCOHOLISM, V28, P445; Miranda M, 2005, J BIOL CHEM, V280, P35617, DOI 10.1074/jbc.M506618200; MIYAMOTO S, 1994, P NATL ACAD SCI USA, V91, P12740, DOI 10.1073/pnas.91.26.12740; MULLER R, 1985, FEBS LETT, V187, P21, DOI 10.1016/0014-5793(85)81205-9; Murray BP, 2001, ARCH BIOCHEM BIOPHYS, V393, P106, DOI 10.1006/abbi.2001.2482; Nishikawa S, 2005, J BIOCHEM, V137, P551, DOI 10.1093/jb/mvi068; Oesch-Bartlomowicz B, 2005, BIOCHEM BIOPH RES CO, V338, P446, DOI 10.1016/j.bbrc.2005.08.092; Oesch-Bartlomowicz B, 1998, EXP CELL RES, V242, P294, DOI 10.1006/excr.1998.4120; Oesch-Bartlomowicz B, 2003, ARCH BIOCHEM BIOPHYS, V409, P228, DOI 10.1016/S0003-9861(02)00558-1; OPRIAN DD, 1983, J BIOL CHEM, V258, P8684; Pabarcus MK, 2009, ARCH BIOCHEM BIOPHYS, V483, P66, DOI 10.1016/j.abb.2008.12.001; PYERIN W, 1983, CARCINOGENESIS, V4, P573, DOI 10.1093/carcin/4.5.573; PYERIN W, 1987, BIOCHEM BIOPH RES CO, V142, P885, DOI 10.1016/0006-291X(87)91496-3; PYERIN W, 1989, EMBO J, V8, P3003, DOI 10.1002/j.1460-2075.1989.tb08450.x; Requena JR, 2001, P NATL ACAD SCI USA, V98, P69, DOI 10.1073/pnas.011526698; RIDDICK DS, 1990, BIOCHEM PHARMACOL, V40, P1915, DOI 10.1016/0006-2952(90)90374-T; ROBERTS BJ, 1995, J BIOL CHEM, V270, P29632; SCHAEFER WH, 1985, BIOCHEMISTRY-US, V24, P3254, DOI 10.1021/bi00334a027; Sepuri NBV, 2007, FEBS J, V274, P4615, DOI 10.1111/j.1742-4658.2007.05990.x; Shimura H, 2004, J BIOL CHEM, V279, P4869, DOI 10.1074/jbc.M305838200; TANIGUCHI H, 1985, BIOCHEM PHARMACOL, V34, P1835, DOI 10.1016/0006-2952(85)90657-4; Taxis C, 2003, J BIOL CHEM, V278, P35903, DOI 10.1074/jbc.M301080200; Trester-Zedlitz M, 2005, BIOCHEMISTRY-US, V44, P6133, DOI 10.1021/bi0475469; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; VILGRAIN I, 1984, BIOCHEM BIOPH RES CO, V125, P554, DOI 10.1016/0006-291X(84)90575-8; VOLLAND C, 1994, J BIOL CHEM, V269, P9833; Wang HF, 1998, BIOCHEMISTRY-US, V37, P12536, DOI 10.1021/bi980895g; Wang HF, 1999, ARCH BIOCHEM BIOPHYS, V365, P45, DOI 10.1006/abbi.1999.1139; Wang XY, 2001, BIOCHEMISTRY-US, V40, P11318, DOI 10.1021/bi010690z; WATKINS PB, 1986, J BIOL CHEM, V261, P6264; Wilhovsky S, 2000, MOL BIOL CELL, V11, P1697, DOI 10.1091/mbc.11.5.1697; Willems AR, 1996, CELL, V86, P453, DOI 10.1016/S0092-8674(00)80118-X; Woods YL, 2001, BIOCHEM J, V355, P609, DOI 10.1042/bj3550609; Yano JK, 2004, J BIOL CHEM, V279, P38091, DOI 10.1074/jbc.C400293200; Zangar RC, 2004, TOXICOL APPL PHARM, V199, P316, DOI 10.1016/j.taap.2004.01.018; Zhukov A, 1999, BIOCHEM J, V340, P453, DOI 10.1042/0264-6021:3400453; ZHUKOV A, 1993, BIOCHEM BIOPH RES CO, V197, P221, DOI 10.1006/bbrc.1993.2464	88	41	44	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5671	5684		10.1074/jbc.M806104200	http://dx.doi.org/10.1074/jbc.M806104200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19095658	Green Published, hybrid			2022-12-25	WOS:000263560600031
J	Cohn, MA; Kee, Y; Haas, W; Gygi, SP; D'Andrea, AD				Cohn, Martin A.; Kee, Younghoon; Haas, Wilhelm; Gygi, Steven P.; D'Andrea, Alan D.			UAF1 Is a Subunit of Multiple Deubiquitinating Enzyme Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; FANCONI-ANEMIA PATHWAY; PROTEIN COMPLEXES; PROTEASOME; UBIQUITIN; REPAIR; UCH37	A balance between ubiquitination and deubiquitination regulates numerous cellular processes and pathways, and specific deubiquitinating enzymes often play the decisive role of controlling this balance. We recently reported that the USP1 deubiquitinating enzyme, which regulates the Fanconi anemia pathway by deubiquitinating the central player of the pathway, FANCD2, is activated by the WD40-repeat containing UAF1 protein through formation of a stable USP1/UAF1 protein complex. Here we present the isolation of two novel multisubunit deubiquitinating enzyme complexes containing USP12 and USP46, respectively. Both complexes contain the UAF1 protein as a bona fide subunit. Interestingly, UAF1 regulates the enzymatic activity of both enzyme complexes, suggesting that this activator protein may regulate a subclass of human deubiquitinating enzymes. We postulate that additional WD40-containing proteins may also form complexes with other human deubiquitinating enzymes and thereby regulate their activity and substrate specificity.	[Cohn, Martin A.; Kee, Younghoon; D'Andrea, Alan D.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA; [Haas, Wilhelm; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	D'Andrea, AD (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Radiat Oncol, 44 Binney St, Boston, MA 02115 USA.	alan_dandrea@dfci.harvard.edu	Kee, Younghoon/J-4107-2019; Classen, Scott/AAY-8176-2020	Cohn, Martin/0000-0002-2988-3009	National Institutes of Health [5P01CA092584]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 5P01CA092584.	Amerik AY, 2000, BIOL CHEM, V381, P981, DOI 10.1515/BC.2000.121; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; D'Andrea A, 1998, CRIT REV BIOCHEM MOL, V33, P337, DOI 10.1080/10409239891204251; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Hanna J, 2007, FEBS LETT, V581, P2854, DOI 10.1016/j.febslet.2007.03.053; Harlow E., 1988, ANTIBODIES LAB MANUA; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Kee Y, 2005, EMBO J, V24, P2414, DOI 10.1038/sj.emboj.7600710; Kennedy RD, 2005, GENE DEV, V19, P2925, DOI 10.1101/gad.1370505; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Maniatis T., 1989, MOL CLONING LAB MAN; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Oestergaard VH, 2007, MOL CELL, V28, P798, DOI 10.1016/j.molcel.2007.09.020; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Qiu XB, 2006, EMBO J, V25, P5742, DOI 10.1038/sj.emboj.7601450; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sigismund S, 2004, CURR TOP MICROBIOL, V286, P149; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Yang XH, 2007, P NATL ACAD SCI USA, V104, P20645, DOI 10.1073/pnas.0710916105; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; Zhang XY, 2008, MOL CELL, V29, P102, DOI 10.1016/j.molcel.2007.12.015	30	132	141	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5343	5351		10.1074/jbc.M808430200	http://dx.doi.org/10.1074/jbc.M808430200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19075014	hybrid, Green Published			2022-12-25	WOS:000263416600064
J	Zhang, LL; Lai, E; Teodoro, T; Volchuk, A				Zhang, Liling; Lai, Elida; Teodoro, Tracy; Volchuk, Allen			GRP78, but Not Protein-disulfide Isomerase, Partially Reverses Hyperglycemia-induced Inhibition of Insulin Synthesis and Secretion in Pancreatic beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; CHRONIC OXIDATIVE STRESS; MESSENGER-RNA; ER STRESS; CHEMICAL CHAPERONES; GLUCOSE-HOMEOSTASIS; GENE-TRANSCRIPTION; FATTY-ACIDS; ACTIVATION; TRANSLATION	Chronic hyperglycemia contributes to pancreatic beta-cell dysfunction during the development of type 2 diabetes. Treatment of pancreatic beta-cells with prolonged high glucose concentrations has been shown to reduce insulin promoter activity and insulin gene expression. Here, we examined the effect of high glucose on endoplasmic reticulum (ER) stress pathway activation and insulin production in INS-1 832/13 pancreatic beta-cells. Treatment of cells with 25 mM glucose for 24-48 h decreased insulin mRNA and protein levels and reduced the proinsulin translation rate, which was accompanied by enhanced unfolded protein response pathway activation (XBP-1 mRNA splicing and increased phospho-eIF2 alpha, CHOP, and active ATF6 levels). Overexpressing the ER chaperone GRP78 partially rescued high glucose-induced suppression of proinsulin levels and improved glucose-stimulated insulin secretion with no effect on insulin 2 mRNA levels. Under these conditions, there was little effect of GRP78 overexpression on ER stress markers. Knockdown of GRP78 expression under basal glucose conditions reduced cellular insulin levels and glucose-stimulated insulin secretion. Thus, GRP78is essential for insulin biosynthesis, and enhancing chaperone capacity can improve beta-cell function in the presence of prolonged hyperglycemia. In contrast, overexpression of the ER chaperone and oxidoreductase protein-disulfide isomerase (PDI) reduced glucose-stimulated insulin secretion and induced ER stress resulting from the accumulation of proinsulin in the ER. These results suggest a role for both GRP78 and PDI in insulin biosynthesis, although an excess of PDI disrupts normal proinsulin processing.	[Zhang, Liling; Lai, Elida; Teodoro, Tracy; Volchuk, Allen] Univ Hlth Network, Toronto Gen Res Inst, Div Cell & Mol Biol, Toronto, ON M5G 1L7, Canada; [Lai, Elida; Teodoro, Tracy; Volchuk, Allen] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Volchuk, Allen] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto	Volchuk, A (corresponding author), Univ Hlth Network, Toronto Gen Res Inst, Div Cell & Mol Biol, 101 Coll St,TMDT 10-707, Toronto, ON M5G 1L7, Canada.	avolchuk@uhnres.utoronto.ca			Canadian Diabetes Association Operating [GA-2-06-2138-AV]; Canadian Foundation for Innovation and the Ontario Innovation Trust	Canadian Diabetes Association Operating; Canadian Foundation for Innovation and the Ontario Innovation Trust	This work was supported, in part, by Canadian Diabetes Association Operating Grant GA-2-06-2138-AV ( to A. V.). Infrastructure support for laboratory of A. V. was provided by funding from the Canadian Foundation for Innovation and the Ontario Innovation Trust.	Choi SE, 2008, ARCH BIOCHEM BIOPHYS, V475, P109, DOI 10.1016/j.abb.2008.04.015; Davis R, 2000, BIOTECHNOL PROGR, V16, P736, DOI 10.1021/bp000107q; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Dowling P, 2006, PROTEOMICS, V6, P6578, DOI 10.1002/pmic.200600298; Elouil H, 2007, DIABETOLOGIA, V50, P1442, DOI 10.1007/s00125-007-0674-4; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Hatahet F, 2007, FEBS J, V274, P5223, DOI 10.1111/j.1742-4658.2007.06058.x; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Kaniuk NA, 2007, DIABETES, V56, P930, DOI 10.2337/db06-1160; Lai E, 2008, AM J PHYSIOL-ENDOC M, V294, pE540, DOI 10.1152/ajpendo.00478.2007; Lipson KL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001648; Lipson KL, 2006, CELL METAB, V4, P245, DOI 10.1016/j.cmet.2006.07.007; Maeda R, 2007, BBA-PROTEINS PROTEOM, V1774, P1619, DOI 10.1016/j.bbapap.2007.08.016; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Melloul D, 2002, DIABETOLOGIA, V45, P309, DOI 10.1007/s00125-001-0728-y; Morris JA, 1997, J BIOL CHEM, V272, P4327, DOI 10.1074/jbc.272.7.4327; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Olson LK, 1998, MOL ENDOCRINOL, V12, P207, DOI 10.1210/me.12.2.207; Ozawa K, 2005, DIABETES, V54, P657, DOI 10.2337/diabetes.54.3.657; Pirot P, 2007, DIABETOLOGIA, V50, P1006, DOI 10.1007/s00125-007-0609-0; Poitout V, 2006, J NUTR, V136, P873, DOI 10.1093/jn/136.4.873; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; REN J, 2007, J TRANSL MED; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; Robertson RP, 2004, J BIOL CHEM, V279, P42351, DOI 10.1074/jbc.R400019200; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Scheuner D, 2005, NAT MED, V11, P757, DOI 10.1038/nm1259; Schuit F, 2002, DIABETES, V51, pS326, DOI 10.2337/diabetes.51.2007.S326; Seo HY, 2008, ENDOCRINOLOGY, V149, P3832, DOI 10.1210/en.2008-0015; SERVIER CS, 2002, NAT REV MOL CELL BIO, V3, P836; Sevier CS, 2008, BBA-MOL CELL RES, V1783, P549, DOI 10.1016/j.bbamcr.2007.12.011; Shalev A, 2002, ENDOCRINOLOGY, V143, P2541, DOI 10.1210/en.143.7.2541; Ubeda M, 2006, J BIOL CHEM, V281, P28858, DOI 10.1074/jbc.M604690200; Wang HY, 2005, J CELL SCI, V118, P3905, DOI 10.1242/jcs.02513; Wang M, 2007, INT J BIOCHEM CELL B, V39, P2076, DOI 10.1016/j.biocel.2007.05.022; Welch WJ, 1996, CELL STRESS CHAPERON, V1, P109, DOI 10.1379/1466-1268(1996)001<0109:IOMACC>2.3.CO;2; Wicksteed B, 2007, CELL METAB, V5, P221, DOI 10.1016/j.cmet.2007.02.007; Winter J, 2002, J BIOL CHEM, V277, P310, DOI 10.1074/jbc.M107832200; Wiseman RL, 2007, CELL, V131, P809, DOI 10.1016/j.cell.2007.10.025; Wiseman RL, 2007, CURR OPIN CELL BIOL, V19, P359, DOI 10.1016/j.ceb.2007.05.005; Yusta B, 2006, CELL METAB, V4, P391, DOI 10.1016/j.cmet.2006.10.001; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002	44	81	83	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5289	5298		10.1074/jbc.M805477200	http://dx.doi.org/10.1074/jbc.M805477200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19103594	hybrid			2022-12-25	WOS:000263416600059
J	Duby, G; Poreba, W; Piotrowiak, D; Bobik, K; Derua, R; Waelkens, E; Boutry, M				Duby, Geoffrey; Poreba, Wojciech; Piotrowiak, Dominik; Bobik, Krzysztof; Derua, Rita; Waelkens, Etienne; Boutry, Marc			Activation of Plant Plasma Membrane H+-ATPase by 14-3-3 Proteins Is Negatively Controlled by Two Phosphorylation Sites within the H+-ATPase C-terminal Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-POINT MUTATIONS; FUNGAL PATHOGENS; DEFENSE RESPONSE; BINDING-SITE; PROTON PUMP; GUARD-CELLS; BLUE-LIGHT; YEAST; ARABIDOPSIS; FUSICOCCIN	The proton pump ATPase (H+-ATPase) of the plant plasma membrane is regulated by an autoinhibitory C-terminal domain, which can be displaced by phosphorylation of the penultimate Thr residue and the subsequent binding of 14-3-3 proteins. We performed a mass spectrometric analysis of PMA2 (plasma membrane H+-ATPase isoform 2) isolated from Nicotiana tabacum suspension cells and identified two new phosphorylated residues in the enzyme 14-3-3 protein binding site: Thr(931) and Ser(938). When PMA2 was expressed in Saccharomyces cerevisiae, mutagenesis of each of these two residues into Asp prevented growth of a yeast strain devoid of its own H+-ATPases. When the Asp mutations were individually introduced in a constitutively activated mutant of PMA2(E14D), they still allowed yeast growth but at a reduced rate. Purification of His-tagged PMA2 showed that the T931D or S938D mutation prevented 14-3-3 protein binding, although the penultimate Thr(955) was still phosphorylated, indicating that Thr(955) phosphorylation is not sufficient for full enzyme activation. Expression of PMA2 in an N. tabacum cell line also showed an absence of 14-3-3 protein binding resulting from the T931D or S938D mutation. Together, the data show that activation of H+-ATPase by the binding of 14-3-3 proteins is negatively controlled by phosphorylation of two residues in the H+-ATPase 14-3-3 protein binding site. The data also show that phosphorylation of the penultimate Thr and 14- 3- 3 binding each contribute in part to H+-ATPase activation.	[Duby, Geoffrey; Poreba, Wojciech; Piotrowiak, Dominik; Bobik, Krzysztof; Boutry, Marc] Catholic Univ Louvain, Inst Sci Vie, B-1348 Louvain, Belgium; [Derua, Rita; Waelkens, Etienne] Katholieke Univ Leuven, Fac Geneeskunde, Afdeling Biochem, B-3000 Louvain, Belgium	Universite Catholique Louvain; KU Leuven	Duby, G (corresponding author), Catholic Univ Louvain, Inst Sci Vie, Croix Sud 5-15, B-1348 Louvain, Belgium.	geoffrey.duby@uclouvain.be		Boutry, Marc/0000-0002-2315-6900	Interuniversity Poles of Attraction Program; Belgian National Fund for Scientific Research	Interuniversity Poles of Attraction Program; Belgian National Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS)	This work was supported by grants from the Interuniversity Poles of Attraction Program ( Belgian State, Scientific, Technical, and Cultural Services) and the Belgian National Fund for Scientific Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arango M, 2003, PLANTA, V216, P355, DOI 10.1007/s00425-002-0856-8; Baxter I, 2003, PLANT PHYSIOL, V132, P618, DOI 10.1104/pp.103.021923; Buch-Pedersen MJ, 2006, J BIOL CHEM, V281, P38285, DOI 10.1074/jbc.M604781200; Camoni L, 2000, J BIOL CHEM, V275, P9919, DOI 10.1074/jbc.275.14.9919; Camoni L, 2006, PLANT CELL PHYSIOL, V47, P743, DOI 10.1093/pcp/pcj046; Dambly S, 2001, J BIOL CHEM, V276, P7017, DOI 10.1074/jbc.M007740200; Desbrosses G, 1998, EUR J BIOCHEM, V251, P496, DOI 10.1046/j.1432-1327.1998.2510496.x; DEXAERDE AD, 1995, J BIOL CHEM, V270, P23828, DOI 10.1074/jbc.270.40.23828; DUBY G, 2008, PFLUG ARCH IN PRESS; Emi T, 2001, PLANT PHYSIOL, V125, P1115, DOI 10.1104/pp.125.2.1115; Fuglsang AT, 2007, PLANT CELL, V19, P1617, DOI 10.1105/tpc.105.035626; Fuglsang AT, 1999, J BIOL CHEM, V274, P36774, DOI 10.1074/jbc.274.51.36774; Fuglsang AT, 2003, J BIOL CHEM, V278, P42266, DOI 10.1074/jbc.M306707200; Fullone MR, 1998, J BIOL CHEM, V273, P7698, DOI 10.1074/jbc.273.13.7698; Goderis IJWM, 2002, PLANT MOL BIOL, V50, P17, DOI 10.1023/A:1016052416053; Kanczewska J, 2005, P NATL ACAD SCI USA, V102, P11675, DOI 10.1073/pnas.0504498102; Kinoshita T, 1999, EMBO J, V18, P5548, DOI 10.1093/emboj/18.20.5548; Lino B, 1998, PLANTA, V204, P352, DOI 10.1007/s004250050266; Martinez-Munoz GA, 2008, J BIOL CHEM, V283, P20309, DOI 10.1074/jbc.M710470200; Maudoux O, 2000, J BIOL CHEM, V275, P17762, DOI 10.1074/jbc.M909690199; Morsomme P, 1996, EMBO J, V15, P5513, DOI 10.1002/j.1460-2075.1996.tb00936.x; Morsomme P, 1998, J BIOL CHEM, V273, P34837, DOI 10.1074/jbc.273.52.34837; NAGATA T, 1992, INT REV CYTOL, V132, P1, DOI 10.1016/S0074-7696(08)62452-3; Niittylae T, 2007, MOL CELL PROTEOMICS, V6, P1711, DOI 10.1074/mcp.M700164-MCP200; Nuhse TS, 2007, PLANT J, V51, P931, DOI 10.1111/j.1365-313X.2007.03192.x; Nuhse TS, 2003, MOL CELL PROTEOMICS, V2, P1234, DOI 10.1074/mcp.T300006-MCP200; Ookura T, 2005, JARQ-JPN AGR RES Q, V39, P99, DOI 10.6090/jarq.39.99; Ottmann C, 2007, MOL CELL, V25, P427, DOI 10.1016/j.molcel.2006.12.017; PALMGREN MG, 1991, J BIOL CHEM, V266, P20470; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; Schaller A, 1999, PLANT CELL, V11, P263, DOI 10.1105/tpc.11.2.263; SCHALLER GE, 1988, PLANT PHYSIOL, V86, P512, DOI 10.1104/pp.86.2.512; Sondergaard TE, 2004, PLANT PHYSIOL, V136, P2475, DOI 10.1104/pp.104.048231; Sugiyama N, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.32; SUZUKI YS, 1992, PLANT PHYSIOL, V99, P1314, DOI 10.1104/pp.99.4.1314; Svennelid F, 1999, PLANT CELL, V11, P2379, DOI 10.1105/tpc.11.12.2379; Treco D. A., 2001, CURRENT PROTOCOLS MO; van der Fits L, 2000, PLANT MOL BIOL, V43, P495, DOI 10.1023/A:1006440221718; VERAESTRELLA R, 1994, PLANT PHYSIOL, V104, P209, DOI 10.1104/pp.104.1.209; WACH A, 1990, EUR J BIOCHEM, V189, P675, DOI 10.1111/j.1432-1033.1990.tb15536.x; Woloszynska M, 2003, ANN NY ACAD SCI, V986, P198, DOI 10.1111/j.1749-6632.2003.tb07160.x; Wurtele M, 2003, EMBO J, V22, P987, DOI 10.1093/emboj/cdg104; Xing T, 1996, PLANT CELL, V8, P555, DOI 10.2307/3870332; Zhao RM, 1999, PLANT SCI, V149, P157, DOI 10.1016/S0168-9452(99)00155-7	44	46	49	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4213	4221		10.1074/jbc.M807311200	http://dx.doi.org/10.1074/jbc.M807311200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19088078	hybrid			2022-12-25	WOS:000263134400018
J	Bansal, PK; Nourse, A; Abdulle, R; Kitagawa, K				Bansal, Parmil K.; Nourse, Amanda; Abdulle, Rashid; Kitagawa, Katsumi			Sgt1 Dimerization Is Required for Yeast Kinetochore Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE KINETOCHORE; CENTROMERE-BINDING PROTEIN; SIZE-DISTRIBUTION ANALYSIS; BUDDING YEAST; CHROMOSOME SEGREGATION; ESSENTIAL COMPONENT; CELL-CYCLE; COMPLEX; HSP90; DNA	The kinetochore, which consists of DNA sequence elements and structural proteins, is essential for high-fidelity chromosome transmission during cell division. In budding yeast, Sgt1 and Hsp90 help assemble the core kinetochore complex CBF3 by activating the CBF3 components Skp1 and Ctf13. In this study, we show that Sgt1 forms homodimers by performing in vitro and in vivo immunoprecipitation and analytical ultracentrifugation analyses. Analyses of the dimerization of Sgt1 deletion proteins showed that the Skp1-binding domain (amino acids 1-211) contains the Sgt1 homodimerization domain. Also, the Sgt1 mutant proteins that were unable to dimerize also did not bind Skp1, suggesting that Sgt1 dimerization is important for Sgt1-Skp1 binding. Restoring dimerization activity of a dimerization-deficient sgt1 mutant (sgt1-L31P) by using the CENP-B (centromere protein-B) dimerization domain suppressed the temperature sensitivity, the benomyl sensitivity, and the chromosome missegregation phenotype of sgt1-L31P. These results strongly suggest that Sgt1 dimerization is required for kinetochore assembly.	[Bansal, Parmil K.; Abdulle, Rashid; Kitagawa, Katsumi] St Jude Childrens Hosp, Dept Mol Pharmacol, Memphis, TN 38105 USA; [Nourse, Amanda] St Jude Childrens Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Kitagawa, K (corresponding author), St Jude Childrens Hosp, Dept Mol Pharmacol, MS 230,262 Danny Thomas Pl, Memphis, TN 38105 USA.	katsumi.kitagawa@stjude.org		Nourse, Amanda/0000-0003-4595-5321	National Institutes of Health [GM68418]; NCI [CA21765]; American Lebanese Syrian Association Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068418] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Lebanese Syrian Association Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM68418 and Cancer Center Support Grant CA21765 from NCI. This work was also supported by the American Lebanese Syrian Association Charities. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Azevedo C, 2002, SCIENCE, V295, P2073, DOI 10.1126/science.1067554; BAKER RE, 1990, MOL CELL BIOL, V10, P2458, DOI 10.1128/MCB.10.6.2458; Bansal PK, 2004, MOL CELL BIOL, V24, P8069, DOI 10.1128/MCB.24.18.8069-8079.2004; CAI MJ, 1989, MOL CELL BIOL, V9, P2544, DOI 10.1128/MCB.9.6.2544; CAI MJ, 1990, CELL, V61, P437, DOI 10.1016/0092-8674(90)90525-J; Catlett MG, 2006, J BIOL CHEM, V281, P33739, DOI 10.1074/jbc.M603847200; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Connelly C, 1996, CELL, V86, P275, DOI 10.1016/S0092-8674(00)80099-9; DOHENY KF, 1993, CELL, V73, P761, DOI 10.1016/0092-8674(93)90255-O; Dubacq C, 2002, EUKARYOT CELL, V1, P568, DOI 10.1128/EC.1.4.568-582.2002; FITZGERALDHAYES M, 1982, CELL, V29, P235, DOI 10.1016/0092-8674(82)90108-8; Garcia-Ranea JA, 2002, FEBS LETT, V529, P162, DOI 10.1016/S0014-5793(02)03321-5; GOH PY, 1993, J CELL BIOL, V121, P503, DOI 10.1083/jcb.121.3.503; HEGEMANN JH, 1988, MOL CELL BIOL, V8, P2523, DOI 10.1128/MCB.8.6.2523; HIETER P, 1985, CELL, V42, P913, DOI 10.1016/0092-8674(85)90287-9; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JIANG WD, 1993, J CELL BIOL, V121, P513, DOI 10.1083/jcb.121.3.513; Kaplan KB, 1997, CELL, V91, P491, DOI 10.1016/S0092-8674(00)80435-3; Kitagawa K, 2003, MOL CELL, V11, P1201, DOI 10.1016/S1097-2765(03)00145-X; KITAGAWA K, 1995, MOL CELL BIOL, V15, P1602; Kitagawa K, 2002, BIOTECHNIQUES, V33, P288, DOI 10.2144/02332bm07; Kitagawa K, 1999, MOL CELL, V4, P21, DOI 10.1016/S1097-2765(00)80184-7; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LECHNER J, 1991, CELL, V64, P717, DOI 10.1016/0092-8674(91)90501-O; LECHNER J, 1994, EMBO J, V13, P5203, DOI 10.1002/j.1460-2075.1994.tb06851.x; Lee YT, 2004, J BIOL CHEM, V279, P16511, DOI 10.1074/jbc.M400215200; Lingelbach LB, 2004, MOL CELL BIOL, V24, P8938, DOI 10.1128/MCB.24.20.8938-8950.2004; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Niikura Y, 2006, ONCOGENE, V25, P4133, DOI 10.1038/sj.onc.1209461; Nyarko A, 2007, BIOCHEMISTRY-US, V46, P11331, DOI 10.1021/bi700735t; Rose MD., 1990, METHODS YEAST GENETI; Russell ID, 1999, J CELL BIOL, V145, P933, DOI 10.1083/jcb.145.5.933; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schuck P, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P26; Sorger PK, 1995, P NATL ACAD SCI USA, V92, P12026, DOI 10.1073/pnas.92.26.12026; Steensgaard P, 2004, EMBO REP, V5, P626, DOI 10.1038/sj.embor.7400154; Stemmann O, 1996, EMBO J, V15, P3611, DOI 10.1002/j.1460-2075.1996.tb00730.x; Stemmann O, 2002, P NATL ACAD SCI USA, V99, P8585, DOI 10.1073/pnas.082223899; STRUNNIKOV AV, 1995, J CELL BIOL, V128, P749, DOI 10.1083/jcb.128.5.749; Sudakin V, 2007, BIODRUGS, V21, P225, DOI 10.2165/00063030-200721040-00003; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Westermann S, 2007, ANNU REV BIOCHEM, V76, P563, DOI 10.1146/annurev.biochem.76.052705.160607	44	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3586	3592		10.1074/jbc.M806281200	http://dx.doi.org/10.1074/jbc.M806281200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19073600	Green Published, hybrid			2022-12-25	WOS:000262872500026
J	Zuckerman, V; Lenos, K; Popowicz, GM; Silberman, I; Grossman, T; Marine, JC; Holak, TA; Jochemsen, AG; Haupt, Y				Zuckerman, Valentina; Lenos, Kristiaan; Popowicz, Grzegorz M.; Silberman, Isabelle; Grossman, Tamar; Marine, Jean-Christophe; Holak, Tad A.; Jochemsen, Aart G.; Haupt, Ygal			c-Abl Phosphorylates Hdmx and Regulates Its Interaction with p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; TYROSINE KINASE; MDMX; ACTIVATION; STABILIZATION; DEGRADATION; PATHWAY; STRESS; ATM; UBIQUITINATION	Upon exposure to DNA damage the p53 tumor suppressor is accumulated and activated to stall cellular growth. For this to occur, p53 must be relieved from its major inhibitors, Mdm2 (Hdm2 in humans) and Mdmx (Mdm4; Hdmx in humans). A key mechanism controlling this relief is the post-translational modifications of p53 and its inhibitors. We have previously demonstrated that the stress-activated tyrosine kinase, c-Abl, contributes to the relief of p53 from Hdm2. Because Hdmx is the major inhibitor of p53 activity, the additional possibility that c-Abl protects p53 through targeting Hdmx was explored in this study. c-Abl was found to interact with and to phosphorylate Hdmx. This phosphorylation was enhanced in response to DNA damage. Importantly, we mapped the sites of phosphorylation to the p53 binding domain of Hdmx. One of these phosphorylations, on tyrosine 99, inhibited Hdmx interaction with p53. This inhibition is consistent with the predicted role of this residue in the interaction with p53 based on the crystal structure of the interaction site. Our results show that c-Abl not only targets Hdm2, but also Hdmx, which together contribute to p53 activation in response to DNA damage.	[Zuckerman, Valentina; Silberman, Isabelle; Grossman, Tamar; Haupt, Ygal] Hebrew Univ Jerusalem, Sch Med, Lautenberg Ctr Gen & Tumor Immunol, IL-91120 Jerusalem, Israel; [Lenos, Kristiaan; Jochemsen, Aart G.] Leiden Univ, Med Ctr, Dept Mol & Cell Biol, NL-2300 RA Leiden, Netherlands; [Popowicz, Grzegorz M.; Holak, Tad A.] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Marine, Jean-Christophe] Univ Ghent, Lab Mol Canc Biol, VIB, B-9052 Ghent, Belgium	Hebrew University of Jerusalem; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Max Planck Society; Flanders Institute for Biotechnology (VIB); Ghent University	Haupt, Y (corresponding author), Peter MacCallum Canc Ctr, Div Res, St Andrews Pl, Melbourne, Vic 3002, Australia.	Ygal.Haupt@petermac.org	Popowicz, Grzegorz/G-4769-2017; Grossman, Tamar/CAI-8262-2022; Marine, Jean Christophe/J-2237-2015; Marine, Jean-Christophe/K-3292-2016	Popowicz, Grzegorz/0000-0003-2818-7498; Grossman, Tamar/0000-0001-6301-1696; Marine, Jean-Christophe/0000-0003-2433-9837; Haupt, Ygal/0000-0001-5925-0096	Israel Science Foundation [1341/05]; Association for International Cancer Research; Dutch Cancer Society [UL 2006-3595]; Deutsche Krebshilfe [108354]; European Community [503576]	Israel Science Foundation(Israel Science Foundation); Association for International Cancer Research; Dutch Cancer Society(KWF Kankerbestrijding); Deutsche Krebshilfe(Deutsche Krebshilfe); European Community(European Commission)	This work was supported by Israel Science Foundation Grant 1341/05, the Association for International Cancer Research, the Dutch Cancer Society Grant UL 2006-3595, the Deutsche Krebshilfe Grant 108354, and by European Community FP6 funding of European Commission Contract 503576. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Chen LH, 2005, EMBO J, V24, P3411, DOI 10.1038/sj.emboj.7600812; Chen LH, 2005, MOL CELL BIOL, V25, P6509, DOI 10.1128/MCB.25.15.6509-6520.2005; Danovi D, 2004, MOL CELL BIOL, V24, P5835, DOI 10.1128/MCB.24.13.5835-5843.2004; de Graaf P, 2003, J BIOL CHEM, V278, P38315, DOI 10.1074/jbc.M213034200; Dias SS, 2006, ONCOGENE, V25, P6666, DOI 10.1038/sj.onc.1209671; Gilkes DM, 2007, CELL CYCLE, V6, P151, DOI 10.4161/cc.6.2.3719; Goldberg Z, 2002, EMBO J, V21, P3715, DOI 10.1093/emboj/cdf384; Gu JJ, 2002, J BIOL CHEM, V277, P19251, DOI 10.1074/jbc.C200150200; Haupt Y, 1996, EMBO J, V15, P1596, DOI 10.1002/j.1460-2075.1996.tb00504.x; Jing Y, 2007, J BIOCHEM, V141, P621, DOI 10.1093/jb/mvm068; Kawai H, 2003, J BIOL CHEM, V278, P45946, DOI 10.1074/jbc.M308295200; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; LeBron C, 2006, EMBO J, V25, P1196, DOI 10.1038/sj.emboj.7601032; Levav-Cohen Y, 2005, BIOCHEM BIOPH RES CO, V331, P737, DOI 10.1016/j.bbrc.2005.03.152; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Li CG, 2002, MOL CELL BIOL, V22, P7562, DOI 10.1128/MCB.22.21.7562-7571.2002; Lopez-Pajares V, 2008, J BIOL CHEM, V283, P13707, DOI 10.1074/jbc.M710030200; Marine JC, 2006, CELL DEATH DIFFER, V13, P927, DOI 10.1038/sj.cdd.4401912; Marine JC, 2005, BIOCHEM BIOPH RES CO, V331, P750, DOI 10.1016/j.bbrc.2005.03.151; Marine JCW, 2007, J CELL SCI, V120, P371, DOI 10.1242/jcs.03362; Meek DW, 2004, DNA REPAIR, V3, P1049, DOI 10.1016/j.dnarep.2004.03.027; Meek DW, 2003, MOL CANCER RES, V1, P1017; Meulmeester E, 2005, CELL CYCLE, V4, P1166, DOI 10.4161/cc.4.9.1981; Meulmeester E, 2005, MOL CELL, V18, P565, DOI 10.1016/j.molcel.2005.04.024; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Migliorini D, 2002, MOL CELL BIOL, V22, P5527, DOI 10.1128/MCB.22.15.5527-5538.2002; Okamoto K, 2005, MOL CELL BIOL, V25, P9608, DOI 10.1128/MCB.25.21.9608-9620.2005; Pan Y, 2003, MOL CELL BIOL, V23, P5113, DOI 10.1128/MCB.23.15.5113-5121.2003; Pereg Y, 2006, MOL CELL BIOL, V26, P6819, DOI 10.1128/MCB.00562-06; Popowicz GM, 2007, CELL CYCLE, V6, P2386, DOI 10.4161/cc.6.19.4740; Prodosmo A, 2008, J MOL MED-JMM, V86, P585, DOI 10.1007/s00109-008-0322-6; Ramos YFM, 2001, CANCER RES, V61, P1839; Sharp DA, 1999, J BIOL CHEM, V274, P38189, DOI 10.1074/jbc.274.53.38189; Shaul Y, 2005, CELL RES, V15, P33, DOI 10.1038/sj.cr.7290261; Sionov RV, 2001, MOL CELL BIOL, V21, P5869; Sionov RV, 1999, J BIOL CHEM, V274, P8371, DOI 10.1074/jbc.274.13.8371; Stad R, 2000, J BIOL CHEM, V275, P28039; Sun XG, 2000, J BIOL CHEM, V275, P17237, DOI 10.1074/jbc.C000099200; Tanimura S, 1999, FEBS LETT, V447, P5, DOI 10.1016/S0014-5793(99)00254-9; Toledo F, 2007, INT J BIOCHEM CELL B, V39, P1476, DOI 10.1016/j.biocel.2007.03.022; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wei G, 2005, J BIOL CHEM, V280, P12271, DOI 10.1074/jbc.M409522200; Wilm M, 1996, ANAL CHEM, V68, P1, DOI 10.1021/ac9509519; Zhu JY, 2004, CURR TOP DEV BIOL, V59, P165, DOI 10.1016/S0070-2153(04)59007-5	46	52	54	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					4031	4039		10.1074/jbc.M809211200	http://dx.doi.org/10.1074/jbc.M809211200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19075013	hybrid			2022-12-25	WOS:000262872500071
J	Zhou, XP; Miller, MR; Motaleb, M; Charon, NW; He, PNA				Zhou, Xueping; Miller, Michael R.; Motaleb, Md; Charon, Nyles W.; He, Pingnian			Spent Culture Medium from Virulent Borrelia burgdorferi Increases Permeability of Individually Perfused Microvessels of Rat Mesentery	PLOS ONE			English	Article								Background: Lyme disease is a common vector-borne disease caused by the spirochete Borrelia burgdorferi (Bb), which manifests as systemic and targeted tissue inflammation. Both in vitro and in vivo studies have shown that Bb-induced inflammation is primarily host-mediated, via cytokine or chemokine production that promotes leukocyte adhesion/migration. Whether Bb produces mediators that can directly alter the vascular permeability in vivo has not been investigated. The objective of the present study was to investigate if Bb produces a mediator(s) that can directly activate endothelial cells resulting in increases in permeability in intact microvessels in the absence of blood cells. Methodology/Principal Findings: The effects of cell-free, spent culture medium from virulent (B31-A3) and avirulent (B31-A) B. burgdorferi on microvessel permeability and endothelial calcium concentration, [Ca2+](i), were examined in individually perfused rat mesenteric venules. Microvessel permeability was determined by measuring hydraulic conductivity (Lp). Endothelial [Ca2+](i), a necessary signal initiating hyperpermeability, was measured in Fura-2 loaded microvessels. B31-A3 spent medium caused a rapid and transient increase in Lp and endothelial [Ca2+](i). Within 2-5 min, the mean peak Lp increased to 5.6 +/- 0.9 times the control, and endothelial [Ca2+](i) increased from 113 +/- 11 nM to a mean peak value of 324 +/- 35 nM. In contrast, neither endothelial [Ca2+](i) nor Lp was altered by B31-A spent medium. Conclusions/Significance: A mediator(s) produced by virulent Bb under culture conditions directly activates endothelial cells, resulting in increases in microvessel permeability. Most importantly, the production of this mediator is associated with Bb virulence and is likely produced by one or more of the 8 plasmid(s) missing from strain B31-A.	[He, Pingnian] W Virginia Univ, Dept Physiol & Pharmacol, Morgantown, WV 26506 USA; [Miller, Michael R.] W Virginia Univ, Dept Biochem, Morgantown, WV USA; [Motaleb, Md; Charon, Nyles W.] W Virginia Univ, Dept Microbiol, Immunol & Cell Biol, Morgantown, WV USA	West Virginia University; West Virginia University; West Virginia University	Zhou, XP (corresponding author), W Virginia Univ, Dept Physiol & Pharmacol, Morgantown, WV 26506 USA.	phe@hsc.wvu.edu		HE, Pingnian/0000-0001-7346-7419; MOTALEB, MD/0000-0003-2761-5104	National Heart, Lung and Blood Institute [HL56237, HL084338]; Allergy and Infectious Diseases Institute [AI29743]; American Heart Association [0755614B]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084338, R01HL056237, R29HL056237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029743] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Allergy and Infectious Diseases Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Heart, Lung and Blood Institute grants HL56237 and HL084338 (P. He), Allergy and Infectious Diseases Institute grant AI29743 (N. W. Charon) and American Heart Association grant 0755614B (M. R. Miller). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson RH, 2005, INFECT IMMUN, V73, P4879, DOI 10.1128/IAI.73.8.4879-4887.2005; Adamson RH, 2003, AM J PHYSIOL-HEART C, V285, pH406, DOI 10.1152/ajpheart.00021.2003; Bakker RG, 2007, APPL ENVIRON MICROB, V73, P1180, DOI 10.1128/AEM.01913-06; Ben-Menachem G, 2003, P NATL ACAD SCI USA, V100, P7913, DOI 10.1073/pnas.1232451100; Bolz DD, 2004, J IMMUNOL, V173, P2003, DOI 10.4049/jimmunol.173.3.2003; Bono JL, 2000, J BACTERIOL, V182, P2445, DOI 10.1128/JB.182.9.2445-2452.2000; Burns MJ, 1997, INFECT IMMUN, V65, P1217, DOI 10.1128/IAI.65.4.1217-1222.1997; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Dame TM, 2007, J IMMUNOL, V178, P1172, DOI 10.4049/jimmunol.178.2.1172; Elias AF, 2002, INFECT IMMUN, V70, P2139, DOI 10.1128/IAI.70.4.2139-2150.2002; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Gergel EI, 2001, INFECT IMMUN, V69, P2190, DOI 10.1128/IAI.69.4.2190-2197.2001; Grab DJ, 2007, CLIN VACCINE IMMUNOL, V14, P1420, DOI 10.1128/CVI.00308-07; Grab DJ, 2005, INFECT IMMUN, V73, P1014, DOI 10.1128/IAI.73.2.1014-1022.2005; Guerau-De-Arellano M, 2005, TRENDS MOL MED, V11, P114, DOI 10.1016/j.molmed.2005.01.003; Haake DA, 2000, MICROBIOL-SGM, V146, P1491, DOI 10.1099/00221287-146-7-1491; HE P, 1990, AM J PHYSIOL, V258, pH1366; HE P, 1994, J APPL PHYSIOL, V76, P2288, DOI 10.1152/jappl.1994.76.6.2288; He P, 1996, AM J PHYSIOL-HEART C, V271, pH2377, DOI 10.1152/ajpheart.1996.271.6.H2377; He PN, 2006, AM J PHYSIOL-HEART C, V291, pH591, DOI 10.1152/ajpheart.01228.2005; Hirschfeld M, 1999, J IMMUNOL, V163, P2382; Jewett MW, 2007, MOL MICROBIOL, V66, P975, DOI 10.1111/j.1365-2958.2007.05969.x; Jewett MW, 2007, MOL MICROBIOL, V64, P1358, DOI 10.1111/j.1365-2958.2007.05746.x; Jiang YY, 2008, AM J PHYSIOL-HEART C, V295, pH898, DOI 10.1152/ajpheart.00309.2008; KENDALL S, 1995, EXP PHYSIOL, V80, P359, DOI 10.1113/expphysiol.1995.sp003853; Kisand KE, 2007, APMIS, V115, P134, DOI 10.1111/j.1600-0463.2007.apm_538.x; KORTHUIS RJ, 1984, MICROVASC RES, V28, P322, DOI 10.1016/0026-2862(84)90004-9; Lawrenz MB, 2002, INFECT IMMUN, V70, P4798, DOI 10.1128/IAI.70.9.4798-4804.2002; Liu NY, 2004, INFECT IMMUN, V72, P3195, DOI 10.1128/IAI.72.6.3195-3203.2004; MCDONALD DM, 1994, AM J PHYSIOL, V266, pL61, DOI 10.1152/ajplung.1994.266.1.L61; Moriarty TJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000090; Norman MU, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000169; Pinto DS, 2002, MED CLIN N AM, V86, P285, DOI 10.1016/S0025-7125(03)00087-7; Purser JE, 2000, P NATL ACAD SCI USA, V97, P13865, DOI 10.1073/pnas.97.25.13865; Schroder NWJ, 2005, J IMMUNOL, V175, P2534, DOI 10.4049/jimmunol.175.4.2534; SELLATI TJ, 1995, INFECT IMMUN, V63, P4439, DOI 10.1128/IAI.63.11.4439-4447.1995; Sellati TJ, 1996, INFECT IMMUN, V64, P3180, DOI 10.1128/IAI.64.8.3180-3187.1996; Steere AC, 2006, WIEN KLIN WOCHENSCHR, V118, P625, DOI 10.1007/s00508-006-0687-x; TAKAYAMA K, 1987, INFECT IMMUN, V55, P2311, DOI 10.1128/IAI.55.9.2311-2313.1987; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Tourand Y, 2006, J BACTERIOL, V188, P7378, DOI 10.1128/JB.00760-06; WHITMIRE WM, 1993, INFECT IMMUN, V61, P1460, DOI 10.1128/IAI.61.4.1460-1467.1993; Wooten RM, 2002, J IMMUNOL, V168, P348, DOI 10.4049/jimmunol.168.1.348; Wormser GP, 2006, NEW ENGL J MED, V354, P2794, DOI 10.1056/NEJMcp061181; Zeng M, 2002, AM J PHYSIOL-HEART C, V283, pH2420, DOI 10.1152/ajpheart.00787.2001; Zhu LK, 2005, AM J PHYSIOL-HEART C, V288, pH2869, DOI 10.1152/ajpheart.01080.2004	46	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4101	10.1371/journal.pone.0004101	http://dx.doi.org/10.1371/journal.pone.0004101			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DO	19116656	Green Published, gold, Green Submitted			2022-12-25	WOS:000265466600019
J	Bauler, TJ; Hendriks, WJAJ; King, PD				Bauler, Timothy J.; Hendriks, Wiljan J. A. J.; King, Philip D.			The FERM and PDZ Domain-Containing Protein Tyrosine Phosphatases, PTPN4 and PTPN3, Are Both Dispensable for T Cell Receptor Signal Transduction	PLOS ONE			English	Article								PTPN3 and PTPN4 are two closely-related non-receptor protein tyrosine phosphatases (PTP) that, in addition to a PTP domain, contain FERM (Band 4.1, Ezrin, Radixin, and Moesin) and PDZ (PSD-95, Dlg, ZO-1) domains. Both PTP have been implicated as negative-regulators of early signal transduction through the T cell antigen receptor (TCR), acting to dephosphorylate the TCR zeta chain, a component of the TCR complex. Previously, we reported upon the production and characterization of PTPN3-deficient mice which show normal TCR signal transduction and T cell function. To address if the lack of a T cell phenotype in PTPN3-deficient mice can be explained by functional redundancy of PTPN3 with PTPN4, we generated PTPN4-deficient and PTPN4/PTPN3 double-deficient mice. As in PTPN3 mutants, T cell development and homeostasis and TCR-induced cytokine synthesis and proliferation were found to be normal in PTPN4-deficient and PTPN4/PTPN3 double-deficient mice. PTPN13 is another FERM and PDZ domain-containing non-receptor PTP that is distantly-related to PTPN3 and PTPN4 and which has been shown to function as a negative-regulator of T helper-1 (Th1) and Th2 differentiation. Therefore, to determine if PTPN13 might compensate for the loss of PTPN3 and PTPN4 in T cells, we generated mice that lack functional forms of all three PTP. T cells from triple-mutant mice developed normally and showed normal cytokine secretion and proliferative responses to TCR stimulation. Furthermore, T cell differentiation along the Th1, Th2 and Th17 lineages was largely unaffected in triple-mutants. We conclude that PTPN3 and PTPN4 are dispensable for TCR signal transduction.	[King, Philip D.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Hendriks, Wiljan J. A. J.] Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Cell Biol, Nijmegen, Netherlands	University of Michigan System; University of Michigan; Radboud University Nijmegen	Bauler, TJ (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	kingp@umich.edu	Hendriks, Wiljan/Q-4325-2019; King, Phil/C-7104-2013; Hendriks, Wiljan J.A.J./A-5214-2013	Hendriks, Wiljan/0000-0001-9481-8281; Hendriks, Wiljan J.A.J./0000-0001-9481-8281; Bauler, Timothy/0000-0002-5170-0125	American Heart Association [0555597Z]; NIH National Research Service Award [5-T32-GM07544]; National Institute of General Medical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007544] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Heart Association grant 0555597Z and by NIH National Research Service Award #5-T32-GM07544 from the National Institute of General Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALGRAIN M, 1993, J CELL BIOL, V120, P129, DOI 10.1083/jcb.120.1.129; Bauler TJ, 2007, J IMMUNOL, V178, P3680, DOI 10.4049/jimmunol.178.6.3680; Bompard G, 2003, J CELL SCI, V116, P2519, DOI 10.1242/jcs.00448; Chu DH, 1998, IMMUNOL REV, V165, P167, DOI 10.1111/j.1600-065X.1998.tb01238.x; Erdmann KS, 2003, EUR J BIOCHEM, V270, P4789, DOI 10.1046/j.1432-1033.2003.03895.x; Gjorloff-Wingren A, 2000, EUR J IMMUNOL, V30, P2412, DOI 10.1002/1521-4141(2000)30:8<2412::AID-IMMU2412>3.0.CO;2-J; GU MX, 1991, P NATL ACAD SCI USA, V88, P5867, DOI 10.1073/pnas.88.13.5867; Han SL, 2000, EUR J IMMUNOL, V30, P1318, DOI 10.1002/(SICI)1521-4141(200005)30:5<1318::AID-IMMU1318>3.0.CO;2-G; Hasegawa K, 2004, SCIENCE, V303, P685, DOI 10.1126/science.1092138; Hendriks WJAJ, 2008, FEBS J, V275, P816, DOI 10.1111/j.1742-4658.2008.06249.x; Hironaka K, 2000, J BIOL CHEM, V275, P16167, DOI 10.1074/jbc.M909302199; Jing M, 2007, J VIROL, V81, P2231, DOI 10.1128/JVI.01979-06; KENNETH M, 2007, JANEWAYS IMMUNOBIOLO; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kina S, 2007, EUR J NEUROSCI, V26, P2269, DOI 10.1111/j.1460-9568.2007.05829.x; Lorber B, 2005, EUR J NEUROSCI, V21, P2375, DOI 10.1111/j.1460-9568.2005.04065.x; Lorenz U, 1996, P NATL ACAD SCI USA, V93, P9624, DOI 10.1073/pnas.93.18.9624; Mustelin T, 2005, NAT REV IMMUNOL, V5, P43, DOI 10.1038/nri1530; Nakahira M, 2007, IMMUNITY, V26, P163, DOI 10.1016/j.immuni.2007.01.010; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Pao LI, 2007, ANNU REV IMMUNOL, V25, P473, DOI 10.1146/annurev.immunol.23.021704.115647; Park KW, 2000, GENE, V257, P45, DOI 10.1016/S0378-1119(00)00351-6; Pasquali C, 2003, MOL ENDOCRINOL, V17, P2228, DOI 10.1210/me.2003-0011; Patrignani C, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-36; Pilecka I, 2007, J BIOL CHEM, V282, P35405, DOI 10.1074/jbc.M705814200; Pitcher LA, 2003, TRENDS IMMUNOL, V24, P554, DOI 10.1016/j.it.2003.08.003; SATO T, 1995, SCIENCE, V268, P411, DOI 10.1126/science.7536343; Sommers CL, 2004, BIOESSAYS, V26, P61, DOI 10.1002/bies.10384; Sozio MS, 2004, J BIOL CHEM, V279, P7760, DOI 10.1074/jbc.M309994200; Spanos WC, 2008, J VIROL, V82, P2493, DOI 10.1128/JVI.02188-07; Topffer S, 2007, J GEN VIROL, V88, P2956, DOI 10.1099/vir.0.83123-0; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; Wansink DG, 2004, PHYSIOL GENOMICS, V19, P50, DOI 10.1152/physiolgenomics.00079.2004; Whited JL, 2007, DEVELOPMENT, V134, P43, DOI 10.1242/dev.02718; YANG Q, 1991, P NATL ACAD SCI USA, V88, P5949, DOI 10.1073/pnas.88.14.5949; Young JA, 2008, MOL IMMUNOL, V45, P3756, DOI 10.1016/j.molimm.2008.05.023; Zimmermann P, 2002, MOL CELL, V9, P1215, DOI 10.1016/S1097-2765(02)00549-X	38	22	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4014	10.1371/journal.pone.0004014	http://dx.doi.org/10.1371/journal.pone.0004014			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107198	Green Submitted, Green Published, gold			2022-12-25	WOS:000265463000009
J	Zhou, JF; Li, WH; Kamei, H; Duan, CM				Zhou, Jianfeng; Li, Wenhong; Kamei, Hiroyasu; Duan, Cunming			Duplication of the IGFBP-2 Gene in Teleost Fish: Protein Structure and Functionality Conservation and Gene Expression Divergence	PLOS ONE			English	Article							FACTOR-BINDING PROTEIN-2; CELL-PROLIFERATION; GROWTH; MUTATION; ROLES; MICE	Background: Insulin-like growth factor binding protein-2 (IGFBP-2) is a secreted protein that binds and regulates IGF actions in controlling growth, development, reproduction, and aging. Elevated expression of IGFBP-2 is often associated with progression of many types of cancers. Methodology/Principal Findings: We report the identification and characterization of two IGFBP-2 genes in zebrafish and four other teleost fish. Comparative genomics and structural analyses suggest that they are co-orthologs of the human IGFBP-2 gene. Biochemical assays show that both zebrafish igfbp-2a and -2b encode secreted proteins that bind IGFs. These two genes exhibit distinct spatiotemporal expression patterns. During embryogenesis, IGFBP-2a mRNA is initially detected in the lens, then in the brain boundary vasculature, and subsequently becomes highly expressed in the liver. In the adult stage, liver has the highest levels of IGFBP-2a mRNA, followed by the brain. Low levels of IGFBP-2a mRNA were detected in muscle and in the gonad in male adults only. IGFBP-2b mRNA is detected initially in all tissues at low levels, but later becomes abundant in the liver. In adult males, IGFBP-2b mRNA is only detected in the liver. In adult females, it is also found in the gut, kidney, ovary, and muscle. To gain insights into how the IGFBP-2 genes may have evolved through partitioning of ancestral functions, functional and mechanistic studies were carried out. Expression of zebrafish IGFBP-2a and -2b caused significant decreases in the growth and developmental rates and their effects are comparable to that of human IGFBP-2. IGFBP-2 mutants with altered IGF binding-, RGD-, and heparin- binding sites were generated and their actions examined. While mutating the RGD and heparin binding sites had little effect, altering the IGF binding site abolished its biological activity. Conclusions/Significance: These results suggest that IGFBP-2 is a conserved regulatory protein and it inhibits growth and development primarily by binding to and inhibiting IGF actions in vivo. The duplicated IGFBP-2 genes may provide additional flexibility in the regulation of IGF activities.	[Zhou, Jianfeng; Li, Wenhong; Kamei, Hiroyasu; Duan, Cunming] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Zhou, Jianfeng; Duan, Cunming] Ocean Univ China, Sch Med & Pharm, Lab Mol Med, Qingdao, Peoples R China; [Li, Wenhong] Guangxi Univ, Dept Aquacult, Nanning, Peoples R China	University of Michigan System; University of Michigan; Ocean University of China; Guangxi University	Zhou, JF (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	cduan@umich.edu		KAMEI, HIROYASU/0000-0001-7123-040X	NSF [IOB 0110864]; Changjiang Scholars Program [fellowship]; Chinese Academy of Sciences [scholarship]; Guangxi Government [fellowship]	NSF(National Science Foundation (NSF)); Changjiang Scholars Program(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Chinese Academy of Sciences(Chinese Academy of Sciences); Guangxi Government	This study was supported by NSF Research Grant IOB 0110864 and by a fellowship from the Changjiang Scholars Program to CD. JZ was supported in part by a scholarship from the Chinese Academy of Sciences and WL was supported in part by a fellowship from the Guangxi Government during this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLANDER SV, 1994, J BIOL CHEM, V269, P10891; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Clemmons DR, 2001, ENDOCR REV, V22, P800, DOI 10.1210/er.22.6.800; DeMambro VE, 2008, ENDOCRINOLOGY, V149, P2051, DOI 10.1210/en.2007-1068; Duan C, 2002, J ENDOCRINOL, V175, P41, DOI 10.1677/joe.0.1750041; Duan CM, 1999, P NATL ACAD SCI USA, V96, P15274, DOI 10.1073/pnas.96.26.15274; Duan CM, 2005, GEN COMP ENDOCR, V142, P44, DOI 10.1016/j.ygcen.2004.12.022; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Forbes BE, 1998, J BIOL CHEM, V273, P4647, DOI 10.1074/jbc.273.8.4647; Hoeflich A, 1999, ENDOCRINOLOGY, V140, P5488, DOI 10.1210/en.140.12.5488; Hoeflich A, 2002, FEBS LETT, V523, P63, DOI 10.1016/S0014-5793(02)02935-6; Honegger Basil, 2008, J Biol, V7, P10, DOI 10.1186/jbiol72; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; Kajimura S, 2005, P NATL ACAD SCI USA, V102, P1240, DOI 10.1073/pnas.0407443102; Kamei H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003091; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Maures T, 2002, ENDOCRINOLOGY, V143, P1858, DOI 10.1210/en.143.5.1858; Neumann GM, 1999, J BIOL CHEM, V274, P14587, DOI 10.1074/jbc.274.21.14587; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Postlethwait JH, 2000, GENOME RES, V10, P1890, DOI 10.1101/gr.164800; Pozios KC, 2001, AM J PHYSIOL-REG I, V280, pR1230, DOI 10.1152/ajpregu.2001.280.4.R1230; Russo VC, 2005, ENDOCRINOLOGY, V146, P4445, DOI 10.1210/en.2005-0467; Schlueter PJ, 2006, FASEB J, V20, P1230, DOI 10.1096/fj.05-3882fje; Schutt BS, 2004, J MOL ENDOCRINOL, V32, P859, DOI 10.1677/jme.0.0320859; Shimizu M, 2000, GEN COMP ENDOCR, V119, P26, DOI 10.1006/gcen.2000.7498; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Wang GK, 2006, J BIOL CHEM, V281, P14085, DOI 10.1074/jbc.M513686200; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Wood AW, 2005, INT REV CYTOL, V243, P215, DOI 10.1016/S0074-7696(05)43004-1; Wood AW, 2005, MOL ENDOCRINOL, V19, P1024, DOI 10.1210/me.2004-0392; Wood TL, 2000, MOL ENDOCRINOL, V14, P1472, DOI 10.1210/me.14.9.1472	31	69	74	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2008	3	12							e3926	10.1371/journal.pone.0003926	http://dx.doi.org/10.1371/journal.pone.0003926			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZW	19081843	gold, Green Published, Green Submitted			2022-12-25	WOS:000265456300005
J	Gupta, SS; Borin, BN; Cover, TL; Krezel, AM				Gupta, Shobhana S.; Borin, Brendan N.; Cover, Timothy L.; Krezel, Andrzej M.			Structural Analysis of the DNA-binding Domain of the Helicobacter pylori Response Regulator ArsR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HP0165-HP0166 2-COMPONENT SYSTEM; GENE-EXPRESSION; PROTEIN; PHOSPHORYLATION; OMPR; ACTIVATION; INFECTION; SEQUENCE; KINASE; PHOB	The Helicobacter pylori ArsS-ArsR two-component signal transduction system, comprised of a sensor histidine kinase (ArsS) and a response regulator (ArsR), allows the bacteria to regulate gene expression in response to acidic pH. We expressed and purified the full-length ArsR protein and the DNA-binding domain of ArsR (ArsR-DBD), and we analyzed the tertiary structure of the ArsR-DBD using solution nuclear magnetic resonance (NMR) methods. Both the full-length ArsR and the ArsR-DBD behaved as monomers in size exclusion chromatography experiments. The structure of ArsR-DBD consists of an N-terminal four-stranded beta-sheet, a helical core, and a C-terminal beta-hairpin. The overall tertiary fold of the ArsR-DBD is most closely related to DBD structures of the OmpR/PhoB subfamily of bacterial response regulators. However, the orientation of the N-terminal beta-sheet with respect to the rest of the DNA-binding domain is substantially different in ArsR compared with the orientation in related response regulators. Molecular modeling of an ArsR-DBD-DNA complex permits identification of protein elements that are predicted to bind target DNA sequences and thereby regulate gene transcription in H. pylori.	[Krezel, Andrzej M.] Vanderbilt Univ, Struct Biol Ctr, Dept Biol Sci, Nashville, TN 37232 USA; [Gupta, Shobhana S.; Cover, Timothy L.] Vanderbilt Univ, Dept Microbiol & Immunol, Nashville, TN 37232 USA; [Cover, Timothy L.] Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA; [Cover, Timothy L.] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Krezel, AM (corresponding author), Vanderbilt Univ, Struct Biol Ctr, Dept Biol Sci, 465 21st Ave,MRBIII 5270A, Nashville, TN 37232 USA.	andrzej.m.krezel@vanderbilt.edu	Cover, Timothy/I-3814-2015	Cover, Timothy/0000-0001-8503-002X	National Institutes of Health [R01 AI39657]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008320] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI39657. This work was also supported by the Department of Veterans Affairs. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AIBA H, 1989, J BIOCHEM-TOKYO, V106, P5, DOI 10.1093/oxfordjournals.jbchem.a122817; Ang S, 2001, INFECT IMMUN, V69, P1679, DOI 10.1128/IAI.69.3.1679-1686.2001; Audia JP, 2001, INT J MED MICROBIOL, V291, P97, DOI 10.1078/1438-4221-00106; Beier D, 2000, J BACTERIOL, V182, P2068, DOI 10.1128/JB.182.8.2068-2076.2000; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Blanco AG, 2002, STRUCTURE, V10, P701, DOI 10.1016/S0969-2126(02)00761-X; Buckler DR, 2002, STRUCTURE, V10, P153, DOI 10.1016/S0969-2126(01)00706-7; Bury-Mone S, 2004, MOL MICROBIOL, V53, P623, DOI 10.1111/j.1365-2958.2004.04137.x; CASE DA, 2004, AMBER, V9; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dietz P, 2002, J BACTERIOL, V184, P350, DOI 10.1128/JB.184.2.350-362.2002; Eguchi Y, 2005, TRENDS BIOCHEM SCI, V30, P70, DOI 10.1016/j.tibs.2004.12.003; FIEDLER U, 1995, EMBO J, V14, P3696, DOI 10.1002/j.1460-2075.1995.tb00039.x; Forsyth MH, 2002, J BACTERIOL, V184, P4630, DOI 10.1128/JB.184.16.4630-4635.2002; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; HALL MN, 1981, J MOL BIOL, V146, P23, DOI 10.1016/0022-2836(81)90364-8; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hong E, 2007, J BIOL CHEM, V282, P20667, DOI 10.1074/jbc.M609104200; JO YL, 1986, J BIOL CHEM, V261, P5252; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Loh JT, 2006, INFECT IMMUN, V74, P3052, DOI 10.1128/IAI.74.5.3052-3059.2006; MARSHALL BJ, 1984, LANCET, V1, P1311; MartinezHackert E, 1997, J MOL BIOL, V269, P301, DOI 10.1006/jmbi.1997.1065; MartinezHackert E, 1997, STRUCTURE, V5, P109, DOI 10.1016/S0969-2126(97)00170-6; McCleary WR, 1996, MOL MICROBIOL, V20, P1155, DOI 10.1111/j.1365-2958.1996.tb02636.x; Merrell DS, 2003, INFECT IMMUN, V71, P3529, DOI 10.1128/IAI.71.6.3529-3539.2003; Mizuno T, 1997, DNA Res, V4, P161, DOI 10.1093/dnares/4.2.161; Mueller A, 2005, CANCER EPIDEM BIOMAR, V14, P1859, DOI 10.1158/1055-9965.EPI-04-0820; NOMURA A, 1991, NEW ENGL J MED, V325, P1132, DOI 10.1056/NEJM199110173251604; Panthel K, 2003, INFECT IMMUN, V71, P5381, DOI 10.1128/IAI.71.9.5381-5385.2003; PARSONNET J, 1994, NEW ENGL J MED, V330, P1267, DOI 10.1056/NEJM199405053301803; PETERSON WL, 1991, NEW ENGL J MED, V324, P1043, DOI 10.1056/NEJM199104113241507; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pflock M, 2005, INFECT IMMUN, V73, P6437, DOI 10.1128/IAI.73.10.6437-6445.2005; Pflock M, 2004, FEMS MICROBIOL LETT, V234, P51, DOI 10.1016/j.femsle.2004.03.023; Pflock M, 2006, J BIOTECHNOL, V126, P52, DOI 10.1016/j.jbiotec.2006.03.045; Pflock M, 2006, J BACTERIOL, V188, P3449, DOI 10.1128/JB.188.10.3449-3462.2006; Robinson VL, 2003, J BACTERIOL, V185, P4186, DOI 10.1128/JB.185.14.4186-4194.2003; Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; SCHADE C, 1994, GASTROENTEROLOGY, V107, P180, DOI 10.1016/0016-5085(94)90075-2; Schar J, 2005, J BACTERIOL, V187, P3100, DOI 10.1128/JB.187.9.3100-3109.2005; Scott DR, 2007, P NATL ACAD SCI USA, V104, P7235, DOI 10.1073/pnas.0702300104; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Wen Y, 2006, J BACTERIOL, V188, P1750, DOI 10.1128/JB.188.5.1750-1761.2006; Wen Y, 2003, INFECT IMMUN, V71, P5921, DOI 10.1128/IAI.71.10.5921-5939.2003; Wen Y, 2007, J BACTERIOL, V189, P2426, DOI 10.1128/JB.01492-06; WISHART DS, 1994, METHOD ENZYMOL, V239, P363	52	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6536	6545		10.1074/jbc.M804592200	http://dx.doi.org/10.1074/jbc.M804592200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19117956	Green Published, hybrid			2022-12-25	WOS:000263742700056
J	Suthammarak, W; Yang, YY; Morgan, PG; Sedensky, MM				Suthammarak, Wichit; Yang, Yu-Ying; Morgan, Phil G.; Sedensky, Margaret M.			Complex I Function Is Defective in Complex IV-deficient Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; RESPIRATORY-CHAIN SUPERCOMPLEXES; MITOCHONDRIAL ELECTRON-TRANSPORT; MAMMALIAN MITOCHONDRIA; LIVER-MITOCHONDRIA; OXIDATIVE-PHOSPHORYLATION; PARKINSONS-DISEASE; NADH DEHYDROGENASE; NDUFS4 GENE; SUBUNIT-IV	Cytochrome c oxidase (COX) is hypothesized to be an important regulator of oxidative phosphorylation. However, no animal phenotypes have been described due to genetic defects in nuclear-encoded subunits of COX. We knocked down predicted homologues of COX IV and COX Va in the nematode Caenorhabditis elegans. Animals treated with W09C5.8 (COX IV) or Y37D8A.14 (COX Va) RNA interference had shortened lifespans and severe defects in mitochondrial respiratory chain function. Amount and activity of complex IV, as well as super-complexes that included complex IV, were decreased in COX-deficient worms. The formation of supercomplex I:III was not dependent on COX. We found that COX deficiencies decreased intrinsic complex I enzymatic activity, as well as complex I-III enzymatic activity. However, overall amounts of complex I were not decreased in these animals. Surprisingly, intrinsic complex I enzymatic activity is dependent on the presence of complex IV, despite no overall decrease in the amount of complex I. Presumably the association of complex I with complex IV within the supercomplex I:III:IV enhances electron flow through complex I. Our results indicate that reduction of a single subunit within the electron transport chain can affect multiple enzymatic steps of electron transfer, including movement within a different protein complex. Patients presenting with multiple defects of electron transport may, in fact, harbor a single genetic defect.	[Morgan, Phil G.; Sedensky, Margaret M.] Childrens Res Inst, Seattle, WA 98101 USA; [Suthammarak, Wichit; Yang, Yu-Ying; Morgan, Phil G.; Sedensky, Margaret M.] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; [Suthammarak, Wichit; Morgan, Phil G.; Sedensky, Margaret M.] Univ Hosp, Dept Anesthesiol, Cleveland, OH 44106 USA; [Morgan, Phil G.; Sedensky, Margaret M.] Univ Washington, Dept Anesthesiol, Seattle, WA 98101 USA; [Suthammarak, Wichit] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Biochem, Bangkok 10700, Thailand	Case Western Reserve University; University Hospitals of Cleveland; University of Washington; University of Washington Seattle; Mahidol University	Sedensky, MM (corresponding author), Childrens Res Inst, 1900 9th Ave, Seattle, WA 98101 USA.	margaret.sedensky@seattlechildrens.org			National Institutes of Health [GM58881, AG026273]; Royal Thai Government, Science and Technology Scholarship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058881] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Thai Government, Science and Technology Scholarship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM58881 and AG026273 (to M.M.S., Y.-Y.Y., and P.G.M.) and by the Royal Thai Government, Science and Technology Scholarship (W.S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284; Arnold S, 1998, EUR J BIOCHEM, V252, P325, DOI 10.1046/j.1432-1327.1998.2520325.x; BENECKE R, 1993, BRAIN, V116, P1451, DOI 10.1093/brain/116.6.1451; Bianchi C, 2004, J BIOL CHEM, V279, P36562, DOI 10.1074/jbc.M405135200; Brass EP, 2001, AM J PHYSIOL-HEART C, V280, pH603, DOI 10.1152/ajpheart.2001.280.2.H603; Budde SMS, 2000, BIOCHEM BIOPH RES CO, V275, P63, DOI 10.1006/bbrc.2000.3257; CARDELLACH F, 1993, NEUROLOGY, V43, P2258, DOI 10.1212/WNL.43.11.2258; Cardol P, 2008, BBA-BIOENERGETICS, V1777, P388, DOI 10.1016/j.bbabio.2008.01.001; CHANCE B, 1955, NATURE, V176, P250, DOI 10.1038/176250a0; CHAZOTTE B, 1988, J BIOL CHEM, V263, P14359; Conway JP, 2005, MOL CELL PROTEOMICS, V4, P1522, DOI 10.1074/mcp.M500111-MCP200; Cruciat CM, 2000, J BIOL CHEM, V275, P18093, DOI 10.1074/jbc.M001901200; D'Aurelio M, 2006, HUM MOL GENET, V15, P2157, DOI 10.1093/hmg/ddl141; Diaz F, 2006, MOL CELL BIOL, V26, P4872, DOI 10.1128/MCB.01767-05; Dudkina NV, 2005, P NATL ACAD SCI USA, V102, P3225, DOI 10.1073/pnas.0408870102; Eubel H, 2004, PLANT PHYSIOL, V134, P1450, DOI 10.1104/pp.103.038018; Eubel H, 2003, PLANT PHYSIOL, V133, P274, DOI 10.1104/pp.103.024620; Genova Maria Luisa, 2003, Ital J Biochem, V52, P58; Grad LI, 2006, BBA-BIOENERGETICS, V1757, P115, DOI 10.1016/j.bbabio.2005.11.009; HACKENBROCK CR, 1986, J BIOENERG BIOMEMBR, V18, P331, DOI 10.1007/BF00743010; Hatefi Y, 1978, Methods Enzymol, V53, P11; HOPPEL C, 1979, J BIOL CHEM, V254, P4164; HOPPEL C, 1969, ARCH BIOCHEM BIOPHYS, V135, P173, DOI 10.1016/0003-9861(69)90528-1; Kadenbach B, 1997, MOL CELL BIOCHEM, V174, P131, DOI 10.1023/A:1006819416358; Kayser EB, 2004, MECH AGEING DEV, V125, P455, DOI 10.1016/j.mad.2004.04.002; Kayser EB, 2001, J BIOL CHEM, V276, P20551, DOI 10.1074/jbc.M011066200; KORENKE GC, 1990, EUR J PEDIATR, V150, P104, DOI 10.1007/BF02072049; KRAHENBUHL S, 1991, J BIOL CHEM, V266, P20998; Krause F, 2005, BIOCHEM BIOPH RES CO, V329, P583, DOI 10.1016/j.bbrc.2005.02.010; LAZAROU M, 2008, BIOCHIM BIOPHYS ACTA, V1793, P78; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Li YF, 2007, J BIOL CHEM, V282, P17557, DOI 10.1074/jbc.M701056200; Li YF, 2006, J BIOENERG BIOMEMBR, V38, P283, DOI 10.1007/s10863-006-9052-z; McKenzie M, 2007, ANAL BIOCHEM, V364, P128, DOI 10.1016/j.ab.2007.02.022; MORGAN PG, 1988, ANESTHESIOLOGY, V69, P246, DOI 10.1097/00000542-198808000-00015; Napiwotzki J, 1997, BIOL CHEM, V378, P1013, DOI 10.1515/bchm.1997.378.9.1013; Napiwotzki J, 1998, BIOL CHEM, V379, P335, DOI 10.1515/bchm.1998.379.3.335; Scacco S, 2003, J BIOL CHEM, V278, P44161, DOI 10.1074/jbc.M307615200; Schafer E, 2006, J BIOL CHEM, V281, P15370, DOI 10.1074/jbc.M513525200; Schagger H, 1996, Methods Enzymol, V264, P555, DOI 10.1016/S0076-6879(96)64048-8; Schagger H, 2004, J BIOL CHEM, V279, P36349, DOI 10.1074/jbc.M404033200; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Schagger H, 2001, IUBMB LIFE, V52, P119, DOI 10.1080/15216540152845911; Schagger H, 2001, J BIOL CHEM, V276, P37861; SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415; Stroh A, 2004, J BIOL CHEM, V279, P5000, DOI 10.1074/jbc.M309505200; van Straaten HLM, 2005, NEUROPEDIATRICS, V36, P193, DOI 10.1055/s-2005-865713; von Kleist-Retzow JC, 2003, J PEDIATR-US, V143, P208, DOI 10.1067/S0022-3476(03)00130-6; VONCK J, 2008, BIOCHIM BIOPHYS ACTA, V1793, P117; Yoshikawa S, 1997, CURR OPIN STRUC BIOL, V7, P574, DOI 10.1016/S0959-440X(97)80124-8	51	62	64	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6425	6435		10.1074/jbc.M805733200	http://dx.doi.org/10.1074/jbc.M805733200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19074434	hybrid, Green Published			2022-12-25	WOS:000263742700045
J	Truty, MJ; Lomberk, G; Fernandez-Zapico, ME; Urrutia, R				Truty, Mark J.; Lomberk, Gwen; Fernandez-Zapico, Martin E.; Urrutia, Raul			Silencing of the Transforming Growth Factor-beta (TGF beta) Receptor II by Kruppel-like Factor 14 Underscores the Importance of a Negative Feedback Mechanism in TGF beta Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC-CANCER CELLS; TRANSCRIPTION FACTORS; SP1-LIKE PROTEIN; GENE PROMOTER; SP1; EXPRESSION; FAMILY; DEACETYLASE; REPRESSORS; MEMBERS	The role of non-Smad proteins in the regulation of transforming growth factor-beta (TGF beta) signaling is an emerging line of active investigation. Here, we characterize the role of KLF14, as a TGF beta-inducible, non-Smad protein that silences the TGF beta receptor II ( TGF beta RII) promoter. Together with endocytosis, transcriptional silencing is a critical mechanism for down-regulating TGF beta receptors at the cell surface. However, the mechanisms underlying transcriptional repression of these receptors remain poorly understood. KLF14 has been chosen from a comprehensive screen of 24 members of the Sp/KLF family due to its TGF beta inducibility, its ability to regulate the TGF beta RII promoter, and the fact that this protein had yet to be functionally characterized. We find that KLF14 represses the TGF beta RII, a function that is augmented by TGF beta treatment. Mapping of the TGF beta RII promoter, in combination with site-directed mutagenesis, electromobility shift, and chromatin immunoprecipitation assays, have identified distinct GC-rich sequences used by KLF14 to regulate this promoter. Mechanistically, KLF14 represses the TGF beta RII promoter via a co-repressor complex containing mSin3A and HDAC2. Furthermore, the TGF beta pathway activation leads to recruitment of a KLF14-mSin3A-HDAC2 repressor complex to the TGF beta RII promoter, as well as the remodeling of chromatin to increase histone marks that associate with transcriptional silencing. Thus, these results describe a novel negative-feedback mechanism by which TGF beta RII activation at the cell surface induces the expression of KLF14 to ultimately silence the TGF beta RII and further expand the network of non-Smad transcription factors that participate in the TGF beta pathway.	[Truty, Mark J.] Mayo Clin, Dept Surg, Clinician Investigator Training Program, Rochester, MN 55905 USA; [Truty, Mark J.; Lomberk, Gwen; Fernandez-Zapico, Martin E.; Urrutia, Raul] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Truty, Mark J.; Lomberk, Gwen; Fernandez-Zapico, Martin E.; Urrutia, Raul] Mayo Clin, Dept Physiol & Biophys, Gastroenterol Res Unit, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Urrutia, R (corresponding author), Mayo Clin, GI Res Unit, 200 1st St SW,Guggenheim 10, Rochester, MN 55905 USA.	urrutia.raul@mayo.edu	Lomberk, Gwen/AAL-8490-2020	Lomberk, Gwen/0000-0001-5463-789X	National Institutes of Health [DK 52913]; Mayo Clinic Pancreatic SPORE [P50 CA102701]; NATIONAL CANCER INSTITUTE [R03CA125127, P50CA102701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052913, R56DK052913] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Pancreatic SPORE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK 52913. This work was also supported by Mayo Clinic Pancreatic SPORE (Grant P50 CA102701 to R. U.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; We dedicate this manuscript to the memory of Kazimierz Truty and to all the other patients who have succumbed to pancreatic cancer.	Bachman KE, 2005, CURR OPIN ONCOL, V17, P49, DOI 10.1097/01.cco.0000143682.45316.ae; BAE HW, 1995, J BIOL CHEM, V270, P29460, DOI 10.1074/jbc.270.49.29460; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Cook T, 2000, AM J PHYSIOL-GASTR L, V278, pG513, DOI 10.1152/ajpgi.2000.278.4.G513; Cook T, 1998, J BIOL CHEM, V273, P25929, DOI 10.1074/jbc.273.40.25929; Ellenrieder V, 2001, CURR OPIN GASTROEN, V17, P434, DOI 10.1097/00001574-200109000-00006; GAZIT D, 1993, MOL ENDOCRINOL, V7, P189, DOI 10.1210/me.7.2.189; Huang WQ, 2005, J BIOL CHEM, V280, P10047, DOI 10.1074/jbc.M408680200; Itman C, 2006, REPRODUCTION, V132, P233, DOI 10.1530/rep.1.01075; Jennings R, 2001, ONCOGENE, V20, P6899, DOI 10.1038/sj.onc.1204808; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kaczynski J, 2001, J BIOL CHEM, V276, P36749, DOI 10.1074/jbc.M105831200; Kaczynski JA, 2002, BIOCHEM J, V366, P873, DOI 10.1042/BJ20020388; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Koli KM, 1997, J BIOL CHEM, V272, P6423, DOI 10.1074/jbc.272.10.6423; Koutsodontis G, 2002, BIOCHEMISTRY-US, V41, P12771, DOI 10.1021/bi026141q; Lee BI, 2001, CANCER RES, V61, P931; Lomberk G, 2005, BIOCHEM J, V392, P1, DOI 10.1042/BJ20051234; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Natesampillai S, 2006, J BIOL CHEM, V281, P3040, DOI 10.1074/jbc.M509417200; Nishikawa Y, 1998, J CELL PHYSIOL, V176, P612, DOI 10.1002/(SICI)1097-4652(199809)176:3<612::AID-JCP18>3.0.CO;2-0; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Park SH, 2002, J BIOL CHEM, V277, P5168, DOI 10.1074/jbc.M106451200; Parker-Katiraee L, 2007, PLOS GENET, V3, P665, DOI 10.1371/journal.pgen.0030065; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; Schneider D, 2002, BBA-MOL BASIS DIS, V1588, P1, DOI 10.1016/S0925-4439(02)00052-2; Subramaniam M, 1995, NUCLEIC ACIDS RES, V23, P4907, DOI 10.1093/nar/23.23.4907; Truty MJ, 2007, PANCREATOLOGY, V7, P423, DOI 10.1159/000108959; Turner J, 1999, TRENDS BIOCHEM SCI, V24, P236, DOI 10.1016/S0968-0004(99)01406-1; Venkatasubbarao K, 2001, CANCER RES, V61, P6239; WOODWARD TL, 1995, J CELL PHYSIOL, V165, P339, DOI 10.1002/jcp.1041650215; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhang JS, 2001, MOL CELL BIOL, V21, P5041, DOI 10.1128/MCB.21.15.5041-5049.2001; Zhao SJ, 2003, CANCER RES, V63, P2624	36	47	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6291	6300		10.1074/jbc.M807791200	http://dx.doi.org/10.1074/jbc.M807791200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19088080	Green Published, hybrid			2022-12-25	WOS:000263742700032
J	Housley, MP; Udeshi, ND; Rodgers, JT; Shabanowitz, J; Puigserver, P; Hunt, DF; Hart, GW				Housley, Michael P.; Udeshi, Namrata D.; Rodgers, Joseph T.; Shabanowitz, Jeffrey; Puigserver, Pere; Hunt, Donald F.; Hart, Gerald W.			A PGC-1 alpha-O-GlcNAc Transferase Complex Regulates FoxO Transcription Factor Activity in Response to Glucose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-GLCNAC TRANSFERASE; LINKED N-ACETYLGLUCOSAMINE; PPAR-GAMMA COACTIVATOR-1; ACTIVATED RECEPTOR-GAMMA; RNA-POLYMERASE-II; INSULIN-RESISTANCE; MASS-SPECTROMETRY; NUCLEOCYTOPLASMIC GLYCOSYLATION; HEPATIC GLUCONEOGENESIS; HEXOSAMINE BIOSYNTHESIS	Metabolic and stress response gene regulation is crucial for the survival of an organism to a changing environment. Three key molecules that sense nutrients and broadly affect gene expression are the FoxO transcription factors, the transcriptional co-activator PGC-1 alpha, and the dynamic post-translational modification, O-linked beta-N-acetylglucosamine (O-GlcNAc). Here we identify novel post-translational modifications of PGC-1 alpha, including O-GlcNAc, and describe a novel mechanism for how PGC-1 alpha co-activates transcription by FoxOs. In liver, in cultured cells, and in vitro with recombinant proteins, PGC-1 alpha binds to O-GlcNAc transferase and targets the enzyme to FoxOs, resulting in their increased GlcNAcylation and increased transcriptional activity. Furthermore, glucose-enhanced activation of FoxO1 occurs via this PGC-1 alpha-O-GlcNAc transferase-mediated GlcNAcylation. Therefore, one mechanism by which PGC-1 alpha can serve as a co-activator of transcription is by targeting the O-GlcNAc transferase to increase GlcNAcylation of specific transcription factors important to nutrient/stress sensing and energy metabolism.	[Housley, Michael P.; Hart, Gerald W.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Udeshi, Namrata D.; Shabanowitz, Jeffrey; Hunt, Donald F.] Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA; [Hunt, Donald F.] Univ Virginia, Dept Pathol, Charlottesville, VA 22904 USA; [Rodgers, Joseph T.; Puigserver, Pere] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Rodgers, Joseph T.; Puigserver, Pere] Dana Farber Canc Inst, Dept Cell Biol, Boston, MA 02115 USA	Johns Hopkins University; University of Virginia; University of Virginia; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Hart, GW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.	gwhart@jhmi.edu	Hunt, Donald F/I-6936-2012	Hunt, Donald F/0000-0003-2815-6368; Hart, Gerald/0000-0001-7812-4351; Rodgers, Joseph/0000-0002-6598-5520	National Institutes of Health [DK61671, HD13563, GM37537]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD013563, R01HD013563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK61671 and HD13563 (to G. W. H.) and GM37537 (to D. F. H.). G. W. H. receives a share of royalties on university sales of the CTD110.6 antibody. Arrangement managed by The Johns Hopkins University School conflict of interest policies. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Birnbaum MJ, 2008, SCIENCE, V319, P1348, DOI 10.1126/science.1155915; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Buse MG, 2006, AM J PHYSIOL-ENDOC M, V290, pE1, DOI 10.1152/ajpendo.00329.2005; CHEUNG WD, 2008, J BIOL CHEM; Cheung WD, 2008, J BIOL CHEM, V283, P13009, DOI 10.1074/jbc.M801222200; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Comer FI, 2001, BIOCHEMISTRY-US, V40, P7845, DOI 10.1021/bi0027480; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Dowell P, 2003, J BIOL CHEM, V278, P45485, DOI 10.1074/jbc.M309069200; Fan M, 2004, GENE DEV, V18, P278, DOI 10.1101/gad.1152204; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Fulop N, 2007, AM J PHYSIOL-HEART C, V292, pH2227, DOI 10.1152/ajpheart.01091.2006; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Hanover JA, 2005, P NATL ACAD SCI USA, V102, P11266, DOI 10.1073/pnas.0408771102; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200; Hu Y, 2009, J BIOL CHEM, V284, P547, DOI 10.1074/jbc.M808518200; Iyer SPN, 2003, J BIOL CHEM, V278, P5399, DOI 10.1074/jbc.M209384200; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Knutti D, 2001, TRENDS ENDOCRIN MET, V12, P360, DOI 10.1016/S1043-2760(01)00457-X; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Liu J, 2006, J MOL CELL CARDIOL, V40, P303, DOI 10.1016/j.yjmcc.2005.11.003; Love, 2005, SCI STKE, V2005, DOI DOI 10.1126/STKE.3122005RE13; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; Martin SE, 2000, ANAL CHEM, V72, P4266, DOI 10.1021/ac000497v; McClain DA, 2002, P NATL ACAD SCI USA, V99, P10695, DOI 10.1073/pnas.152346899; Mikesh LM, 2006, BBA-PROTEINS PROTEOM, V1764, P1811, DOI 10.1016/j.bbapap.2006.10.003; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; MONSIGNY M, 1980, EUR J BIOCHEM, V104, P147, DOI 10.1111/j.1432-1033.1980.tb04410.x; Ngoh GA, 2008, J MOL CELL CARDIOL, V45, P313, DOI 10.1016/j.yjmcc.2008.04.009; Olson BL, 2008, GENE DEV, V22, P252, DOI 10.1101/gad.1624208; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sano M, 2004, EMBO J, V23, P3559, DOI 10.1038/sj.emboj.7600351; Schroeder MJ, 2004, ANAL CHEM, V76, P3590, DOI 10.1021/ac0497104; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Taylor RP, 2008, J BIOL CHEM, V283, P6050, DOI 10.1074/jbc.M707328200; Teyssier C, 2005, GENE DEV, V19, P1466, DOI 10.1101/gad.1295005; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Udeshi ND, 2008, NAT PROTOC, V3, P1709, DOI 10.1038/nprot.2008.159; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Wallberg AE, 2003, MOL CELL, V12, P1137, DOI 10.1016/S1097-2765(03)00391-5; Whelan SA, 2008, J BIOL CHEM, V283, P21411, DOI 10.1074/jbc.M800677200; Wu ZD, 2006, P NATL ACAD SCI USA, V103, P14379, DOI 10.1073/pnas.0606714103; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016	56	145	152	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5148	5157		10.1074/jbc.M808890200	http://dx.doi.org/10.1074/jbc.M808890200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19103600	hybrid, Green Published			2022-12-25	WOS:000263416600045
J	Miraoui, H; Oudina, K; Petite, H; Tanimoto, Y; Moriyama, K; Marie, PJ				Miraoui, Hichem; Oudina, Karim; Petite, Herve; Tanimoto, Yukiho; Moriyama, Keiji; Marie, Pierre J.			Fibroblast Growth Factor Receptor 2 Promotes Osteogenic Differentiation in Mesenchymal Cells via ERK1/2 and Protein Kinase C Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-2; OSTEOBLAST DIFFERENTIATION; APERT-SYNDROME; STEM-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; REGULATED KINASE; STROMAL CELLS; N-CADHERIN; MARROW; EXPRESSION	Mesenchymal stem cells (MSCs) are able to differentiate into several lineages including osteoblasts. The signaling mechanisms involved in the osteogenic differentiation of MSCs are however not fully understood. We investigated the role of fibroblast growth factor receptor 2 (FGFR2) in osteoblast committment and differentiation of murine mesenchymal C3H10T1/2 cells stably transfected with wild type (WT) or activated FGFR2 due to Apert S252W geneticmutation(MT). WTFGFR2 slightly increased, whereas MT FGFR2 strongly increased, FGFR2 tyrosine phosphorylation, indicating activation of the receptor. WT and MT FGFR2 increased C3H10T1/2 cell proliferation but not survival. Both WT and MT FGFR2 increased early and late osteoblast gene expression and matrix mineralization. Forced expression of WT and MT FGFR2 also increased osteoblast gene expression in MC3T3-E1 calvaria osteoblasts. In both cell types, MTFGFR2 was more effective than WTFGFR2. In contrast, WT and MTFGFR2 decreased adipocyte differentiation of C3H10T1/2 cells. WT and MT FGFR2 induced ERK1/2 but not JNK or PI3K/AKT phosphorylation. MT, but not WT, also increased protein kinase C (PKC) activity. Pharmacological inhibition of ERK1/2 prevented cell proliferation induced by WT and MT FGFR2. Using dominant-negative ERK and PKC alpha vectors, we demonstrated that WT and MT FGFR2 promoted osteoblast gene expression through ERK1/2 and PKC alpha signaling, respectively. This study identifies FGFR2 as a novel regulatory molecule that promotes osteogenic differentiation in murine MSCs. The promoting effect of WT and MT FGFR2 is mediated by ERK1/2 and PKC alpha pathways that play essential and distinct roles in FGFR2-induced osteogenic differentiation of mesenchymal cells.	[Marie, Pierre J.] Hop Lariboisiere, INSERM, U606, F-75475 Paris 10, France; [Miraoui, Hichem; Oudina, Karim; Petite, Herve; Marie, Pierre J.] Univ Paris 07, Paris 10, France; [Oudina, Karim; Petite, Herve] CNRS, UMR 7052, Paris 10, France; [Tanimoto, Yukiho; Moriyama, Keiji] Tokyo Med & Dent Univ, Grad Sch, Dept Maxillofacial Orthognath, Tokyo 1138549, Japan	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite; Tokyo Medical & Dental University (TMDU)	Marie, PJ (corresponding author), Hop Lariboisiere, INSERM, U606, 2 Rue Ambroise Pare, F-75475 Paris 10, France.	pierre.marie@inserm.fr	Petite, Herve/E-3478-2016; Moriyama, Keiji/AAC-3193-2019	Petite, Herve/0000-0003-1694-5060; Moriyama, Keiji/0000-0003-0580-4510				Ahdjoudj S, 2001, J CELL BIOCHEM, V81, P23, DOI 10.1002/1097-4644(20010401)81:1<23::AID-JCB1021>3.0.CO;2-H; Anderson J, 1998, HUM MOL GENET, V7, P1475, DOI 10.1093/hmg/7.9.1475; Aubin J E, 2001, Rev Endocr Metab Disord, V2, P81, DOI 10.1023/A:1010011209064; AUBIN JE, 2002, PRINCIPLES BONE BIOL, V1, P59; Baroni T, 2005, J CELL PHYSIOL, V202, P524, DOI 10.1002/jcp.20148; Bensaid W, 2003, BIOMATERIALS, V24, P2497, DOI 10.1016/S0142-9612(02)00618-X; Bezooijen RL, 2005, CYTOKINE GROWTH F R, V16, P319, DOI 10.1016/j.cytogfr.2005.02.005; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Chen L, 2003, BONE, V33, P169, DOI 10.1016/S8756-3282(03)00222-9; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; Debiais F, 2004, EXP CELL RES, V297, P235, DOI 10.1016/j.yexcr.2004.03.032; Debiais F, 2001, J CELL BIOCHEM, V81, P68, DOI 10.1002/1097-4644(20010401)81:1<68::AID-JCB1024>3.0.CO;2-S; Eswarakumar VP, 2004, P NATL ACAD SCI USA, V101, P12555, DOI 10.1073/pnas.0405031101; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Etheridge SL, 2004, STEM CELLS, V22, P849, DOI 10.1634/stemcells.22-5-849; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fragale A, 1999, AM J PATHOL, V154, P1465, DOI 10.1016/S0002-9440(10)65401-6; Fujita T, 2004, J CELL BIOL, V166, P85, DOI 10.1083/jcb.200401138; Gatesman A, 2004, MOL CELL BIOL, V24, P7578, DOI 10.1128/MCB.24.17.7578-7597.2004; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; Gimble JM, 2006, J CELL BIOCHEM, V98, P251, DOI 10.1002/jcb.20777; Gori F, 1999, J BONE MINER RES, V14, P1522, DOI 10.1359/jbmr.1999.14.9.1522; Hanada K, 1997, J BONE MINER RES, V12, P1606, DOI 10.1359/jbmr.1997.12.10.1606; Ibrahimi OA, 2001, P NATL ACAD SCI USA, V98, P7182, DOI 10.1073/pnas.121183798; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Kaabeche K, 2004, J BIOL CHEM, V279, P36259, DOI 10.1074/jbc.M402469200; Karsenty G, 2000, SEMIN CELL DEV BIOL, V11, P343, DOI 10.1006/scdb.2000.0188; Kim BG, 2006, PROTEOMICS, V6, P1166, DOI 10.1002/pmic.200500289; Kim HJ, 2003, J BIOL CHEM, V278, P319, DOI 10.1074/jbc.M203750200; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Lai CF, 2001, J BIOL CHEM, V276, P14443, DOI 10.1074/jbc.M010021200; LAUGHTON C, 1986, ANAL BIOCHEM, V156, P307, DOI 10.1016/0003-2697(86)90258-7; Lemonnier J, 2001, AM J PATHOL, V158, P1833, DOI 10.1016/S0002-9440(10)64139-9; Lemonnier J, 2001, J BONE MINER RES, V16, P832, DOI 10.1359/jbmr.2001.16.5.832; Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1; Ling L, 2006, J CELL PHYSIOL, V209, P811, DOI 10.1002/jcp.20760; Lomri A, 1998, J CLIN INVEST, V101, P1310; Longo M, 2004, BONE, V34, P100, DOI 10.1016/j.bone.2003.09.007; Mansukhani A, 2000, J CELL BIOL, V149, P1297, DOI 10.1083/jcb.149.6.1297; Mansukhani A, 2005, J CELL BIOL, V168, P1065, DOI 10.1083/jcb.200409182; Marie PJ, 2006, REGEN MED, V1, P539, DOI 10.2217/17460751.1.4.539; Marie PJ, 2003, GENE, V316, P23, DOI 10.1016/S0378-1119(03)00748-0; Martin I, 1997, ENDOCRINOLOGY, V138, P4456, DOI 10.1210/en.138.10.4456; Mohammadi M, 1996, MOL CELL BIOL, V16, P977; Montero A, 2000, J CLIN INVEST, V105, P1085, DOI 10.1172/JCI8641; Ng KW, 2007, STEM CELLS DEV, V16, P305, DOI 10.1089/scd.2006.0044; Ong SH, 2001, P NATL ACAD SCI USA, V98, P6074, DOI 10.1073/pnas.111114298; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Ornitz DM, 2005, CYTOKINE GROWTH F R, V16, P205, DOI 10.1016/j.cytogfr.2005.02.003; Osyczka AM, 2005, ENDOCRINOLOGY, V146, P3428, DOI 10.1210/en.2005-0303; OWEN M, 2002, CELL SCI S, V10, P63; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Pratap J, 2003, CANCER RES, V63, P5357; Pri-Chen S, 1998, BONE, V23, P111, DOI 10.1016/S8756-3282(98)00087-8; Pula G, 2005, J BIOL CHEM, V280, P7194, DOI 10.1074/jbc.M409212200; Richardson JA, 2007, J CELL BIOCHEM, V100, P1131, DOI 10.1002/jcb.21112; Rios H. F., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P325; Rucci N, 2005, J CELL SCI, V118, P3263, DOI 10.1242/jcs.02436; Shukla V, 2007, NAT GENET, V39, P1145, DOI 10.1038/ng2096; Tang CH, 2007, J CELL PHYSIOL, V211, P45, DOI 10.1002/jcp.20896; Tanimoto Y, 2004, J BIOL CHEM, V279, P45926, DOI 10.1074/jbc.M404824200; Wang YL, 2005, DEVELOPMENT, V132, P3537, DOI 10.1242/dev.01914; Wilkie AOM, 2002, AM J MED GENET, V112, P266, DOI 10.1002/ajmg.10775; Xiao GZ, 2002, J BIOL CHEM, V277, P36181, DOI 10.1074/JBC.m206057200; Yin L, 2008, BONE, V42, P631, DOI 10.1016/j.bone.2007.11.019	69	116	122	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4897	4904		10.1074/jbc.M805432200	http://dx.doi.org/10.1074/jbc.M805432200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19117954	hybrid			2022-12-25	WOS:000263416600019
J	Tai, DJC; Su, CC; Ma, YL; Lee, EHY				Tai, Derek J. C.; Su, Chia-Chen; Ma, Yun-Li; Lee, Eminy H. Y.			SGK1 Phosphorylation of I kappa B Kinase alpha and p300 Up-regulates NF-kappa B Activity and Increases N-Methyl-D-aspartate Receptor NR2A and NR2B Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOCORTICOID-INDUCIBLE KINASE; SPATIAL MEMORY FORMATION; CELL-SURVIVAL RESPONSE; INDUCED PROTEIN-KINASE; TRANSCRIPTION FACTOR; SYNAPTIC PLASTICITY; SIGNALING PATHWAY; EPITHELIAL-CELLS; GENE-EXPRESSION; NMDA RECEPTOR	Serum- and glucocorticoid-inducible kinase 1 (SGK1) is a downstream target of phosphatidylinositol 3-kinase signaling, and it regulates various cellular and physiological functions, but the SGK1 substrate proteins and genes regulated by SGK1 are less known. Here we have identified I kappa B kinase alpha (IKK alpha) as a novel substrate of SGK1 by using biochemical and bioinformatic approaches. SGK1 directly phosphorylates IKK alpha at Thr-23 and indirectly activates IKK alpha at Ser-180. Furthermore, SGK1 enhanced nuclear factor kappa B (NF-kappa B) activity and up-regulated N-methyl-D-aspartate receptor NR2A and NR2B expression through activation of IKK alpha at Thr-23 and Ser-180, and these two residues play an equally important role in mediating these effects of SGK1. Although SGK1 does not phosphorylate IKK beta, IKK beta activity is still required for IKK complex activation and for SGK1 phosphorylation and activation of NF-kappa B. In addition, SGK1 increased the acetylation of NF-kappa B through phosphorylation of p300 at Ser-1834, and this also leads to NF-kappa B activation and NR2A and NR2B expression. Moreover, an endogenous stimulus of SGK1, insulin, increased IKK alpha and NF-kappa B phosphorylation as well as NF-kappa B acetylation and NF-kappa B activity, but SGK1 small interfering RNA transfection blocked these effects of insulin. In examination of the functional significance of the SGK1-IKK alpha-NF-kappa B signaling pathway, we found that transfection of the IKK alpha double mutant (IKK alpha T23A/S180A) to rat hippocampus antagonized SGK-1-mediated spatial memory facilitation. Our results together demonstrated novel substrate proteins of SGK1 and novel SGK1 signaling pathways. Activation of these signaling pathways enhances NR2A and NR2B expression that is implicated in neuronal plasticity.	[Tai, Derek J. C.] Acad Sinica, Grad Inst Life Sci, Natl Def Med Ctr, Taipei 115, Taiwan; [Su, Chia-Chen; Ma, Yun-Li; Lee, Eminy H. Y.] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan	Academia Sinica - Taiwan; National Defense Medical Center; Academia Sinica - Taiwan	Lee, EHY (corresponding author), 128 Acad Rd,Sect 2, Taipei 115, Taiwan.	eminy@gate.sinica.edu.tw	Lee, Eminy H.Y./S-7014-2018	Lee, Eminy/0000-0001-6342-0940; Ma, Yun Li/0000-0002-6321-8889	National Science Council of Taiwan [NSC96-2321-B-001-001, NSC97-2321-B-001-003]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Grants NSC96-2321-B-001-001 and NSC97-2321-B-001-003 from the National Science Council of Taiwan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abdallah B, 1996, HUM GENE THER, V7, P1947, DOI 10.1089/hum.1996.7.16-1947; Benoliel AM, 1997, J CELL SCI, V110, P2089; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Chao CC, 2007, J NEUROSCI, V27, P6243, DOI 10.1523/JNEUROSCI.1531-07.2007; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Chetty A, 2006, PEDIATR RES, V60, P389, DOI 10.1203/01.pdr.0000238257.15502.f4; Hayashi M, 2001, J BIOL CHEM, V276, P8631, DOI 10.1074/jbc.C000838200; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hoberg JE, 2006, MOL CELL BIOL, V26, P457, DOI 10.1128/MCB.26.2.457-471.2006; Huang WC, 2005, MOL CELL BIOL, V25, P6592, DOI 10.1128/MCB.25.15.6592-6602.2005; Kaltschmidt B, 2006, MOL CELL BIOL, V26, P2936, DOI 10.1128/MCB.26.8.2936-2946.2006; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; Katome T, 2003, J BIOL CHEM, V278, P28312, DOI 10.1074/jbc.M302094200; Kobayashi T, 1999, BIOCHEM J, V344, P189, DOI 10.1042/0264-6021:3440189; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Lee CT, 2006, EUR J NEUROSCI, V23, P1311, DOI 10.1111/j.1460-9568.2006.04650.x; Leong MLL, 2003, J BIOL CHEM, V278, P5871, DOI 10.1074/jbc.M211649200; Liu AG, 2004, J BIOL CHEM, V279, P17449, DOI 10.1074/jbc.M311267200; Liu BH, 2004, GENE THER, V11, P52, DOI 10.1038/sj.gt.3302126; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma YL, 2006, LEARN MEMORY, V13, P114, DOI 10.1101/lm.179206; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Meng FM, 2005, AM J PHYSIOL-CELL PH, V289, pC971, DOI 10.1152/ajpcell.00081.2005; Nemoto S, 1998, MOL CELL BIOL, V18, P7336, DOI 10.1128/MCB.18.12.7336; Oliveira AMM, 2007, LEARN MEMORY, V14, P564, DOI 10.1101/lm.656907; Ozes ON, 1999, NATURE, V401, P82; Park J, 1999, EMBO J, V18, P3024, DOI 10.1093/emboj/18.11.3024; Perrotti N, 2001, J BIOL CHEM, V276, P9406, DOI 10.1074/jbc.M007052200; Rajamanickam J, 2007, J NEUROCHEM, V102, P858, DOI 10.1111/j.1471-4159.2007.04585.x; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Schoenebeck B, 2005, MOL CELL NEUROSCI, V30, P249, DOI 10.1016/j.mcn.2005.07.017; Strutz-Seebohm N, 2005, J PHYSIOL-LONDON, V565, P391, DOI 10.1113/jphysiol.2004.079624; Sun LX, 2000, SYNAPSE, V35, P212, DOI 10.1002/(SICI)1098-2396(20000301)35:3<212::AID-SYN6>3.0.CO;2-O; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tsai KJ, 2002, P NATL ACAD SCI USA, V99, P3990, DOI 10.1073/pnas.062405399; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; Wu W, 2004, CANCER RES, V64, P1757, DOI 10.1158/0008-5472.CAN-03-2546; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yang YC, 2006, MOL CELL BIOL, V26, P8357, DOI 10.1128/MCB.01017-06; Zhang LP, 2005, CANCER RES, V65, P457	43	72	75	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4073	4089		10.1074/jbc.M805055200	http://dx.doi.org/10.1074/jbc.M805055200			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19088076	hybrid			2022-12-25	WOS:000263134400005
J	Jung-Hynes, B; Nihal, M; Zhong, WX; Ahmad, N				Jung-Hynes, Brittney; Nihal, Minakshi; Zhong, Weixiong; Ahmad, Nihal			Role of Sirtuin Histone Deacetylase SIRT1 in Prostate Cancer A TARGET FOR PROSTATE CANCER MANAGEMENT VIA ITS INHIBITION?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOXO TRANSCRIPTION FACTORS; CELL-SURVIVAL; LIFE-SPAN; FORKHEAD; EXPRESSION; LONGEVITY; GROWTH; GENE; PROTEIN; ACETYLATION	Prostate cancer (PCa) is a major age-related malignancy, and according to estimates from the American Cancer Society, a man's chance of developing this cancer significantly increases with increasing age, from 1 in 10,149 by age 39 to 1 in 38 by age 59 to 1 in 7 by age 70. Therefore, it is important to identify the causal connection between mechanisms of aging and PCa. Employing in vitro and in vivo approaches, in this study, we tested the hypothesis that SIRT1, which belongs to the Sir2 (silent information regulator 2) family of sirtuin class III histone deacetylases, is overexpressed in PCa, and its inhibition will have antiproliferative effects in human PCa cells. Our data demonstrated that SIRT1 was significantly overexpressed in human PCa cells (DU145, LNCaP, 22Rv1, and PC3) compared with normal prostate epithelial cells (PrEC) at protein, mRNA, and enzymatic activity levels. SIRT1 was also found to be overexpressed in human PCa tissues compared with adjacent normal prostate tissue. Interestingly, our data demonstrated that SIRT1 inhibition via nicotinamide and sirtinol (at the activity level) as well as via short hairpin RNA-mediated RNA interference (at the genetic level) resulted in a significant inhibition in the growth and viability of human PCa cells while having no effect on normal prostate epithelial cells. Further, we found that inhibition of SIRT1 caused an increase in FOXO1 acetylation and transcriptional activation in PCa cells. Our data suggested that SIRT1, via inhibiting FOXO1 activation, could contribute to the development of PCa. We suggest that SIRT1 could serve as a target toward developing novel strategies for PCa management.	[Ahmad, Nihal] Univ Wisconsin, Med Sci Ctr, Dept Dermatol, Madison, WI 53706 USA; [Jung-Hynes, Brittney; Ahmad, Nihal] Univ Wisconsin, Mol & Environm Toxicol Ctr, Madison, WI 53706 USA; [Nihal, Minakshi; Zhong, Weixiong] Univ Wisconsin, William S Middleton Mem Vet Hosp, Madison, WI 53706 USA; [Zhong, Weixiong] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA; [Zhong, Weixiong; Ahmad, Nihal] Univ Wisconsin, Ctr Comprehens Canc, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ahmad, N (corresponding author), Univ Wisconsin, Med Sci Ctr, Dept Dermatol, 1300 Univ Ave, Madison, WI 53706 USA.	nahmad@wisc.edu	Ahmad, Nihal/AAR-4249-2021	Ahmad, Nihal/0000-0002-4239-9887	National Institutes of Health; NIEHS; Molecular and Environmental Toxicology Center Training [T32ES007015]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Molecular and Environmental Toxicology Center Training; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health, NIEHS, Molecular and Environmental Toxicology Center Training Grant T32ES007015 (predoctoral traineeship to B.J.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Anderson MJ, 1998, GENOMICS, V47, P187, DOI 10.1006/geno.1997.5122; Balestrieri ML, 2008, BBA-PROTEINS PROTEOM, V1784, P936, DOI 10.1016/j.bbapap.2008.03.004; Birkenkamp KU, 2003, BIOCHEM SOC T, V31, P292, DOI 10.1042/bst0310292; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Bouras T, 2005, J BIOL CHEM, V280, P10264, DOI 10.1074/jbc.M408748200; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Chu F, 2005, CANCER RES, V65, P10183, DOI 10.1158/0008-5472.CAN-05-2002; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; Dai JM, 2007, J CELL PHYSIOL, V210, P161, DOI 10.1002/jcp.20831; Dai Y, 2007, MOL ENDOCRINOL, V21, P1807, DOI 10.1210/me.2006-0467; Deng XQ, 2007, LIVER INT, V27, P708, DOI 10.1111/j.1478-3231.2007.01497.x; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Ford J, 2005, CANCER RES, V65, P10457, DOI 10.1158/0008-5472.CAN-05-1923; Fraga MF, 2007, ANN NY ACAD SCI, V1100, P60, DOI 10.1196/annals.1395.005; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Fu MF, 2006, MOL CELL BIOL, V26, P8122, DOI 10.1128/MCB.00289-06; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; Giannakou ME, 2004, TRENDS CELL BIOL, V14, P408, DOI 10.1016/j.tcb.2004.07.006; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617; Hida Y, 2007, ARCH DERMATOL RES, V299, P103, DOI 10.1007/s00403-006-0725-6; Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085; Jacobs FMJ, 2003, J BIOL CHEM, V278, P35959, DOI 10.1074/jbc.M302804200; Jarrard DF, 1999, CANCER RES, V59, P2957; Jeong J, 2007, EXP MOL MED, V39, P8, DOI 10.1038/emm.2007.2; Jin QH, 2007, J CELL PHYSIOL, V213, P88, DOI 10.1002/jcp.21091; Kamel C, 2006, AGING CELL, V5, P81, DOI 10.1111/j.1474-9726.2006.00191.x; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kobayashi Y, 2005, INT J MOL MED, V16, P237; Kojima K, 2008, BIOCHEM BIOPH RES CO, V373, P423, DOI 10.1016/j.bbrc.2008.06.045; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Li H, 2002, BIOGERONTOLOGY, V3, P107, DOI 10.1023/A:1015232102470; Li R, 2007, HUM PATHOL, V38, P1501, DOI 10.1016/j.humpath.2007.02.016; Liang XJ, 2008, MOL CANCER RES, V6, P1499, DOI 10.1158/1541-7786.MCR-07-2130; Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Marmorstein R, 2004, BIOCHEM SOC T, V32, P904, DOI 10.1042/BST0320904; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Modur V, 2002, J BIOL CHEM, V277, P47928, DOI 10.1074/jbc.M207509200; Morris BJ, 2005, J HYPERTENS, V23, P1285, DOI 10.1097/01.hjh.0000173509.45363.dd; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; PARRY P, 1994, GENE CHROMOSOME CANC, V11, P79, DOI 10.1002/gcc.2870110203; Pruitt K, 2006, PLOS GENET, V2, P344, DOI 10.1371/journal.pgen.0020040; REZNIKOFF CA, 1987, J CELL PHYSIOL, V131, P285, DOI 10.1002/jcp.1041310302; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Stuenkel Walter, 2007, Biotechnology Journal, V2, P1360, DOI 10.1002/biot.200700087; Tikoo K, 2007, FEBS LETT, V581, P1071, DOI 10.1016/j.febslet.2007.02.006; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang C, 2005, J PHARMACOL SCI, V97, P494, DOI 10.1254/jphs.FPJ04055X; Wong S, 2007, BIOCHEM J, V407, P451, DOI 10.1042/BJ20070151; Yang YH, 2005, EMBO J, V24, P1021, DOI 10.1038/sj.emboj.7600570; Ying WH, 2006, FRONT BIOSCI-LANDMRK, V11, P3129, DOI 10.2741/2038	62	141	148	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3823	3832		10.1074/jbc.M807869200	http://dx.doi.org/10.1074/jbc.M807869200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19075016	Green Published, hybrid			2022-12-25	WOS:000262872500051
J	Makise, M; Takehara, M; Kuniyasu, A; Matsui, N; Nakayama, H; Mizushima, T				Makise, Masaki; Takehara, Masaya; Kuniyasu, Akihiko; Matsui, Nanako; Nakayama, Hitoshi; Mizushima, Tohru			Linkage between Phosphorylation of the Origin Recognition Complex and Its ATP Binding Activity in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASES; CHROMOSOMAL DNA-REPLICATION; CELL-CYCLE; IN-VIVO; RE-REPLICATION; MCM PROTEINS; CDC6P; ORC; INITIATOR; PROTEOLYSIS	The initiation of chromosomal DNA replication is tightly regulated to achieve genome replication just once per cell cycle and cyclin-dependent kinase (CDK) plays an important role in this process. Adenine nucleotides that bind to the origin recognition complex (ORC) are also suggested to be involved in this process. Of the six subunits of the Saccharomyces cerevisiae ORC(Orc1-6p), both Orc1p and Orc5p have ATP binding activity, and both Orc2p and Orc6p are phosphorylated by CDK in cells. In this study we constructed a series of yeast strains expressing phospho-mimetic mutants of Orc2p or Orc6p and found that expression of a Ser-188 mutant of Orc2p (Orc2-5Dp) delays G(1)-S transition and S phase progression and causes the accumulation of cells with 2C DNA content. Using antibody that specifically recognizes Ser-188-phosphorylated Orc2p, we showed that Ser-188 is phosphorylated by CDK in a cell cycle-regulated manner. Expression of Orc2-5Dp caused phosphorylation of Rad53p and inefficient loading of the six minichromosome maintenance proteins. These results suggest that the accumulation of cells with 2C DNA content is due to inefficient origin firing and induction of the cell cycle checkpoint response and that dephosphorylation of Ser-188 of Orc2p in late M or G(1) phase may be involved in pre-RC formation. In vitro, a purified mutant ORC containing Orc2-5Dp lost Orc5p ATP binding activity. This is the first demonstration of a link between phosphorylation of the ORC and its ability to bind ATP, which may be important for the cell cycle-regulated initiation of DNA replication.	[Makise, Masaki; Takehara, Masaya; Kuniyasu, Akihiko; Matsui, Nanako; Nakayama, Hitoshi; Mizushima, Tohru] Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, Kumamoto 8620973, Japan	Kumamoto University	Mizushima, T (corresponding author), 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	mizu@gpo.kumamoto-u.ac.jp			Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Archambault V, 2005, MOL CELL BIOL, V25, P6707, DOI 10.1128/MCB.25.15.6707-6721.2005; Asano T, 2007, FEMS YEAST RES, V7, P1256, DOI 10.1111/j.1567-1364.2007.00299.x; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Bowers JL, 2004, MOL CELL, V16, P967, DOI 10.1016/j.molcel.2004.11.038; Branzei D, 2006, EXP CELL RES, V312, P2654, DOI 10.1016/j.yexcr.2006.06.012; DAHMANN C, 1995, CURR BIOL, V5, P1257, DOI 10.1016/S0960-9822(95)00252-1; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Drury LS, 2000, CURR BIOL, V10, P231, DOI 10.1016/S0960-9822(00)00355-9; Drury LS, 1997, EMBO J, V16, P5966, DOI 10.1093/emboj/16.19.5966; Dutta A, 1997, ANNU REV CELL DEV BI, V13, P293, DOI 10.1146/annurev.cellbio.13.1.293; Elsasser S, 1999, MOL BIOL CELL, V10, P3263, DOI 10.1091/mbc.10.10.3263; Garber PM, 2002, GENETICS, V161, P521; Gibson DG, 2006, GENES CELLS, V11, P557, DOI 10.1111/j.1365-2443.2006.00967.x; Harvey SL, 2003, CURR BIOL, V13, P264, DOI 10.1016/S0960-9822(03)00049-6; Katayama T, 1998, CELL, V94, P61, DOI 10.1016/S0092-8674(00)81222-2; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; Klemm RD, 1997, CELL, V88, P493, DOI 10.1016/S0092-8674(00)81889-9; Kuniyasu A, 2003, FEBS LETT, V552, P259, DOI 10.1016/S0014-5793(03)00936-0; Labib K, 1999, NAT CELL BIOL, V1, P415, DOI 10.1038/15649; Lee JR, 2002, BIOCHEM J, V362, P395, DOI 10.1042/bj3620395; LIANG C, 1995, CELL, V81, P667, DOI 10.1016/0092-8674(95)90528-6; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; Liku ME, 2005, MOL BIOL CELL, V16, P5026, DOI 10.1091/mbc.E05-05-0412; Makise M, 2003, J BIOL CHEM, V278, P46440, DOI 10.1074/jbc.M307392200; Makise M, 2008, J BIOCHEM, V143, P455, DOI 10.1093/jb/mvn005; Makise M, 2007, BIOCHEM J, V402, P397, DOI 10.1042/BJ20060841; MARAHRENS Y, 1992, SCIENCE, V255, P817, DOI 10.1126/science.1536007; Masumoto H, 2002, NATURE, V415, P651, DOI 10.1038/nature713; Matsuda K, 2007, FEMS YEAST RES, V7, P1263, DOI 10.1111/j.1567-1364.2007.00298.x; Mimura S, 2004, NATURE, V431, P1118, DOI 10.1038/nature03024; Mizushima T, 2000, GENE DEV, V14, P1631; Mizushima T, 1997, EMBO J, V16, P3724, DOI 10.1093/emboj/16.12.3724; Mizushima T, 1998, J BIOL CHEM, V273, P20847, DOI 10.1074/jbc.273.33.20847; Mizushima T, 1996, J BIOL CHEM, V271, P25178, DOI 10.1074/jbc.271.41.25178; Nguyen VQ, 2000, CURR BIOL, V10, P195, DOI 10.1016/S0960-9822(00)00337-7; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; Noton E, 2000, MOL CELL, V5, P85, DOI 10.1016/S1097-2765(00)80405-0; Radichev I, 2006, J BIOL CHEM, V281, P23264, DOI 10.1074/jbc.M603873200; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; RAO H, 1995, P NATL ACAD SCI USA, V92, P2224, DOI 10.1073/pnas.92.6.2224; Sanchez M, 1999, J BIOL CHEM, V274, P9092, DOI 10.1074/jbc.274.13.9092; SEKIMIZU K, 1987, CELL, V50, P259, DOI 10.1016/0092-8674(87)90221-2; Semple JW, 2006, EMBO J, V25, P5150, DOI 10.1038/sj.emboj.7601391; Shimada K, 2002, GENE DEV, V16, P3236, DOI 10.1101/gad.239802; Shimada K, 2007, CELL, V128, P85, DOI 10.1016/j.cell.2006.11.045; SIKORSKI RS, 1989, GENETICS, V122, P19; Tak YS, 2006, EMBO J, V25, P1987, DOI 10.1038/sj.emboj.7601075; Takahashi N, 2004, J BIOL CHEM, V279, P8469, DOI 10.1074/jbc.M305531200; Takahashi N, 2002, J BIOL CHEM, V277, P16033, DOI 10.1074/jbc.M108615200; Takenaka H, 2004, J MOL BIOL, V340, P29, DOI 10.1016/j.jmb.2004.04.045; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Watanabe K, 2002, EUKARYOT CELL, V1, P200, DOI 10.1128/EC.1.2.200-212.2002; Weinreich M, 2001, P NATL ACAD SCI USA, V98, P11211, DOI 10.1073/pnas.201387198; Wilmes GM, 2004, GENE DEV, V18, P981, DOI 10.1101/gad.1202304	57	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3396	3407		10.1074/jbc.M804293200	http://dx.doi.org/10.1074/jbc.M804293200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19068484	hybrid			2022-12-25	WOS:000262872500005
J	Long, JE; Renzette, N; Centore, RC; Sandler, SJ				Long, Jarukit Edward; Renzette, Nicholas; Centore, Richard C.; Sandler, Steven J.			Differential Requirements of Two recA Mutants for Constitutive SOS Expression in Escherichia coli K-12	PLOS ONE			English	Article								Background: Repairing DNA damage begins with its detection and is often followed by elicitation of a cellular response. In E. coli, RecA polymerizes on ssDNA produced after DNA damage and induces the SOS Response. The RecA-DNA filament is an allosteric effector of LexA auto-proteolysis. LexA is the repressor of the SOS Response. Not all RecA-DNA filaments, however, lead to an SOS Response. Certain recA mutants express the SOS Response (recA(C)) in the absence of external DNA damage in log phase cells. Methodology/Principal Findings: Genetic analysis of two recA(C) mutants was used to determine the mechanism of constitutive SOS (SOSC) expression in a population of log phase cells using fluorescence of single cells carrying an SOS reporter system (sulAp-gfp). SOSC expression in recA4142 mutants was dependent on its initial level of transcription, recBCD, recFOR, recX, dinl, xthA and the type of medium in which the cells were grown. SOSC expression in recA730 mutants was affected by none of the mutations or conditions tested above. Conclusions/Significance: It is concluded that not all recA(C) alleles cause SOSC expression by the same mechanism. It is hypothesized that RecA4142 is loaded on to a double-strand end of DNA and that the RecA filament is stabilized by the presence of DinI and destabilized by RecX. RecFOR regulate the activity of RecX to destabilize the RecA filament. RecA730 causes SOSC expression by binding to ssDNA in a mechanism yet to be determined.	[Sandler, Steven J.] Univ Massachusetts, Dept Microbiol, Morrill Sci Ctr 4 N203, Amherst, MA 01003 USA; [Renzette, Nicholas; Centore, Richard C.; Sandler, Steven J.] Univ Massachusetts, Morrill Sci Ctr, Mol & Cellular Biol Grad Program, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Long, JE (corresponding author), Univ Massachusetts, Dept Microbiol, Morrill Sci Ctr 4 N203, Amherst, MA 01003 USA.	sandler@microbio.umass.edu			National Institutes of Health [AI059027]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059027] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by AI059027 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Beaber JW, 2004, NATURE, V427, P72, DOI 10.1038/nature02241; BI E, 1990, J BACTERIOL, V172, P5602, DOI 10.1128/jb.172.10.5602-5609.1990; Blazquez J, 2006, MOL MICROBIOL, V62, P84, DOI 10.1111/j.1365-2958.2006.05366.x; Bork JM, 2001, J BIOL CHEM, V276, P45740, DOI 10.1074/jbc.M109247200; Bork JM, 2001, EMBO J, V20, P7313, DOI 10.1093/emboj/20.24.7313; Centore RC, 2008, MOL MICROBIOL, V67, P88, DOI 10.1111/j.1365-2958.2007.06026.x; Centore RC, 2007, J BACTERIOL, V189, P2915, DOI 10.1128/JB.01777-06; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; CLARK AJ, 1965, P NATL ACAD SCI USA, V53, P451, DOI 10.1073/pnas.53.2.451; Courcelle J, 2001, GENETICS, V158, P41; Courcelle J, 2003, SCIENCE, V299, P1064, DOI 10.1126/science.1081328; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Cox MM, 2001, ANNU REV GENET, V35, P53, DOI 10.1146/annurev.genet.35.102401.090016; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Zutter JK, 2001, STRUCTURE, V9, P47, DOI 10.1016/S0969-2126(00)00552-9; Drees JC, 2004, J BIOL CHEM, V279, P52991, DOI 10.1074/jbc.M409050200; Drees JC, 2004, MOL CELL, V15, P789, DOI 10.1016/j.molcel.2004.08.026; Eggler AL, 2003, J BIOL CHEM, V278, P16389, DOI 10.1074/jbc.M212920200; Flores MJ, 2005, MOL MICROBIOL, V57, P1664, DOI 10.1111/j.1365-2958.2005.04753.x; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; FU Y, 2008, FEMS MICROBIOLOGY RE, P1; Gruenig MC, 2008, MOL MICROBIOL, V69, P1165, DOI 10.1111/j.1365-2958.2008.06341.x; HEGDE S, 1995, MOL GEN GENET, V246, P254, DOI 10.1007/BF00294689; Hishida T, 2004, GENE DEV, V18, P1886, DOI 10.1101/gad.1223804; Hobbs MD, 2007, J BIOL CHEM, V282, P11058, DOI 10.1074/jbc.M611007200; Huang LC, 1997, J BACTERIOL, V179, P6076, DOI 10.1128/jb.179.19.6076-6083.1997; Ivancic-Bace I, 2003, GENETICS, V163, P485; Jasin M, 2002, ONCOGENE, V21, P8981, DOI 10.1038/sj.onc.1206176; Kelley WL, 2006, MOL MICROBIOL, V62, P1228, DOI 10.1111/j.1365-2958.2006.05444.x; KIRBY EP, 1967, P NATL ACAD SCI USA, V58, P1903, DOI 10.1073/pnas.58.5.1903; KNIGHT KL, 1984, J BIOL CHEM, V259, P1279; KONRAD EB, 1977, J BACTERIOL, V130, P167, DOI 10.1128/JB.130.1.167-172.1977; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; LAVERY PE, 1990, J BIOL CHEM, V265, P4004; Lee BI, 2004, EMBO J, V23, P2029, DOI 10.1038/sj.emboj.7600222; Lestini R, 2008, J BACTERIOL, V190, P5995, DOI 10.1128/JB.00620-08; Levin PA, 2002, METHOD MICROBIOL, V31, P115, DOI 10.1016/S0580-9517(02)31007-9; Liberi G, 2005, GENE DEV, V19, P339, DOI 10.1101/gad.322605; LITTLE JW, 1982, CELL, V29, P11, DOI 10.1016/0092-8674(82)90085-X; Lopez E, 2007, MOL MICROBIOL, V64, P83, DOI 10.1111/j.1365-2958.2007.05642.x; Lusetti SL, 2006, MOL CELL, V21, P41, DOI 10.1016/j.molcel.2005.11.011; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; Lusetti SL, 2004, J BIOL CHEM, V279, P30037, DOI 10.1074/jbc.M403064200; McCool JD, 2004, MOL MICROBIOL, V53, P1343, DOI 10.1111/j.1365-2958.2004.04225.x; McGrew DA, 2003, CRIT REV BIOCHEM MOL, V38, P385, DOI 10.1080/10409230390242489; Miller C, 2004, SCIENCE, V305, P1629, DOI 10.1126/science.1101630; Mirshad JK, 2003, BIOCHEMISTRY-US, V42, P5945, DOI 10.1021/bi027233i; O'Reilly EK, 2004, J BACTERIOL, V186, P7149, DOI 10.1128/JB.186.21.7149-7160.2004; OGAWA T, 1993, SCIENCE, V259, P1896, DOI 10.1126/science.8456314; Pages V, 2003, DNA REPAIR, V2, P273, DOI 10.1016/S1568-7864(02)00217-3; Pennington JM, 2007, NAT GENET, V39, P797, DOI 10.1038/ng2051; Ragone S, 2008, EMBO J, V27, P2259, DOI 10.1038/emboj.2008.145; Ramirez BE, 2000, PROTEIN SCI, V9, P2161, DOI 10.1110/ps.9.11.2161; Renzette N, 2005, MOL MICROBIOL, V57, P1074, DOI 10.1111/j.1365-2958.2005.04755.x; Renzette N, 2007, MOL MICROBIOL, V63, P103, DOI 10.1111/j.1365-2958.2006.05496.x; Sandler SJ, 1996, GENETICS, V143, P5; SANDLER SJ, 1994, MOL GEN GENET, V245, P741, DOI 10.1007/BF00297281; Scully R, 2004, CANCER BIOL THER, V3, P521, DOI 10.4161/cbt.3.6.842; Seigneur M, 1998, CELL, V95, P419, DOI 10.1016/S0092-8674(00)81772-9; Steiner WW, 1998, J BACTERIOL, V180, P6269; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; TESSMAN ES, 1985, J BACTERIOL, V163, P677, DOI 10.1128/JB.163.2.677-687.1985; UHLIN BE, 1981, J BACTERIOL, V148, P386, DOI 10.1128/JB.148.1.386-390.1981; UZEST M, 1995, MOL MICROBIOL, V17, P1177, DOI 10.1111/j.1365-2958.1995.mmi_17061177.x; Veaute X, 2005, EMBO J, V24, P180, DOI 10.1038/sj.emboj.7600485; Venkitaraman AR, 2001, J CELL SCI, V114, P3591; Webb BL, 1997, CELL, V91, P347, DOI 10.1016/S0092-8674(00)80418-3; WILLETTS NS, 1969, J BACTERIOL, V97, P244, DOI 10.1128/JB.97.1.244-249.1969; WITKIN EM, 1982, MOL GEN GENET, V185, P43, DOI 10.1007/BF00333788; Yasuda T, 1998, EMBO J, V17, P3207, DOI 10.1093/emboj/17.11.3207; Yasuda T, 2001, EMBO J, V20, P1192, DOI 10.1093/emboj/20.5.1192; Yoshimasu M, 2003, NUCLEIC ACIDS RES, V31, P1735, DOI 10.1093/nar/gkg256; ZIEG J, 1977, J BACTERIOL, V131, P123, DOI 10.1128/JB.131.1.123-132.1977	76	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4100	10.1371/journal.pone.0004100	http://dx.doi.org/10.1371/journal.pone.0004100			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DO	19116657	Green Published, gold			2022-12-25	WOS:000265466600018
J	Sano, K; Miyaji-Yamaguchi, M; Tsutsui, KM; Tsutsui, K				Sano, Kuniaki; Miyaji-Yamaguchi, Mary; Tsutsui, Kimiko M.; Tsutsui, Ken			Topoisomerase II beta Activates a Subset of Neuronal Genes that Are Repressed in AT-Rich Genomic Environment	PLOS ONE			English	Article								DNA topoisomerase II (topo II) catalyzes a strand passage reaction in that one duplex is passed through a transient brake or gate in another. Completion of late stages of neuronal development depends on the presence of active beta isoform (topo II beta). The enzyme appears to aid the transcriptional induction of a limited number of genes essential for neuronal maturation. However, this selectivity and underlying molecular mechanism remains unknown. Here we show a strong correlation between the genomic location of topo II beta action sites and the genes it regulates. These genes, termed group A1, are functionally biased towards membrane proteins with ion channel, transporter, or receptor activities. Significant proportions of them encode long transcripts and are juxtaposed to a long AT-rich intergenic region (termed LAIR). We mapped genomic sites directly targeted by topo II beta using a functional immunoprecipitation strategy. These sites can be classified into two distinct classes with discrete local GC contents. One of the classes, termed c2, appears to involve a strand passage event between distant segments of genomic DNA. The c2 sites are concentrated both in A1 gene boundaries and the adjacent LAIR, suggesting a direct link between the action sites and the transcriptional activation. A higher-order chromatin structure associated with AT richness and gene poorness is likely to serve as a silencer of gene expression, which is abrogated by topo II beta releasing nearby genes from repression. Positioning of these genes and their control machinery may have developed recently in vertebrate evolution to support higher functions of central nervous system.	[Sano, Kuniaki; Miyaji-Yamaguchi, Mary; Tsutsui, Kimiko M.] Okayama Univ, Dept Neurogenom, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Tsutsui, Ken] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Genome Dynam, Okayama, Japan	Okayama University; Okayama University	Sano, K (corresponding author), Okayama Univ, Dept Neurogenom, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan.	tsukken@cc.okayama-u.ac.jp	MIYAJI, Mary/B-2294-2011; TSUTSUI, Kimiko M/B-1955-2011; Tsutsui, Ken/B-1863-2011		MEXT, Japan [Grant-in-Aid]	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by Grant-in-Aid for Scientific Research funding to K. T. from the MEXT, Japan. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Borde V, 1998, BIOCHIMIE, V80, P223, DOI 10.1016/S0300-9084(98)80005-9; Burden DA, 1999, J BIOL CHEM, V274, P5227, DOI 10.1074/jbc.274.8.5227; CAPRANICO G, 1990, NUCLEIC ACIDS RES, V18, P4553, DOI 10.1093/nar/18.15.4553; COCKERILL PN, 1986, CELL, V44, P273, DOI 10.1016/0092-8674(86)90761-0; DRAKE FH, 1987, J BIOL CHEM, V262, P16739; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Isik S, 2003, FEBS LETT, V546, P374, DOI 10.1016/S0014-5793(03)00637-9; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; KAS E, 1992, EMBO J, V11, P705, DOI 10.1002/j.1460-2075.1992.tb05103.x; LEE MP, 1992, NUCLEIC ACIDS RES, V20, P5027, DOI 10.1093/nar/20.19.5027; LIU LF, 1983, J BIOL CHEM, V258, P5365; Lyu YL, 2006, MOL CELL BIOL, V26, P7929, DOI 10.1128/MCB.00617-06; Lyu YL, 2003, P NATL ACAD SCI USA, V100, P7123, DOI 10.1073/pnas.1232376100; Martins RP, 2007, P NATL ACAD SCI USA, V104, P8340, DOI 10.1073/pnas.0700076104; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; OSHEROFF N, 1989, BIOCHEMISTRY-US, V28, P6157, DOI 10.1021/bi00441a005; Ovcharenko I, 2005, GENOME RES, V15, P137, DOI 10.1101/gr.3015505; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; Raetzman LT, 1999, J NEUROBIOL, V38, P559; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Roca J, 1996, P NATL ACAD SCI USA, V93, P4057, DOI 10.1073/pnas.93.9.4057; Salceda J, 2006, EMBO J, V25, P2575, DOI 10.1038/sj.emboj.7601142; SANDER M, 1985, NUCLEIC ACIDS RES, V13, P1057, DOI 10.1093/nar/13.4.1057; Scacheri PC, 2006, METHOD ENZYMOL, V411, P270, DOI 10.1016/S0076-6879(06)11014-9; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; SPITZNER JR, 1988, NUCLEIC ACIDS RES, V16, P5533, DOI 10.1093/nar/16.12.5533; Tsutsui K, 2001, J BIOL CHEM, V276, P5769, DOI 10.1074/jbc.M008517200; UDVARDY A, 1991, MOL CELL BIOL, V11, P4973, DOI 10.1128/MCB.11.10.4973; Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131; ZECHIEDRICH EL, 1990, EMBO J, V9, P4555, DOI 10.1002/j.1460-2075.1990.tb07908.x	33	44	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4103	10.1371/journal.pone.0004103	http://dx.doi.org/10.1371/journal.pone.0004103			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DO	19116664	Green Published, gold, Green Submitted			2022-12-25	WOS:000265466600021
J	Sueur, J; Pavoine, S; Hamerlynck, O; Duvail, S				Sueur, Jerome; Pavoine, Sandrine; Hamerlynck, Olivier; Duvail, Stephanie			Rapid Acoustic Survey for Biodiversity Appraisal	PLOS ONE			English	Article							INDICATOR TAXA; COMMUNICATION; EVOLUTION; FOREST; SIGNAL; IDENTIFICATION; INTERFERENCE; CONSERVATION; DIVERSITY	Biodiversity assessment remains one of the most difficult challenges encountered by ecologists and conservation biologists. This task is becoming even more urgent with the current increase of habitat loss. Many methods-from rapid biodiversity assessments (RBA) to all-taxa biodiversity inventories (ATBI)-have been developed for decades to estimate local species richness. However, these methods are costly and invasive. Several animals-birds, mammals, amphibians, fishes and arthropods-produce sounds when moving, communicating or sensing their environment. Here we propose a new concept and method to describe biodiversity. We suggest to forego species or morphospecies identification used by ATBI and RBA respectively but rather to tackle the problem at another evolutionary unit, the community level. We also propose that a part of diversity can be estimated and compared through a rapid acoustic analysis of the sound produced by animal communities. We produced alpha and beta diversity indexes that we first tested with 540 simulated acoustic communities. The alpha index, which measures acoustic entropy, shows a logarithmic correlation with the number of species within the acoustic community. The beta index, which estimates both temporal and spectral dissimilarities, is linearly linked to the number of unshared species between acoustic communities. We then applied both indexes to two closely spaced Tanzanian dry lowland coastal forests. Indexes reveal for this small sample a lower acoustic diversity for the most disturbed forest and acoustic dissimilarities between the two forests suggest that degradation could have significantly decreased and modified community composition. Our results demonstrate for the first time that an indicator of biological diversity can be reliably obtained in a non-invasive way and with a limited sampling effort. This new approach may facilitate the appraisal of animal diversity at large spatial and temporal scales.	Museum Natl Hist Nat, CNRS, Dept Systemat & Evolut, UMR 5202, Paris, France; [Pavoine, Sandrine] Univ Oxford, Dept Zool, Math Ecol Res Grp, Oxford OX1 2JD, England; [Pavoine, Sandrine] Museum Natl Hist Nat, Dept Ecol Gest Biodivers, CNRS, UPMC USM 305 MNHN, Paris, France; [Hamerlynck, Olivier] Ctr Ecol & Hydrol, Wallingford, Oxon, England; [Duvail, Stephanie] IRD, IFRA, UR 200, Nairobi, Kenya	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); University of Oxford; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; UK Centre for Ecology & Hydrology (UKCEH); Institut de Recherche pour le Developpement (IRD)	Sueur, J (corresponding author), Museum Natl Hist Nat, CNRS, Dept Systemat & Evolut, UMR 5202, CP 50, Paris, France.	sueur@mnhn.fr	Duvail, Stéphanie/B-3297-2011; Sueur, Jerome/G-5364-2011	Duvail, Stéphanie/0000-0001-5963-3038; 	Institut Francais de la Biodiversite (IFB, Paris, France); Marie Curie Programme	Institut Francais de la Biodiversite (IFB, Paris, France); Marie Curie Programme(European Commission)	This work was funded by Institut Francais de la Biodiversite (IFB, Paris, France). The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SP is supported by the European Commission under the Marie Curie Programme.	Amezquita A, 2006, EVOLUTION, V60, P1874; [Anonymous], 2007, FORESTRY GOVERNANCE; [Anonymous], 1995, GLOBAL BIODIVERSITY; Balmford A, 2005, PHILOS T ROY SOC B, V360, P221, DOI 10.1098/rstb.2004.1599; Basset Y, 2000, BIOSCIENCE, V50, P899, DOI 10.1641/0006-3568(2000)050[0899:QBEWPA]2.0.CO;2; Bercher JF, 2000, IEEE T SIGNAL PROCES, V48, P1687, DOI 10.1109/78.845926; BONNET FR, 1995, GUIDE SONORE SAUTERE; Bradbury Jack W., 1998, pi; Brandes TS, 2006, J ACOUST SOC AM, V120, P2950, DOI 10.1121/1.2355479; Buddle CM, 2005, CAN ENTOMOL, V137, P120; Burgess ND, 2007, BIOL CONSERV, V134, P209, DOI 10.1016/j.biocon.2006.08.015; BURGESS ND, 2001, COASTAL FORESTS E AF; Chek AA, 2003, ECOL LETT, V6, P235, DOI 10.1046/j.1461-0248.2003.00420.x; Chen ZX, 2006, J ACOUST SOC AM, V120, P2974, DOI 10.1121/1.2345831; Chesmore ED, 2001, APPL ACOUST, V62, P1359, DOI 10.1016/S0003-682X(01)00009-3; DEROUSSEN F, 2003, GUIDE SONORE AMPHIBI; Deroussen F., 2001, OISEAUX JARDINS FRAN; Diwakar S, 2007, BIOACOUSTICS, V16, P113, DOI 10.1080/09524622.2007.9753571; DURAND JM, 2003, 45 RUF ENV MAN PROJ; ENDLER JA, 1993, PHILOS T R SOC B, V340, P215, DOI 10.1098/rstb.1993.0060; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; FICKEN RW, 1974, SCIENCE, V183, P762, DOI 10.1126/science.183.4126.762; Hammer Oyvind, 2001, Bioacoustics, V12, P21; Hill D., 2005, HDB BIODIVERSITY MET, DOI DOI 10.1017/CBO9780511542084; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Janzen DH, 2004, J APPL ECOL, V41, P181, DOI 10.1111/j.1365-2664.2004.00879.x; Krell FT, 2004, BIODIVERS CONSERV, V13, P795, DOI 10.1023/B:BIOC.0000011727.53780.63; Lawton JH, 1998, NATURE, V391, P72, DOI 10.1038/34166; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Luddecke H, 2000, STUD NEOTROP FAUNA E, V35, P185, DOI 10.1076/snfe.35.3.185.8855; Magurran A. E., 2004, MEASURING BIOL DIVER; McKnight MW, 2007, PLOS BIOL, V5, P2424, DOI 10.1371/journal.pbio.0050272; Mitterrneier R, 1993, RAPID ASSESSMENT PRO; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Narins Peter M., 2001, P61; Oliver I, 1996, CONSERV BIOL, V10, P99, DOI 10.1046/j.1523-1739.1996.10010099.x; Parsons S, 2000, J EXP BIOL, V203, P2641; PEARSON DL, 1994, PHILOS T ROY SOC B, V345, P75, DOI 10.1098/rstb.1994.0088; Peet R.K., 1974, Annual Rev Ecol Syst, V5, P285, DOI 10.1146/annurev.es.05.110174.001441; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Pimm SL, 1998, SCIENCE, V279, P2068, DOI 10.1126/science.279.5359.2068; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; R Development Core Team, 2007, R LANG ENV STAT COMP; Ricketts TH, 1999, BIOSCIENCE, V49, P369, DOI 10.2307/1313630; Riede K., 1997, P442; RIEDE K, 1993, AMBIO, V22, P546; Romer H., 1993, Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, V340, P179, DOI 10.1098/rstb.1993.0056; Rossman AY., 1998, PROTOCOLS ALL TAXA B, P208; Sanborn AF, 2006, CONT T ENT, P111; Shannon CE., 1949, MATH THEORY COMMUNIC; Sueur J, 2002, BIOL J LINN SOC, V75, P379, DOI 10.1111/j.1095-8312.2002.tb02079.x; Sueur J, 2008, BIOACOUSTICS, V18, P213, DOI 10.1080/09524622.2008.9753600; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; Wollerman L, 2002, BEHAV ECOL SOCIOBIOL, V52, P465, DOI 10.1007/s00265-002-0534-7; YOUNG AM, 1981, AM NAT, V117, P826, DOI 10.1086/283770	55	335	352	5	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2008	3	12							e4065	10.1371/journal.pone.0004065	http://dx.doi.org/10.1371/journal.pone.0004065			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DL	19115006	Green Published, Green Submitted, gold			2022-12-25	WOS:000265466300007
J	Banks, WE; d'Errico, F; Peterson, AT; Kageyama, M; Sima, A; Sanchez-Goni, MF				Banks, William E.; d'Errico, Francesco; Peterson, A. Townsend; Kageyama, Masa; Sima, Adriana; Sanchez-Goni, Maria-Fernanda			Neanderthal Extinction by Competitive Exclusion	PLOS ONE			English	Article							CHATELPERRONIAN-TYPE-SITE; UPPER PALEOLITHIC TRANSITION; MODERN HUMAN ORIGINS; EARLY-MODERN HUMANS; SPECIES DISTRIBUTIONS; ECOLOGICAL NICHES; WESTERN-EUROPE; CHRONOLOGY; CLIMATE; AURIGNACIAN	Background: Despite a long history of investigation, considerable debate revolves around whether Neanderthals became extinct because of climate change or competition with anatomically modern humans (AMH). Methodology/Principal Findings: We apply a new methodology integrating archaeological and chronological data with high-resolution paleoclimatic simulations to define eco-cultural niches associated with Neanderthal and AMH adaptive systems during alternating cold and mild phases of Marine Isotope Stage 3. Our results indicate that Neanderthals and AMH exploited similar niches, and may have continued to do so in the absence of contact. Conclusions/Significance: The southerly contraction of Neanderthal range in southwestern Europe during Greenland Interstadial 8 was not due to climate change or a change in adaptation, but rather concurrent AMH geographic expansion appears to have produced competition that led to Neanderthal extinction.	[d'Errico, Francesco] Univ Bordeaux 1, CNRS, Inst Prehist & Geol Quaternaire, UMR 5199 PACEA, F-33405 Talence, France; [d'Errico, Francesco] Univ Witwatersrand, Inst Human Evolut, Johannesburg, South Africa; [Peterson, A. Townsend] Univ Kansas, Nat Hist Mus & Biodivers Res Ctr, Lawrence, KS 66045 USA; [Kageyama, Masa; Sima, Adriana] CEA, Lab Sci Climat Environn, CNRS, UVSQ, UMR 1572, Gif Sur Yvette, France; [Sanchez-Goni, Maria-Fernanda] Univ Bordeaux 1, CNRS, EPOC, UMR5805, EPHE, F-33405 Talence, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; University of Witwatersrand; University of Kansas; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Bordeaux	Banks, WE (corresponding author), Univ Bordeaux 1, CNRS, Inst Prehist & Geol Quaternaire, UMR 5199 PACEA, F-33405 Talence, France.	w.banks@ipgq.u-bordeaux1.fr	Peterson, A. Townsend/I-5697-2013; KAGEYAMA, Masa/F-2389-2010; Goñi, Maria Fernanda Sanchez/R-3699-2019; Banks, William E./H-3494-2019	Peterson, A. Townsend/0000-0003-0243-2379; KAGEYAMA, Masa/0000-0003-0822-5880; Goñi, Maria Fernanda Sanchez/0000-0001-8238-7488; Banks, William E./0000-0003-1835-6315	National Science Foundation International Research Fellowship Program [0653000]; EuroClimate and OMLL programs of the European Science Foundation; ANR-BLANC IDEGLACE project [ANR-05-BLAN-0310-01]; CNRS/ECLIPSE project EOLE	National Science Foundation International Research Fellowship Program(National Science Foundation (NSF)); EuroClimate and OMLL programs of the European Science Foundation; ANR-BLANC IDEGLACE project(French National Research Agency (ANR)); CNRS/ECLIPSE project EOLE(Centre National de la Recherche Scientifique (CNRS))	This research was funded by the National Science Foundation International Research Fellowship Program (grant no. 0653000), and the EuroClimate and OMLL programs of the European Science Foundation. The climate simulations were produced in the framework of the ANR-BLANC IDEGLACE project (ANR-05-BLAN-0310-01) and the CNRS/ECLIPSE project EOLE.	Adjemian JCZ, 2006, J MED ENTOMOL, V43, P93, DOI 10.1603/0022-2585(2006)043[0093:AOGAFR]2.0.CO;2; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Bailey SE, 2006, J HUM EVOL, V50, P485, DOI 10.1016/j.jhevol.2005.11.008; BANKS WE, 2006, PALEOANTHROPOLOGY, V4, P68; Banks WE, 2008, J ARCHAEOL SCI, V35, P481, DOI 10.1016/j.jas.2007.05.011; Bard E, 2004, SCIENCE, V303, P178, DOI 10.1126/science.1091964; Bordes J.-G., 2003, TRABALHOS ARQUEOLOGI, V33, P223; CARNES BA, 1982, ECOLOGY, V63, P888, DOI 10.2307/1937227; Churchill SE, 2000, YEARB PHYS ANTHROPOL, V43, P61; CLIMAP, 1981, MAP CHART SER CLIMAP; d'Errico F, 1998, CURR ANTHROPOL, V39, pS1, DOI 10.1086/204689; d'Errico F, 2003, QUATERNARY SCI REV, V22, P769, DOI 10.1016/S0277-3791(03)00009-X; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; Davies W., 2007, RETHINKING HUMAN REV, P263; DERRICO F, 2006, HOMME FACE CLIMAT, P265; FINLAYSON C, 2004, NEANDERTHALS MODERN, P266; Finlayson C, 2006, NATURE, V443, P850, DOI 10.1038/nature05195; Finlayson C, 2008, QUATERNARY SCI REV, V27, P2246, DOI 10.1016/j.quascirev.2008.08.033; Giaccio B., 2006, NEANDERTHALS MODERN, P343; Goni MFS, 2008, QUATERNARY SCI REV, V27, P1136, DOI 10.1016/j.quascirev.2008.03.003; Gravina B, 2005, NATURE, V438, P51, DOI 10.1038/nature04006; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; HEINRICH H, 1988, QUATERNARY RES, V29, P142, DOI 10.1016/0033-5894(88)90057-9; Higham TFG, 2006, RADIOCARBON, V48, P179, DOI 10.1017/S0033822200066388; Hublin JJ, 1996, NATURE, V381, P224, DOI 10.1038/381224a0; Hublin JJ, 2007, RETHINKING HUMAN REV, P235; Hughen K, 2004, SCIENCE, V303, P202, DOI 10.1126/science.1090300; Jimenez-Espejo FJ, 2007, QUATERNARY SCI REV, V26, P836, DOI 10.1016/j.quascirev.2006.12.013; Joris O., 2003, TRABAJOS PREHIST, V60, P15, DOI DOI 10.3989/TP.2003.V60.I2.79; Jost A, 2005, CLIM DYNAM, V24, P577, DOI 10.1007/s00382-005-0009-4; Kissel C, 2005, CR GEOSCI, V337, P908, DOI 10.1016/j.crte.2005.04.009; Lalueza-Fox C, 2005, MOL BIOL EVOL, V22, P1077, DOI 10.1093/molbev/msi094; LEVEQUE F, 1980, CR ACAD SCI D NAT, V291, P187; Martinez-Meyer E, 2004, GLOBAL ECOL BIOGEOGR, V13, P305, DOI 10.1111/j.1466-822X.2004.00107.x; Mellars P, 2006, NATURE, V439, P931, DOI 10.1038/nature04521; Mellars P, 2004, NATURE, V432, P461, DOI 10.1038/nature03103; Mellars P, 2007, P NATL ACAD SCI USA, V104, P3657, DOI 10.1073/pnas.0608053104; Morin E, 2008, P NATL ACAD SCI USA, V105, P48, DOI 10.1073/pnas.0709372104; Noonan JP, 2006, SCIENCE, V314, P1113, DOI 10.1126/science.1131412; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; PELTIER WR, 1994, SCIENCE, V265, P195, DOI 10.1126/science.265.5169.195; Peterson AT, 2004, EMERG INFECT DIS, V10, P40, DOI 10.3201/eid1001.030125; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Pettitt PB, 2003, J ARCHAEOL SCI, V30, P1685, DOI 10.1016/S0305-4403(03)00070-0; Pettitt PB, 2001, ANTIQUITY, V75, P415, DOI 10.1017/S0003598X0006107X; ROTENBERRY JT, 1980, ECOLOGY, V61, P1228, DOI 10.2307/1936840; Rouquerol N, 2007, CHEMINS ART AURIGNAC, P37; Sanchez-Cordero V, 2000, P NATL ACAD SCI USA, V97, P7074, DOI 10.1073/pnas.97.13.7074; Sarnthein M, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000769; Sepulchre P, 2007, EARTH PLANET SC LETT, V258, P283, DOI 10.1016/j.epsl.2007.03.041; Serre D, 2004, PLOS BIOL, V2, P313, DOI 10.1371/journal.pbio.0020057; Smith FH, 2005, QUATERN INT, V137, P7, DOI 10.1016/j.quaint.2004.11.016; Soberon J, 2004, PHILOS T R SOC B, V359, P689, DOI 10.1098/rstb.2003.1439; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Straus LG, 2005, QUATERN INT, V137, P47, DOI 10.1016/j.quaint.2004.11.019; Stringer C, 2002, PHILOS T R SOC B, V357, P563, DOI 10.1098/rstb.2001.1057; Svensson A, 2008, CLIM PAST, V4, P47, DOI 10.5194/cp-4-47-2008; Trinkaus E, 2007, P NATL ACAD SCI USA, V104, P7367, DOI 10.1073/pnas.0702214104; Tzedakis PC, 2007, NATURE, V449, P206, DOI 10.1038/nature06117; VALDES VC, 2006, NEANDERTHALS MODERNS, P441; Van Der Plicht J, 1999, ANTIQUITY, V73, P119, DOI 10.1017/S0003598X00087895; VANANDEL TH, 2003, NEANDERTHALS MODERN, P265; Vega Toscano L.G., 1990, PALEOLITHIQUE MOYEN, P169; WENINGER B, CALPAL 2007; Weninger B, 2008, J HUM EVOL, V55, P772, DOI 10.1016/j.jhevol.2008.08.017; Zilhao J, 1999, J WORLD PREHIST, V13, P1, DOI 10.1023/A:1022348410845; Zilhao J., 2006, PYRENAE, V37, P7, DOI DOI 10.1039/C4CC09587A; ZILHAO J, 2008, PALEOANTHROPOLOGY, V6, P1; Zilhao J, 2003, TRABALHOS ARQUEOLOGI, P313, DOI DOI 10.1007/S10814-006-9008-1; Zilhao J, 2006, EVOL ANTHROPOL, V15, P183, DOI 10.1002/evan.20110; Zilhao J, 2006, P NATL ACAD SCI USA, V103, P12643, DOI 10.1073/pnas.0605128103	74	136	139	1	616	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e3972	10.1371/journal.pone.0003972	http://dx.doi.org/10.1371/journal.pone.0003972			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437CF	19107186	gold, Green Published, Green Submitted			2022-12-25	WOS:000265463000004
J	Melott, AL				Melott, Adrian L.			Long-Term Cycles in the History of Life: Periodic Biodiversity in the Paleobiology Database	PLOS ONE			English	Article							FOSSIL; DIVERSITY	Time series analysis of fossil biodiversity of marine invertebrates in the Paleobiology Database (PBDB) shows a significant periodicity at approximately 63 My, in agreement with previous analyses based on the Sepkoski database. I discuss how this result did not appear in a previous analysis of the PBDB. The existence of the 63 My periodicity, despite very different treatment of systematic error in both PBDB and Sepkoski databases strongly argues for consideration of its reality in the fossil record. Cross-spectral analysis of the two datasets finds that a 62 My periodicity coincides in phase by 1.6 My, equivalent to better than the errors in either measurement. Consequently, the two data sets not only contain the same strong periodicity, but its peaks and valleys closely correspond in time. Two other spectral peaks appear in the PBDB analysis, but appear to be artifacts associated with detrending and with the increased interval length. Sampling-standardization procedures implemented by the PBDB collaboration suggest that the signal is not an artifact of sampling bias. Further work should focus on finding the cause of the 62 My periodicity.	Univ Kansas, Dept Phys & Astron, Lawrence, KS 66045 USA	University of Kansas	Melott, AL (corresponding author), Univ Kansas, Dept Phys & Astron, Lawrence, KS 66045 USA.	melott@ku.edu			University of Kansas	University of Kansas	The University of Kansas had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alroy J, 2008, P NATL ACAD SCI; Alroy J, 2008, SCIENCE, V321, P97, DOI 10.1126/science.1156963; Arens NC, 2008, PALEOBIOLOGY, V34, P456, DOI 10.1666/07034.1; Bambach RK, 2006, ANNU REV EARTH PL SC, V34, P127, DOI 10.1146/annurev.earth.33.092203.122654; BRIGHAM FO, 1988, FAST FOURIER TRANSFO; Clouvas A, 2003, HEALTH PHYS, V84, P212, DOI 10.1097/00004032-200302000-00009; Cornette JL, 2007, COMPUT SCI ENG, V9, P61, DOI 10.1109/MCSE.2007.76; Ding GH, 2006, PLOS COMPUT BIOL, V2, P918, DOI 10.1371/journal.pcbi.0020102; Ferrari A, 1997, RADIAT PROT DOSIM, V74, P227, DOI 10.1093/oxfordjournals.rpd.a032201; Lieberman BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000759; Lockwood M, 2007, P ROY SOC A-MATH PHY, V463, P2447, DOI 10.1098/rspa.2007.1880; MCNULTY PJ, 1974, INT J RADIAT BIOL, V25, P315, DOI 10.1080/09553007414550381; Medvedev MV, 2007, ASTROPHYS J, V664, P879, DOI 10.1086/518757; Melott AL, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003206; Miller AI, 2000, PALEOBIOLOGY, V26, P53, DOI 10.1666/0094-8373(2000)26[53:CAPGD]2.0.CO;2; MULLER RA, 2002, ICE AGES ASTRONOMICA, P47; Peters SE, 2008, NATURE, V454, P626, DOI 10.1038/nature07032; Press W.H., 2007, NUMERICAL RECIPES AR, P640; Rohde RA, 2005, NATURE, V434, P208, DOI 10.1038/nature03339; ROHDE RA, 2006, GEOL SOC AM ABSTR, V38, P170; SCARGLE JD, 1982, APJ, V263, P835, DOI DOI 10.1086/160554; SEPKOSKI JA, 2002, B AMPALEONTOL; SEPKOSKI JJ, 1981, NATURE, V293, P435, DOI 10.1038/293435a0; Smith AB, 2005, BIOL LETT-UK, V1, P443, DOI 10.1098/rsbl.2005.0345; STANLEY SM, 1990, PALEOBIOLOGY, V16, P401, DOI 10.1017/S0094837300010150; Svensmark H, 2007, ASTRON GEOPHYS, V48, P18; Turner JE, 2005, HEALTH PHYS, V88, P520, DOI 10.1097/00004032-200506000-00002	27	21	21	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4044	10.1371/journal.pone.0004044	http://dx.doi.org/10.1371/journal.pone.0004044			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107212	Green Published, gold, Green Submitted			2022-12-25	WOS:000265463000030
J	Zhang, XY; Xu, JQ; Peng, H; Ma, Y; Han, LF; Ruan, YH; Su, B; Wang, N; Shao, YM				Zhang, Xiaoyan; Xu, Jianqing; Peng, Hong; Ma, Yan; Han, Lifeng; Ruan, Yuhua; Su, Bing; Wang, Ning; Shao, Yiming			HCV Coinfection Associated with Slower Disease Progression in HIV-Infected Former Plasma Donors Naive to ART	PLOS ONE			English	Article								Background: It remains controversial how HCV coinfection influences the disease progression during HIV-1 infection. This study aims to define the influence of HCV infection on the replication of HIV-1 and the disease progression in HIV-infected former plasma donors (FPDs) naive to ART. Methodology/Principal Findings: 168 HIV-1-infected FPDs were enrolled into a cohort study from Anhui province in central China, and thereafter monitored at month 3, 9, 15, 21 and 33. Fresh whole blood samples were used for CD4+ T-cell counting. Their plasma samples were collected and stored for quantification of HIV-1 viral loads and for determination of HCV and Toxoplasma. Out of 168 HIV-infected FBDs, 11.9% (20 cases), 80.4% (135 cases) and 7.7% (13 cases) were infected with HIV-1 alone, HIV-1/HCV and HIV/HCV/Toxoplasma, respectively. During the 33-month follow-up, only 35% (7 out of 20 cases) HIV-1 mono-infected subjects remained their CD4+ T-cell counts above 200 cells/ml and retained on the cohort study, which was significantly lower than 56% (75 out of 135 cases) for HIV/HCV group and 69% (9 out of 13 cases) for HIV/HCV/Toxoplasma group (p < 0.05). CD4+ T cells in HIV mono infection group were consistently lower than that in HIV/HCV group (p = 0.04, 0.18, 0.03 and 0.04 for baseline, month 9, month 21 and month 33 visit, respectively). In accordance with those observations, HIV viral loads in HIV mono- infection group were consistently higher than that in HIV/HCV group though statistical significances were only reached at baseline (p = 0.04). Conclusions/Significance: These data indicated HCV coinfection with HIV-1 is associated with the slower disease progression at the very late stage when comparing with HIV-1 mono-infection. The coinfection of Toxoplasma with HIV and HCV did not exert additional influence on the disease progression. It will be highly interesting to further explore the underlying mechanism for this observation in the future.	[Zhang, Xiaoyan; Xu, Jianqing; Peng, Hong; Ma, Yan; Han, Lifeng; Ruan, Yuhua; Wang, Ning; Shao, Yiming] China CDC, Natl Ctr AIDS STD Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Xu, Jianqing] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China; [Xu, Jianqing] Fudan Univ, Inst Biomed Sci, Shanghai, Peoples R China; [Su, Bing] Anhui Provinc Ctr Dis Control & Prevent, Hefei, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Fudan University; Fudan University	Zhang, XY (corresponding author), China CDC, Natl Ctr AIDS STD Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	yshao@bbn.cn	MA, YAN/HHN-2912-2022		Chinese Ministry of Health [WA-2006-01, 2008ZX10001-015, 2008ZX10001-02]; China National Program on Key Basic Research Projects [2005CB522903]; China Ministry of Science and Technology, China	Chinese Ministry of Health; China National Program on Key Basic Research Projects; China Ministry of Science and Technology, China(Ministry of Science and Technology, China)	This study was supported by grants from Chinese Ministry of Health (WA-2006-01, 2008ZX10001-015, 2008ZX10001-02), and by China National Program on Key Basic Research Projects (973 Program) (No. 2005CB522903), the China Ministry of Science and Technology, China.	Anderson KB, 2004, CLIN INFECT DIS, V39, P1507, DOI 10.1086/425360; Beach MV, 2001, LANCET, V357, P49, DOI 10.1016/S0140-6736(05)71551-8; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; Bertschy S, 2006, CLIN MICROBIOL INFEC, V12, P666, DOI 10.1111/j.1469-0691.2006.01459.x; Bica I, 2001, CLIN INFECT DIS, V32, P492, DOI 10.1086/318501; Chung RT, 2002, AIDS, V16, P1915, DOI 10.1097/00002030-200209270-00008; Dorrucci M, 2004, AIDS, V18, P2313, DOI 10.1097/00002030-200411190-00012; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; Harcourt GC, 2005, AIDS, V19, P1135, DOI 10.1097/01.aids.0000176213.10367.05; Hershow RC, 2005, CLIN INFECT DIS, V40, P859, DOI 10.1086/428121; Kaufman J, 2002, SCIENCE, V296, P2339, DOI 10.1126/science.1074479; Klein MB, 2003, JAIDS-J ACQ IMM DEF, V33, P365, DOI 10.1097/00126334-200307010-00011; Law WP, 2004, AIDS, V18, P1169, DOI 10.1097/00002030-200405210-00010; MCGOVERN H, 2007, J ACQ IMMUN DEF SYND, V45, pS47; MCGOVERN H, 2007, J ACQ IMMUN DEF SYND, V45, pS66; Micheloud D, 2007, PEDIATR INFECT DIS J, V26, P846, DOI 10.1097/INF.0b013e318123e8e6; Miro JM, 2006, CLIN INFECT DIS, V43, P79, DOI 10.1086/504872; Morsica G, 2007, J CLIN VIROL, V39, P82, DOI 10.1016/j.jcv.2007.03.007; Neau D, 2001, AIDS, V15, P1736, DOI 10.1097/00002030-200109070-00021; Rauch A, 2008, ANTIVIR THER, V13, P455; Rockstroh JK, 2006, J HEPATOL, V44, pS25, DOI 10.1016/j.jhep.2005.11.007; Shan H, 2002, LANCET, V360, P1770, DOI 10.1016/S0140-6736(02)11669-2; Shivraj SO, 2006, J TROP PEDIATRICS, V52, P206, DOI 10.1093/tropej/fmi103; Sulkowski MS, 2002, JAMA-J AM MED ASSOC, V288, P199, DOI 10.1001/jama.288.2.199; Trimoulet P, 2002, J MED VIROL, V67, P143, DOI 10.1002/jmv.2203; Voirin N, 2004, J VIRAL HEPATITIS, V11, P559, DOI 10.1111/j.1365-2893.2004.00544.x; Wang Shu-hua, 2007, Zhonghua Yi Xue Za Zhi, V87, P1535; Xu JQ, 2006, CHINESE MED J-PEKING, V119, P1941, DOI 10.1097/00029330-200612010-00002; YANG Y, 2008, CHINESE J M IN PRESS; Yoo TW, 2005, J INFECT DIS, V191, P4, DOI 10.1086/426513; Zhang LQ, 2004, J VIROL, V78, P13591, DOI 10.1128/JVI.78.24.13591-13599.2004	31	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2008	3	12							e3992	10.1371/journal.pone.0003992	http://dx.doi.org/10.1371/journal.pone.0003992			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CA	19098990	gold, Green Published, Green Submitted			2022-12-25	WOS:000265462300005
J	Wilson, JW; Ott, CM; Quick, L; Davis, R; Bentrup, KHZ; Crabbe, A; Richter, E; Sarker, S; Barrila, J; Porwollik, S; Cheng, P; McClelland, M; Tsaprailis, G; Radabaugh, T; Hunt, A; Shah, M; Nelman-Gonzalez, M; Hing, S; Parra, M; Dumars, P; Norwood, K; Bober, R; Devich, J; Ruggles, A; CdeBaca, A; Narayan, S; Benjamin, J; Goulart, C; Rupert, M; Catella, L; Schurr, MJ; Buchanan, K; Morici, L; McCracken, J; Porter, MD; Pierson, DL; Smith, SM; Mergeay, M; Leys, N; Stefanyshyn-Piper, HM; Gorie, D; Nickerson, CA				Wilson, James W.; Ott, C. Mark; Quick, Laura; Davis, Richard; Bentrup, Kerstin Hoener zu; Crabbe, Aurelie; Richter, Emily; Sarker, Shameema; Barrila, Jennifer; Porwollik, Steffen; Cheng, Pui; McClelland, Michael; Tsaprailis, George; Radabaugh, Timothy; Hunt, Andrea; Shah, Miti; Nelman-Gonzalez, Mayra; Hing, Steve; Parra, Macarena; Dumars, Paula; Norwood, Kelly; Bober, Ramona; Devich, Jennifer; Ruggles, Ashleigh; CdeBaca, Autumn; Narayan, Satro; Benjamin, Joseph; Goulart, Carla; Rupert, Mark; Catella, Luke; Schurr, Michael J.; Buchanan, Kent; Morici, Lisa; McCracken, James; Porter, Marc D.; Pierson, Duane L.; Smith, Scott M.; Mergeay, Max; Leys, Natalie; Stefanyshyn-Piper, Heidemarie M.; Gorie, Dominic; Nickerson, Cheryl A.			Media Ion Composition Controls Regulatory and Virulence Response of Salmonella in Spaceflight	PLOS ONE			English	Article								The spaceflight environment is relevant to conditions encountered by pathogens during the course of infection and induces novel changes in microbial pathogenesis not observed using conventional methods. It is unclear how microbial cells sense spaceflight-associated changes to their growth environment and orchestrate corresponding changes in molecular and physiological phenotypes relevant to the infection process. Here we report that spaceflight-induced increases in Salmonella virulence are regulated by media ion composition, and that phosphate ion is sufficient to alter related pathogenesis responses in a spaceflight analogue model. Using whole genome microarray and proteomic analyses from two independent Space Shuttle missions, we identified evolutionarily conserved molecular pathways in Salmonella that respond to spaceflight under all media compositions tested. Identification of conserved regulatory paradigms opens new avenues to control microbial responses during the infection process and holds promise to provide an improved understanding of human health and disease on Earth.	[Quick, Laura; Davis, Richard; Crabbe, Aurelie; Richter, Emily; Sarker, Shameema; Barrila, Jennifer; Nickerson, Cheryl A.] Arizona State Univ, Ctr Infect Dis & Vaccinol, Biodesign Inst, Tempe, AZ 85287 USA; [Wilson, James W.; Quick, Laura] Villanova Univ, Dept Biol, Villanova, PA 19085 USA; [Ott, C. Mark; Pierson, Duane L.] NASA, Johnson Space Center, Habitabil & Environm Factors Div, Houston, TX USA; [Bentrup, Kerstin Hoener zu; Morici, Lisa] Tulane Univ, Hlth Sci Ctr, New Orleans, LA 70118 USA; [Crabbe, Aurelie] Free Univ Brussels, Flanders Inst Biotechnol, B-1050 Brussels, Belgium; [Crabbe, Aurelie; Mergeay, Max; Leys, Natalie] Belgian Nuclear Res Ctr, Mol, Belgium; [Porwollik, Steffen; Cheng, Pui; McClelland, Michael] Sidney Kimmel Canc Ctr, San Diego, CA USA; [Tsaprailis, George; Radabaugh, Timothy; Hunt, Andrea] Univ Arizona, Ctr Toxicol, Tucson, AZ 85721 USA; [Shah, Miti] Arizona State Univ, Ctr Glycosci Technol, Biodesign Inst, Tempe, AZ 85287 USA; [Nelman-Gonzalez, Mayra] Wyle Lab, Houston, TX USA; [Hing, Steve; Parra, Macarena; Dumars, Paula] NASA, Ames Res Ctr, Moffett Field, CA USA; [Norwood, Kelly; Bober, Ramona; Devich, Jennifer; Ruggles, Ashleigh; CdeBaca, Autumn; Narayan, Satro; Benjamin, Joseph; Catella, Luke] Kennedy Space Ctr, Space Life Sci Lab, Cape Canaveral, FL USA; [Goulart, Carla; Rupert, Mark] Univ Colorado, Boulder, CO 80309 USA; [Schurr, Michael J.] Univ Colorado, Sch Med, Aurora, CO USA; [Buchanan, Kent] Oklahoma City Univ, Oklahoma City, OK USA; [McCracken, James] Univ Chicago, Sect Gen Surg, Chicago, IL 60637 USA; [Porter, Marc D.] Univ Utah, Dept Chem, Chem Engn & Bioengn, Salt Lake City, UT 84112 USA; [Smith, Scott M.] Natl Aeronaut & Space Adm, Johnson Space Ctr, Human Adapt & Countermeasures Div, Houston, TX USA; [Stefanyshyn-Piper, Heidemarie M.; Gorie, Dominic] NASA, Johnson Space Ctr, Astronaut Office, Houston, TX USA	Arizona State University; Arizona State University-Tempe; Villanova University; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Tulane University; Flanders Institute for Biotechnology (VIB); Universite Libre de Bruxelles; Vrije Universiteit Brussel; Belgian Nuclear Research Centre (SCK-CEN); University of Arizona; Arizona State University; Arizona State University-Tempe; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Chicago; Utah System of Higher Education; University of Utah; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER	Wilson, JW (corresponding author), Arizona State Univ, Ctr Infect Dis & Vaccinol, Biodesign Inst, Tempe, AZ 85287 USA.	Cheryl.A.Nickerson@asu.edu	Leys, Natalie M.E.J./P-2761-2017; Schurr, Michael/AAX-6596-2020; Mergeay, Max/H-2003-2011; McClelland, Michael/A-8583-2011; Schurr, Michael/I-2481-2013	Schurr, Michael/0000-0003-2585-0477; Ott, Mark/0000-0002-3101-4806; Crabbe, Aurelie/0000-0003-3084-4418; McClelland, Michael/0000-0003-1788-9347; Barrila, Jennifer/0000-0002-6597-3001; Tsaprailis, George/0000-0003-1239-2358	NASA [NCC2-1362]; NIEHS [ES06694]; NIH/NCI [CA023074]; BIO5 Institute of the University of Arizona; King Baudouin Foundation [Henri Benedictus Fellowship]; Belgian American Educational Foundation; NATIONAL CANCER INSTITUTE [P30CA023074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER	NASA(National Aeronautics & Space Administration (NASA)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BIO5 Institute of the University of Arizona; King Baudouin Foundation; Belgian American Educational Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NASA grant NCC2-1362 to CAN; Arizona Proteomics Consortium supported by NIEHS grant ES06694 to the SWEHSC, NIH/NCI grant CA023074 to the AZCC, and by the BIO5 Institute of the University of Arizona; AC supported by Henri Benedictus Fellowship of the King Baudouin Foundation and the Belgian American Educational Foundation (B.A.E.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins JN, 2006, MOL CELL PROTEOMICS, V5, P1450, DOI 10.1074/mcp.M600139-MCP200; Aertsen A, 2004, CRIT REV MICROBIOL, V30, P263, DOI 10.1080/10408410490884757; *ASTM, D4327 ASTM; Beeson JG, 2000, NAT MED, V6, P86, DOI 10.1038/71582; Cai ZQ, 2000, AM J PHYSIOL-RENAL, V279, pF270, DOI 10.1152/ajprenal.2000.279.2.F270; CRABBE A, 2008, ENV MICROBIOL; Eckmann L, 1997, P NATL ACAD SCI USA, V94, P14456, DOI 10.1073/pnas.94.26.14456; Figueroa-Bossi N, 2006, MOL MICROBIOL, V62, P838, DOI 10.1111/j.1365-2958.2006.05413.x; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Guisbert E, 2007, J BACTERIOL, V189, P1963, DOI 10.1128/JB.01243-06; GULIG PA, 1987, INFECT IMMUN, V55, P2891, DOI 10.1128/IAI.55.12.2891-2901.1987; Guo P, 2000, AM J PHYSIOL-RENAL, V279, pF698, DOI 10.1152/ajprenal.2000.279.4.F698; Hernandez LD, 2004, SCIENCE, V304, P1805, DOI 10.1126/science.1098188; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; KHANNA R, 1988, DIGEST DIS SCI, V33, P1147, DOI 10.1007/BF01535792; LENNOX ES, 1955, VIROLOGY, V1, P190, DOI 10.1016/0042-6822(55)90016-7; Mahmood S, 2005, EXP PARASITOL, V110, P91, DOI 10.1016/j.exppara.2005.03.017; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nickerson CA, 2004, MICROBIOL MOL BIOL R, V68, P345, DOI 10.1128/MMBR.68.2.345-361.2004; Nickerson CA, 2000, INFECT IMMUN, V68, P3147, DOI 10.1128/IAI.68.6.3147-3152.2000; Poelstra K, 1997, LAB INVEST, V76, P319; Poelstra K, 1997, AM J PATHOL, V151, P1163; REED LJ, 1938, AM J HYG, V27; Ruiz N, 2003, J BACTERIOL, V185, P5984, DOI 10.1128/JB.185.20.5984-5992.2003; Rychlik I, 2005, FEMS MICROBIOL REV, V29, P1021, DOI 10.1016/j.femsre.2005.03.005; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; Tucker DL, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-15; Vanderpool CK, 2004, MOL MICROBIOL, V54, P1076, DOI 10.1111/j.1365-2958.2004.04348.x; Wilson JW, 2007, P NATL ACAD SCI USA, V104, P16299, DOI 10.1073/pnas.0707155104; Wilson JW, 2002, APPL ENVIRON MICROB, V68, P5408, DOI 10.1128/AEM.68.11.5408-5416.2002; Wilson JW, 2002, P NATL ACAD SCI USA, V99, P13807, DOI 10.1073/pnas.212387899; Xia XQ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-306; Zhang AX, 2003, MOL MICROBIOL, V50, P1111, DOI 10.1046/j.1365-2958.2003.03734.x	33	102	115	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2008	3	12							e3923	10.1371/journal.pone.0003923	http://dx.doi.org/10.1371/journal.pone.0003923			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZW	19079590	Green Submitted, gold, Green Published			2022-12-25	WOS:000265456300003
J	Klemm, K; Eipel, C; Cantre, D; Abshagen, K; Menger, MD; Vollmar, B				Klemm, Katja; Eipel, Christian; Cantre, Daniel; Abshagen, Kerstin; Menger, Michael D.; Vollmar, Brigitte			Multiple Doses of Erythropoietin Impair Liver Regeneration by Increasing TNF-alpha, the Bax to Bcl-xL Ratio and Apoptotic Cell Death	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; RECOMBINANT-HUMAN-ERYTHROPOIETIN; PROTECTS; FAILURE; INFLAMMATION; HEPATECTOMY; DARBEPOETIN; BIOLOGY; SIZE	Background: Liver resection and the use of small-for-size grafts are restricted by the necessity to provide a sufficient amount of functional liver mass. Only few promising strategies to maximize liver regeneration are available. Apart from its erythropoiesis-stimulating effect, erythropoietin (EPO) has meanwhile been recognized as mitogenic, tissue-protective, and anti-apoptotic pleiotropic cytokine. Thus, EPO may support regeneration of hepatic tissue. Methodology: Rats undergoing 68% hepatectomy received daily either high dose (5000 IU/kg bw iv) or low dose (500 IU/kg bw iv) recombinant human EPO or equal amounts of physiologic saline. Parameters of liver regeneration and hepatocellular apoptosis were assessed at 24 h, 48 h and 5 d after resection. In addition, red blood cell count, hematocrit and serum EPO levels as well as plasma concentrations of TNF-alpha and IL-6 were evaluated. Further, hepatic Bcl-x(L) and Bax protein expression were analyzed by Western blot. Principal Findings: Administration of EPO significantly reduced the expression of PCNA at 24 h followed by a significant decrease in restitution of liver mass at day 5 after partial hepatectomy. EPO increased TNF-alpha levels and shifted the Bcl-x(L) to Bax ratio towards the pro-apoptotic Bax resulting in significantly increased hepatocellular apoptosis. Conclusions: Multiple doses of EPO after partial hepatectomy increase hepatocellular apoptosis and impair liver regeneration in rats. Thus, careful consideration should be made in pre- and post-operative recombinant human EPO administration in the setting of liver resection and transplantation.	[Klemm, Katja; Eipel, Christian; Cantre, Daniel; Abshagen, Kerstin; Vollmar, Brigitte] Univ Rostock, Inst Expt Surg, Rostock, Germany; [Menger, Michael D.] Univ Saarland, Inst Clin & Exp Surg, Homburg, Germany	University of Rostock; Saarland University	Klemm, K (corresponding author), Univ Rostock, Inst Expt Surg, Rostock, Germany.	christian.eipel@uni-rostock.de			Deutsche Forschungsgemeinschaft, Bonn-Bad Godesberg, Germany [Vo 450/10-1]	Deutsche Forschungsgemeinschaft, Bonn-Bad Godesberg, Germany(German Research Foundation (DFG))	This work is supported by a grant of the Deutsche Forschungsgemeinschaft, Bonn-Bad Godesberg, Germany (Vo 450/10-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardet V, 2006, LIVER TRANSPLANT, V12, P1649, DOI 10.1002/lt.20898; Belayev L, 2005, STROKE, V36, P1065, DOI 10.1161/01.STR.0000160753.36093.da; Brines M, 2006, KIDNEY INT, V70, P246, DOI 10.1038/sj.ki.5001546; Buemi M., 2006, Cardiovascular & Hematological Agents in Medicinal Chemistry, V4, P299, DOI 10.2174/187152506778520754; Calvillo L, 2003, P NATL ACAD SCI USA, V100, P4802, DOI 10.1073/pnas.0630444100; Cantre D, 2008, BRIT J SURG, V95, P785, DOI 10.1002/bjs.6139; Chen GG, 2002, CLIN EXP METASTAS, V19, P457, DOI 10.1023/A:1016336724463; Diehl AM, 1996, J GASTROEN HEPATOL, V11, P466, DOI 10.1111/j.1440-1746.1996.tb00292.x; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fausto N, 2005, J HEPATO-BILIARY-PAN, V12, P181, DOI 10.1007/s00534-005-0979-y; Ghezzi P, 2004, CELL DEATH DIFFER, V11, pS37, DOI 10.1038/sj.cdd.4401450; Higgins GM, 1931, ARCH PATHOL, V12, P186; Humar A, 2004, LIVER TRANSPLANT, V10, P374, DOI 10.1002/lt.20096; Jelkmann W, 2004, ANN HEMATOL, V83, P673, DOI 10.1007/s00277-004-0911-6; Jelkmann W, 2004, INTERNAL MED, V43, P649, DOI 10.2169/internalmedicine.43.649; Johnson DW, 2006, KIDNEY INT, V69, P1806, DOI 10.1038/sj.ki.5000356; Katavetin P, 2007, KIDNEY INT, V72, pS10, DOI 10.1038/sj.ki.5002482; Kawashima Y, 2001, J HEART LUNG TRANSPL, V20, P568, DOI 10.1016/S1053-2498(01)00243-1; Kountouras J, 2001, HEPATO-GASTROENTEROL, V48, P556; Le Minh K, 2007, AM J PATHOL, V170, P1954, DOI 10.2353/ajpath.2007.061056; Libbrecht L, 2002, SEMIN CELL DEV BIOL, V13, P389, DOI 10.1016/S1084952102001258; MACDOUGALL IC, 1991, CLIN PHARMACOKINET, V20, P99, DOI 10.2165/00003088-199120020-00002; MICHALOPOULOS GK, 1997, LIVER REGENERATION S, V276, P60; Mohammed FF, 2004, NAT GENET, V36, P969, DOI 10.1038/ng1413; Nadalin S, 2004, LIVER TRANSPLANT, V10, P1024, DOI 10.1002/lt.20182; Nagata Y, 1997, BLOOD, V90, P929, DOI 10.1182/blood.V90.3.929.929_929_934; Nagy LE, 2004, ALCOHOL, V33, P229, DOI 10.1016/j.alcohol.2004.09.002; Ogata T, 2008, SURGERY, V143, P545, DOI 10.1016/j.surg.2007.11.010; Okada T, 2007, TRANSPLANTATION, V84, P504, DOI 10.1097/01.tp.0000277672.02783.33; Pomfret EA, 2003, TRANSPLANTATION, V76, P5, DOI 10.1097/01.TP.0000079064.08263.8E; Rafiee P, 2005, BASIC RES CARDIOL, V100, P187, DOI 10.1007/s00395-004-0508-1; Schmeding M, 2008, J GASTROEN HEPATOL, V23, P1125, DOI 10.1111/j.1440-1746.2007.05265.x; Seehofer D, 2008, LANGENBECK ARCH SURG, V393, P325, DOI 10.1007/s00423-008-0290-x; Sharples EJ, 2006, CURR OPIN PHARMACOL, V6, P184, DOI 10.1016/j.coph.2006.01.003; SPIVAK JL, 1989, BLOOD, V73, P90; Tsutsumi R, 2004, HEPATO-GASTROENTEROL, V51, P701; Vairano M, 2002, EUR J NEUROSCI, V16, P584, DOI 10.1046/j.1460-9568.2002.02125.x; Vesey DA, 2004, NEPHROL DIAL TRANSPL, V19, P348, DOI 10.1093/ndt/gfg547; Wiessner C, 2001, J CEREBR BLOOD F MET, V21, P857, DOI 10.1097/00004647-200107000-00011; Yilmaz Sezgin, 2004, HPB (Oxford), V6, P169, DOI 10.1080/13651820410026077; Zhande R, 2007, AM J PHYSIOL-HEART C, V292, pH2467, DOI 10.1152/ajpheart.00649.2006; Zhang F, 2007, NEUROBIOL DIS, V25, P45, DOI 10.1016/j.nbd.2006.08.007	43	23	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2008	3	12							e3924	10.1371/journal.pone.0003924	http://dx.doi.org/10.1371/journal.pone.0003924			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZU	19079544	Green Published, gold, Green Submitted			2022-12-25	WOS:000265455900008
J	Vera, PL; Iczkowski, KA; Wang, XH; Meyer-Siegler, KL				Vera, Pedro L.; Iczkowski, Kenneth A.; Wang, Xihai; Meyer-Siegler, Katherine L.			Cyclophosphamide-Induced Cystitis Increases Bladder CXCR4 Expression and CXCR4-Macrophage Migration Inhibitory Factor Association	PLOS ONE			English	Article							CHEMOKINE RECEPTORS; RAT BLADDER; FACTOR MIF; PAIN HYPERSENSITIVITY; FUNCTIONAL EXPRESSION; URINARY-BLADDER; INFLAMMATION; ACTIVATION; CD74; BARRIER	Background: Macrophage migration inhibitory factor (MIF) is a pro-inflammatory cytokine involved in cystitis and a non-cognate ligand of the chemokine receptor CXCR4 in vitro. We studied whether CXCR4-MIF associations occur in rat bladder and the effect of experimental cystitis. Methods and Findings: Twenty male rats received saline or cyclophosphamide (40 mg/kg; i.p.; every 3(rd) day) to induce persistent cystitis. After eight days, urine was collected and bladders excised under anesthesia. Bladder CXCR4 and CXCR4-MIF co-localization were examined with immunhistochemistry. ELISA determined MIF and stromal derived factor-1 (SDF-1; cognate ligand for CXCR4) levels. Bladder CXCR4 expression (real-time RTC-PCR) and protein levels (Western blotting) were examined. Co-immunoprecipitations studied MIF-CXCR4 associations. Urothelial basal and intermediate (but not superficial) cells in saline-treated rats contained CXCR4, co-localized with MIF. Cyclophosphamide treatment caused: 1) significant redistribution of CXCR4 immunostaining to all urothelial layers (especially apical surface of superficial cells) and increased bladder CXCR4 expression; 2) increased urine MIF with decreased bladder MIF; 3) increased bladder SDF-1; 4) increased CXCR4-MIF associations. Conclusions: These data demonstrate CXCR4-MIF associations occur in vivo in rat bladder and increase in experimental cystitis. Thus, CXCR4 represents an alternative pathway for MIF-mediated signal transduction during bladder inflammation. In the bladder, MIF may compete with SDF-1 (cognate ligand) to activate signal transduction mediated by CXCR4.	[Wang, Xihai; Meyer-Siegler, Katherine L.] Bay Pines VA Healthcare Syst, Res & Dev 151, Bay Pines, FL USA; [Vera, Pedro L.; Wang, Xihai] Univ S Florida, Coll Med, Dept Surg, Tampa, FL USA; [Iczkowski, Kenneth A.] Univ Colorado, Prostate Canc Res Lab, Aurora, CO USA; [Meyer-Siegler, Katherine L.] Univ S Florida, Coll Med, Dept Mol Med, Tampa, FL USA	State University System of Florida; University of South Florida; University of Colorado System; University of Colorado Anschutz Medical Campus; State University System of Florida; University of South Florida	Vera, PL (corresponding author), Bay Pines VA Healthcare Syst, Res & Dev 151, Bay Pines, FL USA.	pvera@health.usf.edu	Vera, Pedro/AAE-1514-2021		Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development; National Institute of Diabetes and Digestive and Kidney Diseases [DK075059]; Bay Pines Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK075059] Funding Source: NIH RePORTER	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Bay Pines Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This material is based upon work supported (or supported in part) by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development (PLV; KLMS). This work was also supported by the National Institute of Diabetes and Digestive and Kidney Diseases DK075059 (PLV; KLMS; XW), and the Bay Pines Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bhangoo S, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-38; Bhangoo SK, 2007, BRAIN BEHAV IMMUN, V21, P581, DOI 10.1016/j.bbi.2006.12.003; Bucala R, 2007, IMMUNITY, V26, P281, DOI 10.1016/j.immuni.2007.03.005; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Dwinell MB, 2004, AM J PHYSIOL-GASTR L, V286, pG844, DOI 10.1152/ajpgi.00112.2003; Eisenhardt A, 2005, EUR UROL, V47, P111, DOI 10.1016/j.eururo.2004.10.001; Fedyk ER, 2001, J IMMUNOL, V166, P5749, DOI 10.4049/jimmunol.166.9.5749; Flaster H, 2007, MOL ENDOCRINOL, V21, P1267, DOI 10.1210/me.2007-0065; Javeed A, 2008, INFLAMM RES, V57, P45, DOI 10.1007/s00011-007-7110-6; Kolodziej A, 2008, J NEUROSCI, V28, P4488, DOI 10.1523/JNEUROSCI.4721-07.2008; KOSS LG, 1967, LAB INVEST, V16, P44; Leng L, 2006, CELL RES, V16, P162, DOI 10.1038/sj.cr.7310022; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Lue H, 2007, ONCOGENE, V26, P5046, DOI 10.1038/sj.onc.1210318; Malley SE, 2002, PHYSIOL GENOMICS, V9, P5, DOI 10.1152/physiolgenomics.00117.2001; McClure CP, 2005, AIDS, V19, P1257, DOI 10.1097/01.aids.0000180096.50393.96; Meyer-Siegler KL, 2006, J UROLOGY, V175, P1523, DOI 10.1016/S0022-5347(05)00650-6; Meyer-Siegler KL, 2005, J UROLOGY, V173, P615, DOI 10.1097/01.ju.0000143188.02802.f3; Meyer-Siegler KL, 2004, J UROLOGY, V172, P1504, DOI 10.1097/01.ju.0000140213.54457.97; Meyer-Siegler KL, 2004, J UROLOGY, V171, P1698, DOI 10.1097/01.ju.0000115883.49365.1a; Meyer-Siegler KL, 2004, J INTERF CYTOK RES, V24, P55, DOI 10.1089/107999004772719918; Mikulowska A, 1997, J IMMUNOL, V158, P5514; Moyer RA, 2007, LAB INVEST, V87, P807, DOI 10.1038/labinvest.3700595; Murdoch C, 1999, IMMUNOLOGY, V98, P36; Oh SB, 2001, J NEUROSCI, V21, P5027, DOI 10.1523/JNEUROSCI.21-14-05027.2001; Ohkawara T, 2002, GASTROENTEROLOGY, V123, P256, DOI 10.1053/gast.2002.34236; PHILIPS FREDERICK S., 1961, CANCER RES, V21, P1577; Smith JM, 2005, AM J PHYSIOL-GASTR L, V288, pG316, DOI 10.1152/ajpgi.00208.2004; Starlets D, 2006, BLOOD, V107, P4807, DOI 10.1182/blood-2005-11-4334; Vera PL, 2008, EXP BIOL MED, V233, P620, DOI 10.3181/0709-RM-240; Vera PL, 2005, J UROLOGY, V174, P338, DOI 10.1097/01.ju.0000161606.15696.79; Vera PL, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-17; Woo LL, 2007, J UROLOGY, V177, P1568, DOI 10.1016/j.juro.2006.11.047; Yuridullah R, 2006, AUTON NEUROSCI-BASIC, V126, P380, DOI 10.1016/j.autneu.2006.02.030; Zimmerman NP, 2008, INFLAMM BOWEL DIS, V14, P1000, DOI 10.1002/ibd.20480	36	38	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2008	3	12							e3898	10.1371/journal.pone.0003898	http://dx.doi.org/10.1371/journal.pone.0003898			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZS	19066630	Green Published, gold, Green Submitted			2022-12-25	WOS:000265455700007
J	Valdez, DJ; Nieto, PS; Garbarino-Pico, E; Avalle, LB; Diaz-Fajreldines, H; Schurrer, C; Cheng, KM; Guido, ME				Valdez, Diego J.; Nieto, Paula S.; Garbarino-Pico, Eduardo; Avalle, Lucia B.; Diaz-Fajreldines, Hugo; Schurrer, Clemar; Cheng, Kimberly M.; Guido, Mario E.			A nonmammalian vertebrate model of blindness reveals functional photoreceptors in the inner retina	FASEB JOURNAL			English	Article						phototransduction; feeding activity rhythms; pupillary responses; extraretinal photoreceptors; vitamin A-based photopigment	EXTRARETINAL LIGHT PERCEPTION; GANGLION-CELLS; NON-CONE; NON-ROD; MOLECULAR-CLONING; VISUAL PIGMENTS; CIRCADIAN CLOCK; CHICKEN; MELANOPSIN; PINEAL	In mammals, photoreceptors located in the inner retina convey photic information to the brain, regulating diverse non-image-forming tasks such as pupillary light reflexes and photic synchronization (entrainment) of daily activity rhythms. In nonmammalian vertebrates, the retina, deep brain photoreceptors, and pineal organ may be photoreceptive. Here we investigated light perception in the absence of functional cone and rod photoreceptors using GUCY1* chickens, birds carrying a null mutation that causes blindness at hatch. They showed light responses in both the pupillary light reflex and the entrainment of feeding rhythms to a 12:12 h light-dark cycle. Light responses persisted even when the extraretinal photoperception was abolished, but they were lost after enucleation; this strongly indicates the essential role played by the inner retina. A sensitivity spectrum study for the pupillary reflex that combined pupil responses to different monochromatic lights of various intensities demonstrated that a single opsin/vitamin A-based photopigment peaking at 484 nm drives photic responses; the best fit (lowest sum of squares, R-2 = 0.9622) was attained with an opsin: vitamin A2 template. The results are the first characterization of functional inner retinal photoreceptors participating in the regulation of non-image-forming activities in nonmammalian vertebrates.-Valdez, D. J., Nieto, P. S., Garbarino-Pico, E., Avalle, L. B., Diaz-Fajreldines, H., Schurrer, C., Cheng, K. M., Guido, M. E. A nonmammalian vertebrate model of blindness reveals functional photoreceptors in the inner retina. FASEB J. 23, 1186-1195 (2009)	[Valdez, Diego J.; Nieto, Paula S.; Garbarino-Pico, Eduardo; Guido, Mario E.] Univ Nacl Cordoba, CIQUIBIC, Dept Quim Biol, Fac Ciencias Quim, RA-5000 Cordoba, Argentina; [Avalle, Lucia B.; Schurrer, Clemar] Univ Nacl Cordoba, Fac Matemat Astron & Fis, RA-5000 Cordoba, Argentina; [Diaz-Fajreldines, Hugo] Inst Neurociencias Cordoba, Cordoba, Argentina; [Cheng, Kimberly M.] Univ British Columbia, Fac Land & Food Syst, Avian Res Ctr, Vancouver, BC V5Z 1M9, Canada	National University of Cordoba; National University of Cordoba; University of British Columbia	Guido, ME (corresponding author), Univ Nacl Cordoba, CIQUIBIC, Dept Quim Biol, Fac Ciencias Quim, RA-5000 Cordoba, Argentina.	mguido@fcq.unc.edu.ar		Garbarino Pico, Eduardo/0000-0002-2931-2038; Valdez, Diego Javier/0000-0002-4467-6761	Fundacion Antorchas, Fundacion Florencio Fiorini; Agencia Nacional de Promocion Cientifica y Tecnica (FONCyT); CAEN-International Society for Neurochemistry; Consejo Nacional de Investigaciones Cientificas y Tecnicas de la Republica Argentina (CONICET); Secretar a de Ciencia y Tecnica-Universidad Nacional de Cordoba (SeCyT-UNC)	Fundacion Antorchas, Fundacion Florencio Fiorini; Agencia Nacional de Promocion Cientifica y Tecnica (FONCyT)(ANPCyTFONCyT); CAEN-International Society for Neurochemistry; Consejo Nacional de Investigaciones Cientificas y Tecnicas de la Republica Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Secretar a de Ciencia y Tecnica-Universidad Nacional de Cordoba (SeCyT-UNC)(Secretaria de Ciencia y Tecnologia (SECYT))	We thank Dr. Carlos Mas, Dr. Agata Carpentieri, and Dr. Pablo Rodriguez for assistance. We are grateful to Dr. Michael Menaker for his comments on the results, to Dr. Russell Van Gelder and Dr. Dan Tu for advice on the iris preparation, to Dr. Silvina Perez for suggestions about sensitivity spectrum analysis, and to Dr. Ignacio Provencio (University of Virginia, Charlottesville, VA, USA) for the gift of the fitting templates. This work has been supported by the Fundacion Antorchas, Fundacion Florencio Fiorini, Agencia Nacional de Promocion Cientifica y Tecnica (FONCyT), CAEN-International Society for Neurochemistry, Consejo Nacional de Investigaciones Cientificas y Tecnicas de la Republica Argentina (CONICET), and Secretar a de Ciencia y Tecnica-Universidad Nacional de Cordoba (SeCyT-UNC).	Arendt D, 2003, INT J DEV BIOL, V47, P563; Babity J M, 1997, Methods Mol Biol, V85, P285; Bailey MJ, 2004, INVEST OPHTH VIS SCI, V45, P769, DOI 10.1167/iovs.03-1125; BARRETT RK, 1991, BRAIN RES, V563, P87, DOI 10.1016/0006-8993(91)91518-6; Bellingham J, 2006, PLOS BIOL, V4, P1334, DOI 10.1371/journal.pbio.0040254; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Bowmaker JK, 1997, VISION RES, V37, P2183, DOI 10.1016/S0042-6989(97)00026-6; Brandstatter R, 2003, J NEUROENDOCRINOL, V15, P398, DOI 10.1046/j.1365-2826.2003.01003.x; CAHILL GM, 1995, PROG RETIN EYE RES, V14, P267, DOI 10.1016/1350-9462(94)00001-Y; CASSONE VM, 1984, J EXP ZOOL, V232, P539, DOI 10.1002/jez.1402320321; Chaurasia SS, 2005, J NEUROCHEM, V92, P158, DOI 10.1111/j.1471-4159.2004.02874.x; CHENG KM, 1980, POULTRY SCI, V59, P2179, DOI 10.3382/ps.0592179; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COLLIN JP, 1981, PINEAL GLAND, V1, P27; Contin MA, 2006, FASEB J, V20, P2648, DOI 10.1096/fj.06-6133fje; David-Gray ZK, 1998, NAT NEUROSCI, V1, P655, DOI 10.1038/3656; Dunlap J.C., 2004, CHRONOBIOLOGY BIOL T; Farber DB, 1997, CURR OPIN NEUROBIOL, V7, P666, DOI 10.1016/S0959-4388(97)80087-6; Foster RG, 2002, PROG RETIN EYE RES, V21, P507, DOI 10.1016/S1350-9462(02)00036-8; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; GAMLIN PDR, 1984, J COMP NEUROL, V226, P523, DOI 10.1002/cne.902260407; Garbarino-Pico E, 2004, J BIOL CHEM, V279, P51172, DOI 10.1074/jbc.M309248200; Garbarino-Pico E, 2004, J NEUROSCI RES, V76, P642, DOI 10.1002/jnr.20126; Guido ME, 2002, NEUROCHEM RES, V27, P1473, DOI 10.1023/A:1021696321391; Gwinner E, 2001, PHILOS T R SOC B, V356, P1801, DOI 10.1098/rstb.2001.0959; Hanein S, 2004, HUM MUTAT, V23, P306, DOI 10.1002/humu.20010; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Heidel J, 1999, J AUST MATH SOC B, V41, P83, DOI 10.1017/S0334270000011048; Kubo Y, 2006, J NEUROCHEM, V97, P1155, DOI 10.1111/j.1471-4159.2006.03826.x; Kumbalasiri T, 2005, EXP EYE RES, V81, P368, DOI 10.1016/j.exer.2005.05.004; Lima LHRG, 2006, BIOL RHYTHM RES, V37, P393, DOI 10.1080/09291010600870230; LUCAS R, 2003, NAT NEUROSCI, V4, P621; Lucas RJ, 1999, SCIENCE, V284, P505, DOI 10.1126/science.284.5413.505; Lythgoe J.N., 1979, ECOLOGY VISION; McGoogan JM, 1999, AM J PHYSIOL-REG I, V277, pR1418, DOI 10.1152/ajpregu.1999.277.5.R1418; MCMILLAN F, 1975, ARCH OPHTHALMOL-CHIC, V93, P420; MENAKER M, 1968, P NATL ACAD SCI USA, V60, P146, DOI 10.1073/pnas.60.1.146; MENAKER M, 1968, P NATL ACAD SCI USA, V59, P414, DOI 10.1073/pnas.59.2.414; MENAKER M, 1976, PHOTOCHEM PHOTOBIOL, V23, P299, DOI 10.1111/j.1751-1097.1976.tb07251.x; MENAKER M, 1971, BIOL REPROD, V4, P295, DOI 10.1093/biolreprod/4.3.295; Miyamoto Y, 1998, P NATL ACAD SCI USA, V95, P6097, DOI 10.1073/pnas.95.11.6097; PARTRIDGE JC, 1991, VISION RES, V31, P619, DOI 10.1016/0042-6989(91)90002-M; Peirson S, 2006, NEURON, V49, P331, DOI 10.1016/j.neuron.2006.01.006; Peirson SN, 2005, METHOD ENZYMOL, V393, P697, DOI 10.1016/S0076-6879(05)93037-1; PILAR G, 1987, J NEUROSCI, V7, P3813, DOI 10.1523/jneurosci.07-12-03813.1987; PROVENCIO I, 1992, VISION RES, V32, P2201, DOI 10.1016/0042-6989(92)90084-V; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Semple-Rowland SL, 1998, P NATL ACAD SCI USA, V95, P1271, DOI 10.1073/pnas.95.3.1271; Semple-Rowland SL, 1999, EXP EYE RES, V69, P579, DOI 10.1006/exer.1999.0743; SKARF B, 1999, NEUROOPHTHALMOLOGY, P7; TABATA M, 1992, NATO ADV SCI INST SE, V236, P223; Tomonari S, 2005, DEV DYNAM, V234, P783, DOI 10.1002/dvdy.20600; Tomonari S, 2007, GENE EXPR PATTERNS, V7, P746, DOI 10.1016/j.modgep.2007.06.001; Tosini G, 2000, CHRONOBIOL INT, V17, P599, DOI 10.1081/CBI-100101067; Tu DC, 2004, SCIENCE, V306, P129, DOI 10.1126/science.1101484; ULSHAFER RJ, 1984, EXP EYE RES, V39, P125, DOI 10.1016/0014-4835(84)90003-4; UNDERWOOD H, 1982, EXPERIENTIA, V38, P1013, DOI 10.1007/BF01955345; Underwood Herbert, 2001, Handbook of Behavioral Neurobiology, V12, P111; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481	59	22	24	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2009	23	4					1186	1195		10.1096/fj.08-117085	http://dx.doi.org/10.1096/fj.08-117085			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZO	19074512				2022-12-25	WOS:000266651600023
J	Pauff, JM; Cao, H; Hille, R				Pauff, James M.; Cao, Hongnan; Hille, Russ			Substrate Orientation and Catalysis at the Molybdenum Site in Xanthine Oxidase CRYSTAL STRUCTURES IN COMPLEX WITH XANTHINE AND LUMAZINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-SITE; MACROMOLECULAR STRUCTURES; MECHANISM; DEHYDROGENASE; SPECIFICITY; REFINEMENT; RESIDUES	Xanthine oxidoreductase is a ubiquitous cytoplasmic protein that catalyzes the final two steps in purine catabolism. We have previously investigated the catalytic mechanism of the enzyme by rapid reaction kinetics and x-ray crystallography using the poor substrate 2-hydroxy-6-methylpurine, focusing our attention on the orientation of substrate in the active site and the role of Arg-880 in catalysis. Here we report additional crystal structures of as-isolated, functional xanthine oxidase in the course of reaction with the pterin substrate lumazine at 2.2 angstrom resolution and of the nonfunctional desulfo form of the enzyme in complex with xanthine at 2.6 angstrom resolution. In both cases the orientation of substrate is such that the pyrimidine subnucleus is oriented opposite to that seen with the slow substrate 2-hydroxy-6-methylpurine. The mechanistic implications as to how the ensemble of active site functional groups in the active site work to accelerate reaction rate are discussed.	[Pauff, James M.; Hille, Russ] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; Ohio State Univ, Med Scientist Program, Columbus, OH 43210 USA	University of California System; University of California Riverside; University System of Ohio; Ohio State University	Pauff, JM (corresponding author), Univ Calif Riverside, Dept Biochem, 1463 Boyce Hall, Riverside, CA 92521 USA.	russ.hille@ucr.edu	Cao, Hongnan/M-2047-2014	Cao, Hongnan/0000-0002-9808-3240; Cao, Hongnan/0000-0003-2496-1298	National Institutes of Health [GM 075036]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; SGX Pharmaceuticals, Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075036] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); SGX Pharmaceuticals, Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 075036 (to R. H.). This work was also supported in part by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357 and by SGX Pharmaceuticals, Inc. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERRY CE, 2004, J PHYSL, V3, P589; BRAY RC, 1988, Q REV BIOPHYS, V21, P299, DOI 10.1017/S0033583500004479; BRAY RC, 1969, BIOCHEM J, V114, P725, DOI 10.1042/bj1140725; DeLano WL, 2004, PYMOL MOL GRAPHICS S; Doonan CJ, 2005, J AM CHEM SOC, V127, P4518, DOI 10.1021/ja042500o; ELION GB, 1989, SCIENCE, V244, P41, DOI 10.1126/science.2649979; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enroth C, 2000, P NATL ACAD SCI USA, V97, P10723, DOI 10.1073/pnas.97.20.10723; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; Hille R, 2002, TRENDS BIOCHEM SCI, V27, P360, DOI 10.1016/S0968-0004(02)02107-2; HILLE R, 1995, FASEB J, V9, P995, DOI 10.1096/fasebj.9.11.7649415; Hille R, 2006, EUR J INORG CHEM, P1913, DOI 10.1002/ejic.200600087; Huber R, 1996, P NATL ACAD SCI USA, V93, P8846, DOI 10.1073/pnas.93.17.8846; Ilich P, 1997, INORG CHIM ACTA, V263, P87, DOI 10.1016/S0020-1693(97)05654-5; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leimkuhler S, 2004, J BIOL CHEM, V279, P40437, DOI 10.1074/jbc.M405778200; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MASSEY V, 1970, J BIOL CHEM, V245, P6595; MASSEY V, 1969, J BIOL CHEM, V244, P1682; MURSHUDOV G, 1996, P DAR STUD WEEK DAR; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishino T, 2005, J BIOL CHEM, V280, P24888, DOI 10.1074/jbc.M501830200; Pacher P, 2006, PHARMACOL REV, V58, P87, DOI 10.1124/pr.58.1.6; Pannu NS, 1998, ACTA CRYSTALLOGR D, V54, P1285, DOI 10.1107/S0907444998004119; Pauff JM, 2008, J BIOL CHEM, V283, P4818, DOI 10.1074/jbc.M707918200; Pauff JM, 2007, J BIOL CHEM, V282, P12785, DOI 10.1074/jbc.M700364200; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Truglio JJ, 2002, STRUCTURE, V10, P115, DOI 10.1016/S0969-2126(01)00697-9; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yamaguchi Y, 2007, J BIOCHEM, V141, P513, DOI 10.1093/jb/mvm053	33	70	72	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8751	8758		10.1074/jbc.M804517200	http://dx.doi.org/10.1074/jbc.M804517200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19109252	Green Published, hybrid			2022-12-25	WOS:000264397800059
J	Saramaki, A; Diermeier, S; Kellner, R; Laitinen, H; Vaisanen, S; Carlberg, C				Saramaki, Anna; Diermeier, Sarah; Kellner, Ruth; Laitinen, Heidi; Vaisanen, Sami; Carlberg, Carsten			Cyclical Chromatin Looping and Transcription Factor Association on the Regulatory Regions of the p21 (CDKN1A) Gene in Response to 1 alpha,25-Dihydroxyvitamin D-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-D; BREAST-CANCER; HISTONE ACETYLATION; RECRUITMENT; EXPRESSION; BINDING; ACTIVATION; PROMOTER; DISTINCT; CELLS	The nuclear receptor vitamin D receptor (VDR) is known to associate with three vitamin D response element (VDREs)-containing regions within the CDKN1A (p21) gene region. Here we show in MDA-MB453 breast cancer cells that the natural VDR ligand 1 alpha,25-dihydroxyvitamin D-3 causes cyclical transcription factor binding and chromatin looping of distal VDREs to the transcription start site (TSS) of the p21 gene, leading to cyclical accumulation of the p21 mRNA. At the chromatin level, association of the mediator protein MED1 precedes both the peaks of VDR binding to VDREs and phosphorylated RNA polymerase (p-Pol II) to the TSS. The loss of co-repressor NCoR1-histone deacetylase (HDAC) 3 complex and inhibitory chromatin looping from VDREs to the TSS are also initial events followed by increased acetylation of histone 3 at lysine 9 at the TSS prior to initiation of transcription. Simultaneous to VDR and p-Pol II peaks, chromatin loops between VDREs and the TSS are formed, and the lysine demethylase LSD1 and the histone acetyltransferase CBP are enriched in both regions. This is followed by a moderate peak in p21 transcript accumulation, repeated in cycles of 45-60 min. The transcript accumulation pattern is disturbed by siRNA inhibition of the mediator protein MED1, LSD1, NCoR1, or various HDACs, whereas CBP appears unnecessary for the response. Inhibition of MED1, HDAC4, or LSD1 by siRNA also attenuates ligand-induced chromatin looping. In conclusion, 1 alpha,25-dihydroxyvitamin D3 regulates p21 transcription by inducing cyclical chromatin looping that depends on both histone deacetylation and demethylation.	[Carlberg, Carsten] Univ Luxembourg, Life Sci Res Unit, L-1511 Luxembourg, Luxembourg; [Saramaki, Anna; Diermeier, Sarah; Kellner, Ruth; Laitinen, Heidi; Vaisanen, Sami; Carlberg, Carsten] Univ Kuopio, Dept Biosci, FIN-70210 Kuopio, Finland	University of Luxembourg; University of Eastern Finland	Carlberg, C (corresponding author), Univ Luxembourg, Life Sci Res Unit, 162A Ave Faiencerie, L-1511 Luxembourg, Luxembourg.	carsten.carlberg@uni.lu	Diermeier, Sarah/H-8024-2019; Carlberg, Carsten/C-9075-2011; Vähärautio, Anna/K-4279-2015	Diermeier, Sarah/0000-0002-6120-2744; Carlberg, Carsten/0000-0003-2633-0684; Vähärautio, Anna/0000-0003-4721-3954	Academy of Finland; Finnish Cancer Organization; Juselius Foundation	Academy of Finland(Academy of Finland); Finnish Cancer Organization; Juselius Foundation	This work was supported by grants from the Academy of Finland, the Finnish Cancer Organization, and the Juselius Foundation.	Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Banwell CM, 2006, CLIN CANCER RES, V12, P2004, DOI 10.1158/1078-0432.CCR-05-1218; Barnett DH, 2008, CANCER RES, V68, P3505, DOI 10.1158/0008-5472.CAN-07-6151; Carlberg C, 1998, CRIT REV EUKAR GENE, V8, P19, DOI 10.1615/CritRevEukarGeneExpr.v8.i1.20; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; Dekker J, 2006, NAT METHODS, V3, P17, DOI 10.1038/NMETH823; DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S, DOI 10.1093/ajcn/80.6.1689S; Esnault C, 2008, MOL CELL, V31, P337, DOI 10.1016/j.molcel.2008.06.021; Esposito F, 1997, EUR J BIOCHEM, V245, P730, DOI 10.1111/j.1432-1033.1997.00730.x; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Ingraham BA, 2008, CURR MED RES OPIN, V24, P139, DOI 10.1185/030079907X253519; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jing HI, 2008, MOL CELL, V29, P232, DOI 10.1016/j.molcel.2007.11.020; Kim S, 2005, J BONE MINER RES, V20, P305, DOI 10.1359/JBMR.041112; Lacroix M, 2006, ENDOCR-RELAT CANCER, V13, P293, DOI 10.1677/erc.1.01172; Liu J, 2000, J BIOL CHEM, V275, P11846, DOI 10.1074/jbc.275.16.11846; Liu M, 1996, GENE DEV, V10, P142, DOI 10.1101/gad.10.2.142; Malinen M, 2008, NUCLEIC ACIDS RES, V36, P121, DOI 10.1093/nar/gkm913; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Saramaki A, 2006, NUCLEIC ACIDS RES, V34, P543, DOI 10.1093/nar/gkj460; Turunen MM, 2007, NUCLEIC ACIDS RES, V35, P2734, DOI 10.1093/nar/gkm179; Zeng L, 2008, STRUCTURE, V16, P643, DOI 10.1016/j.str.2008.01.010; Zhou W, 2008, MOL CELL, V29, P69, DOI 10.1016/j.molcel.2007.11.002	26	86	89	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					8073	8082		10.1074/jbc.M808090200	http://dx.doi.org/10.1074/jbc.M808090200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19122196	Green Published, hybrid			2022-12-25	WOS:000264195600070
J	Gupta, KK; Paulson, BA; Folker, ES; Charlebois, B; Hunt, AJ; Goodson, HV				Gupta, Kamlesh K.; Paulson, Benjamin A.; Folker, Eric S.; Charlebois, Blake; Hunt, Alan J.; Goodson, Holly V.			Minimal Plus-end Tracking Unit of the Cytoplasmic Linker Protein CLIP-170	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE DYNAMICS; STRUCTURAL BASIS; IN-VIVO; EB1; CYTOSKELETON; TUBULIN; BINDING; P150(GLUED); MECHANISMS; DYNACTIN	Cytoplasmic linker protein 170 (CLIP-170) is the prototype microtubule (MT) plus-end tracking protein (+TIP) and is involved in regulating MT dynamics. A comprehensive understanding of the process by which CLIP-170 tracks MT plus ends would provide insight into its function. However, the precise molecular mechanism of CLIP-170 +TIP behavior is unknown, and many potential models have been presented. Here, by separating the two CLIP-170 CAP-Gly domains and their adjacent serine-rich regions into fragments of varied size, we have characterized the minimal plus-end tracking unit of CLIP-170 in vivo. Each CLIP-170 fragment was also characterized for its tubulin polymerization activity in vitro. We found that the two CAP-Gly domains have different activities, whereas CAP-Gly-1 appears incompetent to mediate either +TIP behavior or MT nucleation, a CLIP-170 fragment consisting of the second CAP-Gly domain and its adjacent serine-rich region can both track MT plus ends in vivo and induce tubulin polymerization in vitro. These observations complement recent work on CLIP-170 fragments, demonstrate that CAP-Gly motifs do not require dimerization for +TIP and polymerization-promoting activities, and provide insight into CLIP-170 function and mechanism.	[Gupta, Kamlesh K.; Paulson, Benjamin A.; Goodson, Holly V.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Folker, Eric S.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 11032 USA; [Charlebois, Blake; Hunt, Alan J.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Notre Dame; Columbia University; University of Michigan System; University of Michigan	Goodson, HV (corresponding author), Univ Notre Dame, Dept Chem & Biochem, 439 Stepan Hall Chem & Biochem, Notre Dame, IN 46556 USA.	hgoodson@nd.edu	Goodson, Holly/AAE-6079-2022	Folker, Eric/0000-0003-1619-7330; Goodson, Holly/0000-0001-7942-8349	National Institutes of Health [R01 GM065420, R01 GM076177]; American Heart Association [0825871G]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076177, R01GM065420] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM065420 ( to H. V. G.) and R01 GM076177 ( to A. J. H.). This work was also supported by American Heart Association Postdoctoral Fellowship 0825871G ( to K. K. G.).	Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Arnal I, 2004, CURR BIOL, V14, P2086, DOI 10.1016/j.cub.2004.11.055; Bartolini F, 2005, J CELL SCI, V118, P1197, DOI 10.1242/jcs.01719; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Coquelle FM, 2002, MOL CELL BIOL, V22, P3089, DOI 10.1128/MCB.22.9.3089-3102.2002; Culver-Hanlon TL, 2006, NAT CELL BIOL, V8, P264, DOI 10.1038/ncb1370; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Diamantopoulos GS, 1999, J CELL BIOL, V144, P99, DOI 10.1083/jcb.144.1.99; Folker ES, 2005, MOL BIOL CELL, V16, P5373, DOI 10.1091/mbc.E04-12-1106; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Galjart N, 2005, NAT REV MOL CELL BIO, V6, P487, DOI 10.1038/nrm1664; GASKIN F, 1974, J MOL BIOL, V89, P737, DOI 10.1016/0022-2836(74)90048-5; Goodson HV, 2003, CELL MOTIL CYTOSKEL, V55, P156, DOI 10.1002/cm.10114; Gundersen GG, 2002, NAT REV MOL CELL BIO, V3, P296, DOI 10.1038/nrm777; Gundersen GG, 1999, CURR OPIN CELL BIOL, V11, P81, DOI 10.1016/S0955-0674(99)80010-6; Hayashi I, 2007, NAT STRUCT MOL BIOL, V14, P980, DOI 10.1038/nsmb1299; Honnappa S, 2006, MOL CELL, V23, P663, DOI 10.1016/j.molcel.2006.07.013; Hoogenraad CC, 2000, J CELL SCI, V113, P2285; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Komarova Y, 2005, MOL BIOL CELL, V16, P5334, DOI 10.1091/mbc.E05-07-0614; Lallemand-Breitenbach V, 2004, J BIOL CHEM, V279, P41168, DOI 10.1074/jbc.M406482200; Li SL, 2002, J BIOL CHEM, V277, P48596, DOI 10.1074/jbc.M208512200; Ligon LA, 2006, FEBS LETT, V580, P1327, DOI 10.1016/j.febslet.2006.01.050; Ligon LA, 2003, MOL BIOL CELL, V14, P1405, DOI 10.1091/mbc.E02-03-0155; Miller RK, 2006, CURR TOP DEV BIOL, V76, P49, DOI 10.1016/S0070-2153(06)76002-1; Mishima M, 2007, P NATL ACAD SCI USA, V104, P10346, DOI 10.1073/pnas.0703876104; Morrison EE, 2007, CELL MOL LIFE SCI, V64, P307, DOI 10.1007/s00018-007-6360-3; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; PIERRE P, 1994, J CELL SCI, V107, P1909; PIERRE P, 1992, CELL, V70, P887, DOI 10.1016/0092-8674(92)90240-D; RIEHEMANN K, 1993, TRENDS BIOCHEM SCI, V18, P82, DOI 10.1016/0968-0004(93)90159-K; Ross JL, 2008, CURR OPIN CELL BIOL, V20, P41, DOI 10.1016/j.ceb.2007.11.006; Scheel J, 1999, J BIOL CHEM, V274, P25883, DOI 10.1074/jbc.274.36.25883; Sharp DJ, 2005, CELL CYCLE, V4, P1482, DOI 10.4161/cc.4.11.2116; Sim KL, 2002, MOL CELL PROTEOMICS, V1, P983, DOI 10.1074/mcp.M200032-MCP200; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Tirnauer JS, 2002, MOL BIOL CELL, V13, P3614, DOI 10.1091/mbc.E02-04-0210; Walczak CE, 2000, CURR OPIN CELL BIOL, V12, P52, DOI 10.1016/S0955-0674(99)00056-3; Watson P, 2006, J CELL SCI, V119, P2758, DOI 10.1242/jcs.02999; Weisbrich A, 2007, NAT STRUCT MOL BIOL, V14, P959, DOI 10.1038/nsmb1291	42	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6735	6742		10.1074/jbc.M807675200	http://dx.doi.org/10.1074/jbc.M807675200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19074770	hybrid, Green Published			2022-12-25	WOS:000263919000018
J	Brown, JR; Yang, F; Sinha, A; Ramakrishnan, B; Tor, Y; Qasba, PK; Esko, JD				Brown, Jillian R.; Yang, Feng; Sinha, Anjana; Ramakrishnan, Boopathy; Tor, Yitzhak; Qasba, Pradman K.; Esko, Jeffrey D.			Deoxygenated Disaccharide Analogs as Specific Inhibitors of beta 1-4-Galactosyltransferase 1 and Selectin-mediated Tumor Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIALYL-LEWIS-X; CRYSTAL-STRUCTURE; ACCEPTOR SPECIFICITY; LACTOSE SYNTHASE; CELL-ADHESION; UDP-GAL; BETA-1,4-GALACTOSYLTRANSFERASE; GLYCOSYLATION; COMPLEX; MICE	The disaccharide peracetylated GlcNAc beta 1-3Gal beta-O-naphthalenemethanol (disaccharide 1) diminishes the formation of the glycan sialyl Lewis X (Neu5Ac alpha 2-3Gal beta 1-4(Fuc alpha 1-3)Glc-NAc; sLe(X)) in tumor cells. Previous studies showed that the mechanism of action of disaccharide 1 involves three steps: (i) deacetylation by carboxyesterases, (ii) action as a biosynthetic intermediate for downstream enzymes involved in sLe(X) assembly, and (iii) generation of several glycans related to sLe(X). In this report, we show that GlcNAc beta 1-3Gal beta-O-naphthalenemethanol binds to the acceptor site of human beta 1-4-galactosyltransferase much like the acceptor trisaccharide, GlcNAc beta 1-2Man beta 1-6Man, which is present on N-linked glycans. The 4'-deoxy analog, in which the acceptor hydroxyl group was replaced by -H, did not act as a substrate but instead acted as a competitive inhibitor of the enzyme. The acetylated form of this compound inhibited sLe(X) formation in U937 monocytic leukemia cells, suggesting that it had inhibitory activity in vivo as well. A series of synthetic acetylated analogs of 1 containing -H, -F, -N-3, -NH2, or -OCH3 instead of the hydroxyl groups at C-3'- and C-4'-positions of the terminal N-acetylglucosamine residue also blocked sLe(X) formation in cells. The reduction of sLe(X) by the 4'-deoxy analog also diminished experimental tumor metastasis by Lewis lung carcinoma in vivo. These data suggest that nonsubstrate disaccharides have therapeutic potential through their ability to bind to glycosyltransferases in vivo and to alter glycan-dependent pathologic processes.	[Brown, Jillian R.; Yang, Feng; Sinha, Anjana; Esko, Jeffrey D.] Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Tor, Yitzhak] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Ramakrishnan, Boopathy] Nanobiol Program, Struct Glycobiol Sect, Frederick, MD 21702 USA; [Ramakrishnan, Boopathy] NCI, Basic Res Program, SAIC Frederick Inc, Ctr Canc Res,NIH, Frederick, MD 21702 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Esko, JD (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA.	jesko@ucsd.edu			National Institutes of Health [CA46462, CA112278, N01-CO-12400]; Intramural Research Program of the National Institutes of Health; NCI, Center for Cancer Research; NATIONAL CANCER INSTITUTE [R01CA046462, R01CA112278, ZIABC010041] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA46462 and CA112278 (to J. D. E.) and by the Intramural Research Program of the National Institutes of Health, NCI, Center for Cancer Research. The crystallographic part of this project has been funded, in whole or in part, with federal funds from NCI, National Institutes of Health, under Contract N01-CO-12400. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Asano M, 2003, BLOOD, V102, P1678, DOI 10.1182/blood-2003-03-0836; Barthel SR, 2007, EXPERT OPIN THER TAR, V11, P1473, DOI 10.1517/14728222.11.11.1473; Brockhausen I, 2006, GLYCOCONJUGATE J, V23, P525, DOI 10.1007/s10719-006-7153-x; Brown JR, 2007, CRIT REV BIOCHEM MOL, V42, P481, DOI 10.1080/10409230701751611; Brown JR, 2006, CLIN CANCER RES, V12, P2894, DOI 10.1158/1078-0432.CCR-05-2745; Brown JR, 2003, J BIOL CHEM, V278, P23352, DOI 10.1074/jbc.M303093200; BROWN JR, 2003, CARBOHYDRATE BASED D, P883; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chhabra SR, 2003, MINI-REV MED CHEM, V3, P679, DOI 10.2174/1389557033487791; Chung SJ, 1998, BIOORG MED CHEM LETT, V8, P3359, DOI 10.1016/S0960-894X(98)00618-0; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; ESKO JD, 1987, J BIOL CHEM, V262, P12189; Foster MM, 2003, CANCER RES, V63, P2775; Gastinel LN, 1999, EMBO J, V18, P3546, DOI 10.1093/emboj/18.13.3546; Hennet T, 2002, CELL MOL LIFE SCI, V59, P1081, DOI 10.1007/s00018-002-8489-4; HINDSGAUL O, 1991, J BIOL CHEM, V266, P17858; HUANG J, 1992, ONCOL RES, V4, P507; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAJIHARA Y, 1992, CARBOHYD RES, V229, pC5, DOI 10.1016/S0008-6215(00)90494-4; Kajihara Y, 1998, CARBOHYD RES, V306, P361, DOI 10.1016/S0008-6215(97)10093-3; Kavarana MJ, 1999, J MED CHEM, V42, P221, DOI 10.1021/jm9708036; KOJIMA N, 1992, BIOCHEM BIOPH RES CO, V182, P1288, DOI 10.1016/0006-291X(92)91872-N; Morton CL, 2000, CANCER RES, V60, P4206; Ramakrishnan B, 2006, J MOL BIOL, V357, P1619, DOI 10.1016/j.jmb.2006.01.088; Ramakrishnan B, 2004, BIOCHEMISTRY-US, V43, P12513, DOI 10.1021/bi049007+; Ramakrishnan B, 2002, J MOL BIOL, V318, P491, DOI 10.1016/S0022-2836(02)00020-7; Ramakrishnan B, 2001, J MOL BIOL, V310, P205, DOI 10.1006/jmbi.2001.4757; Ramasamy V, 2005, J MOL BIOL, V353, P53, DOI 10.1016/j.jmb.2005.07.050; Saotome C, 2000, BIOORGAN MED CHEM, V8, P2249, DOI 10.1016/S0968-0896(00)00170-X; Sarkar AK, 1997, J BIOL CHEM, V272, P25608, DOI 10.1074/jbc.272.41.25608; SARKAR AK, 1995, P NATL ACAD SCI USA, V92, P3323, DOI 10.1073/pnas.92.8.3323; Sarkar AK, 2000, CARBOHYD RES, V329, P287, DOI 10.1016/S0008-6215(00)00200-7; SINHA SK, 1980, CARBOHYD RES, V81, P239, DOI 10.1016/S0008-6215(00)85655-4; SOARES ER, 1979, BIOCHEM GENET, V17, P577, DOI 10.1007/BF00502119; Witz IP, 2008, CANCER METAST REV, V27, P19, DOI 10.1007/s10555-007-9101-z; WONG CH, 1991, J AM CHEM SOC, V113, P8137, DOI 10.1021/ja00021a045	36	33	35	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4952	4959		10.1074/jbc.M805782200	http://dx.doi.org/10.1074/jbc.M805782200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19106107	Green Published, hybrid			2022-12-25	WOS:000263416600025
J	Claxton, HB; Akey, DL; Silver, MK; Admiraal, SJ; Smith, JL				Claxton, Heather B.; Akey, David L.; Silver, Monica K.; Admiraal, Suzanne J.; Smith, Janet L.			Structure and Functional Analysis of RifR, the Type II Thioesterase from the Rifamycin Biosynthetic Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYKETIDE SYNTHASE; STREPTOMYCES-VENEZUELAE; PEPTIDE SYNTHETASES; GENE-CLUSTER; SURFACTIN; DOMAINS; ENZYME; ARCHITECTURE; SPECIFICITY; SELECTIVITY	Two thioesterases are commonly found in natural product biosynthetic clusters, a type I thioesterase that is responsible for removing the final product from the biosynthetic complex and a type II thioesterase that is believed to perform housekeeping functions such as removing aberrant units from carrier domains. We present the crystal structure and the kinetic analysis of RifR, a type II thioesterase from the hybrid nonribosomal peptide synthetases/polyketide synthase rifamycin biosynthetic cluster of Amycolatopsis mediterranei. Steady-state kinetics show that RifR has a preference for the hydrolysis of acyl units from the phosphopantetheinyl arm of the acyl carrier domain over the hydrolysis of acyl units from the phosphopantetheinyl arm of acyl-CoAs as well as a modest preference for the decarboxylated substrate mimics acetyl-CoA and propionyl-CoA over malonyl-CoA and methylmalonyl-CoA. Multiple RifR conformations and structural similarities to other thioesterases suggest that movement of a helical lid controls access of substrates to the active site of RifR.	[Claxton, Heather B.; Akey, David L.; Smith, Janet L.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Claxton, Heather B.; Silver, Monica K.; Admiraal, Suzanne J.; Smith, Janet L.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Smith, JL (corresponding author), Univ Michigan, Inst Life Sci, 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	JanetSmith@umich.edu		Silver, Monica K./0000-0002-5920-6906; Admiraal, Suzanne/0000-0003-3334-2499	National Institutes of Health [DK42303]; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK042303, R01DK042303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK42303 (to J. L. S.). This work was also supported by a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund (to S. J. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akey DL, 2006, NAT CHEM BIOL, V2, P537, DOI 10.1038/nchembio824; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bruner SD, 2002, STRUCTURE, V10, P301, DOI 10.1016/S0969-2126(02)00716-5; Butler AR, 1999, CHEM BIOL, V6, P287, DOI 10.1016/S1074-5521(99)80074-X; Chakravarty B, 2004, P NATL ACAD SCI USA, V101, P15567, DOI 10.1073/pnas.0406901101; Chen H, 2002, CHEM BIOL, V9, P103, DOI 10.1016/S1074-5521(02)00090-X; Chen HW, 2001, CHEM BIOL, V8, P301, DOI 10.1016/S1074-5521(01)00009-6; Chen S, 2001, GENE, V263, P255, DOI 10.1016/S0378-1119(00)00560-6; COSMINA P, 1993, MOL MICROBIOL, V8, P821, DOI 10.1111/j.1365-2958.1993.tb01629.x; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Deutsch J, 2002, NEUROCHEM RES, V27, P1577, DOI 10.1023/A:1021614422668; Doi-Katayama Y, 2000, J ANTIBIOT, V53, P484, DOI 10.7164/antibiotics.53.484; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Frueh DP, 2008, NATURE, V454, P903, DOI 10.1038/nature07162; Fujimori DG, 2007, P NATL ACAD SCI USA, V104, P16498, DOI 10.1073/pnas.0708242104; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Geoffroy VA, 2000, INFECT IMMUN, V68, P4452, DOI 10.1128/IAI.68.8.4452-4461.2000; Gokhale RS, 1999, SCIENCE, V284, P482, DOI 10.1126/science.284.5413.482; Guerrero SA, 2001, APPL MICROBIOL BIOT, V56, P718, DOI 10.1007/s002530100690; Heathcole ML, 2001, CHEM BIOL, V8, P207, DOI 10.1016/S1074-5521(01)00002-3; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Hu ZH, 2003, MICROBIOL-SGM, V149, P2213, DOI 10.1099/mic.0.26015-0; Hutchinson CR, 2003, P NATL ACAD SCI USA, V100, P3010, DOI 10.1073/pnas.0730689100; Kim BS, 2002, J BIOL CHEM, V277, P48028, DOI 10.1074/jbc.M207770200; Koglin A, 2008, NATURE, V454, P907, DOI 10.1038/nature07161; Kotowska M, 2002, MICROBIOL-SGM, V148, P1777, DOI 10.1099/00221287-148-6-1777; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; LIBERTINI LJ, 1978, J BIOL CHEM, V253, P1393; Linne U, 2004, EUR J BIOCHEM, V271, P1536, DOI 10.1111/j.1432-1033.2004.04063.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Patel J, 1998, TETRAHEDRON, V54, P15927, DOI 10.1016/S0040-4020(98)01002-3; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Reimmann C, 2004, J BACTERIOL, V186, P6367, DOI 10.1128/JB.186.19.6367-6373.2004; ROBERTS GA, 1993, EUR J BIOCHEM, V214, P305, DOI 10.1111/j.1432-1033.1993.tb17925.x; Roongsawang N, 2007, CHEMBIOCHEM, V8, P501, DOI 10.1002/cbic.200600465; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Samel SA, 2006, J MOL BIOL, V359, P876, DOI 10.1016/j.jmb.2006.03.062; Schneider A, 1998, ARCH MICROBIOL, V169, P404, DOI 10.1007/s002030050590; Schwarzer D, 2002, P NATL ACAD SCI USA, V99, P14083, DOI 10.1073/pnas.212382199; Tang Y, 2004, BIOCHEMISTRY-US, V43, P9546, DOI 10.1021/bi049157k; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Tsai SC, 2001, P NATL ACAD SCI USA, V98, P14808, DOI 10.1073/pnas.011399198; Tsai SC, 2002, BIOCHEMISTRY-US, V41, P12598, DOI 10.1021/bi0260177; Tsuji SY, 2001, BIOCHEMISTRY-US, V40, P2326, DOI 10.1021/bi002463n; Weissman KJ, 2004, PHILOS T R SOC A, V362, P2671, DOI 10.1098/rsta.2004.1470; Wertheimer AM, 1999, INFECT IMMUN, V67, P6496; Xue YQ, 1998, P NATL ACAD SCI USA, V95, P12111, DOI 10.1073/pnas.95.21.12111; Yeh E, 2004, CHEMBIOCHEM, V5, P1290, DOI 10.1002/cbic.200400077; Yu FM, 2006, APPL BIOCHEM BIOTECH, V135, P145, DOI 10.1385/ABAB:135:2:145; Yu TW, 1999, P NATL ACAD SCI USA, V96, P9051, DOI 10.1073/pnas.96.16.9051	56	57	59	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5021	5029		10.1074/jbc.M808604200	http://dx.doi.org/10.1074/jbc.M808604200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19103602	Green Published, hybrid			2022-12-25	WOS:000263416600032
J	Gao, XS; Campian, JL; Qian, MW; Sun, XF; Eaton, JW				Gao, Xueshan; Campian, Jian Li; Qian, Mingwei; Sun, Xiao-Feng; Eaton, John W.			Mitochondrial DNA Damage in Iron Overload	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED-MAMMALIAN-CELLS; RESPIRATORY-CHAIN; HEART-MITOCHONDRIA; SKELETAL-MUSCLE; SERUM IRON; CARDIOMYOPATHY; REPAIR; AGE; HEMOCHROMATOSIS; INHIBITION	Chronic iron overload has slow and insidious effects on heart, liver, and other organs. Because iron-driven oxidation of most biologic materials (such as lipids and proteins) is readily repaired, this slow progression of organ damage implies some kind of biological "memory." We hypothesized that cumulative iron-catalyzed oxidant damage to mtDNA might occur in iron overload, perhaps explaining the often lethal cardiac dysfunction. Real time PCR was used to examine the " intactness" of mttDNA in cultured H9c2 rat cardiac myocytes. After 3 -5 days exposure to high iron, these cells exhibited damage to mtDNA reflected by diminished amounts of near full-length 15.9-kb PCR product with no change in the amounts of a 16.1-kb product from a nuclear gene. With the loss of intact mtDNA, cellular respiration declined and mRNAs for three electron transport chain subunits and 16 S rRNA encoded by mtDNA decreased, whereas no decrements were found in four subunits encoded by nuclear DNA. To examine the importance of the interactions of iron with metabolically generated reactive oxygen species, we compared the toxic effects of iron in wild-type and rhoo cells. In wild-type cells, elevated iron caused increased production of reactive oxygen species, cytostasis, and cell death, whereas the rhoo cells were unaffected. We conclude that long-term damage to cells and organs in iron-overload disorders involves interactions between iron and mitochondrial reactive oxygen species resulting in cumulative damage to mtDNA, impaired synthesis of respiratory chain subunits, and respiratory dysfunction.	[Gao, Xueshan; Campian, Jian Li; Qian, Mingwei; Sun, Xiao-Feng; Eaton, John W.] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40202 USA; [Eaton, John W.] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40202 USA; [Gao, Xueshan; Sun, Xiao-Feng; Eaton, John W.] Linkoping Univ, Dept Oncol, S-58185 Linkoping, Sweden	University of Louisville; University of Louisville; Linkoping University	Eaton, JW (corresponding author), Univ Louisville, James Graham Brown Canc Ctr, 580 S Preston St,Baxter Res Bldg 2,Rm 210, Louisville, KY 40202 USA.	EatonRedox@aol.com			National Institutes of Health [RO1 DK073586]; Commonwealth of Kentucky Research Challenge Trust Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073586] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Kentucky Research Challenge Trust Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 DK073586 (to J. W. E.). This work was also supported by the Commonwealth of Kentucky Research Challenge Trust Fund. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AHMED SA, 1994, J IMMUNOL METHODS, V170, P211, DOI 10.1016/0022-1759(94)90396-4; ALDOURI MA, 1990, ACTA HAEMATOL-BASEL, V84, P113; ALTMAN SA, 1995, FREE RADICAL BIO MED, V19, P897, DOI 10.1016/0891-5849(95)00095-F; ARTISS JD, 1981, CLIN BIOCHEM, V14, P311, DOI 10.1016/S0009-9120(81)91065-1; Ayala-Torres S, 2000, METHODS, V22, P135, DOI 10.1006/meth.2000.1054; Bejma J, 1999, J APPL PHYSIOL, V87, P465, DOI 10.1152/jappl.1999.87.1.465; BOFFOLI D, 1994, BBA-MOL BASIS DIS, V1226, P73, DOI 10.1016/0925-4439(94)90061-2; Bouaziz N, 2002, EUR J PHARMACOL, V441, P35, DOI 10.1016/S0014-2999(02)01490-5; Brunk UT, 2001, REDOX REP, V6, P91, DOI 10.1179/135100001101536094; CARMICHAEL PL, 1995, MUTAT RES-FUND MOL M, V326, P235, DOI 10.1016/0027-5107(94)00177-7; Das N, 2001, BIOCHEM J, V360, P209, DOI 10.1042/0264-6021:3600209; ESKELINEN S, 1983, SCAND J CLIN LAB INV, V43, P453; Fuller KM, 2002, ELECTROPHORESIS, V23, P1571, DOI 10.1002/1522-2683(200206)23:11<1571::AID-ELPS1571>3.0.CO;2-3; GABUTTI V, 1994, BAIL CL HAE, V7, P919, DOI 10.1016/S0950-3536(05)80131-3; GRAF E, 1984, J BIOL CHEM, V259, P3620; Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908; Imam SZ, 2006, NEUROBIOL AGING, V27, P1129, DOI 10.1016/j.neurobiolaging.2005.06.002; JACKSON JH, 1987, J CLIN INVEST, V80, P1090, DOI 10.1172/JCI113165; Jarreta D, 2000, CARDIOVASC RES, V45, P860, DOI 10.1016/S0008-6363(99)00388-0; Kruidering M, 1997, J PHARMACOL EXP THER, V280, P638; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; LINK G, 1993, J LAB CLIN MED, V121, P127; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOSCHEN G, 1974, FEBS LETT, V42, P68, DOI 10.1016/0014-5793(74)80281-4; LUO YZ, 1994, P NATL ACAD SCI USA, V91, P12438, DOI 10.1073/pnas.91.26.12438; Persson HL, 2003, FREE RADICAL BIO MED, V34, P1295, DOI 10.1016/S0891-5849(03)00106-0; PETERS TJ, 1986, FREE RADICALS LIVER, P107; QIAN MW, 1989, ARCH BIOCHEM BIOPHYS, V275, P280, DOI 10.1016/0003-9861(89)90374-3; Quinlan GJ, 2002, FREE RADICAL BIO MED, V33, P1306, DOI 10.1016/S0891-5849(02)00903-6; Requena JR, 2001, P NATL ACAD SCI USA, V98, P69, DOI 10.1073/pnas.011526698; RYAN TP, 1992, CRIT REV TOXICOL, V22, P119, DOI 10.3109/10408449209146308; SCHRAUFSTATTER I, 1988, J CLIN INVEST, V82, P1040, DOI 10.1172/JCI113660; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; STAL P, 1990, J HEPATOL, V11, P172, DOI 10.1016/0168-8278(90)90109-5; Tolentino JH, 2008, NUCLEIC ACIDS RES, V36, P1300, DOI 10.1093/nar/gkm1157; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; VACA CE, 1989, BIOCHIM BIOPHYS ACTA, V1001, P35, DOI 10.1016/0005-2760(89)90304-4; Williams AJ, 1998, ANAL BIOCHEM, V259, P176, DOI 10.1006/abio.1998.2624; Wood JC, 2005, CIRCULATION, V112, P535, DOI 10.1161/CIRCULATIONAHA.104.504415; Yaffee M, 1996, P NATL ACAD SCI USA, V93, P5341, DOI 10.1073/pnas.93.11.5341; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Yang JL, 2008, DNA REPAIR, V7, P1110, DOI 10.1016/j.dnarep.2008.03.012; Yu ZQ, 2003, FREE RADICAL BIO MED, V34, P1243, DOI 10.1016/S0891-5849(03)00109-6; ZASTAWNY TH, 1995, FREE RADICAL BIO MED, V18, P1013, DOI 10.1016/0891-5849(94)00241-B	44	91	100	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4767	4775		10.1074/jbc.M806235200	http://dx.doi.org/10.1074/jbc.M806235200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19095657	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000263416600004
J	Sreeramulu, S; Jonker, HRA; Langer, T; Richter, C; Lancaster, CRD; Schwalbe, H				Sreeramulu, Sridhar; Jonker, Hendrik R. A.; Langer, Thomas; Richter, Christian; Lancaster, C. Roy D.; Schwalbe, Harald			The Human Cdc37 center dot Hsp90 Complex Studied by Heteronuclear NMR Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPOLAR COUPLINGS; BINDING DOMAIN; CO-CHAPERONE; HSP90; CDC37; HEAT-SHOCK-PROTEIN-90; EXPRESSION; PROTEINS; PHOSPHORYLATION; ASSIGNMENT	The cell division cycle protein 37 (Cdc37) and the 90-kDa heat shock protein (Hsp90) are molecular chaperones, which are crucial elements in the protein signaling pathway. The largest class of client proteins for Cdc37 and Hsp90 are protein kinases. The catalytic domains of these kinases are stabilized by Cdc37, and their proper folding and functioning is dependent on Hsp90. Here, we present the x-ray crystal structure of the 16-kDa middle domain of human Cdc37 at 1.88 angstrom resolution and the structure of this domain in complex with the 23-kDa N-terminal domain of human Hsp90 based on heteronuclear solution state NMR data and docking. Our results demonstrate that the middle domain of Cdc37 exists as a monomer. NMR and mutagenesis experiments reveal Leu-205 in Cdc37 as a key residue enabling complex formation. These findings can be very useful in the development of small molecule inhibitors against cancer.	[Sreeramulu, Sridhar; Jonker, Hendrik R. A.; Langer, Thomas; Richter, Christian; Schwalbe, Harald] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance, Inst Organ Chem & Chem Biol, D-60438 Frankfurt, Germany; [Lancaster, C. Roy D.] Max Planck Inst Biophys, Dept Mol Membrane Biol, D-60438 Frankfurt, Germany; [Lancaster, C. Roy D.] Univ Saarland, Fac Med, Dept Biol Struct, D-66421 Homburg, Germany	Goethe University Frankfurt; Max Planck Society; Saarland University	Schwalbe, H (corresponding author), Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance, Inst Organ Chem & Chem Biol, Max von Laue Str 7, D-60438 Frankfurt, Germany.	schwalbe@nmr.uni-frankfurt.de	Schwalbe, Harald J/F-9023-2010; Lancaster, C. Roy/E-4313-2010; Langer, Thomas/AAB-7609-2020; Schwalbe, Harald/AAB-3143-2020	Schwalbe, Harald J/0000-0001-5693-7909; Schwalbe, Harald/0000-0001-5693-7909; Lancaster, C. Roy D./0000-0002-2814-0051	European commission; Deutsche Forschungsgemeinschaft	European commission(European CommissionEuropean Commission Joint Research Centre); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the SPINE (Structural Proteomics in Europe) project of the European commission and by the Cluster of Excellence: Macromolecular Complexes (Deutsche Forschungsgemeinschaft). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; BRUGGE JS, 1986, CURR TOP MICROBIOL, V123, P1; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FERRARINI M, 1992, INT J CANCER, V51, P613, DOI 10.1002/ijc.2910510418; GARCIA MMT, 1990, INT J BIOL MACROMOL, V12, P19; Grammatikakis N, 1999, MOL CELL BIOL, V19, P1661; Gray PJ, 2008, NAT REV CANCER, V8, P491, DOI 10.1038/nrc2420; HONIG B, 1993, J PHYS CHEM-US, V97, P1101, DOI 10.1021/j100108a002; Hunter T, 1997, TRENDS CELL BIOL, V7, P157, DOI 10.1016/S0962-8924(97)01027-1; Jacobs DM, 2006, J BIOMOL NMR, V36, P52, DOI 10.1007/s10858-006-9030-0; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Keller R., 2004, COMPUTER AIDED RESON, V1; Lamphere L, 1997, ONCOGENE, V14, P1999, DOI 10.1038/sj.onc.1201036; Lee P, 2002, J CELL BIOL, V159, P1051, DOI 10.1083/jcb.200210121; Linge JP, 1999, J BIOMOL NMR, V13, P51, DOI 10.1023/A:1008365802830; Lo Conte L, 1999, J MOL BIOL, V285, P2177; MacLean M, 2003, CELL STRESS CHAPERON, V8, P114, DOI 10.1379/1466-1268(2003)008<0114:CGBHAK>2.0.CO;2; Matts Robert, 2007, V2, P331, DOI 10.1007/978-1-4020-6401-2_16; Miyata Y, 2004, MOL CELL BIOL, V24, P4065, DOI 10.1128/MCB.24.9.4065-4074.2004; Mort-Bontemps-Soret M, 2002, MOL GENET GENOMICS, V267, P447, DOI 10.1007/s00438-002-0676-3; MUCHMORE DC, 1989, METHOD ENZYMOL, V177, P44; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pearl LH, 2005, CURR OPIN GENET DEV, V15, P55, DOI 10.1016/j.gde.2004.12.011; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Ramanathan RK, 2005, CLIN CANCER RES, V11, P3385, DOI 10.1158/1078-0432.CCR-04-2322; REED SI, 1985, COLD SPRING HARB SYM, V50, P627, DOI 10.1101/SQB.1985.050.01.076; REED SI, 1980, GENETICS, V95, P561; Roe SM, 2004, CELL, V116, P87, DOI 10.1016/S0092-8674(03)01027-4; Scholz G, 2000, MOL CELL BIOL, V20, P6984, DOI 10.1128/MCB.20.18.6984-6995.2000; Schwarze SR, 2003, CANCER RES, V63, P4614; Shao J, 2001, J BIOL CHEM, V276, P206, DOI 10.1074/jbc.M007583200; Shao JY, 2003, BIOCHEMISTRY-US, V42, P12577, DOI 10.1021/bi035138j; Shao JY, 2003, J BIOL CHEM, V278, P38117, DOI 10.1074/jbc.C300330200; Siligardi G, 2002, J BIOL CHEM, V277, P20151, DOI 10.1074/jbc.M201287200; Sreeramulu S, 2005, J BIOMOL NMR, V32, P262, DOI 10.1007/s10858-005-8529-0; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Stepanova L, 2000, ONCOGENE, V19, P2186, DOI 10.1038/sj.onc.1203561; Takahashi H, 2000, NAT STRUCT BIOL, V7, P220; Terasawa K, 2005, J BIOCHEM, V137, P443, DOI 10.1093/jb/mvi056; VALAY JG, 1995, J MOL BIOL, V249, P535, DOI 10.1006/jmbi.1995.0316; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Wang YX, 1998, J AM CHEM SOC, V120, P7385, DOI 10.1021/ja980862o; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; WELCH WJ, 1982, J BIOL CHEM, V257, P4949; WHITELAW ML, 1991, J BIOL CHEM, V266, P16436; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; YUFU Y, 1992, LEUKEMIA RES, V16, P597, DOI 10.1016/0145-2126(92)90008-U; Zhang T, 2008, MOL CANCER THER, V7, P162, DOI 10.1158/1535-7163.MCT-07-0484; Zhang W, 2004, J MOL BIOL, V340, P891, DOI 10.1016/j.jmb.2004.05.007; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	57	58	60	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3885	3896		10.1074/jbc.M806715200	http://dx.doi.org/10.1074/jbc.M806715200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19073599	hybrid			2022-12-25	WOS:000262872500057
J	Haag, JR; Pontes, O; Pikaard, CS				Haag, Jeremy R.; Pontes, Olga; Pikaard, Craig S.			Metal A and Metal B Sites of Nuclear RNA Polymerases Pol IV and Pol V Are Required for siRNA-Dependent DNA Methylation and Gene Silencing	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; STRUCTURAL BASIS; TRANSCRIPTION; MUTAGENESIS	Plants are unique among eukaryotes in having five multi-subunit nuclear RNA polymerases: the ubiquitous RNA polymerases I, II and III plus two plant-specific activities, nuclear RNA polymerases IV and V (previously known as Polymerases IVa and IVb). Pol IV and Pol V are not required for viability but play non-redundant roles in small interfering RNA (siRNA)-mediated pathways, including a pathway that silences retrotransposons and endogenous repeats via siRNA-directed DNA methylation. RNA polymerase activity has not been demonstrated for Polymerases IV or V in vitro, making it unclear whether they are catalytically active enzymes. Their largest and second-largest subunit sequences have diverged considerably from Pol I, II and III in the vicinity of the catalytic center, yet retain the invariant Metal A and Metal B amino acid motifs that bind magnesium ions essential for RNA polymerization. By using site-directed mutagenesis in conjunction with in vivo functional assays, we show that the Metal A and Metal B motifs of Polymerases IV and V are essential for siRNA production, siRNA-directed DNA methylation, retrotransposon silencing, and the punctate nuclear localization patterns typical of both polymerases. Collectively, these data show that the minimal core sequences of polymerase active sites, the Metal A and B sites, are essential for Pol IV and Pol V biological functions, implying that both are catalytically active.	[Haag, Jeremy R.; Pontes, Olga; Pikaard, Craig S.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Haag, JR (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	pikaard@biology.wustl.edu	Pikaard, Craig S/K-8772-2012; Pontes, Olga MF/F-9768-2011	Pikaard, Craig S/0000-0001-8204-7459; Pontes, Olga MF/0000-0003-3316-1145	National Institutes of Health [GM077590]; Edward Mallinckrodt Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077590] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward Mallinckrodt Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work in the Pikaard lab is supported by National Institutes of Health grant GM077590. The Pontes laboratory is supported by a grant from the Edward Mallinckrodt Foundation. The content of this paper is solely the responsibility of the authors and does not necessarily reflect the views of the NIH or the Edward Mallinckrodt Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; CAMPELL BR, 1992, GENE, V112, P225, DOI 10.1016/0378-1119(92)90380-8; Cao XF, 2003, CURR BIOL, V13, P2212, DOI 10.1016/j.cub.2003.11.052; Carter DRF, 2008, BIOCHEM SOC T, V36, P585, DOI 10.1042/BST0360585; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cramer P, 2006, BIOCHEM SOC T, V34, P1058, DOI 10.1042/BST0341058; Cramer P, 2002, CURR OPIN STRUC BIOL, V12, P89, DOI 10.1016/S0959-440X(02)00294-4; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; DIECI G, 1995, EMBO J, V14, P3766, DOI 10.1002/j.1460-2075.1995.tb00046.x; Ding B, 2007, MOL PLANT MICROBE IN, V20, P7, DOI 10.1094/MPMI-20-0007; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Greco-Stewart VS, 2007, VIROLOGY, V357, P68, DOI 10.1016/j.virol.2006.08.010; Herr AJ, 2005, FEBS LETT, V579, P5879, DOI 10.1016/j.febslet.2005.08.040; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Hirata A, 2008, NATURE, V451, P851, DOI 10.1038/nature06530; Huettel B, 2006, EMBO J, V25, P2828, DOI 10.1038/sj.emboj.7601150; Kanno T, 2005, NAT GENET, V37, P761, DOI 10.1038/ng1580; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Lehmann E, 2007, NATURE, V450, P445, DOI 10.1038/nature06290; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; Luo J, 2007, J MOL EVOL, V64, P101, DOI 10.1007/s00239-006-0093-z; Matzke M, 2006, COLD SPRING HARB SYM, V71, P449, DOI 10.1101/sqb.2006.71.028; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; ONODERA Y, 2008, GENETICS IN PRESS; Pikaard CS, 2008, TRENDS PLANT SCI, V13, P390, DOI 10.1016/j.tplants.2008.04.008; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Pontier D, 2005, GENE DEV, V19, P2030, DOI 10.1101/gad.348405; Sambrook J, 2001, MOL CLONING LAB MANU; Sosunov V, 2003, EMBO J, V22, P2234, DOI 10.1093/emboj/cdg193; Vaucheret H, 2005, NAT GENET, V37, P659, DOI 10.1038/ng0705-659; Vaughn MW, 2005, MOL CELL, V17, P754, DOI 10.1016/j.molcel.2005.03.003; Werner F, 2002, MOL CELL, V10, P635, DOI 10.1016/S1097-2765(02)00629-9; Wierzbicki AT, 2008, CELL, V135, P635, DOI 10.1016/j.cell.2008.09.035; Zaychikov E, 1996, SCIENCE, V273, P107, DOI 10.1126/science.273.5271.107; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	39	41	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2009	4	1							e4110	10.1371/journal.pone.0004110	http://dx.doi.org/10.1371/journal.pone.0004110			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FR	19119310	Green Published, Green Submitted, gold			2022-12-25	WOS:000265472600009
J	Shaish, L; Rinkevich, B				Shaish, Lee; Rinkevich, Baruch			Critical Evaluation of Branch Polarity and Apical Dominance as Dictators of Colony Astogeny in a Branching Coral	PLOS ONE			English	Article							REEF-CORAL; MORPHOLOGICAL PLASTICITY; EVOLUTIONARY ECOLOGY; GROWTH; FORM; RESTORATION; COMPETITION; ADAPTATION; SIMULATION; PRINCIPLES	The high morphological resemblance between branching corals and trees, can lead to comparative studies on pattern formation traits, best exemplified in plants and in some cnidarians. Here, 81 branches of similar size of the hermatypic coral Stylophora pistillata were lopped of three different genets, their skeletons marked with alizarin red-S, and divided haphazardly into three morphometric treatment groups: (I) upright position; (II) horizontal position, intact tip; and (III) horizontal position, cut tip. After 1 y of in-situ growth, the 45 surviving ramets were brought to the laboratory, their tissues removed and their architectures analyzed by 22 morphological parameters (MPs). We found that within 1 y, isolated branches developed into small coral colonies by growing new branches from all branch termini, in all directions. No architectural dissimilarity was assigned among the three studied genets of treatment I colonies. However, a major architectural disparity between treatment I colonies and colonies of treatments II and III was documented as the development of mirror structures from both sides of treatments II and III settings as compared to tip-borne architectures in treatment I colonies. We did not observe apical dominance since fragments grew equally from all branch sides without documented dominant polarity along branch axis. In treatment II colonies, no MP for new branches originating either from tips or from branch bases differed significantly. In treatment III colonies, growth from the cut tip areas was significantly lower compared to the base, again, suggesting lack of apical dominance in this species. Changes in branch polarity revealed genet associated plasticity, which in one of the studied genets, led to enhanced growth. Different genets exhibited canalization flexibility of growth patterns towards either lateral growth, or branch axis extension (skeletal weight and not porosity was measured). This study revealed that colony astogeny in S. pistillata is a regulated process expressed through programmed events and not directly related to simple energy trade-off principles or to environmental conditions, and that branch polarity and apical dominance do not dictate colony astogeny. Therefore, plasticity and astogenic disparities encompass a diversity of genetic (fixed and flexible) induced responses.	[Shaish, Lee; Rinkevich, Baruch] Natl Inst Oceanog, IL-31080 Haifa, Israel	Israel Oceanographic & Limnological Research Institute	Shaish, L (corresponding author), Natl Inst Oceanog, IL-31080 Haifa, Israel.	buki@ocean.org.il			EC-INCO-DEV; GEF/World Bank; AID-CDR project [C23-004]; EC collective research project	EC-INCO-DEV; GEF/World Bank; AID-CDR project; EC collective research project	The study was supported by the EC-INCO-DEV (REEFRES project), by the GEF/World Bank (Remediation and Restoration working Group project), by the AID-CDR project (no C23-004) and by the EC collective research (CORALZOO) project.	Abraham ER, 2001, MAR BIOL, V138, P503, DOI 10.1007/s002270000479; BARKI Y, 1999, THESIS TEL AVIV U IS; BELL AD, 1986, PHILOS T ROY SOC B, V313, P143, DOI 10.1098/rstb.1986.0030; Berking S, 2006, INT J DEV BIOL, V50, P123, DOI 10.1387/ijdb.052043sb; Berking S, 2002, INT J DEV BIOL, V46, P301; BUSS LW, 1991, PHILOS T ROY SOC B, V332, P49, DOI 10.1098/rstb.1991.0032; Cline MG, 1997, AM J BOT, V84, P1064, DOI 10.2307/2446149; DAUGET JM, 1991, CR ACAD SCI III-VIE, V313, P45; DAUGET JM, 1991, MAR BIOL, V111, P157, DOI 10.1007/BF01986357; Epstein N, 2003, AQUAT CONSERV, V13, P387, DOI 10.1002/aqc.558; Foster A.B., 1983, Coral Reefs, V2, P19, DOI 10.1007/BF00304728; Gateno D, 2003, MAR BIOL, V142, P971, DOI 10.1007/s00227-003-1009-8; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; HUGHES RN, 1983, BIOL J LINN SOC, V20, P39, DOI 10.1111/j.1095-8312.1983.tb01588.x; HUGHES TP, 1992, TRENDS ECOL EVOL, V7, P292, DOI 10.1016/0169-5347(92)90225-Z; Ingber D, 1999, FASEB J, V13, pS3; JACKSON JBC, 1979, BIOL SYSTEMATICS COL, V11, P499; Kaandorp JA, 2005, P ROY SOC B-BIOL SCI, V272, P127, DOI 10.1098/rspb.2004.2934; Kaandorp JA, 2001, VIRTUAL LAB, P1; Kaandorp JA, 1997, BIOSYSTEMS, V44, P181, DOI 10.1016/S0303-2647(97)00052-X; KAWAGUTI S, 1973, PALAU TROP BIOL STAT, V12, P209; Kim K, 1997, J EXP MAR BIOL ECOL, V215, P49, DOI 10.1016/S0022-0981(97)00015-4; Kosevich IA, 2006, ZOOLOGY, V109, P244, DOI 10.1016/j.zool.2006.03.004; Lasker HR, 2002, REPRO BIOL, V11, P207; LIDDLE MJ, 1987, BIOL CONSERV, V42, P1, DOI 10.1016/0006-3207(87)90049-8; LOYA Y, 1976, NATURE, V261, P490, DOI 10.1038/261490a0; Marfenin NN, 1997, HYDROBIOLOGIA, V355, P153, DOI 10.1023/A:1003069831832; MARFENIN NN, 1995, RUSSIAN ACAD SCI P Z, V261, P71; Merks RMH, 2004, J THEOR BIOL, V228, P559, DOI 10.1016/j.jtbi.2004.02.020; Meroz E, 2002, P ROY SOC B-BIOL SCI, V269, P717, DOI 10.1098/rspb.2001.1924; Muko S, 2000, B MAR SCI, V66, P225; Napoli C, 1996, PLANT PHYSIOL, V111, P27, DOI 10.1104/pp.111.1.27; Oren U, 1997, MAR ECOL PROG SER, V161, P117, DOI 10.3354/meps161117; PEARSE VB, 1971, BIOL BULL, V141, P350, DOI 10.2307/1540123; Prusinkiewicz P, 1998, SCI HORTIC-AMSTERDAM, V74, P113, DOI 10.1016/S0304-4238(98)00084-3; Rinkevich B, 2000, MAR BIOL, V136, P807, DOI 10.1007/s002270000293; RINKEVICH B, 1985, OECOLOGIA, V66, P100, DOI 10.1007/BF00378559; RINKEVICH B, 1986, EXPERIENTIA, V42, P320, DOI 10.1007/BF01942521; Rinkevich B, 2002, ISRAEL J ZOOL, V48, P71, DOI 10.1560/BCPA-UM3A-MKBP-HGL2; RINKEVICH B, 1984, MAR BIOL, V80, P7, DOI 10.1007/BF00393121; ROOM PM, 1994, ADV ECOL RES, V25, P105, DOI 10.1016/S0065-2504(08)60214-7; ROSEN BR, 1986, PHILOS T ROY SOC B, V313, P115, DOI 10.1098/rstb.1986.0029; RYLAND JS, 1986, PHILOS T ROY SOC B, V313, P53; Sanchez JA, 2004, AM NAT, V163, pE24, DOI 10.1086/382139; SANCHEZ JA, 2003, P R SOC LOND, V271, pS117; Shaish L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000644; Shaish L, 2006, DEV DYNAM, V235, P2111, DOI 10.1002/dvdy.20861; Sokal RR, 1984, BIOMETRY PRINCIPLES; TAYLOR DL, 1977, P 3 INT COR REEF S, P431; Todd PA, 2008, BIOL REV, V83, P315, DOI 10.1111/j.1469-185X.2008.00045.x; Turcotte DL, 1998, J THEOR BIOL, V193, P577, DOI 10.1006/jtbi.1998.0723; Underwood A.J., 1981, Oceanography and Marine Biology an Annual Review, V19, P513; Waddington CH, 1942, J EXP BIOL, V19, P101; WALLER DM, 1985, ECOLOGY EVOLUTION CL, P225; Weinbauer MG, 1998, CAH BIOL MAR, V39, P41; Wolpert L, 1996, TRENDS GENET, V12, P359, DOI 10.1016/S0168-9525(96)80019-9	56	13	13	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2009	4	1							e4095	10.1371/journal.pone.0004095	http://dx.doi.org/10.1371/journal.pone.0004095			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FR	19119311	Green Published, gold, Green Submitted			2022-12-25	WOS:000265472600003
J	Prieto, JH; Koncarevic, S; Park, SK; Yates, J; Becker, K				Prieto, Judith Helena; Koncarevic, Sasa; Park, Sung Kyu; Yates, John, III; Becker, Katja			Large-Scale Differential Proteome Analysis in Plasmodium falciparum under Drug Treatment	PLOS ONE			English	Article								Proteome studies contribute markedly to our understanding of parasite biology, host-parasite interactions, and mechanisms of drug action. For most antimalarial drugs neither mode of action nor mechanisms of resistance development are fully elucidated although this would be important prerequisites for successfully developing urgently required novel antimalarials. Here, we establish a large-scale quantitative proteomic approach to examine protein expression changes in trophozoite stages of the malarial parasite Plasmodium falciparum following chloroquine and artemisinin treatment. For this purpose SIL (stable isotope labeling) using (14)N-isoleucine and (13)C(6), (15)N(1)-isoleucine was optimized to obtain 99% atomic percent enrichment. Proteome fractionation with anion exchange chromatography was used to reduce sample complexity and increase quantitative coverage of protein expression. Tryptic peptides of subfractions were subjected to SCX/RP separation, measured by LC-MS/MS and quantified using the novel software tool Census. In drug treated parasites, we identified a total number of 1,253 proteins, thus increasing the overall number of proteins identified in the trophozoite stage by 30%. A relative quantification was obtained for more than 800 proteins. Under artemisinin and chloroquine treatment 41 and 38 proteins respectively were upregulated (>1.5) whereas 14 and 8 proteins were down-regulated (<0.5). Apart from specifically regulated proteins we also identified sets of proteins which were regulated as a general response to drug treatment. The proteomic data was confirmed by Western blotting. The methodology described here allows for the efficient large-scale differential proteome analysis of P. falciparum study the response to drug treatment or environmental changes. Only 100 mu g of protein is required for the analysis suggesting that the method can also be transferred to other apicomplexan parasites.	[Prieto, Judith Helena; Park, Sung Kyu; Yates, John, III] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Koncarevic, Sasa; Becker, Katja] Univ Giessen, Interdisciplin Res Ctr, D-35390 Giessen, Germany	Scripps Research Institute; Justus Liebig University Giessen	Prieto, JH (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	jyates@scripps.edu; becker.katja@gmx.de		Prieto, Judith/0000-0003-3314-0993	NIH [AI072615-02, P41 RR011823]; German Research Council [Be 1540/9-1]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI072615] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Council(German Research Foundation (DFG)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by the NIH (AI072615-02), P41 RR011823 and the German Research Council (Be 1540/9-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahl A, 2003, NUCLEIC ACIDS RES, V31, P212, DOI 10.1093/nar/gkg081; Cociorva D., 2006, CURR PROTOC BIOINFOR, P1341; Dong MQ, 2007, SCIENCE, V317, P660, DOI 10.1126/science.1139952; Duraisingh MT, 2005, ACTA TROP, V94, P181, DOI 10.1016/j.actatropica.2005.04.008; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Fournier ML, 2007, CHEM REV, V107, P3654, DOI 10.1021/cr068279a; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Gunasekera AM, 2003, MOL MICROBIOL, V50, P1229, DOI 10.1046/j.1365-2958.2003.03787.x; Gunasekera AM, 2007, EXP PARASITOL, V117, P87, DOI 10.1016/j.exppara.2007.03.001; Hyde JE, 2007, FEBS J, V274, P4688, DOI 10.1111/j.1742-4658.2007.05999.x; Koncarevic S, 2007, PROTEOMICS, V7, P711, DOI 10.1002/pmic.200600552; KUHN T, 2008, PROG DRUG RES, V66; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Lelievre J, 2007, CURR OPIN INVEST DR, V8, P117; List E. O., 2008, Infectious Disorders - Drug Targets, V8, P31; MacCoss MJ, 2003, ANAL CHEM, V75, P6912, DOI 10.1021/ac034790h; Maerki S, 2006, J ANTIMICROB CHEMOTH, V58, P52, DOI 10.1093/jac/dkl209; McClatchy DB, 2007, GENOME RES, V17, P1378, DOI 10.1101/gr.6375007; Meshnick SR, 2002, INT J PARASITOL, V32, P1655, DOI 10.1016/S0020-7519(02)00194-7; Nirmalan N, 2004, MOL MICROBIOL, V52, P1187, DOI 10.1111/j.1365-2958.2004.04049.x; Olliaro P, 2001, PHARMACOL THERAPEUT, V89, P207, DOI 10.1016/S0163-7258(00)00115-7; PARK SK, 2006, PROT ORG 5 ANN WORLD; Park SK, 2008, NAT METHODS, V5, P319, DOI [10.1038/NMETH.1195, 10.1038/nmeth.1195]; Radfar A, 2008, FREE RADICAL BIO MED, V44, P2034, DOI 10.1016/j.freeradbiomed.2008.03.010; Roberts L, 2008, ANTIMICROB AGENTS CH, V52, P1840, DOI 10.1128/AAC.01478-07; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; TERKUILE F, 1993, EXP PARASITOL, V76, P85, DOI 10.1006/expr.1993.1010; Venable JD, 2007, ANAL CHEM, V79, P3056, DOI 10.1021/ac062054i; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686	31	66	69	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4098	10.1371/journal.pone.0004098	http://dx.doi.org/10.1371/journal.pone.0004098			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DO	19116658	Green Published, gold, Green Submitted			2022-12-25	WOS:000265466600016
J	Raurell, I; Codina, M; Casagolda, D; del Valle, B; Baulida, J; de Herreros, AG; Dunach, M				Raurell, Imma; Codina, Montserrat; Casagolda, David; del Valle, Beatriz; Baulida, Josep; Garcia de Herreros, Antonio; Dunach, Mireia			Gamma-Secretase-Dependent and -Independent Effects of Presenilin1 on beta-Catenin.Tcf-4 Transcriptional Activity	PLOS ONE			English	Article								Presenilin1 (PS1) is a component of the gamma-secretase complex mutated in cases of Familial Alzheimer's disease (FAD). PS1 is synthesized as a 50 kDa peptide subsequently processed to two 29 and 20 kDa subunits that remain associated. Processing of PS1 is inhibited by several mutations detected in FAD patients. PS1 acts as negative modulator of beta-catenin.Tcf-4 transcriptional activity. In this article we show that in murine embryonic fibroblasts (MEFs) the mechanisms of action of the processed and non-processed forms of PS1 on beta-catenin.Tcf-4 transcription are different. Whereas non-processed PS1 inhibits beta-catenin.Tcf-4 activity through a mechanism independent of gamma-secretase and associated with the interaction of this protein with plakoglobin and Tcf-4, the effect of processed PS1 is prevented by gamma-secretase inhibitors, and requires its interaction with E-or N-cadherin and the generation of cytosolic terminal fragments of these two cadherins, which in turn destabilize the beta-catenin transcriptional cofactor CBP. Accordingly, the two forms of PS1 interact differently with E-cadherin or beta-catenin and plakoglobin: whereas processed PS1 binds E-cadherin with high affinity and beta-catenin or plakoglobin weakly, the non-processed form behaves inversely. Moreover, contrarily to processed PS1, that decreases the levels of c-fos RNA, non-processed PS1 inhibits the expression c-myc, a known target of beta-catenin.Tcf-4, and does not block the activity of other transcriptional factors requiring CBP. These results indicate that prevention of PS1 processing in FAD affects the mechanism of repression of the transcriptional activity dependent on beta-catenin.	[Raurell, Imma; Codina, Montserrat; Casagolda, David; del Valle, Beatriz; Dunach, Mireia] Univ Autonoma Barcelona, Unitat Biofis CEB, Dept Bioquim & Biol Mol, Bellaterra, Spain; [Codina, Montserrat; Baulida, Josep; Garcia de Herreros, Antonio] IMIM Hosp Mar, Programa Recerca Canc, Barcelona, Spain; [Garcia de Herreros, Antonio] Univ Pompeu Fabra, Dept Ciencies Expt Salut, Barcelona, Spain	Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University	Raurell, I (corresponding author), Univ Autonoma Barcelona, Unitat Biofis CEB, Dept Bioquim & Biol Mol, Bellaterra, Spain.	agarcia@imim.es; mireia.dunach@uab.es	Dunach, Mireia/E-3604-2015; de Herreros, A Garcia/H-3104-2014	Dunach, Mireia/0000-0001-9844-5603; de Herreros, A Garcia/0000-0001-5270-0808; Codina, Montserrat/0000-0001-5591-8095	Spanish Ministerio de Educacion y Ciencia [BFU2006-03203, SAF2006-00339, predoctoral fellowships]; Instituto Carlos III [RD06/0020/0040, predoctoral fellowships, postdoctoral fellowship]; Generalitat de Catalunya [2005SGR00970]	Spanish Ministerio de Educacion y Ciencia(Spanish Government); Instituto Carlos III(Instituto de Salud Carlos III); Generalitat de Catalunya(Generalitat de Catalunya)	This study was supported by grants BFU2006-03203 and SAF2006-00339 awarded by the Spanish Ministerio de Educacion y Ciencia to M.D. and A.G.H, repectively. Partial support from Instituto Carlos III (RD06/0020/0040) and the Generalitat de Catalunya (2005SGR00970) is also appreciated. I.R. and D.C. were recipients of predoctoral fellowships from the Instituto Carlos III and from the Ministerio de Educacion y Ciencia, respectively. M.C. was recipient of a postdoctoral fellowship from the Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baki L, 2004, EMBO J, V23, P2586, DOI 10.1038/sj.emboj.7600251; Baki L, 2001, P NATL ACAD SCI USA, V98, P2381, DOI 10.1073/pnas.041603398; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Bryant P, 2004, CURR OPIN IMMUNOL, V16, P96, DOI 10.1016/j.coi.2003.11.011; Castano J, 2002, J BIOL CHEM, V277, P31541, DOI 10.1074/jbc.M204376200; Castano J, 2007, MOL CELL BIOL, V27, P1745, DOI 10.1128/MCB.01974-06; Chan HM, 2001, J CELL SCI, V114, P2363; Charpentier E, 2000, J CELL BIOL, V149, P503, DOI 10.1083/jcb.149.2.503; Cox RT, 2000, GENETICS, V155, P1725; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; Doan A, 1996, NEURON, V17, P1023, DOI 10.1016/S0896-6273(00)80232-9; Doerfler P, 2001, P NATL ACAD SCI USA, V98, P9312, DOI 10.1073/pnas.161102498; Dupre-Crochet S, 2007, MOL CELL BIOL, V27, P3804, DOI 10.1128/MCB.01590-06; Fortini ME, 2002, NAT REV MOL CELL BIO, V3, P673, DOI 10.1038/nrm910; Georgakopoulos A, 1999, MOL CELL, V4, P893, DOI 10.1016/S1097-2765(00)80219-1; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Goodman RH, 2000, GENE DEV, V14, P1553; Gradl D, 1999, MOL CELL BIOL, V19, P5576; Guo Q, 1999, NAT MED, V5, P101, DOI 10.1038/4789; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Herrick C. J., 1899, ARCH NEUROLOGY PSYCH, V2, P1; Kaether C, 2006, TRAFFIC, V7, P408, DOI 10.1111/j.1600-0854.2006.00396.x; Kang DE, 2002, CELL, V110, P751, DOI 10.1016/S0092-8674(02)00970-4; Killick R, 2001, J BIOL CHEM, V276, P48554, DOI 10.1074/jbc.M108332200; Koo EH, 2002, TRAFFIC, V3, P763, DOI 10.1034/j.1600-0854.2002.31101.x; Lalonde R, 2005, BEHAV BRAIN RES, V162, P182, DOI 10.1016/j.bbr.2005.02.037; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Marjaux E, 2004, NEURON, V42, P189, DOI 10.1016/S0896-6273(04)00218-1; Miravet S, 2003, MOL CELL BIOL, V23, P7391, DOI 10.1128/MCB.23.20.7391-7402.2003; Miravet S, 2002, J BIOL CHEM, V277, P1884, DOI 10.1074/jbc.M110248200; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Nishimura M, 1999, NAT MED, V5, P164, DOI 10.1038/5526; Noll E, 2000, DEV BIOL, V227, P450, DOI 10.1006/dbio.2000.9925; Palacino JJ, 2001, J BIOL CHEM, V276, P38563, DOI 10.1074/jbc.M105376200; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Piedra J, 2001, J BIOL CHEM, V276, P20436, DOI 10.1074/jbc.M100194200; Polakis P, 2000, GENE DEV, V14, P1837; Prager K, 2007, J BIOL CHEM, V282, P14083, DOI 10.1074/jbc.M608437200; Raurell I, 2006, J BIOL CHEM, V281, P1401, DOI 10.1074/jbc.M508153200; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Rowan AJ, 2000, P NATL ACAD SCI USA, V97, P3352, DOI 10.1073/pnas.97.7.3352; Saura CA, 2000, J BIOL CHEM, V275, P17136, DOI 10.1074/jbc.M909624199; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Serban G, 2005, J BIOL CHEM, V280, P36007, DOI 10.1074/jbc.M507503200; Solanas G, 2004, J BIOL CHEM, V279, P49849, DOI 10.1074/jbc.M408685200; Solanas G, 2008, J CELL SCI, V121, P2224, DOI 10.1242/jcs.021667; Soria Miguel F., 2001, Monografias del Museo Argentino de Ciencias Naturales, V1, P1; Stahl B, 1999, J BIOL CHEM, V274, P9141, DOI 10.1074/jbc.274.14.9141; Teo JL, 2005, P NATL ACAD SCI USA, V102, P12171, DOI 10.1073/pnas.0504600102; Tomita T, 1999, J NEUROSCI, V19, P10627, DOI 10.1523/JNEUROSCI.19-24-10627.1999; Uemura K, 2007, NEUROSCIENCE, V145, P5, DOI 10.1016/j.neuroscience.2006.12.022; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Xia XF, 2001, P NATL ACAD SCI USA, V98, P10863, DOI 10.1073/pnas.191284198; Zhang ZH, 1998, NATURE, V395, P698, DOI 10.1038/27208; Zhurinsky J, 2000, MOL CELL BIOL, V20, P4238, DOI 10.1128/MCB.20.12.4238-4252.2000	62	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2008	3	12							e4080	10.1371/journal.pone.0004080	http://dx.doi.org/10.1371/journal.pone.0004080			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DL	19114997	Green Published, gold, Green Submitted			2022-12-25	WOS:000265466300018
J	Pan, W; da Graca, LS; Shao, YF; Yin, Q; Wu, H; Jiang, XJ				Pan, Wei; da Graca, Li S.; Shao, Yufang; Yin, Qian; Wu, Hao; Jiang, Xuejun			PHAPI/pp32 Suppresses Tumorigenesis by Stimulating Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACIDIC NUCLEAR-PROTEIN; HISTONE ACETYLATION; NUCLEOTIDE EXCHANGE; CASPASE ACTIVATION; SERINE-PROTEASE; BCL-2 FAMILY; CELL-DEATH; PP32; IAP; INHIBITOR	PHAPI/pp32 is a tumor suppressor whose expression is altered in various human cancers. Although PHAPI possesses multiple biochemical activities, the molecular basis for its tumor-suppressive function has remained obscure. Recently we identified PHAPI as an apoptotic enhancer that stimulates apoptosome-mediated caspase activation. In this study, we defined the structural requirement for its activity to stimulate caspase activation using a series of truncation mutants of PHAPI. Further, utilizing these mutants, we provide evidence to support the model that the apoptotic activity of PHAPI is required for its tumor-suppressive capability. Consistently, pp32R1, a close homolog of PHAPI and yet an oncoprotein, is not able to stimulate caspase activation. Ahighly discrete region between these two proteins localizes to an essential caspase activation motif of PHAPI. Additionally, PHAPI is predominantly a nuclear protein, and it can translocate to the cytoplasm during apoptosis. Disruption of the nuclear localization signal of PHAPI caused a modest decrease of its tumor-suppressive function, indicating that nuclear localization of PHAPI contributes to, but is not essential for, tumor suppression.	[Pan, Wei; da Graca, Li S.; Shao, Yufang; Jiang, Xuejun] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA; [Yin, Qian; Wu, Hao; Jiang, Xuejun] Cornell Univ, Grad Sch Biomed Sci, Weill Med Coll, New York, NY 10021 USA; [Yin, Qian; Wu, Hao] Cornell Univ, Dept Biochem, Weill Med Coll, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University	Jiang, XJ (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave,Box 522, New York, NY 10021 USA.	jiangx@mskcc.org			NATIONAL CANCER INSTITUTE [R01CA113890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045937] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA113890] Funding Source: Medline; NIAID NIH HHS [R01 AI045937] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adams JM, 2001, TRENDS BIOCHEM SCI, V26, P61, DOI 10.1016/S0968-0004(00)01740-0; Adler HT, 1997, J BIOL CHEM, V272, P28407, DOI 10.1074/jbc.272.45.28407; Bai JN, 2001, ONCOGENE, V20, P2153, DOI 10.1038/sj.onc.1204294; Brody JR, 2007, MODERN PATHOL, V20, P1238, DOI 10.1038/modpathol.3800974; Brody JR, 1999, J BIOL CHEM, V274, P20053, DOI 10.1074/jbc.274.29.20053; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Chen TH, 1996, MOL BIOL CELL, V7, P2045, DOI 10.1091/mbc.7.12.2045; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Duckett CS, 1996, EMBO J, V15, P2685, DOI 10.1002/j.1460-2075.1996.tb00629.x; Fukukawa C, 2005, INT J ONCOL, V26, P751; Harris MH, 2000, CELL DEATH DIFFER, V7, P1182, DOI 10.1038/sj.cdd.4400781; Hoffarth S, 2008, CELL DEATH DIFFER, V15, P161, DOI 10.1038/sj.cdd.4402256; Horvitz HR, 1999, CANCER RES, V59, p1701S; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Jiang XJ, 2003, SCIENCE, V299, P223, DOI 10.1126/science.1076807; Jiang XJ, 2000, J BIOL CHEM, V275, P31199, DOI 10.1074/jbc.C000405200; Kadkol SS, 1999, NAT MED, V5, P275, DOI 10.1038/6488; Kadkol SS, 2001, BREAST CANCER RES TR, V68, P65, DOI 10.1023/A:1017919507109; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kim HE, 2005, P NATL ACAD SCI USA, V102, P17545, DOI 10.1073/pnas.0507900102; Kim HE, 2008, MOL CELL, V30, P239, DOI 10.1016/j.molcel.2008.03.014; Li M, 1996, BIOCHEMISTRY-US, V35, P6998, DOI 10.1021/bi960581y; Li M, 1996, J BIOL CHEM, V271, P11059, DOI 10.1074/jbc.271.19.11059; Matilla A, 1997, NATURE, V389, P974, DOI 10.1038/40159; Mazroui R, 2008, J CELL BIOL, V180, P113, DOI 10.1083/jcb.200709030; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Schafer ZT, 2006, CANCER RES, V66, P2210, DOI 10.1158/0008-5472.CAN-05-3923; Seo SB, 2002, J BIOL CHEM, V277, P14005, DOI 10.1074/jbc.M112455200; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Ulitzur N, 1997, J BIOL CHEM, V272, P30577, DOI 10.1074/jbc.272.48.30577; Uren AG, 1996, P NATL ACAD SCI USA, V93, P4974, DOI 10.1073/pnas.93.10.4974; VAESEN M, 1994, BIOL CHEM H-S, V375, P113, DOI 10.1515/bchm3.1994.375.2.113; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Verhagen AM, 2002, J BIOL CHEM, V277, P445, DOI 10.1074/jbc.M109891200	39	29	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6946	6954		10.1074/jbc.M805801200	http://dx.doi.org/10.1074/jbc.M805801200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19121999	Green Published, hybrid			2022-12-25	WOS:000263919000042
J	Deakin, JA; Blaum, BRRS; Gallagher, JT; Uhrin, D; Lyon, M				Deakin, Jon A.; Blaum, Baerbel S.; Gallagher, John T.; Uhrin, Dusan; Lyon, Malcolm			The Binding Properties of Minimal Oligosaccharides Reveal a Common Heparan Sulfate/Dermatan Sulfate-binding Site in Hepatocyte Growth Factor/Scatter Factor That Can Accommodate a Wide Variety of Sulfation Patterns	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR SCATTER FACTOR; C-MET; FACTOR RECEPTOR; GLYCOSAMINOGLYCANS; DISTINCT; HGF/SF; DOMAIN; CELLS; NK1; PROLIFERATION	Heparan sulfate (HS)/heparin and dermatan sulfate (DS) both bind with high affinity to hepatocyte growth factor/scatter factor (HGF/SF) and function as necessary co-factors in vitro. How both these two structurally distinct glycosaminoglycans (GAGs) are recognized has remained unclear. We have now reconciled this issue using a panel of minimal tri- and tetrasaccharide sequences of variable but well defined sulfation patterns in combination with further development of the gel mobility shift assay to allow simultaneous comparisons of relative protein affinities/selectivities for different oligosaccharides. From this approach it would seem that a minimum binding sequence is a disulfated trisaccharide comprised of an internal iduronate flanked by monosulfated hexosamine residues and that additional sulfation further enhances affinity. However, the similarity in recognition of HS/heparin and DS seems to arise primarily from a lack of any apparent positional requirement for sulfation. Thus, isomers of HS/heparin tetrasaccharides containing only two sulfates irrespective of whether they are purely N-, 2-O-, or 6-O-sulfates bind with equivalent apparent affinity as a disulfated DS tetrasaccharide. In addition, the NMR chemical shifts induced in NK1 (the truncated variant of HGF/SF comprised of the N- terminal and first Kringle domains) by titration with either heparin or DS oligosaccharides strongly indicate that both bind to essentially the same site. Together, these observations reveal an unexpected degree of flexibility in the GAG-HGF/SF interface, allowing a single binding site in the protein to accommodate iduronate-containing sequences of variable sulfation pattern and/or density from different GAGs.	[Deakin, Jon A.; Gallagher, John T.; Lyon, Malcolm] Univ Manchester, Paterson Inst Canc Res, Sch Canc & Imaging Sci, Canc Res UK Glycooncol Grp, Manchester M20 4BX, Lancs, England; [Blaum, Baerbel S.; Uhrin, Dusan] Univ Edinburgh, Sch Chem, Edinburgh Biomol NMR Unit, Edinburgh EH9 3JJ, Midlothian, Scotland	Paterson Institute for Cancer Research; University of Manchester; University of Edinburgh	Lyon, M (corresponding author), Univ Manchester, Paterson Inst Canc Res, Sch Canc & Imaging Sci, Canc Res UK Glycooncol Grp, Wilmslow Rd, Manchester M20 4BX, Lancs, England.	MLyon@picr.man.ac.uk		Lyon, Malcolm/0000-0001-9575-6879; Blaum, Baerbel/0000-0003-4312-8912	Cancer Research UK Programme; EaStCHEM Studentship	Cancer Research UK Programme(Cancer Research UK); EaStCHEM Studentship	This work was supported by a Cancer Research UK Programme Grant (to J.A.D.,J.T.G., and M. L.) and an EaStCHEM Studentship (to B. S. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ai XB, 2006, J BIOL CHEM, V281, P4969, DOI 10.1074/jbc.M511902200; Bechard D, 2001, J BIOL CHEM, V276, P48341, DOI 10.1074/jbc.M108395200; Bevan D, 2004, J PATHOL, V203, P831, DOI 10.1002/path.1578; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; CASU B, 1988, TRENDS BIOCHEM SCI, V13, P221, DOI 10.1016/0968-0004(88)90088-6; Catlow KR, 2008, J BIOL CHEM, V283, P5235, DOI 10.1074/jbc.M706589200; Chirgadze DY, 1999, NAT STRUCT BIOL, V6, P72; Chmielowiec J, 2007, J CELL BIOL, V177, P151, DOI 10.1083/jcb.200701086; Corso S, 2005, TRENDS MOL MED, V11, P284, DOI 10.1016/j.molmed.2005.04.005; Deakin JA, 1999, J CELL SCI, V112, P1999; Deakin JA, 2008, GLYCOBIOLOGY, V18, P483, DOI 10.1093/glycob/cwn028; Delehedde M, 2002, J BIOL CHEM, V277, P12456, DOI 10.1074/jbc.M111345200; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Gherardi E, 2006, P NATL ACAD SCI USA, V103, P4046, DOI 10.1073/pnas.0509040103; Gherardi E, 2003, P NATL ACAD SCI USA, V100, P12039, DOI 10.1073/pnas.2034936100; Goodger SJ, 2008, J BIOL CHEM, V283, P13001, DOI 10.1074/jbc.M704531200; Harris EN, 2008, GLYCOBIOLOGY, V18, P638, DOI 10.1093/glycob/cwn045; Hartmann G, 1998, CURR BIOL, V8, P125, DOI 10.1016/S0960-9822(98)70059-4; Higman VA, 2007, J MOL BIOL, V371, P669, DOI 10.1016/j.jmb.2007.05.073; Holmes O, 2007, J MOL BIOL, V367, P395, DOI 10.1016/j.jmb.2006.12.061; Jin L, 2005, PHYS CHEM CHEM PHYS, V7, P3464, DOI 10.1039/b508644b; Lai JP, 2004, ONCOGENE, V23, P1439, DOI 10.1038/sj.onc.1207258; Lai JP, 2004, GASTROENTEROLOGY, V126, P231, DOI 10.1053/j.gastro.2003.09.043; Lietha D, 2001, EMBO J, V20, P5543, DOI 10.1093/emboj/20.20.5543; LUDWIGS U, 1987, BIOCHEM J, V245, P795, DOI 10.1042/bj2450795; Lyon M, 2004, J BIOL CHEM, V279, P43560, DOI 10.1074/jbc.M408510200; LYON M, 1994, J BIOL CHEM, V269, P11216; Lyon M, 1998, J BIOL CHEM, V273, P271, DOI 10.1074/jbc.273.1.271; Lyon M, 2002, J BIOL CHEM, V277, P1040, DOI 10.1074/jbc.M107506200; LYON M, 2007, NEW DEV THERAPEUTIC, P317; Mahoney DJ, 2005, J BIOL CHEM, V280, P27044, DOI 10.1074/jbc.M502068200; MARK MR, 1992, J BIOL CHEM, V267, P26166; Maulik G, 2002, CYTOKINE GROWTH F R, V13, P41, DOI 10.1016/S1359-6101(01)00029-6; Merry CLR, 2001, J BIOL CHEM, V276, P35429, DOI 10.1074/jbc.M100379200; MIZUNO K, 1994, J BIOL CHEM, V269, P1131; Mulloy B, 2000, GLYCOBIOLOGY, V10, P1147, DOI 10.1093/glycob/10.11.1147; Rahmoune H, 1998, BIOCHEMISTRY-US, V37, P6003, DOI 10.1021/bi972468t; Raiber EA, 2007, BIOORG MED CHEM LETT, V17, P6321, DOI 10.1016/j.bmcl.2007.08.074; Raman R, 2003, P NATL ACAD SCI USA, V100, P2357, DOI 10.1073/pnas.0437842100; Rubin JS, 2001, J BIOL CHEM, V276, P32977, DOI 10.1074/jbc.M105486200; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Sergeant N, 2000, J BIOL CHEM, V275, P17094, DOI 10.1074/jbc.M000237200; THUNBERG L, 1982, CARBOHYD RES, V100, P393, DOI 10.1016/S0008-6215(00)81050-2; Tolbert WD, 2007, P NATL ACAD SCI USA, V104, P14592, DOI 10.1073/pnas.0704290104; UEHARA Y, 1995, NATURE, V373, P702, DOI 10.1038/373702a0; van der Voort R, 1999, J BIOL CHEM, V274, P6499, DOI 10.1074/jbc.274.10.6499; Viviano BL, 2004, J BIOL CHEM, V279, P5604, DOI 10.1074/jbc.M310691200; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Zhou HJ, 1999, BIOCHEMISTRY-US, V38, P14793, DOI 10.1021/bi9908641	51	46	48	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6311	6321		10.1074/jbc.M807671200	http://dx.doi.org/10.1074/jbc.M807671200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19114710	hybrid			2022-12-25	WOS:000263742700034
J	Carta, L; Smaldone, S; Zilberberg, L; Loch, D; Dietz, HC; Rifkin, DB; Ramirez, F				Carta, Luca; Smaldone, Silvia; Zilberberg, Lior; Loch, David; Dietz, Harry C.; Rifkin, Daniel B.; Ramirez, Francesco			p38 MAPK Is an Early Determinant of Promiscuous Smad2/3 Signaling in the Aortas of Fibrillin-1 (Fbn1)-null Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATES LATENT TGF-BETA-1; FACTOR-BETA ACTIVATION; SMOOTH-MUSCLE CELLS; TGF-BETA; MARFAN-SYNDROME; MOUSE MODEL; ANEURYSM; RECEPTOR; BINDING; MICROFIBRILS	Excessive transforming growth factor-beta(TGF-beta) signaling characterizes the progression of aortic aneurysm in mouse models of Marfan syndrome, a systemic disorder of the connective tissue that is caused by mutations in the gene encoding the extracellular matrix protein fibrillin-1. Fibrillin-1 mutations are believed to promote abnormal Smad2/3 signaling by impairing the sequestration of latent TGF-beta complexes into the extracellular matrix. Here we report that promiscuous Smad2/3 signaling is the cell-autonomous phenotype of primary cultures of vascular smooth muscle cells (VSMC) explanted from the thoracic aortas of Fbn1 mutant mice with either neonatal onset or progressively severe aortic aneurysm. This cellular phenotype was characterized in VSMC isolated from Fbn1-null (mgN/mgN) mice, which recapitulate the most severe form of Marfan syndrome. We found that loss of fibrillin-1 deposition promotes the production of intracellular reactive oxygen species and abnormal accumulation of phosphorylated TGF-beta-activated kinase 1 and p38 MAPK, in addition to increasing the levels of endogenous phospho-Smad2. We showed that improper Smad2/3 signaling in Fbn1-null VSMC is in part stimulated by phospho-p38 MAPK, which is in turn activated in response to signals other than those mediated by the kinase activity of the ALK5 receptor. Consistent with these cell culture data, in vivo analyses documented that phospho-p38 MAPK accumulates earlier than phospho-Smad2 in the aortic wall of mgN/mgN mice and that systemic inhibition of phospho-p38 MAPK activity lowers the levels of phospho-Smad2 in this tissue. Collectively, these findings indicate that improper activation of p38 MAPK is a precursor of constitutive Smad2/3 signaling in the aortic wall of a mouse model of neonatal lethal Marfan syndrome.	[Carta, Luca; Smaldone, Silvia; Ramirez, Francesco] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Carta, Luca; Smaldone, Silvia; Ramirez, Francesco] Mt Sinai Sch Med, Cardiovasc Inst, New York, NY 10029 USA; [Loch, David; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Loch, David; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Loch, David; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Loch, David; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Zilberberg, Lior; Rifkin, Daniel B.] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; New York University	Ramirez, F (corresponding author), Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, 1 Gustave L Levy Pl,Box 1603, New York, NY 10029 USA.	francesco.ramirez@mssm.edu			National Institutes of Health [AR049698]; Howard Hughes Medical Institute; William S. Smilow Center for Marfan Syndrome Research; National Marfan Foundation; James Elster Research Fund; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR049698] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); William S. Smilow Center for Marfan Syndrome Research; National Marfan Foundation; James Elster Research Fund; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR049698, the Howard Hughes Medical Institute, the William S. Smilow Center for Marfan Syndrome Research, the National Marfan Foundation, and the Drs. Amy and James Elster Research Fund. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BASS DA, 1983, J IMMUNOL, V130, P1910; Bax DV, 2003, J BIOL CHEM, V278, P34605, DOI 10.1074/jbc.M303159200; Brooke BS, 2008, NEW ENGL J MED, V358, P2787, DOI 10.1056/NEJMoa0706585; Bunton TE, 2001, CIRC RES, V88, P37, DOI 10.1161/01.RES.88.1.37; Carta L, 2006, J BIOL CHEM, V281, P8016, DOI 10.1074/jbc.M511599200; Chung AWY, 2008, CIRC RES, V102, pE73, DOI 10.1161/CIRCRESAHA.108.174367; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Hubmacher D, 2006, CURR TOP DEV BIOL, V75, P93, DOI 10.1016/S0070-2153(06)75004-9; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Jenkins G, 2008, INT J BIOCHEM CELL B, V40, P1068, DOI 10.1016/j.biocel.2007.11.026; Jovanovic J, 2007, J BIOL CHEM, V282, P6743, DOI 10.1074/jbc.M607008200; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; Kielty CM, 2002, J CELL SCI, V115, P2817; Koli K, 2008, ANTIOXID REDOX SIGN, V10, P333, DOI 10.1089/ars.2007.1914; Morton S, 2004, FEBS LETT, V572, P177, DOI 10.1016/j.febslet.2004.07.031; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; OHASHI N, 2000, ARTERIOSCL THROM VAS, V20, P166; OHBA M, 1994, J CELL BIOL, V126, P1079, DOI 10.1083/jcb.126.4.1079; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; Ramirez F, 2004, PHYSIOL GENOMICS, V19, P151, DOI 10.1152/physiolgenomics.00092.2004; Ramirez F, 2007, CURR OPIN GENET DEV, V17, P252, DOI 10.1016/j.gde.2007.04.006; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Sakamoto H, 1996, J BIOL CHEM, V271, P4916; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; SPRAGUE EA, 1983, EXP MOL PATHOL, V37, P48; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; TRAVO P, 1980, BLOOD VESSELS, V17, P110; Watkins SJ, 2006, CARDIOVASC RES, V69, P432, DOI 10.1016/j.cardiores.2005.11.007; Winter-Vann AM, 2007, J CELL BIOCHEM, V102, P848, DOI 10.1002/jcb.21522; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Xiong W, 2008, J VASC SURG, V47, P166, DOI 10.1016/j.jvs.2007.09.016; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Zhang W, 2000, J BIOL CHEM, V275, P39237, DOI 10.1074/jbc.M003339200	39	78	81	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5630	5636		10.1074/jbc.M806962200	http://dx.doi.org/10.1074/jbc.M806962200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19109253	Green Published, hybrid			2022-12-25	WOS:000263560600026
J	Hart, EJ; Powers-Lee, SG				Hart, Emily J.; Powers-Lee, Susan G.			Role of Cys-1327 and Cys-1337 in Redox Sensitivity and Allosteric Monitoring in Human Carbamoyl Phosphate Synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; ACETYL-L-GLUTAMATE; N-ACETYLGLUTAMATE; ESCHERICHIA-COLI; SITE; IDENTIFICATION; EVOLUTION; RESIDUES; LOCATION; AMMONIA	Human carbamoyl phosphate synthetase (hCPS) has evolved critical features that allow it to remove excess and potentially neurotoxic ammonia via the urea cycle, including use of only free ammonia as a nitrogen donor, a Km for ammonia 100-fold lower than for CPSs that also use glutamine as a nitrogen donor, and required allosteric activation by N-acetylglutamate (AGA), a sensor of excess amino acids. The recent availability of a Schizosaccharomyces pombe expression system for hCPS allowed us to utilize protein engineering approaches to elucidate the distinctive hCPS properties. Although the site of AGA interaction is not defined, it is known that the binding of AGA to CPS leads to a conformational change in which a pair of cysteine side chains become proximate and can then be selectively induced to undergo disulfide bonding. We analyzed the response of hCPS cysteine mutants to thiol-specific reagents and identified Cys-1327 and Cys-1337 as the AGA-responsive proximate cysteines. Possibly two of the features unique to urea-specific CPSs, relative to other CPSs (the conserved Cys-1327/Cys-1337 pair and the occurrence at very high concentrations in the liver mitochondrial matrix) co-evolved to provide buffering against reactive oxygen species. Reciprocal mutation analysis of Escherichia coli CPS (eCPS), creating P909C and G919C and establishing the ability of these engineered cysteine residues to share a disulfide bond, indicated an eCPS conformational change at least partly similar to the hCPS conformational change induced by AGA. These findings strongly suggested an alternative eCPS conformation relative to the single crystal conformation thus far identified.	[Hart, Emily J.; Powers-Lee, Susan G.] Northeastern Univ, Dept Biol, Boston, MA 02115 USA	Northeastern University	Powers-Lee, SG (corresponding author), Northeastern Univ, Dept Biol, 360 Huntington Ave, Boston, MA 02115 USA.	spl@neu.edu			National Institutes of Health [DK54423]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054423] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK54423. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abyzov A, 2005, BIOINFORMATICS, V21, P3677, DOI 10.1093/bioinformatics/bti602; Ahuja V, 2008, J INHERIT METAB DIS, V31, P481, DOI 10.1007/s10545-008-0913-y; Anderson PM, 1995, MOL ASPECTS CARBAMOY, P33; Belay ED, 1999, NEW ENGL J MED, V340, P1377, DOI 10.1056/NEJM199905063401801; Caldovic L, 2003, BIOCHEM J, V372, P279, DOI 10.1042/BJ20030002; CLARKE S, 1976, J BIOL CHEM, V251, P950; COHEN NS, 1985, BIOCHEM J, V229, P205, DOI 10.1042/bj2290205; Corvi MM, 2001, J BIOL CHEM, V276, P45704, DOI 10.1074/jbc.M102766200; Finckh U, 1998, HUM MUTAT, V12, P206, DOI 10.1002/(SICI)1098-1004(1998)12:3<206::AID-HUMU8>3.3.CO;2-K; GAUTIER C, 1984, CR ACAD SCI III-VIE, V299, P849; GESCHWILL K, 1989, BIOCHEM J, V260, P573, DOI 10.1042/bj2600573; HARAGUCHI Y, 1991, GENE, V107, P335; Kim J, 2004, ARCH BIOCHEM BIOPHYS, V425, P33, DOI 10.1016/j.abb.2004.02.031; Kim J, 2001, BIOCHEMISTRY-US, V40, P11030, DOI 10.1021/bi011121u; Kothe M, 2004, PROTEIN SCI, V13, P466, DOI 10.1110/ps.03416804; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUSTY CJ, 1981, BIOCHEMISTRY-US, V20, P3665, DOI 10.1021/bi00516a001; MARSHALL M, 1985, ARCH BIOCHEM BIOPHYS, V241, P200, DOI 10.1016/0003-9861(85)90376-5; McCudden CR, 1996, J BIOL CHEM, V271, P18285, DOI 10.1074/jbc.271.30.18285; MCGIVAN JD, 1976, BIOCHEM J, V154, P415, DOI 10.1042/bj1540415; Miles BW, 2000, BIOCHEMISTRY-US, V39, P5051, DOI 10.1021/bi992772h; MOMMSEN TP, 1989, SCIENCE, V243, P72, DOI 10.1126/science.2563172; NYUNOYA H, 1983, P NATL ACAD SCI-BIOL, V80, P4629, DOI 10.1073/pnas.80.15.4629; PAULUS H, 1983, CURR TOP CELL REGUL, V22, P177; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POTTER MD, 1992, J BIOL CHEM, V267, P2023; RODRIGUEZAPARICIO LB, 1989, BIOCHEMISTRY-US, V28, P3070, DOI 10.1021/bi00433a050; RUBINO SD, 1986, J BIOL CHEM, V261, P1320; Saeed-Kothe A, 2002, J BIOL CHEM, V277, P7231, DOI 10.1074/jbc.M110926200; Sambrook J, 2001, MOL CLONING LAB MANU; Thoden JB, 1999, ACTA CRYSTALLOGR D, V55, P8, DOI 10.1107/S0907444998006234	31	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5977	5985		10.1074/jbc.M808702200	http://dx.doi.org/10.1074/jbc.M808702200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19106093	Green Published, hybrid			2022-12-25	WOS:000263560600061
J	Wang, HX; Sugiyama, Y; Hikima, T; Sugano, E; Tomita, H; Takahashi, T; Ishizuka, T; Yawo, H				Wang, Hongxia; Sugiyama, Yuka; Hikima, Takuya; Sugano, Eriko; Tomita, Hiroshi; Takahashi, Tetsuo; Ishizuka, Toru; Yawo, Hiromu			Molecular Determinants Differentiating Photocurrent Properties of Two Channelrhodopsins from Chlamydomonas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSORY RHODOPSIN-II; HUMAN COLOR-VISION; GREEN-ALGAE; VISUAL PIGMENTS; GATED CHANNELS; LIGHT; ACTIVATION; RESPONSES; MICE; DEGENERATION	A light signal is converted into an electrical one in a single molecule named channelrhodopsin, one of the archaea-type rhodopsins in unicellular green algae. Although highly homologous, two molecules of this family, channelrhodopsin-1 (ChR1) and -2 (ChR2), are distinct in photocurrent properties such as the wavelength sensitivity, desensitization, and turning-on and -off kinetics. However, the structures regulating these properties have not been completely identified. Photocurrents were analyzed for several chimera molecules made by replacing N-terminal segments of ChR2 with the homologous counterparts of ChR1. We found that the wavelength sensitivity of the photocurrent was red-shifted with negligible desensitization and slowed turning-on and -off kinetics when replacement was made with the segment containing the fifth transmembrane helix of ChR1. Therefore, this segment is involved in the determination of photocurrent properties, the wavelength sensitivity, and the kinetics characterizing ChR1 and ChR2. Eight amino acid residues differentiating this segment were exchanged one-by-one, and the photocurrent properties of each targeted mutant ChR2 were further analyzed. Among them, position Tyr226(ChR1)/Asn187(ChR2) is one of the molecular determinants involved in the wavelength sensitivity, desensitization, and turning-on and -off kinetics. It is suggested that these amino acid residues directly or indirectly interact with the chromophore as well as with the protein structure determining the photocurrent kinetics. Some of the chimera channelrhodopsins are suggested to have several advantages over the wild-type ChR2 in the introduction of light-induced membrane depolarization for the purpose of artificial stimulation of neurons in vivo and visual prosthesis for photoreceptor degeneration.	[Yawo, Hiromu] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Sugiyama, Yuka; Yawo, Hiromu] Tohoku Univ, Sch Med, Dept Physiol & Pharmacol, Sendai, Miyagi 9808575, Japan; [Wang, Hongxia; Sugiyama, Yuka; Hikima, Takuya; Yawo, Hiromu] Tohoku Univ, Basic & Translat Res Ctr Global Brain Sci, Sendai, Miyagi 9808575, Japan; [Sugano, Eriko; Tomita, Hiroshi] Tohoku Univ, Int Adv Res & Educ Org, Sendai, Miyagi 9808575, Japan; [Takahashi, Tetsuo] Toho Univ, Fac Pharmaceut Sci, Chiba 2748510, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Toho University	Yawo, H (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	yawo@mail.tains.tohoku.ac.jp	Ishizuka, Toru/L-8191-2017; Tomita, Hiroshi/O-2135-2018; Yawo, Hiromu/I-4871-2015	Ishizuka, Toru/0000-0003-4405-8792; Tomita, Hiroshi/0000-0003-1051-2301; Yawo, Hiromu/0000-0002-4299-3288	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Suzuken Memorial Foundation	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Suzuken Memorial Foundation	This work was supported by grants-in-aid for scientific research, Global COE Program (Basic and Translational Research Center for Global Brain Science) and Strategic Research Program for Brain Sciences (SRPBS) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, and Suzuken Memorial Foundation.	Adamian L, 2006, PHOTOCHEM PHOTOBIOL, V82, P1426, DOI 10.1562/2006-02-14-RA-802; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Bamann C, 2008, J MOL BIOL, V375, P686, DOI 10.1016/j.jmb.2007.10.072; Berthold P, 2008, PLANT CELL, V20, P1665, DOI 10.1105/tpc.108.057919; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bradley J, 2005, CURR OPIN NEUROBIOL, V15, P343, DOI 10.1016/j.conb.2005.05.014; Douglass AD, 2008, CURR BIOL, V18, P1133, DOI 10.1016/j.cub.2008.06.077; Ernst OP, 2008, J BIOL CHEM, V283, P1637, DOI 10.1074/jbc.M708039200; Hegemann P, 2005, BIOPHYS J, V89, P3911, DOI 10.1529/biophysj.105.069716; HEGEMANN P, 2008, REV PLANT BIOL, V59, P167; Herlitze S, 2007, CURR OPIN NEUROBIOL, V17, P87, DOI 10.1016/j.conb.2006.12.002; Hillebrecht JR, 2006, BIOCHEMISTRY-US, V45, P1579, DOI 10.1021/bi051851s; Hoffmann M, 2006, J AM CHEM SOC, V128, P10808, DOI 10.1021/ja062082i; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Kateriya S, 2004, NEWS PHYSIOL SCI, V19, P133, DOI 10.1152/nips.01517.2004; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kloppmann E, 2005, PROTEINS, V61, P953, DOI 10.1002/prot.20744; Kochendoerfer GG, 1999, TRENDS BIOCHEM SCI, V24, P300, DOI 10.1016/S0968-0004(99)01432-2; Kuhlman SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002005; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Luecke H, 2001, SCIENCE, V293, P1499, DOI 10.1126/science.1062977; MELKONIAN M, 1980, J ULTRA MOL STRUCT R, V72, P90, DOI 10.1016/S0022-5320(80)90138-0; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2005, BIOCHEM SOC T, V33, P863, DOI 10.1042/BST0330863; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Nathans J, 1999, NEURON, V24, P299, DOI 10.1016/S0896-6273(00)80845-4; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Pebay-Peyroula E, 2002, BBA-BIOMEMBRANES, V1565, P196, DOI 10.1016/S0005-2736(02)00569-2; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Sambrook J, 2001, MOL CLONING LAB MANU; Shimono K, 2003, J BIOL CHEM, V278, P23882, DOI 10.1074/jbc.M301200200; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; Suzuki T, 2003, BIOCHEM BIOPH RES CO, V301, P711, DOI 10.1016/S0006-291X(02)03079-6; Tomita H, 2007, INVEST OPHTH VIS SCI, V48, P3821, DOI 10.1167/iovs.06-1501; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120	41	128	170	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5685	5696		10.1074/jbc.M807632200	http://dx.doi.org/10.1074/jbc.M807632200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19103605	hybrid			2022-12-25	WOS:000263560600032
J	Giussani, P; Brioschi, L; Bassi, R; Riboni, L; Viani, P				Giussani, Paola; Brioschi, Loredana; Bassi, Rosaria; Riboni, Laura; Viani, Paola			Phosphatidylinositol 3-Kinase/AKT Pathway Regulates the Endoplasmic Reticulum to Golgi Traffic of Ceramide in Glioma Cells A LINK BETWEEN LIPID SIGNALING PATHWAYS INVOLVED IN THE CONTROL OF CELL SURVIVAL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANNABINOID-INDUCED APOPTOSIS; ELEMENT-BINDING PROTEIN; GLIOBLASTOMA-MULTIFORME; CLINICAL-OUTCOMES; NERVOUS-SYSTEM; KINASE-B; DEATH; PTEN; INHIBITION; TRANSPORT	Different lines of evidence indicate that both aberrant activation of the phosphatidylinositol 3-OH kinase (PI3K)/Akt survival pathway and down-regulation of the death mediator ceramide play a critical role in the aggressive behavior, apoptosis resistance, and adverse clinical outcome of glioblastoma multi-forme. Furthermore, the inhibition of the PI3K/Akt pathway and the up-regulation of ceramide have been found functional to the activity of many cytotoxic treatments against glioma cell lines and glioblastomas as well. A reciprocal control between PI3K/Akt and ceramide signaling in glioma cell survival/death is suggested by data demonstrating a protective role of PI3K/Akt on ceramide-induced cell death in glial cells. In this study we investigated the role of the PI3K/Akt pathway in the regulation of the ceramide metabolism in C6 glioma cells, a cell line in which the PI3K/Akt pathway is constitutively activated. Metabolic experiments performed with different radioactive metabolic precursors of sphingolipids and microscopy studies with fluorescent ceramides demonstrated that the chemical inhibition of PI3K and the transfection with a dominant negative Akt strongly inhibited ceramide utilization for the biosynthesis of complex sphingolipids by controlling the endoplasmic reticulum (ER) to Golgi vesicular transport of ceramide. These findings constitute the first evidence for a PI3K/Akt-dependent regulation of vesicle-mediated movements of ceramide in the ER-Golgi district. Moreover, the findings also suggest the activation of the PI3K/Akt pathway as crucial to coordinate the biosynthesis of membrane complex sphingolipids with cell proliferation and growth and/or to maintain low ceramide levels, especially as concerns those treatments that promote ceramide biosynthesis in the ER.	[Giussani, Paola; Brioschi, Loredana; Bassi, Rosaria; Riboni, Laura; Viani, Paola] Univ Milan, Dept Med Chem Biochem & Biotechnol, LITA, I-20090 Milan, Italy	University of Milan	Viani, P (corresponding author), Univ Milan, Dept Med Chem Biochem & Biotechnol, LITA, Via Flli Cervi 93, I-20090 Milan, Italy.	paola.viani@unimi.it	VIANI, PAOLA/Q-5955-2017; Giussani, Paola/R-4268-2017; Riboni, Laura/R-4281-2017	VIANI, PAOLA/0000-0002-5728-6631; Giussani, Paola/0000-0002-7793-1757; Riboni, Laura/0000-0002-4149-8226; BASSI, ROSARIA/0000-0001-7409-4730	University of Milan	University of Milan	This work was supported by grants from the University of Milan (to P. G., L. R., and P. V.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Bijl N, 2008, J PHARMACOL EXP THER, V326, P849, DOI 10.1124/jpet.108.139394; Blazquez C, 2000, FASEB J, V14, P2315, DOI 10.1096/fj.00-0122com; Brantley EC, 2008, MOL CANCER RES, V6, P675, DOI 10.1158/1541-7786.MCR-07-2180; Carracedo A, 2006, CANCER CELL, V9, P301, DOI 10.1016/j.ccr.2006.03.005; Castellino RC, 2007, NAT CLIN PRACT NEURO, V3, P682, DOI 10.1038/ncpneuro0661; Chakravarti A, 2004, J CLIN ONCOL, V22, P1926, DOI 10.1200/JCO.2004.07.193; Cockcroft S, 2001, J MEMBRANE BIOL, V180, P187, DOI 10.1007/s002320010069; Daido S, 2004, CANCER RES, V64, P4286, DOI 10.1158/0008-5472.CAN-03-3084; Davis F G, 2001, Expert Rev Anticancer Ther, V1, P395, DOI 10.1586/14737140.1.3.395; del Pulgar TG, 2002, J BIOL CHEM, V277, P36527, DOI 10.1074/jbc.M205797200; del Pulgar TG, 2002, BIOCHEM J, V363, P183, DOI 10.1042/0264-6021:3630183; Du XM, 2006, MOL BIOL CELL, V17, P2735, DOI 10.1091/mbc.E05-11-1094; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Ermoian RP, 2002, CLIN CANCER RES, V8, P1100; Fukasawa M, 1999, J CELL BIOL, V144, P673, DOI 10.1083/jcb.144.4.673; Galve-Roperh I, 2000, NAT MED, V6, P313, DOI 10.1038/73171; Giussani P, 2008, BBA-MOL CELL BIOL L, V1781, P40, DOI 10.1016/j.bbalip.2007.11.002; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Guha A, 2004, CURR OPIN NEUROL, V17, P655, DOI 10.1097/00019052-200412000-00004; Guzman M, 2005, HANDB EXP PHARMACOL, V168, P627; Hara S, 2004, CELL DEATH DIFFER, V11, P853, DOI 10.1038/sj.cdd.4401428; Hartmann C, 2005, ACTA NEUROPATHOL, V109, P639, DOI 10.1007/s00401-005-1000-1; Hegi ME, 2008, J CLIN ONCOL, V26, P4189, DOI 10.1200/JCO.2007.11.5964; Hinz B, 2004, MOL PHARMACOL, V66, P1643, DOI 10.1124/mol.104.002618; Kim WH, 2005, NEUROCHEM RES, V30, P969, DOI 10.1007/s11064-005-6223-y; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; Knobbe CB, 2005, NEUROPATH APPL NEURO, V31, P486, DOI 10.1111/j.1365-2990.2005.00660.x; Knobbe CB, 2002, NEURO-ONCOLOGY, V4, P196; Kondo T, 2006, EUR J CANCER, V42, P1237, DOI 10.1016/j.ejca.2006.01.038; Kubiatowski T, 2001, J NEUROSURG, V95, P480, DOI 10.3171/jns.2001.95.3.0480; LOU HOC, 1965, J NEUROCHEM, V12, P619; Mochizuki T, 2002, J BIOL CHEM, V277, P2790, DOI 10.1074/jbc.M106361200; Morales A, 2007, APOPTOSIS, V12, P923, DOI 10.1007/s10495-007-0721-0; Noda S, 2001, J NEURO-ONCOL, V52, P11, DOI 10.1023/A:1010624823158; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Opel D, 2008, CANCER RES, V68, P6271, DOI 10.1158/0008-5472.CAN-07-6769; PAGANO RE, 1991, J CELL BIOL, V113, P1267, DOI 10.1083/jcb.113.6.1267; Pahan K, 2000, J NEUROCHEM, V75, P576, DOI 10.1046/j.1471-4159.2000.0750576.x; Palmer KJ, 2005, J CELL SCI, V118, P3839, DOI 10.1242/jcs.02496; Rao RD, 2004, SEMIN ONCOL, V31, P595, DOI 10.1053/j.seminoncol.2004.07.002; Rasheed BKA, 1997, CANCER RES, V57, P4187; Riboni L, 2000, METHOD ENZYMOL, V311, P656; Riboni L, 2002, GLIA, V39, P105, DOI 10.1002/glia.10087; Riboni L, 2001, J BIOL CHEM, V276, P12797, DOI 10.1074/jbc.M011570200; Sawada M, 2004, CELL DEATH DIFFER, V11, P997, DOI 10.1038/sj.cdd.4401438; Sawada N, 2000, CELL DEATH DIFFER, V7, P761, DOI 10.1038/sj.cdd.4400711; Scheek S, 1997, P NATL ACAD SCI USA, V94, P11179, DOI 10.1073/pnas.94.21.11179; Sekulic A, 2000, CANCER RES, V60, P3504; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Smith JS, 2001, JNCI-J NATL CANCER I, V93, P1246, DOI 10.1093/jnci/93.16.1246; Sullards MC, 2003, CELL MOL BIOL, V49, P789; Testai FD, 2004, J NEUROCHEM, V89, P636, DOI 10.1046/j.1471-4159.2004.02374.x; Toth B, 2006, J BIOL CHEM, V281, P36369, DOI 10.1074/jbc.M604935200; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Viani P, 2003, J BIOL CHEM, V278, P9592, DOI 10.1074/jbc.M207729200; Vogt PK, 2001, TRENDS MOL MED, V7, P482, DOI 10.1016/S1471-4914(01)02161-X; Wong MLH, 2007, J CLIN NEUROSCI, V14, P301, DOI 10.1016/j.jocn.2006.11.005; Worgall TS, 2004, ARTERIOSCL THROM VAS, V24, P943, DOI 10.1161/01.ATV.0000125703.20434.4d; Zinda MJ, 2001, BIOCHEM BIOPH RES CO, V280, P1107, DOI 10.1006/bbrc.2000.4248	61	32	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5088	5096		10.1074/jbc.M808934200	http://dx.doi.org/10.1074/jbc.M808934200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19103588	Green Published, hybrid			2022-12-25	WOS:000263416600039
J	Liang, P; Wang, HY; Chen, H; Cui, YY; Gu, LC; Chai, JJ; Wang, KW				Liang, Ping; Wang, Huayi; Chen, Hao; Cui, Yuanyuan; Gu, Lichuan; Chai, Jijie; Wang, KeWei			Structural Insights into KChIP4a Modulation of Kv4.3 Inactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHANNEL-INTERACTING PROTEINS; CLOSED-STATE INACTIVATION; A-TYPE; K+ CHANNELS; POTASSIUM CHANNELS; FUNCTIONAL INTERACTION; I-TO; SUBUNIT; EXPRESSION; CALCIUM	Dynamic inactivation in Kv4 A-type K+ current plays a critical role in regulating neuronal excitability by shaping action potential waveform and duration. Multifunctional auxiliary KChIP1-4 subunits, which share a high homology in their C-terminal core regions, exhibit distinctive modulation of inactivation and surface expression of pore-forming Kv4 subunits. However, the structural differences that underlie the functional diversity of Kv channel-interacting proteins (KChIPs) remain undetermined. Here we have described the crystal structure of KChIP4a at 3.0 angstrom resolution, which shows distinct N-terminal alpha-helices that differentiate it from other KChIPs. Biochemical experiments showed that competitive binding of the Kv4.3 N-terminal peptide to the hydrophobic groove of the core of KChIP4a causes the release of the KChIP4a N terminus that suppresses the inactivation of Kv4.3 channels. Electrophysiology experiments confirmed that the first N-terminal alpha-helix peptide (residues 1-34) of KChIP4a, either by itself or fused to N-terminal truncated Kv4.3, can confer slow inactivation. We propose that N-terminal binding of Kv4.3 to the core of KChIP4a mobilizes the KChIP4a N terminus, which serves as the slow inactivation gate.	[Liang, Ping; Chen, Hao; Cui, Yuanyuan; Wang, KeWei] Peking Univ, Ctr Prot Sci, Dept Neurobiol, Neurosci Res Inst,Key Lab Neurosci,Minist Educ, Beijing 100083, Peoples R China; [Wang, Huayi; Chai, Jijie] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Gu, Lichuan] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China	Peking University; National Institute of Biological Sciences, Beijing; Shandong University	Wang, KW (corresponding author), Peking Univ, Ctr Prot Sci, Dept Neurobiol, Neurosci Res Inst,Key Lab Neurosci,Minist Educ, 38 Xueyuan Rd, Beijing 100083, Peoples R China.	wangkw@bjmu.edu.cn	Cui, Yuanyuan/G-1899-2015	Chai, Jijie/0000-0001-7591-3873	Chinese Ministry of Science and Technology [2003-AA210090]; National Science Foundation of China [30630017]; Ministry of Science Technology of China [2006AA02Z183, 2007CB512100]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science Technology of China(Ministry of Science and Technology, China)	This work was supported by "863" Grant 2003-AA210090 from the Chinese Ministry of Science and Technology (to J.C.) and Research Grants 30630017 from the National Science Foundation of China and 2006AA02Z183 and 2007CB512100 from the Ministry of Science Technology of China (to K.W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abbott GW, 1998, Q REV BIOPHYS, V31, P357, DOI 10.1017/S0033583599003467; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Bahring R, 2001, J BIOL CHEM, V276, P23888, DOI 10.1074/jbc.M101320200; Beck EJ, 2002, J PHYSIOL-LONDON, V538, P691, DOI 10.1113/jphysiol.2001.013127; Beck EJ, 2001, BIOPHYS J, V81, P867, DOI 10.1016/S0006-3495(01)75747-5; Borek D, 2003, ACTA CRYSTALLOGR D, V59, P2031, DOI 10.1107/S0907444903020924; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen CP, 2006, PROTEIN J, V25, P345, DOI 10.1007/s10930-006-9020-9; Cui YY, 2008, NEUROCHEM RES, V33, P2078, DOI 10.1007/s11064-008-9688-7; Deng XY, 2005, ACTA BIOCH BIOPH SIN, V37, P241, DOI 10.1111/j.1745-7270.2005.00034.x; Deschenes I, 2002, CIRCULATION, V106, P423, DOI 10.1161/01.CIR.0000025417.65658.B6; Dougherty K, 2008, J GEN PHYSIOL, V131, P257, DOI 10.1085/jgp.200709938; Falk T, 2003, NEUROSCIENCE, V120, P387, DOI 10.1016/S0306-4522(03)00044-7; Gebauer M, 2004, BIOPHYS J, V86, P210, DOI 10.1016/S0006-3495(04)74097-7; Guo WN, 2002, CIRC RES, V90, P586, DOI 10.1161/01.RES.0000012664.05949.E0; Hatano N, 2002, PFLUG ARCH EUR J PHY, V444, P80, DOI 10.1007/s00424-002-0798-9; Holmqvist MH, 2002, P NATL ACAD SCI USA, V99, P1035, DOI 10.1073/pnas.022509299; Holmqvist MH, 2001, J NEUROSCI, V21, P4154, DOI 10.1523/JNEUROSCI.21-12-04154.2001; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Hu HJ, 2003, J NEUROPHYSIOL, V90, P1671, DOI 10.1152/jn.00340.2003; Jerng HH, 1999, J GEN PHYSIOL, V113, P641, DOI 10.1085/jgp.113.5.641; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jow F, 2004, P NATL ACAD SCI USA, V101, P15535, DOI 10.1073/pnas.0402081101; Kaulin YA, 2008, BIOPHYS J, V94, P1241, DOI 10.1529/biophysj.107.117796; Kunjilwar K, 2004, J BIOL CHEM, V279, P54542, DOI 10.1074/jbc.M409721200; Kuo HC, 2001, CELL, V107, P801, DOI 10.1016/S0092-8674(01)00588-8; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Morohashi Y, 2002, J BIOL CHEM, V277, P14965, DOI 10.1074/jbc.M200897200; Nadal MS, 2001, J PHYSIOL-LONDON, V537, P801; Oliver D, 2004, SCIENCE, V304, P265, DOI 10.1126/science.1094113; Olschewski A, 2001, ANESTHESIOLOGY, V94, P280, DOI 10.1097/00000542-200102000-00018; Pioletti M, 2006, NAT STRUCT MOL BIOL, V13, P987, DOI 10.1038/nsmb1164; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Scannevin RH, 2004, NEURON, V41, P587, DOI 10.1016/S0896-6273(04)00049-2; Schwenk J, 2008, J BIOL CHEM, V283, P18937, DOI 10.1074/jbc.M800976200; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; Shibata R, 2000, J NEUROSCI, V20, P4145; Shibata R, 2003, J BIOL CHEM, V278, P36445, DOI 10.1074/jbc.M306142200; Wang GY, 2006, J GEN PHYSIOL, V127, P391, DOI 10.1085/jgp.200509442; Wang HY, 2007, NAT NEUROSCI, V10, P32, DOI 10.1038/nn1822; Xiong H, 2004, MOL BRAIN RES, V128, P103, DOI 10.1016/j.molbrainres.2004.06.024; ZAGOTTA WN, 1990, J GEN PHYSIOL, V95, P29, DOI 10.1085/jgp.95.1.29; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500; Zhou W, 2004, NEURON, V41, P573, DOI 10.1016/S0896-6273(04)00045-5	45	25	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4960	4967		10.1074/jbc.M807704200	http://dx.doi.org/10.1074/jbc.M807704200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19109250	hybrid			2022-12-25	WOS:000263416600026
J	Mason, AC; Haring, SJ; Pryor, JM; Staloch, CA; Gan, TF; Wold, MS				Mason, Aaron C.; Haring, Stuart J.; Pryor, John M.; Staloch, Cathy A.; Gan, Tze Fei; Wold, Marc S.			An Alternative Form of Replication Protein A Prevents Viral Replication in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; BINDING-PROTEIN; COMPLEX-FORMATION; POLYMERASE-DELTA; T-ANTIGEN; RPA; SUBUNIT; INITIATION; CANCER; ELONGATION	Replication protein A (RPA), the eukaryotic single-stranded DNA-binding complex, is essential for multiple processes in cellular DNA metabolism. The "canonical" RPA is composed of three subunits (RPA1, RPA2, and RPA3); however, there is a human homolog to the RPA2 subunit, called RPA4, that can substitute for RPA2 in complex formation. We demonstrate that the resulting "alternative" RPA (aRPA) complex has solution and DNA binding properties indistinguishable from the canonical RPA complex; however, aRPA is unable to support DNA replication and inhibits canonical RPA function. Two regions of RPA4, the putative L34 loop and the C terminus, are responsible for inhibiting SV40 DNA replication. Given that aRPA inhibits canonical RPA function in vitro and is found in nonproliferative tissues, these studies indicate that RPA4 expression may prevent cellular proliferation via replication inhibition while playing a role in maintaining the viability of quiescent cells.	[Mason, Aaron C.; Haring, Stuart J.; Pryor, John M.; Staloch, Cathy A.; Gan, Tze Fei; Wold, Marc S.] Univ Iowa, Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA	University of Iowa	Wold, MS (corresponding author), Univ Iowa, Carver Coll Med, Dept Biochem, 375 Newton Rd,3107 MERF, Iowa City, IA 52242 USA.	marc-wold@uiowa.edu	Haring, Stuart/E-7481-2012; Wold, Marc/F-5806-2010	Wold, Marc/0000-0002-4580-1624; Pryor, John/0000-0001-7000-9383	National Institutes of Health [GM44721]; Center for Aging and Cancer at the University of Iowa [CA103672]; NATIONAL CANCER INSTITUTE [P20CA103672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044721] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Aging and Cancer at the University of Iowa; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Research Grant ( GM44721). This work was also supported by grants from the Center for Aging and Cancer at the University of Iowa ( CA103672).	Arunkumar AI, 2005, NAT STRUCT MOL BIOL, V12, P332, DOI 10.1038/nsmb916; Binz SK, 2006, METHOD ENZYMOL, V409, P11, DOI 10.1016/S0076-6879(05)09002-6; Bochkareva E, 2002, EMBO J, V21, P1855, DOI 10.1093/emboj/21.7.1855; Braun KA, 1997, BIOCHEMISTRY-US, V36, P8443, DOI 10.1021/bi970473r; Brush GS, 1995, METHOD ENZYMOL, V262, P522; COLLINS KL, 1991, MOL CELL BIOL, V11, P2108, DOI 10.1128/MCB.11.4.2108; Deng XY, 2007, J MOL BIOL, V374, P865, DOI 10.1016/j.jmb.2007.09.074; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Givalos N, 2007, MODERN PATHOL, V20, P159, DOI 10.1038/modpathol.3800719; Gomes XV, 1996, BIOCHEMISTRY-US, V35, P10558, DOI 10.1021/bi9607517; HARLOW E, 1981, J VIROL, V39, P861, DOI 10.1128/JVI.39.3.861-869.1981; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Ishibashi T, 2006, J BIOCHEM, V139, P99, DOI 10.1093/jb/mvj014; KELLY TJ, 1988, J BIOL CHEM, V263, P17889; KENNY MK, 1989, P NATL ACAD SCI USA, V86, P9757, DOI 10.1073/pnas.86.24.9757; KESHAV KF, 1995, MOL CELL BIOL, V15, P3119; KIM CS, 1994, BIOCHEMISTRY-US, V33, P14197, DOI 10.1021/bi00251a031; MELENDY T, 1993, J BIOL CHEM, V268, P3389; MURAKAMI Y, 1992, P NATL ACAD SCI USA, V89, P952, DOI 10.1073/pnas.89.3.952; Philipova D, 1996, GENE DEV, V10, P2222, DOI 10.1101/gad.10.17.2222; Richard DJ, 2008, NATURE, V453, P677, DOI 10.1038/nature06883; Rider SD, 2005, J BIOL CHEM, V280, P31460, DOI 10.1074/jbc.M504466200; Sibenaller ZA, 1998, BIOCHEMISTRY-US, V37, P12496, DOI 10.1021/bi981110+; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Simmons DT, 2004, NUCLEIC ACIDS RES, V32, P1103, DOI 10.1093/nar/gkh236; Tomkiel JE, 2002, CLIN CANCER RES, V8, P752; Walther AP, 1999, BIOCHEMISTRY-US, V38, P3963, DOI 10.1021/bi982370u; Walther AP, 1999, NUCLEIC ACIDS RES, V27, P656, DOI 10.1093/nar/27.2.656; Wang YX, 2005, NAT GENET, V37, P750, DOI 10.1038/ng1587; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; WOLD MS, 1988, P NATL ACAD SCI USA, V85, P2523, DOI 10.1073/pnas.85.8.2523; Yuzhakov A, 1999, EMBO J, V18, P6189, DOI 10.1093/emboj/18.21.6189; Zhang D, 1998, NUCLEIC ACIDS RES, V26, P631, DOI 10.1093/nar/26.2.631	33	17	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5324	5331		10.1074/jbc.M808963200	http://dx.doi.org/10.1074/jbc.M808963200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19116208	Green Published, hybrid			2022-12-25	WOS:000263416600062
J	Ohnishi, A; Hashimoto, K; Imai, K; Matsumoto, S				Ohnishi, Atsushi; Hashimoto, Kana; Imai, Kiyohiro; Matsumoto, Shogo			Functional Characterization of the Bombyx mori Fatty Acid Transport Protein (BmFATP) within the Silkmoth Pheromone Gland	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COA-BINDING PROTEIN; BIOSYNTHESIS ACTIVATING NEUROPEPTIDE; CYTOPLASMIC LIPID DROPLETS; ACYL-COA; SILKWORM; IDENTIFICATION; RECEPTOR; CLONING; CELLS; ACBP	Fatty acid transport protein (FATP) is an evolutionarily conserved membrane-bound protein that facilitates the uptake of extracellular long chain fatty acids. In humans and mice, six FATP isoforms have been identified and their tissue-specific distributions suggest that each plays a discrete role in lipid metabolism in association with fatty acid uptake. While the presence of FATP homologs in insects has been demonstrated, their functional role remains to be characterized. Pheromonogenesis is defined as the dynamic period in which all machinery required for sex pheromone biosynthesis is generated and organized within the pheromone gland (PG) cells. By exploiting this unique system in the PG of the silkmoth, Bombyx mori, we found that BmFATP is predominantly expressed in the PG and undergoes up-regulation 1 day prior to eclosion. Before eclosion, B. mori PG cells accumulate cytoplasmic lipid droplets (LDs), which play a role in storing the pheromone (bombykol) precursor fatty acid in the form of triacylglycerol. RNAi-mediated gene silencing of BmFATP in vivo significantly suppressed LD accumulation by preventing the synthesis of triacylglycerols and resulted in a significant reduction in bombykol production. These results, in conjunction with the findings that BmFATP stimulates the uptake of extracellular long-chain fatty acids and BmFATP knockdown reduces cellular long-chain acyl-CoA synthetase activity, suggest that BmFATP plays an essential role in bombykol biosynthesis by stimulating both LD accumulation and triacylglycerol synthesis via a process called vectorial acylation that couples the uptake of extracellular fatty acids with activation to CoA thioesters during pheromonogenesis.	[Ohnishi, Atsushi; Hashimoto, Kana; Matsumoto, Shogo] RIKEN, Adv Sci Inst, Mol Entomol Lab, Wako, Saitama 3510198, Japan; [Hashimoto, Kana; Imai, Kiyohiro] Hosei Univ, Dept Chem Mat, Koganei, Tokyo 1848584, Japan	RIKEN; Hosei University	Matsumoto, S (corresponding author), RIKEN, Adv Sci Inst, Mol Entomol Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	smatsu@riken.jp		Ohnishi, Atsushi/0000-0003-1213-4439	RIKEN; Targeted Proteins Research Program (TPRP); Ministry of Education, Culture, Sports, Science and Technology of Japan [20380040, 19580061]	RIKEN; Targeted Proteins Research Program (TPRP)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Bioarchitect Research Program from RIKEN and the Targeted Proteins Research Program (TPRP), Grants-in-Aid for Scientific Research (B) 20380040, and (C) 19580061 from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ANDO T, 1988, AGR BIOL CHEM TOKYO, V52, P141; Choi MY, 2003, P NATL ACAD SCI USA, V100, P9721, DOI 10.1073/pnas.1632485100; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DiRusso CC, 2000, EUR J BIOCHEM, V267, P4422, DOI 10.1046/j.1432-1327.2000.01489.x; Doege H, 2006, PHYSIOLOGY, V21, P259, DOI 10.1152/physiol.00014.2006; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Fonagy A, 2000, J INSECT PHYSIOL, V46, P735, DOI 10.1016/S0022-1910(99)00162-6; Fonagy A, 2001, ARTHROPOD STRUCT DEV, V30, P113, DOI 10.1016/S1467-8039(01)00027-5; Hall AM, 2003, J BIOL CHEM, V278, P43008, DOI 10.1074/jbc.M306575200; Hirsch D, 1998, P NATL ACAD SCI USA, V95, P8625, DOI 10.1073/pnas.95.15.8625; Hull JJ, 2004, J BIOL CHEM, V279, P51500, DOI 10.1074/jbc.M408142200; Jurenka R.A., 2003, P53, DOI 10.1016/B978-012107151-6/50005-0; Kim YJ, 2008, PEPTIDES, V29, P268, DOI 10.1016/j.peptides.2007.12.001; Lewis SE, 2001, J BIOL CHEM, V276, P37042, DOI 10.1074/jbc.M105556200; MATSUMOTO S, 1990, J INSECT PHYSIOL, V36, P427, DOI 10.1016/0022-1910(90)90060-S; Matsumoto S, 2002, INSECT BIOCHEM MOLEC, V32, P1447, DOI 10.1016/S0965-1748(02)00065-6; Matsumoto S, 2001, INSECT BIOCHEM MOLEC, V31, P603, DOI 10.1016/S0965-1748(00)00165-X; MATUMOTO S, 2007, J INSECT PHYSL, V53, P752; MOGENSEN IB, 1987, BIOCHEM J, V241, P189, DOI 10.1042/bj2410189; Moto K, 2004, P NATL ACAD SCI USA, V101, P8631, DOI 10.1073/pnas.0402056101; Moto K, 2003, P NATL ACAD SCI USA, V100, P9156, DOI 10.1073/pnas.1531993100; Obermeyer T, 2007, J LIPID RES, V48, P2354, DOI 10.1194/jlr.M700300-JLR200; Ohnishi A, 2006, P NATL ACAD SCI USA, V103, P4398, DOI 10.1073/pnas.0511270103; Ozawa R, 1996, INSECT BIOCHEM MOLEC, V26, P259, DOI 10.1016/0965-1748(95)00088-7; Rafaeli A, 2002, INT REV CYTOL, V213, P49; Rafaeli Ada, 2003, P107, DOI 10.1016/B978-012107151-6/50007-4; RASMUSSEN JT, 1994, BIOCHEM J, V299, P165, DOI 10.1042/bj2990165; RASMUSSEN JT, 1993, BIOCHEM J, V292, P907, DOI 10.1042/bj2920907; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; Stahl A, 2004, PFLUG ARCH EUR J PHY, V447, P722, DOI 10.1007/s00424-003-1106-z; STANLEYSAMUELSON DW, 1988, ARCH INSECT BIOCHEM, V9, P1, DOI 10.1002/arch.940090102; Tillman JA, 1999, INSECT BIOCHEM MOLEC, V29, P481, DOI 10.1016/S0965-1748(99)00016-8; Watkins PA, 2008, J BIOL CHEM, V283, P1773, DOI 10.1074/jbc.R700037200; Yoshiga T, 2000, GENE, V246, P339, DOI 10.1016/S0378-1119(00)00047-0; Zou ZY, 2002, J BIOL CHEM, V277, P31062, DOI 10.1074/jbc.M205034200	35	41	43	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5128	5136		10.1074/jbc.M806072200	http://dx.doi.org/10.1074/jbc.M806072200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19112106	hybrid			2022-12-25	WOS:000263416600043
J	Darna, M; Schmutz, I; Richter, K; Yelamanchili, SV; Pendyala, G; Holtje, M; Albrecht, U; Ahnert-Hilger, G				Darna, Mahesh; Schmutz, Isabelle; Richter, Karin; Yelamanchili, Sowmya V.; Pendyala, Gurudutt; Hoeltje, Markus; Albrecht, Urs; Ahnert-Hilger, Gudrun			Time of Day-dependent Sorting of the Vesicular Glutamate Transporter to the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTOPHYSIN-SYNAPTOBREVIN COMPLEX; MECHANISM; GABA	Neurotransmitters are concentrated into synaptic vesicles by VGLUT (vesicular glutamate transporter) or VGAT (vesicular GABA transporter). The number of VGLUTs per vesicle determines the amount of stored neurotransmitter, thereby influencing postsynaptic response. Recently, we described a strong diurnal cycling of the amount of VGLUT1 on synaptic vesicles prepared from whole mouse brain at different times of the day (Yelamanchili, S. V., Pendyala, G., Brunk, I., Darna, M., Albrecht, U., and Ahnert-Hilger, G. (2006) J. Biol. Chem. 281, 15671 15679). To analyze whether and how much VGLUT resides in cellular versus vesicular membranes, we developed a Pronase assay. We found that VGLUT and synaptotagmin are highly accessible to proteolytic cleavage in rat and mouse synaptosomal preparations, indicating considerable amounts of these vesicular proteins at the plasma membrane, whereas only minor amounts of synaptophysin and Rab3 are digested. Sucrose stimulation increases digestion of VGLUT, synaptotagmin, and synaptophysin due to membrane fusion that exposes the lumen-facing peptides to the extracellular space. Digestion of mouse synaptosomes prepared at different times of the day revealed a diurnal cycling of VGLUT to the plasma membrane. More VGLUT is digested at noon (Zeitgeber time 6) compared with the start of the light period (Zeitgeber time 0), whereas digestion of synaptophysin and synaptotagmin is independent of diurnal cycling. In contrast to VGLUT, the amount of VGAT appears not to vary diurnally but is decreased in membrane preparations from animals kept under constant darkness. We conclude that VGLUTs are sorted diurnally to the plasma membrane to modulate glutamate transmission during a day/night cycle, whereas VGAT expression is not oscillating but is increased in the presence of a light/dark cycle.	[Darna, Mahesh; Richter, Karin; Yelamanchili, Sowmya V.; Hoeltje, Markus; Ahnert-Hilger, Gudrun] Charite Ctr 2 Basic Med, AG Funct Cell Biol, Inst Integrat Neuroanat, D-10115 Berlin, Germany; [Schmutz, Isabelle; Pendyala, Gurudutt; Albrecht, Urs] Univ Fribourg, Dept Med, Div Biochem, CH-1700 Fribourg, Switzerland	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Fribourg	Ahnert-Hilger, G (corresponding author), Charite Ctr 2 Basic Med, AG Funct Cell Biol, Inst Integrat Neuroanat, Philippstr 12, D-10115 Berlin, Germany.	gudrun.ahnert@charite.de	Albrecht, Urs/A-9831-2011	Albrecht, Urs/0000-0002-0663-8676; Holtje, Markus/0000-0003-3193-4140	German Research Foundation [AH 67/5]; Graduierten Kolleg 1123; Swiss National Science Foundation; State of Fribourg; European Community Grant EUCLOCK	German Research Foundation(German Research Foundation (DFG)); Graduierten Kolleg 1123; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); State of Fribourg; European Community Grant EUCLOCK(European Commission)	This work was supported by German Research Foundation Grant AH 67/5 (to G. A.- H.), Graduierten Kolleg 1123 (to M. D.), and the Swiss National Science Foundation, the State of Fribourg, and European Community Grant EUCLOCK (to U. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Albrecht U, 2003, CURR OPIN GENET DEV, V13, P271, DOI 10.1016/S0959-437X(03)00055-8; Albrecht U, 2002, METHODS, V28, P465, DOI 10.1016/S1046-2023(02)00266-9; Becher A, 1999, J NEUROSCI, V19, P1922; Brunk I, 2006, J BIOL CHEM, V281, P33373, DOI 10.1074/jbc.M603204200; EDELMANN L, 1995, EMBO J, V14, P224, DOI 10.1002/j.1460-2075.1995.tb06995.x; Edwards RH, 2007, NEURON, V55, P835, DOI 10.1016/j.neuron.2007.09.001; Fernandez-Alfonso T, 2006, NEURON, V51, P179, DOI 10.1016/j.neuron.2006.06.008; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Grosse G, 2003, MOL CELL NEUROSCI, V24, P709, DOI 10.1016/S1044-7431(03)00234-3; Hinz B, 2001, EUR J CELL BIOL, V80, P615, DOI 10.1078/0171-9335-00196; Holtje M, 2008, J BIOL CHEM, V283, P9289, DOI 10.1074/jbc.M706499200; Iwamoto H, 2006, J NEUROSCI, V26, P9851, DOI 10.1523/JNEUROSCI.1862-06.2006; JAHN R, 1985, P NATL ACAD SCI USA, V82, P4137, DOI 10.1073/pnas.82.12.4137; JOHNSTON PA, 1989, J BIOL CHEM, V264, P1268; Moechars D, 2006, J NEUROSCI, V26, P12055, DOI 10.1523/JNEUROSCI.2556-06.2006; Moriyama Y, 2004, J BIOCHEM, V135, P155, DOI 10.1093/jb/mvh018; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Steiner JA, 2008, TRAFFIC, V9, P1393, DOI 10.1111/j.1600-0854.2008.00757.x; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Takamori S, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-22-j0002.2001; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Voglmaier SM, 2006, NEURON, V51, P71, DOI 10.1016/j.neuron.2006.05.027; Wallen-Mackenzie A, 2006, J NEUROSCI, V26, P12294, DOI 10.1523/JNEUROSCI.3855-06.2006; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101; Wojcik SM, 2006, NEURON, V50, P575, DOI 10.1016/j.neuron.2006.04.016; Yelamanchili SV, 2006, J BIOL CHEM, V281, P15671, DOI 10.1074/jbc.M600378200; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	27	19	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4300	4307		10.1074/jbc.M805480200	http://dx.doi.org/10.1074/jbc.M805480200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19103593	Green Submitted, hybrid			2022-12-25	WOS:000263134400028
J	Wu, XB; Sinani, D; Kim, H; Lee, J				Wu, Xiaobin; Sinani, Devis; Kim, Heejeong; Lee, Jaekwon			Copper Transport Activity of Yeast Ctr1 Is Down-regulated via Its C Terminus in Response to Excess Copper	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; BIOCHEMICAL-CHARACTERIZATION; STIMULATED ENDOCYTOSIS; MEMBRANE-PROTEINS; CRYSTAL-STRUCTURE; DEGRADATION; UBIQUITIN; TRAFFICKING; MECHANISMS; EXPRESSION	Copper is an essential yet toxic trace element. The Ctr1 family of proteins plays a critical role for copper uptake in eukaryotes. However, the mechanisms of action of Ctr1 are largely unknown. Our previous data demonstrated that copper transport induces conformational changes in the cytosolic C terminus of the yeast Saccharomyces cerevisiae Ctr1. To define the physiological significance of this molecular event and gain better insights into the mechanism of Ctr1-mediated copper uptake, we have characterized the functional roles of the Ctr1 C terminus. A Ctr1 mutant lacking the entire C-terminal cytosolic tail is functional in high affinity copper uptake; however, yeast cells expressing this mutant are extremely sensitive to excess copper. Toxic copper uptake is not attributed to elevated expression or distinct subcellular localization of this mutant as compared with wild type Ctr1. Further characterization of the function of Ctr1 containing deletions or site-directed mutations at the C terminus indicates a structural role for the C terminus in controlling Ctr1 activities. In response to excess copper, Ctr1-mediated copper transport is rapidly blocked in a C terminus-dependent mechanism associated with direct binding of copper. We propose that conformational changes in the cytosolic tail of yeast Ctr1 by copper sensing within this domain lead to the inhibition of Ctr1-mediated copper transport. These data suggest a new regulatory mechanism by which yeast cells maintain homeostatic copper acquisition.	[Wu, Xiaobin; Sinani, Devis; Kim, Heejeong; Lee, Jaekwon] Univ Nebraska, Dept Biochem, Redox Biol Ctr, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln	Lee, J (corresponding author), Univ Nebraska, Dept Biochem, Redox Biol Ctr, N210 Beadle Ctr, Lincoln, NE 68588 USA.	jlee7@unlnotes.unl.edu		Wu, Xiaobin/0000-0001-5479-8597	National Institutes of Health [DK79209, P20-RR-17675]; Nutricia Foundation Fellowship; Hatch Act in the University of Nebraska Agricultural Research Division; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079209] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nutricia Foundation Fellowship(Danone Nutricia); Hatch Act in the University of Nebraska Agricultural Research Division; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK79209 ( to J. L.) and P20-RR-17675 ( to the Nebraska Redox Biology Center). This work was also supported by a Nutricia Foundation Fellowship ( to D. S.), and funds provided through the Hatch Act in the University of Nebraska Agricultural Research Division. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aller SG, 2006, P NATL ACAD SCI USA, V103, P3627, DOI 10.1073/pnas.0509929103; Ausubel F.M., 1987, CURRENT PROTOCOL MOL; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; Cobine PA, 2006, BBA-MOL CELL RES, V1763, P759, DOI 10.1016/j.bbamcr.2006.03.002; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; DANCIS A, 1994, J BIOL CHEM, V269, P25660; Eisses JF, 2005, J BIOL CHEM, V280, P9635, DOI 10.1074/jbc.M500116200; Eshaghi S, 2006, SCIENCE, V313, P354, DOI 10.1126/science.1127121; Georgatsou E, 1997, J BIOL CHEM, V272, P13786, DOI 10.1074/jbc.272.21.13786; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Gitlin JD, 2003, GASTROENTEROLOGY, V125, P1868, DOI 10.1053/j.gastro.2003.05.010; Guo Y, 2004, J BIOL CHEM, V279, P17428, DOI 10.1074/jbc.M401493200; HALL BH, 1990, BROOKINGS PAP ECO AC, P85; HASSETT R, 1995, J BIOL CHEM, V270, P128, DOI 10.1074/jbc.270.1.128; Hattori M, 2007, NATURE, V448, P1072, DOI 10.1038/nature06093; HEIN C, 1995, MOL MICROBIOL, V18, P77, DOI 10.1111/j.1365-2958.1995.mmi_18010077.x; Horak J, 2003, BBA-BIOMEMBRANES, V1614, P139, DOI 10.1016/S0005-2736(03)00195-0; Katzmann DJ, 1999, MOL CELL BIOL, V19, P2998; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Klaassen CD, 1999, ANNU REV PHARMACOL, V39, P267, DOI 10.1146/annurev.pharmtox.39.1.267; Klomp AEM, 2002, BIOCHEM J, V364, P497, DOI 10.1042/BJ20011803; Knight SAB, 1996, GENE DEV, V10, P1917, DOI 10.1101/gad.10.15.1917; Lee J, 2002, J BIOL CHEM, V277, P4380, DOI 10.1074/jbc.M104728200; Lee J, 2006, TOP CURR GENET, V14, P1; Linder M, 1991, BIOCH COPPER; Liu JX, 2007, TRAFFIC, V8, P1375, DOI 10.1111/j.1600-0854.2007.00616.x; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Lunin VV, 2006, NATURE, V440, P833, DOI 10.1038/nature04642; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; NEBOT C, 1993, ANAL BIOCHEM, V214, P442, DOI 10.1006/abio.1993.1521; Nies DH, 2007, SCIENCE, V317, P1695, DOI 10.1126/science.1149048; Ooi CE, 1996, EMBO J, V15, P3515, DOI 10.1002/j.1460-2075.1996.tb00720.x; Overton MC, 2002, J BIOL CHEM, V277, P41463, DOI 10.1074/jbc.M205368200; OYANAGUI Y, 1984, ANAL BIOCHEM, V142, P290; Petris MJ, 2003, J BIOL CHEM, V278, P9639, DOI 10.1074/jbc.M209455200; Prohaska JR, 2000, NUTRITION, V16, P502, DOI 10.1016/S0899-9007(00)00308-7; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; RATHS S, 1993, J CELL BIOL, V120, P55, DOI 10.1083/jcb.120.1.55; Rees EM, 2004, J BIOL CHEM, V279, P54221, DOI 10.1074/jbc.M411669200; Sandoval Ignacio V., 1994, Trends in Cell Biology, V4, P292, DOI 10.1016/0962-8924(94)90220-8; Sinani D, 2007, J BIOL CHEM, V282, P26775, DOI 10.1074/jbc.M703973200; TAN PK, 1993, J CELL BIOL, V123, P1707, DOI 10.1083/jcb.123.6.1707; Uauy R, 1998, AM J CLIN NUTR, V67, p952S, DOI 10.1093/ajcn/67.5.952S; Xiao ZG, 2004, J AM CHEM SOC, V126, P3081, DOI 10.1021/ja0390350; YamaguchiIwai Y, 1997, J BIOL CHEM, V272, P17711, DOI 10.1074/jbc.272.28.17711	48	61	67	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4112	4122		10.1074/jbc.M807909200	http://dx.doi.org/10.1074/jbc.M807909200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19088072	Green Published, hybrid			2022-12-25	WOS:000263134400008
J	Davis, BN; Hilyard, AC; Nguyen, PH; Lagna, G; Hata, A				Davis, Brandi N.; Hilyard, Aaron C.; Nguyen, Peter H.; Lagna, Giorgio; Hata, Akiko			Induction of MicroRNA-221 by Platelet-derived Growth Factor Signaling Is Critical for Modulation of Vascular Smooth Muscle Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; POSTTRANSCRIPTIONAL REGULATION; PULMONARY-HYPERTENSION; BREAST-CANCER; C-KIT; MYOCARDIN; EXPRESSION; MIR-221; TUMORS; CELLS	The platelet-derived growth factor (PDGF) signaling pathway is a critical regulator of animal development and homeostasis. Activation of the PDGF pathway leads to neointimal proliferative responses to artery injury; it promotes a switch of vascular smooth muscle cells (vSMC) to a less contractile phenotype by inhibiting the SMC-specific gene expression and increasing the rate of proliferation and migration. The molecular mechanism for these pleiotropic effects of PDGFs has not been fully described. Here, we identify the microRNA-221 (miR-221), a small noncoding RNA, as a modulator of the phenotypic change of vSMCs in response to PDGF signaling. We demonstrate that miR-221 is transcriptionally induced upon PDGF treatment in primary vSMCs, leading to down-regulation of the targets c-Kit and p27Kip1. Down-regulation of p27Kip1 by miR-221 is critical for PDGF-mediated induction of cell proliferation. Additionally, decreased c-Kit causes inhibition of SMC-specific contractile gene transcription by reducing the expression of Myocardin (Myocd), a potent SMC-specific nuclear coactivator. Our study demonstrates that PDGF signaling, by modulating the expression of miR-221, regulates two critical determinants of the vSMC phenotype; they are SMC gene expression and cell proliferation.	[Davis, Brandi N.; Hilyard, Aaron C.; Nguyen, Peter H.; Lagna, Giorgio; Hata, Akiko] Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA; [Davis, Brandi N.; Nguyen, Peter H.; Hata, Akiko] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA	Tufts Medical Center; Tufts University	Hata, A (corresponding author), Tufts Med Ctr, Mol Cardiol Res Inst, 800 Washington St,Box 8486, Boston, MA 02111 USA.	akiko.hata@tufts.edu	Davis-Dusenbery, Brandi/N-2798-2013	Davis-Dusenbery, Brandi/0000-0001-7811-8613	National Institutes of Health [HL082854, HL086572]; NIHLB; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082854, R21HL086572, R01HL093154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIHLB; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL082854 (to A. Hata) and HL086572 (to G. L.) (NIHLB). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adnot S, 2005, J CLIN INVEST, V115, P1461, DOI 10.1172/JCI25399; Ali S, 2007, GENE, V401, P38, DOI 10.1016/j.gene.2007.06.017; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Callis TE, 2007, DNA CELL BIOL, V26, P219, DOI 10.1089/dna.2006.0556; Chen DH, 1997, J CLIN INVEST, V99, P2334, DOI 10.1172/JCI119414; Chow N, 2007, P NATL ACAD SCI USA, V104, P823, DOI 10.1073/pnas.0608251104; Christoforou N, 2008, J CLIN INVEST, V118, P894, DOI 10.1172/JCI33942; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Creemers EE, 2006, DEVELOPMENT, V133, P4245, DOI 10.1242/dev.02610; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Du KL, 2003, MOL CELL BIOL, V23, P2425, DOI 10.1128/MCB.23.7.2425-2437.2003; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Fornari F, 2008, ONCOGENE, V27, P5651, DOI 10.1038/onc.2008.178; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Ghofrani HA, 2005, NEW ENGL J MED, V353, P1412, DOI 10.1056/NEJMc051946; Gross DJ, 2006, ENDOCR-RELAT CANCER, V13, P535, DOI 10.1677/erc.1.01124; Hammond SM, 2006, CANCER CHEMOTH PHARM, V58, pS63, DOI 10.1007/s00280-006-0318-2; Hammond SM, 2006, CURR OPIN GENET DEV, V16, P4, DOI 10.1016/j.gde.2005.12.005; Harfe BD, 2005, CURR OPIN GENET DEV, V15, P410, DOI 10.1016/j.gde.2005.06.012; Hinson JS, 2008, AM J PHYSIOL-HEART C, V295, pH1067, DOI 10.1152/ajpheart.91421.2007; Hollenbeck ST, 2004, J SURG RES, V120, P288, DOI 10.1016/j.jss.2004.01.005; Kent D, 2008, CLIN CANCER RES, V14, P1926, DOI 10.1158/1078-0432.CCR-07-5134; Kim HJ, 2008, J NUCL MED, V49, P1686, DOI 10.2967/jnumed.108.052894; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Koff A, 2006, CANCER CELL, V9, P75, DOI 10.1016/j.ccr.2006.01.020; Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256; Lagna G, 2007, J BIOL CHEM, V282, P37244, DOI 10.1074/jbc.M708137200; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Mann DL, 2007, NEW ENGL J MED, V356, P2644, DOI 10.1056/NEJMcibr072068; Marsit CJ, 2006, CANCER RES, V66, P10843, DOI 10.1158/0008-5472.CAN-06-1894; McNamara CA, 1996, SEMIN THROMB HEMOST, V22, P139, DOI 10.1055/s-2007-999001; Miano JM, 2004, CIRC RES, V95, P340, DOI 10.1161/01.RES.0000140893.16465.2d; Miano JM, 2000, J BIOL CHEM, V275, P9814, DOI 10.1074/jbc.275.13.9814; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Milyavsky M, 2007, CANCER CELL, V11, P133, DOI 10.1016/j.ccr.2006.11.022; Morrell Nicholas W, 2006, Proc Am Thorac Soc, V3, P680, DOI 10.1513/pats.200605-118SF; Naeije R, 2004, Bull Mem Acad R Med Belg, V159, P219; Nikiforova MN, 2008, J CLIN ENDOCR METAB, V93, P1600, DOI 10.1210/jc.2007-2696; Niwa R, 2007, CURR OPIN GENET DEV, V17, P145, DOI 10.1016/j.gde.2007.02.004; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; OWENS GK, 1995, PHYSIOL REV, V75, P487; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Sanders KM, 2007, J PHYSIOL-LONDON, V578, P33, DOI 10.1113/jphysiol.2006.122473; Schermuly RT, 2005, J CLIN INVEST, V115, P2811, DOI 10.1172/JCI24838; Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Torrado M, 2003, J MOL MED, V81, P566, DOI 10.1007/s00109-003-0470-7; Ueyama T, 2003, MOL CELL BIOL, V23, P9222, DOI 10.1128/MCB.23.24.9222-9232.2003; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; Visone R, 2007, ONCOGENE, V26, P7590, DOI 10.1038/sj.onc.1210564; Weiner JA, 2000, BIOCHEM J, V345, P225, DOI 10.1042/0264-6021:3450225; Wiemer EAC, 2007, EUR J CANCER, V43, P1529, DOI 10.1016/j.ejca.2007.04.002; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com; Yang ZJ, 2007, DNA CELL BIOL, V26, P257, DOI 10.1089/dna.2006.0548; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09; Yoshida T, 2007, AM J PHYSIOL-CELL PH, V292, pC886, DOI 10.1152/ajpcell.00449.2006; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006	67	270	291	0	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3728	3738		10.1074/jbc.M808788200	http://dx.doi.org/10.1074/jbc.M808788200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19088079	Green Published, hybrid			2022-12-25	WOS:000262872500041
J	Benetkiewicz, M; Idbaih, A; Cousin, PY; Boisselier, B; Marie, Y; Criniere, E; Hoang-Xuan, K; Delattre, JY; Sanson, M; Delattre, O				Benetkiewicz, Magdalena; Idbaih, Ahmed; Cousin, Pierre-Yves; Boisselier, Blandine; Marie, Yannick; Criniere, Emmanuelle; Hoang-Xuan, Khe; Delattre, Jean-Yves; Sanson, Marc; Delattre, Olivier			NOTCH2 Is Neither Rearranged nor Mutated in t(1;19) Positive Oligodendrogliomas	PLOS ONE			English	Article							DNA HYPOMETHYLATION; ALLELIC LOSSES; 19Q; 1P; SURVIVAL; REGIONS; TRANSLOCATIONS; ASTROCYTOMAS; CHROMOSOME-1; PREDICTORS	The combined deletion of 1p and 19q chromosomal arms is frequent in oligodendrogliomas (OD) and has recently been shown to be mediated by an unbalanced t(1; 19) translocation. Recent studies of 1p/19q co-deleted OD suggest that the NOTCH2 gene is implicated in oligodendrocyte differentiation and may be involved in this rearrangement. The objective of the present study was to analyze the NOTCH2 locus either as a chromosomal translocation locus that may be altered by the 1p/19q recurrent rearrangement or as a gene that may be inactivated by a two hit process. We performed an array-CGH analysis of 15 ODs presenting 1p/19q co-deletion using a high-density oligonucleotide microarray spanning 1p and 19q pericentromeric regions with 377 bp average probe spacing. We showed that the 1p deletion extends to the centromere of chromosome 1 and includes the entire NOTCH2 gene. No internal rearrangement of this gene was observed. This strongly suggests that the t(1; 19) translocation does not lead to an abnormal NOTCH2 structure. The analysis of the entire NOTCH2 coding sequence was performed in four cases and did not reveal any mutation therefore indicating that NOTCH2 does not harbor genetic characteristics of a tumor suppressor gene. Finally, the detailed analysis of chromosome 19 pericentromeric region led to the identification of two breakpoint clusters at 19p12 and 19q11-12. Interestingly, these two regions share a large stretch of homology. Together with previous observations of similarities between chromosome 1 and 19 alphoid sequences, this suggests that the t(1; 19) translocation arises from complex intra and interchromosomal rearrangements. This is the first comprehensive deletion mapping by high density oligo-array of the 1p/19q co-deletion in oligodendroglioma tumors using a methodological approach superior to others previously applied. As such this paper provides clear evidence that the NOTCH2 gene is not physically rearranged by t(1; 19) translocation of oligodendroglioma tumors.	[Benetkiewicz, Magdalena; Cousin, Pierre-Yves; Delattre, Olivier] INSERM, U830, Paris, France; [Benetkiewicz, Magdalena; Cousin, Pierre-Yves; Delattre, Olivier] Inst Curie, Sect Rech, Unite Genet Biol Canc, Paris, France; [Idbaih, Ahmed; Boisselier, Blandine; Marie, Yannick; Criniere, Emmanuelle; Hoang-Xuan, Khe; Delattre, Jean-Yves; Sanson, Marc] INSERM, Grp Hosp Pitie Salpetriere, Unite 711, Paris, France; [Idbaih, Ahmed; Boisselier, Blandine; Marie, Yannick; Criniere, Emmanuelle; Hoang-Xuan, Khe; Delattre, Jean-Yves; Sanson, Marc] Univ Paris 06, Lab Biol Interact Neurone Glie, Grp Hosp Pitie Salpetriere, Paris, France; [Idbaih, Ahmed; Hoang-Xuan, Khe; Delattre, Jean-Yves; Sanson, Marc] AP HP, Grp Hosp Pitie Salpetriere, Serv Neurol Mazarin, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Benetkiewicz, M (corresponding author), INSERM, U830, Paris, France.	Olivier.Delattre@curie.fr	BOISSELIER, Blandine/K-4377-2015; Hoang-Xuan, Khe/O-7527-2017; Idbaih, Ahmed/N-8746-2017	delattre, olivier/0000-0002-8730-2276; Idbaih, Ahmed/0000-0001-5290-1204	Canceropole Ile-de-France [fellowship]; INCa; INSERM; Ligue Nationale Contre le Cancer (Equipe Labellisee); Carte d'Identite des Tumeurs (CIT) program of the Ligue Nationale Contre le Cancer	Canceropole Ile-de-France(Region Ile-de-France); INCa(Institut National du Cancer (INCA) France); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ligue Nationale Contre le Cancer (Equipe Labellisee)(Ligue nationale contre le cancer); Carte d'Identite des Tumeurs (CIT) program of the Ligue Nationale Contre le Cancer	Magdalena Benetkiewicz is supported by a fellowship from Canceropole Ile-de-France. This work was supported by grants from the INCa, the INSERM and the Ligue Nationale Contre le Cancer (Equipe Labellisee). The BAC-array was supported by grant from the Carte d'Identite des Tumeurs (CIT) program of the Ligue Nationale Contre le Cancer.	Abrey LE, 2006, NEURO-ONCOLOGY, V8, P183, DOI 10.1215/15228517-2005-009; Al-Taie OH, 2002, EUR J HUM GENET, V10, P499, DOI 10.1038/sj.ejhg.5200811; BALDINI A, 1989, GENOMICS, V5, P822, DOI 10.1016/0888-7543(89)90124-9; Barbashina V, 2005, CLIN CANCER RES, V11, P1119; Bigner SH, 1999, AM J PATHOL, V155, P375, DOI 10.1016/S0002-9440(10)65134-6; BLANCO B, 1994, J MED GENET, V31, P74, DOI 10.1136/jmg.31.1.74; Boulay JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000576; Cadieux B, 2006, CANCER RES, V66, P8469, DOI 10.1158/0008-5472.CAN-06-1547; Cairncross JG, 1998, J NATL CANCER I, V90, P1473, DOI 10.1093/jnci/90.19.1473; DiazCastanos L, 1997, GENET COUNSEL, V8, P33; Ehrlich M, 2002, J NUTR, V132, p2424S, DOI 10.1093/jn/132.8.2424S; Ehrlich M, 2003, CANCER GENET CYTOGEN, V141, P97, DOI 10.1016/S0165-4608(02)00668-4; Fan X, 2004, CANCER RES, V64, P7787, DOI 10.1158/0008-5472.CAN-04-1446; Fanelli M, 2008, ONCOGENE, V27, P358, DOI 10.1038/sj.onc.1210642; GRAVHOLT CH, 1992, GENOMICS, V14, P924, DOI 10.1016/S0888-7543(05)80113-2; Gregory SG, 2006, NATURE, V441, P315, DOI 10.1038/nature04727; Griffin CA, 2006, J NEUROPATH EXP NEUR, V65, P988, DOI 10.1097/01.jnen.0000235122.98052.8f; Grimwood J, 2004, NATURE, V428, P529, DOI 10.1038/nature02399; Hoang-Xuan K, 2001, NEUROLOGY, V57, P1278, DOI 10.1212/WNL.57.7.1278; Hu QD, 2003, CELL, V115, P163, DOI 10.1016/S0092-8674(03)00810-9; Idbaih A, 2005, ANN NEUROL, V58, P483, DOI 10.1002/ana.20607; Idbaih A, 2008, INT J CANCER, V122, P1778, DOI 10.1002/ijc.23270; Jenkins RB, 2006, CANCER RES, V66, P9852, DOI 10.1158/0008-5472.CAN-06-1796; Jeuken JWM, 2004, J NEURO-ONCOL, V70, P161, DOI 10.1007/s11060-004-2748-1; Kitange G, 2005, GENE CHROMOSOME CANC, V42, P68, DOI 10.1002/gcc.20108; KRAUS JA, 1995, J NEUROPATH EXP NEUR, V54, P91, DOI 10.1097/00005072-199501000-00011; Locke DP, 2004, J MED GENET, V41, P175, DOI 10.1136/jmg.2003.013813; Nigro JM, 2001, AM J PATHOL, V158, P1253, DOI 10.1016/S0002-9440(10)64076-X; Okamoto Y, 2004, ACTA NEUROPATHOL, V108, P49, DOI 10.1007/s00401-004-0861-z; Reifenberger G, 2003, J NEUROPATH EXP NEUR, V62, P111, DOI 10.1093/jnen/62.2.111; Sawyer JR, 1998, BLOOD, V91, P1732, DOI 10.1182/blood.V91.5.1732.1732_1732_1741; She XW, 2004, NATURE, V430, P857, DOI 10.1038/nature02806; Smith JS, 2000, J CLIN ONCOL, V18, P636, DOI 10.1200/JCO.2000.18.3.636; Smith JS, 1999, ONCOGENE, V18, P4144, DOI 10.1038/sj.onc.1202759; Tsuda H, 2002, AM J PATHOL, V161, P859, DOI 10.1016/S0002-9440(10)64246-0; Wong N, 2001, AM J PATHOL, V159, P465, DOI 10.1016/S0002-9440(10)61718-X	36	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2009	4	1							e4107	10.1371/journal.pone.0004107	http://dx.doi.org/10.1371/journal.pone.0004107			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FR	19119320	Green Published, gold, Green Submitted			2022-12-25	WOS:000265472600007
J	Hashiguchi, Y; Furuta, Y; Nishida, M				Hashiguchi, Yasuyuki; Furuta, Yoshimi; Nishida, Mutsumi			Evolutionary Patterns and Selective Pressures of Odorant/Pheromone Receptor Gene Families in Teleost Fishes	PLOS ONE			English	Article							CHEMOSENSORY RECEPTORS; VOMERONASAL; ODORANT; RECOGNITION; REPERTOIRE; POLYAMINES; PEPTIDES; SYSTEM; MAIN	Background: Teleost fishes do not have a vomeronasal organ (VNO), and their vomeronasal receptors (V1Rs, V2Rs) are expressed in the main olfactory epithelium (MOE), as are odorant receptors (ORs) and trace amine-associated receptors (TAARs). In this study, to obtain insights into the functional distinction among the four chemosensory receptor families in teleost fishes, their evolutionary patterns were examined in zebrafish, medaka, stickleback, fugu, and spotted green pufferfish. Methodology/Principal Findings: Phylogenetic analysis revealed that many lineage-specific gene gains and losses occurred in the teleost fish TAARs, whereas only a few gene gains and losses have taken place in the teleost fish vomeronasal receptors. In addition, synonymous and nonsynonymous nucleotide substitution rate ratios (K-A/K-S) in TAARs tended to be higher than those in ORs and V2Rs. Conclusions/Significance: Frequent gene gains/losses and high K-A/K-S in teleost TAARs suggest that receptors in this family are used for detecting some species-specific chemicals such as pheromones. Conversely, conserved repertoires of V1R and V2R families in teleost fishes may imply that receptors in these families perceive common odorants for teleosts, such as amino acids. Teleost ORs showed intermediate evolutionary pattern between TAARs and vomeronasal receptors. Many teleost ORs seem to be used for common odorants, but some ORs may have evolved to recognize lineage-specific odors.	[Hashiguchi, Yasuyuki; Furuta, Yoshimi; Nishida, Mutsumi] Univ Tokyo, Ocean Res Inst, Div Mol Marine Biol, Tokyo, Japan	University of Tokyo	Hashiguchi, Y (corresponding author), Univ Tokyo, Ocean Res Inst, Div Mol Marine Biol, Tokyo, Japan.	yhashi@ori.u-tokyo.ac.jp	Hashiguchi, Yasuyuki/AAA-4179-2019		Japan Society for Promotion of Science [19207707]	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The authors are supported by Grant-in-Aid from the Japan Society for Promotion of Science (no. 19207707). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alioto TS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-173; Asano-Miyoshi M, 2000, J BIOCHEM, V127, P915, DOI 10.1093/oxfordjournals.jbchem.a022687; Baxi KN, 2006, TRENDS NEUROSCI, V29, P1, DOI 10.1016/j.tins.2005.10.002; Boschat C, 2002, NAT NEUROSCI, V5, P1261, DOI 10.1038/nn978; Cao YX, 1998, P NATL ACAD SCI USA, V95, P11987, DOI 10.1073/pnas.95.20.11987; Del Punta K, 2002, NATURE, V419, P70, DOI 10.1038/nature00955; Grus WE, 2008, MOL BIOL EVOL, V25, P1593, DOI 10.1093/molbev/msn107; Hansen A, 2003, J NEUROSCI, V23, P9328; HARA TJ, 1994, ACTA PHYSIOL SCAND, V152, P207, DOI 10.1111/j.1748-1716.1994.tb09800.x; Hashiguchi Y, 2007, MOL BIOL EVOL, V24, P2099, DOI 10.1093/molbev/msm140; Hashiguchi Y, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-76; Hubbard PC, 2003, CHEM SENSES, V28, P207, DOI 10.1093/chemse/28.3.207; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kimoto H, 2005, NATURE, V437, P898, DOI 10.1038/nature04033; Leinders-Zufall T, 2004, SCIENCE, V306, P1033, DOI 10.1126/science.1102818; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Michel WC, 2003, J EXP BIOL, V206, P1697, DOI 10.1242/jeb.00339; Milinski M, 2005, P NATL ACAD SCI USA, V102, P4414, DOI 10.1073/pnas.0408264102; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; NEI M, 1986, MOL BIOL EVOL, V3, P418; Niimura Y, 2005, P NATL ACAD SCI USA, V102, P6039, DOI 10.1073/pnas.0501922102; Rafferty NE, 2006, BEHAV ECOL, V17, P965, DOI 10.1093/beheco/arl030; Rolen SH, 2003, J EXP BIOL, V206, P1683, DOI 10.1242/jeb.00338; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Saraiva LR, 2007, GENOME RES, V17, P1448, DOI 10.1101/gr.6553207; Sorensen PW, 2005, CHEM SENSES, V30, pI315, DOI 10.1093/chemse/bjh241; Spehr M, 2006, J NEUROSCI, V26, P1961, DOI 10.1523/JNEUROSCI.4939-05.2006; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Yamanoue Y, 2006, GENES GENET SYST, V81, P29, DOI 10.1266/ggs.81.29	29	37	38	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4083	10.1371/journal.pone.0004083	http://dx.doi.org/10.1371/journal.pone.0004083			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DO	19116654	Green Published, Green Submitted, gold			2022-12-25	WOS:000265466600006
J	Smith, L; Willan, J; Warr, N; Brook, FA; Cheeseman, M; Sharpe, R; Siggers, P; Greenfield, A				Smith, Lee; Willan, John; Warr, Nick; Brook, Frances A.; Cheeseman, Michael; Sharpe, Richard; Siggers, Pam; Greenfield, Andy			The Maestro (Mro) Gene Is Dispensable for Normal Sexual Development and Fertility in Mice	PLOS ONE			English	Article								The mammalian gonad arises as a bipotential primordium from which a testis or ovary develops depending on the chromosomal sex of the individual. We have previously used DNA microarrays to screen for novel genes controlling the developmental fate of the indifferent embryonic mouse gonad. Maestro (Mro), which encodes a HEAT-repeat protein, was originally identified as a gene exhibiting sexually dimorphic expression during mouse gonad development. Wholemount in situ hybridisation analysis revealed Mro to be expressed in the embryonic male gonad from approximately 11.5 days post coitum, prior to overt sexual differentiation. No significant expression was detected in female gonads at the same developmental stage. In order to address its physiological function, we have generated mice lacking Maestro using gene targeting. Male and female mice homozygous for a Mro null allele are viable and fertile. We examined gonad development in homozygous male embryos in detail and observed no differences when compared to wild-type controls. Immunohistochemical analysis of homozygous mutant testes of adult mice revealed no overt abnormalities. Expression profiling using DNA microarrays also indicated no significant differences between homozygote embryonic male gonads and controls. We conclude that Maestro is dispensable for normal male sexual development and fertility in laboratory mice; however, the Mro locus itself does have utility as a site for insertion of transgenes for future studies in the fields of sexual development and Sertoli cell function.	[Smith, Lee; Willan, John; Warr, Nick; Cheeseman, Michael; Siggers, Pam; Greenfield, Andy] MRC Harwell, Mammal Genet Unit, Oxford, England; [Brook, Frances A.] Univ Oxford, Dept Zool, Oxford OX1 2JD, England; [Sharpe, Richard] Queens Med Res Inst, MRC Human Reproduct Sci Unit, Edinburgh, Midlothian, Scotland	MRC Harwell; University of Oxford; University of Edinburgh	Smith, L (corresponding author), Queens Med Res Inst, MRC Human Reprod Sci Unit, Edinburgh, Midlothian, Scotland.	l.smith@hrsu.mrc.ac.uk	Sharpe, Richard M/D-2725-2013; willan, john/ABD-8708-2020; Willan, John/AAP-7309-2020; Smith, Lee B/J-4861-2013; Greenfield, Andy/F-5099-2017	Sharpe, Richard M/0000-0003-1686-8085; Willan, John/0000-0001-8700-2073; Warr, Nick/0000-0003-0767-1360; Smith, Lee/0000-0002-4103-3074; Greenfield, Andy/0000-0002-1477-1776	UK Medical Research Council [U.1426.00.004.00001.01]; MRC [MC_UP_1502/1, MC_U142670371, MC_U127685841, MC_U142684167] Funding Source: UKRI; Medical Research Council [MC_UP_1502/1, MC_U142684167, MC_U142670371, MC_U127685841] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the UK Medical Research Council through Unit funding to AG (ref# U.1426.00.004.00001.01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams IR, 2002, DEVELOPMENT, V129, P1155; ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; Beverdam A, 2006, HUM MOL GENET, V15, P417, DOI 10.1093/hmg/ddi463; Bouma GJ, 2007, GENE EXPR PATTERNS, V7, P113, DOI 10.1016/j.modgep.2006.05.011; Bouma GJ, 2004, GENE EXPR PATTERNS, V5, P141, DOI 10.1016/j.modgep.2004.05.001; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Brennan J, 2004, NAT REV GENET, V5, P509, DOI 10.1038/nrg1381; Brook FA, 1997, P NATL ACAD SCI USA, V94, P5709, DOI 10.1073/pnas.94.11.5709; Capel B, 1999, MECH DEVELOP, V84, P127, DOI 10.1016/S0925-4773(99)00047-7; De Gendt K, 2005, ENDOCRINOLOGY, V146, P4117, DOI 10.1210/en.2005-0300; Fisher JS, 2003, HUM REPROD, V18, P1383, DOI 10.1093/humrep/deg273; Grimmond S, 2000, HUM MOL GENET, V9, P1553, DOI 10.1093/hmg/9.10.1553; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Lovell-Badge R, 2002, NOVART FDN SYMP, V244, P4; Malki S, 2005, EMBO J, V24, P1798, DOI 10.1038/sj.emboj.7600660; Nef S, 2005, DEV BIOL, V287, P361, DOI 10.1016/j.ydbio.2005.09.008; Olson Mark O J, 2004, Sci STKE, V2004, ppe10; Olson MOJ, 2000, TRENDS CELL BIOL, V10, P189, DOI 10.1016/S0962-8924(00)01738-4; Petalidis L, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng142; Scherer G, 2002, NOVART FDN SYMP, V244, P225; Siggers P, 2002, MECH DEVELOP, V111, P159, DOI 10.1016/S0925-4773(01)00602-5; Smith L, 2003, DEV DYNAM, V227, P600, DOI 10.1002/dvdy.10342; Smith L, 2003, HUM MOL GENET, V12, pR1, DOI 10.1093/hmg/ddg053; Wilhelm D, 2006, NAT REV GENET, V7, P620, DOI 10.1038/nrg1903; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15	27	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4091	10.1371/journal.pone.0004091	http://dx.doi.org/10.1371/journal.pone.0004091			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DO	19116663	Green Published, gold, Green Submitted			2022-12-25	WOS:000265466600012
J	Cherian, S; Forbes, DA; Cook, AG; Sanfilippo, FM; Kemna, EH; Swinkels, DW; Burgner, DP				Cherian, Sarah; Forbes, David A.; Cook, Angus G.; Sanfilippo, Frank M.; Kemna, Erwin H.; Swinkels, Dorine W.; Burgner, David P.			An Insight into the Relationships between Hepcidin, Anemia, Infections and Inflammatory Cytokines in Pediatric Refugees: A Cross-Sectional Study	PLOS ONE			English	Article							IRON-DEFICIENCY ANEMIA; HELICOBACTER-PYLORI INFECTION; HIGH-PREVALENCE; SERUM HEPCIDIN; CHILDREN; FERRITIN; HYPOFERREMIA; ADOLESCENTS; FERROPORTIN; HEMOJUVELIN	Background: Hepcidin, a key regulator of iron homeostasis, is increased in response to inflammation and some infections, but the in vivo role of hepcidin, particularly in children with iron deficiency anemia (IDA) is unclear. We investigated the relationships between hepcidin, cytokines and iron status in a pediatric population with a high prevalence of both anemia and co-morbid infections. Methodology/Principal Findings: African refugee children,16 years were consecutively recruited at the initial post-resettlement health check with 181 children meeting inclusion criteria. Data on hematological parameters, cytokine levels and co-morbid infections (Helicobacter pylori, helminth and malaria) were obtained and urinary hepcidin assays performed. The primary outcome measure was urinary hepcidin levels in children with and without iron deficiency ( ID) and/or ID anaemia (IDA). The secondary outcome measures included were the relationship between co-morbid infections and (i) ID and IDA, (ii) urinary hepcidin levels and (iii) cytokine levels. IDA was present in 25/181 (13.8%). Children with IDA had significantly lower hepcidin levels (IDA median hepcidin 0.14 nmol/mmol Cr (interquartile range 0.05-0.061) versus non-IDA 2.96 nmol/mmol Cr, (IQR 0.95-6.72), p<0.001). Hemoglobin, log-ferritin, iron, mean cell volume (MCV) and transferrin saturation were positively associated with log-hepcidin levels (log-ferritin beta coefficient (beta): 1.30, 95% CI 1.02 to 1.57) and transferrin was inversely associated (beta: -0.12, 95% CI -0.15 to -0.08). Cytokine levels (including IL-6) and co-morbid infections were not associated with IDA or hepcidin levels. Conclusions/Significance: This is the largest pediatric study of the in vivo associations between hepcidin, iron status and cytokines. Gastro-intestinal infections (H. pylori and helminths) did not elevate urinary hepcidin or IL-6 levels in refugee children, nor were they associated with IDA. Longitudinal and mechanistic studies of IDA will further elucidate the role of hepcidin in paediatric iron regulation.	[Forbes, David A.; Burgner, David P.] Univ Western Australia, Sch Pediat & Child Hlth, Perth, WA 6009, Australia; [Cherian, Sarah; Forbes, David A.; Burgner, David P.] Princess Margaret Hosp Children, Pediat Infect Dis & Refugee Hlth, Perth, WA, Australia; [Cherian, Sarah; Cook, Angus G.; Sanfilippo, Frank M.] Univ Western Australia, Sch Populat Hlth, Perth, WA, Australia; [Kemna, Erwin H.; Swinkels, Dorine W.] Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Clin Chem, Nijmegen, Netherlands	University of Western Australia; University of Western Australia; University of Western Australia; Radboud University Nijmegen	Cherian, S (corresponding author), Univ Western Australia, Sch Pediat & Child Hlth, Perth, WA 6009, Australia.	dburgner@meddent.uwa.edu.au	Cherian, Sarah/ABA-6207-2021; Sanfilippo, Frank M/H-9334-2013; Swinkels, Dorine W./H-8098-2014; Cherian, /411001/H-1332-2016	Sanfilippo, Frank M/0000-0003-3639-0787; Swinkels, Dorine W./0000-0002-1040-9446; Burgner, David/0000-0002-8304-4302; Cook, Angus/0000-0002-1758-6496	University of Western Australia; Royal Australasian College of Physicians; Princess Margaret Foundation	University of Western Australia; Royal Australasian College of Physicians(General Electric); Princess Margaret Foundation	SC received a 2007 University of Western Australia Research Grant, a 2007 Royal Australasian College of Physicians Grant and a 2007 Princess Margaret Foundation Seeding Grant for laboratory assays and consumables.Faecal antigen kits were supplied by Dako, Denmark and Oxoid, Australia to the investigating team without charge or with any other provision of research funding. Neither company had any input or influence into the study design, data collection and analysis, interpretation, decision to publish or preparation of this manuscript.	[Anonymous], 1998, MMWR Recomm Rep, V47, P1; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Baggett HC, 2006, PEDIATRICS, V117, pE396, DOI 10.1542/peds.2005-1129; Cardamone M, 2008, J PAEDIATR CHILD H, V44, P647, DOI 10.1111/j.1440-1754.2008.01374.x; Chaston T, 2008, GUT, V57, DOI 10.1136/gut.2007.131722; Cherian S, 2008, J PEDIATR GASTR NUTR, V47, P130, DOI 10.1097/MPG.0b013e31815bc5b3; Cherian S, 2008, MED J AUSTRALIA, V189, P438, DOI 10.5694/j.1326-5377.2008.tb02116.x; Choe YH, 2003, J GASTROEN HEPATOL, V18, P980, DOI 10.1046/j.1440-1746.2003.03098.x; Dale JC, 2002, AM J CLIN PATHOL, V117, P802, DOI 10.1309/2YT4-CMP3-KYW7-9RK1; DEMAST Q, 2008, J INFECT DI IN PRESS; Detivaud L, 2005, BLOOD, V106, P746, DOI 10.1182/blood-2004-12-4855; DiGirolamo AM, 2007, PEDIATR INFECT DIS J, V26, P927, DOI 10.1097/INF.0b013e31812e52cd; DuBois S, 2005, AM J GASTROENTEROL, V100, P453, DOI 10.1111/j.1572-0241.2005.30252.x; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Fleming RE, 2008, J MOL MED, V86, P491, DOI 10.1007/s00109-008-0349-8; Ganz T, 2006, AM J PHYSIOL-GASTR L, V290, pG199, DOI 10.1152/ajpgi.00412.2005; *GEN DIAGN LTD, 2003, HPG SCREEN ELISA KIT; *GOV W AUSTR, 2006, MIGR HLTH SCREEN PRO, P1; Harris PR, 2008, GASTROENTEROLOGY, V134, P491, DOI 10.1053/j.gastro.2007.11.006; Hopkins RM, 1997, MED J AUSTRALIA, V166, P241, DOI 10.5694/j.1326-5377.1997.tb140103.x; Howard CT, 2007, AM J TROP MED HYG, V77, P623, DOI 10.4269/ajtmh.2007.77.623; Karr MA, 2001, MED J AUSTRALIA, V174, P165, DOI 10.5694/j.1326-5377.2001.tb143208.x; Kato A, 2008, AM J NEPHROL, V28, P115, DOI 10.1159/000109968; Kawabata H, 2007, HAEMATOLOGICA, V92, P857, DOI 10.3324/haematol.10794; Kearney SL, 2007, PEDIATR BLOOD CANCER, V48, P57, DOI 10.1002/pbc.20616; Kemna E, 2005, BLOOD, V106, P3268, DOI 10.1182/blood-2005-05-1873; Kemna E, 2005, BLOOD, V106, P1864, DOI 10.1182/blood-2005-03-1159; Kemna EHJM, 2008, BLOOD CELL MOL DIS, V40, P339, DOI 10.1016/j.bcmd.2007.10.002; Kemna EHJM, 2007, HAEMATOLOGICA, V93, P90, DOI 10.3324/haematol.11705; Kemna EHJM, 2007, CLIN CHEM, V53, P620, DOI 10.1373/clinchem.2006.079186; Lin L, 2005, BLOOD, V106, P2884, DOI 10.1182/blood-2005-05-1845; Lozoff B, 2006, ARCH PEDIAT ADOL MED, V160, P1108, DOI 10.1001/archpedi.160.11.1108; Malfertheiner P, 2007, GUT, V56, P772, DOI 10.1136/gut.2006.101634; Martin JA, 2006, MED J AUSTRALIA, V185, P607, DOI 10.5694/j.1326-5377.2006.tb00726.x; McCann JC, 2007, AM J CLIN NUTR, V85, P931, DOI 10.1093/ajcn/85.4.931; McGillivray G, 2007, ARCH DIS CHILD, V92, P1088, DOI 10.1136/adc.2006.112813; Nahon S, 2003, HELICOBACTER, V8, P573, DOI 10.1111/j.1523-5378.2003.00184.x; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nguyen ND, 2004, J PAEDIATR CHILD H, V40, P424, DOI 10.1111/j.1440-1754.2004.00423.x; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Origa R, 2007, HAEMATOL-HEMATOL J, V92, P583, DOI 10.3324/haematol.10842; Oti-Boateng P, 1998, J PAEDIATR CHILD H, V34, P250, DOI 10.1046/j.1440-1754.1998.00205.x; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Pellicano R, 2004, PANMINERVA MED, V46, P165; Rivera S, 2005, BLOOD, V106, P2196, DOI 10.1182/blood-2005-04-1766; SCHWARTZ E, 2007, NELSONS TXB PEDIAT; Silvestri L, 2008, BLOOD, V111, P924, DOI 10.1182/blood-2007-07-100677; Suoglu OD, 2007, PEDIATR INT, V49, P858, DOI 10.1111/j.1442-200X.2007.02444.x; Swinkels DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002706; Theurl I, 2006, BLOOD, V107, P4142, DOI 10.1182/blood-2005-08-3364; van Dijk BAC, 2008, BRIT J HAEMATOL, V142, P979, DOI 10.1111/j.1365-2141.2008.07273.x; van Dijk BAC, 2007, BLOOD, V109, P5525, DOI 10.1182/blood-2006-11-058560; Velayudhan J, 2000, MOL MICROBIOL, V37, P274, DOI 10.1046/j.1365-2958.2000.01987.x; Weinstein DA, 2002, BLOOD, V100, P3776, DOI 10.1182/blood-2002-04-1260; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; *WOM CHILDR PATH H, 2003, HAEM DEP REF RANG BI; World Health Organization, 2001, INT CLASS FUNCT DIS, P1	59	66	69	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4030	10.1371/journal.pone.0004030	http://dx.doi.org/10.1371/journal.pone.0004030			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107209	Green Published, gold			2022-12-25	WOS:000265463000023
J	Lorkovic, ZJ; Barta, A				Lorkovic, Zdravko J.; Barta, Andrea			Role of Cajal Bodies and Nucleolus in the Maturation of the U1 snRNP in Arabidopsis	PLOS ONE			English	Article								Background: The biogenesis of spliceosomal snRNPs takes place in both the cytoplasm where Sm core proteins are added and snRNAs are modified at the 5' and 3' termini and in the nucleus where snRNP-specific proteins associate. U1 snRNP consists of U1 snRNA, seven Sm proteins and three snRNP-specific proteins, U1-70K, U1A, and U1C. It has been shown previously that after import to the nucleus U2 and U4/U6 snRNP-specific proteins first appear in Cajal bodies ( CB) and then in splicing speckles. In addition, in cells grown under normal conditions U2, U4, U5, and U6 snRNAs/snRNPs are abundant in CBs. Therefore, it has been proposed that the final assembly of these spliceosomal snRNPs takes place in this nuclear compartment. In contrast, U1 snRNA in both animal and plant cells has rarely been found in this nuclear compartment. Methodology/Principal Findings: Here, we analysed the subnuclear distribution of Arabidopsis U1 snRNP-specific proteins fused to GFP or mRFP in transiently transformed Arabidopsis protoplasts. Irrespective of the tag used, U1-70K was exclusively found in the nucleus, whereas U1A and U1C were equally distributed between the nucleus and the cytoplasm. In the nucleus all three proteins localised to CBs and nucleoli although to different extent. Interestingly, we also found that the appearance of the three proteins in nuclear speckles differ significantly. U1-70K was mostly found in speckles whereas U1A and U1C in similar to 90% of cells showed diffuse nucleoplasmic in combination with CBs and nucleolar localisation. Conclusions/Significance: Our data indicate that CBs and nucleolus are involved in the maturation of U1 snRNP. Differences in nuclear accumulation and distribution between U1-70K and U1A and U1C proteins may indicate that either U1-70K or U1A and U1C associate with, or is/are involved, in other nuclear processes apart from pre-mRNA splicing.	[Barta, Andrea] Med Univ Vienna, Dept Med Biochem, Max F Perutz Labs, Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Lorkovic, ZJ (corresponding author), Med Univ Vienna, Dept Med Biochem, Max F Perutz Labs, Vienna, Austria.	zdravko.lorkovic@meduniwien.ac.at		Barta, Andrea/0000-0002-8851-406X; Lorkovic, Zdravko/0000-0002-3074-7258	Oesterreichischer Fonds zur Forderung der wissenschaftlichen Forschung (FWF) [SFB-F017/10/11]; EURASNET	Oesterreichischer Fonds zur Forderung der wissenschaftlichen Forschung (FWF)(Austrian Science Fund (FWF)); EURASNET	This work was supported by grants from the Oesterreichischer Fonds zur Forderung der wissenschaftlichen Forschung (FWF) to Andrea Barta (SFB-F017/10/11) and EURASNET.	Acevedo R, 2002, CHROMOSOMA, V110, P559, DOI 10.1007/s00412-001-0178-9; Ali GS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001953; ANDRADE LEC, 1993, P NATL ACAD SCI USA, V90, P1947, DOI 10.1073/pnas.90.5.1947; BEVEN AF, 1995, J CELL SCI, V108, P509; Boudonck K, 1998, J CELL SCI, V111, P3687; Boudonck K, 1999, MOL BIOL CELL, V10, P2297, DOI 10.1091/mbc.10.7.2297; Carmo-Fonseca M, 2002, EMBO REP, V3, P726, DOI 10.1093/embo-reports/kvf154; CARMOFONSECA M, 1991, EMBO J, V10, P1863, DOI 10.1002/j.1460-2075.1991.tb07712.x; CARMOFONSECA M, 1991, EMBO J, V10, P195, DOI 10.1002/j.1460-2075.1991.tb07936.x; CARMOFONSECA M, 1992, J CELL BIOL, V117, P11; Cioce M, 2005, ANNU REV CELL DEV BI, V21, P105, DOI 10.1146/annurev.cellbio.20.010403.103738; Darzacq X, 2002, EMBO J, V21, P2746, DOI 10.1093/emboj/21.11.2746; Du HS, 2002, NATURE, V419, P86, DOI 10.1038/nature00947; Gall JG, 2003, NAT REV MOL CELL BIO, V4, P975, DOI 10.1038/nrm1262; Gall JG, 2000, ANNU REV CELL DEV BI, V16, P273, DOI 10.1146/annurev.cellbio.16.1.273; Gall JG, 2001, FEBS LETT, V498, P164, DOI 10.1016/S0014-5793(01)02461-9; Guan F, 2003, MOL CELL BIOL, V23, P3163, DOI 10.1128/MCB.23.9.3163-3172.2003; Gubitz AK, 2004, EXP CELL RES, V296, P51, DOI 10.1016/j.yexcr.2004.03.022; Gunnewiek JMTK, 1997, EXP CELL RES, V235, P265, DOI 10.1006/excr.1997.3663; Hetzer M, 2000, J CELL BIOL, V148, P293, DOI 10.1083/jcb.148.2.293; Hieda M, 2001, J BIOL CHEM, V276, P16824, DOI 10.1074/jbc.M008299200; Hoet RMA, 1998, MOL IMMUNOL, V35, P1045, DOI 10.1016/S0161-5890(98)00093-5; Jady BE, 2003, EMBO J, V22, P1878, DOI 10.1093/emboj/cdg187; Jady BE, 2001, EMBO J, V20, P541, DOI 10.1093/emboj/20.3.541; JANTSCH MF, 1992, J CELL BIOL, V119, P1037, DOI 10.1083/jcb.119.5.1037; KAMBACH C, 1994, J CELL SCI, V107, P1807; KAMBACH C, 1992, J CELL BIOL, V118, P11, DOI 10.1083/jcb.118.1.11; Kiss T, 2004, J CELL SCI, V117, P5949, DOI 10.1242/jcs.01487; Lambermon MHL, 2000, EMBO J, V19, P1638, DOI 10.1093/emboj/19.7.1638; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lorkovic ZJ, 2008, EXP CELL RES, V314, P3175, DOI 10.1016/j.yexcr.2008.06.020; Lorkovic ZJ, 2000, RNA, V6, P1610, DOI 10.1017/S1355838200001163; Lorkovic ZJ, 2005, RNA, V11, P1095, DOI 10.1261/rna.2440305; Lorkovic ZJ, 2004, J BIOL CHEM, V279, P33890, DOI 10.1074/jbc.M400270200; Lorkovic ZJ, 2004, MOL BIOL CELL, V15, P3233, DOI 10.1091/mbc.E04-01-0055; LUHRMANN R, 1982, NUCLEIC ACIDS RES, V10, P7103, DOI 10.1093/nar/10.22.7103; Ma JL, 2006, RNA, V12, P122, DOI 10.1261/rna.2159506; MATERA AG, 1993, J CELL BIOL, V121, P715, DOI 10.1083/jcb.121.4.715; Matera AG, 2006, CURR OPIN CELL BIOL, V18, P317, DOI 10.1016/j.ceb.2006.03.005; Nesic D, 2004, J CELL SCI, V117, P4423, DOI 10.1242/jcs.01308; Ogg SC, 2002, J CELL BIOL, V159, P17, DOI 10.1083/jcb.200206111; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; Pendle AF, 2005, MOL BIOL CELL, V16, P260, DOI 10.1091/mbc.E04-09-0791; Platani M, 2000, J CELL BIOL, V151, P1561, DOI 10.1083/jcb.151.7.1561; ROMAC JM, 1993, MOL CELL BIOL, V14, P4662; SIMPSON GG, 1995, EMBO J, V14, P4540, DOI 10.1002/j.1460-2075.1995.tb00133.x; Sleeman JE, 1999, CURR BIOL, V9, P1065, DOI 10.1016/S0960-9822(99)80475-8; Sleeman JE, 2001, J CELL SCI, V114, P4407; Stanek D, 2004, J CELL BIOL, V166, P1015, DOI 10.1083/jcb.200405160; Stanek D, 2003, J CELL BIOL, V160, P505, DOI 10.1083/jcb.200210087; Stanek D, 2006, CHROMOSOMA, V115, P343, DOI 10.1007/s00412-006-0056-6; Tanackovic G, 2005, MOL BIOL CELL, V16, P1366, DOI 10.1091/mbc.E04-11-1034; Will CL, 2004, RNA, V10, P929, DOI 10.1261/rna.7320604; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; WU ZG, 1991, J CELL BIOL, V113, P465, DOI 10.1083/jcb.113.3.465; Yu YT, 1998, EMBO J, V17, P5783, DOI 10.1093/emboj/17.19.5783; Yu YT, 2001, J CELL BIOL, V152, P1279, DOI 10.1083/jcb.152.6.1279; Zhao XL, 2004, RNA, V10, P681, DOI 10.1261/rna.5159504	58	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2008	3	12							e3989	10.1371/journal.pone.0003989	http://dx.doi.org/10.1371/journal.pone.0003989			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CA	19098980	Green Published, gold, Green Submitted			2022-12-25	WOS:000265462300002
J	McIntyre, KM; Gubbins, S; Goldmann, W; Hunter, N; Baylis, M				McIntyre, K. Marie; Gubbins, Simon; Goldmann, Wilfred; Hunter, Nora; Baylis, Matthew			Epidemiological Characteristics of Classical Scrapie Outbreaks in 30 Sheep Flocks in the United Kingdom	PLOS ONE			English	Article							PRP GENOTYPE; NATURAL SCRAPIE; GREAT-BRITAIN; BRITISH SHEEP; TRANSMISSION FACTORS; CLOSED FLOCK; SUSCEPTIBILITY; GENE; ASSOCIATION; FREQUENCIES	Background: Most previous analyses of scrapie outbreaks have focused on flocks run by research institutes, which may not reflect the field situation. Within this study, we attempt to rectify this deficit by describing the epidemiological characteristics of 30 sheep flocks naturally-infected with classical scrapie, and by exploring possible underlying causes of variation in the characteristics between flocks, including flock-level prion protein (PrP) genotype profile. In total, the study involved PrP genotype data for nearly 8600 animals and over 400 scrapie cases. Methodology/Principal Findings: We found that most scrapie cases were restricted to just two PrP genotypes (ARQ/VRQ and VRQ/VRQ), though two flocks had markedly different affected genotypes, despite having similar underlying genotype profiles to other flocks of the same breed; we identified differences amongst flocks in the age of cases of certain PrP genotypes; we found that the age-at-onset of clinical signs depended on peak incidence and flock type; we found evidence that purchasing infected animals is an important means of introducing scrapie to a flock; we found some evidence that flock-level PrP genotype profile and flock size account for variation in outbreak characteristics; identified seasonality in cases associated with lambing time in certain flocks; and we identified one case that was homozygous for phenylalanine at codon 141, a polymorphism associated with a very high risk of atypical scrapie, and 28 cases that were heterozygous at this codon. Conclusions/Significance: This paper presents the largest study to date on commercially-run sheep flocks naturally-infected with classical scrapie, involving 30 study flocks, more than 400 scrapie cases and over 8500 PrP genotypes. We show that some of the observed variation in epidemiological characteristics between farms is related to differences in their PrP genotype profile; although much remains unexplained and may instead be attributed to the stochastic nature of scrapie dynamics.	[Gubbins, Simon] Inst Anim Hlth, Pirbright Lab, Pirbright, Surrey, England; [Goldmann, Wilfred; Hunter, Nora] Univ Edinburgh, RDSVS, Edinburgh EH8 9YL, Midlothian, Scotland; [Goldmann, Wilfred; Hunter, Nora] Univ Edinburgh, Roslin Inst, Neuropathogenesis Div, Edinburgh EH8 9YL, Midlothian, Scotland; [Baylis, Matthew] Univ Liverpool, Liverpool L69 3BX, Merseyside, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Liverpool	McIntyre, KM (corresponding author), Inst Anim Hlth, Pirbright Lab, Pirbright, Surrey, England.	simon.gubbins@bbsrc.ac.uk	Baylis, Matthew/S-7694-2019; McIntyre, (Kirsty) Marie/B-6907-2013	Baylis, Matthew/0000-0003-0335-187X; Gubbins, Simon/0000-0003-0538-4173; McIntyre, Kirsty Marie/0000-0003-1360-122X	Biotechnology and Biological Sciences Research Council (BBSRC) [BS309857, IAH1055, IAH1320]; Biotechnology and Biological Sciences Research Council [BBS/E/D/05241340, BBS/E/A/00001651, BBS/E/I/00001055, BBS/E/I/00001320] Funding Source: researchfish; BBSRC [BBS/E/A/00001651, BBS/E/D/05241340, BBS/E/I/00001320] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) [grant numbers BS309857, IAH1055, IAH1320]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Baylis M, 2004, J GEN VIROL, V85, P2735, DOI 10.1099/vir.0.79876-0; Baylis M, 2004, CURR MOL MED, V4, P385, DOI 10.2174/1566524043360672; Baylis M, 2002, J GEN VIROL, V83, P2907, DOI 10.1099/0022-1317-83-11-2907; Baylis M, 2000, P ROY SOC B-BIOL SCI, V267, P2029, DOI 10.1098/rspb.2000.1245; BELT PBGM, 1995, J GEN VIROL, V76, P509, DOI 10.1099/0022-1317-76-3-509; Benestad SL, 2003, VET REC, V153, P202, DOI 10.1136/vr.153.7.202; Collett D, 1994, MODELLING SURVIVAL D; Dawson M, 1998, VET REC, V142, P623; Diaz C, 2005, J GEN VIROL, V86, P849, DOI 10.1099/vir.0.80412-0; Elsen JM, 1999, ARCH VIROL, V144, P431, DOI 10.1007/s007050050516; *EUR FOOD SAF AUTH, 2005, EFSA J, V276, P1; FOSTER JD, 1989, VET REC, V125, P415, DOI 10.1136/vr.125.16.415; Goldmann W, 2005, J APPL MICROBIOL, V98, P1294, DOI 10.1111/j.1365-2672.2005.02568.x; GOLDMANN W, 1994, J GEN VIROL, V75, P989, DOI 10.1099/0022-1317-75-5-989; Goldmann W, 2006, J GEN VIROL, V87, P3741, DOI 10.1099/vir.0.82083-0; Gubbins S, 2006, PREV VET MED, V73, P17, DOI 10.1016/j.prevetmed.2005.08.001; Gubbins S, 2005, PREV VET MED, V67, P143, DOI 10.1016/j.prevetmed.2004.08.007; Hagenaars TJ, 2003, EPIDEMIOL INFECT, V131, P1015, DOI 10.1017/S0950268803001055; Hagenaars TJ, 2001, EPIDEMIOL INFECT, V127, P157, DOI 10.1017/S0950268801005738; Healy AM, 2004, VET REC, V155, P493, DOI 10.1136/vr.155.16.493; Hoinville LJ, 2000, VET REC, V146, P455, DOI 10.1136/vr.146.16.455; Hopp P, 2001, PREV VET MED, V51, P183, DOI 10.1016/S0167-5877(01)00225-2; Houston EF, 2003, VET REC, V152, P333, DOI 10.1136/vr.152.11.333; Hunter N, 1998, J GEN VIROL, V79, P2079, DOI 10.1099/0022-1317-79-8-2079; Hunter N, 1997, VET REC, V140, P59, DOI 10.1136/vr.140.3.59; Hunter N, 1996, ARCH VIROL, V141, P809, DOI 10.1007/BF01718157; Luhken G, 2004, ARCH VIROL, V149, P1571, DOI 10.1007/s00705-004-0303-1; Matthews L, 1999, P ROY SOC B-BIOL SCI, V266, P1085, DOI 10.1098/rspb.1999.0747; McIntyre K Marie, 2006, BMC Vet Res, V2, P20, DOI 10.1186/1746-6148-2-20; McIntyre K Marie, 2006, BMC Vet Res, V2, P25, DOI 10.1186/1746-6148-2-25; McLean AR, 1999, P ROY SOC B-BIOL SCI, V266, P2531, DOI 10.1098/rspb.1999.0956; Moum T, 2005, J GEN VIROL, V86, P231, DOI 10.1099/vir.0.80437-0; Parry H.B., 1983, SCRAPIE DIS SHEEP HI; Redman CA, 2002, EPIDEMIOL INFECT, V128, P513, DOI 10.1017/S0950268802007008; Saunders GC, 2006, J GEN VIROL, V87, P3141, DOI 10.1099/vir.0.81779-0; Sivam SK, 2006, VET REC, V158, P501, DOI 10.1136/vr.158.15.501; Sokal R. R., 1981, BIOMETRY; Tongue SC, 2006, VET REC, V158, P43, DOI 10.1136/vr.158.2.43; Touzeau S, 2006, ARCH VIROL, V151, P735, DOI 10.1007/s00705-005-0666-y; Vaccari G, 2007, J VIROL, V81, P7306, DOI 10.1128/JVI.02880-06; Vilas VJDR, 2006, VET REC, V159, P799; Woolhouse MEJ, 1998, P ROY SOC B-BIOL SCI, V265, P1205, DOI 10.1098/rspb.1998.0421; Woolhouse MEJ, 2001, TRENDS MICROBIOL, V9, P67, DOI 10.1016/S0966-842X(00)01912-0	44	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2008	3	12							e3994	10.1371/journal.pone.0003994	http://dx.doi.org/10.1371/journal.pone.0003994			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CA	19098982	Green Published, gold, Green Submitted			2022-12-25	WOS:000265462300006
J	Habuchi, S; Tsutsui, H; Kochaniak, AB; Miyawaki, A; van Oijen, AM				Habuchi, Satoshi; Tsutsui, Hidekazu; Kochaniak, Anna B.; Miyawaki, Atsushi; van Oijen, Antoine M.			mKikGR, a Monomeric Photoswitchable Fluorescent Protein	PLOS ONE			English	Article							PHOTOINDUCED PEPTIDE CLEAVAGE; TO-RED CONVERSION; PHOTOCONVERSION; MICROSCOPY; RESOLUTION; PROBES; GFP	The recent demonstration and utilization of fluorescent proteins whose fluorescence can be switched on and off has greatly expanded the toolkit of molecular and cell biology. These photoswitchable proteins have facilitated the characterization of specifically tagged molecular species in the cell and have enabled fluorescence imaging of intracellular structures with a resolution far below the classical diffraction limit of light. Applications are limited, however, by the fast photobleaching, slow photoswitching, and oligomerization typical for photoswitchable proteins currently available. Here, we report the molecular cloning and spectroscopic characterization of mKikGR, a monomeric version of the previously reported KikGR that displays high photostability and switching rates. Furthermore, we present single-molecule imaging experiments that demonstrate that individual mKikGR proteins can be localized with a precision of better than 10 nanometers, suggesting their suitability for super-resolution imaging.	[Kochaniak, Anna B.; van Oijen, Antoine M.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Tsutsui, Hidekazu; Miyawaki, Atsushi] RIKEN, Brain Sci Inst, Lab Cell Funct Dynam, Wako, Saitama, Japan; [Habuchi, Satoshi] Tokyo Inst Technol, Graduate School of Science and Engineering, Tokyo, Japan; [Kochaniak, Anna B.] Harvard Univ, Grad Program Biophys, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; RIKEN; Tokyo Institute of Technology; Harvard University	Habuchi, S (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	matsushi@brain.riken.go.jp; antoine_van_oijen@hms.harvard.edu	Miyawaki, Atsushi/K-3569-2014; van Oijen, Antoine/I-3167-2014; Habuchi, Satoshi/N-6037-2018	Miyawaki, Atsushi/0000-0002-2329-3235; van Oijen, Antoine/0000-0002-1794-5161; Habuchi, Satoshi/0000-0002-6663-2807; Loveland, Anna B./0000-0001-9172-7747	Armenise-Harvard Foundation; Searle Scholars Program	Armenise-Harvard Foundation; Searle Scholars Program	A.M.v.O. acknowledges financial support from the Armenise-Harvard Foundation and the Searle Scholars Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; CADWELL RC, 1994, PCR METH APPL, V3, pS136; Chudakov DM, 2003, NAT BIOTECHNOL, V21, P191, DOI 10.1038/nbt778; Chudakov DM, 2005, TRENDS BIOTECHNOL, V23, P605, DOI 10.1016/j.tibtech.2005.10.005; Chudakov DM, 2004, NAT BIOTECHNOL, V22, P1435, DOI 10.1038/nbt1025; Cotlet M, 2001, CHEM PHYS LETT, V336, P415, DOI 10.1016/S0009-2614(01)00165-8; Dittrich PS, 2005, BIOPHYS J, V89, P3446, DOI 10.1529/biophysj.105.061713; Flors C, 2007, J AM CHEM SOC, V129, P13970, DOI 10.1021/ja074704l; Geisler C, 2007, APPL PHYS A-MATER, V88, P223, DOI 10.1007/s00339-007-4144-0; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Habuchi S, 2005, P NATL ACAD SCI USA, V102, P9511, DOI 10.1073/pnas.0500489102; Habuchi S, 2005, J AM CHEM SOC, V127, P8977, DOI 10.1021/ja047023o; Habuchi S, 2006, PHOTOCH PHOTOBIO SCI, V5, P567, DOI 10.1039/b516339k; Hayashi I, 2007, J MOL BIOL, V372, P918, DOI 10.1016/j.jmb.2007.06.037; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Lippincott-Schwartz J, 2003, NAT CELL BIOL, pS7, DOI 10.1038/ncb1032; Lukyanov KA, 2005, NAT REV MOL CELL BIO, V6, P885, DOI 10.1038/nrm1741; Miyawaki A, 2003, NAT CELL BIOL, pS1, DOI 10.1038/ncb1031; Mizuno H, 2003, MOL CELL, V12, P1051, DOI 10.1016/S1097-2765(03)00393-9; Nienhaus K, 2005, P NATL ACAD SCI USA, V102, P9156, DOI 10.1073/pnas.0501874102; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sawano A, 2000, Nucleic Acids Res, V28, pE78, DOI 10.1093/nar/28.16.e78; Shroff H, 2007, P NATL ACAD SCI USA, V104, P20308, DOI 10.1073/pnas.0710517105; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Tsutsui H, 2005, EMBO REP, V6, P233, DOI 10.1038/sj.embor.7400361; Verkhusha VV, 2005, CHEM BIOL, V12, P279, DOI 10.1016/j.chembiol.2005.01.005; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976	34	132	142	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2008	3	12							e3944	10.1371/journal.pone.0003944	http://dx.doi.org/10.1371/journal.pone.0003944			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AP	19079591	gold, Green Published, Green Submitted			2022-12-25	WOS:000265458200008
J	Ren, CC; Gao, XW; Niu, G; Yan, ZM; Chen, XY; Zhao, H				Ren, Chuancheng; Gao, Xuwen; Niu, Gang; Yan, Zhimin; Chen, Xiaoyuan; Zhao, Heng			Delayed Postconditioning Protects against Focal Ischemic Brain Injury in Rats	PLOS ONE			English	Article								Background: We and others have reported that rapid ischemic postconditioning, interrupting early reperfusion after stroke, reduces infarction in rats. However, its extremely short therapeutic time windows, from a few seconds to minutes after reperfusion, may hinder its clinical translation. Thus, in this study we explored if delayed postconditioning, which is conducted a few hours after reperfusion, offers protection against stroke. Methods and Results: Focal ischemia was generated by 30 min occlusion of bilateral common carotid artery (CCA) combined with permanent occlusion of middle cerebral artery (MCA); delayed postconditioning was performed by repetitive, brief occlusion and release of the bilateral CCAs, or of the ipsilateral CCA alone. As a result, delayed postconditioning performed at 3h and 6h after stroke robustly reduced infarct size, with the strongest protection achieved by delayed postconditioning with 6 cycles of 15 min occlusion/15 min release of the ipsilateral CCA executed from 6h. We found that this delayed postconditioning provided long-term protection for up to two months by reducing infarction and improving outcomes of the behavioral tests; it also attenuated reduction in 2-[(18)F]-fluoro-2-deoxy-D-glucose (FDG)-uptake therefore improving metabolism, and reduced edema and blood brain barrier leakage. Reperfusion in ischemic stroke patients is usually achieved by tissue plasminogen activator (tPA) application, however, t-PA's side effect may worsen ischemic injury. Thus, we tested whether delayed postconditioning counteracts the exacerbating effect of t-PA. The results showed that delayed postconditioning mitigated the worsening effect of t-PA on infarction. Conclusion: Delayed postconditioning reduced ischemic injury after focal ischemia, which opens a new research avenue for stroke therapy and its underlying protective mechanisms.	[Gao, Xuwen; Yan, Zhimin; Zhao, Heng] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Niu, Gang; Chen, Xiaoyuan] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Ren, Chuancheng] Fudan Univ, Shanghai Med Sch, Shanghai No 5 Hosp, Dept Neurol, Shanghai, Peoples R China	Stanford University; Stanford University; Fudan University	Ren, CC (corresponding author), Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA.	hzhao@stanford.edu	Chen, Xiaoyuan/D-1860-2014	Chen, Xiaoyuan/0000-0002-9622-0870	AHA [SDG 0730113N]; NIH [1R21NS057750-01A2]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS057750] Funding Source: NIH RePORTER	AHA(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by AHA grant SDG 0730113N (HZ) and NIH grant 1R21NS057750-01A2 (HZ). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov AV, 2001, CIRCULATION, V103, P2897, DOI 10.1161/01.CIR.103.24.2897; Armstead WM, 2006, NAT NEUROSCI, V9, P1150, DOI 10.1038/nn1757; Belayev L, 1996, NEUROREPORT, V8, P55, DOI 10.1097/00001756-199612200-00012; Benarroch EE, 2007, NEUROLOGY, V69, P799, DOI 10.1212/01.wnl.0000269668.08747.78; Burda J, 2006, CELL MOL NEUROBIOL, V26, P1141, DOI 10.1007/s10571-006-9036-x; CHEN ST, 1986, STROKE, V17, P738, DOI 10.1161/01.STR.17.4.738; Deriu G P, 1994, Ann Vasc Surg, V8, P337, DOI 10.1007/BF02132994; GAO X, 2008, J NEUROSCI RES; Gao XW, 2008, J NEUROSCI RES, V86, P2505, DOI 10.1002/jnr.21703; Gao XW, 2008, J NEUROCHEM, V105, P943, DOI 10.1111/j.1471-4159.2008.05218.x; GELB AW, 1989, ANESTHESIOLOGY, V70, P678, DOI 10.1097/00000542-198904000-00023; Goldstein LB, 2007, CIRCULATION, V116, P1504, DOI 10.1161/CIRCULATIONAHA.106.670885; Grego F, 2005, ANN VASC SURG, V19, P882, DOI 10.1007/s10016-005-7719-2; Kaur J, 2004, J CEREBR BLOOD F MET, V24, P945, DOI 10.1097/01.WCB.0000137868.50767.E8; Kawaguchi Masahiko, 2005, J Anesth, V19, P150, DOI 10.1007/s00540-005-0305-5; Kitano H, 2007, J CEREBR BLOOD F MET, V27, P1377, DOI 10.1038/sj.jcbfm.9600444; Lee JJ, 2008, ANESTHESIOLOGY, V108, P1055, DOI 10.1097/ALN.0b013e3181730257; Ma XJ, 2006, SCAND CARDIOVASC J, V40, P327, DOI 10.1080/14017430601047864; NEHLS DG, 1987, ANESTHESIOLOGY, V66, P453, DOI 10.1097/00000542-198704000-00002; Nemethova M, 2008, CELL BIOL INT, V32, P128, DOI 10.1016/j.cellbi.2007.08.023; Neumann-Haefelin T, 2004, STROKE, V35, P109, DOI 10.1161/01.STR.0000106482.31425.D1; Pignataro G, 2008, J CEREBR BLOOD F MET, V28, P232, DOI 10.1038/sj.jcbfm.9600559; Prinz V, 2008, STROKE, V39, P433, DOI 10.1161/STROKEAHA.107.492470; Rehni AK, 2007, PHARMACOL REP, V59, P192; Ren C, 2008, NEUROSCIENCE, V151, P1099, DOI 10.1016/j.neuroscience.2007.11.056; Sakakibara Y, 1998, ANN SURG, V227, P134, DOI 10.1097/00000658-199801000-00019; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; TODD MM, 1992, ANESTHESIOLOGY, V76, P161; Wang JY, 2008, STROKE, V39, P983, DOI 10.1161/STROKEAHA.107.499079; Wang Y, 2007, BRIT J PHARMACOL, V151, P1377, DOI 10.1038/sj.bjp.0707285; Wang ZF, 2008, J NEUROCHEM, V106, P1594, DOI 10.1111/j.1471-4159.2008.05504.x; WARNER DS, 1986, ANESTHESIOLOGY, V64, P19, DOI 10.1097/00000542-198601000-00004; Yang DY, 2007, NEUROL RES, V29, P274, DOI 10.1179/016164107X159171; Yoshimura S, 2006, AM J NEURORADIOL, V27, P1710; Zhang HF, 2008, NEUROREPORT, V19, P821, DOI 10.1097/WNR.0b013e3282ffda72; Zhao H, 2005, J NEUROSCI, V25, P9794, DOI 10.1523/JNEUROSCI.3163-05.2005; Zhao H, 2004, J CEREBR BLOOD F MET, V24, P681, DOI 10.1097/01.WCB.0000127161.89708.A5; Zhao H, 2003, J NEUROCHEM, V85, P1026, DOI 10.1046/j.1471-4159.2003.01756.x; Zhao H, 2006, J CEREBR BLOOD F MET, V26, P1114, DOI 10.1038/sj.jcbfm.9600348; Zhao JL, 2007, MICROVASC RES, V73, P137, DOI 10.1016/j.mvr.2006.09.002; Zhao ZQ, 2003, AM J PHYSIOL-HEART C, V285, pH579, DOI 10.1152/ajpheart.01064.2002	41	94	105	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2008	3	12							e3851	10.1371/journal.pone.0003851	http://dx.doi.org/10.1371/journal.pone.0003851			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZS	19066627	Green Submitted, Green Published, gold			2022-12-25	WOS:000265455700001
J	Graner, MW; Alzate, O; Dechkovskaia, AM; Keene, JD; Sampson, JH; Mitchell, DA; Bigner, DD				Graner, Michael W.; Alzate, Oscar; Dechkovskaia, Angelika M.; Keene, Jack D.; Sampson, John H.; Mitchell, Duane A.; Bigner, Darell D.			Proteomic and immunologic analyses of brain tumor exosomes	FASEB JOURNAL			English	Article						microvesicles; heat shock proteins; antibody; T cells; EGFRvIII; patient sera	CELL-DERIVED-EXOSOMES; GROWTH-FACTOR RECEPTOR; NF-KAPPA-B; BIOLOGICAL SIGNIFICANCE; RELEASED MICROVESICLES; MULTIVESICULAR BODY; MURINE ASTROCYTOMA; SURFACE EXPRESSION; SHOCK PROTEINS; MECHANISMS	Brain tumors are horrific diseases with almost universally fatal outcomes; new therapeutics are desperately needed and will come from improved understandings of glioma biology. Exosomes are endosomally derived 30-100 nm membranous vesicles released from many cell types into the extracellular milieu; surprisingly, exosomes are virtually unstudied in neuro-oncology. These microvesicles were used as vaccines in other tumor settings, but their immunological significance is unevaluated in brain tumors. Our purpose here is to report the initial biochemical, proteomic, and immunological studies on murine brain tumor exosomes, following known procedures to isolate exosomes. Our findings show that these vesicles have biophysical characteristics and proteomic profiles similar to exosomes from other cell types but that brain tumor exosomes have unique features (e. g., very basic isoelectric points, expressing the mutated tumor antigen EGFRvIII and the putatively immunosuppressive cytokine TGF-beta). Administration of such exosomes into syngeneic animals produced both humoral and cellular immune responses in immunized hosts capable of rejecting subsequent tumor challenges but failed to prolong survival in established orthotopic models. Control animals received saline or cell lysate vaccines and showed no antitumor responses. Exosomes and microvesicles isolated from sera of patients with brain tumors also possess EGFR, EGFRvIII, and TGF-beta. We conclude that exosomes released from brain tumor cells are biochemically/biophysically like other exosomes and have immune-modulating properties. They can escape the blood-brain barrier, with potential systemic and distal signaling and immune consequences.-Graner, M. W., Alzate, O., Dechkovskaia, A. M., Keene, J. D., Sampson, J. H., Mitchell, D. A., Bigner, D. D. Proteomic and immunologic analyses of brain tumor exosomes. FASEB J. 23, 1541-1557 (2009)	[Graner, Michael W.; Sampson, John H.; Bigner, Darell D.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Alzate, Oscar] Duke Univ, Med Ctr, Dept Neurosci Neuroprote, Durham, NC 27710 USA; [Dechkovskaia, Angelika M.; Sampson, John H.; Mitchell, Duane A.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Keene, Jack D.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Graner, Michael W.; Alzate, Oscar; Dechkovskaia, Angelika M.; Keene, Jack D.; Sampson, John H.; Mitchell, Duane A.; Bigner, Darell D.] Duke Univ, Preston Robert Tisch Brain Tumor Ctr, Durham, NC USA	Duke University; Duke University; Duke University; Duke University; Duke University	Graner, MW (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Box 3050,210 Sands Bldg, Durham, NC 27710 USA.	granermichael@yahoo.com	, Proteomics Core UNC/AFQ-7201-2022; Alzate, Oscar/A-2533-2008	Sampson, John/0000-0002-0104-7658; Alzate, Oscar/0000-0002-1083-2551	Duke University Brain Cancer Specialized Programs of Research Excellence [5 P50 CA108786-02]; SPORE Career Development Award; National Institute of Neurological Disorders and Stroke SRC [5 P50 20023-21]; Pediatric Brain Tumor Foundation; Brian Cless Research Foundation; Southeast Brain Tumor Foundation; NATIONAL CANCER INSTITUTE [P50CA108786] Funding Source: NIH RePORTER	Duke University Brain Cancer Specialized Programs of Research Excellence; SPORE Career Development Award; National Institute of Neurological Disorders and Stroke SRC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Pediatric Brain Tumor Foundation; Brian Cless Research Foundation; Southeast Brain Tumor Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Dr. Sara Miller of the Duke University Cancer Center electron microscopy facility for performing the electron microscopy; R. Ian Cumming, Shelley Davis, and Nichole Satterwhite for superb technical support; and Dr. Steve Griffiths (Atlantic Cancer Research Institute, Moncton, NB, Canada) for ideas and sharing unpublished observations. This work was supported by the Duke University Brain Cancer Specialized Programs of Research Excellence 5 P50 CA108786-02; SPORE Career Development Award (to M. W. G.); National Institute of Neurological Disorders and Stroke SRC 5 P50 20023-21; the Pediatric Brain Tumor Foundation; the Brian Cless Research Foundation; and the Southeast Brain Tumor Foundation (to M. W. G.).	Abusamra AJ, 2005, BLOOD CELL MOL DIS, V35, P169, DOI 10.1016/j.bcmd.2005.07.001; Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Altieri SL, 2004, J IMMUNOTHER, V27, P282, DOI 10.1097/00002371-200407000-00004; Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; Andre F, 2002, LANCET, V360, P295, DOI 10.1016/S0140-6736(02)09552-1; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Bard MP, 2004, AM J RESP CELL MOL, V31, P114, DOI 10.1165/rcmb.2003-0238OC; Bausero MA, 2004, TUMOR BIOL, V25, P243, DOI 10.1159/000081387; Bu N, 2006, LEUKEMIA LYMPHOMA, V47, P913, DOI 10.1080/10428190500376191; Burchardt T, 1999, J UROLOGY, V162, P1800, DOI 10.1016/S0022-5347(05)68241-9; Calzolari A, 2006, J CELL SCI, V119, P4486, DOI 10.1242/jcs.03228; Chaput N, 2006, J LEUKOCYTE BIOL, V80, P471, DOI 10.1189/jlb.0206094; Chertova E, 2006, J VIROL, V80, P9039, DOI 10.1128/JVI.01013-06; Choy L, 1998, J BIOL CHEM, V273, P31455, DOI 10.1074/jbc.273.47.31455; Clayton A, 2005, BLOOD CELL MOL DIS, V34, P206, DOI 10.1016/j.bcmd.2005.03.003; Clayton A, 2007, CANCER RES, V67, P7458, DOI 10.1158/0008-5472.CAN-06-3456; DAUM G, 1988, BIOCHIM BIOPHYS ACTA, V939, P277, DOI 10.1016/0005-2736(88)90071-5; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; Delcayre A, 2006, CURR OPIN MOL THER, V8, P31; Denzer K, 2000, J CELL SCI, V113, P3365; Dudani AK, 2005, BIOCHEM CELL BIOL, V83, P28, DOI 10.1139/O04-109; Elsner L, 2007, J IMMUNOL, V179, P5523, DOI 10.4049/jimmunol.179.8.5523; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Escudier B, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-10; Fang Y, 2007, PLOS BIOL, V5, P1267, DOI 10.1371/journal.pbio.0050158; Fecci PE, 2006, CANCER RES, V66, P3294, DOI 10.1158/0008-5472.CAN-05-3773; Feng HP, 2001, BLOOD, V97, P3505, DOI 10.1182/blood.V97.11.3505; FRIEDMAN HS, 1985, J NEUROPATH EXP NEUR, V44, P592, DOI 10.1097/00005072-198511000-00005; Gabrilovich D, 2004, NAT REV IMMUNOL, V4, P941, DOI 10.1038/nri1498; GARG PK, 1995, NUCL MED BIOL, V22, P467, DOI 10.1016/0969-8051(94)00134-6; Gastpar R, 2005, CANCER RES, V65, P5238, DOI 10.1158/0008-5472.CAN-04-3804; Gerbod-Giannone MC, 2006, P NATL ACAD SCI USA, V103, P3112, DOI 10.1073/pnas.0510345103; Girard J, 1997, ANNU REV NUTR, V17, P325, DOI 10.1146/annurev.nutr.17.1.325; Gomez GG, 2006, GENE THER MOL BIOL, V10A, P133; Graner MW, 2007, J NEUROSCI, V27, P11214, DOI 10.1523/JNEUROSCI.3588-07.2007; Graner MW, 2005, NEURO-ONCOLOGY, V7, P260, DOI 10.1215/S1152851704001188; Hegmans JPJJ, 2004, AM J PATHOL, V164, P1807, DOI 10.1016/S0002-9440(10)63739-X; Iero M, 2008, CELL DEATH DIFFER, V15, P80, DOI 10.1038/sj.cdd.4402237; Jin M, 2005, PROTEOMICS, V5, P1940, DOI 10.1002/pmic.200401057; Johnstone RM, 2006, BLOOD CELL MOL DIS, V36, P315, DOI 10.1016/j.bcmd.2005.12.001; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Keller S, 2007, KIDNEY INT, V72, P1095, DOI 10.1038/sj.ki.5002486; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Khan WA, 2000, TOXICOL SCI, V57, P112, DOI 10.1093/toxsci/57.1.112; Kim JW, 2005, CLIN CANCER RES, V11, P1010; Kim SH, 2006, MOL THER, V13, P289, DOI 10.1016/j.ymthe.2005.09.015; Kuan C T, 2000, Brain Tumor Pathol, V17, P71, DOI 10.1007/BF02482738; Kuan CT, 2006, CLIN CANCER RES, V12, P1970, DOI 10.1158/1078-0432.CCR-05-2797; Kuate S, 2007, VIROLOGY, V362, P26, DOI 10.1016/j.virol.2006.12.011; Liu CR, 2006, J IMMUNOL, V176, P1375, DOI 10.4049/jimmunol.176.3.1375; Mangeney M, 2005, CANCER RES, V65, P2588, DOI 10.1158/0008-5472.CAN-04-4231; Mears R, 2004, PROTEOMICS, V4, P4019, DOI 10.1002/pmic.200400876; Mignot G, 2006, J CELL MOL MED, V10, P376, DOI 10.1111/j.1582-4934.2006.tb00406.x; Mitchell DA, 2008, NEURO-ONCOLOGY, V10, P10, DOI 10.1215/15228517-2007-035; Morishima A, 2003, J BIOL CHEM, V278, P38188, DOI 10.1074/jbc.M306336200; Morse MA, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-9; Moscatello DK, 1997, CANCER RES, V57, P1419; Mourad PD, 2005, SURG NEUROL, V63, P511, DOI 10.1016/j.surneu.2004.08.062; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Olofsson S, 2005, ANN MED, V37, P154, DOI 10.1080/07853890510007340; Osorio C, 2007, NEUROBIOL AGING, V28, P1853, DOI 10.1016/j.neurobiolaging.2006.08.011; Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910; Parker Carol E., 2005, V301, P117; Pedersen MW, 2001, ANN ONCOL, V12, P745, DOI 10.1023/A:1011177318162; Pelchen-Matthews A, 2004, TRENDS MICROBIOL, V12, P310, DOI 10.1016/j.tim.2004.05.004; Pinaud R, 2008, EUR J NEUROSCI, V27, P1409, DOI 10.1111/j.1460-9568.2008.06102.x; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Potolicchio A, 2005, J IMMUNOL, V175, P2237, DOI 10.4049/jimmunol.175.4.2237; RUBARTELLI A, 1993, CYTOKINE, V5, P117, DOI 10.1016/1043-4666(93)90050-F; Safaei R, 2005, MOL CANCER THER, V4, P1595, DOI 10.1158/1535-7163.MCT-05-0102; Sampson JH, 2000, P NATL ACAD SCI USA, V97, P7503, DOI 10.1073/pnas.130166597; Sampson JH, 1997, NEUROSURGERY, V41, P1365, DOI 10.1097/00006123-199712000-00024; Savina A, 2002, J CELL SCI, V115, P2505; Segura E, 2005, BLOOD, V106, P216, DOI 10.1182/blood-2005-01-0220; SERANO RD, 1980, ACTA NEUROPATHOL, V51, P53, DOI 10.1007/BF00688850; Simpson RJ, 2008, PROTEOMICS, V8, P4083, DOI 10.1002/pmic.200800109; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Taieb J, 2005, CRIT REV IMMUNOL, V25, P215, DOI 10.1615/CritRevImmunol.v25.i3.30; Taylor DD, 2003, CLIN CANCER RES, V9, P5113; Taylor DD, 2005, BRIT J CANCER, V92, P305, DOI 10.1038/sj.bjc.6602316; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Thery C, 1999, J CELL BIOL, V147, P599, DOI 10.1083/jcb.147.3.599; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Valenti R, 2007, CANCER RES, V67, P2912, DOI 10.1158/0008-5472.CAN-07-0520; Valenti R, 2006, CANCER RES, V66, P9290, DOI 10.1158/0008-5472.CAN-06-1819; van Niel G, 2001, GASTROENTEROLOGY, V121, P337, DOI 10.1053/gast.2001.26263; Wieckowski E, 2006, IMMUNOL RES, V36, P247, DOI 10.1385/IR:36:1:247; WIKSTRAND CJ, 1995, CANCER RES, V55, P3140; Wikstrand CJ, 1997, CANCER RES, V57, P4130; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200; Yang G, 1997, PROSTATE, V33, P151, DOI 10.1002/(SICI)1097-0045(19971101)33:3<151::AID-PROS1>3.0.CO;2-M; Yu SH, 2007, J IMMUNOL, V178, P6867, DOI 10.4049/jimmunol.178.11.6867; Zhou H, 2006, KIDNEY INT, V69, P1471, DOI 10.1038/sj.ki.5000273; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	95	290	311	1	34	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2009	23	5					1541	1557		10.1096/fj.08-122184	http://dx.doi.org/10.1096/fj.08-122184			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZP	19109410	Green Published			2022-12-25	WOS:000266651700030
J	Chabwine, JN; Talavera, K; Verbert, L; Eggermont, J; Vanderwinden, JM; De Smedt, H; Van Den Bosch, L; Robberecht, W; Callewaert, G				Chabwine, J. N.; Talavera, K.; Verbert, L.; Eggermont, J.; Vanderwinden, J. -M.; De Smedt, H.; Van Den Bosch, L.; Robberecht, W.; Callewaert, G.			Differential contribution of the Na+-K+-2Cl(-) cotransporter NKCC1 to chloride handling in rat embryonic dorsal root ganglion neurons and motor neurons	FASEB JOURNAL			English	Article						GABA receptor; bumetanide; primary afferent depolarization; kinetic model	NA-K-CL; PRESYNAPTIC INHIBITION; MEDIATED INHIBITION; EXCITATORY ACTIONS; CHICK-EMBRYO; GABA; CELLS; MOTONEURON; CURRENTS; BRAIN	Plasma membrane chloride (Cl-) pathways play an important role in neuronal physiology. Here, we investigated the role of NKCC1 cotransporters (a secondary active Cl- uptake mechanism) in Cl- handling in cultured rat dorsal root ganglion neurons (DRGNs) and motor neurons (MNs) derived from fetal stage embryonic day 14. Gramicidin-perforated patch-clamp recordings revealed that DRGNs accumulate intracellular Cl- through a bumetanide- and Na+-sensitive mechanism, indicative of the functional expression of NKCC1. Western blotting confirmed the expression of NKCC1 in both DRGNs and MNs, but immunocytochemistry experiments showed a restricted expression in dendrites of MNs, which contrasts with a homogeneous expression in DRGNs. Both MNs and DRGNs could be readily loaded with or depleted of Cl- during GABA(A) receptor activation at depolarizing or hyperpolarizing membrane potentials. After loading, the rate of recovery to the resting Cl- concentration (i.e., [Cl-](i) decrease) was similar in both cell types and was unaffected by lowering the extracellular Na+ concentration. In contrast, the recovery on depletion (i. e., [Cl-](i) increase) was significantly faster in DRGNs in control conditions but not in low extracellular Na+. The experimental observations could be reproduced by a mathematical model for intracellular Cl- kinetics, in which DRGNs show higher NKCC1 activity and smaller Cl--handling volume than MNs. On the basis of these results, we conclude that embryonic DRGNs show a higher somatic functional expression of NKCC1 than embryonic MNs. The high NKCC1 activity in DRGNs is important for maintaining high [Cl-](i), whereas lower NKCC1 activity in MNs allows large [Cl-](i) variations during neuronal activity.-Chabwine, J. N., Talavera, K., Verbert, L., Eggermont, J., Vanderwinden, J.-M., De Smedt, H., Van Den Bosch, L., Robberecht, W., Callewaert, G. Differential contribution of the Na+-K+-2Cl(-) cotransporter NKCC1 to chloride handling in rat embryonic dorsal root ganglion neurons and motor neurons. FASEB J. 23, 1168-1176 (2009)	[Chabwine, J. N.; Talavera, K.; Verbert, L.; Eggermont, J.; De Smedt, H.; Callewaert, G.] Katholieke Univ Leuven VIB, Dept Mol & Cell Biol, Vesalius Res Ctr, B-3000 Louvain, Belgium; [Van Den Bosch, L.; Robberecht, W.] Katholieke Univ Leuven VIB, Neurobiol Lab, Vesalius Res Ctr, B-3000 Louvain, Belgium; [Vanderwinden, J. -M.] Univ Libre Bruxelles, Neurophysiol Lab, Brussels, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; Universite Libre de Bruxelles	Chabwine, JN (corresponding author), Katholieke Univ Leuven VIB, Dept Mol & Cell Biol, Vesalius Res Ctr, Campus Gasthuisberg O&N1,Herestr 49-802, B-3000 Louvain, Belgium.	jo.nsimy@gmail.com	Van Den Bosch, Ludo/B-7258-2012; Talavera, Karel/K-7990-2014	Talavera, Karel/0000-0002-3124-138X; Van Den Bosch, Ludo/0000-0003-0104-4067; Eggermont, Jan/0000-0002-8497-1159				Achilles K, 2007, J NEUROSCI, V27, P8616, DOI 10.1523/JNEUROSCI.5041-06.2007; ALVAREZLEEFMANS FJ, 1988, J PHYSIOL-LONDON, V406, P225, DOI 10.1113/jphysiol.1988.sp017378; ANDERSEN P, 1980, J PHYSIOL-LONDON, V305, P279, DOI 10.1113/jphysiol.1980.sp013363; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Ben-Ari Y, 2006, EPILEPTIC DISORD, V8, P91; Capo-Aponte JE, 2007, EXP EYE RES, V84, P361, DOI 10.1016/j.exer.2006.10.011; Chabwine JN, 2004, NEUROSCI LETT, V365, P69, DOI 10.1016/j.neulet.2004.04.049; Chub N, 2006, J NEUROPHYSIOL, V95, P323, DOI 10.1152/jn.00162.2005; Chub N, 2001, J NEUROPHYSIOL, V85, P2166, DOI 10.1152/jn.2001.85.5.2166; Delpire E, 2002, ANNU REV PHYSIOL, V64, P803, DOI 10.1146/annurev.physiol.64.081501.155847; Delpire E, 2000, NEWS PHYSIOL SCI, V15, P309, DOI 10.1152/physiologyonline.2000.15.6.309; Delpy A, 2008, J PHYSIOL-LONDON, V586, P1059, DOI 10.1113/jphysiol.2007.146993; Devor M, 1999, PAIN, pS27, DOI 10.1016/S0304-3959(99)00135-9; Di Ciano-Oliveira C, 2005, AM J PHYSIOL-CELL PH, V289, pC68, DOI 10.1152/ajpcell.00631.2004; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Genzen JR, 2001, J NEUROPHYSIOL, V86, P1773, DOI 10.1152/jn.2001.86.4.1773; Gillen CM, 1999, AM J PHYSIOL-CELL PH, V276, pC328, DOI 10.1152/ajpcell.1999.276.2.C328; Gold MS, 2004, J NEUROPHYSIOL, V91, P2524, DOI 10.1152/jn.00866.2003; Gulledge AT, 2003, NEURON, V37, P299, DOI 10.1016/S0896-6273(02)01146-7; Haas M, 2000, ANNU REV PHYSIOL, V62, P515, DOI 10.1146/annurev.physiol.62.1.515; Hecht G, 1999, AM J PHYSIOL-CELL PH, V277, pC441, DOI 10.1152/ajpcell.1999.277.3.C441; Hoffmann EK, 2007, COMP BIOCHEM PHYS A, V148, P29, DOI 10.1016/j.cbpa.2006.11.023; Hoffmann EK, 2007, AM J PHYSIOL-CELL PH, V292, pC1854, DOI 10.1152/ajpcell.00474.2006; Holohean AM, 1996, BRAIN RES, V711, P138, DOI 10.1016/0006-8993(95)01414-4; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Isenring P, 1997, J BIOL CHEM, V272, P24556, DOI 10.1074/jbc.272.39.24556; Valencia-de Ita S, 2006, J NEUROPHYSIOL, V95, P3553, DOI 10.1152/jn.01091.2005; Kahle KT, 2006, PHYSIOLOGY, V21, P326, DOI 10.1152/physiol.00015.2006; Kahle KT, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC/2008/25/9/E22; Laird JMA, 2004, NEUROSCI LETT, V361, P200, DOI 10.1016/j.neulet.2003.12.015; Lytle C, 2002, AM J PHYSIOL-CELL PH, V283, pC1422, DOI 10.1152/ajpcell.00130.2002; MAA E, 2007, EPILEPSIA, V48, pS6; Martin DJ, 2002, NEUROPHARMACOLOGY, V42, P353, DOI 10.1016/S0028-3908(01)00181-2; Mercado A, 2004, NEUROCHEM RES, V29, P17, DOI 10.1023/B:NERE.0000010432.44566.21; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Rivera C, 2005, J PHYSIOL-LONDON, V562, P27, DOI 10.1113/jphysiol.2004.077495; Rocha-Gonzalez HI, 2008, J NEUROPHYSIOL, V100, P169, DOI 10.1152/jn.01007.2007; Rudomin P, 1999, EXP BRAIN RES, V129, P1, DOI 10.1007/s002210050933; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; SCHLATTER E, 1983, PFLUG ARCH EUR J PHY, V396, P210, DOI 10.1007/BF00587857; Stein V, 2003, NEURON, V37, P375, DOI 10.1016/S0896-6273(03)00056-4; Sun DD, 1999, J NEUROPHYSIOL, V81, P1939, DOI 10.1152/jn.1999.81.4.1939; Sung KW, 2000, J NEUROSCI, V20, P7531; Tyzio R, 2006, SCIENCE, V314, P1788, DOI 10.1126/science.1133212; Van Damme P, 2003, J NEUROSCI, V23, P4942; Van Den Bosch L, 2000, J NEUROL SCI, V180, P29, DOI 10.1016/S0022-510X(00)00414-7; Vandenberghe W, 1998, BRAIN RES, V807, P1, DOI 10.1016/S0006-8993(98)00569-1; Willis WD, 1999, EXP BRAIN RES, V124, P395, DOI 10.1007/s002210050637; Yan YP, 2003, BRAIN RES, V961, P22, DOI 10.1016/S0006-8993(02)03832-5	51	13	13	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2009	23	4					1168	1176		10.1096/fj.08-116012	http://dx.doi.org/10.1096/fj.08-116012			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZO	19103648	Green Accepted			2022-12-25	WOS:000266651600021
J	Leung, WC; Hessel, S; Meplan, C; Flint, J; Oberhauser, V; Tourniaire, F; Hesketh, JE; von Lintig, J; Lietz, G				Leung, W. C.; Hessel, S.; Meplan, C.; Flint, J.; Oberhauser, V.; Tourniaire, F.; Hesketh, J. E.; von Lintig, J.; Lietz, G.			Two common single nucleotide polymorphisms in the gene encoding beta-carotene 15,15 '-monoxygenase alter beta-carotene metabolism in female volunteers	FASEB JOURNAL			English	Article						vitamin A; SNP; triglyceride-rich lipoprotein; supplementation; nutrient-gene interaction	VITAMIN-A INTAKE; BETA,BETA-CAROTENE 15,15'-MONOOXYGENASE; DOUBLE-TRACER; EXPRESSION; CONVERSION; RETINOL; WOMEN; 15,15-MONOOXYGENASE; EQUIVALENCE; VARIABILITY	The key enzyme responsible for beta-carotene conversion into retinal is beta-carotene 15,15'-monoxygenase (BCMO1). Since it has been reported that the conversion of beta-carotene into vitamin A is highly variable in up to 45% of healthy individuals, we hypothesized that genetic polymorphisms in the BCMO1 gene could contribute to the occurrence of the poor converter phenotype. Here we describe the screening of the total open reading frame of the BCMO1 coding region that led to the identification of two common nonsynonymous single nucleotide polymorphisms (R267S: rs12934922; A379V: rs7501331) with variant allele frequencies of 42 and 24%, respectively. In vitro biochemical characterization of the recombinant 267S + 379V double mutant revealed a reduced catalytic activity of BCMO1 by 57% (P<0.001). Assessment of the responsiveness to a pharmacological dose of beta-carotene in female volunteers confirmed that carriers of both the 379V and 267S + 379V variant alleles had a reduced ability to convert beta-carotene, as indicated through reduced retinyl palmitate: beta-carotene ratios in the triglyceride-rich lipoprotein fraction [-32% (P=0.005) and -69% (P=0.001), respectively] and increased fasting beta-carotene concentrations [+160% (P=0.025) and +240% (P=0.041), respectively]. Our data show that there is genetic variability in beta-carotene metabolism and may provide an explanation for the molecular basis of the poor converter phenotype within the population.-Leung, W. C., Hessel, S., Meplan, C., Flint, J., Oberhauser, V., Tourniaire, F., Hesketh, J. E., von Lintig, J., Lietz, G. Two common single nucleotide polymorphisms in the gene encoding beta-carotene 15,15'-monoxygenase alter beta-carotene metabolism in female volunteers. FASEB J. 23, 1041-1053 (2009)	[Tourniaire, F.; Lietz, G.] Univ Newcastle, Sch Agr Food & Rural Dev, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Leung, W. C.; Hessel, S.; Meplan, C.; Tourniaire, F.; Hesketh, J. E.; Lietz, G.] Univ Newcastle, Human Nutr Res Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Meplan, C.; Flint, J.; Hesketh, J. E.] Univ Newcastle, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Hessel, S.; Oberhauser, V.; von Lintig, J.] Inst Biol Anim Physiol & Neurobiol 1, Freiburg, Germany; [von Lintig, J.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Case Western Reserve University	Lietz, G (corresponding author), Univ Newcastle, Sch Agr Food & Rural Dev, Agr Bldg, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	georg.lietz@ncl.ac.uk	Lietz, Georg/A-4084-2012; Tourniaire, Franck/K-9131-2017	Tourniaire, Franck/0000-0002-6394-7045; Flint, James/0000-0003-2923-7813; von Lintig, Johannes/0000-0002-2079-2143	Biotechnology and Biological Sciences Research Council; European Nutrigenomics Organisation NuGO	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Nutrigenomics Organisation NuGO	This work was supported by a Biotechnology and Biological Sciences Research Council studentship to W. C. L. and a research grant from the European Nutrigenomics Organisation NuGO. We thank Andrew Dodd and David Lamb for help in the analysis of the BCMO1 promoter. We also thank Simon Kometa for help with the statistical analysis, Tevfik Dorak for help with Haploview, and Muriel Caslake and Dermot Neely for help and advice in the TRL separation. We acknowledge the help of Sophie Whelan during the intervention study. In addition, we thank DSM (Heerlen, Basel, Switzerland) for kindly supplying us with the beta-carotene supplement.	Bachmann H, 2002, J NUTR, V132, P3616, DOI 10.1093/jn/132.12.3616; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barua AB, 2000, J NUTR, V130, P1996, DOI 10.1093/jn/130.8.1996; Borel P, 1998, J LIPID RES, V39, P2250; Borel P, 2009, BRIT J NUTR, V101, P680, DOI 10.1017/S0007114508030754; Cornish-Bowden A, 2012, FUNDAMENTALS ENZYME, V4th; de Pee S, 2007, INT J VITAM NUTR RES, V77, P182, DOI 10.1024/0300-9831.77.3.182; *DEP HLTH, 2003, AD AG 19 64 YEARS VI, V3; *DEP HLTH, 2003, AD AG 19 64 YEARS EN, V2; During A, 1996, ANAL BIOCHEM, V241, P199, DOI 10.1006/abio.1996.0400; During A, 1998, J NUTR, V128, P1614, DOI 10.1093/jn/128.10.1614; Edwards AJ, 2001, AM J CLIN NUTR, V74, P348; Feskanich D, 2002, JAMA-J AM MED ASSOC, V287, P47, DOI 10.1001/jama.287.1.47; Gong XM, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-7; Herbeth B, 2007, J AM COLL NUTR, V26, P655, DOI 10.1080/07315724.2007.10719644; Hessel S, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706763200; Hickenbottom SJ, 2002, AM J CLIN NUTR, V75, P900, DOI 10.1093/ajcn/75.5.900; Kloer DP, 2005, SCIENCE, V308, P267, DOI 10.1126/science.1108965; Lemke SL, 2003, J LIPID RES, V44, P1591, DOI 10.1194/jlr.M300116-JLR200; Lin YM, 2000, AM J CLIN NUTR, V71, P1545; Lindqvist A, 2002, J BIOL CHEM, V277, P23942, DOI 10.1074/jbc.M202756200; Lindqvist A, 2004, J HISTOCHEM CYTOCHEM, V52, P491, DOI 10.1177/002215540405200407; Lindqvist A, 2007, J NUTR, V137, P2346, DOI 10.1093/jn/137.11.2346; Meplan C, 2007, FASEB J, V21, P3063, DOI 10.1096/fj.07-8166com; Miller M, 2002, J NUTR, V132, p2867S, DOI 10.1093/jn/132.9.2867S; OLSON JA, 1994, J NUTR, V124, pS1461, DOI 10.1093/jn/124.suppl_8.1461S; Park CS, 2008, BIOTECHNOL LETT, V30, P735, DOI 10.1007/s10529-007-9598-9; Poliakov E, 2005, J BIOL CHEM, V280, P29217, DOI 10.1074/jbc.M500409200; Seino Y, 2008, J BIOL CHEM, V283, P4905, DOI 10.1074/jbc.M707928200; Strobel M, 2007, EUR J NUTR, V46, P1, DOI 10.1007/s00394-007-1001-z; Tang GW, 2003, AM J CLIN NUTR, V78, P259, DOI 10.1093/ajcn/78.2.259; Underwood BA, 2004, J NUTR, V134, p231S, DOI 10.1093/jn/134.1.231S; VANVLIET T, 1995, AM J CLIN NUTR, V62, P110, DOI 10.1093/ajcn/62.1.110; von Lintig J, 2000, J BIOL CHEM, V275, P11915, DOI 10.1074/jbc.275.16.11915; Wang ZX, 2004, BRIT J NUTR, V91, P121, DOI 10.1079/BJN20031030; West KP, 2002, J NUTR, V132, p2857S, DOI 10.1093/jn/132.9.2857S; Wyss A, 2004, J NUTR, V134, p246S, DOI 10.1093/jn/134.1.246S	37	147	152	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2009	23	4					1041	1053		10.1096/fj.08-121962	http://dx.doi.org/10.1096/fj.08-121962			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZO	19103647				2022-12-25	WOS:000266651600008
J	Sheng, JZ; Ella, S; Davis, MJ; Hill, MA; Braun, AP				Sheng, Jian-zhong; Ella, Srikanth; Davis, Michael J.; Hill, Michael A.; Braun, Andrew P.			Openers of SKCa and IKCa channels enhance agonist-evoked endothelial nitric oxide synthesis and arteriolar vasodilation	FASEB JOURNAL			English	Article						hyperpolarization; calcium; resistance artery; myogenic tone; Ca2+-activated; relaxation	ACTIVATED POTASSIUM CHANNELS; CA2+-ACTIVATED K+ CHANNELS; MIDDLE CEREBRAL-ARTERY; RAT MESENTERIC-ARTERY; HAMSTER FEED ARTERIES; SMALL-CONDUCTANCE; HYPERPOLARIZING FACTOR; MEDIATED DILATIONS; BLOOD-PRESSURE; CALCIUM	Recent data have led us to hypothesize that selective activation of endothelial small- and/or intermediate-conductance, calcium-activated potassium channels (SKCa and IKCa channels, respectively) by the opener compounds NS309 and DCEBIO would augment stimulated nitric oxide (NO) synthesis and vasodilation in resistance arteries. Experimentally, ATP-evoked changes in membrane potential, cytosolic Ca2+, and NO synthesis were recorded by patch clamp and microfluorimetry in single human endothelial cells. Agonist-evoked inhibition of myogenic tone in isolated, pressurized arterioles from rat cremaster skeletal muscle was analyzed by video microscopy. NS309 and DCEBIO enhanced ATP-evoked membrane hyperpolarization and cytosolic Ca2+ transients, along with acute NO synthesis in isolated endothelial cells. The acetylcholine-mediated inhibition of myogenic tone (IC50 = 237 nM) was left-shifted in the presence of NS309 and DCEBIO (10, 100, and 1000 nM) to IC50 values of 101, 78, and 43 nM; endothelial denudation inhibited this drug effect. L-NAME attenuated the acetylcholine-induced inhibition of myogenic tone but did not interfere with NS309 and DCEBIO-evoked vasodilation. Collectively, our data demonstrate that drug-induced enhancement of endothelial SKCa and IKCa channel activities represents a novel cellular mechanism to increase vasodilation of small-resistance arterioles, thereby highlighting these channels as potential therapeutic targets in cardiovascular disease states associated with compromised NO signaling.-Sheng, J.S., Ella, S., Davis, M. J., Hill, M. A., Braun, A. P. Openers of SKCa and IKCa channels enhance agonist-evoked endothelial nitric oxide synthesis and arteriolar vasodilation. FASEB J. 23, 1138-1145 (2009)	[Braun, Andrew P.] Univ Calgary, Dept Pharmacol & Therapeut, Fac Med, Libin Cardiovasc Inst,Smooth Muscle Res Grp, Calgary, AB T2N 4N1, Canada; [Ella, Srikanth; Davis, Michael J.; Hill, Michael A.] Univ Missouri, Dept Med Pharmacol & Physiol, Dalton Cardiovasc Res Ctr, Columbia, MO USA	Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Missouri System; University of Missouri Columbia	Braun, AP (corresponding author), Univ Calgary, Dept Pharmacol & Therapeut, Fac Med, Libin Cardiovasc Inst,Smooth Muscle Res Grp, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	abraun@ucalgary.ca	Hill, Michael/AAV-5350-2020	Hill, Michael/0000-0002-4455-2072	Canadian Institutes of Health Research; U.S. National Institutes of Health [NHLBI-71796]; Alberta Heritage Foundation for Medical Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	This work was supported by operating grants from the Canadian Institutes of Health Research ( A. P. B.) and the U.S. National Institutes of Health (M.J.D., NHLBI-71796). A senior research scholarship to A. P. B. from the Alberta Heritage Foundation for Medical Research during the initial stages of this work is gratefully acknowledged.	Absi M, 2007, BRIT J PHARMACOL, V151, P332, DOI 10.1038/sj.bjp.0707222; Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Burnham MP, 2002, BRIT J PHARMACOL, V135, P1133, DOI 10.1038/sj.bjp.0704551; Busse R, 2002, TRENDS PHARMACOL SCI, V23, P374, DOI 10.1016/S0165-6147(02)02050-3; Crane GJ, 2003, J PHYSIOL-LONDON, V553, P183, DOI 10.1113/jphysiol.2003.051896; Davis MJ, 2005, MICROCIRCULATION, V12, P361, DOI 10.1080/10739680590934772; Domeier TL, 2007, J PHYSIOL-LONDON, V579, P175, DOI 10.1113/jphysiol.2006.124529; Doughty JM, 1999, AM J PHYSIOL-HEART C, V276, pH1107, DOI 10.1152/ajpheart.1999.276.3.H1107; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Feelisch M, 1998, N-S ARCH PHARMACOL, V358, P113, DOI 10.1007/PL00005231; FURCHGOTT RF, 1984, ANNU REV PHARMACOL, V24, P175, DOI 10.1146/annurev.pa.24.040184.001135; Kamouchi M, 1999, GEN PHYSIOL BIOPHYS, V18, P199; KNOWLES RG, 1994, BIOCHEM J, V298, P249, DOI 10.1042/bj2980249; Kohler R, 2007, KIDNEY INT, V72, P145, DOI 10.1038/sj.ki.5002303; Kohler R, 2000, CIRC RES, V87, P496; Kojima H, 1999, ANGEW CHEM INT EDIT, V38, P3209, DOI 10.1002/(SICI)1521-3773(19991102)38:21<3209::AID-ANIE3209>3.0.CO;2-6; Ledoux J, 2008, P NATL ACAD SCI USA, V105, P9627, DOI 10.1073/pnas.0801963105; Ledoux J, 2008, J GEN PHYSIOL, V131, P125, DOI 10.1085/jgp.200709875; Leuranguer V, 2008, N-S ARCH PHARMACOL, V377, P101, DOI 10.1007/s00210-008-0267-x; Marchenko SM, 1996, J PHYSIOL-LONDON, V492, P53, DOI 10.1113/jphysiol.1996.sp021288; MCININGER GA, 1991, AM J PHYSIOL-HEART C, V261, pH950; McNeish AJ, 2006, STROKE, V37, P1277, DOI 10.1161/01.STR.0000217307.71231.43; RUSKO J, 1992, J PHYSIOL-LONDON, V455, P601, DOI 10.1113/jphysiol.1992.sp019318; Sheng JZ, 2007, AM J PHYSIOL-CELL PH, V293, pC458, DOI 10.1152/ajpcell.00036.2007; Sheng JZ, 2005, J PHARMACOL EXP THER, V315, P931, DOI 10.1124/jpet.105.087932; Si H, 2006, CIRC RES, V99, P537, DOI 10.1161/01.RES.0000238377.08219.0c; Singh S, 2001, J PHARMACOL EXP THER, V296, P600; Sokoya EM, 2007, J VASC RES, V44, P169, DOI 10.1159/000099630; Stankevicius E, 2006, BRIT J PHARMACOL, V149, P560, DOI 10.1038/sj.bjp.0706886; Strobaek D, 2004, BBA-BIOMEMBRANES, V1665, P1, DOI 10.1016/j.bbamem.2004.07.006; Taylor MS, 2003, CIRC RES, V93, P124, DOI 10.1161/01.RES.0000081980.63146.69; Uhrenholt TR, 2007, AM J PHYSIOL-HEART C, V292, pH1634, DOI 10.1152/ajpheart.00605.2006; Wulff H, 2007, CURR MED CHEM, V14, P1437, DOI 10.2174/092986707780831186	33	70	73	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2009	23	4					1138	1145		10.1096/fj.08-120451	http://dx.doi.org/10.1096/fj.08-120451			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZO	19074509	Green Published			2022-12-25	WOS:000266651600017
J	Urtishak, KA; Smith, KD; Chanoux, RA; Greenberg, RA; Johnson, FB; Brown, EJ				Urtishak, Karen A.; Smith, Kevin D.; Chanoux, Rebecca A.; Greenberg, Roger A.; Johnson, F. Brad; Brown, Eric J.			Timeless Maintains Genomic Stability and Suppresses Sister Chromatid Exchange during Unperturbed DNA Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS EGG EXTRACTS; BLOOMS-SYNDROME GENE; CHROMOSOME FRAGILE SITES; S-PHASE ARREST; HOMOLOGOUS RECOMBINATION; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; INTERACTING PROTEIN; SYNDROME HELICASE; VERTEBRATE CELLS	Genome integrity is maintained during DNA replication by coordination of various replisome-regulated processes. Although it is known that Timeless (Tim) is a replisome component that participates in replication checkpoint responses to genotoxic stress, its importance for genome maintenance during normal DNA synthesis has not been reported. Here we demonstrate that Tim reduction leads to genomic instability during unperturbed DNA replication, culminating in increased chromatid breaks and translocations (triradials, quadriradials, and fusions). Tim deficiency led to increased H2AX phosphorylation and Rad51 and Rad52 foci formation selectively during DNA synthesis and caused a 3-4-fold increase in sister chromatid exchange. The sister chromatid exchange events stimulated by Tim reduction were largely mediated via a Brca2/Rad51-dependent mechanism and were additively increased by deletion of the Blm helicase. Therefore, Tim deficiency leads to an increased reliance on homologous recombination for proper continuation of DNA synthesis. Together, these results indicate a pivotal role for Tim in maintaining genome stability throughout normal DNA replication.	[Brown, Eric J.] Univ Penn, Sch Med, Dept Canc Biol, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Greenberg, Roger A.; Johnson, F. Brad] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Brown, EJ (corresponding author), 421 Curie Blvd,514 BRB 2-3, Philadelphia, PA 19104 USA.	brownej@mail.med.upenn.edu			W.W. Smith Charitable Trust; American Cancer Society Institutional Grant [IRG 78-002-29]; Abramson Family Cancer Research Institute	W.W. Smith Charitable Trust; American Cancer Society Institutional Grant(American Cancer Society); Abramson Family Cancer Research Institute	This work was supported by the W.W. Smith Charitable Trust, American Cancer Society Institutional Grant IRG 78-002-29, and the Abramson Family Cancer Research Institute. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Amor-Gueret M, 2006, CANCER LETT, V236, P1, DOI 10.1016/j.canlet.2005.04.023; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Calzada A, 2005, GENE DEV, V19, P1905, DOI 10.1101/gad.337205; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; Chester N, 1998, GENE DEV, V12, P3382, DOI 10.1101/gad.12.21.3382; Chou DM, 2006, P NATL ACAD SCI USA, V103, P18143, DOI 10.1073/pnas.0609251103; Davies SL, 2004, MOL CELL BIOL, V24, P1279, DOI 10.1128/MCB.24.3.1279-1291.2004; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Errico A, 2007, P NATL ACAD SCI USA, V104, P14929, DOI 10.1073/pnas.0706347104; Fujimori A, 2001, EMBO J, V20, P5513, DOI 10.1093/emboj/20.19.5513; Goss KH, 2002, SCIENCE, V297, P2051, DOI 10.1126/science.1074340; Gotter AL, 2003, J MOL BIOL, V331, P167, DOI 10.1016/S0022-2836(03)00633-8; Gotter AL, 2007, J MOL BIOL, V366, P36, DOI 10.1016/j.jmb.2006.10.097; Gudmundsdottir K, 2006, ONCOGENE, V25, P5864, DOI 10.1038/sj.onc.1209874; Haber JE, 1999, TRENDS BIOCHEM SCI, V24, P271, DOI 10.1016/S0968-0004(99)01413-9; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Henry-Mowatt J, 2003, MOL CELL, V11, P1109, DOI 10.1016/S1097-2765(03)00132-1; Hodgson B, 2007, MOL BIOL CELL, V18, P3894, DOI 10.1091/mbc.E07-05-0500; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Krings G, 2004, P NATL ACAD SCI USA, V101, P14085, DOI 10.1073/pnas.0406037101; KUHN EM, 1986, CANCER GENET CYTOGEN, V22, P1, DOI 10.1016/0165-4608(86)90132-9; Lemoine FJ, 2005, CELL, V120, P587, DOI 10.1016/j.cell.2004.12.039; Liu YL, 2000, EMBO REP, V1, P85, DOI 10.1093/embo-reports/kvd002; Lupardus PJ, 2002, GENE DEV, V16, P2327, DOI 10.1101/gad.1013502; McDaniel LD, 2003, DNA REPAIR, V2, P1387, DOI 10.1016/j.dnarep.2003.08.006; Mcllwraith MJ, 2008, MOL CELL, V29, P510, DOI 10.1016/j.molcel.2007.11.037; Michael WM, 2000, SCIENCE, V289, P2133, DOI 10.1126/science.289.5487.2133; Mimura S, 2000, GENES CELLS, V5, P439, DOI 10.1046/j.1365-2443.2000.00340.x; Mirzoeva OK, 2003, MOL CANCER RES, V1, P207; Mohanty BK, 2006, P NATL ACAD SCI USA, V103, P897, DOI 10.1073/pnas.0506540103; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; Nagaraju G, 2007, DNA REPAIR, V6, P1018, DOI 10.1016/j.dnarep.2007.02.020; Nedelcheva MN, 2005, J MOL BIOL, V347, P509, DOI 10.1016/j.jmb.2005.01.041; Nedelcheva-Veleva MN, 2006, NUCLEIC ACIDS RES, V34, P4138, DOI 10.1093/nar/gkl528; Noguchi E, 2004, MOL CELL BIOL, V24, P8342, DOI 10.1128/MCB.24.19.8342-8355.2004; Noguchi E, 2003, MOL CELL BIOL, V23, P7861, DOI 10.1128/MCB.23.21.7861-7874.2003; OGAWA T, 1993, SCIENCE, V259, P1896, DOI 10.1126/science.8456314; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; Rijkers T, 1998, MOL CELL BIOL, V18, P6423, DOI 10.1128/MCB.18.11.6423; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sengupta S, 2004, J CELL BIOL, V166, P801, DOI 10.1083/jcb.200405128; Sommariva E, 2005, MOL CELL BIOL, V25, P2770, DOI 10.1128/MCB.25.7.2770-2784.2005; Thorpe PH, 2006, MOL CELL BIOL, V26, P3752, DOI 10.1128/MCB.26.10.3752-3763.2006; Tourriere H, 2005, MOL CELL, V19, P699, DOI 10.1016/j.molcel.2005.07.028; Tourriere H, 2007, DNA REPAIR, V6, P900, DOI 10.1016/j.dnarep.2007.02.004; Unsal-Kacmaz K, 2005, MOL CELL BIOL, V25, P3109, DOI 10.1128/MCB.25.8.3109-3116.2005; Unsal-Kacmaz K, 2007, MOL CELL BIOL, V27, P3131, DOI 10.1128/MCB.02190-06; Walter JC, 2000, J BIOL CHEM, V275, P39773, DOI 10.1074/jbc.M008107200; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wilson DM, 2007, MUTAT RES-FUND MOL M, V616, P11, DOI 10.1016/j.mrfmmm.2006.11.017; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Xiao J, 2003, DEV DYNAM, V228, P82, DOI 10.1002/dvdy.10346; Yamaguchi-Iwai Y, 1998, MOL CELL BIOL, V18, P6430, DOI 10.1128/MCB.18.11.6430; Yoshizawa-Sugata N, 2007, J BIOL CHEM, V282, P2729, DOI 10.1074/jbc.M605596200; Yu YJ, 2002, J VIROL, V76, P3731, DOI 10.1128/JVI.76.8.3731-3738.2002; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	62	27	27	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8768	8776		10.1074/jbc.M806103200	http://dx.doi.org/10.1074/jbc.M806103200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19112184	Green Published, hybrid			2022-12-25	WOS:000264397800061
J	Aziz, A; Hess, JF; Budamagunta, MS; FitzGerald, PG; Voss, JC				Aziz, Atya; Hess, John F.; Budamagunta, Madhu S.; FitzGerald, Paul G.; Voss, John C.			Head and Rod 1 Interactions in Vimentin IDENTIFICATION OF CONTACT SITES, STRUCTURE, AND CHANGES WITH PHOSPHORYLATION USING SITE-DIRECTED SPIN LABELING AND ELECTRON PARAMAGNETIC RESONANCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEDIATE-FILAMENT STRUCTURE; EPIDERMOLYSIS-BULLOSA SIMPLEX; PREDICTING COILED COILS; IN-VITRO; PARAMAGNETIC-RESONANCE; ASSEMBLY PROPERTIES; CIRCULAR-DICHROISM; CROSS-LINKING; AMNION CELLS; PROTEINS	We have used site-directed spin labeling (SDSL) and electron paramagnetic resonance (EPR) to identify residues 17 and 137 as sites of interaction between the head domain and rod domain 1A of the intermediate filament protein vimentin. This interaction was maximal when compared with the spin labels placed at up- and downstream positions in both head and rod regions, indicating that residues 17 and 137 were the closest point of interaction in this region. SDSL EPR characterization of residues 120-145, which includes the site of head contact with rod 1A, reveals that this region exhibits the heptad repeat pattern indicative of alpha-helical coiled-coil structure, but that this heptad repeat pattern begins to decay near residue 139, suggesting a transition out of coiled-coil structure. By monitoring the spectra of spin labels placed at the 17 and 137 residues during in vitro assembly, we show that 17-137 interaction occurs early in the assembly process. We also explored the effect of phosphorylation on the 17-137 interaction and found that phosphorylation-induced changes affected the head-head interaction (17-17) in the dimer, without significantly influencing the rod-rod (137-137) and head-rod (17-137) interactions in the dimer. These data provide the first direct evidence for, and location of, head-rod interactions in assembled intermediate filaments, as well as direct evidence of coiled-coil structure in rod 1A. Finally, the data identify changes in the structure in this region following in vitro phosphorylation.	[Aziz, Atya; Hess, John F.; FitzGerald, Paul G.; Voss, John C.] Univ Calif Davis, Dept Cell Biol & Human Anat, Sch Med, Davis, CA 95616 USA; [Budamagunta, Madhu S.; Voss, John C.] Univ Calif Davis, Dept Biochem & Mol Med, Sch Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Voss, JC (corresponding author), Univ Calif Davis, Dept Cell Biol & Human Anat, Sch Med, Davis, CA 95616 USA.	pgfitzgerald@ucdavis.edu	Budamagunta, Madhu S/C-4628-2011	Voss, John/0000-0001-9279-209X	National Institutes of Health [EY017575, P30 EY012576, AG029246]; National Center for Research Resources, National Institutes of Health [C06 RR-12088-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR012088] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY012576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029246] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants EY017575 ( to P. G. F.) and P30 EY012576 and AG029246 (to J. C. V.). Work was conducted in a facility constructed with support from Research Facilities Improvement Program Grant Number C06 RR-12088-01 from the National Center for Research Resources, National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALBERS K, 1992, INT REV CYTOL, V134, P243, DOI 10.1016/S0074-7696(08)62030-6; Bar H, 2004, J STRUCT BIOL, V148, P137, DOI 10.1016/j.jsb.2004.04.003; BERGER B, 1995, P NATL ACAD SCI USA, V92, P8259, DOI 10.1073/pnas.92.18.8259; BEUTTENMULLER M, 1994, EXP CELL RES, V213, P128, DOI 10.1006/excr.1994.1182; CARTER JM, 1995, EXP EYE RES, V60, P181, DOI 10.1016/S0014-4835(95)80009-3; CELIS JE, 1983, J CELL BIOL, V97, P1429, DOI 10.1083/jcb.97.5.1429; Chomiki N, 2001, EUR J BIOCHEM, V268, P903, DOI 10.1046/j.1432-1327.2001.01946.x; CONWAY JF, 1990, INT J BIOL MACROMOL, V12, P328, DOI 10.1016/0141-8130(90)90023-4; CONWAY JF, 1988, INT J BIOL MACROMOL, V10, P79, DOI 10.1016/0141-8130(88)90015-3; COULOMBE PA, 1991, J CELL BIOL, V115, P1661, DOI 10.1083/jcb.115.6.1661; COULOMBE PA, 1993, SEMIN DERMATOL, V12, P173; DELACOURTE A, 1982, BIOCHIM BIOPHYS ACTA, V709, P99, DOI 10.1016/0167-4838(82)90426-5; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; EVANS RM, 1982, CELL, V29, P43, DOI 10.1016/0092-8674(82)90088-5; FEY SJ, 1983, FEBS LETT, V157, P165, DOI 10.1016/0014-5793(83)81138-7; FUCHS E, 1994, J CELL BIOL, V125, P511, DOI 10.1083/jcb.125.3.511; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; FUCHS E, 1983, CELL, V34, P332, DOI 10.1016/0092-8674(83)90367-7; FUCHS E, 1994, J INVEST DERMATOL, V103, P25; GEISLER N, 1993, J STRUCT BIOL, V110, P205, DOI 10.1006/jsbi.1993.1023; Gohara R, 2001, FEBS LETT, V489, P182, DOI 10.1016/S0014-5793(01)02108-1; Goldie KN, 2007, J STRUCT BIOL, V158, P378, DOI 10.1016/j.jsb.2006.12.007; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688; HERRMANN H, 1992, J MOL BIOL, V223, P637, DOI 10.1016/0022-2836(92)90980-X; HERRMANN H, 1998, INTERMEDIATE FILAMEN; Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197; Hess JF, 2005, J BIOL CHEM, V280, P2141, DOI 10.1074/jbc.M412254200; Hess JF, 2004, J BIOL CHEM, V279, P44841, DOI 10.1074/jbc.M406257200; Hess JF, 2002, J BIOL CHEM, V277, P35516, DOI 10.1074/jbc.M206500200; Hess JF, 2006, BIOCHEMISTRY-US, V45, P11737, DOI 10.1021/bi060741y; HUBBELL WL, 1987, REV SCI INSTRUM, V58, P1879, DOI 10.1063/1.1139536; INAGAKI M, 1987, NATURE, V328, P649, DOI 10.1038/328649a0; KAUFMANN E, 1985, J MOL BIOL, V185, P733, DOI 10.1016/0022-2836(85)90058-0; LIKHTENSHTEIN GI, 1993, BIOPHYSICAL LABELING, P57; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mucke N, 2004, J MOL BIOL, V340, P97, DOI 10.1016/j.jmb.2004.04.039; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; OMARY MB, 2004, INTERMEDIATE FILAMEN; Oshima RG, 2007, EXP CELL RES, V313, P1981, DOI 10.1016/j.yexcr.2007.04.007; PARRY D, 1985, CELLULAR MOL BIOL IN; PARRY D A D, 1992, Current Opinion in Cell Biology, V4, P94, DOI 10.1016/0955-0674(92)90064-J; PARRY DAD, 1985, BIOCHEM BIOPH RES CO, V127, P1012, DOI 10.1016/S0006-291X(85)80045-0; PARRY DAD, 1995, INTERMEDIATE FILAMEN; Parry DAD, 2007, EXP CELL RES, V313, P2204, DOI 10.1016/j.yexcr.2007.04.009; Pittenger JT, 2008, BIOCHEMISTRY-US, V47, P10863, DOI 10.1021/bi801137m; QUINLAN RA, 1983, EUR J BIOCHEM, V132, P477, DOI 10.1111/j.1432-1033.1983.tb07386.x; Sokolova AV, 2006, P NATL ACAD SCI USA, V103, P16206, DOI 10.1073/pnas.0603629103; STEINERT PM, 1993, J MOL BIOL, V230, P436, DOI 10.1006/jmbi.1993.1161; Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255; Strelkov SV, 2004, METHOD CELL BIOL, V78, P25; Strelkov SV, 2004, J MOL BIOL, V343, P1067, DOI 10.1016/j.jmb.2004.08.093; Strelkov SV, 2001, J MOL BIOL, V306, P773, DOI 10.1006/jmbi.2001.4442; TRAUB P, 1993, J MOL BIOL, V230, P837, DOI 10.1006/jmbi.1993.1205; TRAUB P, 1992, J CELL SCI, V101, P363; TRAUB P, 1983, J CELL SCI, V63, P43; Wang H, 2000, J CELL BIOL, V151, P1459, DOI 10.1083/jcb.151.7.1459	57	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7330	7338		10.1074/jbc.M809029200	http://dx.doi.org/10.1074/jbc.M809029200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19117942	Green Published, hybrid			2022-12-25	WOS:000263919000079
J	Kovacs, WJ; Tape, KN; Shackelford, JE; Wikander, TM; Richards, MJ; Fliesler, SJ; Krisans, SK; Faust, PL				Kovacs, Werner J.; Tape, Khanichi N.; Shackelford, Janis E.; Wikander, Thomas M.; Richards, Michael J.; Fliesler, Steven J.; Krisans, Skaidrite K.; Faust, Phyllis L.			Peroxisome Deficiency Causes a Complex Phenotype because of Hepatic SREBP/Insig Dysregulation Associated with Endoplasmic Reticulum Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHESIS; CHOLESTEROL HOMEOSTASIS; ZELLWEGER-SYNDROME; LIVER DYSFUNCTION; STEROL RESISTANCE; GENE-EXPRESSION; KNOCKOUT MOUSE; MESSENGER-RNA; PROTEIN; ACTIVATION	Regulation of hepatic cholesterol biosynthesis, lipogenesis, and insulin signaling intersect at the transcriptional level by control of SREBP and Insig genes. We previously demonstrated that peroxisome-deficient PEX2(-/-) mice activate SREBP-2 pathways but are unable to maintain normal cholesterol homeostasis. In this study, we demonstrate that oral bile acid treatment normalized hepatic and plasma cholesterol levels and hepatic cholesterol synthesis in early postnatal PEX2 mutants, but SREBP-2 and its target gene expressions remained increased. SREBP-2 pathway induction was also observed in neonatal and longer surviving PEX2 mutants, where hepatic cholesterol levels were normal. Abnormal expression patterns for SREBP-1c and Insig-2a, and novel regulation of Insig-2b, further demonstrate that peroxisome deficiency widely affects the regulation of related metabolic pathways. We have provided the first demonstration that peroxisome deficiency activates hepatic endoplasmic reticulum (ER) stress pathways, especially the integrated stress response mediated by PERK and ATF4 signaling. Our studies suggest a mechanism whereby ER stress leads to dysregulation of the endogenous sterol response mechanism and concordantly activates oxidative stress pathways. Several metabolic derangements in peroxisome-deficient PEX2(-/-) liver are likely to trigger ER stress, including perturbed flux of mevalonate metabolites, altered bile acid homeostasis, changes in fatty acid levels and composition, and oxidative stress.	[Kovacs, Werner J.] ETH, Inst Cell Biol, CH-8093 Zurich, Switzerland; [Kovacs, Werner J.; Tape, Khanichi N.; Shackelford, Janis E.; Krisans, Skaidrite K.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Wikander, Thomas M.; Faust, Phyllis L.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Richards, Michael J.; Fliesler, Steven J.] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA; [Richards, Michael J.; Fliesler, Steven J.] St Louis Univ, Inst Eye, Dept Ophthalmol, St Louis, MO 63104 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; California State University System; San Diego State University; Columbia University; Saint Louis University; Saint Louis University	Kovacs, WJ (corresponding author), ETH Honggerberg, Inst Cell Biol, Schafmattstr 18,HPM F39-2, CH-8093 Zurich, Switzerland.	werner.kovacs@cell.biol.ethz.ch	Kovacs, Werner/AAD-1107-2019; Fliesler, Steven J./AAE-9243-2020	Kovacs, Werner/0000-0002-4440-4344; Fliesler, Steven/0000-0002-2557-142X	National Institutes of Health [DK58238, DK58040, HD36807, NS050602, EY007361]; Research to Prevent Blindness; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036807] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY007361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058040, R01DK058238] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050602] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK58238 and DK58040 (to S. K. K.), HD36807 and NS050602 (to P. L. F.), and EY007361 (to S. J. F.). This work was also supported by an unrestricted departmental grant from Research to Prevent Blindness (to S. J. F.).	Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; Allen-Jennings AE, 2002, J BIOL CHEM, V277, P20020, DOI 10.1074/jbc.M200727200; Allen-Jennings AE, 2001, J BIOL CHEM, V276, P29507, DOI 10.1074/jbc.M100986200; Alvarez C, 1999, EUR J CELL BIOL, V78, P1; Baes M, 2006, BBA-MOL CELL RES, V1763, P1785, DOI 10.1016/j.bbamcr.2006.08.018; Baumgart E, 2001, AM J PATHOL, V159, P1477, DOI 10.1016/S0002-9440(10)62534-5; Bochkis IM, 2008, NAT MED, V14, P828, DOI 10.1038/nm.1853; Colgan SM, 2007, INT J BIOCHEM CELL B, V39, P1843, DOI 10.1016/j.biocel.2007.05.002; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Dirkx R, 2005, HEPATOLOGY, V41, P868, DOI 10.1002/hep.20628; Faust PL, 2003, J COMP NEUROL, V461, P394, DOI 10.1002/cne.10699; Faust PL, 1997, J CELL BIOL, V139, P1293, DOI 10.1083/jcb.139.5.1293; Faust PL, 2001, J MOL NEUROSCI, V16, P289, DOI 10.1385/JMN:16:2-3:289; FLIESLER SJ, 2002, STEROLS OXYSTEROLS C; Flowers MT, 2008, PHYSIOL GENOMICS, V33, P361, DOI 10.1152/physiolgenomics.00139.2007; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Harding HP, 2005, CELL METAB, V2, P361, DOI 10.1016/j.cmet.2005.11.005; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hinnebusch AG, 2002, EUKARYOT CELL, V1, P22, DOI 10.1128/EC.01.1.22-32.2002; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; Iovanna JL, 2002, J GASTROINTEST CANC, V31, P89; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Janowski BA, 2002, P NATL ACAD SCI USA, V99, P12675, DOI 10.1073/pnas.202471599; Jousse C, 2007, J BIOL CHEM, V282, P15851, DOI 10.1074/jbc.M611723200; Keane MH, 2007, HEPATOLOGY, V45, P982, DOI 10.1002/hep.21532; Kovacs WJ, 2007, HISTOCHEM CELL BIOL, V127, P273, DOI 10.1007/s00418-006-0254-6; Kovacs WJ, 2004, MOL CELL BIOL, V24, P1, DOI 10.1128/MCB.24.1.1-13.2004; Kovacs WJ, 2002, PROG LIPID RES, V41, P369, DOI 10.1016/S0163-7827(02)00002-4; Lee JN, 2004, J BIOL CHEM, V279, P45257, DOI 10.1074/jbc.M408235200; Lee PCW, 2005, J BIOL CHEM, V280, P25242, DOI 10.1074/jbc.M502989200; Lee PCW, 2007, J LIPID RES, V48, P1944, DOI 10.1194/jlr.M700225-JLR200; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lipson KL, 2006, CELL METAB, V4, P245, DOI 10.1016/j.cmet.2006.07.007; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Niknejad N, 2007, J BIOL CHEM, V282, P29748, DOI 10.1074/jbc.M705859200; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Palmeira CM, 2004, TOXICOLOGY, V203, P1, DOI 10.1016/j.tox.2004.06.001; Passe CMM, 2006, ENDOCRINE, V30, P81, DOI 10.1385/ENDO:30:1:81; Repa JJ, 2000, J BIOL CHEM, V275, P39685, DOI 10.1074/jbc.M007653200; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; Rutkowski DT, 2007, MOL BIOL CELL, V18, P3681, DOI 10.1091/mbc.e07-03-0272; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Schrader M, 2006, BBA-MOL CELL RES, V1763, P1755, DOI 10.1016/j.bbamcr.2006.09.006; Schwarz M, 2001, J LIPID RES, V42, P1594; Seabra MC, 2002, TRENDS MOL MED, V8, P23, DOI 10.1016/S1471-4914(01)02227-4; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Tirasophon W, 2000, GENE DEV, V14, P2725, DOI 10.1101/gad.839400; Wanders RJA, 1998, MOL ASPECTS MED, V19, P71, DOI 10.1016/S0098-2997(98)00003-X; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yabe D, 2003, P NATL ACAD SCI USA, V100, P3155, DOI 10.1073/pnas.0130116100; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Yeagle PL., 1988, BIOL CHOLESTEROL	64	43	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7232	7245		10.1074/jbc.M809064200	http://dx.doi.org/10.1074/jbc.M809064200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19110480	hybrid, Green Published			2022-12-25	WOS:000263919000070
J	Ogusucu, R; Rettori, D; Netto, LES; Augusto, O				Ogusucu, Renata; Rettori, Daniel; Netto, Luis E. S.; Augusto, Ohara			Superoxide Dismutase 1-mediated Production of Ethanol- and DNA-derived Radicals in Yeasts Challenged with Hydrogen Peroxide MOLECULAR INSIGHTS INTO THE GENOME INSTABILITY OF PEROXIREDOXIN-NULL STRAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; OXIDATIVE STRESS-RESPONSE; STRAND BREAK REPAIR; SACCHAROMYCES-CEREVISIAE; OXYGEN-METABOLISM; CELL-DEATH; COPPER; ANION; DECOMPOSITION; MECHANISMS	Peroxiredoxins are receiving increasing attention as defenders against oxidative damage and sensors of hydrogen peroxide-mediated signaling events. In the yeast Saccharomyces cerevisiae, deletion of one or more isoforms of the peroxiredoxins is not lethal but compromises genome stability by mechanisms that remain under scrutiny. Here, we show that cytosolic peroxiredoxin-null cells (tsa1 Delta tsa2 Delta) are more resistant to hydrogen peroxide than wildtype (WT) cells and consume it faster under fermentative conditions. Also, tsa1 Delta tsa2 Delta cells produced higher yields of the 1-hydroxyethyl radical from oxidation of the glucose metabolite ethanol, as proved by spin-trapping experiments. A major role for Fenton chemistry in radical formation was excluded by comparing WT and tsa1 Delta tsa2 Delta cells with respect to their levels of total and chelatable metal ions and of radical produced in the presence of chelators. The main route for 1-hydroxyethyl radical formation was ascribed to the peroxidase activity of Cu, Zn-superoxide dismutase (Sod1), whose expression and activity increased similar to 5- and 2-fold, respectively, in tsa1 Delta tsa2 Delta compared with WT cells. Accordingly, overexpression of human Sod1 in WT yeasts led to increased 1-hydroxyethyl radical production. Relevantly, tsa1 Delta tsa2 Delta cells challenged with hydrogen peroxide contained higher levels of DNA-derived radicals and adducts as monitored by immuno-spin trapping and incorporation of C-14 from glucose into DNA, respectively. The results indicate that part of hydrogen peroxide consumption by tsa1 Delta tsa2 Delta cells is mediated by induced Sod1, which oxidizes ethanol to the 1-hydroxyethyl radical, which, in turn, leads to increased DNA damage. Overall, our studies provide a pathway to account for the hypermutability of peroxiredoxin-null strains.	[Ogusucu, Renata; Rettori, Daniel; Augusto, Ohara] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05513970 Sao Paulo, Brazil; [Netto, Luis E. S.] Univ Sao Paulo, Dept Biol, Inst Biociencias, BR-05513970 Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Augusto, O (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, Caixa Postal 26077, BR-05513970 Sao Paulo, Brazil.	oaugusto@iq.usp.br	Rettori, Daniel/F-4596-2012; Netto, Luis/A-3783-2008; Augusto, Ohara/D-3839-2012	Netto, Luis/0000-0002-4250-9177; Augusto, Ohara/0000-0002-7220-4286	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Projeto Milenio Redoxoma)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Projeto Milenio Redoxoma)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Projeto Milenio Redoxoma).	AUGUSTO O, 1993, FREE RADICAL BIO MED, V15, P329, DOI 10.1016/0891-5849(93)90079-A; Augusto O, 2002, FREE RADICAL BIO MED, V32, P841, DOI 10.1016/S0891-5849(02)00786-4; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Bonatto D, 2007, FREE RADICAL BIO MED, V43, P557, DOI 10.1016/j.freeradbiomed.2007.05.013; Chen L, 2007, CHEM RES TOXICOL, V20, P108, DOI 10.1021/tx060232x; Claiborne A., 1985, CRC HDB METHODS OXYG, P283; Demasi APD, 2006, FEBS J, V273, P805, DOI 10.1111/j.1742-4658.2006.05116.x; DULING DR, 1994, J MAGN RESON SER B, V104, P105, DOI 10.1006/jmrb.1994.1062; FLOHE L, 1984, METHOD ENZYMOL, V105, P93; GRALLA EB, 1991, P NATL ACAD SCI USA, V88, P8558, DOI 10.1073/pnas.88.19.8558; GRALLA EB, 1991, J BACTERIOL, V173, P5918, DOI 10.1128/jb.173.18.5918-5920.1991; Halliwell B., 2007, FREE RADICAL BIO MED, P79; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Huang ME, 2003, P NATL ACAD SCI USA, V100, P11529, DOI 10.1073/pnas.2035018100; Iraqui I, 2008, CANCER RES, V68, P1055, DOI 10.1158/0008-5472.CAN-07-2683; Izawa S, 1996, BIOCHEM J, V320, P61, DOI 10.1042/bj3200061; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Joffe A, 2003, CHEM RES TOXICOL, V16, P1528, DOI 10.1021/tx034142t; Karanjawala ZE, 2003, DNA REPAIR, V2, P285, DOI 10.1016/S1568-7864(02)00218-5; Karanjawala ZE, 2002, CURR BIOL, V12, P397, DOI 10.1016/S0960-9822(02)00684-X; KNECHT KT, 1993, ARCH BIOCHEM BIOPHYS, V303, P339, DOI 10.1006/abbi.1993.1293; Kono H, 2000, J CLIN INVEST, V106, P867, DOI 10.1172/JCI9020; Lee J, 1999, J BIOL CHEM, V274, P16040, DOI 10.1074/jbc.274.23.16040; Lee YA, 2007, CHEM-EUR J, V13, P4571, DOI 10.1002/chem.200601434; Linares E, 2003, FREE RADICAL BIO MED, V34, P766, DOI 10.1016/S0891-5849(02)01424-7; Liochev SI, 2004, P NATL ACAD SCI USA, V101, P743, DOI 10.1073/pnas.0307635100; Liochev SI, 2007, FREE RADICAL BIO MED, V42, P1465, DOI 10.1016/j.freeradbiomed.2007.02.015; Matsuda T, 2007, CARCINOGENESIS, V28, P2363, DOI 10.1093/carcin/bgm057; Matter B, 2007, CHEM RES TOXICOL, V20, P1379, DOI 10.1021/tx7001146; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Medinas DB, 2007, IUBMB LIFE, V59, P255, DOI 10.1080/15216540701230511; MISRA HP, 1979, J BIOL CHEM, V254, P1623; Monje-Casas F, 2004, BIOCHEM J, V383, P139, DOI 10.1042/BJ20040851; Moon JC, 2005, J BIOL CHEM, V280, P28775, DOI 10.1074/jbc.M505362200; Munhoz DC, 2004, J BIOL CHEM, V279, P35219, DOI 10.1074/jbc.M313773200; Nakao LS, 1998, CHEM RES TOXICOL, V11, P888, DOI 10.1021/tx9800351; Nakao LS, 2002, CHEM RES TOXICOL, V15, P1248, DOI 10.1021/tx0255166; Naozuka J, 2007, J BRAZIL CHEM SOC, V18, P1547, DOI 10.1590/S0103-50532007000800015; Oberley L.W., 1985, HDB METHODS OXYGEN R, P217; Ogusucu R, 2007, FREE RADICAL BIO MED, V42, P326, DOI 10.1016/j.freeradbiomed.2006.10.042; PACKER JE, 1981, INT J RADIAT BIOL, V39, P135, DOI 10.1080/09553008114550151; Park SG, 2000, J BIOL CHEM, V275, P5723, DOI 10.1074/jbc.275.8.5723; Peter Y, 2001, EMBO J, V20, P1538, DOI 10.1093/emboj/20.7.1538; PHILIPPSEN P, 1991, METHOD ENZYMOL, V194, P169; RABIZADEH S, 1995, P NATL ACAD SCI USA, V92, P3024, DOI 10.1073/pnas.92.7.3024; RAEM TD, 1999, SCIENCE, V284, P805; Ragu S, 2007, P NATL ACAD SCI USA, V104, P9747, DOI 10.1073/pnas.0703192104; Ramirez DC, 2007, NAT PROTOC, V2, P512, DOI 10.1038/nprot.2007.5; Ramirez DC, 2005, FREE RADICAL BIO MED, V38, P201, DOI 10.1016/j.freeradbiomed.2004.10.008; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Roe JA, 2002, FREE RADICAL BIO MED, V32, P169, DOI 10.1016/S0891-5849(01)00778-X; Rolland F, 2002, FEMS YEAST RES, V2, P183, DOI 10.1111/j.1567-1364.2002.tb00084.x; Salmon JM, 2000, FOOD CHEM, V71, P519, DOI 10.1016/S0308-8146(00)00204-1; Seitz HK, 2007, ALCOHOL RES HEALTH, V30, P38; SENTANDREU R, 1969, BIOCHEM J, V115, P231, DOI 10.1042/bj1150231; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Srinivasan C, 2000, J BIOL CHEM, V275, P29187, DOI 10.1074/jbc.M004239200; Trujillo Madia, 2007, V44, P83; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; WOLFF SP, 1994, METHOD ENZYMOL, V233, P182; Wong CM, 2004, J BIOL CHEM, V279, P23207, DOI 10.1074/jbc.M402095200; Wong CM, 2002, J BIOL CHEM, V277, P5385, DOI 10.1074/jbc.M106846200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; YEGOROV DY, 1993, FREE RADICAL BIO MED, V15, P565, DOI 10.1016/0891-5849(93)90158-Q; YIM MB, 1993, J BIOL CHEM, V268, P4099; ZAMOCKY M, 1995, FEBS LETT, V367, P241, DOI 10.1016/0014-5793(95)00568-T; Zhang H, 2000, J BIOL CHEM, V275, P14038, DOI 10.1074/jbc.275.19.14038	69	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5546	5556		10.1074/jbc.M805526200	http://dx.doi.org/10.1074/jbc.M805526200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19106092	hybrid			2022-12-25	WOS:000263560600018
J	Webster, RJ; Giles, KM; Price, KJ; Zhang, PM; Mattick, JS; Leedman, PJ				Webster, Rebecca J.; Giles, Keith M.; Price, Karina J.; Zhang, Priscilla M.; Mattick, John S.; Leedman, Peter J.			Regulation of Epidermal Growth Factor Receptor Signaling in Human Cancer Cells by MicroRNA-7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; 3'-UNTRANSLATED REGION; TYROSINE KINASE; EXPRESSION; TARGET; EGFR; IDENTIFICATION; STIMULATION; INVOLVEMENT; MICROARRAY	The epidermal growth factor receptor (EGFR) is frequently overexpressed in cancer and is an important therapeutic target. Aberrant expression and function of microRNAs have been associated with tumorigenesis. Bioinformatic predictions suggest that the human EGFR mRNA 3'-untranslated region contains three microRNA-7 (miR-7) target sites, which are not conserved across mammals. We found that miR-7 down-regulates EGFR mRNA and protein expression in cancer cell lines (lung, breast, and glioblastoma) via two of the three sites, inducing cell cycle arrest and cell death. Because miR-7 was shown to decrease EGFR mRNA expression, we used microarray analysis to identify additional mRNA targets of miR-7. These included Raf1 and multiple other genes involved in EGFR signaling and tumorigenesis. Furthermore, miR-7 attenuated activation of protein kinase B (Akt) and extracellular signal-regulated kinase 1/2, two critical effectors of EGFR signaling, in different cancer cell lines. These data establish an important role for miR-7 in controlling mRNA expression and indicate that miR-7 has the ability to coordinately regulate EGFR signaling in multiple human cancer cell types.	[Webster, Rebecca J.; Giles, Keith M.; Price, Karina J.; Zhang, Priscilla M.; Leedman, Peter J.] Univ Western Australia, Med Res Ctr, Western Australian Inst Med Res, Lab Canc Med, Perth, WA 6000, Australia; [Webster, Rebecca J.; Price, Karina J.; Leedman, Peter J.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6000, Australia; [Mattick, John S.] Univ Queensland, Australian Res Council, Special Res Ctr Funct & Appl Genom, Inst Mol Biosci, Brisbane, Qld 4000, Australia	University of Western Australia; University of Western Australia; University of Queensland	Leedman, PJ (corresponding author), Univ Western Australia, Med Res Ctr, Western Australian Inst Med Res, Lab Canc Med, Level 6,MRF Bldg,Rear 50 Murray St, Perth, WA 6000, Australia.	peterl@waimr.uwa.edu.au	Mattick, John/ABH-6130-2020; Mattick, John S/I-7789-2012; Leedman, Peter J/O-4044-2014	Mattick, John/0000-0002-7680-7527; Mattick, John S/0000-0002-7680-7527; 	National Health and Medical Research Council of Australia; The Office of Innovation; Industry at the University of Western Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); The Office of Innovation; Industry at the University of Western Australia	This work was supported by the National Health and Medical Research Council of Australia and the The Office of Innovation and Industry at the University of Western Australia co-funded the PCT application on miR-7 (lodged August 28, 2007).	Akao Y, 2007, CANCER SCI, V98, P1914, DOI 10.1111/j.1349-7006.2007.00618.x; Aoki H, 2007, CLIN CANCER RES, V13, P6603, DOI 10.1158/1078-0432.CCR-07-0145; Arteaga CL, 2001, J CLIN ONCOL, V19, p32S; Balmer LA, 2001, MOL CELL BIOL, V21, P2070, DOI 10.1128/MCB.21.6.2070-2084.2001; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bianco R, 2005, ENDOCR-RELAT CANCER, V12, pS159, DOI 10.1677/erc.1.00999; Bottoni A, 2007, J CELL PHYSIOL, V210, P370, DOI 10.1002/jcp.20832; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Giles KM, 2003, J BIOL CHEM, V278, P2937, DOI 10.1074/jbc.M208439200; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Haisenleder DJ, 2003, ENDOCRINOLOGY, V144, P2768, DOI 10.1210/en.2002-0168; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Kim SW, 2003, J BIOL CHEM, V278, P2661, DOI 10.1074/jbc.M205819200; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kuhn DE, 2008, METHODS, V44, P47, DOI 10.1016/j.ymeth.2007.09.005; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Kunin V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-401; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee HJ, 2006, P NATL ACAD SCI USA, V103, P15669, DOI 10.1073/pnas.0605781103; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li X, 2005, CELL, V123, P1267, DOI 10.1016/j.cell.2005.10.040; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mattick JS, 2005, HUM MOL GENET, V14, pR121, DOI 10.1093/hmg/ddi101; Maziere P, 2007, DRUG DISCOV TODAY, V12, P452, DOI 10.1016/j.drudis.2007.04.002; Newman JC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r81; Perkins DO, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r27; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Reddy SDN, 2008, CANCER RES, V68, P8195, DOI 10.1158/0008-5472.CAN-08-2103; Ritter CA, 2003, SEMIN ONCOL, V30, P3, DOI 10.1053/sonc.2003.50027; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tripp SR, 2005, ANAL QUANT CYTOL, V27, P71; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Weihua Z, 2008, CANCER CELL, V13, P385, DOI 10.1016/j.ccr.2008.03.015; Yano S, 2003, ANTICANCER RES, V23, P3639; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	51	347	388	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5731	5741		10.1074/jbc.M804280200	http://dx.doi.org/10.1074/jbc.M804280200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19073608	hybrid			2022-12-25	WOS:000263560600037
J	Oliveira, JMA; Goncalves, J				Oliveira, Jorge M. A.; Goncalves, Jorge			In Situ Mitochondrial Ca2+ Buffering Differences of Intact Neurons and Astrocytes from Cortex and Striatum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED PERMEABILITY TRANSITION; HUNTINGTONS-DISEASE; CYCLOSPORINE-A; BRAIN MITOCHONDRIA; NEURODEGENERATIVE DISEASE; SYNAPTIC MITOCHONDRIA; CALCIUM INFLUX; CYCLOPHILIN-D; GLIAL-CELLS; HETEROGENEITY	The striatum is particularly vulnerable to neurological disorders, such as Huntington disease. Previous studies, with nonsynaptic mitochondria isolated from cortical and striatal homogenates, suggest that striatal mitochondria are highly vulnerable to Ca2+ loads, possibly influencing striatal vulnerability. However, whether and how neuronal and glial mitochondria from cortex and striatum differ in Ca2+ vulnerability remains unknown. We test this hypothesis using a novel strategy allowing comparisons of mitochondrial Ca2+ buffering capacity in cortical and striatal neuron-astrocyte co-cultures. We provide original evidence that mitochondria not only in neurons but also in astrocytes from striatal origin exhibit a decreased Ca2+ buffering capacity when compared with cortical counterparts. The decreased mitochondrial Ca2+ buffering capacity in striatal versus cortical astrocytes does not stem from variation in mitochondrial concentration or in the rate of intracellular Ca2+ elevation, being mechanistically linked to an increased propensity to undergo cyclosporin A (CsA)-sensitive permeability transition. Indeed, 1 mu M CsA selectively increased the mitochondrial Ca2+ buffering capacity of striatal astrocytes, without modifying that of neurons or cortical astrocytes. Neither thapsigargin nor FK506 modified mitochondrial Ca2+ buffering differences between cell types, excluding a predominant contribution of endoplasmic reticulum or calcineurin. These results provide additional insight into the mechanisms of striatal vulnerability, showing that the increased Ca2+ vulnerability of striatal versus cortical mitochondria resides in both intact neurons and astrocytes, thus positioning the striatum at greater risk for disturbed neuron-astrocyte interactions. Also, the selective effect of CsA over striatal astrocytes suggests that in vivo neuronal sheltering with this compound may indirectly result from astrocytic protection.	[Oliveira, Jorge M. A.; Goncalves, Jorge] Univ Porto, Fac Farm, Serv Farmacol, REQUIMTE, P-4050047 Oporto, Portugal	Universidade do Porto	Oliveira, JMA (corresponding author), Univ Porto, Fac Farm, Serv Farmacol, REQUIMTE, Rua Anibal Cunha 164, P-4050047 Oporto, Portugal.	jorgemao@ff.up.pt	Goncalves, Jorge MM/X-4629-2018; Gonçalves, Jorge/E-1726-2013; REQUIMTE, PHYTO/M-4633-2013; Oliveira, Jorge M. A./D-4787-2013	Goncalves, Jorge MM/0000-0002-3045-2150; Gonçalves, Jorge/0000-0002-3045-2150; Oliveira, Jorge M. A./0000-0002-6040-5355				Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Bambrick L, 2004, NEUROCHEM RES, V29, P601, DOI 10.1023/B:NERE.0000014830.06376.e6; Bambrick LL, 2006, J BIOENERG BIOMEMBR, V38, P43, DOI 10.1007/s10863-006-9004-7; Brown AM, 2004, J NEUROCHEM, V89, P537, DOI 10.1111/j.1471-4159.2004.02421.x; Brown MR, 2006, J BIOL CHEM, V281, P11658, DOI 10.1074/jbc.M510303200; Brustovetsky N, 2003, J NEUROSCI, V23, P4858; Brustovetsky N, 2000, J NEUROSCI, V20, P8229, DOI 10.1523/JNEUROSCI.20-22-08229.2000; Calabresi P, 2000, NEUROLOGY, V55, P1249, DOI 10.1212/WNL.55.9.1249; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chalmers S, 2003, J BIOL CHEM, V278, P19062, DOI 10.1074/jbc.M212661200; Chinopoulos C, 2003, J BIOL CHEM, V278, P27382, DOI 10.1074/jbc.M303808200; Cho JH, 1997, BIOCHEM J, V324, P971, DOI 10.1042/bj3240971; Collins TJ, 2002, EMBO J, V21, P1616, DOI 10.1093/emboj/21.7.1616; Cowan CM, 2006, CURR TOP DEV BIOL, V75, P25, DOI 10.1016/S0070-2153(06)75002-5; Dienel GA, 2005, GLIA, V50, P362, DOI 10.1002/glia.20157; Eliseev RA, 2007, NEUROBIOL AGING, V28, P1532, DOI 10.1016/j.neurobiolaging.2006.06.022; Friberg H, 1998, J NEUROSCI, V18, P5151, DOI 10.1523/JNEUROSCI.18-14-05151.1998; GARCIA JH, 1995, STROKE, V26, P636, DOI 10.1161/01.STR.26.4.636; HAUGLAND RP, 2002, HDB FLUORESCENT PROB, P776; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; Krieger C, 2002, EUR J PHARMACOL, V447, P177, DOI 10.1016/S0014-2999(02)01842-3; Kristian T, 2006, J NEUROSCI METH, V152, P136, DOI 10.1016/j.jneumeth.2005.08.018; Kristian T, 2002, J NEUROCHEM, V83, P1297, DOI 10.1046/j.1471-4159.2002.01238.x; Leventhal L, 2000, J COMP NEUROL, V425, P471, DOI 10.1002/1096-9861(20001002)425:4<471::AID-CNE1>3.0.CO;2-U; Li LJ, 2003, NEUROBIOL AGING, V24, P1113, DOI 10.1016/j.neurobiolaging.2003.04.003; LI SH, 1993, NEURON, V11, P985, DOI 10.1016/0896-6273(93)90127-D; Lobsiger CS, 2007, NAT NEUROSCI, V10, P1355, DOI 10.1038/nn1988; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Makowska A, 2000, EUR J BIOCHEM, V267, P877, DOI 10.1046/j.1432-1327.2000.01066.x; McDonald JW, 1996, ANN NEUROL, V40, P750, DOI 10.1002/ana.410400511; Naga KK, 2007, J NEUROSCI, V27, P7469, DOI 10.1523/JNEUROSCI.0646-07.2007; Nicholls DG, 2006, J BIOL CHEM, V281, P14864, DOI 10.1074/jbc.M510916200; Nicholls DG, 2005, CELL CALCIUM, V38, P311, DOI 10.1016/j.ceca.2005.06.011; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Oliveira JMA, 2007, J NEUROCHEM, V101, P241, DOI 10.1111/j.1471-4159.2006.04361.x; Oliveira JMA, 2006, J NEUROSCI, V26, P11174, DOI 10.1523/JNEUROSCI.3004-06.2006; Rizzuto Rosario, 2004, Sci STKE, V2004, pre1, DOI 10.1126/stke.2152004re1; Rosas HD, 2008, BRAIN, V131, P1057, DOI 10.1093/brain/awn025; Rossi DJ, 2007, NAT NEUROSCI, V10, P1377, DOI 10.1038/nn2004; Shin JY, 2005, J CELL BIOL, V171, P1001, DOI 10.1083/jcb.200508072; Smith R, 2005, CELL MOL LIFE SCI, V62, P1901, DOI 10.1007/s00018-005-5084-5; Sonnewald U, 1998, J CEREBR BLOOD F MET, V18, P231, DOI 10.1097/00004647-199803000-00001; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Ward MW, 2000, J NEUROSCI, V20, P7208; Weber JT, 2001, J BIOL CHEM, V276, P1800, DOI 10.1074/jbc.M009209200; Wokosin DL, 2004, BIOPHYS J, V86, P1726, DOI 10.1016/S0006-3495(04)74241-1	47	32	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5010	5020		10.1074/jbc.M807459200	http://dx.doi.org/10.1074/jbc.M807459200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19106091	Green Published, hybrid			2022-12-25	WOS:000263416600031
J	Ray, S; Dutta, D; Rumi, MAK; Kent, LN; Soares, MJ; Paul, S				Ray, Soma; Dutta, Debasree; Rumi, M. A. Karim; Kent, Lindsey N.; Soares, Michael J.; Paul, Soumen			Context-dependent Function of Regulatory Elements and a Switch in Chromatin Occupancy between GATA3 and GATA2 Regulate Gata2 Transcription during Trophoblast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BINDING PROTEIN; CELL-DIFFERENTIATION; GENE-EXPRESSION; STEM-CELLS; ERYTHROID-DIFFERENTIATION; PROLACTIN FAMILY; FACTOR INTERPLAY; THYROID-HORMONE; NERVOUS-SYSTEM; MICE LACKING	GATA transcription factors are important regulators of tissue-specific gene expression during development. GATA2 and GATA3 have been implicated in the regulation of trophoblast-specific genes. However, the regulatory mechanisms of GATA2 expression in trophoblast cells are poorly understood. In this study, we demonstrate that Gata2 is transcriptionally induced during trophoblast giant cell-specific differentiation. Transcriptional induction is associated with displacement of GATA3-dependent nucleoprotein complexes by GATA2-dependent nucleoprotein complexes at two regulatory regions, the -3.9- and +9.5-kb regions, of the mouse Gata2 locus. Analyses with reporter genes showed that, in trophoblast cells, -3.9- and +9.5-kb regions function as transcriptional enhancers in GATA motif independent and dependent fashions, respectively. We also found that knockdown of GATA3 by RNA interference induces GATA2 in undifferentiated trophoblast cells. Interestingly, three other known GATA motif-dependent Gata2 regulatory elements, the -1.8-, -2.8-, and -77-kb regions, which are important to regulate Gata2 in hematopoietic cells are not occupied by GATA factors in trophoblast cells. These elements do not show any enhancer activity and also possess inaccessible chromatin structure in trophoblast cells indicating a context-dependent function. Our results indicate that GATA3 directly represses Gata2 in undifferentiated trophoblast cells, and a switch in chromatin occupancy between GATA3 and GATA2 (GATA3/GATA2 switch) induces transcription during trophoblast differentiation. We predict that this GATA3/GATA2 switch is an important mechanism for the transcriptional regulation of other trophoblast-specific genes.	[Paul, Soumen] Univ Kansas, Med Ctr, Inst Maternal Fetal Biol, Kansas City, KS 66160 USA; Univ Kansas, Med Ctr, Div Canc & Dev Biol, Dept Pathol & Lab Med, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Paul, S (corresponding author), Univ Kansas, Med Ctr, Inst Maternal Fetal Biol, Kansas City, KS 66160 USA.	spaul2@kumc.edu		Kent, Lindsey N./0000-0003-4990-8477	National Institutes of Health [P20 RRO24214, HD20676]; NIH/Kansas INBRE [P20 RRO16475]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD020676] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475, P20RR024214] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/Kansas INBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants COBRE P20 RRO24214 and HD20676. This work was also supported by NIH/Kansas INBRE Grant P20 RRO16475. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ain R, 2003, DEV BIOL, V260, P176, DOI 10.1016/S0012-1606(03)00210-0; Blobel GA, 1998, P NATL ACAD SCI USA, V95, P2061, DOI 10.1073/pnas.95.5.2061; Bresnick EH, 2005, J CELL PHYSIOL, V205, P1, DOI 10.1002/jcp.20393; Cheng YH, 2005, BIOL REPROD, V73, P500, DOI 10.1095/biolreprod.105.039941; Craven SE, 2004, DEVELOPMENT, V131, P1165, DOI 10.1242/dev.01024; Crawford SE, 2002, J BIOL CHEM, V277, P3585, DOI 10.1074/jbc.M107995200; Crispino JD, 1999, MOL CELL, V3, P219, DOI 10.1016/S1097-2765(00)80312-3; Cross JC, 2003, PLACENTA, V24, P123, DOI 10.1053/plac.2002.0887; Cross JC, 2005, PLACENTA, V26, pS3, DOI 10.1016/j.placenta.2005.01.015; Dutta D, 2008, J BIOL CHEM, V283, P25404, DOI 10.1074/jbc.M804349200; FARIA TN, 1991, ENDOCRINOLOGY, V129, P2895, DOI 10.1210/endo-129-6-2895; Flavell RA, 1999, COLD SPRING HARB SYM, V64, P563, DOI 10.1101/sqb.1999.64.563; Follows GA, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm108; GEORGE KM, 1994, DEVELOPMENT, V120, P2673; Gordon DF, 2006, MOL ENDOCRINOL, V20, P1073, DOI 10.1210/me.2005-0115; Grass JA, 2003, P NATL ACAD SCI USA, V100, P8811, DOI 10.1073/pnas.1432147100; Grass JA, 2006, MOL CELL BIOL, V26, P7056, DOI 10.1128/MCB.01033-06; Im Hogune, 2004, Methods Mol Biol, V284, P129; Khandekar M, 2007, DEVELOPMENT, V134, P1703, DOI 10.1242/dev.001297; Kobayashi-Osaki M, 2005, MOL CELL BIOL, V25, P7005, DOI 10.1128/MCB.25.16.7005-7020.2005; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Kurata H, 2002, J IMMUNOL, V168, P4538, DOI 10.4049/jimmunol.168.9.4538; Landles C, 2003, MOL ENDOCRINOL, V17, P2418, DOI 10.1210/me.2003-0097; Ma GT, 1997, DEVELOPMENT, V124, P907; Ma GT, 2000, BIOL REPROD, V63, P570, DOI 10.1095/biolreprod63.2.570; Martindill DMJ, 2007, NAT CELL BIOL, V9, P1131, DOI 10.1038/ncb1633; Martowicz ML, 2005, J BIOL CHEM, V280, P1724, DOI 10.1074/jbc.M406038200; Matsushita A, 2007, MOL ENDOCRINOL, V21, P865, DOI 10.1210/me.2006-0208; Minegishi N, 1998, J BIOL CHEM, V273, P3625, DOI 10.1074/jbc.273.6.3625; Minegishi N, 1999, BLOOD, V93, P4196, DOI 10.1182/blood.V93.12.4196.412k23_4196_4207; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Molkentin JD, 2000, MOL CELL BIOL, V20, P5256, DOI 10.1128/MCB.20.14.5256-5260.2000; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Nardelli J, 1999, DEV BIOL, V210, P305, DOI 10.1006/dbio.1999.9278; NG YK, 1994, DEVELOPMENT, V120, P3257; ORLIC D, 1995, P NATL ACAD SCI USA, V92, P4601, DOI 10.1073/pnas.92.10.4601; Pal S, 2004, P NATL ACAD SCI USA, V101, P980, DOI 10.1073/pnas.0307612100; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; Peng LH, 2004, MOL ENDOCRINOL, V18, P2049, DOI 10.1210/me.2004-0028; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Rossant J, 2001, STEM CELLS, V19, P477, DOI 10.1634/stemcells.19-6-477; Sahgal N, 2006, METH MOLEC MED, V121, P159; Sahgal N, 2005, DIFFERENTIATION, V73, P452, DOI 10.1111/j.1432-0436.2005.00044.x; Simmons DG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-352; Simmons DG, 2005, DEV BIOL, V284, P12, DOI 10.1016/j.ydbio.2005.05.010; Soares MJ, 2007, TRENDS ENDOCRIN MET, V18, P114, DOI 10.1016/j.tem.2007.02.005; STEGER DJ, 1994, MOL CELL BIOL, V14, P5592, DOI 10.1128/MCB.14.8.5592; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Wiemers DO, 2003, ENDOCRINOLOGY, V144, P313, DOI 10.1210/en.2002-220724; Wozniak RJ, 2008, MOL CELL BIOL, V28, P6681, DOI 10.1128/MCB.01061-08; Wozniak RJ, 2007, J BIOL CHEM, V282, P14665, DOI 10.1074/jbc.M700792200; YAMAMOTO M, 1990, GENE DEV, V4, P1650, DOI 10.1101/gad.4.10.1650; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhou MX, 2001, J EXP MED, V194, P1461, DOI 10.1084/jem.194.10.1461; Zhu YJ, 2000, J BIOL CHEM, V275, P14779, DOI 10.1074/jbc.C000121200	58	54	55	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4978	4988		10.1074/jbc.M807329200	http://dx.doi.org/10.1074/jbc.M807329200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19106099	hybrid, Green Published			2022-12-25	WOS:000263416600028
J	Huang, S; Ryan, RM; Vandenberg, RJ				Huang, Shiwei; Ryan, Renae M.; Vandenberg, Robert J.			The Role of Cation Binding in Determining Substrate Selectivity of Glutamate Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID TRANSPORTER; EXTRACELLULAR GATE; CHLORIDE CONDUCTANCE; HIGH-AFFINITY; ION; SODIUM; CHANNELS; HOMOLOG; FLUXES; EAAC1	Glutamate transport is coupled to the co-transport of 3Na(+) and 1H(+) and the countertransport of 1K(+). However, the mechanism of how this process occurs is not well understood. The crystal structure of an archaeal homolog of the human glutamate transporters, Glt(Ph), has provided the framework to begin to understand the mechanism of transport. The glutamate transporter EAAT2 is different from other subtypes in two respects. First, Li+ cannot support transport by EAAT2, whereas it can support transport by the other excitatory amino acid transporters, and second, EAAT2 is sensitive to a wider range of blockers than other subtypes. We have investigated the relationship between the cation driving transport and whether the glutamate analogues, L-anti-endo-3,4-methanopyrrolidine-dicarboxylic acid (MPDC) and (2S,4R)-4-methylglutamate (4MG), are substrates or blockers of transport. We have also investigated the molecular basis for these differences. EAAT2 has a Ser residue at position 441 with hairpin loop 2, whereas the corresponding residue in EAAT1 is a Gly residue. We demonstrate that if the transporter has a Ser residue at this position, then 4MG and MPDC are poor substrates in Na+, and Li+ cannot support transport of any substrate. Conversely, if the transporter has a Gly residue at this position, then in Na+ 4MG and MPDC are substrates with efficacy comparable with glutamate, but in Li+ 4MG and MPDC are poor substrates relative to glutamate. This Ser/Gly residue is located between the bound substrate and one of the cation binding sites, which provides an explanation for the coupling of substrate and cation binding.	[Huang, Shiwei; Ryan, Renae M.; Vandenberg, Robert J.] Univ Sydney, Transporter Biol Grp, Discipline Pharmacol, Sch Med Sci,Bosch Inst, Sydney, NSW 2006, Australia	University of Sydney	Huang, S (corresponding author), Univ Sydney, Transporter Biol Grp, Discipline Pharmacol, Sch Med Sci,Bosch Inst, Sydney, NSW 2006, Australia.		Vandenberg, Robert John/E-6018-2016; Ryan, Renae/AAC-3540-2021	Vandenberg, Robert John/0000-0003-1523-4814; Ryan, Renae/0000-0002-8680-4610	Australian National Health and Medical Research Council (NHMRC); University of Sydney; NHMRC	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); University of Sydney(University of Sydney); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by an Australian National Health and Medical Research Council (NHMRC) project grant. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by a University of Sydney postgraduate award.; Supported by an NHMRC C. J. Martin Fellowship.; Supported by an NHMRC Senior Research Fellowship.	ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Bridges RJ, 1999, CURR PHARM DESIGN, V5, P363; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Huang ZJ, 2008, BIOPHYS J, V95, P2292, DOI 10.1529/biophysj.108.133421; Melzer N, 2003, J BIOL CHEM, V278, P50112, DOI 10.1074/jbc.M307990200; Menaker D, 2006, J NEUROCHEM, V99, P20, DOI 10.1111/j.1471-4159.2006.04003.x; Ryan RM, 2007, NAT STRUCT MOL BIOL, V14, P365, DOI 10.1038/nsmb1230; Ryan RM, 2004, J BIOL CHEM, V279, P20742, DOI 10.1074/jbc.M304433200; Shimamoto K, 2007, MOL PHARMACOL, V71, P294, DOI 10.1124/mol.106.027250; Shrivastava IH, 2008, J BIOL CHEM, V283, P28680, DOI 10.1074/jbc.M800889200; Tao Z, 2006, J BIOL CHEM, V281, P10263, DOI 10.1074/jbc.M510739200; Tao Z, 2007, J GEN PHYSIOL, V129, P331, DOI 10.1085/jgp.200609678; Vandenberg RJ, 1997, MOL PHARMACOL, V51, P809, DOI 10.1124/mol.51.5.809; Vandenberg RJ, 1998, BRIT J PHARMACOL, V123, P1593, DOI 10.1038/sj.bjp.0701776; Vandenberg RJ, 2008, CHANNELS, V2, P51, DOI 10.4161/chan.2.1.6047; Veruki ML, 2006, NAT NEUROSCI, V9, P1388, DOI 10.1038/nn1793; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhang YM, 1999, P NATL ACAD SCI USA, V96, P1710, DOI 10.1073/pnas.96.4.1710; Zhang YM, 1998, P NATL ACAD SCI USA, V95, P751, DOI 10.1073/pnas.95.2.751	25	17	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4510	4515		10.1074/jbc.M808495200	http://dx.doi.org/10.1074/jbc.M808495200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19074430	hybrid			2022-12-25	WOS:000263134400051
J	Shi, L; Jian, K; Ko, ML; Trump, D; Ko, GYP				Shi, Liheng; Jian, Kuihuan; Ko, Michael L.; Trump, Dorothy; Ko, Gladys Y. -P.			Retinoschisin, a New Binding Partner for L-type Voltage-gated Calcium Channels in the Retina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-LINKED RETINOSCHISIS; ARYLALKYLAMINE N-ACETYLTRANSFERASE; STATIONARY NIGHT BLINDNESS; CIRCADIAN REGULATION; CA2+ CHANNEL; JUVENILE RETINOSCHISIS; DEPENDENT FACILITATION; CONE PHOTORECEPTORS; CALMODULIN KINASE; BIPOLAR CELLS	The L-type voltage-gated calcium channels (L-VGCCs) are activated under high depolarization voltages. They are vital for diverse biological events, including cell excitability, differentiation, and synaptic transmission. In retinal photoreceptors, L-VGCCs are responsible for neurotransmitter release and are under circadian influences. However, the mechanism of L-VGCC regulation in photoreceptors is not fully understood. Here, we show that retinoschisin, a highly conserved extracellular protein, interacts with the L-VGCC alpha 1D subunit and regulates its activities in a circadian manner. Mutations in the gene encoding retinoschisin (RS1) cause retinal disorganization that leads to early onset of macular degeneration. Since ion channel activities can be modulated through interactions with extracellular proteins, disruption of these interactions can alter physiology and be the root cause of disease states. Co-immunoprecipitation and mammalian two-hybrid assays showed that retinoschisin and the N-terminal fragment of the L-VGCC alpha 1D subunit physically interacted with one another. The expression and secretion of retinoschisin are under circadian regulation with a peak at night and nadir during the day. Inhibition of L-type VGCCs decreased membrane-bound retinoschisin at night. Overexpression of a missense RS1 mutant gene, R141G, into chicken cone photoreceptors caused a decrease of L-type VGCC currents at night. Our findings demonstrate a novel bidirectional relationship between an ion channel and an extracellular protein; L-type VGCCs regulate the circadian rhythm of retinoschisin secretion, whereas secreted retinoschisin feeds back to regulate L-type VGCCs. Therefore, physical interactions between L-VGCC alpha 1D subunits and retinoschisin play an important role in the membrane retention of L-VGCC alpha 1D subunits and photoreceptor-bipolar synaptic transmission.	[Shi, Liheng; Jian, Kuihuan; Ko, Michael L.; Ko, Gladys Y. -P.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX 77843 USA; [Trump, Dorothy] Univ Manchester, Fac Med & Hlth Sci, Med Genet Res Grp, Manchester M13 9PT, Lancs, England; [Trump, Dorothy] Univ Manchester, Fac Med & Hlth Sci, Ctr Mol Med, Manchester M13 9PT, Lancs, England	Texas A&M University System; Texas A&M University College Station; University of Manchester; University of Manchester	Ko, GYP (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, Mail Stop 4458, College Stn, TX 77843 USA.	gko@cvm.tamu.edu	Tuluc, Petronel/C-2527-2011; Jian, Kuihuan/C-3646-2012		National Institutes of Health [NIHRO1EY017452, S10RR022532, P42ES004917, P30ES009106]; Department of Veterinary Integrative Bioscience Programmatic Development Minigrant; Texas AM University; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022532] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY017452] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004917, P30ES009106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterinary Integrative Bioscience Programmatic Development Minigrant; Texas AM University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health, NEI Grant NIHRO1EY017452 (to G.Y.-P.K.). This work was also supported by a Department of Veterinary Integrative Bioscience Programmatic Development Minigrant (to G.Y.-P.K.) and the start-up fund from Texas A&M University (to G.Y.-P.K.). The Image Analysis Laboratory has been supported in part by National Institutes of Health Grants S10RR022532, P42ES004917, and P30ES009106. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Abernethy DR, 2002, J PHARMACOL EXP THER, V300, P724, DOI 10.1124/jpet.300.3.724; Barnes S, 2002, ADV EXP MED BIOL, V514, P465; Bech-Hansen NT, 1998, NAT GENET, V19, P264, DOI 10.1038/947; Bodi I, 2005, J CLIN INVEST, V115, P3306, DOI 10.1172/JCI27167; Bradshaw K, 2004, DOC OPHTHALMOL, V108, P135, DOI 10.1023/B:DOOP.0000036786.22179.44; CAHILL GM, 1995, PROG RETIN EYE RES, V14, P267, DOI 10.1016/1350-9462(94)00001-Y; Chae KS, 2005, J NEUROCHEM, V94, P367, DOI 10.1111/j.1471-4159.2005.03201.x; Dzhura I, 2003, J PHYSIOL-LONDON, V550, P731, DOI 10.1113/jphysiol.2003.043778; Dzhura I, 2002, J PHYSIOL-LONDON, V545, P399, DOI 10.1113/jphysiol.2002.021881; Dzhura I, 2000, NAT CELL BIOL, V2, P173, DOI 10.1038/35004052; Evers MR, 2002, J NEUROSCI, V22, P7177; Gehrig A, 1999, J MED GENET, V36, P932; GLEASON E, 1992, VISUAL NEUROSCI, V8, P315, DOI 10.1017/S0952523800005058; Grayson C, 2000, HUM MOL GENET, V9, P1873, DOI 10.1093/hmg/9.12.1873; Green CB, 2004, J BIOL RHYTHM, V19, P91, DOI 10.1177/0748730404263002; Gui PC, 2006, J BIOL CHEM, V281, P14015, DOI 10.1074/jbc.M600433200; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Hull C, 2006, J NEUROPHYSIOL, V96, P2025, DOI 10.1152/jn.00364.2006; Ivanova TN, 2003, BRAIN RES, V973, P56, DOI 10.1016/S0006-8993(03)02540-X; Ivanova TN, 2003, BRAIN RES, V991, P96, DOI 10.1016/j.brainres.2003.08.003; Ko GYP, 2004, BRAIN RES, V1021, P277, DOI 10.1016/j.brainres.2004.05.072; Ko GYP, 2004, J NEUROSCI, V24, P1296, DOI 10.1523/JNEUROSCI.3560-03.2004; Ko GYP, 2003, J NEUROSCI, V23, P3145; Ko GYP, 2001, NEURON, V29, P255, DOI 10.1016/S0896-6273(01)00195-7; Ko ML, 2008, INVEST OPHTH VIS SCI, V49, P1615, DOI 10.1167/iovs.07-1189; Ko ML, 2007, J NEUROCHEM, V103, P784, DOI 10.1111/j.1471-4159.2007.04816.x; Molday LL, 2007, J BIOL CHEM, V282, P32792, DOI 10.1074/jbc.M706321200; Molday LL, 2001, INVEST OPHTH VIS SCI, V42, P816; Molday RS, 2007, EXP EYE RES, V84, P227, DOI 10.1016/j.exer.2005.12.013; Morgans CW, 2005, VISUAL NEUROSCI, V22, P561, DOI 10.1017/S0952523805225038; Norris CM, 2002, NEUROSCIENCE, V110, P213, DOI 10.1016/S0306-4522(01)00574-7; Reid SNM, 1999, GENE, V227, P257, DOI 10.1016/S0378-1119(98)00578-2; Reid SNM, 2005, GLIA, V49, P397, DOI 10.1002/glia.20131; Reid SNM, 2003, J NEUROSCI, V23, P6030, DOI 10.1523/JNEUROSCI.23-14-06030.2003; Singh A, 2008, J BIOL CHEM, V283, P20733, DOI 10.1074/jbc.M802254200; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; Takada Y, 2004, INVEST OPHTH VIS SCI, V45, P3302, DOI 10.1167/iovs.04-0156; Takada Y, 2006, MOL VIS, V12, P1108; Tantri A, 2004, SURV OPHTHALMOL, V49, P214, DOI 10.1016/j.survophthal.2003.12.007; Waitkus-Edwards KR, 2002, CIRC RES, V90, P473, DOI 10.1161/hh0402.105899; Wang T, 2006, BRIT J OPHTHALMOL, V90, P81, DOI 10.1136/bjo.2005.078048; Wang T, 2002, HUM MOL GENET, V11, P3097, DOI 10.1093/hmg/11.24.3097; Wu WWH, 2005, J BIOL CHEM, V280, P10721, DOI 10.1074/jbc.M413117200; Wu X, 2001, J BIOL CHEM, V276, P30285, DOI 10.1074/jbc.M102436200; Zeng Y, 2004, INVEST OPHTH VIS SCI, V45, P3279, DOI 10.1167/iovs.04-0576	45	38	39	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3966	3975		10.1074/jbc.M806333200	http://dx.doi.org/10.1074/jbc.M806333200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19074145	hybrid, Green Published			2022-12-25	WOS:000262872500065
J	Rotolo, T; Smallwood, PM; Williams, J; Nathans, J				Rotolo, Thomas; Smallwood, Philip M.; Williams, John; Nathans, Jeremy			Genetically-Directed, Cell Type-Specific Sparse Labeling for the Analysis of Neuronal Morphology	PLOS ONE			English	Article								Background: In mammals, genetically-directed cell labeling technologies have not yet been applied to the morphologic analysis of neurons with very large and complex arbors, an application that requires extremely sparse labeling and that is only rendered practical by limiting the labeled population to one or a few predetermined neuronal subtypes. Methods and Findings: In the present study we have addressed this application by using CreER technology to non-invasively label very small numbers of neurons so that their morphologies can be fully visualized. Four lines of IRES-CreER knock-in mice were constructed to permit labeling selectively in cholinergic or catecholaminergic neurons [choline acetyltransferase (ChAT)-IRES-CreER or tyrosine hydroxylase (TH)-IRES-CreER], predominantly in projection neurons [neurofilament light chain (NFL)-IRES-CreER], or broadly in neurons and some glia [vesicle-associated membrane protein2 (VAMP2)-IRES-CreER]. When crossed to the Z/AP reporter and exposed to 4-hydroxytamoxifen in the early postnatal period, the number of neurons expressing the human placental alkaline phosphatase reporter can be reproducibly lowered to fewer than 50 per brain. Sparse Cre-mediated recombination in ChAT-IRES-CreER;Z/AP mice shows the full axonal and dendritic arbors of individual forebrain cholinergic neurons, the first time that the complete morphologies of these very large neurons have been revealed in any species. Conclusions: Sparse genetically-directed, cell type-specific neuronal labeling with IRES-creER lines should prove useful for studying a wide variety of questions in neuronal development and disease.	[Rotolo, Thomas; Smallwood, Philip M.; Williams, John; Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21218 USA; [Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21218 USA; [Smallwood, Philip M.; Williams, John; Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Rotolo, T (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	jnathans@jhmi.edu		Nathans, Jeremy/0000-0001-8106-5460	Howard Hughes Medical Institute, National Eye Institute (NIH)	Howard Hughes Medical Institute, National Eye Institute (NIH)(Howard Hughes Medical InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Howard Hughes Medical Institute, National Eye Institute (NIH).	Auld DS, 2002, PROG NEUROBIOL, V68, P209, DOI 10.1016/S0301-0082(02)00079-5; Badea TC, 2003, J NEUROSCI, V23, P2314; Badea TC, 2004, J COMP NEUROL, V480, P331, DOI 10.1002/cne.20304; Beitz Alvin J., 1995, P173; Bestman JE, 2006, NAT PROTOC, V1, P1267, DOI 10.1038/nprot.2006.186; Burns A, 2006, J PSYCHOPHARMACOL, V20, P732, DOI 10.1177/0269881106068299; Cajal S. R., 1911, HISTOLOGIE SYSTEME N; D'Apuzzo M, 2001, J NEUROPHYSIOL, V86, P1037, DOI 10.1152/jn.2001.86.2.1037; DACEY DM, 1994, NATURE, V367, P731, DOI 10.1038/367731a0; Dacey DM, 2003, NEURON, V37, P15, DOI 10.1016/S0896-6273(02)01143-1; DAVIES P, 1976, LANCET, V2, P1403; Duque A, 2007, BRAIN STRUCT FUNCT, V212, P55, DOI 10.1007/s00429-007-0143-3; FAMIGLIETTI EV, 1983, VISION RES, V23, P1265, DOI 10.1016/0042-6989(83)90102-5; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; FIELDSBERRY SC, 1992, P NATL ACAD SCI USA, V89, P693, DOI 10.1073/pnas.89.2.693; Fischer LR, 2007, NEURODEGENER DIS, V4, P431, DOI 10.1159/000107704; Gan WB, 2000, NEURON, V27, P219, DOI 10.1016/S0896-6273(00)00031-3; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Gustincich S, 1997, NEURON, V18, P723, DOI 10.1016/S0896-6273(00)80313-X; Hamel E, 2004, PROG BRAIN RES, V145, P171, DOI 10.1016/S0079-6123(02)45012-7; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Jakobs TC, 2008, J COMP NEUROL, V510, P221, DOI 10.1002/cne.21795; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LEVENTHAL AG, 1985, J COMP NEUROL, V237, P216, DOI 10.1002/cne.902370206; LI XM, 1994, POTENTIAL ANAL, V3, P339, DOI 10.1007/BF01049807; Liu C, 2008, J NEUROSCI, V28, P5641, DOI 10.1523/JNEUROSCI.1056-08.2008; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Lucas-Meunier E, 2003, PFLUG ARCH EUR J PHY, V446, P17, DOI 10.1007/s00424-002-0999-2; Morgan JL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-8; Moriyoshi K, 1996, NEURON, V16, P255, DOI 10.1016/S0896-6273(00)80044-6; Ngoi SM, 2004, CURR GENE THER, V4, P15, DOI 10.2174/1566523044578095; PEICHL L, 1993, J NEUROSCI, V13, P4091; PRICE DL, 1993, PROG BRAIN RES, V98, P51; SIK A, 1993, EUR J NEUROSCI, V5, P1719, DOI 10.1111/j.1460-9568.1993.tb00239.x; Szmajda BA, 2008, J COMP NEUROL, V510, P251, DOI 10.1002/cne.21783; Tsiola A, 2003, J COMP NEUROL, V461, P415, DOI 10.1002/cne.10628; van den Pol AN, 2004, NEURON, V42, P635, DOI 10.1016/S0896-6273(04)00251-X; WAINER BH, 1993, PROG BRAIN RES, V98, P9; Wellmann H, 1999, J NEUROSCI METH, V92, P55, DOI 10.1016/S0165-0270(99)00094-1; WHITEHOUSE PJ, 1983, ANN NEUROL, V13, P243, DOI 10.1002/ana.410130304; Wittner L, 2007, BRAIN STRUCT FUNCT, V212, P75, DOI 10.1007/s00429-007-0148-y; WONG YW, 1994, BIOCHEM J, V301, P205, DOI 10.1042/bj3010205; YATES CM, 1980, LANCET, V2, P979; Young P, 2008, NAT NEUROSCI, V11, P721, DOI 10.1038/nn.2118; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	49	52	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4099	10.1371/journal.pone.0004099	http://dx.doi.org/10.1371/journal.pone.0004099			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DO	19116659	Green Published, gold, Green Submitted			2022-12-25	WOS:000265466600017
J	Cummings, WJ; Bednarski, DW; Maizels, N				Cummings, W. Jason; Bednarski, David W.; Maizels, Nancy			Genetic Variation Stimulated by Epigenetic Modification	PLOS ONE			English	Article								Homologous recombination is essential for maintaining genomic integrity. A common repair mechanism, it uses a homologous or homeologous donor as a template for repair of a damaged target gene. Such repair must be regulated, both to identify appropriate donors for repair, and to avoid excess or inappropriate recombination. We show that modifications of donor chromatin structure can promote homology-directed repair. These experiments demonstrate that either the activator VP16 or the histone chaperone, HIRA, accelerated gene conversion approximately 10-fold when tethered within the donor array for Ig gene conversion in the chicken B cell line DT40. VP16 greatly increased levels of acetylated histones H3 and H4, while tethered HIRA did not affect histone acetylation, but caused an increase in local nucleosome density and levels of histone H3.3. Thus, epigenetic modification can stimulate genetic variation. The evidence that distinct activating modifications can promote similar functional outcomes suggests that a variety of chromatin changes may regulate homologous recombination, and that disregulation of epigenetic marks may have deleterious genetic consequences.	[Cummings, W. Jason; Bednarski, David W.; Maizels, Nancy] Univ Washington, Dept Immunol, Sch Med, Seattle, WA 98195 USA; [Maizels, Nancy] Univ Washington, Sch Med, Dept Biochem, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Cummings, WJ (corresponding author), Univ Washington, Dept Immunol, Sch Med, Seattle, WA 98195 USA.	maizels@u.washington.edu			NIH [R01 GM41712, RL1 GM084434]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041712, RL1GM084434] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by NIH R01 GM41712 and RL1 GM084434. The funders played no role in the study design, implementation or decision to write or publish this manuscript.	Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Bushman F, 2005, NAT REV MICROBIOL, V3, P848, DOI 10.1038/nrmicro1263; Carpenter AE, 2005, MOL CELL BIOL, V25, P958, DOI 10.1128/MCB.25.3.958-968.2005; Chakraborty T, 2007, MOL CELL, V27, P842, DOI 10.1016/j.molcel.2007.07.010; Cobb RM, 2006, ADV IMMUNOL, V91, P45, DOI 10.1016/S0065-2776(06)91002-5; CUMMINGS WJ, 2007, PLOS BIOL IN PRESS; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; Hatanaka A, 2005, MOL CELL BIOL, V25, P1124, DOI 10.1128/MCB.25.3.1124-1134.2005; Henikoff S, 2008, NAT REV GENET, V9, P15, DOI 10.1038/nrg2206; Jin C, 2006, P NATL ACAD SCI USA, V103, P574, DOI 10.1073/pnas.0509974103; Jin CY, 2007, GENE DEV, V21, P1519, DOI 10.1101/gad.1547707; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Kawamoto T, 2005, MOL CELL, V20, P793, DOI 10.1016/j.molcel.2005.10.016; Kaye JA, 2004, CURR BIOL, V14, P2096, DOI 10.1016/j.cub.2004.10.051; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Lin W, 2008, GENES CELLS, V13, P255, DOI 10.1111/j.1365-2443.2008.01166.x; Lobachev K, 2004, CURR BIOL, V14, P2107, DOI 10.1016/j.cub.2004.11.051; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; McIlwraith MJ, 2005, MOL CELL, V20, P783, DOI 10.1016/j.molcel.2005.10.001; McKittrick E, 2004, P NATL ACAD SCI USA, V101, P1525, DOI 10.1073/pnas.0308092100; McMurray MA, 2003, SCIENCE, V301, P1908, DOI 10.1126/science.1087706; Memedula S, 2003, CURR BIOL, V13, P241, DOI 10.1016/S0960-9822(03)00048-4; Murre C, 2007, CURR OPIN GENET DEV, V17, P415, DOI 10.1016/j.gde.2007.08.006; Neely KE, 2002, MOL CELL BIOL, V22, P1615, DOI 10.1128/MCB.22.6.1615-1625.2002; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Preston CR, 2006, CURR BIOL, V16, P2009, DOI 10.1016/j.cub.2006.08.058; Prioleau MN, 1999, EMBO J, V18, P4035, DOI 10.1093/emboj/18.14.4035; Ray-Gallet D, 2002, MOL CELL, V9, P1091, DOI 10.1016/S1097-2765(02)00526-9; Rodrigue A, 2006, EMBO J, V25, P222, DOI 10.1038/sj.emboj.7600914; Sale JE, 2001, NATURE, V412, P921, DOI 10.1038/35091100; Saribasak H, 2006, J IMMUNOL, V176, P365, DOI 10.4049/jimmunol.176.1.365; Sen R, 2006, CURR OPIN IMMUNOL, V18, P237, DOI 10.1016/j.coi.2006.03.008; Seo H, 2005, NAT BIOTECHNOL, V23, P731, DOI 10.1038/nbt1092; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Shroff R, 2004, CURR BIOL, V14, P1703, DOI 10.1016/j.cub.2004.09.047; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tumbar T, 1999, J CELL BIOL, V145, P1341, DOI 10.1083/jcb.145.7.1341; Tumbar T, 2001, NAT CELL BIOL, V3, P134, DOI 10.1038/35055033; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Tycko B, 2003, ANN NY ACAD SCI, V983, P43, DOI 10.1111/j.1749-6632.2003.tb05961.x; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wiktor-Brown DM, 2006, P NATL ACAD SCI USA, V103, P11862, DOI 10.1073/pnas.0604943103; Yabuki M, 2005, NAT IMMUNOL, V6, P730, DOI 10.1038/ni1215; Yamamoto K, 2005, MOL CELL BIOL, V25, P34, DOI 10.1128/MCB.25.1.34-43.2005; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019; Zhang RG, 2007, MOL CELL BIOL, V27, P2343, DOI 10.1128/MCB.02019-06	53	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2008	3	12							e4075	10.1371/journal.pone.0004075	http://dx.doi.org/10.1371/journal.pone.0004075			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DL	19115012	gold, Green Submitted, Green Published			2022-12-25	WOS:000265466300014
J	Liu, YJ; Papasian, CJ; Liu, JF; Hamilton, J; Deng, HW				Liu, Yong-Jun; Papasian, Christopher J.; Liu, Jian-Feng; Hamilton, James; Deng, Hong-Wen			Is Replication the Gold Standard for Validating Genome-Wide Association Findings?	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM PATTERNS; GENETIC ASSOCIATION; POPULATION STRATIFICATION; ADULT OBESITY; FTO GENE; DISEASE; EPIDEMIOLOGY; TRAITS; FALSE; POWER	With the advent of genome-wide association (GWA) studies, researchers are hoping that reliable genetic association of common human complex diseases/traits can be detected. Currently, there is an increasing enthusiasm about GWA and a number of GWA studies have been published. In the field a common practice is that replication should be used as the gold standard to validate an association finding. In this article, based on empirical and theoretical data, we emphasize that replication of GWA findings can be quite difficult, and should not always be expected, even when true variants are identified. The probability of replication becomes smaller with the increasing number of independent GWA studies if the power of individual replication studies is less than 100% (which is usually the case), and even a finding that is replicated may not necessarily be true. We argue that the field may have unreasonably high expectations on success of replication. We also wish to raise the question whether it is sufficient or necessary to treat replication as the ultimate and gold standard for defining true variants. We finally discuss the usefulness of integrating evidence from multiple levels/sources such as genetic epidemiological studies (at the DNA level), gene expression studies (at the RNA level), proteomics (at the protein level), and follow-up molecular and cellular studies for eventual validation and illumination of the functional relevance of the genes uncovered.	[Liu, Yong-Jun; Papasian, Christopher J.; Liu, Jian-Feng; Hamilton, James; Deng, Hong-Wen] Univ Missouri, Sch Med, Kansas City, MO 64108 USA; [Deng, Hong-Wen] Xi An Jiao Tong Univ, Key Lab Biomed Informat Engn Minist Ed, Xian, Peoples R China; [Deng, Hong-Wen] Xi An Jiao Tong Univ, Inst Mol Genet, Sch Life Sci & Technol, Xian, Peoples R China; [Deng, Hong-Wen] Hunan Normal Univ, Coll Life Sci, Lab Mol & Stat Genet, Changsha, Peoples R China	University of Missouri System; University of Missouri Kansas City; Xi'an Jiaotong University; Xi'an Jiaotong University; Hunan Normal University	Liu, YJ (corresponding author), Univ Missouri, Sch Med, Kansas City, MO 64108 USA.	dengh@umkc.edu		Deng, Hong-Wen/0000-0002-0387-8818; Liu, Jian-Feng/0000-0002-5766-7864	NIH [R01 AR050496, R21 AG027110, R01 AG026564, P50 AR055081, R21 AA015973]; National Natural Science Foundation of China [30570875]; Xi'an Jiaotong University; Huo YingDong Education Foundation, Hunan Province; Ministry of Education of China; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR055081, R01AR050496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG027110, R01AG026564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA015973] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Xi'an Jiaotong University(Xi'an Jiaotong University); Huo YingDong Education Foundation, Hunan Province; Ministry of Education of China(Ministry of Education, China); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Investigators of this work were partially supported by grants from NIH (R01 AR050496, R21 AG027110, R01 AG026564, P50 AR055081 and R21 AA015973). The study also benefited from National Natural Science Foundation of China (30570875), Xi'an Jiaotong University, Huo YingDong Education Foundation, Hunan Province, and the Ministry of Education of China.	Abecasis GR, 2001, AM J HUM GENET, V68, P191, DOI 10.1086/316944; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Clarke GM, 2007, AM J HUM GENET, V81, P995, DOI 10.1086/521952; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Couzin J, 2007, SCIENCE, V316, P820, DOI 10.1126/science.316.5826.820; DE LV, 2005, GENOME RES, V15, P454; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dina C, 2008, CURR OPIN CLIN NUTR, V11, P378, DOI 10.1097/MCO.0b013e328303e5e6; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Epstein MP, 2007, AM J HUM GENET, V80, P921, DOI 10.1086/516842; Evangelou E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000196; Evans DM, 2005, AM J HUM GENET, V76, P681, DOI 10.1086/429274; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Kohler K, 2006, ANN HUM GENET, V70, P98, DOI 10.1111/j.1529-8817.2005.00214.x; Liu NJ, 2004, GENET EPIDEMIOL, V27, P385, DOI 10.1002/gepi.20026; Lundmark PE, 2008, EUR J HUM GENET, V16, P1142, DOI 10.1038/ejhg.2008.77; Lusis AJ, 2008, NAT REV GENET, V9, P819, DOI 10.1038/nrg2468; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Moonesinghe R, 2008, P NATL ACAD SCI USA, V105, P617, DOI 10.1073/pnas.0705554105; Moskvina V, 2007, HUM HERED, V64, P63, DOI 10.1159/000101424; Mueller JC, 2005, AM J HUM GENET, V76, P387, DOI 10.1086/427925; Munafo MR, 2004, TRENDS GENET, V20, P439, DOI 10.1016/j.tig.2004.06.014; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Sawyer SL, 2005, EUR J HUM GENET, V13, P677, DOI 10.1038/sj.ejhg.5201368; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Setakis E, 2006, GENOME RES, V16, P290, DOI 10.1101/gr.4346306; Sham PC, 2000, AM J HUM GENET, V66, P1616, DOI 10.1086/302891; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Smith GD, 2007, PLOS MED, V4, P1985, DOI 10.1371/journal.pmed.0040352; Terwilliger JD, 2006, EUR J HUM GENET, V14, P426, DOI 10.1038/sj.ejhg.5201583; Tsai HJ, 2005, HUM GENET, V118, P424, DOI 10.1007/s00439-005-0067-z; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wakefield J, 2007, AM J HUM GENET, V81, P208, DOI 10.1086/519024; Zollner S, 2007, AM J HUM GENET, V80, P605, DOI 10.1086/512821; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	49	39	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2008	3	12							e4037	10.1371/journal.pone.0004037	http://dx.doi.org/10.1371/journal.pone.0004037			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DI	19112512	Green Submitted, gold, Green Published			2022-12-25	WOS:000265466000007
J	Walsh, MC; Kim, GK; Maurizio, PL; Molnar, EE; Choi, Y				Walsh, Matthew C.; Kim, Gregory K.; Maurizio, Paul L.; Molnar, Elizabeth E.; Choi, Yongwon			TRAF6 Autoubiquitination-Independent Activation of the NF kappa B and MAPK Pathways in Response to IL-1 and RANKL	PLOS ONE			English	Article								The adapter protein TRAF6 is critical for mediating signal transduction from members of the IL-1R/TLR and TNFR superfamilies. The TRAF6 RING finger domain functions as an ubiquitin E3 ligase capable of generating non-degradative K63-linked ubiquitin chains. It is believed that these chains serve as docking sites for formation of signaling complexes, and that K63-linked autoubiquitination of TRAF6 is essential for formation and activation of a complex involving the kinase TAK1 and its adapters, TAB1 and TAB2. In order to assess independently the E3 ligase and ubiquitin substrate functions of TRAF6, we generated, respectively, RING domain and complete lysine-deficient TRAF6 mutants. We found that while the TRAF6 RING domain is required for activation of TAK1, it is dispensable for interaction between TRAF6 and the TAK1-TAB1-TAB2 complex. Likewise, lysine-deficient TRAF6 was found to interact with the TAK1-TAB1-TAB2 complex, but surprisingly was also found to be fully competent to activate TAK1, as well as NF kappa B and AP-1 reporters. Furthermore, lysine-deficient TRAF6 rescued IL-1-mediated NF kappa B and MAPK activation, as well as IL-6 elaboration in retrovirally-rescued TRAF6-deficient fibroblasts. Lysine-deficient TRAF6 also rescued RANKL-mediated NF kappa B and MAPK activation, and osteoclastogenesis in retrovirally-rescued TRAF6-deficient bone marrow macrophages. While incapable of being ubiquitinated itself, we demonstrate that lysine-deficient TRAF6 remains competent to induce ubiquitination of IKK gamma/NEMO. Further, this NEMO modification contributes to TRAF6-mediated activation of NF kappa B. Collectively, our results suggest that while TRAF6 autoubiquitination may serve as a marker of activation, it is unlikely to underpin RING finger-dependent TRAF6 function.	[Walsh, Matthew C.; Kim, Gregory K.; Maurizio, Paul L.; Molnar, Elizabeth E.; Choi, Yongwon] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Walsh, MC (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	ychoi3@mail.med.upenn.edu	Maurizio, Paul L/B-7747-2013	Maurizio, Paul L/0000-0002-5859-6260	 [5R01AI044264-10]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044264] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant 5R01AI044264-10 (Y.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DW, 2007, MOL CELL BIOL, V27, P6012, DOI 10.1128/MCB.00270-07; BALKHI MY, 2008, MOL CELL BIOL; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Chung JY, 2002, J CELL SCI, V115, P679; Conze DB, 2008, MOL CELL BIOL, V28, P3538, DOI 10.1128/MCB.02098-07; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Geetha T, 2005, EMBO J, V24, P3859, DOI 10.1038/sj.emboj.7600845; Geetha T, 2005, MOL CELL, V20, P301, DOI 10.1016/j.molcel.2005.09.014; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Huang QJ, 2004, NAT IMMUNOL, V5, P98, DOI 10.1038/ni1014; Jadhav T, 2008, BIOCHEM BIOPH RES CO, V371, P521, DOI 10.1016/j.bbrc.2008.04.138; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Laine Aaron, 2005, Sci STKE, V2005, pre5, DOI 10.1126/stke.2812005re5; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Lowe EL, 2006, J ENDOTOXIN RES, V12, P337, DOI 10.1179/096805106X118915; Maezawa Y, 2006, J IMMUNOL, V176, P1013, DOI 10.4049/jimmunol.176.2.1013; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Mochida Y, 2000, J BIOL CHEM, V275, P32747, DOI 10.1074/jbc.M003042200; Moscat J, 2007, TRENDS BIOCHEM SCI, V32, P95, DOI 10.1016/j.tibs.2006.12.002; Ning SB, 2008, MOL CELL BIOL, V28, P6536, DOI 10.1128/MCB.00785-08; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Rudolph D, 2000, GENE DEV, V14, P854; Sakurai H, 2002, BIOCHEM BIOPH RES CO, V297, P1277, DOI 10.1016/S0006-291X(02)02379-3; Schwandner R, 2000, J EXP MED, V191, P1233, DOI 10.1084/jem.191.7.1233; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Takayanagi H, 2005, J MOL MED, V83, P170, DOI 10.1007/s00109-004-0612-6; VanDemark AP, 2002, CURR OPIN STRUC BIOL, V12, P822, DOI 10.1016/S0959-440X(02)00389-5; Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Windheim M, 2008, MOL CELL BIOL, V28, P1783, DOI 10.1128/MCB.02380-06; Wu H, 2003, BIOESSAYS, V25, P1096, DOI 10.1002/bies.10352; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yang YB, 2007, J BIOL CHEM, V282, P36223, DOI 10.1074/jbc.M703079200; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888	42	132	139	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2008	3	12							e4064	10.1371/journal.pone.0004064	http://dx.doi.org/10.1371/journal.pone.0004064			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DI	19112497	Green Published, gold, Green Submitted			2022-12-25	WOS:000265466000020
J	Susanto, J; Lin, YH; Chen, YN; Shen, CR; Yan, YT; Tsai, ST; Chen, CH; Shen, CN				Susanto, Jimmy; Lin, Yu-Hsing; Chen, Yun-Nan; Shen, Chia-Rui; Yan, Yu-Ting; Tsai, Sheng-Ta; Chen, Chung-Hsuan; Shen, Chia-Ning			Porphyrin Homeostasis Maintained by ABCG2 Regulates Self-Renewal of Embryonic Stem Cells	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; PROTOPORPHYRIN-IX; DNA-DAMAGE; 5-AMINOLEVULINIC ACID; HEME-SYNTHESIS; P53 PROTEIN; PHOSPHORYLATION; EXPRESSION; RESISTANCE; ACCUMULATION	Background: Under appropriate culture conditions, undifferentiated embryonic stem (ES) cells can undergo multiple self-renewal cycles without loss of pluripotency suggesting they must be equipped with specific defense mechanisms to ensure sufficient genetic stability during self-renewal expansion. The ATP binding cassette transporter ABCG2 is expressed in a wide variety of somatic and embryonic stem cells. However, whether it plays an important role in stem cell maintenance remains to be defined. Methodology/Principal Findings: Here we provide evidence to show that an increase in the level of ABCG2 was observed accompanied by ES colony expansion and then were followed by decreases in the level of protoporphyrin IX (PPIX) indicating that ABCG2 plays a role in maintaining porphyrin homoeostasis. RNA-interference mediated inhibition of ABCG2 as well as functional blockage of ABCG2 transporter with fumitremorgin C (FTC), a specific and potent inhibitor of ABCG2, not only elevated the cellular level of PPIX, but also arrest the cell cycle and reduced expression of the pluripotent gene Nanog. Overexpression of ABCG2 in ES cells was able to counteract the increase of endogenous PPIX induced by treatment with 5-Aminolevulinic acid suggesting ABCG2 played a direct role in removal of PPIX from ES cells. We also found that excess PPIX in ES cells led to elevated levels of reactive oxygen species which in turn triggered DNA damage signals as indicated by increased levels of gamma H2AX and phosphorylated p53. The increased level of p53 reduced Nanog expression because RNA-interference mediated inhibition of p53 was able to prevent the downregulation of Nanog induced by FTC treatment. Conclusions/Significance: The present work demonstrated that ABCG2 protects ES cells from PPIX accumulation during colony expansion, and that p53 and gamma H2AX acts as a downstream checkpoint of ABCG2-dependent defense machinery in order to maintain the self-renewal of ES cells.	[Tsai, Sheng-Ta; Chen, Chung-Hsuan; Shen, Chia-Ning] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Lin, Yu-Hsing; Shen, Chia-Ning] Natl Defense Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Chen, Yun-Nan; Shen, Chia-Ning] Natl Yang Ming Univ, Dept Biotechnol & Lab Sci Med, Taipei, Taiwan; [Shen, Chia-Rui] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Tao Yuan, Taiwan; [Yan, Yu-Ting] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan	Academia Sinica - Taiwan; National Defense Medical Center; National Yang Ming Chiao Tung University; Chang Gung University; Academia Sinica - Taiwan	Susanto, J (corresponding author), Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan.	cnshen@gate.sinica.edu.tw	Shen, Chia-Rui/B-1617-2012; SHEN, CHIA-NING/C-6878-2011; Yan, Yu-Ting/Q-3065-2018; Chen, Chung-Hsuan/F-7940-2012	Shen, Chia-Rui/0000-0002-8386-3965; SHEN, CHIA-NING/0000-0002-0747-217X; Yan, Yu-Ting/0000-0002-9559-706X; 	Academia Sinica [5202402020-0, 96-3114-P-001-006-Y02, 95-2311-B-001-057-MY3]; Genomics Research Center; National Science Council [96-3114-P-001-006-Y02, 95-2311-B-001-057-MY3]	Academia Sinica(Academia Sinica - Taiwan); Genomics Research Center; National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported in part by Summit Project Grants of Academia Sinica #5202402020-0; Genomics Research Center, Academia Sinica and National Science Council grants 96-3114-P-001-006-Y02 and 95-2311-B-001-057-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya B, 2004, BLOOD, V103, P2956, DOI 10.1182/blood-2003-09-3314; Bunting KD, 2002, STEM CELLS, V20, P11, DOI 10.1002/stem.200011; Challen GA, 2006, STEM CELLS, V24, P3, DOI 10.1634/stemcells.2005-0116; Chao C, 2003, J BIOL CHEM, V278, P41028, DOI 10.1074/jbc.M306938200; de Waard H, 2003, DNA REPAIR, V2, P13, DOI 10.1016/S1568-7864(02)00188-X; de Waard H, 2008, DNA REPAIR, V7, P1659, DOI 10.1016/j.dnarep.2008.06.009; GLAVINAS H, 2005, CURRENT DRUG DELIVER, V1, P27; Hensley K, 2000, FREE RADICAL BIO MED, V28, P1456, DOI 10.1016/S0891-5849(00)00252-5; Hofer T, 2003, BLOOD, V101, P348, DOI 10.1182/blood-2002-03-0773; Jonker JW, 2007, AM J PHYSIOL-CELL PH, V292, pC2204, DOI 10.1152/ajpcell.00359.2006; Jonker JW, 2002, P NATL ACAD SCI USA, V99, P15649, DOI 10.1073/pnas.202607599; Krishnamurthy P, 2005, BIOMETALS, V18, P349, DOI 10.1007/s10534-005-3709-7; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Krishnamurthy P, 2006, ANNU REV PHARMACOL, V46, P381, DOI 10.1146/annurev.pharmtox.46.120604.141238; Krishnamurthy P, 2007, PHARMACOL THERAPEUT, V114, P345, DOI 10.1016/j.pharmthera.2007.02.001; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Lu H, 1998, P NATL ACAD SCI USA, V95, P6399, DOI 10.1073/pnas.95.11.6399; Lu SJ, 2002, STEM CELLS, V20, P428, DOI 10.1634/stemcells.20-5-428; MARTIN CM, 2008, CIRC RES; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Maynard S, 2008, STEM CELLS, V26, P2266, DOI 10.1634/stemcells.2007-1041; Moan J, 1998, INT J CANCER, V75, P134, DOI 10.1002/(SICI)1097-0215(19980105)75:1<134::AID-IJC20>3.0.CO;2-F; Mouthon MA, 2006, J NEUROCHEM, V99, P807, DOI 10.1111/j.1471-4159.2006.04118.x; Mutoh K, 2006, MOL CANCER THER, V5, P877, DOI 10.1158/1535-7163.MCT-05-0240; Olson A, 2006, NUCLEIC ACIDS RES, V34, pD153, DOI 10.1093/nar/gkj051; Onuki J, 2004, ARCH BIOCHEM BIOPHYS, V432, P178, DOI 10.1016/j.abb.2004.09.030; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; Ponka P, 1997, BLOOD, V89, P1; Powers DE, 2008, BIOTECHNOL BIOENG, V101, P241, DOI 10.1002/bit.21986; Rabindran SK, 2000, CANCER RES, V60, P47; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; Saretzki G, 2004, STEM CELLS, V22, P962, DOI 10.1634/stemcells.22-6-962; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Storm MP, 2007, J BIOL CHEM, V282, P6265, DOI 10.1074/jbc.M610906200; Takada T, 2005, DRUG METAB DISPOS, V33, P905, DOI 10.1124/dmd.104.003228; Tanaka T, 2006, CELL CYCLE, V5, P1940, DOI 10.4161/cc.5.17.3191; Tichy ED, 2008, EXP CELL RES, V314, P1929, DOI 10.1016/j.yexcr.2008.02.007; Van Sloun PPH, 1999, NUCLEIC ACIDS RES, V27, P3276, DOI 10.1093/nar/27.16.3276; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Wolun-Cholewa M, 2007, PHOTOMED LASER SURG, V25, P526, DOI 10.1089/pho.2007.2113; Wu ZQ, 2002, MOL CELL BIOL, V22, P2441, DOI 10.1128/MCB.22.8.2441-2449.2002; Zawacka-Pankau J, 2007, J BIOL CHEM, V282, P2466, DOI 10.1074/jbc.M608906200; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	43	48	51	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4023	10.1371/journal.pone.0004023	http://dx.doi.org/10.1371/journal.pone.0004023			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107196	gold, Green Submitted, Green Published			2022-12-25	WOS:000265463000018
J	Jin, RZ; Lv, ZB; Chen, Q; Quan, YP; Zhang, HH; Li, S; Chen, GG; Zheng, QL; Jin, LR; Wu, XF; Chen, JG; Zhang, YZ				Jin, Rongzhong; Lv, Zhengbing; Chen, Qin; Quan, Yanping; Zhang, Haihua; Li, Si; Chen, Guogang; Zheng, Qingliang; Jin, Lairong; Wu, Xiangfu; Chen, Jianguo; Zhang, Yaozhou			Safety and Immunogenicity of H5N1 Influenza Vaccine Based on Baculovirus Surface Display System of Bombyx mori	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; AVIAN INFLUENZA; MF59-ADJUVANTED INFLUENZA; A H5N1; HEMAGGLUTININ; ANTIGENICITY; EXPRESSION; MORTALITY; STRAINS; PROTECT	Avian influenza virus (H5N1) has caused serious infections in human beings. This virus has the potential to emerge as a pandemic threat in humans. Effective vaccines against H5N1 virus are needed. A recombinant Bombyx mori baculovirus, Bmg64HA, was constructed for the expression of HA protein of H5N1 influenza virus displaying on the viral envelope surface. The HA protein accounted for approximately 3% of the total viral proteins in silkworm pupae infected with the recombinant virus. Using a series of separation and purification methods, pure Bmgp64HA virus was isolated from these silkworm pupae bioreactors. Aluminum hydroxide adjuvant was used for an H5N1 influenza vaccine. Immunization with this vaccine at doses of 2 mg/kg and 0.67 mg/kg was carried out to induce the production of neutralizing antibodies, which protected monkeys against influenza virus infection. At these doses, the vaccine induced 1: 40 antibody titers in 50% and 67% of the monkeys, respectively. The results of safety evaluation indicated that the vaccine did not cause any toxicity at the dosage as large as 3.2 mg/kg in cynomolgus monkeys and 1.6 mg/kg in mice. The results of dose safety evaluation of vaccine indicated that the safe dose of the vaccine were higher than 0.375 mg/kg in rats and 3.2 mg/kg in cynomolgus monkeys. Our work showed the vaccine may be a candidate for a highly effective, cheap, and safe influenza vaccine for use in humans.	[Zhang, Yaozhou] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Jin, Rongzhong; Lv, Zhengbing; Chen, Qin; Quan, Yanping; Zhang, Haihua; Li, Si; Chen, Guogang; Zheng, Qingliang; Jin, Lairong; Wu, Xiangfu; Zhang, Yaozhou] Zhejiang Sci Tech Univ, Coll Life Sci, Inst Biochem, Hangzhou, Peoples R China; [Chen, Jianguo] Peking Univ, Coll Life Sci, Beijing, Peoples R China	Zhejiang University; Zhejiang Sci-Tech University; Peking University	Jin, RZ (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	chenjg@pku.edu.cn; yaozhou@zstu.edu			National High Technology Research and Development Program [2007AA021703, 2007AA100504]; National Basic Research Program of China [2005CB121006]; National Natural Science Foundation of China [30740015]; Zhejiang Natural Science Foundation [Y205449]	National High Technology Research and Development Program(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	This work was supported by grants from the National High Technology Research and Development Program (No. 2007AA021703, No. 2007AA100504), the National Basic Research Program of China (973 Program, No. 2005CB121006), the National Natural Science Foundation of China (No. 30740015), and the Zhejiang Natural Science Foundation (No.Y205449).	Bender C, 1999, VIROLOGY, V254, P115, DOI 10.1006/viro.1998.9529; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Bresson JL, 2006, LANCET, V367, P1657, DOI 10.1016/S0140-6736(06)68656-X; Chotpitayasunondh T, 2005, EMERG INFECT DIS, V11, P201, DOI 10.3201/eid1102.041061; Crawford J, 1999, VACCINE, V17, P2265, DOI 10.1016/S0264-410X(98)00494-0; De Clercq E, 2006, NAT REV DRUG DISCOV, V5, P1015, DOI 10.1038/nrd2175; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Hehme N, 2002, MED MICROBIOL IMMUN, V191, P203, DOI 10.1007/s00430-002-0147-9; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Hoelscher MA, 2006, LANCET, V367, P475, DOI 10.1016/S0140-6736(06)68076-8; Horimoto T, 2006, TRENDS MOL MED, V12, P506, DOI 10.1016/j.molmed.2006.09.003; Johansson BE, 1999, VACCINE, V17, P2073, DOI 10.1016/S0264-410X(98)00413-7; JX H, 1994, THESIS SHANGHAI I BI; Kost TA, 2005, NAT BIOTECHNOL, V23, P567, DOI 10.1038/nbt1095; Lin JT, 2006, LANCET, V368, P991, DOI 10.1016/S0140-6736(06)69294-5; Lu LQ, 2007, BIOCHEM BIOPH RES CO, V358, P404, DOI 10.1016/j.bbrc.2007.04.148; Matsouka Y, 2003, AVIAN DIS, V47, P926, DOI 10.1637/0005-2086-47.s3.926; MILLER LK, 1983, SCIENCE, V219, P715, DOI 10.1126/science.219.4585.715; Nicholson KG, 1996, EPIDEMIOL INFECT, V116, P51, DOI 10.1017/S0950268800058957; Nicholson KG, 2001, LANCET, V357, P1937, DOI 10.1016/S0140-6736(00)05066-2; Poland GA, 2006, NEW ENGL J MED, V354, P1411, DOI 10.1056/NEJMe068047; Possee R.D., 1992, BACULOVIRUS EXPRESSI, Vfirst; Stephenson I, 2006, LANCET INFECT DIS, V6, P71, DOI 10.1016/S1473-3099(06)70364-4; Stephenson I, 2005, J INFECT DIS, V191, P1210, DOI 10.1086/428948; Stephenson I, 2003, LANCET, V362, P1959, DOI 10.1016/S0140-6736(03)15014-3; Stephenson I, 2004, LANCET INFECT DIS, V4, P499, DOI 10.1016/S1473-3099(04)01105-3; Stephenson I, 2006, LANCET, V368, P965, DOI 10.1016/S0140-6736(06)69340-9; Subbarao K, 2007, NAT REV IMMUNOL, V7, P267, DOI 10.1038/nri2054; Subbarao K, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030040; Tami C, 2004, VACCINE, V23, P840, DOI 10.1016/j.vaccine.2004.03.070; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Treanor JJ, 2001, VACCINE, V19, P1732, DOI 10.1016/S0264-410X(00)00395-9; Wang K, 2006, VACCINE, V24, P2176, DOI 10.1016/j.vaccine.2005.11.005; Wood JM, 2004, NAT REV MICROBIOL, V2, P842, DOI 10.1038/nrmicro979; Wood JM, 2001, INT CONGR SER, V1219, P751, DOI 10.1016/S0531-5131(01)00385-5; Yan JY, 2007, DIAGN MICR INFEC DIS, V58, P399, DOI 10.1016/j.diagmicrobio.2007.03.004; Yang DG, 2007, MOL THER, V15, P989, DOI 10.1038/mt.sj.6300131; Yongfeng Jin, 2002, J Biochem Mol Biol Biophys, V6, P293; Yoshida S, 2003, VIROLOGY, V316, P161, DOI 10.1016/j.virol.2003.08.003; Zhang W, 2006, CHAOS SOLITON FRACT, V29, P223, DOI 10.1016/j.chaos.2005.08.020; 1988, ANN REV MICROBIOL, V42, P177; 2002, WKLY EPIDEMIOL REC, V77, P381	43	32	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2008	3	12							e3933	10.1371/journal.pone.0003933	http://dx.doi.org/10.1371/journal.pone.0003933			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZW	19079592	Green Published, gold, Green Submitted			2022-12-25	WOS:000265456300009
J	Amniai, L; Barbier, P; Sillen, A; Wieruszeski, JM; Peyrot, V; Lippens, G; Landrieu, I				Amniai, Laziza; Barbier, Pascale; Sillen, Alain; Wieruszeski, Jean-Michel; Peyrot, Vincent; Lippens, Guy; Landrieu, Isabelle			Alzheimer disease specific phosphoepitopes of Tau interfere with assembly of tubulin but not binding to microtubules	FASEB JOURNAL			English	Article						post-translational modifications; nuclear magnetic resonance spectroscopy; kinase; phosphorylation; diagnostic antibodies; unfolded protein	GLYCOGEN-SYNTHASE KINASE-3-BETA; PAIRED HELICAL FILAMENTS; MONOCLONAL-ANTIBODIES; STRUCTURAL BASIS; NMR ASSIGNMENT; PROLINE-RICH; PROTEIN-TAU; PHOSPHORYLATION; HYPERPHOSPHORYLATION; ABILITY	In Alzheimer disease (AD)-affected neurons, the Tau protein is found in an aggregated and hyperphosphorylated state. A common hypothesis is that Tau hyperphosphorylation causes its dissociation from the microtubular surface, with consequently a breakdown of the microtubules (MTs) and aggregation of the unbound Tau. We evaluated the effect of Tau phosphorylation on both tubulin assembly and MT binding. We show that the cyclin-dependent kinase 2/cyclin A3 kinase complex can generate the AT8 and AT180 AD-specific phospho-epitopes and use NMR spectroscopy to validate qualitatively and quantitatively the phospho content of our samples. The simultaneous presence of both epitopes disables the tubulin assembly capacity of Tau in conditions whereby Tau is the driving force for the assembly process but does not, however, inhibit MT assembly when the latter is driven by an increased tubulin concentration. When compared to the isolated MT binding repeats (K-d = 0.3 mu M), the phospho-Tau retains a substantial affinity for preformed MTs (K-d = 11 nM), suggesting that the phosphorylated proline-rich region still participates in the binding event. Our results hence indicate that the sole phosphorylation at the AT8/AT180 epitopes, although leading to a functional defect for Tau, is not sufficient for its dissociation from the MT surface and subsequent aggregation as observed in AD.-Amniai, L., Barbier, P., Sillen, A., Wieruszeski, J.-M., Peyrot, V., Lippens, G., Landrieu, I. Alzheimer disease specific phosphoepitopes of Tau interfere with assembly of tubulin but not binding to microtubules. FASEB J. 23, 1146-1152 (2009)	[Landrieu, Isabelle] Univ Sci & Technol Lille 1, CNRS, UMR 8576, UGSF IFR 147, F-59655 Villeneuve Dascq, France; [Barbier, Pascale; Peyrot, Vincent] Univ Aix Marseille, INSERM, UMR 911, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Landrieu, I (corresponding author), Univ Sci & Technol Lille 1, CNRS, UMR 8576, UGSF IFR 147, F-59655 Villeneuve Dascq, France.	isabelle.landrieu@univ-lille1.fr	peyrot, vincent/B-6365-2015; Barbier, Pascale/AAE-1781-2019; Landrieu, Isabelle/AAF-8495-2019	Landrieu, Isabelle/0000-0002-4883-2637; Lippens, Guy/0000-0002-8236-0901	CNRS/Region Nord-Pas de Calais (France); Region Nord; CNRS; Pasteur Institute of Lille; European Community (FEDER),; French Research Ministry; University of Sciences and Technologies of Lille I;  [ANR-05-blanc-6320-01]	CNRS/Region Nord-Pas de Calais (France)(Centre National de la Recherche Scientifique (CNRS)Region Hauts-de-France); Region Nord(Region Hauts-de-France); CNRS(Centre National de la Recherche Scientifique (CNRS)); Pasteur Institute of Lille; European Community (FEDER),(European Commission); French Research Ministry(Ministry of Research, France); University of Sciences and Technologies of Lille I; 	We thank Soazic Douillard and Diane Allegro for technical assistance; Jane Endicott and Martin Noble (University of Oxford, Oxford, UK) for providing the clones, protocols, and advice necessary to prepare the CDK2/CycA3 kinase; David Eliezer (Cornell University, Ithaca, NY, USA) for sending the K18 expression plasmid; Andre Van de Voorde for help with the AT8 and AT180 monoclonal antibodies; and Beno t Gigant and Marcel Knossow for insightful discussion on the Tau/tubulin interaction. L. A. was supported by a predoctoral fellowship of the CNRS/Region Nord-Pas de Calais (France). This work was supported by an ANR-05-blanc-6320-01 grant. The NMR facilities were funded by the Region Nord, CNRS, Pasteur Institute of Lille, European Community (FEDER), French Research Ministry, and the University of Sciences and Technologies of Lille I.	Alonso AD, 1996, NAT MED, V2, P783, DOI 10.1038/nm0796-783; ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; Alonso AD, 2004, J BIOL CHEM, V279, P34873, DOI 10.1074/jbc.M405131200; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Ball LJ, 2005, ANGEW CHEM INT EDIT, V44, P2852, DOI 10.1002/anie.200400618; Barbier P, 1998, BIOCHEMISTRY-US, V37, P758, DOI 10.1021/bi970568t; Bienkiewicz EA, 1999, J BIOMOL NMR, V15, P203, DOI 10.1023/A:1008375029746; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Brown NR, 1999, NAT CELL BIOL, V1, P438, DOI 10.1038/15674; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; Cho JH, 2004, J NEUROCHEM, V88, P349, DOI 10.1046/j.1471-4159.2003.02155.x; Chohan MO, 2006, FEBS LETT, V580, P3973, DOI 10.1016/j.febslet.2006.06.021; Devred F, 2004, BIOCHEMISTRY-US, V43, P10520, DOI 10.1021/bi0493160; Evans DB, 2000, J BIOL CHEM, V275, P24977, DOI 10.1074/jbc.M000808200; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; GOEDERT M, 1994, BIOCHEM J, V301, P871, DOI 10.1042/bj3010871; Goode BL, 1997, MOL BIOL CELL, V8, P353, DOI 10.1091/mbc.8.2.353; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GUSTKE N, 1992, FEBS LETT, V307, P199, DOI 10.1016/0014-5793(92)80767-B; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; HASEGAWA M, 1992, J BIOL CHEM, V267, P17047; Hoffmann R, 1997, BIOCHEMISTRY-US, V36, P8114, DOI 10.1021/bi970380+; Jicha GA, 1997, J NEUROCHEM, V69, P2087; Johnson GVW, 2004, J CELL SCI, V117, P5721, DOI 10.1242/jcs.01558; Jourdain L, 1997, BIOCHEMISTRY-US, V36, P10817, DOI 10.1021/bi971491b; Landrieu I, 2006, J AM CHEM SOC, V128, P3575, DOI 10.1021/ja054656+; LINDWALL G, 1984, J BIOL CHEM, V259, P5301; Lippens G, 2004, CHEMBIOCHEM, V5, P73, DOI 10.1002/cbic.200300763; Lippens G, 2007, PRION, V1, P21, DOI 10.4161/pri.1.1.4055; Makrides V, 2004, P NATL ACAD SCI USA, V101, P6746, DOI 10.1073/pnas.0400992101; MANDELKOW EM, 1995, NEUROBIOL AGING, V16, P355, DOI 10.1016/0197-4580(95)00025-A; MERCKEN M, 1992, ACTA NEUROPATHOL, V84, P265, DOI 10.1007/BF00227819; Preuss U, 1997, J CELL SCI, V110, P789; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Russo AA, 1996, NAT STRUCT BIOL, V3, P696, DOI 10.1038/nsb0896-696; Schneider A, 1999, BIOCHEMISTRY-US, V38, P3549, DOI 10.1021/bi981874p; Schuck P, 2000, BIOPOLYMERS, V54, P328, DOI 10.1002/1097-0282(20001015)54:5<328::AID-BIP40>3.0.CO;2-P; Selenko P, 2008, NAT STRUCT MOL BIOL, V15, P321, DOI 10.1038/nsmb.1395; Sengupta A, 1997, MOL CELL BIOCHEM, V167, P99, DOI 10.1023/A:1006883924775; Sillen A, 2007, BIOCHEMISTRY-US, V46, P3055, DOI 10.1021/bi061920i; Smet C, 2004, CHEMBIOCHEM, V5, P1639, DOI 10.1002/cbic.200400145; Wang YY, 2007, CHINESE J CHEM, V25, P68, DOI 10.1002/cjoc.200790019; Welburn Julie, 2004, V296, P219; Zheng-Fischhofer QY, 1998, EUR J BIOCHEM, V252, P542, DOI 10.1046/j.1432-1327.1998.2520542.x	46	68	71	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2009	23	4					1146	1152		10.1096/fj.08-121590	http://dx.doi.org/10.1096/fj.08-121590			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZO	19074508				2022-12-25	WOS:000266651600018
J	Deevska, GM; Rozenova, KA; Giltiay, NV; Chambers, MA; White, J; Boyanovsky, BB; Wei, J; Daugherty, A; Smart, EJ; Reid, MB; Merrill, AH; Nikolova-Karakashian, M				Deevska, Gergana M.; Rozenova, Krassimira A.; Giltiay, Natalia V.; Chambers, Melissa A.; White, James; Boyanovsky, Boris B.; Wei, Jia; Daugherty, Alan; Smart, Eric J.; Reid, Michael B.; Merrill, Alfred H., Jr.; Nikolova-Karakashian, Mariana			Acid Sphingomyelinase Deficiency Prevents Diet-induced Hepatic Triacylglycerol Accumulation and Hyperglycemia in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED INSULIN-RESISTANCE; SKELETAL-MUSCLE CELLS; NIEMANN-PICK DISEASE; METABOLIC SYNDROME; SERINE PALMITOYLTRANSFERASE; SPHINGOLIPID METABOLISM; CERAMIDE SYNTHESIS; INHIBITION; OBESITY; LIVER	Acid sphingomyelinase plays important roles in ceramide homeostasis, which has been proposed to be linked to insulin resistance. To test this association in vivo, acid sphingomyelinase deletion (asm(-/-)) was transferred to mice lacking the low density lipoprotein receptor (ldlr(-/-)), and then offsprings were placed on control or modified (enriched in saturated fat and cholesterol) diets for 10 weeks. The modified diet caused hypercholesterolemia in all genotypes; however, in contrast to asm(-/-) / ldlr(-/-), the acid sphingomyelinase-deficient littermates did not display hepatic triacylglyceride accumulation, although sphingomyelin and other sphingolipids were substantially elevated, and the liver was enlarged. asm(-/-) / ldlr(-/-) mice on a modified diet did not accumulate body fat and were protected against diet-induced hyperglycemia and insulin resistance. Experiments with hepatocytes revealed that acid sphingomyelinase regulates the partitioning of the major fatty acid in the modified diet, palmitate, into two competitive and inversely related pools, triacylglycerides and sphingolipids, apparently via modulation of serine palmitoyltransferase, a rate-limiting enzyme in de novo sphingolipid synthesis. These studies provide evidence that acid sphingomyelinase activity plays an essential role in the regulation of glucose metabolism by regulating the hepatic accumulation of triacylglycerides and sphingolipids during consumption of a diet rich in saturated fats.	[Nikolova-Karakashian, Mariana] Univ Kentucky, Coll Med, Albert B Chandler Med Ctr, Dept Physiol, Lexington, KY 40536 USA; [White, James; Smart, Eric J.] Univ Kentucky, Coll Med, Dept Pediat, Lexington, KY 40536 USA; [Daugherty, Alan] Univ Kentucky, Coll Med, Dept Internal Med, Lexington, KY 40536 USA; [Wei, Jia; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Biol, Dept Mol Cell Biol, Atlanta, GA 30332 USA; [Wei, Jia; Merrill, Alfred H., Jr.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University of Kentucky; University of Kentucky; University of Kentucky; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Nikolova-Karakashian, M (corresponding author), Univ Kentucky, Coll Med, Albert B Chandler Med Ctr, Dept Physiol, 800 Rose St, Lexington, KY 40536 USA.	mnikolo@uky.edu	Daugherty, Alan/C-8282-2009; Boyanovsky, Boris/AAQ-5194-2021; Giltiay, Natalia/AAH-2130-2019; Giltiay, Natalia V./H-8655-2019	Daugherty, Alan/0000-0003-2093-3775; Giltiay, Natalia/0000-0001-7284-514X; Merrill, Alfred/0000-0002-6673-968X	National Institutes of Health [R01 AG 19223]; American Heart Association Scientist Development [0130238N, P20RR15592]; LIPID MAPS Consortium [GM069338]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019223, R01AG026711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Scientist Development(American Heart Association); LIPID MAPS Consortium; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AG 19223 (NIA to M. N. K.). This work was also supported by American Heart Association Scientist Development Grants 0130238N (to N. K.) and P20RR15592 (to E. J. S.) and LIPID MAPS Consortium Grant GM069338 (to A. H. M.).	Bagnato C, 2003, J BIOL CHEM, V278, P52203, DOI 10.1074/jbc.M305760200; Chavez JA, 2003, ARCH BIOCHEM BIOPHYS, V419, P101, DOI 10.1016/j.abb.2003.08.020; Choi CS, 2007, J BIOL CHEM, V282, P22678, DOI 10.1074/jbc.M704213200; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; CROCKER AC, 1958, MEDICINE, V37, P1, DOI 10.1097/00005792-195802000-00001; den Boer M, 2004, ARTERIOSCL THROM VAS, V24, P644, DOI 10.1161/01.ATV.0000116217.57583.6e; Dickson RC, 2000, METHOD ENZYMOL, V311, P3; FUTERMAN AH, 1990, J BIOL CHEM, V265, P8650; Ghosh N, 2007, ENDOCRINOLOGY, V148, P1359, DOI 10.1210/en.2006-0750; Herschkovitz A, 2007, J BIOL CHEM, V282, P18018, DOI 10.1074/jbc.M610949200; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; HORINOUCHI K, 1995, NAT GENET, V10, P288, DOI 10.1038/ng0795-288; JeBailey L, 2007, DIABETES, V56, P394, DOI 10.2337/db06-0823; KAHOVCOVA J, 1969, J CHROMATOGR, V40, P90, DOI 10.1016/S0021-9673(01)96622-1; KOVAL M, 1990, J CELL BIOL, V111, P429, DOI 10.1083/jcb.111.2.429; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Leventhal AR, 2001, J BIOL CHEM, V276, P44976, DOI 10.1074/jbc.M106455200; MacDonald MLE, 2008, J LIPID RES, V49, P217, DOI 10.1194/jlr.M700478-JLR200; Marathe S, 1999, ARTERIOSCL THROM VAS, V19, P2648, DOI 10.1161/01.ATV.19.11.2648; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; MERRILL AH, 1995, J BIOL CHEM, V270, P13834, DOI 10.1074/jbc.270.23.13834; MERRILL AH, 1988, ANAL BIOCHEM, V171, P373, DOI 10.1016/0003-2697(88)90500-3; Pickersgill L, 2007, J BIOL CHEM, V282, P12583, DOI 10.1074/jbc.M611157200; Powell DJ, 2004, BIOCHEM J, V382, P619, DOI 10.1042/BJ20040139; Reynoso R, 2003, MOL CELL BIOCHEM, V246, P155, DOI 10.1023/A:1023423005187; Samad F, 2006, DIABETES, V55, P2579, DOI 10.2337/db06-0330; Schmitz-Peiffer C, 1999, J BIOL CHEM, V274, P24202, DOI 10.1074/jbc.274.34.24202; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Summers SA, 2006, PROG LIPID RES, V45, P42, DOI 10.1016/j.plipres.2005.11.002; Turpin SM, 2006, AM J PHYSIOL-ENDOC M, V291, pE1341, DOI 10.1152/ajpendo.00095.2006; Unger RH, 2003, TRENDS ENDOCRIN MET, V14, P398, DOI 10.1016/j.tem.2003.09.008; Weinberg JM, 2006, KIDNEY INT, V70, P1560, DOI 10.1038/sj.ki.5001834; WILLIAMS RD, 1984, ARCH BIOCHEM BIOPHYS, V228, P282, DOI 10.1016/0003-9861(84)90069-9; Worgall TS, 2002, J BIOL CHEM, V277, P3878, DOI 10.1074/jbc.M102393200; Wu L, 2006, J LIPID RES, V47, P2215, DOI 10.1194/jlr.M600146-JLR200; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784	36	66	68	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8359	8368		10.1074/jbc.M807800200	http://dx.doi.org/10.1074/jbc.M807800200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19074137	Green Published, hybrid			2022-12-25	WOS:000264397800020
J	Bailey, MJ; Coon, SL; Carter, DA; Humphries, A; Kim, JS; Shi, Q; Gaildrat, P; Morin, F; Ganguly, S; Hogenesch, JB; Weller, JL; Rath, MF; Moller, M; Baler, R; Sugden, D; Rangel, ZG; Munson, PJ; Klein, DC				Bailey, Michael J.; Coon, Steven L.; Carter, David A.; Humphries, Ann; Kim, Jong-So; Shi, Qiong; Gaildrat, Pascaline; Morin, Fabrice; Ganguly, Surajit; Hogenesch, John B.; Weller, Joan L.; Rath, Martin F.; Moller, Morten; Baler, Ruben; Sugden, David; Rangel, Zoila G.; Munson, Peter J.; Klein, David C.			Night/Day Changes in Pineal Expression of > 600 Genes CENTRAL ROLE OF ADRENERGIC/cAMP SIGNALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ARYLALKYLAMINE-N-ACETYLTRANSFERASE; O-METHYLTRANSFERASE ACTIVITY; OTX2 HOMEOBOX GENE; RAT PINEAL; MELATONIN SYNTHESIS; THYROID-HORMONE; MESSENGER-RNA; E-BOX; CIRCADIAN CLOCK; DAILY RHYTHM	The pineal gland plays an essential role in vertebrate chronobiology by converting time into a hormonal signal, melatonin, which is always elevated at night. Here we have analyzed the rodent pineal transcriptome using Affymetrix GeneChip (R) technology to obtain a more complete description of pineal cell biology. The effort revealed that 604 genes (1,268 probe sets) with Entrez Gene identifiers are differentially expressed greater than 2-fold between midnight and mid-day (false discovery rate <0.20). Expression is greater at night in similar to 70%. These findings were supported by the results of radiochemical in situ hybridization histology and quantitative real time-PCR studies. We also found that the regulatory mechanism controlling the night/day changes in the expression of most genes involves norepinephrine-cyclic AMP signaling. Comparison of the pineal gene expression profile with that in other tissues identified 334 genes (496 probe sets) that are expressed greater than 8-fold higher in the pineal gland relative to other tissues. Of these genes, 17% are expressed at similar levels in the retina, consistent with a common evolutionary origin of these tissues. Functional categorization of the highly expressed and/or night/day differentially expressed genes identified clusters that are markers of specialized functions, including the immune/inflammation response, melatonin synthesis, photodetection, thyroid hormone signaling, and diverse aspects of cellular signaling and cell biology. These studies produce a paradigm shift in our understanding of the 24-h dynamics of the pineal gland from one focused on melatonin synthesis to one including many cellular processes.	[Bailey, Michael J.; Coon, Steven L.; Kim, Jong-So; Shi, Qiong; Gaildrat, Pascaline; Morin, Fabrice; Ganguly, Surajit; Weller, Joan L.; Klein, David C.] NICHD, Sect Neuroendocrinol, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA; [Carter, David A.; Humphries, Ann] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Hogenesch, John B.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Rath, Martin F.; Moller, Morten] Univ Copenhagen, Fac Hlth Sci, Dept Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark; [Baler, Ruben] NIMH, Unit Temporal Gene Express, Lab Cellular & Mol Regulat, Bethesda, MD 20892 USA; [Sugden, David] Kings Coll London, Sch Biomed & Hlth Sci, Div Reprod & Endocrinol, London SE1 1UL, England; [Rangel, Zoila G.; Munson, Peter J.] NIH, Math & Stat Comp Lab, Ctr Informat Technol, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Cardiff University; Novartis; University of Copenhagen; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of London; King's College London; National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT)	Klein, DC (corresponding author), 49 Convent Dr,Bldg 49,Rm 6A82, Bethesda, MD 20892 USA.	kleind@mail.nih.gov	Carter, David/A-4479-2010; Rath, Martin/AAL-9732-2021	Carter, David/0000-0002-8419-3975; Morin, Fabrice/0000-0001-6785-1967; Klein, David/0000-0002-1792-5806; Moller, Morten/0000-0002-3263-7482; Rath, Martin/0000-0002-4047-6324; Ganguly, Surajit/0000-0002-1876-9147	CENTER FOR INFORMATION TECHNOLOGY [ZIACT000266] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008838, ZIAHD008837, ZIAHD008836] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [ZIAHD000095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054794] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIMH NIH HHS [P50 MH074924] Funding Source: Medline; NINDS NIH HHS [R01 NS054794] Funding Source: Medline; Wellcome Trust Funding Source: Medline	CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission)		ALTSHULER D, 1993, DEVELOPMENT, V119, P1317; Amelio AL, 2007, P NATL ACAD SCI USA, V104, P20314, DOI 10.1073/pnas.0707999105; Appelbaum L, 2006, J MOL ENDOCRINOL, V36, P337, DOI 10.1677/jme.1.01893; Appelbaum L, 2005, J BIOL CHEM, V280, P11544, DOI 10.1074/jbc.M412935200; Appelbaum L, 2004, MOL ENDOCRINOL, V18, P1210, DOI 10.1210/me.2003-0439; Appelbaum L, 2006, MOL CELL ENDOCRINOL, V252, P27, DOI 10.1016/j.mce.2006.03.021; ARAKI M, 1990, CELL DIFFER DEV, V31, P129, DOI 10.1016/0922-3371(90)90016-P; ARAKI M, 1992, DEV BIOL, V149, P440, DOI 10.1016/0012-1606(92)90298-U; ARENDT J, 1994, MELATONIN MAMMALIAN, P1; AUERBACH DA, 1981, ENDOCRINOLOGY, V108, P559, DOI 10.1210/endo-108-2-559; Auerbach G, 2000, P NATL ACAD SCI USA, V97, P13567, DOI 10.1073/pnas.240463497; Bai L, 2008, BRAIN RES, V1203, P89, DOI 10.1016/j.brainres.2008.01.073; Bajic Vladimir B., 2004, In Silico Biology, V4, P109; BALER R, 1995, J BIOL CHEM, V270, P27319, DOI 10.1074/jbc.270.45.27319; Baler R, 1997, J BIOL CHEM, V272, P6979, DOI 10.1074/jbc.272.11.6979; Baler R, 1996, BIOCHEM BIOPH RES CO, V220, P975, DOI 10.1006/bbrc.1996.0517; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernard M, 1996, J NEUROCHEM, V67, P1032; Bernard M, 1997, J NEUROCHEM, V68, P213; Bernard M, 2001, J NEUROCHEM, V79, P248, DOI 10.1046/j.1471-4159.2001.00555.x; Borjigin J, 1999, J NEUROSCI, V19, P1018; Borjigin J, 1999, J BIOL CHEM, V274, P35012, DOI 10.1074/jbc.274.49.35012; Borjigin J, 2003, J BIOL CHEM, V278, P16315, DOI 10.1074/jbc.M300828200; Ceinos RM, 2004, NEUROSIGNALS, V13, P308, DOI 10.1159/000081966; Chen W, 2000, MOL BRAIN RES, V81, P43, DOI 10.1016/S0169-328X(00)00160-1; Chik CL, 2007, ENDOCRINOLOGY, V148, P1465, DOI 10.1210/en.2006-1454; CHIK CL, 1988, ENDOCRINOLOGY, V122, P702, DOI 10.1210/endo-122-2-702; Coon SL, 1997, MOL PHARMACOL, V51, P551, DOI 10.1124/mol.51.4.551; Davies JS, 2006, MOL CELL ENDOCRINOL, V252, P19, DOI 10.1016/j.mce.2006.03.020; Dinet V, 2006, EXP EYE RES, V83, P276, DOI 10.1016/j.exer.2005.12.011; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Estivill-Torrus G, 2001, MECH DEVELOP, V109, P215, DOI 10.1016/S0925-4773(01)00527-5; Falcon J, 2003, J NEUROENDOCRINOL, V15, P378, DOI 10.1046/j.1365-2826.2003.00993.x; FALCON J, 1989, J NEUROSCI, V9, P1943; Forrest D, 2002, CURR OPIN NEUROBIOL, V12, P49, DOI 10.1016/S0959-4388(02)00289-1; Foulkes NS, 1996, NATURE, V381, P83, DOI 10.1038/381083a0; Fukada Y, 2002, MOL NEUROBIOL, V25, P19, DOI 10.1385/MN:25:1:019; Fukuhara C, 2004, J NEUROSCI, V24, P1803, DOI 10.1523/JNEUROSCI.4988-03.2004; Fukuhara C, 2003, J PINEAL RES, V35, P196, DOI 10.1034/j.1600-079X.2003.00078.x; Furukawa A, 2002, J NEUROSCI, V22, P1640, DOI 10.1523/JNEUROSCI.22-05-01640.2002; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Gaildrat P, 2005, J BIOL CHEM, V280, P16851, DOI 10.1074/jbc.M414587200; Ganguly S, 2007, J BIOL CHEM, V282, P32758, DOI 10.1074/jbc.M705950200; Gehring WJ, 2002, INT J DEV BIOL, V46, P65; Gothilf Y, 2002, DEV DYNAM, V225, P241, DOI 10.1002/dvdy.10152; Gothilf Y, 1999, ENDOCRINOLOGY, V140, P4895, DOI 10.1210/en.140.10.4895; HADA T, 1994, BBA-LIPID LIPID MET, V1211, P221, DOI 10.1016/0005-2760(94)90272-0; Harpavat S, 2003, THYROID, V13, P1013, DOI 10.1089/105072503770867183; Ho AK, 2007, ENDOCRINOLOGY, V148, P4592, DOI 10.1210/en.2007-0578; Ho AK, 2007, ENDOCRINOLOGY, V148, P743, DOI 10.1210/en.2006-1154; HO AK, 1988, J PINEAL RES, V5, P553, DOI 10.1111/j.1600-079X.1988.tb00798.x; HO AK, 1987, J BIOL CHEM, V262, P11764; HO AK, 1987, J NEUROCHEM, V48, P1033, DOI 10.1111/j.1471-4159.1987.tb05622.x; Humphries A, 2002, J NEUROENDOCRINOL, V14, P101, DOI 10.1046/j.0007-1331.2001.00738.x; Humphries A, 2007, MOL CELL ENDOCRINOL, V270, P43, DOI 10.1016/j.mce.2007.02.003; Insel PA, 2003, CELL MOL NEUROBIOL, V23, P305, DOI 10.1023/A:1023684503883; Iuvone PM, 1997, BIOL SIGNAL, V6, P217; Karolczak M, 2004, EUR J NEUROSCI, V19, P3382, DOI 10.1111/j.0953-816X.2004.03444.x; Kim JS, 2007, ENDOCRINOLOGY, V148, P1475, DOI 10.1210/en.2006-1420; Kim JS, 2005, J BIOL CHEM, V280, P677, DOI 10.1074/jbc.M408438200; Kimura A, 2000, J BIOL CHEM, V275, P1152, DOI 10.1074/jbc.275.2.1152; Klein D C, 1983, Prog Clin Biol Res, V125, P169; Klein DC, 2007, J BIOL CHEM, V282, P4233, DOI 10.1074/jbc.R600036200; Klein DC, 1997, RECENT PROG HORM RES, V52, P307; Klein DC, 2006, CHRONOBIOL INT, V23, P5, DOI 10.1080/07420520500545839; KLEIN DC, 1985, CIBA F SYMP, V117, P38; Klein DC, 2004, J BIOL RHYTHM, V19, P264, DOI 10.1177/0748730404267340; KLEIN DC, 1983, P NATL ACAD SCI-BIOL, V80, P599, DOI 10.1073/pnas.80.2.599; Kofler B, 2002, HISTOCHEM J, V34, P167, DOI 10.1023/A:1020946631937; Kohrle J, 2005, THYROID, V15, P841, DOI 10.1089/thy.2005.15.841; LAITINEN JT, 1995, CELL MOL NEUROBIOL, V15, P177, DOI 10.1007/BF02073327; Li AM, 2003, INVEST OPHTH VIS SCI, V44, P996, DOI 10.1167/iovs.02-0434; Li XD, 1998, P NATL ACAD SCI USA, V95, P1876, DOI 10.1073/pnas.95.4.1876; Lincoln GA, 2006, CHRONOBIOL INT, V23, P301, DOI 10.1080/07420520500464452; Mani SS, 1999, J BIOL CHEM, V274, P15590, DOI 10.1074/jbc.274.22.15590; Mansouri A, 1996, CURR OPIN CELL BIOL, V8, P851, DOI 10.1016/S0955-0674(96)80087-1; Maronde E, 2007, TRENDS ENDOCRIN MET, V18, P142, DOI 10.1016/j.tem.2007.03.001; McLean DJ, 2002, MOL ENDOCRINOL, V16, P2780, DOI 10.1210/me.2002-0059; Moller M, 2002, CELL TISSUE RES, V309, P139, DOI 10.1007/s00441-002-0580-5; Moller M, 2006, CHRONOBIOL INT, V23, P393, DOI 10.1080/07420520500521855; Moller M, 1997, CELL TISSUE RES, V288, P279, DOI 10.1007/s004410050813; Munoz EM, 2007, J NEUROCHEM, V102, P887, DOI 10.1111/j.1471-4159.2007.04605.x; MURAKAMI M, 1989, LIFE SCI, V44, P425, DOI 10.1016/0024-3205(89)90267-1; Namihira M, 1999, NEUROSCI LETT, V267, P69, DOI 10.1016/S0304-3940(99)00324-9; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; NIR I, 1978, J NEURAL TRANSM, V42, P117, DOI 10.1007/BF01675350; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; PACEASCIAK CR, 1993, BIOCHEM BIOPH RES CO, V197, P869, DOI 10.1006/bbrc.1993.2559; PACEASCIAK CR, 1995, J LIPID MEDIAT CELL, V12, P307, DOI 10.1016/0929-7855(95)00036-P; PARFITT A, 1976, NEUROPHARMACOLOGY, V15, P353, DOI 10.1016/0028-3908(76)90083-6; RATH M, 2009, ENDOCRINOLO IN PRESS; Rath MF, 2006, J NEUROCHEM, V97, P556, DOI 10.1111/j.1471-4159.2006.03773.x; Ren J, 2005, J BIOL CHEM, V280, P36912, DOI 10.1074/jbc.M507725200; Reynaud D, 1997, BBA-LIPID LIPID MET, V1346, P305, DOI 10.1016/S0005-2760(97)00041-6; REYNAUD D, 1994, J BIOL CHEM, V269, P23976; REYNAUD D, 1994, J NEUROCHEM, V62, P126; REYNAUD D, 1995, ADV PROSTAG THROMB L, V23, P183; Ribelayga C, 1997, BRAIN RES, V777, P247, DOI 10.1016/S0006-8993(97)01231-6; Roberts MR, 2006, P NATL ACAD SCI USA, V103, P6218, DOI 10.1073/pnas.0509981103; Roseboom PH, 1996, ENDOCRINOLOGY, V137, P3033, DOI 10.1210/en.137.7.3033; ROSEBOOM PH, 1995, MOL PHARMACOL, V47, P439; Scheetz TE, 2006, P NATL ACAD SCI USA, V103, P14429, DOI 10.1073/pnas.0602562103; Schomerus C, 1999, REPROD NUTR DEV, V39, P305, DOI 10.1051/rnd:19990303; SEAMON KB, 1986, ADV CYCLIC NUCL PROT, V20, P1; Simonneaux V, 2004, MOL BRAIN RES, V120, P164, DOI 10.1016/j.molbrainres.2003.10.019; Smith SB, 1999, MOL CELL BIOL, V19, P8272; STEHLE JH, 1993, NATURE, V365, P314, DOI 10.1038/365314a0; SUGDEN AL, 1986, J BIOL CHEM, V261, P1608; SUGDEN D, 1984, ENDOCRINOLOGY, V114, P435, DOI 10.1210/endo-114-2-435; Sugden D, 1996, BRIT J PHARMACOL, V118, P1246, DOI 10.1111/j.1476-5381.1996.tb15530.x; SUGDEN LA, 1987, J BIOL CHEM, V262, P741; TANAKA K, 1987, ENDOCRINOLOGY, V121, P74, DOI 10.1210/endo-121-1-74; Tosini G, 2006, CHRONOBIOL INT, V23, P381, DOI 10.1080/07420520500482066; Tosini G, 2000, P NATL ACAD SCI USA, V97, P11540, DOI 10.1073/pnas.210248297; Van Loo P, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r66; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VANECEK J, 1985, ENDOCRINOLOGY, V116, P2167, DOI 10.1210/endo-116-6-2167; Walker JR, 2004, GENOME RES, V14, P742, DOI 10.1101/gr.2161804; Wang X, 1996, MOL BRAIN RES, V41, P269, DOI 10.1016/0169-328X(96)00107-6; Wang X, 1997, J NEUROSCI METH, V73, P187, DOI 10.1016/S0165-0270(97)02237-1; Yamada H, 1998, J NEUROSCI, V18, P4946; Yeh JJ, 2001, J NEUROCHEM, V77, P336, DOI 10.1046/j.1471-4159.2001.00259.x; Young JE, 2007, GENOMICS, V90, P236, DOI 10.1016/j.ygeno.2007.03.004; Yu AM, 2003, PHARMACOGENETICS, V13, P173, DOI 10.1097/00008571-200303000-00007	124	115	123	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7606	7622		10.1074/jbc.M808394200	http://dx.doi.org/10.1074/jbc.M808394200			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19103603	Green Published, hybrid			2022-12-25	WOS:000264195600023
J	Wu, CL; Kim, PY; Manuel, R; Seto, M; Whitlow, M; Nagashima, M; Morser, J; Gils, A; Declerck, P; Nesheim, ME				Wu, Chengliang; Kim, Paul Y.; Manuel, Reg; Seto, Marian; Whitlow, Marc; Nagashima, Mariko; Morser, John; Gils, Ann; Declerck, Paul; Nesheim, Michael E.			The Roles of Selected Arginine and Lysine Residues of TAFI (Pro-CPU) in Its Activation to TAFIa by the Thrombin-Thrombomodulin Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVABLE FIBRINOLYSIS INHIBITOR; PLASMA PROCARBOXYPEPTIDASE B; PROTEIN-C; PROTEOLYTIC CLEAVAGE; CATALYZED ACTIVATION; CARBOXYPEPTIDASE-B; THERMAL-STABILITY; STRUCTURAL BASIS; INACTIVATION; THROMBOLYSIS	Thrombomodulin (TM) increases the catalytic efficiency of thrombin (IIa)-mediated activation of thrombin-activable fibrinolysis inhibitor (TAFI) 1250-fold. Negatively charged residues of the C-loop of TM-EGF-like domain 3 are required for TAFI activation. Molecular models suggested several positively charged residues of TAFI with which the C-loop residues could interact. Seven TAFI mutants were constructed to determine if these residues are required for efficient TAFI activation. TAFI wild-type or mutants were activated in the presence or absence of TM and the kinetic parameters of TAFI activation were determined. When the three consecutive lysine residues in the activation peptide of TAFI were substituted with alanine (K42/43/44A), the catalytic efficiencies for TAFI activation with TM decreased 8-fold. When other positively charged surface residues of TAFI (Lys-133, Lys-211, Lys-212, Arg-220, Lys-240, or Arg-275) were mutated to alanine, the catalytic efficiencies for TAFI activation with TM decreased by 1.7-2.7-fold. All decreases were highly statistically significant. In the absence of TM, catalytic efficiencies ranged from 2.8-fold lower to 1.24-fold higher than wild-type. None of these, except the 2.8-fold lower value, was statistically significant. The average half-life of the TAFIa mutants was 8.1 +/- 0.6 min, and that of wild type was 8.4 +/- 0.3 min at 37 degrees C. Our data show that these residues are important in the activation of TAFI by IIa, especially in the presence of TM. Whether the mutated residues promote a TAFI-TM or TAFI-IIa interaction remains to be determined. In addition, these residues do not influence spontaneous inactivation of TAFIa.	[Wu, Chengliang; Kim, Paul Y.; Manuel, Reg; Nesheim, Michael E.] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; [Nesheim, Michael E.] Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada; [Gils, Ann; Declerck, Paul] Katholieke Univ Leuven, Fac Pharmaceut Sci, Lab Pharmaceut Biol, B-3000 Louvain, Belgium; [Seto, Marian; Whitlow, Marc; Nagashima, Mariko; Morser, John] Berlex Biosci, Richmond, CA 94804 USA	Queens University - Canada; Queens University - Canada; KU Leuven	Nesheim, ME (corresponding author), Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada.	nesheimm@queensu.ca	Kim, Paul/GYV-3258-2022; Declerck, Paul J/A-2330-2017	Kim, Paul/0000-0003-0943-4924; Declerck, Paul J/0000-0003-1259-9105	National Institutes of Health [5 P01 HL046703]; CIHR [MT-9781]; Heart and Stroke Foundation of Ontario [T5575]; Heart and Stroke Foundation of Canada; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL046703] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant 5 P01 HL046703 (to M. E. N.). This work was also supported by CIHR Grant MT-9781 (to M. E. N.), as well as Heart and Stroke Foundation of Ontario Grant T5575 (to M. E. N.). This study was also supported by the Heart and Stroke Foundation of Canada Doctoral Research Award (to P. Y. K.). The costs of publication of this article were defrayed in part by the payment of page charges.	Anand K, 2008, J BIOL CHEM, V283, P29416, DOI 10.1074/jbc.M804003200; Bajzar L, 1996, J BIOL CHEM, V271, P16603, DOI 10.1074/jbc.271.28.16603; BAJZAR L, 1995, J BIOL CHEM, V270, P14477, DOI 10.1074/jbc.270.24.14477; Bajzar L, 1996, BLOOD, V88, P2093, DOI 10.1182/blood.V88.6.2093.bloodjournal8862093; Boffa MB, 1998, J BIOL CHEM, V273, P2127, DOI 10.1074/jbc.273.4.2127; Boffa MB, 2000, J BIOL CHEM, V275, P12868, DOI 10.1074/jbc.275.17.12868; BOSKOVIC DS, 1990, J BIOL CHEM, V265, P10497; CAMPBELL W, 1989, BIOCHEM BIOPH RES CO, V162, P933, DOI 10.1016/0006-291X(89)90762-6; Campbell WD, 2002, MICROBIOL IMMUNOL, V46, P131, DOI 10.1111/j.1348-0421.2002.tb02669.x; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; EATON DL, 1991, J BIOL CHEM, V266, P21833; ESMON CT, 1995, FASEB J, V9, P946, DOI 10.1096/fasebj.9.10.7615164; ESMON CT, 1982, J BIOL CHEM, V257, P7944; ESMON CT, 1991, ANN NY ACAD SCI, V614, P30; ESMON NL, 1982, J BIOL CHEM, V257, P859; FAN BQ, 1993, J BIOL CHEM, V268, P17588; Fuentes-Prior P, 2000, NATURE, V404, P518, DOI 10.1038/35006683; Gils A, 2005, J THROMB HAEMOST, V3, P2745, DOI 10.1111/j.1538-7836.2005.01629.x; Gils A, 2003, ARTERIOSCL THROM VAS, V23, P1122, DOI 10.1161/01.ATV.0000074145.58172.BD; GOMISRUTH FX, 1995, EMBO J, V14, P4387, DOI 10.1002/j.1460-2075.1995.tb00117.x; Hall SW, 1999, J BIOL CHEM, V274, P25510, DOI 10.1074/jbc.274.36.25510; Klement P, 1999, BLOOD, V94, P2735, DOI 10.1182/blood.V94.8.2735.420k30_2735_2743; Kokame K, 1998, J BIOL CHEM, V273, P12135, DOI 10.1074/jbc.273.20.12135; Mao SS, 1999, J BIOL CHEM, V274, P35046, DOI 10.1074/jbc.274.49.35046; Marx PF, 2008, BLOOD, V112, P2803, DOI 10.1182/blood-2008-03-146001; Marx PF, 2000, J BIOL CHEM, V275, P12410, DOI 10.1074/jbc.275.17.12410; Myles T, 2003, J BIOL CHEM, V278, P51059, DOI 10.1074/jbc.M306977200; Nagashima M, 2000, THROMB RES, V98, P333, DOI 10.1016/S0049-3848(00)00184-5; Nesheim ME, 1999, FIBRINOLYSIS PROTEOL, V13, P72, DOI 10.1016/S0268-9499(99)90082-6; NEVILLE DM, 1971, J BIOL CHEM, V246, P6328; PARKINSON JF, 1992, BIOCHEM BIOPH RES CO, V185, P567, DOI 10.1016/0006-291X(92)91662-A; Refino CJ, 2000, FIBRINOLYSIS PROTEOL, V14, P305, DOI 10.1054/fipr.2000.0087; SADLER JE, 1993, HAEMOSTASIS, V23, P183; Schneider M, 2002, J BIOL CHEM, V277, P1021, DOI 10.1074/jbc.M104444200; Schneider M, 2002, J BIOL CHEM, V277, P9944, DOI 10.1074/jbc.M111685200; SHINOHARA T, 1994, INT ARCH ALLERGY IMM, V103, P400, DOI 10.1159/000236661; TAN AK, 1995, BIOCHEMISTRY-US, V34, P5811, DOI 10.1021/bi00017a012; TSIANG M, 1992, J BIOL CHEM, V267, P6164; Walker JB, 1999, J BIOL CHEM, V274, P5201, DOI 10.1074/jbc.274.8.5201; Wang W, 1998, J BIOL CHEM, V273, P27176, DOI 10.1074/jbc.273.42.27176; WANG W, 1994, J BIOL CHEM, V269, P15937; Wang W, 2000, J BIOL CHEM, V275, P22942, DOI 10.1074/jbc.M001760200; Wu CL, 2003, THROMB HAEMOSTASIS, V90, P414, DOI 10.1160/TH02-09-0104; Wu CL, 2003, J BIOL CHEM, V278, P25847, DOI 10.1074/jbc.M301223200	44	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7059	7067		10.1074/jbc.M804745200	http://dx.doi.org/10.1074/jbc.M804745200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19074424	hybrid, Green Published			2022-12-25	WOS:000263919000054
J	Harada, H; Itasaka, S; Kizaka-Kondoh, S; Shibuya, K; Morinibu, A; Shinomiya, K; Hiraoka, M				Harada, Hiroshi; Itasaka, Satoshi; Kizaka-Kondoh, Shinae; Shibuya, Keiko; Morinibu, Akiyo; Shinomiya, Kazumi; Hiraoka, Masahiro			The Akt/mTOR Pathway Assures the Synthesis of HIF-1 alpha Protein in a Glucose- and Reoxygenation-dependent Manner in Irradiated Tumors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR-1; GROWTH-FACTOR EXPRESSION; COLON-CANCER CELLS; GENE-EXPRESSION; FACTOR-I; OXYGEN; HIF-1; RADIOTHERAPY; RADIATION; RADIOSENSITIVITY	Transcriptional activity of HIF-1 (hypoxia-inducible factor-1) has been reported to be up-regulated in solid tumors after ionizing radiation; however, the molecular mechanism underlying the response remains to be elucidated. In the present study, we performed a series of molecular imaging experiments using a HIF-1-dependent reporter gene, 5HREp-ODD-luc, and found an essential role of the Akt/mTOR pathway. Hypoxic tumor cells distant from blood vessels were dramatically reoxygenated at 24 h postirradiation, and HIF-1 activity increased as HIF-1 alpha accumulated in the reoxygenated regions. The accumulation was inhibited with a nonmetabolizable glucose analog, 2-deoxy-D- glucose, through the suppression of radiation-induced phosphorylation of Akt in the reoxygenated regions. Akt knockdown and an mTOR inhibitor revealed the importance of the Akt/mTOR pathway in the postirradiation accumulation of HIF-1 alpha. In vitro experiments confirmed that an increase in glucose availability induced Akt phosphorylation under reoxygenated conditions and consequently up-regulated HIF-1 alpha translation. Moreover, both the accelerated translation and the previously reported reactive oxygen species-mediated stabilization of HIF-1 alpha protein were essential to the activation of HIF-1. All of these results indicate that Akt/mTOR- dependent translation of HIF-1 alpha plays a critical role in the postirradiation up-regulation of intratumoral HIF-1 activity in response to radiation-induced alterations of glucose and oxygen availability in a solid tumor.	[Harada, Hiroshi] Kyoto Univ, Grad Sch Med, Dept Radiat Oncol & Image Appl Therapy, Sakyo Ku, Kyoto 6068507, Japan; [Harada, Hiroshi; Hiraoka, Masahiro] Kyoto Univ, Grad Sch Med, Nanomed Merger Educ Unit, Kyoto 6068507, Japan	Kyoto University; Kyoto University	Harada, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Radiat Oncol & Image Appl Therapy, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	hharada@kuhp.kyoto-u.ac.jp	Kondoh, Shinae/AAF-8745-2020; Kondoh, Shinae/C-6937-2015	Kondoh, Shinae/0000-0003-3085-5782; Kondoh, Shinae/0000-0003-3085-5782	New Energy and Industrial Technology Development Organization (NEDO) Japan; Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science, and Technology, Japan	New Energy and Industrial Technology Development Organization (NEDO) Japan(New Energy and Industrial Technology Development Organization (NEDO)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was part of the programs "R&D of Molecular Imaging Equipment for Malignant Tumor Therapy Support" supported by New Energy and Industrial Technology Development Organization (NEDO) Japan and "Research for Promoting Technological Seeds" supported by the Japan Science and Technology Agency. This study was supported by Grants-in-aid for Scientific Research on Priority Areas (Cancer Research) and for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Aebersold DM, 2001, CANCER RES, V61, P2911; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Berra E, 2001, EMBO REP, V2, P615, DOI 10.1093/embo-reports/kve130; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Chen CH, 2001, J BIOL CHEM, V276, P9519, DOI 10.1074/jbc.M010144200; DORIE MJ, 1984, INT J RADIAT ONCOL, V10, P687, DOI 10.1016/0360-3016(84)90300-6; Ettinger SN, 2001, CANCER RES, V61, P7964; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; FOWLER JF, 1991, RADIOTHER ONCOL, V22, P156, DOI 10.1016/0167-8140(91)90017-B; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Fukuda R, 2003, CANCER RES, V63, P2330; Gorski DH, 1999, CANCER RES, V59, P3374; Harada H, 2007, ONCOGENE, V26, P7508, DOI 10.1038/sj.onc.1210556; Harada H, 2002, CANCER RES, V62, P2013; Harada H, 2007, BIOCHEM BIOPH RES CO, V360, P791, DOI 10.1016/j.bbrc.2007.06.149; Harada H, 2005, MOL IMAGING, V4, P182; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kennedy AS, 1997, INT J RADIAT ONCOL, V37, P897, DOI 10.1016/S0360-3016(96)00539-1; Kim JJ, 2005, NAT REV CANCER, V5, P516, DOI 10.1038/nrc1650; KUBOTA R, 1992, J NUCL MED, V33, P1972; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Moeller BJ, 2005, CANCER CELL, V8, P99, DOI 10.1016/j.ccr.2005.06.016; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; MUELLERKLIESER W, 1993, HISTOCHEM J, V25, P407, DOI 10.1007/BF00157805; Murata R, 1996, INT J RADIAT ONCOL, V34, P859, DOI 10.1016/0360-3016(95)02155-8; NORRIS ML, 1995, J BIOL CHEM, V270, P23774, DOI 10.1074/jbc.270.40.23774; Schroeder T, 2005, CANCER RES, V65, P5163, DOI 10.1158/0008-5472.CAN-04-3900; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Shibata T, 2000, GENE THER, V7, P493, DOI 10.1038/sj.gt.3301124; THOMLINSON RH, 1955, BRIT J CANCER, V9, P539, DOI 10.1038/bjc.1955.55; VAUPEL P, 1989, CANCER RES, V49, P6449; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Zeng LH, 2008, CANCER SCI, V99, P2327, DOI 10.1111/j.1349-7006.2008.00943.x; Zhong H, 2000, CANCER RES, V60, P1541; Zundel W, 2000, GENE DEV, V14, P391	35	133	139	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5332	5342		10.1074/jbc.M806653200	http://dx.doi.org/10.1074/jbc.M806653200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19098000	hybrid			2022-12-25	WOS:000263416600063
J	Bhalla, AD; Gudikote, JP; Wang, J; Chan, WK; Chang, YF; Olivas, OR; Wilkinson, MF				Bhalla, Angela D.; Gudikote, Jayanthi P.; Wang, Jun; Chan, Wai-Kin; Chang, Yao-Fu; Olivas, O. Renee; Wilkinson, Miles F.			Nonsense Codons Trigger an RNA Partitioning Shift	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXON-JUNCTION COMPLEX; CELL-RECEPTOR TRANSCRIPTS; ISOMERASE MESSENGER-RNA; MEDIATED DECAY; TRANSLATION TERMINATION; REGULATORY MECHANISM; NUCLEAR TRANSLATION; PROTEIN-SYNTHESIS; SURVEILLANCE; GENE	T-cell receptor-beta (TCR beta) genes naturally acquire premature termination codons (PTCs) as a result of programmed gene rearrangements. PTC-bearing TCR beta transcripts are dramatically down-regulated to protect T-cells from the deleterious effects of the truncated proteins that would otherwise be produced. Here we provide evidence that two responses collaborate to elicit this dramatic down-regulation. One is rapid mRNA decay triggered by the nonsense-mediated decay (NMD) RNA surveillance pathway. We demonstrate that this occurs in highly purified nuclei lacking detectable levels of three different cytoplasmic markers, but containing an outer nuclear membrane marker, suggesting that decay occurs either in the nucleoplasm or at the outer nuclear membrane. The second response is a dramatic partitioning shift in the nuclear fraction-to-cytoplasmic fraction mRNA ratio that results in few TCR beta transcripts escaping to the cytoplasmic fraction of cells. Analysis of TCR beta mRNA kinetics after either transcriptional repression or induction suggested that this nonsense codon-induced partitioning shift ( NIPS) response is not the result of cytoplasmic NMD but instead reflects retention of PTC+ TCR beta mRNA in the nuclear fraction of cells. We identified TCR beta sequences crucial for NIPS but found that NIPS is not exclusively a property of TCR beta transcripts, and we identified non-TCR beta sequences that elicit NIPS. RNA interference experiments indicated that NIPS depends on the NMD factors UPF1 and eIF4AIII but not the NMD factor UPF3B. We propose that NIPS collaborates with NMD to retain and degrade a subset of PTC+ transcripts at the outer nuclear membrane and/or within the nucleoplasm.	[Bhalla, Angela D.; Gudikote, Jayanthi P.; Wang, Jun; Chan, Wai-Kin; Chang, Yao-Fu; Olivas, O. Renee; Wilkinson, Miles F.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Bhalla, Angela D.] Univ Texas MD Anderson Canc Ctr, Program Genes & Dev, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Wilkinson, MF (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, 1515 Holcombe Blvd,Unit 1000, Houston, TX 77030 USA.	mwilkins@mdanderson.org	Chan, Waikin/AAI-4995-2020		National Institutes of Health [GM058595]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058595] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM058595. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BASERGA SJ, 1988, P NATL ACAD SCI USA, V85, P2056, DOI 10.1073/pnas.85.7.2056; BELGRADER P, 1993, P NATL ACAD SCI USA, V90, P482, DOI 10.1073/pnas.90.2.482; BELGRADER P, 1994, MOL CELL BIOL, V14, P8219, DOI 10.1128/MCB.14.12.8219; Bohnsack MT, 2002, EMBO J, V21, P6205, DOI 10.1093/emboj/cdf613; Brogna S, 2002, MOL CELL, V10, P93, DOI 10.1016/S1097-2765(02)00565-8; Buhler M, 2005, MOL CELL, V18, P307, DOI 10.1016/j.molcel.2005.03.030; Buhler M, 2002, EMBO REP, V3, P646, DOI 10.1093/embo-reports/kvf129; Caputi M, 2002, GENE DEV, V16, P1754, DOI 10.1101/gad.997502; Carter MS, 1996, EMBO J, V15, P5965, DOI 10.1002/j.1460-2075.1996.tb00983.x; CARTER MS, 1995, J BIOL CHEM, V270, P28995, DOI 10.1074/jbc.270.48.28995; Chan WK, 2007, EMBO J, V26, P1820, DOI 10.1038/sj.emboj.7601628; Chang YF, 2007, J BIOL CHEM, V282, P29738, DOI 10.1074/jbc.M704372200; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; CHENG J, 1993, MOL CELL BIOL, V13, P1892, DOI 10.1128/MCB.13.3.1892; CHENG J, 1990, MOL CELL BIOL, V10, P5502, DOI 10.1128/MCB.10.10.5502; Clement JQ, 2001, J BIOL CHEM, V276, P16919, DOI 10.1074/jbc.M005104200; Culbertson MR, 1999, TRENDS GENET, V15, P74, DOI 10.1016/S0168-9525(98)01658-8; DAAR IO, 1988, MOL CELL BIOL, V8, P802, DOI 10.1128/MCB.8.2.802; Dahlberg JE, 2003, RNA, V9, P1, DOI 10.1261/rna.2121703; Durand S, 2007, J CELL BIOL, V178, P1145, DOI 10.1083/jcb.200611086; Ferraiuolo MA, 2004, P NATL ACAD SCI USA, V101, P4118, DOI 10.1073/pnas.0400933101; Gehring NH, 2005, MOL CELL, V20, P65, DOI 10.1016/j.molcel.2005.08.012; Gehring NH, 2003, MOL CELL, V11, P939, DOI 10.1016/S1097-2765(03)00142-4; Gudikote JP, 2002, EMBO J, V21, P125, DOI 10.1093/emboj/21.1.125; Gudikote JP, 2005, NAT STRUCT MOL BIOL, V12, P801, DOI 10.1038/nsmb980; GUDIKOTE JP, 2006, NONSENSE MEDIATED MR, P71; HE F, 1993, P NATL ACAD SCI USA, V90, P7034, DOI 10.1073/pnas.90.15.7034; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Hilleren P, 1999, RNA, V5, P711, DOI 10.1017/S1355838299990519; Iborra FJ, 2001, SCIENCE, V293, P1139, DOI 10.1126/science.1061216; Jacobson A, 2000, COLD SPRING HARBOR M, V39, P827; Kessler O, 1996, MOL CELL BIOL, V16, P4426; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; KOZAK M, 1989, MOL CELL BIOL, V9, P5073, DOI 10.1128/MCB.9.11.5073; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Lejeune F, 2002, EMBO J, V21, P3536, DOI 10.1093/emboj/cdf345; Li SL, 1997, J EXP MED, V185, P985, DOI 10.1084/jem.185.6.985; LOZANO F, 1994, EMBO J, V13, P4617, DOI 10.1002/j.1460-2075.1994.tb06783.x; Lund E, 1998, SCIENCE, V282, P2082, DOI 10.1126/science.282.5396.2082; Lytle JR, 2004, RNA, V10, P657, DOI 10.1261/rna.5241404; MacLean JA, 2005, CELL, V120, P369, DOI 10.1016/j.cell.2004.12.022; Mangiarotti G, 1999, BIOCHEMISTRY-US, V38, P3996, DOI 10.1021/bi9822022; Mendell JT, 2002, SCIENCE, V298, P419, DOI 10.1126/science.1074428; Mendell JT, 2001, CELL, V107, P411, DOI 10.1016/S0092-8674(01)00583-9; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Muhlemann O, 2001, MOL CELL, V8, P33, DOI 10.1016/S1097-2765(01)00288-X; Nathanson L, 2003, RNA, V9, P9, DOI 10.1261/rna.2990203; Paillusson A, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni052; Palacios IM, 2004, NATURE, V427, P753, DOI 10.1038/nature02351; Rodriguez AJ, 2007, SEMIN CELL DEV BIOL, V18, P202, DOI 10.1016/j.semcdb.2007.02.002; Schell T, 2002, GENOME BIOL, V3; Sheth U, 2006, CELL, V125, P1095, DOI 10.1016/j.cell.2006.04.037; Shibuya T, 2004, NAT STRUCT MOL BIOL, V11, P346, DOI 10.1038/nsmb750; Thermann R, 1998, EMBO J, V17, P3484, DOI 10.1093/emboj/17.12.3484; Wagner E, 2002, J CELL SCI, V115, P3033; Wang J, 2002, MOL CELL, V10, P951, DOI 10.1016/S1097-2765(02)00635-4; Wang J, 2002, J BIOL CHEM, V277, P18489, DOI 10.1074/jbc.M111781200; Wang J, 2002, SCIENCE, V297, P108, DOI 10.1126/science.1069757; Wang J, 2002, EMBO REP, V3, P274, DOI 10.1093/embo-reports/kvf036; Weischenfeldt J, 2008, GENE DEV, V22, P1381, DOI 10.1101/gad.468808; WILKINSON M, 2000, ESSENTIAL MOL BIOL, P69; Wilkinson MF, 2005, TRENDS GENET, V21, P143, DOI 10.1016/j.tig.2005.01.007; Wilkinson MF, 2002, NAT CELL BIOL, V4, pE144, DOI 10.1038/ncb0602-e144; Wilusz CJ, 2001, GENE DEV, V15, P2781; Zhang J, 1998, MOL CELL BIOL, V18, P5272, DOI 10.1128/MCB.18.9.5272; Zhang J, 1998, RNA, V4, P801, DOI 10.1017/S1355838298971849; Zhang J, 1997, EMBO J, V16, P826, DOI 10.1093/emboj/16.4.826; Zhang SA, 1997, RNA, V3, P234	68	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4062	4072		10.1074/jbc.M805193200	http://dx.doi.org/10.1074/jbc.M805193200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19091751	Green Published, hybrid			2022-12-25	WOS:000263134400004
J	Etxebarria, A; Terrones, O; Yamaguchi, H; Landajuela, A; Landeta, O; Antonsson, B; Wang, HG; Basanez, G				Etxebarria, Aitor; Terrones, Oihana; Yamaguchi, Hirohito; Landajuela, Ane; Landeta, Olatz; Antonsson, Bruno; Wang, Hong-Gang; Basanez, Gorka			Endophilin B1/Bif-1 Stimulates BAX Activation Independently from Its Capacity to Produce Large Scale Membrane Morphological Rearrangements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL OUTER-MEMBRANE; MOLECULAR-DYNAMICS SIMULATIONS; POLYMORPHIC PHASE-BEHAVIOR; X-RAY-DIFFRACTION; CELL-DEATH; PROTEIN FAMILY; CYTOCHROME-C; APOPTOSIS; DOMAIN; CURVATURE	Endophilin B1/BAX-interacting factor 1 (Bif-1) is a protein that cooperates with dynamin-like protein 1 (DLP1/Drp1) to maintain normal mitochondrial outer membrane (MOM) dynamics in healthy cells and also contributes to BAX-driven MOM permeabilization ( MOMP), the irreversible commitment point to cell death for the majority of apoptotic stimuli. However, despite its importance, exactly how Bif-1 fulfils its proapoptotic role is unknown. Here, we demonstrate that the stimulatory effect of Bif-1 on BAX-driven MOMP and on BAX conformational activation observed in intact cells during apoptosis can be recapitulated in a simplified system consisting of purified proteins and MOM-like liposomes. In this reconstituted model system the N-BAR domain of Bif-1 reproduced the stimulatory effect of Bif-1 on functional BAX activation. This process was dependent on physical interaction between Bif-1 N-BAR and BAX as well as on the presence of the mitochondrion-specific lipid cardiolipin. Despite that Bif-1 N-BAR produced large scale morphological rearrangements in MOM-like liposomes, this phenomenon could be separated from functional BAX activation. Furthermore, DLP1 also caused global morphological changes in MOM-like liposomes, but DLP1 did not stimulate BAX-permeabilizing function in the absence or presence of Bif-1. Taken together, our findings not only provide direct evidence for a functional interplay between Bif-1, BAX, and cardiolipin during MOMP but also add significantly to the growing body of evidence indicating that components of the mitochondrial morphogenesis machinery possess proapoptotic functions that are independent from their recognized roles in normal mitochondrial dynamics.	[Etxebarria, Aitor; Terrones, Oihana; Landajuela, Ane; Landeta, Olatz; Basanez, Gorka] Univ Basque Country, EHU, Ctr Mixto,CSIC, Unidad Biofis, E-48080 Bilbao, Spain; [Yamaguchi, Hirohito] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Antonsson, Bruno] Merck Serono Int SA, CH-1202 Geneva, Switzerland; [Wang, Hong-Gang] Penn State Coll Med, Dept Pharmacol, Hershey, PA 17033 USA	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Texas System; UTMD Anderson Cancer Center; Merck & Company; Serono International S.A.; Merck KGaA; EMD Serono Inc.; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Basanez, G (corresponding author), EHU, CSIC UPV, Unidad Biofis, Barrio Sarriena S-N, Leioa 48940, Spain.	gbzbaasg@lg.ehu.es	Terrones, Oihana/AAA-8903-2019; Basanez, Gorka/L-9509-2014; Wang, Hong-Gang/A-3018-2015; Terrones, Oihana/I-4023-2015	Basanez, Gorka/0000-0002-7475-7861; Wang, Hong-Gang/0000-0003-0551-0571; Terrones, Oihana/0000-0001-7421-6486; Landeta, Olatz/0000-0002-5494-0271	Ministerio de Ciencia e Innovacion [BFU2008-01637, CA82197-09]; NATIONAL CANCER INSTITUTE [R01CA082197] Funding Source: NIH RePORTER	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Ministerio de Ciencia e Innovacion Grants BFU2008-01637 ( to G. B.) and CA82197-09 ( to H.-G. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alirol E, 2006, MOL BIOL CELL, V17, P4593, DOI 10.1091/mbc.E06-05-0377; Antonny B, 2006, CURR OPIN CELL BIOL, V18, P386, DOI 10.1016/j.ceb.2006.06.003; Ayton GS, 2007, BIOPHYS J, V92, P3595, DOI 10.1529/biophysj.106.101709; Basanez G, 2002, CELL MOL LIFE SCI, V59, P1478, DOI 10.1007/s00018-002-8523-6; Basanez G, 2008, PLOS BIOL, V6, P1148, DOI 10.1371/journal.pbio.0060154; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Blood PD, 2008, BIOPHYS J, V95, P1866, DOI 10.1529/biophysj.107.121160; Blood PD, 2006, P NATL ACAD SCI USA, V103, P15068, DOI 10.1073/pnas.0603917103; Campelo F, 2008, BIOPHYS J, V95, P2325, DOI 10.1529/biophysj.108.133173; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Cuddeback SM, 2001, J BIOL CHEM, V276, P20559, DOI 10.1074/jbc.M101527200; Dahlberg M, 2007, J PHYS CHEM B, V111, P7194, DOI 10.1021/jp071954f; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; FROLOV VA, 2008, J CELL, V132, P727; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Germain M, 2005, EMBO J, V24, P1546, DOI 10.1038/sj.emboj.7600592; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; James DI, 2008, DEV CELL, V15, P341, DOI 10.1016/j.devcel.2008.08.011; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Karbowski M, 2004, J CELL BIOL, V166, P1027, DOI 10.1083/jcb.200407046; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Lewis RNAH, 2007, BIOPHYS J, V92, P3166, DOI 10.1529/biophysj.106.094003; Liu JH, 2003, MOL CANCER RES, V1, P892; Liu JH, 2008, BIOCHEMISTRY-US, V47, P4518, DOI 10.1021/bi701962c; Low C, 2008, BIOPHYS J, V95, P4315, DOI 10.1529/biophysj.108.134155; Lucken-Ardjomande S, 2008, CELL DEATH DIFFER, V15, P929, DOI 10.1038/cdd.2008.9; MARSH D, 1996, BIOCHIM BIOPHYS ACTA, V1286, P182; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; Modregger J, 2003, J BIOL CHEM, V278, P4160, DOI 10.1074/jbc.M208568200; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pierrat B, 2001, GENOMICS, V71, P222, DOI 10.1006/geno.2000.6378; POWELL GL, 1985, BIOCHEMISTRY-US, V24, P2902, DOI 10.1021/bi00333a013; REICHERT AS, 2002, BIOCHIM BIOPHYS ACTA, V1542, P41; Scorrano L, 2008, J CELL BIOL, V183, P579, DOI 10.1083/jcb.200810125; Sheridan C, 2008, TRENDS CELL BIOL, V18, P353, DOI 10.1016/j.tcb.2008.06.002; Solary E, 2008, NAT GENET, V40, P379, DOI 10.1038/ng0408-379; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Takahashi Y, 2005, MOL CELL BIOL, V25, P9369, DOI 10.1128/MCB.25.21.9369-9382.2005; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Terrones O, 2004, J BIOL CHEM, V279, P30081, DOI 10.1074/jbc.M313420200; Terrones O, 2008, J BIOL CHEM, V283, P7790, DOI 10.1074/jbc.M708814200; VANDENBRINKVAND.E, 2006, BIOCHIM BIOPHYS ACTA, V1666, P275; Wan J, 2008, J NEUROSCI, V28, P9002, DOI 10.1523/JNEUROSCI.0767-08.2008; Weissenhorn W, 2005, J MOL BIOL, V351, P653, DOI 10.1016/j.jmb.2005.06.013; Wells RC, 2007, J BIOL CHEM, V282, P33769, DOI 10.1074/jbc.M700807200; Yamaguchi H, 2008, J BIOL CHEM, V283, P19112, DOI 10.1074/jbc.M709882200; Yamaguchi R, 2008, MOL CELL, V31, P557, DOI 10.1016/j.molcel.2008.07.010; Yang JS, 2006, NAT CELL BIOL, V8, P1376, DOI 10.1038/ncb1503; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	57	47	50	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4200	4212		10.1074/jbc.M808050200	http://dx.doi.org/10.1074/jbc.M808050200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19074440	hybrid, Green Published			2022-12-25	WOS:000263134400017
J	Besnard, V; Wert, SE; Stahlman, MT; Postle, AD; Xu, Y; Ikegami, M; Whitsett, JA				Besnard, Valerie; Wert, Susan E.; Stahlman, Mildred T.; Postle, Anthony D.; Xu, Yan; Ikegami, Machiko; Whitsett, Jeffrey A.			Deletion of Scap in Alveolar Type II Cells Influences Lung Lipid Homeostasis and Identifies a Compensatory Role for Pulmonary Lipofibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATION-RELATED PROTEIN; ENDOPLASMIC-RETICULUM STRESS; ELEMENT-BINDING PROTEIN; FATTY-ACID SYNTHESIS; ACTIVATING TRANSCRIPTION FACTOR-3; KERATINOCYTE GROWTH-FACTOR; PROBE LEVEL DATA; GENE-EXPRESSION; RESPIRATORY EPITHELIUM; C/EBP-ALPHA	Pulmonary function after birth is dependent upon surfactant lipids that reduce surface tension in the alveoli. The sterol-responsive element-binding proteins (SREBPs) are transcription factors regulating expression of genes controlling lipid homeostasis in many tissues. To identify the role of SREBPs in the lung, we conditionally deleted the SREBP cleavage-activating protein gene, Scap, in respiratory epithelial cells (Scap(Delta/Delta)) in vivo. Prior to birth (E18.5), deletion of Scap decreased the expression of both SREBPs and a number of genes regulating fatty acid and cholesterol metabolism. Nevertheless, Scap(Delta/Delta) mice survived postnatally, surfactant and lung tissue lipids being substantially normalized in adult Scap(Delta/Delta) mice. Although phospholipid synthesis was decreased in type II cells from adult Scap(Delta/Delta) mice, lipid storage, synthesis, and transfer by lung lipofibroblasts were increased. mRNA microarray data indicated that SCAP influenced two major gene networks, one regulating lipid metabolism and the other stress-related responses. Deletion of the SCAP/SREBP pathway in respiratory epithelial cells altered lung lipid homeostasis and induced compensatory lipid accumulation and synthesis in lung lipofibroblasts.	[Whitsett, Jeffrey A.] Univ Cincinnati, Coll Med, Dept Pediat,Sect Neonatol Perinatal & Pulm Biol, Cincinnati Childrens Hosp Med Ctr,Div Pulm Biol, Cincinnati, OH 45229 USA; [Stahlman, Mildred T.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Postle, Anthony D.] Univ Southampton, Sch Med, Div Infect Inflammat & Repair, Southampton SO16 6YD, Hants, England	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Vanderbilt University; University of Southampton	Whitsett, JA (corresponding author), Univ Cincinnati, Coll Med, Dept Pediat,Sect Neonatol Perinatal & Pulm Biol, Cincinnati Childrens Hosp Med Ctr,Div Pulm Biol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	jeff.whitsett@cchmc.org		Postle, Anthony/0000-0001-7361-0756; Besnard, Valerie/0000-0002-2614-629X; , Yan/0000-0003-2025-027X	National Institutes of Health [HL-85610, HL-90156]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105433, R01HL090156, R01HL085610] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-85610 and HL-90156 (to J. A. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Barbosa-Tessmann IP, 1999, J BIOL CHEM, V274, P31139, DOI 10.1074/jbc.274.44.31139; BARTLETT GR, 1959, J BIOL CHEM, V234, P468; Besnard V, 2005, AM J PHYSIOL-LUNG C, V289, pL750, DOI 10.1152/ajplung.00151.2005; Besnard V, 2007, AM J PHYSIOL-LUNG C, V293, pL1395, DOI 10.1152/ajplung.00275.2007; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOLENDER RP, 1993, AM J PHYSIOL, V265, pL521, DOI 10.1152/ajplung.1993.265.6.L521; Chang YS, 2006, AM J RESP CELL MOL, V35, P268, DOI 10.1165/rcmb.2006-0037OC; Chang YS, 2005, J LIPID RES, V46, P2624, DOI 10.1194/jlr.M500154-JLR200; Dalen KT, 2006, J LIPID RES, V47, P931, DOI 10.1194/jlr.M500459-JLR200; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Edvardsson U, 2006, J LIPID RES, V47, P329, DOI 10.1194/jlr.M500203-JLR200; Felder TK, 2005, BBA-GENE STRUCT EXPR, V1731, P41, DOI 10.1016/j.bbaexp.2005.08.004; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Fitzgerald ML, 2007, J LIPID RES, V48, P621, DOI 10.1194/jlr.M600449-JLR200; Flodby P, 1996, J BIOL CHEM, V271, P24753, DOI 10.1074/jbc.271.40.24753; Flowers MT, 2008, PHYSIOL GENOMICS, V33, P361, DOI 10.1152/physiolgenomics.00139.2007; Garmany TH, 2006, PEDIATR RES, V59, P801, DOI 10.1203/01.pdr.0000219311.14291.df; Glasser SW, 2001, P NATL ACAD SCI USA, V98, P6366, DOI 10.1073/pnas.101500298; Harding HP, 2005, CELL METAB, V2, P361, DOI 10.1016/j.cmet.2005.11.005; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Iwamoto N, 2006, J LIPID RES, V47, P1915, DOI 10.1194/jlr.M600127-JLR200; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Jousse C, 2007, J BIOL CHEM, V282, P15851, DOI 10.1074/jbc.M611723200; Kilberg M, 2002, J NUTR, V132, P1801, DOI 10.1093/jn/132.7.1801; Lee JN, 2004, J BIOL CHEM, V279, P45257, DOI 10.1074/jbc.M408235200; Little JL, 2007, CANCER RES, V67, P1262, DOI 10.1158/0008-5472.CAN-06-1794; Lopez AB, 2007, BIOCHEM J, V402, P163, DOI 10.1042/BJ20060941; Magra AL, 2006, J LIPID RES, V47, P2367, DOI 10.1194/jlr.M600157-JLR200; Martis PC, 2006, DEVELOPMENT, V133, P1155, DOI 10.1242/dev.02273; Mason RJ, 2003, J CLIN INVEST, V112, P244, DOI 10.1172/JCI200316793; Matsuda M, 2001, GENE DEV, V15, P1206, DOI 10.1101/gad.891301; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Okamoto K, 2006, BRAIN RES, V1081, P19, DOI 10.1016/j.brainres.2006.01.081; Pan YX, 2003, J BIOL CHEM, V278, P38402, DOI 10.1074/jbc.M304574200; Pascual M, 2008, DRUG METAB DISPOS, V36, P1063, DOI 10.1124/dmd.107.019380; Perl AKT, 2002, TRANSGENIC RES, V11, P21, DOI 10.1023/A:1013986627504; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; Perl AKT, 2005, AM J RESP CELL MOL, V33, P455, DOI 10.1165/rcmb.2005-0180OC; Postle AD, 2006, J LIPID RES, V47, P1322, DOI 10.1194/jlr.M600054-JLR200; Rice WR, 2002, AM J PHYSIOL-LUNG C, V283, pL256, DOI 10.1152/ajplung.00302.2001; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; RUGH R, 1993, MOUSE ITS REPROD DEV, P299; Schultz CJ, 2002, AM J PHYSIOL-LUNG C, V283, pL288, DOI 10.1152/ajplung.00204.2001; Shimano H, 1997, J CLIN INVEST, V100, P2115, DOI 10.1172/JCI119746; Shulenin S, 2004, NEW ENGL J MED, V350, P1296, DOI 10.1056/NEJMoa032178; TORDAY J, 1995, BBA-LIPID LIPID MET, V1254, P198, DOI 10.1016/0005-2760(94)00184-Z; Torday JS, 2002, AM J PHYSIOL-LUNG C, V282, pL405, DOI 10.1152/ajplung.2002.282.3.L405; Torday JS, 2002, AM J PHYSIOL-LUNG C, V283, pL130, DOI 10.1152/ajplung.00380.2001; Van Dyck F, 2007, CELL METAB, V6, P406, DOI 10.1016/j.cmet.2007.09.010; Wang HY, 2005, J CELL SCI, V118, P3905, DOI 10.1242/jcs.02513; Wang ZW, 2005, DIABETES, V54, P2328, DOI 10.2337/diabetes.54.8.2328; Watatani Y, 2008, J BIOL CHEM, V283, P2543, DOI 10.1074/jbc.M707781200; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Weinhofer I, 2005, J BIOL CHEM, V280, P41243, DOI 10.1074/jbc.M509450200; Wert SE, 2000, P NATL ACAD SCI USA, V97, P5972, DOI 10.1073/pnas.100448997; WERT SE, 1993, DEV BIOL, V156, P426, DOI 10.1006/dbio.1993.1090; Whitsett JA, 2002, NEW ENGL J MED, V347, P2141, DOI 10.1056/NEJMra022387; Whitsett JA, 2006, PAEDIATR RESPIR REV, V7, pS240, DOI 10.1016/j.prrv.2006.04.191; Wolfgang CD, 1997, MOL CELL BIOL, V17, P6700, DOI 10.1128/MCB.17.11.6700; Wong J, 2006, BIOCHEM J, V400, P485, DOI 10.1042/BJ20060914; Yang MCW, 2005, AM J RESP CELL MOL, V32, P35, DOI 10.1165/rcmb.2003-0422OC; Zeng LF, 2004, J BIOL CHEM, V279, P48801, DOI 10.1074/jbc.M407817200; Zhang FJ, 2004, AM J RESP CELL MOL, V30, P174, DOI 10.1165/rcmb.2003-0235OC; Zhou DH, 2008, J BIOL CHEM, V283, P7064, DOI 10.1074/jbc.M708530200; Zhou L, 1997, DEV DYNAM, V210, P305, DOI 10.1002/(SICI)1097-0177(199711)210:3<305::AID-AJA10>3.0.CO;2-9	73	48	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					4018	4030		10.1074/jbc.M805388200	http://dx.doi.org/10.1074/jbc.M805388200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19074148	hybrid, Green Published			2022-12-25	WOS:000262872500070
J	Kaneko, O; Gong, L; Zhang, JL; Hansen, JK; Hassan, R; Lee, B; Ho, M				Kaneko, Osamu; Gong, Lucy; Zhang, Jingli; Hansen, Johanna K.; Hassan, Raffit; Lee, Byungkook; Ho, Mitchell			A Binding Domain on Mesothelin for CA125/MUC16	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OVARIAN-CANCER ANTIGEN; MONOCLONAL-ANTIBODY; MOLECULAR-CLONING; EXTRACELLULAR SUPERSTRUCTURE; MALIGNANT MESOTHELIOMA; CELL-ADHESION; HIGH-AFFINITY; TUMOR-CELLS; CA-125 GENE; EXPRESSION	Ovarian cancer and malignant mesothelioma frequently express both mesothelin and CA125 (also known as MUC16) at high levels on the cell surface. The interaction between mesothelin and CA125 may facilitate the implantation and peritoneal spread of tumors by cell adhesion, whereas the detailed nature of this interaction is still unknown. Here, we used truncated mutagenesis and alanine replacement techniques to identify a binding site on mesothelin for CA125. We examined the molecular interaction by Western blot overlay assays and further quantitatively analyzed by enzyme-linked immunosorbent assay. We also evaluated the binding on cancer cells by flow cytometry. We identified the region (296-359) consisting of 64 amino acids at the N-terminal of cell surface mesothelin as the minimum fragment for complete binding activity to CA125. We found that substitution of tyrosine 318 with an alanine abolished CA125 binding. Replacement of tryptophan 321 and glutamic acid 324 with alanine could partially decrease binding to CA125, whereas mutation of histidine 354 had no effect. These results indicate that a conformation-sensitive structure of the region (296 359) is required and sufficient for the binding of mesothelin to CA125. In addition, we have shown that a single chain monoclonal antibody (SS1) recognizes this CA125-binding domain and blocks the mesothelin-CA125 interaction on cancer cells. The identified CA125-binding domain significantly inhibits cancer cell adhesion and merits evaluation as a new therapeutic agent for preventing or treating peritoneal malignant tumors.	[Ho, Mitchell] NCI, Antibody Therapy Unit, Mol Biol Lab, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ho, M (corresponding author), NCI, Antibody Therapy Unit, Mol Biol Lab, Ctr Canc Res,NIH, 37 Convent Dr,Rm 5002C, Bethesda, MD 20892 USA.	homi@mail.nih.gov	Ho, Mitchell/F-5059-2015	Ho, Mitchell/0000-0002-9152-5405	National Institutes of Health Intramural Research Program of the NCI; Center for Cancer Research; Ovarian Cancer Research Fund Individual Investigator Award; Mesothelioma Applied Research Foundation; NATIONAL CANCER INSTITUTE [ZIABC010891, ZIABC011013, Z01BC011013, Z01BC010891] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ovarian Cancer Research Fund Individual Investigator Award; Mesothelioma Applied Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the NCI, Center for Cancer Research. This work was also supported in part by a Ovarian Cancer Research Fund Individual Investigator Award (M. H.) and an Mesothelioma Applied Research Foundation Grant in Honor of Craig Kozicki (M. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Attanoos RL, 2002, HISTOPATHOLOGY, V40, P237, DOI 10.1046/j.1365-2559.2002.01352.x; BAST RC, 1983, NEW ENGL J MED, V309, P883, DOI 10.1056/NEJM198310133091503; BAST RC, 1981, J CLIN INVEST, V68, P1331, DOI 10.1172/JCI110380; Bateman AC, 1997, HISTOPATHOLOGY, V30, P49, DOI 10.1046/j.1365-2559.1996.d01-562.x; BORK P, 1995, PROTEIN SCI, V4, P1421, DOI 10.1002/pro.5560040716; CHANG K, 1992, INT J CANCER, V50, P373, DOI 10.1002/ijc.2910500308; Chang K, 1996, P NATL ACAD SCI USA, V93, P136, DOI 10.1073/pnas.93.1.136; Desseyn JL, 2008, GENE, V410, P215, DOI 10.1016/j.gene.2007.12.014; Gubbels JAA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-50; Hassan Raffit, 2007, Cancer Immun, V7, P20; Hassan R, 2008, EUR J CANCER, V44, P46, DOI 10.1016/j.ejca.2007.08.028; Hellstrom I, 2008, CANCER EPIDEM BIOMAR, V17, P1520, DOI 10.1158/1055-9965.EPI-08-0039; Hellstrom I, 2006, CANCER EPIDEM BIOMAR, V15, P1014, DOI 10.1158/1055-9965.EPI-05-0334; Ho M, 2005, CLIN CANCER RES, V11, P3814, DOI 10.1158/1078-0432.CCR-04-2304; Ho M, 2005, J BIOL CHEM, V280, P607, DOI 10.1074/jbc.M409783200; Ho M, 2007, CLIN CANCER RES, V13, P1571, DOI 10.1158/1078-0432.CCR-06-2161; Ho M, 2006, CANCER EPIDEM BIOMAR, V15, P1751, DOI 10.1158/1055-9965.EPI-06-0479; Ho M, 2006, P NATL ACAD SCI USA, V103, P9637, DOI 10.1073/pnas.0603653103; KOJIMA T, 1995, J BIOL CHEM, V270, P21984, DOI 10.1074/jbc.270.37.21984; Maeda T, 2004, J BIOL CHEM, V279, P13174, DOI 10.1074/jbc.M309417200; McGregor DP, 2008, CURR OPIN PHARMACOL, V8, P616, DOI 10.1016/j.coph.2008.06.002; Miettinen M, 2003, AM J SURG PATHOL, V27, P150, DOI 10.1097/00000478-200302000-00002; O'Brien TJ, 2002, TUMOR BIOL, V23, P154, DOI 10.1159/000064032; O'Brien TJ, 2001, TUMOR BIOL, V22, P348, DOI 10.1159/000050638; Ordonez NG, 2003, AM J SURG PATHOL, V27, P1418, DOI 10.1097/00000478-200311000-00003; Palumbo C, 2008, CURR MED CHEM, V15, P855, DOI 10.2174/092986708783955446; Pastan I, 2006, NAT REV CANCER, V6, P559, DOI 10.1038/nrc1891; Rump A, 2004, J BIOL CHEM, V279, P9190, DOI 10.1074/jbc.M312372200; Runowicz CD, 2008, CANCER J, V14, P7, DOI 10.1097/PPO.0b013e318163c2e0; Scholler N, 2007, CANCER LETT, V247, P130, DOI 10.1016/j.canlet.2006.03.029; Sterman DH, 2007, CLIN CANCER RES, V13, P4456, DOI 10.1158/1078-0432.CCR-07-0403; Yin BWT, 2001, J BIOL CHEM, V276, P27371, DOI 10.1074/jbc.M103554200	32	114	127	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3739	3749		10.1074/jbc.M806776200	http://dx.doi.org/10.1074/jbc.M806776200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19075018	Green Published, hybrid			2022-12-25	WOS:000262872500042
J	Mendiola, M; Barriuso, J; Redondo, A; Marino-Enriquez, A; Madero, R; Espinosa, E; Vara, JAF; Sanchez-Navarro, I; Hernandez-Cortes, G; Zamora, P; Perez-Fernandez, E; Miguel-Martin, M; Suarez, A; Palacios, J; Gonzalez-Baron, M; Hardisson, D				Mendiola, Marta; Barriuso, Jorge; Redondo, Andres; Marino-Enriquez, Adrian; Madero, Rosario; Espinosa, Enrique; Fresno Vara, Juan Angel; Sanchez-Navarro, Iker; Hernandez-Cortes, Gines; Zamora, Pilar; Perez-Fernandez, Elia; Miguel-Martin, Maria; Suarez, Asuncion; Palacios, Jose; Gonzalez-Baron, Manuel; Hardisson, David			Angiogenesis-Related Gene Expression Profile with Independent Prognostic Value in Advanced Ovarian Carcinoma	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PROTEIN EXPRESSION; PHASE-II; CANCER; MODEL; BEVACIZUMAB; RESISTANCE; RECEPTORS; SIGNATURE; PATTERNS	Background: Ovarian carcinoma is the most important cause of gynecological cancer-related mortality in Western societies. Despite the improved median overall survival in patients receiving chemotherapy regimens such as paclitaxel and carboplatin combination, relapse still occurs in most advanced diseased patients. Increased angiogenesis is associated with rapid recurrence and decreased survival in ovarian cancer. This study was planned to identify an angiogenesis-related gene expression profile with prognostic value in advanced ovarian carcinoma patients. Methodology/Principal Findings: RNAs were collected from formalin-fixed paraffin-embedded samples of 61 patients with III/IV FIGO stage ovarian cancer who underwent surgical cytoreduction and received a carboplatin plus paclitaxel regimen. Expression levels of 82 angiogenesis related genes were measured by quantitative real-time polymerase chain reaction using TaqMan low-density arrays. A 34-gene-profile which was able to predict the overall survival of ovarian carcinoma patients was identified. After a leave-one-out cross validation, the profile distinguished two groups of patients with different outcomes. Median overall survival and progression-free survival for the high risk group was 28.3 and 15.0 months, respectively, and was not reached by patients in the low risk group at the end of follow-up. Moreover, the profile maintained an independent prognostic value in the multivariate analysis. The hazard ratio for death was 2.3 (95% CI, 1.5 to 3.2; p<0.001). Conclusions/Significance: It is possible to generate a prognostic model for advanced ovarian carcinoma based on angiogenesis-related genes using formalin-fixed paraffin-embedded samples. The present results are consistent with the increasing weight of angiogenesis genes in the prognosis of ovarian carcinoma.	[Mendiola, Marta; Marino-Enriquez, Adrian; Miguel-Martin, Maria; Suarez, Asuncion; Hardisson, David] Univ Autonoma Madrid, Dept Pathol, Hosp Univ La Paz, Dept Pathol, Madrid, Spain; [Barriuso, Jorge; Redondo, Andres; Espinosa, Enrique; Zamora, Pilar; Gonzalez-Baron, Manuel] Univ Autonoma Madrid, Hosp Univ La Paz, Translat Oncol Unit, Madrid, Spain; [Madero, Rosario; Perez-Fernandez, Elia] Univ Autonoma Madrid, Hosp Univ La Paz, Unit Biostat, Madrid, Spain; [Mendiola, Marta; Barriuso, Jorge; Madero, Rosario; Fresno Vara, Juan Angel; Sanchez-Navarro, Iker; Perez-Fernandez, Elia; Miguel-Martin, Maria] FIBHULP, Madrid, Spain; [Hernandez-Cortes, Gines; Palacios, Jose] Hosp Univ Virgen Rocio, Dept Pathol, Seville, Spain	Autonomous University of Madrid; Hospital Universitario La Paz; Autonomous University of Madrid; Hospital Universitario La Paz; Autonomous University of Madrid; Hospital Universitario La Paz; Virgen del Rocio University Hospital	Mendiola, M (corresponding author), Univ Autonoma Madrid, Dept Pathol, Hosp Univ La Paz, Dept Pathol, Madrid, Spain.	dhardisson.hulp@salud.madrid.org	Vara, Juan Ángel Fresno/Y-9928-2019; Hardisson, David/A-6259-2011; Fresno Vara, Juan Angel/F-6702-2010; Zamora, Pilar/AAM-9336-2021; Hardisson, David/E-2832-2010; Hardisson, David/AAN-3833-2020	Vara, Juan Ángel Fresno/0000-0003-1527-1252; Fresno Vara, Juan Angel/0000-0003-1527-1252; Hardisson, David/0000-0002-2183-3699; Barriuso, Jorge/0000-0002-5641-9105; Perez-Fernandez, Elia/0000-0003-2726-8683; Marino-Enriquez, Adrian/0000-0002-7680-9901; Redondo Sanchez, Andres/0000-0002-7257-5642; Espinosa Arranz, Enrique/0000-0001-6562-7902	Fondo de Investigacion Sanitaria; Instituto de Salud Carlos III; Ministerio de Sanidad y Consumo, Spain [FIS07/0651, CM05/00143, CP05/00248]; Fundacion de Investigacion Medica Mutua Madrilena	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Sanidad y Consumo, Spain; Fundacion de Investigacion Medica Mutua Madrilena	Financial support was given by Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Spain (FIS07/0651 to MM, JB, AR, GHC, and DH), CM05/00143 to JB, and CP05/00248 to JAFV); and Fundacion de Investigacion Medica Mutua Madrilena (MM, JB, AR, AME, EE, JAFV, GHC, and DH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuJawdeh GM, 1996, LAB INVEST, V74, P1105; Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; Antonov J, 2005, LAB INVEST, V85, P1040, DOI 10.1038/labinvest.3700303; Bonome T, 2008, CANCER RES, V68, P5478, DOI 10.1158/0008-5472.CAN-07-6595; Borgstrom P, 1996, CANCER RES, V56, P4032; Burger RA, 2007, J CLIN ONCOL, V25, P5165, DOI 10.1200/JCO.2007.11.5345; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Cannistra SA, 2007, J CLIN ONCOL, V25, P5180, DOI 10.1200/JCO.2007.12.0782; Cronin M, 2004, AM J PATHOL, V164, P35, DOI 10.1016/S0002-9440(10)63093-3; Deeds J, 2000, HUM PATHOL, V31, P1346, DOI 10.1053/hupa.2000.19441; du Bois A, 2003, JNCI-J NATL CANCER I, V95, P1320, DOI 10.1093/jnci/djg036; Duncan TJ, 2008, CLIN CANCER RES, V14, P3030, DOI 10.1158/1078-0432.CCR-07-1888; Fehrmann RSN, 2007, ONCOLOGIST, V12, P960, DOI 10.1634/theoncologist.12-8-960; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Friedlander ML, 1998, SEMIN ONCOL, V25, P305; Goodheart MJ, 2005, CLIN CANCER RES, V11, P3733, DOI 10.1158/1078-0432.CCR-04-0056; Hartmann LC, 2005, CLIN CANCER RES, V11, P2149, DOI 10.1158/1078-0432.CCR-04-1673; Hefler LA, 2007, CLIN CANCER RES, V13, P898, DOI 10.1158/1078-0432.CCR-06-1008; Helleman J, 2006, INT J CANCER, V118, P1963, DOI 10.1002/ijc.21599; HENRIKSEN R, 1993, CANCER RES, V53, P4550; Husain A, 1998, CANCER RES, V58, P1120; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jeong JY, 2008, INT J CANCER, V122, P274, DOI 10.1002/ijc.23068; Lancaster JM, 2004, J SOC GYNECOL INVEST, V11, P51, DOI 10.1016/j.jsgi.2003.07.004; Lassus H, 2004, BRIT J CANCER, V91, P2048, DOI 10.1038/sj.bjc.6602252; McGuire WP, 1997, SEMIN ONCOL, V24, pS13; Olivier RI, 2006, EUR J CANCER, V42, P2930, DOI 10.1016/j.ejca.2006.04.013; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; QAZI F, 1995, CA-CANCER J CLIN, V45, P88, DOI 10.3322/canjclin.45.2.88; Schindl M, 2003, CLIN CANCER RES, V9, P779; Simon R, 2006, PHARMACOGENOMICS J, V6, P166, DOI 10.1038/sj.tpj.6500349; Spentzos D, 2004, J CLIN ONCOL, V22, P4700, DOI 10.1200/JCO.2004.04.070; Spentzos D, 2005, J CLIN ONCOL, V23, P7911, DOI 10.1200/JCO.2005.02.9363; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VERSNEL MA, 1994, CANCER GENET CYTOGEN, V73, P60, DOI 10.1016/0165-4608(94)90183-X; Wu QH, 2006, GYNECOL ONCOL, V102, P15, DOI 10.1016/j.ygyno.2005.11.034; You B, 2008, CLIN BIOCHEM, V41, P785, DOI 10.1016/j.clinbiochem.2008.04.001; Yuan SSF, 1999, CANCER RES, V59, P3547	38	18	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2008	3	12							e4051	10.1371/journal.pone.0004051	http://dx.doi.org/10.1371/journal.pone.0004051			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DI	19112514	gold, Green Published, Green Submitted			2022-12-25	WOS:000265466000013
J	Gross, E; Busse, B; Riemenschneider, M; Neubauer, S; Seck, K; Klein, HG; Kiechle, M; Lordick, F; Meindl, A				Gross, Eva; Busse, Birgit; Riemenschneider, Matthias; Neubauer, Steffi; Seck, Katharina; Klein, Hanns-Georg; Kiechle, Marion; Lordick, Florian; Meindl, Alfons			Strong Association of a Common Dihydropyrimidine Dehydrogenase Gene Polymorphism with Fluoropyrimidine-Related Toxicity in Cancer Patients	PLOS ONE			English	Article							DPD DEFICIENCY; IVS14+1G-GREATER-THAN-A MUTATION; 5-FLUOROURACIL TOXICITY; BREAST-CANCER; PHARMACOGENETICS; IDENTIFICATION; CHEMOTHERAPY; CAPECITABINE; PHARMACOKINETICS; FLUOROURACIL	Background: Cancer patients carrying mutations in the dihydropyrimidine dehydrogenase gene (DPYD) have a high risk to experience severe drug-adverse effects following chemotherapy with fluoropyrimidine drugs such as 5-fluorouracil (5-FU) or capecitabine. The pretreatment detection of this impairment of pyrimidine catabolism could prevent serious, potentially lethal side effects. As known deleterious mutations explain only a limited proportion of the drug-adverse events, we systematically searched for additional DPYD variations associated with enhanced drug toxicity. Methodology/Principal Findings: We performed a whole gene approach covering the entire coding region and compared DPYD genotype frequencies between cancer patients with good (n = 89) and with poor ( n = 39) tolerance of a fluoropyrimidine-based chemotherapy regimen. Applying logistic regression analysis and sliding window approaches we identified the strongest association with fluoropyrimidine-related grade III and IV toxicity for the non-synonymous polymorphism c.496A>G (p.Met166Val). We then confirmed our initial results using an independent sample of 53 individuals suffering from drug-adverse-effects. The combined odds ratio calculated for 92 toxicity cases was 4.42 [95% CI 2.12-9.23]; p (trend)<0.001; p (corrected) = 0.001; the attributable risk was 56.9%. Comparing tumor-type matched sets of samples, correlation of c.496A>G with toxicity was particularly present in patients with gastroesophageal and breast cancer, but did not reach significance in patients with colorectal malignancies. Conclusion: Our results show compelling evidence that, at least in distinct tumor types, a common DPYD polymorphism strongly contributes to the occurrence of fluoropyrimidine-related drug adverse effects. Carriers of this variant could benefit from individual dose adjustment of the fluoropyrimidine drug or alternate therapies.	[Gross, Eva; Neubauer, Steffi; Seck, Katharina; Kiechle, Marion; Meindl, Alfons] Tech Univ Munich, Klinikum Rechts Isar, Dept Gynecol, D-8000 Munich, Germany; [Busse, Birgit; Klein, Hanns-Georg] Ctr Human Genet & Lab Med, Martinsried, Germany; [Riemenschneider, Matthias] Tech Univ Munich, Klinikum Rechts Isar, Dept Psych & Psychotherapy, Munich, Germany; [Lordick, Florian] Natl Ctr Tumor Dis, Dept Med Oncol, Heidelberg, Germany	Technical University of Munich; Technical University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Gross, E (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Gynecol, D-8000 Munich, Germany.	eva.gross@lrz.tum.de			Kommission fur klinische Forschung (KKF); Technischen Universitat Munchen [18-02]; Deutsche Krebshilfe e.V. [107352]; German National Genome Research Network (NGFN) [01GS0465]	Kommission fur klinische Forschung (KKF); Technischen Universitat Munchen; Deutsche Krebshilfe e.V.(Deutsche Krebshilfe); German National Genome Research Network (NGFN)	This work was supported by the Kommission fur klinische Forschung (KKF) der Technischen Universitat Munchen (No. 18-02), by the Deutsche Krebshilfe e.V. (DKH No. 107352) and by the German National Genome Research Network (NGFN) (No. 01GS0465). The funding organizations had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajani J, 2006, CANCER-AM CANCER SOC, V107, P221, DOI 10.1002/cncr.21986; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENFREDJ R, 2008, PATHOL BIOL PAR 0710; Bosch Tessa M., 2008, V448, P63, DOI 10.1007/978-1-59745-205-2_5; Ciccolini J, 2006, THER DRUG MONIT, V28, P678, DOI 10.1097/01.ftd.0000245771.82720.c7; Cinieri S, 2007, ANN ONCOL, V18, P63, DOI 10.1093/annonc/mdm227; Collie-Duguid ESR, 2000, PHARMACOGENETICS, V10, P217, DOI 10.1097/00008571-200004000-00002; Di Paolo A, 2001, ANN ONCOL, V12, P1301, DOI 10.1023/A:1012294617392; Diasio R B, 2001, Oncology (Williston Park), V15, P21; Diasio RB, 2000, PHARMACOLOGY, V61, P199, DOI 10.1159/000028401; Dobritzsch D, 2001, EMBO J, V20, P650, DOI 10.1093/emboj/20.4.650; Goldberg RM, 2006, ONCOLOGIST, V11, P981, DOI 10.1634/theoncologist.11-9-981; Gross E, 2003, INT J ONCOL, V22, P325; Gross E, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9201; HEGGIE GD, 1987, CANCER RES, V47, P2203; Hormozian F, 2007, CANCER LETT, V246, P82, DOI 10.1016/j.canlet.2006.02.004; Johnson MR, 2002, CLIN CANCER RES, V8, P768; Largillier R, 2006, CLIN CANCER RES, V12, P5496, DOI 10.1158/1078-0432.CCR-06-0320; Lazar A, 2008, DEUT MED WOCHENSCHR, V133, P1501, DOI 10.1055/s-2008-1081098; Maekawa K, 2007, J HUM GENET, V52, P804, DOI 10.1007/s10038-007-0186-6; Magne N, 2007, BRIT J CLIN PHARMACO, V64, P237, DOI 10.1111/j.1365-2125.2007.02869.x; Mattison LK, 2004, CLIN CANCER RES, V10, P2652, DOI 10.1158/1078-0432.CCR-03-0374; Mattison LK, 2002, PHARMACOGENETICS, V12, P133, DOI 10.1097/00008571-200203000-00007; Mercier C, 2008, J CLIN ONCOL, V26; Morel A, 2006, MOL CANCER THER, V5, P2895, DOI 10.1158/1535-7163.MCT-06-0327; Ogura K, 2005, CLIN CANCER RES, V11, P5104, DOI 10.1158/1078-0432.CCR-05-0217; Reerink O, 2004, ANTICANCER RES, V24, P1969; Ridge SA, 1998, BRIT J CLIN PHARMACO, V46, P151, DOI 10.1046/j.1365-2125.1998.00751.x; Rivera F, 2007, CANCER TREAT REV, V33, P315, DOI 10.1016/j.ctrv.2007.01.004; Saif AW, 2006, CLIN COLORECTAL CANC, V5, P359, DOI 10.3816/CCC.2006.n.007; Salgueiro N, 2004, GENET MED, V6, P102, DOI 10.1097/01.GIM.0000118061.66602.A5; Scheithauer W, 2003, ANN ONCOL, V14, P1735, DOI 10.1093/annonc/mdg500; Schwab M, 2008, J CLIN ONCOL, V26, P2131, DOI 10.1200/JCO.2006.10.4182; Seck K, 2005, CLIN CANCER RES, V11, P5886, DOI 10.1158/1078-0432.CCR-04-1784; Sun Weijing, 2005, Curr Oncol Rep, V7, P181, DOI 10.1007/s11912-005-0071-4; van Kuilenburg ABP, 2004, EUR J CANCER, V40, P939, DOI 10.1016/j.ejca.2003.12.004; van Kuilenburg ABP, 2002, BIOCHEM J, V364, P157, DOI 10.1042/bj3640157; van Kuilenburg ABP, 2002, PHARMACOGENETICS, V12, P555, DOI 10.1097/00008571-200210000-00007; Van Kuilenburg ABP, 2000, ADV EXP MED BIOL, V486, P251; van Kuilenburg ABP, 2000, CLIN CANCER RES, V6, P4705; van Kuilenburg ABP, 2007, EUR J CANCER, V43, P459, DOI 10.1016/j.ejca.2006.09.017; Vreken P, 1997, HUM GENET, V101, P333, DOI 10.1007/s004390050637; YOKOTA H, 1994, J BIOL CHEM, V269, P23192; Zhang H, 2007, MED ONCOL, V24, P251, DOI 10.1007/BF02698048; Zhou ZW, 2007, CHEMOTHERAPY, V53, P127, DOI 10.1159/000099984	45	84	88	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2008	3	12							e4003	10.1371/journal.pone.0004003	http://dx.doi.org/10.1371/journal.pone.0004003			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CB	19104657	gold, Green Published, Green Submitted			2022-12-25	WOS:000265462400004
J	Lo, LJ; Zhang, ZH; Hong, N; Peng, JR; Hong, YH				Lo, Lijan; Zhang, Zhenhai; Hong, Ni; Peng, Jinrong; Hong, Yunhan			3640 Unique EST Clusters from the Medaka Testis and Their Potential Use for Identifying Conserved Testicular Gene Expression in Fish and Mammals	PLOS ONE			English	Article								Background: The fish medaka is the first vertebrate capable of full spermatogenesis in vitro from self-renewing spermatogonial stem cells to motile test-tube sperm. Precise staging and molecular dissection of this process has been hampered by the lack of suitable molecular markers. Methodology and Principal Findings: We have generated a normalized medaka testis cDNA library and obtained 7040 high quality sequences representing 3641 unique gene clusters. Among these, 1197 unique clusters are homologous to known genes, and 2444 appear to be novel genes. Ontology analysis shows that the 1197 gene products are implicated in diverse molecular and cellular processes. These genes include markers for all major types of testicular somatic and germ cells. Furthermore, markers were identified for major spermatogenic stages ranging from spermatogonial stem cell self-renewal to meiosis entry, progression and completion. Intriguingly, the medaka testis expresses at least 13 homologs of the 33 mouse X-chromosomal genes that are enriched in the testis. More importantly, we show that key components of several signaling pathways known to be important for testicular function in mammals are well represented in the medaka testicular EST collection. Conclusions/Significance: Medaka exhibits a considerable similarity in testicular gene expression to mammals. The medaka testicular EST collection we obtained has wide range coverage and will not only consolidate our knowledge on the comparative analysis of known genes' functions in the testis but also provide a rich resource to dissect molecular events and mechanism of spermatogenesis in vivo and in vitro in medaka as an excellent vertebrate model.	[Lo, Lijan; Hong, Ni; Peng, Jinrong; Hong, Yunhan] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Zhang, Zhenhai; Peng, Jinrong] Inst Mol & Cell Biol, Proteos, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Lo, LJ (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	pengjr@imcb.a-star.edu.sg; dbshyh@nus.edu.sg	Hong, Yunhan/D-4197-2009; Hong, Ni/Y-6114-2018; Zhang, Zhenhai/GRX-5887-2022; Test Account, SLB-WOS/E-5790-2010	Hong, Ni/0000-0002-9404-3110; Zhang, Zhenhai/0000-0002-4310-0525; Peng, Jinrong/0000-0002-0793-4848	National University of Singapore [R-154-000-153-720]; Biomedical Research Council of Singapore [R-154-000-204-305]; Ministry of Education of Singapore [R154-000-285-112]; Agency for Science, Technology and Research (A*STAR), Singapore	National University of Singapore(National University of Singapore); Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); Ministry of Education of Singapore(Ministry of Education, Singapore); Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by grants from the National University of Singapore (R-154-000-153-720), Biomedical Research Council of Singapore (R-154-000-204-305) and Ministry of Education of Singapore (R154-000-285-112), and by Agency for Science, Technology and Research (A*STAR) in Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almstrup K, 2004, BIOL REPROD, V70, P1751, DOI 10.1095/biolreprod.103.026575; Chalmel F, 2007, P NATL ACAD SCI USA, V104, P8346, DOI 10.1073/pnas.0701883104; Chini V, 2008, GENE, V410, P207, DOI 10.1016/j.gene.2007.12.012; Coimbra RS, 2002, GENOME RES, V12, P1007, DOI 10.1101/gr.227502; Cooke HJ, 2002, NAT REV GENET, V3, P790, DOI 10.1038/nrg911; Feng LX, 2002, SCIENCE, V297, P392, DOI 10.1126/science.1073162; Guo R, 2004, MOL REPROD DEV, V67, P264, DOI 10.1002/mrd.20026; Hayashi T, 2001, J ANDROL, V22, P999; HOFMANN MC, 1994, P NATL ACAD SCI USA, V91, P5533, DOI 10.1073/pnas.91.12.5533; Hong YH, 2004, P NATL ACAD SCI USA, V101, P8011, DOI 10.1073/pnas.0308668101; Itman C, 2008, DEV DYNAM, V237, P97, DOI 10.1002/dvdy.21401; JOHNSTON DS, 2008, P NATL ACAD SCI US; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; Kimura T, 2004, MECH DEVELOP, V121, P915, DOI 10.1016/j.mod.2004.03.033; Kimura T, 2003, DEVELOPMENT, V130, P1691, DOI 10.1242/dev.00392; KO MSH, 1990, NUCLEIC ACIDS RES, V18, P5705, DOI 10.1093/nar/18.19.5705; Li CY, 2007, DEV BIOL, V309, P70, DOI 10.1016/j.ydbio.2007.06.019; Lo J, 2003, GENOME RES, V13, P455, DOI 10.1101/gr.885403; Maratou K, 2004, MOL REPROD DEV, V67, P26, DOI 10.1002/mrd.20010; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; MIURA T, 1991, P NATL ACAD SCI USA, V88, P5774, DOI 10.1073/pnas.88.13.5774; Mori S, 2003, DEV GROWTH DIFFER, V45, P7, DOI 10.1046/j.1440-169X.2003.00670.x; Mueller JL, 2008, NAT GENET, V40, P794, DOI 10.1038/ng.126; Nanda I, 2002, P NATL ACAD SCI USA, V99, P11778, DOI 10.1073/pnas.182314699; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Pang ALY, 2003, J ANDROL, V24, P899; PATANJALI SR, 1991, P NATL ACAD SCI USA, V88, P1943, DOI 10.1073/pnas.88.5.1943; Piquet-Pellorce C, 2000, ENDOCRINOLOGY, V141, P1136, DOI 10.1210/en.141.3.1136; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Sakai N, 2002, DEVELOPMENT, V129, P3359; Schlecht U, 2004, MOL BIOL CELL, V15, P1031, DOI 10.1091/mbc.E03-10-0762; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Sreenivasan R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001791; Strothmann K, 2004, CELL TISSUE RES, V315, P249, DOI 10.1007/s00441-003-0834-x; Wen CM, 2005, DEV DYNAM, V232, P171, DOI 10.1002/dvdy.20210; Wu SM, 2004, GENOMICS, V84, P971, DOI 10.1016/j.ygeno.2004.08.018; Xiao P, 2008, BIOL PHARM BULL, V31, P201, DOI 10.1248/bpb.31.201; Xu HY, 2007, GENE EXPR PATTERNS, V7, P332, DOI 10.1016/j.modgep.2006.08.001; Zeng S, 2002, GENE, V294, P45, DOI 10.1016/S0378-1119(02)00791-6	39	16	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2008	3	12							e3915	10.1371/journal.pone.0003915	http://dx.doi.org/10.1371/journal.pone.0003915			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CB	19104663	Green Published, Green Submitted, gold			2022-12-25	WOS:000265462400001
J	Sabath, N; Landan, G; Graur, D				Sabath, Niv; Landan, Giddy; Graur, Dan			A Method for the Simultaneous Estimation of Selection Intensities in Overlapping Genes	PLOS ONE			English	Article							H5N1 INFLUENZA-VIRUS; NUCLEOTIDE SUBSTITUTION; READING FRAMES; SEQUENCE-ANALYSIS; EVOLUTION; LIKELIHOOD; RATES; MODELS; COMPRESSION; ANNOTATION	Inferring the intensity of positive selection in protein-coding genes is important since it is used to shed light on the process of adaptation. Recently, it has been reported that overlapping genes, which are ubiquitous in all domains of life, seem to exhibit inordinate degrees of positive selection. Here, we present a new method for the simultaneous estimation of selection intensities in overlapping genes. We show that the appearance of positive selection is caused by assuming that selection operates independently on each gene in an overlapping pair, thereby ignoring the unique evolutionary constraints on overlapping coding regions. Our method uses an exact evolutionary model, thereby voiding the need for approximation or intensive computation. We test the method by simulating the evolution of overlapping genes of different types as well as under diverse evolutionary scenarios. Our results indicate that the independent estimation approach leads to the false appearance of positive selection even though the gene is in reality subject to negative selection. Finally, we use our method to estimate selection in two influenza A genes for which positive selection was previously inferred. We find no evidence for positive selection in both cases.	[Sabath, Niv; Landan, Giddy; Graur, Dan] Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA	University of Houston System; University of Houston	Sabath, N (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA.	nsabath@uh.edu	Landan, Giddy/C-1086-2019	Landan, Giddy/0000-0002-2502-8750	National Science Foundation [DBI-0543342]	National Science Foundation(National Science Foundation (NSF))	This work was supported in part by grant DBI-0543342 from the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; BARRELL BG, 1976, NATURE, V264, P34, DOI 10.1038/264034a0; Belshaw R, 2007, GENOME RES, V17, P1496, DOI 10.1101/gr.6305707; Campitelli L, 2006, J GEN VIROL, V87, P955, DOI 10.1099/vir.0.81397-0; Cooper PR, 1998, GENOMICS, V49, P38, DOI 10.1006/geno.1998.5221; de Groot S, 2007, BIOINFORMATICS, V23, P1080, DOI 10.1093/bioinformatics/btm078; de Groot S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-304; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Guyader S, 2002, J GEN VIROL, V83, P1799, DOI 10.1099/0022-1317-83-7-1799; HEIN J, 1995, J MOL EVOL, V40, P181, DOI 10.1007/BF00167112; Holmes EC, 2006, SCIENCE, V313, DOI 10.1126/science.1131729; Hughes AL, 2005, VIRUS RES, V113, P81, DOI 10.1016/j.virusres.2005.03.030; Hughes AL, 2001, J VIROL, V75, P7966, DOI 10.1128/JVI.75.17.7966-7972.2001; Johnson ZI, 2004, GENOME RES, V14, P2268, DOI 10.1101/gr.2433104; JONES CE, 1995, EUR J BIOCHEM, V233, P800, DOI 10.1111/j.1432-1033.1995.800_3.x; KEESE PK, 1992, P NATL ACAD SCI USA, V89, P9489, DOI 10.1073/pnas.89.20.9489; Krakauer DC, 2000, EVOLUTION, V54, P731, DOI 10.1111/j.0014-3820.2000.tb00075.x; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; LI WH, 1985, MOL BIOL EVOL, V2, P150; Lillo F, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-22; Makalowska I, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-193; McCauley S, 2007, BIOINFORMATICS, V23, P2978, DOI 10.1093/bioinformatics/btm472; McCauley S, 2006, BIOINFORMATICS, V22, P1308, DOI 10.1093/bioinformatics/btl092; MIYATA T, 1978, NATURE, V272, P532, DOI 10.1038/272532a0; MONTOYA J, 1983, CELL, V34, P151, DOI 10.1016/0092-8674(83)90145-9; Narechania A, 2005, J GEN VIROL, V86, P1307, DOI 10.1099/vir.0.80747-0; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nielsen R, 1998, GENETICS, V148, P929; NORMARK S, 1983, ANNU REV GENET, V17, P499, DOI 10.1146/annurev.ge.17.120183.002435; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; OKAMOTO H, 1986, J GEN VIROL, V67, P2305, DOI 10.1099/0022-1317-67-11-2305; PAMILO P, 1993, MOL BIOL EVOL, V10, P271; Pavesi A, 2006, J GEN VIROL, V87, P1013, DOI 10.1099/vir.0.81375-0; Pavesi A, 2007, GENE, V402, P28, DOI 10.1016/j.gene.2007.07.013; Pedersen AMK, 2001, MOL BIOL EVOL, V18, P763, DOI 10.1093/oxfordjournals.molbev.a003859; Rogozin IB, 2002, TRENDS GENET, V18, P228, DOI 10.1016/S0168-9525(02)02649-5; Sakharkar KR, 2005, INT J SYST EVOL MICR, V55, P1205, DOI 10.1099/ijs.0.63446-0; SMITH RA, 1980, P NATL ACAD SCI-BIOL, V77, P5370, DOI 10.1073/pnas.77.9.5370; Suzuki Y, 2006, MOL BIOL EVOL, V23, P1902, DOI 10.1093/molbev/msl050; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Yang ZH, 1998, J MOL EVOL, V46, P409, DOI 10.1007/PL00006320; Yang ZH, 1998, MOL BIOL EVOL, V15, P1600, DOI 10.1093/oxfordjournals.molbev.a025888; Zaaijer HL, 2007, J GEN VIROL, V88, P2137, DOI 10.1099/vir.0.82906-0; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	45	31	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2008	3	12							e3996	10.1371/journal.pone.0003996	http://dx.doi.org/10.1371/journal.pone.0003996			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CA	19098983	gold, Green Submitted, Green Published			2022-12-25	WOS:000265462300007
J	Foerstner, KU; Doerks, T; Muller, J; Raes, J; Bork, P				Foerstner, Konrad U.; Doerks, Tobias; Muller, Jean; Raes, Jeroen; Bork, Peer			A Nitrile Hydratase in the Eukaryote Monosiga brevicollis	PLOS ONE			English	Article								Bacterial nitrile hydratase (NHases) are important industrial catalysts and waste water remediation tools. In a global computational screening of conventional and metagenomic sequence data for NHases, we detected the two usually separated NHase subunits fused in one protein of the choanoflagellate Monosiga brevicollis, a recently sequenced unicellular model organism from the closest sister group of Metazoa. This is the first time that an NHase is found in eukaryotes and the first time it is observed as a fusion protein. The presence of an intron, subunit fusion and expressed sequence tags covering parts of the gene exclude contamination and suggest a functional gene. Phylogenetic analyses and genomic context imply a probable ancient horizontal gene transfer (HGT) from proteobacteria. The newly discovered NHase might open biotechnological routes due to its unconventional structure, its new type of host and its apparent integration into eukaryotic protein networks.	[Foerstner, Konrad U.; Doerks, Tobias; Muller, Jean; Raes, Jeroen; Bork, Peer] European Mol Biol Lab, Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Foerstner, KU (corresponding author), European Mol Biol Lab, Heidelberg, Germany.	bork@embl.de	Förstner, Konrad U./B-1531-2010; raes, jeroen/D-7835-2018; Muller, Jean/L-7412-2018; Bork, Peer/F-1813-2013	Förstner, Konrad U./0000-0002-1481-2996; raes, jeroen/0000-0002-1337-041X; Muller, Jean/0000-0002-7682-559X; Bork, Peer/0000-0002-2627-833X	EU FP7 programme [HEALTH-F4-2007-201052]	EU FP7 programme(European Commission)	This work was supported by the EU FP7 programme (HEALTH-F4-2007-201052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa T, 2007, J MOL BIOL, V366, P1497, DOI 10.1016/j.jmb.2006.12.011; Banerjee A, 2002, APPL MICROBIOL BIOT, V60, P33, DOI 10.1007/s00253-002-1062-0; BLAKEY AJ, 1995, FEMS MICROBIOL LETT, V129, P57; Brandao PFB, 2003, ANTON LEEUW INT J G, V84, P89, DOI 10.1023/A:1025409818275; BUCK KR, 1988, MAR BIOL, V98, P263, DOI 10.1007/BF00391204; Colquhoun JA, 1998, EXTREMOPHILES, V2, P269, DOI 10.1007/s007920050069; Creevey CJ, 2005, BIOINFORMATICS, V21, P390, DOI 10.1093/bioinformatics/bti020; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; DIGERONIMO MJ, 1976, APPL ENVIRON MICROB, V31, P900, DOI 10.1128/AEM.31.6.900-906.1976; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Endo I, 2001, J INORG BIOCHEM, V83, P247, DOI 10.1016/S0162-0134(00)00171-9; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harrop TC, 2004, ACCOUNTS CHEM RES, V37, P253, DOI 10.1021/ar0301532; Huang WJ, 1997, STRUCTURE, V5, P691, DOI 10.1016/S0969-2126(97)00223-2; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Kobayashi M, 2000, CURR OPIN CHEM BIOL, V4, P95, DOI 10.1016/S1367-5931(99)00058-7; Kovacs JA, 2004, CHEM REV, V104, P825, DOI 10.1021/cr020619e; Langdahl BR, 1996, MICROBIOL-UK, V142, P145, DOI 10.1099/13500872-142-1-145; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LAYH N, 1994, J BIOTECHNOL, V33, P175, DOI 10.1016/0168-1656(94)90109-0; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Martin HG, 2006, NAT BIOTECHNOL, V24, P1263, DOI 10.1038/nbt1247; Mitra S, 2007, J BIOL CHEM, V282, P7397, DOI 10.1074/jbc.M604117200; NAGASAWA T, 1995, PURE APPL CHEM, V67, P1241, DOI 10.1351/pac199567071241; Nakasako M, 1999, BIOCHEMISTRY-US, V38, P9887, DOI 10.1021/bi982753s; NARAYANASAMY K, 1990, INDIAN J EXP BIOL, V28, P968; Pereira RA, 1998, EXTREMOPHILES, V2, P347, DOI 10.1007/s007920050078; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Shaw NM, 2003, ADV SYNTH CATAL, V345, P425, DOI 10.1002/adsc.200390049; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; TOSHIFUMI Y, 1997, J FERMENTATION BIOEN, V83, P474; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340	38	18	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2008	3	12							e3976	10.1371/journal.pone.0003976	http://dx.doi.org/10.1371/journal.pone.0003976			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AV	19096720	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000265458800003
J	Moioli, EK; Clark, PA; Chen, M; Dennis, JE; Erickson, HP; Gerson, SL; Mao, JJ				Moioli, Eduardo K.; Clark, Paul A.; Chen, Mo; Dennis, James E.; Erickson, Helaman P.; Gerson, Stanton L.; Mao, Jeremy J.			Synergistic Actions of Hematopoietic and Mesenchymal Stem/Progenitor Cells in Vascularizing Bioengineered Tissues	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; EX-VIVO EXPANSION; STEM-CELLS; BONE-MARROW; PROGENITOR CELLS; MYOCARDIAL-INFARCTION; ENDOTHELIAL-CELLS; ADIPOSE-TISSUE; ANGIOGENESIS; REGENERATION	Poor angiogenesis is a major road block for tissue repair. The regeneration of virtually all tissues is limited by angiogenesis, given the diffusion of nutrients, oxygen, and waste products is limited to a few hundred micrometers. We postulated that co-transplantation of hematopoietic and mesenchymal stem/progenitor cells improves angiogenesis of tissue repair and hence the outcome of regeneration. In this study, we tested this hypothesis by using bone as a model whose regeneration is impaired unless it is vascularized. Hematopoietic stem/progenitor cells (HSCs) and mesenchymal stem/progenitor cells (MSCs) were isolated from each of three healthy human bone marrow samples and reconstituted in a porous scaffold. MSCs were seeded in micropores of 3D calcium phosphate (CP) scaffolds, followed by infusion of gel-suspended CD34(+) hematopoietic cells. Co-transplantation of CD34(+) HSCs and CD34(-) MSCs in microporous CP scaffolds subcutaneously in the dorsum of immunocompromized mice yielded vascularized tissue. The average vascular number of co-transplanted CD34(+) and MSC scaffolds was substantially greater than MSC transplantation alone. Human osteocalcin was expressed in the micropores of CP scaffolds and was significantly increased upon co-transplantation of MSCs and CD34(+) cells. Human nuclear staining revealed the engraftment of transplanted human cells in vascular endothelium upon co-transplantation of MSCs and CD34(+) cells. Based on additional in vitro results of endothelial differentiation of CD34(+) cells by vascular endothelial growth factor (VEGF), we adsorbed VEGF with co-transplanted CD34(+) and MSCs in the microporous CP scaffolds in vivo, and discovered that vascular number and diameter further increased, likely owing to the promotion of endothelial differentiation of CD34(+) cells by VEGF. Together, co-transplantation of hematopoietic and mesenchymal stem/progenitor cells may improve the regeneration of vascular dependent tissues such as bone, adipose, muscle and dermal grafts, and may have implications in the regeneration of internal organs.	[Moioli, Eduardo K.; Chen, Mo; Erickson, Helaman P.; Mao, Jeremy J.] Columbia Univ, Med Ctr, Coll Dent Med, TERML, New York, NY 10027 USA; [Clark, Paul A.] Univ Wisconsin, Madison Hosp, Dept Neurol Surg CSC, Madison, WI 53706 USA; [Dennis, James E.] Case Western Reserve Univ, Dept Orthopaed, Cleveland, OH 44106 USA; [Gerson, Stanton L.] Case Western Reserve Univ, Case Comprehensive Canc Ctr, Cleveland, OH 44106 USA	Columbia University; University of Wisconsin System; University of Wisconsin Madison; Case Western Reserve University; Case Western Reserve University	Moioli, EK (corresponding author), Columbia Univ, Med Ctr, Coll Dent Med, TERML, New York, NY 10027 USA.	jmao@columbia.edu	Chen, Mo/E-8234-2010		NIH [DE015391, EB02332, P30CA043703]; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002332] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015391, RC2DE020767] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by NIH grants DE015391 and EB02332 to J.J.M and P30CA043703 to SLG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhadlaq A, 2005, TISSUE ENG, V11, P556, DOI 10.1089/ten.2005.11.556; Alhadlaq A, 2004, ANN BIOMED ENG, V32, P911, DOI 10.1023/B:ABME.0000032454.53116.ee; Alhadlaq A, 2003, J DENT RES, V82, P951, DOI 10.1177/154405910308201203; Aubin JE, 1998, J CELL BIOCHEM, P73, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<73::AID-JCB11>3.0.CO;2-L; Bachier CR, 1999, EXP HEMATOL, V27, P615, DOI 10.1016/S0301-472X(98)00085-X; Carano RAD, 2003, DRUG DISCOV TODAY, V8, P980, DOI 10.1016/S1359-6446(03)02866-6; Cassell OCS, 2002, BRIT J PLAST SURG, V55, P603, DOI 10.1054/bjps.2002.3950; Clark PA, 2008, FASEB J, V22, P1684, DOI 10.1096/fj.07-094789; Collins JM, 2005, J BIOMECH, V38, P485, DOI 10.1016/j.jbiomech.2004.04.018; Dominici M, 2004, P NATL ACAD SCI USA, V101, P11761, DOI 10.1073/pnas.0404626101; Duvall CL, 2007, J BONE MINER RES, V22, P286, DOI 10.1359/JBMR.061103; Eghbali-Fatourechi GZ, 2007, BONE, V40, P1370, DOI 10.1016/j.bone.2006.12.064; FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267; Fuchs JR, 2001, ANN THORAC SURG, V72, P577, DOI 10.1016/S0003-4975(01)02820-X; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Graziano A, 2008, CELL PROLIFERAT, V41, P1, DOI 10.1111/j.1365-2184.2007.00497.x; Huang YC, 2005, J BONE MINER RES, V20, P848, DOI 10.1359/JBMR.041226; Jain RK, 2005, NAT BIOTECHNOL, V23, P821, DOI 10.1038/nbt0705-821; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Johnson PC, 2007, TISSUE ENG, V13, P2827, DOI 10.1089/ten.2007.0335; Jung YG, 2008, STEM CELLS, V26, P2042, DOI 10.1634/stemcells.2008-0149; Jyotsna M, 2006, CARDIOVASC REVASCULA, V7, P217, DOI 10.1016/j.carrev.2006.06.004; Kaigler D, 2006, J DENT RES, V85, P633, DOI 10.1177/154405910608500710; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kestendjieva S, 2008, CELL BIOL INT, V32, P724, DOI 10.1016/j.cellbi.2008.02.002; Kirito K, 2005, BLOOD, V105, P4258, DOI 10.1182/blood-2004-07-2712; Koike Y, 2003, SPINE, V28, P1928, DOI 10.1097/01.BRS.0000083324.65405.AE; Kopp HG, 2006, CURR OPIN HEMATOL, V13, P175, DOI 10.1097/01.moh.0000219664.26528.da; Laing AJ, 2007, J BONE JOINT SURG BR, V89B, P116, DOI 10.1302/0301-620X.89B1.18222; Laing AJ, 2007, J ORTHOP RES, V25, P44, DOI 10.1002/jor.20228; Lee DY, 2008, BONE, V42, P932, DOI 10.1016/j.bone.2008.01.007; Lundell BI, 1999, J HEMATOTHER, V8, P115, DOI 10.1089/106161299320398; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Marion NW, 2006, METHOD ENZYMOL, V420, P339, DOI 10.1016/S0079-6879(06)20016-8; Marion NW, 2005, MECH ADV MATER STRUC, V12, P239, DOI 10.1080/15376490590928615; Matsumoto T, 2006, AM J PATHOL, V169, P1440, DOI 10.2353/ajpath.2006.060064; Mayack SR, 2008, BLOOD, V112, P519, DOI 10.1182/blood-2008-01-133710; McKee JA, 2003, EMBO REP, V4, P633, DOI 10.1038/sj.embor.embor847; Mendes SC, 2005, DEVELOPMENT, V132, P1127, DOI 10.1242/dev.01615; Moioli EK, 2008, BONE, V42, P332, DOI 10.1016/j.bone.2007.10.004; Moioli EK, 2007, WOUND REPAIR REGEN, V15, P413, DOI 10.1111/j.1524-475X.2007.00244.x; Murphy WL, 2004, J DENT RES, V83, P204, DOI 10.1177/154405910408300304; Nomi M, 2002, MOL ASPECTS MED, V23, P463, DOI 10.1016/S0098-2997(02)00008-0; Olmsted-Davis EA, 2003, P NATL ACAD SCI USA, V100, P15877, DOI 10.1073/pnas.2632959100; Peng HR, 2005, J BONE MINER RES, V20, P2017, DOI 10.1359/JBMR.050708; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Porter RL, 2008, ARCH BIOCHEM BIOPHYS, V473, P193, DOI 10.1016/j.abb.2008.04.001; Rafii S, 2002, NAT REV CANCER, V2, P826, DOI 10.1038/nrc925; Rafii S, 2002, SEMIN CELL DEV BIOL, V13, P61, DOI 10.1006/scdb.2001.0285; Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029; Rivas R, 2002, J BONE JOINT SURG AM, V84A, P85, DOI 10.2106/00004623-200201000-00013; Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212; Schachinger V, 2004, J AM COLL CARDIOL, V44, P1690, DOI 10.1016/j.jacc.2004.08.014; Schechner JS, 2000, P NATL ACAD SCI USA, V97, P9191, DOI 10.1073/pnas.150242297; Shi Q, 1998, BLOOD, V92, P362, DOI 10.1182/blood.V92.2.362.414k38_362_367; Stamm C, 2003, LANCET, V361, P45, DOI 10.1016/S0140-6736(03)12110-1; Stosich MS, 2007, TISSUE ENG, V13, P2881, DOI 10.1089/ten.2007.0078; Tabata Y, 1998, BIOMATERIALS, V19, P807, DOI 10.1016/S0142-9612(98)00233-6; Tang JM, 2006, EUR J CARDIO-THORAC, V30, P353, DOI 10.1016/j.ejcts.2006.02.070; Tanihara M, 2001, J BIOMED MATER RES, V56, P216, DOI 10.1002/1097-4636(200108)56:2<216::AID-JBM1086>3.0.CO;2-N; Vij K, 2006, BONE, V38, P722, DOI 10.1016/j.bone.2005.10.028; Woo SY, 2002, SCAND J IMMUNOL, V55, P88, DOI 10.1046/j.1365-3083.2002.01031.x; WRIGHT KT, 2008, SPINAL CORD; Yue WM, 2008, STEM CELLS DEV, V17, P785, DOI 10.1089/scd.2007.0243	64	75	83	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2008	3	12							e3922	10.1371/journal.pone.0003922	http://dx.doi.org/10.1371/journal.pone.0003922			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AP	19081793	Green Published, gold, Green Submitted			2022-12-25	WOS:000265458200002
J	Horita, H; Frankel, AE; Thorburn, A				Horita, Henrick; Frankel, Arthur E.; Thorburn, Andrew			Acute Myeloid Leukemia-Targeted Toxin Activates Both Apoptotic and Necroptotic Death Mechanisms	PLOS ONE			English	Article							NONAPOPTOTIC CELL-DEATH; DIPHTHERIA-TOXIN; FUSION PROTEIN; RECEPTOR; RESISTANCE; INTERLEUKIN-3; INDUCTION	Background: Acute myelogenous leukemia (AML) is the second most common leukemia with approximately 13,410 new cases and 8,990 deaths annually in the United States. A novel fusion toxin treatment, diphtheria toxin GM-CSF (DT-GMCSF) has been shown to selectively eliminate leukemic repopulating cells that are critical for the formation of AML. We previously showed that DT-GMCSF treatment of U937 cells, an AML cell line, causes activation of caspases and the induction of apoptosis. Methods and Findings: In this study we further investigate the mechanisms of cell death induced by DT-GMCSF and show that, in addition to the activation of caspase-dependent apoptosis, DT-GMCSF also kills AML cells by simultaneously activating caspase-independent necroptosis. These mechanisms depend on the ability of the targeted toxin to inhibit protein synthesis, and are not affected by the receptor that is targeted or the mechanism through which protein synthesis is blocked. Conclusions: We conclude that fusion toxin proteins may be effective for treating AML cells whether or not they are defective in apoptosis.	[Thorburn, Andrew] Univ Colorado Denver, Sch Med, Dept Pharmacol, Aurora, CO USA; [Frankel, Arthur E.] Scott & White Canc Res Inst, Temple, TX USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Horita, H (corresponding author), Univ Colorado Denver, Sch Med, Dept Pharmacol, Aurora, CO USA.	Andrew.Thorburn@ucdenver.edu			NIH [CA11421]; Leukemia Society [LLS-R-6028-08]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia Society	NIH grant CA11421. Leukemia Society Grant LLS-R-6028-08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abi-Habib RJ, 2004, BLOOD, V104, P2143, DOI 10.1182/blood-2004-01-0339; BUDEL LM, 1989, BLOOD, V74, P565; Cros E, 2004, LEUKEMIA LYMPHOMA, V45, P1123, DOI 10.1080/1042819032000159861; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Frankel AE, 2002, CLIN CANCER RES, V8, P1004; Frankel A, 2008, LEUKEMIA LYMPHOMA, V49, P543, DOI 10.1080/10428190701799035; Han WD, 2007, MOL CANCER THER, V6, P1641, DOI 10.1158/1535-7163.MCT-06-0511; Hara T, 1996, STEM CELLS, V14, P605, DOI 10.1002/stem.140605; Hogge DE, 1998, BLOOD, V92, P589; Holmes RK, 2000, J INFECT DIS, V181, pS156, DOI 10.1086/315554; Horita H, 2008, LEUKEMIA, V22, P652, DOI 10.1038/sj.leu.2404956; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kern W, 2006, CANCER-AM CANCER SOC, V107, P116, DOI 10.1002/cncr.21543; Lewis J, 2000, J BIOL CHEM, V275, P10519, DOI 10.1074/jbc.275.14.10519; Lin Y, 2004, J BIOL CHEM, V279, P10822, DOI 10.1074/jbc.M313141200; Pastan I, 2006, NAT REV CANCER, V6, P559, DOI 10.1038/nrc1891; Terpstra W, 1997, BLOOD, V90, P3735, DOI 10.1182/blood.V90.9.3735; Thorburn A, 2004, APOPTOSIS, V9, P19, DOI 10.1023/B:APPT.0000012118.95548.88; Thorburn A, 2008, DRUG RESIST UPDATE, V11, P17, DOI 10.1016/j.drup.2008.02.001; Thorburn J, 2003, CLIN CANCER RES, V9, P861; Thorburn J, 2009, CELL DEATH DIFFER, V16, P175, DOI 10.1038/cdd.2008.143; Vanden Berghe T, 2004, J BIOL CHEM, V279, P7925, DOI 10.1074/jbc.M307807200; Westcott MM, 2004, MOL CANCER THER, V3, P1681	23	39	40	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2008	3	12							e3909	10.1371/journal.pone.0003909	http://dx.doi.org/10.1371/journal.pone.0003909			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZU	19079542	gold, Green Published, Green Submitted			2022-12-25	WOS:000265455900003
J	Mann, J; Sargeant, BL; Watson-Capps, JJ; Gibson, QA; Heithaus, MR; Connor, RC; Patterson, E				Mann, Janet; Sargeant, Brooke L.; Watson-Capps, Jana J.; Gibson, Quincy A.; Heithaus, Michael R.; Connor, Richard C.; Patterson, Eric			Why Do Dolphins Carry Sponges?	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; TOOL-USE; TURSIOPS SP.; INDIVIDUAL VARIATION; SEX-DIFFERENCES; NICHE WIDTH; WILD; SPECIALIZATION; COMPETITION; ECOLOGY	Tool use is rare in wild animals, but of widespread interest because of its relationship to animal cognition, social learning and culture. Despite such attention, quantifying the costs and benefits of tool use has been difficult, largely because if tool use occurs, all population members typically exhibit the behavior. In Shark Bay, Australia, only a subset of the bottlenose dolphin population uses marine sponges as tools, providing an opportunity to assess both proximate and ultimate costs and benefits and document patterns of transmission. We compared sponge-carrying (sponger) females to non-sponge-carrying (non-sponger) females and show that spongers were more solitary, spent more time in deep water channel habitats, dived for longer durations, and devoted more time to foraging than non-spongers; and, even with these potential proximate costs, calving success of sponger females was not significantly different from non-spongers. We also show a clear female-bias in the ontogeny of sponging. With a solitary lifestyle, specialization, and high foraging demands, spongers used tools more than any non-human animal. We suggest that the ecological, social, and developmental mechanisms involved likely (1) help explain the high intrapopulation variation in female behaviour, (2) indicate tradeoffs (e. g., time allocation) between ecological and social factors and, (3) constrain the spread of this innovation to primarily vertical transmission.	[Mann, Janet; Sargeant, Brooke L.; Watson-Capps, Jana J.; Gibson, Quincy A.; Patterson, Eric] Georgetown Univ, Dept Biol, Washington, DC 20057 USA; [Mann, Janet] Georgetown Univ, Dept Psychol, Washington, DC USA; [Sargeant, Brooke L.] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [Watson-Capps, Jana J.] Metropolitan State Coll, Dept Biol, Denver, CO USA; [Heithaus, Michael R.] Florida Int Univ, Marine Sci Program, Dept Biol Sci, Miami, FL 33199 USA; [Connor, Richard C.] Univ Massachusetts, Dept Biol, Dartmouth, MA USA	Georgetown University; Georgetown University; State University System of Florida; Florida International University; State University System of Florida; Florida International University; University of Massachusetts System; University Massachusetts Dartmouth	Mann, J (corresponding author), Georgetown Univ, Dept Biol, Washington, DC 20057 USA.	mannj2@georgetown.edu	Mann, Janet/L-2311-2019; Heithaus, Michael/AAF-9914-2020	Heithaus, Michael/0000-0002-3219-1003	NSF [0316800, OCE0526065]; The Eppley Foundation for Research; The Brach Foundation; The National Geographic Society; Georgetown University; West Australian Department of Environment and Conservation	NSF(National Science Foundation (NSF)); The Eppley Foundation for Research; The Brach Foundation; The National Geographic Society(National Geographic Society); Georgetown University; West Australian Department of Environment and Conservation	Support for this research was from grants to JM from NSF#0316800, The Eppley Foundation for Research, The Brach Foundation, The National Geographic Society, and Georgetown University. The orthophoto in Fig. 2 was supported by NSF grant OCE0526065 to MRH and the West Australian Department of Environment and Conservation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauchamp G, 1997, ETHOL ECOL EVOL, V9, P105, DOI 10.1080/08927014.1997.9522890; Beck B. B., 1980, ANIMAL TOOL BEHAV US; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bolnick DI, 2001, NATURE, V410, P463, DOI 10.1038/35068555; Breuer T, 2005, PLOS BIOL, V3, P2041, DOI 10.1371/journal.pbio.0030380; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; CHEVALIERSKOLNIKOFF S, 1993, ANIM BEHAV, V46, P209, DOI 10.1006/anbe.1993.1183; Connor RC, 2000, CETACEAN SOCIETIES, P91; Connor RC, 1999, NATURE, V397, P571, DOI 10.1038/17501; Gibson QA, 2008, ANIM BEHAV, V76, P375, DOI 10.1016/j.anbehav.2008.01.021; Gibson QA, 2008, ANIM BEHAV, V76, P389, DOI 10.1016/j.anbehav.2008.01.022; Goodall J., 1986, CHIMPANZEES GOMBE PA; Harley HE, 2003, NATURE, V424, P667, DOI 10.1038/nature01846; Herman LM, 2002, COGNITIVE ANIMAL, P275; Krutzen M, 2007, TRENDS ECOL EVOL, V22, P6, DOI 10.1016/j.tree.2006.10.011; Krutzen M, 2005, P NATL ACAD SCI USA, V102, P8939, DOI 10.1073/pnas.0500232102; Laland KN, 2006, TRENDS ECOL EVOL, V21, P542, DOI 10.1016/j.tree.2006.06.005; LALAND KN, 2006, TREE, V22, P7; Lefebvre L, 2002, BEHAVIOUR, V139, P939, DOI 10.1163/156853902320387918; Lonsdorf EV, 2004, NATURE, V428, P715, DOI 10.1038/428715a; Mann J, 2005, ANIM BEHAV, V69, P899, DOI 10.1016/j.anbehav.2004.04.024; Mann J, 2000, BEHAV ECOL, V11, P210, DOI 10.1093/beheco/11.2.210; Mann Janet, 2003, P236, DOI 10.1017/CBO9780511584022.010; Maynard Smith J., 1982, pi; McCullagh P, 1989, GEN LINEAR MODELS; Mercado E, 1998, ANIM LEARN BEHAV, V26, P210, DOI 10.3758/BF03199213; Partridge L., 1985, P207; Pruetz JD, 2007, CURR BIOL, V17, P412, DOI 10.1016/j.cub.2006.12.042; ROITBLAT HL, 1988, SYSTEMS LEARNING MEM, P13; ROITBLAT HL, 1991, SIMULATION ADAPTIVE, P444; Sargeant BL, 2005, CAN J ZOOL, V83, P1400, DOI 10.1139/Z05-136; Sargeant BL, 2007, BEHAV ECOL SOCIOBIOL, V61, P679, DOI 10.1007/s00265-006-0296-8; Sargent BL, 2009, QUESTION ANIMAL CULT, P152; Scott EM, 2005, BEHAVIOUR, V142, P21, DOI 10.1163/1568539053627712; Smolker R, 1997, ETHOLOGY, V103, P454, DOI 10.1111/j.1439-0310.1997.tb00160.x; St Amant R, 2008, ANIM BEHAV, V75, P1199, DOI 10.1016/j.anbehav.2007.09.028; Svanback R, 2004, J ANIM ECOL, V73, P973, DOI 10.1111/j.0021-8790.2004.00868.x; Tebbich S, 2002, ECOL LETT, V5, P656, DOI 10.1046/j.1461-0248.2002.00370.x; Tinker MT, 2008, P NATL ACAD SCI USA, V105, P560, DOI 10.1073/pnas.0709263105; van Schaik CP, 1999, J HUM EVOL, V36, P719, DOI 10.1006/jhev.1999.0304; van Schaik CP, 2003, J HUM EVOL, V44, P11, DOI 10.1016/S0047-2484(02)00164-1	41	96	99	18	148	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2008	3	12							e3868	10.1371/journal.pone.0003868	http://dx.doi.org/10.1371/journal.pone.0003868			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436ZS	19066625	gold, Green Published, Green Submitted			2022-12-25	WOS:000265455700002
J	Martin, D; Galisteo, R; Gutkind, JS				Martin, Daniel; Galisteo, Rebeca; Gutkind, J. Silvio			CXCL8/IL8 Stimulates Vascular Endothelial Growth Factor (VEGF) Expression and the Autocrine Activation of VEGFR2 in Endothelial Cells by Activating NF kappa B through the CBM (Carma3/Bcl10/Malt1) Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER CELLS; ANGIOGENESIS; INTERLEUKIN-8; HYPOXIA; SECRETION; PERMEABILITY; HIF-1-ALPHA; PATHWAYS; GENE	Vascular endothelial growth factor (VEGF) is a potent mitogen and permeability factor for endothelial cells that plays a central role in angiogenesis, vascular maintenance, inflammation, and cancer. VEGF also mediates the homeostatic adaptation to hypoxic conditions by promoting an increase in vascular density to compensate for decreased oxygenation. This process is triggered by an oxygen-sensitive transcription factor, hypoxia-inducible factor-1 (HIF1 alpha), which becomes active in hypoxic tissues, leading to the synthesis and secretion of VEGF. The role of HIF1 alpha in other processes that involve angiogenesis such as in inflammation is less clear. Of interest, endothelial cells not only respond to but also store and secrete VEGF, which is required for the maintenance of the integrity of the vascular system. How this intracellular pool of VEGF is regulated is still not understood. Here, we found that CXCL8/IL8, a potent proangiogenic and inflammatory chemokine, up-regulates VEGF mRNA and protein levels in endothelial cells by acting on its cognate receptor, CXCR2, and that this results in the autocrine activation of VEGFR2. Surprisingly, this process does not involve HIFI alpha but instead requires the activation of the transcription factor NF kappa B. Furthermore, we identified the components of the CBM complex, Carma3, Bcl10, and Malt1, as key mediators of the CXCL8/IL8-induced NF kappa B activation and VEGF up-regulation. Together, these findings support the existence of an NF kappa B-mediated pathway by which the proinflammatory chemokine CXCL8/IL8 controls the expression of VEGF in endothelial cells, thereby promoting the activation of VEGF receptors in an autocrine fashion.	[Martin, Daniel; Galisteo, Rebeca; Gutkind, J. Silvio] NIDCR, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Gutkind, JS (corresponding author), NIDCR, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA.	sg39v@nih.gov	Gutkind, J. Silvio/A-1053-2009; Gutkind, J. Silvio/J-1201-2016	Gutkind, J. Silvio/0000-0002-5150-4482; Martin Izquierdo, Daniel/0000-0002-8880-9087	National Institutes of Health Intramural AIDS Targeted Antiviral Program; NIDCR (National Institutes of Health); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000551] Funding Source: NIH RePORTER	National Institutes of Health Intramural AIDS Targeted Antiviral Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by a National Institutes of Health Intramural AIDS Targeted Antiviral Program and by the a grant from the NIDCR (National Institutes of Health).	Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Huang S, 2000, CANCER RES, V60, P5334; Klemm S, 2007, P NATL ACAD SCI USA, V104, P134, DOI 10.1073/pnas.0608388103; KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554; Koehne P, 2000, AM J PHYSIOL-HEART C, V279, pH817, DOI 10.1152/ajpheart.2000.279.2.H817; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Martin D, 2008, ONCOGENE, V27, P1844, DOI [10.1038/sj.onc.1210817, 10.1038/onc.2009.351]; Mizukami Y, 2005, NAT MED, V11, P992, DOI 10.1038/nm1294; Nagy JA, 2002, J EXP MED, V196, P1497, DOI 10.1084/jem.20021244; Nathan AT, 1999, BRIT MED BULL, V55, P96, DOI 10.1258/0007142991902312; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Ramanathan M, 2007, MOL BIOL CELL, V18, P14, DOI 10.1091/mbc.E06-07-0596; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Shibata A, 2002, BREAST CANCER RES TR, V73, P237, DOI 10.1023/A:1015872531675; Shima DT, 1996, J BIOL CHEM, V271, P3877, DOI 10.1074/jbc.271.7.3877; Sodhi A, 2000, CANCER RES, V60, P4873; Squarize CH, 2006, NEOPLASIA, V8, P733, DOI 10.1593/neo.06274; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Tang N, 2004, CANCER CELL, V6, P485, DOI 10.1016/j.ccr.2004.09.026; Utgaard JO, 1998, J EXP MED, V188, P1751, DOI 10.1084/jem.188.9.1751; Weibel ER, 1984, PATHWAY OXYGEN STRUC	25	296	309	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6038	6042		10.1074/jbc.C800207200	http://dx.doi.org/10.1074/jbc.C800207200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19112107	Green Published, hybrid			2022-12-25	WOS:000263742700004
J	Peng, H; Vijayakumar, S; Schiene-Fischer, C; Li, H; Purkerson, JM; Malesevic, M; Liebscher, J; Al-Awqati, Q; Schwartz, GJ				Peng, Hu; Vijayakumar, Soundarapandian; Schiene-Fischer, Cordelia; Li, Hui; Purkerson, Jeffrey M.; Malesevic, Miroslav; Liebscher, Juergen; Al-Awqati, Qais; Schwartz, George J.			Secreted Cyclophilin A, a Peptidylprolyl cis-trans Isomerase, Mediates Matrix Assembly of Hensin, a Protein Implicated in Epithelial Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL TUBULAR-ACIDOSIS; PROLYL ISOMERASE; EXTRACELLULAR-MATRIX; PEPTIDE ARRAYS; SPOT SYNTHESIS; POLARITY; CELLS; DMBT1; POLYMERIZATION; REVERSES	Hensin is a rabbit ortholog of DMBT1, a multifunctional, multidomain protein implicated in the regulation of epithelial differentiation, innate immunity, and tumorigenesis. Hensin in the extracellular matrix (ECM) induced morphological changes characteristic of terminal differentiation in a clonal cell line (clone C) of rabbit kidney intercalated cells. Although hensin is secreted in monomeric and various oligomeric forms, only the polymerized ECM form is able to induce these phenotypic changes. Here we report that hensin secretion and matrix assembly were inhibited by the peptidylprolyl cis-trans isomerase (PPIase) inhibitors cyclosporin A (CsA) and a derivative of cyclosporin A with modifications in the D-Ser side chain (Cs9) but not by the calcineurin pathway inhibitor FK506. PPIase inhibition led to failure of hensin polymerization in the medium and ECM, plus the loss of apical cytoskeleton, apical microvilli, and the columnar epithelial shape of clone C cells. Cyclophilin A was produced and secreted into the media to a much greater extent than cyclophilins B and C. Our results also identified the direct CsA-sensitive interaction of cyclophilin A with hensin, suggesting that cyclophilin A is the PPIase that mediates the polymerization and matrix assembly of hensin. These results are significant because this is the first time a direct role of peptidylprolyl cis-trans isomerase activity has been implicated in the process of epithelial differentiation.	[Schwartz, George J.] Univ Rochester, Med Ctr, Sch Med, Dept Pediat, Rochester, NY 14642 USA; [Schiene-Fischer, Cordelia; Malesevic, Miroslav] Max Planck Res Unit Enzymol Prot Folding, D-06120 Halle, Germany; [Liebscher, Juergen] Humboldt Univ, Dept Chem, D-10115 Berlin, Germany; [Al-Awqati, Qais] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10032 USA	University of Rochester; Max Planck Society; Humboldt University of Berlin; Columbia University	Schwartz, GJ (corresponding author), Univ Rochester, Med Ctr, Sch Med, Dept Pediat, Box 777,601 Elmwood Ave, Rochester, NY 14642 USA.	George_Schwartz@urmc.rochester.edu	Al-Awqati, Qais/B-2465-2009; Liebscher, Jürgen/A-8964-2012; Liebscher, Jürgen/R-1689-2019; Malesevic, Miroslav/D-8128-2012; vijayakumar, soundarapandian/B-4539-2010	Liebscher, Jürgen/0000-0002-1802-5543; Liebscher, Jürgen/0000-0002-1802-5543; Malesevic, Miroslav/0000-0002-1484-3709; Al-Awqati, Qais/0000-0001-7141-1040	National Institutes of Health [DK-20999, DK-50603]; American Heart Association [0150138N]; Deutsche Forschungsgemeinschaft [GK1026]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK020999, R01DK050603, R01DK020999] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-20999 (to Q. AI-A.) and DK-50603 (to G.J.S.). This work was also supported by Grant-in-aid 0150138N from the American Heart Association (to G.J.S.) and by Deutsche Forschungsgemeinschaft Grant GK1026 (to C.S.- F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BILLICH A, 1995, J VIROL, V69, P2451, DOI 10.1128/JVI.69.4.2451-2461.1995; Bosco DA, 2002, P NATL ACAD SCI USA, V99, P5247, DOI 10.1073/pnas.082100499; Bukrinsky MI, 2002, TRENDS IMMUNOL, V23, P323, DOI 10.1016/S1471-4906(02)02237-8; Dornan J, 2003, CURR TOP MED CHEM, V3, P1392, DOI 10.2174/1568026033451899; Fanghanel J, 2004, FRONT BIOSCI-LANDMRK, V9, P3453, DOI 10.2741/1494; Fischer G, 2004, REV PHYSIOL BIOCH P, V148, P105, DOI 10.1007/s10254-003-0011-3; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; FRIEDMAN J, 1994, AM J PATHOL, V144, P1247; Hikita C, 2000, J CELL BIOL, V151, P1235, DOI 10.1083/jcb.151.6.1235; Hikita C, 1999, J BIOL CHEM, V274, P17671, DOI 10.1074/jbc.274.25.17671; Hilpert K, 2007, NAT PROTOC, V2, P1333, DOI 10.1038/nprot.2007.160; Jin ZG, 2000, CIRC RES, V87, P789, DOI 10.1161/01.RES.87.9.789; Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802; Kang WQ, 2003, FEBS LETT, V540, P21, DOI 10.1016/S0014-5793(03)00217-5; Mi ZY, 2007, CANCER RES, V67, P4088, DOI 10.1158/0008-5472.CAN-06-4066; Mollenhauer J, 2000, CANCER RES, V60, P1704; Mollenhauer J, 2002, GENE CHROMOSOME CANC, V35, P242, DOI 10.1002/gcc.10115; Obama K, 2006, CLIN CANCER RES, V12, P70, DOI 10.1158/1078-0432.CCR-05-0588; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; PRICE ER, 1991, P NATL ACAD SCI USA, V88, P1903, DOI 10.1073/pnas.88.5.1903; Schwartz GJ, 2002, J CLIN INVEST, V109, P89, DOI 10.1172/JCI13292; Takito J, 1999, AM J PHYSIOL-RENAL, V277, pF277, DOI 10.1152/ajprenal.1999.277.2.F277; Takito J, 1996, J CLIN INVEST, V98, P2324, DOI 10.1172/JCI119044; Takito J, 2004, J CELL BIOL, V166, P1093, DOI 10.1083/jcb.200405159; Tsuruoka S, 2003, J PHARMACOL EXP THER, V305, P840, DOI 10.1124/jpet.102.048207; VANADELSBERG J, 1989, AM J PHYSIOL, V256, pC1004, DOI 10.1152/ajpcell.1989.256.5.C1004; VANADELSBERG J, 1994, CELL, V76, P1053, DOI 10.1016/0092-8674(94)90382-4; Vijayakumar S, 1999, J CELL BIOL, V144, P1057, DOI 10.1083/jcb.144.5.1057; Wang P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-226; Watanabe S, 2005, AM J PHYSIOL-RENAL, V288, pF40, DOI 10.1152/ajprenal.00218.2004; Wulf G, 2003, BREAST CANCER RES, V5, P76, DOI 10.1186/bcr572; Yang F, 2008, J VIROL, V82, P5269, DOI 10.1128/JVI.02614-07; Yang H, 2005, J SURG RES, V123, P312, DOI 10.1016/j.jss.2004.08.026; Yurchenko V, 2002, J BIOL CHEM, V277, P22959, DOI 10.1074/jbc.M201593200; Zhang YX, 2005, J BIOL CHEM, V280, P4842, DOI 10.1074/jbc.M409178200	35	38	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6465	6475		10.1074/jbc.M808964200	http://dx.doi.org/10.1074/jbc.M808964200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19112104	hybrid, Green Published			2022-12-25	WOS:000263742700049
J	Mines, MA; Goodwin, JS; Limbird, LE; Cui, FF; Fan, GH				Mines, Marjelo A.; Goodwin, J. Shawn; Limbird, Lee E.; Cui, Fei-Fei; Fan, Guo-Huang			Deubiquitination of CXCR4 by USP14 Is Critical for Both CXCL12-induced CXCR4 Degradation and Chemotaxis but Not ERK Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOKINE RECEPTOR CXCR4; PROTEIN-COUPLED RECEPTOR; REGULATED KINASE ACTIVATION; LUNG-CANCER CELLS; NUCLEAR TRANSLOCATION; EXTRACELLULAR SIGNAL; PROGENITOR CELLS; BREAST-CANCER; TUMOR-CELLS; BONE-MARROW	The chemokine receptor CXCR4 plays important roles in the immune and nervous systems. Abnormal expression of CXCR4 contributes to cancer and inflammatory and neurodegenerative disorders. Although ligand-dependent CXCR4 ubiquitination is known to accelerate CXCR4 degradation, little is known about counter mechanisms for receptor deubiquitination. CXCL12, a CXCR4 agonist, induces a time-dependent association of USP14 with CXCR4, or its C terminus, that is not mimicked by USP2A, USP4, or USP7, other members of the deubiquitination catalytic family. Co-localization of CXCR4 and USP14 also is time-dependent following CXCL12 stimulation. The physical interaction of CXCR4 and USP14 is paralleled by USP14-catalyzed deubiquitination of the receptor; knockdown of endogenous USP14 by RNA interference (RNAi) blocks CXCR4 deubiquitination, whereas overexpression of USP14 promotes CXCR4 deubiquitination. We also observed that ubiquitination of CXCR4 facilitated receptor degradation, whereas overexpression of USP14 or RNAi-induced knockdown of USP14 blocked CXCL12-mediated CXCR4 degradation. Most interestingly, CXCR4-mediated chemotactic cell migration was blocked by either overexpression or RNAi-mediated knockdown of USP14, implying that a CXCR4-ubiquitin cycle on the receptor, rather than a particular ubiquitinated state of the receptor, is critical for the ligand gradient sensing and directed motility required for chemokine-mediated chemotaxis. Our observation that a mutant of CXCR4, HA-3K/R CXCR4, which cannot be ubiquitinated and does not mediate a chemotactic response to CXCL12, indicates the importance of this covalent modification not only in marking receptors for degradation but also for permitting CXCR4-mediated signaling. Finally, the indistinguishable activation of ERK by wild type- or 3K/R-CXCR4 suggests that chemotaxis in response to CXCL12 may be independent of the ERK cascade.	[Limbird, Lee E.] Meharry Med Coll, Dept Cardiovasc Biol, Nashville, TN 37208 USA; [Mines, Marjelo A.; Fan, Guo-Huang] Meharry Med Coll, Dept Neurobiol & Neurotoxicol, Nashville, TN 37208 USA; [Goodwin, J. Shawn] Meharry Med Coll, Dept Canc Biol, Nashville, TN 37208 USA; [Cui, Fei-Fei] Chinese Acad Sci, Inst Hlth Sci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Cui, Fei-Fei] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200031, Peoples R China; [Fan, Guo-Huang] Tennessee Healthcare Syst, Dept Vet Affairs, Nashville, TN 37212 USA	Meharry Medical College; Meharry Medical College; Meharry Medical College; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Limbird, LE (corresponding author), Meharry Med Coll, Dept Cardiovasc Biol, Nashville, TN 37208 USA.	llimbird@mmc.edu			National Institutes of Health [U54NS41071, RR0303-19]; Veterans Affairs Hospital; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS041071] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Hospital; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health grants and Grants U54NS41071 (NINDS) and RR0303-19. This work was also supported by a career investigator award from the Veterans Affairs Hospital (to G.-H.F.).	Abu El-Asrar AM, 2001, BRIT J OPHTHALMOL, V85, P1357; Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Anderson C, 2005, J NEUROCHEM, V95, P724, DOI 10.1111/j.1471-4159.2005.03409.x; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Brady AE, 2005, MOL PHARMACOL, V67, P1690, DOI 10.1124/mol.104.005215; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Burger M, 2003, ONCOGENE, V22, P8093, DOI 10.1038/sj.onc.1207097; Cabioglu N, 2005, CLIN EXP METASTAS, V22, P39, DOI 10.1007/s10585-005-3222-y; Cook LB, 2003, MOL ENDOCRINOL, V17, P1777, DOI 10.1210/me.2003-0073; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; DApuzzo M, 1997, EUR J IMMUNOL, V27, P1788, DOI 10.1002/eji.1830270729; Ding Y, 2006, MOL PHARMACOL, V69, P1269, DOI 10.1124/mol.105.020271; Ding Y, 2008, EXP CELL RES, V314, P590, DOI 10.1016/j.yexcr.2007.10.032; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Haribabu B, 1997, J BIOL CHEM, V272, P28726, DOI 10.1074/jbc.272.45.28726; Hong X, 2006, CANCER LETT, V236, P39, DOI 10.1016/j.canlet.2005.05.011; Kang H, 2005, BREAST, V14, P360, DOI 10.1016/j.breast.2004.12.007; Li RS, 2006, J BIOL CHEM, V281, P37616, DOI 10.1074/jbc.M607266200; Luo C, 2006, J BIOL CHEM, V281, P30081, DOI 10.1074/jbc.M605837200; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Milojevic T, 2006, MOL PHARMACOL, V69, P1083, DOI 10.1124/mol.105.015818; Mines M, 2007, CURR MED CHEM, V14, P2456, DOI 10.2174/092986707782023686; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Oh JW, 2001, J IMMUNOL, V166, P2695, DOI 10.4049/jimmunol.166.4.2695; Pan H, 2008, J BIOL CHEM, V283, P623, DOI 10.1074/jbc.M704934200; Peng SB, 2005, MOL CANCER RES, V3, P227; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Priolo C, 2006, CANCER RES, V66, P8625, DOI 10.1158/0008-5472.CAN-06-1374; Rauer M, 2002, J NEUROVIROL, V8, P168, DOI 10.1080/13550280290049741; Rempel SA, 2000, CLIN CANCER RES, V6, P102; Richman JG, 2001, J BIOL CHEM, V276, P15003, DOI 10.1074/jbc.M011679200; Saur D, 2005, GASTROENTEROLOGY, V129, P1237, DOI 10.1053/j.gastro.2005.06.056; Su LP, 2005, CLIN CANCER RES, V11, P8273, DOI 10.1158/1078-0432.CCR-05-0537; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; Walter DH, 2005, CIRC RES, V97, P1142, DOI 10.1161/01.RES.0000193596.94936.2c; Wang ZQ, 2008, J BIOL CHEM, V283, P3951, DOI 10.1074/jbc.M706848200; WILSON SM, 2000, EMBO J, V20, P5187; Woerner BM, 2005, CANCER RES, V65, P11392, DOI 10.1158/0008-5472.CAN-05-0847; Wysoczynski M, 2005, BLOOD, V105, P40, DOI 10.1182/blood-2004-04-1430; Xia MQ, 1999, J NEUROVIROL, V5, P32, DOI 10.3109/13550289909029743; Zhou Y, 2002, J BIOL CHEM, V277, P49481, DOI 10.1074/jbc.M206222200; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	45	74	78	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5742	5752		10.1074/jbc.M808507200	http://dx.doi.org/10.1074/jbc.M808507200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19106094	hybrid, Green Published			2022-12-25	WOS:000263560600038
J	Dayal, S; Sparks, A; Jacob, J; Allende-Vega, N; Lane, DP; Saville, MK				Dayal, Saurabh; Sparks, Alison; Jacob, Jimmy; Allende-Vega, Nerea; Lane, David P.; Saville, Mark K.			Suppression of the Deubiquitinating Enzyme USP5 Causes the Accumulation of Unanchored Polyubiquitin and the Activation of p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASOME INHIBITOR BORTEZOMIB; UBIQUITIN-CONJUGATING ENZYMES; PROTEIN-DEGRADATION; TUMOR-CELLS; MDM2; CHAINS; ISOPEPTIDASE; BINDING; SUBUNIT; SYSTEM	Both p53 and its repressor Mdm2 are subject to ubiquitination and proteasomal degradation. We show that knockdown of the deubiquitinating enzyme USP5 (isopeptidase T) results in an increase in the level and transcriptional activity of p53. Suppression of USP5 stabilizes p53, whereas it has little or no effect on the stability of Mdm2. This provides a mechanism for transcriptional activation of p53. USP5 knockdown interferes with the degradation of ubiquitinated p53 rather than attenuating p53 ubiquitination. In vitro studies have shown that a preferred substrate for USP5 is unanchored polyubiquitin. Consistent with this, we observed for the first time in a mammalian system that USP5 makes a major contribution to Lys-48-linked polyubiquitin disassembly and that suppression of USP5 results in the accumulation of unanchored polyubiquitin chains. Ectopic expression of a C-terminal mutant of ubiquitin (G75A/G76A), which also causes the accumulation of free polyubiquitin, recapitulates the effects of USP5 knockdown on the p53 pathway. We propose a model in which p53 is selectively stabilized because the unanchored polyubiquitin that accumulates after USP5 knockdown is able to compete with ubiquitinated p53 but not with Mdm2 for proteasomal recognition. This raises the possibility that there are significant differences in proteasomal recognition of p53 and Mdm2. These differences could be exploited therapeutically. Our study reveals a novel mechanism for regulation of p53 and identifies USP5 as a potential target for p53 activating therapeutic agents for the treatment of cancer.	[Dayal, Saurabh; Sparks, Alison; Jacob, Jimmy; Allende-Vega, Nerea; Lane, David P.; Saville, Mark K.] Univ Dundee, Ninewells Hosp & Med Sch, Dept Surg & Mol Oncol, CR UK Cell Transformat Res Grp, Dundee DD1 9SY, Scotland	University of Dundee	Saville, MK (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Dept Surg & Mol Oncol, CR UK Cell Transformat Res Grp, Dundee DD1 9SY, Scotland.	m.k.saville@dundee.ac.uk	高, 雨莉/HGU-8187-2022	Lane, David/0000-0003-0551-3545; Allende-Vega, Nerea/0000-0001-5569-6461	Cancer Research UK	Cancer Research UK(Cancer Research UK)	This work was funded by Cancer Research UK. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amerik AY, 1997, EMBO J, V16, P4826; Badciong JC, 2002, J BIOL CHEM, V277, P49668, DOI 10.1074/jbc.M208593200; Beal R, 1996, P NATL ACAD SCI USA, V93, P861, DOI 10.1073/pnas.93.2.861; Blattner C, 2002, MOL CELL BIOL, V22, P6170, DOI 10.1128/MCB.22.17.6170-6182.2002; Blaydes JP, 1998, ONCOGENE, V17, P1045, DOI 10.1038/sj.onc.1202014; Boccadoro M, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-18; Boutet SC, 2007, CELL, V130, P349, DOI 10.1016/j.cell.2007.05.044; Brignone C, 2004, ONCOGENE, V23, P4121, DOI 10.1038/sj.onc.1207540; Brooks CL, 2004, CELL CYCLE, V3, P895; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cheok CF, 2007, MOL CANCER RES, V5, P1133, DOI 10.1158/1541-7786.MCR-07-0161; Ciechanover A, 2006, EXP BIOL MED, V231, P1197; Concannon CG, 2007, ONCOGENE, V26, P1681, DOI 10.1038/sj.onc.1209974; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Dey A, 2008, BRIT J CANCER, V98, P4, DOI 10.1038/sj.bjc.6604098; Dicato M, 2006, ONCOLOGY-BASEL, V70, P474, DOI 10.1159/000099284; Dierssen U, 2007, HEPATOLOGY, V46, p780A; Doelling JH, 2001, PLANT J, V27, P393, DOI 10.1046/j.1365-313X.2001.01106.x; Eisele F, 2006, BIOCHEM BIOPH RES CO, V350, P329, DOI 10.1016/j.bbrc.2006.09.041; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; FALQUET L, 1995, FEBS LETT, V359, P73, DOI 10.1016/0014-5793(94)01451-6; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Fujimuro M, 1997, EUR J BIOCHEM, V249, P427, DOI 10.1111/j.1432-1033.1997.00427.x; Gabriel JM, 2002, BIOCHEMISTRY-US, V41, P13755, DOI 10.1021/bi026096m; Glockzin S, 2003, MOL CELL BIOL, V23, P8960, DOI 10.1128/MCB.23.24.8960-8969.2003; Guterman A, 2004, J BIOL CHEM, V279, P1729, DOI 10.1074/jbc.M307050200; HADARI T, 1992, J BIOL CHEM, V267, P719; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Higashitsuji H, 2005, CANCER CELL, V8, P75, DOI 10.1016/j.ccr.2005.06.006; Hishiya A, 2006, EMBO J, V25, P554, DOI 10.1038/sj.emboj.7600945; HODGINS RRW, 1992, J BIOL CHEM, V267, P8807; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Itahana K, 2007, CANCER CELL, V12, P355, DOI 10.1016/j.ccr.2007.09.007; Jin Y, 2008, MOL CELL BIOL, V28, P1218, DOI 10.1128/MCB.01198-07; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; Lindsey DF, 1998, J BIOL CHEM, V273, P29178, DOI 10.1074/jbc.273.44.29178; Lukashchuk N, 2007, MOL CELL BIOL, V27, P8284, DOI 10.1128/MCB.00050-07; Martinez LA, 2002, P NATL ACAD SCI USA, V99, P14849, DOI 10.1073/pnas.222406899; Mayor T, 2007, MOL CELL PROTEOMICS, V6, P1885, DOI 10.1074/mcp.M700264-MCP200; Meulmeester E, 2005, MOL CELL, V18, P565, DOI 10.1016/j.molcel.2005.04.024; Mimnaugh EG, 1997, BIOCHEMISTRY-US, V36, P14418, DOI 10.1021/bi970998j; Nair VD, 2006, J BIOL CHEM, V281, P39550, DOI 10.1074/jbc.M603950200; Nandi D, 2006, J BIOSCIENCES, V31, P137, DOI 10.1007/BF02705243; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; Perroy J, 2004, NAT METHODS, V1, P203, DOI 10.1038/NMETH722; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Piotrowski J, 1997, J BIOL CHEM, V272, P23712, DOI 10.1074/jbc.272.38.23712; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Saville MK, 2004, J BIOL CHEM, V279, P42169, DOI 10.1074/jbc.M403362200; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Shabek N, 2007, BIOCHEM BIOPH RES CO, V363, P425, DOI 10.1016/j.bbrc.2007.08.185; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; STEIN RL, 1995, BIOCHEMISTRY-US, V34, P12616, DOI 10.1021/bi00039a017; Stevenson LF, 2007, EMBO J, V26, P976, DOI 10.1038/sj.emboj.7601567; Stommel JM, 2004, EMBO J, V23, P1547, DOI 10.1038/sj.emboj.7600145; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; WILKINSON KD, 1995, BIOCHEMISTRY-US, V34, P14535, DOI 10.1021/bi00044a032; Wilkinson KD, 2005, EMBO REP, V6, P815, DOI 10.1038/sj.embor.7400506; Williams SA, 2003, CANCER RES, V63, P7338; Wolf DH, 2004, BBA-MOL CELL RES, V1695, P19, DOI 10.1016/j.bbamcr.2004.10.007; Woods Yvonne L, 2003, Hematol J, V4, P233, DOI 10.1038/sj.thj.6200260; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016; Xu Q, 2004, MOL CANCER THER, V3, P1263; Young P, 1998, J BIOL CHEM, V273, P5461, DOI 10.1074/jbc.273.10.5461; Zhu Q, 2007, ONCOGENE, V26, P4199, DOI 10.1038/sj.onc.1210191; Zhu QZ, 2001, J BIOL CHEM, V276, P29695, DOI 10.1074/jbc.M102634200	81	145	151	3	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5030	5041		10.1074/jbc.M805871200	http://dx.doi.org/10.1074/jbc.M805871200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19098288	hybrid, Green Accepted			2022-12-25	WOS:000263416600033
J	Lee, HS; Lim, CJ; Puzon-McLaughlin, W; Shattil, SJ; Ginsberg, MH				Lee, Ho-Sup; Lim, Chinten James; Puzon-McLaughlin, Wilma; Shattil, Sanford J.; Ginsberg, Mark H.			RIAM Activates Integrins by Linking Talin to Ras GTPase Membrane-targeting Sequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATES RAP1-INDUCED ADHESION; HUMAN-PLATELETS; CELL-ADHESION; RAP1; BINDING; LIGAND; ALPHA(IIB)BETA(3); ALPHA-IIB-BETA-3; HEMOSTASIS; INHIBITION	Rap1 small GTPases interact with Rap1-GTP-interacting adaptor molecule (RIAM), a member of the MRL (Mig-10/RIAM/Lamellipodin) protein family, to promote talin-dependent integrin activation. Here, we show that MRL proteins function as scaffolds that connect the membrane targeting sequences in Ras GTPases to talin, thereby recruiting talin to the plasma membrane and activating integrins. The MRL proteins bound directly to talin via short, N-terminal sequences predicted to form amphipathic helices. RIAM-induced integrin activation required both its capacity to bind to Rap1 and to talin. Moreover, we constructed a minimized 50-residue Rap-RIAM module containing the talin binding site of RIAM joined to the membrane-targeting sequence of Rap1A. This minimized Rap-RIAM module was sufficient to target talin to the plasma membrane and to mediate integrin activation, even in the absence of Rap1 activity. We identified a short talin binding sequence in Lamellipodin (Lpd), another MRL protein; talin binding Lpd sequence joined to a Rap1 membrane-targeting sequence is sufficient to recruit talin and activate integrins. These data establish the mechanism whereby MRL proteins interact with both talin and Ras GTPases to activate integrins.	[Lee, Ho-Sup; Lim, Chinten James; Puzon-McLaughlin, Wilma; Shattil, Sanford J.; Ginsberg, Mark H.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Ginsberg, MH (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr,Mail Code 0726, La Jolla, CA 92093 USA.	mhginsberg@ucsd.edu	Lim, Chinten James/G-3777-2013	Lim, Chinten James/0000-0001-6381-7585	National Institutes of Health [HL 078784, AR27214, HL 31950]; Cell Migration Consortium [U54 GM06434]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL031950, P01HL078784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR027214, R37AR027214] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cell Migration Consortium; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL 078784, AR27214, and HL 31950. This work was also supported by Cell Migration Consortium Grant U54 GM06434. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BECKERLE MC, 1989, J CELL BIOL, V109, P3333, DOI 10.1083/jcb.109.6.3333; Bergmeier W, 2007, J CLIN INVEST, V117, P1699, DOI 10.1172/JCI30575; Bertoni A, 2002, J BIOL CHEM, V277, P25715, DOI 10.1074/jbc.M202791200; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Caron E, 2000, CURR BIOL, V10, P974, DOI 10.1016/S0960-9822(00)00641-2; Chrzanowska-Wodnicka M, 2005, J CLIN INVEST, V115, P680, DOI 10.1172/JCI200522973; Franke B, 2000, MOL CELL BIOL, V20, P779, DOI 10.1128/MCB.20.3.779-785.2000; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; GUTIERREZ L, 1989, EMBO J, V8, P1093, DOI 10.1002/j.1460-2075.1989.tb03478.x; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Kinbara K, 2003, NAT REV MOL CELL BIO, V4, P767, DOI 10.1038/nrm1229; Kooistra MRH, 2007, J CELL SCI, V120, P17, DOI 10.1242/jcs.03306; KOVACSOVICS TJ, 1995, J BIOL CHEM, V270, P11358, DOI 10.1074/jbc.270.19.11358; Krause M, 2004, DEV CELL, V7, P571, DOI 10.1016/j.devcel.2004.07.024; Lafuente EM, 2004, DEV CELL, V7, P585, DOI 10.1016/j.devcel.2004.07.021; LOFTUS JC, 1990, SCIENCE, V249, P915, DOI 10.1126/science.2392682; Marshall CJ, 1996, CURR OPIN CELL BIOL, V8, P197, DOI 10.1016/S0955-0674(96)80066-4; Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800; Petrich BG, 2007, J CLIN INVEST, V117, P2250, DOI 10.1172/JCI31024; Quinn CC, 2006, CURR BIOL, V16, P845, DOI 10.1016/j.cub.2006.03.025; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; Sebzda E, 2002, NAT IMMUNOL, V3, P251, DOI 10.1038/ni765; SHADLE PJ, 1984, J CELL BIOL, V99, P2056, DOI 10.1083/jcb.99.6.2056; SHATTIL SJ, 1987, BLOOD, V70, P307; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Watanabe N, 2008, J CELL BIOL, V181, P1211, DOI 10.1083/jcb.200803094; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Yan B, 2001, J BIOL CHEM, V276, P28164, DOI 10.1074/jbc.M104161200; Zhang ZC, 2005, J BIOL CHEM, V280, P33200, DOI 10.1074/jbc.M505057200	34	225	228	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5119	5127		10.1074/jbc.M807117200	http://dx.doi.org/10.1074/jbc.M807117200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19098287	Green Published, hybrid			2022-12-25	WOS:000263416600042
J	Rosker, C; Meur, G; Taylor, EJA; Taylor, CW				Rosker, Christian; Meur, Gargi; Taylor, Emily J. A.; Taylor, Colin W.			Functional Ryanodine Receptors in the Plasma Membrane of RINm5F Pancreatic beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCAGON-LIKE PEPTIDE-1; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; MUSCLE SARCOPLASMIC-RETICULUM; NONSELECTIVE CATION CHANNEL; CA2+-INDUCED CA2+ RELEASE; PROTEIN-KINASE-A; INSULIN-SECRETION; INTRACELLULAR CALCIUM; TRISPHOSPHATE RECEPTORS; SIGNAL-TRANSDUCTION	Ryanodine receptors (RyR) are Ca2+ channels that mediate Ca2+ release from intracellular stores in response to diverse intracellular signals. In RINm5F insulinoma cells, caffeine, and 4-chloro-m-cresol (4CmC), agonists of RyR, stimulated Ca2+ entry that was independent of store-operated Ca2+ entry, and blocked by prior incubation with a concentration of ryanodine that inactivates RyR. Patch-clamp recording identified small numbers of large-conductance (gamma(K) = 169 pS) cation channels that were activated by caffeine, 4CmC or low concentrations of ryanodine. Similar channels were detected in rat pancreatic beta-cells. InRINm5Fcells, the channels were blocked by cytosolic, but not extracellular, ruthenium red. Subcellular fractionation showed that type 3 IP3 receptors (IP3R3) were expressed predominantly in endoplasmic reticulum, whereas RyR2 were present also in plasma membrane fractions. Using RNAi selectively to reduce expression of RyR1, RyR2, or IP3R3, we showed that RyR2 mediates both the Ca2+ entry and the plasma membrane currents evoked by agonists of RyR. We conclude that small numbers of RyR2 are selectively expressed in the plasma membrane of RINm5F pancreatic beta-cells, where they mediate Ca2+ entry.	[Rosker, Christian; Meur, Gargi; Taylor, Emily J. A.; Taylor, Colin W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Cambridge	Taylor, CW (corresponding author), Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England.	cwt1000@cam.ac.uk	Taylor, Colin/G-2447-2010	Taylor, Colin/0000-0001-7771-1044; Meur, Gargi/0000-0002-8466-2997; Taylor, Emily/0000-0001-7974-1538	Wellcome Trust; Biotechnology and Biological Sciences Research Council (UK); Biotechnology and Biological Sciences Research Council [BB/E004660/1] Funding Source: researchfish; BBSRC [BB/E004660/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Wellcome Trust and the Biotechnology and Biological Sciences Research Council (UK). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ASHCROFT FM, 1994, J CELL BIOCHEM, V55, P54, DOI 10.1002/jcb.240550007; Barrera NP, 2007, BIOCHEM BIOPH RES CO, V364, P815, DOI 10.1016/j.bbrc.2007.10.104; Bers DM, 2004, J MOL CELL CARDIOL, V37, P417, DOI 10.1016/j.yjmcc.2004.05.026; BLONDEL O, 1994, J BIOL CHEM, V269, P27167; BLONDEL O, 1993, J BIOL CHEM, V268, P11356; BOKVIST K, 1995, EMBO J, V14, P50, DOI 10.1002/j.1460-2075.1995.tb06974.x; Dellis O, 2008, J BIOL CHEM, V283, P751, DOI 10.1074/jbc.M706960200; Dellis O, 2006, SCIENCE, V313, P229, DOI 10.1126/science.1125203; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Dyachok O, 2004, J BIOL CHEM, V279, P45455, DOI 10.1074/jbc.M407673200; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; FADOOL DA, 1992, NEURON, V9, P907, DOI 10.1016/0896-6273(92)90243-7; Fessenden JD, 2003, J BIOL CHEM, V278, P28727, DOI 10.1074/jbc.M303821200; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Gillespie D, 2008, BIOPHYS J, V95, P3706, DOI 10.1529/biophysj.108.131987; GROMADA J, 1995, DIABETES, V44, P767, DOI 10.2337/diabetes.44.7.767; GUERRERO A, 1994, J GEN PHYSIOL, V104, P375, DOI 10.1085/jgp.104.2.375; Gustafsson AJ, 2004, FASEB J, V18, P301, DOI 10.1096/fj.04-2621fje; Hamilton SL, 2005, CELL CALCIUM, V38, P253, DOI 10.1016/j.ceca.2005.06.037; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Holz GG, 2004, DIABETES, V53, P5, DOI 10.2337/diabetes.53.1.5; Holz GG, 1999, J BIOL CHEM, V274, P14147, DOI 10.1074/jbc.274.20.14147; Huang CLH, 2007, ANN NY ACAD SCI, V1116, P255, DOI 10.1196/annals.1402.064; Islam MS, 2002, DIABETES, V51, P1299, DOI 10.2337/diabetes.51.5.1299; Johnson JD, 2004, FASEB J, V18, P878, DOI 10.1096/fj.03-1280fje; Johnson JD, 2004, J BIOL CHEM, V279, P24794, DOI 10.1074/jbc.M401216200; Kang GX, 2001, J PHYSIOL-LONDON, V536, P375, DOI 10.1111/j.1469-7793.2001.0375c.xd; Kermode H, 1998, BIOPHYS J, V74, P1296, DOI 10.1016/S0006-3495(98)77843-9; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; Lee B, 1998, J MOL ENDOCRINOL, V21, P31, DOI 10.1677/jme.0.0210031; LINDSAY ARG, 1991, J PHYSIOL-LONDON, V439, P463, DOI 10.1113/jphysiol.1991.sp018676; Liu YJ, 1997, CELL CALCIUM, V22, P277, DOI 10.1016/S0143-4160(97)90066-X; LOIRAND G, 1991, J PHYSIOL-LONDON, V437, P461, DOI 10.1113/jphysiol.1991.sp018606; MacDonald PE, 2007, PHYSIOLOGY, V22, P113, DOI 10.1152/physiol.00047.2006; Mears D, 1999, CELL CALCIUM, V25, P59, DOI 10.1054/ceca.1998.0007; MEISSNER G, 1989, J BIOL CHEM, V264, P1715; Mitchell KJ, 2003, J BIOL CHEM, V278, P11057, DOI 10.1074/jbc.M210257200; Mitchell KJ, 2001, J CELL BIOL, V155, P41, DOI 10.1083/jcb.200103145; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Penfornis A, 2006, DIABETES METAB, V32, P539, DOI 10.1016/S1262-3636(06)72809-9; PRENTKI M, 1984, NATURE, V309, P562, DOI 10.1038/309562a0; Ravazzola M, 1996, P NATL ACAD SCI USA, V93, P2745, DOI 10.1073/pnas.93.7.2745; ROJAS E, 1994, ENDOCRINOLOGY, V134, P1771, DOI 10.1210/en.134.4.1771; Samso M, 2006, J MOL BIOL, V356, P917, DOI 10.1016/j.jmb.2005.12.023; Santonastasi M, 2007, ACTA PHARMACOL SIN, V28, P937, DOI 10.1111/j.1745-7254.2007.00582.x; Shigeto M, 2007, J PHARMACOL EXP THER, V322, P1, DOI 10.1124/jpet.107.120592; Sutko JL, 1996, PHYSIOL REV, V76, P1027, DOI 10.1152/physrev.1996.76.4.1027; Swatton JE, 1999, BIOCHEM J, V344, P55, DOI 10.1042/0264-6021:3440055; Szaszak M, 2008, CELL SIGNAL, V20, P590, DOI 10.1016/j.cellsig.2007.10.020; Takasawa S, 1998, J BIOL CHEM, V273, P2497, DOI 10.1074/jbc.273.5.2497; Taylor CW, 1999, CELL CALCIUM, V26, P237, DOI 10.1054/ceca.1999.0090; Tian M, 2006, BRIT J PHARMACOL, V147, P289, DOI 10.1038/sj.bjp.0706590; Tsuboi T, 2003, BIOCHEM J, V369, P287, DOI 10.1042/BJ20021288; Warton K, 2004, GENE, V342, P85, DOI 10.1016/j.gene.2004.07.027; Welker S, 1997, N-S ARCH PHARMACOL, V356, P543, DOI 10.1007/PL00005089; Wiederkehr A, 2006, ENDOCRINOLOGY, V147, P2643, DOI 10.1210/en.2006-0057; Williams AJ, 2001, Q REV BIOPHYS, V34, P61, DOI 10.1017/S0033583501003675; Willmann MR, 2002, TRENDS PLANT SCI, V7, P8, DOI 10.1016/S1360-1385(01)02218-X; Woolcott OO, 2006, CELL CALCIUM, V39, P529, DOI 10.1016/j.ceca.2006.02.003; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200; Zhan X, 2008, EUR BIOPHYS J BIOPHY, V37, P773, DOI 10.1007/s00249-008-0269-0; Zhang YA, 2007, AM J PHYSIOL-HEART C, V293, pH2448, DOI 10.1152/ajpheart.00032.2007	66	14	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5186	5194		10.1074/jbc.M805587200	http://dx.doi.org/10.1074/jbc.M805587200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19116207	Green Published, hybrid			2022-12-25	WOS:000263416600049
J	Stowell, SR; Cho, MJ; Feasley, CL; Arthur, CM; Song, XZ; Colucci, JK; Karmakar, S; Mehta, P; Dias-Baruffi, M; McEver, RP; Cummings, RD				Stowell, Sean R.; Cho, Moonjae; Feasley, Christa L.; Arthur, Connie M.; Song, Xuezheng; Colucci, Jennifer K.; Karmakar, Sougata; Mehta, Padmaja; Dias-Baruffi, Marcelo; McEver, Rodger P.; Cummings, Richard D.			Ligand Reduces Galectin-1 Sensitivity to Oxidative Inactivation by Enhancing Dimer Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GALACTOSIDE-BINDING LECTIN; PROMOTES AXONAL REGENERATION; HAMSTER OVARY CELLS; T-CELLS; PHOSPHATIDYLSERINE EXTERNALIZATION; ELECTROPHORUS-ELECTRICUS; OXIDIZED GALECTIN-1; SECONDARY STRUCTURE; SURFACE EXPOSURE; GLYCAN ARRAY	Galectin-1 (Gal-1) regulates leukocyte turnover by inducing the cell surface exposure of phosphatidylserine (PS), a ligand that targets cells for phagocytic removal, in the absence of apoptosis. Gal-1 monomer- dimer equilibrium appears to modulate Gal-1-induced PS exposure, although the mechanism underlying this regulation remains unclear. Here we show that monomer- dimer equilibrium regulates Gal-1 sensitivity to oxidation. A mutant form of Gal-1, containing C2S and V5D mutations (mGal-1), exhibits impaired dimerization and fails to induce cell surface PS exposure while retaining the ability to recognize carbohydrates and signal Ca2+ flux in leukocytes. mGal-1 also displayed enhanced sensitivity to oxidation, whereas ligand, which partially protected Gal-1 from oxidation, enhanced Gal-1 dimerization. Continual incubation of leukocytes with Gal-1 resulted in gradual oxidative inactivation with concomitant loss of cell surface PS, whereas rapid oxidation prevented mGal-1 from inducing PS exposure. Stabilization of Gal-1 or mGal-1 with iodoacetamide fully protected Gal-1 and mGal-1 from oxidation. Alkylation-induced stabilization allowed Gal-1 to signal sustained PS exposure in leukocytes and mGal-1 to signal both Ca2+ flux and PS exposure. Taken together, these results demonstrate that monomer-dimer equilibrium regulates Gal-1 sensitivity to oxidative inactivation and provides a mechanism whereby ligand partially protects Gal-1 from oxidation.	[Stowell, Sean R.; Arthur, Connie M.; Song, Xuezheng; Colucci, Jennifer K.; Cummings, Richard D.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Cho, Moonjae] Cheju Natl Univ, Sch Med, Cheju 690756, South Korea; [Feasley, Christa L.; McEver, Rodger P.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem, Norman, OK 73019 USA; [Feasley, Christa L.; McEver, Rodger P.] Oklahoma Med Res Fdn, Oklahoma Ctr Med Glycobiol, Oklahoma City, OK 73104 USA; [Karmakar, Sougata; Mehta, Padmaja; McEver, Rodger P.] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; [Dias-Baruffi, Marcelo] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Anal Clin Toxicol & Bromatol, BR-14049 Ribeirao Preto, SP, Brazil	Emory University; Jeju National University; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma - Norman; Oklahoma Medical Research Foundation; Oklahoma Medical Research Foundation; Universidade de Sao Paulo	Cummings, RD (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.	rdcummi@emory.edu	Baruffi, Marcelo D/I-7199-2015	Baruffi, Marcelo D/0000-0002-2039-1884	National Institutes of Health [HL085607]; NIGMS [GM62116]; Consortium for Functional Glycomics (CoreDand Core H); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL054502, P01HL085607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169, U54GM062116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Consortium for Functional Glycomics (CoreDand Core H); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant HL085607 and NIGMS Grant GM62116. This work was also supported by the Consortium for Functional Glycomics (CoreDand Core H). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Andre S, 2005, INT J CANCER, V114, P46, DOI 10.1002/ijc.20699; BARONDES SH, 1984, SCIENCE, V223, P1259, DOI 10.1126/science.6367039; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Bochner BS, 2005, J BIOL CHEM, V280, P4307, DOI 10.1074/jbc.M412378200; BOURNE Y, 1994, NAT STRUCT BIOL, V1, P863, DOI 10.1038/nsb1294-863; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; Carden DL, 1996, AM J PHYSIOL-HEART C, V271, pH1947, DOI 10.1152/ajpheart.1996.271.5.H1947; Carlow DA, 2003, J IMMUNOL, V171, P5100, DOI 10.4049/jimmunol.171.10.5100; Cerri DG, 2008, GLYCOBIOLOGY, V18, P842, DOI 10.1093/glycob/cwn079; CHO MJ, 1995, J BIOL CHEM, V270, P5198, DOI 10.1074/jbc.270.10.5198; CHO MJ, 1995, J BIOL CHEM, V270, P5207, DOI 10.1074/jbc.270.10.5207; CLERCH LB, 1988, BIOCHEMISTRY-US, V27, P692, DOI 10.1021/bi00402a030; Cleves AE, 1996, J CELL BIOL, V133, P1017, DOI 10.1083/jcb.133.5.1017; COOPER DNW, 1990, J CELL BIOL, V110, P1681, DOI 10.1083/jcb.110.5.1681; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Dias-Baruffi M, 2003, J BIOL CHEM, V278, P41282, DOI 10.1074/jbc.M306624200; GALTON MM, 1965, APPL MICROBIOL, V13, P81, DOI 10.1128/AEM.13.1.81-85.1965; GIBBONS RJ, 1969, J BACTERIOL, V98, P341, DOI 10.1128/JB.98.2.341-346.1969; GIUDICELLI V, 1997, GLYCOBIOLOGY, V7, pR7; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; He LZ, 2003, BIOPHYS J, V85, P511, DOI 10.1016/S0006-3495(03)74496-8; HIRABAYASHI J, 1991, J BIOL CHEM, V266, P23648; Horie H, 2005, CURR DRUG TARGETS, V6, P385, DOI 10.2174/1389450054021954; Iglesias MM, 2003, BBA-PROTEINS PROTEOM, V1648, P164, DOI 10.1016/S1570-9639(03)00119-5; Inagaki Y, 2000, EUR J BIOCHEM, V267, P2955, DOI 10.1046/j.1432-1033.2000.01311.x; Jaffe EK, 2005, TRENDS BIOCHEM SCI, V30, P490, DOI 10.1016/j.tibs.2005.07.003; KAKIMOTO K, 1995, CELL IMMUNOL, V165, P26, DOI 10.1006/cimm.1995.1183; Kaltner H, 2002, CELL TISSUE RES, V307, P35, DOI 10.1007/s004410100457; Karmakar S, 2005, J BIOL CHEM, V280, P28623, DOI 10.1074/jbc.M414140200; Kopcow HD, 2008, P NATL ACAD SCI USA, V105, P18472, DOI 10.1073/pnas.0809233105; La M, 2003, AM J PATHOL, V163, P1505, DOI 10.1016/S0002-9440(10)63507-9; LEVI G, 1981, J BIOL CHEM, V256, P5735; LIAO DI, 1994, P NATL ACAD SCI USA, V91, P1428, DOI 10.1073/pnas.91.4.1428; Lopez-Lucendo MF, 2004, J MOL BIOL, V343, P957, DOI 10.1016/j.jmb.2004.08.078; Miura T, 2004, CELL DEATH DIFFER, V11, P1076, DOI 10.1038/sj.cdd.4401462; Nam HJ, 2006, J BIOL CHEM, V281, P25670, DOI 10.1074/jbc.M604421200; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; Pace KE, 2003, METHOD ENZYMOL, V363, P499; Pande AH, 2003, PROTEIN PEPTIDE LETT, V10, P265, DOI 10.2174/0929866033478960; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; POWELL JT, 1988, BIOCHEM J, V252, P447, DOI 10.1042/bj2520447; POWELL JT, 1984, BIOCHEM J, V223, P769, DOI 10.1042/bj2230769; Shahwan M, 2004, BIOCHEMISTRY-MOSCOW+, V69, P506, DOI 10.1023/B:BIRY.0000029848.01019.de; Simon HU, 2003, IMMUNOL REV, V193, P101, DOI 10.1034/j.1600-065X.2003.00038.x; Smrz D, 2008, J BIOL CHEM, V283, P10904, DOI 10.1074/jbc.M710386200; Smrz D, 2007, J BIOL CHEM, V282, P10487, DOI 10.1074/jbc.M611090200; Stowell SR, 2008, J BIOL CHEM, V283, P20547, DOI 10.1074/jbc.M802495200; Stowell SR, 2008, J IMMUNOL, V180, P3091, DOI 10.4049/jimmunol.180.5.3091; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Stowell SR, 2007, BLOOD, V109, P219, DOI 10.1182/blood-2006-03-007153; Stowell SR, 2004, GLYCOBIOLOGY, V14, P157, DOI 10.1093/glycob/cwh018; Tartier L, 2000, CELL DEATH DIFFER, V7, P1002, DOI 10.1038/sj.cdd.4400726; Teichberg V I, 1978, Methods Enzymol, V50, P291; TEICHBERG VI, 1975, P NATL ACAD SCI USA, V72, P1383, DOI 10.1073/pnas.72.4.1383; Than NG, 2008, P NATL ACAD SCI USA, V105, P15819, DOI 10.1073/pnas.0807606105; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; TRACEY BM, 1992, J BIOL CHEM, V267, P10342; van den Brule F, 2003, LAB INVEST, V83, P377, DOI 10.1097/01.LAB.0000059949.01480.40; van Liempt E, 2006, FEBS LETT, V580, P6123, DOI 10.1016/j.febslet.2006.10.009; Wasano K, 1997, J HISTOCHEM CYTOCHEM, V45, P275, DOI 10.1177/002215549704500212; WHITNEY PL, 1986, BIOCHEM J, V238, P683, DOI 10.1042/bj2380683	61	63	65	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4989	4999		10.1074/jbc.M808925200	http://dx.doi.org/10.1074/jbc.M808925200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19103599	Green Published, hybrid			2022-12-25	WOS:000263416600029
J	Suzuki, N; Tsumoto, K; Hajicek, N; Daigo, K; Tokita, R; Minami, S; Kodama, T; Hamakubo, T; Kozasa, T				Suzuki, Nobuchika; Tsumoto, Kouhei; Hajicek, Nicole; Daigo, Kenji; Tokita, Reiko; Minami, Shiro; Kodama, Tatsuhiko; Hamakubo, Takao; Kozasa, Tohru			Activation of Leukemia-associated RhoGEF by G alpha(13) with Significant Conformational Rearrangements in the Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; HETEROTRIMERIC G-PROTEINS; ISOTHERMAL TITRATION CALORIMETRY; P115 RHOGEF; STRUCTURAL DETERMINANTS; GTPASE; P115RHOGEF; RGS; IDENTIFICATION; MECHANISMS	The transient protein-protein interactions induced by guanine nucleotide-dependent conformational changes of G proteins play central roles in G protein-coupled receptor-mediated signaling systems. Leukemia-associated RhoGEF (LARG), a guanine nucleotide exchange factor for Rho, contains an RGS homology (RH) domain and Dbl homology/pleckstrin homology (DH/PH) domains and acts both as a GTPase-activating protein (GAP) and an effector for G alpha(13). However, the molecular mechanism of LARG activation upon G alpha(13) binding is not yet well understood. In this study, we analyzed the G alpha(13)-LARG interaction using cellular and biochemical methods, including a surface plasmon resonance (SPR) analysis. The results obtained using various LARG fragments demonstrated that active G alpha(13) interacts with LARG through the RH domain, DH/PH domains, and C-terminal region. However, an alanine substitution at the RH domain contact position in G alpha(13) resulted in a large decrease in affinity. Thermodynamic analysis revealed that binding of G alpha(13) proceeds with a large negative heat capacity change (Delta Cp degrees), accompanied by a positive entropy change (Delta S degrees). These results likely indicate that the binding of G alpha(13) with the RH domain triggers conformational rearrangements between G alpha(13) and LARG burying an exposed hydrophobic surface to create a large complementary interface, which facilitates complex formation through both GAP and effector interfaces, and activates the RhoGEF. We propose that LARG activation	[Suzuki, Nobuchika; Daigo, Kenji; Kodama, Tatsuhiko; Hamakubo, Takao; Kozasa, Tohru] Univ Tokyo, Adv Sci & Technol Res Ctr, Lab Syst Biol & Med, Tokyo 1538904, Japan; [Suzuki, Nobuchika; Tokita, Reiko; Minami, Shiro] Univ Tokyo, Dept Bioregulat, Nippon Med Sch, Tokyo 2778562, Japan; [Tsumoto, Kouhei] Univ Tokyo, Dept Med Genome Sci, Grad Sch Frontier Sci, Tokyo 2778562, Japan; [Hajicek, Nicole; Kozasa, Tohru] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA	University of Tokyo; Nippon Medical School; University of Tokyo; University of Tokyo; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Kozasa, T (corresponding author), 835 S Wolcott Ave, Chicago, IL 60612 USA.	tkozas@uic.edu	Daigo, Kenji/S-8915-2016	Daigo, Kenji/0000-0001-6398-3356	National Institutes of Health [GM61454]; American Heart Association; Ministry of Education, Culture, Sports, Science and Technology of Japan; National Institute of Biomedical Innovation in Japan; New Energy and Industrial Technology Development Organization in Japan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061454] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation in Japan(National Institute of Biomedical Innovation); New Energy and Industrial Technology Development Organization in Japan(New Energy and Industrial Technology Development Organization (NEDO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM61454 (to T. K.). This work was also supported by the American Heart Association (to T. K.), by Translational Systems Biology and Medicine Initiative from the Ministry of Education, Culture, Sports, Science and Technology of Japan, by the Program of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation in Japan, and by the NFAT project of the New Energy and Industrial Technology Development Organization in Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ARAGAY AM, 1995, J BIOL CHEM, V270, P20073, DOI 10.1074/jbc.270.34.20073; BERSTEIN G, 1992, CELL, V70, P411, DOI 10.1016/0092-8674(92)90165-9; Bhattacharyya R, 2003, BIOCHEM J, V371, P709, DOI 10.1042/BJ20021897; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; Chen Z, 2005, NAT STRUCT MOL BIOL, V12, P191, DOI 10.1038/nsmb888; Chikumi H, 2004, ONCOGENE, V23, P233, DOI 10.1038/sj.onc.1207012; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Eisenhaure TM, 2003, J BIOL CHEM, V278, P30975, DOI 10.1074/jbc.M303277200; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Ghosh M, 2003, J BIOL CHEM, V278, P34747, DOI 10.1074/jbc.C300271200; Grabocka E, 2007, MOL PHARMACOL, V72, P993, DOI 10.1124/mol.107.035162; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; He W, 1998, NEURON, V20, P95, DOI 10.1016/S0896-6273(00)80437-7; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; Horn JR, 2001, BIOCHEMISTRY-US, V40, P1774, DOI 10.1021/bi002408e; Johnston CA, 2005, STRUCTURE, V13, P1069, DOI 10.1016/j.str.2005.04.007; Kelly P, 2006, P NATL ACAD SCI USA, V103, P8173, DOI 10.1073/pnas.0510254103; Kourlas PJ, 2000, P NATL ACAD SCI USA, V97, P2145, DOI 10.1073/pnas.040569197; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Kreutz B, 2006, BIOCHEMISTRY-US, V45, P167, DOI 10.1021/bi051729t; Kreutz B, 2007, CELL SIGNAL, V19, P1681, DOI 10.1016/j.cellsig.2007.03.004; Kristelly R, 2004, J BIOL CHEM, V279, P47352, DOI 10.1074/jbc.M406056200; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; Lutz S, 2007, SCIENCE, V318, P1923, DOI 10.1126/science.1147554; McEntaffer RL, 1999, BIOCHEMISTRY-US, V38, P4931, DOI 10.1021/bi982636x; MURPHY KP, 1992, J MOL BIOL, V227, P293, DOI 10.1016/0022-2836(92)90699-K; Nakamura S, 2004, MOL PHARMACOL, V66, P1029, DOI 10.1124/mol.104.002287; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Roos H, 1998, J MOL RECOGNIT, V11, P204, DOI 10.1002/(SICI)1099-1352(199812)11:1/6<204::AID-JMR424>3.0.CO;2-T; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; ROSS EM, 1989, NEURON, V3, P141, DOI 10.1016/0896-6273(89)90027-5; Scott JK, 2001, EMBO J, V20, P767, DOI 10.1093/emboj/20.4.767; SINGER WD, 1994, J BIOL CHEM, V269, P19796; Skiba NP, 2000, J BIOL CHEM, V275, P32716, DOI 10.1074/jbc.C000413200; Skiba NP, 1999, J BIOL CHEM, V274, P8770, DOI 10.1074/jbc.274.13.8770; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; Sowa ME, 2000, P NATL ACAD SCI USA, V97, P1483, DOI 10.1073/pnas.030409597; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Suzuki N, 2003, P NATL ACAD SCI USA, V100, P733, DOI 10.1073/pnas.0234057100; Tanabe S, 2004, METHOD ENZYMOL, V390, P285; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Wear MA, 2006, ANAL BIOCHEM, V359, P285, DOI 10.1016/j.ab.2006.08.038; Wells CD, 2002, J BIOL CHEM, V277, P1174, DOI 10.1074/jbc.M105274200; Wells CD, 2001, J BIOL CHEM, V276, P28897, DOI 10.1074/jbc.M102913200; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Zerangue N, 1998, CURR BIOL, V8, pR313, DOI 10.1016/S0960-9822(98)70196-4	47	21	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5000	5009		10.1074/jbc.M804073200	http://dx.doi.org/10.1074/jbc.M804073200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19074425	Green Published, hybrid			2022-12-25	WOS:000263416600030
J	Kayed, R; Pensalfini, A; Margol, L; Sokolov, Y; Sarsoza, F; Head, E; Hall, J; Glabe, C				Kayed, Rakez; Pensalfini, Anna; Margol, Larry; Sokolov, Yuri; Sarsoza, Floyd; Head, Elizabeth; Hall, James; Glabe, Charles			Annular Protofibrils Are a Structurally and Functionally Distinct Type of Amyloid Oligomer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-BETA; ALPHA-SYNUCLEIN; NEURODEGENERATIVE DISEASE; PROTEIN AGGREGATION; ALZHEIMER-DISEASE; COMMON MECHANISM; IN-VITRO; PEPTIDE; TOXICITY; FIBRILS	Amyloid oligomers are believed to play causal roles in several types of amyloid-related neurodegenerative diseases. Several different types of amyloid oligomers have been reported that differ in morphology, size, or toxicity, raising the question of the pathological significance and structural relationships between different amyloid oligomers. Annular protofibrils (APFs) have been described in oligomer preparations of many different amyloidogenic proteins and peptides as ring-shaped or pore-like structures. They are interesting because their pore-like morphology is consistent with numerous reports of membrane-permeabilizing activity of amyloid oligomers. Here we report the preparation of relatively homogeneous preparations of APFs and an antiserum selective for APFs (alpha APF) compared with pre-fibrillar oligomers (PFOs) and fibrils. PFOs appear to be precursors for APF formation, which form in high yield after exposure to a hydrophobic-hydrophilic interface. Surprisingly, preformed APFs do not permeabilize lipid bilayers, unlike the precursor PFOs. APFs display a conformation-dependent, generic epitope that is distinct from that of PFOs and amyloid fibrils. Incubation of PFOs with phospholipids vesicles results in a loss of PFO immunoreactivity with a corresponding increase in alpha APF immunoreactivity, suggesting that lipid vesicles catalyze the conversion of PFOs into APFs. The annular anti-protofibril antibody also recognizes heptameric alpha-hemolysin pores, but not monomers, suggesting that the antibody recognizes an epitope that is specific for a beta barrel structural motif.	[Kayed, Rakez; Pensalfini, Anna; Margol, Larry; Glabe, Charles] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Sarsoza, Floyd; Head, Elizabeth] Univ Calif Irvine, Inst Brain Aging & Dementia, Irvine, CA 92697 USA; [Sarsoza, Floyd; Head, Elizabeth] Univ Calif Irvine, Dept Neurol, Irvine, CA 92697 USA; [Sokolov, Yuri; Hall, James] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Kayed, R (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.	cglabe@uci.edu	Pensalfini, Anna/X-5563-2019		National Institutes of Health [NS31230, AG16573, AG00538]; Cure Alzheimer Fund; Larry L. Hillblom Foundation; NATIONAL INSTITUTE ON AGING [P50AG016573, P01AG000538] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Alzheimer Fund; Larry L. Hillblom Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS31230, AG16573, and AG00538. This work was also supported by the Cure Alzheimer Fund and The Larry L. Hillblom Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anguiano M, 2002, BIOCHEMISTRY-US, V41, P11338, DOI 10.1021/bi020314u; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567; Baglioni S, 2006, J NEUROSCI, V26, P8160, DOI 10.1523/JNEUROSCI.4809-05.2006; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; BURDICK D, 1992, J BIOL CHEM, V267, P546; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Ding TT, 2002, BIOCHEMISTRY-US, V41, P10209, DOI 10.1021/bi020139h; Dobson CM, 2006, PROTEIN PEPTIDE LETT, V13, P219, DOI 10.2174/092986606775338362; FUSSLE R, 1981, J CELL BIOL, V91, P83, DOI 10.1083/jcb.91.1.83; GarzonRodriguez W, 1997, J BIOL CHEM, V272, P21037, DOI 10.1074/jbc.272.34.21037; Glabe CG, 2006, NEUROLOGY, V66, pS74, DOI 10.1212/01.wnl.0000192103.24796.42; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hadders MA, 2007, SCIENCE, V317, P1552, DOI 10.1126/science.1147103; Hafner JH, 2001, PROG BIOPHYS MOL BIO, V77, P73, DOI 10.1016/S0079-6107(01)00011-6; Hardy J, 2005, BIOCHEM SOC T, V33, P578, DOI 10.1042/BST0330578; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; HILBICH C, 1991, J MOL BIOL, V218, P149, DOI 10.1016/0022-2836(91)90881-6; Hrncic R, 2000, AM J PATHOL, V157, P1239, DOI 10.1016/S0002-9440(10)64639-1; Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491; Kagan BL, 2004, J MEMBRANE BIOL, V202, P1, DOI 10.1007/s00232-004-0709-4; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kayed R, 2006, METHOD ENZYMOL, V413, P326, DOI 10.1016/S0076-6879(06)13017-7; Lal R, 2007, BBA-BIOMEMBRANES, V1768, P1966, DOI 10.1016/j.bbamem.2007.04.021; Lashuel HA, 2003, J MOL BIOL, V332, P795, DOI 10.1016/S0022-2836(03)00927-6; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lashuel HA, 2006, Q REV BIOPHYS, V39, P167, DOI 10.1017/S0033583506004422; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Martins IC, 2008, EMBO J, V27, P224, DOI 10.1038/sj.emboj.7601953; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Montoya M, 2003, BBA-BIOMEMBRANES, V1609, P19, DOI 10.1016/S0005-2736(02)00663-6; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Rosado CJ, 2007, SCIENCE, V317, P1548, DOI 10.1126/science.1144706; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Shtilerman MD, 2002, BIOCHEMISTRY-US, V41, P3855, DOI 10.1021/bi0120906; Sokolov Yuri, 2006, J Gen Physiol, V128, P637, DOI 10.1085/jgp.200609533; SOREGHAN B, 1994, J BIOL CHEM, V269, P28551; Terry RD, 1996, J NEUROPATH EXP NEUR, V55, P1023, DOI 10.1097/00005072-199655100-00001; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Yoshiike Y, 2007, NEUROMOL MED, V9, P270, DOI 10.1007/s12017-007-0003-6	45	249	257	1	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4230	4237		10.1074/jbc.M808591200	http://dx.doi.org/10.1074/jbc.M808591200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19098006	Green Published, hybrid			2022-12-25	WOS:000263134400020
J	Kenneth, NS; Mudie, S; van Uden, P; Rocha, S				Kenneth, Niall S.; Mudie, Sharon; van Uden, Patrick; Rocha, Sonia			SWI/SNF Regulates the Cellular Response to Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CHROMATIN-REMODELING COMPLEX; ARF TUMOR-SUPPRESSOR; GENE-EXPRESSION; INDUCIBLE FACTOR-1-ALPHA; PROTEASOMAL DEGRADATION; VASCULAR DEVELOPMENT; HIF-1-ALPHA; SUBUNIT; IDENTIFICATION	Hypoxia induces a variety of cellular responses such as cell cycle arrest, apoptosis, and autophagy. Most of these responses are mediated by the hypoxia-inducible factor-1 alpha. To induce target genes, hypoxia-inducible factor-1 alpha requires a chromatin environment conducive to allow binding to specific sequences. Here, we have studied the role of the chromatin-remodeling complex SWI/SNF in the cellular response to hypoxia. We find that SWI/SNF is required for several of the cellular responses induced by hypoxia. Surprisingly, hypoxia-inducible factor-1 alpha is a direct target of the SWI/SNF chromatin-remodeling complex. SWI/SNF components are found associated with the hypoxia-inducible factor-1 alpha promoter and modulation of SWI/SNF levels results in pronounced changes in hypoxia-inducible factor-1 alpha expression and its ability to transactivate target genes. Furthermore, impairment of SWI/SNF function renders cells resistant to hypoxia-induced cell cycle arrest. These results reveal a previously uncharacterized dependence of hypoxia signaling on the SWI/SNF complex and demonstrate a new level of control over the hypoxia-inducible factor-1 alpha system.	[Kenneth, Niall S.; Mudie, Sharon; van Uden, Patrick; Rocha, Sonia] Univ Dundee, Coll Life Sci, Wellcome Trust Ctr Gene Regulat & Express, Dundee DD1 5EH, Scotland	University of Dundee	Rocha, S (corresponding author), Univ Dundee, Coll Life Sci, Wellcome Trust Ctr Gene Regulat & Express, MSI-WTB-JBC Complex, Dundee DD1 5EH, Scotland.	s.rocha@dundee.ac.uk		KENNETH, NIALL/0000-0001-8528-1021; Rocha, Sonia/0000-0002-2413-4981	Royal Society research; MRC [G0601098] Funding Source: UKRI; Medical Research Council [G0601098] Funding Source: researchfish	Royal Society research(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Royal Society research grant and a Tenovus Scotland small grant. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abbott BD, 2000, DEV DYNAM, V219, P526, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1080>3.0.CO;2-N; Bardos JI, 2005, BBA-REV CANCER, V1755, P107, DOI 10.1016/j.bbcan.2005.05.001; Bardos JI, 2004, MOL CELL BIOL, V24, P2905, DOI 10.1128/MCB.24.7.2905-2914.2004; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bruegge K, 2007, CURR MED CHEM, V14, P1853; Chau NM, 2005, CANCER RES, V65, P4918, DOI 10.1158/0008-5472.CAN-04-4453; Chen JG, 2005, MOL CELL BIOL, V25, P9016, DOI 10.1128/MCB.25.20.9016-9027.2005; Chi TH, 2002, NATURE, V418, P195, DOI 10.1038/nature00876; Fandrey J, 2006, CARDIOVASC RES, V71, P642, DOI 10.1016/j.cardiores.2006.05.005; Garcia-Pedrero JM, 2006, J BIOL CHEM, V281, P22656, DOI 10.1074/jbc.M602561200; Gardner LB, 2001, J BIOL CHEM, V276, P7919, DOI 10.1074/jbc.M010189200; Gorlach Agnes, 2008, Biochem J, V412, pe17, DOI 10.1042/BJ20080920; Greijer AE, 2004, J CLIN PATHOL, V57, P1009, DOI 10.1136/jcp.2003.015032; Griffin CT, 2008, DEVELOPMENT, V135, P493, DOI 10.1242/dev.010090; Hakimi MA, 2002, NATURE, V418, P994, DOI 10.1038/nature01024; Han D, 2008, DEV BIOL, V315, P136, DOI 10.1016/j.ydbio.2007.12.024; Hassan AH, 2002, CELL, V111, P369, DOI 10.1016/S0092-8674(02)01005-X; Hassan AH, 2007, BIOCHEM J, V402, P125, DOI 10.1042/BJ20060907; Heeboll S, 2008, HISTOL HISTOPATHOL, V23, P1069, DOI 10.14670/HH-23.1069; Heimeier RA, 2008, MOL ENDOCRINOL, V22, P1065, DOI 10.1210/me.2007-0492; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jin JJ, 2005, TRENDS BIOCHEM SCI, V30, P680, DOI 10.1016/j.tibs.2005.10.003; Kenneth NS, 2008, BIOCHEM J, V414, P19, DOI 10.1042/BJ20081055; Koshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Link KA, 2005, MOL CELL BIOL, V25, P2200, DOI 10.1128/MCB.25.6.2200-2215.2005; Metzen E, 2005, BIOCHEM J, V387, P711, DOI 10.1042/BJ20041736; Mohrmann L, 2005, BBA-GENE STRUCT EXPR, V1681, P59, DOI 10.1016/j.bbaexp.2004.10.005; PAPANDREOU I, 2008, CELL DEATH DIFFER, V28, P7212; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Rocha S, 2003, MOL CELL, V12, P15, DOI 10.1016/S1097-2765(03)00223-5; Rocha S, 2005, EMBO J, V24, P1157, DOI 10.1038/sj.emboj.7600608; Rocha S, 2007, TRENDS BIOCHEM SCI, V32, P389, DOI 10.1016/j.tibs.2007.06.005; Roche KC, 2004, ONCOGENE, V23, P8185, DOI 10.1038/sj.onc.1208025; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Schumm K, 2006, EMBO J, V25, P4820, DOI 10.1038/sj.emboj.7601343; Shadeo A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-64; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Simone C, 2006, J CELL PHYSIOL, V207, P309, DOI 10.1002/jcp.20514; Singh M, 2007, CHEMBIOCHEM, V8, P1308, DOI 10.1002/cbic.200600562; Sohn DH, 2007, J BIOL CHEM, V282, P10614, DOI 10.1074/jbc.M610563200; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Varga-Weisz PD, 2006, CURR OPIN GENET DEV, V16, P151, DOI 10.1016/j.gde.2006.02.006; Wang F, 2004, J BIOL CHEM, V279, P46733, DOI 10.1074/jbc.M409002200; Yan ZJ, 2005, GENE DEV, V19, P1662, DOI 10.1101/gad.1323805; Yu L, 2008, AUTOPHAGY, V4, P567, DOI 10.4161/auto.5902; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200	48	84	87	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4123	4131		10.1074/jbc.M808491200	http://dx.doi.org/10.1074/jbc.M808491200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19097995	hybrid			2022-12-25	WOS:000263134400009
J	Pautz, A; Linker, K; Altenhofer, S; Heil, S; Schmidt, N; Art, J; Knauer, S; Stauber, R; Sadri, N; Pont, A; Schneider, RJ; Kleinert, H				Pautz, Andrea; Linker, Katrin; Altenhoefer, Sebastian; Heil, Sebastian; Schmidt, Nadine; Art, Julia; Knauer, Shirley; Stauber, Roland; Sadri, Navid; Pont, Adam; Schneider, Robert J.; Kleinert, Hartmut			Similar Regulation of Human Inducible Nitric-oxide Synthase Expression by Different Isoforms of the RNA-binding Protein AUF1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN INOS-EXPRESSION; ALPHA MESSENGER-RNA; GENE-EXPRESSION; RICH ELEMENT; 3'-UNTRANSLATED REGION; POSTTRANSCRIPTIONAL REGULATION; HUR; STABILITY; TURNOVER; DISEASE	The ARE/poly-(U) binding factor 1 (AUF1), a protein family consisting of four isoforms, is believed to mediate mRNA degradation by binding to AU-rich elements (ARE). However, evidence exists that individual AUF1 isoforms may stabilize ARE-containing mRNAs. The 3'-untranslated region of the human inducible nitric-oxide synthase (iNOS) contains five AREs, which promote RNA degradation. We have recently shown that the RNA-binding protein KSRP is critically involved in the decay of the iNOS mRNA. In this study we examined the effects of the individual AUF1 isoforms on iNOS expression. Overexpression of each AUF1 isoform reduces iNOS expression on mRNA and protein levels to the same extent by modulation of mRNA stability. Accordingly, knockdown of all or individual AUF1 isoforms by an RNA interference approach enhances iNOS expression. The AUF1 effect on iNOS expression is dependent on the iNOS 3'-untranslated region sequence, as demonstrated in transfection experiments with a reporter mRNA. Binding studies showed that all AUF1 isoforms interact with the same AU-rich region in the iNOS-3'-untranslated region. Cytokine stimulation altered intracellular AUF1 binding activities. These data demonstrate that AUF1 is an important factor that promotes iNOS mRNA degradation. Furthermore, all individual AUF1 isoforms act in a similar manner.	[Pautz, Andrea; Linker, Katrin; Altenhoefer, Sebastian; Heil, Sebastian; Schmidt, Nadine; Art, Julia; Kleinert, Hartmut] Johannes Gutenberg Univ Mainz, Dept Pharmacol, D-55101 Mainz, Germany; [Knauer, Shirley; Stauber, Roland] Univ Hosp Mainz, D-55101 Mainz, Germany; [Sadri, Navid; Pont, Adam; Schneider, Robert J.] NYU, Sch Med, Dept Microbiol, New York, NY 10003 USA	Johannes Gutenberg University of Mainz; University Hospital Mainz; New York University	Kleinert, H (corresponding author), Johannes Gutenberg Univ Mainz, Dept Pharmacol, Obere Zahlbacher Str 67, D-55101 Mainz, Germany.	kleinert@mail.uni-mainz.de	Knauer, Shirley K/E-7931-2012; Kleinert, Hartmut/M-2988-2018	Knauer, Shirley K/0000-0003-4321-0924; Kleinert, Hartmut/0000-0003-2202-3548; sadri, navid/0000-0001-5051-717X; Stauber, Roland/0000-0002-1341-4523; Schneider, Robert/0000-0001-5807-5564	Innovation Foundation of the State of Rhineland-Palatinate [8312-386261/322a]; Collaborative Research Center [SFB 553]; Deutsche Forschungsgemeinschaft [LI 1759/1-1]	Innovation Foundation of the State of Rhineland-Palatinate; Collaborative Research Center; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Grant 8312-386261/322a and -b from the Innovation Foundation of the State of Rhineland-Palatinate, by the Collaborative Research Center SFB 553 (Project A7 (to H. K.), and by the Deutsche Forschungsgemeinschaft Grant LI 1759/1-1. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Benjamin D, 2007, EXPERT OPIN BIOL TH, V7, P1515, DOI 10.1517/14712598.7.10.1515; Bogdan C, 2001, TRENDS CELL BIOL, V11, P66, DOI 10.1016/S0962-8924(00)01900-0; Bros M, 2006, GENOMICS, V87, P463, DOI 10.1016/j.ygeno.2005.11.013; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; Dember LM, 1996, J BIOL CHEM, V271, P2783, DOI 10.1074/jbc.271.5.2783; Dobi A, 2006, J BIOL CHEM, V281, P28889, DOI 10.1074/jbc.M511858200; Doller A, 2008, CELL SIGNAL, V20, P2165, DOI 10.1016/j.cellsig.2008.05.007; Eberhardt W, 2007, PHARMACOL THERAPEUT, V114, P56, DOI 10.1016/j.pharmthera.2007.01.002; Espel E, 2005, SEMIN CELL DEV BIOL, V16, P59, DOI 10.1016/j.semcdb.2004.11.008; Fechir M, 2005, MOL PHARMACOL, V67, P2148, DOI 10.1124/mol.104.008763; Fechir M, 2003, N-S ARCH PHARMACOL, V367, pR41; Fuentes-Panana EM, 2000, J VIROL, V74, P8166, DOI 10.1128/JVI.74.17.8166-8175.2000; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; GOOD PJ, 1995, P NATL ACAD SCI USA, V92, P4557, DOI 10.1073/pnas.92.10.4557; Gueydan C, 1999, J BIOL CHEM, V274, P2322, DOI 10.1074/jbc.274.4.2322; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; HAMILTON BJ, 1993, J BIOL CHEM, V268, P8881; Hollams EM, 2002, NEUROCHEM RES, V27, P957, DOI 10.1023/A:1020992418511; Ing NH, 2008, J BIOL CHEM, V283, P1764, DOI 10.1074/jbc.M704745200; Jiao RQ, 2006, J CELL BIOCHEM, V98, P1257, DOI 10.1002/jcb.20843; Katsanou V, 2005, MOL CELL, V19, P777, DOI 10.1016/j.molcel.2005.08.007; Khabar KSA, 2005, J INTERF CYTOK RES, V25, P1, DOI 10.1089/jir.2005.25.1; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Lee C, 2008, CEREB CORTEX, V18, P2909, DOI 10.1093/cercor/bhn051; Lin SK, 2000, MOL CELL BIOL, V20, P7903, DOI 10.1128/MCB.20.21.7903-7913.2000; Linker K, 2005, NUCLEIC ACIDS RES, V33, P4813, DOI 10.1093/nar/gki797; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu JY, 2006, GENE DEV, V20, P3174, DOI 10.1101/gad.1467606; MAZANMAMCZARZ K, 2008, NUCL ACIDS IN PRESS; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Palanisamy V, 2008, J DENT RES, V87, P772, DOI 10.1177/154405910808700803; Pautz A, 2006, J BIOL CHEM, V281, P32294, DOI 10.1074/jbc.M603915200; Raineri I, 2004, NUCLEIC ACIDS RES, V32, P1279, DOI 10.1093/nar/gkh282; Rodriguez-Pascual F, 2000, J BIOL CHEM, V275, P26040, DOI 10.1074/jbc.M910460199; SADRI N, 2008, J INVESTIG IN PRESS; Sagliocco F, 2006, BIOCHEM J, V400, P337, DOI 10.1042/BJ20060328; Sarkar B, 2003, MOL CELL BIOL, V23, P6685, DOI 10.1128/MCB.23.18.6685-6693.2003; Sarkar S, 2008, J INTERF CYTOK RES, V28, P679, DOI 10.1089/jir.2008.0028; Seko Y, 2006, AUTOIMMUN REV, V5, P299, DOI 10.1016/j.autrev.2005.10.013; Sobue S, 2008, ONCOGENE, V27, P6023, DOI 10.1038/onc.2008.198; Soderberg M, 2007, MOL IMMUNOL, V44, P434, DOI 10.1016/j.molimm.2006.02.019; Stoecklin G, 2006, ADV IMMUNOL, V89, P1, DOI 10.1016/S0065-2776(05)89001-7; Torrisani J, 2007, MOL CELL BIOL, V27, P395, DOI 10.1128/MCB.01236-06; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Wagner BJ, 1998, GENOMICS, V48, P195, DOI 10.1006/geno.1997.5142; Wilson GM, 2003, J BIOL CHEM, V278, P33029, DOI 10.1074/jbc.M305772200; Wilson GM, 2003, J BIOL CHEM, V278, P33039, DOI 10.1074/jbc.M305775200; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Xu NH, 2001, MOL CELL BIOL, V21, P6960, DOI 10.1128/MCB.21.20.6960-6971.2001; ZHANG W, 1993, MOL CELL BIOL, V13, P7652, DOI 10.1128/MCB.13.12.7652	55	26	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2755	2766		10.1074/jbc.M809314200	http://dx.doi.org/10.1074/jbc.M809314200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19074427	hybrid			2022-12-25	WOS:000262700900018
J	Frobius, AC; Matus, DQ; Seaver, EC				Frobius, Andreas C.; Matus, David Q.; Seaver, Elaine C.			Genomic Organization and Expression Demonstrate Spatial and Temporal Hox Gene Colinearity in the Lophotrochozoan Capitella sp I	PLOS ONE			English	Article								Hox genes define regional identities along the anterior-posterior axis in many animals. In a number of species, Hox genes are clustered in the genome, and the relative order of genes corresponds with position of expression in the body. Previous Hox gene studies in lophotrochozoans have reported expression for only a subset of the Hox gene complement and/or lack detailed genomic organization information, limiting interpretations of spatial and temporal colinearity in this diverse animal clade. We studied expression and genomic organization of the single Hox gene complement in the segmented polychaete annelid Capitella sp. I. Total genome searches identified 11 Hox genes in Capitella, representing 11 distinct paralog groups thought to represent the ancestral lophotrochozoan complement. At least 8 of the 11 Capitella Hox genes are genomically linked in a single cluster, have the same transcriptional orientation, and lack interspersed non-Hox genes. Studying their expression by situ hybridization, we find that the 11 Capitella Hox genes generally exhibit spatial and temporal colinearity. With the exception of CapI-Post1, Capitella Hox genes are all expressed in broad ectodermal domains during larval development, consistent with providing positional information along the anterior-posterior axis. The anterior genes CapI-lab, CapI-pb, and CapI-Hox3 initiate expression prior to the appearance of segments, while more posterior genes appear at or soon after segments appear. Many of the Capitella Hox genes have either an anterior or posterior expression boundary coinciding with the thoracic-abdomen transition, a major body tagma boundary. Following metamorphosis, several expression patterns change, including appearance of distinct posterior boundaries and restriction to the central nervous system. Capitella Hox genes have maintained a clustered organization, are expressed in the canonical anterior-posterior order found in other metazoans, and exhibit spatial and temporal colinearity, reflecting Hox gene characteristics that likely existed in the protostome-deuterostome ancestor.	[Frobius, Andreas C.; Matus, David Q.; Seaver, Elaine C.] Univ Hawaii, Pacific Biosci Res Ctr, Kewalo Marine Lab, Honolulu, HI 96822 USA	University of Hawaii System	Frobius, AC (corresponding author), Univ Giessen, Inst Allgemeine & Spezielle Zool, Abt Entwicklungsbiol, Heinrich Buff Ring 29, D-6300 Giessen, Germany.	seaver@hawaii.edu	Matus, David/E-9972-2010	Matus, David/0000-0002-1570-5025	Robert Black Fellow of the Damon Runyon Cancer Research Foundation [DRG-1949-07]; National Science Foundation [IBN00-94925]	Robert Black Fellow of the Damon Runyon Cancer Research Foundation; National Science Foundation(National Science Foundation (NSF))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. David Q. Matus is a Robert Black Fellow of the Damon Runyon Cancer Research Foundation (DRG-1949-07). This work was supported by the National Science Foundation to E. C. S. (IBN00-94925).	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ACAMPORA D, 1989, NUCLEIC ACIDS RES, V17, P10385, DOI 10.1093/nar/17.24.10385; AISEMBERG GO, 1993, J NEUROBIOL, V24, P1423, DOI 10.1002/neu.480241012; AISEMBERG GO, 1994, DEV BIOL, V161, P455, DOI 10.1006/dbio.1994.1044; Aronowicz J, 2006, INTEGR COMP BIOL, V46, P890, DOI 10.1093/icb/icl045; AVEROF M, 1993, CURR BIOL, V3, P73, DOI 10.1016/0960-9822(93)90158-K; BALAVOINE G, 1995, P NATL ACAD SCI USA, V92, P7227, DOI 10.1073/pnas.92.16.7227; Balavoine G, 2002, MOL PHYLOGENET EVOL, V24, P366, DOI 10.1016/S1055-7903(02)00237-3; Bayascas Jose Ramon, 1996, International Journal of Developmental Biology, V40, p173S; Bayascas JR, 1998, DEV GENES EVOL, V208, P467, DOI 10.1007/s004270050204; Bayascas JR, 1997, DEVELOPMENT, V124, P141; BEEMAN RW, 1987, NATURE, V327, P247, DOI 10.1038/327247a0; BENDER W, 1983, SCIENCE, V221, P23, DOI 10.1126/science.221.4605.23; BHUP R, 1982, CAN J ZOOL, V60, P2284, DOI 10.1139/z82-295; Boyle MJ, 2008, EVOL DEV, V10, P89, DOI 10.1111/j.1525-142X.2007.00216.x; BREIER G, 1988, EMBO J, V7, P1329, DOI 10.1002/j.1460-2075.1988.tb02948.x; Brown SJ, 2002, GENETICS, V160, P1067; Callaerts P, 2002, P NATL ACAD SCI USA, V99, P2088, DOI 10.1073/pnas.042683899; Cameron RA, 2006, J EXP ZOOL PART B, V306B, P45, DOI 10.1002/jez.b.21070; CARROLL SB, 1995, NATURE, V376, P479, DOI 10.1038/376479a0; Cook CE, 2004, EVOL DEV, V6, P154, DOI 10.1111/j.1525-142X.2004.04020.x; Damen WGM, 1998, DEV GENES EVOL, V208, P586, DOI 10.1007/s004270050218; de Rosa R, 1999, NATURE, V399, P772, DOI 10.1038/21631; DUBOULE D, 1986, EMBO J, V5, P1973, DOI 10.1002/j.1460-2075.1986.tb04452.x; DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; EISIG H, 1899, MITTHEILUNGEN ZOOLOG, V13, P1; Ferrier DEK, 1996, P NATL ACAD SCI USA, V93, P13024, DOI 10.1073/pnas.93.23.13024; Ferrier DEK, 2000, EVOL DEV, V2, P284, DOI 10.1046/j.1525-142x.2000.00070.x; Ferrier DEK, 2001, NAT REV GENET, V2, P33, DOI 10.1038/35047605; Fischer A, 2004, BIOESSAYS, V26, P314, DOI 10.1002/bies.10409; Frobius AC, 2006, DEV GENES EVOL, V216, P81, DOI 10.1007/s00427-005-0049-0; GARCIAFERNANDEZ J, 1994, NATURE, V370, P563, DOI 10.1038/370563a0; GRAHAM A, 1988, GENE DEV, V2, P1424, DOI 10.1101/gad.2.11.1424; GRASSLE JP, 1976, SCIENCE, V192, P567, DOI 10.1126/science.1257794; Hinman VF, 2003, EVOL DEV, V5, P508, DOI 10.1046/j.1525-142X.2003.03056.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hughes CL, 2002, EVOL DEV, V4, P459, DOI 10.1046/j.1525-142X.2002.02034.x; Irvine SQ, 2000, DEV BIOL, V217, P333, DOI 10.1006/dbio.1999.9541; Irvine SQ, 2001, AM ZOOL, V41, P640, DOI 10.1668/0003-1569(2001)041[0640:CAOHGE]2.0.CO;2; Kaufman T C, 1990, Adv Genet, V27, P309; Kmita-Cunisse M, 1998, P NATL ACAD SCI USA, V95, P3030, DOI 10.1073/pnas.95.6.3030; Kourakis MJ, 1997, DEV BIOL, V190, P284, DOI 10.1006/dbio.1997.8689; Kourakis MJ, 2000, J EXP ZOOL, V288, P175, DOI 10.1002/1097-010X(20000815)288:2<175::AID-JEZ8>3.0.CO;2-N; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Kulakova M, 2007, DEV GENES EVOL, V217, P39, DOI 10.1007/s00427-006-0119-y; Lee PN, 2003, NATURE, V424, P1061, DOI 10.1038/nature01872; Martinez P, 1999, P NATL ACAD SCI USA, V96, P1469, DOI 10.1073/pnas.96.4.1469; Matus DQ, 2007, INTEGR COMP BIOL, V47, P854, DOI 10.1093/icb/icm077; Minguillon C, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r12; Pierce RJ, 2005, MOL BIOL EVOL, V22, P2491, DOI 10.1093/molbev/msi239; Prince VE, 1998, AM ZOOL, V38, P634; PULTZ MA, 1988, GENE DEV, V2, P901, DOI 10.1101/gad.2.7.901; Reish D.J., 1974, Thalassia Jugosl, V10, P181; Santini S, 2003, GENOME RES, V13, P1111, DOI 10.1101/gr.700503; Schubert M, 2005, DEVELOPMENT, V132, P61, DOI 10.1242/dev.01554; Schwager EE, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-10; Schweigkofler M, 1998, ZOOMORPHOLOGY, V118, P117, DOI 10.1007/s004350050062; Seaver EC, 2006, DEV BIOL, V289, P179, DOI 10.1016/j.ydbio.2005.10.025; Seaver EC, 2005, EVOL DEV, V7, P312, DOI 10.1111/j.1525-142X.2005.05037.x; Seo HC, 2004, NATURE, V431, P67, DOI 10.1038/nature02709; Sharkey M, 1997, TRENDS GENET, V13, P145, DOI 10.1016/S0168-9525(97)01096-2; Shippy TD, 2008, DEV GENES EVOL, V218, P127, DOI 10.1007/s00427-008-0213-4; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Telford MJ, 2000, CURR BIOL, V10, P349, DOI 10.1016/S0960-9822(00)00387-0; Thamm K, 2008, DEV BIOL, V320, P304, DOI 10.1016/j.ydbio.2008.04.015; Werbrock AH, 2001, DEV BIOL, V235, P476, DOI 10.1006/dbio.2001.0272; WONG VY, 1995, J NEUROSCI, V15, P5551; WYSOCKADILLER JW, 1989, NATURE, V341, P760, DOI 10.1038/341760a0	70	76	78	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2008	3	12							e4004	10.1371/journal.pone.0004004	http://dx.doi.org/10.1371/journal.pone.0004004			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CB	19104667	gold, Green Submitted, Green Published			2022-12-25	WOS:000265462400005
J	Zhang, WY; Chen, GY; Niewiadomska, AM; Xu, RZ; Yu, XF				Zhang, Wenyan; Chen, Gongying; Niewiadomska, Anna Maria; Xu, Rongzhen; Yu, Xiao-Fang			Distinct Determinants in HIV-1 Vif and Human APOBEC3 Proteins Are Required for the Suppression of Diverse Host Anti-Viral Proteins	PLOS ONE			English	Article							VIRUS TYPE-1 VIF; E3 UBIQUITIN LIGASE; CYTIDINE DEAMINASE; URACIL-DNA; SOCS-BOX; ANTIRETROVIRAL FACTOR; ENZYME APOBEC3G; EDITING ENZYMES; IMMUNODEFICIENCY; INHIBITION	Background: APOBEC3G (A3G) and related cytidine deaminases of the APOBEC3 family of proteins are potent inhibitors of many retroviruses, including HIV-1. Formation of infectious HIV-1 requires the suppression of multiple cytidine deaminases by Vif. HIV-1 Vif suppresses various APOBEC3 proteins through the common mechanism of recruiting the Cullin5-ElonginB-ElonginC E3 ubiquitin ligase to induce target protein polyubiquitination and proteasome-mediated degradation. The domains in Vif and various APOBEC3 proteins required for APOBEC3 recognition and degradation have not been fully characterized. Methods and Findings: In the present study, we have demonstrated that the regions of APOBEC3F (A3F) that are required for its HIV-1-mediated binding and degradation are distinct from those reported for A3G. We found that the C-terminal cytidine deaminase domain (C-CDD) of A3F alone is sufficient for its interaction with HIV-1 Vif and its Vif-mediated degradation. We also observed that the domains of HIV-1 Vif that are uniquely required for its functional interaction with full-length A3F are also required for the degradation of the C-CDD of A3F; in contrast, those Vif domains that are uniquely required for functional interaction with A3G are not required for the degradation of the C-CDD of A3F. Interestingly, the HIV-1 Vif domains required for the degradation of A3F are also required for the degradation of A3C and A3DE. On the other hand, the Vif domains uniquely required for the degradation of A3G are dispensable for the degradation of cytidine deaminases A3C and A3DE. Conclusions: Our data suggest that distinct regions of A3F and A3G are targeted by HIV-1 Vif molecules. However, HIV-1 Vif suppresses A3F, A3C, and A3DE through similar recognition determinants, which are conserved among Vif molecules from diverse HIV-1 strains. Mapping these determinants may be useful for the design of novel anti-HIV inhibitors.	[Zhang, Wenyan; Chen, Gongying; Niewiadomska, Anna Maria; Yu, Xiao-Fang] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Xu, Rongzhen; Yu, Xiao-Fang] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Zhejiang, Peoples R China; [Zhang, Wenyan] Jilin Univ, Coll Life Sci, Changchun, Jilin, Peoples R China; [Chen, Gongying] Hosp Hangzhou 6, Zhejiang, Peoples R China	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Zhejiang University; Jilin University	Zhang, WY (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA.	xfyu@jhsph.edu			 [AI062644];  [AI071769]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI062644, R21AI071769, R01AI062644] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	AI062644 and AI071769	Alce TM, 2004, J BIOL CHEM, V279, P34083, DOI 10.1074/jbc.C400235200; Berk LS, 2008, FASEB J, V22; Bieniasz PD, 2004, NAT IMMUNOL, V5, P1109, DOI 10.1038/ni1125; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Bogerd HP, 2004, P NATL ACAD SCI USA, V101, P3770, DOI 10.1073/pnas.0307713101; Bonvin M, 2006, HEPATOLOGY, V43, P1364, DOI 10.1002/hep.21187; Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; Chen H, 2006, CURR BIOL, V16, P480, DOI 10.1016/j.cub.2006.01.031; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; Chiu YL, 2006, P NATL ACAD SCI USA, V103, P15588, DOI 10.1073/pnas.0604524103; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Cullen BR, 2006, J VIROL, V80, P1067, DOI 10.1128/JVI.80.3.1067-1076.2006; Dang Y, 2006, J VIROL, V80, P10522, DOI 10.1128/JVI.01123-06; Douaisi M, 2004, BIOCHEM BIOPH RES CO, V321, P566, DOI 10.1016/j.bbrc.2004.07.005; Esnault C, 2005, NATURE, V433, P430, DOI 10.1038/nature03238; Goff SP, 2004, MOL CELL, V16, P849, DOI 10.1016/j.molcel.2004.12.001; Golla-Gaur R, 2008, VIROLOGY, V372, P136, DOI 10.1016/j.virol.2007.10.017; Guo F, 2007, J VIROL, V81, P11322, DOI 10.1128/JVI.00162-07; Guo F, 2006, J VIROL, V80, P11710, DOI 10.1128/JVI.01038-06; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; He ZW, 2008, J MOL BIOL, V381, P1000, DOI 10.1016/j.jmb.2008.06.061; Hulme AE, 2007, GENE, V390, P199, DOI 10.1016/j.gene.2006.08.032; Huthoff H, 2007, J VIROL, V81, P3807, DOI 10.1128/JVI.02795-06; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Kaiser SM, 2006, J VIROL, V80, P875, DOI 10.1128/JVI.80.2.875-882.2006; Khan MA, 2005, J VIROL, V79, P5870, DOI 10.1128/JVI.79.9.5870-5874.2005; Kobayashi M, 2005, J BIOL CHEM, V280, P18573, DOI 10.1074/jbc.C500082200; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Li XY, 2007, J BIOL CHEM, V282, P32065, DOI 10.1074/jbc.M703423200; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; Liu BD, 2005, J VIROL, V79, P9579, DOI 10.1128/JVI.79.15.9579-9587.2005; Liu BD, 2004, J VIROL, V78, P2072, DOI 10.1128/JVI.78.4.2072-2081.2004; Luo K, 2005, P NATL ACAD SCI USA, V102, P11444, DOI 10.1073/pnas.0502440102; Luo K, 2004, J VIROL, V78, P11841, DOI 10.1128/JVI.78.21.11841-11852.2004; Luo K, 2007, J VIROL, V81, P7238, DOI 10.1128/JVI.02584-06; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mangeat B, 2004, J BIOL CHEM, V279, P14481, DOI 10.1074/jbc.C400060200; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mbisa JL, 2007, J VIROL, V81, P7099, DOI 10.1128/JVI.00272-07; Mehle A, 2004, GENE DEV, V18, P2861, DOI 10.1101/gad.1249904; Mehle A, 2007, J VIROL, V81, P13235, DOI 10.1128/JVI.00204-07; Mehle A, 2006, J BIOL CHEM, V281, P17259, DOI 10.1074/jbc.M602413200; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Navarro F, 2004, CURR OPIN IMMUNOL, V16, P477, DOI 10.1016/j.coi.2004.05.006; Niewiadomska AM, 2007, J VIROL, V81, P9577, DOI 10.1128/JVI.02800-06; OhAinle M, 2006, J VIROL, V80, P3853, DOI 10.1128/JVI.80.8.3853-3862.2006; Rogozin IB, 2005, CELL CYCLE, V4, P1281, DOI 10.4161/cc.4.9.1994; Rose KM, 2004, J BIOL CHEM, V279, P41744, DOI 10.1074/jbc.M406760200; Rosler C, 2004, SCIENCE, V305, p1403A, DOI 10.1126/science.1100464; Russell RA, 2007, J VIROL, V81, P8201, DOI 10.1128/JVI.00395-07; Schafer A, 2004, VIROLOGY, V328, P163, DOI 10.1016/j.virol.2004.08.006; Schrofelbauer B, 2005, J VIROL, V79, P10978, DOI 10.1128/JVI.79.17.10978-10987.2005; Schrofelbauer B, 2006, J VIROL, V80, P5984, DOI 10.1128/JVI.00388-06; Schrofelbauer R, 2004, P NATL ACAD SCI USA, V101, P3927, DOI 10.1073/pnas.0307132101; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Simon V, 2005, PLOS PATHOG, V1, P20, DOI 10.1371/journal.ppat.0010006; Stanley BJ, 2008, J VIROL, V82, P8656, DOI 10.1128/JVI.00767-08; Stenglein MD, 2006, J BIOL CHEM, V281, P16837, DOI 10.1074/jbc.M602367200; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Suspene R, 2004, NUCLEIC ACIDS RES, V32, P2421, DOI 10.1093/nar/gkh554; Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200; Tian CJ, 2006, J VIROL, V80, P3112, DOI 10.1128/JVI.80.6.3112-3115.2006; Turelli P, 2005, SCIENCE, V307, P1061, DOI 10.1126/science.1105964; Turelli P, 2004, SCIENCE, V305, p1403B; Turelli P, 2004, SCIENCE, V303, P1829, DOI 10.1126/science.1092066; Vodicka MA, 1997, VIROLOGY, V233, P193, DOI 10.1006/viro.1997.8606; Wang T, 2007, J VIROL, V81, P13112, DOI 10.1128/JVI.00892-07; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Xiao ZX, 2007, FASEB J, V21, P217, DOI 10.1096/fj.06-6773com; Xiao ZX, 2006, VIROLOGY, V349, P290, DOI 10.1016/j.virol.2006.02.002; Xu HZ, 2004, P NATL ACAD SCI USA, V101, P5652, DOI 10.1073/pnas.0400830101; Xu RZ, 2007, HEPATOLOGY, V46, P1810, DOI 10.1002/hep.21893; Yang B, 2007, J BIOL CHEM, V282, P11667, DOI 10.1074/jbc.M606864200; Yu Q, 2004, J BIOL CHEM, V279, P53379, DOI 10.1074/jbc.M408802200; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Yu XF, 2006, CURR OPIN HIV AIDS, V1, P187, DOI 10.1097/01.COH.0000221590.03670.32; Yu YK, 2004, GENE DEV, V18, P2867, DOI 10.1101/gad.1250204; Zennou W, 2004, J VIROL, V78, P12058, DOI 10.1128/JVI.78.21.12058-12061.2004; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhang L, 2008, VIROLOGY, V370, P113, DOI 10.1016/j.virol.2007.08.027; Zhang W, 2008, CELL MICROBIOL, V10, P112, DOI 10.1111/j.1462-5822.2007.01020.x; Zhang WY, 2008, CELL MICROBIOL, V10, P1662, DOI 10.1111/j.1462-5822.2008.01157.x; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	91	48	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2008	3	12							e3963	10.1371/journal.pone.0003963	http://dx.doi.org/10.1371/journal.pone.0003963			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AS	19088851	gold, Green Published, Green Submitted			2022-12-25	WOS:000265458500009
J	Fadista, J; Nygaard, M; Holm, LE; Thomsen, B; Bendixen, C				Fadista, Joao; Nygaard, Marianne; Holm, Lars-Erik; Thomsen, Bo; Bendixen, Christian			A Snapshot of CNVs in the Pig Genome	PLOS ONE			English	Article								Recent studies of mammalian genomes have uncovered the extent of copy number variation (CNV) that contributes to phenotypic diversity, including health and disease status. Here we report a first account of CNVs in the pig genome covering part of the chromosomes 4, 7, 14, and 17 already sequenced and assembled. A custom tiling oligonucleotide array was used with a median probe spacing of 409 bp for screening 12 unrelated Duroc boars that are founders of a large family material. After a strict CNV calling pipeline, 37 copy number variable regions (CNVRs) across all four chromosomes were identified, with five CNVRs overlapping segmental duplications, three overlapping pig unigenes and one overlapping a RefSeq pig mRNA. This CNV snapshot analysis is the first of its kind in the porcine genome and constitutes the basis for a better understanding of porcine phenotypes and genotypes with the prospect of identifying important economic traits.	[Fadista, Joao; Nygaard, Marianne; Holm, Lars-Erik; Thomsen, Bo; Bendixen, Christian] Aarhus Univ, Fac Agr Sci, Dept Genet & Biotechnol, Grp Mol Genet & Syst Biol, Tjele, Denmark	Aarhus University	Fadista, J (corresponding author), Aarhus Univ, Fac Agr Sci, Dept Genet & Biotechnol, Grp Mol Genet & Syst Biol, Tjele, Denmark.	Christian.Bendixen@agrsci.dk	Holm, Lars-Erik/A-4678-2013; Fadista, Joao/AAM-4870-2020	Holm, Lars-Erik/0000-0002-5312-3579; Fadista, Joao/0000-0003-2539-634X; Thomsen, Bo/0000-0001-9622-0929; Nygaard, Marianne/0000-0003-0703-2665; fadista, joao/0000-0001-7558-7043	Marie Curie [Host Fellowships for Early Stage Research Training]; European Commission	Marie Curie(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	The authors of this paper did not receive any commercial funding for this project. This work was conducted as part of the SABRETRAIN Project, funded by the Marie Curie Host Fellowships for Early Stage Research Training, as part of the 6th Framework Programme of the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bailey JA, 2004, GENOME RES, V14, P789, DOI 10.1101/gr.2238404; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Bruder CEG, 2008, AM J HUM GENET, V82, P763, DOI 10.1016/j.ajhg.2007.12.011; Chen G, 2005, NAT MED, V11, P1295, DOI 10.1038/nm1330; Cheng Z, 2005, NATURE, V437, P88, DOI 10.1038/nature04000; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Cutler G, 2007, GENOME RES, V17, P1743, DOI 10.1101/gr.6754607; Dopman EB, 2007, P NATL ACAD SCI USA, V104, P19920, DOI 10.1073/pnas.0709888104; Emerson JJ, 2008, SCIENCE, V320, P1629, DOI 10.1126/science.1158078; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Fridlyand J, 2004, J MULTIVARIATE ANAL, V90, P132, DOI 10.1016/j.jmva.2004.02.008; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gorodkin J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r45; Graubert TA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030003; Hart EA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r168; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Lai WR, 2005, BIOINFORMATICS, V21, P3763, DOI 10.1093/bioinformatics/bti611; Li JZ, 2004, NAT GENET, V36, P952, DOI 10.1038/ng1417; LIU G, 2007, INT S AN GEN AN HLTH; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Luethy Roland, 2004, Biosilico, V2, P12; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Madsen LB, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-72; Maydan JS, 2007, GENOME RES, V17, P337, DOI 10.1101/gr.5690307; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Morgulis A, 2006, BIOINFORMATICS, V22, P134, DOI 10.1093/bioinformatics/bti774; Newman TL, 2005, GENOME RES, V15, P1344, DOI 10.1101/gr.4338005; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Nuwaysir EF, 2002, GENOME RES, V12, P1749, DOI 10.1101/gr.362402; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Perry GH, 2006, P NATL ACAD SCI USA, V103, P8006, DOI 10.1073/pnas.0602318103; Pinkel D, 2005, ANNU REV GENOM HUM G, V6, P331, DOI 10.1146/annurev.genom.6.080604.162140; Piotrowski A, 2008, HUM MUTAT, V29, P1118, DOI 10.1002/humu.20815; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rennie C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-317; RETTENBERGER G, 1995, GENOMICS, V26, P372, DOI 10.1016/0888-7543(95)80222-8; SAMBROOK J, 1989, MOL CLONING LAB MANU, V2, P11; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Shaw CJ, 2004, HUM MOL GENET, V13, pR57, DOI 10.1093/hmg/ddh073; Singh-Gasson S, 1999, NAT BIOTECHNOL, V17, P974, DOI 10.1038/13664; Smith M.L., 2006, BIOCONDUCTOR; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858; Tumbleson ME, 1996, ADV SWINE BIOMEDICAL; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Watkins-Chow DE, 2008, GENOME RES, V18, P60, DOI 10.1101/gr.6927808; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Willenbrock H, 2005, BIOINFORMATICS, V21, P4084, DOI 10.1093/bioinformatics/bti677; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560	63	97	105	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2008	3	12							e3916	10.1371/journal.pone.0003916	http://dx.doi.org/10.1371/journal.pone.0003916			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AR	19079605	gold, Green Published, Green Submitted			2022-12-25	WOS:000265458400002
J	Rigourd, V; Chauvet, C; Chelbi, ST; Rebourcet, R; Mondon, F; Letourneur, F; Mignot, TM; Barbaux, S; Vaiman, D				Rigourd, Virginie; Chauvet, Caroline; Chelbi, Sonia T.; Rebourcet, Regis; Mondon, Francoise; Letourneur, Franck; Mignot, Therese-Marie; Barbaux, Sandrine; Vaiman, Daniel			STOX1 Overexpression in Choriocarcinoma Cells Mimics Transcriptional Alterations Observed in Preeclamptic Placentas	PLOS ONE			English	Article								Background: Mutations in STOX1 were proposed to be causal for predisposing to preeclampsia, a hypertensive disorder originating from placental defects, affecting up to 10% of human pregnancies. However, after the first study published in 2005 three other groups have dismissed the polymorphism described in the first paper as a causal mutation. Methodology and Principal Findings: In the present study, we have produced a choriocarcinoma cell line overexpressing STOX1. This overexpression results in transcriptional modification of 12.5% of the genes, some of them being direct targets as shown by chromatin immunoprecipitation. STOX1 overexpression correlates strongly and specifically with transcriptomic alterations in preeclamptic placentas (r=0.30, p=9.10(-7)). Numerous known key modulators of preeclampsia (such as Endoglin, Syncytin, human chorionic gonadotrophin -hCG-, and Glial Cell Missing Homolog -GCM1-) were modified in these transformed choriocarcinoma cells. Conclusions: Our results contribute to reconcile contradictory data concerning the involvement of STOX1 in preeclampsia. In addition, they strongly suggest that anomalies in STOX1 expression are associated with the onset of preeclampsia, thus indicating that this gene should be the target of future studies. Our cellular model could constitute an invaluable resource for studying specific aspects of this human disease.	[Rigourd, Virginie; Chelbi, Sonia T.; Rebourcet, Regis; Mondon, Francoise; Letourneur, Franck; Mignot, Therese-Marie; Barbaux, Sandrine; Vaiman, Daniel] Univ Paris 05, CNRS, UMR 8104, Inst Cochin,Equipe 21, Paris, France; [Rigourd, Virginie; Chelbi, Sonia T.; Rebourcet, Regis; Mondon, Francoise; Letourneur, Franck; Mignot, Therese-Marie; Barbaux, Sandrine; Vaiman, Daniel] Inserm, U567, Paris, France; [Letourneur, Franck] Univ Paris 05, CNRS, UMR 8104, Inst Cochin, Plate forme Genom, Paris, France; [Chauvet, Caroline] Univ Paris 05, Ctr Univ St Peres 45, Inserm, UMR S747, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Rigourd, V (corresponding author), Univ Paris 05, CNRS, UMR 8104, Inst Cochin,Equipe 21, Paris, France.	vaiman@cochin.inserm.fr	Vaiman, Daniel/O-6030-2015; chelbi, sonia/Q-5150-2019; chelbi, sonia/C-1165-2016; Barbaux, Sandrine C/B-2878-2019	Vaiman, Daniel/0000-0002-1915-0717; chelbi, sonia/0000-0003-3465-6537; chelbi, sonia/0000-0003-3465-6537; Barbaux, Sandrine C/0000-0002-8204-1855; rigourd, virginie/0000-0002-2638-4343	INSERM	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	Funding by INSERM. INSERM has no role in managing the research.	Al-Nasiry S, 2006, HUM REPROD, V21, P193, DOI 10.1093/humrep/dei272; Berends AL, 2007, BJOG-INT J OBSTET GY, V114, P1163, DOI 10.1111/j.1471-0528.2007.01414.x; Buffat C, 2007, J PATHOL, V213, P337, DOI 10.1002/path.2233; Chen CP, 2004, PLACENTA, V25, P413, DOI 10.1016/j.placenta.2003.10.014; Coulomb-L'Hermine A, 2007, PLACENTA, V28, P1133, DOI 10.1016/j.placenta.2007.06.004; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Djian P, 2000, J CELL BIOL, V151, P381, DOI 10.1083/jcb.151.2.381; Dupressoir A, 2005, P NATL ACAD SCI USA, V102, P725, DOI 10.1073/pnas.0406509102; FERRE F, 1993, J CARDIOVASC PHARM, V22, pS214, DOI 10.1097/00005344-199322008-00058; Graves JAM, 1998, REPROD FERT DEVELOP, V10, P23, DOI 10.1071/R98014; Heazell AEP, 2007, PLACENTA, V28, pS33, DOI 10.1016/j.placenta.2006.10.007; Iglesias-Platas I, 2007, NAT GENET, V39, P279, DOI 10.1038/ng0307-279; Kivinen K, 2007, EUR J HUM GENET, V15, P494, DOI 10.1038/sj.ejhg.5201788; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; Kudo Y, 2004, PLACENTA, V25, P479, DOI 10.1016/j.placenta.2003.12.001; Ledee-Bataille N, 2005, FERTIL STERIL, V83, P598, DOI 10.1016/j.fertnstert.2004.11.021; MALASSINE A, 1990, PLACENTA, V11, P191, DOI 10.1016/S0143-4004(05)80180-8; MONDON F, 1993, J CLIN ENDOCR METAB, V76, P237, DOI 10.1210/jc.76.1.237; Nishizawa H, 2007, PLACENTA, V28, P487, DOI 10.1016/j.placenta.2006.05.010; Perkins J, 2002, MOL MED, V8, P847, DOI 10.1007/BF03402090; Rinkenberger J, 2000, NAT GENET, V25, P248, DOI 10.1038/76985; Sibai BM, 2005, HYPERTENSION, V46, P1252, DOI 10.1161/01.HYP.0000188904.47575.7e; Thomassin H, 2001, EMBO J, V20, P1974, DOI 10.1093/emboj/20.8.1974; Vaiman D, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-111; van Dijk M, 2005, NAT GENET, V37, P514, DOI 10.1038/ng1541; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Winn VD, 2007, ENDOCRINOLOGY, V148, P1059, DOI 10.1210/en.2006-0683	27	50	56	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2008	3	12							e3905	10.1371/journal.pone.0003905	http://dx.doi.org/10.1371/journal.pone.0003905			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZU	19079545	Green Published, Green Submitted, gold			2022-12-25	WOS:000265455900002
J	Bartling, B; Desole, M; Rohrbach, S; Silber, RE; Simm, A				Bartling, Babett; Desole, Maximilian; Rohrbach, Susanne; Silber, Rolf-Edgar; Simm, Andreas			Age-associated changes of extracellular matrix collagen impair lung cancer cell migration	FASEB JOURNAL			English	Article						advanced glycation end products; tumor stroma; invasiveness; adhesion; proliferation; matrix metalloproteinase	ADVANCED GLYCATION ENDPRODUCTS; MAILLARD REACTION; CROSS-LINKING; EPITHELIAL-CELLS; TUMOR-CELLS; METHYLGLYOXAL; FIBROBLASTS; PROTEINS; ADHESION; GROWTH	Although advanced age is linked with an increased incidence of lung carcinomas, elderly patients develop fewer metastatic tumors than their younger counterparts. Since extracellular matrix controls carcinogenesis, we studied the effect of aged fibrillar collagen (rat tail) on the invasiveness of lung carcinoma cells (H322, H358). Two- and three-dimensional invasion assays revealed a reduced migration of lung cancer cells through a matrix of collagen from old (24 mo) compared with young (2 mo) or adult (12 mo) rats. This was most strongly observed for H322 cells, which had a better migration behavior than H358 cells. Since old collagen was increasingly modified by advanced glycation end products (AGEs; fluorescing AGEs, nonfluorescing carboxymethyllysine), we generated different AGE-collagens by treating collagen with ribose or alpha-dicarbonyls. Similarly to old collagen, AGE-collagen reduced the invasive migration of H322 cells. Subsequent analyses demonstrated that old and AGE-collagens impair distinct mechanisms contributing to cell migration, i.e., efficient cell adhesion and proteolytic degradation of collagen by membrane-type matrix metalloproteinase (MT-MMP; MT-MMP3 in H322 cells). Our data indicate that age-related alterations of the extracellular matrix contribute to a less invasive behavior of lung carcinoma cells, in which AGE modifications of aged collagen seem to play an important role. Bartling, B., Desole, M., Rohrbach, S., Silber, R.-E., Simm, A. Age-associated changes of extracellular matrix collagen impair lung cancer cell migration. FASEB J. 23, 1510-1520 (2009)	[Bartling, Babett; Desole, Maximilian; Silber, Rolf-Edgar; Simm, Andreas] Univ Hosp Halle Saale, Dept Cardiothorac Surg, D-06120 Halle, Saale, Germany; [Rohrbach, Susanne] Univ Halle Wittenberg, Inst Pathophysiol, Halle, Saale, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Bartling, B (corresponding author), Univ Hosp Halle Saale, Dept Cardiothorac Surg, Ernst Grube Str 40, D-06120 Halle, Saale, Germany.	babett.bartling@medizin.uni-halle.de			Deutsche Krebshilfe [107078]; Bundesministerium fur Bildung und Forschung (BMBF) [FKZ SI/07, FKZ3/30]; Deutsche Forschungsgemeinschaft (DFG) [Si-1317/1-1]	Deutsche Krebshilfe(Deutsche Krebshilfe); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by Deutsche Krebshilfe (107078), Wilhelm Roux grants of the Bundesministerium fur Bildung und Forschung (BMBF; FKZ SI/07, FKZ3/30), and Deutsche Forschungsgemeinschaft (DFG; Si-1317/1-1).	Ahmed MU, 1997, BIOCHEM J, V324, P565, DOI 10.1042/bj3240565; ALBINI A, 1987, CANCER RES, V47, P3239; Avery NC, 2006, PATHOL BIOL, V54, P387, DOI 10.1016/j.patbio.2006.07.005; Bartling B, 2006, EXP GERONTOL, V41, P532, DOI 10.1016/j.exger.2006.02.006; Bartling B, 2007, EUR J CANCER, V43, P1935, DOI 10.1016/j.ejca.2007.06.010; Baynes JW, 2001, EXP GERONTOL, V36, P1527, DOI 10.1016/S0531-5565(01)00138-3; BELLMUNT MJ, 1995, BBA-MOL BASIS DIS, V1272, P53, DOI 10.1016/0925-4439(95)00069-G; BELLMUNT MJ, 1995, LUNG, V173, P177; Bjorklund M, 2005, BBA-REV CANCER, V1755, P37, DOI 10.1016/j.bbcan.2005.03.001; Bobbink IWG, 1997, DIABETES, V46, P87, DOI 10.2337/diabetes.46.1.87; BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; d'Ortho MP, 1997, EUR J BIOCHEM, V250, P751, DOI 10.1111/j.1432-1033.1997.00751.x; Davenport EA, 1996, EXP CELL RES, V223, P155, DOI 10.1006/excr.1996.0069; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; DEYL Z, 1971, EXP GERONTOL, V6, P227, DOI 10.1016/0531-5565(71)90035-0; DYER DG, 1993, J CLIN INVEST, V91, P2463, DOI 10.1172/JCI116481; DYER DG, 1991, Z ERNAHRUNGSWISS, V30, P29, DOI 10.1007/BF01910730; EBBESEN P, 1984, MECH AGEING DEV, V25, P269, DOI 10.1016/0047-6374(84)90001-0; EGYUD LG, 1968, SCIENCE, V160, P1140, DOI 10.1126/science.160.3832.1140; ERSHLER WB, 1983, J AM GERIATR SOC, V31, P673, DOI 10.1111/j.1532-5415.1983.tb04153.x; ERSHLER WB, 1984, JNCI-J NATL CANCER I, V72, P161, DOI 10.1093/jnci/72.1.161; Ghosh M, 2006, TOXICOL APPL PHARM, V212, P45, DOI 10.1016/j.taap.2005.07.003; Ishikawa S, 2004, CLIN CANCER RES, V10, P6579, DOI 10.1158/1078-0432.CCR-04-0272; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Kim SH, 2007, J SURG ONCOL, V95, P337, DOI 10.1002/jso.20643; Kinzler KW, 1998, SCIENCE, V280, P1036, DOI 10.1126/science.280.5366.1036; Krtolica A, 2002, INT J BIOCHEM CELL B, V34, P1401, DOI 10.1016/S1357-2725(02)00053-5; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lederer MO, 1999, BIOORGAN MED CHEM, V7, P2499, DOI 10.1016/S0968-0896(99)00212-6; Lingelbach LB, 2000, J NUTR, V130, P1247, DOI 10.1093/jn/130.5.1247; Matsumoto SI, 1997, BBA-GENE STRUCT EXPR, V1354, P159, DOI 10.1016/S0167-4781(97)00120-6; McCarthy AD, 2004, INT J BIOCHEM CELL B, V36, P840, DOI 10.1016/j.biocel.2003.09.006; MIKSIK I, 1991, J GERONTOL, V46, pB111, DOI 10.1093/geronj/46.3.B111; MONNIER VM, 1984, P NATL ACAD SCI-BIOL, V81, P583, DOI 10.1073/pnas.81.2.583; Morita K, 2005, WOUND REPAIR REGEN, V13, P93, DOI 10.1111/j.1067-1927.2005.130112.x; Munch G, 1999, NAT BIOTECHNOL, V17, P1006, DOI 10.1038/13704; Park CC, 2000, MOL MED TODAY, V6, P324, DOI 10.1016/S1357-4310(00)01756-1; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635; PIANTANELLI L, 1988, ANN NY ACAD SCI, V521, P99, DOI 10.1111/j.1749-6632.1988.tb35268.x; Ray M, 1997, MOL CELL BIOCHEM, V177, P21, DOI 10.1023/A:1006831511527; RAY S, 1994, BIOCHEM J, V303, P69, DOI 10.1042/bj3030069; Reigle KL, 2008, J CELL BIOCHEM, V104, P1684, DOI 10.1002/jcb.21735; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Sakata N, 2000, CONNECT TISSUE RES, V41, P213, DOI 10.3109/03008200009005291; Sell DR, 2001, J GERONTOL A-BIOL, V56, pB405, DOI 10.1093/gerona/56.9.B405; Shimada T, 1999, EUR J BIOCHEM, V262, P907, DOI 10.1046/j.1432-1327.1999.00459.x; Simm A, 1997, FEBS LETT, V410, P481, DOI 10.1016/S0014-5793(97)00644-3; STREULI CH, 1990, J CELL BIOL, V110, P1405; Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109; Ulrich P, 2001, RECENT PROG HORM RES, V56, P1, DOI 10.1210/rp.56.1.1; Weisberg E, 1997, CRIT REV ONCOGENESIS, V8, P343, DOI 10.1615/CritRevOncog.v8.i4.40; Zamir E, 2001, J CELL SCI, V114, P3583; Zhao HR, 2004, J BIOL CHEM, V279, P8592, DOI 10.1074/jbc.M308708200	57	39	39	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2009	23	5					1510	1520		10.1096/fj.08-122648	http://dx.doi.org/10.1096/fj.08-122648			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZP	19109409				2022-12-25	WOS:000266651700027
J	Gao, B; Sherman, P; Luo, L; Bowie, J; Zhu, SY				Gao, Bin; Sherman, Patrick; Luo, Lan; Bowie, John; Zhu, Shunyi			Structural and functional characterization of two genetically related meucin peptides highlights evolutionary divergence and convergence in antimicrobial peptides	FASEB JOURNAL			English	Article						innate immunity; NMR structure; venomous arthropod; gene cloning; virus fusion domain	PROTEIN SECONDARY STRUCTURE; CODON-SUBSTITUTION MODELS; SCORPION-VENOM; ANTIBACTERIAL PEPTIDES; CYTOLYTIC PEPTIDES; AMPHIBIAN SKIN; DEFENSINS; SELECTION; TOXINS; DOMAIN	Both vertebrates and invertebrates employ alpha-helical antimicrobial peptides (AMPs) as an essential component of their innate immune system. However, evolutionary relation of these immune molecules remains unresolved. Venoms, as key weapons of venomous arthropods for prey and defense, receive increasing recognition as an emerging source of such peptides. From a cDNA library prepared from the venom gland of the scorpion Mesobuthus eupeus, clones encoding precursors of two new AMPs, named meucin-13 (IFGAIAGLLKNIF-NH2) and meucin-18 (FFGHLFKLATKIIPSLFQ), have been isolated. The precursor of meucins consists of a signal peptide, a mature peptide, and an acidic propeptide, in which dibasic residues as the typical processing signal are located between the mature and propeptide. Meucin-13 is an ortholog of several previously described AMPs from scorpion venom and has also detectable sequence similarity to temporins, a large family of AMPs from frog skin, whereas meucin-18 displays some similarity to AMPs from diverse origin including arthropod venoms, fish mast cells, and frog skins. These two meucin peptides form alpha-helical structure in the presence of 50% trifluoroethanol (TFE), a membrane-mimicking environment, as identified by circular dichroism (CD) spectroscopy. This finding is further verified by their NMR structures that show a typical alpha-helical amphipathic design, a structural prerequisite for cytolytic activity. Meucins exhibit extensive cytolytic effects on both prokaryotic and eukaryotic cells (gram(+) and gram(-) bacteria, fungi, yeasts, rabbit erythrocytes, and rat dorsal root ganglion cells) at micromolar concentrations. It is remarkable that muecin-18 was 2- to > 14-fold more potent than meucin-13 against nearly all the cells tested. Structural differences in hydrophilic/hydrophobic balance and cationic amino acid location between two meucins could account for their differential potency. Despite these differences, commonalities at precursor organization, three-dimensional structure, and biological function suggests that meucins are two evolutionarily related AMPs and likely originated from a common ancestor by gene duplication. Our work presented here also provides new insights into an evolutionary link among AMPs from invertebrates and vertebrates and clues for evolutionary convergence between AMPs and virus fusion domains.-Gao, B., Sherman, P., Luo, L., Bowie, J., Zhu, S. Structural and functional characterization of two genetically related meucin peptides highlights evolutionary divergence and convergence in antimicrobial peptides. FASEB J. 23, 1230-1245 (2009)	[Gao, Bin; Luo, Lan; Zhu, Shunyi] Chinese Acad Sci, Inst Zool, Grp Anim Innate Immun, State Key Lab Integrated Management Pest Insects, Beijing 100101, Peoples R China; [Sherman, Patrick; Bowie, John] Univ Adelaide, Dept Chem, Adelaide, SA, Australia	Chinese Academy of Sciences; Institute of Zoology, CAS; University of Adelaide	Zhu, SY (corresponding author), Chinese Acad Sci, Inst Zool, Grp Anim Innate Immun, State Key Lab Integrated Management Pest Insects, Datun Rd, Beijing 100101, Peoples R China.	zhusy@ioz.ac.cn			National Natural Science Foundation of China [90608009, 30621003, 30570381]; Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by grants from the National Natural Science Foundation of China ( 90608009, 30621003, and 30570381) and the Bairen Plan from the Chinese Academy of Sciences.	Amino R, 2002, J BIOL CHEM, V277, P6207, DOI 10.1074/jbc.M109874200; Andersson M, 2003, CELL MOL LIFE SCI, V60, P599, DOI 10.1007/s000180300051; Boman HG, 2003, J INTERN MED, V254, P197, DOI 10.1046/j.1365-2796.2003.01228.x; Bowdish DME, 2006, CURR TOP MICROBIOL, V306, P27; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Comeron JM, 1995, J MOL EVOL, V41, P1152, DOI 10.1007/BF00173196; Conde R, 2000, FEBS LETT, V471, P165, DOI 10.1016/S0014-5793(00)01384-3; Conlon JM, 2004, BBA-PROTEINS PROTEOM, V1696, P1, DOI 10.1016/j.bbapap.2003.09.004; Corzo G, 2001, BIOCHEM J, V359, P35, DOI 10.1042/0264-6021:3590035; Dai L, 2001, BIOCHEM BIOPH RES CO, V286, P820, DOI 10.1006/bbrc.2001.5472; Dathe M, 1999, BBA-BIOMEMBRANES, V1462, P71, DOI 10.1016/S0005-2736(99)00201-1; Dimarcq JL, 1998, BIOPOLYMERS, V47, P465, DOI 10.1002/(SICI)1097-0282(1998)47:6<465::AID-BIP5>3.0.CO;2-#; Duda TF, 1999, P NATL ACAD SCI USA, V96, P6820, DOI 10.1073/pnas.96.12.6820; Elgar D, 2006, AFR J BIOTECHNOL, V5, P2495; Fahrner RL, 1996, CHEM BIOL, V3, P543, DOI 10.1016/S1074-5521(96)90145-3; Ferrandon D, 1998, EMBO J, V17, P1217, DOI 10.1093/emboj/17.5.1217; Fjell CD, 2007, BIOINFORMATICS, V23, P1148, DOI 10.1093/bioinformatics/btm068; GAETA BA, 1998, DATABASE SEARCHING U; Gao B, 2008, INSECT MOL BIOL, V17, P405, DOI 10.1111/j.1365-2583.2008.00810.x; Gao B, 2007, PEPTIDES, V28, P2299, DOI 10.1016/j.peptides.2007.10.004; Han X, 2004, BIOINFORMATICS, V20, P970, DOI 10.1093/bioinformatics/bth027; Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434; HANZAWA H, 1990, FEBS LETT, V269, P413, DOI 10.1016/0014-5793(90)81206-4; Klaudiny J, 2005, INSECT BIOCHEM MOLEC, V35, P11, DOI 10.1016/j.ibmb.2004.09.007; Kozlov SA, 2006, J BIOL CHEM, V281, P20983, DOI 10.1074/jbc.M602168200; Kuhn-Nentwig L, 2003, CELL MOL LIFE SCI, V60, P2651, DOI 10.1007/s00018-003-3106-8; LEE JY, 1989, P NATL ACAD SCI USA, V86, P9159, DOI 10.1073/pnas.86.23.9159; Lee K, 2004, BIOCHEM BIOPH RES CO, V323, P712, DOI 10.1016/j.bbrc.2004.08.144; Li JX, 2007, MOL CELL PROTEOMICS, V6, P882, DOI 10.1074/mcp.M600334-MCP200; Lorenzini DM, 2003, DEV COMP IMMUNOL, V27, P781, DOI 10.1016/S0145-305X(03)00058-2; Mader JS, 2006, EXPERT OPIN INV DRUG, V15, P933, DOI 10.1517/13543784.15.8.933; Mangoni ML, 2006, CELL MOL LIFE SCI, V63, P1060, DOI 10.1007/s00018-005-5536-y; Murakami M, 2002, J INVEST DERMATOL, V119, P1090, DOI 10.1046/j.1523-1747.2002.19507.x; Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051; Nilges M, 1998, PROG NUCL MAG RES SP, V32, P107, DOI 10.1016/S0079-6565(97)00025-3; Nilges M, 1997, J MOL BIOL, V269, P408, DOI 10.1006/jmbi.1997.1044; Possani LD, 1999, EUR J BIOCHEM, V264, P287, DOI 10.1046/j.1432-1327.1999.00625.x; Pukala TL, 2007, FEBS J, V274, P1778, DOI 10.1111/j.1742-4658.2007.05726.x; Rinaldi AC, 2002, CURR OPIN CHEM BIOL, V6, P799, DOI 10.1016/S1367-5931(02)00401-5; Silphaduang U, 2001, NATURE, V414, P268, DOI 10.1038/35104690; STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0; Suzuki H, 2007, PEPTIDES, V28, P2061, DOI 10.1016/j.peptides.2007.07.028; Tennessen JA, 2005, J EVOLUTION BIOL, V18, P1387, DOI 10.1111/j.1420-9101.2005.00925.x; Tennessen JA, 2007, J MOL EVOL, V65, P605, DOI 10.1007/s00239-007-9045-5; Tian CH, 2008, TOXICON, V51, P555, DOI 10.1016/j.toxicon.2007.11.010; TOSSI A, 1997, ANTIBACTERIAL PEPTID, P133; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wong H, 1997, EUR J BIOCHEM, V247, P545, DOI 10.1111/j.1432-1033.1997.00545.x; WUTHRUCH K, 1986, NMR PROTEINS NUCL AC; Yamakawa M., 1998, TECHNIQUES INSECT IM, P103; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2000, GENETICS, V155, P431; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Yount NY, 2004, P NATL ACAD SCI USA, V101, P7363, DOI 10.1073/pnas.0401567101; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zelezetsky I, 2005, PEPTIDES, V26, P2368, DOI 10.1016/j.peptides.2005.05.002; Zhao CQ, 2001, INFECT IMMUN, V69, P2684, DOI 10.1128/IAI.69.4.2684-2691.2001; Zhu S, 2006, FEBS LETT, V580, P6825, DOI 10.1016/j.febslet.2006.11.040; Zhu S, 2005, CELL MOL LIFE SCI, V62, P2257, DOI 10.1007/s00018-005-5200-6; Zhu S, 2004, CELL MOL LIFE SCI, V61, P1751, DOI 10.1007/s00018-004-4149-1; Zhu SY, 2008, TRENDS MICROBIOL, V16, P353, DOI 10.1016/j.tim.2008.05.007; Zhu SY, 2008, MOL IMMUNOL, V45, P2531, DOI 10.1016/j.molimm.2008.01.007; Zhu SY, 2008, MOL IMMUNOL, V45, P828, DOI 10.1016/j.molimm.2007.06.354; Zhu SY, 2009, FASEB J, V23, P13, DOI 10.1096/fj.08-114579; Zhu SY, 2004, J MOL EVOL, V58, P145, DOI 10.1007/s00239-003-2534-2; Zhu SY, 2003, FASEB J, V17, P1765, DOI 10.1096/fj.02-1044fje	71	60	65	1	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2009	23	4					1230	1245		10.1096/fj.08-122317	http://dx.doi.org/10.1096/fj.08-122317			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZO	19088182				2022-12-25	WOS:000266651600027
J	Neppl, RL; Lubomirov, LT; Momotani, K; Pfitzer, G; Eto, M; Somlyo, AV				Neppl, Ronald L.; Lubomirov, Lubomir T.; Momotani, Ko; Pfitzer, Gabriele; Eto, Masumi; Somlyo, Avril V.			Thromboxane A(2)-induced Bi-directional Regulation of Cerebral Arterial Tone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; LIGHT-CHAIN PHOSPHATASE; VASCULAR SMOOTH-MUSCLE; VASODILATOR-STIMULATED PHOSPHOPROTEIN; PORCINE CORONARY-ARTERY; MYOSIN-BINDING SUBUNIT; RHO-ASSOCIATED KINASE; NITRIC-OXIDE; CA2+ SENSITIZATION; SIGNAL-TRANSDUCTION	Myosin light chain phosphatase plays a critical role in modulating smooth muscle contraction in response to a variety of physiologic stimuli. A downstream target of the RhoA/Rho-kinase and nitric oxide (NO)/cGMP/cyclic GMP-dependent kinase (cGKI) pathways, myosin light chain phosphatase activity reflects the sum of both calcium sensitization and desensitization pathways through phosphorylation and dephosphorylation of the myosin phosphatase targeting subunit (MYPT1). As cerebral blood flow is highly spatio-temporally modulated under normal physiologic conditions, severe perturbations in normal cerebral blood flow, such as in cerebral vasospasm, can induce neurological deficits. In nonpermeabilized cerebral vessels stimulated with U-46619, a stable mimetic of endogenous thromboxane A(2) implicated in the etiology of cerebral vasospasm, we observed significant increases in contractile force, RhoA activation, regulatory light chain phosphorylation, as well as phosphorylation of MYPT1 at Thr-696, Thr-853, and surprisingly Ser-695. Inhibition of nitric oxide signaling completely abrogated basal MYPT1 Ser-695 phosphorylation and significantly increased and potentiated U-46619-induced MYPT1 Thr-853 phosphorylation and contractile force, indicating that NO/cGMP/cGKI signaling maintains basal vascular tone through active inhibition of calcium sensitization. Surprisingly, a fall in Ser-695 phosphorylation did not result in an increase in phosphorylation of the Thr-696 site. Although activation of cGKI with exogenous cyclic nucleotides inhibited thromboxane A(2)-induced MYPT1 membrane association, RhoA activation, contractile force, and regulatory light chain phosphorylation, the anticipated decreases in MYPT1 phosphorylation at Thr-696/Thr-853 were not observed, indicating that the vasorelaxant effects of cGKI are not through dephosphorylation of MYPT1. Thus, thromboxane A2 signaling within the intact cerebral vasculature induces "buffered" vasoconstrictions, in which both the RhoA/Rho-kinase calcium-sensitizing and the NO/cGMP/cGKI calcium-desensitizing pathways are activated.	[Neppl, Ronald L.; Momotani, Ko; Somlyo, Avril V.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Neppl, Ronald L.; Somlyo, Avril V.] Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; [Lubomirov, Lubomir T.; Pfitzer, Gabriele] Univ Cologne, Inst Vegetat Physiol, D-50931 Cologne, Germany; [Eto, Masumi] Thomas Jefferson Univ, Dept Mol Physiol & Biophys, Philadelphia, PA 19107 USA	University of Virginia; University of Virginia; University of Cologne; Jefferson University	Somlyo, AV (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, POB 800736, Charlottesville, VA 22908 USA.	avs5u@virginia.edu	Neppl, Ronald L/AAW-1257-2020; Eto, Masumi/ABE-4700-2020	Neppl, Ronald L/0000-0003-1497-6058; Eto, Masumi/0000-0002-0651-5836	National Institutes of Health [PO1 HL19242, PO1 HL48807, RO1 HL83261]; Pennsylvania Department of Health CURE; medical faculty of the University of Cologne; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048807, R01HL083261, P01HL019242] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health CURE; medical faculty of the University of Cologne; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 HL19242, PO1 HL48807 ( to A. V. S.), RO1 HL83261, and PO1 HL48807. This work was also supported by a Pennsylvania Department of Health CURE Grant ( to M. E.) and grants from the medical faculty of the University of Cologne ( to G. P. and L. T. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ammendola A, 2001, J BIOL CHEM, V276, P24153, DOI 10.1074/jbc.M101530200; Bolz SS, 2003, CIRCULATION, V107, P3081, DOI 10.1161/01.CIR.0000074202.19612.8C; BOULANGER CM, 1995, HYPERTENSION, V26, P752, DOI 10.1161/01.HYP.26.5.752; BRADLEY AB, 1987, J PHYSIOL-LONDON, V385, P437, DOI 10.1113/jphysiol.1987.sp016500; BUTT E, 1994, J BIOL CHEM, V269, P14509; Choudhury N, 2004, J MUSCLE RES CELL M, V25, P657, DOI 10.1007/s10974-004-7807-x; Davidge ST, 2001, CIRC RES, V89, P650, DOI 10.1161/hh2001.098351; Dimopoulos GJ, 2007, CIRC RES, V100, P121, DOI 10.1161/01.RES.0000253902.90489.df; ELLIS EF, 1976, SCIENCE, V193, P1135, DOI 10.1126/science.959827; Eto M, 2007, STRUCTURE, V15, P1591, DOI 10.1016/j.str.2007.10.014; Etter EF, 2001, J BIOL CHEM, V276, P34681, DOI 10.1074/jbc.M104737200; Feng JH, 1999, J BIOL CHEM, V274, P37385, DOI 10.1074/jbc.274.52.37385; Fritsch RM, 2004, J BIOL CHEM, V279, P12551, DOI 10.1074/jbc.M313365200; Gong MC, 1997, J BIOL CHEM, V272, P10704; GRAY DW, 1992, BRIT J PHARMACOL, V107, P691, DOI 10.1111/j.1476-5381.1992.tb14508.x; HAMBERG M, 1975, P NATL ACAD SCI USA, V72, P2994, DOI 10.1073/pnas.72.8.2994; Hansen-Schwartz J, 2007, TRENDS PHARMACOL SCI, V28, P252, DOI 10.1016/j.tips.2007.04.002; HIMPENS B, 1990, PFLUG ARCH EUR J PHY, V417, P21, DOI 10.1007/BF00370764; Hofmann F, 2006, PHYSIOL REV, V86, P1, DOI 10.1152/physrev.00015.2005; Hou X, 2000, STROKE, V31, P516, DOI 10.1161/01.STR.31.2.516; Huang JS, 2004, CELL SIGNAL, V16, P521, DOI 10.1016/j.cellsig.2003.10.008; Ibarra-Alvarado C, 2002, MOL PHARMACOL, V61, P312, DOI 10.1124/mol.61.2.312; Ito M, 1997, BIOCHEMISTRY-US, V36, P7607, DOI 10.1021/bi9702647; Khatri JJ, 2001, J BIOL CHEM, V276, P37250, DOI 10.1074/jbc.M105275200; Khromov AS, 2006, P NATL ACAD SCI USA, V103, P2440, DOI 10.1073/pnas.0508566103; KITAZAWA T, 1991, J BIOL CHEM, V266, P1708; Koga Y, 2005, J BIOL CHEM, V280, P4983, DOI 10.1074/jbc.M410909200; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Lincoln TM, 2001, J APPL PHYSIOL, V91, P1421, DOI 10.1152/jappl.2001.91.3.1421; Lontay B, 2005, CELL SIGNAL, V17, P1265, DOI 10.1016/j.cellsig.2005.01.008; Lubomirov LT, 2006, CIRC RES, V98, P1159, DOI 10.1161/01.RES.0000219904.43852.3e; MacDonald JA, 2000, FEBS LETT, V479, P83, DOI 10.1016/S0014-5793(00)01884-6; Maguire JJ, 2005, TRENDS PHARMACOL SCI, V26, P448, DOI 10.1016/j.tips.2005.07.007; Manganello JM, 2003, J BIOL CHEM, V278, P124, DOI 10.1074/jbc.M209219200; Michael SK, 2008, P NATL ACAD SCI USA, V105, P6702, DOI 10.1073/pnas.0802128105; Miyamoto A, 2007, VASC PHARMACOL, V46, P85, DOI 10.1016/j.vph.2006.06.018; Muranyi A, 2005, FEBS LETT, V579, P6611, DOI 10.1016/j.febslet.2005.10.055; Muranyi A, 2002, BIOCHEM J, V366, P211, DOI 10.1042/BJ20020401; Muranyi A, 2001, FEBS LETT, V493, P80, DOI 10.1016/S0014-5793(01)02283-9; Murthy KS, 2006, ANNU REV PHYSIOL, V68, P345, DOI 10.1146/annurev.physiol.68.040504.094707; Nakamura K, 2007, CIRC RES, V101, P712, DOI 10.1161/CIRCRESAHA.107.153981; Nishizawa S, 2005, TRENDS CARDIOVAS MED, V15, P24, DOI 10.1016/j.tcm.2004.12.002; Nobe K, 2001, CIRC RES, V88, P1283, DOI 10.1161/hh1201.092035; Oelze M, 2000, CIRC RES, V87, P999, DOI 10.1161/01.RES.87.11.999; OKUBO S, 1994, BIOCHEM BIOPH RES CO, V200, P429, DOI 10.1006/bbrc.1994.1467; Reid HM, 2003, J BIOL CHEM, V278, P51190, DOI 10.1074/jbc.M309314200; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ren XD, 2004, J CELL SCI, V117, P3511, DOI 10.1242/jcs.01205; ROBERTSON BE, 1993, AM J PHYSIOL, V265, pC299; Rybalkin SD, 2003, CIRC RES, V93, P280, DOI 10.1161/01.RES.0000087541.15600.2B; Sausbier M, 2000, CIRC RES, V87, P825, DOI 10.1161/01.RES.87.9.825; Sauzeau V, 2000, J BIOL CHEM, V275, P21722, DOI 10.1074/jbc.M000753200; Sawada N, 2001, BIOCHEM BIOPH RES CO, V280, P798, DOI 10.1006/bbrc.2000.4194; Schlossmann J, 2000, NATURE, V404, P197, DOI 10.1038/35004606; Schnackenberg CG, 2000, AM J PHYSIOL-RENAL, V279, pF302, DOI 10.1152/ajprenal.2000.279.2.F302; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; Seko T, 2003, CIRC RES, V92, P411, DOI 10.1161/01.RES.0000059987.90200.44; Senba S, 1999, J BIOCHEM-TOKYO, V125, P354, DOI 10.1093/oxfordjournals.jbchem.a022294; Shimokawa H, 2005, ARTERIOSCL THROM VAS, V25, P1767, DOI 10.1161/01.ATV.0000176193.83629.c8; Shin HM, 2002, CIRC RES, V90, P546, DOI 10.1161/01.RES.0000012822.23273.EC; SHIRAHASE H, 1987, BLOOD VESSELS, V24, P117; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; SOMLYO AV, 1992, J BIOL CHEM, V267, P22316; Surks HK, 2003, J BIOL CHEM, V278, P51484, DOI 10.1074/jbc.M305622200; Surks HK, 2003, CELL SIGNAL, V15, P937, DOI 10.1016/S0898-6568(03)00057-3; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Suzuki H, 2006, ENDOCRINOLOGY, V147, P5914, DOI 10.1210/en.2006-0834; Tan I, 2001, J BIOL CHEM, V276, P21209, DOI 10.1074/jbc.M102615200; Tang M, 2003, NAT MED, V9, P1506, DOI 10.1038/nm958; UHLER MD, 1993, J BIOL CHEM, V268, P13586; van Lieshout JJ, 2003, J APPL PHYSIOL, V94, P833, DOI 10.1152/japplphysiol.00260.2002; Velasco G, 2002, FEBS LETT, V527, P101, DOI 10.1016/S0014-5793(02)03175-7; Walker LA, 2001, J BIOL CHEM, V276, P24519, DOI 10.1074/jbc.M103560200; Wilson DP, 2005, BIOCHEM J, V389, P763, DOI 10.1042/BJ20050237; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Wooldridge AA, 2004, J BIOL CHEM, V279, P34496, DOI 10.1074/jbc.M405957200; Wooldridge AA, 2008, J BIOL CHEM, V283, P11850, DOI 10.1074/jbc.M708628200; Worner R, 2007, AM J PHYSIOL-HEART C, V292, pH237, DOI 10.1152/ajpheart.00079.2006; Wu XQ, 1998, J BIOL CHEM, V273, P11362, DOI 10.1074/jbc.273.18.11362	80	43	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6348	6360		10.1074/jbc.M807040200	http://dx.doi.org/10.1074/jbc.M807040200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19095646	Green Published, hybrid			2022-12-25	WOS:000263742700038
J	Fenske, SA; Yesilaltay, A; Pal, R; Daniels, K; Barker, C; Quinones, V; Rigotti, A; Krieger, M; Kocher, O				Fenske, Sara A.; Yesilaltay, Ayce; Pal, Rinku; Daniels, Kathleen; Barker, Caroline; Quinones, Veronica; Rigotti, Attilio; Krieger, Monty; Kocher, Olivier			Normal Hepatic Cell Surface Localization of the High Density Lipoprotein Receptor, Scavenger Receptor Class B, Type I, Depends on All Four PDZ Domains of PDZK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SR-BI; CHYLOMICRON METABOLISM; TARGETED DISRUPTION; CHOLESTEROL EFFLUX; CONTAINING PROTEIN; LIPID-METABOLISM; APOLIPOPROTEIN-E; EXPRESSION; MICE; LIVER	PDZK1 is a four PDZ domain-containing scaffold protein that binds to scavenger receptor class B, type I (SR-BI), the high density lipoprotein receptor, by its first PDZ domain (PDZ1). PDZK1 knock-out mice exhibit a >95% decrease in hepatic SR-BI protein and consequently an similar to 70% increase in plasma cholesterol in abnormally large high density lipoprotein particles. These defects are corrected by hepatic overexpression of full-length PDZK1 but not the PDZ1 domain alone, which partially restores SR-BI protein abundance but not cell surface expression or function. We have generated PDZK1 knock-out mice with hepatic expression of four PDZK1 transgenes encoding proteins with nested C-terminal truncations: pTEM, which lacks the three C-terminal residues (putative PDZ-binding motif), and PDZ1.2, PDZ1.2.3, or PDZ1.2.3.4, which contain only the first two, three, or four N-terminalPDZ domains, respectively, but not the remaining C-terminal sequences. Hepatic overexpression of pTEM restored normal hepatic SR-BI abundance, localization, and function. Hepatic overexpression of PDZ1.2 or PDZ1.2.3 partially restored SR-BI abundance (similar to 12 or similar to 30% of wild type, respectively) but did not (PDZ1.2) or only slightly (PDZ1.2.3) restored hepatic SR-BI cell surface localization and function. Hepatic overexpression of PDZ1.2.3.4 completely restored SR-BI protein abundance, cell surface expression, and function (normalization of plasma cholesterol levels). Thus, all four PDZ domains in PDZK1, but not PDZ1-3 alone, are sufficient for its normal control of the abundance, localization, and therefore function of hepatic SR-BI, whereas the residues C-terminal to the PDZ4 domain, including the C-terminal putative PDZ-binding domain, are not required.	[Fenske, Sara A.; Yesilaltay, Ayce; Barker, Caroline; Krieger, Monty] MIT, Dept Biol, Cambridge, MA 02139 USA; [Pal, Rinku; Daniels, Kathleen; Kocher, Olivier] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Pal, Rinku; Daniels, Kathleen; Kocher, Olivier] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Quinones, Veronica; Rigotti, Attilio] Pontificia Univ Catolica Chile, Dept Gastroenterol, Fac Med, Santiago 8330024, Chile	Massachusetts Institute of Technology (MIT); Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Pontificia Universidad Catolica de Chile	Krieger, M (corresponding author), MIT, Dept Biol, Rm 68-483,77 Massachusetts Ave, Cambridge, MA 02139 USA.	krieger@mit.edu			National Institutes of Health [HL077780]; Clinical Translational Science Award [1UL1RR025758-01]; Fondo Nacional de Desarrollo Cientifico y Tecnologico [1070634];  [HL64737];  [HL52212];  [HL66105]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052212, R01HL077780, P01HL066105, R01HL064737] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical Translational Science Award; Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL077780 (to O.K.); Grants HL64737, HL52212, and HL66105 (to M. K.); and Clinical Translational Science Award Grant 1UL1RR025758-01 (to the Massachusetts Institute of Technology). This work was also supported by4Grant 1070634 (to A.R.).	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; ACTON SL, 1994, J BIOL CHEM, V269, P21003; Braun A, 2003, P NATL ACAD SCI USA, V100, P7283, DOI 10.1073/pnas.1237725100; Eckhardt ERM, 2006, J BIOL CHEM, V281, P4348, DOI 10.1074/jbc.M513154200; Eckhardt ERM, 2004, J BIOL CHEM, V279, P14372, DOI 10.1074/jbc.M313793200; Fenske SA, 2008, J BIOL CHEM, V283, P22097, DOI 10.1074/jbc.M800029200; Fu T, 2003, J BIOL CHEM, V278, P52559, DOI 10.1074/jbc.M310892200; Gisler SM, 2003, KIDNEY INT, V64, P1733, DOI 10.1046/j.1523-1755.2003.00266.x; GLASS C, 1983, P NATL ACAD SCI-BIOL, V80, P5435, DOI 10.1073/pnas.80.17.5435; Gomperts SN, 1996, CELL, V84, P659, DOI 10.1016/S0092-8674(00)81043-0; Guo Q, 1996, J BIOL CHEM, V271, P11191, DOI 10.1074/jbc.271.19.11191; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Ikemoto M, 2000, P NATL ACAD SCI USA, V97, P6538, DOI 10.1073/pnas.100114397; Ji Y, 1997, J BIOL CHEM, V272, P20982, DOI 10.1074/jbc.272.34.20982; Jian B, 1998, J BIOL CHEM, V273, P5599, DOI 10.1074/jbc.273.10.5599; Kocher O, 1998, LAB INVEST, V78, P117; Kocher O, 2003, J BIOL CHEM, V278, P52820, DOI 10.1074/jbc.M310482200; Kocher O, 2003, MOL CELL BIOL, V23, P1175, DOI 10.1128/MCB.23.4.1175-1180.2003; Kocher O, 1999, LAB INVEST, V79, P1161; Nakamura T, 2005, P NATL ACAD SCI USA, V102, P13404, DOI 10.1073/pnas.0506679102; Out R, 2005, J LIPID RES, V46, P1172, DOI 10.1194/jlr.M400361-JLR200; Out R, 2004, J BIOL CHEM, V279, P18401, DOI 10.1074/jbc.M401170200; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; REAVEN E, 1984, J CLIN INVEST, V74, P1384, DOI 10.1172/JCI111549; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Silver DL, 2002, J BIOL CHEM, V277, P34042, DOI 10.1074/jbc.M206584200; SIMONET WS, 1993, J BIOL CHEM, V268, P8221; STEIN Y, 1983, BIOCHIM BIOPHYS ACTA, V752, P98, DOI 10.1016/0005-2760(83)90237-0; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; Van Eck M, 2003, J BIOL CHEM, V278, P23699, DOI 10.1074/jbc.M211233200; Van Eck M, 2008, J LIPID RES, V49, P136, DOI 10.1194/jlr.M700355-JLR200; Wang PJ, 2005, J BIOL CHEM, V280, P30143, DOI 10.1074/jbc.M503969200; Webb NR, 1998, J BIOL CHEM, V273, P15241, DOI 10.1074/jbc.273.24.15241; Webb NR, 1997, J LIPID RES, V38, P1490; Yesilaltay A, 2006, ENDOCRINOLOGY, V147, P1577, DOI 10.1210/en.2005-1286; Yesilaltay A, 2005, CURR OPIN LIPIDOL, V16, P147, DOI 10.1097/01.mol.0000162319.54795.e5; Yesilaltay A, 2006, J BIOL CHEM, V281, P28975, DOI 10.1074/jbc.M603802200; Zhang XH, 2007, ENDOCRINOLOGY, V148, P5295, DOI 10.1210/en.2007-0376	39	32	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5797	5806		10.1074/jbc.M808211200	http://dx.doi.org/10.1074/jbc.M808211200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19116202	Green Published, hybrid			2022-12-25	WOS:000263560600043
J	Tvorogov, D; Sundvall, M; Kurppa, K; Hollmen, M; Repo, S; Johnson, MS; Elenius, K				Tvorogov, Denis; Sundvall, Maria; Kurppa, Kari; Hollmen, Maija; Repo, Susanna; Johnson, Mark S.; Elenius, Klaus			Somatic Mutations of ErbB4 SELECTIVE LOSS-OF-FUNCTION PHENOTYPE AFFECTING SIGNAL TRANSDUCTION PATHWAYS IN CANCER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE DOMAIN; LUNG-CANCER; INTRACELLULAR DOMAIN; RECEPTOR; GROWTH; ACTIVATION; EGFR; MECHANISM; ISOFORM; PHOSPHORYLATION	Cancer drugs targeting ErbB receptors, such as epidermal growth factor receptor and ErbB2, are currently in clinical use. However, the role of ErbB4 as a potential cancer drug target has remained controversial. Recently, somatic mutations altering the coding region of ErbB4 were described in patients with breast, gastric, colorectal, or non-small cell lung cancer, but the functional significance of these mutations is unknown. Here we demonstrate that 2 of 10 of the cancer-associated mutations of ErbB4 lead to loss of ErbB4 kinase activity due to disruption of functionally important structural features. Interestingly, the kinase-dead ErbB4 mutants were as efficient as wild-type ErbB4 in forming a heterodimeric neuregulin receptor with ErbB2 and promoting phosphorylation of Erk1/2 and Akt in an ErbB2 kinase-dependent manner. However, the mutant ErbB4 receptors failed to phosphorylate STAT5 and suppressed differentiation of MDA-MB-468 mammary carcinoma cells. These findings suggest that the somatic ErbB4 mutations have functional consequences and lead to selective changes in ErbB4 signaling.	[Tvorogov, Denis; Sundvall, Maria; Kurppa, Kari; Hollmen, Maija; Elenius, Klaus] Univ Turku, Dept Med Biochem & Genet, FIN-20520 Turku, Finland; [Tvorogov, Denis; Sundvall, Maria; Kurppa, Kari; Hollmen, Maija; Elenius, Klaus] Univ Turku, MediCity Res Lab, FIN-20520 Turku, Finland; [Repo, Susanna; Johnson, Mark S.] Abo Akad Univ, Dept Biochem & Pharm, Struct Bioinformat Lab, FIN-20520 Turku, Finland; [Hollmen, Maija] Turku Grad Sch Biomed Sci, FIN-20520 Turku, Finland; [Elenius, Klaus] Turku Univ Hosp, Dept Oncol, FIN-20520 Turku, Finland	University of Turku; University of Turku; Abo Akademi University; University of Turku; University of Turku	Elenius, K (corresponding author), Univ Turku, Dept Med Biochem & Genet, Kiinanmyllynkatu 10, FIN-20520 Turku, Finland.	klaus.elenius@utu.fi	Hollmén, Maija/B-5831-2017; Elenius, Klaus/AAI-7594-2021	Hollmén, Maija/0000-0002-3250-7653; Elenius, Klaus/0000-0001-5700-0827; Sundvall, Maria H/0000-0002-0494-2965; Kurppa, Kari/0000-0001-8286-2429; Tvorogov, Denis/0000-0002-2009-1347; Susanna, Repo/0000-0003-3488-4767	Academy of Finland,; Finnish Cancer Organizations; Finnish Cultural Foundation; Foundation for the Finnish Cancer Institute; Foundation of Abo Akademi University; Oscar Oflund's Foundation; Tor, Joe and Pentti Borg's Memorial Fund; Sigrid Juselius Foundation; TEKES National Agency for Technology; Turku University Central Hospital	Academy of Finland,(Academy of FinlandEuropean Commission); Finnish Cancer Organizations; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Foundation for the Finnish Cancer Institute; Foundation of Abo Akademi University; Oscar Oflund's Foundation; Tor, Joe and Pentti Borg's Memorial Fund; Sigrid Juselius Foundation(Sigrid Juselius Foundation); TEKES National Agency for Technology(Finnish Funding Agency for Technology & Innovation (TEKES)); Turku University Central Hospital	This work was supported by the Academy of Finland, Finnish Cancer Organizations, Finnish Cultural Foundation, Foundation for the Finnish Cancer Institute, Foundation of Abo Akademi University ( Center of Excellence Program in Cell Stress), Oscar Oflund's Foundation, Tor, Joe and Pentti Borg's Memorial Fund, Sigrid Juselius Foundation, TEKES National Agency for Technology, and Turku University Central Hospital. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Brignola PS, 2002, J BIOL CHEM, V277, P1576, DOI 10.1074/jbc.M105907200; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; DeLano W. L., 2007, PYMOL MOL GRAPHICS S; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Du X, 2004, GENETICS, V166, P331, DOI 10.1534/genetics.166.1.331; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gullick WJ, 2003, J PATHOL, V200, P279, DOI 10.1002/path.1335; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Johnson M. S., 2000, BIOINFORMATICS SEQUE, P15; Jones FE, 1999, J CELL BIOL, V147, P77, DOI 10.1083/jcb.147.1.77; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Junttila TT, 2005, CANCER RES, V65, P1384, DOI 10.1158/0008-5472.CAN-04-3150; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Linggi B, 2006, J BIOL CHEM, V281, P25373, DOI 10.1074/jbc.M603998200; Liu B, 2006, PROTEINS, V65, P331, DOI 10.1002/prot.21111; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maatta JA, 2006, MOL BIOL CELL, V17, P67, DOI 10.1091/mbc.E05-05-0402; Muraoka-Cook RS, 2006, MOL BIOL CELL, V17, P4118, DOI 10.1091/mbc.E06-02-0101; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Pircher TJ, 1997, MOL CELL ENDOCRINOL, V133, P169, DOI 10.1016/S0303-7207(97)00164-0; PLOWMAN GD, 1993, P NATL ACAD SCI USA, V90, P1746, DOI 10.1073/pnas.90.5.1746; Qiu C, 2008, STRUCTURE, V16, P460, DOI 10.1016/j.str.2007.12.016; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schulze WX, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100012; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Soung YH, 2006, INT J CANCER, V118, P1426, DOI 10.1002/ijc.21507; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Sundvall M, 2007, ONCOGENE, V26, P6905, DOI 10.1038/sj.onc.1210501; Sundvall M, 2008, J MAMMARY GLAND BIOL, V13, P259, DOI 10.1007/s10911-008-9079-3; Sundvall M, 2008, P NATL ACAD SCI USA, V105, P4162, DOI 10.1073/pnas.0708333105; TIMMS JF, 1995, BIOCHEM J, V308, P219, DOI 10.1042/bj3080219; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang SZE, 2006, CANCER CELL, V10, P25, DOI 10.1016/j.ccr.2006.05.023; Weihua Z, 2008, CANCER CELL, V13, P385, DOI 10.1016/j.ccr.2008.03.015; Williams CC, 2004, J CELL BIOL, V167, P469, DOI 10.1083/jcb.200403155; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhang Q, 2007, NAT MED, V13, P1341, DOI 10.1038/nm1659; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	49	51	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5582	5591		10.1074/jbc.M805438200	http://dx.doi.org/10.1074/jbc.M805438200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19098003	hybrid			2022-12-25	WOS:000263560600021
J	Darbellay, B; Arnaudeau, S; Konig, S; Jousset, H; Bader, C; Demaurex, N; Bernheim, L				Darbellay, Basile; Arnaudeau, Serge; Koenig, Stephane; Jousset, Helene; Bader, Charles; Demaurex, Nicolas; Bernheim, Laurent			STIM1-and Orai1-dependent Store-operated Calcium Entry Regulates Human Myoblast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ CHANNELS; PORE SUBUNIT; MICE LACKING; CRAC CHANNEL; K+ CURRENT; T-CELLS; HYPERPOLARIZATION; ACTIVATION; FUSION; SENSOR	Our previous work on human myoblasts suggested that a hyperpolarization followed by a rise in [Ca2(+)](in) involving store-operated Ca2+ entry (SOCE) channels induced myoblast differentiation. Advances in the understanding of the SOCE pathway led us to examine more precisely its role in post-natal human myoblast differentiation. We found that SOCE orchestrated by STIM1, the endoplasmic reticulum Ca2+ sensor activating Orai Ca2+ channels, is crucial. Silencing STIM1, Orai1, or Orai3 reduced SOCE amplitude and myoblast differentiation, whereas Orai2 knockdown had no effect. Conversely, overexpression of STIM1 with Orai1 increased SOCE and accelerated myoblast differentiation. STIM1 or Orai1 silencing decreased resting [Ca2+](in) and intracellular Ca2+ store content, but correction of these parameters did not rescue myoblast differentiation. Remarkably, SOCE amplitude correlated linearly with the expression of two early markers of myoblast differentiation, MEF2 and myogenin, regardless of the STIM1 or Orai isoform that was silenced. Unexpectedly, we found that the hyperpolarization also depends on SOCE, placing SOCE upstream of K+ channel activation in the signaling cascade that controls myoblast differentiation. These findings indicate that STIM1 and Orai1 are key molecules for the induction of human myoblast differentiation.	[Arnaudeau, Serge; Koenig, Stephane; Bernheim, Laurent] Univ Geneva, Fac Med, Dept Basic Neurosci, CH-1211 Geneva 4, Switzerland; [Darbellay, Basile; Bader, Charles] Univ Geneva, Fac Med, Dept Clin Neurosci, CH-1211 Geneva 4, Switzerland; [Arnaudeau, Serge; Jousset, Helene; Demaurex, Nicolas] Univ Geneva, Fac Med, Dept Cell Physiol & Metab, CH-1211 Geneva 4, Switzerland	University of Geneva; University of Geneva; University of Geneva	Bernheim, L (corresponding author), Univ Geneva, Fac Med, Dept Basic Neurosci, Rue Michel Servet 1, CH-1211 Geneva 4, Switzerland.	laurent.bernheim@unige.ch	Darbellay, Basile/B-1708-2018	Demaurex, Nicolas/0000-0002-9933-6772; Koenig, Stephane/0000-0002-0801-279X	Fonds National Suisse pour la Recherche Scientifique [3100A0-105331, 3100A0-118393]; Fondation Suisse pour la Recherche sur les Maladies Musculaires; Association Francaise contre les Myopathies; Fondation Marcel Levaillant	Fonds National Suisse pour la Recherche Scientifique; Fondation Suisse pour la Recherche sur les Maladies Musculaires; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Fondation Marcel Levaillant	This work was supported by Fonds National Suisse pour la Recherche Scientifique Grants 3100A0-105331 ( to L. B.) and 3100A0-118393 ( to N.D.), the Fondation Suisse pour la Recherche sur les Maladies Musculaires, the Association Francaise contre les Myopathies, and the Fondation Marcel Levaillant.	Arnaudeau S, 2006, J CELL PHYSIOL, V208, P435, DOI 10.1002/jcp.20679; Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; BAROFFIO A, 1993, MUSCLE NERVE, V16, P498, DOI 10.1002/mus.880160511; Bijlenga P, 1998, J PHYSIOL-LONDON, V512, P317, DOI 10.1111/j.1469-7793.1998.317be.x; Bijlenga P, 2000, P NATL ACAD SCI USA, V97, P7627, DOI 10.1073/pnas.97.13.7627; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Demaurex N, 2005, CELL CALCIUM, V38, P213, DOI 10.1016/j.ceca.2005.06.026; Demaurex N, 2003, CELL CALCIUM, V34, P109, DOI 10.1016/S0143-4160(03)00081-2; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Espinos E, 2001, NEUROMUSCULAR DISORD, V11, P341, DOI 10.1016/S0960-8966(00)00204-2; Feske S, 1996, EUR J IMMUNOL, V26, P2119, DOI 10.1002/eji.1830260924; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Fischer-Lougheed J, 2001, J CELL BIOL, V153, P677, DOI 10.1083/jcb.153.4.677; Grosse J, 2007, J CLIN INVEST, V117, P3540, DOI 10.1172/JCI32312; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Gwack Y, 2008, MOL CELL BIOL, V28, P5209, DOI 10.1128/MCB.00360-08; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; HAMANN M, 1994, J PHYSIOL-LONDON, V475, P305, DOI 10.1113/jphysiol.1994.sp020071; Hinard V, 2008, DEVELOPMENT, V135, P859, DOI 10.1242/dev.011387; Hogan PG, 2007, TRENDS BIOCHEM SCI, V32, P235, DOI 10.1016/j.tibs.2007.03.009; Jousset H, 2007, J BIOL CHEM, V282, P11456, DOI 10.1074/jbc.M609551200; Konig S, 2004, J BIOL CHEM, V279, P28187, DOI 10.1074/jbc.M313932200; Konig S, 2006, DEVELOPMENT, V133, P3107, DOI 10.1242/dev.02479; Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012; Lewis RS, 2003, BIOCHEM SOC T, V31, P925; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Liu JH, 1998, J PHYSIOL-LONDON, V510, P467, DOI 10.1111/j.1469-7793.1998.467bk.x; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; O'Connor RS, 2007, J CELL SCI, V120, P149, DOI 10.1242/jcs.03307; Occhiodoro T, 1998, FEBS LETT, V434, P177, DOI 10.1016/S0014-5793(98)00973-9; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Putney JW, 2007, J CELL SCI, V120, P1959, DOI 10.1242/jcs.03462; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Schindl R, 2008, J BIOL CHEM, V283, P20261, DOI 10.1074/jbc.M803101200; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Stiber J, 2008, NAT CELL BIOL, V10, P688, DOI 10.1038/ncb1731; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Varga-Szabo D, 2008, J EXP MED, V205, P1583, DOI 10.1084/jem.20080302; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Vig M, 2007, CELL CALCIUM, V42, P157, DOI 10.1016/j.ceca.2007.03.008; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103	49	110	111	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5370	5380		10.1074/jbc.M806726200	http://dx.doi.org/10.1074/jbc.M806726200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19088073	hybrid			2022-12-25	WOS:000263416600067
J	Lauer, ME; Fulop, C; Mukhopadhyay, D; Comhair, S; Erzurum, SC; Hascall, VC				Lauer, Mark E.; Fulop, Csaba; Mukhopadhyay, Durba; Comhair, Suzy; Erzurum, Serpil C.; Hascall, Vincent C.			Airway Smooth Muscle Cells Synthesize Hyaluronan Cable Structures Independent of Inter-alpha-inhibitor Heavy Chain Attachment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; TRYPSIN INHIBITOR; EXTRACELLULAR-MATRIX; LEUKOCYTE ADHESION; EPITHELIAL-CELLS; VIRUS-INFECTION; SHAP; COMPLEX; PROTEIN; SERUM	The covalent association of inter-alpha-inhibitor-derived heavy chains (HCs) with hyaluronan was first described in synovial fluid from arthritic patients and later described as a structural and functional component of hyaluronan "cable" structures produced by many different cells and stimuli. HC transfer has been shown to be mediated by the protein product of TSG-6 (tumor necrosis factor-stimulated gene 6). Considering the accumulation of hyaluronan in airways following asthmatic attacks and the subsequent infiltration of leukocytes, we sought to characterize HC substitution of hyaluronan "cables" in primary mouse airway smooth muscle cells (MASM) and primary human airway smooth muscle cells (HASM). We found that cells derived from mice lacking TSG-6 had no defect in hyaluronan production or hyaluronan-mediated leukocyte adhesion when treated with the viral mimic poly(I,C). Functional hyaluronan cables were induced by cycloheximide in the confirmed absence of protein synthesis, with or without simultaneous treatment with poly(I, C). We characterized the species specificity of the antibody other investigators used to describe the HC-hyaluronan complex of hyaluronan cables and found minimal affinity to bovine-derived HCs in contrast to HCs from mouse and human sera. Thus, we cultured MASM and HASM cells in serum from these three sources and analyzed hyaluronan extracts for HCs and other hyaluronan-binding proteins, using parallel cumulus cell-oocyte complex (COC) extracts as positive controls. We conclude that, if hyaluronan cables derived from MASM and HASM cells are substituted with HCs, the amount of substitution is significantly below the limit of detection when compared with COC extracts of similar hyaluronan mass.	[Lauer, Mark E.; Fulop, Csaba; Mukhopadhyay, Durba; Hascall, Vincent C.] Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44195 USA; [Comhair, Suzy; Erzurum, Serpil C.] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Hascall, VC (corresponding author), Cleveland Clin, Dept Biomed Engn ND20, Cleveland, OH 44195 USA.	hascalv@ccf.org			National Institutes of Health [PO1 HL081064]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL081064] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant PO1 HL081064 ( Pathology of Asthma).	Al'Qteishat A, 2006, BRAIN, V129, P2158, DOI 10.1093/brain/awl139; Calabro A, 2000, GLYCOBIOLOGY, V10, P273, DOI 10.1093/glycob/10.3.273; Cowman MK, 2005, CARBOHYD RES, V340, P791, DOI 10.1016/j.carres.2005.01.022; Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; DELAMOTTE CA, 2000, HYALURONAN 2000, P381; Forteza R, 2007, AM J RESP CELL MOL, V36, P20, DOI 10.1165/rcmb.2006-0018OC; Fries E, 2003, ACTA BIOCHIM POL, V50, P735; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; HUANG L, 1993, J BIOL CHEM, V268, P26725; Jessen TE, 2003, REPRODUCTION, V125, P27, DOI 10.1530/rep.0.1250027; Kida D, 1999, J RHEUMATOL, V26, P1230; Kishida T, 2008, CONNECT TISSUE RES, V49, P105, DOI 10.1080/03008200701818629; Lauer ME, 2008, J BIOL CHEM, V283, P26283, DOI 10.1074/jbc.M803350200; Lauer ME, 2009, J BIOL CHEM, V284, P5299, DOI 10.1074/jbc.M807965200; Majors AK, 2003, J BIOL CHEM, V278, P47223, DOI 10.1074/jbc.M304871200; Milner CM, 2007, BIOCHEM SOC T, V35, P672, DOI 10.1042/BST0350672; Mukhopadhyay D, 2004, J BIOL CHEM, V279, P11119, DOI 10.1074/jbc.M313471200; Mukhopadhyay D, 2001, ARCH BIOCHEM BIOPHYS, V394, P173, DOI 10.1006/abbi.2001.2552; Obayashi Y, 2008, ONCOL REP, V19, P1245; Selbi W, 2006, KIDNEY INT, V70, P1287, DOI 10.1038/sj.ki.5001760; Selbi W, 2004, J AM SOC NEPHROL, V15, P1199, DOI 10.1097/01.ASN.0000125619.27422.8E; Shen L, 2006, HEPATOL RES, V34, P178, DOI 10.1016/j.hepres.2005.12.008; Shi T, 2006, MOL PHARMACOL, V70, P129, DOI 10.1124/mol.105.020735; Wang AM, 2004, J BIOL CHEM, V279, P10279, DOI 10.1074/jbc.M312045200; Wisniewski HG, 2004, CYTOKINE GROWTH F R, V15, P129, DOI 10.1016/j.cytogfr.2004.01.005; ZHAO M, 1995, J BIOL CHEM, V270, P26657, DOI 10.1074/jbc.270.44.26657; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200; Zhuo LS, 2001, J BIOL CHEM, V276, P7693, DOI 10.1074/jbc.C000899200	30	32	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5313	5323		10.1074/jbc.M807979200	http://dx.doi.org/10.1074/jbc.M807979200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19075022	Green Published, hybrid			2022-12-25	WOS:000263416600061
J	Hirschler-Laszkiewicz, I; Tong, Q; Conrad, K; Zhang, WY; Flint, WW; Barber, AJ; Barber, DL; Cheung, JY; Miller, BA				Hirschler-Laszkiewicz, Iwona; Tong, Qin; Conrad, Kathleen; Zhang, Wenyi; Flint, Wesley W.; Barber, Alistair J.; Barber, Dwayne L.; Cheung, Joseph Y.; Miller, Barbara A.			TRPC3 Activation by Erythropoietin Is Modulated by TRPC6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ERYTHROID PRECURSORS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; CA2+-PERMEABLE CATION CHANNEL; MURINE ERYTHROLEUKEMIA-CELLS; FREE CALCIUM-CONCENTRATION; PLASMA-MEMBRANE; LIVING CELLS; FUNCTIONAL-CHARACTERIZATION; PHYSIOLOGICAL RELEVANCE; SIGNAL-TRANSDUCTION	Regulation of intracellular calcium ([Ca2+](i)) by erythropoietin (Epo) is an essential part of signaling pathways controlling proliferation and differentiation of erythroid progenitors, but regulatory mechanisms are largely unknown. TRPC3 and the homologous TRPC6 are two members of the transient receptor potential channel (TRPC) superfamily that are expressed on normal human erythroid precursors. Here we show that TRPC3 expression increases but TRPC6 decreases during erythroid differentiation. This is associated with a significantly greater increase in [Ca2+](i) in response to Epo stimulation, suggesting that the ratio of TRPC3/TRPC6 is physiologically important. In HEK 293T cells heterologously expressing TRPC and erythropoietin receptor (Epo-R), Epo stimulated an increase in [Ca2+](i) through TRPC3 but not TRPC6. Replacement of the C terminus of TRPC3 with the TRPC6 C terminus (TRPC3-C6C) resulted in loss of activation by Epo. In contrast, substitution of the C terminus of TRPC6 with that of TRPC3 (TRPC6-C3C) resulted in an increase in [Ca2+](i) in response to Epo. Substitution of the N termini had no effect. Domains in the TRPC3 C terminus between amino acids 671 and 746 are critical for the response to Epo. Epo-R and phospholipase C gamma associated with TRPC3, and these interactions were significantly reduced with TRPC6 and TRPC3-C6C chimeras. TRPC3 and TRPC6 form heterotetramers. Coexpression of TRPC6 or C3/C6 chimeras with TRPC3 and Epo-R inhibited the Epo-stimulated increase in [Ca2+](i). In a heterologous expression system, Epo stimulation increased cell surface expression of TRPC3, which was inhibited by TRPC6. However, in primary erythroblasts, an increase in TRPC3 cell surface expression was not observed in erythroblasts in which Epo stimulated an increase in [Ca2+](i), demonstrating that increased membrane insertion of TRPC3 is not required. These data demonstrate that TRPC6 regulates TRPC3 activation by Epo. Endogenously, regulation of TRPC3 by TRPC6 may primarily be through modulation of signaling mechanisms, including reduced interaction of TRPC6 with phospholipase C gamma and Epo-R.	[Miller, Barbara A.] Penn State Univ, Milton S Hershey Med Ctr, Dept Pediat, Coll Med, Hershey, PA 17033 USA; [Barber, Alistair J.] Penn State Univ, Dept Ophthalmol, Coll Med, Hershey, PA 17033 USA; [Miller, Barbara A.] Penn State Univ, Dept Biochem & Mol Biol, Coll Med, Hershey, PA 17033 USA; [Barber, Dwayne L.] Ontario Canc Inst, Div Stem Cells & Dev Biol, Toronto, ON M5G 2M9, Canada; [Cheung, Joseph Y.] Thomas Jefferson Univ, Jefferson Med Coll, Dept Med, Philadelphia, PA 19107 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Jefferson University	Miller, BA (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Dept Pediat, Coll Med, POB 850, Hershey, PA 17033 USA.	bmiller3@psu.edu		Barber, Alistair/0000-0003-4235-2293; Barber, Dwayne/0000-0001-5528-8150	National Institutes of Health [R01 DK46778, R01 HL58672, R01 HL74854]; Four Diamonds Fund of the Pennsylvania State University College of Medicine; Canadian Institute for Health Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074854, R01HL058672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046778] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Four Diamonds Fund of the Pennsylvania State University College of Medicine; Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK46778 (to B. A. M.) and R01 HL58672 and R01 HL74854 (to J.Y.C.). This work was also supported by the Four Diamonds Fund of the Pennsylvania State University College of Medicine and by the Canadian Institute for Health Research (to D. L. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ANAGNOSTOU A, 1990, P NATL ACAD SCI USA, V87, P5978, DOI 10.1073/pnas.87.15.5978; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Bogoyevitch MA, 2004, CARDIOVASC RES, V63, P208, DOI 10.1016/j.cardiores.2004.03.017; Bony V, 1999, BRIT J HAEMATOL, V107, P263, DOI 10.1046/j.1365-2141.1999.01721.x; Boulay G, 2002, CELL CALCIUM, V32, P201, DOI 10.1016/S0143416002001550; Cayouette S, 2004, J BIOL CHEM, V279, P7241, DOI 10.1074/jbc.M312042200; Cayouette S, 2007, CELL CALCIUM, V42, P225, DOI 10.1016/j.ceca.2007.01.014; Cheung JY, 1997, BLOOD, V89, P92, DOI 10.1182/blood.V89.1.92.92_92_100; CHEUNG JY, 1992, J CLIN INVEST, V90, P1850, DOI 10.1172/JCI116061; Chu X, 2004, J BIOL CHEM, V279, P10514, DOI 10.1074/jbc.M308478200; Chu X, 2002, J BIOL CHEM, V277, P34375, DOI 10.1074/jbc.M205541200; Dietrich A, 2005, PFLUG ARCH EUR J PHY, V451, P72, DOI 10.1007/s00424-005-1460-0; Dietrich A, 2005, N-S ARCH PHARMACOL, V371, P257, DOI 10.1007/s00210-005-1052-8; Eder P., 2007, V179, P77; FRASER JK, 1989, EXP HEMATOL, V17, P10; Garcia-Sanz N, 2007, J NEUROSCI, V27, P11641, DOI 10.1523/JNEUROSCI.2457-07.2007; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; GILLO B, 1993, BLOOD, V81, P783; Goel M, 2006, AM J PHYSIOL-RENAL, V290, pF1241, DOI 10.1152/ajprenal.00376.2005; Goel M, 2002, J BIOL CHEM, V277, P48303, DOI 10.1074/jbc.M207882200; Goel M, 2007, AM J PHYSIOL-RENAL, V293, pF1476, DOI 10.1152/ajprenal.00186.2007; Gomez CY, 2006, J VIROL, V80, P8796, DOI 10.1128/JVI.02159-05; Hasselblatt M, 2006, J NEUROSURG ANESTH, V18, P132, DOI 10.1097/00008506-200604000-00007; HENSOLD JO, 1991, BLOOD, V77, P1362; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Huang WC, 2007, CELL CALCIUM, V42, P1, DOI 10.1016/j.ceca.2006.11.002; Inoue R, 2001, CIRC RES, V88, P325, DOI 10.1161/01.RES.88.3.325; Jia YC, 2007, NAT NEUROSCI, V10, P559, DOI 10.1038/nn1870; Kawasaki BT, 2006, P NATL ACAD SCI USA, V103, P335, DOI 10.1073/pnas.0508030102; KUREBAYASHI N, 1993, BIOPHYS J, V64, P1934, DOI 10.1016/S0006-3495(93)81564-9; Kwon Y, 2007, MOL CELL, V25, P491, DOI 10.1016/j.molcel.2007.01.021; LEVENSON R, 1980, P NATL ACAD SCI-BIOL, V77, P5948, DOI 10.1073/pnas.77.10.5948; Liu DY, 2007, J HYPERTENS, V25, P799, DOI 10.1097/HJH.0b013e32803cae2b; Manolis Antonis S., 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P355, DOI 10.2174/156800605774370326; Maruyama Y, 2007, J BIOL CHEM, V282, P36961, DOI 10.1074/jbc.M705694200; MASUDA S, 1993, J BIOL CHEM, V268, P11208; May KA, 2008, CANCER RES, V68, P4013, DOI 10.1158/0008-5472.CAN-07-3324; Mei ZZ, 2006, J BIOL CHEM, V281, P38748, DOI 10.1074/jbc.M607591200; MILLER BA, 1989, BLOOD, V73, P1188; Miller BA, 1999, J BIOL CHEM, V274, P20465, DOI 10.1074/jbc.274.29.20465; MILLER BA, 1988, J CLIN INVEST, V82, P309, DOI 10.1172/JCI113588; Miller BA, 1996, J CLIN INVEST, V98, P1728, DOI 10.1172/JCI118971; Mio K, 2007, J MOL BIOL, V367, P373, DOI 10.1016/j.jmb.2006.12.043; MISITI J, 1979, J CLIN INVEST, V64, P1573, DOI 10.1172/JCI109618; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Ogilvie M, 2000, J BIOL CHEM, V275, P39754, DOI 10.1074/jbc.M004999200; Peppiatt-Wildman CM, 2007, J PHYSIOL-LONDON, V580, P755, DOI 10.1113/jphysiol.2006.126656; Phelps CB, 2007, J BIOL CHEM, V282, P36474, DOI 10.1074/jbc.M707205200; Pope SH, 2000, EUR J HAEMATOL, V64, P292, DOI 10.1034/j.1600-0609.2000.90032.x; Reaves BJ, 2007, BIOCHEM SOC T, V35, P77, DOI 10.1042/BST0350077; Reits EAJ, 2001, NAT CELL BIOL, V3, pE145, DOI 10.1038/35078615; Richmond TD, 2005, TRENDS CELL BIOL, V15, P146, DOI 10.1016/j.tcb.2005.01.007; Rossert J, 2005, NEPHROL DIAL TRANSPL, V20, P1025, DOI 10.1093/ndt/gfh800; SAWYER ST, 1989, BLOOD, V74, P103; Singh BB, 2004, MOL CELL, V15, P635, DOI 10.1016/j.molcel.2004.07.010; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Smyth JT, 2006, J BIOL CHEM, V281, P11712, DOI 10.1074/jbc.M510541200; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Tang J, 2001, J BIOL CHEM, V276, P21303, DOI 10.1074/jbc.M102316200; Tong Q, 2008, J BIOL CHEM, V283, P10385, DOI 10.1074/jbc.M710231200; Uemura T, 2005, BIOCHEM BIOPH RES CO, V328, P1232, DOI 10.1016/j.bbrc.2005.01.086; van Rossum DB, 2005, NATURE, V434, P99, DOI 10.1038/nature03340; Vazquez E, 2006, SEMIN CELL DEV BIOL, V17, P607, DOI 10.1016/j.semcdb.2006.11.004; Vazquez G, 2003, J BIOL CHEM, V278, P21649, DOI 10.1074/jbc.M302162200; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; WAKAO H, 1995, EMBO J, V14, P2527, DOI 10.1002/j.1460-2075.1995.tb07250.x; Wu YM, 1997, AM J PHYSIOL-HEART C, V273, pH2161, DOI 10.1152/ajpheart.1997.273.5.H2161; YELAMARTY RV, 1990, J CLIN INVEST, V85, P1799, DOI 10.1172/JCI114638; Zhang MY, 1998, BLOOD, V92, P1225, DOI 10.1182/blood.V92.4.1225.416k20_1225_1234; Zhang ZM, 2001, P NATL ACAD SCI USA, V98, P3168, DOI 10.1073/pnas.051632698	72	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4567	4581		10.1074/jbc.M804734200	http://dx.doi.org/10.1074/jbc.M804734200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19074769	Green Published, hybrid			2022-12-25	WOS:000263134400057
J	Li, YL; Gao, XF; Chen, LL				Li, Yali; Gao, Xinfeng; Chen, Lingling			GroEL Recognizes an Amphipathic Helix and Binds to the Hydrophobic Side	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; 2.8 ANGSTROM RESOLUTION; CHAPERONIN GROEL; CRYSTAL-STRUCTURE; NMR-SPECTROSCOPY; POLYPEPTIDE; COMPLEX; RHODANESE; IDENTIFICATION; CONFORMATIONS	GroEL is an essential Escherichia coli molecular chaperon that uses ATP to facilitate correct folding of a range of proteins in a cell. Central to the GroEL substrate diversity is how GroEL recognizes the substrates. The interaction between GroEL and substrate has been proposed to be largely hydrophobic because GroEL interacts with proteins in non-native conformations but not in native forms. Analysis of GroEL substrate proteins reveals that one of its main substrates are proteins with alpha beta folding domains, suggesting that GroEL may stabilize the collapsed alpha beta core by binding to hydrophobic surfaces that are usually buried between the alpha and beta elements. In this study, we characterize the interaction between GroEL and a peptide derived from our previous selection via a phage display method. NMR studies map the peptide-binding site to the region containing Helices H and I, which is consistent with evidence that this region comprises the primary substrate-binding site. The peptide is largely unstructured in solution but adopts a helical conformation when bound to the GroEL apical domain with a moderate affinity (K-d = 17.1 +/- 2.5 mu M). The helical conformation aligns residues to form an amphipathic structure, and the hydrophobic side of this amphipathic helix interacts with GroEL as suggested by fluorescence quenching studies. Together with previous structural studies on the GroEL-peptide complexes, our work supports the notion that the amphipathic secondary elements in the substrate proteins may be the structural motif recognized by GroEL.	[Li, Yali; Chen, Lingling] Indiana Univ, Interdisciplinary Biochem Program, Bloomington, IN 47405 USA; [Gao, Xinfeng] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA; [Chen, Lingling] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Chen, LL (corresponding author), Indiana Univ, Dept Biol, 212 S Hawthorne Dr, Bloomington, IN 47405 USA.	linchen@indiana.edu	Chen, Ling-Ling/AAY-3547-2021		National Institutes of Health [GM065260-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065260] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM065260-01A1 (to L. C.).	*ACC, 1996, DISC US GUID; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; BRAIG K, 1995, NAT STRUCT BIOL, V2, P1083, DOI 10.1038/nsb1295-1083; Buckle AM, 1997, P NATL ACAD SCI USA, V94, P3571, DOI 10.1073/pnas.94.8.3571; CAMPBELL AP, 1993, ANNU REV BIOPH BIOM, V22, P99, DOI 10.1146/annurev.bb.22.060193.000531; Chen LL, 1999, CELL, V99, P757, DOI 10.1016/S0092-8674(00)81673-6; CHEN S, 1994, NATURE, V371, P261, DOI 10.1038/371261a0; CLORE GM, 1982, J MAGN RESON, V48, P402, DOI 10.1016/0022-2364(82)90073-7; EFTINK MR, 1976, BIOCHEMISTRY-US, V15, P672, DOI 10.1021/bi00648a035; Elad N, 2007, MOL CELL, V26, P415, DOI 10.1016/j.molcel.2007.04.004; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; Fenton WA, 2003, Q REV BIOPHYS, V36, P229, DOI 10.1017/S0033583503003883; Goddard T.D., 2004, SPARKY 3; HAYERHARTL MK, 1994, EMBO J, V13, P3192, DOI 10.1002/j.1460-2075.1994.tb06618.x; Horst R, 2005, P NATL ACAD SCI USA, V102, P12748, DOI 10.1073/pnas.0505642102; Horst R, 2007, P NATL ACAD SCI USA, V104, P20788, DOI 10.1073/pnas.0710042105; Horwich AL, 2006, CHEM REV, V106, P1917, DOI 10.1021/cr040435v; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; Hunt JF, 1996, NATURE, V379, P37, DOI 10.1038/379037a0; Kobayashi N, 1999, J MOL BIOL, V292, P181, DOI 10.1006/jmbi.1999.3042; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LANDRY SJ, 1991, BIOCHEMISTRY-US, V30, P7359, DOI 10.1021/bi00244a001; LANDRY SJ, 1992, NATURE, V355, P455, DOI 10.1038/355455a0; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lin Z, 2006, CRIT REV BIOCHEM MOL, V41, P211, DOI 10.1080/10409230600760382; LIPPENS G, 1995, J BIOMOL NMR, V5, P327, DOI 10.1007/BF00211762; Mande SC, 1996, SCIENCE, V271, P203, DOI 10.1126/science.271.5246.203; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; MENDOZA JA, 1992, J BIOL CHEM, V267, P24648; NILGES M, 1988, FEBS LETT, V229, P317, DOI 10.1016/0014-5793(88)81148-7; PARDI A, 1984, J MOL BIOL, V180, P741, DOI 10.1016/0022-2836(84)90035-4; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Preuss M, 1999, BIOCHEMISTRY-US, V38, P10272, DOI 10.1021/bi990342l; Saibil HR, 2002, TRENDS BIOCHEM SCI, V27, P627, DOI 10.1016/S0968-0004(02)02211-9; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Thirumalai D, 2001, ANNU REV BIOPH BIOM, V30, P245, DOI 10.1146/annurev.biophys.30.1.245; Thiyagarajan P, 1996, STRUCTURE, V4, P79, DOI 10.1016/S0969-2126(96)00011-1; Wang JM, 2003, J MOL BIOL, V334, P489, DOI 10.1016/j.jmb.2003.09.074; Wang ZL, 1999, BIOCHEMISTRY-US, V38, P12537, DOI 10.1021/bi991070p; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; ZAHN R, 1994, NATURE, V368, P261, DOI 10.1038/368261a0	43	24	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4324	4331		10.1074/jbc.M804818200	http://dx.doi.org/10.1074/jbc.M804818200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19074438	hybrid, Green Published			2022-12-25	WOS:000263134400031
J	Zhao, J; Shigaki, T; Mei, H; Guo, YQ; Cheng, NH; Hirschi, KD				Zhao, Jian; Shigaki, Toshiro; Mei, Hui; Guo, Ying-qing; Cheng, Ning-Hui; Hirschi, Kendal D.			Interaction between Arabidopsis Ca2(+)/H+ Exchangers CAX1 and CAX3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CA2+/H+ ANTIPORTER; H+/CA2+ ANTIPORTER; ION HOMEOSTASIS; SALT TOLERANCE; CROSS-TALK; TRANSPORT; YEAST; EXPRESSION; IDENTIFICATION	In plants, high capacity tonoplast cation/H+ antiport is mediated in part by a family of CAX (cation exchanger) transporters. Functional association between CAX1 and CAX3 has previously been inferred; however, the nature of this interaction has not been established. Here we analyze the formation of "hetero-CAX" complexes and their transport properties. Co-expressing both CAX1 and CAX3 mediated lithium and salt tolerance in yeast, and these phenotypes could not be recapitulated by expression of deregulated versions of either transporter. Coincident expression of Arabidopsis CAX1 and CAX3 occurs during particular stress responses, flowering, and seedling growth. Analysis of cax1, cax3, and cax1/3 seedlings demonstrated similar stress sensitivities. When plants expressed high levels of both CAXs, alterations in transport properties were evident that could not be recapitulated by high level expression of either transporter individually. In planta coimmunoprecipitation suggested that a protein-protein interaction occurred between CAX1 and CAX3. In vivo interaction between the CAX proteins was shown using a split ubiquitin yeast two-hybrid system and gel shift assays. These findings demonstrate cation exchange plasticity through hetero-CAX interactions.	[Zhao, Jian; Shigaki, Toshiro; Guo, Ying-qing; Cheng, Ning-Hui; Hirschi, Kendal D.] Baylor Coll Med, USDA ARS, Childrens Nutr Res Ctr, Houston, TX 77030 USA; [Mei, Hui; Hirschi, Kendal D.] Texas A&M Univ, Vegetable & Fruit Improvement Ctr, College Stn, TX 77845 USA	Baylor College of Medicine; United States Department of Agriculture (USDA); Texas A&M University System; Texas A&M University College Station	Hirschi, KD (corresponding author), Baylor Coll Med, USDA ARS, Childrens Nutr Res Ctr, 1100 Bates St,Suite 9018,Campus Mail Stop BCM 320, Houston, TX 77030 USA.	kendalh@bcm.edu	Zhao, Jian/Q-8591-2019; hirschi, kendal/GNP-0351-2022	Zhao, Jian/0000-0002-4416-7334; Guo, Yingqing/0000-0002-9527-6119	United States Department of Agriculture/Agricultural Research Service [58-6250-6001]; National Science Foundation [90344350]; United States Department of Agriculture [2005-34402-17121]	United States Department of Agriculture/Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture(United States Department of Agriculture (USDA))	This work was supported by United States Department of Agriculture/Agricultural Research Service under Cooperative Agreement 58-6250-6001, National Science Foundation Grant 90344350, and United States Department of Agriculture Grant 2005-34402-17121, Designing Foods for Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Cai XJ, 2004, MOL BIOL EVOL, V21, P1692, DOI 10.1093/molbev/msh177; Catala R, 2003, PLANT CELL, V15, P2940, DOI 10.1105/tpc.015248; Cheng NH, 2005, PLANT PHYSIOL, V138, P2048, DOI 10.1104/pp.105.061218; Cheng NH, 2003, PLANT CELL, V15, P347, DOI 10.1105/tpc.007385; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cousins RJ, 2006, J BIOL CHEM, V281, P24085, DOI 10.1074/jbc.R600011200; Cunningham KW, 1996, MOL CELL BIOL, V16, P2226; Eide DJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r77; Hirschi KD, 1996, P NATL ACAD SCI USA, V93, P8782, DOI 10.1073/pnas.93.16.8782; Hirschi KD, 2004, PLANT PHYSIOL, V136, P2438, DOI 10.1104/pp.104.046490; Hirschi KD, 1999, PLANT CELL, V11, P2113, DOI 10.1105/tpc.11.11.2113; Lahner B, 2003, NAT BIOTECHNOL, V21, P1215, DOI 10.1038/nbt865; Leonhardt N, 2004, PLANT CELL, V16, P596, DOI 10.1105/tpc.019000; Li JS, 2005, SCIENCE, V310, P121, DOI 10.1126/science.1115711; Liang F, 1997, P NATL ACAD SCI USA, V94, P8579, DOI 10.1073/pnas.94.16.8579; Loque D, 2007, NATURE, V446, P195, DOI 10.1038/nature05579; Ludewig U, 2003, J BIOL CHEM, V278, P45603, DOI 10.1074/jbc.M307424200; Luo GZ, 2005, PLANT MOL BIOL, V59, P809, DOI 10.1007/s11103-005-1386-0; Marini AM, 2000, MOL MICROBIOL, V35, P378, DOI 10.1046/j.1365-2958.2000.01704.x; Marty F, 1999, PLANT CELL, V11, P587, DOI 10.1105/tpc.11.4.587; Mei H, 2007, J EXP BOT, V58, P3419, DOI 10.1093/jxb/erm190; Mitsui K, 2005, BBA-BIOMEMBRANES, V1720, P125, DOI 10.1016/j.bbamem.2005.11.005; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Neuhauser B, 2007, PLANT PHYSIOL, V143, P1651, DOI 10.1104/pp.106.094243; Obrdlik P, 2004, P NATL ACAD SCI USA, V101, P12242, DOI 10.1073/pnas.0404467101; Pandey S, 2004, PLANT CELL, V16, P1616, DOI 10.1105/tpc.020321; Peiter E, 2005, NATURE, V434, P404, DOI 10.1038/nature03381; Pighin JA, 2004, SCIENCE, V306, P702, DOI 10.1126/science.1102331; Pittman JK, 2001, PLANT PHYSIOL, V127, P1020, DOI 10.1104/pp.010409; Reinders A, 2002, PLANT CELL, V14, P1567, DOI 10.1105/tpc.002428; RODRIGUEZNAVARRO A, 1984, J BACTERIOL, V159, P940; Ros R, 1998, J BACTERIOL, V180, P3131, DOI 10.1128/JB.180.12.3131-3136.1998; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Schulz B, 2004, SCIENCE, V306, P622, DOI 10.1126/science.1105227; SCHUMAKER KS, 1986, J BIOL CHEM, V261, P2172; Shigaki T, 2006, J MOL EVOL, V63, P815, DOI 10.1007/s00239-006-0048-4; Shigaki T, 2006, PLANT BIOLOGY, V8, P419, DOI 10.1055/s-2006-923950; Shigaki T, 2005, J BIOL CHEM, V280, P30136, DOI 10.1074/jbc.M503610200; Shigaki T, 2001, J BIOL CHEM, V276, P43152, DOI 10.1074/jbc.M106637200; Shigaki T, 2000, GENE, V257, P291, DOI 10.1016/S0378-1119(00)00390-5; Suga S, 2004, PLANT CELL PHYSIOL, V45, P823, DOI 10.1093/pcp/pch120; Sze H, 2000, ANNU REV PLANT PHYS, V51, P433, DOI 10.1146/annurev.arplant.51.1.433; Ueoka-Nakanishi H, 2000, EUR J BIOCHEM, V267, P3090, DOI 10.1046/j.1432-1033.2000.01343.x; Venema K, 2003, J BIOL CHEM, V278, P22453, DOI 10.1074/jbc.M210794200; WARD JM, 1992, PLANT PHYSIOL, V99, P161, DOI 10.1104/pp.99.1.161; Zhao J, 2008, PLANTA, V227, P659, DOI 10.1007/s00425-007-0648-2; ZOTTOLA RJ, 1995, BIOCHEMISTRY-US, V34, P9734, DOI 10.1021/bi00030a011	48	44	48	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4605	4615		10.1074/jbc.M804462200	http://dx.doi.org/10.1074/jbc.M804462200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19098009	hybrid			2022-12-25	WOS:000263134400060
J	Vogel, P; Donoviel, MS; Read, R; Hansen, GM; Hazlewood, J; Anderson, SJ; Sun, WM; Swaffield, J; Oravecz, T				Vogel, Peter; Donoviel, Michael S.; Read, Robert; Hansen, Gwenn M.; Hazlewood, Jill; Anderson, Stephen J.; Sun, Weimei; Swaffield, Jonathan; Oravecz, Tamas			Incomplete Inhibition of Sphingosine 1-Phosphate Lyase Modulates Immune System Function yet Prevents Early Lethality and Non-Lymphoid Lesions	PLOS ONE			English	Article							LYMPHOCYTE EGRESS; SPHINGOSINE-1-PHOSPHATE LYASE; QUANTITATIVE MEASUREMENT; BARRIER INTEGRITY; CELL-DEVELOPMENT; IN-VITRO; T-CELLS; APOPTOSIS; INDUCTION; FTY720	Background: S1PL is an aldehyde-lyase that irreversibly cleaves sphingosine 1-phosphate (S1P) in the terminal step of sphingolipid catabolism. Because S1P modulates a wide range of physiological processes, its concentration must be tightly regulated within both intracellular and extracellular environments. Methodology: In order to better understand the function of S1PL in this regulatory pathway, we assessed the in vivo effects of different levels of S1PL activity using knockout (KO) and humanized mouse models. Principal Findings: Our analysis showed that all S1PL-deficient genetic models in this study displayed lymphopenia, with sequestration of mature T cells in the thymus and lymph nodes. In addition to the lymphoid phenotypes, S1PL KO mice (S1PL(-/-)) also developed myeloid cell hyperplasia and significant lesions in the lung, heart, urinary tract, and bone, and had a markedly reduced life span. The humanized knock-in mice harboring one allele (S1PL(H/-)) or two alleles (S1PL(H/H)) of human S1PL expressed less than 10 and 20% of normal S1PL activity, respectively. This partial restoration of S1PL activity was sufficient to fully protect both humanized mouse lines from the lethal non-lymphoid lesions that developed in S1PL(-/-) mice, but failed to restore normal T-cell development and trafficking. Detailed analysis of T-cell compartments indicated that complete absence of S1PL affected both maturation/development and egress of mature T cells from the thymus, whereas low level S1PL activity affected T-cell egress more than differentiation. Significance: These findings demonstrate that lymphocyte trafficking is particularly sensitive to variations in S1PL activity and suggest that there is a window in which partial inhibition of S1PL could produce therapeutic levels of immunosuppression without causing clinically significant S1P-related lesions in non-lymphoid target organs.	[Vogel, Peter; Donoviel, Michael S.; Read, Robert; Hansen, Gwenn M.; Hazlewood, Jill; Anderson, Stephen J.; Sun, Weimei; Swaffield, Jonathan; Oravecz, Tamas] Lexicon Pharmaceut Inc, The Woodlands, TX USA	Lexicon Pharmaceuticals	Vogel, P (corresponding author), Lexicon Pharmaceut Inc, The Woodlands, TX USA.	pvogel@lexgen.com	Vogel, Peter/N-2490-2018	Vogel, Peter/0000-0002-7535-0545	Lexicon Pharmaceuticals, Inc	Lexicon Pharmaceuticals, Inc	The work described in this paper was funded by Lexicon Pharmaceuticals, Inc. All authors are employees of Lexicon Pharmaceuticals, Inc and in this respect the company had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brinkmann V, 2001, TRANSPLANT P, V33, P3078, DOI 10.1016/S0041-1345(01)02312-0; Buccoliero R, 2007, J INHERIT METAB DIS, V30, P983, DOI 10.1007/s10545-007-0597-8; Chalfant CE, 2005, J CELL SCI, V118, P4605, DOI 10.1242/jcs.02637; Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Gabor MJ, 1997, EUR J IMMUNOL, V27, P2010, DOI 10.1002/eji.1830270827; Gardell SE, 2006, TRENDS MOL MED, V12, P65, DOI 10.1016/j.molmed.2005.12.001; Goetzl EJ, 1999, J IMMUNOL, V162, P2049; Gon Y, 2005, P NATL ACAD SCI USA, V102, P9270, DOI 10.1073/pnas.0501997102; Grahler MH, 2005, J IMMUNOL, V174, P1997; Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007; Hisano N, 1999, BLOOD, V93, P4293, DOI 10.1182/blood.V93.12.4293.412k26_4293_4299; Hung WC, 1996, BIOCHEM BIOPH RES CO, V229, P11, DOI 10.1006/bbrc.1996.1750; Huwiler A, 2008, BIOCHEM PHARMACOL, V75, P1893, DOI 10.1016/j.bcp.2007.12.018; Ikeda M, 2004, BIOCHEM BIOPH RES CO, V325, P338, DOI 10.1016/j.bbrc.2004.10.036; Isoyama N, 2006, TRANSPL IMMUNOL, V15, P265, DOI 10.1016/j.trim.2006.02.004; Ito K, 2007, BIOCHEM BIOPH RES CO, V357, P212, DOI 10.1016/j.bbrc.2007.03.123; Kabashima K, 2006, J EXP MED, V203, P2683, DOI 10.1084/jem.20061289; Leclercq TM, 2006, IUBMB LIFE, V58, P467, DOI 10.1080/15216540600871126; Liao JJ, 2007, J IMMUNOL, V178, P5425, DOI 10.4049/jimmunol.178.9.5425; Liao JJ, 2007, J BIOL CHEM, V282, P1964, DOI 10.1074/jbc.M608597200; LIESCHKE GJ, 1994, BLOOD, V84, P27; Lo CG, 2005, J EXP MED, V201, P291, DOI 10.1084/jem.20041509; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; McVerry BJ, 2005, CELL SIGNAL, V17, P131, DOI 10.1016/j.cellsig.2004.08.006; Moore AN, 1999, NEUROSCIENCE, V94, P405, DOI 10.1016/S0306-4522(99)00288-2; Murata N, 2000, ANAL BIOCHEM, V282, P115, DOI 10.1006/abio.2000.4580; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; Oskouian B, 2006, P NATL ACAD SCI USA, V103, P17384, DOI 10.1073/pnas.0600050103; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Pettus BJ, 2004, CURR MOL MED, V4, P405, DOI 10.2174/1566524043360573; Pham THM, 2008, IMMUNITY, V28, P122, DOI 10.1016/j.immuni.2007.11.017; Pyne S, 2000, BIOCHEM J, V349, P385, DOI 10.1042/0264-6021:3490385; Reiss U, 2004, J BIOL CHEM, V279, P1281, DOI 10.1074/jbc.M309646200; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Rosen H, 2003, P NATL ACAD SCI USA, V100, P10907, DOI 10.1073/pnas.1832725100; Ryu J, 2006, EMBO J, V25, P5840, DOI 10.1038/sj.emboj.7601430; Saba JD, 2004, CIRC RES, V94, P724, DOI 10.1161/01.RES.0000122383.60368.24; Saba JD, 1997, J BIOL CHEM, V272, P26087, DOI 10.1074/jbc.272.42.26087; Sanna MG, 2006, NAT CHEM BIOL, V2, P434, DOI 10.1038/nchembio804; Schmahl J, 2007, NAT GENET, V39, P52, DOI 10.1038/ng1922; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Sillence DJ, 2003, TRENDS CELL BIOL, V13, P195, DOI 10.1016/S0962-8924(03)00033-3; Suzuki S, 1997, CLIN EXP IMMUNOL, V107, P103, DOI 10.1046/j.1365-2249.1997.d01-885.x; Takahama Y, 2006, NAT REV IMMUNOL, V6, P127, DOI 10.1038/nri1781; Trapnell BC, 2003, NEW ENGL J MED, V349, P2527, DOI 10.1056/NEJMra023226; VANVELDHOVEN PP, 1991, J BIOL CHEM, V266, P12502; VANVELDHOVEN PP, 1993, ADV LIPID RES, V26, P69; Wattler S, 1999, BIOTECHNIQUES, V26, P1150, DOI 10.2144/99266rr02; Wei SH, 2005, NAT IMMUNOL, V6, P1228, DOI 10.1038/ni1269; Yagi H, 2000, EUR J IMMUNOL, V30, P1435, DOI 10.1002/(SICI)1521-4141(200005)30:5<1435::AID-IMMU1435>3.0.CO;2-O; YATOMI Y, 1995, ANAL BIOCHEM, V230, P315, DOI 10.1006/abio.1995.1480; Zambrowicz BP, 2003, P NATL ACAD SCI USA, V100, P14109, DOI 10.1073/pnas.2336103100; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423; Zhang Z, 2007, MINI-REV MED CHEM, V7, P845	59	132	136	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2009	4	1							e4112	10.1371/journal.pone.0004112	http://dx.doi.org/10.1371/journal.pone.0004112			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FR	19119317	Green Published, gold, Green Submitted			2022-12-25	WOS:000265472600011
J	Brandie, FM; Aran, V; Verma, A; McNew, JA; Bryant, NJ; Gould, GW				Brandie, Fiona M.; Aran, Veronica; Verma, Avani; McNew, James A.; Bryant, Nia J.; Gould, Gwyn W.			Negative Regulation of Syntaxin4/SNAP-23/VAMP2-Mediated Membrane Fusion by Munc18c In Vitro	PLOS ONE			English	Article								Background: Translocation of the facilitative glucose transporter GLUT4 from an intracellular store to the plasma membrane is responsible for the increased rate of glucose transport into fat and muscle cells in response to insulin. This represents a specialised form of regulated membrane trafficking. Intracellular membrane traffic is subject to multiple levels of regulation by conserved families of proteins in all eukaryotic cells. Notably, all intracellular fusion events require SNARE proteins and Sec1p/Munc18 family members. Fusion of GLUT4-containing vesicles with the plasma membrane of insulin-sensitive cells involves the SM protein Munc18c, and is regulated by the formation of syntaxin 4/SNAP23/VAMP2 SNARE complexes. Methodology/Principal Findings: Here we have used biochemical approaches to characterise the interaction(s) of Munc18c with its cognate SNARE proteins and to examine the role of Munc18c in regulating liposome fusion catalysed by syntaxin 4/SNAP23/VAMP2 SNARE complex formation. We demonstrate that Munc18c makes contacts with both t- and v-SNARE proteins of this complex, and directly inhibits bilayer fusion mediated by the syntaxin 4/SNAP23/VAMP2 SNARE complex. Conclusion/Significance: Our reductionist approach has enabled us to ascertain a direct inhibitory role for Munc18c in regulating membrane fusion mediated by syntaxin 4/SNAP23/VAMP2 SNARE complex formation. It is important to note that two different SM proteins have recently been shown to stimulate liposome fusion mediated by their cognate SNARE complexes. Given the structural similarities between SM proteins, it seems unlikely that different members of this family perform opposing regulatory functions. Hence, our findings indicate that Munc18c requires a further level of regulation in order to stimulate SNARE-mediated membrane fusion.	[Brandie, Fiona M.; Aran, Veronica; Bryant, Nia J.; Gould, Gwyn W.] Univ Glasgow, Henry Wellcome Lab Cell Biol, Div Biochem & Mol Biol, Inst Biomed & Life Sci, Glasgow, Lanark, Scotland; [Verma, Avani; McNew, James A.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA	University of Glasgow; Rice University	Brandie, FM (corresponding author), Univ Glasgow, Henry Wellcome Lab Cell Biol, Div Biochem & Mol Biol, Inst Biomed & Life Sci, Glasgow, Lanark, Scotland.	G.Gould@bio.gla.ac.uk	Bryant, Nia/AAS-5637-2021; Aran, Veronica/C-7085-2017; Gould, Gwyn/AAF-6721-2019; McNew, James/ABD-8081-2020; McNew, James/AAV-4911-2020	Aran, Veronica/0000-0003-2751-0986; Gould, Gwyn/0000-0001-6571-2875; McNew, James/0000-0001-8459-3664; Bryant, Nia Jane/0000-0001-7431-3809	BBSRC [BB/D000211/1]; Diabetes UK [Studentship]; The Wellcome Trust [Research Leave Award]; NIH [GM071832]; The Lister Institute of Preventive Medicine [Prize Fellow]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071832] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/D000211/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Diabetes UK(Diabetes UK); The Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Lister Institute of Preventive Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the BBSRC (Grant BB/D000211/1 to NJB and GWG), Diabetes UK (Studentship to VA), The Wellcome Trust (Research Leave Award to GWG) and The NIH (Grant GM071832 to JMcN). NJB is a Prize Fellow of The Lister Institute of Preventive Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bracher A, 2002, EMBO J, V21, P6114, DOI 10.1093/emboj/cdf608; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Bryant NJ, 2001, EMBO J, V20, P3380, DOI 10.1093/emboj/20.13.3380; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Carpp LN, 2006, J CELL BIOL, V173, P927, DOI 10.1083/jcb.200512024; Carr CM, 1999, J CELL BIOL, V146, P333, DOI 10.1083/jcb.146.2.333; D'Andrea-Merrins M, 2007, J BIOL CHEM, V282, P16553, DOI 10.1074/jbc.M610818200; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Gerst JE, 2003, BBA-MOL CELL RES, V1641, P99, DOI 10.1016/S0167-4889(03)00096-X; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; Hu SH, 2007, P NATL ACAD SCI USA, V104, P8773, DOI 10.1073/pnas.0701124104; Jahn R, 2000, NEURON, V27, P201, DOI 10.1016/S0896-6273(00)00029-5; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jewell JL, 2008, J BIOL CHEM, V283, P21734, DOI 10.1074/jbc.M710445200; Kanda H, 2005, J CLIN INVEST, V115, P291, DOI 10.1172/JCI200522681; Khvotchev M, 2007, J NEUROSCI, V27, P12147, DOI 10.1523/JNEUROSCI.3655-07.2007; Latham CF, 2006, TRAFFIC, V7, P1408, DOI 10.1111/j.1600-0854.2006.00474.x; Millar CA, 1999, MOL BIOL CELL, V10, P3675, DOI 10.1091/mbc.10.11.3675; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Oh E, 2005, DIABETES, V54, P638, DOI 10.2337/diabetes.54.3.638; Oh E, 2006, J BIOL CHEM, V281, P17624, DOI 10.1074/jbc.M601581200; Peng RW, 2004, EMBO J, V23, P3939, DOI 10.1038/sj.emboj.7600410; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; RODKEY TL, 2008, MOL BIOL CELL; Schmelzle K, 2006, DIABETES, V55, P2171, DOI 10.2337/db06-0148; Scott BL, 2004, J CELL BIOL, V167, P75, DOI 10.1083/jcb.200405018; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Simonsen A, 1998, EUR J CELL BIOL, V75, P223, DOI 10.1016/S0171-9335(98)80116-7; Tellam JT, 1997, J BIOL CHEM, V272, P6179, DOI 10.1074/jbc.272.10.6179; Thurmond DC, 2000, MOL CELL BIOL, V20, P379, DOI 10.1128/MCB.20.1.379-388.2000; Thurmond DC, 2000, EMBO J, V19, P3565, DOI 10.1093/emboj/19.14.3565; Thurmond DC, 1998, J BIOL CHEM, V273, P33876, DOI 10.1074/jbc.273.50.33876; Umahara M, 2008, ENDOCRINOLOGY, V149, P40, DOI 10.1210/en.2006-1549; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Williams D, 2008, J CELL BIOL, V180, P375, DOI 10.1083/jcb.200709108; Yamaguchi T, 2002, DEV CELL, V2, P295, DOI 10.1016/S1534-5807(02)00125-9	36	36	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4074	10.1371/journal.pone.0004074	http://dx.doi.org/10.1371/journal.pone.0004074			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DO	19116655	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000265466600004
J	Vanengelsdorp, D; Hayes, J; Underwood, RM; Pettis, J				vanEngelsdorp, Dennis; Hayes, Jerry, Jr.; Underwood, Robyn M.; Pettis, Jeffery			A Survey of Honey Bee Colony Losses in the US, Fall 2007 to Spring 2008	PLOS ONE			English	Article								Background: Honey bees are an essential component of modern agriculture. A recently recognized ailment, Colony Collapse Disorder (CCD), devastates colonies, leaving hives with a complete lack of bees, dead or alive. Up to now, estimates of honey bee population decline have not included losses occurring during the wintering period, thus underestimating actual colony mortality. Our survey quantifies the extent of colony losses in the United States over the winter of 2007-2008. Methodology/Principal Findings: Surveys were conducted to quantify and identify management factors (e. g. operation size, hive migration) that contribute to high colony losses in general and CCD symptoms in particular. Over 19% of the country's estimated 2.44 million colonies were surveyed. A total loss of 35.8% of colonies was recorded; an increase of 11.4% compared to last year. Operations that pollinated almonds lost, on average, the same number of colonies as those that did not. The 37.9% of operations that reported having at least some of their colonies die with a complete lack of bees had a total loss of 40.8% of colonies compared to the 17.1% loss reported by beekeepers without this symptom. Large operations were more likely to have this symptom suggesting that a contagious condition may be a causal factor. Sixty percent of all colonies that were reported dead in this survey died without dead bees, and thus possibly suffered from CCD. In PA, losses varied with region, indicating that ambient temperature over winter may be an important factor. Conclusions/Significance: Of utmost importance to understanding the recent losses and CCD is keeping track of losses over time and on a large geographic scale. Given that our surveys are representative of the losses across all beekeeping operations, between 0.75 and 1.00 million honey bee colonies are estimated to have died in the United States over the winter of 2007-2008. This article is an extensive survey of U. S. beekeepers across the continent, serving as a reference for comparison with future losses as well as providing guidance to future hypothesis-driven research on the causes of colony mortality.	Bur Plant Ind Apiculture, Penn Dept Agr, Harrisburg, PA USA; [vanEngelsdorp, Dennis; Underwood, Robyn M.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Hayes, Jerry, Jr.] Florida State Dept Agr, Bur Plant & Apiary Inspect, Div Plant Ind, Apiary Inspect Sect, Gainesville, FL USA; [Pettis, Jeffery] USDA, ARS Bee Res Lab, Beltsville, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of Agriculture (USDA)	Vanengelsdorp, D (corresponding author), Bur Plant Ind Apiculture, Penn Dept Agr, Harrisburg, PA USA.	dennis.vanengelsdorp@gmail.com	vanEngelsdorp, Dennis/E-7934-2010		Pennsylvania and Florida Departments of Agriculture; United States Department of Agriculture - Ag. Research Station in Beltsville, MD	Pennsylvania and Florida Departments of Agriculture; United States Department of Agriculture - Ag. Research Station in Beltsville, MD	Funding was provided by the Pennsylvania and Florida Departments of Agriculture and United States Department of Agriculture - Ag. Research Station in Beltsville, MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey L., 1991, HONEY BEE PATHOLOGY; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Calderone, 2000, BEE CULT, V128, P1, DOI DOI 10.3896/IBRA.1.49.1.01; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Downey DL, 2001, APIDOLOGIE, V32, P567, DOI 10.1051/apido:2001144; GALLAI N, 2008, ECOL EC IN PRESS; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Koepsell T. D, 2003, EPIDEMIOLOGIC METHOD; *NAT AGR STAT SERV, 2008, HON; *NAT RES COUNC, 2006, STAT POLL N AM; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; Paoli B., 2002, CONFIDENCE INTERVALS; Pernal S, 2008, CAPA STATEMENT HONEY; Vanengelsdorp D, 2007, AM BEE J, V147, P599	15	391	411	5	297	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2008	3	12							e4071	10.1371/journal.pone.0004071	http://dx.doi.org/10.1371/journal.pone.0004071			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DL	19115015	gold, Green Published, Green Submitted			2022-12-25	WOS:000265466300011
J	D'Agata, EMC; Dupont-Rouzeyrol, M; Magal, P; Olivier, D; Ruan, S				D'Agata, Erika M. C.; Dupont-Rouzeyrol, Myrielle; Magal, Pierre; Olivier, Damien; Ruan, Shigui			The Impact of Different Antibiotic Regimens on the Emergence of Antimicrobial-Resistant Bacteria	PLOS ONE			English	Article								Backgroud: The emergence and ongoing spread of antimicrobial-resistant bacteria is a major public health threat. Infections caused by antimicrobial-resistant bacteria are associated with substantially higher rates of morbidity and mortality compared to infections caused by antimicrobial-susceptible bacteria. The emergence and spread of these bacteria is complex and requires incorporating numerous interrelated factors which clinical studies cannot adequately address. Methods/Principal Findings: A model is created which incorporates several key factors contributing to the emergence and spread of resistant bacteria including the effects of the immune system, acquisition of resistance genes and antimicrobial exposure. The model identifies key strategies which would limit the emergence of antimicrobial-resistant bacterial strains. Specifically, the simulations show that early initiation of antimicrobial therapy and combination therapy with two antibiotics prevents the emergence of resistant bacteria, whereas shorter courses of therapy and sequential administration of antibiotics promote the emergence of resistant strains. Conclusions/Significance: The principal findings suggest that (i) shorter lengths of antibiotic therapy and early interruption of antibiotic therapy provide an advantage for the resistant strains, (ii) combination therapy with two antibiotics prevents the emergence of resistance strains in contrast to sequential antibiotic therapy, and (iii) early initiation of antibiotics is among the most important factors preventing the emergence of resistant strains. These findings provide new insights into strategies aimed at optimizing the administration of antimicrobials for the treatment of infections and the prevention of the emergence of antimicrobial resistance.	Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Infect Dis, Boston, MA 02215 USA; [Dupont-Rouzeyrol, Myrielle] Univ Havre, Lab Ecotoxicol Milieux Aquatiques, Le Havre, France; [Magal, Pierre] Univ Havre, Lab Math Appl, Le Havre, France; [Olivier, Damien] Univ Havre, Lab Informat Traitement Informat Syst, Le Havre, France; [Ruan, Shigui] Univ Miami, Dept Math, Coral Gables, FL 33124 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Universite Le Havre Normandie; Universite Le Havre Normandie; Universite Le Havre Normandie; University of Miami	D'Agata, EMC (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Infect Dis, Boston, MA 02215 USA.	ruan@math.miami.edu	Dupont-Rouzeyrol, Myrielle/GZH-2138-2022; Ruan, Shigui/AAF-9165-2020	Ruan, Shigui/0000-0002-6348-8205; magal, pierre/0000-0002-4776-0061	DMS/NIGMS Initiative through the National Institute of Health (NIH) [R01GM083607]; National Science Foundation (NSF) [DMS-0715772]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083607] Funding Source: NIH RePORTER	DMS/NIGMS Initiative through the National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the joint DMS/NIGMS Initiative through the National Institute of Health (NIH) grant R01GM083607 (E.M.C.D., S.R.) and the National Science Foundation (NSF) grant DMS-0715772 (S.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin DJ, 1998, J THEOR BIOL, V194, P313, DOI 10.1006/jtbi.1997.0438; Austin DJ, 1999, PHILOS T R SOC B, V354, P721, DOI 10.1098/rstb.1999.0425; Bahl ML, 2004, FEMS MICROBIOL LETT, V232, P45, DOI 10.1016/S0378-1097(04)00015-1; Bergstrom CT, 2004, P NATL ACAD SCI USA, V101, P13285, DOI 10.1073/pnas.0402298101; Boldin B, 2007, B MATH BIOL, V69, P2227, DOI 10.1007/s11538-007-9205-1; Bonhoeffer S, 1997, P NATL ACAD SCI USA, V94, P12106, DOI 10.1073/pnas.94.22.12106; Bonten MJM, 2001, CLIN INFECT DIS, V33, P1739, DOI 10.1086/323761; Cassell GH, 2001, JAMA-J AM MED ASSOC, V285, P601, DOI 10.1001/jama.285.5.601; *CONS REX, 2007, PLOS ONE, V2, pE1275, DOI DOI 10.1371/JOURNAL.PONE.0001275; Cottarel G, 2007, TRENDS BIOTECHNOL, V25, P547, DOI 10.1016/j.tibtech.2007.09.004; D'Agata EMC, 2007, J THEOR BIOL, V249, P487, DOI 10.1016/j.jtbi.2007.08.011; Daxboeck F, 2006, J HOSP INFECT, V62, P214, DOI 10.1016/j.jhin.2005.07.009; Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; Dutta C, 2002, J BIOSCIENCES, V27, P27, DOI 10.1007/BF02703681; Forum on Emerging Infections Institute of Medicine, 1998, ANT RES ISS OPT; FRETER R, 1983, INFECT IMMUN, V39, P686, DOI 10.1128/IAI.39.2.686-703.1983; GIBBONS RJ, 1967, J BACTERIOL, V93, P510, DOI 10.1128/JB.93.1.510-512.1967; Grundmann H, 2006, LANCET INFECT DIS, V6, P39, DOI 10.1016/S1473-3099(05)70325-X; Haneda T, 2004, PLASMID, V52, P218, DOI 10.1016/j.plasmid.2004.07.002; HARTL DL, 1984, ANNU REV GENET, V18, P31, DOI 10.1146/annurev.ge.18.120184.000335; Imran M, 2007, DISCRETE CONT DYN-B, V8, P127; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kurland CG, 2003, P NATL ACAD SCI USA, V100, P9658, DOI 10.1073/pnas.1632870100; Lenski R E, 1998, Int Microbiol, V1, P265; Leverstein-van Hall MA, 2003, J INFECT DIS, V187, P251, DOI 10.1086/345880; Levin BR, 2001, CLIN INFECT DIS, V33, pS161, DOI 10.1086/321843; Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Lipsitch M, 1997, ANTIMICROB AGENTS CH, V41, P363, DOI 10.1128/AAC.41.2.363; LIPSITCH M, 2002, INFECT CONTROL ICU E, P1; Livermore DM, 2007, J ANTIMICROB CHEMOTH, V59, P165, DOI 10.1093/jac/dkl483; Monack DM, 2004, NAT REV MICROBIOL, V2, P747, DOI 10.1038/nrmicro955; Nordstrom K, 2006, PLASMID, V55, P1, DOI 10.1016/j.plasmid.2005.07.002; NORDSTROM K, 1984, MOL GEN GENET, V197, P1, DOI 10.1007/BF00327915; Pilyugin SS, 2000, B MATH BIOL, V62, P869, DOI 10.1006/bulm.2000.0181; POULSEN LK, 1995, J BACTERIOL, V177, P5840, DOI 10.1128/jb.177.20.5840-5845.1995; Reluga TC, 2005, MATH MED BIOL, V22, P187, DOI 10.1093/imammb/dqi002; Schwaber MJ, 2006, ANTIMICROB AGENTS CH, V50, P1257, DOI 10.1128/AAC.50.4.1257-1262.2006; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS165, DOI 10.1016/j.ajic.2007.10.006; Smets BF, 2005, NAT REV MICROBIOL, V3, P675, DOI 10.1038/nrmicro1253; Smith MA, 1998, CAN J MICROBIOL, V44, P351, DOI 10.1139/cjm-44-4-351; Sorensen SJ, 2005, NAT REV MICROBIOL, V3, P700, DOI 10.1038/nrmicro1232; Sorensen TL, 2001, NEW ENGL J MED, V345, P1161, DOI 10.1056/NEJMoa010692; Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891; Spratt BG, 2001, CURR OPIN MICROBIOL, V4, P602, DOI 10.1016/S1369-5274(00)00257-5; Temime L, 2008, EPIDEMIOL INFECT, V136, P289, DOI 10.1017/S0950268807009442; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; Walsh TR, 2005, CLIN MICROBIOL INFEC, V11, P2, DOI 10.1111/j.1469-0691.2005.01264.x; Waters V L, 1999, Front Biosci, V4, pD433, DOI 10.2741/Waters; Webb GF, 2005, P NATL ACAD SCI USA, V102, P13343, DOI 10.1073/pnas.0504053102	50	73	74	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2008	3	12							e4036	10.1371/journal.pone.0004036	http://dx.doi.org/10.1371/journal.pone.0004036			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DI	19112501	Green Published, gold, Green Submitted			2022-12-25	WOS:000265466000006
J	Grieve, IC; Dickens, NJ; Pravenec, M; Kren, V; Hubner, N; Cook, SA; Aitman, TJ; Petretto, E; Mangion, J				Grieve, Ian C.; Dickens, Nicholas J.; Pravenec, Michal; Kren, Vladimir; Hubner, Norbert; Cook, Stuart A.; Aitman, Timothy J.; Petretto, Enrico; Mangion, Jonathan			Genome-Wide Co-Expression Analysis in Multiple Tissues	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; SEGREGATING MOUSE-POPULATION; GENE-EXPRESSION; SUSCEPTIBILITY GENE; LINKAGE ANALYSIS; BLOOD-PRESSURE; IDENTIFICATION; NETWORK; MICE; DISCOVERY	Expression quantitative trait loci (eQTLs) represent genetic control points of gene expression, and can be categorized as cis- and trans-acting, reflecting local and distant regulation of gene expression respectively. Although there is evidence of co-regulation within clusters of trans-eQTLs, the extent of co-expression patterns and their relationship with the genotypes at eQTLs are not fully understood. We have mapped thousands of cis- and trans-eQTLs in four tissues ( fat, kidney, adrenal and left ventricle) in a large panel of rat recombinant inbred ( RI) strains. Here we investigate the genome-wide correlation structure in expression levels of eQTL transcripts and underlying genotypes to elucidate the nature of co-regulation within cis- and trans-eQTL datasets. Across the four tissues, we consistently found statistically significant correlations of cis-regulated gene expression to be rare (<0.9% of all pairs tested). Most (>80%) of the observed significant correlations of cis-regulated gene expression are explained by correlation of the underlying genotypes. In comparison, co-expression of transregulated gene expression is more common, with significant correlation ranging from 2.9%-14.9% of all pairs of trans-eQTL transcripts. We observed a total of 81 trans-eQTL clusters (hot-spots), defined as consisting of >= 10 eQTLs linked to a common region, with very high levels of correlation between trans-regulated transcripts (77.2-90.2%). Moreover, functional analysis of large trans-eQTL clusters (>= 30 eQTLs) revealed significant functional enrichment among genes comprising 80% of the large clusters. The results of this genome-wide co-expression study show the effects of the eQTL genotypes on the observed patterns of correlation, and suggest that functional relatedness between genes underlying trans-eQTLs is reflected in the degree of co-expression observed in trans-eQTL clusters. Our results demonstrate the power of an integrative, systematic approach to the analysis of a large gene expression dataset to uncover underlying structure, and inform future eQTL studies.	[Grieve, Ian C.; Dickens, Nicholas J.; Cook, Stuart A.; Aitman, Timothy J.; Petretto, Enrico; Mangion, Jonathan] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, MRC Clin Sci Ctr, London, England; [Dickens, Nicholas J.] Inst Canc Res, Sutton, Surrey, England; [Pravenec, Michal; Kren, Vladimir] Charles Univ Prague, First Fac Med & Gen Teaching Hosp, Inst Biol & Med Genet, Prague, Czech Republic; [Pravenec, Michal; Kren, Vladimir] Czech Acad Sci, Inst Physiol, Prague, Czech Republic; [Hubner, Norbert] Max Delbruck Ctr Mol Med, Berlin, Germany; [Cook, Stuart A.] Univ London Imperial Coll, Natl Heart & Lung Inst, London, England; [Petretto, Enrico] Univ London Imperial Coll, Div Epidemiol, London, England	Imperial College London; University of London; Institute of Cancer Research - UK; Charles University Prague; General University Hospital Prague; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Imperial College London; Imperial College London	Grieve, IC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, MRC Clin Sci Ctr, London, England.	enrico.petretto@imperial.ac.uk	Pravenec, Michal/B-1666-2012; Cook, Stuart/G-9567-2011; Dickens, Nicholas/G-1445-2013	Pravenec, Michal/0000-0001-9197-5871; Dickens, Nicholas/0000-0003-0492-5855; Cook, Stuart/0000-0001-6628-194X; Aitman, Timothy/0000-0002-7875-4502	Wellcome Trust [069962/Z/02/Z]; Medical Research Council Clinical Sciences Centre; Wellcome Trust Cardiovascular Functional Genomics award; Fondation Leducq; Medical Research Council; Department of Health UK; British Heart Foundation; German Ministry of Science and Education (BMBF/NGFN); Grant Agency of the Czech Republic; Ministry of Education of the Czech Republic; Howard Hughes Medical Institute; EU-funded EURATools Integrated Project; Medical Research Council [MC_U120085815, MC_U120061454] Funding Source: researchfish; MRC [MC_U120061454, MC_U120085815] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council Clinical Sciences Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Cardiovascular Functional Genomics award(Wellcome Trust); Fondation Leducq(Leducq Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health UK; British Heart Foundation(British Heart Foundation); German Ministry of Science and Education (BMBF/NGFN)(Federal Ministry of Education & Research (BMBF)); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EU-funded EURATools Integrated Project; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We acknowledge funding to ICG from the Wellcome Trust (069962/Z/02/Z); to TJA from the Medical Research Council Clinical Sciences Centre, the Wellcome Trust Cardiovascular Functional Genomics award; to TJA and SAC from the Fondation Leducq; to EP, NJD, SAC and JM from the Medical Research Council; to SAC from The Department of Health UK and British Heart Foundation; to NH from the German Ministry of Science and Education (BMBF/NGFN); to MP from the Grant Agency of the Czech Republic; to MP and VK from the Ministry of Education of the Czech Republic; MP is an international research scholar of the Howard Hughes Medical Institute; and to NH, MP and TJA from the EU-funded EURATools Integrated Project. Sponsors/funders played no direct role in the design or conduct of this study.	Bing N, 2005, GENETICS, V170, P533, DOI 10.1534/genetics.105.041103; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Cervino AC, 2005, GENOMICS, V86, P505, DOI 10.1016/j.ygeno.2005.07.010; CHURCHILL GA, 1994, GENETICS, V138, P963; DAMERVAL C, 1994, GENETICS, V137, P289; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Deutsch S, 2005, HUM MOL GENET, V14, P3741, DOI 10.1093/hmg/ddi404; Doss S, 2005, GENOME RES, V15, P681, DOI 10.1101/gr.3216905; Duan S, 2008, AM J HUM GENET, V82, P1101, DOI 10.1016/j.ajhg.2008.03.006; Fuller TF, 2007, MAMM GENOME, V18, P463, DOI 10.1007/s00335-007-9043-3; Ghazalpour A, 2006, PLOS GENET, V2, P1182, DOI 10.1371/journal.pgen.0020130; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Keurentjes JJB, 2007, P NATL ACAD SCI USA, V104, P1708, DOI 10.1073/pnas.0610429104; Lan H, 2006, PLOS GENET, V2, P51, DOI 10.1371/journal.pgen.0020006; Lum PY, 2006, J NEUROCHEM, V97, P50, DOI 10.1111/j.1471-4159.2006.03661.x; Mehrabian M, 2005, NAT GENET, V37, P1224, DOI 10.1038/ng1619; Meng HJ, 2007, P NATL ACAD SCI USA, V104, P4530, DOI 10.1073/pnas.0607620104; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Mueller M, 2006, BIOINFORMATICS, V22, P509, DOI 10.1093/bioinformatics/btk007; Petretto E, 2008, NAT GENET, V40, P546, DOI 10.1038/ng.134; Petretto E, 2006, PLOS GENET, V2, P1625, DOI 10.1371/journal.pgen.0020172; Petretto E, 2006, MAMM GENOME, V17, P480, DOI 10.1007/s00335-005-0181-1; PRAVENEC M, 1995, J CLIN INVEST, V96, P1973, DOI 10.1172/JCI118244; Pravenec M, 2008, NAT GENET, V40, P952, DOI 10.1038/ng.164; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tu ZD, 2006, BIOINFORMATICS, V22, pE489, DOI 10.1093/bioinformatics/btl234; Wang SS, 2007, CIRC RES, V101, pE11, DOI 10.1161/CIRCRESAHA.107.152975; WU C, 2008, PLOS GENETICS, V4; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222	35	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2008	3	12							e4033	10.1371/journal.pone.0004033	http://dx.doi.org/10.1371/journal.pone.0004033			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DI	19112506	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000265466000005
J	Xue, XY; Sun, J; Zhang, QF; Wang, ZX; Huang, YF; Pan, WQ				Xue, Xiangyang; Sun, Jun; Zhang, Qingfeng; Wang, Zhangxun; Huang, Yufu; Pan, Weiqing			Identification and Characterization of Novel MicroRNAs from Schistosoma japonicum	PLOS ONE			English	Article							RT-PCR; RNA; EXPRESSION; GENE; MANSONI; QUANTIFICATION; BIOGENESIS; PATHWAYS	Background: Schistosomiasis japonica remains a major public health problem in China. Its pathogen, Schistosoma japonicum has a complex life cycle and a unique repertoire of genes expressed at different life cycle stages. Exploring schistosome gene regulation will yield the best prospects for new drug targets and vaccine candidates. MicroRNAs (miRNAs) are a highly conserved class of noncoding RNA that control many biological processes by sequence-specific inhibition of gene expression. Although a large number of miRNAs have been identified from plants to mammals, it remains no experimental proof whether schistosome exist miRNAs. Methodology and Results: We have identified novel miRNAs from Schistosoma japonicum by cloning and sequencing a small (18-26 nt) RNA cDNA library from the adult worms. Five novel miRNAs were identified from 227 cloned RNA sequences and verified by Northern blot. Alignments of the miRNAs with corresponding family members indicated that four of them belong to a metazoan miRNA family: let-7, miR-71, bantam and miR-125. The fifth potentially new (non conserved) miRNA appears to belong to a previously undescribed family in the genus Schistosome. The novel miRNAs were designated as sja-let-7, sja-miR-71, sja-bantam, sja-miR-125 and sja-miR-new1, respectively. Expression of sja-let-7, sja-miR-71 and sja-bantam were analyzed in six stages of the life cycle, i.e. egg, miracidium, sporocyst, cercaria, schistosomulum, and adult worm, by a modified stem-loop reverse transcribed polymerase chain reaction (RT-PCR) method developed in our laboratory. The expression patterns of these miRNAs were highly stage-specific. In particular, sja-miR-71 and sja-bantam expression reach their peaks in the cercaria stage and then drop quickly to the nadirs in the schistosomulum stage, following penetration of cercaria into a mammalian host. Conclusions: Authentic miRNAs were identified for the first time in S. japonicum, including a new schistosome family member. The different expression patterns of the novel miRNAs over the life stages of S. japonicum suggest that they may mediate important roles in Schistosome growth and development.	[Xue, Xiangyang; Sun, Jun; Zhang, Qingfeng; Wang, Zhangxun; Pan, Weiqing] Tongji Univ, Sch Med, Inst Infect Dis & Vaccine Dev, Shanghai 200092, Peoples R China; [Huang, Yufu; Pan, Weiqing] Second Milit Med Univ, Dept Pathogen Biol, Shanghai, Peoples R China; [Xue, Xiangyang] Wenzhou Med Coll, Dept Microbiol, Wenzhou, Peoples R China	Tongji University; Naval Medical University; Wenzhou Medical University	Xue, XY (corresponding author), Tongji Univ, Sch Med, Inst Infect Dis & Vaccine Dev, Shanghai 200092, Peoples R China.	wqpan0912@yahoo.com.cn		Sun, Jun/0000-0003-0720-1879	National Basic Research Program (973 Program) in China [2007CB513100]	National Basic Research Program (973 Program) in China(National Basic Research Program of China)	This work is supported by grants from the National Basic Research Program (973 Program) in China (2007CB513100).	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Ason B, 2006, P NATL ACAD SCI USA, V103, P14385, DOI 10.1073/pnas.0603529103; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bilen J, 2006, MOL CELL, V24, P157, DOI 10.1016/j.molcel.2006.07.030; Boyle JP, 2003, MOL BIOCHEM PARASIT, V128, P205, DOI 10.1016/S0166-6851(03)00078-1; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Grad Y, 2003, MOL CELL, V11, P1253, DOI 10.1016/S1097-2765(03)00153-9; Hertel J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-25; Hirai H, 2000, INT J PARASITOL, V30, P441, DOI 10.1016/S0020-7519(99)00186-1; Kim VN, 2005, MOL CELLS, V19, P1; Krautz-Peterson G, 2008, EXP PARASITOL, V118, P122, DOI 10.1016/j.exppara.2007.06.013; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Liu F, 2006, PLOS PATHOG, V2, P268, DOI 10.1371/journal.ppat.0020029; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Rajewsky N, 2004, DEV BIOL, V267, P529, DOI 10.1016/j.ydbio.2003.12.003; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Sempere LF, 2002, DEV BIOL, V244, P170, DOI 10.1006/dbio.2002.0594; Skelly PJ, 2003, INT J PARASITOL, V33, P363, DOI 10.1016/S0020-7519(03)00030-4; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; TENNISWOOD MPR, 1982, PARASITOLOGY, V84, P253, DOI 10.1017/S0031182000044814; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Verjovski-Almeida S, 2003, NAT GENET, V35, P148, DOI 10.1038/ng1237; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4	28	90	113	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4034	10.1371/journal.pone.0004034	http://dx.doi.org/10.1371/journal.pone.0004034			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107204	Green Submitted, Green Published, gold			2022-12-25	WOS:000265463000025
J	Kidder, BL; Yang, J; Palmer, S				Kidder, Benjamin L.; Yang, Jim; Palmer, Stephen			Stat3 and c-Myc Genome-Wide Promoter Occupancy in Embryonic Stem Cells	PLOS ONE			English	Article							ZINC-FINGER PROTEINS; SELF-RENEWAL; TRANSCRIPTIONAL NETWORK; REGULATORY CIRCUITRY; COREPRESSOR COMPLEX; BINDING-SITES; MOUSE; PLURIPOTENCY; ACTIVATION; TARGET	Embryonic stem ( ES) cell pluripotency is regulated in part by transcription factor (TF) pathways that maintain self-renewal and inhibit differentiation. Stat3 and c-Myc TFs are essential for maintaining mouse ES cell self-renewal. c-Myc, together with Oct4, Sox2, and Klf4, is a reprogramming factor. While previous studies have investigated core transcriptional circuitry in ES cells, other TF pathways that promote ES cell pluripotency have yet to be investigated. Therefore, to further understand ES cell transcriptional networks, we used genome-wide chromatin immunoprecipitation and microarray analysis (ChIP-chip) to map Stat3 and c-Myc binding targets in ES cells. Our results show that Stat3 and c-Myc occupy a significant number of genes whose expression is highly enriched in ES cells. By comparing Stat3 and c-Myc target genes with gene expression data from undifferentiated ES cells and embryoid bodies (EBs), we found that Stat3 binds active and inactive genes in ES cells, while c-Myc binds predominantly active genes. Moreover, the transcriptional states of Stat3 and c-Myc targets are correlated with co-occupancy of pluripotency-related TFs, polycomb group proteins, and active and repressive histone modifications. We also provide evidence that Stat3 targets are differentially expressed in ES cells following removal of LIF, where culture of ES cells in the absence of LIF resulted in downregulation of Stat3 target genes enriched in ES cells, and upregulation of lineage specific Stat3 target genes. Altogether, we reveal transcriptional targets of two key pluripotency-related genes in ES cells - Stat3 and c-Myc, thus providing further insight into the ES cell transcriptional network.	[Palmer, Stephen] EMD Serono Res Inst Inc, Rockland, MA USA; [Yang, Jim] EMD Serono Res Ctr, Billerica, MA USA	Merck KGaA; EMD Serono Inc.	Kidder, BL (corresponding author), EMD Serono Res Inst Inc, Rockland, MA USA.	benjamin.kidder@emdserono.com			EMD Serono Research Institute, Inc	EMD Serono Research Institute, Inc	Funding was provided by EMD Serono Research Institute, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Agata Y, 1999, J BIOL CHEM, V274, P16412, DOI 10.1074/jbc.274.23.16412; Amati Bruno, 1998, Frontiers in Bioscience, V3, pD250; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; BOULTON TG, 1994, J BIOL CHEM, V269, P11648; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Ji HK, 2005, BIOINFORMATICS, V21, P3629, DOI 10.1093/bioinformatics/bti593; JIANG J, 2008, NAT CELL BIOL; Kidder BL, 2008, CLONING STEM CELLS, V10, P231, DOI 10.1089/clo.2007.0039; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim SS, 1996, P NATL ACAD SCI USA, V93, P15299, DOI 10.1073/pnas.93.26.15299; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kwon MC, 2008, EMBO J, V27, P642, DOI 10.1038/sj.emboj.7601986; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Pavesi G, 2004, NUCLEIC ACIDS RES, V32, pW199, DOI 10.1093/nar/gkh465; Rasmussen MD, 2003, PLANT PHYSIOL, V133, P510, DOI 10.1104/pp.103.024885; Raz R, 1999, P NATL ACAD SCI USA, V96, P2846, DOI 10.1073/pnas.96.6.2846; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Satou A, 2001, J BIOL CHEM, V276, P46562, DOI 10.1074/jbc.M104937200; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Sene KH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-85; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Ulloa-Montoya F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r163; Underhill C, 2000, J BIOL CHEM, V275, P40463, DOI 10.1074/jbc.M007864200; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wu CH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000090; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103	48	146	153	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2008	3	12							e3932	10.1371/journal.pone.0003932	http://dx.doi.org/10.1371/journal.pone.0003932			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZU	19079543	gold, Green Published, Green Submitted			2022-12-25	WOS:000265455900011
J	Zartler, ER; Porambo, RJ; Anderson, CL; Chen, LH; Yu, JG; Nahm, MH				Zartler, Edward R.; Porambo, Richard J.; Anderson, Carrie L.; Chen, Lorenzo H.; Yu, Jigui; Nahm, Moon H.			Structure of the Capsular Polysaccharide of Pneumococcal Serotype 11A Reveals a Novel Acetylglycerol That Is the Structural Basis for 11A Subtypes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGLE-SPINNING NMR; GENETIC-BASIS; ASSIGNMENT; RESOLUTION; H-1; SENSITIVITY; ANTIBODIES; HSQC; 15B	We have undertaken a structural assessment of Streptococcus pneumoniae 11A polysaccharide as well as two clinical isolates related to 11A. The clinical isolates were labeled 11A alpha and 11A beta. The result of our experiments is a revision to the old structure for S. pneumoniae 11A polysaccharide. The new structure differs from the old structure in both the primary connectivities and acetylation pattern. We also show that 11A contains an acetylglycerol-PO4 moiety, a substitution that is heretofore unknown in the bacterial polysaccharide literature. The two clinical isolates were also structurally characterized. 11A alpha was determined to be identical to 11A. 11A beta is a new serotype, which differs from 11A in the absence of the acetylation of the glycerol-PO4 moiety and a different acetylation pattern of the saccharides. Thus, we propose that the acetylglycerol is the structural basis for 11A alpha and 11A beta subtypes.	[Zartler, Edward R.; Porambo, Richard J.; Anderson, Carrie L.; Chen, Lorenzo H.] Merck & Co Inc, Merck Res Labs, Bioproc Analyt & Formulat Sci, West Point, PA 19486 USA; [Yu, Jigui; Nahm, Moon H.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35249 USA	Merck & Company; University of Alabama System; University of Alabama Birmingham	Zartler, ER (corresponding author), 770 Sumneytown Pike,WP42A-20, West Point, PA 19486 USA.	edward_zartler@merck.com		Nahm, Moon/0000-0002-6922-1042	National Institutes of Health [AI-30021]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant AI-30021 (to M. H. N.).	Abeygunawardana C, 2000, ANAL BIOCHEM, V279, P226, DOI 10.1006/abio.1999.4470; AVERY OSWALD T., 1931, JOUR EXP MED, V54, P73, DOI 10.1084/jem.54.1.73; BAX A, 1986, J MAGN RESON, V67, P565, DOI 10.1016/0022-2364(86)90395-1; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Cerda-Garcia-Rojas CM, 2000, MAGN RESON CHEM, V38, P494; Duus JO, 2000, CHEM REV, V100, P4589, DOI 10.1021/cr990302n; Gasmi G, 1996, MAGN RESON CHEM, V34, P185, DOI 10.1002/(SICI)1097-458X(199603)34:3<185::AID-OMR866>3.3.CO;2-Y; Gudlavalleti SK, 2006, CARBOHYD RES, V341, P557, DOI 10.1016/j.carres.2005.11.036; HENRICHSEN J, 1995, J CLIN MICROBIOL, V33, P2759, DOI 10.1128/JCM.33.10.2759-2762.1995; Kamerling JP., 2000, STREPTOCOCCUS PNEUMO, P81; KENNEDY DA, 1969, BIOCHEM J, V115, P37, DOI 10.1042/bj1150037; Kim JS, 2006, ANAL BIOCHEM, V358, P136, DOI 10.1016/j.ab.2006.08.016; Kim JS, 2005, ANAL BIOCHEM, V347, P262, DOI 10.1016/j.ab.2005.09.022; Kotsubo V, 1996, ADV CRYOG ENG, P1857; Li W, 2005, ANAL CHEM, V77, P5785, DOI 10.1021/ac050906t; McNeely TB, 1998, INFECT IMMUN, V66, P3705, DOI 10.1128/IAI.66.8.3705-3710.1998; MERCHANT TE, 1990, J LIPID RES, V31, P479; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; OTTER A, 1995, J MAGN RESON SER B, V109, P194, DOI 10.1006/jmrb.1995.0009; Park IH, 2007, INFECT IMMUN, V75, P4482, DOI 10.1128/IAI.00510-07; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; Rajam G, 2007, CLIN VACCINE IMMUNOL, V14, P1223, DOI 10.1128/CVI.00184-07; Reynolds WF, 1997, MAGN RESON CHEM, V35, P455, DOI 10.1002/(SICI)1097-458X(199707)35:7<455::AID-OMR116>3.0.CO;2-6; RICHARDS JC, 1985, CAN J BIOCHEM CELL B, V63, P953, DOI 10.1139/o85-118; RICHARDS JC, 1988, ADV EXP MED BIOL, V228, P595; Russell DJ, 2000, J NAT PROD, V63, P1047, DOI 10.1021/np0003140; SUMMERS MF, 1986, J AM CHEM SOC, V108, P4285, DOI 10.1021/ja00275a008; Tezuka Y, 1997, CARBOHYD RES, V305, P155, DOI 10.1016/S0008-6215(97)10036-2; Vammen B, 1939, J IMMUNOL, V37, P359; van Selm S, 2003, INFECT IMMUN, V71, P6192, DOI 10.1128/IAI.71.11.6192-6198.2003; VANDERIJN I, 1980, INFECT IMMUN, V27, P444, DOI 10.1128/IAI.27.2.444-448.1980; Xu QW, 2005, ANAL BIOCHEM, V336, P262, DOI 10.1016/j.ab.2004.10.019; Yu F, 2006, BIOPHYS J, V91, P1952, DOI 10.1529/biophysj.105.079913; Yu J, 2008, J MED MICROBIOL, V57, P171, DOI 10.1099/jmm.0.47549-0	34	27	27	4	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7318	7329		10.1074/jbc.M807952200	http://dx.doi.org/10.1074/jbc.M807952200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19114709	hybrid, Green Published			2022-12-25	WOS:000263919000078
J	Cunningham, F; Rath, A; Johnson, RM; Deber, CM				Cunningham, Fiona; Rath, Arianna; Johnson, Rachel M.; Deber, Charles M.			Distinctions between Hydrophobic Helices in Globular Proteins and Transmembrane Segments as Factors in Protein Sorting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; K+ CHANNEL; MEMBRANE; RECOGNITION; PREDICTION; PEPTIDES; OLIGOMERIZATION; ENVIRONMENTS; ASSOCIATION; TRANSLOCON	Transmembrane (TM) segments in proteins can be distinguished in amino acid sequences as continuous stretches of hydrophobic residues. However, examination of a data base of helical water-soluble (globular) proteins revealed that nearly one-third contained helices of sufficient length to span a bilayer (>= 19 residues) that had mean hydrophobicity >= actual TM segments. We now report that synthetic peptides corresponding to these globular protein sequences, which we termed "delta-helices," behave like native TM sequences and readily insert into membrane mimetic environments in helical conformations. As well, certain delta-helix sequences can integrate into the membrane bilayer when placed into a membrane-targeted chimeric protein. We establish that delta-helices can be distinguished computationally from bona fide TM segments by the decreased frequency of occurrence of Ile/Val residues and by their relatively decreased solvent accessibilities (versus other globular helices) within tertiary structure. The further observations that (i) delta-helices generally contain three or more charged residues and (ii) delta-helices display relatively even distribution of these charged residues along their lengths, rather than concentration near their N and C termini as observed for TM segments, may constitute key recognition factors in diverting delta-helices from the membrane in vivo. Although a discrete biological role for delta-helices remains to be pinpointed, our overall results suggest that such segments may be required for globular protein folding and identify additional factors that may be important in the correct selection of TM segments by the cellular machinery.	[Deber, Charles M.] Hosp Sick Children, Res Inst, Div Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Deber, CM (corresponding author), Hosp Sick Children, Res Inst, Div Mol Struct & Funct, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	deber@sickkids.ca			Natural Sciences and Engineering Research Council of Canada [A-2807]; Canadian Institutes of Health Research [5810]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported, in part, by grants ( to C. M. D.) from the Natural Sciences and Engineering Research Council of Canada ( NSERC Discovery Grant A-2807) and Canadian Institutes of Health Research ( Grant FRN-5810).	CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Cserzo M, 2002, PROTEIN ENG, V15, P745, DOI 10.1093/protein/15.9.745; Cuthbertson JM, 2006, BIOCHEMISTRY-US, V45, P14298, DOI 10.1021/bi0610911; Deber CM, 2001, PROTEIN SCI, V10, P212, DOI 10.1110/ps.30301; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; Eshaghi S, 2006, SCIENCE, V313, P354, DOI 10.1126/science.1127121; Galdiero S, 2007, CURR PROTEIN PEPT SC, V8, P63, DOI 10.2174/138920307779941541; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Hubbard ST, 1993, NACCESS; IMAMURA T, 2006, ENCY SURFACE COLLOID, V7, P5251; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Johnson RM, 2006, BIOCHEMISTRY-US, V45, P8507, DOI 10.1021/bi060063f; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Liu LP, 1999, BIOORGAN MED CHEM, V7, P1, DOI 10.1016/S0968-0896(98)00233-8; Liu LP, 1996, BIOPOLYMERS, V39, P465, DOI 10.1002/(SICI)1097-0282(199609)39:3<465::AID-BIP17>3.0.CO;2-A; Liu LP, 1998, J BIOL CHEM, V273, P23645, DOI 10.1074/jbc.273.37.23645; Lu LP, 1998, BIOPOLYMERS, V47, P41, DOI 10.1002/(SICI)1097-0282(1998)47:1<41::AID-BIP6>3.0.CO;2-X; Lupo D, 2007, P NATL ACAD SCI USA, V104, P19303, DOI 10.1073/pnas.0706563104; Melnyk RA, 2003, BIOPOLYMERS, V71, P675, DOI 10.1002/bip.10595; Melnyk RA, 2001, BIOCHEMISTRY-US, V40, P11106, DOI 10.1021/bi010642e; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Netz DJA, 2002, APPL ENVIRON MICROB, V68, P5274, DOI 10.1128/AEM.68.11.5274-5280.2002; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Paivio A, 2004, PROTEIN SCI, V13, P1251, DOI 10.1110/ps.03442404; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rath A, 2008, PROTEINS, V70, P786, DOI 10.1002/prot.21569; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Wang C, 2000, PEPTIDES FOR THE NEW MILLENNIUM, P367; Zhang LY, 2007, P NATL ACAD SCI USA, V104, P8263, DOI 10.1073/pnas.0611007104; Zhao G, 2006, PROTEIN SCI, V15, P1987, DOI 10.1110/ps.062286306	34	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5395	5402		10.1074/jbc.M809017200	http://dx.doi.org/10.1074/jbc.M809017200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19095650	hybrid			2022-12-25	WOS:000263416600069
J	Millard, EL; Nevin, ST; Loughnan, ML; Nicke, A; Clark, RJ; Alewood, PF; Lewis, RJ; Adams, DJ; Craik, DJ; Daly, NL				Millard, Emma L.; Nevin, Simon T.; Loughnan, Marion L.; Nicke, Annette; Clark, Richard J.; Alewood, Paul F.; Lewis, Richard J.; Adams, David J.; Craik, David J.; Daly, Norelle L.			Inhibition of Neuronal Nicotinic Acetylcholine Receptor Subtypes by alpha-Conotoxin GID and Analogues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR STRUCTURE CALCULATION; TORSION ANGLE DYNAMICS; XENOPUS-LAEVIS OOCYTES; CRYSTAL-STRUCTURE; HOMOLOG ACHBP; ANTAGONISTS; BINDING; DETERMINANTS; CARCINOMA; PROTEINS	alpha-Conotoxins are small disulfide-rich peptides from the venom of the Conus species that target the nicotinic acetylcholine receptor (nAChR). They are valuable pharmacological tools and also have potential therapeutic applications particularly for the treatment of chronic pain. alpha-Conotoxin GID is isolated from the venom of Conus geographus and has an unusual N-terminal tail sequence that has been shown to be important for binding to the alpha 4 beta 2 subtype of the nAChR. To date, only four conotoxins that inhibit the alpha 4 beta 2 subtype have been characterized, but they are of considerable interest as it is the most abundant nAChR subtype in the mammalian brain and has been implicated in a range of diseases. In this study, analysis of alaninescan and truncation mutants of GID reveals that a conserved proline in alpha-conotoxins is important for activity at the alpha 7, alpha 3 beta 2, and alpha 4 beta 2 subtypes. Although the proline residue was the most critical residue for activity at the alpha 3 beta 2 subtype, Asp3, Arg12, and Asn14 are also critical at the alpha 7 subtype. Interestingly, very few of the mutations tested retained activity at the alpha 4 beta 2 subtype indicating a tightly defined binding site. This lack of tolerance to sequence variation may explain the lack of selective ligands discovered for the alpha 4 beta 2 subtype to date. Overall, our findings contribute to the understanding of the structureactivity relationships of alpha-conotoxins and may be beneficial for the ongoing attempts to exploit modulators of the neuronal nAChRs as therapeutic agents.	[Millard, Emma L.; Loughnan, Marion L.; Clark, Richard J.; Alewood, Paul F.; Lewis, Richard J.; Craik, David J.; Daly, Norelle L.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Millard, Emma L.; Nevin, Simon T.; Adams, David J.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Nicke, Annette] Max Planck Inst Brain Res, D-60528 Frankfurt, Germany	University of Queensland; University of Queensland; University of Queensland; Max Planck Society	Daly, NL (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	n.daly@imb.uq.edu.au	Daly, Norelle L/D-4302-2013; Clark, Richard J/G-8848-2012; Alewood, Paul F/J-2412-2014; Loughnan, Marion/B-4508-2009; Nevin, Simon/B-2663-2014; Craik, David/B-1695-2010; Lewis, Richard J/E-8674-2013; Adams, David John/K-3578-2019; Lewis, Richard/T-8763-2019	Daly, Norelle L/0000-0002-4697-6602; Clark, Richard J/0000-0002-6807-5426; Craik, David/0000-0003-0007-6796; Lewis, Richard J/0000-0003-3470-923X; Adams, David John/0000-0002-7030-2288; Lewis, Richard/0000-0003-3470-923X; Nicke, Annette/0000-0001-6798-505X; Alewood, Paul/0000-0001-7454-6522	Australian Research Council; Deutsche Forschungsgemeinschaft [NI 592/3]; National Health and Medical Research Council	Australian Research Council(Australian Research Council); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the Australian Research Council (to D. J.A., R.J.L., P.F.A., and D.J.C.), Deutsche Forschungsgemeinschaft Grant NI 592/3 (to A. N.), and the National Health and Medical Research Council (to N.L.D. and R.J.C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BIDLINGMEYER BA, 1984, J CHROMATOGR, V336, P93, DOI 10.1016/S0378-4347(00)85133-6; Cartier GE, 1996, J BIOL CHEM, V271, P7522, DOI 10.1074/jbc.271.13.7522; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Codignola A, 1996, NEUROSCI LETT, V206, P53, DOI 10.1016/0304-3940(96)12423-X; Dutertre S, 2005, J BIOL CHEM, V280, P30460, DOI 10.1074/jbc.M504229200; Dutertre S, 2004, EUR J BIOCHEM, V271, P2327, DOI 10.1111/j.1432-1033.2004.04147.x; Dutertre S, 2006, BIOCHEM PHARMACOL, V72, P661, DOI 10.1016/j.bcp.2006.03.027; Dutton JL, 2001, CURR MED CHEM, V8, P327, DOI 10.2174/0929867013373453; Dwoskin LP, 2001, J PHARMACOL EXP THER, V298, P395; ECCLES C, 1991, Journal of Biomolecular NMR, V1, P111, DOI 10.1007/BF01877224; Ellison M, 2003, J BIOL CHEM, V278, P757, DOI 10.1074/jbc.M204565200; Everhart D, 2004, BIOCHEMISTRY-US, V43, P2732, DOI 10.1021/bi036180h; FAINZILBER M, 1994, BIOCHEMISTRY-US, V33, P9523, DOI 10.1021/bi00198a018; Geerts H, 2002, J NEURAL TRANSM-SUPP, P203; Gehrmann J, 1998, J MOL BIOL, V278, P401, DOI 10.1006/jmbi.1998.1701; GLOOR S, 1995, GENE, V160, P213, DOI 10.1016/0378-1119(95)00226-V; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hill JM, 1998, BIOCHEMISTRY-US, V37, P15621, DOI 10.1021/bi981535w; Hu SH, 1997, BIOCHEMISTRY-US, V36, P11323, DOI 10.1021/bi9713052; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Jin AH, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-28; Kang TS, 2005, ANGEW CHEM INT EDIT, V44, P6333, DOI 10.1002/anie.200502300; Lam Sum, 2007, Cardiol Rev, V15, P154, DOI 10.1097/01.crd.0000260270.12829.45; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Linge JP, 1999, J BIOMOL NMR, V13, P51, DOI 10.1023/A:1008365802830; McIntosh JM, 1999, ANNU REV BIOCHEM, V68, P59, DOI 10.1146/annurev.biochem.68.1.59; Meyer EM, 1998, J PHARMACOL EXP THER, V287, P918; Millard EL, 2004, EUR J BIOCHEM, V271, P2320, DOI 10.1111/j.1432-1033.2004.04148.x; Nevin ST, 2007, MOL PHARMACOL, V72, P1406, DOI 10.1124/mol.107.040568; Nicke A, 2003, J BIOL CHEM, V278, P3137, DOI 10.1074/jbc.M210280200; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; O'Neill MJ, 2002, CNS NEUROL DISORD-DR, V1, P399, DOI 10.2174/1568007023339166; RICE LM, 1994, PROTEINS, V19, P277, DOI 10.1002/prot.340190403; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Sciamanna MA, 1997, J NEUROCHEM, V69, P2302; Ulens C, 2006, P NATL ACAD SCI USA, V103, P3615, DOI 10.1073/pnas.0507889103; VIBAT CRT, 1995, CELL MOL NEUROBIOL, V15, P411, DOI 10.1007/BF02071877; Wuthrich K, 1986, NMR PROTEINS NUCL AC, P117	39	34	38	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4944	4951		10.1074/jbc.M804950200	http://dx.doi.org/10.1074/jbc.M804950200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19098004	hybrid			2022-12-25	WOS:000263416600024
J	Mikami, T; Yasunaga, D; Kitagawa, H				Mikami, Tadahisa; Yasunaga, Daiki; Kitagawa, Hiroshi			Contactin-1 Is a Functional Receptor for Neuroregulatory Chondroitin Sulfate-E	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROMOTES NEURITE OUTGROWTH; TYROSINE-PHOSPHATASE ALPHA; E-DISACCHARIDE EXPRESSION; NEURONAL CELL-ADHESION; HIPPOCAMPAL-NEURONS; DERMATAN SULFATE; GROWTH-FACTORS; KINASE FYN; BINDING; MOLECULE	Chondroitin sulfate (CS) plays critical roles in central nervous system development and regeneration, and individual modifications of CS form a "sulfation code" that regulates growth factor signaling or neuronal growth. Although we have shown that CS-E polysaccharide, but not CS-A or -C polysaccharide, has an inherent ability to promote neurite outgrowth toward primary neurons, its molecular mechanism remains elusive. Here, we show the involvement of a plasma membrane-tethered cell adhesion molecule, contactin-1 (CNTN-1), in CS-E-mediated neurite extension in a mouse neuroblastoma cell line and primary hippocampal neurons. CS-E, but not CS-A, -C, or heparan sulfate, engaged CNTN-1 with significant affinity and induced intracellular signaling downstream of CNTN-1, indicating that CS-E is a selective ligand for a potential CS receptor, CNTN-1, leading to neurite outgrowth. Our data provide the first evidence that biological functions of CS are exerted through the CS receptor-mediated signaling pathway(s).	[Mikami, Tadahisa; Yasunaga, Daiki; Kitagawa, Hiroshi] Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan; [Kitagawa, Hiroshi] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Kobe Pharmaceutical University; Japan Science & Technology Agency (JST)	Kitagawa, H (corresponding author), Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan.	kitagawa@kobepharma-u.ac.jp	Kitagawa, Hiroshi/AAJ-1344-2020	Kitagawa, Hiroshi/0000-0002-9307-7079	Japan Private School Promotion Foundation [19390025]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [20790080, 18790073]; Ministry of Health, Labour, and Welfare	Japan Private School Promotion Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by the scientific promotion fund from the Japan Private School Promotion Foundation, Grants-in-aid for Scientific Research-B # 19390025 (to H. K.) and Encouragement of Young Scientists # 20790080 and # 18790073 (to T. M.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and a grant-in-aid for research on psychiatric and neurological diseases and mental health (to H. K.) from the Ministry of Health, Labour, and Welfare.	Bhandari V, 1998, J BIOL CHEM, V273, P8691, DOI 10.1074/jbc.273.15.8691; Brackenbury WJ, 2008, J NEUROSCI, V28, P3246, DOI 10.1523/JNEUROSCI.5446-07.2008; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Carulli D, 2005, CURR OPIN NEUROBIOL, V15, P252, DOI 10.1016/j.conb.2005.03.018; Clement AM, 1999, NEUROSCI LETT, V269, P125, DOI 10.1016/S0304-3940(99)00432-2; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Falk J, 2002, BIOL CELL, V94, P327, DOI 10.1016/S0248-4900(02)00006-0; Gama CI, 2006, NAT CHEM BIOL, V2, P467, DOI 10.1038/nchembio810; GENNARINI G, 1991, NEURON, V6, P595, DOI 10.1016/0896-6273(91)90062-5; Hikino M, 2003, J BIOL CHEM, V278, P43744, DOI 10.1074/jbc.M308169200; Izumikawa T, 2008, J BIOL CHEM, V283, P11396, DOI 10.1074/jbc.M707549200; Mizuguchi S, 2003, NATURE, V423, P443, DOI 10.1038/nature01635; Nadanaka S, 2008, J BIOL CHEM, V283, P27333, DOI 10.1074/jbc.M802997200; Nandini CD, 2004, J BIOL CHEM, V279, P50799, DOI 10.1074/jbc.M404746200; Nicholson MW, 1998, J BIOL CHEM, V273, P763, DOI 10.1074/jbc.273.2.763; PELES E, 1995, CELL, V82, P251, DOI 10.1016/0092-8674(95)90312-7; Rabinovich GA, 2007, CURR OPIN STRUC BIOL, V17, P513, DOI 10.1016/j.sbi.2007.09.002; Revest JM, 1999, EUR J NEUROSCI, V11, P1134, DOI 10.1046/j.1460-9568.1999.00521.x; Sakurai T, 1997, J CELL BIOL, V136, P907, DOI 10.1083/jcb.136.4.907; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Sugahara K, 2007, CURR OPIN STRUC BIOL, V17, P536, DOI 10.1016/j.sbi.2007.08.015; Thiele H, 2004, P NATL ACAD SCI USA, V101, P10155, DOI 10.1073/pnas.0400334101; Tully SE, 2004, J AM CHEM SOC, V126, P7736, DOI 10.1021/ja0484045; Ueoka C, 2000, J BIOL CHEM, V275, P37407, DOI 10.1074/jbc.M002538200; Uyama T, 2006, J BIOL CHEM, V281, P38668, DOI 10.1074/jbc.M609320200; Zeng L, 1999, J CELL BIOL, V147, P707, DOI 10.1083/jcb.147.4.707; ZISCH AH, 1995, MOL CELL NEUROSCI, V6, P263, DOI 10.1006/mcne.1995.1021	28	93	96	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4494	4499		10.1074/jbc.M809227200	http://dx.doi.org/10.1074/jbc.M809227200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19075012	hybrid			2022-12-25	WOS:000263134400049
J	Zen, K; Liu, DQ; Li, LM; Chen, CXJ; Guo, YL; Ha, B; Chen, X; Zhang, CY; Liu, Y				Zen, Ke; Liu, Dan-Qing; Li, Li-Min; Chen, Celia X. -J.; Guo, Ya-Lan; Ha, Bihn; Chen, Xi; Zhang, Chen-Yu; Liu, Yuan			The Heparan Sulfate Proteoglycan Form of Epithelial CD44v3 Serves as a CD11b/CD18 Counter-receptor during Polymorphonuclear Leukocyte Transepithelial Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRIN MAC-1 CD11B/CD18; INFLAMMATORY-BOWEL-DISEASE; NEUTROPHIL TRANSMIGRATION; INTESTINAL EPITHELIUM; ULCERATIVE-COLITIS; ADHESION RECEPTOR; INTERFERON-GAMMA; CROHNS-DISEASE; EXPRESSION; LIGAND	Leukocyte beta(2)-integrin CD11b/CD18 mediates the firm adhesion and subsequent transepithelial migration of polymorphonuclear leukocytes, but the identity of its counter-receptor(s) on epithelia remains elusive. Here we identified a monoclonal antibody, clone C3H7, which strongly bound to the basolateral membranes of epithelial cells and inhibited both the adhesion of epithelial cells to immobilized CD11b/CD8 and the transepithelial migration of PMNs in a physiologically relevant basolateral-to-apical direction. C3H7 antigen expression in epithelial monolayers was significantly increased by treatment with pro-inflammatory cytokine interferon-gamma or a combination of interferon-gamma and tumor necrosis factor-alpha. Up-regulation of C3H7 antigen was also observed in the epithelium of inflamed human colon tissues. Microsequencing and Western blotting of the purified antigen showed it to be CD44 variant 3 (CD44v3), a similar to 160-kDa membrane glycoprotein. Further studies demonstrated that this epithelial CD44v3 specifically binds to CD11b/CD18 through its heparan sulfate moieties. In summary, our study demonstrates for the first time that the heparan sulfate proteoglycan form of epithelial CD44v3 plays a critical role in facilitating PMN recruitment during inflammatory episodes via directly binding to CD11b/CD18.	[Zen, Ke; Liu, Dan-Qing; Li, Li-Min; Guo, Ya-Lan; Chen, Xi; Zhang, Chen-Yu] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Diabet Res Ctr, Nanjing 210093, Jiangsu, Peoples R China; [Zen, Ke; Chen, Celia X. -J.; Guo, Ya-Lan; Ha, Bihn; Liu, Yuan] Georgia State Univ, Dept Biol, Program Mol Biol & Physiol, Atlanta, GA 30303 USA	Nanjing University; University System of Georgia; Georgia State University	Zen, K (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Diabet Res Ctr, 22 Hankou Rd, Nanjing 210093, Jiangsu, Peoples R China.	kzen@nju.edu.cn			National Institutes of Health [R21 AI073622]; American Heart Association [0535263N]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073622] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R21 AI073622. This work was also supported by Scientist Development Grant 0535263N from the American Heart Association. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALTIERI DC, 1988, J CELL BIOL, V107, P1893, DOI 10.1083/jcb.107.5.1893; BROWN TA, 1991, J CELL BIOL, V113, P207, DOI 10.1083/jcb.113.1.207; Cai TQ, 1996, J EXP MED, V184, P1213, DOI 10.1084/jem.184.4.1213; Camacho FI, 1999, HISTOPATHOLOGY, V35, P144, DOI 10.1046/j.1365-2559.1999.00712.x; Cichy J, 2003, J CELL BIOL, V161, P839, DOI 10.1083/jcb.200302098; Colgan Sean P, 2002, ScientificWorldJournal, V2, P76; COLGAN SP, 1995, J BIOL CHEM, V270, P10531, DOI 10.1074/jbc.270.18.10531; COLGAN SP, 1994, AM J PHYSIOL, V267, pC402, DOI 10.1152/ajpcell.1994.267.2.C402; DANA N, 1991, P NATL ACAD SCI USA, V88, P3106, DOI 10.1073/pnas.88.8.3106; DeGrendele HC, 1996, J EXP MED, V183, P1119, DOI 10.1084/jem.183.3.1119; DIAMOND MS, 1993, J CELL BIOL, V120, P1031, DOI 10.1083/jcb.120.4.1031; DIAMOND MS, 1990, J CELL BIOL, V111, P3129, DOI 10.1083/jcb.111.6.3129; DIAMOND MS, 1995, J CELL BIOL, V130, P1473, DOI 10.1083/jcb.130.6.1473; Frick C, 2005, EUR J IMMUNOL, V35, P3610, DOI 10.1002/eji.200425914; HAWKER PC, 1980, GASTROENTEROLOGY, V79, P508; Huang GTJ, 1996, J CLIN INVEST, V98, P572, DOI 10.1172/JCI118825; JACKSON DG, 1995, J CELL BIOL, V128, P673, DOI 10.1083/jcb.128.4.673; Khan AI, 2004, J IMMUNOL, V173, P7594, DOI 10.4049/jimmunol.173.12.7594; Lawrence DW, 2003, J EXP MED, V198, P999, DOI 10.1084/jem.20030380; Leir SH, 2000, AM J PHYSIOL-LUNG C, V278, pL1129, DOI 10.1152/ajplung.2000.278.6.L1129; LESLEY J, 1993, ADV IMMUNOL, V54, P271, DOI 10.1016/S0065-2776(08)60537-4; Liu Y, 2002, J BIOL CHEM, V277, P10028, DOI 10.1074/jbc.M109720200; Liu Y, 2001, J BIOL CHEM, V276, P40156, DOI 10.1074/jbc.M104138200; Macdonald DC, 2003, EUR J GASTROEN HEPAT, V15, P1101, DOI 10.1097/00042737-200310000-00007; Naor D, 1997, ADV CANCER RES, V71, P241, DOI 10.1016/S0065-230X(08)60101-3; Parish CR, 2006, NAT REV IMMUNOL, V6, P633, DOI 10.1038/nri1918; Parkos CA, 1996, J CELL BIOL, V132, P437, DOI 10.1083/jcb.132.3.437; PARKOS CA, 1991, J CLIN INVEST, V88, P1605, DOI 10.1172/JCI115473; Peter K, 1999, CIRCULATION, V100, P1533, DOI 10.1161/01.CIR.100.14.1533; Pituch-Noworolska A, 1998, ANTICANCER RES, V18, P3747; Reaves TA, 2001, AM J PHYSIOL-GASTR L, V280, pG746, DOI 10.1152/ajpgi.2001.280.4.G746; Reinisch W, 1998, GUT, V43, P375, DOI 10.1136/gut.43.3.375; ROSENBERG WMC, 1995, LANCET, V345, P1205, DOI 10.1016/S0140-6736(95)91991-0; Santoso S, 2002, J EXP MED, V196, P679, DOI 10.1084/jem.20020267; Schenauer MR, 2007, J BIOL CHEM, V282, P25182, DOI 10.1074/jbc.M703387200; Schober JM, 2002, BLOOD, V99, P4457, DOI 10.1182/blood.V99.12.4457; Siegelman MH, 1999, J LEUKOCYTE BIOL, V66, P315, DOI 10.1002/jlb.66.2.315; SMITH CW, 1988, J CLIN INVEST, V82, P1746, DOI 10.1172/JCI113788; STAUNTON DE, 1990, CELL, V61, P243, DOI 10.1016/0092-8674(90)90805-O; Trejdosiewicz LK, 1998, CYTOKINE, V10, P756, DOI 10.1006/cyto.1998.0361; UNDERHILL C, 1992, J CELL SCI, V103, P293; Vachon E, 2007, BLOOD, V110, P4492, DOI 10.1182/blood-2007-02-076539; WALZOG B, 1995, EXP CELL RES, V218, P28, DOI 10.1006/excr.1995.1127; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Weg-Remers S, 1998, AM J GASTROENTEROL, V93, P790; WEILAND JE, 1986, AM REV RESPIR DIS, V133, P218; Wittig B, 1999, LAB INVEST, V79, P747; Yan Y, 2007, AM J PHYSIOL-GASTR L, V292, pG535, DOI 10.1152/ajpgi.00385.2006; Zen K, 2004, MOL BIOL CELL, V15, P3926, DOI 10.1091/mbc.E04-04-0317; Zen K, 2002, J IMMUNOL, V169, P5270, DOI 10.4049/jimmunol.169.9.5270	50	24	26	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3768	3776		10.1074/jbc.M807805200	http://dx.doi.org/10.1074/jbc.M807805200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19073595	hybrid, Green Published			2022-12-25	WOS:000262872500045
J	Lee, JY; Kang, MB; Jang, SH; Qian, T; Kim, HJ; Kim, CH; Kim, Y; Kong, G				Lee, J-Y; Kang, M-B; Jang, S-H; Qian, T.; Kim, H-J; Kim, C-H; Kim, Y.; Kong, G.			Id-1 activates Akt-mediated Wnt signaling and p27(Kip1) phosphorylation through PTEN inhibition	ONCOGENE			English	Article						Id-1; PTEN; p53; breast cancer	CELL-CYCLE PROGRESSION; BETA-CATENIN; EXPRESSION; P53; TRANSCRIPTION; PATHWAY	Inhibitor of differentiation-1 (Id-1) has been accepted as a putative oncogene to promote oncogenic processes through inactivation of tumor suppressors and activation of growth promoting pathways. Here, we show that Id-1 activates the Akt pathway by inhibition of phosphatase and tensin homologue deleted on chromosome 10 (PTEN) transcription through downregulation of p53. Id-1 negatively regulated both p53 and PTEN at the transcriptional level. In promoter assay with serial deletion and chromatin immunoprecipitation assay, the binding of p53 to the PTEN promoter was reduced by Id-1, suggesting that Id-1 regulates PTEN transcription through its p53 modulation. This led to Akt phosphorylation at Ser473 and the activation of the Akt-mediated canonical Wnt signaling pathway. The glycogen synthase kinase-3 beta phosphorylation at Ser9, stabilization and nuclear localization of beta-catenin, T-cell factor (TCF)/lymphoid enhancer factor transactivation activity and cyclin D1 expression were enhanced by Id-1. On the other hand, Akt-mediated p27(Kip1) phosphorylation at Thr157 and its cytosolic localization were also increased in Id-1 overexpressing MCF7 cells. In conclusion, our results disclose Id-1 as a novel PTEN inhibitor that could activate the Akt pathway and its downstream effectors, the Wnt/TCF pathway and p27(Kip1) phosphorylation and suggest that the oncogenic function of Id-1 may be partly attributed to its PTEN inhibition in human breast carcinogenesis.	[Lee, J-Y; Kang, M-B; Jang, S-H; Qian, T.; Kim, H-J; Kong, G.] Hanyang Univ, Dept Pathol, Coll Med, Seoul 133791, South Korea; [Kim, C-H] Sungkyunkwan Univ, Dept Biol Sci, Kyonggi Do, South Korea; [Kim, Y.] Hanyang Univ, Dept Biochem, Coll Med, Seoul 133791, South Korea	Hanyang University; Sungkyunkwan University (SKKU); Hanyang University	Kong, G (corresponding author), Hanyang Univ, Dept Pathol, Coll Med, 17 Haengdang Dong, Seoul 133791, South Korea.	gkong@hanyang.ac.kr			Korean Government (MOEHRD) [KRF-2007-314-E00041]	Korean Government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government)	This work was supported by a Korea Research Foundation Grant (KRF-2007-314-E00041) funded by the Korean Government (MOEHRD, Basic Research Promotion Fund).	BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P1379, DOI 10.1093/carcin/bgm052; Chung TW, 2003, CANCER RES, V63, P3453; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Jang KS, 2006, CANCER LETT, V244, P203, DOI 10.1016/j.canlet.2005.12.016; Kim H, 2008, BREAST CANCER RES TR, V112, P287, DOI 10.1007/s10549-007-9871-6; Kim HJ, 2007, MOL CANCER RES, V5, P321, DOI 10.1158/1541-7786.MCR-06-0218; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Li B, 2007, CARCINOGENESIS, V28, P2313, DOI 10.1093/carcin/bgm152; Ling MT, 2006, DIFFERENTIATION, V74, P481, DOI 10.1111/j.1432-0436.2006.00083.x; Mayo LD, 2002, J BIOL CHEM, V277, P5484, DOI 10.1074/jbc.M108302200; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Swarbrick A, 2005, ONCOGENE, V24, P381, DOI 10.1038/sj.onc.1208188; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Vikhanskaya F, 2007, NUCLEIC ACIDS RES, V35, P2093, DOI 10.1093/nar/gkm099; Virolle T, 2001, NAT CELL BIOL, V3, P1124, DOI 10.1038/ncb1201-1124; Wang J, 2005, CANCER RES, V65, P6601, DOI 10.1158/0008-5472.CAN-04-4184; Yoo YG, 2003, J BIOL CHEM, V278, P39076, DOI 10.1074/jbc.M305101200; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Zhang XM, 2007, J BIOL CHEM, V282, P33284, DOI 10.1074/jbc.M705089200	22	50	58	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2009	28	6					824	831		10.1038/onc.2008.451	http://dx.doi.org/10.1038/onc.2008.451			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	406UI	19079342				2022-12-25	WOS:000263320000005
J	Osipova, D; Hermes, D; Jensen, O				Osipova, Daria; Hermes, Dora; Jensen, Ole			Gamma Power Is Phase-Locked to Posterior Alpha Activity	PLOS ONE			English	Article							EVOKED-RESPONSES; NEURONAL OSCILLATIONS; HIGH-FREQUENCY; MEMORY TASK; THETA; EEG; HUMANS; CORTEX; ELECTROENCEPHALOGRAM; SYNCHRONIZATION	Neuronal oscillations in various frequency bands have been reported in numerous studies in both humans and animals. While it is obvious that these oscillations play an important role in cognitive processing, it remains unclear how oscillations in various frequency bands interact. In this study we have investigated phase to power locking in MEG activity of healthy human subjects at rest with their eyes closed. To examine cross-frequency coupling, we have computed coherence between the time course of the power in a given frequency band and the signal itself within every channel. The time-course of the power was calculated using a sliding tapered time window followed by a Fourier transform. Our findings show that high-frequency gamma power (30-70 Hz) is phase-locked to alpha oscillations (8-13 Hz) in the ongoing MEG signals. The topography of the coupling was similar to the topography of the alpha power and was strongest over occipital areas. Interestingly, gamma activity per se was not evident in the power spectra and only became detectable when studied in relation to the alpha phase. Intracranial data from an epileptic subject confirmed these findings albeit there was slowing in both the alpha and gamma band. A tentative explanation for this phenomenon is that the visual system is inhibited during most of the alpha cycle whereas a burst of gamma activity at a specific alpha phase ( e. g. at troughs) reflects a window of excitability.	[Jensen, Ole] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Hermes, Dora] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol & Neurosurg, Sect Brain Funct & Plasticity, Utrecht, Netherlands	Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center	Osipova, D (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	daria.osipova@fcdonders.ru.nl	Jensenq, Ole/D-2120-2010	Jensenq, Ole/0000-0001-8193-8348; Hermes, Dora/0000-0002-8683-8909	Netherlands Organization for Scientific Research Innovative Research Incentive Schemes [864.03.007, Rubicon]; Dutch Technology Foundation STW applied science division of the Netherlands Organization for Scientific Research; Technology Program of the Ministry of Economic Affairs; University of Utrecht [UGT7685]	Netherlands Organization for Scientific Research Innovative Research Incentive Schemes(Netherlands Organization for Scientific Research (NWO)); Dutch Technology Foundation STW applied science division of the Netherlands Organization for Scientific Research; Technology Program of the Ministry of Economic Affairs; University of Utrecht	This work was supported by the Netherlands Organization for Scientific Research Innovative Research Incentive Schemes 864.03.007 (to O.J.) and the Rubicon grant from the Netherlands Organization for Scientific Research (to D.O). Intracranial recordings were funded by the Dutch Technology Foundation STW, applied science division of the Netherlands Organization for Scientific Research and the Technology Program of the Ministry of Economic Affairs, and the University of Utrecht grant UGT7685. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjamian P, 2004, EUR J NEUROSCI, V20, P587, DOI 10.1111/j.1460-9568.2004.03495.x; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; BRAGIN A, 1995, J NEUROSCI, V15, P47; Bruns A, 2004, INT J PSYCHOPHYSIOL, V51, P97, DOI 10.1016/j.ijpsycho.2003.07.001; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Chorlian DB, 2006, INT J PSYCHOPHYSIOL, V61, P262, DOI 10.1016/j.ijpsycho.2005.11.002; Demiralp T, 2007, INT J PSYCHOPHYSIOL, V64, P24, DOI 10.1016/j.ijpsycho.2006.07.005; Diaz GF, 1998, ELECTROEN CLIN NEURO, V106, P501, DOI 10.1016/S0013-4694(98)00026-1; DUNCAN JS, 1987, EPILEPSIA, V28, P259, DOI 10.1111/j.1528-1157.1987.tb04216.x; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; GELETY TJ, 1985, CLIN ELECTROENCEPHAL, V16, P94, DOI 10.1177/155005948501600208; Hari R, 1997, TRENDS NEUROSCI, V20, P44, DOI 10.1016/S0166-2236(96)10065-5; Hoogenboom N, 2006, NEUROIMAGE, V29, P764, DOI 10.1016/j.neuroimage.2005.08.043; Hughes SW, 2005, NEUROSCIENTIST, V11, P357, DOI 10.1177/1073858405277450; Jensen O, 2007, TRENDS COGN SCI, V11, P267, DOI 10.1016/j.tics.2007.05.003; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Jokisch D, 2007, J NEUROSCI, V27, P3244, DOI 10.1523/JNEUROSCI.5399-06.2007; Kaiser J, 2004, NEUROIMAGE, V23, P551, DOI 10.1016/j.neuroimage.2004.06.033; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Lakatos P, 2005, NEUROREPORT, V16, P933, DOI 10.1097/00001756-200506210-00011; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Mazaheri A, 2008, J NEUROSCI, V28, P7781, DOI 10.1523/JNEUROSCI.1631-08.2008; MIYAUCHI T, 1991, EPILEPSIA, V32, P870, DOI 10.1111/j.1528-1157.1991.tb05544.x; Mormann F, 2005, HIPPOCAMPUS, V15, P890, DOI 10.1002/hipo.20117; Nikulin VV, 2007, EUR J NEUROSCI, V25, P3146, DOI 10.1111/j.1460-9568.2007.05553.x; Osipova D, 2006, J NEUROSCI, V26, P7523, DOI 10.1523/JNEUROSCI.1948-06.2006; Palva JM, 2005, J NEUROSCI, V25, P3962, DOI 10.1523/JNEUROSCI.4250-04.2005; Salinsky MC, 2002, EPILEPSIA, V43, P482, DOI 10.1046/j.1528-1157.2002.22501.x; Schack B, 2002, INT J PSYCHOPHYSIOL, V44, P143, DOI 10.1016/S0167-8760(01)00199-4; SOLTESZ I, 1993, J NEUROPHYSIOL, V70, P97, DOI 10.1152/jn.1993.70.1.97; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; White JA, 2000, P NATL ACAD SCI USA, V97, P8128, DOI 10.1073/pnas.100124097	35	220	221	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2008	3	12							e3990	10.1371/journal.pone.0003990	http://dx.doi.org/10.1371/journal.pone.0003990			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437CA	19098986	Green Submitted, Green Published, gold			2022-12-25	WOS:000265462300003
J	Ben-Simon, E; Podlipsky, I; Arieli, A; Zhdanov, A; Hendler, T				Ben-Simon, Eti; Podlipsky, Ilana; Arieli, Amos; Zhdanov, Andrey; Hendler, Talma			Never Resting Brain: Simultaneous Representation of Two Alpha Related Processes in Humans	PLOS ONE			English	Article							EEG ALPHA; DEFAULT MODE; RHYTHM; OSCILLATIONS; NETWORKS; FMRI; LOCALIZATION; GENERATION; HYPOTHESIS; TRANSFORM	Brain activity is continuously modulated, even at "rest". The alpha rhythm (8-12 Hz) has been known as the hallmark of the brain's idle-state. However, it is still debated if the alpha rhythm reflects synchronization in a distributed network or focal generator and whether it occurs spontaneously or is driven by a stimulus. This EEG/fMRI study aimed to explore the source of alpha modulations and their distribution in the resting brain. By serendipity, while computing the individually defined power modulations of the alpha-band, two simultaneously occurring components of these modulations were found. An 'induced alpha' that was correlated with the paradigm (eyes open/eyes closed), and a 'spontaneous alpha' that was ongoing and unrelated to the paradigm. These alpha components when used as regressors for BOLD activation revealed two segregated activation maps: the 'induced map' included left lateral temporal cortical regions and the hippocampus; the 'spontaneous map' included prefrontal cortical regions and the thalamus. Our combined fMRI/EEG approach allowed to computationally untangle two parallel patterns of alpha modulations and underpin their anatomical basis in the human brain. These findings suggest that the human alpha rhythm represents at least two simultaneously occurring processes which characterize the 'resting brain'; one is related to expected change in sensory information, while the other is endogenous and independent of stimulus change.	[Hendler, Talma] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Ben-Simon, Eti; Podlipsky, Ilana; Zhdanov, Andrey; Hendler, Talma] Tel Aviv Sourasky Med Ctr, Wohl Inst Advanced Imaging, Funct Brain Ctr, Tel Aviv, Israel; [Podlipsky, Ilana] Tel Aviv Univ, Dept Biomed Engn, Tel Aviv, Israel; [Arieli, Amos] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Hendler, Talma] Tel Aviv Univ, Dept Psychol, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Weizmann Institute of Science; Tel Aviv University	Ben-Simon, E (corresponding author), Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel.	talma@tasmc.health.gov.il	Zhdanov, Andrey/I-7136-2012	Ben Simon, Eti/0000-0002-3862-8288; Zhadnov, Andrey/0000-0002-3379-0251	Israeli Science Foundation; US-Israel Bi-national Science Foundation; National Institute for psychobiology; The Levi-Edersheim-Gitter Institute for Neuroimaging, Tel Aviv University	Israeli Science Foundation(Israel Science Foundation); US-Israel Bi-national Science Foundation(US-Israel Binational Science Foundation); National Institute for psychobiology; The Levi-Edersheim-Gitter Institute for Neuroimaging, Tel Aviv University	This research was supported by the Israeli Science Foundation (Bikura program, TH), the US-Israel Bi-national Science Foundation (TH) and the National Institute for psychobiology (TH), The Levi-Edersheim-Gitter Institute for Neuroimaging, Tel Aviv University (EBS, IP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian ED, 1934, J PHYSIOL-LONDON, V81, P440, DOI 10.1113/jphysiol.1934.sp003147; [Anonymous], [No title captured]; Barry RJ, 2007, CLIN NEUROPHYSIOL, V118, P2765, DOI 10.1016/j.clinph.2007.07.028; Basar E, 1997, INT J PSYCHOPHYSIOL, V26, P5, DOI 10.1016/S0167-8760(97)00753-8; Basar E, 2001, INT J PSYCHOPHYSIOL, V39, P241, DOI 10.1016/S0167-8760(00)00145-8; Benca RM, 1999, PSYCHOPHYSIOLOGY, V36, P430, DOI 10.1111/1469-8986.3640430; CHAPMAN RM, 1984, ELECTROEN CLIN NEURO, V58, P569, DOI 10.1016/0013-4694(84)90047-6; Christov II, 2004, BIOMED ENG ONLINE, V3, DOI 10.1186/1475-925X-3-28; CREUTZFELDT OD, 1995, PERFORMANCE STRUCTUR, pCH5; DASILVA FHL, 1980, ELECTROEN CLIN NEURO, V50, P449, DOI 10.1016/0013-4694(80)90011-5; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Goldman RI, 2002, NEUROREPORT, V13, P2487, DOI 10.1097/00001756-200212200-00022; Goncalves SI, 2006, NEUROIMAGE, V30, P203, DOI 10.1016/j.neuroimage.2005.09.062; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Kim KH, 2004, J NEUROSCI METH, V135, P193, DOI 10.1016/j.jneumeth.2003.12.016; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Larson CL, 1998, PSYCHOPHYSIOLOGY, V35, P162, DOI 10.1017/S0048577298001620; Laufs H, 2003, NEUROIMAGE, V19, P1463, DOI 10.1016/S1053-8119(03)00286-6; Le Van Quyen M, 2001, J NEUROSCI METH, V111, P83, DOI 10.1016/S0165-0270(01)00372-7; LOPESDASILVA FH, 1973, ELECTROEN CLIN NEURO, V35, P627, DOI 10.1016/0013-4694(73)90216-2; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Marx E, 2003, NEUROIMAGE, V19, P924, DOI 10.1016/S1053-8119(03)00150-2; Miller, 2000, TIME BRAIN; Moosmann M, 2003, NEUROIMAGE, V20, P145, DOI 10.1016/S1053-8119(03)00344-6; Niedermeyer E, 1997, INT J PSYCHOPHYSIOL, V26, P31, DOI 10.1016/S0167-8760(97)00754-X; Niedermeyer E., 2011, NIEDERMEYERS ELECTRO, V6; Nunez PL, 2001, HUM BRAIN MAPP, V13, P125, DOI 10.1002/hbm.1030; Nunez PL, 2005, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Sadato N, 1998, NEUROREPORT, V9, P893, DOI 10.1097/00001756-199803300-00024; Schreckenberger M, 2004, NEUROIMAGE, V22, P637, DOI 10.1016/j.neuroimage.2004.01.047; Schurmann M, 2001, INT J PSYCHOPHYSIOL, V39, P151, DOI 10.1016/S0167-8760(00)00138-0; Schurmann M, 2000, NEUROSCI LETT, V292, P175, DOI 10.1016/S0304-3940(00)01456-7; Stockwell RG, 1996, IEEE T SIGNAL PROCES, V44, P998, DOI 10.1109/78.492555; Travis F, 1999, CONSCIOUS COGN, V8, P302, DOI 10.1006/ccog.1999.0403; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; Yazawa S, 2001, INTERNAL MED, V40, P443, DOI 10.2169/internalmedicine.40.443	40	73	74	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2008	3	12							e3984	10.1371/journal.pone.0003984	http://dx.doi.org/10.1371/journal.pone.0003984			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437AV	19096714	Green Published, Green Submitted, gold			2022-12-25	WOS:000265458800006
J	Watson, BO; MacLean, JN; Yuste, R				Watson, Brendon O.; MacLean, Jason N.; Yuste, Rafael			UP States Protect Ongoing Cortical Activity from Thalamic Inputs	PLOS ONE			English	Article								Cortical neurons in vitro and in vivo fluctuate spontaneously between two stable membrane potentials: a depolarized UP state and a hyperpolarized DOWN state. UP states temporally correspond with multineuronal firing sequences which may be important for information processing. To examine how thalamic inputs interact with ongoing cortical UP state activity, we used calcium imaging and targeted whole-cell recordings of activated neurons in thalamocortical slices of mouse somatosensory cortex. Whereas thalamic stimulation during DOWN states generated multineuronal, synchronized UP states, identical stimulation during UP states had no effect on the subthreshold membrane dynamics of the vast majority of cells or on ongoing multineuronal temporal patterns. Both thalamocortical and corticocortical PSPs were significantly reduced and neuronal input resistance was significantly decreased during cortical UP states - mechanistically consistent with UP state insensitivity. Our results demonstrate that cortical dynamics during UP states are insensitive to thalamic inputs.	[Watson, Brendon O.; MacLean, Jason N.; Yuste, Rafael] Columbia Univ, Dept Biol Sci, Howard Hughes Med Inst, New York, NY 10027 USA	Columbia University; Howard Hughes Medical Institute	Watson, BO (corresponding author), Columbia Univ, Dept Biol Sci, Howard Hughes Med Inst, New York, NY 10027 USA.	bow4@columbia.edu	Watson, Brendon/GON-4927-2022	MacLean, Jason/0000-0002-8021-8063	Kavli Institute for Brain Science; National Eye Institute; National Institute of Neurological Disorders and Stroke; Human Frontiers Science Project	Kavli Institute for Brain Science; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Human Frontiers Science Project	Supported by the Kavli Institute for Brain Science, the National Eye Institute, the National Institute of Neurological Disorders and Stroke and the Human Frontiers Science Project.	AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; Araya R, 2006, P NATL ACAD SCI USA, V103, P17961, DOI 10.1073/pnas.0608755103; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Beierlein M, 2002, J NEUROSCI, V22, P9885; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Gonzalez-Burgos G, 2001, J NEUROPHYSIOL, V86, P1671, DOI 10.1152/jn.2001.86.4.1671; Hasenstaub A, 2007, J NEUROSCI, V27, P9607, DOI 10.1523/JNEUROSCI.2184-07.2007; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Kali S, 2004, NAT NEUROSCI, V7, P286, DOI 10.1038/nn1202; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; MacLean JN, 2006, NAT METHODS, V3, P129, DOI 10.1038/NMETH849; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; Moore D., 2006, INTRO PRACTICE STAT; No R L, 1959, Proc Natl Acad Sci U S A, V45, P592, DOI 10.1073/pnas.45.4.592; Peterlin ZA, 2000, P NATL ACAD SCI USA, V97, P3619, DOI 10.1073/pnas.97.7.3619; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Rieke F., 1999, SPIKES EXPLORING NEU; Sachdev RNS, 2004, J NEUROPHYSIOL, V92, P3511, DOI 10.1152/jn.00347.2004; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Smetters D, 1999, METHODS, V18, P215, DOI 10.1006/meth.1999.0774; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Sutherland GR, 2000, CURR OPIN NEUROBIOL, V10, P180, DOI 10.1016/S0959-4388(00)00079-9; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; YUSTE R, 1991, NEURON, V6, P333, DOI 10.1016/0896-6273(91)90243-S	30	48	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2008	3	12							e3971	10.1371/journal.pone.0003971	http://dx.doi.org/10.1371/journal.pone.0003971			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AT	19092994	Green Published, gold, Green Submitted			2022-12-25	WOS:000265458600008
J	Luchman, HA; Benediktsson, H; Villemaire, ML; Peterson, AC; Jirik, FR				Luchman, H. Artee; Benediktsson, Hallgrimur; Villemaire, Michelle L.; Peterson, Alan C.; Jirik, Frank R.			The Pace of Prostatic Intraepithelial Neoplasia Development Is Determined by the Timing of Pten Tumor Suppressor Gene Excision	PLOS ONE			English	Article								Loss of the PTEN tumor suppressor is a common occurrence in human prostate cancer, particularly in advanced disease. In keeping with its role as a pivotal upstream regulator of the phosphatidylinositol 3-kinase signaling pathway, experimentally-induced deletion of Pten in the murine prostate invariably results in neoplasia. However, and unlike humans where prostate tumorigenesis likely evolves over decades, disease progression in the constitutively Pten deficient mouse prostate is relatively rapid, culminating in invasive cancer within several weeks post-puberty. Given that the prostate undergoes rapid androgen-dependent growth at puberty, and that Pten excisions during this time might be especially tumorigenic, we hypothesized that delaying prostate-specific Pten deletions until immediately after puberty might alter the pace of tumorigenesis. To this end we generated mice with a tamoxifen-inducible Cre recombinase transgene enabling temporal control over prostate-specific gene alterations. This line was then interbred with mice carrying floxed Pten alleles. Despite evidence of increased Akt/mTOR/S6K axis activity at early time points in Pten-deficient epithelial cells, excisions induced in the post-pubertal (6 wk-old) prostate yielded gradual acquisition of a range of lesions. These progressed from premalignant changes (nuclear atypia, focal hyperplasia) and low grade prostatic intraepithelial neoplasia (PIN) at 16-20 wks post-tamoxifen exposure, to overtly malignant lesions by similar to 1 yr of age, characterized by high-grade PIN and microinvasive carcinoma. In contrast, when Pten excisions were triggered in the pre-pubertal (2 week-old) prostate, neoplasia evolved over a more abbreviated time-frame, with a spectrum of premalignant lesions, as well as overt PIN and microinvasive carcinoma by 10-12 wks post-tamoxifen exposure. These results indicate that the developmental stage at which Pten deletions are induced dictates the pace of PIN development.	[Villemaire, Michelle L.; Jirik, Frank R.] Univ Calgary, Dept Biochem & Mol Biol, McCaig Inst Bone & Joint Hlth, Calgary, AB, Canada; [Benediktsson, Hallgrimur] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB T2N 1N4, Canada; [Peterson, Alan C.] McGill Univ, Roy Victoria Hosp, Dept Neurol & Neurosurg, Montreal, PQ H3A 2T5, Canada	University of Calgary; University of Calgary; McGill University; Royal Victoria Hospital	Luchman, HA (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, McCaig Inst Bone & Joint Hlth, Calgary, AB, Canada.	jirik@ucalgary.ca		Benediktsson, Hallgrimur/0000-0001-8920-3610	National Cancer Institute of Canada/Prostate Cancer Research Initiative; Alberta Cancer Board [fellowships]; Genome Quebec; Genome Canada; Alberta Heritage Foundation for Medical Research [fellowships]; Canada Research Chair	National Cancer Institute of Canada/Prostate Cancer Research Initiative; Alberta Cancer Board; Genome Quebec; Genome Canada(Genome Canada); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was supported in its initial stages by a National Cancer Institute of Canada/Prostate Cancer Research Initiative Pilot Grant and subsequently the Alberta Cancer Board (to F.R.J). A.C.P was supported by Genome Quebec and Genome Canada; H.A.L held fellowships from both the Alberta Heritage Foundation for Medical Research and the Alberta Cancer Board. F.R.J. was the recipient of a Canada Research Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen Cory, 2002, Trends Genet, V18, pS1, DOI 10.1016/S0168-9525(02)02683-5; Backman SA, 2004, P NATL ACAD SCI USA, V101, P1725, DOI 10.1073/pnas.0308217100; Carver BS, 2006, CLIN CANCER RES, V12, P5305, DOI 10.1158/1078-0432.CCR-06-0482; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chow LML, 2006, CANCER LETT, V241, P184, DOI 10.1016/j.canlet.2005.11.042; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; GREENBERG NM, 1994, MOL ENDOCRINOL, V8, P230, DOI 10.1210/me.8.2.230; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Hughes C, 2005, J CLIN PATHOL, V58, P673, DOI 10.1136/jcp.2002.003954; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kasper S, 1999, J MOL ENDOCRINOL, V22, P313, DOI 10.1677/jme.0.0220313; Kasper S, 2005, J CELL BIOCHEM, V94, P279, DOI 10.1002/jcb.20339; KASPER S, 1994, J BIOL CHEM, V269, P31763; Luchman HA, 2008, GENESIS, V46, P229, DOI 10.1002/dvg.20386; Ma XQ, 2005, CANCER RES, V65, P5730, DOI 10.1158/0008-5472.CAN-04-4519; Maddison LA, 2000, GENESIS, V26, P154, DOI 10.1002/(SICI)1526-968X(200002)26:2<154::AID-GENE18>3.0.CO;2-2; Majumder PK, 2003, P NATL ACAD SCI USA, V100, P7841, DOI 10.1073/pnas.1232229100; Memarzadeh S, 2007, CANCER CELL, V12, P572, DOI 10.1016/j.ccr.2007.11.002; Ratnacaram CK, 2008, P NATL ACAD SCI USA, V105, P2521, DOI 10.1073/pnas.0712021105; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Singh J, 1999, J ANDROL, V20, P251; Thomson AA, 1999, DEVELOPMENT, V126, P3693; Tomlins SA, 2006, ANNU REV PATHOL-MECH, V1, P243, DOI 10.1146/annurev.pathol.1.110304.100047; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Yan Y, 1997, PROSTATE, V32, P129; Zhang JF, 2000, ENDOCRINOLOGY, V141, P4698, DOI 10.1210/en.141.12.4698	30	24	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2008	3	12							e3940	10.1371/journal.pone.0003940	http://dx.doi.org/10.1371/journal.pone.0003940			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AP	19081794	Green Published, gold, Green Submitted			2022-12-25	WOS:000265458200006
J	Morgan, B; Ang, SK; Yan, GH; Lu, H				Morgan, Bruce; Ang, Swee Kim; Yan, Guanhua; Lu, Hui			Zinc Can Play Chaperone-like and Inhibitor Roles during Import of Mitochondrial Small Tim Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE RELAY SYSTEM; INTERMEMBRANE SPACE; BINDING; MIA40; OXIDATION; FINGERS; BIOLOGY; MOTIF	Zinc is an essential cofactor required for the function of similar to 8% of the yeast and 10% of the human proteome. All of the "small Tim" proteins of the mitochondrial intermembrane space contain a strictly conserved "twin CX3C" zinc finger motif, which can bind zinc ions in the Cys-reduced form. We have shown previously that although disulfide bond formation is essential for the function of these proteins in mitochondria, only reduced proteins can be imported into mitochondria (Lu, H., Allen, S., Wardleworth, L., Savory, P., and Tokatlidis, K. (2004) J. Biol. Chem. 279, 18952-18958 and Morgan, B., and Lu, H. (2008) Biochem. J. 411, 115-122). However, the role of zinc during the import of these proteins is unclear. This study shows that the function of zinc is complex. It can play a thiol stabilizer role preventing oxidative folding of the small Tim proteins and maintaining the proteins in an import-competent form. On the other hand, zinc-bound forms cannot be imported into mitochondria efficiently. Furthermore, our results show that zinc is a powerful inhibitor of Erv1, an essential component of the import pathway used by the small Tim proteins. We propose that zinc plays a chaperone-like role in the cytosol during biogenesis of the small Tim proteins and that the proteins are imported into mitochondria through the apo-forms.	[Morgan, Bruce; Ang, Swee Kim; Yan, Guanhua; Lu, Hui] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Lu, H (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	hui.lu@manchester.ac.uk	Lu, Hui/AAB-5476-2021	Lu, Hui/0000-0002-7029-2681; Ang, Swee Kim/0000-0003-3058-6105; Morgan, Bruce/0000-0001-9393-1071	Biotechnology and Biological Sciences Research Council [BB/C514323, BB/C514323/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; Curran SP, 2004, J BIOL CHEM, V279, P43744, DOI 10.1074/jbc.M404878200; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; FRAUSTO JJR, 2001, BIOL CHEM ELEMENTS, P315; HAASE H, 2006, BIOGERONTOLOGY, V28, P1; Hell K, 2008, BBA-MOL CELL RES, V1783, P601, DOI 10.1016/j.bbamcr.2007.12.005; Ivanova E, 2008, J MOL BIOL, V375, P229, DOI 10.1016/j.jmb.2007.10.037; Ivanova E, 2008, PROTEINS, V71, P467, DOI 10.1002/prot.21713; Jakob U, 2000, J BIOL CHEM, V275, P38302, DOI 10.1074/jbc.M005957200; Koehler CM, 2004, TRENDS BIOCHEM SCI, V29, P1, DOI 10.1016/j.tibs.2003.11.003; Krezel A, 2003, INORG CHEM, V42, P1994, DOI 10.1021/ic025969y; Leuenberger D, 2003, TRAFFIC, V4, P144, DOI 10.1034/j.1600-0854.2003.00095.x; Li W, 2003, J MOL BIOL, V333, P461, DOI 10.1016/j.jmb.2003.08.038; Lu H, 2005, J MOL BIOL, V353, P897, DOI 10.1016/j.jmb.2005.09.002; Lu H, 2004, J BIOL CHEM, V279, P18952, DOI 10.1074/jbc.M313045200; Lu H, 2004, J BIOL CHEM, V279, P18959, DOI 10.1074/jbc.M313046200; Maret W, 2005, J TRACE ELEM MED BIO, V19, P7, DOI 10.1016/j.jtemb.2005.02.003; Maret W, 2004, BIOCHEMISTRY-US, V43, P3301, DOI 10.1021/bi036340p; Matthews JM, 2002, IUBMB LIFE, V54, P351, DOI 10.1080/15216540216035; Meisinger Chris, 2006, Methods Mol Biol, V313, P33; Mesecke N, 2008, EMBO REP, V9, P1107, DOI 10.1038/embor.2008.173; Morgan B, 2008, BIOCHEM J, V411, P115, DOI 10.1042/BJ20071476; Muller JM, 2008, MOL BIOL CELL, V19, P226, DOI 10.1091/mbc.E07-08-0814; Pfanner N, 2004, NAT STRUCT MOL BIOL, V11, P1044, DOI 10.1038/nsmb852; Sensi SL, 2003, P NATL ACAD SCI USA, V100, P6157, DOI 10.1073/pnas.1031598100; Sensi SL, 1997, J NEUROSCI, V17, P9554; Simm C, 2007, EUKARYOT CELL, V6, P1166, DOI 10.1128/EC.00077-07; Tang W, 2001, BIOCHEMISTRY-US, V40, P14985, DOI 10.1021/bi0107593; Terziyska N, 2005, FEBS LETT, V579, P179, DOI 10.1016/j.febslet.2004.11.072; Tokatlidis K, 2005, CELL, V121, P965, DOI 10.1016/j.cell.2005.06.019; Tottey S, 2008, NATURE, V455, P1138, DOI 10.1038/nature07340; Vallee B L, 1995, EXS, V73, P259; Wang WZ, 2007, BIOCHEMISTRY-US, V46, P3246, DOI 10.1021/bi602499t; WILLIAMS RJP, 1984, ENDEAVOUR, V8, P65, DOI 10.1016/0160-9327(84)90040-1	35	30	32	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6818	6825		10.1074/jbc.M808691200	http://dx.doi.org/10.1074/jbc.M808691200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19117943	hybrid, Green Published			2022-12-25	WOS:000263919000027
J	Park, EY; Sung, YH; Yang, MH; Noh, JY; Park, SY; Lee, TY; Yook, YJ; Yoo, KH; Roh, KJ; Kim, I; Hwang, YH; Oh, GT; Seong, JK; Ahn, C; Lee, HW; Park, JH				Park, Eun Young; Sung, Young Hoon; Yang, Moon Hee; Noh, Ji Yeun; Park, So Young; Lee, Tae Young; Yook, Yeon Joo; Yoo, Kyung Hyun; Roh, Kyung Jin; Kim, Ingyu; Hwang, Young-Hwan; Oh, Goo Taeg; Seong, Je Kyung; Ahn, Curie; Lee, Han-Woong; Park, Jong Hoon			Cyst Formation in Kidney via B-Raf Signaling in the PKD2 Transgenic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYCYSTIN-2 INTERACTS; EPITHELIAL-CELLS; REGULATED KINASE; DISEASE; GENE; CHANNEL; PROTEIN; CYSTOGENESIS; PATHOGENESIS; MUTATIONS	The pathogenic mechanisms of human autosomal dominant polycystic kidney disease (ADPKD) have been well known to include the mutational inactivation of PKD2. Although haploinsufficiency and loss of heterozygosity at the Pkd2 locus can cause cyst formation in mice, polycystin-2 is frequently expressed in the renal cyst of human ADPKD, raising the possibility that deregulated activation of PKD2 may be associated with the cystogenesis of human ADPKD. To determine whether increased PKD2 expression is physiologically pathogenic, we generated PKD2-overexpressing transgenic mice. These mice developed typical renal cysts and an increase of proliferation and apoptosis, which are reflective of the human ADPKD phenotype. These manifestations were first observed at six months, and progressed with age. In addition, we found that ERK activation was induced by PKD2 overexpression via B-Raf signaling, providing a possible molecular mechanism of cystogenesis. In PKD2 transgenic mice, B-Raf/MEK/ERK sequential signaling was up-regulated. Additionally, the transgenic human polycystin-2 partially rescues the lethality of Pkd2 knock-out mice and therefore demonstrates that the transgene generated a functional product. Functional strengthening or deregulated activation of PKD2 may be a direct cause of ADPKD. The present study provides evidence for an in vivo role of overexpressed PKD2 in cyst formation. This transgenic mouse model should provide new insights into the pathogenic mechanism of human ADPKD.	[Sung, Young Hoon; Lee, Han-Woong] Yonsei Univ, Dept Biochem, Seoul 120749, South Korea; [Park, Eun Young; Yang, Moon Hee; Noh, Ji Yeun; Park, So Young; Lee, Tae Young; Yook, Yeon Joo; Yoo, Kyung Hyun; Park, Jong Hoon] Sookmyung Womens Univ, Dept Biol Sci, Seoul 140742, South Korea; [Ahn, Curie] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 110744, South Korea; [Oh, Goo Taeg] Ewha Womans Univ, Div Mol Life Sci, Seoul 120750, South Korea; [Oh, Goo Taeg] Ewha Womans Univ, Ctr Cell Signaling Res, Seoul 120750, South Korea; [Hwang, Young-Hwan] Eulji Med Ctr, Dept Internal Med, Seoul 139711, South Korea; [Kim, Ingyu] Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA; [Roh, Kyung Jin; Seong, Je Kyung] Seoul Natl Univ, Coll Vet Med, Lab Dev Biol & Genom, Seoul 151742, South Korea	Yonsei University; Sookmyung Women's University; Seoul National University (SNU); Ewha Womans University; Ewha Womans University; Vanderbilt University; Seoul National University (SNU)	Lee, HW (corresponding author), Yonsei Univ, Dept Biochem, Seoul 120749, South Korea.	hwl@yonsei.ac.kr; parkjh@sookmyung.ac.kr	Oh, Goo Taeg/AAQ-9995-2021; Ahn, Curie/J-5527-2012	Seong, Je Kyung/0000-0003-1177-6958; Hwang, Young-Hwan/0000-0001-8935-2659	National Research Laboratory [R0A-2005-000-10101-0]; KOSEF grant funded by MEST (Research Center for Women's Disease); MEST [M106KB010014-07K0201-01410, M103KV010025-07K2201-02510]	National Research Laboratory(Korea Science and Engineering Foundation); KOSEF grant funded by MEST (Research Center for Women's Disease)(Korea Science and Engineering Foundation); MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by National Research Laboratory Grant R0A-2005-000-10101-0, the SRC/ERC program of the KOSEF grant funded by MEST (Research Center for Women's Disease), and 21C Frontier Projects (Functional Human Genome Project, M106KB010014-07K0201-01410 and Brain Research Center, M103KV010025-07K2201-02510) from the MEST.	Arnaout MA, 2001, ANNU REV MED, V52, P93, DOI 10.1146/annurev.med.52.1.93; Boletta A, 2003, TRENDS CELL BIOL, V13, P484, DOI 10.1016/S0962-8924(03)00169-7; Burtey S, 2008, CELL BIOL INT, V32, P1193, DOI 10.1016/j.cellbi.2008.07.021; Burtey S, 2008, NEPHROL DIAL TRANSPL, V23, P1157, DOI 10.1093/ndt/gfm763; CARONE FA, 1996, ETIOLOGY PATHOGENESI, P111; Chang FM, 2003, INT J ONCOL, V22, P469; Chang MY, 2006, NEPHROL DIAL TRANSPL, V21, P2078, DOI 10.1093/ndt/gfl150; DAGATI V, 1992, J AM SOC NEPHROL, V3, P975; GABOW PA, 1993, NEW ENGL J MED, V329, P332, DOI 10.1056/NEJM199307293290508; Gallagher AR, 2006, J AM SOC NEPHROL, V17, P2719, DOI 10.1681/ASN.2005090979; Gonzalez-Perrett S, 2001, P NATL ACAD SCI USA, V98, P1182, DOI 10.1073/pnas.021456598; Grantham JJ, 1996, AM J KIDNEY DIS, V28, P788, DOI 10.1016/S0272-6386(96)90378-9; Grimm DH, 2003, J BIOL CHEM, V278, P36786, DOI 10.1074/jbc.M306536200; Hidaka S, 2004, J BIOL CHEM, V279, P35009, DOI 10.1074/jbc.M314206200; Igarashi P, 2002, J AM SOC NEPHROL, V13, P2384, DOI 10.1097/01.ASN.0000028643.17901.42; Kottgen M, 2005, EMBO J, V24, P705, DOI 10.1038/sj.emboj.7600566; Lehtonen S, 2000, J BIOL CHEM, V275, P32888, DOI 10.1074/jbc.M006624200; Li Q, 2005, HUM MOL GENET, V14, P1587, DOI 10.1093/hmg/ddi167; Li Q, 2003, J MOL BIOL, V325, P949, DOI 10.1016/S0022-2836(02)01333-5; Li Q, 2003, BIOCHEMISTRY-US, V42, P450, DOI 10.1021/bi0267792; Li XG, 2005, NAT CELL BIOL, V7, P1202, DOI 10.1038/ncb1326; Li Y, 2005, J BIOL CHEM, V280, P41298, DOI 10.1074/jbc.M510082200; Lu WN, 2001, HUM MOL GENET, V10, P2385, DOI 10.1093/hmg/10.21.2385; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; NADASDY T, 1995, J AM SOC NEPHROL, V5, P1462; Nagao S, 2003, KIDNEY INT, V63, P427, DOI 10.1046/j.1523-1755.2003.00755.x; Omori S, 2006, J AM SOC NEPHROL, V17, P1604, DOI 10.1681/ASN.2004090800; Ong ACM, 1999, AM J PATHOL, V154, P1721, DOI 10.1016/S0002-9440(10)65428-4; Pei Y, 1998, J AM SOC NEPHROL, V9, P1853; Pei Y, 2001, TRENDS MOL MED, V7, P151, DOI 10.1016/S1471-4914(01)01953-0; Pennekamp P, 2002, CURR BIOL, V12, P938, DOI 10.1016/S0960-9822(02)00869-2; PETERS DJM, 1992, CONTRIB NEPHROL, V97, P128; Pritchard L, 2000, HUM MOL GENET, V9, P2617, DOI 10.1093/hmg/9.18.2617; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; ROSCOE JM, 1993, KIDNEY INT, V44, P1101, DOI 10.1038/ki.1993.355; Rundle DR, 2004, J BIOL CHEM, V279, P29728, DOI 10.1074/jbc.M400544200; Somlo S, 2001, CURR BIOL, V11, pR356, DOI 10.1016/S0960-9822(01)00193-2; Thivierge C, 2006, MOL CELL BIOL, V26, P1538, DOI 10.1128/MCB.26.4.1538-1548.2006; Torra R, 1999, AM J HUM GENET, V65, P345, DOI 10.1086/302501; Torra R, 1996, J AM SOC NEPHROL, V7, P2142; Tsiokas L, 1999, P NATL ACAD SCI USA, V96, P3934, DOI 10.1073/pnas.96.7.3934; Tsiokas L, 1997, P NATL ACAD SCI USA, V94, P6965, DOI 10.1073/pnas.94.13.6965; Tsiokas L, 2007, CELL SIGNAL, V19, P444, DOI 10.1016/j.cellsig.2006.09.005; Veldhuisen B, 1997, AM J HUM GENET, V61, P547, DOI 10.1086/515497; Viribay M, 1997, HUM GENET, V101, P229, DOI 10.1007/s004390050621; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; WRIGHT AF, 1993, HUM GENET, V90, P569, DOI 10.1007/BF00217461; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6; Xenophontos S, 1997, HUM MOL GENET, V6, P949, DOI 10.1093/hmg/6.6.949; Yamaguchi T, 2003, KIDNEY INT, V63, P1983, DOI 10.1046/j.1523-1755.2003.00023.x; Yamaguchi T, 2004, J BIOL CHEM, V279, P40419, DOI 10.1074/jbc.M405079200; Yamaguchi T, 2006, J AM SOC NEPHROL, V17, P178, DOI 10.1681/ASN.2005060645; Zhou XJ, 1998, DIAGN MOL PATHOL, V7, P65, DOI 10.1097/00019606-199804000-00001	53	63	66	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7214	7222		10.1074/jbc.M805890200	http://dx.doi.org/10.1074/jbc.M805890200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19098310	Green Published, hybrid			2022-12-25	WOS:000263919000068
J	Barone, S; Fussell, SL; Singh, AK; Lucas, F; Xu, J; Kim, C; Wu, XD; Yu, YL; Amlal, H; Seidler, U; Zuo, J; Soleimani, M				Barone, Sharon; Fussell, Stacey L.; Singh, Anurag Kumar; Lucas, Fred; Xu, Jie; Kim, Charles; Wu, Xudong; Yu, Yiling; Amlal, Hassane; Seidler, Ursula; Zuo, Jian; Soleimani, Manoocher			Slc2a5 (Glut5) Is Essential for the Absorption of Fructose in the Intestine and Generation of Fructose-induced Hypertension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOLIC SYNDROME; FUNCTIONAL-CHARACTERIZATION; BASOLATERAL MEMBRANES; INSULIN-RESISTANCE; TRANSPORTER GLUT5; DIETARY FRUCTOSE; PARIETAL-CELLS; EXCHANGER; CHLORIDE; DISEASE	The identity of the transporter responsible for fructose absorption in the intestine in vivo and its potential role in fructose-induced hypertension remain speculative. Here we demonstrate that Glut5 (Slc2a5) deletion reduced fructose absorption by similar to 75% in the jejunum and decreased the concentration of serum fructose by similar to 90% relative to wild-type mice on increased dietary fructose. When fed a control (60% starch) diet, Glut5(-/-) mice had normal blood pressure and displayed normal weight gain. However, whereas Glut5(-/-) mice showed enhanced salt absorption in their jejuna in response to luminal fructose and developed systemic hypertension when fed a high fructose (60% fructose) diet for 14 weeks, Glut5(-/-) mice did not display fructose-stimulated salt absorption in their jejuna, and they experienced a significant impairment of nutrient absorption in their intestine with accompanying hypotension as early as 3-5 days after the start of a high fructose diet. Examination of the intestinal tract of Glut5(-/-) mice fed a high fructose diet revealed massive dilatation of the caecum and colon, consistent with severe malabsorption, along with a unique adaptive up-regulation of ion transporters. In contrast to the malabsorption of fructose, Glut5(-/-) mice did not exhibit an absorption defect when fed a high glucose (60% glucose) diet. We conclude that Glut5 is essential for the absorption of fructose in the intestine and plays a fundamental role in the generation of fructose-induced hypertension. Deletion of Glut5 results in a serious nutrient-absorptive defect and volume depletion only when the animals are fed a high fructose diet and is associated with compensatory adaptive up-regulation of ion-absorbing transporters in the colon.	[Soleimani, Manoocher] Univ Cincinnati, Dept Internal Med, Ctr Genet Transport & Epithelial Biol, Cincinnati, OH 45267 USA; [Barone, Sharon; Fussell, Stacey L.; Xu, Jie; Amlal, Hassane; Soleimani, Manoocher] Univ Cincinnati, Dept Med, Cincinnati, OH 45267 USA; [Lucas, Fred] Univ Cincinnati, Dept Pathol, Cincinnati, OH 45267 USA; [Singh, Anurag Kumar; Seidler, Ursula] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany; [Wu, Xudong; Yu, Yiling; Zuo, Jian] St Jude Childrens Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Soleimani, Manoocher] Vet Adm Med Ctr, Res Serv, Cincinnati, OH 45220 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Hannover Medical School; St Jude Children's Research Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Soleimani, M (corresponding author), Univ Cincinnati, Dept Internal Med, Ctr Genet Transport & Epithelial Biol, 231 Albert Sabin Way,MSB G259, Cincinnati, OH 45267 USA.	manoocher.soleimani@uc.edu	Seidler, Ursula/HII-8049-2022	Seidler, Ursula/0000-0002-9600-2769; Singh, Anurag Kumar/0000-0003-0818-0993	National Institutes of Health [DK 62809]; Merit Review Award [DC06471, CA21765]; ALSAC; Deutsche Forschungsgemeinschaft [460/9-5]; Hartwell Foundation; DCI, Inc.; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK062809, R01DK062809] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006471] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merit Review Award(US Department of Veterans Affairs); ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hartwell Foundation; DCI, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grant DK 62809 and a Merit Review Award (to M. S.) and Grants DC06471, CA21765, and ALSAC (to J. Z.). This work was also supported by the Deutsche Forschungsgemeinschaft (Grant Se 460/9-5 to U.S.) and research funds from the Hartwell Foundation (to J. Z.) and DCI, Inc. (to M. S. and H. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Basciano Heather, 2005, Nutr Metab (Lond), V2, P5, DOI 10.1186/1743-7075-2-5; Batsis JA, 2007, CLIN PHARMACOL THER, V82, P509, DOI 10.1038/sj.clpt.6100355; Bollen M, 1998, BIOCHEM J, V336, P19, DOI 10.1042/bj3360019; Campbell JA, 1999, J SCI FOOD AGR, V79, P232, DOI [10.1002/(SICI)1097-0010(199902)79:2<232::AID-JSFA176>3.3.CO;2-M, 10.1002/(SICI)1097-0010(199902)79:2&lt;232::AID-JSFA176&gt;3.0.CO;2-V]; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Corpe CP, 1996, PFLUG ARCH EUR J PHY, V432, P192, DOI 10.1007/s004240050124; Douard V, 2008, AM J PHYSIOL-ENDOC M, V295, pE227, DOI 10.1152/ajpendo.90245.2008; Elliott SS, 2002, AM J CLIN NUTR, V76, P911, DOI 10.1093/ajcn/76.5.911; HALLFRISCH J, 1990, FASEB J, V4, P2652, DOI 10.1096/fasebj.4.9.2189777; Helliwell PA, 2000, BIOCHEM J, V350, P149, DOI 10.1042/0264-6021:3500149; Higashiura K, 1999, AM J HYPERTENS, V12, P596, DOI 10.1016/S0895-7061(99)00025-4; Hirabayashi J, 1996, Q REV BIOL, V71, P365, DOI 10.1086/419443; Johnson RJ, 2007, AM J CLIN NUTR, V86, P899; KAYANO T, 1990, J BIOL CHEM, V265, P13276; Kellett GL, 2008, ANNU REV NUTR, V28, P35, DOI 10.1146/annurev.nutr.28.061807.155518; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lee DH, 2001, METABOLISM, V50, P74, DOI 10.1053/meta.2001.19527; Macdonald IA, 1999, EUR J CLIN NUTR, V53, pS101, DOI 10.1038/sj.ejcn.1600750; Mayes Peter A., 1993, American Journal of Clinical Nutrition, V58, p754S, DOI 10.1093/ajcn/58.5.754S; Merediz EFC, 2004, EQUINE VET J, V36, P532, DOI 10.2746/0425164044877378; Miller A, 2008, CURR OPIN GASTROEN, V24, P204, DOI 10.1097/MOG.0b013e3282f3f4c4; Nagai Y, 2002, AM J PHYSIOL-ENDOC M, V282, pE1180, DOI 10.1152/ajpendo.00471.2001; Obunai K, 2007, MED CLIN N AM, V91, P1169, DOI 10.1016/j.mcna.2007.06.003; Petrovic S, 2003, AM J PHYSIOL-GASTR L, V284, pG1093, DOI 10.1152/ajpgi.00454.2002; Petrovic S, 2002, AM J PHYSIOL-GASTR L, V283, pG1207, DOI 10.1152/ajpgi.00137.2002; RAND EB, 1993, AM J PHYSIOL, V264, pG1169, DOI 10.1152/ajpgi.1993.264.6.G1169; RUMESSEN JJ, 1992, SCAND J GASTROENTERO, V27, P819, DOI 10.3109/00365529209000148; Sacks FM, 2004, J CLIN PSYCHIAT, V65, P3; Sanchez-Lozada LG, 2007, AM J PHYSIOL-RENAL, V292, pF423, DOI 10.1152/ajprenal.00124.2006; Schurmann A, 2008, AM J PHYSIOL-ENDOC M, V295, pE225, DOI 10.1152/ajpendo.90406.2008; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Schweinfest CW, 2006, J BIOL CHEM, V281, P37962, DOI 10.1074/jbc.M607527200; Shu R, 1997, AM J PHYSIOL-GASTR L, V272, pG446, DOI 10.1152/ajpgi.1997.272.3.G446; Singh AK, 2008, KIDNEY INT, V74, P438, DOI 10.1038/ki.2008.184; SOLEIMANI M, 1994, CIRC RES, V74, P48, DOI 10.1161/01.RES.74.1.48; SOLEIMANI M, 1991, J CLIN INVEST, V88, P1135, DOI 10.1172/JCI115413; vandenBerghe G, 1996, J INHERIT METAB DIS, V19, P470, DOI 10.1007/BF01799108; VANDENBERGHE G, 1994, ANNU REV NUTR, V14, P41, DOI 10.1146/annurev.nu.14.070194.000353; VANDENBERGHE N, 1991, BIOCHEM J, V278, P565, DOI 10.1042/bj2780565; Wright EM, 2007, J INTERN MED, V261, P32, DOI 10.1111/j.1365-2796.2006.01746.x; Wright EM, 2004, PFLUG ARCH EUR J PHY, V447, P510, DOI 10.1007/s00424-003-1063-6; Wu XD, 2008, BRAIN RES, V1210, P20, DOI 10.1016/j.brainres.2008.02.094; Wu XD, 2007, DEV NEUROBIOL, V67, P483, DOI 10.1002/dneu.20357	43	159	171	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5056	5066		10.1074/jbc.M808128200	http://dx.doi.org/10.1074/jbc.M808128200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19091748	Green Published, hybrid			2022-12-25	WOS:000263416600036
J	Lauer, ME; Mukhopadhyay, D; Fulop, C; de la Motte, CA; Majors, AK; Hascall, VC				Lauer, Mark E.; Mukhopadhyay, Durba; Fulop, Csaba; de la Motte, Carol A.; Majors, Alana K.; Hascall, Vincent C.			Primary Murine Airway Smooth Muscle Cells Exposed to Poly(I,C) or Tunicamycin Synthesize a Leukocyte-adhesive Hyaluronan Matrix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; DEPENDENT PROTEIN-KINASE; TUBULAR EPITHELIAL-CELLS; ALPHA-TRYPSIN INHIBITOR; DOUBLE-STRANDED-RNA; EXTRACELLULAR-MATRIX; ATOPIC ASTHMA; INFLAMMATION; CD44; MUCOSAL	Asthmatic attacks often follow viral infections with subsequent airway smooth muscle cell proliferation and the formation of an abnormal hyaluronan extracellular matrix with infiltrated leukocytes. In this study, we show that murine airway smooth muscle cells (MASM) treated with polyinosinic acid-polycytidylic acid (poly(I,C)), a double-stranded RNA that simulates a viral infection, synthesize an abnormal hyaluronan matrix that binds leukocytes (U937 cells). Synthesis of this matrix is initiated rapidly and accumulates linearly for 10 h, reaching a plateau level similar to 7-fold higher than control cultures. MASM cells treated with tunicamycin, to induce endoplasmic reticulum stress, also rapidly initiate synthesis of the abnormal hyaluronan matrix with linear accumulation for similar to 10 h, but only reach a plateau level similar to 2-fold higher than control cultures. In contrast to poly(I,C), the response to tunicamycin depends on cell density, with pre-confluent cells producing more abnormal matrix per cell. Furthermore, U937 cell adhesion per hyaluronan content is higher in the sparse matrix produced in response to tunicamycin, suggesting that the structure in the poly(I,C)induced matrix masks potential binding sites. When MASM cells were exposed to tunicamycin and poly(I,C) at the same time, U937 cell adhesion was partially additive, implying that these two toxins stimulate hyaluronan synthesis through two different pathways. We also characterized the size of hyaluronan produced by MASM cells, in response to poly(I,C) and tunicamycin, and we found that it ranges from 1500 to 4000 kDa, the majority of which was similar to 4000 kDa and not different in size than hyaluronan made by untreated cells.	[Lauer, Mark E.; Mukhopadhyay, Durba; Fulop, Csaba; Hascall, Vincent C.] Cleveland Clin, Dept Biomed Engn, Lerner Res Inst, Cleveland, OH 44195 USA; [de la Motte, Carol A.; Majors, Alana K.] Cleveland Clin, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44195 USA; [de la Motte, Carol A.; Majors, Alana K.] Cleveland Clin, Dept Colorectal Surg, Lerner Res Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Hascall, VC (corresponding author), Cleveland Clin, Dept Biomed Engn ND20, Cleveland, OH 44195 USA.	hascalv@ccf.org			National Institutes of Health [P11 HL081064]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL081064] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P11 HL081064 ( Pathology of Asthma). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alcorn JF, 2007, AM J RESP CRIT CARE, V176, P974, DOI 10.1164/rccm.200702-334OC; An SS, 2007, EUR RESPIR J, V29, P834, DOI 10.1183/09031936.00112606; Bourguignon LYW, 2007, J BIOL CHEM, V282, P19426, DOI 10.1074/jbc.M610054200; BOUSQUET J, 1991, J ALLERGY CLIN IMMUN, V88, P649, DOI 10.1016/0091-6749(91)90159-L; Bousquet J, 2000, AM J RESP CRIT CARE, V161, P1720, DOI 10.1164/ajrccm.161.5.9903102; Braunstahl GJ, 2003, CLIN EXP ALLERGY, V33, P579, DOI 10.1046/j.1365-2222.2003.01652.x; Calabro A, 2000, GLYCOBIOLOGY, V10, P283, DOI 10.1093/glycob/10.3.283; Corne JM, 2002, LANCET, V359, P831, DOI 10.1016/S0140-6736(02)07953-9; Coyle AJ, 1996, ANN NY ACAD SCI, V796, P97, DOI 10.1111/j.1749-6632.1996.tb32571.x; Day AJ, 1999, BIOCHEM SOC T, V27, P115, DOI 10.1042/bst0270115; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; Ehlenfield DR, 2000, PEDIATRICS, V105, P79, DOI 10.1542/peds.105.1.79; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Forteza R, 2001, FASEB J, V15, P2179, DOI 10.1096/fj.01-0036com; FRASER JRE, 1988, BIOCHEM J, V256, P153, DOI 10.1042/bj2560153; Goentzel BJ, 2006, BIOCHEM J, V396, P347, DOI 10.1042/BJ20051782; Grissell TV, 2005, AM J RESP CRIT CARE, V172, P433, DOI 10.1164/rccm.200412-1621OC; Hakonarson H, 1998, J CLIN INVEST, V102, P1732, DOI 10.1172/JCI4141; Han CY, 2007, DIABETES, V56, P2260, DOI 10.2337/db07-0218; Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013; HASCALL VC, 1997, SCI HYALURONAN TODAY; Hirst SJ, 2000, AM J RESP CELL MOL, V23, P335, DOI 10.1165/ajrcmb.23.3.3990; Homer RJ, 2000, CLIN CHEST MED, V21, P331, DOI 10.1016/S0272-5231(05)70270-7; Isler JA, 2005, J VIROL, V79, P6890, DOI 10.1128/JVI.79.11.6890-6899.2005; Jokela TA, 2008, CONNECT TISSUE RES, V49, P115, DOI 10.1080/03008200802148439; Katoh S, 2003, J CLIN INVEST, V111, P1563, DOI 10.1172/JCI200316583; Lauer ME, 2009, J BIOL CHEM, V284, P5313, DOI 10.1074/jbc.M807979200; LAURENT UBG, 1991, EXP PHYSIOL, V76, P695, DOI 10.1113/expphysiol.1991.sp003536; LAURENT UBG, 1992, MATRIX, V12, P130, DOI 10.1016/S0934-8832(11)80054-5; LAZAAR AL, 1994, J EXP MED, V180, P807, DOI 10.1084/jem.180.3.807; Lee ES, 2007, FEBS LETT, V581, P4325, DOI 10.1016/j.febslet.2007.08.001; LESLEY J, 1993, ADV IMMUNOL, V54, P271, DOI 10.1016/S0065-2776(08)60537-4; Ludwig MS, 2007, J APPL PHYSIOL, V103, P735, DOI 10.1152/japplphysiol.00751.2007; Majors AK, 2003, J BIOL CHEM, V278, P47223, DOI 10.1074/jbc.M304871200; Milinkovic M, 2004, BLOOD, V103, P740, DOI 10.1182/blood-2003-05-1500; Mukhopadhyay D, 2006, MATRIX BIOL, V25, pS94, DOI 10.1016/j.matbio.2006.08.257; Mulvey M, 2006, J VIROL, V80, P7354, DOI 10.1128/JVI.00479-06; Nag SS, 2003, J ALLERGY CLIN IMMUN, V111, P558, DOI 10.1067/mai.2003.131; Niimi K, 2007, J IMMUNOL, V178, P489, DOI 10.4049/jimmunol.178.1.489; Oliver BGG, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-71; Papadopoulos NG, 2000, J INFECT DIS, V181, P1875, DOI 10.1086/315513; Park JW, 2004, AM J RESP CELL MOL, V30, P830, DOI 10.1165/rcmb.2003-0373OC; Phipps S, 2004, AM J RESP CELL MOL, V31, P626, DOI 10.1165/rcmb.2004-0193OC; Roberts C R, 1998, Can Respir J, V5, P48; ROBERTS CR, 1995, CHEST, V107, pS111, DOI 10.1378/chest.107.3_Supplement.111S; Robinson DS, 1999, INT ARCH ALLERGY IMM, V118, P98, DOI 10.1159/000024039; Robinson DS, 2004, J ALLERGY CLIN IMMUN, V114, P58, DOI 10.1016/j.jaci.2004.03.034; Saavalainen K, 2007, J BIOL CHEM, V282, P11530, DOI 10.1074/jbc.M607871200; SAHU S, 1978, BIOCHEM J, V173, P565, DOI 10.1042/bj1730565; Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272; Selbi W, 2006, KIDNEY INT, V70, P1287, DOI 10.1038/sj.ki.5001760; Selbi W, 2006, J AM SOC NEPHROL, V17, P1553, DOI 10.1681/ASN.2005080879; Shimazawa M, 2007, INVEST OPHTH VIS SCI, V48, P3729, DOI 10.1167/iovs.06-1122; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; Toole BP, 1990, CURR OPIN CELL BIOL, V2, P839, DOI 10.1016/0955-0674(90)90081-O; Wang AM, 2004, J BIOL CHEM, V279, P10279, DOI 10.1074/jbc.M312045200; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997; ZHAO M, 1995, J BIOL CHEM, V270, P26657, DOI 10.1074/jbc.270.44.26657	59	65	67	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5299	5312		10.1074/jbc.M807965200	http://dx.doi.org/10.1074/jbc.M807965200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19088077	Green Published, hybrid			2022-12-25	WOS:000263416600060
J	Schroeder, S; Lawernce, AD; Biedendieck, R; Rose, RS; Deery, E; Graham, RM; McLean, KJ; Munro, AW; Rigby, SEJ; Warren, MJ				Schroeder, Susanne; Lawernce, Andrew D.; Biedendieck, Rebekka; Rose, Ruth-Sarah; Deery, Evelyne; Graham, Ross M.; McLean, Kirsty J.; Munro, Andrew W.; Rigby, Stephen E. J.; Warren, Martin J.			Demonstration That CobG, the Monooxygenase Associated with the Ring Contraction Process of the Aerobic Cobalamin (Vitamin B-12) Biosynthetic Pathway, Contains an Fe-S Center and a Mononuclear Non-heme Iron Center	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; COLI SULFITE REDUCTASE; PERNICIOUS-ANEMIA; OXYGEN; MECHANISM; MOSSBAUER; EVOLUTION; SUBSTRATE; INSIGHTS; SIROHEME	The ring contraction process that occurs during cobalamin (vitamin B-12) biosynthesis is mediated via the action of two enzymes, CobG and CobJ. The first of these generates a tertiary alcohol at the C-20 position of precorrin-3A by functioning as a monooxygenase, a reaction that also forms a gamma lactone with the acetic acid side chain on ring A. The product, precorrin-3B, is then acted upon by CobJ, which methylates at the C-17 position and promotes ring contraction of the macrocycle by catalyzing a masked pinacol rearrangement. Here, we report the characterization of CobG enzymes from Pseudomonas denitrificans and Brucella melitensis. We show that both contain a [4Fe-4S] center as well as a mononuclear non-heme iron. Although both enzymes are active in vivo, the P. denitrificans enzyme was found to be inactive in vitro. Further analysis of this enzyme revealed that the mononuclear non-heme iron was not reducible, and it was concluded that it is rapidly inactivated once it is released from the bacterial cell. In contrast, the B. melitensis enzyme was found to be fully active in vitro and the mononuclear non-heme iron was reducible by dithionite. The reduced mononuclear non-heme was able to react with the oxygen analogue NO, but only in the presence of the substrate precorrin-3A. The cysteine residues responsible for binding the Fe-S center were identified by site-directed mutagenesis. A mechanism for CobG is presented.	[Schroeder, Susanne; Lawernce, Andrew D.; Biedendieck, Rebekka; Deery, Evelyne; Warren, Martin J.] Univ Kent, Dept Biosci, Prot Sci Grp, Canterbury CT2 7NJ, Kent, England; [Graham, Ross M.] Univ Western Australia, Fremantle Hosp, Sch Med & Pharmacol M704, Fremantle, WA 6160, Australia; [McLean, Kirsty J.; Munro, Andrew W.; Rigby, Stephen E. J.] Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England	University of Kent; University of Western Australia; University of Manchester	Warren, MJ (corresponding author), Univ Kent, Dept Biosci, Prot Sci Grp, Canterbury CT2 7NJ, Kent, England.	m.j.warren@kent.ac.uk	Munro, Andrew/G-5639-2019; McLean, Kirsty J/GXI-2853-2022; Rose, Ruth/AAW-3844-2020	Munro, Andrew/0000-0002-4642-180X; Rose, Ruth/0000-0001-6406-137X; Schroeder, Susanne/0000-0003-1703-9158; Warren, Martin/0000-0002-6028-6456; Biedendieck, Rebekka/0000-0002-3567-6196; McLean, Kirsty/0000-0002-7193-5044	Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC [BB/D003997/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D003997/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ARCIERO DM, 1983, J BIOL CHEM, V258, P4981; Bartlett GJ, 2003, J MOL BIOL, V331, P829, DOI 10.1016/S0022-2836(03)00734-4; BATTERSBY AR, 1994, SCIENCE, V264, P1551, DOI 10.1126/science.8202709; BERTINI I, 1995, STRUCT BOND, V83, P1; BERTRAND P, 1982, J CHEM PHYS, V76, P4715, DOI 10.1063/1.442788; Bian SM, 1999, COORDIN CHEM REV, V190, P1049, DOI 10.1016/S0010-8545(99)00157-5; BLANCHE F, 1993, ANGEW CHEM INT EDIT, V32, P1651, DOI 10.1002/anie.199316511; BURGER RM, 1981, J BIOL CHEM, V256, P1636; CHEN VJ, 1989, J BIOL CHEM, V264, P21677; CHRISTNER JA, 1981, J BIOL CHEM, V256, P2098; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; CRANE BR, 1995, SCIENCE, V270, P59, DOI 10.1126/science.270.5233.59; DEBUSSCHE L, 1993, J CHEM SOC CHEM COMM, P1100, DOI 10.1039/c39930001100; DEBUSSCHE L, 1993, J BACTERIOL, V175, P7430, DOI 10.1128/JB.175.22.7430-7440.1993; Dutton P L, 1978, Methods Enzymol, V54, P411; ESCHENMOSER A, 1988, ANGEW CHEM INT EDIT, V27, P5, DOI 10.1002/anie.198800051; Gaffney BJ, 1996, ANNU REV BIOPH BIOM, V25, P431, DOI 10.1146/annurev.bb.25.060196.002243; Girerd JJ, 2000, STRUCT BOND, V97, P145; HODGKIN DC, 1955, NATURE, V176, P325, DOI 10.1038/176325a0; Jackson TA, 2003, J AM CHEM SOC, V125, P8348, DOI 10.1021/ja029523s; JANICK PA, 1982, BIOCHEMISTRY-US, V21, P3538, DOI 10.1021/bi00258a003; Johnson MK, 1999, ADV INORG CHEM, V47, P1, DOI 10.1016/S0898-8838(08)60076-8; Leech HK, 2003, J BIOL CHEM, V278, P41900, DOI 10.1074/jbc.M306112200; LOVENBERG W, 1973, IRON SULPHUR PROTEIN, V2, P195; McGoldrick HM, 2005, J BIOL CHEM, V280, P1086, DOI 10.1074/jbc.M411884200; MINOT GR, 1983, JAMA-J AM MED ASSOC, V250, P3328, DOI 10.1001/jama.250.24.3328; Mouesca JM, 1998, COORDIN CHEM REV, V178, P1573, DOI 10.1016/S0010-8545(98)00155-6; Munro AW, 2001, BIOCHEMISTRY-US, V40, P1956, DOI 10.1021/bi001718u; Neidig ML, 2005, CHEM COMMUN, P5843, DOI 10.1039/b510233m; NELSON MJ, 1987, J BIOL CHEM, V262, P12137; Ost TWB, 2001, BIOCHEMISTRY-US, V40, P13421, DOI 10.1021/bi010716m; Parsons JB, 2008, J BIOL CHEM, V283, P14366, DOI 10.1074/jbc.M709214200; Raux E, 1999, BIOORG CHEM, V27, P100, DOI 10.1006/bioo.1998.1125; Raux E, 1996, J BACTERIOL, V178, P753, DOI 10.1128/jb.178.3.753-767.1996; RICKES EL, 1948, SCIENCE, V107, P396, DOI 10.1126/science.107.2781.396; Roessner CA, 2001, VITAM HORM, V61, P267; Ryle MJ, 2002, CURR OPIN CHEM BIOL, V6, P193, DOI 10.1016/S1367-5931(02)00302-2; SCOTT AI, 1993, FEBS LETT, V331, P105, DOI 10.1016/0014-5793(93)80306-F; SCOTT AI, 1994, HETEROCYCLES, V39, P471; Simaan AJ, 1999, EUR J INORG CHEM, P993; Simaan AJ, 2001, INORG CHEM, V40, P6538, DOI 10.1021/ic010635e; SMITH EL, 1948, NATURE, V161, P638, DOI 10.1038/161638a0; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; SPENCER JB, 1993, J AM CHEM SOC, V115, P11610, DOI 10.1021/ja00077a075; SPENCER JB, 1994, J AM CHEM SOC, V116, P4991, DOI 10.1021/ja00090a056; Stolowich NJ, 1996, J AM CHEM SOC, V118, P1657, DOI 10.1021/ja952739s; SWEENEY WV, 1980, ANNU REV BIOCHEM, V49, P139, DOI 10.1146/annurev.bi.49.070180.001035; Warren MJ, 2002, NAT PROD REP, V19, P390, DOI 10.1039/B108967F	48	10	11	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4796	4805		10.1074/jbc.M807184200	http://dx.doi.org/10.1074/jbc.M807184200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19068481	hybrid			2022-12-25	WOS:000263416600007
J	Tachibana, T; Okazaki, S; Murayama, A; Naganuma, A; Nomoto, A; Kuge, S				Tachibana, Tsuyoshi; Okazaki, Shoko; Murayama, Asako; Naganuma, Akira; Nomoto, Akio; Kuge, Shusuke			A Major Peroxiredoxin-induced Activation of Yap1 Transcription Factor Is Mediated by Reduction-sensitive Disulfide Bonds and Reveals a Low Level of Transcriptional Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEROXIDE-INDUCED OXIDATION; CYSTEINE-SULFINIC ACID; SACCHAROMYCES-CEREVISIAE; HYDROGEN-PEROXIDE; 2-CYS PEROXIREDOXIN; REDOX REGULATION; NUCLEAR EXPORT; BUDDING YEAST; STRESS; H2O2	Redox reactions involving cysteine thiol-disulfide exchange are crucial for the intracellular monitoring of hydrogen peroxide (H2O2). Yap1, the master transcription factor for the oxidative stress response in budding yeast, is activated by the formation of disulfide bonds in response to H2O2. Gpx3 (glutathione peroxidase-like protein 3) acts as a receptor for H2O2, and Ybp1 (Yap1-binding protein 1) is crucial for Gpx3-dependent disulfide bond formation in Yap1. We previously reported that Tsa1, a major peroxiredoxin in yeast cells, is required for activation of Yap1 in a widely used yeast strain, W303-1b, carrying the ybp1-1 mutant allele encoding a truncated Ybp1 protein. In the present study, we show that Tsa1 can interact with Yap1 via disulfide linkages and induce the formation of intramolecular disulfide bonds in Yap1 in ybp1-1 cells. The results provide evidence that Prx can have intrinsic activity as an H2O2 receptor and can relay H2O2 as a signal to the Prx target proteins in terms of formation of disulfide linkage. Furthermore, our data reveal that there is more of the reduction-resistant active form of Yap1 (i.e. Yap1 (oxII)) when it is partnered with Gpx3 than with Tsa1. These data support our hypothesis that changes in the redox status of Yap1 to reduction-resistant forms by multiple disulfide bond formation are important for determining the level and duration of Yap1 activity in the dynamic equilibrium of redox reactions in cells exposed to H2O2.	[Tachibana, Tsuyoshi; Okazaki, Shoko; Naganuma, Akira; Kuge, Shusuke] Tohoku Univ, Lab Mol & Biochem Toxicol, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9800861, Japan; [Murayama, Asako; Nomoto, Akio] Univ Tokyo, Dept Microbiol, Grad Sch Med, Minato Ku, Tokyo 1130033, Japan	Tohoku University; University of Tokyo	Kuge, S (corresponding author), 6-3 Azaaoba,Aoba Ku, Sendai, Miyagi 9800861, Japan.	skuge@mail.pharm.tohoku.ac.jp	NAGANUMA, AKIRA/V-2918-2019		Ministry of Education, Culture, Sports, Science, and Technology (Japan); "Program for Promotion of Fundamental Studies in Health Sciences" of the National Institute of Biomedical Innovation	Ministry of Education, Culture, Sports, Science, and Technology (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); "Program for Promotion of Fundamental Studies in Health Sciences" of the National Institute of Biomedical Innovation(National Institute of Biomedical Innovation)	This work was supported by grants-in-aid for exploratory research and a grant-in-aid for scientific research on priority areas from the Ministry of Education, Culture, Sports, Science, and Technology (Japan) and by the "Program for Promotion of Fundamental Studies in Health Sciences" of the National Institute of Biomedical Innovation.	Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; Azevedo D, 2003, FREE RADICAL BIO MED, V35, P889, DOI 10.1016/S0891-5849(03)00434-9; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Bozonet SM, 2005, J BIOL CHEM, V280, P23319, DOI 10.1074/jbc.M502757200; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Delaunay A, 2000, EMBO J, V19, P5157, DOI 10.1093/emboj/19.19.5157; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; DUNN B, 1997, CURRENT PROTOCOLS MO; Frankel EN, 1996, J AGR FOOD CHEM, V44, P131, DOI 10.1021/jf950374p; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Izawa S, 1999, J BIOL CHEM, V274, P28459, DOI 10.1074/jbc.274.40.28459; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Juarez JC, 2008, P NATL ACAD SCI USA, V105, P7147, DOI 10.1073/pnas.0709451105; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; Kuge S, 1998, GENES CELLS, V3, P521, DOI 10.1046/j.1365-2443.1998.00209.x; KUGE S, 1994, EMBO J, V13, P655, DOI 10.1002/j.1460-2075.1994.tb06304.x; Kuge S, 1997, EMBO J, V16, P1710, DOI 10.1093/emboj/16.7.1710; Kuge S, 2001, MOL CELL BIOL, V21, P6139, DOI 10.1128/MCB.21.18.6139-6150.2001; Lee CJ, 2004, NAT STRUCT MOL BIOL, V11, P1179, DOI 10.1038/nsmb856; Lee SY, 2008, BIOCHEM BIOPH RES CO, V367, P67, DOI 10.1016/j.bbrc.2007.12.105; Morgan BA, 1997, EMBO J, V16, P1035, DOI 10.1093/emboj/16.5.1035; Okazaki S, 2005, ANTIOXID REDOX SIGN, V7, P327, DOI 10.1089/ars.2005.7.327; Okazaki S, 2007, MOL CELL, V27, P675, DOI 10.1016/j.molcel.2007.06.035; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Tanaka T, 2005, J BIOL CHEM, V280, P42078, DOI 10.1074/jbc.M508622200; Tao K, 1999, FEBS LETT, V457, P90, DOI 10.1016/S0014-5793(99)01013-3; Veal EA, 2004, MOL CELL, V15, P129, DOI 10.1016/j.molcel.2004.06.021; Veal EA, 2003, J BIOL CHEM, V278, P30896, DOI 10.1074/jbc.M303542200; Vivancos AP, 2005, P NATL ACAD SCI USA, V102, P8875, DOI 10.1073/pnas.0503251102; Vivancos AP, 2004, MOL MICROBIOL, V52, P1427, DOI 10.1111/j.1365-2958.2004.04065.x; Wong CM, 2004, J BIOL CHEM, V279, P23207, DOI 10.1074/jbc.M402095200; Wood MJ, 2004, NATURE, V430, P917, DOI 10.1038/nature02790; Wood MJ, 2003, BIOCHEMISTRY-US, V42, P11982, DOI 10.1021/bi035003d; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yan C, 1998, EMBO J, V17, P7416, DOI 10.1093/emboj/17.24.7416; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	36	56	60	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4464	4472		10.1074/jbc.M807583200	http://dx.doi.org/10.1074/jbc.M807583200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19106090	hybrid			2022-12-25	WOS:000263134400046
J	Chen, W; Chen, Y; Xu, BE; Juang, YC; Stippec, S; Zhao, YM; Cobb, MH				Chen, Wei; Chen, Yue; Xu, Bing-e; Juang, Yu-Chi; Stippec, Steve; Zhao, Yingming; Cobb, Melanie H.			Regulation of a Third Conserved Phosphorylation Site in SGK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; WNK1 ACTIVATES SGK1; TURN MOTIF; SERUM; IDENTIFICATION; DEGRADATION; MECHANISM; RAPAMYCIN; P70(S6K); TERMINUS	SGK1 (serum- and glucocorticoid-induced kinase 1) is a member of the AGC branch of the protein kinase family. Among well described functions of SGK1 is the regulation of epithelial transport through phosphorylation of the ubiquitin protein ligase Nedd4-2 (neuronal precursor cell expressed developmentally down-regulated 4-2). The activation of SGK1 has been widely accepted to be dependent on the phosphorylation of Thr(256) in the activation loop and Ser(422) in the hydrophobic motif near the C terminus. Here, we report the identification of two additional phosphorylation sites, Ser(397) and Ser(401). Both are required for maximum SGK1 activity induced by extracellular agents or by coexpression with other protein kinases, with the largest loss of activity from mutation of Ser(397). Coexpression with active Akt1 increased the phosphorylation of Ser(397) and thereby SGK1 kinase activity. SGK1 activation was further augmented by coexpression with the protein kinase WNK1(with no lysine kinase 1). These findings reveal further complexity underlying the regulation of SGK1 activity.	[Cobb, Melanie H.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Cobb, MH (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	Melanie.Cobb@UTSouthwestern.edu		Cobb, Melanie/0000-0003-0833-5473	National Institutes of Health Grant [GM53032]; Innovative Technologies for the Molecular Analysis of Cancer [CA107943]; Welch Foundation Grant [I1243]; NATIONAL CANCER INSTITUTE [R33CA107943, R21CA107943] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Innovative Technologies for the Molecular Analysis of Cancer; Welch Foundation Grant(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant GM53032 (to M. H. C.) and "Innovative Technologies for the Molecular Analysis of Cancer" Program Grant CA107943 from NCI (to Y.Z.). This work was also supported by Welch Foundation Grant I1243 (to M. H. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Belova L, 2006, BIOCHEM J, V400, P235, DOI 10.1042/BJ20060905; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Bogusz AM, 2006, FEBS J, V273, P2913, DOI 10.1111/j.1742-4658.2006.05304.x; Brickley DR, 2002, J BIOL CHEM, V277, P43064, DOI 10.1074/jbc.M207604200; Chen W, 2004, J BIOL CHEM, V279, P11129, DOI 10.1074/jbc.M313562200; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Gao TY, 2002, J BIOL CHEM, V277, P31585, DOI 10.1074/jbc.M204335200; Gao TY, 2001, J BIOL CHEM, V276, P19588, DOI 10.1074/jbc.M101357200; HAN JW, 1995, J BIOL CHEM, V270, P21396, DOI 10.1074/jbc.270.36.21396; Hauge C, 2007, EMBO J, V26, P2251, DOI 10.1038/sj.emboj.7601682; Hong F, 2008, MOL CELL, V30, P701, DOI 10.1016/j.molcel.2008.04.027; Kamynina E, 2002, AM J PHYSIOL-RENAL, V283, pF377, DOI 10.1152/ajprenal.00143.2002; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Leong MLL, 2003, J BIOL CHEM, V278, P5871, DOI 10.1074/jbc.M211649200; McCoy CE, 2005, BIOCHEM J, V387, P507, DOI 10.1042/BJ20041501; Moser BA, 1997, MOL CELL BIOL, V17, P5648, DOI 10.1128/MCB.17.9.5648; MUKHOPADHYAY NK, 1992, J BIOL CHEM, V267, P3325; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Pao AC, 2007, AM J PHYSIOL-RENAL, V292, pF1741, DOI 10.1152/ajprenal.00027.2007; Parekh D, 1999, J BIOL CHEM, V274, P34758, DOI 10.1074/jbc.274.49.34758; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Saitoh M, 2002, J BIOL CHEM, V277, P20104, DOI 10.1074/jbc.M201745200; Shu HJ, 2004, MOL CELL PROTEOMICS, V3, P279, DOI 10.1074/mcp.D300003-MCP200; Tessier M, 2006, J CELL BIOCHEM, V98, P1391, DOI 10.1002/jcb.20894; Vallon V, 2005, AM J PHYSIOL-REG I, V289, pR395, DOI 10.1152/ajpregu.00731.2004; Vitari AC, 2004, BIOCHEM J, V378, P257, DOI 10.1042/BJ20031692; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; Wulff P, 2002, J CLIN INVEST, V110, P1263, DOI 10.1172/JCI200215696; Xu BE, 2005, J BIOL CHEM, V280, P34218, DOI 10.1074/jbc.M505735200; Xu BE, 2005, P NATL ACAD SCI USA, V102, P10315, DOI 10.1073/pnas.0504422102; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; Zhao B, 2007, PROTEIN SCI, V16, P2761, DOI 10.1110/ps.073161707	35	22	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3453	3460		10.1074/jbc.M807502200	http://dx.doi.org/10.1074/jbc.M807502200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19068477	hybrid, Green Published			2022-12-25	WOS:000262872500011
J	Wang, W; Fridman, A; Blackledge, W; Connelly, S; Wilson, IA; Pilz, RB; Boss, GR				Wang, Wei; Fridman, Alla; Blackledge, William; Connelly, Stephen; Wilson, Ian A.; Pilz, Renate B.; Boss, Gerry R.			The Phosphatidylinositol 3-Kinase/Akt Cassette Regulates Purine Nucleotide Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID STARVATION; HUMAN-LYMPHOBLASTS; PROTEIN-KINASE; PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE; GLUCOSE-METABOLISM; MAMMALIAN TARGET; BIOSYNTHESIS; CELLS; MECHANISM; GROWTH	The phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway is highly conserved throughout evolution and regulates cell size and survival and cell cycle progression. It regulates the latter by stimulating procession through G(1) and the G(1)/S phase transition. Entry into S phase requires an abundant supply of purine nucleotides, but the effect of the PI3K/Akt pathway on purine synthesis has not been studied. We now show that the PI3K/Akt cassette regulates both de novo and salvage purine nucleotide synthesis in insulin-responsive mouse mesenchymal cells. We found that serum and insulin stimulated de novo purine synthesis in serum-starved cells largely through PI3K/Akt signaling, and pharmacologic and genetic inhibition of PI3K/Akt reduced de novo synthesis by 75% in logarithmically growing cells. PI3K/Akt regulated early steps of de novo synthesis by modulating phosphoribosylpyrophosphate production by the non-oxidative pentose phosphate pathway and late steps by modulating activity of the bifunctional enzyme aminoimidazole-carboxamide ribonucleotide transformylase IMP cyclohydrolase, an enzyme not previously known to be regulated. The effects of PI3K/Akt on purine nucleotide salvage were likely through regulating phosphoribosylpyrophosphate availability. These studies define a new mechanism whereby the PI3K/Akt cassette functions as a master regulator of cellular metabolism and a key player in oncogenesis.	[Wang, Wei; Fridman, Alla; Blackledge, William; Pilz, Renate B.; Boss, Gerry R.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Wang, Wei; Fridman, Alla; Blackledge, William; Pilz, Renate B.; Boss, Gerry R.] Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA; [Connelly, Stephen; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Connelly, Stephen; Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; Scripps Research Institute	Boss, GR (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	gboss@ucsd.edu		Boss, Gerry/0000-0002-9758-8714	National Institutes of Health [NS58030, AI42266, DK69263]; Skaggs Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042266, R01AI042266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK069263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS058030] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS58030 (to G. R. B.) and AI42266 (to I. A. W. and S. C.) and Training Grant DK69263 (to W. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported in part by the Skaggs Institute.	Becker MA, 2001, PROG NUCLEIC ACID RE, V69, P115, DOI 10.1016/S0079-6603(01)69046-9; Boros LG, 2001, PANCREAS, V22, P1, DOI 10.1097/00006676-200101000-00001; Boros LG, 1997, CANCER RES, V57, P4242; BOSS GR, 1984, J BIOL CHEM, V259, P2936; BOSS GR, 1985, J BIOL CHEM, V260, P6054; BOSS GR, 1987, BIOCHEM J, V242, P425, DOI 10.1042/bj2420425; BOSS GR, 1980, J IMMUNOL, V125, P679; BOSS GR, 1982, J BIOL CHEM, V257, P4242; BOYLE JA, 1972, BIOCHIM BIOPHYS ACTA, V269, P179, DOI 10.1016/0005-2787(72)90424-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Coffer PJ, 1998, BIOCHEM J, V335, P1; Doughty CA, 2006, BLOOD, V107, P4458, DOI 10.1182/blood-2005-12-4788; Gassmann MG, 1999, ONCOGENE, V18, P6667, DOI 10.1038/sj.onc.1203120; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; HENDERSON JF, 1968, CAN J BIOCHEM CELL B, V46, P703, DOI 10.1139/o68-108; HENDERSON JF, 1962, J BIOL CHEM, V237, P2631; HENIN N, 1995, FASEB J, V9, P541, DOI 10.1096/fasebj.9.7.7737463; HERSHFIELD MS, 1976, J BIOL CHEM, V251, P7348; HOLMES EW, 1973, J BIOL CHEM, V248, P6035; Isotani S, 1999, J BIOL CHEM, V274, P34493, DOI 10.1074/jbc.274.48.34493; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; KRENITSKY TA, 1969, J BIOL CHEM, V244, P1263; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marie S, 2004, AM J HUM GENET, V74, P1276, DOI 10.1086/421475; MARTIN DW, 1972, J BIOL CHEM, V247, P5477; MUELLER WT, 1981, BIOCHEMISTRY-US, V20, P337, DOI 10.1021/bi00505a017; PILZ RB, 1984, J BIOL CHEM, V259, P2927; RABINOWITZ JC, 1963, METHOD ENZYMOL, V6, P814, DOI 10.1016/0076-6879(63)06256-X; RAIVIO KO, 1981, BIOCHIM BIOPHYS ACTA, V678, P51, DOI 10.1016/0304-4165(81)90046-5; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; SCHEELE JS, 1994, J BIOL CHEM, V269, P18599; SIDI Y, 1985, J CLIN INVEST, V76, P2416, DOI 10.1172/JCI112255; Torres RJ, 1996, CLIN CHIM ACTA, V245, P105, DOI 10.1016/0009-8981(95)06178-9; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wolan DW, 2002, BIOCHEMISTRY-US, V41, P15505, DOI 10.1021/bi020505x; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222	39	43	44	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3521	3528		10.1074/jbc.M806707200	http://dx.doi.org/10.1074/jbc.M806707200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19068483	Green Published, hybrid			2022-12-25	WOS:000262872500019
J	Gonzalez, ME; Li, X; Toy, K; DuPrie, M; Ventura, AC; Banerjee, M; Ljungman, M; Merajver, SD; Kleer, CG				Gonzalez, M. E.; Li, X.; Toy, K.; DuPrie, M.; Ventura, A. C.; Banerjee, M.; Ljungman, M.; Merajver, S. D.; Kleer, C. G.			Downregulation of EZH2 decreases growth of estrogen receptor-negative invasive breast carcinoma and requires BRCA1	ONCOGENE			English	Article						EZH2; polycomb group protein; breast cancer; basal-cell phenotype; BRCA1; G(2)/M	GROUP PROTEIN EZH2; DNA-DAMAGE RESPONSE; CELL-CYCLE; CDC25C PHOSPHATASE; GENE-EXPRESSION; TARGET GENES; CANCER; POLYCOMB; PHOSPHORYLATION; PROLIFERATION	Increased levels of enhancer of zeste homolog 2 (EZH2), a critical regulator of cellular memory, are associated with negative estrogen receptor (ER) expression and disease progression in breast cancer. High levels of EZH2 signal the presence of metastasis and poor outcome in breast cancer patients. To test the hypothesis that deregulation of EZH2 contributes to ER-negative breast cancer progression, EZH2 expression was inhibited in ER-negative breast cancer cells MDA-MB-231 and CAL51 using a lentivirus system. EZH2 knockdown decreased proliferation and delayed the G(2)/M cell-cycle transition, although not affecting apoptosis. In vivo, EZH2 downregulation significantly decreased breast xenograft growth and improved survival. EZH2 knockdown upregulated BRCA1 protein. Of note, BRCA1 knockdown was sufficient to rescue the effects of EZH2 downregulation on proliferation, G(2)/M arrest, and on the levels of hyperphosphorylated mitotic Cdc25C and Cyclin B1 proteins, crucial for entry into mitosis. Invasive ER-negative breast carcinomas show significant overexpression of EZH2 and downregulation of BRCA1 proteins. Taken together, we show that EZH2 is important in ER-negative breast cancer growth in vivo and in vitro, and that BRCA1 is required for the proliferative effects of EZH2. Blockade of EZH2 may provide a prime target to prevent and/or halt ER-negative breast cancer progression.	[Gonzalez, M. E.; Li, X.; Toy, K.; DuPrie, M.; Kleer, C. G.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Ventura, A. C.; Merajver, S. D.] Univ Michigan, Sch Med, Div Hematol Oncol, Dept Internal Med, Ann Arbor, MI 48109 USA; [Ventura, A. C.; Banerjee, M.; Ljungman, M.; Merajver, S. D.; Kleer, C. G.] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Banerjee, M.] Univ Michigan, Sch Med, Dept Biostat, Ann Arbor, MI 48109 USA; [Ljungman, M.] Univ Michigan, Sch Med, Dept Radiat Oncol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Kleer, CG (corresponding author), Univ Michigan, Sch Med, Dept Pathol, 4217 Comprehens Canc Ctr,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	kleer@umich.edu			NIH [CA090876, CA107469, CA77612]; Avon Foundation; Burroughs Wellcome Fund; Department of Defense Breast Cancer Research Program; NATIONAL CANCER INSTITUTE [R01CA077612, K08CA090876, R01CA107469] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Avon Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Department of Defense Breast Cancer Research Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Arul Chinnaiyan for the EZH2 plasmid, and Tracey Filzen for technical support. We thank Robin Kunkel for assistance with artwork. We thank the University of Michigan Vector Core for virus generation. This work was supported by NIH grants CA090876 (CGK), CA107469 (CGK), CA77612 (SDM), a grant from the Avon Foundation (CGK), a grant from the Burroughs Wellcome Fund (SDM) and a grant from the Department of Defense Breast Cancer Research Program(ACV).	Bachmann IM, 2006, J CLIN ONCOL, V24, P268, DOI 10.1200/JCO.2005.01.5180; Bae I, 2005, CELL CYCLE, V4, P1641, DOI 10.4161/cc.4.11.2152; Bonnet J, 2008, BIOCHEM BIOPH RES CO, V370, P483, DOI 10.1016/j.bbrc.2008.03.117; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Bulavin DV, 2003, NAT CELL BIOL, V5, P545, DOI 10.1038/ncb994; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Collett K, 2006, CLIN CANCER RES, V12, P1168, DOI 10.1158/1078-0432.CCR-05-1533; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Ding L, 2006, CANCER RES, V66, P4095, DOI 10.1158/0008-5472.CAN-05-4300; Dunphy William G., 1994, Trends in Cell Biology, V4, P202; ELLIS MJ, 2000, DIS BREAST, P749; Elstrodt F, 2006, CANCER RES, V66, P41, DOI 10.1158/0008-5472.CAN-05-2853; Fan MY, 2000, CANCER RES, V60, P6403; Foulkes WD, 2003, J NATL CANCER I, V95, P1482, DOI 10.1093/jnci/djg050; Hayes DF, 2001, J MAMMARY GLAND BIOL, V6, P375, DOI 10.1023/A:1014778713034; HOFFMANN I, 1993, EMBO J, V12, P53, DOI 10.1002/j.1460-2075.1993.tb05631.x; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Laible G, 1997, EMBO J, V16, P3219, DOI 10.1093/emboj/16.11.3219; Lakhani SR, 2005, CLIN CANCER RES, V11, P5175, DOI 10.1158/1078-0432.CCR-04-2424; MacLachlan TK, 2000, J BIOL CHEM, V275, P2777, DOI 10.1074/jbc.275.4.2777; Mullan PB, 2006, ONCOGENE, V25, P5854, DOI 10.1038/sj.onc.1209872; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Roshak AK, 2000, CELL SIGNAL, V12, P405, DOI 10.1016/S0898-6568(00)00080-2; Satijn DPE, 1999, BBA-GENE STRUCT EXPR, V1447, P1, DOI 10.1016/S0167-4781(99)00130-X; Shi B, 2007, MOL CELL BIOL, V27, P5105, DOI 10.1128/MCB.00162-07; Smits VAJ, 2001, BBA-GENE STRUCT EXPR, V1519, P1, DOI 10.1016/S0167-4781(01)00204-4; STRAUSFELD U, 1994, J BIOL CHEM, V269, P5989; Su I, 2005, CELL, V121, P425, DOI 10.1016/j.cell.2005.02.029; Tonini T, 2004, ONCOGENE, V23, P4930, DOI 10.1038/sj.onc.1207608; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Turner NC, 2007, ONCOGENE, V26, P2126, DOI 10.1038/sj.onc.1210014; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wilson CA, 1999, NAT GENET, V21, P236, DOI 10.1038/6029; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Yan Y, 2005, ONCOGENE, V24, P3285, DOI 10.1038/sj.onc.1208492; Yoshikawa K, 2000, INT J CANCER, V88, P28, DOI 10.1002/1097-0215(20001001)88:1<28::AID-IJC5>3.0.CO;2-4; Yuli C, 2007, ONCOGENE, V26, P6031, DOI 10.1038/sj.onc.1210420	44	140	151	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2009	28	6					843	853		10.1038/onc.2008.433	http://dx.doi.org/10.1038/onc.2008.433			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	406UI	19079346	Green Accepted			2022-12-25	WOS:000263320000007
J	Xu, JL; Bae, E; Zhang, QH; Annis, DS; Erickson, HP; Mosher, DF				Xu, Jielin; Bae, Eunnyung; Zhang, Qinghong; Annis, Douglas S.; Erickson, Harold P.; Mosher, Deane F.			Display of Cell Surface Sites for Fibronectin Assembly Is Modulated by Cell Adherence to (1)F3 and C-Terminal Modules of Fibronectin	PLOS ONE			English	Article								Background: Fibronectin-null cells assemble soluble fibronectin shortly after adherence to a substrate coated with intact fibronectin but not when adherent to the cell-binding domain of fibronectin (modules (7)F3-(10)F3). Interactions of adherent cells with regions of adsorbed fibronectin other than modules (7)F3-(10)F3, therefore, are required for early display of the cell surface sites that initiate and direct fibronectin assembly. Methodology/Principal Findings: To identify these regions, coatings of proteolytically derived or recombinant pieces of fibronectin containing modules in addition to (7)F3-(10)F3 were tested for effects on fibronectin assembly by adherent fibronectin-null fibroblasts. Pieces as large as one comprising modules (2)F3-(14)F3, which include the heparin-binding and cell adhesion domains, were not effective in supporting fibronectin assembly. Addition of module (1)F3 or the C-terminal modules to modules (2)F3-(14)F3 resulted in some activity, and addition of both (1)F3 and the C-terminal modules resulted in a construct, (1)F3-C, that best mimicked the activity of a coating of intact fibronectin. Constructs (1)F3-C V0, (1)F3-C V64, and (1)F3-C Delta(V(15)F3(10)F1) were all able to support fibronectin assembly, suggesting that (1)F3 through (11)F1 and/or (12)F1 were important for activity. Coatings in which the active parts of (1)F3-C were present in different proteins were much less active than intact (1)F3-C. Conclusions: These results suggest that (1)F3 acts together with C-terminal modules to induce display of fibronectin assembly sites on adherent cells.	[Xu, Jielin; Bae, Eunnyung; Zhang, Qinghong; Annis, Douglas S.; Mosher, Deane F.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Xu, Jielin; Bae, Eunnyung; Zhang, Qinghong; Annis, Douglas S.; Mosher, Deane F.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA; [Xu, Jielin; Bae, Eunnyung; Zhang, Qinghong; Annis, Douglas S.; Mosher, Deane F.] Univ Wisconsin, Dept Med, Madison, WI 53706 USA; [Erickson, Harold P.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Duke University	Xu, JL (corresponding author), Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA.	dfmosher@wisc.edu			NIH [21644]; NATIONAL CANCER INSTITUTE [R01CA115468] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	NIH 21644. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Lail NI, 2006, MATRIX BIOL, V25, P175, DOI 10.1016/j.matbio.2005.10.007; AGUIRRE KM, 1994, J BIOL CHEM, V269, P27863; Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; AKIYAMA SK, 1989, J CELL BIOL, V109, P863, DOI 10.1083/jcb.109.2.863; Bae E, 2004, J BIOL CHEM, V279, P35749, DOI 10.1074/jbc.M406283200; BALIAN G, 1979, J BIOL CHEM, V254, P1429; Beauvais DLM, 2004, J CELL BIOL, V167, P171, DOI 10.1083/jcb.200404171; BERNARD MP, 1985, BIOCHEMISTRY-US, V24, P2698, DOI 10.1021/bi00332a016; Bloom L, 1999, MOL BIOL CELL, V10, P1521, DOI 10.1091/mbc.10.5.1521; Burton-Wurster N, 1998, MATRIX BIOL, V17, P193, DOI 10.1016/S0945-053X(98)90058-0; Burton-Wurster N, 1999, BIOCHEM J, V341, P555, DOI 10.1042/0264-6021:3410555; Campbell ID, 1998, NAT STRUCT BIOL, V5, P496, DOI 10.1038/733; CHERNOUSOV MA, 1991, J BIOL CHEM, V266, P10851; Cho JH, 2006, BLOOD, V107, P3555, DOI 10.1182/blood-2005-10-4168; Chung CY, 1997, J CELL SCI, V110, P1413; Couchman JR, 1999, J CELL SCI, V112, P3415; Curnis F, 2006, J BIOL CHEM, V281, P36466, DOI 10.1074/jbc.M604812200; Feral CC, 2007, J CELL BIOL, V178, P701, DOI 10.1083/jcb.200705090; FOGERTY FJ, 1990, J CELL BIOL, V111, P699, DOI 10.1083/jcb.111.2.699; Gao M, 2003, P NATL ACAD SCI USA, V100, P14784, DOI 10.1073/pnas.2334390100; GARCIAPARDO A, 1985, J BIOL CHEM, V260, P320; GIANCOTTI FG, 1990, CELL, V60, P849, DOI 10.1016/0092-8674(90)90098-Y; Hocking DC, 1999, J BIOL CHEM, V274, P27257, DOI 10.1074/jbc.274.38.27257; Hocking DC, 1996, J CELL BIOL, V133, P431, DOI 10.1083/jcb.133.2.431; HOCKING DC, 1994, J BIOL CHEM, V269, P19183; Hocking DC, 2002, J CELL BIOL, V158, P175, DOI 10.1083/jcb.200112031; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; HYNES RO, 1978, CELL, V15, P875, DOI 10.1016/0092-8674(78)90272-6; Ingham KC, 1997, J BIOL CHEM, V272, P1718, DOI 10.1074/jbc.272.3.1718; Johnson KJ, 1999, J BIOL CHEM, V274, P15473, DOI 10.1074/jbc.274.22.15473; Klass CM, 2000, J CELL SCI, V113, P493; Klein RM, 2003, J CELL SCI, V116, P4663, DOI 10.1242/jcs.00778; Kusano Y, 2004, J BIOCHEM, V135, P129, DOI 10.1093/jb/mvh015; LAFLAMME SE, 1992, J CELL BIOL, V117, P437, DOI 10.1083/jcb.117.2.437; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; MCKEOWNLONGO PJ, 1983, J CELL BIOL, V97, P466, DOI 10.1083/jcb.97.2.466; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; MERCURIUS KO, 2001, BMC CELL BIOL, V18, P1; Millard CJ, 2007, J BIOL CHEM, V282, P35530, DOI 10.1074/jbc.M707532200; Monaghan E, 2004, J BIOL CHEM, V279, P1400, DOI 10.1074/jbc.M310374200; MORLA A, 1992, J CELL BIOL, V118, P421, DOI 10.1083/jcb.118.2.421; MORLA A, 1994, NATURE, V367, P193, DOI 10.1038/367193a0; MOSHER DF, 1980, J BIOL CHEM, V255, P1181; Mosher DF, 2002, METHOD CELL BIOL, V69, P69, DOI 10.1016/S0091-679X(02)69008-9; MOSHER DF, 1983, J BIOL CHEM, V258, P6595; Mostafavi-Pour Z, 2003, J CELL BIOL, V161, P155, DOI 10.1083/jcb.200210176; Moyano JV, 1999, J BIOL CHEM, V274, P135, DOI 10.1074/jbc.274.1.135; Ohashi T, 2005, J BIOL CHEM, V280, P39143, DOI 10.1074/jbc.M509082200; PETERS DMP, 1987, J CELL BIOL, V104, P121, DOI 10.1083/jcb.104.1.121; Peterson JA, 2005, J BIOL CHEM, V280, P6915, DOI 10.1074/jbc.M406625200; Santas AJ, 2002, J BIOL CHEM, V277, P13650, DOI 10.1074/jbc.M111361200; Saoncella S, 1999, P NATL ACAD SCI USA, V96, P2805, DOI 10.1073/pnas.96.6.2805; SCHWARZBAUER JE, 1991, J CELL BIOL, V113, P1463, DOI 10.1083/jcb.113.6.1463; SCHWARZBAUER JE, 1983, CELL, V35, P421, DOI 10.1016/0092-8674(83)90175-7; Sechler JL, 2000, J CELL SCI, V113, P1491; Sechler JL, 1996, J CELL BIOL, V134, P573, DOI 10.1083/jcb.134.2.573; Sechler JL, 2001, J CELL BIOL, V154, P1081, DOI 10.1083/jcb.200102034; SMITH DE, 1982, J BIOL CHEM, V257, P5831; Sottile J, 2000, J CELL SCI, V113, P4287; Takahashi S, 2007, J CELL BIOL, V178, P167, DOI 10.1083/jcb.200703021; Tomasini-Johansson BR, 2006, MATRIX BIOL, V25, P282, DOI 10.1016/j.matbio.2006.02.002; Tomasini-Johansson BR, 2001, J BIOL CHEM, V276, P23430, DOI 10.1074/jbc.M103467200; TURNER PM, 1989, BIOCHEMISTRY-US, V28, P628, DOI 10.1021/bi00428a032; UMEZAWA K, 1985, FEBS LETT, V186, P31, DOI 10.1016/0014-5793(85)81333-8; Vakonakis I, 2007, EMBO J, V26, P2575, DOI 10.1038/sj.emboj.7601694; Vial D, 2008, J CELL SCI, V121, P1661, DOI 10.1242/jcs.020149; WALTZ DA, 1994, J BIOL CHEM, V269, P14746; Wei Y, 2005, J CELL BIOL, V168, P501, DOI 10.1083/jcb.200404112; Wei Y, 1999, J CELL BIOL, V144, P1285, DOI 10.1083/jcb.144.6.1285; Wennerberg K, 1996, J CELL BIOL, V132, P227, DOI 10.1083/jcb.132.1.227; WILLIAMS EC, 1983, J BIOL CHEM, V258, P5911; Woods A, 1998, TRENDS CELL BIOL, V8, P189, DOI 10.1016/S0962-8924(98)01244-6; Wu CY, 1996, CELL ADHES COMMUN, V4, P149, DOI 10.3109/15419069609014219; WU CY, 1995, CELL, V83, P715, DOI 10.1016/0092-8674(95)90184-1; Yamada KM, 1989, FIBRONECTIN, P47; Zhang QH, 1997, MOL BIOL CELL, V8, P1415, DOI 10.1091/mbc.8.8.1415; ZHANG QH, 1994, J CELL BIOL, V127, P1447, DOI 10.1083/jcb.127.5.1447; Zhang QH, 1999, J BIOL CHEM, V274, P368, DOI 10.1074/jbc.274.1.368; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539	79	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2009	4	1							e4113	10.1371/journal.pone.0004113	http://dx.doi.org/10.1371/journal.pone.0004113			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FR	19119318	Green Submitted, gold, Green Published			2022-12-25	WOS:000265472600012
J	Hollands, A; Aziz, RK; Kansal, R; Kotb, M; Nizet, V; Walker, MJ				Hollands, Andrew; Aziz, Ramy K.; Kansal, Rita; Kotb, Malak; Nizet, Victor; Walker, Mark J.			A Naturally Occurring Mutation in ropB Suppresses SpeB Expression and Reduces M1T1 Group A Streptococcal Systemic Virulence	PLOS ONE			English	Article							CYSTEINE PROTEASE; RGG REGULATOR; PYOGENES; PATHOGENESIS; GENES; INTERNALIZATION; STREPTOKINASE; PHAGOCYTOSIS; INFECTIONS; PROTEINASE	Epidemiological studies of group A streptococcus (GAS) have noted an inverse relationship between SpeB expression and invasive disease. However, the role of SpeB in the course of infection is still unclear. In this study we utilize a SpeB-negative M1T1 clinical isolate, 5628, with a naturally occurring mutation in the gene encoding the regulator RopB, to elucidate the role of RopB and SpeB in systemic virulence. Allelic exchange mutagenesis was used to replace the mutated ropB allele in 5628 with the intact allele from the well characterized isolate 5448. The inverse allelic exchange was also performed to replace the intact ropB in 5448 with the mutated allele from 5628. An intact ropB was found to be essential for SpeB expression. While the ropB mutation was shown to have no effect on hemolysis of RBC's, extracellular DNase activity or survival in the presence of neutrophils, strains with the mutated ropB allele were less virulent in murine systemic models of infection. An isogenic SpeB knockout strain containing an intact RopB showed similarly reduced virulence. Microarray analysis found genes of the SpeB operon to be the primary target of RopB regulation. These data show that an intact RopB and efficient SpeB production are necessary for systemic infection with GAS.	[Walker, Mark J.] Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia; [Aziz, Ramy K.] Cairo Univ, Fac Pharm, Dept Microbiol & Immunol, Cairo, Egypt; [Kansal, Rita; Kotb, Malak] VA Hosp, Memphis, TN USA; [Hollands, Andrew; Kotb, Malak] Univ Cincinnati, Coll Med, Dept Mol Genet, Biochem & Microbiol, Cincinnati, OH 45221 USA; [Nizet, Victor] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of Wollongong; Egyptian Knowledge Bank (EKB); Cairo University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; University System of Ohio; University of Cincinnati; University of California System; University of California San Diego; University of California System; University of California San Diego	Hollands, A (corresponding author), Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia.	mwalker@uow.edu	Nizet, Victor/AAF-3190-2019; Walker, Mark J./F-6940-2011; Aziz, Ramy/B-2918-2009	Aziz, Ramy/0000-0002-4448-7100; Nizet, Victor/0000-0003-3847-0422; Walker, Mark/0000-0001-7423-2769	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077780] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ashbaugh CD, 1998, J CLIN INVEST, V102, P550, DOI 10.1172/JCI3065; Ashbaugh CD, 2001, INFECT IMMUN, V69, P6683, DOI 10.1128/IAI.69.11.6683-6686.2001; Aziz RK, 2004, MOL MICROBIOL, V54, P184, DOI 10.1111/j.1365-2958.2004.04255.x; Aziz RK, 2004, MOL MICROBIOL, V51, P123, DOI 10.1046/j.1365-2958.2003.03797.x; Beckert S, 2001, INFECT IMMUN, V69, P534, DOI 10.1128/IAI.69.1.534-537.2001; Buchanan JT, 2006, CURR BIOL, V16, P396, DOI 10.1016/j.cub.2005.12.039; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Chatellier S, 2000, INFECT IMMUN, V68, P3523, DOI 10.1128/IAI.68.6.3523-3534.2000; Chaussee MA, 2004, J BACTERIOL, V186, P7091, DOI 10.1128/JB.186.21.7091-7099.2004; Chaussee MS, 1999, INFECT IMMUN, V67, P1715; Chaussee MS, 2003, J BACTERIOL, V185, P6016, DOI 10.1128/JB.185.20.6016-6024.2003; Chaussee MS, 2002, INFECT IMMUN, V70, P762, DOI 10.1128/IAI.70.2.762-770.2002; CLEARY PP, 1992, LANCET, V339, P518, DOI 10.1016/0140-6736(92)90339-5; Cole JN, 2006, FASEB J, V20, P1745, DOI 10.1096/fj.06-5804fje; Collin M, 2000, MOL MICROBIOL, V36, P1306, DOI 10.1046/j.1365-2958.2000.01942.x; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; DEMERS B, 1993, CLIN INFECT DIS, V16, P792, DOI 10.1093/clind/16.6.792; Dmitriev AV, 2008, FEMS MICROBIOL LETT, V284, P43, DOI 10.1111/j.1574-6968.2008.01171.x; Dmitriev AV, 2006, J BACTERIOL, V188, P7230, DOI 10.1128/JB.00877-06; Hynes W, 2004, FRONT BIOSCI-LANDMRK, V9, P3399, DOI 10.2741/1491; JENG A, 2003, MOL GENETIC ANAL GRO, P1208; Kansal RG, 2000, INFECT IMMUN, V68, P6362, DOI 10.1128/IAI.68.11.6362-6369.2000; Kansal RG, 2003, J INFECT DIS, V187, P398, DOI 10.1086/368022; KAPLAN EL, 1991, EUR J CLIN MICROBIOL, V10, P55, DOI 10.1007/BF01964407; KAZMI SU, 2001, RECIPROCAL TEMPORAL, P4988; Lukomski S, 1998, INFECT IMMUN, V66, P771, DOI 10.1128/IAI.66.2.771-776.1998; Lyon WR, 2003, J BACTERIOL, V185, P3661, DOI 10.1128/JB.185.12.3661-3667.2003; Marouni MJ, 2003, INFECT IMMUN, V71, P5633, DOI 10.1128/IAI.71.10.5633-5639.2003; McArthur JD, 2008, FASEB J, V22, P3146, DOI 10.1096/fj.08-109348; Musser JM, 1996, INFECT IMMUN, V64, P1913, DOI 10.1128/IAI.64.6.1913-1917.1996; Neely MN, 2003, J BACTERIOL, V185, P5166, DOI 10.1128/JB.185.17.5166-5174.2003; Neely MN, 2002, INFECT IMMUN, V70, P3904, DOI 10.1128/IAI.70.7.3904-3914.2002; Nyberg P, 2004, MICROBIOL-SGM, V150, P1559, DOI 10.1099/mic.0.27076-0; Pulliainen AT, 2008, J BACTERIOL, V190, P3225, DOI 10.1128/JB.01843-07; Raeder R, 1998, RES MICROBIOL, V149, P539, DOI 10.1016/S0923-2508(99)80001-1; Rezcallah MS, 2004, MICROBIOL-SGM, V150, P365, DOI 10.1099/mic.0.26826-0; Ringdahl U, 2000, MOL MICROBIOL, V37, P1318, DOI 10.1046/j.1365-2958.2000.02062.x; Sumby P, 2005, P NATL ACAD SCI USA, V102, P1679, DOI 10.1073/pnas.0406641102; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Svensson MD, 2000, MOL MICROBIOL, V38, P242, DOI 10.1046/j.1365-2958.2000.02144.x; Tart AH, 2007, TRENDS MICROBIOL, V15, P318, DOI 10.1016/j.tim.2007.05.001; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; Walker MJ, 2005, TRENDS MICROBIOL, V13, P308, DOI 10.1016/j.tim.2005.05.006	43	54	55	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4102	10.1371/journal.pone.0004102	http://dx.doi.org/10.1371/journal.pone.0004102			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DO	19116661	Green Published, gold, Green Submitted			2022-12-25	WOS:000265466600020
J	Gavin, EJ; Song, B; Wang, Y; Xi, YG; Ju, JF				Gavin, Elaine J.; Song, Bo; Wang, Yuan; Xi, Yaguang; Ju, Jingfang			Reduction of Orc6 Expression Sensitizes Human Colon Cancer Cells to 5-Fluorouracil and Cisplatin	PLOS ONE			English	Article								Previous studies from our group have shown that the expression levels of Orc6 were highly elevated in colorectal cancer patient specimens and the induction of Orc6 was associated with 5-fluorouracil (5-FU) treatment. The goal of this study was to investigate the molecular and cellular impact of Orc6 in colon cancer. In this study, we use HCT116 (wt-p53) and HCT116 (null-p53) colon cancer cell lines as a model system to investigate the impact of Orc6 on cell proliferation, chemosensitivity and pathways involved with Orc6. We demonstrated that the down regulation of Orc6 sensitizes colon cancer cells to both 5-FU and cisplatin (cis-pt) treatment. Decreased Orc6 expression in HCT-116 (wt-p53) cells by RNA interference triggered cell cycle arrest at G1 phase. Prolonged inhibition of Orc6 expression resulted in multinucleated cells in HCT-116 (wt-p53) cell line. Western immunoblot analysis showed that down regulation of Orc6 induced p21 expression in HCT-116 (wt-p53) cells. The induction of p21 was mediated by increased level of phosphorylated p53 at ser-15. By contrast, there is no elevated expression of p21 in HCT-116 (null-p53) cells. Orc6 down regulation also increased the expression of DNA damaging repair protein GADD45b and reduced the expression level of JNK1. Orc6 may be a potential novel target for future anti cancer therapeutic development in colon cancer.	[Gavin, Elaine J.; Xi, Yaguang; Ju, Jingfang] Univ S Alabama, Canc Genom Lab, Mitchell Canc Inst, Mobile, AL 36688 USA; [Song, Bo; Wang, Yuan; Ju, Jingfang] SUNY Stony Brook, Sch Med, Dept Pathol, Translat Res Lab, Stony Brook, NY USA	University of South Alabama; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Gavin, EJ (corresponding author), Univ S Alabama, Canc Genom Lab, Mitchell Canc Inst, Mobile, AL 36688 USA.	jiju@notes.cc.sunysb.edu		Xi, Yaguang/0000-0003-3681-9352; Ju, Jingfang/0000-0002-4821-7458	Mitchell Cancer Institute cancer genomics laboratory; NIH [CA114043]; NATIONAL CANCER INSTITUTE [R21CA114043] Funding Source: NIH RePORTER	Mitchell Cancer Institute cancer genomics laboratory; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Mitchell Cancer Institute cancer genomics laboratory start-up fund to (J. Ju) and NIH CA114043 (J. Ju). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azam N, 2001, J BIOL CHEM, V276, P2766, DOI 10.1074/jbc.M005626200; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; BAKER SJ, 1990, CANCER RES, V50, P7717; Balasov M, 2007, MOL CELL BIOL, V27, P3143, DOI 10.1128/MCB.02382-06; Chen JM, 2007, SENSORS-BASEL, V7, P2907, DOI 10.3390/S7112907; Chen ZQ, 2008, P NATL ACAD SCI USA, V105, P10326, DOI 10.1073/pnas.0803829105; Chesnokov IN, 2003, P NATL ACAD SCI USA, V100, P9150, DOI 10.1073/pnas.1633580100; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Hess P, 2002, NAT GENET, V32, P201, DOI 10.1038/ng946; Jin SQ, 2002, ONCOGENE, V21, P8696, DOI 10.1038/sj.onc.1206034; Lamb JA, 2003, MOL CELL, V11, P1479, DOI 10.1016/S1097-2765(03)00203-X; LI JJ, 1993, SCIENCE, V262, P1870, DOI 10.1126/science.8266075; Mani A, 2005, J CLIN ONCOL, V23, P4776, DOI 10.1200/JCO.2005.05.081; Prasanth SG, 2002, SCIENCE, V297, P1026, DOI 10.1126/science.1072802; Semple JW, 2006, EMBO J, V25, P5150, DOI 10.1038/sj.emboj.7601391; Siddiqui K, 2007, J BIOL CHEM, V282, P32370, DOI 10.1074/jbc.M705905200; SMITH ML, 1994, SCIENCE, V266, P1376, DOI 10.1126/science.7973727; Vairapandi M, 2000, J BIOL CHEM, V275, P16810, DOI 10.1074/jbc.275.22.16810; Wada T, 2001, J BIOL CHEM, V276, P30892, DOI 10.1074/jbc.M011780200; Wang XW, 1999, P NATL ACAD SCI USA, V96, P3706, DOI 10.1073/pnas.96.7.3706; Wilmes GM, 2004, GENE DEV, V18, P981, DOI 10.1101/gad.1202304; Xi Y, 2008, ONCOL REP, V19, P257; Xi YG, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-68; Yang JF, 2001, NAT IMMUNOL, V2, P157, DOI 10.1038/84264	24	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2008	3	12							e4054	10.1371/journal.pone.0004054	http://dx.doi.org/10.1371/journal.pone.0004054			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DI	19112505	gold, Green Published, Green Submitted			2022-12-25	WOS:000265466000015
J	Takagaki, K; Lippert, MT; Dann, B; Wanger, T; Ohl, FW				Takagaki, Kentaroh; Lippert, Michael Thomas; Dann, Benjamin; Wanger, Tim; Ohl, Frank W.			Normalization of Voltage-Sensitive Dye Signal with Functional Activity Measures	PLOS ONE			English	Article								In general, signal amplitude in optical imaging is normalized using the well-established Delta F/F method, where functional activity is divided by the total fluorescent light flux. This measure is used both directly, as a measure of population activity, and indirectly, to quantify spatial and spatiotemporal activity patterns. Despite its ubiquitous use, the stability and accuracy of this measure has not been validated for voltage-sensitive dye imaging of mammalian neocortex in vivo. In this report, we find that this normalization can introduce dynamic biases. In particular, the Delta F/F is influenced by dye staining quality, and the ratio is also unstable over the course of experiments. As methods to record and analyze optical imaging signals become more precise, such biases can have an increasingly pernicious impact on the accuracy of findings, especially in the comparison of cytoarchitechtonic areas, in area-of-activation measurements, and in plasticity or developmental experiments. These dynamic biases of the Delta F/F method may, to an extent, be mitigated by a novel method of normalization, Delta F/DFepileptiform. This normalization uses as a reference the measured activity of epileptiform spikes elicited by global disinhibition with bicuculline methiodide. Since this normalization is based on a functional measure, i.e. the signal amplitude of "hypersynchronized'' bursts of activity in the cortical network, it is less influenced by staining of non-functional elements. We demonstrate that such a functional measure can better represent the amplitude of population mass action, and discuss alternative functional normalizations based on the amplitude of synchronized spontaneous sleep-like activity. These findings demonstrate that the traditional Delta F/F normalization of voltage-sensitive dye signals can introduce pernicious inaccuracies in the quantification of neural population activity. They further suggest that normalization-independent metrics such as waveform propagation patterns, oscillations in single detectors, and phase relationships between detector pairs may better capture the biological information which is obtained by high-sensitivity imaging.	[Takagaki, Kentaroh; Lippert, Michael Thomas; Dann, Benjamin; Wanger, Tim; Ohl, Frank W.] Leibniz Inst Neurobiol, Magdeburg, Germany; [Takagaki, Kentaroh] Georgetown Univ, Sch Med, Washington, DC 20057 USA; [Lippert, Michael Thomas] Max Planck Inst Biol Cybernet, Tubingen, Germany; [Dann, Benjamin] Max Planck Inst Brain Res, Frankfurt, Germany; [Lippert, Michael Thomas; Dann, Benjamin; Wanger, Tim; Ohl, Frank W.] Otto Von Guericke Univ, Inst Biol, Magdeburg, Germany	Leibniz Institut fur Neurobiologie (LIN); Georgetown University; Max Planck Society; Max Planck Society; Otto von Guericke University	Takagaki, K (corresponding author), Leibniz Inst Neurobiol, Magdeburg, Germany.	frank.ohl@ifn-magdeburg.de	Takagaki, Kentaroh/A-9829-2009	Takagaki, Kentaroh/0000-0002-1852-529X; Dann, Benjamin/0000-0003-4332-0285	German Ministry of Science and Technology [0311891]; Bernstein Cooperation [01GQ0733]; European Community [FP6-IST-027787]	German Ministry of Science and Technology; Bernstein Cooperation; European Community(European Commission)	This work was supported by German Ministry of Science and Technology Grant BMBF BioFuture 0311891, Bernstein Cooperation Grant 01GQ0733 and European Community Grant FP6-IST-027787. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ARIELI A, 1995, J NEUROPHYSIOL, V73, P2072, DOI 10.1152/jn.1995.73.5.2072; Bai L, 2006, J NEUROPHYSIOL, V96, P2528, DOI 10.1152/jn.00645.2006; Civillico EF, 2006, J NEUROPHYSIOL, V96, P336, DOI 10.1152/jn.00128.2006; COHEN LB, 1978, ANNU REV NEUROSCI, V1, P171, DOI 10.1146/annurev.ne.01.030178.001131; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; GRINVALD A, 1994, J NEUROSCI, V14, P2545; GRINVALD A, 1984, NATURE, V308, P848, DOI 10.1038/308848a0; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; Grinvald A., 2002, OPTICAL IMAGING ELEC; Huang XY, 2004, J NEUROSCI, V24, P9897, DOI 10.1523/JNEUROSCI.2705-04.2004; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; KLEINFELD D, 1994, J NEUROPHYSIOL, V72, P1402, DOI 10.1152/jn.1994.72.3.1402; Kleinfeld D, 1996, J COMP NEUROL, V375, P89, DOI 10.1002/(SICI)1096-9861(19961104)375:1<89::AID-CNE6>3.0.CO;2-K; Lippert MT, 2007, J NEUROPHYSIOL, V98, P502, DOI 10.1152/jn.01169.2006; Ma HT, 2004, J NEUROPHYSIOL, V91, P934, DOI 10.1152/jn.00274.2003; Miyakawa N, 2003, NEUROIMAGE, V18, P622, DOI 10.1016/S1053-8119(02)00056-3; MOLOKANOVA E, 2007, QDOT NANOPARTICLE BA; Momose-Sato Y, 2001, PROG NEUROBIOL, V63, P151, DOI 10.1016/S0301-0082(00)00023-X; Obaid AL, 2004, J NEUROSCI METH, V134, P179, DOI 10.1016/j.jneumeth.2003.11.011; Patrick MJ, 2007, ORG BIOMOL CHEM, V5, P3347, DOI 10.1039/b711438a; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Petersen CCH, 2003, J NEUROSCI, V23, P1298, DOI 10.1523/JNEUROSCI.23-04-01298.2003; ROHR S, 1994, J GEN PHYSIOL, V104, P287, DOI 10.1085/jgp.104.2.287; ROHR S, 1994, BIOPHYS J, V67, P1301, DOI 10.1016/S0006-3495(94)80602-2; Roland PE, 2006, P NATL ACAD SCI USA, V103, P12586, DOI 10.1073/pnas.0604925103; Salama G, 2007, J ELECTROCARDIOL, V40, pS56, DOI 10.1016/j.jelectrocard.2007.06.021; Salzberg B.M., 1983, CURRENT METHODS CELL, V3, P139; Schwartz TH, 2001, NAT MED, V7, P1063, DOI 10.1038/nm0901-1063; Sharpee TO, 2006, NATURE, V439, P936, DOI 10.1038/nature04519; Shoham D, 1999, NEURON, V24, P791, DOI 10.1016/S0896-6273(00)81027-2; Spors H, 2006, J NEUROSCI, V26, P1247, DOI 10.1523/JNEUROSCI.3100-05.2006; Steriade M, 2004, NAT REV NEUROSCI, V5, P121, DOI 10.1038/nrn1325; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; TAKAGAKI K, 2007, NEUROSCI LE IN PRESS; Takagaki K, 2008, NEUROSCI LETT, V431, P191, DOI 10.1016/j.neulet.2007.11.069; Wu J.-Y., 1993, FLUORESCENT LUMINESC, P389; Xu WF, 2007, NEURON, V55, P119, DOI 10.1016/j.neuron.2007.06.016; Zhou WL, 2007, J NEUROSCI METH, V164, P225, DOI 10.1016/j.jneumeth.2007.05.002	39	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4041	10.1371/journal.pone.0004041	http://dx.doi.org/10.1371/journal.pone.0004041			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19116673	Green Published, Green Submitted, gold			2022-12-25	WOS:000265463000029
J	Prieto, C; Risueno, A; Fontanillo, C; De Las Rivas, J				Prieto, Carlos; Risueno, Alberto; Fontanillo, Celia; De Las Rivas, Javier			Human Gene Coexpression Landscape: Confident Network Derived from Tissue Transcriptomic Profiles	PLOS ONE			English	Article							MICROARRAY DATA; EXPRESSION; AFFYMETRIX; SENSITIVITY; ALGORITHM	Background: Analysis of gene expression data using genome-wide microarrays is a technique often used in genomic studies to find coexpression patterns and locate groups of co-transcribed genes. However, most studies done at global "omic'' scale are not focused on human samples and when they correspond to human very often include heterogeneous datasets, mixing normal with disease-altered samples. Moreover, the technical noise present in genome-wide expression microarrays is another well reported problem that many times is not addressed with robust statistical methods, and the estimation of errors in the data is not provided. Methodology/Principal Findings: Human genome-wide expression data from a controlled set of normal-healthy tissues is used to build a confident human gene coexpression network avoiding both pathological and technical noise. To achieve this we describe a new method that combines several statistical and computational strategies: robust normalization and expression signal calculation; correlation coefficients obtained by parametric and non-parametric methods; random cross-validations; and estimation of the statistical accuracy and coverage of the data. All these methods provide a series of coexpression datasets where the level of error is measured and can be tuned. To define the errors, the rates of true positives are calculated by assignment to biological pathways. The results provide a confident human gene coexpression network that includes 3327 gene-nodes and 15841 coexpression-links and a comparative analysis shows good improvement over previously published datasets. Further functional analysis of a subset core network, validated by two independent methods, shows coherent biological modules that share common transcription factors. The network reveals a map of coexpression clusters organized in well defined functional constellations. Two major regions in this network correspond to genes involved in nuclear and mitochondrial metabolism and investigations on their functional assignment indicate that more than 60% are house-keeping and essential genes. The network displays new non-described gene associations and it allows the placement in a functional context of some unknown non-assigned genes based on their interactions with known gene families. Conclusions/Significance: The identification of stable and reliable human gene to gene coexpression networks is essential to unravel the interactions and functional correlations between human genes at an omic scale. This work contributes to this aim, and we are making available for the scientific community the validated human gene coexpression networks obtained, to allow further analyses on the network or on some specific gene associations. The data are available free online at http://bioinfow.dep.usal.es/coexpression/.	[Prieto, Carlos; Risueno, Alberto; Fontanillo, Celia; De Las Rivas, Javier] USAL, CSIC, CIC IBMCC, Bioinformat & Funct Genom Res Grp,Canc Res Ctr, Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Prieto, C (corresponding author), USAL, CSIC, CIC IBMCC, Bioinformat & Funct Genom Res Grp,Canc Res Ctr, Salamanca, Spain.	jrivas@usal.es	Prieto, Carlos/G-2382-2016; De Las Rivas, Javier/G-5936-2014; 2008, Ibsal/A-1268-2012	Prieto, Carlos/0000-0001-8178-9768; De Las Rivas, Javier/0000-0002-0984-9946; Fontanillo, Celia/0000-0002-3631-7881; , Alberto/0000-0002-5544-0762	Ministery of Health, Spanish Government [PI061153]; Ministery of Education, Castilla-Leon Local Government [CSI03A06]	Ministery of Health, Spanish Government; Ministery of Education, Castilla-Leon Local Government	Funding and grant support was provided by the Ministery of Health, Spanish Government (ISCiii-FIS, MSyC; Project reference PI061153) and by the Ministery of Education, Castilla-Leon Local Government (JCyL; Project reference CSI03A06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki-Kinoshita Kiyoko F., 2007, V396, P71; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Barnes M, 2005, NUCLEIC ACIDS RES, V33, P5914, DOI 10.1093/nar/gki890; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Calza S, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm537; Chang LW, 2007, NUCLEIC ACIDS RES, V35, pW238, DOI 10.1093/nar/gkm308; Choi JK, 2005, BIOINFORMATICS, V21, P4348, DOI 10.1093/bioinformatics/bti722; Dallas PB, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-59; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Falvo JV, 2000, MOL CELL BIOL, V20, P4814, DOI 10.1128/MCB.20.13.4814-4825.2000; Griffith OL, 2005, GENOMICS, V86, P476, DOI 10.1016/j.ygeno.2005.06.009; Hsiao LL, 2001, PHYSIOL GENOMICS, V7, P97, DOI 10.1152/physiolgenomics.00040.2001; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kypriotou M, 2007, J BIOL CHEM, V282, P32000, DOI 10.1074/jbc.M705197200; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lim WK, 2007, BIOINFORMATICS, V23, pI282, DOI 10.1093/bioinformatics/btm201; Liu WM, 2002, BIOINFORMATICS, V18, P1593, DOI 10.1093/bioinformatics/18.12.1593; Loong TW, 2003, BMJ-BRIT MED J, V327, P716, DOI 10.1136/bmj.327.7417.716; Magee C, 2005, J BIOL CHEM, V280, P25331, DOI 10.1074/jbc.M412549200; Magwene PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r100; Murtagh F., 1985, MULTIDIMENSIONAL CLU; Panne D, 2004, EMBO J, V23, P4384, DOI 10.1038/sj.emboj.7600453; Poree B, 2008, J BIOL CHEM, V283, P4850, DOI 10.1074/jbc.M706387200; Prieto C, 2006, BIOINFORMATICS, V22, P1103, DOI 10.1093/bioinformatics/btl053; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Suojanen JN, 1999, NEW ENGL J MED, V341, P131, DOI 10.1056/NEJM199907083410217; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tirosh I, 2006, NAT GENET, V38, P830, DOI 10.1038/ng1819; van Noort V, 2004, EMBO REP, V5, P280, DOI 10.1038/sj.embor.7400090; Wang YH, 2007, BIOINFORMATICS, V23, P2088, DOI 10.1093/bioinformatics/btm306	33	194	200	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2008	3	12							e3911	10.1371/journal.pone.0003911	http://dx.doi.org/10.1371/journal.pone.0003911			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AP	19081792	Green Published, gold			2022-12-25	WOS:000265458200001
J	Sharkey, D; Gardner, DS; Fainberg, HP; Sebert, S; Bos, P; Wilson, V; Bell, R; Symonds, ME; Budge, H				Sharkey, Don; Gardner, David S.; Fainberg, Hernan P.; Sebert, Sylvain; Bos, Petra; Wilson, Vicky; Bell, Rhonda; Symonds, Michael E.; Budge, Helen			Maternal nutrient restriction during pregnancy differentially alters the unfolded protein response in adipose and renal tissue of obese juvenile offspring	FASEB JOURNAL			English	Article						endoplasmic reticulum; inflammation; fetus; metabolic syndrome	ENDOPLASMIC-RETICULUM STRESS; METABOLIC SYNDROME; DEVELOPMENTAL ORIGINS; MACROPHAGE INFILTRATION; GLUCOSE-HOMEOSTASIS; ADIPOCYTE DEATH; KIDNEY-DISEASE; ER STRESS; EXPRESSION; DIET	Maternal diet during pregnancy can program an offspring's risk of disease in later life. Obesity adversely alters renal and adipose tissue function, resulting in chronic kidney disease and insulin resistance, respectively, the latter associated with dysregulation of the unfolded protein response (UPR). In view of the current obesity epidemic, we explored the combined effects of in utero early-to midgestational nutrient restriction and postnatal obesity on the UPR in ovine juvenile offspring. Nutrient restriction was coincident with fetal kidney development but prior to exponential adipose tissue deposition. Nutrient restricted (NR) and normal diet (control) offspring were exposed to an obesogenic environment throughout adolescence, resulting in similar degrees of juvenile obesity. NR offspring showed enhanced adipose tissue dysregulation characterized by activation of the UPR, perturbed insulin signaling, and marked inflammation, as demonstrated by increased abundance of crownlike structures and proinflammatory genes. Conversely, in renal tissue NR offspring had marked attenuation of cellular stress and inflammation evident as reduced activation of the UPR, down-regulation of proinflammatory genes, and less histological damage. In conclusion, obesity-related activation of the UPR can be determined by the in utero nutritional environment, demonstrating organ-specific effects dependent on the developmental phase targeted within the fetus.-Sharkey, D., Gardner, D. S., Fainberg, H. P., Sebert, S., Bos, P., Wilson, V., Bell, R., Symonds, M. E., Budge, H. Maternal nutrient restriction during pregnancy differentially alters the unfolded protein response in adipose and renal tissue of obese juvenile offspring. FASEB J. 23, 1314-1324 (2009)	[Sharkey, Don; Fainberg, Hernan P.; Sebert, Sylvain; Bos, Petra; Wilson, Vicky; Symonds, Michael E.; Budge, Helen] Univ Nottingham, Inst Clin Res, Ctr Reprod & Early Life, Nottingham NG7 2RD, England; [Gardner, David S.] Univ Nottingham, Sch Vet Med & Sci, Loughborough, England; [Bell, Rhonda] Univ Alberta, Alberta Inst Human Nutr, Edmonton, AB, Canada	University of Nottingham; University of Nottingham; University of Alberta	Symonds, ME (corresponding author), Univ Hosp, Sch Clin Sci, Div Human Dev, E Floor E Block,Derby Rd, Nottingham NG7 2UH, England.	michael.symonds@nottingham.ac.uk	Gardner, David S/A-7484-2010; Fainberg, Hernan P/A-2449-2012; Fainberg, Hernan/GQZ-6651-2022	Gardner, David S/0000-0002-6490-2412; Sebert, Sylvain/0000-0001-6681-6983; Sharkey, Don/0000-0002-4989-8697; Fainberg, Hernan Pablo/0000-0001-9330-9047; Symonds, Michael/0000-0001-9649-8963; Bell, Rhonda C./0000-0002-4298-9641	British Heart Foundation [FS/05/098/19942, BS/03/01]; European Union Sixth Framework for Research and Technical Development of the European Community [FOOD-CT-2005-007036]; National Institute for Health Research [CL-2006-12-003] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); European Union Sixth Framework for Research and Technical Development of the European Community(European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was support by a British Heart Foundation clinical fellowship (D. S., FS/05/098/19942) and lectureship (D. S. G., BS/03/01) and the European Union Sixth Framework for Research and Technical Development of the European Community, the Early Nutrition Programming Project (FOOD-CT-2005-007036).	Alderman G., 1993, ENERGY PROTEIN REQUI; Bedard K, 2004, BASIC CLIN PHARMACOL, V94, P124, DOI 10.1111/j.1742-7843.2004.pto940305.x; Boden G, 2008, DIABETES, V57, P2438, DOI 10.2337/db08-0604; Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392; Cameron AJ, 2004, ENDOCRIN METAB CLIN, V33, P351, DOI 10.1016/j.ecl.2004.03.005; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Dunphy J, 2001, VET IMMUNOL IMMUNOP, V82, P153, DOI 10.1016/S0165-2427(01)00356-7; Eckersall PD, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-1; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gopalakrishnan GS, 2005, BRIT J NUTR, V94, P938, DOI 10.1079/BJN20051559; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; Hall JE, 1999, ANN NY ACAD SCI, V892, P91, DOI 10.1111/j.1749-6632.1999.tb07788.x; Harman-Boehm I, 2007, J CLIN ENDOCR METAB, V92, P2240, DOI 10.1210/jc.2006-1811; Henegar JR, 2001, J AM SOC NEPHROL, V12, P1211, DOI 10.1681/ASN.V1261211; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Inagi R, 2005, KIDNEY INT, V68, P2639, DOI 10.1111/j.1523-1755.2005.00736.x; Inagi R, 2008, J AM SOC NEPHROL, V19, P915, DOI 10.1681/ASN.2007070745; Ingelfinger JR, 2005, J AM SOC NEPHROL, V16, P2533, DOI 10.1681/ASN.2005060622; Johann AM, 2007, FASEB J, V21, P2704, DOI 10.1096/fj.06-7815com; Kaaman M, 2007, DIABETOLOGIA, V50, P2526, DOI 10.1007/s00125-007-0818-6; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kelishadi R, 2007, CLIN CHEM, V53, P456, DOI 10.1373/clinchem.2006.073668; KELLY T, 2008, INT J OBES IN PRESS; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Koh EH, 2007, DIABETES, V56, P2973, DOI 10.2337/db07-0510; Lomax MA, 2007, ENDOCRINOLOGY, V148, P461, DOI 10.1210/en.2006-0918; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Moritz KM, 2003, BIOESSAYS, V25, P212, DOI 10.1002/bies.10240; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ozanne SE, 2007, NAT CLIN PRACT ENDOC, V3, P539, DOI 10.1038/ncpendmet0531; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pan Y, 2008, J AM DIET ASSOC, V108, P276, DOI 10.1016/j.jada.2007.10.049; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plisov SY, 2000, GENESIS, V27, P22, DOI 10.1002/1526-968X(200005)27:1<22::AID-GENE40>3.3.CO;2-M; SEBERT SP, 2008, ENDOCRINOLO IN PRESS; Serra A, 2008, KIDNEY INT, V73, P947, DOI 10.1038/sj.ki.5002796; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Symonds ME, 2003, J ENDOCRINOL, V179, P293, DOI 10.1677/joe.0.1790293; Taylor PD, 2005, AM J PHYSIOL-REG I, V288, pR134, DOI 10.1152/ajpregu.00355.2004; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Westerbacka J, 2008, AM J PHYSIOL-ENDOC M, V294, pE841, DOI 10.1152/ajpendo.00653.2006; Williams PJ, 2007, KIDNEY INT, V72, P279, DOI 10.1038/sj.ki.5002276; Wood CE, 2005, AM J PHYSIOL-REG I, V289, pR613, DOI 10.1152/ajpregu.00722.2004; Zandi-Nejad K, 2006, HYPERTENSION, V47, P502, DOI 10.1161/01.HYP.0000198544.09909.1a; Zhao LH, 2006, CURR OPIN CELL BIOL, V18, P444, DOI 10.1016/j.ceb.2006.06.005	49	38	39	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2009	23	5					1314	1324		10.1096/fj.08-114330	http://dx.doi.org/10.1096/fj.08-114330			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZP	19103646				2022-12-25	WOS:000266651700008
J	Chandler, RJ; Zerfas, PM; Shanske, S; Sloan, J; Hoffmann, V; DiMauro, S; Venditti, CP				Chandler, Randy J.; Zerfas, Patricia M.; Shanske, Sara; Sloan, Jennifer; Hoffmann, Victoria; DiMauro, Salvatore; Venditti, Charles P.			Mitochondrial dysfunction in mut methylmalonic acidemia	FASEB JOURNAL			English	Article						methylmalonyl-CoA mutase; cytochrome c oxidase; glutathione; oxidant stress; vitamin B12	LIVER-KIDNEY TRANSPLANTATION; RESPIRATORY-CHAIN; ORGANIC ACIDEMIAS; GLOBUS-PALLIDUS; KNOCKOUT MICE; INBORN ERROR; ACIDURIA; DEFICIENCY; METABOLISM; MANAGEMENT	Methylmalonic acidemia is an autosomal recessive inborn error of metabolism caused by defective activity of methylmalonyl-CoA mutase (MUT) that exhibits multiorgan system pathology. To examine whether mitochondrial dysfunction is a feature of this organic acidemia, a background-modified Mut-knockout mouse model was constructed and used to examine mitochondrial ultrastructure and respiratory chain function in the tissues that manifest pathology in humans. In parallel, the liver from a patient with mut methylmalonic acidemia was studied in a similar fashion. Megamitochondria formed early in life in the hepatocytes of the Mut(-/-) animals and progressively enlarged. Liver extracts prepared from the mutants at multiple time points displayed respiratory chain dysfunction, with diminished cytochrome c oxidase activity and reduced intracellular glutathione compared to control littermates. Over time, the exocrine pancreas and proximal tubules of the kidney also exhibited megamitochondria, and older mutant mice eventually developed tubulointerstitial renal disease. The patient liver displayed similar morphological and enzymatic findings as observed in the murine tissues. These murine and human studies establish that megamitochondria formation with respiratory chain dysfunction occur in a tissue-specific fashion in methylmalonic acidemia and suggest treatment approaches based on improving mitochondrial function and ameliorating the effects of oxidative stress.-Chandler, R. J., Zerfas, P. M., Shanske, S., Sloan, J., Hoffmann, V., DiMauro, S., Venditti, C. P. Mitochondrial dysfunction in mut methylmalonic acidemia. FASEB J. 23, 1252-1261 (2009)	[Chandler, Randy J.; Sloan, Jennifer; Venditti, Charles P.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA; [Zerfas, Patricia M.; Hoffmann, Victoria] NIH, Div Vet Resources, Off Res Serv, Bethesda, MD 20892 USA; [Shanske, Sara; DiMauro, Salvatore] Columbia Univ, Dept Neurol, Med Ctr, New York, NY USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; Columbia University	Venditti, CP (corresponding author), NHGRI, Genet Dis Res Branch, NIH, Bldg 49 Rm 4A62A, Bethesda, MD 20892 USA.	venditti@mail.nih.gov	Chandler, Randy Joseph/Y-1164-2019	Chandler, Randy Joseph/0000-0002-6047-5230	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD032062] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200318] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 HG200318-04, Z99 HG999999, Z01 HG200318-05] Funding Source: Medline; NICHD NIH HHS [HD32062, P01 HD032062] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALLEN RH, 1993, METABOLISM, V42, P978, DOI 10.1016/0026-0495(93)90010-L; ANDO T, 1972, P NATL ACAD SCI USA, V69, P2807, DOI 10.1073/pnas.69.10.2807; BAUMGARTER ER, 1995, J INHERIT METAB DIS, V18, P138, DOI 10.1007/BF00711749; BRASS EP, 1990, BIOCHEM J, V266, P809; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Chandler RJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-64; Chandler RJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-24; Chandler RJ, 2008, HUM GENE THER, V19, P53, DOI 10.1089/hum.2007.0118; de Baulny HO, 2005, J INHERIT METAB DIS, V28, P415, DOI 10.1007/s10545-005-7056-1; DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409; Dionisi-Vici C, 2006, J INHERIT METAB DIS, V29, P383, DOI 10.1007/s10545-006-0278-z; Fenton WA, 2001, METABOLIC MOL BASES, P2165; FENTON WA, 2001, METABOLIC MOL BASES, P3897; HAYASAKA K, 1982, TOHOKU J EXP MED, V137, P329, DOI 10.1620/tjem.137.329; HEIDENREICH R, 1988, J PEDIATR-US, V113, P1022, DOI 10.1016/S0022-3476(88)80574-2; Horster F, 2007, PEDIATR RES, V62, P225; KAHLER SG, 1994, J PEDIATR-US, V124, P239, DOI 10.1016/S0022-3476(94)70311-6; Kaplan P, 2006, MOL GENET METAB, V88, P322, DOI 10.1016/j.ymgme.2006.04.003; Kokoszka JE, 2001, P NATL ACAD SCI USA, V98, P2278, DOI 10.1073/pnas.051627098; Kolker S, 2003, J BIOL CHEM, V278, P47388, DOI 10.1074/jbc.M308861200; KORF B, 1986, ANN NEUROL, V20, P364, DOI 10.1002/ana.410200317; KRAHENBUHL S, 1990, J CLIN INVEST, V86, P2054, DOI 10.1172/JCI114942; KRAHENBUHL S, 1991, J BIOL CHEM, V266, P20998; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; Leonard JV, 2001, J INHERIT METAB DIS, V24, P309, DOI 10.1023/A:1010395724012; Li H, 2000, P NATL ACAD SCI USA, V97, P3467, DOI 10.1073/pnas.97.7.3467; LINDBLAD B, 1968, ACTA PAEDIATR SCAND, V57, P417, DOI 10.1111/j.1651-2227.1968.tb07314.x; MATSUI SM, 1983, NEW ENGL J MED, V308, P857, DOI 10.1056/NEJM198304143081501; MORROW G, 1969, J PEDIATR, V74, P680, DOI 10.1016/S0022-3476(69)80130-7; Nadeau JH, 2001, NAT REV GENET, V2, P165, DOI 10.1038/35056009; Nagarajan S, 2005, J INHERIT METAB DIS, V28, P517, DOI 10.1007/s10545-005-0517-8; Nicolaides P, 1998, ARCH DIS CHILD, V78, P508, DOI 10.1136/adc.78.6.508; OBERHOLZ.VG, 1967, ARCH DIS CHILD, V42, P492, DOI 10.1136/adc.42.225.492; Okun JG, 2002, J BIOL CHEM, V277, P14674, DOI 10.1074/jbc.M200997200; Peters H, 2003, J BIOL CHEM, V278, P52909, DOI 10.1074/jbc.M310533200; Pettenuzzo LF, 2006, INT J DEV NEUROSCI, V24, P45, DOI 10.1016/j.ijdevneu.2005.10.005; Richard E, 2007, J PATHOL, V213, P453, DOI 10.1002/path.2248; Spinazzola A, 2007, BIOSCIENCE REP, V27, P39, DOI 10.1007/s10540-007-9036-1; STABLER SP, 1991, J CLIN INVEST, V87, P1422, DOI 10.1172/JCI115148; STOKKE O, 1967, SCAND J CLIN LAB INV, V20, P313, DOI 10.3109/00365516709076961; TANDLER B, 1991, ANAT RECORD, V231, P1, DOI 10.1002/ar.1092310102; Treacy E, 1996, J PEDIATR-US, V129, P445, DOI 10.1016/S0022-3476(96)70080-X; van't Hoff WG, 1998, J PEDIATR-US, V132, P1043, DOI 10.1016/S0022-3476(98)70407-X; VANDERMEER SB, 1994, J PEDIATR-US, V125, P903, DOI 10.1016/S0022-3476(05)82005-0; Wakabayashi T, 2002, J CELL MOL MED, V6, P497, DOI 10.1111/j.1582-4934.2002.tb00452.x; WALTER JH, 1989, EUR J PEDIATR, V148, P344, DOI 10.1007/BF00444131; Williams MD, 1998, J BIOL CHEM, V273, P28510, DOI 10.1074/jbc.273.43.28510	47	130	132	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2009	23	4					1252	1261		10.1096/fj.08-121848	http://dx.doi.org/10.1096/fj.08-121848			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZO	19088183	Green Published			2022-12-25	WOS:000266651600029
J	Thompson, JL; Mignen, O; Shuttleworth, TJ				Thompson, Jill L.; Mignen, Olivier; Shuttleworth, Trevor J.			The Orai1 Severe Combined Immune Deficiency Mutation and Calcium Release-activated Ca2+ Channel Function in the Heterozygous Condition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-SELECTIVE ARC CHANNELS; CRAC CHANNEL; STORE DEPLETION; PLASMA-MEMBRANE; T-LYMPHOCYTES; MIC CHANNELS; STIM1; IMMUNODEFICIENCY; INFLUX; SENSOR	Homozygous expression of Orai1 bearing the R91W mutation results in the complete abrogation of currents through the store-operated Ca2+ release-activated Ca2+ (CRAC) channels, resulting in a form of hereditary severe combined immune deficiency(SCID) syndrome (Feske, S., Gwack, Y., Prakriya, M., Srikanth, S., Puppel, S. H., Tanasa, B., Hogan, P. G., Lewis, R. S., Daly, M., and Rao, A. (2006) Nature 441, 179-185). Although heterozygous carriers of the mutation show no clinical symptoms of immunodeficiency, store-operated Ca2+ entry in their T cells is impaired, suggesting a gene-dosage effect of the mutation. We have recently demonstrated that the functional CRAC channel pore is composed of a tetrameric assembly of Orai1 subunits (Mignen, O., Thompson, J. L., and Shuttleworth, T. J. (2008) J. Physiol. 586, 419-425). Therefore, to directly quantify the effect of the SCID mutant in the heterozygous situation, we generated a series of concatenated tetramers of Orai1 that included different numbers and arrangements of the R91W Orai1 subunits. The data obtained show that inclusion of increasing numbers of mutant subunits results in a graded reduction in CRAC channel currents and that this effect is independent of the spatial arrangement or order of the mutant subunits in the tetramer. Macroscopic biophysical properties of the channels were unchanged by inclusion of the mutant subunits, although the rate at which the current activates on store depletion was slowed. We conclude that incorporation of R91W mutant Orai1 subunits in the CRAC channel pore affects the overall magnitude of its conductance and that this effect is related solely to the number of mutant subunits incorporated. Predictions based on the tetrameric channel structure indicate that the graded effect of incorporation of SCID mutant subunits into such an assembly is quantitatively consistent with the previously demonstrated impaired effects on Ca2+ entry recorded in the heterozygous carriers.	[Thompson, Jill L.; Mignen, Olivier; Shuttleworth, Trevor J.] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Mignen, Olivier] Univ Paris Sud, Hop Marie Lannelongue, CNRS, UMR 8062, F-92350 Le Plessis Robinson, France	University of Rochester; Centre National de la Recherche Scientifique (CNRS); Hopital Marie Lannelongue; UDICE-French Research Universities; Universite Paris Saclay	Shuttleworth, TJ (corresponding author), Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, 601 Elmwood Ave, Rochester, NY 14642 USA.	trevor_shuttleworth@urmc.rochester.edu	MIGNEN, Olivier/M-3258-2019	MIGNEN, Olivier/0000-0001-7913-6119	National Institutes of Health [GM040457]; Alfred and Eleanor Wedd Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040457] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred and Eleanor Wedd Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM040457 (to T. J. S.).; Supported in part by funds from the Alfred and Eleanor Wedd Endowment.	Feske S, 1996, EUR J IMMUNOL, V26, P2119, DOI 10.1002/eji.1830260924; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2005, J EXP MED, V202, P651, DOI 10.1084/jem.20050687; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Hermosura MC, 2002, J PHYSIOL-LONDON, V539, P445, DOI 10.1113/jphysiol.2001.013361; Ji W, 2008, P NATL ACAD SCI USA, V105, P13668, DOI 10.1073/pnas.0806499105; Kozak JA, 2002, J GEN PHYSIOL, V120, P221, DOI 10.1085/jgp.20028601; LEDEIST F, 1995, BLOOD, V85, P1053, DOI 10.1182/blood.V85.4.1053.bloodjournal8541053; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liao Y, 2007, P NATL ACAD SCI USA, V104, P4682, DOI 10.1073/pnas.0611692104; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Mignen O, 2000, J BIOL CHEM, V275, P9114, DOI 10.1074/jbc.275.13.9114; Mignen O, 2008, J PHYSIOL-LONDON, V586, P185, DOI 10.1113/jphysiol.2007.146258; Mignen O, 2008, J PHYSIOL-LONDON, V586, P419, DOI 10.1113/jphysiol.2007.147249; Mignen O, 2007, J PHYSIOL-LONDON, V579, P703, DOI 10.1113/jphysiol.2006.122432; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Navarro-Borelly L, 2008, J PHYSIOL-LONDON, V586, P5383, DOI 10.1113/jphysiol.2008.162503; PARTISETI M, 1994, J BIOL CHEM, V269, P32327; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Prakriya M, 2002, J GEN PHYSIOL, V119, P487, DOI 10.1085/jgp.20028551; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; ZWEIFACH A, 1995, J GEN PHYSIOL, V105, P209, DOI 10.1085/jgp.105.2.209	35	34	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6620	6626		10.1074/jbc.M808346200	http://dx.doi.org/10.1074/jbc.M808346200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19075015	Green Published, hybrid			2022-12-25	WOS:000263919000006
J	Tsai, AG; Engelhart, AE; Hatmal, MM; Houston, SI; Hud, NV; Haworth, IS; Lieber, MR				Tsai, Albert G.; Engelhart, Aaron E.; Hatmal, Ma'mon M.; Houston, Sabrina I.; Hud, Nicholas V.; Haworth, Ian S.; Lieber, Michael R.			Conformational Variants of Duplex DNA Correlated with Cytosine-rich Chromosomal Fragile Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR BREAKPOINT REGION; B-DNA; RAG COMPLEX; CRYSTALLOGRAPHIC MAP; A-DNA; BISULFITE; MOTIFS; TRANSLOCATIONS; ELECTROSTATICS; DEAMINATION	We found that several major chromosomal fragile sites in human lymphomas, including the bcl-2 major breakpoint region, bcl-1 major translocation cluster, and c-Myc exon 1-intron 1 boundary, contain distinctive sequences of consecutive cytosines exhibiting a high degree of reactivity with the structure-specific chemical probe bisulfite. To assess the inherent structural variability of duplex DNA in these regions and to determine the range of structures reactive to bisulfite, we have performed bisulfite probing on genomic DNA in vitro and in situ; on duplex DNA in supercoiled and linearized plasmids; and on oligonucleotide DNA/DNA and DNA/2'-O-methyl RNA duplexes. Bisulfite is significantly more reactive at the frayed ends of DNA duplexes, which is expected given that bisulfite is an established probe of single-stranded DNA. We observed that bisulfite also distinguishes between more subtle sequence/structural differences in duplex DNA. Supercoiled plasmids are more reactive than linear DNA; and sequences containing consecutive cytosines, namely GGGCCC, are more reactive than those with alternating guanine and cytosine, namely GCGCGC. Circular dichroism and x-ray crystallography show that the GGGCCC sequence forms an intermediate B/A structure. Molecular dynamics simulations also predict an intermediate B/A structure for this sequence, and probe calculations suggest greater bisulfite accessibility of cytosine bases in the intermediate B/A structure over canonical B- or A-form DNA. Electrostatic calculations reveal that consecutive cytosine bases create electropositive patches in the major groove, predicting enhanced localization of the bisulfite anion at homo-C tracts over alternating G/C sequences. These characteristics of homo-C tracts in duplex DNA may be associated with DNA-protein interactions in vivo that predispose certain genomic regions to chromosomal fragility.	[Engelhart, Aaron E.; Hud, Nicholas V.] Georgia Inst Technol, Dept Chem & Biochem, Atlanta, GA 30332 USA; [Lieber, Michael R.] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Dept Pathol, Los Angeles, CA 90089 USA; [Tsai, Albert G.; Hatmal, Ma'mon M.; Houston, Sabrina I.; Haworth, Ian S.; Lieber, Michael R.] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Dept Biochem, Los Angeles, CA 90089 USA; [Hatmal, Ma'mon M.; Haworth, Ian S.] Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA	University System of Georgia; Georgia Institute of Technology; University of Southern California; University of Southern California; University of Southern California	Hud, NV (corresponding author), Georgia Inst Technol, Dept Chem & Biochem, Atlanta, GA 30332 USA.	hud@chemistry.gatech.edu; ihaworth@usc.edu; lieber@usc.edu	Hud, Nicholas V/T-7017-2017; Hatmal, Ma'mon M./AAF-7164-2020	Lieber, Michael/0000-0003-3700-6345; Hud, Nicholas/0000-0001-7711-6472; Tsai, Albert/0000-0002-6607-3347; Engelhart, Aaron/0000-0002-1849-7700; M. Hatmal, Ma'mon/0000-0003-1745-8985; Lieber, Michael/0000-0001-8809-0909	National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health grants (to M. R. L. and N. V. H. laboratories). The costs of publication of this article were defrayed in part by the payment of page charges.	Abeysinghe SS, 2003, HUM MUTAT, V22, P229, DOI 10.1002/humu.10254; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bertoni F, 2004, BRIT J HAEMATOL, V124, P130, DOI 10.1046/j.1365-2141.2003.04761.x; Busch K, 2007, LEUKEMIA, V21, P1739, DOI 10.1038/sj.leu.2404753; Calladine C. R., 2004, UNDERSTANDING DNA MO; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dornberger U, 1999, J BIOL CHEM, V274, P6957, DOI 10.1074/jbc.274.11.6957; GOUGH GW, 1986, EMBO J, V5, P191, DOI 10.1002/j.1460-2075.1986.tb04195.x; Greenbaum JA, 2007, GENOME RES, V17, P940, DOI 10.1101/gr.5602807; Hays FA, 2005, P NATL ACAD SCI USA, V102, P7157, DOI 10.1073/pnas.0409455102; Hud NV, 2003, BIOPOLYMERS, V69, P144, DOI 10.1002/bip.10364; HUMPHREY W, 1996, J MOL GRAPHICS, V14, P27, DOI DOI 10.1016/0263-7855(96)00018-5; Lamm G, 2003, REV COMP CH, V19, P147, DOI 10.1002/0471466638.ch4; LAVERY R, 1988, J BIOMOL STRUCT DYN, V6, P63, DOI 10.1080/07391102.1988.10506483; Lu XJ, 2000, J MOL BIOL, V300, P819, DOI 10.1006/jmbi.2000.3690; Ma YM, 2005, DNA REPAIR, V4, P845, DOI 10.1016/j.dnarep.2005.04.013; Mirkin SM, 2006, CURR OPIN STRUC BIOL, V16, P351, DOI 10.1016/j.sbi.2006.05.004; Ng HL, 2000, P NATL ACAD SCI USA, V97, P2035, DOI 10.1073/pnas.040571197; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Raghavan SC, 2007, DNA REPAIR, V6, P751, DOI 10.1016/j.dnarep.2006.12.016; Raghavan SC, 2005, MOL CELL BIOL, V25, P5904, DOI 10.1128/MCB.25.14.5904-5919.2005; Raghavan SC, 2004, NATURE, V428, P88, DOI 10.1038/nature02355; RAIZIS AM, 1995, ANAL BIOCHEM, V226, P161, DOI 10.1006/abio.1995.1204; Saenger W., 1984, PRINCIPLES NUCL ACID; SHAPIRO R, 1974, J AM CHEM SOC, V96, P906, DOI 10.1021/ja00810a043; SINDEN R. R., 1994, DNA STRUCTURE FUNCTI; SONO M, 1973, J AM CHEM SOC, V95, P4745, DOI 10.1021/ja00795a044; Svozil D, 2008, NUCLEIC ACIDS RES, V36, P3690, DOI 10.1093/nar/gkn260; Vargason JM, 2001, P NATL ACAD SCI USA, V98, P7265, DOI 10.1073/pnas.121176898; Wahl MC, 1997, BIOPOLYMERS, V44, P45, DOI 10.1002/(SICI)1097-0282(1997)44:1<45::AID-BIP4>3.0.CO;2-#; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919	33	34	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7157	7164		10.1074/jbc.M806866200	http://dx.doi.org/10.1074/jbc.M806866200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19106104	Green Published, hybrid			2022-12-25	WOS:000263919000063
J	Deshpande, AM; Dai, YS; Kim, Y; Kim, J; Kimlin, L; Gao, K; Wong, DT				Deshpande, Amit M.; Dai, Yan-Shan; Kim, Yong; Kim, Jeffrey; Kimlin, Lauren; Gao, Kai; Wong, David T.			Cdk2ap1 Is Required for Epigenetic Silencing of Oct4 during Murine Embryonic Stem Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKEMIA INHIBITORY FACTOR; TUMOR-SUPPRESSOR GENE; SELF-RENEWAL; DNA METHYLATION; MOUSE EMBRYO; PLURIPOTENCY; EXPRESSION; NURD; COMPONENT; NETWORK	Oct4 is a known master regulator of stem cell renewal and differentiation. Expression of Oct4 during differentiation is regulated by promoter methylation by the nucleosome remodeling and histone deacetylation (NuRD) complex. Here, we show that Cdk2ap1, a negative regulator of Cdk2 function and cell cycle, promotes Oct4 promoter methylation during murine embryonic stem cell differentiation to down-regulate Oct4 expression. We further show that this repressor function of Cdk2ap1 is dependent on its physical interaction with the methyl DNA-binding protein, Mbd3. Our data support a potential molecular link between the known differentiation promoters, including bone morphogenetic proteins and transforming growth factor signaling, and embryonic stem cell differentiation.	[Deshpande, Amit M.; Dai, Yan-Shan; Kim, Yong; Kim, Jeffrey; Kimlin, Lauren; Gao, Kai; Wong, David T.] Univ Calif Los Angeles, Sch Dent, Dent Res Inst, Los Angeles, CA 90025 USA	University of California System; University of California Los Angeles	Deshpande, AM (corresponding author), 10833 Conte Ave,CHS 73-017, Los Angeles, CA 90095 USA.	adeshpan@ucla.edu; dtww@ucla.edu	Dai, Yanshan/B-8577-2009; Kumar, Rajesh/E-7957-2010	Dai, Yanshan/0000-0001-5048-7417	National Institutes of Health [DE014857]; National Institutes of Health T32 grant [DE07296]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007296, R01DE014857] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health T32 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant DE014857 and by a National Institutes of Health T32 grant ( Grant DE07296 to Y. K.).	Buitrago W, 2007, J INVEST DERMATOL, V127, P260, DOI 10.1038/sj.jid.5700654; Chambers I, 2004, CLONING STEM CELLS, V6, P386, DOI 10.1089/clo.2004.6.386; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Crook JM, 2006, NAT CELL BIOL, V8, P212, DOI 10.1038/ncb0306-212; Deb-Rinker P, 2005, J BIOL CHEM, V280, P6257, DOI 10.1074/jbc.C400479200; Di-Gregorio A, 2007, DEVELOPMENT, V134, P3359, DOI 10.1242/dev.005967; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; GOUGH NM, 1989, CANCER CELL-MON REV, V1, P77; GOUGH NM, 1989, REPROD FERT DEVELOP, V1, P281, DOI 10.1071/RD9890281; Gu PL, 2006, MOL CELL BIOL, V26, P9471, DOI 10.1128/MCB.00898-06; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Hu MG, 2004, CANCER RES, V64, P490, DOI 10.1158/0008-5472.CAN-03-2284; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kaji K, 2007, DEVELOPMENT, V134, P1123, DOI 10.1242/dev.02802; Kim Y, 2005, ONCOGENE, V24, P407, DOI 10.1038/sj.onc.1208222; Lan ZJ, 2002, J BIOL CHEM, V277, P50660, DOI 10.1074/jbc.M209586200; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Mullen EM, 2007, PPAR RES, V2007, DOI 10.1155/2007/61563; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Ogawa K, 2007, J CELL SCI, V120, P55, DOI 10.1242/jcs.03296; Ovitt CE, 1998, MOL HUM REPROD, V4, P1021, DOI 10.1093/molehr/4.11.1021; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Rao M, 2004, DEV BIOL, V275, P269, DOI 10.1016/j.ydbio.2004.08.013; Rao S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-230; Shintani S, 2000, MOL CELL BIOL, V20, P6300, DOI 10.1128/MCB.20.17.6300-6307.2000; Siegfried Z, 1999, NAT GENET, V22, P203, DOI 10.1038/9727; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Temple S, 2003, CELL, V115, P247, DOI 10.1016/S0092-8674(03)00853-5; TODD R, 1995, FASEB J, V9, P1362, DOI 10.1096/fasebj.9.13.7557027; Tsuji T, 1998, J BIOL CHEM, V273, P6704, DOI 10.1074/jbc.273.12.6704; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Watabe Tetsuro, 2006, V330, P341; Watson CM, 2001, CELL STRUCT FUNCT, V26, P123; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhang JW, 2005, DEV BIOL, V284, P1, DOI 10.1016/j.ydbio.2005.05.009	38	31	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6043	6047		10.1074/jbc.C800158200	http://dx.doi.org/10.1074/jbc.C800158200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19117947	Green Published, hybrid			2022-12-25	WOS:000263742700005
J	Liu, Y; Veena, CK; Morgan, JB; Mohammed, KA; Jekabsons, MB; Nagle, DG; Zhou, YD				Liu, Yang; Veena, Coothan K.; Morgan, J. Brian; Mohammed, Kaleem A.; Jekabsons, Mika B.; Nagle, Dale G.; Zhou, Yu-Dong			Methylalpinumisoflavone Inhibits Hypoxia-inducible Factor-1 (HIF-1) Activation by Simultaneously Targeting Multiple Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITORS; MITOCHONDRIAL COMPLEX-III; FACTOR 1-ALPHA; PROTEIN-KINASE; IDENTIFICATION; CANCER; FACTOR-1-ALPHA; HIF-1-ALPHA; ALPHA; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA	Hypoxia is a common feature of solid tumors, and the extent of tumor hypoxia correlates with advanced disease stages and treatment resistance. The transcription factor hypoxia-inducible factor-1 (HIF-1) represents an important tumor-selective molecular target for anticancer drug discovery directed at tumor hypoxia. A natural product chemistry-based approach was employed to discover small molecule inhibitors of HIF-1. Bioassay-guided isolation of an active lipid extract of the tropical legumaceous plant Lonchocarpus glabrescens and structure elucidation afforded two new HIF-1 inhibitors: alpinumisoflavone (compound 1) and 4'-O-methylalpinumisoflavone (compound 2). In human breast tumor T47D cells, compounds 1 and 2 inhibited hypoxia-induced HIF-1 activation with IC50 values of 5 and 0.6 mu M, respectively. At the concentrations that inhibited HIF-1 activation, compound 2 inhibited hypoxic induction of HIF-1 target genes (CDKN1A, GLUT-1, and VEGF), tumor angiogenesis in vitro, cell migration, and chemotaxis. Compound 2 inhibits HIF-1 activation by blocking the induction of nuclear HIF-1 alpha protein, the oxygen-regulated subunit that controls HIF-1 activity. Mechanistic studies indicate that, unlike rotenone and other mitochondrial inhibitors, compound 2 represents the first small molecule that inhibits HIF-1 activation by simultaneously suppressing mitochondrial respiration and disrupting protein translation in vitro. This unique mechanism distinguishes compound 2 from other small molecule HIF-1 inhibitors that are simple mitochondrial inhibitors or flavanoid-based protein kinase inhibitors.	[Liu, Yang; Veena, Coothan K.; Morgan, J. Brian; Mohammed, Kaleem A.; Nagle, Dale G.; Zhou, Yu-Dong] Univ Mississippi, Dept Pharmacognosy, University, MS 38677 USA; [Nagle, Dale G.] Univ Mississippi, Res Inst Pharmaceut Sci, Sch Pharm, University, MS 38677 USA; [Jekabsons, Mika B.] Univ Mississippi, Dept Biol, University, MS 38677 USA	University of Mississippi; University of Mississippi; University of Mississippi	Nagle, DG (corresponding author), Univ Mississippi, Dept Pharmacognosy, University, MS 38677 USA.	dnagle@olemiss.edu; ydzhou@olemiss.edu	Liu, Yang/G-7780-2011	Nagle, Dale/0000-0001-7883-2673; Liu, Yang/0000-0002-0413-5637	National Institutes of Health [CA98787 and P20RR021929]; National Institutes of Health Research Facilities Improvement [C06 RR-14503-01]; National Oceanic and Atmospheric Administration/National Institute of Undersea Science and Technology [NA16RU1496]; NATIONAL CANCER INSTITUTE [R56CA098787, R01CA098787] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR014503, P20RR021929] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Research Facilities Improvement(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Oceanic and Atmospheric Administration/National Institute of Undersea Science and Technology(National Oceanic Atmospheric Admin (NOAA) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants CA98787 and P20RR021929 and conducted in a facility constructed with National Institutes of Health Research Facilities Improvement Grant C06 RR-14503-01. This work was also supported by National Oceanic and Atmospheric Administration/National Institute of Undersea Science and Technology Grant NA16RU1496.	Bell EL, 2007, J CELL BIOL, V177, P1029, DOI 10.1083/jcb.200609074; Birner P, 2000, CANCER RES, V60, P4693; Bos R, 2001, JNCI-J NATL CANCER I, V93, P309, DOI 10.1093/jnci/93.4.309; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chau NM, 2005, CANCER RES, V65, P4918, DOI 10.1158/0008-5472.CAN-04-4453; Dewhirst MW, 1998, SEMIN RADIAT ONCOL, V8, P143, DOI 10.1016/S1053-4296(98)80040-4; Fang NB, 1999, J AGR FOOD CHEM, V47, P2130, DOI 10.1021/jf981188x; Gong YQ, 2005, AM J PHYSIOL-CELL PH, V288, pC1023, DOI 10.1152/ajpcell.00443.2004; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Han XH, 2005, ARCH PHARM RES, V28, P1324, DOI 10.1007/BF02977895; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hodges TW, 2004, J NAT PROD, V67, P767, DOI 10.1021/np030514m; Hossain CF, 2005, BIOCHEM BIOPH RES CO, V333, P1026, DOI 10.1016/j.bbrc.2005.05.191; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; JACKSON B, 1971, J CHEM SOC C, P3389, DOI 10.1039/j39710003389; Jones DT, 2006, MOL CANCER THER, V5, P2193, DOI 10.1158/1535-7163.MCT-05-0443; Kingsford-Adaboh R, 2006, ACTA CRYSTALLOGR B, V62, P843, DOI 10.1107/S0108768106019616; Kong DH, 2005, CANCER RES, V65, P9047, DOI 10.1158/0008-5472.CAN-05-1235; Kung AL, 2004, CANCER CELL, V6, P33, DOI 10.1016/j.ccr.2004.06.009; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Le QT, 2004, CANCER METAST REV, V23, P293, DOI 10.1023/B:CANC.0000031768.89246.d7; Liao D, 2007, CANCER RES, V67, P563, DOI 10.1158/0008-5472.CAN-06-2701; Lin X, 2008, P NATL ACAD SCI USA, V105, P174, DOI 10.1073/pnas.0706585104; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Moeller BJ, 2005, CANCER CELL, V8, P99, DOI 10.1016/j.ccr.2005.06.016; Na M, 2006, J NAT PROD, V69, P1572, DOI 10.1021/np0601861; Nagle DG, 2006, CURR DRUG TARGETS, V7, P355, DOI 10.2174/138945006776054979; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Pan Y, 2007, MOL CELL BIOL, V27, P912, DOI 10.1128/MCB.01223-06; Rapisarda A, 2002, CANCER RES, V62, P4316; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Rucci N, 2008, ANTI-CANCER AGENT ME, V8, P342, DOI 10.2174/187152008783961905; Ryan HE, 2000, CANCER RES, V60, P4010; Schroedl C, 2002, AM J PHYSIOL-LUNG C, V283, pL922, DOI 10.1152/ajplung.00014.2002; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2007, DRUG DISCOV TODAY, V12, P853, DOI 10.1016/j.drudis.2007.08.006; Simon MC, 2006, ADV EXP MED BIOL, V588, P165; Tan C, 2005, CANCER RES, V65, P605; Tatum JL, 2006, INT J RADIAT BIOL, V82, P699, DOI 10.1080/09553000601002324; Unruh A, 2003, ONCOGENE, V22, P3213, DOI 10.1038/sj.onc.1206385; Vaux EC, 2001, BLOOD, V98, P296, DOI 10.1182/blood.V98.2.296; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; WANG GL, 1995, BIOCHEM BIOPH RES CO, V216, P669, DOI 10.1006/bbrc.1995.2674; Zhong H, 1999, CANCER RES, V59, P5830; Zhou YD, 2005, J NAT PROD, V68, P947, DOI 10.1021/np050029m	50	53	55	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5859	5868		10.1074/jbc.M806744200	http://dx.doi.org/10.1074/jbc.M806744200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19091749	Green Published, hybrid			2022-12-25	WOS:000263560600049
J	Van de Walle, GR; Kaufer, BB; Chbab, N; Osterrieder, N				Van de Walle, Gerlinde R.; Kaufer, Benedikt B.; Chbab, Najet; Osterrieder, Nikolaus			Analysis of the Herpesvirus Chemokine-binding Glycoprotein G Residues Essential for Chemokine Binding and Biological Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; EQUINE HERPESVIRUS-4; VIRUS; PROTEINS; INHIBITOR; RECEPTORS; CYTOKINES; MUTANTS; DISEASE; HEPARIN	Viral chemokine-binding protein (vCKBP) are expressed by large DNA viruses, such as herpesviruses and poxviruses. vCKBP can bind chemokines with high affinity and efficiently neutralize their ability to induce cell migration. Recently, herpesvirus glycoprotein G (gG) was identified as a member of the vCKBP-4 subfamily. The structural domains of gG important for binding to chemokines and biological activity, however, are unknown. Here, we used equine herpesvirus type 1 (EHV-1) as a model to determine residues in EHV-1 gG that are involved in the processes of chemokine binding and interaction with target cells. First, comprehensive analysis of glycosylation of EHV-1 gG revealed that N-glycosylation is not required for binding of gG to chemokines but is essential for biological activity of the protein. Second, the epitope responsible for the binding to chemokines was localized to 40 amino acids in the hypervariable region (amino acids 301-340) of the protein. Third, hybrid molecules, designed as loss- and gain-of-function gG proteins, were engineered. In these hybrid glycoproteins the hypervariable regions of EHV-1 gG, a vCKBP, and the closely related EHV-4 gG, which does not display any chemokine binding capabilities, were exchanged. gG variants containing the EHV-1 hypervariable region were able to bind chemokines and were biologically active, whereas hybrid gGs containing the corresponding region of EHV-4 gG were not. Taking these results together, this report is the first to provide insight into the functional residues of an alphaherpesviral vCKBP.	[Van de Walle, Gerlinde R.; Kaufer, Benedikt B.; Chbab, Najet; Osterrieder, Nikolaus] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA; [Van de Walle, Gerlinde R.] Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, B-9820 Merelbeke, Belgium; [Chbab, Najet; Osterrieder, Nikolaus] Free Univ Berlin, Inst Virol, D-10115 Berlin, Germany	Cornell University; Ghent University; Free University of Berlin	Osterrieder, N (corresponding author), Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA.	no34@cornell.edu	Kaufer, Benedikt B./AAZ-8216-2020	Kaufer, Benedikt B./0000-0003-1328-2695; Osterrieder, Nikolaus/0000-0002-5313-2176; Van de Walle, Gerlinde/0000-0002-2064-8029	Deutsche Forschungsgemeinschaft [OS143/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Harry M. Zweig Memorial Fund for Equine Research at Cornell University and Grant OS143/4-1 from the Deutsche Forschungsgemeinschaft (to N.O.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; Alexander JM, 2002, CELL, V111, P343, DOI 10.1016/S0092-8674(02)01007-3; Allen G P, 1986, Prog Vet Microbiol Immunol, V2, P78; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Bahar MW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040005; Beck CG, 2001, J BIOL CHEM, V276, P43270, DOI 10.1074/jbc.M106305200; Bryant NA, 2003, EMBO J, V22, P833, DOI 10.1093/emboj/cdg092; Carfi A, 1999, P NATL ACAD SCI USA, V96, P12379, DOI 10.1073/pnas.96.22.12379; COHEN JI, 1994, J GEN VIROL, V75, P3087, DOI 10.1099/0022-1317-75-11-3087; CRABB BS, 1993, J VIROL, V67, P6332, DOI 10.1128/JVI.67.10.6332-6338.1993; Drummer HE, 1998, J GEN VIROL, V79, P1205, DOI 10.1099/0022-1317-79-5-1205; Huang J, 2005, ARCH VIROL, V150, P2583, DOI 10.1007/s00705-005-0607-9; Kamil JP, 2005, J VIROL, V79, P6984, DOI 10.1128/JVI.79.11.6984-6996.2005; Lalani AS, 2000, IMMUNOL TODAY, V21, P100, DOI 10.1016/S0167-5699(99)01556-X; Lalani AS, 1997, J VIROL, V71, P4356, DOI 10.1128/JVI.71.6.4356-4363.1997; Lusso P, 2000, VIROLOGY, V273, P228, DOI 10.1006/viro.2000.0443; McFadden G, 1998, SEMIN CELL DEV BIOL, V9, P359, DOI 10.1006/scdb.1998.0245; Parry CM, 2000, J EXP MED, V191, P573, DOI 10.1084/jem.191.3.573; Patel JR, 2005, VET J, V170, P14, DOI 10.1016/j.tvjl.2004.04.018; PELLETT PE, 2007, HERPESVIRIDAE, P2479; PYCOCK JF, 1987, RES VET SCI, V42, P411, DOI 10.1016/S0034-5288(18)30727-6; Seet BT, 2002, J LEUKOCYTE BIOL, V72, P24; Seet BT, 2001, J BIOL CHEM, V276, P30504, DOI 10.1074/jbc.M011401200; VAN B, 2000, J VIROL, V74, P6741; Van de Walle GR, 2008, J VIROL, V82, P6090, DOI 10.1128/JVI.00098-08; Van de Walle GR, 2008, J VIROL, V82, P1714, DOI 10.1128/JVI.02137-07; Van de Walle GR, 2007, J IMMUNOL, V179, P4161, DOI 10.4049/jimmunol.179.6.4161; van Maanen C, 2002, VET QUART, V24, P57, DOI 10.1080/01652176.2002.9695126; von Einem J, 2007, VIROLOGY, V362, P151, DOI 10.1016/j.virol.2006.12.008; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9; Webb LMC, 2005, MINI-REV MED CHEM, V5, P833, DOI 10.2174/1389557054867110; Webb LMC, 2003, J VIROL, V77, P8588, DOI 10.1128/JVI.77.15.8588-8592.2003; WILSON ME, 1985, REV INFECT DIS, V7, P404	33	14	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5968	5976		10.1074/jbc.M808127200	http://dx.doi.org/10.1074/jbc.M808127200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19074431	hybrid			2022-12-25	WOS:000263560600060
J	Brombacher, E; Urwyler, S; Ragaz, C; Weber, SS; Kami, K; Overduin, M; Hilbi, H				Brombacher, Eva; Urwyler, Simon; Ragaz, Curdin; Weber, Stefan S.; Kami, Keiichiro; Overduin, Michael; Hilbi, Hubert			Rab1 Guanine Nucleotide Exchange Factor SidM Is a Major Phosphatidylinositol 4-Phosphate-binding Effector Protein of Legionella pneumophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR-DICHROISM SPECTRA; TRANSLOCATED SUBSTRATE; LEGIONNAIRES-DISEASE; ENDOPLASMIC-RETICULUM; HOMOLOGY-DOMAIN; HUMAN-MONOCYTES; EXIT SITES; BINDING; SYSTEM; GENES	The causative agent o f Legionnaires disease, Legionella pneumophila, forms a replicative vacuole in phagocytes by means of the intracellular multiplication/defective organelle trafficking (Icm/Dot) type IV secretion system and translocated effector proteins, some of which subvert host GTP and phosphoinositide (PI) metabolism. The Icm/Dot substrate SidC anchors to the membrane of Legionella-containing vacuoles (LCVs) by specifically binding to phosphatidylinositol 4-phosphate (PtdIns(4) P). Using a nonbiased screen for novel L. pneumophila PI-binding proteins, we identified the Rab1 guanine nucleotide exchange factor (GEF) SidM/DrrA as the predominant PtdIns(4) P-binding protein. Purified SidM specifically and directly bound to PtdIns(4) P, whereas the SidM-interacting Icm/Dot substrate LidA preferentially bound PtdIns(3) P but also PtdIns(4) P, and the L. pneumophila Arf1 GEF RalF did not bind to any PIs. The PtdIns(4) P-binding domain of SidM was mapped to the 12-kDa C-terminal sequence, termed "P4M" (PtdIns4P binding of SidM/DrrA). The isolated P4M domain is largely helical and displayed higher PtdIns(4) P binding activity in the context of the alpha-helical, monomeric full-length protein. SidM constructs containing P4M were translocated by Icm/Dot-proficient L. pneumophila and localized to the LCV membrane, indicating that SidM anchors to PtdIns(4) P on LCVs via its P4M domain. An L. pneumophila Delta sidM mutant strain displayed significantly higher amounts of SidC on LCVs, suggesting that SidM and SidC compete for limiting amounts of PtdIns(4) P on the vacuole. Finally, RNA interference revealed that PtdIns(4) P on LCVs is specifically formed by host PtdIns 4-kinase III beta. Thus, L. pneumophila exploits PtdIns(4) P produced by PtdIns 4-kinase III beta to anchor the effectors SidC and SidM to LCVs.	[Brombacher, Eva; Urwyler, Simon; Ragaz, Curdin; Weber, Stefan S.; Hilbi, Hubert] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland; [Kami, Keiichiro; Overduin, Michael] Univ Birmingham, Canc Res UK Inst Canc Studies, Birmingham B15 2TT, W Midlands, England	Swiss Federal Institutes of Technology Domain; ETH Zurich; Cancer Research UK; University of Birmingham	Hilbi, H (corresponding author), ETH, Inst Microbiol, Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.	hilbi@micro.biol.ethz.ch	Hilbi, Hubert/AAU-5815-2020	Hilbi, Hubert/0000-0002-5462-9301; Overduin, Michael/0000-0002-3114-6585	Swiss National Science Foundation [631-065952, PP00A-112592]; ETH Zu r rich [TH 17/02-3, TH-26 06-2]; Novartis; Velux Foundation; OPO Foundation; Biotechnology and Biological Sciences Research Council [BBS/B/10714] Funding Source: researchfish	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zu r rich; Novartis(Novartis); Velux Foundation(Velux Fonden); OPO Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by Grants 631-065952 and PP00A-112592 from the Swiss National Science Foundation, Grants TH 17/02-3 and TH-26 06-2 from ETH Zu r rich, and grants from Novartis, the Velux Foundation, and the OPO Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Albers U, 2007, MICROBIOL-SGM, V153, P3817, DOI 10.1099/mic.0.2007/009829-0; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Blumental-Perry A, 2006, DEV CELL, V11, P671, DOI 10.1016/j.devcel.2006.09.001; Bruggemann H, 2006, CURR OPIN MICROBIOL, V9, P86, DOI 10.1016/j.mib.2005.12.009; Cambronne ED, 2007, PLOS PATHOG, V3, P1837, DOI 10.1371/journal.ppat.0030188; Chen J, 2004, SCIENCE, V303, P1358, DOI 10.1126/science.1094226; Conover GM, 2003, MOL MICROBIOL, V48, P305, DOI 10.1046/j.1365-2958.2003.03400.x; de Felipe KS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000117; De Matteis MA, 2004, NAT CELL BIOL, V6, P487, DOI 10.1038/ncb0604-487; Demmel L, 2008, MOL BIOL CELL, V19, P1991, DOI 10.1091/mbc.E06-10-0937; Derre I, 2005, INFECT IMMUN, V73, P4370, DOI 10.1128/IAI.73.7.4370-4380.2005; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dorer MS, 2006, PLOS PATHOG, V2, P315, DOI 10.1371/journal.ppat.0020034; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Hilbi H, 2001, MOL MICROBIOL, V42, P603, DOI 10.1046/j.1365-2958.2001.02645.x; Hilbi H, 2007, ENVIRON MICROBIOL, V9, P563, DOI 10.1111/j.1462-2920.2007.01238.x; Hilbi H, 2006, CELL MICROBIOL, V8, P1697, DOI 10.1111/j.1462-5822.2006.00793.x; HORWITZ MA, 1983, J EXP MED, V158, P1319, DOI 10.1084/jem.158.4.1319; HORWITZ MA, 1983, J EXP MED, V158, P2108, DOI 10.1084/jem.158.6.2108; Ingmundson A, 2007, NATURE, V450, P365, DOI 10.1038/nature06336; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Kagan JC, 2004, J EXP MED, V199, P1201, DOI 10.1084/jem.20031706; Kagan JC, 2002, NAT CELL BIOL, V4, P945, DOI 10.1038/ncb883; Laguna RK, 2006, P NATL ACAD SCI USA, V103, P18745, DOI 10.1073/pnas.0609012103; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Lu H, 2005, CELL MICROBIOL, V7, P995, DOI 10.1111/j.1462-5822.2005.00528.x; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; Machner MP, 2007, SCIENCE, V318, P974, DOI 10.1126/science.1149121; Machner MP, 2006, DEV CELL, V11, P47, DOI 10.1016/j.devcel.2006.05.013; Mampel J, 2006, APPL ENVIRON MICROB, V72, P2885, DOI 10.1128/AEM.72.4.2885-2895.2006; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mezzasalma TM, 2007, J BIOMOL SCREEN, V12, P418, DOI 10.1177/1087057106297984; Murata T, 2006, NAT CELL BIOL, V8, P971, DOI 10.1038/ncb1463; Nagai H, 2005, P NATL ACAD SCI USA, V102, P826, DOI 10.1073/pnas.0406239101; Nagai H, 2002, SCIENCE, V295, P679, DOI 10.1126/science.1067025; Newton HJ, 2007, INFECT IMMUN, V75, P5575, DOI 10.1128/IAI.00443-07; Newton HJ, 2006, INFECT IMMUN, V74, P1683, DOI 10.1128/IAI.74.3.1683-1691.2006; Ninio S, 2005, MOL MICROBIOL, V55, P912, DOI 10.1111/j.1365-2958.2004.04435.x; Ninio S, 2007, TRENDS MICROBIOL, V15, P372, DOI 10.1016/j.tim.2007.06.006; PFEFFER SR, 1995, J BIOL CHEM, V270, P17057, DOI 10.1074/jbc.270.29.17057; Ragaz C, 2008, CELL MICROBIOL, V10, P2416, DOI 10.1111/j.1462-5822.2008.01219.x; Robinson CG, 2006, CELL MICROBIOL, V8, P793, DOI 10.1111/j.1462-5822.2005.00666.x; Segal G, 1998, P NATL ACAD SCI USA, V95, P1669, DOI 10.1073/pnas.95.4.1669; Segal G, 2005, FEMS MICROBIOL REV, V29, P65, DOI 10.1016/j.femsre.2004.07.001; Seidel RD, 2004, BIOCHEMISTRY-US, V43, P15393, DOI 10.1021/bi0490385; Spirig T, 2008, J BIOL CHEM, V283, P18113, DOI 10.1074/jbc.M801929200; Stahelin RV, 2007, J BIOL CHEM, V282, P25737, DOI 10.1074/jbc.M702861200; Tiaden A, 2008, J BACTERIOL, V190, P7532, DOI 10.1128/JB.01002-08; Tiaden A, 2007, CELL MICROBIOL, V9, P2903, DOI 10.1111/j.1462-5822.2007.01005.x; Urwyler S, 2009, TRAFFIC, V10, P76, DOI 10.1111/j.1600-0854.2008.00851.x; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; Weber Stefan S., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020046; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pD593, DOI 10.1093/nar/gkh077; WIATER LA, 1994, PLASMID, V32, P280, DOI 10.1006/plas.1994.1067	62	193	195	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4846	4856		10.1074/jbc.M807505200	http://dx.doi.org/10.1074/jbc.M807505200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19095644	Green Published, hybrid			2022-12-25	WOS:000263416600013
J	Nakamoto, T; Brown, DA; Catalan, MA; Gonzalez-Begne, M; Romanenko, VG; Melvin, JE				Nakamoto, Tetsuji; Brown, David A.; Catalan, Marcelo A.; Gonzalez-Begne, Mireya; Romanenko, Victor G.; Melvin, James E.			Purinergic P2X(7) Receptors Mediate ATP-induced Saliva Secretion by the Mouse Submandibular Gland	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAROTID ACINAR-CELLS; REFLEX SECRETION; NONCHOLINERGIC MECHANISMS; P-2Z PURINOCEPTORS; CONSCIOUS RATS; SUBSTANCE-P; DUCT CELLS; CHANNELS; CARBACHOL; RELEASE	Salivary glands express multiple isoforms of P2X and P2Y nucleotide receptors, but their in vivo physiological roles are unclear. P2 receptor agonists induced salivation in an ex vivo submandibular gland preparation. The nucleotide selectivity sequence of the secretion response was BzATP >> ATP > ADP >> UTP, and removal of external Ca2+ dramatically suppressed the initial ATP-induced fluid secretion (similar to 85%). Together, these results suggested that P2X receptors are the major purinergic receptor subfamily involved in the fluid secretion process. Mice with targeted disruption of the P2X(7) gene were used to evaluate the role of the P2X(7) receptor in nucleotideevoked fluid secretion. P2X(7) receptor protein and BzATPactivated inward cation currents were absent, and importantly, purinergic receptor agonist-stimulated salivation was suppressed by more than 70% in submandibular glands from P2X(7)-null mice. Consistent with these observations, the ATP-induced increases in [Ca2+](i) were nearly abolished in P2X(7)(-/-)submandibular acinar and duct cells. ATP appeared to also act through the P2X(7) receptor to inhibit muscarinic-induced fluid secretion. These results demonstrate that the ATP-sensitive P2X(7) receptor regulates fluid secretion in the mouse submandibular gland.	[Nakamoto, Tetsuji; Brown, David A.; Catalan, Marcelo A.; Gonzalez-Begne, Mireya; Romanenko, Victor G.; Melvin, James E.] Univ Rochester, Med Ctr, Ctr Oral Biol, Rochester, NY 14642 USA; [Nakamoto, Tetsuji; Romanenko, Victor G.; Melvin, James E.] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Melvin, JE (corresponding author), Univ Rochester, Med Ctr, Ctr Oral Biol, Box 611,601 Elmwood Ave, Rochester, NY 14642 USA.	james_melvin@urmc.rochester.edu	Catalan, Marcelo/AAW-3848-2020; Catalan, Marcelo/ABE-7044-2021	Catalan, Marcelo/0000-0003-3544-2821	National Institutes of Health [DE09692, DE08921]; NIDCR Training [T32DE07202]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE008921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007202, R01DE009692, R37DE008921] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE09692 and DE08921 (to J. E. M.) and NIDCR Training Grant T32DE07202 (to D. A. B. and M. G.- B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ASZTELY A, 1994, ACTA PHYSIOL SCAND, V151, P373, DOI 10.1111/j.1748-1716.1994.tb09756.x; Brown DA, 2004, J BIOL CHEM, V279, P39485, DOI 10.1074/jbc.M406201200; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; COOK D, 1994, SECRETION MAJOR SALI; Dubyak GR, 2007, MOL PHARMACOL, V72, P1402, DOI 10.1124/mol.107.042077; EKSTROM J, 1993, J PHYSIOL-LONDON, V472, P233, DOI 10.1113/jphysiol.1993.sp019944; Ekstrom J, 1998, EUR J MORPHOL, V36, P208; Ekstrom J, 2001, EXP PHYSIOL, V86, P475, DOI 10.1113/eph8602199; Ekstrom J, 1998, EXP PHYSIOL, V83, P697, DOI 10.1113/expphysiol.1998.sp004150; EKSTROM J, 1988, Q J EXP PHYSIOL CMS, V73, P163, DOI 10.1113/expphysiol.1988.sp003129; EKSTROM J, 1994, ACTA PHYSIOL SCAND, V150, P83, DOI 10.1111/j.1748-1716.1994.tb09662.x; Fukushi Y, 1999, EUR J PHARMACOL, V364, P55, DOI 10.1016/S0014-2999(98)00824-3; GALLACHER DV, 1982, NATURE, V296, P83, DOI 10.1038/296083a0; Gonzalez-Begne M, 2007, J BIOL CHEM, V282, P35125, DOI 10.1074/jbc.M707266200; Guo C, 2007, MOL PHARMACOL, V72, P1447, DOI 10.1124/mol.107.035980; JORGENSEN TD, 1995, BIOCHEM J, V312, P457, DOI 10.1042/bj3120457; Lee MG, 1997, J BIOL CHEM, V272, P32951, DOI 10.1074/jbc.272.52.32951; Li Q, 2003, J BIOL CHEM, V278, P47554, DOI 10.1074/jbc.M308306200; Melvin JE, 2005, ANNU REV PHYSIOL, V67, P445, DOI 10.1146/annurev.physiol.67.041703.084745; MERRITT JE, 1987, J BIOL CHEM, V262, P14912; Metioui M, 1996, J CELL PHYSIOL, V168, P462, DOI 10.1002/(SICI)1097-4652(199608)168:2<462::AID-JCP25>3.0.CO;2-3; Nakamoto T, 2008, AM J PHYSIOL-CELL PH, V294, pC810, DOI 10.1152/ajpcell.00511.2007; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Novak I, 2003, NEWS PHYSIOL SCI, V18, P12, DOI 10.1152/nips.01409.2002; Pochet S, 2007, CELL SIGNAL, V19, P2155, DOI 10.1016/j.cellsig.2007.06.012; REID AM, 1988, Q J EXP PHYSIOL CMS, V73, P413, DOI 10.1113/expphysiol.1988.sp003157; RICHARDSON PJ, 1987, J NEUROCHEM, V48, P622, DOI 10.1111/j.1471-4159.1987.tb04138.x; Romanenko V, 2006, J BIOL CHEM, V281, P27964, DOI 10.1074/jbc.M603871200; Romanenko VG, 2007, J PHYSIOL-LONDON, V581, P801, DOI 10.1113/jphysiol.2006.127498; Sim JA, 2004, J NEUROSCI, V24, P6307, DOI 10.1523/JNEUROSCI.1469-04.2004; SOLTOFF SP, 1990, J GEN PHYSIOL, V95, P319, DOI 10.1085/jgp.95.2.319; SOLTOFF SP, 1990, ANN NY ACAD SCI, V603, P91; SOLTOFF SP, 1990, ANN N Y ACAD SCI, V603, P76; Sorensen CE, 2001, J BIOL CHEM, V276, P32925, DOI 10.1074/jbc.M103313200; Torres GE, 1999, J BIOL CHEM, V274, P6653, DOI 10.1074/jbc.274.10.6653; Turner JT, 1999, CRIT REV ORAL BIOL M, V10, P210, DOI 10.1177/10454411990100020701	37	58	60	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4815	4822		10.1074/jbc.M808597200	http://dx.doi.org/10.1074/jbc.M808597200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19097994	Green Published, hybrid			2022-12-25	WOS:000263416600009
J	Sergeant, MJ; Li, JJ; Fox, C; Brookbank, N; Rea, D; Bugg, TDH; Thompson, AJ				Sergeant, Martin J.; Li, Jian-Jun; Fox, Christine; Brookbank, Nicola; Rea, Dean; Bugg, Timothy D. H.; Thompson, Andrew J.			Selective Inhibition of Carotenoid Cleavage Dioxygenases PHENOTYPIC EFFECTS ON SHOOT BRANCHING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABSCISIC-ACID BIOSYNTHESIS; NOSTOC SP PCC-7120; BETA-CAROTENE; 9-CIS-EPOXYCAROTENOID DIOXYGENASE; BIOCHEMICAL-CHARACTERIZATION; CHEMICAL GENETICS; IN-VITRO; IDENTIFICATION; ARABIDOPSIS; ENZYME	Members of the carotenoid cleavage dioxygenase family catalyze the oxidative cleavage of carotenoids at various chain positions, leading to the formation of a wide range of apocarotenoid signaling molecules. To explore the functions of this diverse enzyme family, we have used a chemical genetic approach to design selective inhibitors for different classes of carotenoid cleavage dioxygenase. A set of 18 arylalkyl-hydroxamic acids was synthesized in which the distance between an iron-chelating hydroxamic acid and an aromatic ring was varied; these compounds were screened as inhibitors of four different enzyme classes, either in vitro or in vivo. Potent inhibitors were found that selectively inhibited enzymes that cleave carotenoids at the 9,10 position; 50% inhibition was achieved at submicromolar concentrations. Application of certain inhibitors at 100 mu M to Arabidopsis node explants or whole plants led to increased shoot branching, consistent with inhibition of 9,10-cleavage.	[Sergeant, Martin J.; Thompson, Andrew J.] Univ Warwick, Warwick HRI, Wellesbourne CV35 9EF, Warwick, England; [Li, Jian-Jun; Fox, Christine; Brookbank, Nicola; Rea, Dean; Bugg, Timothy D. H.] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England	University of Warwick; University of Warwick	Thompson, AJ (corresponding author), Univ Warwick, Warwick HRI, Wellesbourne CV35 9EF, Warwick, England.	a.j.thompson@warwick.ac.uk	Thompson, Andrew J./AAF-3017-2020	Thompson, Andrew J./0000-0002-7419-3402; Sergeant, Martin/0000-0001-7264-2668	UK Biological and Biotechnological Sciences Research Council; Selective Chemical Intervention in Biological Systems initiative [BB/D005787]; Biotechnology and Biological Sciences Research Council [BB/D005787/1] Funding Source: researchfish	UK Biological and Biotechnological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Selective Chemical Intervention in Biological Systems initiative(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the UK Biological and Biotechnological Sciences Research Council, Selective Chemical Intervention in Biological Systems initiative ( Project BB/D005787).	Akiyama K, 2006, ANN BOT-LONDON, V97, P925, DOI 10.1093/aob/mcl063; Alder A, 2008, BIOCHEM J, V416, P289, DOI 10.1042/BJ20080568; Alija AJ, 2006, CARCINOGENESIS, V27, P1128, DOI 10.1093/carcin/bgi342; Armstrong JI, 2007, J SCI FOOD AGR, V87, P1985, DOI 10.1002/jsfa.2967; Auldridge ME, 2006, CURR OPIN PLANT BIOL, V9, P315, DOI 10.1016/j.pbi.2006.03.005; Bennett T, 2006, CURR BIOL, V16, P553, DOI 10.1016/j.cub.2006.01.058; BERGERON RJ, 1989, TETRAHEDRON, V45, P4939, DOI 10.1016/S0040-4020(01)81074-7; Booker J, 2005, DEV CELL, V8, P443, DOI 10.1016/j.devcel.2005.01.009; Booker J, 2004, CURR BIOL, V14, P1232, DOI 10.1016/j.cub.2004.06.061; Borowski T, 2008, CHEM-EUR J, V14, P2264, DOI 10.1002/chem.200701344; Bouvier F, 2003, SCIENCE, V300, P2089, DOI 10.1126/science.1085162; Bouvier F, 2003, PLANT CELL, V15, P47, DOI 10.1105/tpc.006536; Burbidge A, 1999, PLANT J, V17, P427, DOI 10.1046/j.1365-313X.1999.00386.x; Chatfield SP, 2000, PLANT J, V24, P159, DOI 10.1046/j.1365-313x.2000.00862.x; Cunningham FX, 2007, PHOTOSYNTH RES, V92, P245, DOI 10.1007/s11120-007-9210-0; Cunningham FX, 1996, PLANT CELL, V8, P1613, DOI 10.2307/3870254; Dudareva N, 2006, CRIT REV PLANT SCI, V25, P417, DOI 10.1080/07352680600899973; EISNER T, 1966, SCIENCE, V153, P1341, DOI 10.1126/science.153.3742.1341; Fester T, 2002, PLANTA, V216, P148, DOI 10.1007/s00425-002-0917-z; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Han SY, 2004, PLANT PHYSIOL, V135, P1574, DOI 10.1104/pp.104.039511; Han SY, 2004, BIOORG MED CHEM LETT, V14, P3033, DOI 10.1016/j.bmcl.2004.04.035; Holger S, 2006, J BIOL CHEM, V281, P9845, DOI 10.1074/jbc.M511668200; Hu KQ, 2006, J BIOL CHEM, V281, P19327, DOI 10.1074/jbc.M512095200; JUTTNER F, 1985, ARCH MICROBIOL, V141, P337, DOI 10.1007/BF00428846; Kaschani F, 2007, CURR OPIN CHEM BIOL, V11, P88, DOI 10.1016/j.cbpa.2006.11.038; KAWASE M, 1979, J CHEM SOC PERK T 1, P643, DOI 10.1039/p19790000643; Kiefer C, 2001, J BIOL CHEM, V276, P14110, DOI 10.1074/jbc.M011510200; Kitahata N, 2006, BIOORGAN MED CHEM, V14, P5555, DOI 10.1016/j.bmc.2006.04.025; Kloer DP, 2005, SCIENCE, V308, P267, DOI 10.1126/science.1108965; Kontogiorgis CA, 2005, CURR MED CHEM, V12, P339, DOI 10.2174/0929867053363243; Marasco EK, 2006, J BIOL CHEM, V281, P31583, DOI 10.1074/jbc.M606299200; Matusova R, 2005, PLANT PHYSIOL, V139, P920, DOI 10.1104/pp.105.061382; Paik J, 2001, J BIOL CHEM, V276, P32160, DOI 10.1074/jbc.M010086200; QUINLAN JD, 1990, HORTSCIENCE, V25, P60, DOI 10.21273/HORTSCI.25.1.60; Scherzinger D, 2008, MOL MICROBIOL, V69, P231, DOI 10.1111/j.1365-2958.2008.06282.x; Schwartz SH, 2004, J BIOL CHEM, V279, P46940, DOI 10.1074/jbc.M409004200; Schwartz SH, 2001, J BIOL CHEM, V276, P25208, DOI 10.1074/jbc.M102146200; Schwartz SH, 1997, PLANT PHYSIOL, V114, P798; Simkin AJ, 2004, PLANT J, V40, P882, DOI 10.1111/j.1365-313X.2004.02263.x; Sorefan K, 2003, GENE DEV, V17, P1469, DOI 10.1101/gad.256603; Stockwell BR, 2000, NAT REV GENET, V1, P116, DOI 10.1038/35038557; Suzuki A, 2004, PLANT CELL PHYSIOL, V45, P914, DOI 10.1093/pcp/pch107; Taylor IB, 2005, J PLANT GROWTH REGUL, V24, P253, DOI 10.1007/s00344-005-0070-6; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; Vogel JT, 2008, J BIOL CHEM, V283, P11364, DOI 10.1074/jbc.M710106200; von Lintig J, 2000, J BIOL CHEM, V275, P11915, DOI 10.1074/jbc.275.16.11915; Walter MH, 2007, PHYTOCHEMISTRY, V68, P130, DOI 10.1016/j.phytochem.2006.09.032; Ward SP, 2004, CURR OPIN PLANT BIOL, V7, P73, DOI 10.1016/j.pbi.2003.10.002; WILSON AK, 1990, MOL GEN GENET, V222, P377, DOI 10.1007/BF00633843; Wyss A, 2000, BIOCHEM BIOPH RES CO, V271, P334, DOI 10.1006/bbrc.2000.2619; Yeh SL, 2006, CHEM-BIOL INTERACT, V163, P199, DOI 10.1016/j.cbi.2006.08.002; ZEEVAART JAD, 1988, ANNU REV PLANT PHYS, V39, P439, DOI 10.1146/annurev.pp.39.060188.002255	53	38	40	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5257	5264		10.1074/jbc.M805453200	http://dx.doi.org/10.1074/jbc.M805453200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19098002	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000263416600056
J	Namba, T; Homan, T; Nishimura, T; Mima, S; Hoshino, T; Mizushima, T				Namba, Takushi; Homan, Takashi; Nishimura, Tomoko; Mima, Shinji; Hoshino, Tatsuya; Mizushima, Tohru			Up-regulation of S100P Expression by Non-steroidal Anti-inflammatory Drugs and Its Role in Anti-tumorigenic Effects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC-MUCOSAL CELLS; PANCREATIC-CANCER GROWTH; GENE-EXPRESSION; COLON-CANCER; MATRIX METALLOPROTEINASES; INDUCED APOPTOSIS; SULINDAC SULFONE; RETINOIC ACID; BREAST-CANCER; PROTEIN	Epidemiological studies have revealed that prolonged use non-steroidal anti-inflammatory drugs ( NSAIDs) reduces risk of cancer. Various mechanisms, including induction of and inhibition of the growth and invasion of cancer have been implicated in this anti-tumorigenic activity. In study we focused on S100P, which is known to be in clinically isolated tumors and which functions through intracellular and extracellular mechanisms. We showed the of S100P expression in human gastric cells treated with various NSAIDs, including celecoxib. celecoxib-mediated up-regulation of S100P was suppressed the transfection of cells with small interfering RNA for transcription factor 4 (ATF4), a transcription factor in the endoplasmic reticulum stress response. deletion of ATF4 binding consensus sequence located in promoter of the S100P gene resulted in inhibition of transcriptional activation of the gene. These suggest that celecoxib up-regulates the expression of through an ATF4-mediated endoplasmic reticulum stress Celecoxib inhibited the growth and induced and these actions could be either suppressed or stimulated transfection of cells with S100P overexpression plasmid or interfering RNA, respectively. Celecoxib also inhibited the activity of the cells. Cromolyn, which inhibits the binding S100P to its receptor, enhanced the celecoxib-mediated of cell invasion and growth but did not affect These results suggest that S100P affects apoptosis, cell and invasion through either an intracellular or an mechanism and that the up-regulation of S100P expression NSAIDs reduces their anti-tumorigenic activity.	[Namba, Takushi; Homan, Takashi; Nishimura, Tomoko; Mima, Shinji; Hoshino, Tatsuya; Mizushima, Tohru] Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, Kumamoto 8620973, Japan	Kumamoto University	Mizushima, T (corresponding author), Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	mizu@gpo.kumamoto-u.ac.jp			Scientific Research from the Ministry of Health, Labor, and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Science and Technology Agency	Scientific Research from the Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by grants-in-aid for Scientific Research from the Ministry of Health, Labor, and Welfare of Japan, grants-in-aid from Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and grants-in-aid from the Japan Science and Technology Agency. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aburaya M, 2006, J BIOL CHEM, V281, P33422, DOI 10.1074/jbc.M602074200; Arumugam T, 2004, J BIOL CHEM, V279, P5059, DOI 10.1074/jbc.M310124200; Arumugam T, 2005, CLIN CANCER RES, V11, P5356, DOI 10.1158/1078-0432.CCR-05-0092; Arumugam T, 2006, J NATL CANCER I, V98, P1806, DOI 10.1093/jnci/djj498; Averboukh L, 1996, PROSTATE, V29, P350; Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200; BECKER T, 1992, EUR J BIOCHEM, V207, P541, DOI 10.1111/j.1432-1033.1992.tb17080.x; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bertram J, 1998, ANTI-CANCER DRUG, V9, P311, DOI 10.1097/00001813-199804000-00004; Birkenkamp-Demtroder K, 2005, GUT, V54, P374, DOI 10.1136/gut.2003.036848; Bond M, 1998, FEBS LETT, V435, P29, DOI 10.1016/S0014-5793(98)01034-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cherasse Y, 2007, NUCLEIC ACIDS RES, V35, P5954, DOI 10.1093/nar/gkm642; da Costa CA, 2002, P NATL ACAD SCI USA, V99, P4043, DOI 10.1073/pnas.062059899; Diederichs S, 2004, CANCER RES, V64, P5564, DOI 10.1158/0008-5472.CAN-04-2004; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fernandez PM, 2000, BREAST CANCER RES TR, V59, P15, DOI 10.1023/A:1006332011207; Filipek A, 2002, J BIOL CHEM, V277, P28848, DOI 10.1074/jbc.M203602200; Fuentes MK, 2007, DIS COLON RECTUM, V50, P1230, DOI 10.1007/s10350-006-0850-5; Gum R, 1997, ONCOGENE, V14, P1481, DOI 10.1038/sj.onc.1200973; Gupta RA, 2001, NAT REV CANCER, V1, P11, DOI 10.1038/35094017; Hoshino T, 2003, J BIOL CHEM, V278, P12752, DOI 10.1074/jbc.M212097200; Huang SY, 2001, ONCOGENE, V20, P4188, DOI 10.1038/sj.onc.1204535; Hunter KW, 2004, TRENDS MOL MED, V10, P201, DOI 10.1016/j.molmed.2004.03.001; Huo R, 2004, CELL TISSUE RES, V316, P359, DOI 10.1007/s00441-004-0885-7; Jiang F, 2005, LEUKEMIA RES, V29, P1181, DOI 10.1016/j.leukres.2005.03.012; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kismet K, 2004, CANCER DETECT PREV, V28, P127, DOI 10.1016/j.cdp.2003.12.005; Koltzscher M, 2003, MOL BIOL CELL, V14, P2372, DOI 10.1091/mbc.E02-09-0553; Koomagi R, 1999, ANTICANCER RES, V19, P4333; Logsdon CD, 2003, CANCER RES, V63, P2649; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Mima S, 2005, CANCER RES, V65, P1868, DOI 10.1158/0008-5472.CAN-04-2770; Mima S, 2008, CARCINOGENESIS, V29, P1994, DOI 10.1093/carcin/bgn134; Munoz-Najar UM, 2006, ONCOGENE, V25, P2379, DOI 10.1038/sj.onc.1209273; Namba T, 2007, MOL PHARMACOL, V71, P860, DOI 10.1124/mol.106.027698; Piazza GA, 1997, CANCER RES, V57, P2909; Reddy BS, 1999, CANCER RES, V59, P3387; ROLLAND PH, 1980, JNCI-J NATL CANCER I, V64, P1061; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Sato N, 2004, ONCOGENE, V23, P1531, DOI 10.1038/sj.onc.1207269; Saukkonen K, 2001, CLIN CANCER RES, V7, P1923; Shyu RY, 2003, J BIOMED SCI, V10, P313, DOI 10.1159/000070096; Tanaka K, 2005, J BIOL CHEM, V280, P31059, DOI 10.1074/jbc.M502956200; Taraboletti G, 2000, EXP CELL RES, V258, P384, DOI 10.1006/excr.2000.4936; Tomisato W, 2004, BIOCHEM BIOPH RES CO, V323, P1032, DOI 10.1016/j.bbrc.2004.08.205; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; Tsutsumi S, 2006, ONCOGENE, V25, P1018, DOI 10.1038/sj.onc.1209139; Tsutsumi S, 2004, CELL DEATH DIFFER, V11, P1009, DOI 10.1038/sj.cdd.4401436; Tsutsumi S, 2002, BBA-MOL CELL RES, V1589, P168, DOI 10.1016/S0167-4889(02)00171-4; Wang GZ, 2006, CANCER RES, V66, P1199, DOI 10.1158/0008-5472.CAN-05-2605; Wang Q, 2007, ONCOGENE, V26, P6560, DOI 10.1038/sj.onc.1210472; Wang WH, 2003, JNCI-J NATL CANCER I, V95, P1784, DOI 10.1093/jnci/djg106; Whiteman HJ, 2007, CANCER RES, V67, P8633, DOI 10.1158/0008-5472.CAN-07-0545; Xu YY, 2007, J CELL BIOCHEM, V100, P773, DOI 10.1002/jcb.21088; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000	57	35	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4158	4167		10.1074/jbc.M806051200	http://dx.doi.org/10.1074/jbc.M806051200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19073601	hybrid			2022-12-25	WOS:000263134400013
J	Sprouse, RO; Wells, MN; Auble, DT				Sprouse, Rebekka O.; Wells, Melissa N.; Auble, David T.			TATA-binding Protein Variants That Bypass the Requirement for Mot1 in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-II TRANSCRIPTION; GENE-EXPRESSION; TBP BINDING; CRYSTAL-STRUCTURE; MINOR-GROOVE; RNA; DNA; RECRUITMENT; PROMOTER; COMPLEX	Mot1 is an essential TATA-binding protein (TBP)-associated factor and Snf2/Swi2 ATPase that both represses and activates transcription. Biochemical and structural results support a model in which ATP binding and hydrolysis induce a conformational change in Mot1 that drives local translocation along DNA, thus removing TBP. Although this activity explains transcriptional repression, it does not as easily explain Mot1-mediated transcriptional activation, and several different models have been proposed to explain how Mot1 activates transcription. To better understand the function of Mot1 in yeast cells in vivo, particularly with regard to gene activation, TBP mutants were identified that bypass the requirement for Mot1 in vivo. Although TBP has been extensively mutated and analyzed previously, this screen uncovered two novel TBP variants that are unique in their ability to bypass the requirement for Mot1. Surprisingly, in vitro analyses reveal that rather than having acquired an improved biochemical activity, one of the TBPs was defective for interaction with polymerase II preinitiation complex (PIC) components and other regulators of TBP function. The other mutant was defective for DNA binding in vitro yet was still recruited to chromatin in vivo. These results suggest that Mot1-mediated dissociation of TBP (or TBP-containing complexes) from chromatin can explain the Mot1 activation mechanism at some promoters. The results also suggest that PICs can be dynamically unstable and that appropriate PIC instability is critical for the regulation of transcription in vivo.	[Sprouse, Rebekka O.; Wells, Melissa N.; Auble, David T.] Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of Virginia	Auble, DT (corresponding author), 1340 Jefferson Pk Ave,POB 800733, Charlottesville, VA 22908 USA.	dta4n@virginia.edu			National Institutes of Health [GM55763]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055763, T32GM008136] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM55763 (to D. T. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adamkewicz JI, 2001, J BIOL CHEM, V276, P11883, DOI 10.1074/jbc.M010665200; Andrau JC, 2002, EMBO J, V21, P5173, DOI 10.1093/emboj/cdf485; ARNDT KM, 1995, EMBO J, V14, P1490, DOI 10.1002/j.1460-2075.1995.tb07135.x; AUBLE DT, 1993, GENE DEV, V7, P844, DOI 10.1101/gad.7.5.844; AUBLE DT, 1994, GENE DEV, V8, P1920, DOI 10.1101/gad.8.16.1920; Auble DT, 1997, MOL CELL BIOL, V17, P4842, DOI 10.1128/MCB.17.8.4842; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Blair WS, 1997, MOL CELL BIOL, V17, P2888, DOI 10.1128/MCB.17.5.2888; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Cang Y, 1999, EMBO J, V18, P6662, DOI 10.1093/emboj/18.23.6662; Chitikila C, 2002, MOL CELL, V10, P871, DOI 10.1016/S1097-2765(02)00683-4; COLGAN J, 1992, GENE DEV, V6, P304, DOI 10.1101/gad.6.2.304; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; Darst RP, 2003, J BIOL CHEM, V278, P13216, DOI 10.1074/jbc.M211445200; Darst RP, 2001, EMBO J, V20, P2028, DOI 10.1093/emboj/20.8.2028; Dasgupta A, 2005, EMBO J, V24, P1717, DOI 10.1038/sj.emboj.7600646; Dasgupta A, 2002, P NATL ACAD SCI USA, V99, P2666, DOI 10.1073/pnas.052397899; Dasgupta A, 2007, MOL CELL BIOL, V27, P2886, DOI 10.1128/MCB.00054-07; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Davidson I, 2003, TRENDS BIOCHEM SCI, V28, P391, DOI 10.1016/S0968-0004(03)00117-8; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; GANSHEROFF LJ, 1995, GENETICS, V139, P523; Geisberg JV, 2004, MOL CELL, V14, P479, DOI 10.1016/j.molcel.2004.05.003; Geisberg JV, 2002, MOL CELL BIOL, V22, P8122, DOI 10.1128/MCB.22.23.8122-8134.2002; Geisberg JV, 2001, MOL CELL BIOL, V21, P2736, DOI 10.1128/MCB.21.8.2736-2742.2001; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; HOOPES BC, 1992, J BIOL CHEM, V267, P11539; Huisinga KL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r46; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Jackson-Fisher AJ, 1999, MOL CELL, V3, P717, DOI 10.1016/S1097-2765(01)80004-6; Kamada K, 2001, CELL, V106, P71, DOI 10.1016/S0092-8674(01)00417-2; Karpova TS, 2008, SCIENCE, V319, P466, DOI 10.1126/science.1150559; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; Kim JW, 2004, MOL CELL BIOL, V24, P8104, DOI 10.1128/MCB.24.18.8104-8112.2004; KIM TK, 1995, J BIOL CHEM, V270, P10976, DOI 10.1074/jbc.270.18.10976; KLEIN C, 1994, SCIENCE, V266, P280, DOI 10.1126/science.7939664; Klejman MP, 2004, MOL CELL BIOL, V24, P10072, DOI 10.1128/MCB.24.22.10072-10082.2004; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; Lee M, 1997, MOL CELL BIOL, V17, P1336, DOI 10.1128/MCB.17.3.1336; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; Li XY, 1999, NATURE, V399, P605, DOI 10.1038/21232; Liu DJ, 1998, CELL, V94, P573, DOI 10.1016/S0092-8674(00)81599-8; Masson P, 2008, NUCLEIC ACIDS RES, V36, P539, DOI 10.1093/nar/gkm1078; Matangkasombut O, 2004, ADV PROTEIN CHEM, V67, P67; Moss T, 2004, CURR OPIN GENET DEV, V14, P210, DOI 10.1016/j.gde.2004.02.005; Muldrow TA, 1999, MOL CELL BIOL, V19, P2835; Muller F, 2004, EMBO J, V23, P2, DOI 10.1038/sj.emboj.7600027; Patikoglou GA, 1999, GENE DEV, V13, P3217, DOI 10.1101/gad.13.24.3217; Patterson GH, 1998, YEAST, V14, P813, DOI 10.1002/(SICI)1097-0061(19980630)14:9<813::AID-YEA280>3.0.CO;2-2; Pereira LA, 2003, GENE, V315, P1, DOI 10.1016/S0378-1119(03)00714-5; Petri V, 1998, BIOCHEMISTRY-US, V37, P15842, DOI 10.1021/bi981072u; Pray-Grant MG, 2002, MOL CELL BIOL, V22, P8774, DOI 10.1128/MCB.22.24.8774-8786.2002; RANISH JA, 1991, J BIOL CHEM, V266, P19320; Reese JC, 2003, CURR OPIN GENET DEV, V13, P114, DOI 10.1016/S0959-437X(03)00013-3; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; SIKORSKI RS, 1989, GENETICS, V122, P19; Sprouse RO, 2008, P NATL ACAD SCI USA, V105, P13304, DOI 10.1073/pnas.0801901105; Sprouse RO, 2008, J BIOL CHEM, V283, P24935, DOI 10.1074/jbc.M803749200; Stargell LA, 1996, MOL CELL BIOL, V16, P4456; STARGELL LA, 1995, SCIENCE, V269, P75, DOI 10.1126/science.7604282; Sterner DE, 2002, P NATL ACAD SCI USA, V99, P11622, DOI 10.1073/pnas.182021199; Topalidou I, 2004, EMBO J, V23, P1943, DOI 10.1038/sj.emboj.7600199; van Oevelen CJC, 2005, MOL CELL BIOL, V25, P4863, DOI 10.1128/MCB.25.12.4863-4872.2005; van Werven FJ, 2008, GENE DEV, V22, P2359, DOI 10.1101/gad.1682308; Weng L, 2006, BIOINFORMATICS, V22, P1111, DOI 10.1093/bioinformatics/btl045; Yudkovsky N, 2000, NATURE, V408, P225, DOI 10.1038/35041603; Zanton SJ, 2004, P NATL ACAD SCI USA, V101, P16843, DOI 10.1073/pnas.0404988101	67	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4525	4535		10.1074/jbc.M808951200	http://dx.doi.org/10.1074/jbc.M808951200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19098311	hybrid, Green Published			2022-12-25	WOS:000263134400053
J	Ren, Y; Jiang, H; Yang, F; Nakaso, K; Feng, J				Ren, Yong; Jiang, Houbo; Yang, Fang; Nakaso, Kazuhiro; Feng, Jian			Parkin Protects Dopaminergic Neurons against Microtubule-depolymerizing Toxins by Attenuating Microtubule-associated Protein Kinase Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROTENONE INHIBITION; TUBULIN; DISEASE; PHOSPHORYLATION; PATHWAYS; CELLS	Mitogen-activated protein kinases, originally known as microtubule-associated protein (MAP) kinases, are activated in response to a variety of stimuli. Here we report that microtubule-depolymerizing agents such as colchicine or nocodazole induced strong activation of MAP kinases including JNK, ERK, and p38. This effect was markedly attenuated by parkin, whose mutations are linked to Parkinson disease (PD). Our previous study has shown that parkin stabilizes microtubules through strong interactions mediated by three independent domains. We found that each of the three microtubule-binding domains of parkin was sufficient to reduce MAP kinase activation induced by microtubule depolymerization. The ability to attenuate microtubule depolymerization and the ensuing MAP kinase activation was abrogated in B-lymphocytes and fibroblasts derived from PD patients with parkin mutations such as exon 4 deletion. Such mutations produced truncated parkin proteins lacking any microtubule binding domain and prevented parkin from protecting midbrain dopaminergic neurons against microtubule-depolymerizing toxins such as rotenone or colchicine. Consistent with these, blocking MAP kinase activation in midbrain dopaminergic neurons by knocking down MAP kinase kinases (MKK) significantly reduced the selective toxicity of rotenone or colchicine. Conversely, overexpression of MAP kinases caused marked toxicities that were significantly attenuated by parkin. Thus, the results suggest that parkin protects midbrain dopaminergic neurons against microtubule-depolymerizing PD toxins such as rotenone by stabilizing microtubules to attenuate MAP kinase activation.	[Ren, Yong; Jiang, Houbo; Yang, Fang; Feng, Jian] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA; [Nakaso, Kazuhiro] Tottori Univ, Dept Neurol, Yonago, Tottori 6838504, Japan	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Tottori University	Feng, J (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, 124 Sherman Hall, Buffalo, NY 14214 USA.	jianfeng@buffalo.edu			National Institutes of Health [NS41722]; New York State Center of Excellence in Bioinformatics and Life Sciences; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041722] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Center of Excellence in Bioinformatics and Life Sciences; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS41722 (to J. F.). This work was also supported by the New York State Center of Excellence in Bioinformatics and Life Sciences (to J. F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; BRINKLEY BR, 1974, EXP CELL RES, V85, P41, DOI 10.1016/0014-4827(74)90210-9; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; Dogu O, 2004, MOVEMENT DISORD, V19, P812, DOI 10.1002/mds.20028; Feijoo C, 2005, J CELL SCI, V118, P397, DOI 10.1242/jcs.01655; Feng J, 2006, NEUROSCIENTIST, V12, P469, DOI 10.1177/1073858406293853; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Jiang HB, 2004, HUM MOL GENET, V13, P1745, DOI 10.1093/hmg/ddh180; Lewis SA, 1997, TRENDS CELL BIOL, V7, P479, DOI 10.1016/S0962-8924(97)01168-9; MARSHALL LE, 1978, BIOCHIM BIOPHYS ACTA, V543, P590, DOI 10.1016/0304-4165(78)90315-X; Nakaso K, 2006, NEUROSCI LETT, V400, P44, DOI 10.1016/j.neulet.2006.02.035; RAY LB, 1988, P NATL ACAD SCI USA, V85, P3753, DOI 10.1073/pnas.85.11.3753; Ren Y, 2005, J BIOL CHEM, V280, P34105, DOI 10.1074/jbc.M503483200; Ren Y, 2003, J NEUROSCI, V23, P3316; RESZKA AA, 1995, P NATL ACAD SCI USA, V92, P8881, DOI 10.1073/pnas.92.19.8881; STURGILL TW, 1986, BIOCHEM BIOPH RES CO, V134, P565, DOI 10.1016/S0006-291X(86)80457-0; Yang F, 2005, J BIOL CHEM, V280, P17154, DOI 10.1074/jbc.M500843200; Yuen EY, 2005, J NEUROSCI, V25, P5488, DOI 10.1523/JNEUROSCI.1187-05.2005	19	76	78	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					4009	4017		10.1074/jbc.M806245200	http://dx.doi.org/10.1074/jbc.M806245200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19074146	Green Published, hybrid			2022-12-25	WOS:000262872500069
J	Laouar, A; Manocha, M; Haridas, V; Manjunath, N				Laouar, Amale; Manocha, Monika; Haridas, Viraga; Manjunath, N.			Concurrent Generation of Effector and Central Memory CD8 T Cells during Vaccinia Virus Infection	PLOS ONE			English	Article								It is generally thought that during the contraction phase of an acute anti-viral T cell reponse, the effector T cells that escape activation-induced cell death eventually differentiate into central memory T cells over the next several weeks. Here we report that antigen-specific CD8T cells with the phenotype and function of central memory cells develop concomitantly with effector T cells during vaccinia virus (vv) infection. As soon as 5 days after an intraperitoneal infection with vv, we could identify a subset of CD44(hi) and CD62L(+) vv-specific CD8 T cells in the peritoneal exudate lymphocytes. This population constituted approximately 10% of all antigen-specific T cells and like central memory T cells, they also expressed high levels of CCR7 and IL-7R but expressed little granzyme B. Importantly, upon adoptive transfer into naive congenic hosts, CD62L(+), but not CD62L(-) CD8 T cells were able to expand and mediate a rapid recall response to a new vv challenge initiated 6 weeks after transfer, confirming that the CD62L(+) vv-specific CD8 T cells are bonafide memory cells. Our results are thus consistent with the branched differentiation model, where effector and memory cells develop simultaneously. These results are likely to have implications in the context of vaccine design, particularly those based on vaccinia virus recombinants.	[Laouar, Amale; Manocha, Monika; Haridas, Viraga; Manjunath, N.] Harvard Univ, Sch Med, Immune Dis Inst Inc, Boston, MA 02115 USA; [Laouar, Amale; Manocha, Monika; Haridas, Viraga; Manjunath, N.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School	Laouar, A (corresponding author), Harvard Univ, Sch Med, Immune Dis Inst Inc, Boston, MA 02115 USA.	laouar@cbr.med.harvard.edu; manjunath.swamy@ttuhsc.edu	Laouar, Amale/AAO-2903-2020		NIH/NIAID	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH/NIAID. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Amanna IJ, 2006, IMMUNOL REV, V211, P320, DOI 10.1111/j.0105-2896.2006.00392.x; Antia R, 2005, NAT REV IMMUNOL, V5, P101, DOI 10.1038/nri1550; Bachmann MF, 2005, J IMMUNOL, V175, P4686, DOI 10.4049/jimmunol.175.7.4686; Badovinac VP, 2006, IMMUNOL REV, V211, P67, DOI 10.1111/j.0105-2896.2006.00384.x; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Carrio R, 2004, J IMMUNOL, V172, P7315, DOI 10.4049/jimmunol.172.12.7315; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Curtsinger JM, 1998, J IMMUNOL, V160, P3236; Gourley TS, 2004, SEMIN IMMUNOL, V16, P323, DOI 10.1016/j.smim.2004.08.013; Holmes S, 2005, P NATL ACAD SCI USA, V102, P5519, DOI 10.1073/pnas.0501437102; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Lanzavecchia A, 2002, NAT REV IMMUNOL, V2, P982, DOI 10.1038/nri959; Laouar A, 2005, NAT IMMUNOL, V6, P698, DOI 10.1038/ni1212; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI13296; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Masopust D, 2007, EUR J IMMUNOL, V37, pS103, DOI 10.1002/eji.200737584; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Opferman JT, 1999, SCIENCE, V283, P1745, DOI 10.1126/science.283.5408.1745; Richards H, 2008, J IMMUNOL, V180, P198, DOI 10.4049/jimmunol.180.1.198; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schildknecht A, 2007, EUR J IMMUNOL, V37, P716, DOI 10.1002/eji.200636824; Sprent J, 2001, SCIENCE, V293, P245, DOI 10.1126/science.1062416; Tscharke DC, 2005, J EXP MED, V201, P95, DOI 10.1084/jem.20041912; Unsoeld H, 2005, J VIROL, V79, P4510, DOI 10.1128/JVI.79.7.4510-4513.2005; Weninger W, 2002, IMMUNOL REV, V186, P221, DOI 10.1034/j.1600-065X.2002.18618.x; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Wolint P, 2004, J EXP MED, V199, P925, DOI 10.1084/jem.20031799	30	25	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4089	10.1371/journal.pone.0004089	http://dx.doi.org/10.1371/journal.pone.0004089			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DO	19116651	Green Published, Green Submitted, gold			2022-12-25	WOS:000265466600010
J	Feng, L; Reeves, PR; Lan, RT; Ren, Y; Gao, CX; Zhou, ZM; Ren, Y; Cheng, JS; Wang, W; Wang, JM; Qian, WB; Li, D; Wang, L				Feng, Lu; Reeves, Peter R.; Lan, Ruiting; Ren, Yi; Gao, Chunxu; Zhou, Zhemin; Ren, Yan; Cheng, Jiansong; Wang, Wei; Wang, Jianmei; Qian, Wubin; Li, Dan; Wang, Lei			A Recalibrated Molecular Clock and Independent Origins for the Cholera Pandemic Clones	PLOS ONE			English	Article								Cholera, caused by Vibrio cholerae, erupted globally from South Asia in 7 pandemics, but there were also local outbreaks between the 6(th) (1899-1923) and 7(th) (1961-present) pandemics. All the above are serotype O1, whereas environmental or invertebrate isolates are antigenically diverse. The pre 7th pandemic isolates mentioned above, and other minor pathogenic clones, are related to the 7(th) pandemic clone, while the 6(th) pandemic clone is in the same lineage but more distantly related, and non-pathogenic isolates show no clonal structure. To understand the origins and relationships of the pandemic clones, we sequenced the genomes of a 1937 prepandemic strain and a 6(th) pandemic isolate, and compared them with the published 7(th) pandemic genome. We distinguished mutational and recombinational events, and allocated these and other events, to specific branches in the evolutionary tree. There were more mutational than recombinational events, but more genes, and 44 times more base pairs, changed by recombination. We used the mutational single-nucleotide polymorphisms and known isolation dates of the prepandemic and 7(th) pandemic isolates to estimate the mutation rate, and found it to be 100 fold higher than usually assumed. We then used this to estimate the divergence date of the 6(th) and 7(th) pandemic clones to be about 1880. While there is a large margin of error, this is far more realistic than the 10,000-50,000 years ago estimated using the usual assumptions. We conclude that the 2 pandemic clones gained pandemic potential independently, and overall there were 29 insertions or deletions of one or more genes. There were also substantial changes in the major integron, attributed to gain of individual cassettes including copying from within, or loss of blocks of cassettes. The approaches used open up new avenues for analysing the origin and history of other important pathogens.	[Feng, Lu; Ren, Yi; Gao, Chunxu; Zhou, Zhemin; Ren, Yan; Cheng, Jiansong; Wang, Wei; Wang, Jianmei; Qian, Wubin; Li, Dan; Wang, Lei] Nankai Univ, TEDA Sch Biol Sci & Biotechnol, Tianjin 300071, Peoples R China; [Feng, Lu; Wang, Lei] TEDA, Tianjin Res Ctr Funct Genom & Biochip, Tianjin, Peoples R China; [Reeves, Peter R.] Univ Sydney, Sch Mol & Microb Biosci, Sydney, NSW 2006, Australia; [Lan, Ruiting] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Wang, Wei; Wang, Lei] Nankai Univ, TEDA, Tianjin Key Lab Microb Funct Genom, Tianjin, Peoples R China	Nankai University; University of Sydney; University of New South Wales Sydney; Nankai University	Feng, L (corresponding author), Nankai Univ, TEDA Sch Biol Sci & Biotechnol, Tianjin 300071, Peoples R China.	wanglei@nankai.edu.cn	Zhou, Zhemin/AAX-5539-2020; Wang, Lei/C-5176-2009; feng, lu/M-5113-2015; Wang, Jianmei/HHZ-0585-2022; Reeves, Peter R/A-6064-2008	Zhou, Zhemin/0000-0001-9783-0366; Wang, Lei/0000-0003-4427-0881; Reeves, Peter R/0000-0003-4479-7974; Lan, Ruiting/0000-0001-9834-5258; Wang, Wei/0000-0002-6660-8540	Tianjin Municipal Special Fund for Science and Technology Innovation [05FZZDSH00800]; National Natural Science Foundation of China (NSFC) [30530010, 20536040, 30670038]; National 863 program of China [2006AA020703, 2006AA06Z409]; National Key Science and Technology Project from Ministry of Health of the People's Republic of China [2008ZX10004-009]; National 973 program of China [2007CB9143010, 2009CB522603]	Tianjin Municipal Special Fund for Science and Technology Innovation; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National 863 program of China(National High Technology Research and Development Program of China); National Key Science and Technology Project from Ministry of Health of the People's Republic of China; National 973 program of China(National Basic Research Program of China)	This work was supported by the Tianjin Municipal Special Fund for Science and Technology Innovation Grant 05FZZDSH00800, the National Natural Science Foundation of China (NSFC) Key Programs Grants 30530010 and 20536040, NSFC General Program Grant 30670038, the National 863 program of China Grants 2006AA020703 and 2006AA06Z409, The National Key Science and Technology Project from Ministry of Health of the People's Republic of China Grant 2008ZX10004-009 and the National 973 program of China Grants 2007CB9143010 and 2009CB522603. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Berriman Matt, 2003, Briefings in Bioinformatics, V4, P124, DOI 10.1093/bib/4.2.124; Blake Paul A., 1994, P293; Bouvier M, 2005, EMBO J, V24, P4356, DOI 10.1038/sj.emboj.7600898; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Chain PSG, 2006, J BACTERIOL, V188, P4453, DOI 10.1128/JB.00124-06; Collis CM, 2002, MOL MICROBIOL, V46, P1415, DOI 10.1046/j.1365-2958.2002.03260.x; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Dziejman M, 2002, P NATL ACAD SCI USA, V99, P1556, DOI 10.1073/pnas.042667999; Faruque SM, 2003, P NATL ACAD SCI USA, V100, P1304, DOI 10.1073/pnas.0337468100; GUIDOLIN A, 1987, MICROBIOL REV, V51, P285, DOI 10.1128/MMBR.51.2.285-298.1987; GUTTMAN DS, 1994, SCIENCE, V266, P1380, DOI 10.1126/science.7973728; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Ho SYW, 2007, SYST BIOL, V56, P515, DOI 10.1080/10635150701435401; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; KAPUR V, 1994, J INFECT DIS, V170, P1348, DOI 10.1093/infdis/170.5.1348; Kidgell C, 2002, INFECT GENET EVOL, V2, P39, DOI 10.1016/S1567-1348(02)00089-8; Lerat E, 2004, GENOME RES, V14, P2273, DOI 10.1101/gr.2925604; MacDonald D, 2006, NATURE, V440, P1157, DOI 10.1038/nature04643; Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462; Meibom KL, 2005, SCIENCE, V310, P1824, DOI 10.1126/science.1120096; Miller MC, 2007, APPL ENVIRON MICROB, V73, P3695, DOI 10.1128/AEM.02735-06; MUKERJEE S, 1963, AM J TROP MED HYG, V12, P388, DOI 10.4269/ajtmh.1963.12.388; Pupo GM, 2000, P NATL ACAD SCI USA, V97, P10567, DOI 10.1073/pnas.180094797; Reeves PR, 1998, BRIT MED BULL, V54, P611, DOI 10.1093/oxfordjournals.bmb.a011714; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; Rowe-Magnus DA, 2003, GENOME RES, V13, P428, DOI 10.1101/gr.617103; Safa A, 2005, J CLIN MICROBIOL, V43, P1401, DOI 10.1128/JCM.43.3.1401-1404.2005; Salim A, 2005, EMERG INFECT DIS, V11, P1758, DOI 10.3201/eid1111.041170; Thomason Lynn, 2007, Curr Protoc Mol Biol, VChapter 1, DOI 10.1002/0471142727.mb0117s79; WHITTAM TS, 1996, ESCHERICHIA COLI SAL, P2708; Zhang W, 2006, GENOME RES, V16, P757, DOI 10.1101/gr.4759706	32	115	1066	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2008	3	12							e4053	10.1371/journal.pone.0004053	http://dx.doi.org/10.1371/journal.pone.0004053			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DL	19115014	Green Submitted, gold, Green Published			2022-12-25	WOS:000265466300003
J	Habig, JW; Aruscavage, PJ; Bass, BL				Habig, Jeffrey W.; Aruscavage, P. Joseph; Bass, Brenda L.			In C. elegans, High Levels of dsRNA Allow RNAi in the Absence of RDE-4	PLOS ONE			English	Article								C. elegans Dicer requires an accessory double-stranded RNA binding protein, RDE-4, to enact the first step of RNA interference, the cleavage of dsRNA to produce siRNA. While RDE-4 is typically essential for RNAi, we report that in the presence of high concentrations of trigger dsRNA, rde-4 deficient animals are capable of silencing a transgene. By multiple criteria the silencing occurs by the canonical RNAi pathway. For example, silencing is RDE-1 dependent and exhibits a decrease in the targeted mRNA in response to an increase in siRNA. We also find that high concentrations of dsRNA trigger lead to increased accumulation of primary siRNAs, consistent with the existence of a rate-limiting step during the conversion of primary to secondary siRNAs. Our studies also revealed that transgene silencing occurs at low levels in the soma, even in the presence of ADARs, and that at least some siRNAs accumulate in a temperature-dependent manner. We conclude that an RNAi response varies with different conditions, and this may allow an organism to tailor a response to specific environmental signals.	[Habig, Jeffrey W.; Aruscavage, P. Joseph; Bass, Brenda L.] Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA; [Habig, Jeffrey W.; Aruscavage, P. Joseph; Bass, Brenda L.] Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; [Habig, Jeffrey W.] Crowley Davis Res, Eagle, ID USA	Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Habig, JW (corresponding author), Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA.	bbass@biochem.utah.edu			National Institutes of Health [GM067106]; Howard Hughes Medical Institute Investigator; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Investigator(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funds to B.L.B. from the National Institutes of Health (GM067106). B.L.B. is a Howard Hughes Medical Institute Investigator. The study sponsor (BLB) helped in the design, analysis and interpretation of the data, as well as in writing of the paper and the decision to submit the work for publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Aoki K, 2007, EMBO J, V26, P5007, DOI 10.1038/sj.emboj.7601910; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Blanchard D, 2006, MOL CELL PROTEOMICS, V5, P2175, DOI 10.1074/mcp.T600025-MCP200; BRENNER S, 1974, GENETICS, V77, P71; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; EMMONS SW, 1979, P NATL ACAD SCI USA, V76, P1333, DOI 10.1073/pnas.76.3.1333; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; HOUGH RF, 1994, J BIOL CHEM, V269, P9933; Jannot G, 2008, RNA, V14, P829, DOI 10.1261/rna.901908; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Knight SW, 2002, MOL CELL, V10, P809, DOI 10.1016/S1097-2765(02)00649-4; Lee RC, 2006, RNA, V12, P589, DOI 10.1261/rna.2231506; Mello C, 1995, METHOD CELL BIOL, V48, P451; Paddison PJ, 2008, RNA INTERFERENCE; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112; Parker GS, 2008, J MOL BIOL, V384, P967, DOI 10.1016/j.jmb.2008.10.002; Parker GS, 2006, RNA, V12, P807, DOI 10.1261/rna.2338706; Parrish S, 2001, RNA, V7, P1397; Robert VJP, 2005, GENE DEV, V19, P782, DOI 10.1101/gad.332305; Scadden ADJ, 2001, EMBO REP, V2, P1107, DOI 10.1093/embo-reports/kve244; Schott DH, 2005, P NATL ACAD SCI USA, V102, P18420, DOI 10.1073/pnas.0507123102; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Steiner FA, 2007, NAT STRUCT MOL BIOL, V14, P927, DOI 10.1038/nsmb1308; STINCHCOMB DT, 1985, MOL CELL BIOL, V5, P3484, DOI 10.1128/MCB.5.12.3484; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582; Zhang Y, 2006, NUCLEIC ACIDS RES, V34, P3465, DOI 10.1093/nar/gkl473	32	17	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2008	3	12							e4052	10.1371/journal.pone.0004052	http://dx.doi.org/10.1371/journal.pone.0004052			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DI	19112503	gold, Green Submitted, Green Published			2022-12-25	WOS:000265466000014
J	Nestor, A; Vettel, JM; Tarr, MJ				Nestor, Adrian; Vettel, Jean M.; Tarr, Michael J.			Task-Specific Codes for Face Recognition: How they Shape the Neural Representation of Features for Detection and Individuation	PLOS ONE			English	Article							OBJECT RECOGNITION; PERCEPTION; FUSIFORM; FMRI; AREA; PROSOPAGNOSIA; INFORMATION; ACTIVATION; IDENTITY; FRAGMENTS	Background: The variety of ways in which faces are categorized makes face recognition challenging for both synthetic and biological vision systems. Here we focus on two face processing tasks, detection and individuation, and explore whether differences in task demands lead to differences both in the features most effective for automatic recognition and in the featural codes recruited by neural processing. Methodology/Principal Findings: Our study appeals to a computational framework characterizing the features representing object categories as sets of overlapping image fragments. Within this framework, we assess the extent to which task-relevant information differs across image fragments. Based on objective differences we find among task-specific representations, we test the sensitivity of the human visual system to these different face descriptions independently of one another. Both behavior and functional magnetic resonance imaging reveal effects elicited by objective task-specific levels of information. Behaviorally, recognition performance with image fragments improves with increasing task-specific information carried by different face fragments. Neurally, this sensitivity to the two tasks manifests as differential localization of neural responses across the ventral visual pathway. Fragments diagnostic for detection evoke larger neural responses than non-diagnostic ones in the right posterior fusiform gyrus and bilaterally in the inferior occipital gyrus. In contrast, fragments diagnostic for individuation evoke larger responses than non-diagnostic ones in the anterior inferior temporal gyrus. Finally, for individuation only, pattern analysis reveals sensitivity to task-specific information within the right "fusiform face area". Conclusions/Significance: Our results demonstrate: 1) information diagnostic for face detection and individuation is roughly separable; 2) the human visual system is independently sensitive to both types of information; 3) neural responses differ according to the type of task-relevant information considered. More generally, these findings provide evidence for the computational utility and the neural validity of fragment-based visual representation and recognition.	[Nestor, Adrian; Vettel, Jean M.; Tarr, Michael J.] Brown Univ, Dept Cognit & Linguist Sci, Providence, RI 02912 USA	Brown University	Nestor, A (corresponding author), Brown Univ, Dept Cognit & Linguist Sci, Providence, RI 02912 USA.	michael_tarr@brown.edu		Nestor, Adrian/0000-0002-2250-8759	NSF [0339122, SBE-0542013]; The Ittleson Foundation; DOD SMART Graduate Fellowship	NSF(National Science Foundation (NSF)); The Ittleson Foundation; DOD SMART Graduate Fellowship	This research was supported by NSF Award #0339122, by the Temporal Dynamics of Learning Center (NSF Science of Learning Center SBE-0542013), and through the generosity of The Ittleson Foundation. The MRI system used in the study was purchased in part by an MRI grant from the NSF. JMV was supported by a DOD SMART Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avidan G, 2005, J COGNITIVE NEUROSCI, V17, P1150, DOI 10.1162/0898929054475145; Balas BJ, 2006, ACM T APPL PERCEPT, V3, P354, DOI DOI 10.1145/1190036.1190038; Barton JJS, 2002, NEUROLOGY, V58, P71, DOI 10.1212/WNL.58.1.71; Behrmann M, 2007, CEREB CORTEX, V17, P2354, DOI 10.1093/cercor/bhl144; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Cover TM, 1991, ELEMENTS INFORM THEO; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; DAMASIO AR, 1982, NEUROLOGY, V32, P331, DOI 10.1212/WNL.32.4.331; Eckstein MP, 2002, J VISION, V2, pI, DOI 10.1167/2.1.i; Epshtein B, 2008, P NATL ACAD SCI USA, V105, P14298, DOI 10.1073/pnas.0800968105; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; Gosselin F, 2001, VISION RES, V41, P2261, DOI 10.1016/S0042-6989(01)00097-9; Gosselin F, 2004, VISION RES, V44, P471, DOI 10.1016/j.visres.2003.10.007; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Hadjikhani N, 2002, HUM BRAIN MAPP, V16, P176, DOI 10.1002/hbm.10043; Hancock PJB, 1996, MEM COGNITION, V24, P26, DOI 10.3758/BF03197270; Harel A, 2007, VISION RES, V47, P2010, DOI 10.1016/j.visres.2007.04.004; Hasson U, 2003, J COGNITIVE NEUROSCI, V15, P419, DOI 10.1162/089892903321593135; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Hegde J, 2008, CURR BIOL, V18, P597, DOI 10.1016/j.cub.2008.03.058; Jiang X, 2006, NEURON, V50, P159, DOI 10.1016/j.neuron.2006.03.012; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kriegeskorte N, 2007, P NATL ACAD SCI USA, V104, P20600, DOI 10.1073/pnas.0705654104; Lerner Y, 2008, J COGNITIVE NEUROSCI, V20, P1189, DOI 10.1162/jocn.2008.20082; Liu J, 2002, NAT NEUROSCI, V5, P910, DOI 10.1038/nn909; Loffler G, 2005, NAT NEUROSCI, V8, P1386, DOI 10.1038/nn1538; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; Moghaddam B, 2000, PATTERN RECOGN, V33, P1771, DOI 10.1016/S0031-3203(99)00179-X; Murray RF, 2002, J VISION, V2, P79, DOI 10.1167/2.1.6; Neri P, 2006, VISION RES, V46, P2465, DOI 10.1016/j.visres.2006.02.002; Nestor A, 2008, J VISION, V8, DOI 10.1167/8.7.7; O'Toole AJ, 2007, J COGNITIVE NEUROSCI, V19, P1735, DOI 10.1162/jocn.2007.19.11.1735; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pourtois G, 2005, J COGNITIVE NEUROSCI, V17, P1043, DOI 10.1162/0898929054475181; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Rotshtein P, 2005, NAT NEUROSCI, V8, P107, DOI 10.1038/nn1370; Serre T, 2007, P NATL ACAD SCI USA, V104, P6424, DOI 10.1073/pnas.0700622104; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Talairach J., 1988, COPLANAR STEREOTAXIC; THOMAS C, NAT NEUROSC IN PRESS; Thomas C, 2008, J COGNITIVE NEUROSCI, V20, P268, DOI 10.1162/jocn.2008.20025; TURK M, 1991, J COGNITIVE NEUROSCI, V3, P71, DOI 10.1162/jocn.1991.3.1.71; Ullman S, 2002, NAT NEUROSCI, V5, P682, DOI 10.1038/nn870; Ullman S, 2007, TRENDS COGN SCI, V11, P58, DOI 10.1016/j.tics.2006.11.009; Winston JS, 2004, J NEUROPHYSIOL, V92, P1830, DOI 10.1152/jn.00155.2004; Zhang L., 2005, P 27 ANN COGN SCI C, P2428; Zhao W, 2003, ACM COMPUT SURV, V35, P399, DOI 10.1145/954339.954342	51	52	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2008	3	12							e3978	10.1371/journal.pone.0003978	http://dx.doi.org/10.1371/journal.pone.0003978			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437DI	19112516	gold, Green Published, Green Submitted			2022-12-25	WOS:000265466000001
J	Han, D; Kim, K; Kim, Y; Kang, Y; Lee, JY; Kim, Y				Han, Dohyun; Kim, Kyunggon; Kim, Yeonjung; Kang, Yup; Lee, Ji Yoon; Kim, Youngsoo			Crystal Structure of the N-terminal Domain of Anaphase-promoting Complex Subunit 7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOMATED STRUCTURE SOLUTION; PROTEIN-STRUCTURE; DENSITY MODIFICATION; SECONDARY-STRUCTURE; TPR SUBUNITS; CDH1; MODEL; APC/C; MITOSIS; COMPLEX/CYCLOSOME	Anaphase-promoting complex or cyclosome (APC/C) is an unusual E3 ubiquitin ligase and an essential protein that controls mitotic progression. APC/C includes at least 13 subunits, but no structure has been determined for any tetratricopeptide repeat (TPR)-containing subunit (Apc3 and -6-8) in the TPR subcomplex of APC/C. Apc7 is a TPR-containing subunit that exists only in vertebrate APC/C. Here we report the crystal structure of quad mutant of nApc7 (N-terminal fragment, residues 1-147) of human Apc7 at a resolution of 2.5 angstrom. The structure of nApc7 adopts a TPR-like motif and has a unique dimerization interface, although the protein does not contain the conserved TPR sequence. Based on the structure of nApc7, in addition to previous experimental findings, we proposed a putative homodimeric structure for full-length Apc7. This model suggests that TPR-containing subunits self-associate and bind to adaptors and substrates via an IR peptide in TPR-containing subunits of APC/C.	[Kim, Youngsoo] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Chongno Ku, Seoul 110799, South Korea; [Han, Dohyun; Kim, Kyunggon; Kim, Yeonjung; Kim, Youngsoo] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul 110799, South Korea; [Kang, Yup] Ajou Univ, Inst Med Sci, Sch Med, Suwon 442749, Kyunggi Do, South Korea; [Lee, Ji Yoon] Seoul Natl Univ, Natl Instrumentat Ctr Environm Management, Seoul 151921, South Korea	Seoul National University (SNU); Seoul National University (SNU); Ajou University; Seoul National University (SNU)	Kim, Y (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci, Chongno Ku, 28 Yongon Dong, Seoul 110799, South Korea.	biolab@snu.ac.kr	Han, Dohyun/AAU-7871-2020; Kim, Youngsoo/D-6046-2012	Han, Dohyun/0000-0002-0841-1598; 	Korean Ministry of Science and Technology [FPR 08-A2-110]; Innovative Research Institute for Cell Therapy, Republic of Korea [A062260]	Korean Ministry of Science and Technology(Ministry of Science & Technology (MOST), Republic of Korea); Innovative Research Institute for Cell Therapy, Republic of Korea	This work was supported by the 21C Frontier Functional Proteomics Project of the Korean Ministry of Science and Technology Grant FPR 08-A2-110 and by the Innovative Research Institute for Cell Therapy, Republic of Korea, Grant A062260.	Dube P, 2005, MOL CELL, V20, P867, DOI 10.1016/j.molcel.2005.11.008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eytan E, 2006, P NATL ACAD SCI USA, V103, P2081, DOI 10.1073/pnas.0510695103; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Gieffers C, 2001, MOL CELL, V7, P907, DOI 10.1016/S1097-2765(01)00234-9; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Gonzalez A, 2003, ACTA CRYSTALLOGR D, V59, P1935, DOI 10.1107/S0907444903017700; Han D, 2008, PROTEINS, V70, P900, DOI 10.1002/prot.21597; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Hayes MJ, 2006, NAT CELL BIOL, V8, P607, DOI 10.1038/ncb1410; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAMB JR, 1994, EMBO J, V13, P4321, DOI 10.1002/j.1460-2075.1994.tb06752.x; Main ERG, 2003, STRUCTURE, V11, P497, DOI 10.1016/S0969-2126(03)00076-5; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Nyarko A, 2007, BIOCHEMISTRY-US, V46, P11331, DOI 10.1021/bi700735t; Ohi MD, 2007, MOL CELL, V28, P871, DOI 10.1016/j.molcel.2007.10.003; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pal M, 2007, J CELL SCI, V120, P3238, DOI 10.1242/jcs.004762; Park KH, 2005, BREAST CANCER RES, V7, pR238, DOI 10.1186/bcr978; Passmore LA, 2005, MOL CELL, V20, P855, DOI 10.1016/j.molcel.2005.11.003; Passmore LA, 2004, BIOCHEM J, V379, P513, DOI 10.1042/BJ20040198; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Pfleger CM, 2000, GENE DEV, V14, P655; Tanaka T, 2006, BIOPOLYMERS, V84, P161, DOI 10.1002/bip.20361; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thornton BR, 2006, GENE DEV, V20, P449, DOI 10.1101/gad.1396906; Thornton BR, 2006, GENE DEV, V20, P3069, DOI 10.1101/gad.1478306; Turnell AS, 2005, NATURE, V438, P690, DOI 10.1038/nature04151; van Roessel P, 2004, CELL, V119, P707, DOI 10.1016/j.cell.2004.11.028; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Vodermaier HC, 2003, CURR BIOL, V13, P1459, DOI 10.1016/S0960-9822(03)00581-5; Wilson CGM, 2005, FEBS J, V272, P166, DOI 10.1111/j.1432-1033.2004.04397.x; Winn MD, 2002, ACTA CRYSTALLOGR D, V58, P1929, DOI 10.1107/S0907444902016116; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wu YK, 2006, NAT STRUCT MOL BIOL, V13, P589, DOI 10.1038/nsmb1106; Yoon HJ, 2002, CURR BIOL, V12, P2048, DOI 10.1016/S0960-9822(02)01331-3	46	18	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15137	15146		10.1074/jbc.M804887200	http://dx.doi.org/10.1074/jbc.M804887200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19091741	Green Published, hybrid			2022-12-25	WOS:000266288200049
J	Wang, CY; Wang, Y; Huffman, NT; Cui, CY; Yao, XM; Midura, S; Midura, RJ; Gorski, JP				Wang, Chuanyi; Wang, Yong; Huffman, Nichole T.; Cui, Chaoying; Yao, Xiaomei; Midura, Sharon; Midura, Ronald J.; Gorski, Jeff P.			Confocal Laser Raman Microspectroscopy of Biomineralization Foci in UMR 106 Osteoblastic Cultures Reveals Temporally Synchronized Protein Changes Preceding and Accompanying Mineral Crystal Deposition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Proceedings Paper	9th International Conference on the Chemistry and Biology of Mineralized Tissues	NOV 04-08, 2007	Lakeland, TX				BONE ACIDIC GLYCOPROTEIN-75; INORGANIC-PHOSPHATE; MARROW ABLATION; MATRIX; SIALOPROTEIN; NUCLEATION; TISSUE; HYDROXYAPATITE; CALCIFICATION; HYPERCALCEMIA	Mineralization in UMR 106-01 osteoblastic cultures occurs within extracellular biomineralization foci (BMF) within 12 h after addition of beta-glycerol phosphate to cells at 64 h after plating. BMF are identified by their enrichment with an 85-kDa glycoprotein reactive with Maackia amurensis lectin. Laser Raman microspectroscopic scans were made on individual BMF at times preceding (64-76h) and following the appearance of mineral crystals(76-88 h). The range of variation between spectra for different BMF in the same culture was rather small. In contrast, significant differences were observed for spectral bands at 957-960, 1004, and 1660 cm(-1) when normalized BMF spectra at different times were compared. Protein-dependent spectral bands at 1004 and 1660 cm(-1) increased and then decreased preceding the detection of hydroxyapatite crystals via the phosphate stretching peak at 959-960 cm(-1). When sodium phosphate was substituted for beta-glycerol phosphate, mineralization occurred 3-6 h earlier. Irrespective of phosphate source, the Raman full peak width at half-maximum ratio for 88 h cultures was similar to that for 10-day-old marrow ablation primary bone. However, if mineralization was blocked with serine protease inhibitor 4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride, 64-88-h BMF spectra remained largely invariant. In summary, Raman spectral data demonstrate for the first time that formation of hydroxyapatite crystals within individual BMF is a multistep process. Second, changes in protein-derived signals at 1004 and 1660 cm(-1) reflect events within BMFs that precede or accompany mineral crystal production because they are blocked by mineralization inhibitor 4-(2-aminoethyl) benzenesulfonyl fluoride hydrochloride. Finally, the low extent of spectral variability detected among different BMF at the same time point indicates that mineralization of individual BMF within a culture is synchronized.	[Huffman, Nichole T.; Gorski, Jeff P.] Univ Missouri, Sch Dent, Dept Oral Biol, Bone Biol Program, Kansas City, MO 64108 USA; [Wang, Chuanyi; Wang, Yong; Yao, Xiaomei] Univ Missouri, Sch Dent, Dept Oral Biol, Biomat Sect, Kansas City, MO 64108 USA; [Midura, Sharon; Midura, Ronald J.] Cleveland Clin, Dept Biomed Engn, Lerner Inst, Cleveland, OH 44195 USA; [Cui, Chaoying] Tibet Univ Med Coll, Lhasa 850002, Tibet, Peoples R China	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; Cleveland Clinic Foundation; Tibet University	Gorski, JP (corresponding author), Univ Missouri, Sch Dent, Dept Oral Biol, Bone Biol Program, 625 E 25th St, Kansas City, MO 64108 USA.	GorskiJ@UMKC.edu	Wang, Yong/GPX-3217-2022; Wang, Chuanyi/AAO-6346-2020	Wang, Yong/0000-0002-2862-5075; Wang, Chuanyi/0000-0002-7146-115X	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052775] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR052775, R01 AR052775-04, R01AR052775] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Anderson H Clarke, 2003, Curr Rheumatol Rep, V5, P222, DOI 10.1007/s11926-003-0071-z; Balooch M, 2008, J STRUCT BIOL, V162, P404, DOI 10.1016/j.jsb.2008.02.010; Beck GR, 2003, J CELL BIOCHEM, V90, P234, DOI 10.1002/jcb.10622; BIANCO P, 1985, CALCIFIED TISSUE INT, V37, P684, DOI 10.1007/BF02554931; BIANCO P, 1993, J HISTOCHEM CYTOCHEM, V41, P193, DOI 10.1177/41.2.8419459; Bohic S, 1998, BIOCHEM BIOPH RES CO, V253, P506, DOI 10.1006/bbrc.1998.9781; BONUCCI E, 2007, BIOL CALCIFICATION N, P511; Carden A, 2003, CALCIFIED TISSUE INT, V72, P166, DOI 10.1007/s00223-002-1039-0; Carden A, 2000, J BIOMED OPT, V5, P259, DOI 10.1117/1.429994; Conradas KA, 2005, MOL CELL PROTEOMICS, V4, P1284, DOI 10.1074/mcp.M500082-MCP200; Conrads KA, 2004, ELECTROPHORESIS, V25, P1342, DOI 10.1002/elps.200405892; Crane NJ, 2006, BONE, V39, P434, DOI 10.1016/j.bone.2006.02.059; Dempster DW., 2006, PRIMER METABOLIC BON, P7; Freeman JJ, 2001, CALCIFIED TISSUE INT, V68, P156, DOI 10.1007/s002230001206; Goldstein J, 2003, SCANNING ELECT MICRO, V3rd, P689, DOI [10.1007/978-1-4615-0215-9, DOI 10.1007/978-1-4615-0215-9]; Gorski JP, 2009, CELLS TISSUES ORGANS, V189, P25, DOI 10.1159/000151723; GORSKI JP, 1992, CALCIFIED TISSUE INT, V50, P391, DOI 10.1007/BF00296767; Gorski JP, 2004, J BIOL CHEM, V279, P25455, DOI 10.1074/jbc.M312408200; Gorski JP, 2002, J BIOL CHEM, V277, P18840, DOI 10.1074/jbc.M109578200; Gorski JP, 1998, CRIT REV ORAL BIOL M, V9, P201, DOI 10.1177/10454411980090020401; Gorski JP, 2000, BONE, V27, P103, DOI 10.1016/S8756-3282(00)00295-7; Grynpas MD, 2007, BONE, V41, P162, DOI 10.1016/j.bone.2007.04.176; Hale LV, 2000, CALCIFIED TISSUE INT, V67, P80, DOI 10.1007/s00223001101; Huffman NT, 2007, J BIOL CHEM, V282, P26002, DOI 10.1074/jbc.M701332200; Hulmes DJS, 1997, MATRIX BIOL, V16, P41, DOI 10.1016/S0945-053X(97)90115-3; Hunter GK, 1996, BIOCHEM J, V317, P59, DOI 10.1042/bj3170059; HUNTER GK, 1993, P NATL ACAD SCI USA, V90, P8562, DOI 10.1073/pnas.90.18.8562; Jell G, 2008, J BIOMED MATER RES A, V86A, P31, DOI 10.1002/jbm.a.31542; Kale S, 2000, NAT BIOTECHNOL, V18, P954, DOI 10.1038/79439; Kessler E, 1996, SCIENCE, V271, P360, DOI 10.1126/science.271.5247.360; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lane NE, 2006, J BONE MINER RES, V21, P466, DOI 10.1359/JBMR.051103; Lu YB, 2009, CELLS TISSUES ORGANS, V189, P175, DOI 10.1159/000151727; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Magnuson SK, 1997, J BONE MINER RES, V12, P200, DOI 10.1359/jbmr.1997.12.2.200; Meng ZJ, 2006, J PROTEOME RES, V5, P1931, DOI 10.1021/pr060009l; Midura RJ, 2004, J BIOL CHEM, V279, P25464, DOI 10.1074/jbc.M312409200; MIDURA RJ, 1990, J BIOL CHEM, V265, P5285; Murshed M, 2004, J CELL BIOL, V165, P625, DOI 10.1083/jcb.200402046; Murshed M, 2005, GENE DEV, V19, P1093, DOI 10.1101/gad.1276205; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Pasteris JD, 2004, BIOMATERIALS, V25, P229, DOI 10.1016/S0142-9612(03)00487-3; PENEL G, 2000, BONE ELMSFORD, V36, P893; Pettway GJ, 2005, BONE, V36, P959, DOI 10.1016/j.bone.2005.02.015; Rousseau M, 2008, J BIOMED MATER RES A, V85A, P487, DOI 10.1002/jbm.a.31553; SAUER GR, 1994, CALCIFIED TISSUE INT, V54, P414, DOI 10.1007/BF00305529; Schinke T, 1999, NAT GENET, V21, P150, DOI 10.1038/5928; STANFORD CM, 1995, J BIOL CHEM, V270, P9420, DOI 10.1074/jbc.270.16.9420; Stewart S, 2002, J RAMAN SPECTROSC, V33, P536, DOI 10.1002/jrs.892; TSUBOI M, 2005, BIOCHEMISTRY-US, V39, P2677; TSUDA H, 1993, J DENT RES, V72, P1609, DOI 10.1177/00220345930720121401; TURNER CH, 1994, J BONE MINER RES, V9, P87; Wang AM, 2000, J BIOL CHEM, V275, P11082, DOI 10.1074/jbc.275.15.11082	53	34	34	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7100	7113		10.1074/jbc.M805898200	http://dx.doi.org/10.1074/jbc.M805898200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology	415FF	19116206	Green Published, hybrid			2022-12-25	WOS:000263919000058
J	Yu, M; Gipp, J; Yoon, JW; Iannaccone, P; Walterhouse, D; Bushman, W				Yu, Min; Gipp, Jerry; Yoon, Joon Won; Iannaccone, Phillip; Walterhouse, David; Bushman, Wade			Sonic Hedgehog-responsive Genes in the Fetal Prostate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE INHIBITOR; TUMOR-GROWTH; EXPRESSION; TARGET; MORPHOGENESIS; PROTEIN; DIFFERENTIATION; PROLIFERATION; ANGIOGENESIS; ACTIVATION	The Hedgehog (Hh) signaling pathway plays an important role in prostate development and appears to play an equally important role in promoting growth of advanced prostate cancer. During prostate development, epithelial cells in the urogenital sinus (UGS) express Sonic Hedgehog (Shh) and secrete Shh peptide. The secreted Hh peptide acts on adjacent mesenchymal cells to activate the Hh signal transduction pathway and elicit paracrine effects on epithelial proliferation and differentiation. To identify mesenchymal targets of Shh signaling, we performed microarray analysis on a Shh-responsive, immortalized urogential sinus mesenchymal cell line. We found 68 genes that were up-regulated by Shh and 21 genes that were down-regulated. Eighteen of those were selected for further study with Ptc1 and Gli1 serving as reference controls. We found 10 of 18 were also Hh-regulated in primary UGS mesenchymal cells and 13 of 18 in the cultured UGS. Seven of 18 exhibited Shh-regulated expression in both assays (Igfbp-6, Igfbp-3, Fbn2, Ntrk3, Agpt4, Dmp1, and Mmp13). Three of the 18 genes contained putative Gli binding motifs that bound Gli1 peptide in electrophoretic mobility shift assays. With the exception of Tiam1, target gene expression generally showed no differences in the concentration dependence of ligand-induced expression, but we observed strikingly different responses to direct pathway activation by transfection with activated Smo, Gli1, and Gli2.	[Yu, Min] Univ Wisconsin, Sch Med, Mol & Environm Toxicol Ctr, Madison, WI 53705 USA; [Yu, Min; Gipp, Jerry; Bushman, Wade] Univ Wisconsin, Sch Med, Ctr Clin Sci, Dept Urol, Madison, WI 53792 USA; [Yoon, Joon Won; Iannaccone, Phillip; Walterhouse, David] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60614 USA; [Yoon, Joon Won; Iannaccone, Phillip; Walterhouse, David] Childrens Mem Res Ctr, Chicago, IL 60614 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Northwestern University; Feinberg School of Medicine	Bushman, W (corresponding author), K6-562 CSC,600 Highland Ave, Madison, WI 53792 USA.	bushman@surgery.wisc.edu			National Institutes of Health [P50 DK065303, RO1DK056238]; Robert and Delores Schnoes Chair in Urologic Research.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK065303, R01DK056238] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert and Delores Schnoes Chair in Urologic Research.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P50 DK065303 andRO1DK056238. This work was also supported by the Robert and Delores Schnoes Chair in Urologic Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Albig AR, 2005, MOL BIOL CELL, V16, P609, DOI 10.1091/mbc.e04-06-0479; Berman DM, 2004, DEV BIOL, V267, P387, DOI 10.1016/j.ydbio.2003.11.018; Bigelow RLH, 2004, J BIOL CHEM, V279, P1197, DOI 10.1074/jbc.M310589200; Callahan CA, 2004, GENE DEV, V18, P2724, DOI 10.1101/gad.1221804; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Dakubo GD, 2006, J NEURO-ONCOL, V79, P221, DOI 10.1007/s11060-006-9132-2; Docheva D, 2005, MOL CELL BIOL, V25, P699, DOI 10.1128/MCB.25.2.699-705.2005; Doles JD, 2005, PROSTATE, V65, P390, DOI 10.1002/pros.20321; Eichberger T, 2004, J INVEST DERMATOL, V122, P1180, DOI 10.1111/j.0022-202X.2004.22505.x; Eiraku M, 2005, NAT NEUROSCI, V8, P873, DOI 10.1038/nn1492; Fan L, 2004, ENDOCRINOLOGY, V145, P3961, DOI 10.1210/en.2004-0079; Freestone SH, 2003, DEV BIOL, V264, P352, DOI 10.1016/j.ydbio.2003.08.018; Garrett W.M., 1998, BIOCHEMICA, V1, P17; Gaur T, 2006, J CELL PHYSIOL, V208, P87, DOI 10.1002/jcp.20637; Gerety SS, 2002, DEVELOPMENT, V129, P1397; Gill SE, 2006, DEV BIOL, V298, P540, DOI 10.1016/j.ydbio.2006.07.004; He J, 2006, J BIOL CHEM, V281, P35598, DOI 10.1074/jbc.C600200200; Hochman E, 2006, J BIOL CHEM, V281, P33860, DOI 10.1074/jbc.M605905200; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Ingham PW, 2006, NAT REV GENET, V7, P841, DOI 10.1038/nrg1969; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Ingram WJ, 2002, ONCOGENE, V21, P8196, DOI 10.1038/sj.onc.1205975; Izraeli S, 2001, GENESIS, V31, P72, DOI 10.1002/gene.10004; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; Krishnan V, 1997, SCIENCE, V278, P1947, DOI 10.1126/science.278.5345.1947; Lamm MLG, 2002, DEV BIOL, V249, P349, DOI 10.1006/dbio.2002.0774; Lipinski RJ, 2005, DEV DYNAM, V233, P829, DOI 10.1002/dvdy.20414; Lipinski RJ, 2006, EXP CELL RES, V312, P1925, DOI 10.1016/j.yexcr.2006.02.019; Mahlapuu M, 2001, DEVELOPMENT, V128, P2397; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Oliver TG, 2003, P NATL ACAD SCI USA, V100, P7331, DOI 10.1073/pnas.0832317100; Olsen MWB, 2006, NEOPLASIA, V8, P364, DOI 10.1593/neo.06127; Podlasek CA, 1999, DEV BIOL, V209, P28, DOI 10.1006/dbio.1999.9229; Regl G, 2004, CANCER RES, V64, P7724, DOI 10.1158/0008-5472.CAN-04-1085; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; Shaw A, 2007, J UROLOGY, V177, P832, DOI 10.1016/j.juro.2006.10.061; Shaw A, 2006, PROSTATE, V66, P1347, DOI 10.1002/pros.20357; Shukunami C, 2005, BIOCHEM BIOPH RES CO, V333, P299, DOI 10.1016/j.bbrc.2005.05.133; Spurbeck WW, 2002, BLOOD, V100, P3361, DOI 10.1182/blood.V100.9.3361; Teh MT, 2002, CANCER RES, V62, P4773; Wang BE, 2003, J BIOL CHEM, V278, P18506, DOI 10.1074/jbc.M300968200; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang YP, 2005, DEVELOPMENT, V132, P5103, DOI 10.1242/dev.02096; Wu SCY, 1998, MECH DEVELOP, V70, P3, DOI 10.1016/S0925-4773(97)00157-3; Yoon JW, 2002, J BIOL CHEM, V277, P5548, DOI 10.1074/jbc.M105708200	47	38	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5620	5629		10.1074/jbc.M809172200	http://dx.doi.org/10.1074/jbc.M809172200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19095649	Green Published, hybrid			2022-12-25	WOS:000263560600025
J	Romanova, L; Grand, A; Zhang, LY; Rayner, S; Katoku-Kikyo, N; Kellner, S; Kikyo, N				Romanova, Liudmila; Grand, Anthony; Zhang, Liying; Rayner, Samuel; Katoku-Kikyo, Nobuko; Kellner, Steven; Kikyo, Nobuaki			Critical Role of Nucleostemin in Pre-rRNA Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE ARREST; PROTEIN NUCLEOSTEMIN; FAMILY PROTEINS; MESSENGER-RNA; YEAST HOMOLOG; STEM-CELLS; PROLIFERATION; BIOGENESIS; MECHANISM; P53	Nucleostemin is a nucleolar protein widely expressed in proliferating cells. Nucleostemin is involved in the regulation of cell proliferation, and both depletion and overexpression of nucleostemin induce cell cycle arrest through the p53 signaling pathway. Although the presence of p53-independent functions of nucleostemin has been previously suggested, the identities of these additional functions remained to be investigated. Here, we show that nucleostemin has a novel role as an integrated component of ribosome biogenesis, particularly pre-rRNA processing. Nucleostemin forms a large protein complex (> 700 kDa) that co-fractionates with the pre-60 S ribosomal subunit in a sucrose gradient. This complex contains proteins related to pre-rRNA processing, such as Pes1, DDX21, and EBP2, in addition to several ribosomal proteins. We show that the nucleolar retention of DDX21 and EBP2 is dependent on the presence of nucleostemin in the nucleolus. Furthermore, the knockdown of nucleostemin delays the processing of 32 S pre-rRNA into 28 S rRNA. This is accompanied by a substantial decrease of protein synthesis as well as the levels of rRNAs and some mRNAs. In addition, overexpressed nucleostemin significantly promotes the processing of 32 S pre-rRNA. Collectively, these biochemical and functional studies demonstrate a novel role of nucleostemin in ribosome biogenesis. This is a key aspect of the role of nucleostemin in regulating cell proliferation.	[Romanova, Liudmila; Grand, Anthony; Zhang, Liying; Rayner, Samuel; Katoku-Kikyo, Nobuko; Kellner, Steven; Kikyo, Nobuaki] Univ Minnesota, Stem Cell Inst, Div Hematol Oncol & Transplantat, Dept Med, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Kikyo, N (corresponding author), Univ Minnesota, Stem Cell Inst, Div Hematol Oncol & Transplantat, Dept Med, Rm 2-216,Mail Code 2873,2001 6th St SE, Minneapolis, MN 55455 USA.	kikyo001@umn.edu		Rayner, Samuel/0000-0002-2541-4221	National Institutes of Health [R01 GM068027]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068027] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM068027 (to N. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Beekman C, 2006, MOL CELL BIOL, V26, P9291, DOI 10.1128/MCB.01183-06; Bommer U, 1997, SUBCELLULAR FRACTION, P271; BOWMAN LH, 1981, NUCLEIC ACIDS RES, V9, P4951, DOI 10.1093/nar/9.19.4951; Curtis NE, 1998, J MOL ENDOCRINOL, V21, P225, DOI 10.1677/jme.0.0210225; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; Du XM, 2006, MOL BIOL CELL, V17, P460, DOI 10.1091/mbc.E05-09-0848; Du YCN, 2002, CELL, V109, P835, DOI 10.1016/S0092-8674(02)00773-0; Fan Y, 2006, BRIT J CANCER, V94, P1658, DOI 10.1038/sj.bjc.6603145; Fuller-Pace FV, 2006, NUCLEIC ACIDS RES, V34, P4206, DOI 10.1093/nar/gkl460; Gilles C, 2001, J CELL SCI, V114, P2967; Gonda K, 2006, J BIOL CHEM, V281, P8153, DOI 10.1074/jbc.M512890200; Grimm T, 2006, NUCLEIC ACIDS RES, V34, P3030, DOI 10.1093/nar/gkl378; Henning D, 2003, J BIOL CHEM, V278, P52307, DOI 10.1074/jbc.M310846200; Holzel M, 2005, J CELL BIOL, V170, P367, DOI 10.1083/jcb.200501141; Huber MD, 2000, J BIOL CHEM, V275, P28764, DOI 10.1074/jbc.M000594200; Kafienah W, 2006, STEM CELLS, V24, P1113, DOI 10.1634/stemcells.2005-0416; Kapoor P, 2005, MOL CELL BIOL, V25, P4934, DOI 10.1128/MCB.25.12.4934-4945.2005; Kudron MM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000181; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lapik YR, 2004, MOL CELL, V15, P17, DOI 10.1016/j.molcel.2004.05.020; Ma HH, 2007, MOL BIOL CELL, V18, P2630, DOI 10.1091/mbc.E07-03-0244; Meng LJ, 2007, MOL CELL BIOL, V27, P8670, DOI 10.1128/MCB.00635-07; OLSON EN, 1994, GENE DEV, V8, P1, DOI 10.1101/gad.8.1.1; Politz JCR, 2005, MOL BIOL CELL, V16, P3401, DOI 10.1091/mbc.E05-02-0106; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Shirai C, 2004, J BIOL CHEM, V279, P25353, DOI 10.1074/jbc.M403338200; SLEBOS RJC, 1994, P NATL ACAD SCI USA, V91, P5320, DOI 10.1073/pnas.91.12.5320; SYLVESTER JE, 1986, HUM GENET, V73, P193, DOI 10.1007/BF00401226; Tsai RYL, 2002, GENE DEV, V16, P2991, DOI 10.1101/gad.55671; Tsai RYL, 2005, J CELL BIOL, V168, P179, DOI 10.1083/jcb.200409053; Wu H, 2000, EMBO REP, V1, P140, DOI 10.1093/embo-reports/kvd026; Yang HS, 2003, J BIOL CHEM, V278, P38847, DOI 10.1074/jbc.M302258200; Zhang L, 2007, BIOCHEM BIOPH RES CO, V361, P611, DOI 10.1016/j.bbrc.2007.07.089; Zhu QB, 2006, MOL CELL BIOL, V26, P9279, DOI 10.1128/MCB.00724-06	34	88	92	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4968	4977		10.1074/jbc.M804594200	http://dx.doi.org/10.1074/jbc.M804594200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19106111	hybrid, Green Published			2022-12-25	WOS:000263416600027
J	Mourskaia, AA; Dong, Z; Ng, S; Banville, M; Zwaagstra, JC; O'Connor-McCourt, MD; Siegel, PM				Mourskaia, A. A.; Dong, Z.; Ng, S.; Banville, M.; Zwaagstra, J. C.; O'Connor-McCourt, M. D.; Siegel, P. M.			Transforming growth factor-beta 1 is the predominant isoform required for breast cancer cell outgrowth in bone	ONCOGENE			English	Article						TGF-beta isoforms; breast cancer; ligand trap; bone microenvironment	HORMONE-RELATED PROTEIN; TUMOR-SUPPRESSOR; I RECEPTOR; SKELETAL METASTASIS; BETA; EXPRESSION; SMAD; MECHANISMS; VIVO	Transforming growth factor (TGF)-beta signaling is a potent modulator of the invasive and metastatic behavior of breast cancer cells. Indeed, breast tumor responsiveness to TGF-beta is important for the development of osteolytic bone metastases. However, the specific TGF-beta isoforms that promote breast cancer outgrowth in bone is unknown. We demonstrate that expression of a TGF-beta ligand trap, which neutralizes TGF-beta 1 and TGF-beta 3, in MDA-MB-231 breast cancer cells diminished their outgrowth in bone and reduced the severity of osteolytic lesion formation when compared with controls. We further show that a reduction or loss of TGF-beta 1 expression within the bone microenvironment of TGF-beta 1+/- and TGF-beta 1-/- mice significantly reduced the incidence of breast tumor outgrowth compared with wild-type animals. Interestingly, those tumors capable of growing within the tibiae of TGF-beta 1-deficient mice had upregulated expression of all three TGF-b isoforms. Finally, breast cancer cells expressing the TGF-b ligand trap showed a pronounced reduction in their ability to form osteolytic lesions when injected into the tibiae of TGF-beta 1-/- mice. Thus, our studies show that both host- and tumor-derived TGF-beta expression plays a critical role during the establishment and outgrowth of breast cancer cells in bone.	[Mourskaia, A. A.; Dong, Z.; Zwaagstra, J. C.; Siegel, P. M.] McGill Univ, Dept Med, Montreal, PQ H3A 1A4, Canada; [Ng, S.; O'Connor-McCourt, M. D.; Siegel, P. M.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 1A4, Canada; [Banville, M.; Zwaagstra, J. C.; O'Connor-McCourt, M. D.] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada; [O'Connor-McCourt, M. D.; Siegel, P. M.] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A4, Canada	McGill University; McGill University; National Research Council Canada; McGill University	Siegel, PM (corresponding author), McGill Univ, Dept Med, 740 Dr Penfield Ave,Room 2201, Montreal, PQ H3A 1A4, Canada.	peter.siegel@mcgill.ca						Bandyopadhyay A, 2006, CANCER RES, V66, P6714, DOI 10.1158/0008-5472.CAN-05-3565; Baselga J, 2008, BIOMARKERS, V13, P217, DOI [10.1080/13547500701676019, 10.1080/13547500701676019 ]; Broussau S, 2008, MOL THER, V16, P500, DOI 10.1038/sj.mt.6300383; Coleman RE, 2006, CLIN CANCER RES, V12, p6243S, DOI 10.1158/1078-0432.CCR-06-0931; De Crescenzo G, 2006, J MOL BIOL, V355, P47, DOI 10.1016/j.jmb.2005.10.022; Deckers M, 2006, CANCER RES, V66, P2202, DOI 10.1158/0008-5472.CAN-05-3560; del Re E, 2004, J BIOL CHEM, V279, P22765, DOI 10.1074/jbc.M401350200; Ehata S, 2007, CANCER SCI, V98, P127, DOI 10.1111/j.1349-7006.2006.00357.x; Engle SJ, 1999, CANCER RES, V59, P3379; Geiser AG, 1998, BONE, V23, P87, DOI 10.1016/S8756-3282(98)00078-7; Groppe J, 2008, MOL CELL, V29, P157, DOI 10.1016/j.molcel.2007.11.039; Hering S, 2001, EXP CLIN ENDOCR DIAB, V109, P107, DOI 10.1055/s-2001-14830; Hering S, 2001, EXP CLIN ENDOCR DIAB, V109, P217, DOI 10.1055/s-2001-15109; Hess KR, 2006, CANCER, V106, P1624, DOI 10.1002/cncr.21778; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Kakonen SM, 2002, J BIOL CHEM, V277, P24571, DOI 10.1074/jbc.M202561200; Kang YB, 2005, P NATL ACAD SCI USA, V102, P13909, DOI 10.1073/pnas.0506517102; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Komesli S, 1998, EUR J BIOCHEM, V254, P505, DOI 10.1046/j.1432-1327.1998.2540505.x; Kozlow W, 2005, J MAMMARY GLAND BIOL, V10, P169, DOI 10.1007/s10911-005-5399-8; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Liao JH, 2006, CANCER METAST REV, V25, P559, DOI 10.1007/s10555-006-9033-z; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; MANOLAGAS SC, 1995, BONE, V17, pS63, DOI 10.1016/8756-3282(95)00180-L; Mastro AM, 2003, CLIN EXP METASTAS, V20, P275, DOI 10.1023/A:1022995403081; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Mourskaia AA, 2007, ANTI-CANCER AGENT ME, V7, P504, DOI 10.2174/187152007781668689; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Northey JJ, 2008, MOL CELL BIOL, V28, P3162, DOI 10.1128/MCB.01734-07; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rose AAN, 2006, B CANCER, V93, P931; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Sotiriou C, 2001, CANCER LETT, V169, P87, DOI 10.1016/S0304-3835(01)00524-9; Tang BW, 1998, NAT MED, V4, P802, DOI 10.1038/nm0798-802; WANG XF, 1991, CELL, V67, P797, DOI 10.1016/0092-8674(91)90074-9; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523; Yoneda T, 2001, J BONE MINER RES, V16, P1486, DOI 10.1359/jbmr.2001.16.8.1486; Yoneda T, 2005, BIOCHEM BIOPH RES CO, V328, P679, DOI 10.1016/j.bbrc.2004.11.070	41	37	39	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 19	2009	28	7					1005	1015		10.1038/onc.2008.454	http://dx.doi.org/10.1038/onc.2008.454			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	408TH	19079339	Green Published			2022-12-25	WOS:000263457400007
J	Kliment, CR; Englert, JM; Gochuico, BR; Yu, GY; Kaminski, N; Rosas, I; Oury, TD				Kliment, Corrine R.; Englert, Judson M.; Gochuico, Bernadette R.; Yu, Guoying; Kaminski, Naftali; Rosas, Ivan; Oury, Tim D.			Oxidative Stress Alters Syndecan-1 Distribution in Lungs with Pulmonary Fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-SUPEROXIDE-DISMUTASE; HEPARAN-SULFATE PROTEOGLYCANS; IN-VITRO; SOLUBLE SYNDECAN-1; WOUND REPAIR; MOUSE LUNG; EC-SOD; INFLAMMATION; INJURY; NEUTROPHILS	Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease characterized by severe, progressive fibrosis. Roles for inflammation and oxidative stress have recently been demonstrated, but despite advances in understanding the pathogenesis, there are still no effective therapies for IPF. This study investigates how extracellular superoxide dismutase (EC-SOD), a syndecan-binding antioxidant enzyme, inhibits inflammation and lung fibrosis. We hypothesize that EC-SOD protects the lung from oxidant damage by preventing syndecan fragmentation/shedding. Wild-type or EC-SOD-null mice were exposed to an intratracheal instillation of asbestos or bleomycin. Western blot was used to detect syndecans in the bronchoalveolar lavage fluid and lung. Human lung samples (normal and IPF) were also analyzed. Immunohistochemistry for syndecan-1 and EC-SOD was performed on human and mouse lungs. In vitro, alveolar epithelial cells were exposed to oxidative stress and EC-SOD. Cell supernatants were analyzed for shed syndecan-1 by Western blot. Syndecan-1 ectodomain was assessed in wound healing and neutrophil chemotaxis. Increases in human syndecan-1 are detected in lung homogenates and lavage fluid of IPF lungs. Syndecan-1 is also significantly elevated in the lavage fluid of EC-SOD-null mice after asbestos and bleomycin exposure. On IHC, syndecan-1 staining increases within fibrotic areas of human and mouse lungs. In vitro, EC-SOD inhibits oxidant-induced loss of syndecan-1 from A549 cells. Shed and exogenous syndecan-1 ectodomain induce neutrophil chemotaxis, inhibit alveolar epithelial wound healing, and promote fibrogenesis. Oxidative shedding of syndecan-1 is an underlying cause of neutrophil chemotaxis and aberrant wound healing that may contribute to pulmonary fibrosis.	[Kliment, Corrine R.; Englert, Judson M.; Oury, Tim D.] Univ Pittsburgh, Sch Med, Dept Cellular & Mol Pathol, Pittsburgh, PA 15213 USA; [Yu, Guoying; Kaminski, Naftali] Univ Pittsburgh, Sch Med, Dept Med, Div Pulm, Pittsburgh, PA 15213 USA; [Gochuico, Bernadette R.] NHGRI, NIH, Bethesda, MD 20892 USA; [Rosas, Ivan] Brigham & Womens Hosp, Div Pulm, Boston, MA 02115 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Harvard University; Brigham & Women's Hospital	Oury, TD (corresponding author), Univ Pittsburgh, Dept Pathol, 200 Lothrop St,Biomed Sci Tower W904, Pittsburgh, PA 15261 USA.	tdoury@pitt.edu	Kliment, Corrine/HGE-0877-2022	Kaminski, Naftali/0000-0001-5917-4601	National Institutes of Health [1F30ES016483-01]; Research Project Grant [R01HL063700-07]; Intramural Research Program of the NGRI and NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F30ES016483] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Project Grant; Intramural Research Program of the NGRI and NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)NIH National Human Genome Research Institute (NHGRI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by the National Institutes of Health under a Ruth L. Kirschstein National Research Service Award (1F30ES016483-01, to C. R. K.), a Research Project Grant (R01HL063700-07, to T.D.O.), and by the Intramural Research Program of the NGRI and NHLBI. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; Bowler RP, 2004, AM J RESP CELL MOL, V31, P432, DOI 10.1165/rcmb.2004-0057OC; CANTIN AM, 1987, J CLIN INVEST, V79, P1665, DOI 10.1172/JCI113005; CARLSSON LM, 1995, P NATL ACAD SCI USA, V92, P6264, DOI 10.1073/pnas.92.14.6264; Daniil ZD, 2008, PULM PHARMACOL THER, V21, P26, DOI 10.1016/j.pupt.2006.10.005; Dempsey OJ, 2006, RESP MED, V100, P1871, DOI 10.1016/j.rmed.2006.08.017; Echtermeyer F, 2001, J CLIN INVEST, V107, pR9, DOI 10.1172/JCI10559; Elenius V, 2004, J BIOL CHEM, V279, P41928, DOI 10.1074/jbc.M404506200; Enghild JJ, 1999, J BIOL CHEM, V274, P14818, DOI 10.1074/jbc.274.21.14818; Englert JM, 2008, AM J PATHOL, V172, P583, DOI 10.2353/ajpath.2008.070569; Fattman CL, 2000, BIOCHEM BIOPH RES CO, V275, P542, DOI 10.1006/bbrc.2000.3327; Fattman CL, 2006, FREE RADICAL BIO MED, V40, P601, DOI 10.1016/j.freeradbiomed.2005.09.030; Fattman CL, 2003, FREE RADICAL BIO MED, V35, P763, DOI 10.1016/S0891-5849(03)00402-7; Fattman CL, 2003, FREE RADICAL BIO MED, V35, P236, DOI 10.1016/S0891-5849(03)00275-2; Fattman CL, 2001, FREE RADICAL BIO MED, V31, P1198, DOI 10.1016/S0891-5849(01)00699-2; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; Flaherty KR, 2001, AM J RESP CRIT CARE, V164, P1722, DOI 10.1164/ajrccm.164.9.2103074; Folz RJ, 1999, J CLIN INVEST, V103, P1055, DOI 10.1172/JCI3816; Gao F, 2008, J BIOL CHEM, V283, P6058, DOI 10.1074/jbc.M709273200; Gross TJ, 2001, NEW ENGL J MED, V345, P517, DOI 10.1056/NEJMra003200; Heit B, 2005, J CELL SCI, V118, P5205, DOI 10.1242/jcs.02632; KARLSSON K, 1988, BIOCHEM J, V256, P29, DOI 10.1042/bj2560029; Kato M, 1998, NAT MED, V4, P691, DOI 10.1038/nm0698-691; Kinder BW, 2008, CHEST, V133, P226, DOI 10.1378/chest.07-1948; Kinnula VL, 2005, AM J RESP CRIT CARE, V172, P417, DOI 10.1164/rccm.200501-017PP; Kliment CR, 2008, ANTIOXID REDOX SIGN, V10, P261, DOI 10.1089/ars.2007.1906; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Manning CB, 2002, INT IMMUNOPHARMACOL, V2, P191, DOI 10.1016/S1567-5769(01)00172-2; McQuade KJ, 2006, J CELL SCI, V119, P2445, DOI 10.1242/jcs.02970; Obayashi Y, 1997, CHEST, V112, P1338, DOI 10.1378/chest.112.5.1338; Ojeh N, 2008, J INVEST DERMATOL, V128, P26, DOI 10.1038/sj.jid.5700967; Oury TD, 1996, BIOCHEM J, V317, P51, DOI 10.1042/bj3170051; Oury TD, 2002, AM J PHYSIOL-LUNG C, V283, pL777, DOI 10.1152/ajplung.00011.2002; Oury TD, 1996, LAB INVEST, V75, P617; OZAKI T, 1992, AM REV RESPIR DIS, V145, P85, DOI 10.1164/ajrccm/145.1.85; Pardo A, 2005, PLOS MED, V2, P891, DOI 10.1371/journal.pmed.0020251; Parish CR, 2005, NAT IMMUNOL, V6, P861, DOI 10.1038/ni0905-861; Petersen SV, 2004, J BIOL CHEM, V279, P13705, DOI 10.1074/jbc.M310217200; Raats CJI, 1997, J BIOL CHEM, V272, P26734, DOI 10.1074/jbc.272.42.26734; Rice WR, 2002, AM J PHYSIOL-LUNG C, V283, pL256, DOI 10.1152/ajplung.00302.2001; Selman M, 2001, RESP RES, V3, DOI 10.1186/rr175; Sergejeva S, 2005, AM J RESP CELL MOL, V33, P248, DOI 10.1165/rcmb.2004-0213OC; Tan RJ, 2006, AM J RESP CELL MOL, V34, P226, DOI 10.1165/rcmb.2005-0212OC; TERAMOTO S, 1995, BIOCHEM MOL MED, V55, P66, DOI 10.1006/bmme.1995.1033; Venkatesan N, 2002, AM J PHYSIOL-LUNG C, V283, pL806, DOI 10.1152/ajplung.00061.2002; Walter Nicholas, 2006, Proc Am Thorac Soc, V3, P330, DOI 10.1513/pats.200602-016TK; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Zen K, 2006, J IMMUNOL METHODS, V309, P86, DOI 10.1016/j.jim.2005.11.014	50	98	105	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3537	3545		10.1074/jbc.M807001200	http://dx.doi.org/10.1074/jbc.M807001200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19073610	Green Published, hybrid			2022-12-25	WOS:000262872500021
J	Zhu, B; Yao, P; Tan, M; Eriani, G; Wang, ED				Zhu, Bin; Yao, Peng; Tan, Min; Eriani, Gilbert; Wang, En-Duo			tRNA-independent Pretransfer Editing by Class I Leucyl-tRNA Synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOACYL-TRANSFER-RNA; RIBONUCLEIC-ACID SYNTHETASE; ISOLEUCYL-TRANSFER-RNA; PROTEIN-SYNTHESIS; ESCHERICHIA-COLI; AQUIFEX-AEOLICUS; MECHANISM; HYDROLYSIS; COMPLEX; ERRORS	Aminoacyl-tRNA synthetases catalyze the formation of aminoacyl-tRNA in a two-step reaction starting with amino acid activation followed by aminoacyl group transfer to tRNA. To clear mistakes that occasionally occur, some of these enzymes carry out editing activities, acting on the misactivated amino acid (pretransfer editing) or after the transfer on the tRNA (post-transfer editing). The post-transfer editing pathway of leucyl-tRNA synthetase has been extensively studied by structural and biochemical approaches. Here, we report the finding of a tRNA-independent pretransfer editing pathway in leucyl-tRNA synthetases from Aquifex aeolicus. Using a CP1-mutant defective in its post-transfer editing function, we showed that this new editing pathway is distinct from the post-transfer editing site and may occur at the synthetic catalytic site, as recently proposed for other aminoacyl-tRNA synthetases.	[Zhu, Bin; Yao, Peng; Tan, Min; Wang, En-Duo] Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol,State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Eriani, Gilbert] Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Architecture & React ARN, F-67084 Strasbourg, France	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Wang, ED (corresponding author), Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol,State Key Lab Mol Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	edwang@sibs.ac.cn	Tan, Min/K-1780-2016; Yao, Peng/Y-8047-2019; Yao, Peng/G-5218-2015; Yao, Peng/J-4492-2013	Yao, Peng/0000-0002-1145-3967; Yao, Peng/0000-0003-1022-3948; Yao, Peng/0000-0002-7029-8629; Eriani, Gilbert/0000-0002-8518-4675	Natural Science Foundation of China [30570380, 30630463]; National Key Basic Research Foundation of China [2006CB910301]; Shanghai Committee of Science and Technology [06JC14076]; Exchange Program and Programme International de Cooperation Scientifique (CNRS) [3606]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Foundation of China(National Basic Research Program of China); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); Exchange Program and Programme International de Cooperation Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This work was funded by Natural Science Foundation of China Grants 30570380 and 30630463, National Key Basic Research Foundation of China Grant 2006CB910301, and Shanghai Committee of Science and Technology Grant 06JC14076 and by Exchange Program and Programme International de Cooperation Scientifique (CNRS) Grant 3606. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Apostol I, 1997, J BIOL CHEM, V272, P28980, DOI 10.1074/jbc.272.46.28980; BALDWIN AN, 1966, J BIOL CHEM, V241, P839; Beebe K, 2003, EMBO J, V22, P668, DOI 10.1093/emboj/cdg065; Beuning PJ, 2000, P NATL ACAD SCI USA, V97, P8916, DOI 10.1073/pnas.97.16.8916; Beuning PJ, 2001, J BIOL CHEM, V276, P30779, DOI 10.1074/jbc.M104761200; Bishop AC, 2003, P NATL ACAD SCI USA, V100, P490, DOI 10.1073/pnas.0237335100; Cusack S, 2000, EMBO J, V19, P2351, DOI 10.1093/emboj/19.10.2351; Dock-Bregeon AC, 2000, CELL, V103, P877, DOI 10.1016/S0092-8674(00)00191-4; ELDRED EW, 1972, J BIOL CHEM, V247, P2961; ENGLISCH S, 1986, NUCLEIC ACIDS RES, V14, P7529, DOI 10.1093/nar/14.19.7529; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; FERSHT AR, 1977, BIOCHEMISTRY-US, V16, P1025, DOI 10.1021/bi00624a034; FERSHT AR, 1976, BIOCHEMISTRY-US, V15, P3342, DOI 10.1021/bi00660a026; FERSHT AR, 1979, BIOCHEMISTRY-US, V18, P2627, DOI 10.1021/bi00579a030; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; Fukunaga R, 2005, NAT STRUCT MOL BIOL, V12, P915, DOI 10.1038/nsmb985; Gruic-Sovulj I, 2005, J BIOL CHEM, V280, P23978, DOI 10.1074/jbc.M414260200; Gruic-Sovulj I, 2007, FEBS LETT, V581, P5110, DOI 10.1016/j.febslet.2007.09.058; Hendrickson TL, 2004, ANNU REV BIOCHEM, V73, P147, DOI 10.1146/annurev.biochem.73.012803.092429; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; KISUMI M, 1976, J BIOCHEM-TOKYO, V80, P333, DOI 10.1093/oxfordjournals.jbchem.a131281; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Lincecum TL, 2003, MOL CELL, V11, P951, DOI 10.1016/S1097-2765(03)00098-4; LOFTFIELD RB, 1972, BIOCHEM J, V128, P1353, DOI 10.1042/bj1281353; MULVEY RS, 1977, BIOCHEMISTRY-US, V16, P4731, DOI 10.1021/bi00640a031; NANDI S, 1953, NATURE, V172, P871; Nomanbhoy TK, 1999, MOL CELL, V4, P519, DOI 10.1016/S1097-2765(00)80203-8; Nomanbhoy TK, 2000, P NATL ACAD SCI USA, V97, P5119, DOI 10.1073/pnas.090102197; Nordin BE, 2003, BIOCHEMISTRY-US, V42, P12989, DOI 10.1021/bi035052q; Roy H, 2004, EMBO J, V23, P4639, DOI 10.1038/sj.emboj.7600474; SCHIMMEL P, 1987, ANNU REV BIOCHEM, V56, P125, DOI 10.1146/annurev.bi.56.070187.001013; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; Splan KE, 2008, J BIOL CHEM, V283, P7128, DOI 10.1074/jbc.M709902200; TSUI WC, 1981, NUCLEIC ACIDS RES, V9, P4627, DOI 10.1093/nar/9.18.4627; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; Xu MG, 2002, J BIOL CHEM, V277, P41590, DOI 10.1074/jbc.M205126200; YARUS M, 1972, P NATL ACAD SCI USA, V69, P1915, DOI 10.1073/pnas.69.7.1915; Zhao MW, 2005, EMBO J, V24, P1430, DOI 10.1038/sj.emboj.7600618; Zhu B, 2007, RNA, V13, P15, DOI 10.1261/rna.228707	39	44	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3418	3424		10.1074/jbc.M806717200	http://dx.doi.org/10.1074/jbc.M806717200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19068478	hybrid			2022-12-25	WOS:000262872500007
J	Grosjean-Raillard, J; Tailler, M; Ades, L; Perfettini, JL; Fabre, C; Braun, T; De Botton, S; Fenaux, P; Kroemer, G				Grosjean-Raillard, J.; Tailler, M.; Ades, L.; Perfettini, J-L; Fabre, C.; Braun, T.; De Botton, S.; Fenaux, P.; Kroemer, G.			ATM mediates constitutive NF-kappa B activation in high-risk myelodysplastic syndrome and acute myeloid leukemia	ONCOGENE			English	Article						myelodysplastic syndrome; acute myeloid leukemia; ATM; NF-kappa B; IKK	INTERNAL TANDEM DUPLICATION; WORLD-HEALTH-ORGANIZATION; DNA-DAMAGE RESPONSE; THERAPEUTIC TARGET; INHIBITION; APOPTOSIS; CLASSIFICATION; MITOCHONDRIAL; SYSTEM; MUTATIONS	The anti-apoptotic transcription factor nuclear factor-kappa B (NF-kappa B) is constitutively activated in CD34(+) myeloblasts from high-risk myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) patients. Inhibition of NF-kappa B by suppressing the canonical NF-kappa B activation pathway, for instance by knockdown of the three subunits of the inhibitor of NF-kappa B (I kappa B) kinase (IKK) complex (IKK1, IKK2 and NEMO) triggers apoptosis in such cells. Here, we show that an MDS/AML model cell line exhibits a constitutive interaction, within the nucleus, of activated, S1981-phosphorylated ataxia telangiectasia mutated (ATM) with NEMO. Inhibition of ATM with two distinct pharmacological inhibitors suppressed the activating autophosphorylation of ATM, blocked the interaction of ATM and NEMO, delocalized NEMO as well as another putative NF-kappa B activator, PIDD, from the nucleus, abolished the activating phosphorylation of the catalytic proteins of the IKK complex (IKK1/2 on serines 176/180), enhanced the expression of I kappa B alpha and caused the relocalization of NF-kappa B from the nucleus to the cytoplasm, followed by apoptosis. Knockdown of ATM with small-interfering RNAs had a similar effect that could not be enhanced by knockdown of NEMO, PIDD and the p65 NF-kappa B subunit, suggesting that an ATM inhibition/depletion truly induced apoptosis through inhibition of the NF-kappa B system. Pharmacological inhibition of ATM also induced the nucleocytoplasmic relocalization of p65 in malignant myeloblasts purified from patients with high-risk MDS or AML, correlating with the induction of apoptosis. Altogether, these results support the contention that constitutively active ATM accounts for the activation of NF-kappa B in high-risk MDS and AML.	[Grosjean-Raillard, J.; Tailler, M.; Ades, L.; Perfettini, J-L; Fabre, C.; Fenaux, P.; Kroemer, G.] Inst Gustave Roussy, INSERM, U848, F-94805 Villejuif, France; [Grosjean-Raillard, J.; Tailler, M.; Ades, L.; Perfettini, J-L; Fabre, C.; Fenaux, P.; Kroemer, G.] Univ Paris 11, Villejuif, France; [Ades, L.; Braun, T.; Fenaux, P.] Univ Paris 13, AP HP, Hop Avicenne, Serv Hematol Clin, Bobigny, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13	Kroemer, G (corresponding author), Inst Gustave Roussy, INSERM, U848, Pavillon Rech 1,39 Rue Camille Desmoulins, F-94805 Villejuif, France.	kroemer@igr.fr	Braun, Thorsten/GRJ-8918-2022; PERFETTINI, Jean-Luc/N-4699-2017; Ades, lionel/T-6882-2019; Kroemer, Guido/AAY-9859-2020; KROEMER, Guido/B-4263-2013	PERFETTINI, Jean-Luc/0000-0002-2427-2604; KROEMER, Guido/0000-0002-9334-4405				Bakkenist CJ, 2004, TRENDS CELL BIOL, V14, P339, DOI 10.1016/j.tcb.2004.05.001; Bartkova J, 2005, CELL CYCLE, V4, P838, DOI 10.4161/cc.4.6.1742; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Barzilai A, 2004, DNA REPAIR, V3, P1109, DOI 10.1016/j.dnarep.2004.03.002; Bennett JM, 2000, INT J HEMATOL, V72, P131; BENNETT JM, 1976, BRIT J HAEMATOL, V33, P451, DOI 10.1111/j.1365-2141.1976.tb03563.x; Birkenkamp KU, 2004, LEUKEMIA, V18, P103, DOI 10.1038/sj.leu.2403145; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Braun T, 2006, CELL DEATH DIFFER, V13, P748, DOI 10.1038/sj.cdd.4401874; Braun T, 2006, BLOOD, V107, P1156; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; Carvalho G, 2007, ONCOGENE, V26, P2299, DOI 10.1038/sj.onc.1210043; Castedo M, 2002, J EXP MED, V196, P1121, DOI 10.1084/jem.20021758; Castedo M, 1996, J IMMUNOL, V157, P512; Fabre C, 2007, ONCOGENE, V26, P4071, DOI 10.1038/sj.onc.1210187; Gale RE, 2008, BLOOD, V111, P2776, DOI 10.1182/blood-2007-08-109090; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Greten FR, 2004, CANCER LETT, V206, P193, DOI 10.1016/j.canlet.2003.08.029; Grosjean-Raillard J, 2008, APOPTOSIS, V13, P1148, DOI 10.1007/s10495-008-0243-4; Guzman ML, 2001, BLOOD, V98, P2301, DOI 10.1182/blood.V98.8.2301; Habraken Y, 2006, BIOCHEM PHARMACOL, V72, P1132, DOI 10.1016/j.bcp.2006.07.015; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hassan Z, 1999, EXP HEMATOL, V27, P1322, DOI 10.1016/S0301-472X(99)00066-1; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Janssens S, 2005, CELL, V123, P1079, DOI 10.1016/j.cell.2005.09.036; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Knapper S, 2007, BRIT J HAEMATOL, V138, P687, DOI 10.1111/j.1365-2141.2007.06700.x; Leone G, 2007, HAEMATOLOGICA, V92, P1389, DOI 10.3324/haematol.11034; Li NX, 2001, J BIOL CHEM, V276, P8898, DOI 10.1074/jbc.M009809200; Lin XJ, 2000, MOL PHARMACOL, V58, P1222, DOI 10.1124/mol.58.6.1222; Lin YP, 2000, NAT GENET, V26, P122, DOI 10.1038/79102; Metivier D, 1998, IMMUNOL LETT, V61, P157, DOI 10.1016/S0165-2478(98)00013-3; Mufti Ghulam, 2003, Hematology Am Soc Hematol Educ Program, P176; Rajkumar SV, 2005, J CLIN ONCOL, V23, P630, DOI 10.1200/JCO.2005.11.030; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Vardiman JW, 2002, BLOOD, V100, P2292, DOI 10.1182/blood-2002-04-1199; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Yanada M, 2005, LEUKEMIA, V19, P1345, DOI 10.1038/sj.leu.2403838; ZAMZAMI N, 2003, METH MOL B, V282, P103	41	54	59	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2009	28	8					1099	1109		10.1038/onc.2008.457	http://dx.doi.org/10.1038/onc.2008.457			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	412KE	19079347				2022-12-25	WOS:000263722900005
J	Rose, AP				Rose, Alexandra P.			Temporal and Individual Variation in Offspring Provisioning by Tree Swallows: A New Method of Automated Nest Attendance Monitoring	PLOS ONE			English	Article							INCUBATION; ATTENTIVENESS; SPARROWS; TIME; CARE	Studies of the ecology and evolution of avian nesting behavior have been limited by the difficulty and expense of sampling nest attendance behavior across entire days or throughout a substantial portion of the nestling period. Direct observation of nesting birds using human observers and most automated devices requires sub-sampling of the nestling period, which does not allow for the quantification of the duration of chick-feeding by parents within a day, and may also inadequately capture temporal variation in the rate at which chicks are fed. Here I describe an inexpensive device, the Automated Perch Recorder (APR) system, which collects accurate, long-term data on hourly rates of nest visitation, the duration of a pair's workday, and the total number of visits the pair makes to their nest across the entire period for which it is deployed. I also describe methods for verifying the accuracy of the system in the field, and several examples of how these data can be used to explore the causes of variation in and tradeoffs between the rate at which birds feed their chicks and the total length of time birds spend feeding chicks in a day.	Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Rose, AP (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	rose@biology.ucsc.edu			American Museum of Natural History; American Ornithologist's Union; STEPS Institute for Innovation in Environmental Research	American Museum of Natural History; American Ornithologist's Union; STEPS Institute for Innovation in Environmental Research	This project was funded by the American Museum of Natural History, the American Ornithologist's Union, and the STEPS Institute for Innovation in Environmental Research. No sponsors or funders had any role in any aspect of the design or conduct of this study or manuscript.	CARTAR RV, 1987, CONDOR, V89, P252, DOI 10.2307/1368478; Cooper CB, 2005, J FIELD ORNITHOL, V76, P352, DOI 10.1648/0273-8570-76.4.352; Gill F. B., 1990, ORNITHOLOGY; JONES G, 1987, J ANIM ECOL, V56, P229, DOI 10.2307/4812; Joyce EM, 2001, J FIELD ORNITHOL, V72, P369, DOI 10.1648/0273-8570-72.3.369; Kluijver H.N., 1950, PARUS M MAJOR L ARDE, V38, P99; Lack D., 1968, pvii; LACK D, 1947, IBIS, V89, P302, DOI 10.1111/j.1474-919X.1947.tb04155.x; Magrath MJL, 1997, P ROY SOC B-BIOL SCI, V264, P1731, DOI 10.1098/rspb.1997.0240; MARTIN TE, 1993, J FIELD ORNITHOL, V64, P507; Martin TE, 2000, SCIENCE, V287, P1482, DOI 10.1126/science.287.5457.1482; McCarty JP, 2002, J FIELD ORNITHOL, V73, P9, DOI 10.1648/0273-8570-73.1.9; Norment CJ, 1995, J FIELD ORNITHOL, V66, P553; OEHLERT GW, 1992, AM STAT, V46, P27, DOI 10.2307/2684406; ORIANS GH, 1969, AM NAT, V103, P589, DOI 10.1086/282628; Quinn GP, 2003, EXPT DESIGN DATA ANA; SIMMONS GA, 1969, AM MIDL NAT, V81, P276, DOI 10.2307/2423675; Skutch A.F., 1976, PARENT BIRDS THEIR Y; SZEP T, 1995, J FIELD ORNITHOL, V66, P1; WEEDEN JS, 1966, AUK, V83, P368, DOI 10.2307/4083049	20	14	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2009	4	1							e4111	10.1371/journal.pone.0004111	http://dx.doi.org/10.1371/journal.pone.0004111			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FR	19119316	Green Published, Green Submitted, gold			2022-12-25	WOS:000265472600010
J	Oro, D; Margalida, A; Carrete, M; Heredia, R; Donazar, JA				Oro, Daniel; Margalida, Antoni; Carrete, Martina; Heredia, Rafael; Antonio Donazar, Jose			Testing the Goodness of Supplementary Feeding to Enhance Population Viability in an Endangered Vulture	PLOS ONE			English	Article							GYPAETUS-BARBATUS; EXTINCTION RISK; BEARDED VULTURES; CONSERVATION; HABITAT; BIRDS; REPRODUCTION; PERSECUTION; DICLOFENAC; MORTALITY	Background: Human-predator conflicts are directly or indirectly threatening many species with extinction. Thus, biologists are urged to find simple solutions to complex situations while avoiding unforeseen conservation outcomes. The provision of supplementary food at artificial feeding sites (AFS) is frequently used in the conservation of scavenger bird populations currently suffering from indirect poisoning, although no scientific studies on its effectiveness have been conducted. Methodology/Principal Findings: We used a long-term data set of 95 individually marked birds from the largest European core of the endangered bearded vulture (Gypaetus barbatus) to test the long-term effects of specific AFS for bearded vultures on their survival rates (by CMR models) and population dynamics (by Monte Carlo simulations) in an area where fatalities derived from illegal poisoning and the use of other toxics like veterinary drugs have increased over the last several years. Our data support the positive relationship between the use of AFS and survival. However, contrary to theoretical predictions (e. g. high and more stable adult survival among long-lived species), the use of AFS increased only survival of pre-adults. Moreover, AFS buffered the effects of illegal poisoning on this age-class, while adult survival decreased over years. Our simulations predicted a maximum value of extinction probability over a time horizon of 50 years. Population projections run with survival rates expected in scenarios without poisoning predicted the situation of least conservation concern, while including only AFS can maintain a large floater surplus that may delay population decline but fails to reduce poisoning risk among adults. Conclusions/Significance: Although AFS are not effective to save bearded vultures from an expected population decline, they delay population extinction and can be a useful tool for prolonging population viability while combating illegal and indirect poisoning. The eradication of different sources of poisoning is of top priority to ensure the long-term viability of this and many other species.	IMEDEA CSIC UIB, Esporles, Mallorca, Spain; [Margalida, Antoni] Bearded Vulture Study & Protect Grp, Lleida, Spain; [Carrete, Martina; Antonio Donazar, Jose] CSIC, Dept Conservat Biol, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; Fundacion para la Conservacion del Quebranthuesos (FCQ); Consejo Superior de Investigaciones Cientificas (CSIC)	Oro, D (corresponding author), IMEDEA CSIC UIB, Esporles, Mallorca, Spain.	margalida@inf.entorno.es	Carrete, Martina/D-2618-2017; Margalida, Antoni/A-2723-2011; Margalida, Antoni/AAG-5337-2020; Oro, Daniel/H-4208-2012; Carrete, Martina/A-6376-2009; Margalida, Antoni/A-2723-2011	Margalida, Antoni/0000-0002-0576-3993; Oro, Daniel/0000-0003-4782-3007; Carrete, Martina/0000-0002-0491-2950; Margalida, Antoni/0000-0002-7383-671X; Donazar, Jose Antonio/0000-0002-9433-9755; Margalida, Antoni/0000-0002-3904-6212	Departament of Medi Ambient i Habitatge of Generalitat de Catalunya; Ministry of Environment; Junta de Andalucia	Departament of Medi Ambient i Habitatge of Generalitat de Catalunya(Generalitat de Catalunya); Ministry of Environment(Ministry of Environment (ME), Republic of Korea); Junta de Andalucia(Junta de Andalucia)	Financial support for AM was obtained from the Departament of Medi Ambient i Habitatge of Generalitat de Catalunya and Ministry of Environment. MC was supported by an Excellence post-doctoral contract (Junta de Andalucia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antor RJ, 2007, ACTA ORNITHOL, V42, P114, DOI 10.3161/068.042.0106; Bennett PM, 1997, P ROY SOC B-BIOL SCI, V264, P401, DOI 10.1098/rspb.1997.0057; Blanco G, 2007, ENVIRON MICROBIOL, V9, P1738, DOI 10.1111/j.1462-2920.2007.01291.x; Blanco G, 2006, ARDEOLA, V53, P341; Bretagnolle V, 2004, BIOL CONSERV, V120, P19, DOI 10.1016/j.biocon.2004.01.023; Cardillo M, 2004, PLOS BIOL, V2, P909, DOI 10.1371/journal.pbio.0020197; Carrete M, 2007, BIOL CONSERV, V136, P143, DOI 10.1016/j.biocon.2006.11.025; Carrete M, 2006, ECOL APPL, V16, P1674, DOI 10.1890/1051-0761(2006)016[1674:DPDIPB]2.0.CO;2; Carrete M, 2006, BIOL LETTERS, V2, P624, DOI 10.1098/rsbl.2006.0498; Chamberlain CP, 2005, P NATL ACAD SCI USA, V102, P16707, DOI 10.1073/pnas.0508529102; CHOQUET R, 2008, ENV ECOL ST IN PRESS; CLUTHBERT R, 2007, BIOL LETT, V3, P90; CUSHING JM, 2003, CHAOS ECOLOGY EXPT N; Gilbert M, 2007, BIRD CONSERV INT, V17, P63, DOI 10.1017/S0959270906000621; Green RE, 2006, J APPL ECOL, V43, P949, DOI 10.1111/j.1365-2664.2006.01225.x; Halley JM, 1996, TRENDS ECOL EVOL, V11, P33, DOI 10.1016/0169-5347(96)81067-6; Heredia R., 1990, Acta Biologica Montana, V9, P39; HEREDIA R, 2005, BIOL CONSERVACION QU, P335; Hernandez M, 2008, ECOTOXICOLOGY, V17, P264, DOI 10.1007/s10646-008-0193-1; Inchausti P, 2003, J ANIM ECOL, V72, P899, DOI 10.1046/j.1365-2656.2003.00767.x; IUCN [International Union for Conservation of Nature], 1990, 1990 IUCN RED LIST T; Lande R., 2003, OXFORD SERIES ECOLOG; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Legendre S, 1995, J APPL STAT, V22, P817, DOI 10.1080/02664769524649; Lemus JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001444; Margalida A, 2004, IBIS, V146, P386, DOI 10.1111/j.1474-919X.2004.00261.x; Margalida A, 2003, IBIS, V145, P244, DOI 10.1046/j.1474-919X.2003.00148.x; MARGALIDA A, 2009, J APPL ECOL; Margalida A, 2008, BIRD CONSERV INT, V18, P1, DOI 10.1017/S0959270908000026; Margalida A, 2008, IBIS, V150, P242, DOI 10.1111/j.1474-919X.2007.00768.x; Gonzalez L, 2006, BIOL CONSERV, V129, P477, DOI 10.1016/j.biocon.2005.11.014; Mills LS, 2001, CONSERV BIOL, V15, P281, DOI 10.1046/j.1523-1739.2001.00300.x; Mundy P., 1992, VULTURES AFRICA; Owens IPF, 2000, P NATL ACAD SCI USA, V97, P12144, DOI 10.1073/pnas.200223397; Robb GN, 2008, FRONT ECOL ENVIRON, V6, P476, DOI 10.1890/060152; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; Sanz-Aguilar A, 2008, ECOLOGY, V89, P3195, DOI 10.1890/08-0431.1; SCHAUB M, 2008, J APPL ECOL; Sese JA, 2005, BIOL CONSERVACION QU, P279; Tavecchia G, 2001, ECOLOGY, V82, P165, DOI 10.1890/0012-9658(2001)082[0165:SAARVI]2.0.CO;2; Tavecchia G, 2007, OIKOS, V116, P1481, DOI 10.1111/j.2007.0030-1299.15791.x; Tella JL, 2001, NATURE, V410, P408, DOI 10.1038/35068717; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Whitfield DP, 2004, BIOL CONSERV, V119, P319, DOI 10.1016/j.biocon.2003.11.015; WILBUR SR, 1974, J WILDLIFE MANAGE, V38, P343, DOI 10.2307/3800743; WILLIAMS B. K., 2001, ANAL MANAGEMENT ANIM	46	134	137	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2008	3	12							e4084	10.1371/journal.pone.0004084	http://dx.doi.org/10.1371/journal.pone.0004084			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DL	19115009	Green Submitted, gold, Green Published			2022-12-25	WOS:000265466300020
J	Sasaki, T; Maier, B; Koclega, KD; Chruszcz, M; Gluba, W; Stukenberg, PT; Minor, W; Scrable, H				Sasaki, Tsutomu; Maier, Bernhard; Koclega, Katarzyna D.; Chruszcz, Maksymilian; Gluba, Wendy; Stukenberg, P. Todd; Minor, Wladek; Scrable, Heidi			Phosphorylation Regulates SIRT1 Function	PLOS ONE			English	Article								Background: SIR2 is an NAD(+)-dependent deacetylase [1-3] implicated in the regulation of lifespan in species as diverse as yeast [4], worms [5], and flies [6]. We previously reported that the level of SIRT1, the mammalian homologue of SIR2 [7,8], is coupled to the level of mitotic activity in cells both in vitro and in vivo [9]. Cells from long-lived mice maintained SIRT1 levels of young mice in tissues that undergo continuous cell replacement by proliferating stem cells. Changes in SIRT1 protein level were not associated with changes in mRNA level, suggesting that SIRT1 could be regulated post-transcriptionally. However, other than a recent report on sumoylation [10] and identification of SIRT1 as a nuclear phospho-protein by mass spectrometry [11], post-translational modifications of this important protein have not been reported. Methodology/Principal Findings: We identified 13 residues in SIRT1 that are phosphorylated in vivo using mass spectrometry. Dephosphorylation by phosphatases in vitro resulted in decreased NAD(+)- dependent deacetylase activity. We identified cyclinB/Cdk1 as a cell cycle-dependent kinase that forms a complex with and phosphorylates SIRT1. Mutation of two residues phosphorylated by Cyclin B/Cdk1 (threonine 530 and serine 540) disturbs normal cell cycle progression and fails to rescue proliferation defects in SIRT1-deficient cells [12,13]. Conclusions/Significance: Pharmacological manipulation of SIRT1 activity is currently being tested as a means of extending lifespan in mammals. Treatment of obese mice with resveratrol, a pharmacological activator of SIRT1, modestly but significantly improved longevity and, perhaps more importantly, offered some protection against the development of type 2 diabetes mellitus and metabolic syndrome [14-16]. Understanding the endogenous mechanisms that regulate the level and activity of SIRT1, therefore, has obvious relevance to human health and disease. Our results identify phosphorylation by cell cycle dependent kinases as a major mechanism controlling the level and function of this sirtuin and complement recent reports of factors that inhibit [17,18] and activate [19] SIRT1 by protein-protein interactions.	[Sasaki, Tsutomu; Scrable, Heidi] Univ Virginia, Neurosci Grad Program, Charlottesville, VA 22903 USA; [Sasaki, Tsutomu; Maier, Bernhard; Gluba, Wendy; Scrable, Heidi] Univ Virginia, Dept Neurosci, Charlottesville, VA 22903 USA; [Koclega, Katarzyna D.; Chruszcz, Maksymilian; Minor, Wladek] Univ Virginia, Dept Mol Physiol & Biophys, Charlottesville, VA 22903 USA; [Stukenberg, P. Todd] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22903 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia	Sasaki, T (corresponding author), Gunma Univ, Inst Mol & Cellular Regulat, Lab Metab Signal, Gunma, Japan.	hs2n@virginia.edu	Chruszcz, Maksymilian/E-6407-2011; Minor, Wladek/F-3096-2014	Chruszcz, Maksymilian/0000-0001-7521-5485; Minor, Wladek/0000-0001-7075-7090; Stukenberg, Todd/0000-0002-6788-2111; Sasaki, Tsutomu/0000-0001-8041-1915	NIH [AG026094, GM53163, GM74942]; Ellison Foundation for Medical Research [fellow]; Cancer Center [P30 CA45579]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053163, U54GM074942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026094] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Foundation for Medical Research; Cancer Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by PHS grant NIH AG026094 (H.S.) and NIH GM53163 and GM74942 (W.M.). H.S. is a fellow of the Ellison Foundation for Medical Research. The flow cytometry core facility is supported by Cancer Center Support Grant P30 CA45579.	Abbas T, 2007, CELL CYCLE, V6, P843, DOI 10.4161/cc.6.7.4000; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Berdichevsky A, 2006, CELL, V125, P1165, DOI 10.1016/j.cell.2006.04.036; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Dequiedt F, 2006, MOL CELL BIOL, V26, P7086, DOI 10.1128/MCB.00231-06; Dryden SC, 2003, MOL CELL BIOL, V23, P3173, DOI 10.1128/MCB.23.9.3173-3185.2003; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Gallo CA, 2004, MOL CELL BIOL, V24, P1301, DOI 10.1128/MCB.24.3.1301-1312.2004; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pW226, DOI 10.1093/nar/gki471; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kim EJ, 2007, MOL CELL, V28, P277, DOI 10.1016/j.molcel.2007.08.030; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Li MG, 2006, CELL SIGNAL, V18, P1318, DOI 10.1016/j.cellsig.2005.10.020; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; North BJ, 2007, J BIOL CHEM, V282, P19546, DOI 10.1074/jbc.M702990200; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Parra M, 2007, GENE DEV, V21, P638, DOI 10.1101/gad.1513107; Pflum MKH, 2001, J BIOL CHEM, V276, P47733, DOI 10.1074/jbc.M105590200; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; RINE J, 1987, GENETICS, V116, P9; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Sasaki T, 2006, AGING CELL, V5, P413, DOI 10.1111/j.1474-9726.2006.00235.x; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; SRINIVASAN J, 1995, BIOCHEM J, V309, P927, DOI 10.1042/bj3090927; Takeda DY, 2001, J BIOL CHEM, V276, P1993, DOI 10.1074/jbc.M005719200; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Wang Y, 2006, MECH AGEING DEV, V127, P741, DOI 10.1016/j.mad.2006.05.005; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Yang YH, 2007, NAT CELL BIOL, V9, P1253, DOI 10.1038/ncb1645; ZHANG JW, 1994, ARCH BIOCHEM BIOPHYS, V315, P415, DOI 10.1006/abbi.1994.1519; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	46	211	218	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4020	10.1371/journal.pone.0004020	http://dx.doi.org/10.1371/journal.pone.0004020			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107194	Green Published, Green Submitted, gold			2022-12-25	WOS:000265463000015
J	Gopalan, S; Ausubel, FM				Gopalan, Suresh; Ausubel, Frederick M.			A Metasystem of Framework Model Organisms to Study Emergence of New Host-Microbe Adaptations	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; SECRETION SYSTEM; BACTERIAL; DEFENSE; PATHOGENICITY; INFECTION; MUTUALISM; RESPONSES; PA14	An unintended consequence of global industrialization and associated societal rearrangements is new interactions of microbes and potential hosts (especially mammals and plants), providing an opportunity for the rapid emergence of host-microbe adaptation and eventual establishment of new microbe-related diseases. We describe a new model system comprising the model plant Arabidopsis thaliana and several microbes, each representing different modes of interaction, to study such "maladaptations". The model microbes include human and agricultural pathogens and microbes that are commonly considered innocuous. The system has a large knowledge base corresponding to each component organism and is amenable to high-throughput automation assisted perturbation screens for identifying components that modulate host-pathogen interactions. This would aid in the study of emergence and progression of host-microbe maladaptations in a controlled environment.	[Ausubel, Frederick M.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Gopalan, Suresh; Ausubel, Frederick M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Gopalan, S (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	gopalan@molbio.mgh.harvard.edu			NIH [R37 GM48707]; NSF [DBI-0114783]; Inflammatory Bowel Disease [DK43351]; Boston Area Diabetes and Endocrinology Research Center Award [DK57521]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, P30DK057521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM048707] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Inflammatory Bowel Disease; Boston Area Diabetes and Endocrinology Research Center Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by grants R37 GM48707 from NIH and DBI-0114783 from NSF to F.M.A. The Microscopy core is partially supported by an Inflammatory Bowel Disease Grant DK43351 and a Boston Area Diabetes and Endocrinology Research Center Award DK57521. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bergmann DC, 2004, SCIENCE, V304, P1494, DOI 10.1126/science.1096014; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Denoux C, 2008, MOL PLANT, V1, P423, DOI 10.1093/mp/ssn019; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Fawcett P, 2000, P NATL ACAD SCI USA, V97, P8063, DOI 10.1073/pnas.140209597; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Gallagher LA, 2001, J BACTERIOL, V183, P6207, DOI 10.1128/JB.183.21.6207-6214.2001; Gopalan S, 1996, PLANT CELL, V8, P1095, DOI 10.1105/tpc.8.7.1095; GRAY KM, 1994, J BACTERIOL, V176, P3076, DOI 10.1128/JB.176.10.3076-3080.1994; Hara K, 2007, GENE DEV, V21, P1720, DOI 10.1101/gad.1550707; HOLLOWAY BW, 1955, J GEN MICROBIOL, V13, P572, DOI 10.1099/00221287-13-3-572; Iandolo JJ, 2002, GENE, V289, P109, DOI 10.1016/S0378-1119(02)00481-X; Lai LB, 2005, PLANT CELL, V17, P2754, DOI 10.1105/tpc.105.034116; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Lynch AS, 2008, ANNU REV MED, V59, P415, DOI 10.1146/annurev.med.59.110106.132000; Mahajan-Miklos S, 2000, MOL MICROBIOL, V37, P981, DOI 10.1046/j.1365-2958.2000.02056.x; Miyata S, 2003, INFECT IMMUN, V71, P2404, DOI 10.1128/IAI.71.5.2404-2413.2003; Nadeau JA, 2002, SCIENCE, V296, P1697, DOI 10.1126/science.1069596; Naitza S, 2002, IMMUNITY, V17, P575, DOI 10.1016/S1074-7613(02)00454-5; Pamer EG, 2007, NAT IMMUNOL, V8, P1173, DOI 10.1038/ni1526; Plotnikova JM, 2000, PLANT PHYSIOL, V124, P1766, DOI 10.1104/pp.124.4.1766; Quintana-Murci L, 2007, NAT IMMUNOL, V8, P1165, DOI 10.1038/ni1535; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; SONGNUAN W, 2008, P 13 INT C MOL PLANT; Subramanian C, 2006, PLANT J, V48, P138, DOI 10.1111/j.1365-313X.2006.02851.x; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715	31	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2008	3	12							e3891	10.1371/journal.pone.0003891	http://dx.doi.org/10.1371/journal.pone.0003891			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZS	19066631	Green Published, gold			2022-12-25	WOS:000265455700005
J	Dubey, RN; Nakwal, N; Bisht, KK; Saini, A; Haldar, S; Singh, J				Dubey, Rudra Narayan; Nakwal, Nandni; Bisht, Kamlesh Kumar; Saini, Ashok; Haldar, Swati; Singh, Jagmohan			Interaction of APC/C-E3 Ligase with Swi6/HP1 and Clr4/Suv39 in Heterochromatin Assembly in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-ALPHA; CELL-CYCLE CONTROL; CHROMODOMAIN PROTEIN; HISTONE H3; LYSINE-4 METHYLATION; UBIQUITIN LIGASE; ANAPHASE; ESTABLISHMENT; MAINTENANCE; INHERITANCE	Heterochromatin assembly in fission yeast is initiated by binding of Swi6/HP1 to the Lys-9-dimethylated H3 followed by spreading via cooperative recruitment of Swi6/HP1. Recruitment of Cohesin by Swi6/HP1 further stabilizes the heterochromatin structure and integrity. Subsequently, polyubiquitylation of Cut2 by anaphase-promoting complex-cyclosome (APC/C)-ubiquitin-protein isopeptide ligase (E3 ligase) followed by degradation of Cut2 releases Cut1, which cleaves the Rad21 subunit of Cohesin, facilitating sister chromatid separation during mitosis. Here, we demonstrate a surprising role of APC/C in assembly of heterochromatin and silencing at mating type, centromere, and ribosomal DNA loci. Coincidentally with the loss of silencing, recruitment of Swi6, H3-Lys- 9-Me2, and Clr4 at dg-dh repeats at cen1 and the K region of mat locus is abrogated in mutants cut4, cut9, and nuc2. Surprisingly, both Cut4 and Cut9 are also highly enriched at these regions in wild type and depleted in swi6 Delta mutant. Cut4 and Cut9 interact directly with Swi6/HP1 and Clr4, whereas the mutant Cut4 does not, suggesting that a direct physical interaction of APC subunits Cut4 and Cut9 with Swi6 and Clr4 is instrumental in heterochromatin assembly. The silencing defect in APC mutants is causally related to ubiquitylation activity of APC-E3 ligase. Like swi6 mutant, APC mutants are also defective in Cohesin recruitment and exhibit defects like lagging chromosomes, chromosome loss, and aberrant recombination in the mat region. In addition, APC mutants exhibit a bidirectional expression of dh repeats, suggesting a role in the RNA interference pathway. Thus, APC and heterochromatin proteins Swi6 and Clr4 play a mutually cooperative role in heterochromatin assembly, thereby ensuring chromosomal integrity, inheritance, and segregation during mitosis and meiosis.	[Dubey, Rudra Narayan; Nakwal, Nandni; Bisht, Kamlesh Kumar; Saini, Ashok; Haldar, Swati; Singh, Jagmohan] Inst Microbial Technol, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Singh, J (corresponding author), Inst Microbial Technol, Sector 39A, Chandigarh 160036, India.	jag@imtech.res.in	Haldar, Swati/AAH-5388-2021	saini, ashok/0000-0001-6530-4281; Haldar, Swati/0000-0002-1566-1907	Department of Science and Technology, New Delhi	Department of Science and Technology, New Delhi(Department of Science & Technology (India))	This work was supported by a grant from the Department of Science and Technology, New Delhi. The costs of publication of this article were defrayed in part by the payment of page charges.	Ahmed S, 2001, J BIOL CHEM, V276, P47814, DOI 10.1074/jbc.M109186200; ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bailis JM, 2003, NAT CELL BIOL, V5, P1111, DOI 10.1038/ncb1069; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; BEACH DH, 1984, EMBO J, V3, P603, DOI 10.1002/j.1460-2075.1984.tb01855.x; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; EGEL R, 1984, P NATL ACAD SCI-BIOL, V81, P3481, DOI 10.1073/pnas.81.11.3481; EKWALL K, 1995, SCIENCE, V269, P1429, DOI 10.1126/science.7660126; Ekwall K, 1996, J CELL SCI, V109, P2637; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; Grewal SIS, 1996, CELL, V86, P95, DOI 10.1016/S0092-8674(00)80080-X; Grewal SIS, 1997, GENETICS, V146, P1221; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Horn PJ, 2006, CHROMOSOME RES, V14, P83, DOI 10.1007/s10577-005-1018-1; Horn PJ, 2005, GENE DEV, V19, P1705, DOI 10.1101/gad.1328005; Huang HH, 1997, MOL CELL BIOL, V17, P6693, DOI 10.1128/MCB.17.11.6693; JAMES SW, 1995, J CELL SCI, V108, P3485; Jia ST, 2005, NAT CELL BIOL, V7, P1007, DOI 10.1038/ncb1300; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Jorgensen PM, 1998, MOL CELL BIOL, V18, P468; Kim HS, 2004, J BIOL CHEM, V279, P42850, DOI 10.1074/jbc.M407259200; KIPLING D, 1990, MOL CELL BIOL, V10, P265, DOI 10.1128/MCB.10.1.265; KUMADA K, 1995, J CELL SCI, V108, P895; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; Lau A, 2002, GENE DEV, V16, P2935, DOI 10.1101/gad.764102; LORENTZ A, 1994, GENE, V143, P139, DOI 10.1016/0378-1119(94)90619-X; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nakayama J, 2001, EMBO J, V20, P2857, DOI 10.1093/emboj/20.11.2857; Naresh A, 2003, J BIOL CHEM, V278, P9185, DOI 10.1074/jbc.M212732200; Nielsen IS, 2002, EUKARYOT CELL, V1, P613, DOI 10.1128/EC1.4.613-625.2002; Noma K, 2002, P NATL ACAD SCI USA, V99, P16438, DOI 10.1073/pnas.182436399; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Partridge J.F., 1999, PRACT APPROACH SER, P38; Pidoux AL, 2000, J CELL SCI, V113, P4177; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Roguev A, 2003, J BIOL CHEM, V278, P8487, DOI 10.1074/jbc.M209562200; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Shin JA, 2005, MOL CELL, V19, P817, DOI 10.1016/j.molcel.2005.08.021; SINGH J, 1993, NATURE, V361, P271, DOI 10.1038/361271a0; Singh J, 1998, MOL CELL BIOL, V18, P5511, DOI 10.1128/MCB.18.9.5511; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Thon G, 1999, GENETICS, V151, P945; Thon G, 2005, GENETICS, V171, P1583, DOI 10.1534/genetics.105.048298; Thon G, 1997, GENETICS, V145, P685; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Uhlmann F, 2004, EXP CELL RES, V296, P80, DOI 10.1016/j.yexcr.2004.03.005; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wang GZ, 2000, MOL CELL BIOL, V20, P6970, DOI 10.1128/MCB.20.18.6970-6983.2000; Yamashita YM, 1996, NATURE, V384, P276, DOI 10.1038/384276a0; Yanagida M, 1999, PHILOS T R SOC B, V354, P1559, DOI 10.1098/rstb.1999.0499; Yoon HJ, 2002, CURR BIOL, V12, P2048, DOI 10.1016/S0960-9822(02)01331-3	53	6	6	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7165	7176		10.1074/jbc.M806461200	http://dx.doi.org/10.1074/jbc.M806461200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19117951	Green Published, hybrid			2022-12-25	WOS:000263919000064
J	Cha, JYY; Maddileti, S; Mitin, N; Harden, TK; Der, CJ				Cha, Jiyoung Y.; Maddileti, Savitri; Mitin, Natalia; Harden, T. Kendall; Der, Channing J.			Aberrant Receptor Internalization and Enhanced FRS2-dependent Signaling Contribute to the Transforming Activity of the Fibroblast Growth Factor Receptor 2 IIIb C3 Isoform	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING SPECIFICITY; NEONATAL FC-RECEPTOR; EPITHELIAL-CELLS; PHOSPHOLIPASE-C; POINT MUTATION; MESSENGER-RNA; FGF RECEPTORS; ENDOCYTOSIS; ACTIVATION; EXPRESSION	Alternative splice variants of fibroblast growth factor receptor 2 (FGFR2) IIIb, designated C1, C2, and C3, possess progressive reduction in their cytoplasmic carboxyl termini ( 822, 788, and 769 residues, respectively), with preferential expression of the C2 and C3 isoforms in human cancers. We determined that the progressive deletion of carboxyl-terminal sequences correlated with increasing transforming potency. The highly transforming C3 variant lacks five tyrosine residues present in C1, and we determined that the loss of Tyr-770 alone enhanced FGFR2 IIIb C1 transforming activity. Because Tyr-770 may compose a putative YXXL sorting motif, we hypothesized that loss of Tyr-770 in the (YXXL)-Y-770 motif may cause disruption of FGFR2 IIIb C1 internalization and enhance transforming activity. Surprisingly, we found that mutation of Leu-773 but not Tyr-770 impaired receptor internalization and increased receptor stability and activation. Interestingly, concurrent mutations of Tyr-770 and Leu-773 caused 2-fold higher transforming activity than caused by the Y770F or L773A single mutations, suggesting loss of Tyr and Leu residues of the (YXXL773)-Y-770 motif enhances FGFR2 IIIb transforming activity by distinct mechanisms. We also determined that loss of Tyr-770 caused persistent activation of FRS2 by enhancing FRS2 binding to FGFR2 IIIb. Furthermore, we found that FRS2 binding to FGFR2 IIIb is required for increased FRS2 tyrosine phosphorylation and enhanced transforming activity by Y770F mutation. Our data support a dual mechanism where deletion of the 770YXXL773 motif promotes FGFR2 IIIb C3 transforming activity by causing aberrant receptor recycling and stability and persistent FRS2-dependent signaling.	[Cha, Jiyoung Y.; Maddileti, Savitri; Mitin, Natalia; Harden, T. Kendall; Der, Channing J.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Der, CJ (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pharmacol, CB 7295, Chapel Hill, NC 27599 USA.	cjder@med.unc.edu	Mitin, Natalia/E-8043-2012	Der, Channing/0000-0002-7751-2747	National Institutes of Health [CA69577, GM65533]; NATIONAL CANCER INSTITUTE [R01CA069577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM065533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA69577 (to C.J.D.) and GM65533 (to T.K.H.) (USPHS). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bache KG, 2004, EMBO J, V23, P2707, DOI 10.1038/sj.emboj.7600292; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; BROWN HA, 1991, MOL PHARMACOL, V40, P648; CANFIELD WM, 1991, J BIOL CHEM, V266, P5682; Ceridono M, 2005, BIOCHEM BIOPH RES CO, V327, P523, DOI 10.1016/j.bbrc.2004.12.031; Cha JY, 2008, MOL CANCER RES, V6, P435, DOI 10.1158/1541-7786.MCR-07-0187; CHANG CP, 1993, J BIOL CHEM, V268, P19312; Chang JS, 1997, CANCER RES, V57, P5465; Chen J, 2005, BLOOD, V106, P328, DOI 10.1182/blood-2004-09-3686; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; DELL KR, 1992, J BIOL CHEM, V267, P21225; DeMali KA, 1997, J BIOL CHEM, V272, P9011; Dikic I, 2003, CURR OPIN CELL BIOL, V15, P128, DOI 10.1016/S0955-0674(03)00004-8; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Fabbri M, 1999, EMBO J, V18, P4915, DOI 10.1093/emboj/18.18.4915; FINCH PW, 1989, SCIENCE, V245, P752, DOI 10.1126/science.2475908; Grose R, 2005, CYTOKINE GROWTH F R, V16, P179, DOI 10.1016/j.cytogfr.2005.01.003; Igarashi M, 1998, J BIOL CHEM, V273, P13230, DOI 10.1074/jbc.273.21.13230; ITOH H, 1994, CANCER RES, V54, P3237; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Lax I, 2002, MOL CELL, V10, P709, DOI 10.1016/S1097-2765(02)00689-5; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MASON IJ, 1994, MECH DEVELOP, V45, P15, DOI 10.1016/0925-4773(94)90050-7; MIKI T, 1992, P NATL ACAD SCI USA, V89, P246, DOI 10.1073/pnas.89.1.246; MIKI T, 1991, SCIENCE, V251, P72, DOI 10.1126/science.1846048; Moffa AB, 2004, MOL CANCER RES, V2, P643; Moffa AB, 2007, J CELL PHYSIOL, V210, P720, DOI 10.1002/jcp.20880; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; MOHAMMADI M, 1991, MOL CELL BIOL, V11, P5068, DOI 10.1128/MCB.11.10.5068; MOHAMMADI M, 1992, NATURE, V358, P681, DOI 10.1038/358681a0; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Ohuchi H, 1997, DEVELOPMENT, V124, P2235; Ong SH, 2001, P NATL ACAD SCI USA, V98, P6074, DOI 10.1073/pnas.111114298; Ong SH, 2000, MOL CELL BIOL, V20, P979, DOI 10.1128/MCB.20.3.979-989.2000; ORRURTREGER A, 1993, DEV BIOL, V158, P475, DOI 10.1006/dbio.1993.1205; PETERS KG, 1992, NATURE, V358, P678, DOI 10.1038/358678a0; Pollock PM, 2007, ONCOGENE, V26, P7158, DOI 10.1038/sj.onc.1210529; Reddi AL, 2007, J BIOL CHEM, V282, P29336, DOI 10.1074/jbc.M701797200; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; RUBIN JS, 1989, P NATL ACAD SCI USA, V86, P802, DOI 10.1073/pnas.86.3.802; Schlessinger J, 2004, SCIENCE, V306, P1506, DOI 10.1126/science.1105396; Sharrocks AD, 2006, CURR BIOL, V16, pR540, DOI 10.1016/j.cub.2006.06.038; Smith MR, 1998, CARCINOGENESIS, V19, P177, DOI 10.1093/carcin/19.1.177; Wernick NLB, 2005, J BIOL CHEM, V280, P7309, DOI 10.1074/jbc.M410752200; Wu Z, 2001, J BIOL CHEM, V276, P5240, DOI 10.1074/jbc.M006684200; Yamasaki M, 1996, J BIOL CHEM, V271, P15918, DOI 10.1074/jbc.271.27.15918; YAN GC, 1992, MOL ENDOCRINOL, V6, P2123, DOI 10.1210/me.6.12.2123; YAYON A, 1992, EMBO J, V11, P1885, DOI 10.1002/j.1460-2075.1992.tb05240.x; ZHENG J, 1995, J CELL BIOL, V129, P843, DOI 10.1083/jcb.129.3.843	50	49	67	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6227	6240		10.1074/jbc.M803998200	http://dx.doi.org/10.1074/jbc.M803998200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19103595	Green Published, hybrid			2022-12-25	WOS:000263742700026
J	Graves, JA; Metukuri, M; Scott, D; Rothermund, K; Prochownik, EV				Graves, J. Anthony; Metukuri, Mallikarjuna; Scott, Donald; Rothermund, Kristi; Prochownik, Edward V.			Regulation of Reactive Oxygen Species Homeostasis by Peroxiredoxins and c-Myc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; DNA-DAMAGE; MAMMALIAN PEROXIREDOXIN; HYDROGEN-PEROXIDE; CELL-PROLIFERATION; TYROSINE KINASE; GENE-EXPRESSION; PROTEIN; CARCINOGENESIS; IDENTIFICATION	Peroxiredoxins (Prxs) are highly conserved proteins found in most organisms, where they function primarily to scavenge reactive oxygen species (ROS). Loss of the most ubiquitous member of the family, Prx1, is associated with the accumulation of oxidatively damaged DNA and a tumor-prone phenotype. Prx1 interacts with the transcriptional regulatory domain of the c-Myc oncoprotein and suppresses its transforming activity. The DNA damage in tissues of prx1(-/-) mice is associated in some cases with only modest increases in total ROS levels. However, these cells show dramatic increases in nuclear ROS and reduced levels of cytoplasmic ROS, which explains their mutational susceptibility. In the current work, we have investigated whether changes in other ROS scavengers might account for the observed ROS redistribution pattern in prx1(-/-) cells. We show similar to 5-fold increases in Prx5 levels in prx1(-/-) embryo fibroblasts relative to prx1(-/-) cells. Moreover, Prx5 levels normalize when Prx1 expression is restored. Prx5 levels also appear to be highly dependent on c-Myc, and chromatin immunoprecipitation experiments showed differential occupancy of c-Myc and Prx1 complexes at E-box elements in the prx5 gene proximal promoter. This study represents a heretofore unreported mechanism for the c-Myc-dependent regulation of one Prx family member by another and identifies a novel means by which cells reestablish ROS homeostasis when one of these family members is compromised.	[Graves, J. Anthony; Rothermund, Kristi; Prochownik, Edward V.] UPMC, Childrens Hosp Pittsburgh, Div Hematol Oncol, Dept Pediat, Pittsburgh, PA 15213 USA; [Prochownik, Edward V.] Univ Pittsburgh, Med Ctr, Dept Microbiol & Biochem, Pittsburgh, PA 15213 USA; [Prochownik, Edward V.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15213 USA; [Metukuri, Mallikarjuna; Scott, Donald] Univ Pittsburgh, Sch Med, Div Endocrinol & Metab, Dept Med, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Prochownik, EV (corresponding author), UPMC, Childrens Hosp Pittsburgh, Div Hematol Oncol, Dept Pediat, 3705 5th Ave, Pittsburgh, PA 15213 USA.	procev@chp.edu			National Institutes of Health [RO1 CA105033, R01 DK065149]; K12 National Institutes of Health Mentored Clinical Scientist Development Program Award [HD052892]; Hyundai Hope on Wheels Scholarship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD052892] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA105033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065149] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); K12 National Institutes of Health Mentored Clinical Scientist Development Program Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hyundai Hope on Wheels Scholarship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 CA105033 ( to E. V. P.) and R01 DK065149 ( to M. M. and D. S.). This work was also supported by K12 National Institutes of Health Mentored Clinical Scientist Development Program Award HD052892 and the Hyundai Hope on Wheels Scholarship ( to J. A. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Cao Zhenbo, 2007, V44, P295; Collier JJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE48, DOI 10.1152/ajpendo.00357.2006; Dang CV, 2005, CELL CYCLE, V4, P1465, DOI 10.4161/cc.4.11.2121; Declercq JP, 2001, J MOL BIOL, V311, P751, DOI 10.1006/jmbi.2001.4853; Diet A, 2007, J BIOL CHEM, V282, P36199, DOI 10.1074/jbc.M706420200; Egler RA, 2005, ONCOGENE, V24, P8038, DOI 10.1038/sj.onc.1208821; Fang YZ, 2002, NUTRITION, V18, P872, DOI 10.1016/S0899-9007(02)00916-4; Fleming I, 2001, CIRC RES, V88, P44, DOI 10.1161/01.RES.88.1.44; Fourquet S, 2008, ANTIOXID REDOX SIGN, V10, P1565, DOI 10.1089/ars.2008.2049; Fujii J, 2002, REDOX REP, V7, P123, DOI 10.1179/135100002125000352; Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; Immenschuh S, 2005, ANTIOXID REDOX SIGN, V7, P768, DOI 10.1089/ars.2005.7.768; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; ISHII T, 1993, J BIOL CHEM, V268, P18633; IWAHARA S, 1995, BIOCHEMISTRY-US, V34, P13398, DOI 10.1021/bi00041a017; Jin DY, 1997, J BIOL CHEM, V272, P30952, DOI 10.1074/jbc.272.49.30952; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kim YJ, 2007, CANCER RES, V67, P546, DOI 10.1158/0008-5472.CAN-06-2401; Klaunig JE, 1998, ENVIRON HEALTH PERSP, V106, P289, DOI 10.2307/3433929; Kropotov A, 2006, FEBS J, V273, P2607, DOI 10.1111/j.1742-4658.2006.05265.x; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Mu ZM, 2002, J BIOL CHEM, V277, P43175, DOI 10.1074/jbc.M206066200; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Neumann CA, 2007, CURR OPIN PHARMACOL, V7, P375, DOI 10.1016/j.coph.2007.04.007; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Nguyen-nhu NT, 2007, BBA-GENE STRUCT EXPR, V1769, P472, DOI 10.1016/j.bbaexp.2007.05.004; Oberley TD, 2001, FREE RADICAL BIO MED, V30, P412, DOI 10.1016/S0891-5849(00)00486-X; Park SY, 2007, CANCER RES, V67, P9294, DOI 10.1158/0008-5472.CAN-07-0651; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; PROSPERI MT, 1993, J BIOL CHEM, V268, P11050; Ray S, 2006, CANCER RES, V66, P6598, DOI 10.1158/0008-5472.CAN-05-3115; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; RHEE SG, 2000, J SCI STKE, pPE1; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Rothermund K, 2005, CANCER RES, V65, P2097, DOI 10.1158/0008-5472.CAN-04-2928; Seo MS, 2000, J BIOL CHEM, V275, P20346, DOI 10.1074/jbc.M001943200; SHAU HY, 1993, CELL IMMUNOL, V147, P1, DOI 10.1006/cimm.1993.1043; Slupphaug G, 2003, MUTAT RES-FUND MOL M, V531, P231, DOI 10.1016/j.mrfmmm.2003.06.002; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; Thorgeirsson SS, 2000, TOXICOL LETT, V112, P553, DOI 10.1016/S0378-4274(99)00224-6; TODARO GJ, 1964, P NATL ACAD SCI USA, V51, P66, DOI 10.1073/pnas.51.1.66; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Toyokuni S, 2008, IUBMB LIFE, V60, P441, DOI 10.1002/iub.61; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Valko M, 2004, MOL CELL BIOCHEM, V266, P37, DOI 10.1023/B:MCBI.0000049134.69131.89; Veal EA, 2004, MOL CELL, V15, P129, DOI 10.1016/j.molcel.2004.06.021; Wen ST, 1997, GENE DEV, V11, P2456, DOI 10.1101/gad.11.19.2456; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8	51	69	73	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6520	6529		10.1074/jbc.M807564200	http://dx.doi.org/10.1074/jbc.M807564200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19098005	Green Published, hybrid			2022-12-25	WOS:000263742700054
J	Chen, JL; Olsen, J; Ford, S; Mirza, S; Walker, A; Murphy, JM; Young, IG				Chen, Jinglong; Olsen, Jane; Ford, Sally; Mirza, Shamaruh; Walker, Andrew; Murphy, James M.; Young, Ian G.			A New Isoform of Interleukin-3 Receptor alpha with Novel Differentiation Activity and High Affinity Binding Mode	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; ACUTE MYELOGENOUS LEUKEMIA; COMMON BETA-SUBUNIT; GM-CSF; SELF-RENEWAL; STRUCTURAL BASIS; MOUSE BASOPHIL; MAST-CELL; IN-VITRO; EXPRESSION	Interleukin-3 (IL-3) promotes both self-renewal and differentiation of early multipotential progenitors and is involved in inducible hematopoiesis in response to infections. Here we report new insights into these processes with the identification of a new isoform (SP2) of IL-3 receptor alpha(IL-3R alpha), present in mouse and human hematopoietic cells, which lacks domain 1 of the full-length receptor (SP1). Binding assays with beta(IL-3) mutants showed that mouse SP2 uses a different high affinity binding mode to SP1, although both mouse and human SP2 and SP1 can stimulate IL-3-dependent growth. In IL-3-dependent differentiation models, human SP2 and SP1 gave differential effects on lineage commitment or self-renewal dependent on the cellular context, suggesting that different modes of ectodomain binding may modulate intracellular signaling. In a multipotential factor dependent cell-Paterson mix, the transcription factors C/EBP alpha and PU.1 and microRNAs miRNA-15a, -223, and -181a were up-regulated in cells undergoing SP2-supported differentiation compared with SP1-supported self-renewal. Similarly in M1 cells, SP2 promoted differentiation compared with SP1 and gave up-regulation of PU.1 and miRNA-155 and -223. These findings suggest that IL-3-promoted lineage commitment uses similar mechanisms to those of steady-state hematopoiesis. Both the SP1 and SP2 isoforms activated the Jak2/STAT5, Akt, and Erk1/2 signaling pathways in M1 cells, although the activation was more prolonged for the SP2 isoform.	[Chen, Jinglong; Olsen, Jane; Ford, Sally; Mirza, Shamaruh; Walker, Andrew; Young, Ian G.] Australian Natl Univ, John Curtin Sch Med Res, Div Mol Biosci, Canberra, ACT 2601, Australia; [Murphy, James M.] Walter & Eliza Hall Inst Med Res, Div Mol Med, Melbourne, Vic 3050, Australia	Australian National University; John Curtin School of Medical Research; Walter & Eliza Hall Institute	Young, IG (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Div Mol Biosci, Canberra, ACT 2601, Australia.	ian.young@anu.edu.au	Walker, Andrew/D-2665-2012; Murphy, James/B-4863-2017	Walker, Andrew/0000-0003-1296-6593; Murphy, James/0000-0003-0195-3949	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia.	Arinobu Y, 2005, P NATL ACAD SCI USA, V102, P18105, DOI 10.1073/pnas.0509148102; Barry SC, 1997, BLOOD, V89, P842, DOI 10.1182/blood.V89.3.842; Bellon T, 1997, BLOOD, V90, P1828, DOI 10.1182/blood.V90.5.1828; Brizzi MF, 2001, CIRCULATION, V103, P549, DOI 10.1161/01.CIR.103.4.549; Bruno L, 2004, MOL CELL BIOL, V24, P741, DOI 10.1128/MCB.24.2.741-756.2004; Carr PD, 2001, CELL, V104, P291, DOI 10.1016/S0092-8674(01)00213-6; Chen CZ, 2005, SEMIN IMMUNOL, V17, P155, DOI 10.1016/j.smim.2005.01.001; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen XN, 2008, AM J PSYCHIAT, V165, P13, DOI 10.1176/appi.ajp.2007.07121868; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; CORNELIS S, 1995, EMBO J, V14, P3395, DOI 10.1002/j.1460-2075.1995.tb07345.x; Dahl R, 2003, NAT IMMUNOL, V4, P1029, DOI 10.1038/ni973; Dentelli P, 2005, ONCOGENE, V24, P6394, DOI 10.1038/sj.onc.1208786; Dvorak AM, 2005, J HISTOCHEM CYTOCHEM, V53, P1043, DOI 10.1369/jhc.5R6647.2005; Dvorak AM, 2004, INT ARCH ALLERGY IMM, V134, P332, DOI 10.1159/000079536; Evans CA, 1999, BLOOD, V94, P1504, DOI 10.1182/blood.V94.5.1504.417a27_1504_1514; Falcone FH, 2000, BLOOD, V96, P4028; Fatica A, 2006, COLD SPRING HARB SYM, V71, P205, DOI 10.1101/sqb.2006.71.014; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; HARA T, 1992, EMBO J, V11, P1875, DOI 10.1002/j.1460-2075.1992.tb05239.x; HAYASHIDA K, 1990, P NATL ACAD SCI USA, V87, P9655, DOI 10.1073/pnas.87.24.9655; Heyworth C M, 1991, Growth Factors, V5, P87, DOI 10.3109/08977199109000274; Heyworth CM, 1990, GROWTH FACTORS, V2, P197, DOI 10.3109/08977199009071506; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Ishino T, 2004, J BIOL CHEM, V279, P9547, DOI 10.1074/jbc.M309327200; ITOH N, 1990, SCIENCE, V247, P324, DOI 10.1126/science.2404337; Iwasaki H, 2006, GENE DEV, V20, P3010, DOI 10.1101/gad.1493506; Jankovic V, 2007, P NATL ACAD SCI USA, V104, P1260, DOI 10.1073/pnas.0607894104; Jordan CT, 2000, LEUKEMIA, V14, P1777, DOI 10.1038/sj.leu.2401903; KITAMURA T, 1991, CELL, V66, P1165, DOI 10.1016/0092-8674(91)90039-2; Lantz CS, 1998, NATURE, V392, P90, DOI 10.1038/32190; Lantz CS, 1997, J IMMUNOL, V158, P2517; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; Lee JJ, 2007, BLOOD, V109, P859, DOI 10.1182/blood-2006-06-027490; Lin YH, 2000, MOL CELL BIOL, V20, P2734, DOI 10.1128/MCB.20.8.2734-2742.2000; Lin YH, 2001, J BIOL CHEM, V276, P46024, DOI 10.1074/jbc.M105132200; Liu Z, 2007, CANCER RES, V67, P2712, DOI 10.1158/0008-5472.CAN-06-3843; Mack M, 2005, J IMMUNOL, V174, P735, DOI 10.4049/jimmunol.174.2.735; MAYER P, 1989, BLOOD, V74, P613; METCALF D, 1986, BLOOD, V68, P46; Munoz L, 2001, HAEMATOLOGICA, V86, P1261; Murphy JM, 2006, VITAM HORM, V74, P1, DOI 10.1016/S0083-6729(06)74001-8; Murphy JM, 2004, J BIOL CHEM, V279, P26500, DOI 10.1074/jbc.M402705200; Murphy JM, 2003, J BIOL CHEM, V278, P10572, DOI 10.1074/jbc.M211664200; NISHINAKAMURA R, 1995, IMMUNITY, V2, P211, DOI 10.1016/1074-7613(95)90046-2; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; Pajares MJ, 2007, LANCET ONCOL, V8, P349, DOI 10.1016/S1470-2045(07)70104-3; Reddy EP, 2000, ONCOGENE, V19, P2532, DOI 10.1038/sj.onc.1203594; Robb L, 2007, ONCOGENE, V26, P6715, DOI 10.1038/sj.onc.1210756; Smith A, 1997, EMBO J, V16, P451, DOI 10.1093/emboj/16.3.451; SPIVAK JL, 1985, J CLIN INVEST, V76, P1613, DOI 10.1172/JCI112145; TAKAKI S, 1993, J EXP MED, V177, P1523, DOI 10.1084/jem.177.6.1523; TAVERNIER J, 1991, CELL, V66, P1175, DOI 10.1016/0092-8674(91)90040-6; Testa U, 2005, BLOOD, V106, P2527, DOI 10.1182/blood-2005-02-0540; Testa U, 2004, DRUG FUTURE, V29, P821, DOI 10.1358/dof.2004.029.08.854174; Testa U, 2002, BLOOD, V100, P2980, DOI 10.1182/blood-2002-03-0852; WAGEMAKER G, 1990, BLOOD, V76, P2235; Yamaguchi M, 1997, J EXP MED, V185, P663, DOI 10.1084/jem.185.4.663; Yeh BK, 2003, P NATL ACAD SCI USA, V100, P2266, DOI 10.1073/pnas.0436500100; Zaks-Zilberman M, 2008, J BIOL CHEM, V283, P13398, DOI 10.1074/jbc.M710230200; Zhu J, 2005, P NATL ACAD SCI USA, V102, P11728, DOI 10.1073/pnas.0503405102	62	33	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5763	5773		10.1074/jbc.M808197200	http://dx.doi.org/10.1074/jbc.M808197200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19109256	hybrid			2022-12-25	WOS:000263560600040
J	Kadohara, K; Nagumo, M; Asami, S; Tsukumo, Y; Sugimoto, H; Igarashi, M; Nagai, K; Kataoka, T				Kadohara, Kimiko; Nagumo, Michiko; Asami, Shun; Tsukumo, Yoshinori; Sugimoto, Hikaru; Igarashi, Masayuki; Nagai, Kazuo; Kataoka, Takao			Caspase-8 Mediates Mitochondrial Release of Pro-apoptotic Proteins in a Manner Independent of Its Proteolytic Activity in Apoptosis Induced by the Protein Synthesis Inhibitor Acetoxycycloheximide in Human Leukemia Jurkat Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; RIBOTOXIC STRESS-RESPONSE; CYTOCHROME-C RELEASE; FAS LIGAND; TERMINAL KINASE; TNF-ALPHA; GLUTARIMIDE ANTIBIOTICS; STRUCTURAL BASIS; ACTIVATION; DEATH	The cysteine protease caspase-8 plays an essential role in apoptosis induced by death receptors. The protein synthesis inhibitor acetoxycycloheximide (Ac-CHX) has been previously shown to induce rapid apoptosis mediated by the release of cytochrome c in human leukemia Jurkat cells. In this study, the novel molecular mechanism that links caspase-8 to the mitochondrial release of pro-apoptotic proteins has been identified. Jurkat cells deficient in caspase-8 were more resistant to Ac-CHX than wild-type Jurkat cells and manifested decreased apoptosis induction and caspase activation as well as inefficient release of cytochrome c, Smac/DIABLO, and AIF into the cytosol. In contrast to Fas ligand stimulation, the general caspase inhibitor barely prevented the mitochondrial release of these pro-apoptotic proteins in Ac-CHX-treated cells, suggesting that caspase-8 activity is dispensable for triggering the mitochondrial pathway in Ac-CHX-induced apoptosis. Consistent with this notion, caspase-8-deficient Jurkat cells reconstituted with catalytically inactive caspase-8 became sensitive to Ac-CHX and exhibited apoptosis, caspase activation, the liberation of pro-apoptotic proteins into the cytosol, and Bak conformational change as efficiently as wild-type Jurkat cells. Unlike caspase- 3, -6, -7, and -9, a small but significant portion of caspase-8 was found to localize in mitochondria before and after exposure to Ac-CHX. These results clearly demonstrate that caspase-8 is able to mediate the mitochondrial release of pro-apoptotic proteins in a manner independent of its proteolytic activity in Ac-CHX-induced apoptosis.	[Kadohara, Kimiko; Nagumo, Michiko; Asami, Shun; Tsukumo, Yoshinori; Kataoka, Takao] Tokyo Inst Technol, Ctr Biol Resources & Informat, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Kadohara, Kimiko; Nagumo, Michiko; Asami, Shun; Tsukumo, Yoshinori; Sugimoto, Hikaru; Nagai, Kazuo; Kataoka, Takao] Tokyo Inst Technol, Dept Bioengn, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Igarashi, Masayuki] Microbial Chem Res Ctr, Bioact Mol Res Grp, Shinagawa Ku, Tokyo 1410021, Japan; [Nagai, Kazuo] Chubu Univ, Dept Biol Chem, Aichi 4878501, Japan; [Kataoka, Takao] Kyoto Inst Technol, Dept Appl Biol, Sakyo Ku, Kyoto 6068585, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology; Chubu University; Kyoto Institute of Technology	Kataoka, T (corresponding author), Tokyo Inst Technol, Ctr Biol Resources & Informat, Midori Ku, 4259 Nagatsuta Cho, Yokohama, Kanagawa 2268501, Japan.	takao.kataoka@kit.ac.jp	Igarashi, Masayuki/AAG-1628-2020		Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Bao Q, 2007, CELL DEATH DIFFER, V14, P56, DOI 10.1038/sj.cdd.4402028; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Boatright KM, 2004, BIOCHEM J, V382, P651, DOI 10.1042/BJ20040809; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; Chandra D, 2004, MOL CELL BIOL, V24, P6592, DOI 10.1128/mcb.24.15.6592-6607.2004; Chang DW, 2002, EMBO J, V21, P3704, DOI 10.1093/emboj/cdf356; Chang DW, 2003, EMBO J, V22, P4132, DOI 10.1093/emboj/cdg414; Chen Y, 2001, J BIOL CHEM, V276, P8350, DOI 10.1074/jbc.M008431200; Chen YR, 1998, ONCOGENE, V17, P173, DOI 10.1038/sj.onc.1201941; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P1396, DOI 10.1038/sj.cdd.4401963; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Donepudi M, 2003, MOL CELL, V11, P543, DOI 10.1016/S1097-2765(03)00059-5; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Engels IH, 2000, ONCOGENE, V19, P4563, DOI 10.1038/sj.onc.1203824; ENNIS HL, 1968, BIOCHEM PHARMACOL, V17, P1197, DOI 10.1016/0006-2952(68)90056-7; Faris M, 1998, J IMMUNOL, V160, P134; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; Gonzalvez F, 2008, J CELL BIOL, V183, P681, DOI 10.1083/jcb.200803129; Griffiths GJ, 1999, J CELL BIOL, V144, P903, DOI 10.1083/jcb.144.5.903; Huang DCS, 1997, ONCOGENE, V14, P405, DOI 10.1038/sj.onc.1200848; Iordanov MS, 1997, MOL CELL BIOL, V17, P3373, DOI 10.1128/MCB.17.6.3373; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; JOHNSON F, 1968, J ORG CHEM, V33, P904, DOI 10.1021/jo01266a113; JOHNSON F, 1965, J AM CHEM SOC, V87, P3492, DOI 10.1021/ja01093a038; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Juo P, 1999, CELL GROWTH DIFFER, V10, P797; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; Kadohara K, 2005, BIOCHEM PHARMACOL, V69, P551, DOI 10.1016/j.bcp.2004.11.009; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Kataoka T, 2004, MOL CELL BIOL, V24, P2627, DOI 10.1128/MCB.24.7.2627-2636.2004; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; Kataoka T, 2005, CRIT REV IMMUNOL, V25, P31, DOI 10.1615/CritRevImmunol.v25.i1.30; Kataoka T, 2002, EXP CELL RES, V273, P256, DOI 10.1006/excr.2001.5438; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; MARTIN SJ, 1990, J IMMUNOL, V145, P1859; Micheau O, 2002, J BIOL CHEM, V277, P45162, DOI 10.1074/jbc.M206882200; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Munoz-Pinedo C, 2006, P NATL ACAD SCI USA, V103, P11573, DOI 10.1073/pnas.0603007103; Murphy BM, 2004, J BIOL CHEM, V279, P36916, DOI 10.1074/jbc.M402039200; Nagata S, 1999, ANNU REV GENET, V33, P29, DOI 10.1146/annurev.genet.33.1.29; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Nguyen TK, 2007, BLOOD, V109, P4006, DOI 10.1182/blood-2006-09-045039; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; O'Reilly LA, 2004, CELL DEATH DIFFER, V11, P724, DOI 10.1038/sj.cdd.4401408; Ogura H, 2008, INT IMMUNOPHARMACOL, V8, P922, DOI 10.1016/j.intimp.2008.02.010; Ogura H, 2008, EXP CELL RES, V314, P1406, DOI 10.1016/j.yexcr.2008.01.019; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Pop C, 2006, MOL CELL, V22, P269, DOI 10.1016/j.molcel.2006.03.009; RAO KV, 1960, J AM CHEM SOC, V82, P1127, DOI 10.1021/ja01490a026; RAO KV, 1960, J AM CHEM SOC, V82, P1129, DOI 10.1021/ja01490a027; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schafer ZT, 2006, DEV CELL, V10, P549, DOI 10.1016/j.devcel.2006.04.008; Shifrin VI, 1999, J BIOL CHEM, V274, P13985, DOI 10.1074/jbc.274.20.13985; Sidhu JS, 1998, J BIOL CHEM, V273, P4769, DOI 10.1074/jbc.273.8.4769; SIEGEL MR, 1966, BIOCHEM PHARMACOL, V15, P1213, DOI 10.1016/0006-2952(66)90286-3; Siegel RM, 2000, NAT IMMUNOL, V1, P469, DOI 10.1038/82712; Siegel RM, 2006, NAT REV IMMUNOL, V6, P308, DOI 10.1038/nri1809; Slee EA, 2000, CELL DEATH DIFFER, V7, P556, DOI 10.1038/sj.cdd.4400689; Stegh AH, 2002, J BIOL CHEM, V277, P4351, DOI 10.1074/jbc.M108947200; Stegh AH, 2000, MOL CELL BIOL, V20, P5665, DOI 10.1128/MCB.20.15.5665-5679.2000; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Sugimoto H, 2000, BIOCHEM BIOPH RES CO, V277, P330, DOI 10.1006/bbrc.2000.3680; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Takahashi Y, 2005, MOL CELL BIOL, V25, P9369, DOI 10.1128/MCB.25.21.9369-9382.2005; Tang DM, 1999, J BIOL CHEM, V274, P7245, DOI 10.1074/jbc.274.11.7245; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; TSUCHIDA H, 1995, J IMMUNOL, V154, P2403; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wajant H, 2000, J BIOL CHEM, V275, P24357, DOI 10.1074/jbc.M000811200; Wang XD, 2001, GENE DEV, V15, P2922; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012	79	12	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5478	5487		10.1074/jbc.M808523200	http://dx.doi.org/10.1074/jbc.M808523200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19112105	hybrid			2022-12-25	WOS:000263560600010
J	Peroz, D; Dahimene, S; Baro, I; Loussouarn, G; Merot, J				Peroz, David; Dahimene, Shehrazade; Baro, Isabelle; Loussouarn, Gildas; Merot, Jean			LQT1-associated Mutations Increase KCNQ1 Proteasomal Degradation Independently of Derlin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-QT SYNDROME; TRANSMEMBRANE CONDUCTANCE REGULATOR; RETICULUM-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; RETRO-TRANSLOCATION; CHANNEL; PROTEINS; TRAFFICKING; ER	Mutations in the potassium channel KCNQ1 that determine retention of the mutated proteins in the endoplasmic reticulum (ER) are associated with the autosomal dominant negative Romano-Ward LQT1 cardiac syndrome. In the present study, we have analyzed the consequences and the potential molecular mechanisms involved in the ER retention of three Romano-Ward mutations located in KCNQ1 N terminus (Y111C, L114P, and P117L). We showed that the mutant KCNQ1 proteins exhibited reduced expression levels with respect to wild-type (WT)-KCNQ1. Radiolabeling pulse-chase experiments revealed that the lower expression levels did not result from reduced rate of synthesis. Instead, using a combination of Western blot and pulse-chase experiments, we showed that the mutant channel Y111C-KCNQ1, used as a model, was ubiquitinated and degraded in the proteasome more rapidly (t(1/2) = 82 min) than WT-KCNQ1 channel (t(1/2) = 113 min). On the other hand, KCNQ1 degradation did not appear to involve the GTP-dependent pathway. We also showed that KCNE1 stabilized both wildtype and Y111C proteins. To identify potential actors involved in KCNQ1 degradation, we studied the implication of the ER-resident protein Derlin-1 in KCNQ1 degradation. We showed that although KCNQ1 and Derlin-1 share the same molecular complex and co-immunoprecipitate when co-expressed in HEK293FT cells, Derlin-1 did not affect KCNQ1 steady state expression and degradation. These data were confirmed in T84 cells that express endogenous KCNQ1 and Derlin-1. Small interfering RNA knock-down of Derlin-1 did not modify KCNQ1 expression level, and no interaction between endogenous KCNQ1 and Derlin-1 could be detected.	[Peroz, David; Dahimene, Shehrazade; Baro, Isabelle; Loussouarn, Gildas; Merot, Jean] INSERM, UMR915, F-44000 Nantes, France; [Peroz, David; Dahimene, Shehrazade; Baro, Isabelle; Loussouarn, Gildas; Merot, Jean] CNRS, ERL3147, F-44000 Nantes, France; [Peroz, David; Dahimene, Shehrazade; Baro, Isabelle; Loussouarn, Gildas; Merot, Jean] Univ Nantes, Fac Med, Inst Thorax, F-44000 Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Nantes Universite; CHU de Nantes	Merot, J (corresponding author), INSERM, Fac Med, UMR915, 1 Rue G Veil, F-44035 Nantes 01, France.	jean.merot@univ-nantes.fr	Loussouarn, Gildas/ABH-6043-2020; Loussouarn, Gildas/D-3590-2015; MEROT, Jean/D-5741-2015; Baró, Isabelle/D-3604-2015; Baró, Isabelle/ABH-5667-2020	Loussouarn, Gildas/0000-0001-8007-5931; Loussouarn, Gildas/0000-0001-8007-5931; Baró, Isabelle/0000-0003-4850-4171; Baró, Isabelle/0000-0003-4850-4171	Agence Nationale de la Recherche [ANR/A05045GS, ANR/08GEN000602]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by a grant from the Agence Nationale de la Recherche ( ANR/A05045GS and ANR/08GEN000602).	Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Dahimene S, 2006, CIRC RES, V99, P1076, DOI 10.1161/01.RES.0000250262.12219.95; De Keukeleire B, 2008, INT J BIOCHEM CELL B, V40, P1729, DOI 10.1016/j.biocel.2007.12.015; Deutsch C, 2003, NEURON, V40, P265, DOI 10.1016/S0896-6273(03)00506-3; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; Gao YJ, 2008, J BIOL CHEM, V283, P9049, DOI 10.1074/jbc.M708022200; Goldstein RF, 2007, AM J RESP CELL MOL, V36, P706, DOI 10.1165/rcmb.2006-0365OC; Haynes CM, 2002, J CELL BIOL, V158, P91, DOI 10.1083/jcb.200201053; Hegde NR, 2006, J BIOL CHEM, V281, P20910, DOI 10.1074/jbc.M602989200; Ikrar T, 2008, J CARDIOVASC ELECTR, V19, P541, DOI 10.1111/j.1540-8167.2007.01076.x; Jansen JA, 2008, BIOCHEM BIOPH RES CO, V367, P687, DOI 10.1016/j.bbrc.2007.12.168; Krumerman A, 2004, AM J PHYSIOL-CELL PH, V286, pC1453, DOI 10.1152/ajpcell.00275.2003; Kunjilwar K, 2004, J BIOL CHEM, V279, P54542, DOI 10.1074/jbc.M409721200; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Lilley BN, 2006, J VIROL, V80, P8739, DOI 10.1128/JVI.00791-06; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Morin TJ, 2008, P NATL ACAD SCI USA, V105, P1478, DOI 10.1073/pnas.0710366105; Napolitano C, 2005, JAMA-J AM MED ASSOC, V294, P2975, DOI 10.1001/jama.294.23.2975; Nathan DF, 1997, P NATL ACAD SCI USA, V94, P12949, DOI 10.1073/pnas.94.24.12949; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Peroz D, 2008, J PHYSIOL-LONDON, V586, P1785, DOI 10.1113/jphysiol.2007.148254; Roden DM, 2008, NEW ENGL J MED, V358, P169, DOI 10.1056/NEJMcp0706513; Rusconi R, 2007, J NEUROSCI, V27, P11037, DOI 10.1523/JNEUROSCI.3515-07.2007; Schmitt N, 2000, EMBO J, V19, P332, DOI 10.1093/emboj/19.3.332; Schmitt N, 2007, BIOCHEM BIOPH RES CO, V358, P304, DOI 10.1016/j.bbrc.2007.04.127; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Splawski I, 1997, NAT GENET, V17, P338, DOI 10.1038/ng1197-338; Sun F, 2006, J BIOL CHEM, V281, P36856, DOI 10.1074/jbc.M607085200; Tester DJ, 2005, HEART RHYTHM, V2, P507, DOI 10.1016/j.hrthm.2005.01.020; Toyoda F, 2006, BIOCHEM BIOPH RES CO, V344, P814, DOI 10.1016/j.bbrc.2006.03.213; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Wilson AJ, 2005, CARDIOVASC RES, V67, P476, DOI 10.1016/j.cardiores.2005.04.036; Wu DM, 2006, HEART RHYTHM, V3, P1031, DOI 10.1016/j.hrthm.2006.05.022; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zafar KS, 2007, J NEUROCHEM, V102, P913, DOI 10.1111/j.1471-4159.2007.04637.x	38	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5250	5256		10.1074/jbc.M806459200	http://dx.doi.org/10.1074/jbc.M806459200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19114714	hybrid			2022-12-25	WOS:000263416600055
J	di Patti, MC; Maio, N; Rizzo, G; De Francesco, G; Persichini, T; Colasanti, M; Polticelli, F; Musci, G				Bonaccorsi di Patti, Maria Carmela; Maio, Nunziata; Rizzo, Gianluca; De Francesco, Giovanni; Persichini, Tiziana; Colasanti, Marco; Polticelli, Fabio; Musci, Giovanni			Dominant Mutants of Ceruloplasmin Impair the Copper Loading Machinery in Aceruloplasminemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED FORM; AMYOTROPHIC-LATERAL-SCLEROSIS; GOLGI-APPARATUS; GENE MUTATION; NEURODEGENERATIVE DISEASES; COMPOUND HETEROZYGOSITY; MOVEMENT-DISORDER; MISSENSE MUTATION; IRON OVERLOAD; EXPRESSION	The multicopper oxidase ceruloplasmin plays a key role in iron homeostasis, and its ferroxidase activity is required to stabilize cell surface ferroportin, the only known mammalian iron exporter. Missense mutations causing the rare autosomal neurodegenerative disease aceruloplasminemia were investigated by testing their ability to prevent ferroportin degradation in rat glioma C6 cells silenced for endogenous ceruloplasmin. Most of the mutants did not complement (i.e. did not stabilize ferroportin) because of the irreversible loss of copper binding ability. Mutant R701W, which was found in a heterozygous very young patient with severe neurological problems, was unable to complement per se but did so in the presence of copper-glutathione or when the yeast copper ATPase Ccc2p was co-expressed, indicating that the protein was structurally able to bind copper but that metal loading involving the mammalian copper ATPase ATP7B was impaired. Notably, R701W exerted a dominant negative effect on wild type, and it induced the subcellular relocalization of ATP7B. Our results constitute the first evidence of "functional silencing" of ATP7B as a novel molecular defect in aceruloplasminemia. The possibility to reverse the deleterious effects of some aceruloplasminemia mutations may disclose new possible therapeutic strategies.	[Maio, Nunziata; Rizzo, Gianluca; Persichini, Tiziana; Colasanti, Marco; Polticelli, Fabio; Musci, Giovanni] Univ Roma Tre, Dipartimento Biol, I-00146 Rome, Italy; [Bonaccorsi di Patti, Maria Carmela; De Francesco, Giovanni] Univ Roma La Sapienza, Dipartimento Sci Biochim, I-00185 Rome, Italy; [Musci, Giovanni] Univ Molise, Dipartimento Sci & Tecnol Agroaliment, I-86100 Campobasso, Italy	Roma Tre University; Sapienza University Rome; University of Molise	Musci, G (corresponding author), Univ Roma Tre, Dipartimento Biol, Viale Marconi 446, I-00146 Rome, Italy.	musci@unimol.it	Polticelli, Fabio/A-4573-2009; COLASANTI, MARCO/A-5616-2010; Musci, Giovanni/H-2862-2012; Bonaccorsi di Patti, Maria Carmela/F-1198-2011; Rizzo, Gianluca/J-6540-2019	Polticelli, Fabio/0000-0002-7657-2019; COLASANTI, MARCO/0000-0002-5752-4943; Musci, Giovanni/0000-0002-5196-709X; Bonaccorsi di Patti, Maria Carmela/0000-0002-4794-7037; Rizzo, Gianluca/0000-0002-5540-0621; PERSICHINI, TIZIANA/0000-0001-8291-6706; Maio, Nunziata/0000-0002-6225-6058	Telethon-Italy [GGP06173]	Telethon-Italy(Fondazione Telethon)	This work was supported by Telethon-Italy Grant GGP06173 (to G. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bosio S, 2002, BLOOD, V100, P2246, DOI 10.1182/blood-2002-02-0584; Chen L, 2003, MOL VIS, V9, P151; Daimon M, 2000, TOHOKU J EXP MED, V191, P119, DOI 10.1620/tjem.191.119; De Domenico I, 2005, P NATL ACAD SCI USA, V102, P8955, DOI 10.1073/pnas.0503804102; De Domenico I, 2007, EMBO J, V26, P2823, DOI 10.1038/sj.emboj.7601735; El Meskini R, 2003, J BIOL CHEM, V278, P12278, DOI 10.1074/jbc.M211413200; Fan J, 2008, INT J DEV NEUROSCI, V26, P523, DOI 10.1016/j.ijdevneu.2008.05.006; Fortna RR, 1999, BIOL REPROD, V61, P1042, DOI 10.1095/biolreprod61.4.1042; Fujita Y, 2000, J NEUROL SCI, V174, P137, DOI 10.1016/S0022-510X(00)00265-3; Gonatas NK, 2006, J NEUROL SCI, V246, P21, DOI 10.1016/j.jns.2006.01.019; HARRIS ZL, 1995, P NATL ACAD SCI USA, V92, P2539, DOI 10.1073/pnas.92.7.2539; Hellman NE, 2002, ANNU REV NUTR, V22, P439, DOI 10.1146/annurev.nutr.22.012502.114457; Hellman NE, 2002, J BIOL CHEM, V277, P46632, DOI 10.1074/jbc.M206246200; Hellman NE, 2002, J BIOL CHEM, V277, P1375, DOI 10.1074/jbc.M109123200; Hofmann WP, 2007, SCAND J GASTROENTERO, V42, P1088, DOI 10.1080/00365520701278810; HOLTZMAN NA, 1970, J BIOL CHEM, V245, P2354; Hsi G, 2008, HUM MUTAT, V29, P491, DOI 10.1002/humu.20674; Hung IH, 1997, J BIOL CHEM, V272, P21461, DOI 10.1074/jbc.272.34.21461; Jimenez-Huete A, 2008, J NEUROL, V255, P1083, DOI 10.1007/s00415-008-0823-9; Kono S, 2006, BIOL RES, V39, P15, DOI 10.4067/S0716-97602006000100003; Kono S, 2007, J HEPATOL, V47, P844, DOI 10.1016/j.jhep.2007.05.013; Kono S, 2006, NEUROMOL MED, V8, P361, DOI 10.1385/NMM:8:3:361; Kono S, 2006, GASTROENTEROLOGY, V131, P240, DOI 10.1053/j.gastro.2006.04.017; Kuhn J, 2005, J NEUROL, V252, P111, DOI 10.1007/s00415-005-0608-3; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Mariani R, 2004, GUT, V53, P756, DOI 10.1136/gut.2003.030429; Miyajima H, 2003, NEUROPATHOLOGY, V23, P345, DOI 10.1046/j.1440-1789.2003.00521.x; Musci G, 1996, J BIOL CHEM, V271, P1972, DOI 10.1074/jbc.271.4.1972; Patel BN, 2000, J BIOL CHEM, V275, P4305, DOI 10.1074/jbc.275.6.4305; Patel BN, 1997, J BIOL CHEM, V272, P20185, DOI 10.1074/jbc.272.32.20185; Perez-Aguilar F, 2005, J HEPATOL, V42, P947, DOI 10.1016/j.jhep.2005.02.013; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; SATO M, 1991, J BIOL CHEM, V266, P5128; Sears IB, 1998, YEAST, V14, P783, DOI 10.1002/(SICI)1097-0061(19980615)14:8<783::AID-YEA272>3.0.CO;2-Y; Shang HF, 2006, MOVEMENT DISORD, V21, P2217, DOI 10.1002/mds.21121; Stieber A, 2004, J NEUROL SCI, V219, P45, DOI 10.1016/j.jns.2003.12.004; Stieber A, 1996, AM J PATHOL, V148, P415; Yomono Harumi, 2003, Rinsho Shinkeigaku, V43, P398; YOSHIDA K, 1995, NAT GENET, V9, P267, DOI 10.1038/ng0395-267; YUAN DS, 1995, P NATL ACAD SCI USA, V92, P2632, DOI 10.1073/pnas.92.7.2632	40	36	36	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4545	4554		10.1074/jbc.M805688200	http://dx.doi.org/10.1074/jbc.M805688200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19095659	hybrid			2022-12-25	WOS:000263134400055
J	Hsieh, JY; Hung, HC				Hsieh, Ju-Yi; Hung, Hui-Chih			Engineering of the Cofactor Specificities and Isoform-specific Inhibition of Malic Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASCARIS-SUUM; FUNCTIONAL ROLES; CRYSTAL-STRUCTURE; CDNA CLONING; BINDING-SITE; PURIFICATION; MECHANISM; MALATE; NAD; ATP	Malic enzyme (ME) is a family of enzymes that catalyze a reversible oxidative decarboxylation of L-malate to pyruvate with simultaneous reduction of NAD(P)(+) to NAD(P)H. According to the cofactor specificity, the mammalian enzyme can be categorized into three isoforms. The cytosolic (c) and mitochondrial (m) NADP(+)-dependent MEs utilize NADP(+) as the cofactor. The mitochondrial NAD(P)(+)-dependent ME can use either NAD(+) or NADP(+) as the cofactor. In addition, the m-NAD(P)-ME isoform can be inhibited by ATP and allosterically activated by fumarate. In this study, we delineated the determinants for cofactor specificity and isoform-specific inhibition among the ME isoforms. Our data strongly suggest that residue 362 is the decisive factor determining cofactor preference. All the mutants containing Q362K (Q362K, K346S/Q362K, Y347K/Q362K, and K346S/Y347K/Q362K) have a larger k(cat,NADP) value compared with the k(cat,NAD) value, indicating that the enzyme has changed to use NADP(+) as the preferred cofactor. Furthermore, we suggest that Lys-346 in m-NAD(P)-ME is crucial for the isoform-specific ATP inhibition. The enzymes containing the K346S mutation (K346S, K346S/Y347K, K346S/Q362K, and K346S/Y347K/Q362K) are much less inhibited by ATP and have a larger K-i,K-ATP value. Kinetic analysis also suggests that residue 347 functions in cofactor specificity. Here we demonstrate that the human K346S/Y347K/Q362K m-NAD(P)-ME has completely shifted its cofactor preference to become an NADP(+)-specific ME. In the triple mutant, Lys-362, Lys-347, and Ser-346 work together and function synergistically to increase the binding affinity for NADP(+).	[Hsieh, Ju-Yi; Hung, Hui-Chih] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Hung, Hui-Chih] Natl Chung Hsing Univ, Inst Bioinformat, Taichung 40227, Taiwan	National Chung Hsing University; National Chung Hsing University	Hung, HC (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan.	hchung@dragon.nchu.edu.tw	Hung, Hui-Chih/G-4485-2013; Hung, Hui-Chih/L-8061-2019	Hung, Hui-Chih/0000-0003-0180-1822; Hung, Hui-Chih/0000-0003-0180-1822	National Science Council [NSC-962311-B-005-005]; Ministry of Education, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan(Ministry of Education, Taiwan)	This work was supported by the National Science Council Grant NSC-962311-B-005-005 and in part by the Ministry of Education, Taiwan, under the ATU plan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aktas DF, 2008, BIOCHEMISTRY-US, V47, P2539, DOI 10.1021/bi702261m; Aktas DF, 2008, BBA-PROTEINS PROTEOM, V1784, P2059, DOI 10.1016/j.bbapap.2008.07.014; ALTSCHUL SF, 1994, NAT GENET, V6, P119, DOI 10.1038/ng0294-119; BAGGETTO LG, 1992, BIOCHIMIE, V74, P959, DOI 10.1016/0300-9084(92)90016-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHANG GG, 1991, EUR J BIOCHEM, V202, P681, DOI 10.1111/j.1432-1033.1991.tb16423.x; Chang GG, 2003, BIOCHEMISTRY-US, V42, P12721, DOI 10.1021/bi035251+; Cleland WW, 2000, PROTEIN PEPTIDE LETT, V7, P305; Coleman DE, 2002, BIOCHEMISTRY-US, V41, P6928, DOI 10.1021/bi0255120; FAHIEN LA, 1992, J BIOL CHEM, V267, P10411; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hsieh JY, 2008, FEBS J, V275, P5383, DOI 10.1111/j.1742-4658.2008.06668.x; Hsieh JY, 2006, J BIOL CHEM, V281, P23237, DOI 10.1074/jbc.M603451200; HSU RY, 1982, MOL CELL BIOCHEM, V43, P3; Hsu WC, 2004, BIOCHEMISTRY-US, V43, P7382, DOI 10.1021/bi049600r; Hung HC, 2005, BIOCHEM J, V392, P39, DOI 10.1042/BJ20050641; Hung HC, 2005, BIOCHEMISTRY-US, V44, P12737, DOI 10.1021/bi050510b; Karsten WE, 2003, BIOCHEMISTRY-US, V42, P9712, DOI 10.1021/bi034101w; Kuo CC, 2000, BIOCHEM BIOPH RES CO, V270, P821, DOI 10.1006/bbrc.2000.2502; LAI CJ, 1992, ARCH BIOCHEM BIOPHYS, V299, P214, DOI 10.1016/0003-9861(92)90266-Y; LANDSPERGER WJ, 1976, J BIOL CHEM, V251, P3599; LOEBER G, 1994, BIOCHEM J, V304, P687, DOI 10.1042/bj3040687; LOEBER G, 1994, FEBS LETT, V344, P181, DOI 10.1016/0014-5793(94)00386-6; LOEBER G, 1991, J BIOL CHEM, V266, P3016; MANDELLA RD, 1975, J BIOL CHEM, V250, P5877; MCKEEHAN WL, 1982, CELL BIOL INT REP, V6, P635, DOI 10.1016/0309-1651(82)90125-4; MOREADITH RW, 1984, J BIOL CHEM, V259, P6215; MOREADITH RW, 1984, J BIOL CHEM, V259, P6222; Sanz N, 1997, BRIT J CANCER, V75, P487, DOI 10.1038/bjc.1997.85; SAUER LA, 1973, BIOCHEM BIOPH RES CO, V50, P524, DOI 10.1016/0006-291X(73)90871-1; SAUER LA, 1980, J BIOL CHEM, V255, P3844; Teller J K, 1990, Protein Expr Purif, V1, P151, DOI 10.1016/1046-5928(90)90009-N; TELLER JK, 1992, J BIOL CHEM, V267, P10423; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Xu YW, 1999, STRUCT FOLD DES, V7, P877, DOI 10.1016/S0969-2126(99)80115-4; Yang ZR, 2000, NAT STRUCT BIOL, V7, P251; Yang ZR, 2002, PROTEIN SCI, V11, P332, DOI 10.1110/ps.38002; Yang ZR, 2002, STRUCTURE, V10, P951, DOI 10.1016/S0969-2126(02)00788-8; ZDNIEROWICZ S, 1988, BIOCHEM MED METAB B, V39, P208	39	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4536	4544		10.1074/jbc.M807008200	http://dx.doi.org/10.1074/jbc.M807008200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19091740	hybrid			2022-12-25	WOS:000263134400054
J	Li, TB; Yang, YS; Canessa, CM				Li, Tianbo; Yang, Youshan; Canessa, Cecilia M.			Interaction of the Aromatics Tyr-72/Trp-288 in the Interface of the Extracellular and Transmembrane Domains Is Essential for Proton Gating of Acid-sensing Ion Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATION; COOPERATIVITY; BINDING; MUTANT; PORE	Acid-sensing ion channels are proton-activated ion channels expressed in the nervous system. They belong to the family of ENaC/Degenerins whose members share a conserved structure but are activated by widely diverse stimuli. We show that interaction of two aromatic residues, Tyr-72, located immediately after the first transmembrane segment, and Trp-288, located at the tip of a loop of the extracellular domain directed toward the first transmembrane segment, is essential for proton activation of the acid-sensing ion channels. The subdomain containing Trp-288 is a module tethered to the rest of the extracellular domain by short linkers and intrasubunit interactions between residues in the putative "proton sensor." Mutations in these two areas shift the apparent affinity of protons toward a more acidic range and change the kinetics of activation and desensitization. These results are consisting with displacement of the module relative to the rest of the extracellular domain to allow interaction of Trp-288 with Tyr-72 during gating. We propose that such interaction may provide functional coupling between the extracellular domain and the pore domain.	[Li, Tianbo; Yang, Youshan; Canessa, Cecilia M.] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Yale University	Canessa, CM (corresponding author), Yale Univ, Dept Cellular & Mol Physiol, 333 Cedar St, New Haven, CT 06520 USA.	Cecilia.canessa@yale.edu	Li, Tianbo/C-6118-2012		National Institutes of Health [DK544602]; American Heart Association [R06523]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported, in whole or in part, by National Institutes of Health Grant DK544602 (NIDDK). This work was also supported by American Heart Association Grant-in-aid R06523 (to C. M. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Coric T, 2005, J PHYSIOL-LONDON, V568, P725, DOI 10.1113/jphysiol.2005.087734; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Dougherty DA, 2007, J NUTR, V137, p1504S, DOI 10.1093/jn/137.6.1504S; Gervasio FL, 2002, PROTEINS, V48, P117, DOI 10.1002/prot.10116; Golubovic A, 2007, J BIOL CHEM, V282, P35098, DOI 10.1074/jbc.M706849200; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; HOROVITZ A, 1990, J MOL BIOL, V214, P613, DOI 10.1016/0022-2836(90)90275-Q; HURLE MR, 1986, BIOCHEMISTRY-US, V25, P6356, DOI 10.1021/bi00369a002; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200; PERRY KM, 1989, BIOCHEMISTRY-US, V28, P7961, DOI 10.1021/bi00445a061; Shaikh SA, 2008, BIOPHYS J, V95, P5153, DOI 10.1529/biophysj.108.141606; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Zhang P, 2002, J GEN PHYSIOL, V120, P553, DOI 10.1085/jgp.20028574	21	63	63	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4689	4694		10.1074/jbc.M805302200	http://dx.doi.org/10.1074/jbc.M805302200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19074149	Green Published, hybrid			2022-12-25	WOS:000263134400068
J	Murase, D; Hachiya, A; Amano, Y; Ohuchi, A; Kitahara, T; Takema, Y				Murase, Daiki; Hachiya, Akira; Amano, Yasuko; Ohuchi, Atsushi; Kitahara, Takashi; Takema, Yoshinori			The Essential Role of p53 in Hyperpigmentation of the Skin via Regulation of Paracrine Melanogenic Cytokine Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELL FACTOR; NORMAL HUMAN MELANOCYTES; ULTRAVIOLET-B; HUMAN KERATINOCYTES; TYROSINASE GENE; GROWTH-FACTOR; EPIDERMAL HYPERPIGMENTATION; GLYCOSYLATION INHIBITORS; INDUCED APOPTOSIS; DNA-DAMAGE	Hyperpigmentation of the skin is characterized by increases in melanin synthesis and deposition. Although considered a significant psychosocial distress, little is known about the detailed mechanisms of hyperpigmentation. Recently, the tumor suppressor protein p53 has been demonstrated to promote ultraviolet B-induced skin pigmentation by stimulating the transcription of a melanogenic cytokine, POMC(pro-opiomelanocortin), in keratinocytes. Given that p53 can be activated by various kinds of diverse stresses, including sun exposure, inflammation, and aging, this finding led us to examine the involvement of p53 in cytokine receptor signaling, which might result in skin hyperpigmentation. Immunohistochemical and reverse transcription-PCR analyses revealed the increased expression and phosphorylation of p53 in the epidermis of hyperpigmented spots, accompanied by the higher expression of melanogenic cytokines, including stem cell factor, endothelin-1, and POMC. The involvement of p53 in hyperpigmentation was also indicated by the significantly higher expression of p53 transcriptional targets in the epidermis of hyperpigmented spots. Treatment of human keratinocytes and melanocytes with known p53 activators or inhibitors, including pifithrin-alpha (PFT), demonstrated significant increases or decreases, respectively, in the expression of melanogenic factors, including cytokines and their receptors. Additionally, PFT administration abolished stem cell factor-induced phosphorylation of mitogen-activated protein kinase in human melanocytes. Furthermore, when organ-cultured hyperpigmented spots, in vitro human skin substitutes, and mouse skin were treated with PFT or p53 small interfering RNA, the expression of melanogenic cytokines and their receptors was significantly decreased, as were levels of tyrosinase and melanogenesis. Taken together, these data reveal the essential role of p53 in hyperpigmentation of the skin via the regulation of paracrine-cytokine signaling, both in keratinocytes and in melanocytes.	[Murase, Daiki; Hachiya, Akira; Amano, Yasuko; Ohuchi, Atsushi; Kitahara, Takashi; Takema, Yoshinori] Kao Biol Sci Labs, Haga, Tochigi 3213497, Japan		Hachiya, A (corresponding author), Kao Biol Sci Labs, Haga, Tochigi 3213497, Japan.	hachiya.akira@kao.co.jp						ABDELMALEK Z, 1995, P NATL ACAD SCI USA, V92, P1789, DOI 10.1073/pnas.92.5.1789; BARGONETTI J, 1991, CELL, V65, P1083, DOI 10.1016/0092-8674(91)90560-L; Bertolotto C, 1998, MOL CELL BIOL, V18, P694, DOI 10.1128/MCB.18.2.694; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Bykov VJ, 2000, J INVEST DERMATOL, V114, P40, DOI 10.1046/j.1523-1747.2000.00821.x; Chakraborty AK, 1996, BBA-MOL CELL RES, V1313, P130, DOI 10.1016/0167-4889(96)00063-8; Chehab NH, 1999, P NATL ACAD SCI USA, V96, P13777, DOI 10.1073/pnas.96.24.13777; CHEN CY, 1994, P NATL ACAD SCI USA, V91, P2684, DOI 10.1073/pnas.91.7.2684; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Corre S, 2004, J BIOL CHEM, V279, P51226, DOI 10.1074/jbc.M409768200; Cui RT, 2007, CELL, V128, P853, DOI 10.1016/j.cell.2006.12.045; D'Orazio JA, 2006, NATURE, V443, P340, DOI 10.1038/nature05098; EL DW, 1993, CELL, V75, P817; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Funasaka Y, 1998, BRIT J DERMATOL, V139, P216; FURUKAWA F, 1987, J INVEST DERMATOL, V89, P460, DOI 10.1111/1523-1747.ep12460904; Gilchrest BA, 1996, PHOTOCHEM PHOTOBIOL, V63, P1, DOI 10.1111/j.1751-1097.1996.tb02988.x; Grichnik JM, 1998, J INVEST DERMATOL, V111, P233, DOI 10.1046/j.1523-1747.1998.00272.x; Hachiya A, 2004, AM J PATHOL, V165, P2099, DOI 10.1016/S0002-9440(10)63260-9; Hachiya A, 2001, J INVEST DERMATOL, V116, P578, DOI 10.1046/j.1523-1747.2001.01290.x; HALABAN R, 1988, J CELL BIOL, V107, P1611, DOI 10.1083/jcb.107.4.1611; Hao MM, 1996, J BIOL CHEM, V271, P29380, DOI 10.1074/jbc.271.46.29380; Hattori H, 2004, J INVEST DERMATOL, V122, P1256, DOI 10.1111/j.0022-202X.2004.22503.x; Hedley SJ, 1998, PIGM CELL RES, V11, P45, DOI 10.1111/j.1600-0749.1998.tb00710.x; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; Hou L, 2000, DEVELOPMENT, V127, P5379; Imokawa G, 2000, J BIOL CHEM, V275, P33321, DOI 10.1074/jbc.M004346200; IMOKAWA G, 1982, CANCER RES, V42, P1994; Imokawa G, 1996, BIOCHEM J, V314, P305, DOI 10.1042/bj3140305; Imokawa G, 1997, PIGM CELL RES, V10, P218, DOI 10.1111/j.1600-0749.1997.tb00488.x; IMOKAWA G, 1995, J INVEST DERMATOL, V105, P32, DOI 10.1111/1523-1747.ep12312500; IMOKAWA G, 1992, J BIOL CHEM, V267, P24675; IYENGAR B, 1994, MELANOMA RES, V4, P293; Kadekaro AL, 2003, ANN NY ACAD SCI, V994, P359, DOI 10.1111/j.1749-6632.2003.tb03200.x; Kadono S, 2001, J INVEST DERMATOL, V116, P571, DOI 10.1046/j.1523-1747.2001.01296.x; Kaeser MD, 2004, J BIOL CHEM, V279, P7598, DOI 10.1074/jbc.M311732200; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Khlgatian MK, 2002, J INVEST DERMATOL, V118, P126, DOI 10.1046/j.0022-202x.2001.01667.x; Kichina J, 1996, PIGM CELL RES, V9, P85, DOI 10.1111/j.1600-0749.1996.tb00094.x; Kobayashi N, 1998, J INVEST DERMATOL, V110, P806, DOI 10.1046/j.1523-1747.1998.00178.x; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; LOWE SW, 1994, SCIENCE, V266, P807, DOI 10.1126/science.7973635; McGowan KA, 2008, NAT GENET, V40, P963, DOI 10.1038/ng.188; MISHIMA Y, 1983, J INVEST DERMATOL, V81, P106, DOI 10.1111/1523-1747.ep12542192; Motokawa T, 2005, J DERMATOL SCI, V37, P120, DOI 10.1016/j.jdermsci.2004.10.009; OKAZAKI K, 1976, J INVEST DERMATOL, V67, P541, DOI 10.1111/1523-1747.ep12664554; Okazaki M, 2003, BRIT J DERMATOL, V148, P689, DOI 10.1046/j.1365-2133.2003.05283.x; PATHAK MA, 1983, J AM ACAD DERMATOL, V9, P724, DOI 10.1016/S0190-9622(83)70186-6; Rees JL, 2003, ANNU REV GENET, V37, P67, DOI 10.1146/annurev.genet.37.110801.143233; Riley PA, 1997, INT J BIOCHEM CELL B, V29, P1235, DOI 10.1016/S1357-2725(97)00013-7; RomeroGraillet C, 1997, J CLIN INVEST, V99, P635, DOI 10.1172/JCI119206; ROSDAHL IK, 1978, J INVEST DERMATOL, V70, P143, DOI 10.1111/1523-1747.ep12258559; Saito S, 2003, J BIOL CHEM, V278, P37536, DOI 10.1074/jbc.M305135200; Sakaguchi K, 1997, BIOCHEMISTRY-US, V36, P10117, DOI 10.1021/bi970759w; SCHAUER E, 1994, J CLIN INVEST, V93, P2258, DOI 10.1172/JCI117224; SCHWARZ A, 1995, J INVEST DERMATOL, V104, P922, DOI 10.1111/1523-1747.ep12606202; Scott G, 2001, J INVEST DERMATOL, V117, P1412, DOI 10.1046/j.0022-202x.2001.01575.x; Seiberg M, 2001, PIGM CELL RES, V14, P236, DOI 10.1034/j.1600-0749.2001.140402.x; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shishido E, 2001, J INVEST DERMATOL, V117, P627, DOI 10.1046/j.0022-202x.2001.01440.x; Singh S, 2007, FEBS LETT, V581, P289, DOI 10.1016/j.febslet.2006.12.035; Sirsjo A, 1996, BRIT J DERMATOL, V134, P643, DOI 10.1111/j.1365-2133.1996.tb06963.x; Tada A, 1998, CELL GROWTH DIFFER, V9, P575; Teraki E, 1996, BRIT J DERMATOL, V135, P918, DOI 10.1046/j.1365-2133.1996.d01-1095.x; Tsatmali M, 2000, PIGM CELL RES, V13, P125, DOI 10.1034/j.1600-0749.13.s8.22.x; Tsujimura T, 1996, BLOOD, V88, P1225, DOI 10.1182/blood.V88.4.1225.bloodjournal8841225; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; WANG Y, 1995, NATURE, V376, P88, DOI 10.1038/376088a0; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Wintzen M, 1996, J INVEST DERMATOL, V106, P3, DOI 10.1111/1523-1747.ep12326950; Wintzen M, 1996, J INVEST DERMATOL, V106, P673, DOI 10.1111/1523-1747.ep12345496; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; YADA Y, 1991, J BIOL CHEM, V266, P18352; YOHN JJ, 1993, J INVEST DERMATOL, V100, P23, DOI 10.1111/1523-1747.ep12349932; ZHAN QM, 1994, CANCER RES, V54, P2755; ZIEGLER A, 1994, NATURE, V372, P773, DOI 10.1038/372773a0	77	64	68	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4343	4353		10.1074/jbc.M805570200	http://dx.doi.org/10.1074/jbc.M805570200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19098008	hybrid			2022-12-25	WOS:000263134400033
J	Price, PA; Toroian, D; Chan, WS				Price, Paul A.; Toroian, Damon; Chan, Wai Si			Tissue-nonspecific Alkaline Phosphatase Is Required for the Calcification of Collagen in Serum A POSSIBLE MECHANISM FOR BIOMINERALIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEXOSEPHOSPHORIC ESTERS; MINERALIZATION; BONE; INHIBITION; RESIDUES; ARTERIES; MATRIX; FETUIN; WATER; MICE	Previous studies have shown that the type I collagen of tendon and demineralized bone both calcify rapidly in serum. The speed, collagen matrix-type specificity, and extent of the re-calcification of demineralized bone in serum suggest that the serum calcification activity identified in these studies may participate in normal biomineralization. Because of its presence in serum and its long history of association with the normal mineralization of the collagen matrix of bone, tissue-nonspecific alkaline phosphatase (TNAP) is an obvious candidate for a protein that could be a component of serum calcification activity, and experiments were therefore carried out to test this possibility. These experiments show that the inactivation of TNAP in serum prevents collagen calcification, and that the addition of physiological levels of purified TNAP restores the ability of TNAP-deficient serum to calcify collagen. Additional experiments show that the role of TNAP in collagen calcification is to activate a serum nucleator of apatite crystal formation. Based on these and earlier studies, the mechanism of collagen calcification in serum requires at least four elements as follows. 1) A matrix (collagen fibrils) that is accessible to small apatite crystals but not large molecules (Toroian, D., Lim, J.E., and Price, P. A. (2007) J. Biol. Chem. 282, 22437-22447). 2) A large serum nucleator that generates small crystals, some of which diffuse into the fibrils. 3) A source of TNAP to activate the serum nucleator. 4) A large protein (fetuin) that selectively inhibits growth of crystals remaining in solution, thereby ensuring that only crystals within fibrils grow (Toroian, D. T., and Price, P. A. (2008) Calcif. Tissue Int. 82, 116-126).	[Price, Paul A.; Toroian, Damon; Chan, Wai Si] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Price, PA (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	pprice@ucsd.edu						Aikawa E, 2007, CIRCULATION, V116, P2841, DOI 10.1161/CIRCULATIONAHA.107.732867; BEERTSEN W, 1992, J CLIN INVEST, V89, P1974, DOI 10.1172/JCI115805; BILTZ RM, 1969, J BONE JOINT SURG AM, VA 51, P456, DOI 10.2106/00004623-196951030-00003; Boivin G, 2002, CALCIFIED TISSUE INT, V70, P503, DOI 10.1007/s00223-001-2048-0; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Christensen B, 2007, J BIOL CHEM, V282, P19463, DOI 10.1074/jbc.M703055200; Doty S B, 1976, Prog Histochem Cytochem, V8, P1; FALLON MD, 1980, LAB INVEST, V43, P489; Fedde KN, 1999, J BONE MINER RES, V14, P2015, DOI 10.1359/jbmr.1999.14.12.2015; Ferguson MAJ, 1999, J CELL SCI, V112, P2799; Fullerton GD, 2006, CELL BIOL INT, V30, P56, DOI 10.1016/j.cellbi.2005.09.008; GRIER RS, 1949, J BIOL CHEM, V180, P289; HALE JE, 1991, J BIOL CHEM, V266, P21145; Hamlin NJ, 2006, CALCIFIED TISSUE INT, V78, P326, DOI 10.1007/s00223-005-0205-6; Hamlin NJ, 2004, CALCIFIED TISSUE INT, V75, P231, DOI 10.1007/s00223-004-0190-1; IX JH, 2008, J BONE MINER RES; KLEMPERER FW, 1949, J BIOL CHEM, V180, P281; Kozlenkov A, 2004, J BONE MINER RES, V19, P1862, DOI 10.1359/JBMR.040608; Magnusson P, 2002, TUMOR BIOL, V23, P228, DOI 10.1159/000067254; Magnusson P, 2002, CALCIFIED TISSUE INT, V71, P508, DOI 10.1007/s00223-001-1137-4; MATSUZAWA T, 1971, J HISTOCHEM CYTOCHEM, V19, P801, DOI 10.1177/19.12.801; Murshed M, 2005, GENE DEV, V19, P1093, DOI 10.1101/gad.1276205; Parfitt AM, 2000, BONE, V26, P319, DOI 10.1016/S8756-3282(00)80937-0; Price PA, 2006, ARTERIOSCL THROM VAS, V26, P1079, DOI 10.1161/01.ATV.0000216406.44762.7c; Price PA, 2004, J BIOL CHEM, V279, P19169, DOI 10.1074/jbc.M307880200; Price PA, 2003, J BIOL CHEM, V278, P22144, DOI 10.1074/jbc.M300744200; Rattazzi M, 2005, ARTERIOSCL THROM VAS, V25, P1420, DOI 10.1161/01.ATV.0000166600.58468.1b; REJ R, 1980, CLIN CHEM, V26, P423; ROBINSON RA, 1957, J BONE JOINT SURG AM, V39, P167, DOI 10.2106/00004623-195739010-00015; Robison R, 1923, BIOCHEM J, V17, P286, DOI 10.1042/bj0170286; Robison R, 1924, BIOCHEM J, V18, P740, DOI 10.1042/bj0180740; Schinke T, 1996, J BIOL CHEM, V271, P20789, DOI 10.1074/jbc.271.34.20789; STINSON RA, 1987, BIOCHIM BIOPHYS ACTA, V913, P272, DOI 10.1016/0167-4838(87)90135-X; TANIMURA A, 1986, Journal of Experimental Pathology (New York), V2, P261; THOMAS M, 1966, BIOCHEM J, V98, P94, DOI 10.1042/bj0980094; Toroian D, 2008, CALCIFIED TISSUE INT, V82, P116, DOI 10.1007/s00223-007-9085-2; Toroian D, 2007, J BIOL CHEM, V282, P22437, DOI 10.1074/jbc.M700591200; VANBELLE H, 1976, CLIN CHEM, V22, P972; Whyte M.P., 2001, METABOLIC MOL BASES, P5313; WHYTE MP, 1994, ENDOCR REV, V15, P439, DOI 10.1210/er.15.4.439	40	38	41	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4594	4604		10.1074/jbc.M803205200	http://dx.doi.org/10.1074/jbc.M803205200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19098289	hybrid			2022-12-25	WOS:000263134400059
J	Singh, LR; Kruger, WD				Singh, Laishram R.; Kruger, Warren D.			Functional Rescue of Mutant Human Cystathionine beta-Synthase by Manipulation of Hsp26 and Hsp70 Levels in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; MOLECULAR CHAPERONES; YEAST; MUTATIONS; HOMOCYSTINURIA; METABOLISM; PROTEASOME; PATHWAY; CYTOSOL; HSP104	Many human diseases are caused by missense substitutions that result in misfolded proteins that lack biological function. Here we express a mutant form of the human cystathionine beta-synthase protein, I278T, in Saccharomyces cerevisiae and show that it is possible to dramatically restore protein stability and enzymatic function by manipulation of the cellular chaperone environment. We demonstrate that Hsp70 and Hsp26 bind specifically to I278T but that these chaperones have opposite biological effects. Ethanol treatment induces Hsp70 and causes increased activity and steady-state levels of I278T. Deletion of the SSA2 gene, which encodes a cytoplasmic isoform of Hsp70, eliminates the ability of ethanol to restore function, indicating that Hsp70 plays a positive role in proper I278T folding. In contrast, deletion of HSP26 results in increased I278T protein and activity, whereas overexpression of Hsp26 results in reduced I278T protein. The Hsp26-I278T complex is degraded via a ubiquitin/proteosome-dependent mechanism. Based on these results we propose a novel model in which the ratio of Hsp70 and Hsp26 determines whether misfolded proteins will either be refolded or degraded.	[Singh, Laishram R.; Kruger, Warren D.] Fox Chase Canc Ctr, Div Populat Sci, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Kruger, WD (corresponding author), Fox Chase Canc Ctr, Div Populat Sci, 333 Cottman Ave, Philadelphia, PA 19111 USA.	warren.kruger@fccc.edu	kruger, warren/A-6407-2008	kruger, warren/0000-0002-4990-3695	National Institutes of Health [HL57299, CA06927]; Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057299, R29HL057299] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL57299 and CA06927 ( core grant). This work was also supported by an appropriation from the Commonwealth of Pennsylvania. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahner A, 2007, MOL BIOL CELL, V18, P806, DOI 10.1091/mbc.E06-05-0458; Alexandre H, 2001, FEBS LETT, V498, P98, DOI 10.1016/S0014-5793(01)02503-0; Cashikar AG, 2005, J BIOL CHEM, V280, P23869, DOI 10.1074/jbc.M502854200; Chen X, 2006, HUM MUTAT, V27, P474, DOI 10.1002/humu.20320; Dutkiewicz R, 2003, J BIOL CHEM, V278, P29719, DOI 10.1074/jbc.M303527200; Ghaboosi N, 2007, MOL BIOL CELL, V18, P1953, DOI 10.1091/mbc.E06-10-0965; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Haslbeck M, 1999, EMBO J, V18, P6744, DOI 10.1093/emboj/18.23.6744; Haslbeck M, 2002, CELL MOL LIFE SCI, V59, P1649, DOI 10.1007/PL00012492; Haslbeck M, 2005, J BIOL CHEM, V280, P23861, DOI 10.1074/jbc.M502697200; Jhee KH, 2005, ANTIOXID REDOX SIGN, V7, P813, DOI 10.1089/ars.2005.7.813; Kappe G, 2003, CELL STRESS CHAPERON, V8, P53, DOI 10.1379/1466-1268(2003)8<53:THGECS>2.0.CO;2; Kim CE, 1997, HUM MOL GENET, V6, P2213, DOI 10.1093/hmg/6.13.2213; Kraus JP, 1999, HUM MUTAT, V13, P362; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; KRUGER WD, 1995, HUM MOL GENET, V4, P1155, DOI 10.1093/hmg/4.7.1155; Kruger WD, 2003, HUM MUTAT, V22, P434, DOI 10.1002/humu.10290; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Meier M, 2001, EMBO J, V20, P3910, DOI 10.1093/emboj/20.15.3910; Michel JJ, 2003, J BIOL CHEM, V278, P22828, DOI 10.1074/jbc.M210358200; Shan XY, 1998, NAT GENET, V19, P91, DOI 10.1038/ng0598-91; Shan XY, 2001, HUM MOL GENET, V10, P635, DOI 10.1093/hmg/10.6.635; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Shoemaker DD, 1996, NAT GENET, V14, P450, DOI 10.1038/ng1296-450; Singh LR, 2007, MOL GENET METAB, V91, P335, DOI 10.1016/j.ymgme.2007.04.011; Smith DF, 1998, PHARMACOL REV, V50, P493; van Slegtenhorst M, 2004, J BIOL CHEM, V279, P12706, DOI 10.1074/jbc.M313874200	27	22	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4238	4245		10.1074/jbc.M806387200	http://dx.doi.org/10.1074/jbc.M806387200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19074437	Green Published, hybrid			2022-12-25	WOS:000263134400021
J	Bhunia, A; Tang, XY; Mohanram, H; Tan, SM; Bhattacharjya, S				Bhunia, Anirban; Tang, Xiao-Yan; Mohanram, Harini; Tan, Suet-Mien; Bhattacharjya, Surajit			NMR Solution Conformations and Interactions of Integrin alpha L beta 2 Cytoplasmic Tails	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-LYMPHOCYTE MIGRATION; BINDING PROTEIN; TRANSMEMBRANE SEGMENT; STRUCTURAL BASIS; CHEMICAL-SHIFT; CELL-ADHESION; ALPHA-CHAIN; ACTIVATION; TALIN; DOMAIN	The integrins are bi-directional signal transducers. Devoid of enzymatic activity, the integrin cytoplasmic tail serves as a hub for the recruitment of cytosolic proteins, and many of these are signaling molecules. The leukocyte-restricted integrin alpha L beta 2 is essential for the adhesion, migration, and proliferation of leukocytes. Here we report solution conformations and interactions of the alpha L beta 2 cytoplasmic tails by NMR analyses. The alpha L tail is characterized by three helical segments in the order of helix 1-3 that are connected by two loops with helix 3 having a number of nuclear Overhauser effect contacts with helix 1 and helix 2. The conformation of the beta 2 tail is less defined with only a helical segment restricted at its N terminus. Acidic residues from the helix 2-loop-helix 3 motif of alpha L were found to be responsible for its binding to calcium ion. There were detectable interactions between alpha L and beta 2 tails, involving helix 1 and helix 3 of the alpha L tail and the N-terminal helix of the beta 2 tail. Talin head domain that contains the FERM domain showed binding affinity of K-d similar to 0.5 mu M with the beta 2 tail. The binding affinity of alpha L and beta 2 tails is K-d similar to 2.63 mu M. These data are in line with the activating property of talin head domain on alpha L beta 2 by which binding of talin head domain to beta 2 tail disrupts the interface of the alpha L and beta 2 tails that constrains alpha L beta 2 in a resting state.	[Bhunia, Anirban; Tang, Xiao-Yan; Mohanram, Harini; Tan, Suet-Mien; Bhattacharjya, Surajit] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Tan, SM (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	smtan@ntu.edu.sg; surajit@ntu.edu.sg	Tan, Suet/A-2224-2011; Bhattacharjya, SURAJIT/A-2183-2011; Mohanram, Harini/L-9207-2019	Mohanram, Harini/0000-0002-8179-2665; Tan, Suet-Mien/0000-0003-2371-8739; Bhunia, Anirban/0000-0002-8752-2842	A*STAR BMRC [04/1/22/19/358, 06/1/22/19/445, 06/01/22/19/446]	A*STAR BMRC(Agency for Science Technology & Research (A*STAR))	This work was supported by Grants A*STAR BMRC 04/1/22/19/358 and 06/1/22/19/445 (to X.-Y.T., and S.M.T.) and by Grant A*STAR BMRC 06/01/22/19/446 (to A.B., H.M., and S.B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Alahari SK, 2004, EMBO J, V23, P2777, DOI 10.1038/sj.emboj.7600291; Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Barclay A. N., 1997, LEUCOCYTE ANTIGEN FA, V2nd; Bouaouina M, 2008, J BIOL CHEM, V283, P6118, DOI 10.1074/jbc.M709527200; Bryceson YT, 2006, IMMUNOL REV, V214, P73, DOI 10.1111/j.1600-065X.2006.00457.x; Cairo CW, 2006, IMMUNITY, V25, P297, DOI 10.1016/j.immuni.2006.06.012; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; CHAN BM, 1992, CELL, V68, P1051, DOI 10.1016/0092-8674(92)90077-P; CHATILA TA, 1989, J CELL BIOL, V109, P3435, DOI 10.1083/jcb.109.6.3435; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Critchley DR, 2004, BIOCHEM SOC T, V32, P831, DOI 10.1042/BST0320831; Fagerholm S, 2002, J BIOL CHEM, V277, P1728, DOI 10.1074/jbc.M106856200; Fagerholm SC, 2005, J CELL BIOL, V171, P705, DOI 10.1083/jcb.200504016; Fagerholm SC, 2004, TRENDS BIOCHEM SCI, V29, P504, DOI 10.1016/j.tibs.2004.07.005; Geng X, 2005, IMMUNOLOGY, V115, P347, DOI 10.1111/j.1365-2567.2005.02175.x; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Haas TA, 1996, J BIOL CHEM, V271, P6017, DOI 10.1074/jbc.271.11.6017; Hilden TJ, 2003, J IMMUNOL, V170, P4170, DOI 10.4049/jimmunol.170.8.4170; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; KASSNER PD, 1993, J EXP MED, V178, P649, DOI 10.1084/jem.178.2.649; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Kinashi T, 2007, ADV IMMUNOL, V93, P185, DOI 10.1016/S0065-2776(06)93005-3; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lau TL, 2008, J BIOL CHEM, V283, P16162, DOI 10.1074/jbc.M801748200; Lau TL, 2008, BIOCHEMISTRY-US, V47, P4008, DOI 10.1021/bi800107a; Li RH, 2001, P NATL ACAD SCI USA, V98, P12462, DOI 10.1073/pnas.221463098; Li YF, 2007, J BIOL CHEM, V282, P24310, DOI 10.1074/jbc.M701860200; Lim J, 2007, MOL BIOL CELL, V18, P976, DOI 10.1091/mbc.E06-09-0813; Liu S, 1999, NATURE, V402, P676, DOI 10.1038/45264; Liu SC, 2000, J CELL SCI, V113, P3563; Luo BH, 2006, CURR OPIN CELL BIOL, V18, P579, DOI 10.1016/j.ceb.2006.08.005; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Morin NA, 2008, J EXP MED, V205, P195, DOI 10.1084/jem.20071543; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Naik UP, 1997, J BIOL CHEM, V272, P4651, DOI 10.1074/jbc.272.8.4651; Nurmi SM, 2007, J BIOL CHEM, V282, P968, DOI 10.1074/jbc.M608524200; PAVALKO FM, 1993, J IMMUNOL, V151, P3795; Pellinen T, 2006, J CELL SCI, V119, P3723, DOI 10.1242/jcs.03216; Reymond MT, 1997, PROTEIN SCI, V6, P706; Smith A, 2005, J CELL BIOL, V170, P141, DOI 10.1083/jcb.200412032; Smith A, 2007, IMMUNOL REV, V218, P135, DOI 10.1111/j.1600-065X.2007.00537.x; Stanley P, 2008, EMBO J, V27, P62, DOI 10.1038/sj.emboj.7601959; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Takala H, 2008, BLOOD, V112, P1853, DOI 10.1182/blood-2007-12-127795; Tan SM, 2001, J BIOL CHEM, V276, P36370, DOI 10.1074/jbc.M102392200; Tang RH, 2006, FEBS LETT, V580, P4435, DOI 10.1016/j.febslet.2006.06.099; Tang XY, 2008, J IMMUNOL, V180, P4793, DOI 10.4049/jimmunol.180.7.4793; Tohyama Y, 2003, MOL BIOL CELL, V14, P2570, DOI 10.1091/mbc.E02-09-0615; Ulmer TS, 2003, BIOCHEMISTRY-US, V42, P8307, DOI 10.1021/bi034384s; Ulmer TS, 2001, BIOCHEMISTRY-US, V40, P7498, DOI 10.1021/bi010338l; Vallar L, 1999, J BIOL CHEM, V274, P17257, DOI 10.1074/jbc.274.24.17257; Vinogradova O, 2000, P NATL ACAD SCI USA, V97, P1450, DOI 10.1073/pnas.040548197; Vinogradova O, 2004, P NATL ACAD SCI USA, V101, P4094, DOI 10.1073/pnas.0400742101; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Weber KSC, 1999, MOL BIOL CELL, V10, P861, DOI 10.1091/mbc.10.4.861; Wegener KL, 2008, MOL MEMBR BIOL, V25, P376, DOI 10.1080/09687680802269886; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Weljie AM, 2002, P NATL ACAD SCI USA, V99, P5878, DOI 10.1073/pnas.092515799; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Ziegler WH, 2008, BIOCHEM SOC T, V36, P235, DOI 10.1042/BST0360235	63	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3873	3884		10.1074/jbc.M807236200	http://dx.doi.org/10.1074/jbc.M807236200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19073598	hybrid			2022-12-25	WOS:000262872500056
J	Brown, G; Singer, A; Lunin, VV; Proudfoot, M; Skarina, T; Flick, R; Kochinyan, S; Sanishvili, R; Joachimiak, A; Edwards, AM; Savchenko, A; Yakunin, AF				Brown, Greg; Singer, Alexander; Lunin, Vladimir V.; Proudfoot, Michael; Skarina, Tatiana; Flick, Robert; Kochinyan, Samvel; Sanishvili, Ruslan; Joachimiak, Andrzej; Edwards, Aled M.; Savchenko, Alexei; Yakunin, Alexander F.			Structural and Biochemical Characterization of the Type II Fructose-1,6-bisphosphatase GlpX from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL MONOPHOSPHATASE; FRUCTOSE 1,6-BISPHOSPHATASE; CRYSTAL-STRUCTURE; CORYNEBACTERIUM-GLUTAMICUM; PHOSPHATASE-ACTIVITIES; PUTATIVE TARGET; ENZYME; GENE; LITHIUM; EXPRESSION	Gluconeogenesis is an important metabolic pathway, which produces glucose from noncarbohydrate precursors such as organic acids, fatty acids, amino acids, or glycerol. Fructose-1,6-bisphosphatase, a key enzyme of gluconeogenesis, is found in all organisms, and five different classes of these enzymes have been identified. Here we demonstrate that Escherichia coli has two class II fructose-1,6-bisphosphatases, GlpX and YggF, which show different catalytic properties. We present the first crystal structure of a class II fructose-1,6-bisphosphatase (GlpX) determined in a free state and in the complex with a substrate (fructose 1,6-bisphosphate) or inhibitor (phosphate). The crystal structure of the ligand-free GlpX revealed a compact, globular shape with two alpha/beta-sandwich domains. The core fold of GlpX is structurally similar to that of Li+-sensitive phosphatases implying that they have a common evolutionary origin and catalytic mechanism. The structure of the GlpX complex with fructose 1,6-bisphosphate revealed that the active site is located between two domains and accommodates several conserved residues coordinating two metal ions and the substrate. The third metal ion is bound to phosphate 6 of the substrate. Inorganic phosphate strongly inhibited activity of both GlpX and YggF, and the crystal structure of the GlpX complex with phosphate demonstrated that the inhibitor molecule binds to the active site. Alanine replacement mutagenesis of GlpX identified 12 conserved residues important for activity and suggested that Thr(90) is the primary catalytic residue. Our data provide insight into the molecular mechanisms of the substrate specificity and catalysis of GlpX and other class II fructose-1,6-bisphosphatases.	[Brown, Greg; Singer, Alexander; Proudfoot, Michael; Skarina, Tatiana; Flick, Robert; Kochinyan, Samvel; Edwards, Aled M.; Savchenko, Alexei; Yakunin, Alexander F.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; [Lunin, Vladimir V.] Natl Renewable Energy Lab, Chem & Biosci Ctr, Golden, CO 80401 USA; [Sanishvili, Ruslan; Joachimiak, Andrzej] Argonne Natl Lab, Midwest Ctr Struct Genom, Biosci Div, Argonne, IL 60439 USA; [Sanishvili, Ruslan; Joachimiak, Andrzej] Struct Biol Ctr, Argonne, IL 60439 USA	University of Toronto; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); Argonne National Laboratory	Yakunin, AF (corresponding author), Univ Toronto, Banting & Best Dept Med Res, 112 Coll St, Toronto, ON M5G 1L6, Canada.	a.iakounine@utoronto.ca	Yakunin, Alexander/J-1519-2014	Edwards, Aled/0000-0002-4782-6016; Yakunin, Alexander/0000-0003-0813-6490	National Institutes of Health [GM074942]; Genome Canada (through the Ontario Genomics Institute); United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genome Canada (through the Ontario Genomics Institute)(Genome Canada); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM074942. This work was also supported by Genome Canada (through the Ontario Genomics Institute) and by the United States Department of Energy, Office of Biological and Environmental Research, Contract DE-AC02-06CH11357. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Albert A, 2000, J MOL BIOL, V295, P927, DOI 10.1006/jmbi.1999.3408; BABUL J, 1983, ARCH BIOCHEM BIOPHYS, V225, P944, DOI 10.1016/0003-9861(83)90109-1; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Becker J, 2005, APPL ENVIRON MICROB, V71, P8587, DOI 10.1128/AEM.71.12.8587-8596.2005; BONE R, 1992, P NATL ACAD SCI USA, V89, P10031, DOI 10.1073/pnas.89.21.10031; BONE R, 1994, BIOCHEMISTRY-US, V33, P9468, DOI 10.1021/bi00198a012; Choe JY, 2000, BIOCHEMISTRY-US, V39, P8565, DOI 10.1021/bi000574g; Donahue JL, 2000, J BACTERIOL, V182, P5624, DOI 10.1128/JB.182.19.5624-5627.2000; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRAENKEL DG, 1966, ARCH BIOCHEM BIOPHYS, V114, P4, DOI 10.1016/0003-9861(66)90298-0; FRAENKEL DG, 1965, J BACTERIOL, V90, P837, DOI 10.1128/JB.90.4.837-842.1965; Fujita Y, 1998, J BACTERIOL, V180, P4309, DOI 10.1128/JB.180.16.4309-4313.1998; Fukuda C, 2007, APPL ENVIRON MICROB, V73, P5447, DOI 10.1128/AEM.02703-06; Hines JK, 2007, J BIOL CHEM, V282, P11696, DOI 10.1074/jbc.M611104200; Hines JK, 2006, J BIOL CHEM, V281, P18386, DOI 10.1074/jbc.M602553200; HORECKER BL, 1975, ADV ENZYMOL RAMB, V42, P193; INHORN RC, 1988, J BIOL CHEM, V263, P14559; Johnson KA, 2001, BIOCHEMISTRY-US, V40, P618, DOI 10.1021/bi0016422; KE HM, 1989, P NATL ACAD SCI USA, V86, P1475, DOI 10.1073/pnas.86.5.1475; Kelley-Loughnane N, 2002, BBA-PROTEIN STRUCT M, V1594, P6, DOI 10.1016/S0167-4838(01)00261-8; Kimber MS, 2003, PROTEINS, V51, P562, DOI 10.1002/prot.10340; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Kuznetsova E, 2006, J BIOL CHEM, V281, P36149, DOI 10.1074/jbc.M605449200; LEECH AP, 1993, EUR J BIOCHEM, V212, P693, DOI 10.1111/j.1432-1033.1993.tb17707.x; MARCUS F, 1982, METHOD ENZYMOL, V90, P352; MATSUHISA A, 1995, J BACTERIOL, V177, P200, DOI 10.1128/jb.177.1.200-205.1995; MCALLISTER G, 1992, BIOCHEM J, V284, P749, DOI 10.1042/bj2840749; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Movahedzadeh F, 2004, MICROBIOL-SGM, V150, P3499, DOI 10.1099/mic.0.27204-0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naderer T, 2006, P NATL ACAD SCI USA, V103, P5502, DOI 10.1073/pnas.0509196103; NAHORSKI SR, 1991, TRENDS PHARMACOL SCI, V12, P297, DOI 10.1016/0165-6147(91)90581-C; NEUWALD AF, 1992, J BACTERIOL, V174, P415, DOI 10.1128/jb.174.2.415-425.1992; Nishimasu H, 2004, STRUCTURE, V12, P949, DOI 10.1016/j.str.2004.03.026; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel S, 2002, J MOL BIOL, V320, P1087, DOI 10.1016/S0022-2836(02)00564-8; Patel S, 2002, J MOL BIOL, V315, P677, DOI 10.1006/jmbi.2001.5271; POLLACK SJ, 1994, P NATL ACAD SCI USA, V91, P5766, DOI 10.1073/pnas.91.13.5766; Proudfoot M, 2004, J BIOL CHEM, V279, P54687, DOI 10.1074/jbc.M411023200; Rashid N, 2002, J BIOL CHEM, V277, P30649, DOI 10.1074/jbc.M202868200; Rittmann D, 2003, ARCH MICROBIOL, V180, P285, DOI 10.1007/s00203-003-0588-6; Rosenbaum G, 2006, J SYNCHROTRON RADIAT, V13, P30, DOI 10.1107/S0909049505036721; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sato T, 2004, J BACTERIOL, V186, P5799, DOI 10.1128/JB.186.17.5799-5807.2004; SEDIVY JM, 1984, J BACTERIOL, V158, P1048, DOI 10.1128/JB.158.3.1048-1053.1984; Stec B, 2000, NAT STRUCT BIOL, V7, P1046, DOI 10.1038/80968; Stieglitz KA, 2002, J BIOL CHEM, V277, P22863, DOI 10.1074/jbc.M201042200; Tamoi M, 1998, BBA-PROTEIN STRUCT M, V1383, P232, DOI 10.1016/S0167-4838(97)00208-2; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Verhees CH, 2002, J BACTERIOL, V184, P3401, DOI 10.1128/JB.184.12.3401-3405.2002; VILLERET V, 1995, BIOCHEMISTRY-US, V34, P4299, DOI 10.1021/bi00013a019; Wang YL, 2007, J BIOL CHEM, V282, P26989, DOI 10.1074/jbc.M701210200; Wright SW, 2002, J MED CHEM, V45, P3865, DOI 10.1021/jm010496a; XUE YF, 1994, P NATL ACAD SCI USA, V91, P12482, DOI 10.1073/pnas.91.26.12482; YORK JD, 1995, P NATL ACAD SCI USA, V92, P5149, DOI 10.1073/pnas.92.11.5149; Zhang RG, 2001, STRUCTURE, V9, P1095, DOI 10.1016/S0969-2126(01)00675-X; ZHANG YP, 1993, BIOCHEM BIOPH RES CO, V190, P1080, DOI 10.1006/bbrc.1993.1159	61	37	39	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3784	3792		10.1074/jbc.M808186200	http://dx.doi.org/10.1074/jbc.M808186200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19073594	Green Published, hybrid			2022-12-25	WOS:000262872500047
J	Prassl, R; Pregetter, M; Amenitsch, H; Kriechbaum, M; Schwarzenbacher, R; Chapman, JM; Laggner, P				Prassl, Ruth; Pregetter, Magdalena; Amenitsch, Heinz; Kriechbaum, Manfred; Schwarzenbacher, Robert; Chapman, John M.; Laggner, Peter			Low Density Lipoproteins as Circulating Fast Temperature Sensors	PLOS ONE			English	Article							HUMAN-PLASMA; THERMAL TRANSITIONS; CORE; LDL; LIPIDS; ORGANIZATION; CHOLESTEROL; RESOLUTION	Background: The potential physiological significance of the nanophase transition of neutral lipids in the core of low density lipoprotein (LDL) particles is dependent on whether the rate is fast enough to integrate small (+2 degrees C) temperature changes in the blood circulation. Methodology/Principal Findings: Using sub-second, time-resolved small-angle X-ray scattering technology with synchrotron radiation, we have monitored the dynamics of structural changes within LDL, which were triggered by temperature-jumps and -drops, respectively. Our findings reveal that the melting transition is complete within less than 10 milliseconds. The freezing transition proceeds slowly with a half-time of approximately two seconds. Thus, the time period over which LDL particles reside in cooler regions of the body readily facilitates structural reorientation of the apolar core lipids. Conclusions/Significance: Low density lipoproteins, the biological nanoparticles responsible for the transport of cholesterol in blood, are shown to act as intrinsic nano-thermometers, which can follow the periodic temperature changes during blood circulation. Our results demonstrate that the lipid core in LDL changes from a liquid crystalline to an oily state within fractions of seconds. This may, through the coupling to the protein structure of LDL, have important repercussions on current theories of the role of LDL in the pathogenesis of atherosclerosis.	[Prassl, Ruth; Pregetter, Magdalena; Amenitsch, Heinz; Kriechbaum, Manfred; Laggner, Peter] Austrian Acad Sci, Inst Biophys & Nanosyst Res, Graz, Austria; [Schwarzenbacher, Robert] Salzburg Univ, A-5020 Salzburg, Austria; [Chapman, John M.] INSERM, Hop Pitie, Dyslipoproteinem & Atherosclerosis Res Unit, Paris, France	Austrian Academy of Sciences; Salzburg University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Prassl, R (corresponding author), Austrian Acad Sci, Inst Biophys & Nanosyst Res, Graz, Austria.	ruth.prassl@oeaw.ac.at	Prassl, Ruth/AAE-1523-2021	Kriechbaum, Manfred/0000-0002-3852-4198; Prassl, Ruth/0000-0002-1010-9494; Amenitsch, Heinz/0000-0002-0788-1336	Austrian Science Foundation [P-16479-CHE, P-20455-B12]; Seegen Stiftung of the Austrian Acad. Sci.; INSERM; Austrian Science Fund (FWF) [P 20455] Funding Source: researchfish	Austrian Science Foundation(Austrian Science Fund (FWF)); Seegen Stiftung of the Austrian Acad. Sci.; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grants from the Austrian Science Foundation (Project No. P-16479-CHE and P-20455-B12 to RP), Seegen Stiftung of the Austrian Acad. Sci. to PL and by INSERM to JMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON D, 1977, P NATL ACAD SCI USA, V74, P1042, DOI 10.1073/pnas.74.3.1042; BAUMSTARK MW, 1990, BIOCHIM BIOPHYS ACTA, V1037, P48, DOI 10.1016/0167-4838(90)90100-T; BAZETT HC, 1948, J APPL PHYSIOL, V1, P3, DOI 10.1152/jappl.1948.1.1.3; BROWN MS, 1976, SCIENCE, V191, P150, DOI 10.1126/science.174194; CHAPMAN MJ, 1988, J LIPID RES, V29, P442; DECKELBAUM RJ, 1977, J BIOL CHEM, V252, P744; DECKELBAUM RJ, 1975, SCIENCE, V190, P392, DOI 10.1126/science.170681; Galeano NF, 1998, J LIPID RES, V39, P1263; GALEANO NF, 1994, J BIOL CHEM, V269, P511; Granberg P O, 1991, Arctic Med Res, V50 Suppl 6, P23; KRIECHBAUM M, 1989, REV SCI INSTRUM, V60, P2541, DOI 10.1063/1.1140670; LAGGNER P, 1978, EUR J BIOCHEM, V84, P227, DOI 10.1111/j.1432-1033.1978.tb12160.x; LAGGNER P, 1977, H-S Z PHYSIOL CHEM, V358, P771, DOI 10.1515/bchm2.1977.358.2.771; LAGGNER P, 1984, P NATL ACAD SCI-BIOL, V81, P4389, DOI 10.1073/pnas.81.14.4389; Lund-Katz S, 1998, BIOCHEMISTRY-US, V37, P12867, DOI 10.1021/bi980828m; Lunin VY, 2001, ACTA CRYSTALLOGR D, V57, P108, DOI 10.1107/S0907444900014608; MATEU L, 1979, ACTA CIENT VENEZ, V30, P478; McCullough L, 2004, AM FAM PHYSICIAN, V70, P2325; Morton RE, 1996, J LIPID RES, V37, P1915; Nathan HJ, 2001, CIRCULATION, V104, pI85; Orlova EV, 1999, P NATL ACAD SCI USA, V96, P8420, DOI 10.1073/pnas.96.15.8420; Pabst G, 2000, LANGMUIR, V16, P8994, DOI 10.1021/1a0003140; Prassl R, 1996, J BIOL CHEM, V271, P28731, DOI 10.1074/jbc.271.46.28731; Prassl R, 1998, BIOCHEMISTRY-US, V37, P938, DOI 10.1021/bi971853f; Pregetter M, 1999, J BIOL CHEM, V274, P1334, DOI 10.1074/jbc.274.3.1334; SCHUSTER B, 1995, P NATL ACAD SCI USA, V92, P2509, DOI 10.1073/pnas.92.7.2509; Sherman MB, 2003, BIOCHEMISTRY-US, V42, P14988, DOI 10.1021/bi0354738; SMALL DM, 1977, COLL INTERF SCI, V1, P615; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; YANG CY, 1992, STRUCTURE FUNCTION A, P63; ZECHNER R, 1984, CHEM PHYS LIPIDS, V36, P111, DOI 10.1016/0009-3084(84)90064-1	31	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2008	3	12							e4079	10.1371/journal.pone.0004079	http://dx.doi.org/10.1371/journal.pone.0004079			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DL	19114995	Green Submitted, Green Published, gold			2022-12-25	WOS:000265466300017
J	Borgatti, M; Rizzo, R; Dal Canto, MB; Fumagalli, D; Renzini, MM; Fadini, R; Stignani, M; Baricordi, OR; Gambari, R				Borgatti, Monica; Rizzo, Roberta; Dal Canto, Maria Beatrice; Fumagalli, Daniela; Renzini, Mario Mignini; Fadini, Rubens; Stignani, Marina; Baricordi, Olavio Roberto; Gambari, Roberto			Release of sICAM-1 in Oocytes and In Vitro Fertilized Human Embryos	PLOS ONE			English	Article								Background: During the last years, several studies have reported the significant relationship between the production of soluble HLA-G molecules (sHLA-G) by 48-72 hours early embryos and an increased implantation rate in IVF protocols. As consequence, the detection of HLA-G modulation was suggested as a marker to identify the best embryos to be transferred. On the opposite, no suitable markers are available for the oocyte selection. Methodology/Principal Findings: The major finding of the present paper is that the release of ICAM-1 might be predictive of oocyte maturation. The results obtained are confirmed using three independent methodologies, such as ELISA, Bio-Plex assay and Western blotting. The sICAM-1 release is very high in immature oocytes, decrease in mature oocytes and become even lower in in vitro fertilized embryos. No significant differences were observed in the levels of sICAM-1 release between immature oocytes with different morphological characteristics. On the contrary, when the mature oocytes were subdivided accordingly to morphological criteria, the mean sICAM-I levels in grade 1 oocytes were significantly decreased when compared to grade 2 and 3 oocytes. Conclusions/Significance: The reduction of the number of fertilized oocytes and transferred embryos represents the main target of assisted reproductive medicine. We propose sICAM-1 as a biochemical marker for oocyte maturation and grading, with a possible interesting rebound in assisted reproduction techniques.	[Gambari, Roberto] Univ Ferrara, Dept Biochem & Mol Biol, I-44100 Ferrara, Italy; [Rizzo, Roberta; Stignani, Marina; Baricordi, Olavio Roberto] Univ Ferrara, Dept Expt & Diagnost Med, Lab Immunogenet, I-44100 Ferrara, Italy; [Dal Canto, Maria Beatrice; Fumagalli, Daniela; Renzini, Mario Mignini; Fadini, Rubens] Ist Clin Zucchi, BIOGENESI Reprod Med Ctr, Monza, Italy; [Gambari, Roberto] Univ Ferrara, Biotechnol Ctr, I-44100 Ferrara, Italy	University of Ferrara; University of Ferrara; University of Ferrara	Borgatti, M (corresponding author), Univ Ferrara, Dept Biochem & Mol Biol, I-44100 Ferrara, Italy.	bri@unife.it; gam@unife.it	Gambari, Roberto/F-9555-2015; Borgatti, Monica/G-2611-2015; Rizzo, Roberta/K-4844-2016	Gambari, Roberto/0000-0001-9205-6033; Borgatti, Monica/0000-0001-8470-2496; Dal Canto, Mariabeatrice/0000-0001-5716-4127; Rizzo, Roberta/0000-0001-9507-9126	Fondazione Cariparo; CIB; UE ITHANET Project; Telethon [GGP07257]; Regione Emilia-Romagna; Associazione Veneta per la Lotta alla Talassemia (AVLT), Rovigo	Fondazione Cariparo(Fondazione Cariparo); CIB; UE ITHANET Project(European CommissionEuropean Commission Joint Research Centre); Telethon(Fondazione Telethon); Regione Emilia-Romagna(Regione Emilia Romagna); Associazione Veneta per la Lotta alla Talassemia (AVLT), Rovigo	R.G. is granted by Fondazione Cariparo (Cassa di Risparmio di Padova e Rovigo), CIB, by UE ITHANET Project (eInfrastructure for the Thalassaemia Research Network) and by Telethon (contract GGP07257). This research is also supported by Regione Emilia-Romagna (Spinner Project) and by Associazione Veneta per la Lotta alla Talassemia (AVLT), Rovigo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arikan C, 2008, DIGEST DIS SCI, V53, P2000, DOI 10.1007/s10620-007-9914-1; Coticchio G, 2004, ANN NY ACAD SCI, V1034, P132, DOI 10.1196/annals.1335.016; de Jager W, 2003, CLIN DIAGN LAB IMMUN, V10, P133, DOI 10.1128/CDLI.10.1.133-139.2003; Deonandan R, 2000, J ASSIST REPROD GEN, V17, P498, DOI 10.1023/A:1009489624045; Desai N, 2006, REPROD BIOMED ONLINE, V13, P272, DOI 10.1016/S1472-6483(10)60626-8; Dumollard R, 2007, CURR TOP DEV BIOL, V77, P21, DOI 10.1016/S0070-2153(06)77002-8; Ebner T, 2000, HUM REPROD, V15, P427, DOI 10.1093/humrep/15.2.427; Ebner T, 2006, REPROD BIOMED ONLINE, V12, P507, DOI 10.1016/S1472-6483(10)62006-8; Fineschi V, 2005, J MED ETHICS, V31, P536, DOI 10.1136/jme.2004.010231; Fuzzi B, 2002, EUR J IMMUNOL, V32, P311, DOI 10.1002/1521-4141(200202)32:2<311::AID-IMMU311>3.3.CO;2-#; Hallahan DE, 1997, P NATL ACAD SCI USA, V94, P6432, DOI 10.1073/pnas.94.12.6432; Kerr JR, 2004, J MED VIROL, V74, P147, DOI 10.1002/jmv.20158; Madaschi C, 2008, FERTIL STERIL, V90, P194, DOI 10.1016/j.fertnstert.2007.05.071; Montag M, 2008, REPROD BIOMED ONLINE, V16, P239, DOI 10.1016/S1472-6483(10)60580-9; Mousavi SAR, 2007, EUR J NEUROL, V14, P1397, DOI 10.1111/j.1468-1331.2007.01956.x; Noci I, 2005, HUM REPROD, V20, P138, DOI 10.1093/humrep/deh572; PASCALE MP, 2007, CURRENT TOPICS DEV B, V77, P51; Patrizio P, 2007, REPROD BIOMED ONLINE, V15, P346, DOI 10.1016/S1472-6483(10)60349-5; Rebmann V, 2007, HUM IMMUNOL, V68, P251, DOI 10.1016/j.humimm.2006.11.003; Rizzo R, 2007, J REPROD IMMUNOL, V74, P133, DOI 10.1016/j.jri.2007.02.005; Shen Y, 2005, HUM REPROD, V20, P1596, DOI 10.1093/humrep/deh811; Sher G, 2005, HUM REPROD, V20, P1359, DOI 10.1093/humrep/deh758; van den Borne SWM, 2008, J AM COLL CARDIOL, V51, P2184, DOI 10.1016/j.jacc.2008.02.056; Veeck L., 1999, ATLAS HUMAN GAMETES, P47; Wang HW, 2005, FASEB J, V19, P1018, DOI 10.1096/fj.04-3094fje; Yie S, 2005, FERTIL STERIL, V83, P30, DOI 10.1016/j.fertnstert.2004.06.059	26	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2008	3	12							e3970	10.1371/journal.pone.0003970	http://dx.doi.org/10.1371/journal.pone.0003970			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AT	19092999	Green Published, Green Submitted, gold			2022-12-25	WOS:000265458600007
J	Dansithong, W; Wolf, CM; Sarkar, P; Paul, S; Chiang, A; Holt, I; Morris, GE; Branco, D; Sherwood, MC; Comai, L; Berul, CI; Reddy, S				Dansithong, Warunee; Wolf, Cordula M.; Sarkar, Partha; Paul, Sharan; Chiang, Andy; Holt, Ian; Morris, Glenn E.; Branco, Dorothy; Sherwood, Megan C.; Comai, Lucio; Berul, Charles I.; Reddy, Sita			Cytoplasmic CUG RNA Foci Are Insufficient to Elicit Key DM1 Features	PLOS ONE			English	Article							EXPANDED CTG REPEATS; MYOTONIC-DYSTROPHY; CARDIAC INVOLVEMENT; BINDING PROTEIN; TRIPLET REPEAT; MESSENGER-RNA; MOUSE MODEL; CONDUCTION ABNORMALITIES; MUSCLEBLIND PROTEINS; UNTRANSLATED REGION	The genetic basis of myotonic dystrophy type I (DM1) is the expansion of a CTG tract located in the 39 untranslated region of DMPK. Expression of mutant RNAs encoding expanded CUG repeats plays a central role in the development of cardiac disease in DM1. Expanded CUG tracts form both nuclear and cytoplasmic aggregates, yet the relative significance of such aggregates in eliciting DM1 pathology is unclear. To test the pathophysiology of CUG repeat encoding RNAs, we developed and analyzed mice with cardiac-specific expression of a beta-galactosidase cassette in which a (CTG) 400 repeat tract was positioned 39 of the termination codon and 59 of the bovine growth hormone polyadenylation signal. In these animals CUG aggregates form exclusively in the cytoplasm of cardiac cells. A key pathological consequence of expanded CUG repeat RNA expression in DM1 is aberrant RNA splicing. Abnormal splicing results from the functional inactivation of MBNL1, which is hypothesized to occur due to MBNL1 sequestration in CUG foci or from elevated levels of CUG-BP1. We therefore tested the ability of cytoplasmic CUG foci to elicit these changes. Aggregation of CUG RNAs within the cytoplasm results both in Mbnl1 sequestration and in approximately a two fold increase in both nuclear and cytoplasmic Cug-bp1 levels. Significantly, despite these changes RNA splice defects were not observed and functional analysis revealed only subtle cardiac dysfunction, characterized by conduction defects that primarily manifest under anesthesia. Using a human myoblast culture system we show that this transgene, when expressed at similar levels to a second transgene, which encodes expanded CTG tracts and facilitates both nuclear focus formation and aberrant splicing, does not elicit aberrant splicing. Thus the lack of toxicity of cytoplasmic CUG foci does not appear to be a consequence of low expression levels. Our results therefore demonstrate that the cellular location of CUG RNA aggregates is an important variable that influences toxicity and support the hypothesis that small molecules that increase the rate of transport of the mutant DMPK RNA from the nucleus into the cytoplasm may significantly improve DM1 pathology.	[Paul, Sharan; Chiang, Andy; Reddy, Sita] Univ So Calif, Inst Genet, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA; [Wolf, Cordula M.; Branco, Dorothy; Sherwood, Megan C.; Berul, Charles I.] Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Cardiol, Boston, MA USA; [Wolf, Cordula M.; Branco, Dorothy; Sherwood, Megan C.; Berul, Charles I.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA USA; [Sarkar, Partha] Univ Texas, Med Branch, Dept Neurol, Galveston, TX USA; [Holt, Ian; Morris, Glenn E.] Robert Jones & Agnes Hunt Orthoped Hosp, Wolfson Ctr Inherited Neuromusc Dis, Oswestry, Shrops, England; [Comai, Lucio] Univ So Calif, Inst Genet Med, Dept Microbiol & Immunol, Los Angeles, CA USA	University of Southern California; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; University of Texas System; University of Texas Medical Branch Galveston; University of Southern California	Dansithong, W (corresponding author), Univ So Calif, Inst Genet, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA.	sitaredd@usc.edu	Comai, Lucio/L-5905-2019; Comai, Lucio/H-9524-2019	Comai, Lucio/0000-0003-3109-1841; 	National Center for Research Resources, National Institutes of Health (NIH) [5R01NS050861, 1R01NS060839]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060839, R01NS050861] Funding Source: NIH RePORTER	National Center for Research Resources, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We gratefully acknowledge support from the Dr. Hauschneckt for funds that partially supported this work. This work was conducted in a facility constructed with support from Research Facilities Improvement Program Grant Number C06 (5R01NS050861, 1R01NS060839) from the National Center for Research Resources, National Institutes of Health (NIH).	Amack JD, 2001, HUM MOL GENET, V10, P1879, DOI 10.1093/hmg/10.18.1879; Berul CI, 2000, J INTERV CARD ELECTR, V4, P351, DOI 10.1023/A:1009842114968; Berul CI, 1999, J CLIN INVEST, V103, pR1, DOI 10.1172/JCI5346; Berul CI, 1996, CIRCULATION, V94, P2641, DOI 10.1161/01.CIR.94.10.2641; BOUCHER CA, 1995, HUM MOL GENET, V4, P1919, DOI 10.1093/hmg/4.10.1919; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Caskey CT, 1996, COLD SPRING HARB SYM, V61, P607; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; Dansithong W, 2005, J BIOL CHEM, V280, P5773, DOI 10.1074/jbc.M410781200; FALL LH, 1990, OBSTET GYNECOL, V76, P481; FORSBERG H, 1990, BRIT HEART J, V63, P119; FRAGOLA PV, 1994, AM J CARDIOL, V74, P1070, DOI 10.1016/0002-9149(94)90864-8; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1993, SCIENCE, V260, P235, DOI 10.1126/science.8469976; Garcia-Lopez A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001595; GULICK J, 1991, J BIOL CHEM, V266, P9180; Harper PS, 2001, MYOTONIC DYSTROPHY; HAWLEY RJ, 1991, NEUROLOGY, V41, P259, DOI 10.1212/WNL.41.2_Part_1.259; Ho TH, 2005, HUM MOL GENET, V14, P1539, DOI 10.1093/hmg/ddi162; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Holt I, 2007, GENES CELLS, V12, P1035, DOI 10.1111/j.1365-2443.2007.01112.x; Houseley JM, 2005, HUM MOL GENET, V14, P873, DOI 10.1093/hmg/ddi080; Huang CQ, 2003, J BIOL CHEM, V278, P7360, DOI 10.1074/jbc.M211875200; Igarashi H, 1998, PEDIATR NEUROL, V18, P366, DOI 10.1016/S0887-8994(97)00216-6; Kanadia RN, 2006, P NATL ACAD SCI USA, V103, P11748, DOI 10.1073/pnas.0604970103; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; KANG S, 1995, NAT GENET, V10, P213, DOI 10.1038/ng0695-213; Kim DH, 2005, NUCLEIC ACIDS RES, V33, P3866, DOI 10.1093/nar/gki698; Klesert TR, 1997, NAT GENET, V16, P402, DOI 10.1038/ng0897-402; Le Mee G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001466; Lin XY, 2006, HUM MOL GENET, V15, P2087, DOI 10.1093/hmg/ddl132; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Mahadevan MS, 2006, NAT GENET, V38, P1066, DOI 10.1038/ng1857; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Mankodi A, 2005, CIRC RES, V97, P1152, DOI 10.1161/01.RES.0000193598.89753.e3; Mastroyiannopoulos NP, 2005, EMBO REP, V6, P458, DOI 10.1038/sj.embor.7400390; MELACINI P, 1995, J AM COLL CARDIOL, V25, P239, DOI 10.1016/0735-1097(94)00351-P; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Mitchell GF, 1998, AM J PHYSIOL-HEART C, V274, pH747, DOI 10.1152/ajpheart.1998.274.3.H747; Orengo JP, 2008, P NATL ACAD SCI USA, V105, P2646, DOI 10.1073/pnas.0708519105; OTTEN AD, 1995, P NATL ACAD SCI USA, V92, P5465, DOI 10.1073/pnas.92.12.5465; Paul S, 2006, EMBO J, V25, P4271, DOI 10.1038/sj.emboj.7601296; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Poizat C, 2000, MOL CELL BIOL, V20, P8643, DOI 10.1128/MCB.20.23.8643-8654.2000; Saba S, 1999, J CARDIOVASC ELECTR, V10, P1214, DOI 10.1111/j.1540-8167.1999.tb00298.x; Sarkar PS, 1998, CELL, V95, P531, DOI 10.1016/S0092-8674(00)81620-7; Seznec H, 2001, HUM MOL GENET, V10, P2717, DOI 10.1093/hmg/10.23.2717; TANAKA N, 1973, JPN HEART J, V14, P202; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Thornton CA, 1997, NAT GENET, V16, P407, DOI 10.1038/ng0897-407; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407; TOKGOZOGLU LS, 1995, JAMA-J AM MED ASSOC, V274, P813, DOI 10.1001/jama.274.10.813; Wakimoto H, 2002, J INTERV CARD ELECTR, V7, P127, DOI 10.1023/A:1020881520353; Wang GS, 2007, J CLIN INVEST, V117, P2802, DOI 10.1172/JCI32308	54	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2008	3	12							e3968	10.1371/journal.pone.0003968	http://dx.doi.org/10.1371/journal.pone.0003968			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AT	19092997	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000265458600005
J	Epstein, JM; Parker, J; Cummings, D; Hammond, RA				Epstein, Joshua M.; Parker, Jon; Cummings, Derek; Hammond, Ross A.			Coupled Contagion Dynamics of Fear and Disease: Mathematical and Computational Explorations	PLOS ONE			English	Article								Background: In classical mathematical epidemiology, individuals do not adapt their contact behavior during epidemics. They do not endogenously engage, for example, in social distancing based on fear. Yet, adaptive behavior is well-documented in true epidemics. We explore the effect of including such behavior in models of epidemic dynamics. Methodology/Principal Findings: Using both nonlinear dynamical systems and agent-based computation, we model two interacting contagion processes: one of disease and one of fear of the disease. Individuals can "contract'' fear through contact with individuals who are infected with the disease (the sick), infected with fear only (the scared), and infected with both fear and disease (the sick and scared). Scared individuals-whether sick or not-may remove themselves from circulation with some probability, which affects the contact dynamic, and thus the disease epidemic proper. If we allow individuals to recover from fear and return to circulation, the coupled dynamics become quite rich, and can include multiple waves of infection. We also study flight as a behavioral response. Conclusions/Significance: In a spatially extended setting, even relatively small levels of fear-inspired flight can have a dramatic impact on spatio-temporal epidemic dynamics. Self-isolation and spatial flight are only two of many possible actions that fear-infected individuals may take. Our main point is that behavioral adaptation of some sort must be considered.	[Parker, Jon; Hammond, Ross A.] Brookings Inst, Ctr Social & Econ Dynam, Washington, DC 20036 USA; [Epstein, Joshua M.] Santa Fe Inst, Santa Fe, NM USA; [Epstein, Joshua M.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA 15260 USA; [Cummings, Derek] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA	Brookings Institution; The Santa Fe Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Epstein, JM (corresponding author), Brookings Inst, Ctr Social & Econ Dynam, Washington, DC 20036 USA.	jepstein@brookings.edu			NIH 2008 Director's Pioneer Award [1DP1OD003874-01]; National Institute of General Medical Sciences Models of Infectious Disease Agent Study (MIDAS) [U01-GM070749]; U.S. Department of Homeland Security [N00014-06-1-0991]; Career Award at the Scientific Interface from the Burroughs Wellcome Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088491, U01GM070749] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003874] Funding Source: NIH RePORTER	NIH 2008 Director's Pioneer Award; National Institute of General Medical Sciences Models of Infectious Disease Agent Study (MIDAS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); Career Award at the Scientific Interface from the Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by the NIH 2008 Director's Pioneer Award [1DP1OD003874-01], the National Institute of General Medical Sciences Models of Infectious Disease Agent Study (MIDAS) through grant U01-GM070749, and the U.S. Department of Homeland Security through grant N00014-06-1-0991 awarded to the National Center for Study of Preparedness and Critical Event Response (PACER) at the Johns Hopkins University. Derek Cummings holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson R. M., 1993, INFECT DIS HUMANS DY; Bartholomew RE, 2002, BRIT J PSYCHIAT, V180, P300, DOI 10.1192/bjp.180.4.300; CAPLINGER C, 2002, TENNESSEE ENCY HIST; Del Valle S, 2005, MATH BIOSCI, V195, P228, DOI 10.1016/j.mbs.2005.03.006; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Hatfield E., 1994, REV PERSONALITY SOCI; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kremer M, 1996, Q J ECON, V111, P549, DOI 10.2307/2946687; Kuhnke L., 1990, LIVES RISK PUBLIC HL, V24, P134; Martin A. Lynn, 1973, SIXTEENTH CENT J, V4, P31; MURRAY B, 1989, MATH BIOL BIOMATHEMA, V19; Rosenberg Charles E, 1987, CHOLERA YEARS US 183	12	187	193	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2008	3	12							e3955	10.1371/journal.pone.0003955	http://dx.doi.org/10.1371/journal.pone.0003955			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AR	19079607	gold, Green Accepted, Green Published			2022-12-25	WOS:000265458400011
J	Drouyer, E; Dkhissi-Benyahya, O; Chiquet, C; WoldeMussie, E; Ruiz, G; Wheeler, LA; Denis, P; Cooper, HM				Drouyer, Elise; Dkhissi-Benyahya, Ouria; Chiquet, Christophe; WoldeMussie, Elizabeth; Ruiz, Guadalupe; Wheeler, Larry A.; Denis, Philippe; Cooper, Howard M.			Glaucoma Alters the Circadian Timing System	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; OPEN-ANGLE GLAUCOMA; OCULAR HYPERTENSION TREATMENT; AFFERENT PUPILLARY DEFECTS; SUPRACHIASMATIC NUCLEUS; AXONAL-TRANSPORT; MELANOPSIN; RESPONSES; LIGHT; PROJECTIONS	Glaucoma is a widespread ocular disease and major cause of blindness characterized by progressive, irreversible damage of the optic nerve. Although the degenerative loss of retinal ganglion cells (RGC) and visual deficits associated with glaucoma have been extensively studied, we hypothesize that glaucoma will also lead to alteration of the circadian timing system. Circadian and non-visual responses to light are mediated by a specialized subset of melanopsin expressing RGCs that provide photic input to mammalian endogenous clock in the suprachiasmatic nucleus (SCN). In order to explore the molecular, anatomical and functional consequences of glaucoma we used a rodent model of chronic ocular hypertension, a primary causal factor of the pathology. Quantitative analysis of retinal projections using sensitive anterograde tracing demonstrates a significant reduction (similar to 50-70%) of RGC axon terminals in all visual and non-visual structures and notably in the SCN. The capacity of glaucomatous rats to entrain to light was challenged by exposure to successive shifts of the light dark (LD) cycle associated with step-wise decreases in light intensity. Although glaucomatous rats are able to entrain their locomotor activity to the LD cycle at all light levels, they require more time to re-adjust to a shifted LD cycle and show significantly greater variability in activity onsets in comparison with normal rats. Quantitative PCR reveals the novel finding that melanopsin as well as rod and cone opsin mRNAs are significantly reduced in glaucomatous retinas. Our findings demonstrate that glaucoma impacts on all these aspects of the circadian timing system. In light of these results, the classical view of glaucoma as pathology unique to the visual system should be extended to include anatomical and functional alterations of the circadian timing system.	[Dkhissi-Benyahya, Ouria; Chiquet, Christophe; Denis, Philippe; Cooper, Howard M.] Stem Cell & Brain Res Inst, U846, INSERM, Dept Chronobiol, Bron, France; [Drouyer, Elise; Dkhissi-Benyahya, Ouria; Cooper, Howard M.] Univ Lyon 1, UMR S 846, Lyon, France; [Cooper, Howard M.] Ctr Natl Rech Sci, Lyon, France; [Chiquet, Christophe] Univ Joseph Fourier, Fac Med, CHU Grenoble, Dept Ophthalmol, F-38041 Grenoble, France; [WoldeMussie, Elizabeth] Pfizer Inc, San Diego, CA USA; [Ruiz, Guadalupe; Wheeler, Larry A.] Allergan Pharmaceut Inc, Irvine, CA USA; [Denis, Philippe] CHU Lyon Hop Edouard Herriot, Dept Ophthalmol, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CHU Grenoble Alpes; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Pfizer; AbbVie; Allergan; CHU Lyon	Drouyer, E (corresponding author), Stem Cell & Brain Res Inst, U846, INSERM, Dept Chronobiol, Bron, France.	howard.cooper@inserm.fr	Dkhissi-Benyahya, Ouria/M-5665-2014; Chiquet, Christophe/M-7426-2014; COOPER, HOWARD/M-7304-2014	Dkhissi-Benyahya, Ouria/0000-0001-9168-3801; Chiquet, Christophe/0000-0002-7601-4885; 	Allergan, Inc; Rhone-Alpes-Emergence/Cible; ACT-Vieillissement; ACI Neurosciences; Fondation Recherche Medicale stipend; FP6- EUCLOCK	Allergan, Inc(AbbVieAllergan); Rhone-Alpes-Emergence/Cible; ACT-Vieillissement; ACI Neurosciences; Fondation Recherche Medicale stipend; FP6- EUCLOCK	This work was supported by grants from Allergan, Inc, Rhone-Alpes-Emergence/Cible, ACT-Vieillissement, ACI Neurosciences, Fondation Recherche Medicale stipend to ED, FP6- EUCLOCK.	Barnard AR, 2006, CURR BIOL, V16, P389, DOI 10.1016/j.cub.2005.12.045; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Boland MV, 2007, J GLAUCOMA, V16, P406, DOI 10.1097/IJG.0b013e31806540a1; Cajochen C, 2005, J CLIN ENDOCR METAB, V90, P1311, DOI 10.1210/jc.2004-0957; Chiquet C, 2006, J FR OPHTALMOL, V29, P847, DOI 10.1016/S0181-5512(06)73858-X; Chiquet C, 2004, INVEST OPHTH VIS SCI, V45, pU425; COOPER HM, 1993, NATURE, V361, P156, DOI 10.1038/361156a0; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; DANDONA L, 1991, INVEST OPHTH VIS SCI, V32, P1593; Diaz F, 2005, HISTOL HISTOPATHOL, V20, P1077, DOI 10.14670/HH-20.1077; Dkhissi-Benyahya O, 2000, J NEUROSCI, V20, P7790; Dkhissi-Benyahya O, 2007, NEURON, V53, P677, DOI 10.1016/j.neuron.2007.02.005; Filippopoulos T, 2006, INVEST OPHTH VIS SCI, V47, P1968, DOI 10.1167/iovs.05-0955; Friedman DS, 2004, AM J OPHTHALMOL, V138, pS19, DOI 10.1016/j.ajo.2004.04.058; Gherghel D, 2004, SURV OPHTHALMOL, V49, P491, DOI 10.1016/j.survophthal.2004.06.003; GLOVINSKY Y, 1993, INVEST OPHTH VIS SCI, V34, P395; GLOVINSKY Y, 1991, INVEST OPHTH VIS SCI, V32, P484; Goz D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003153; Gooley JJ, 2003, J NEUROSCI, V23, P7093, DOI 10.1523/JNEUROSCI.23-18-07093.2003; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; Hannibal J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0002.2002; Hare WA, 2001, INVEST OPHTH VIS SCI, V42, P127; Harwerth RS, 2004, INVEST OPHTH VIS SCI, V45, P3152, DOI 10.1167/iovs.04-0227; Harwerth RS, 2006, ARCH OPHTHALMOL-CHIC, V124, P853, DOI 10.1001/archopht.124.6.853; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Jakobs TC, 2005, J CELL BIOL, V171, P313, DOI 10.1083/jcb.200506099; KABACK MB, 1976, AM J OPHTHALMOL, V81, P768, DOI 10.1016/0002-9394(76)90360-3; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; KENDELL KR, 1995, INVEST OPHTH VIS SCI, V36, P200; KOHN AN, 1979, ARCH OPHTHALMOL-CHIC, V97, P294; LESKE MC, 1983, AM J EPIDEMIOL, V118, P166, DOI 10.1093/oxfordjournals.aje.a113626; Li RS, 2006, INVEST OPHTH VIS SCI, V47, P2951, DOI 10.1167/iovs.05-1295; Lockley SW, 1997, J CLIN ENDOCR METAB, V82, P3763, DOI 10.1210/jc.82.11.3763; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; LUND RD, 1974, J COMP NEUROL, V158, P383, DOI 10.1002/cne.901580403; Morgan JE, 2000, BRIT J OPHTHALMOL, V84, P303, DOI 10.1136/bjo.84.3.303; Morin LP, 2003, J COMP NEUROL, V465, P401, DOI 10.1002/cne.10881; Mrosovsky N, 2003, CHRONOBIOL INT, V20, P989, DOI 10.1081/CBI-120026043; Mrosovsky N, 2003, J COMP PHYSIOL A, V189, P69, DOI 10.1007/s00359-002-0378-7; Mure LS, 2007, J BIOL RHYTHM, V22, P411, DOI 10.1177/0748730407306043; Nork TM, 2000, ARCH OPHTHALMOL-CHIC, V118, P235; Onen SH, 2000, ACTA OPHTHALMOL SCAN, V78, P638, DOI 10.1034/j.1600-0420.2000.078006638.x; Palmberg P, 2002, ARCH OPHTHALMOL-CHIC, V120, P829; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Pelzel HR, 2006, MOL VIS, V12, P1272; Provencio I, 1998, J COMP NEUROL, V395, P417, DOI 10.1002/(SICI)1096-9861(19980615)395:4<417::AID-CNE1>3.0.CO;2-4; PRYWES AS, 1976, ARCH OPHTHALMOL-CHIC, V94, P1286; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; QUIGLEY HA, 1987, INVEST OPHTH VIS SCI, V28, P913; Quigley HA, 1999, PROG RETIN EYE RES, V18, P39, DOI 10.1016/S1350-9462(98)00014-7; QUIGLEY HA, 1993, NEW ENGL J MED, V328, P1097, DOI 10.1056/NEJM199304153281507; QUIGLEY HA, 1988, OPHTHALMOLOGY, V95, P357; Raz D, 2002, INVEST OPHTH VIS SCI, V43, P2027; Rieux C, 2002, J BIOL RHYTHM, V17, P121, DOI 10.1177/074873002129002410; Sawada A, 1999, EXP EYE RES, V69, P525, DOI 10.1006/exer.1999.0732; SIMINOFF R, 1966, J COMP NEUROL, V127, P435, DOI 10.1002/cne.901270402; Skene DJ, 1999, CLIN ENDOCRINOL, V50, P715; Son YJ, 2007, MOL CELLS, V23, P215; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Tabandeh H, 1998, AM J OPHTHALMOL, V126, P707, DOI 10.1016/S0002-9394(98)00133-0; VANBUSKIRK EM, 1992, AM J OPHTHALMOL, V113, P447, DOI 10.1016/S0002-9394(14)76171-9; Ver Hoeve JN, 2001, INVEST OPHTH VIS SCI, V42, pS148; Warren EJ, 2003, EUR J NEUROSCI, V17, P1727, DOI 10.1046/j.1460-9568.2003.02594.x; WoldeMussie E, 2001, INVEST OPHTH VIS SCI, V42, P2849; Wright KP, 2001, P NATL ACAD SCI USA, V98, P14027, DOI 10.1073/pnas.201530198; WYGNANSKI T, 1995, AM J OPHTHALMOL, V120, P184, DOI 10.1016/S0002-9394(14)72606-6	69	104	106	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2008	3	12							e3931	10.1371/journal.pone.0003931	http://dx.doi.org/10.1371/journal.pone.0003931			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZW	19079596	Green Published, gold			2022-12-25	WOS:000265456300008
J	Dushek, O; Mueller, S; Soubies, S; Depoil, D; Caramalho, I; Coombs, D; Valitutti, S				Dushek, Omer; Mueller, Sabina; Soubies, Sebastien; Depoil, David; Caramalho, Iris; Coombs, Daniel; Valitutti, Salvatore			Effects of Intracellular Calcium and Actin Cytoskeleton on TCR Mobility Measured by Fluorescence Recovery	PLOS ONE			English	Article								Background: The activation of T lymphocytes by specific antigen is accompanied by the formation of a specialized signaling region termed the immunological synapse, characterized by the clustering and segregation of surface molecules and, in particular, by T cell receptor (TCR) clustering. Methodology/Principal Findings: To better understand TCR motion during cellular activation, we used confocal microscopy and photo-bleaching recovery techniques to investigate the lateral mobility of TCR on the surface of human T lymphocytes under various pharmacological treatments. Using drugs that cause an increase in intracellular calcium, we observed a decrease in TCR mobility that was dependent on a functional actin cytoskeleton. In parallel experiments measurement of filamentous actin by FACS analysis showed that raising intracellular calcium also causes increased polymerization of the actin cytoskeleton. These in vitro results were analyzed using a mathematical model that revealed effective binding parameters between TCR and the actin cytoskeleton. Conclusion/Significance: We propose, based on our results, that increase in intracellular calcium levels leads to actin polymerization and increases TCR/cytoskeleton interactions that reduce the overall mobility of the TCR. In a physiological setting, this may contribute to TCR re-positioning at the immunological synapse.	[Coombs, Daniel] Univ British Columbia, Dept Math, Inst Appl Math, Vancouver, BC, Canada; [Mueller, Sabina; Soubies, Sebastien; Depoil, David; Caramalho, Iris; Valitutti, Salvatore] INSERM, Ctr Physiopathol Toulouse Purpan, U563, Sect Dynam Mol Interact Lymphocytaires, Toulouse, France	University of British Columbia; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Dushek, O (corresponding author), Univ British Columbia, Dept Math, Inst Appl Math, Vancouver, BC, Canada.	salvatore.valitutti@inserm.fr	Caramalho, Iris/L-2491-2014; Valitutti, Salvatore/M-2999-2014	Caramalho, Iris/0000-0003-2479-7846; Valitutti, Salvatore/0000-0002-6432-4421; Soubies, Sebastien Mathieu/0000-0003-3065-3558; Coombs, Daniel/0000-0002-8038-6278	Ligue contre le Cancer "Equipe labellisee 2008", France; National Science and Engineering Research Council; Mathematics in Technology and Complex Systems National Centre of Excellence, Canada; Fundacao para Ciencia e a Tecnologia, Portugal; France-Canada Research Fund	Ligue contre le Cancer "Equipe labellisee 2008", France; National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Mathematics in Technology and Complex Systems National Centre of Excellence, Canada; Fundacao para Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); France-Canada Research Fund	Ligue contre le Cancer "Equipe labellisee 2008", France. National Science and Engineering Research Council and from the Mathematics in Technology and Complex Systems National Centre of Excellence, Canada. Fundacao para Ciencia e a Tecnologia, Portugal. France-Canada Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; Burroughs NJ, 2002, BIOPHYS J, V83, P1784, DOI 10.1016/S0006-3495(02)73944-1; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Cemerski S, 2007, IMMUNITY, V26, P345, DOI 10.1016/j.immuni.2007.01.013; Davis MM, 2007, ANNU REV IMMUNOL, V25, P681, DOI 10.1146/annurev.immunol.24.021605.090600; Depoil D, 2005, IMMUNITY, V22, P185, DOI 10.1016/j.immuni.2004.12.010; DOWNEY GP, 1990, J CELL BIOL, V110, P1975, DOI 10.1083/jcb.110.6.1975; DUSHEK O, 2008, EUR BIOPHYS J; Dushek O, 2008, J BIOCHEM BIOPH METH, V70, P1224, DOI 10.1016/j.jbbm.2007.07.002; Dustin ML, 2008, IMMUNOL REV, V221, P77, DOI 10.1111/j.1600-065X.2008.00589.x; Faroudi M, 2003, P NATL ACAD SCI USA, V100, P14145, DOI 10.1073/pnas.2334336100; Favier B, 2001, INT IMMUNOL, V13, P1525, DOI 10.1093/intimm/13.12.1525; Figge MT, 2006, PLOS COMPUT BIOL, V2, P1377, DOI 10.1371/journal.pcbi.0020171; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; HARDING CV, 1990, NATURE, V346, P574, DOI 10.1038/346574a0; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Kaizuka Y, 2007, P NATL ACAD SCI USA, V104, P20296, DOI 10.1073/pnas.0710258105; LANZAVECCHIA A, 1987, EUR J IMMUNOL, V17, P105, DOI 10.1002/eji.1830170118; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Moss WC, 2002, P NATL ACAD SCI USA, V99, P15024, DOI 10.1073/pnas.192573999; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Purtic B, 2005, P NATL ACAD SCI USA, V102, P2904, DOI 10.1073/pnas.0406867102; Qi SY, 2001, P NATL ACAD SCI USA, V98, P6548, DOI 10.1073/pnas.111536798; Roumier A, 2001, IMMUNITY, V15, P715, DOI 10.1016/S1074-7613(01)00225-4; Sloan-Lancaster J, 1998, J CELL BIOL, V143, P613, DOI 10.1083/jcb.143.3.613; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Tooley AJ, 2005, SEMIN IMMUNOL, V17, P65, DOI 10.1016/j.smim.2004.09.006; VALITUTTI S, 1993, EUR J IMMUNOL, V23, P790, DOI 10.1002/eji.1830230403; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Weikl TR, 2004, BIOPHYS J, V87, P3665, DOI 10.1529/biophysj.104.045609; Wiedemann A, 2006, P NATL ACAD SCI USA, V103, P10985, DOI 10.1073/pnas.0600651103; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Zaru R, 2002, J IMMUNOL, V168, P4287, DOI 10.4049/jimmunol.168.9.4287	38	36	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2008	3	12							e3913	10.1371/journal.pone.0003913	http://dx.doi.org/10.1371/journal.pone.0003913			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZU	19079546	gold, Green Submitted, Green Published			2022-12-25	WOS:000265455900005
J	Casteel, DE; Zhuang, SH; Zeng, Y; Perrino, FW; Boss, GR; Goulian, M; Pilz, RB				Casteel, Darren E.; Zhuang, Shunhui; Zeng, Ying; Perrino, Fred W.; Boss, Gerry R.; Goulian, Mehran; Pilz, Renate B.			A DNA Polymerase-alpha.Primase Cofactor with Homology to Replication Protein A-32 Regulates DNA Replication in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACCESSORY PROTEIN; ALPHA-PRIMASE; NUCLEAR ANTIGEN; BINDING DOMAIN; OB-FOLD; S-PHASE; A RPA; DAMAGE; CHECKPOINT; MECHANISM	alpha-Accessory factor (AAF) stimulates the activity of DNA polymerase-alpha-primase, the only enzyme known to initiate DNA replication in eukaryotic cells ( Goulian, M., Heard, C. J., and Grimm, S. L. (1990) J. Biol. Chem. 265, 13221-13230). We purified the AAF heterodimer composed of 44- and 132-kDa subunits from cultured cells and identified full-length cDNA clones using amino acid sequences from internal peptides. AAF-132 demonstrated no homologies to known proteins; AAF-44, however, is evolutionarily related to the 32-kDa subunit of replication protein A (RPA-32) and contains an oligonucleotide/oligosaccharide-binding (OB) fold domain similar to the OB fold domains of RPA involved in single-stranded DNA binding. Epitope-tagged versions of AAF-44 and -132 formed a complex in intact cells, and purified recombinant AAF-44 bound to single-stranded DNA and stimulated DNA primase activity only in the presence of AAF-132. Mutations in conserved residues within the OB fold of AAF-44 reduced DNA binding activity of the AAF-44.AAF-132 complex. Immunofluorescence staining of AAF-44 and AAF-132 in S phase-enriched HeLa cells demonstrated punctate nuclear staining, and AAF co-localized with proliferating cell nuclear antigen, a marker for replication foci containing DNA polymerase-alpha.primase and RPA. Small interfering RNA-mediated depletion of AAF-44 in tumor cell lines inhibited [methyl-H-3] thymidine uptake into DNA but did not affect cell viability. Weconclude that AAF shares structural and functional similarities with RPA-32 and regulates DNA replication, consistent with its ability to increase polymerase-alpha.primase template affinity and stimulate both DNA primase and polymerase-alpha activities in vitro.	[Casteel, Darren E.; Zhuang, Shunhui; Zeng, Ying; Boss, Gerry R.; Goulian, Mehran; Pilz, Renate B.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Casteel, Darren E.; Zhuang, Shunhui; Zeng, Ying; Boss, Gerry R.; Goulian, Mehran; Pilz, Renate B.] Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA; [Perrino, Fred W.] Wake Forest Univ, Dept Biochem, Ctr Canc, Winston Salem, NC 27157 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Wake Forest University	Pilz, RB (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	rpilz@ucsd.edu		Boss, Gerry/0000-0002-9758-8714	NATIONAL CANCER INSTITUTE [K22CA124517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051300] Funding Source: NIH RePORTER; NCI NIH HHS [K22-CA124517] Funding Source: Medline; NIAMS NIH HHS [R01-AR051300, R01 AR051300, R01 AR051300-10] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bastin-Shanower SA, 2001, J BIOL CHEM, V276, P36446, DOI 10.1074/jbc.M104386200; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bochkarev A, 2004, CURR OPIN STRUC BIOL, V14, P36, DOI 10.1016/j.sbi.2004.01.001; Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; Bochkarev A, 1999, EMBO J, V18, P4498, DOI 10.1093/emboj/18.16.4498; Bochkareva E, 2002, EMBO J, V21, P1855, DOI 10.1093/emboj/21.7.1855; Bochkareva E, 1998, J BIOL CHEM, V273, P3932, DOI 10.1074/jbc.273.7.3932; BRAVO R, 1987, J CELL BIOL, V105, P1549, DOI 10.1083/jcb.105.4.1549; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Casteel DE, 2002, J BIOL CHEM, V277, P32003, DOI 10.1074/jbc.M112332200; Chattopadhyay S, 2007, MOL BIOL CELL, V18, P4085, DOI 10.1091/mbc.E06-12-1148; Chen YC, 2003, MOL CELL BIOL, V23, P4066, DOI 10.1128/MCB.23.12.4066-4082.2003; Crouch E, 1997, MUTAT RES-FUND MOL M, V374, P109, DOI 10.1016/S0027-5107(96)00231-X; Dimitrova DS, 2002, J CELL SCI, V115, P4037, DOI 10.1242/jcs.00087; Dimitrova DS, 2000, EXP CELL RES, V254, P321, DOI 10.1006/excr.1999.4770; Dodson GE, 2004, J BIOL CHEM, V279, P34010, DOI 10.1074/jbc.C400242200; Fanning Ellen, 2006, V47, P627; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Feng DF, 1996, METHOD ENZYMOL, V266, P368; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Fuss J, 2002, J BIOL CHEM, V277, P8658, DOI 10.1074/jbc.M110615200; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; GOULIAN M, 1990, J BIOL CHEM, V265, P13231; GOULIAN M, 1990, J BIOL CHEM, V265, P13221; GOULIAN M, 1989, J BIOL CHEM, V264, P19407; Haring SJ, 2008, J BIOL CHEM, V283, P19095, DOI 10.1074/jbc.M800881200; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; HURWITZ J, 1990, J BIOL CHEM, V265, P18043; Jiang GC, 2006, MOL CELL BIOL, V26, P39, DOI 10.1128/MCB.26.1.39-49.2006; KIM CS, 1994, BIOCHEMISTRY-US, V33, P14197, DOI 10.1021/bi00251a031; Maga G, 2001, J BIOL CHEM, V276, P18235, DOI 10.1074/jbc.M009599200; Olson E, 2006, J BIOL CHEM, V281, P39517, DOI 10.1074/jbc.M605121200; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; PERRINO FW, 1992, J BIOL CHEM, V267, P23043; PERRINO FW, 1989, J BIOL CHEM, V264, P2898; Philimonenko AA, 2000, J STRUCT BIOL, V132, P201, DOI 10.1006/jsbi.2000.4326; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; Zeng Y, 2006, J BIOL CHEM, V281, P16951, DOI 10.1074/jbc.M602099200; Zhang T, 2007, J BIOL CHEM, V282, P33367, DOI 10.1074/jbc.M707186200; Zou Y, 2006, J CELL PHYSIOL, V208, P267, DOI 10.1002/jcp.20622	43	120	123	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5807	5818		10.1074/jbc.M807593200	http://dx.doi.org/10.1074/jbc.M807593200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19119139	Green Published, hybrid			2022-12-25	WOS:000263560600044
J	de Zoeten, EF; Lee, I; Wang, LQ; Chen, CX; Ge, GH; Wells, AD; Hancock, WW; Ozkaynak, E				de Zoeten, Edwin F.; Lee, Iris; Wang, Liqing; Chen, Chunxia; Ge, Guanghui; Wells, Andrew D.; Hancock, Wayne W.; Ozkaynak, Engin			Foxp3 Processing by Proprotein Convertases and Control of Regulatory T Cell Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER CHROMATIN; IMMUNE DYSREGULATION; CUTTING EDGE; HELPER-CELLS; ENTEROPATHY; PROTEIN; POLYENDOCRINOPATHY; EXPRESSION; RECEPTOR; IPEX	Foxp3 is a 47-kDa transcription factor central to regulatory Tcell (Treg) function. The importance of Foxp3(+) Tregs in controlling self-reactive T cells and preventing autoimmunity is well established. Our analysis of Foxp3 expression in natural Tregs led to identification of a shorter 41-kDa Foxp3 species in activated Tregs, indicating that Foxp3 may be processed by proteolytic cleavage upon cell activation. Searches of murine and human Foxp3 sequences for potential cleavage sites responsible for the generation of the short Foxp3 species revealed the presence of two RXXR proprotein convertase (PC) motifs, (RDLR51)-R-48 and (RKKR417)-R-414, located near the N- and C-terminal ends, respectively. We show, using retroviral expression of Foxp3 in CD4(+) T cells, that Foxp3 is cleaved at both the N- and C-terminal RXXR sites and that mutagenesis of the RXXR motif prevents cleavage. The cleaved forms of Foxp3 are found in the chromatin fraction but not in nuclear or cytoplasmic extracts. CD4(+) T cells expressing Foxp3 species engineered to mimic N- terminally, C-terminally, or N- and C-terminally cleaved Foxp3 forms are functionally distinct, as indicated by differences in expression of key Treg genes, such as interleukin-10 and cytotoxic T-lymphocyte antigen 4 (CTLA-4). In addition, CD4(+) cells expressing C-cleaved Foxp3 are superior to those that express WT Foxp3 in preventing experimental colitis. Coexpression of Foxp3 with PC1 or PC7 results in cleavage of the Foxp3 C terminus. The mechanism by which Foxp3 is processed likely extends to other members of the FoxP subfamily, because Foxp1 and Foxp2 also have N-terminal RXXR proteolytic cleavage motifs at similar locations to Foxp3. Our results indicate that the generation of fully functionally competent Tregs is complex and dependent on the generation of multiple forms of Foxp3 that have differing effects on Treg cytokine production and suppressive function.	[Lee, Iris; Wang, Liqing; Chen, Chunxia; Ge, Guanghui; Wells, Andrew D.; Hancock, Wayne W.; Ozkaynak, Engin] Childrens Hosp Philadelphia, Div Transplant Immunol, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [de Zoeten, Edwin F.] Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA; [Lee, Iris; Wang, Liqing; Chen, Chunxia; Ge, Guanghui; Wells, Andrew D.; Hancock, Wayne W.; Ozkaynak, Engin] Childrens Hosp Philadelphia, Biesecker Ctr Pediat Liver Dis, Philadelphia, PA 19104 USA; [Lee, Iris; Wang, Liqing; Chen, Chunxia; Ge, Guanghui; Wells, Andrew D.; Hancock, Wayne W.; Ozkaynak, Engin] Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Ozkaynak, E (corresponding author), Childrens Hosp Philadelphia, Div Transplantat Immunol Pathol & Lab Med, 916C ARC,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	ozkaynak@email.chop.edu		de Zoeten, Edwin/0000-0002-0946-9759	National Institutes of Health [AI54720]; Foerderer-Murray Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054720] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foerderer-Murray Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI54720 (to W.W.H.). This work was also supported by a Foerderer-Murray Award (to E.O.).	Allan SE, 2008, MOL THER, V16, P194, DOI 10.1038/sj.mt.6300341; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; BURTON K, 1956, BIOCHEM J, V62, P315, DOI 10.1042/bj0620315; Chen CX, 2006, J BIOL CHEM, V281, P36828, DOI 10.1074/jbc.M608848200; Constam DB, 1999, J CELL BIOL, V144, P139, DOI 10.1083/jcb.144.1.139; Dieckmann D, 2002, J EXP MED, V196, P247, DOI 10.1084/jem.20020642; Du JG, 2008, J IMMUNOL, V180, P4785, DOI 10.4049/jimmunol.180.7.4785; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gambineri E, 2003, CURR OPIN RHEUMATOL, V15, P430, DOI 10.1097/00002281-200307000-00010; GARRARD WT, 1974, BIOCHEM BIOPH RES CO, V58, P50, DOI 10.1016/0006-291X(74)90889-4; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Lee I, 2005, J EXP MED, V201, P1037, DOI 10.1084/jem.20041709; Lee SM, 2008, BLOOD, V111, P3599, DOI 10.1182/blood-2007-09-115014; Li B, 2007, INT IMMUNOL, V19, P825, DOI 10.1093/intimm/dxm043; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Munzer JS, 1997, J BIOL CHEM, V272, P19672, DOI 10.1074/jbc.272.32.19672; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Ostanin DV, 2006, AM J PHYSIOL-GASTR L, V290, pG109, DOI 10.1152/ajpgi.00214.2005; OZKAYNAK E, 1992, J BIOL CHEM, V267, P25220; PANYIM S, 1969, ARCH BIOCHEM BIOPHYS, V130, P337, DOI 10.1016/0003-9861(69)90042-3; PESU M, 2008, J NATURE, V455, P246; Remacle AG, 2008, J BIOL CHEM, V283, P20897, DOI 10.1074/jbc.M803762200; Roers A, 2004, J EXP MED, V200, P1289, DOI 10.1084/jem.20041789; RUSSEV G, 1974, EUR J BIOCHEM, V43, P253, DOI 10.1111/j.1432-1033.1974.tb03407.x; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Scamuffa N, 2006, FASEB J, V20, P1954, DOI 10.1096/fj.05-5491rev; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Seidah NG, 1996, P NATL ACAD SCI USA, V93, P3388, DOI 10.1073/pnas.93.8.3388; Stassen M, 2004, EUR J IMMUNOL, V34, P1303, DOI 10.1002/eji.200324656; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; VONDERDECKEN A, 1977, J NUTR, V107, P949, DOI 10.1093/jn/107.6.949; Wildin RS, 2002, J MED GENET, V39, P537, DOI 10.1136/jmg.39.8.537; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; YI Z, 1993, J BIOL CHEM, V268, P5615; Zhou A, 1999, J BIOL CHEM, V274, P20745, DOI 10.1074/jbc.274.30.20745; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	44	29	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5709	5716		10.1074/jbc.M807322200	http://dx.doi.org/10.1074/jbc.M807322200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19117830	hybrid, Green Published			2022-12-25	WOS:000263560600034
J	Jenkinson, ER; Costa, A; Leech, AP; Patwardhan, A; Onesti, S; Chong, JPJ				Jenkinson, Elizabeth R.; Costa, Alessandro; Leech, Andrew P.; Patwardhan, Ardan; Onesti, Silvia; Chong, James P. J.			Mutations in Subdomain B of the Minichromosome Maintenance (MCM) Helicase Affect DNA Binding and Modulate Conformational Transitions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHANOTHERMOBACTER-THERMAUTOTROPHICUS MCM; METHANOBACTERIUM-THERMOAUTOTROPHICUM MCM; SACCHAROMYCES-CEREVISIAE; PROTEIN COMPLEX; REPLICATION; POLYMORPHISM; MICROSCOPY; INITIATION; SYMMETRY; MOTIFS	Minichromosome maintenance (MCM) proteins are believed to provide the replicative helicase activity in eukaryotes and archaea. The single MCM orthologue from Methanothermobacter thermautotrophicus (MthMCM) has been extensively characterized as a model of the eukaryotic heterohexameric MCM complex. MthMCM forms high molecular weight complexes in solution consistent with a dodecamer. Visualization of this complex by electron microscopy suggests that single and double heptameric or hexameric rings can form. We have mutated two arginine residues (Arg-137, Arg-160) in the N-terminal subdomain B of MthMCM based on their apparent potential to form inter-ring hydrogen bonds. Both the single R137A and the double R137A, R160A mutants were characterized by a combination of biophysical, biochemical, and electron microscopy techniques. Biophysical analysis coupled with electron microscopy studies shows that the R137A mutant forms a double heptameric ring, whereas the R137A, R160A protein assembles as a single heptamer. They both show a defect in DNA binding and a concomitant conformational change in subdomain A, with the double mutant displaying significant defects in helicase activity as well. We propose a model in which MCM loading and the subsequent activation of the helicase activity involve a conformational transition that is connected to a DNA binding event.	[Jenkinson, Elizabeth R.; Chong, James P. J.] Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England; [Leech, Andrew P.] Univ York, Technol Facil, York YO10 5YW, N Yorkshire, England; [Costa, Alessandro; Patwardhan, Ardan; Onesti, Silvia] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England; [Onesti, Silvia] Sincrotrone Trieste, Elettra Synchrotron Light Lab, I-34012 Basovizza, TS, Italy	University of York - UK; University of York - UK; Imperial College London; Elettra Sincrotrone Trieste	Chong, JPJ (corresponding author), Univ York, Dept Biol, Area 5, POB 373, York YO10 5YW, N Yorkshire, England.	jpjc1@york.ac.uk	Chong, James/AAC-4957-2019	Onesti, Silvia/0000-0002-0612-7948; Jenkinson, Elizabeth/0000-0002-1826-7200; Patwardhan, Ardan/0000-0001-7663-9028; Chong, James/0000-0001-9447-7421	Biotechnology and Biological Sciences Research Council David Phillips Research Fellowship [86/AF/14817, BB/X510703/1]; University of York Innovation and Research Priming Funds; BBSRC [BB/F003099/1, BB/D525056/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F003099/1, BB/D525056/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council David Phillips Research Fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of York Innovation and Research Priming Funds; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Biotechnology and Biological Sciences Research Council David Phillips Research Fellowship (Refs 86/AF/14817 and BB/X510703/1) and University of York Innovation and Research Priming Funds ( to J.P.J.C.) and an Imperial College studentship ( to A. C.).	Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Carpentieri F, 2002, J BIOL CHEM, V277, P12118, DOI 10.1074/jbc.M200091200; Castella S, 2006, NUCLEIC ACIDS RES, V34, P3731, DOI 10.1093/nar/gkl554; Chen YJ, 2005, J MOL BIOL, V346, P389, DOI 10.1016/j.jmb.2004.11.076; Chong JPJ, 2005, NAT STRUCT MOL BIOL, V12, P734, DOI 10.1038/nsmb0905-734; Chong JPJ, 2000, P NATL ACAD SCI USA, V97, P1530, DOI 10.1073/pnas.030539597; Costa A, 2008, EMBO J, V27, P2250, DOI 10.1038/emboj.2008.135; Costa A, 2008, J MOL BIOL, V378, P273, DOI 10.1016/j.jmb.2008.02.054; Costa A, 2006, J STRUCT BIOL, V156, P210, DOI 10.1016/j.jsb.2006.04.001; Costa A, 2006, NUCLEIC ACIDS RES, V34, P5829, DOI 10.1093/nar/gkl708; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; DUBE P, 1993, EMBO J, V12, P1303, DOI 10.1002/j.1460-2075.1993.tb05775.x; Dutta A, 1997, ANNU REV CELL DEV BI, V13, P293, DOI 10.1146/annurev.cellbio.13.1.293; Edgell DR, 1997, CELL, V89, P995, DOI 10.1016/S0092-8674(00)80285-8; Fletcher RJ, 2005, J BIOL CHEM, V280, P42405, DOI 10.1074/jbc.M509773200; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Gomez-Llorente Y, 2005, J BIOL CHEM, V280, P40909, DOI 10.1074/jbc.M509760200; Grainge I, 2003, NUCLEIC ACIDS RES, V31, P4888, DOI 10.1093/nar/gkg662; Hoang ML, 2007, MOL CELL BIOL, V27, P7594, DOI 10.1128/MCB.00997-07; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Jenkinson ER, 2006, P NATL ACAD SCI USA, V103, P7613, DOI 10.1073/pnas.0509297103; Kasiviswanathan R, 2004, J BIOL CHEM, V279, P28358, DOI 10.1074/jbc.M403202200; Kelman Z, 1999, P NATL ACAD SCI USA, V96, P14783, DOI 10.1073/pnas.96.26.14783; KOONIN EV, 1993, NUCLEIC ACIDS RES, V21, P2541, DOI 10.1093/nar/21.11.2541; LI M, 1993, TRANSCRIPTION FACTOR, P181; LISZIEWICZ J, 1988, NUCLEIC ACIDS RES, V16, P11507, DOI 10.1093/nar/16.24.11507; McGeoch AT, 2005, NAT STRUCT MOL BIOL, V12, P756, DOI 10.1038/nsmb974; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Pape T, 2003, EMBO REP, V4, P1079, DOI 10.1038/sj.embor.7400010; Prokhorova TA, 2000, J BIOL CHEM, V275, P2491, DOI 10.1074/jbc.275.4.2491; ROARK DE, 1976, BIOPHYS CHEM, V5, P185, DOI 10.1016/0301-4622(76)80034-8; Sakakibara N, 2008, NUCLEIC ACIDS RES, V36, P1309, DOI 10.1093/nar/gkm1160; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shechter DF, 2000, J BIOL CHEM, V275, P15049, DOI 10.1074/jbc.M000398200; Shin JH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni009; SHIN JH, J BIOL CHEM, V284, P540; Stillman B, 1996, SCIENCE, V274, P1659, DOI 10.1126/science.274.5293.1659; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tye BK, 2000, P NATL ACAD SCI USA, V97, P2399, DOI 10.1073/pnas.97.6.2399; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Yu X, 2002, EMBO REP, V3, P792, DOI 10.1093/embo-reports/kvf160	41	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5654	5661		10.1074/jbc.M806973200	http://dx.doi.org/10.1074/jbc.M806973200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19116205	hybrid, Green Accepted			2022-12-25	WOS:000263560600029
J	Itahana, Y; Ke, HM; Zhang, YP				Itahana, Yoko; Ke, Hengming; Zhang, Yanping			p53 Oligomerization Is Essential for Its C-terminal Lysine Acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR EXPORT SIGNAL; TETRAMERIZATION DOMAIN; DNA-BINDING; TUMOR-SUPPRESSOR; LI-FRAUMENI; IN-VITRO; PROTEIN; ACTIVATION; PHOSPHORYLATION; DEGRADATION	Acetylation of multiple lysine residues in the p53 plays critical roles in the protein stability and transcriptional activity of p53. To better understand how p53 acetylation is regulated, we generated a number of p53 mutants and examined acetylation of each mutant in transfected cells. We found that p53 mutants that are defective in tetramer formation are also defective in C-terminal lysine residue acetylation. Consistently, we found that several cancer-derived p53 mutants that bear mutations in the tetramerization domain cannot form oligomers and are defective in C-terminal lysine acetylation, and these mutants are inactive in p21 transactivation. We demonstrated that the acetyltransferase p300 interacts with and promotes acetylation of wild-type p53 but not with any of the artificially generated or human cancer-derived p53 mutants that are defective in oligomerization. These results, combined with a computer-aided crystal structure analysis, suggest a model in which p53 oligomerization precedes its acetylation by providing docking sites for acetyltransferases.	[Zhang, Yanping] Univ N Carolina, Sch Med, Dept Radiat Oncol, Chapel Hill, NC 27599 USA; [Itahana, Yoko; Ke, Hengming; Zhang, Yanping] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Zhang, Yanping] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Ke, Hengming] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Zhang, YP (corresponding author), Univ N Carolina, Sch Med, Dept Radiat Oncol, Chapel Hill, NC 27599 USA.	ypzhang@med.unc.edu	, PEP-MX Core/AGV-4051-2022		National Institutes of Health; American Cancer Society; NATIONAL CANCER INSTITUTE [R01CA127770, R01CA100302] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by a National Institutes of Health grant. This work was also supported by a grant from the American Cancer Society (to Y. Z.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; Azran I, 2005, ONCOGENE, V24, P4521, DOI 10.1038/sj.onc.1208645; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; Chen YH, 2007, EXP PHYSIOL, V92, P99, DOI 10.1113/expphysiol.2006.036079; CLORE GM, 1994, SCIENCE, V265, P386, DOI 10.1126/science.8023159; Grossman SR, 1998, MOL CELL, V2, P405, DOI 10.1016/S1097-2765(00)80140-9; Gu W, 1997, NATURE, V387, P819, DOI 10.1038/42972; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; JEFFREY PD, 1995, SCIENCE, V267, P1498, DOI 10.1126/science.7878469; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; Li AG, 2006, MOL CELL, V23, P575, DOI 10.1016/j.molcel.2006.06.028; Liang SH, 1999, J BIOL CHEM, V274, P32699, DOI 10.1074/jbc.274.46.32699; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; Liu L, 1999, MOL CELL BIOL, V19, P1202; Livengood JA, 2002, J BIOL CHEM, V277, P9054, DOI 10.1074/jbc.M108870200; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Mateu MG, 1999, NAT STRUCT BIOL, V6, P191; Nakamura S, 2000, MOL CELL BIOL, V20, P9391, DOI 10.1128/MCB.20.24.9391-9398.2000; O'Keefe K, 2003, MOL CELL BIOL, V23, P6396, DOI 10.1128/MCB.23.18.6396-6405.2003; Olivier M, 2003, CANCER RES, V63, P6643; PIETENPOL JA, 1994, P NATL ACAD SCI USA, V91, P1998, DOI 10.1073/pnas.91.6.1998; Poon GMK, 2007, J MOL BIOL, V365, P1217, DOI 10.1016/j.jmb.2006.10.051; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Sakaguchi K, 1997, BIOCHEMISTRY-US, V36, P10117, DOI 10.1021/bi970759w; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Teufel DP, 2007, P NATL ACAD SCI USA, V104, P7009, DOI 10.1073/pnas.0702010104; Van Orden K, 1999, J BIOL CHEM, V274, P26321, DOI 10.1074/jbc.274.37.26321; Varley JM, 1996, ONCOGENE, V12, P2437; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wadgaonkar R, 1999, J BIOL CHEM, V274, P13760, DOI 10.1074/jbc.274.20.13760; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Zhang YP, 2001, SCIENCE, V292, P1910, DOI 10.1126/science.1058637	38	55	54	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5158	5164		10.1074/jbc.M805696200	http://dx.doi.org/10.1074/jbc.M805696200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19106109	Green Published, hybrid			2022-12-25	WOS:000263416600046
J	Mangialavori, I; Giraldo, AMV; Buslje, CM; Gomes, MF; Caride, AJ; Rossi, JPFC				Mangialavori, Irene; Giraldo, Ana Maria Villamil; Buslje, Cristina Marino; Gomes, Mariela Ferreira; Caride, Ariel J.; Rossi, Juan Pablo F. C.			A New Conformation in Sarcoplasmic Reticulum Calcium Pump and Plasma Membrane Ca2+ Pumps Revealed by a Photoactivatable Phospholipidic Probe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; MONOCLONAL-ANTIBODIES; CALMODULIN; ACTIVATION; TRANSPORT; PEPTIDE; REGION; CA-2; ATP	The purpose of this work was to obtain structural information about conformational changes in the membrane region of the sarcoplasmic reticulum (SERCA) and plasma membrane (PMCA) Ca2+ pumps. We have assessed changes in the overall exposure of these proteins to surrounding lipids by quantifying the extent of protein labeling by a photoactivatable phosphatidylcholine analog 1-palmitoyl-2-[9-[2'-[I-125] iodo-4'-(trifluoromethyldiazirinyl)benzyloxycarbonyl]-nonaoyl]-sn-glycero-3-phosphocholine ([I-125] TID-PC/16) under different conditions. We determined the following. 1) Incorporation of [I-125] TID-PC/16 to SERCA decreases 25% when labeling is performed in the presence of Ca2+. This decrease in labeling matches qualitatively the decrease in transmembrane surface exposed to the solvent calculated from crystallographic data for SERCA structures. 2) Labeling of PMCA incubated with Ca2+ and calmodulin decreases by approximately the same amount. However, incubation with Ca2+ alone increases labeling by more than 50%. Addition of C28, a peptide that prevents activation of PMCAby calmodulin, yields similar results. C28 has also been shown to inhibit ATPase SERCA activity. Interestingly, incubation of SERCA with C28 also increases [I-125] TID-PC/16 incorporation to the protein. These results suggest that in both proteins there are two different E-1 conformations as follows: one that is auto-inhibited and is in contact with a higher amount of lipids (Ca2+ + C28 for SERCA and Ca2+ alone for PMCA), and one in which the enzyme is fully active (Ca2+ for SERCA and Ca2+-calmodulin for PMCA) and that exhibits a more compact transmembrane arrangement. These results are the first evidence that there is an autoinhibited conformation in these P-type ATPases, which involves both the cytoplasmic regions and the transmembrane segments.	[Mangialavori, Irene; Giraldo, Ana Maria Villamil; Buslje, Cristina Marino; Gomes, Mariela Ferreira; Rossi, Juan Pablo F. C.] Univ Buenos Aires, Fac Farm & Bioquim, CONICET, Inst Quim & Fisicoquim Biol, RA-1113 Buenos Aires, DF, Argentina; [Caride, Ariel J.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Mayo Clinic	Rossi, JPFC (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, CONICET, Inst Quim & Fisicoquim Biol, Junin 956, RA-1113 Buenos Aires, DF, Argentina.	jprossi@mail.retina.ar	Marino-Buslje, Cristina/J-7438-2019	Marino-Buslje, Cristina/0000-0002-6564-1920; Rossi, Juan Pablo/0000-0001-7087-844X; Mangialavori, Irene/0000-0003-3187-3130	Fogarty International Center [R03TW006837]; Agencia Nacional de Promocion Cientifica y Tecnologica; Consejo Nacional de Investigaciones Cientificas y Tecnicas; Universidad de Buenos Aires Ciencia y Tecnica from Argentina; FOGARTY INTERNATIONAL CENTER [R03TW006837] Funding Source: NIH RePORTER	Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires Ciencia y Tecnica from Argentina(University of Buenos Aires); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported, in whole or in part, by a National Institutes of Health grant. This work was also supported by Fogarty International Center Grant R03TW006837 and by Agencia Nacional de Promocion Cientifica y Tecnologica, Consejo Nacional de Investigaciones Cientificas y Tecnicas, and Universidad de Buenos Aires Ciencia y Tecnica from Argentina. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement"	ADAMO HP, 1992, J BIOL CHEM, V267, P14244; ANDERSEN JP, 1985, J BIOL CHEM, V260, P371; BALL EH, 1986, ANAL BIOCHEM, V155, P23, DOI 10.1016/0003-2697(86)90218-6; BRUNNER J, 1981, BIOCHEMISTRY-US, V20, P7174, DOI 10.1021/bi00528a019; BRUNNER J, 1993, ANNU REV BIOCHEM, V62, P483, DOI 10.1146/annurev.bi.62.070193.002411; Caride AJ, 1996, BIOCHEM J, V316, P353, DOI 10.1042/bj3160353; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Corradi GR, 2007, J BIOL CHEM, V282, P35440, DOI 10.1074/jbc.M703377200; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; Durrer P, 1996, J BIOL CHEM, V271, P13417, DOI 10.1074/jbc.271.23.13417; ENYEDI A, 1993, J BIOL CHEM, V268, P17120; Filomatori CV, 2003, J BIOL CHEM, V278, P22265, DOI 10.1074/jbc.M302657200; Filoteo AG, 1997, J BIOL CHEM, V272, P23741, DOI 10.1074/jbc.272.38.23741; FILOTEO AG, 1992, J BIOL CHEM, V267, P11800; Fiske C. H., 1925, J BIOL CHEM, V179, P66; Giraldo AMM, 2006, CELL BIOCHEM BIOPHYS, V44, P431, DOI 10.1385/CBB:44:3:431; Giraldo AMV, 2006, FEBS LETT, V580, P607, DOI 10.1016/j.febslet.2005.12.078; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LAURIERE M, 1993, ANAL BIOCHEM, V212, P206, DOI 10.1006/abio.1993.1313; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; LUTERBACHER S, 1983, EXPERIENTIA, V39, P311, DOI 10.1007/BF01955322; LYTTON J, 1992, J BIOL CHEM, V267, P14483; Marsh D, 1998, BBA-REV BIOMEMBRANES, V1376, P267, DOI 10.1016/S0304-4157(98)00009-4; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; Penheiter AR, 2005, BIOCHEMISTRY-US, V44, P2009, DOI 10.1021/bi0488552; ROSSI JPFC, 1981, BIOCHIM BIOPHYS ACTA, V648, P145, DOI 10.1016/0005-2736(81)90029-8; SARKADI B, 1986, J BIOL CHEM, V261, P9552; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Takahashi M, 2007, P NATL ACAD SCI USA, V104, P5800, DOI 10.1073/pnas.0700979104; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; WEBER T, 1995, J AM CHEM SOC, V117, P3084, DOI 10.1021/ja00116a013; Ye YZ, 2005, BIOINFORMATICS, V21, P2362, DOI 10.1093/bioinformatics/bti353	36	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4823	4828		10.1074/jbc.M806912200	http://dx.doi.org/10.1074/jbc.M806912200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19074772	hybrid, Green Published			2022-12-25	WOS:000263416600010
J	Voevodskaya, N; Lendzian, F; Sanganas, O; Grundmeier, A; Graslund, A; Haumann, M				Voevodskaya, Nina; Lendzian, Friedhelm; Sanganas, Oliver; Grundmeier, Alexander; Graslund, Astrid; Haumann, Michael			Redox Intermediates of the Mn-Fe Site in Subunit R2 of Chlamydia trachomatis Ribonucleotide Reductase AN X-RAY ABSORPTION AND EPR STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN-EVOLVING COMPLEX; PHOTOSYNTHETIC WATER-OXIDATION; BIOLOGICAL METAL CENTERS; II-MANGANESE COMPLEX; VALENCE SUM ANALYSIS; LIGAND BOND LENGTHS; ESCHERICHIA-COLI; PHOTOSYSTEM-II; PROTEIN R2; METHANE MONOOXYGENASE	The R2 protein of class I ribonucleotide reductase (RNR) from Chlamydia trachomatis (Ct) can contain a Mn-Fe instead of the standard Fe-Fe cofactor. Ct R2 has a redox-inert phenylalanine replacing the radical-forming tyrosine of classic RNRs, which implies a different mechanism of O-2 activation. We studied the Mn-Fe site by x-ray absorption spectroscopy (XAS) and EPR. Reduced R2 in the R1R2 complex (R2(red)) showed an isotropic six-line EPR signal at g similar to 2 of the Mn(II)Fe(II) state. In oxidized R2 (R2(ox)), the Mn(III)Fe(III) state exhibited EPR g values of 2.013, 2.009, and 2.015. By XAS, Mn-Fe distances and oxidation states of intermediates were determined and assigned as follows: similar to 4.15 angstrom, Mn(II)Fe(II); similar to 3.25 angstrom, Mn(III)Fe(II); similar to 2.90 angstrom, Mn(III)Fe(III); and similar to 2.75 angstrom, Mn(IV)Fe(III). Shortening of the Mn/Fe-ligand bond lengths indicated formation of additional metal bridges, i.e. mu O(H) and/or peroxidic species, upon O-2 activation at the site. The structural parameters suggest overall configurations of the Mn-Fe site similar to those of homo-metallic sites in other R2 proteins. However, the similar to 2.90 angstrom and similar to 2.75 angstrom Mn-Fe distances, typical for di-mu O(H) metal bridging, are shorter than inter-metal distances in any R2 crystal structure. In diffraction data collection, such bridges may be lost due to rapid x-ray photoreduction of high-valent metal ions, as demonstrated here for Fe(III) by XAS.	[Sanganas, Oliver; Grundmeier, Alexander; Haumann, Michael] Free Univ Berlin, Inst Expt Phys, D-14195 Berlin, Germany; [Voevodskaya, Nina; Graslund, Astrid] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; [Lendzian, Friedhelm] Tech Univ Berlin, Max Volmer Inst, D-10623 Berlin, Germany	Free University of Berlin; Stockholm University; Technical University of Berlin	Haumann, M (corresponding author), Free Univ Berlin, Inst Expt Phys, Arnimallee 14, D-14195 Berlin, Germany.	michael.haumann@fu-berlin.de	MIchael, Haumann/A-7087-2013		Deutsche Forschungsgemeinschaft [SFB498-C8, SFB498-C9]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by Deutsche Forschungsgemeinschaft Grants SFB498-C8 (to M. H.) and SFB498-C9 (to F. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adrait A, 2002, BIOCHEMISTRY-US, V41, P6510, DOI 10.1021/bi012043d; ATTA M, 1992, J BIOL CHEM, V267, P20682; Baldwin J, 2003, BIOCHEMISTRY-US, V42, P13269, DOI 10.1021/bi035198p; Baldwin MJ, 1999, INORG CHEM, V38, P4801, DOI 10.1021/ic990346e; Barra M, 2006, BIOCHEMISTRY-US, V45, P14523, DOI 10.1021/bi061842z; Bennati M, 2005, BIOL CHEM, V386, P1007, DOI 10.1515/BC.2005.117; Boelrijk AEM, 2000, INORG CHEM, V39, P3009, DOI 10.1021/ic9911769; Brunold TC, 2007, P NATL ACAD SCI USA, V104, P20641, DOI 10.1073/pnas.0710734105; Buhrke T, 2005, J BIOL CHEM, V280, P19488, DOI 10.1074/jbc.M500601200; BUNKER G, 1987, BIOCHEMISTRY-US, V26, P4708, DOI 10.1021/bi00389a017; Cerqueira NMFSA, 2007, RECENT PAT ANTI-CANC, V2, P11; Dau H, 2003, ANAL BIOANAL CHEM, V376, P562, DOI 10.1007/s00216-003-1982-2; Dau H, 2004, PHYS CHEM CHEM PHYS, V6, P4781, DOI 10.1039/b408146c; Dau H, 2008, COORDIN CHEM REV, V252, P273, DOI 10.1016/j.ccr.2007.09.001; Dau H, 2005, PHYS SCRIPTA, VT115, P844; Davydov RM, 1997, BIOCHEMISTRY-US, V36, P9093, DOI 10.1021/bi9700375; Eklund H, 2001, PROG BIOPHYS MOL BIO, V77, P177, DOI 10.1016/S0079-6107(01)00014-1; GEREZ C, 1992, BIOCHEMISTRY-US, V31, P780, DOI 10.1021/bi00118a020; Grabolle M, 2006, J BIOL CHEM, V281, P4580, DOI 10.1074/jbc.M509724200; Graslund A, 1996, ANNU REV BIOPH BIOM, V25, P259; Han WG, 2006, J INORG BIOCHEM, V100, P771, DOI 10.1016/j.jinorgbio.2006.01.032; Han WG, 2005, J AM CHEM SOC, V127, P15778, DOI 10.1021/ja050904q; Haumann M, 2005, SCIENCE, V310, P1019, DOI 10.1126/science.1117551; Haumann M, 2005, BIOCHEMISTRY-US, V44, P1894, DOI 10.1021/bi048697e; Herrick J, 2007, MOL MICROBIOL, V63, P22, DOI 10.1111/j.1365-2958.2006.05493.x; Hogbom M, 2004, SCIENCE, V305, P245, DOI 10.1126/science.1098419; Hogbom M, 2002, BIOCHEMISTRY-US, V41, P1381, DOI 10.1021/bi011429l; Iuzzolino L, 1998, BIOCHEMISTRY-US, V37, P17112, DOI 10.1021/bi9817360; Jiang W, 2008, BIOCHEMISTRY-US, V47, P8477, DOI 10.1021/bi800881m; Jiang W, 2008, BIOCHEMISTRY-US, V47, P4477, DOI 10.1021/bi702085z; Jiang W, 2007, BIOCHEMISTRY-US, V46, P8709, DOI 10.1021/bi700906g; Jiang W, 2007, J AM CHEM SOC, V129, P7504, DOI 10.1021/ja072528a; Jiang W, 2007, SCIENCE, V316, P1188, DOI 10.1126/science.1141179; Joo M S, 1990, Biol Met, V3, P171, DOI 10.1007/BF01140575; Klockenkamper R., 1996, TOTAL REFLECTION XRA; Kolberg M, 2004, BBA-PROTEINS PROTEOM, V1699, P1, DOI 10.1016/j.bbapap.2004.02.007; Krebs C, 2007, BIOCHEMISTRY-US, V46, P10413, DOI 10.1021/bi701060g; Lange SJ, 1998, CURR OPIN CHEM BIOL, V2, P159, DOI 10.1016/S1367-5931(98)80057-4; LARSSON A, 1986, EMBO J, V5, P2037, DOI 10.1002/j.1460-2075.1986.tb04461.x; Licht S, 1996, SCIENCE, V271, P477, DOI 10.1126/science.271.5248.477; Lieberman RL, 2006, INORG CHEM, V45, P8372, DOI 10.1021/ic060739v; Liu A, 1998, BIOCHEM BIOPH RES CO, V246, P740, DOI 10.1006/bbrc.1998.8701; LIU WT, 1993, INORG CHEM, V32, P4102, DOI 10.1021/ic00071a023; Logan DT, 1996, STRUCTURE, V4, P1053, DOI 10.1016/S0969-2126(96)00112-8; Loscher S, 2007, INORG CHEM, V46, P11094, DOI 10.1021/ic701255p; Magnuson A, 2006, J INORG BIOCHEM, V100, P1234, DOI 10.1016/j.jinorgbio.2006.02.001; MAO SS, 1992, BIOCHEMISTRY-US, V31, P9733, DOI 10.1021/bi00155a029; Meinke C, 2000, BIOCHEMISTRY-US, V39, P7033, DOI 10.1021/bi9924258; Mitic N, 2007, J AM CHEM SOC, V129, P9049, DOI 10.1021/ja070909i; Mooney RCL, 1931, PHYS REV, V37, P1306, DOI 10.1103/PhysRev.37.1306; NORDLUND P, 1993, J MOL BIOL, V232, P123, DOI 10.1006/jmbi.1993.1374; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; PECORARO VL, 1992, MANGANESE REDOX ENZY, P197; Penner-Hahn JE, 1999, METAL SITES PROTEINS, P1; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; Reece SY, 2006, PHILOS T R SOC B, V361, P1351, DOI 10.1098/rstb.2006.1874; Riggs-Gelasco PJ, 2004, J AM CHEM SOC, V126, P8108, DOI 10.1021/ja048255q; Roshick C, 2000, J BIOL CHEM, V275, P38111, DOI 10.1074/jbc.M006367200; Rudd DJ, 2004, INORG CHEM, V43, P4579, DOI 10.1021/ic049716b; Saleh L, 2004, BIOCHEMISTRY-US, V43, P5953, DOI 10.1021/bi036099e; Schenk G, 2001, J BIOL CHEM, V276, P19084, DOI 10.1074/jbc.M009778200; Scott R.A, 2000, PHYS METHODS BIOINOR, P465; Shao J, 2006, CURR CANCER DRUG TAR, V6, P409, DOI 10.2174/156800906777723949; Shu LJ, 1997, SCIENCE, V275, P515, DOI 10.1126/science.275.5299.515; Sommerhalter M, 2005, INORG CHEM, V44, P770, DOI 10.1021/ic0485256; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; STESMANS A, 1989, REV SCI INSTRUM, V60, P2949, DOI 10.1063/1.1140633; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Stubbe J, 1998, TRENDS BIOCHEM SCI, V23, P438, DOI 10.1016/S0968-0004(98)01296-1; THORP HH, 1992, INORG CHEM, V31, P1585, DOI 10.1021/ic00035a012; Tong W, 1998, BIOCHEMISTRY-US, V37, P5840, DOI 10.1021/bi9728811; Torrents E, 2002, J MOL EVOL, V55, P138, DOI 10.1007/s00239-002-2311-7; Visser H, 2001, J AM CHEM SOC, V123, P7031, DOI 10.1021/ja004306h; Voevodskaya N, 2006, P NATL ACAD SCI USA, V103, P9850, DOI 10.1073/pnas.0600603103; Voevodskaya N, 2007, BBA-PROTEINS PROTEOM, V1774, P1254, DOI 10.1016/j.bbapap.2007.07.001; Voevodskaya N, 2007, FEBS LETT, V581, P3351, DOI 10.1016/j.febslet.2007.06.023; Weng TC, 2004, J AM CHEM SOC, V126, P8070, DOI 10.1021/ja0494104; Westre TE, 1997, J AM CHEM SOC, V119, P6297, DOI 10.1021/ja964352a; Yano J, 2005, P NATL ACAD SCI USA, V102, P12047, DOI 10.1073/pnas.0505207102; Younker JM, 2008, J AM CHEM SOC, V130, P15022, DOI 10.1021/ja804365e; ZABINSKY SI, 1995, PHYS REV B, V52, P2995, DOI 10.1103/PhysRevB.52.2995; Zein S, 2008, INORG CHEM, V47, P134, DOI 10.1021/ic701293n	82	23	23	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4555	4566		10.1074/jbc.M807190200	http://dx.doi.org/10.1074/jbc.M807190200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19095645	hybrid			2022-12-25	WOS:000263134400056
J	Jang, S; Ohtani, K; Fukuoh, A; Yoshizaki, T; Fukuda, M; Motomura, W; Mori, K; Fukuzawa, J; Kitamoto, N; Yoshida, I; Suzuki, Y; Wakamiya, N				Jang, SeongJae; Ohtani, Katsuki; Fukuoh, Atsushi; Yoshizaki, Takayuki; Fukuda, Mitsuko; Motomura, Wataru; Mori, Kenichiro; Fukuzawa, Jun; Kitamoto, Noritoshi; Yoshida, Itsuro; Suzuki, Yasuhiko; Wakamiya, Nobutaka			Scavenger Receptor Collectin Placenta 1 (CL-P1) Predominantly Mediates Zymosan Phagocytosis by Human Vascular Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN BINDING; NITRIC-OXIDE SYNTHASE; C-TYPE LECTIN; BETA-GLUCAN; IN-VITRO; PHOSPHOINOSITIDE 3-KINASE; EXPRESSION CLONING; CLASS-B; MACROPHAGES; DECTIN-1	Collectin placenta 1 (CL-P1), a recently discovered scavenger receptor, mediates the uptake of oxidized low density lipoprotein and microbes. In this study, we investigated CL-P1-mediated binding and ingestion of yeast-derived zymosan bioparticles using Chinese hamster ovary (CHO) cells stably expressing human CL-P1 (CHO/CL-P1) and human vascular endothelial cells constitutively expressed CL-P1. The uptake of zymosan by CHO/CL-P1 was dependent upon the level of CL-P1 expressed on the membrane and was inhibited by cytochalasin D and wortmannin. The binding of zymosan was also inhibited by ligands of other scavenger receptors such as poly(I) and dextran sulfate. Real time reverse transcription-PCR analyses showed that other scavenger receptors, namely LOX-1, Stabilin-2, or macrophage receptor with collagenous structure (MARCO), were not expressed in human umbilical vein endothelial cells isolated from different individuals. Nonopsonic zymosan ingestion was inhibited in three primary cultured vascular endothelial cells, including different human umbilical vein endothelial cells from nine individuals treated with CL-P1 small interfering RNAs, although small interfering RNAs of other scavenger receptors had no effect on zymosan uptake in these cells. Furthermore, we confirmed that CL-P1 is expressed in human and murine vascular endothelial layers. Our results demonstrated that CL-P1 predominantly mediated phagocytosis for fungi in vascular endothelia.	[Jang, SeongJae; Ohtani, Katsuki; Fukuoh, Atsushi; Yoshizaki, Takayuki; Fukuda, Mitsuko; Motomura, Wataru; Mori, Kenichiro; Fukuzawa, Jun; Yoshida, Itsuro; Wakamiya, Nobutaka] Asahikawa Med Coll, Dept Microbiol & Immunochem, Asahikawa, Hokkaido 0788510, Japan; [Kitamoto, Noritoshi] Univ Hyogo, Sch Human Sci & Environm, Dept Microbiol, Himeji, Hyogo 6700092, Japan; [Suzuki, Yasuhiko] Hokkaido Univ, Res Ctr Zoonosis Control, Dept Global Epidemiol, Sapporo, Hokkaido 0600818, Japan	Asahikawa Medical College; University of Hyogo; Hokkaido University	Wakamiya, N (corresponding author), Asahikawa Med Coll, Dept Microbiol & Immunochem, 2-1-1-1 Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan.	wakamiya@asahikawa-med.ac.jp	Suzuki, Yasuhiko/F-6890-2012; Jang, Seongjae/AAV-5628-2021	Jang, SeongJae/0000-0001-8116-2279	Ministry of Education, Culture, Sports, Science, and Technology [16390161, 19390227]; Japan Society for the Promotion of Sciences; Japan Health Sciences Foundation [KH21011]; Fuso Pharmaceutical Industry, Co.; Fugaku Trust for Medical Research; Smoking Research Foundation; Akiyama Foundation; Hokkaido Heart Association; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Health Sciences Foundation; Fuso Pharmaceutical Industry, Co.; Fugaku Trust for Medical Research; Smoking Research Foundation; Akiyama Foundation; Hokkaido Heart Association; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by Grants-in-aid for Scientific Research 16390161 and 19390227, National Project "Knowledge Cluster Initiative" (2nd Stage, "Sapporo Biocluster Bio-S") from the Ministry of Education, Culture, Sports, Science, and Technology, by a grant from Core Research for Evolution Science and Technology of the Japan Society for the Promotion of Sciences, by the Japan Health Sciences Foundation KH21011, grants from Fuso Pharmaceutical Industry, Co., the Fugaku Trust for Medical Research, the Smoking Research Foundation, the Akiyama Foundation, Hokkaido Heart Association Grants for Research, and the Takeda Science Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ACTON SL, 1994, J BIOL CHEM, V269, P21003; Adachi H, 1997, J BIOL CHEM, V272, P31217, DOI 10.1074/jbc.272.50.31217; Adachi H, 2002, J BIOL CHEM, V277, P34264, DOI 10.1074/jbc.M204277200; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; BONDESON J, 1999, J IMMUNOL, V236, P404; BROWN EJ, 1995, BIOESSAYS, V17, P109, DOI 10.1002/bies.950170206; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Chimini G, 2000, NAT CELL BIOL, V2, pE191, DOI 10.1038/35036454; Coombs PJ, 2005, J BIOL CHEM, V280, P22993, DOI 10.1074/jbc.M504197200; Cox D, 1999, J BIOL CHEM, V274, P1240, DOI 10.1074/jbc.274.3.1240; Estrada A, 1997, MICROBIOL IMMUNOL, V41, P991, DOI 10.1111/j.1348-0421.1997.tb01959.x; Feinberg H, 2007, J BIOL CHEM, V282, P17250, DOI 10.1074/jbc.M701624200; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; GASPARI AA, 1988, J IMMUNOL, V141, P2216; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; Greaves DR, 1998, CURR OPIN LIPIDOL, V9, P425, DOI 10.1097/00041433-199810000-00006; HUGHES CCW, 1990, J EXP MED, V171, P1453, DOI 10.1084/jem.171.5.1453; KODAMA T, 1990, NATURE, V343, P531, DOI 10.1038/343531a0; KOYAMA S, 2005, GLYCOCONJ J, V22, P281; Langeggen H, 2003, FEMS IMMUNOL MED MIC, V36, P55, DOI 10.1016/S0928-8244(03)00033-6; Leverrier Y, 2003, J BIOL CHEM, V278, P38437, DOI 10.1074/jbc.M306649200; Li XA, 2002, J BIOL CHEM, V277, P11058, DOI 10.1074/jbc.M110985200; Murphy JE, 2005, ATHEROSCLEROSIS, V182, P1, DOI 10.1016/j.atherosclerosis.2005.03.036; Ohtani K, 2001, J BIOL CHEM, V276, P44222, DOI 10.1074/jbc.M103942200; Sawamura T, 1997, NATURE, V386, P73, DOI 10.1038/386073a0; Suzuki H, 1997, J Atheroscler Thromb, V4, P1; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P89, DOI 10.1016/S0962-8924(00)88956-4; Tjelle TE, 2000, BIOESSAYS, V22, P255, DOI 10.1002/(SICI)1521-1878(200003)22:3<255::AID-BIES7>3.0.CO;2-R; Tse SML, 2003, J BIOL CHEM, V278, P3331, DOI 10.1074/jbc.M207966200; Underhill DM, 2002, CURR OPIN IMMUNOL, V14, P103, DOI 10.1016/S0952-7915(01)00304-1; Vestweber D, 1999, PHYSIOL REV, V79, P181, DOI 10.1152/physrev.1999.79.1.181; WAGNER CR, 1985, HUM IMMUNOL, V13, P33, DOI 10.1016/0198-8859(85)90025-4; WARRENS AN, 1994, INT IMMUNOL, V6, P847, DOI 10.1093/intimm/6.6.847; Yoshida T, 2003, J BIOCHEM, V133, P271, DOI 10.1093/jb/mvg037; Yuhanna IS, 2001, NAT MED, V7, P853, DOI 10.1038/89986; Yun CH, 2003, FEMS IMMUNOL MED MIC, V35, P67, DOI 10.1016/S0928-8244(02)00460-1	38	48	48	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3956	3965		10.1074/jbc.M807477200	http://dx.doi.org/10.1074/jbc.M807477200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19073604	Green Submitted, hybrid			2022-12-25	WOS:000262872500064
J	Grandison, RC; Wong, R; Bass, TM; Partridge, L; Piper, MDW				Grandison, Richard C.; Wong, Richard; Bass, Timothy M.; Partridge, Linda; Piper, Matthew D. W.			Effect of a Standardised Dietary Restriction Protocol on Multiple Laboratory Strains of Drosophila melanogaster	PLOS ONE			English	Article							LIFE-SPAN; CALORIC RESTRICTION; HISTORY; SENESCENCE; LONGEVITY; SELECTION; REPRODUCTION; WOLBACHIA; EVOLUTION; GENOTYPE	Background: Outcomes of lifespan studies in model organisms are particularly susceptible to variations in technical procedures. This is especially true of dietary restriction, which is implemented in many different ways among laboratories. Principal Findings: In this study, we have examined the effect of laboratory stock maintenance, genotype differences and microbial infection on the ability of dietary restriction (DR) to extend life in the fruit fly Drosophila melanogaster. None of these factors block the DR effect. Conclusions: These data lend support to the idea that nutrient restriction genuinely extends lifespan in flies, and that any mechanistic discoveries made with this model are of potential relevance to the determinants of lifespan in other organisms.	[Grandison, Richard C.; Wong, Richard; Bass, Timothy M.; Partridge, Linda; Piper, Matthew D. W.] UCL, UCL Inst Hlth Ageing, Dept Genet Evolut & Environm, London, England	University of London; University College London	Grandison, RC (corresponding author), UCL, UCL Inst Hlth Ageing, Dept Genet Evolut & Environm, London, England.	l.partridge@ucl.ac.uk	Partridge, Linda/A-5501-2010; Partridge, Linda/E-7342-2015; Wong, Richard/H-5189-2015; Piper, Matthew/C-1714-2008	Wong, Richard/0000-0002-4382-1568; Piper, Matthew/0000-0003-3245-7219; Partridge, Linda/0000-0001-9615-0094; Grandison, Richard/0000-0002-4552-0494	Wellcome Trust Strategic Award; Medical Research Council; Research into Ageing; Biotechnology and Biological Science Research Council	Wellcome Trust Strategic Award(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Research into Ageing; Biotechnology and Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Wellcome Trust Strategic Award (MP and LP); Medical Research Council (RW); Research into Ageing (RG); and the Biotechnology and Biological Science Research Council (TB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anson RM, 2005, AGE, V27, P17, DOI 10.1007/s11357-005-3286-2; Bass TM, 2007, J GERONTOL A-BIOL, V62, P1071, DOI 10.1093/gerona/62.10.1071; Carey JR, 2002, AGING CELL, V1, P140, DOI 10.1046/j.1474-9728.2002.00019.x; CHIPPINDALE AK, 1993, J EVOLUTION BIOL, V6, P171, DOI 10.1046/j.1420-9101.1993.6020171.x; Clancy David J., 2001, Drosophila Information Service, V84, P168; Clancy DJ, 2002, SCIENCE, V296, P319, DOI 10.1126/science.1069366; Cooper TM, 2004, FASEB J, V18, P1591, DOI 10.1096/fj.03-1464fje; Forster MJ, 2003, FASEB J, V17, P690, DOI 10.1096/fj.02-0533fje; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Giannakou ME, 2008, AGING CELL, V7, P187, DOI 10.1111/j.1474-9726.2007.00362.x; GOODRICK CL, 1990, MECH AGEING DEV, V55, P69, DOI 10.1016/0047-6374(90)90107-Q; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; Harper JM, 2006, AGING CELL, V5, P441, DOI 10.1111/j.1474-9726.2006.00236.x; HARRISON DE, 1987, J NUTR, V117, P376, DOI 10.1093/jn/117.2.376; IWASAKI K, 1988, J GERONTOL, V43, pB5, DOI 10.1093/geronj/43.1.B5; Jiang JC, 2000, FASEB J, V14, P2135; Kirk KL, 2001, J GERONTOL A-BIOL, V56, pB123, DOI 10.1093/gerona/56.3.B123; KIRKWOOD TBL, 1979, PROC R SOC SER B-BIO, V205, P531, DOI 10.1098/rspb.1979.0083; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; Kopec S, 1928, BR J EXP BIOL, V5, P204; Le Bourg E, 2005, AGEING RES REV, V4, P409, DOI 10.1016/j.arr.2004.12.001; Le Bourg E., 1991, AGE NUTR, V2, P90; Linnen C, 2001, EVOL ECOL RES, V3, P877; LUCKINBILL LS, 1984, EVOLUTION, V38, P996, DOI 10.1111/j.1558-5646.1984.tb00369.x; MAEDA H, 1985, J GERONTOL, V40, P671, DOI 10.1093/geronj/40.6.671; Mair W, 2005, PLOS BIOL, V3, P1305, DOI 10.1371/journal.pbio.0030223; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; MIN KJ, 2008, AGING CELL IN PRESS; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Oishi K, 2004, NEUROREPORT, V15, P739, DOI 10.1097/00001756-200403220-00034; Partridge L, 2005, MECH AGEING DEV, V126, P938, DOI 10.1016/j.mad.2005.03.023; Partridge L, 2002, NAT REV GENET, V3, P165, DOI 10.1038/nrg753; PARTRIDGE L, 1992, EVOLUTION, V46, P76, DOI [10.2307/2409806, 10.1111/j.1558-5646.1992.tb01986.x]; Piper MDW, 2008, CELL METAB, V8, P99, DOI 10.1016/j.cmet.2008.06.012; Piper MDW, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030057; R Development Core Team, 2005, R LANG ENV STAT COMP; ROSE MR, 1984, EVOLUTION, V38, P1004, DOI 10.1111/j.1558-5646.1984.tb00370.x; Sgro CM, 2000, AM NAT, V156, P341, DOI 10.1086/303394; Sgro CM, 1999, SCIENCE, V286, P2521, DOI 10.1126/science.286.5449.2521; Sutphin GL, 2008, EXP GERONTOL, V43, P130, DOI 10.1016/j.exger.2007.10.019; Toivonen JM, 2007, PLOS GENET, V3, P973, DOI 10.1371/journal.pgen.0030095; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; Weindruch R., 1988, RETARDATION AGING DI; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	46	71	73	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2009	4	1							e4067	10.1371/journal.pone.0004067	http://dx.doi.org/10.1371/journal.pone.0004067			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FR	19119322	Green Published, Green Submitted, gold			2022-12-25	WOS:000265472600001
J	Bossi, P; Gay, F; Fouzai, I; Combadiere, B; Brousse, G; Lebrun-Vignes, B; Crance, JM; Autran, B; Garin, D				Bossi, Philippe; Gay, Frederick; Fouzai, Imene; Combadiere, Behazine; Brousse, Genevieve; Lebrun-Vignes, Benedicte; Crance, Jean-Marc; Autran, Brigitte; Garin, Daniel		IMMUVAR Grp	Demographic and Clinical Factors Associated with Response to Smallpox Vaccine in Preimmunized Volunteers	PLOS ONE			English	Article								Context: In March 2003, the French Ministry of Health implemented a program on preparedness and response to a biological attack using smallpox as weapon. This program included the establishment of a preoutbreak national team that could be revaccinated against smallpox. Objective: To identify demographic and clinical factors associated with vaccination success defined as the presence of a pustule at the inoculation site at day 8 (days 7-9), with an undiluted vaccinia virus derived from a Lister strain among preimmunized volunteers. Volunteers and Methods: From March 2003 to November 2006, we have studied prospectively 226 eligible volunteers. Demographic data were recorded for each volunteer (age, sex, number of previously smallpox vaccinations and date of the last vaccination). Smallpox vaccine adverse reactions were diagnosed on the basis of clinical examination performed at days 0, 7, 14, 21 and 28 after revaccination. Results: A total of 226 volunteers (sex ratio H/F = 2.7) were revaccinated. Median age was 45 years (range: 27-63 yrs). All volunteers completed follow-up. Median number of vaccinations before revaccination was 2 (range: 1-8). The median delay between time of the study and the last vaccination was 29 years (range; 18-60 yrs). Sixty-one volunteers (27%) experienced one (n = 40) or more (n = 21) minor side effects during the 2-14 days after revaccination. Successful vaccination was noted in 216/226 volunteers (95.6%) at day 8 and the median of the pustule diameter was 5 mm (range: 1-20 mm). Size of the pustule at day 8 was correlated with age (p = 0.03) and with the presence of axillary adenopathy after revaccination (p = 0.007). Sex, number of prior vaccinations, delay between the last vaccination and revaccination, and local or systemic side effects with the exception of axillary adenopathy, were not correlated with the size of the pustule at day 8. Conclusions: Previously vaccinated volunteers can be successfully revaccinated with the Lister strain.	[Bossi, Philippe; Gay, Frederick; Fouzai, Imene; Combadiere, Behazine] Univ Paris 06, Dept Infect Dis, Paris, France; [Brousse, Genevieve; Autran, Brigitte] Univ Paris 06, Dept Immunol, INSERM U543, F-75252 Paris, France; [Lebrun-Vignes, Benedicte] Univ Paris 06, Dept Pharmacol, Paris, France; [Bossi, Philippe; Gay, Frederick; Combadiere, Behazine; Brousse, Genevieve; Lebrun-Vignes, Benedicte; Autran, Brigitte; Garin, Daniel] Univ Paris 06, Pitie Salpetriere Hosp, Paris, France; [Crance, Jean-Marc; Garin, Daniel] CRSSA Emile Parde, Dept Virol, Grenoble, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Bossi, P (corresponding author), Univ Paris 06, Dept Infect Dis, Paris, France.	philippe.bossi@psl.aphp.fr	Combadiere, Behazine/G-3881-2013; Combadiere, Behazine/S-8054-2019	Combadiere, Behazine/0000-0002-2353-4406	INSERM	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	The financial contribution of INSERM (Institut National de la Sante et de la Recherche Medicale) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artenstein AW, 2005, VACCINE, V23, P3301, DOI 10.1016/j.vaccine.2005.01.079; Bartlett J, 2003, CLIN INFECT DIS, V36, P883, DOI 10.1086/374792; Bossi P, 2006, CELL MOL LIFE SCI, V63, P2196, DOI 10.1007/s00018-006-6308-z; Breman JG, 2002, NEW ENGL J MED, V346, P1300, DOI 10.1056/NEJMra020025; Casey CG, 2005, JAMA-J AM MED ASSOC, V294, P2734, DOI 10.1001/jama.294.21.2734; Casey Christine, 2006, Morbidity and Mortality Weekly Report, V55, P1; Combadiere B, 2004, J EXP MED, V199, P1585, DOI 10.1084/jem.20032083; Demkowicz WE, 1996, J VIROL, V70, P2627, DOI 10.1128/JVI.70.4.2627-2631.1996; Ennis FA, 2002, J INFECT DIS, V185, P1657, DOI 10.1086/340517; Ferrier-Rembert A, 2007, VACCINE, V25, P8290, DOI 10.1016/j.vaccine.2007.09.050; Frey SE, 2002, NEW ENGL J MED, V346, P1265, DOI 10.1056/NEJMoa020534; Frey SE, 2002, NEW ENGL J MED, V346, P1275, DOI 10.1056/NEJMoa013431; Frey SE, 2003, JAMA-J AM MED ASSOC, V289, P3295, DOI 10.1001/jama.289.24.3295; Graham PL, 2007, VACCINE, V25, P5763, DOI 10.1016/j.vaccine.2007.04.063; Greenberg RN, 2005, LANCET, V365, P398, DOI 10.1016/S0140-6736(05)70234-8; Halsell JS, 2003, JAMA-J AM MED ASSOC, V289, P3283, DOI 10.1001/jama.289.24.3283; Hammarlund E, 2005, NAT MED, V11, P1005, DOI 10.1038/nm1273; Henderson DA, 1999, JAMA-J AM MED ASSOC, V281, P2127, DOI 10.1001/jama.281.22.2127; Hsieh SM, 2006, VACCINE, V24, P510, DOI 10.1016/j.vaccine.2005.07.082; Kim SH, 2007, CLIN MICROBIOL INFEC, V13, P91, DOI 10.1111/j.1469-0691.2006.01576.x; Kim SH, 2005, J INFECT DIS, V192, P1066, DOI 10.1086/432765; Levy-Bruhl D, 2001, Euro Surveill, V6, P171; Metzger W, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004913.pub2; Orr N, 2004, J INFECT DIS, V190, P1295, DOI 10.1086/423851; Parrino J, 2007, VACCINE, V25, P1513, DOI 10.1016/j.vaccine.2006.10.047; Sejvar JJ, 2005, JAMA-J AM MED ASSOC, V294, P2744, DOI 10.1001/jama.294.21.2744; Talbot TR, 2004, JAMA-J AM MED ASSOC, V292, P1205, DOI 10.1001/jama.292.10.1205; Vellozzi C, 2005, CLIN INFECT DIS, V41, P689, DOI 10.1086/432584; World Health Organization, 1980, GLOB ER SMALLP FIN R; 2006, PLAN NATL REPONSE ME	30	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4087	10.1371/journal.pone.0004087	http://dx.doi.org/10.1371/journal.pone.0004087			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DO	19116649	gold, Green Submitted, Green Published			2022-12-25	WOS:000265466600008
J	Lee, J; Han, K; Meyer, TJ; Kim, HS; Batzer, MA				Lee, Jungnam; Han, Kyudong; Meyer, Thomas J.; Kim, Heui-Soo; Batzer, Mark A.			Chromosomal Inversions between Human and Chimpanzee Lineages Caused by Retrotransposons	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; SEGMENTAL DUPLICATIONS; PERICENTRIC INVERSIONS; STRUCTURAL VARIATION; DNA-SEQUENCES; HUMAN GENOME; RECOMBINATION; EVOLUTION; DELETION; AMPLIFICATION	The long interspersed element-1 (LINE-1 or L1) and Alu elements are the most abundant mobile elements comprising 21% and 11% of the human genome, respectively. Since the divergence of human and chimpanzee lineages, these elements have vigorously created chromosomal rearrangements causing genomic difference between humans and chimpanzees by either increasing or decreasing the size of genome. Here, we report an exotic mechanism, retrotransposon recombination-mediated inversion (RRMI), that usually does not alter the amount of genomic material present. Through the comparison of the human and chimpanzee draft genome sequences, we identified 252 inversions whose respective inversion junctions can clearly be characterized. Our results suggest that L1 and Alu elements cause chromosomal inversions by either forming a secondary structure or providing a fragile site for double-strand breaks. The detailed analysis of the inversion breakpoints showed that L1 and Alu elements are responsible for at least 44% of the 252 inversion loci between human and chimpanzee lineages, including 49 RRMI loci. Among them, three RRMI loci inverted exonic regions in known genes, which implicates this mechanism in generating the genomic and phenotypic differences between human and chimpanzee lineages. This study is the first comprehensive analysis of mobile element bases inversion breakpoints between human and chimpanzee lineages, and highlights their role in primate genome evolution.	[Lee, Jungnam; Han, Kyudong; Meyer, Thomas J.; Batzer, Mark A.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Lee, Jungnam; Han, Kyudong; Meyer, Thomas J.; Batzer, Mark A.] Louisiana State Univ, Biol Comput & Visual Ctr, Baton Rouge, LA 70803 USA; [Kim, Heui-Soo] Pusan Natl Univ, Coll Nat Sci, Interdisciplin Res Program Bioinformat, PBBRC, Busan, South Korea; [Kim, Heui-Soo] Pusan Natl Univ, Coll Nat Sci, Div Biol Sci, Busan, South Korea	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Pusan National University; Pusan National University	Lee, J (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	mbatzer@lsu.edu	Han, Kyudong/AAF-1788-2019; Kim, Heui-Soo/ABF-3773-2021	Han, Kyudong/0000-0001-6791-2408; Kim, Heui-Soo/0000-0002-5226-6594	National Science Foundation [BCS-0218338]; National Institutes of Health [RO1 GM59290]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059290] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation grant BCS-0218338 (M.A.B.), and National Institutes of Health RO1 GM59290 (M.A.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JA, 2004, GENOME RES, V14, P789, DOI 10.1101/gr.2238404; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; BATZER MA, 1991, NUCLEIC ACIDS RES, V19, P5081, DOI 10.1093/nar/19.18.5081; Callinan PA, 2005, J MOL BIOL, V348, P791, DOI 10.1016/j.jmb.2005.02.043; Casals F, 2007, HEREDITY, V99, P479, DOI 10.1038/sj.hdy.6801046; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Cordaux R, 2006, GENE, V373, P138, DOI 10.1016/j.gene.2006.01.020; de Silva MG, 2003, J MED GENET, V40, P733, DOI 10.1136/jmg.40.10.733; DEININGER PL, 1992, TRENDS GENET, V8, P307, DOI 10.1016/0168-9525(92)90262-3; Deininger PL, 2003, CURR OPIN GENET DEV, V13, P651, DOI 10.1016/j.gde.2003.10.013; Dennis A. P., 2004, MOL ENDOCRINOL, V18, P493; FANNING T, 1987, NUCLEIC ACIDS RES, V15, P2251, DOI 10.1093/nar/15.5.2251; Feuk L, 2005, PLOS GENET, V1, P489, DOI 10.1371/journal.pgen.0010056; Fullerton SM, 2001, MOL BIOL EVOL, V18, P1139, DOI 10.1093/oxfordjournals.molbev.a003886; Gebow D, 2000, MOL CELL BIOL, V20, P4028, DOI 10.1128/MCB.20.11.4028-4035.2000; Giordano J, 2007, PLOS COMPUT BIOL, V3, P1321, DOI 10.1371/journal.pcbi.0030137; Goidts V, 2005, GENOME RES, V15, P1232, DOI 10.1101/gr.3732505; GORDENIN DA, 1993, MOL CELL BIOL, V13, P5315, DOI 10.1128/MCB.13.9.5315; GRAUR D, 2000, FUNDAMENTALS MOL EVO; Gross SS, 2006, J COMPUT BIOL, V13, P379, DOI 10.1089/cmb.2006.13.379; Han KD, 2005, NUCLEIC ACIDS RES, V33, P4040, DOI 10.1093/nar/gki718; Han K, 2007, PLOS GENET, V3, P1939, DOI 10.1371/journal.pgen.0030184; Jaarola M, 1998, AM J HUM GENET, V63, P218, DOI 10.1086/301900; Keightley PD, 2005, PLOS BIOL, V3, P282, DOI 10.1371/journal.pbio.0030042; Kelchner SA, 1996, CURR GENET, V30, P259, DOI 10.1007/s002940050130; Khaja R, 2006, NAT GENET, V38, P1413, DOI 10.1038/ng1921; Khan H, 2006, GENOME RES, V16, P78, DOI 10.1101/gr.4001406; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kin TS, 2007, BIOINFORMATICS, V23, P2945, DOI 10.1093/bioinformatics/btm455; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee J, 2007, GENE, V390, P18, DOI 10.1016/j.gene.2006.08.029; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; LI L, 1993, AM J HUM GENET, V53, P140; Li YH, 2006, HUM MUTAT, V27, P1017, DOI 10.1002/humu.20382; Lobachev KS, 2000, EMBO J, V19, P3822, DOI 10.1093/emboj/19.14.3822; Lobachev KS, 1998, GENETICS, V148, P1507; Lobachev KS, 2002, CELL, V108, P183, DOI 10.1016/S0092-8674(02)00614-1; Locke DP, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-8-r50; Lovsin N, 2001, MOL BIOL EVOL, V18, P2213, DOI 10.1093/oxfordjournals.molbev.a003768; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; MATHIAS SL, 1991, SCIENCE, V254, P1808, DOI 10.1126/science.1722352; Nag DK, 1997, GENETICS, V146, P835; Narayanan V, 2006, CELL, V125, P1283, DOI 10.1016/j.cell.2006.04.042; Payseur BA, 2002, MOL BIOL EVOL, V19, P336, DOI 10.1093/oxfordjournals.molbev.a004086; Rieseberg LH, 2003, SCIENCE, V300, P267, DOI 10.1126/science.1084192; Schmidt S, 2005, HUM GENET, V117, P213, DOI 10.1007/s00439-005-1294-z; Sen SK, 2006, AM J HUM GENET, V79, P41, DOI 10.1086/504600; Shaw CJ, 2004, HUM MOL GENET, V13, pR57, DOI 10.1093/hmg/ddh073; SHEN MR, 1991, J MOL EVOL, V33, P311; Stenger JE, 2001, GENOME RES, V11, P12, DOI 10.1101/gr.158801; Szamalek JM, 2005, HUM GENET, V117, P168, DOI 10.1007/s00439-005-1287-y; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Weiner AM, 2000, NAT GENET, V24, P332, DOI 10.1038/74135; Wessler SR, 2006, IMPLICIT GENOME, P138; YUNIS JJ, 1982, SCIENCE, V215, P1525, DOI 10.1126/science.7063861; ZHENG GX, 1988, J BIOL CHEM, V263, P5356	58	58	59	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2008	3	12							e4047	10.1371/journal.pone.0004047	http://dx.doi.org/10.1371/journal.pone.0004047			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DI	19112500	Green Published, gold, Green Submitted			2022-12-25	WOS:000265466000011
J	Agrawal, N; Banerjee, R				Agrawal, Nitish; Banerjee, Ruma			Human Polycomb 2 Protein Is a SUMO E3 Ligase and Alleviates Substrate-Induced Inhibition of Cystathionine beta-Synthase Sumoylation	PLOS ONE			English	Article							REDOX REGULATION; PROLIFERATION; GLUTATHIONE; REPRESSION; MECHANISM; MUTATION; TARGET; DOMAIN; HEME; H2S	Human cystathionine beta-synthase (CBS) catalyzes the first irreversible step in the transsulfuration pathway and commits homocysteine to the synthesis of cysteine. Mutations in CBS are the most common cause of severe hereditary hyperhomocysteinemia. A yeast two-hybrid approach to screen for proteins that interact with CBS had previously identified several components of the sumoylation pathway and resulted in the demonstration that CBS is a substrate for sumoylation. In this study, we demonstrate that sumoylation of CBS is enhanced in the presence of human polycomb group protein 2 (hPc2), an interacting partner that was identified in the initial yeast two-hybrid screen. When the substrates for CBS, homocysteine and serine for cystathionine generation and homocysteine and cysteine for H2S generation, are added to the sumoylation mixture, they inhibit the sumoylation reaction, but only in the absence of hPc2. Similarly, the product of the CBS reaction, cystathionine, inhibits sumoylation in the absence of hPc2. Sumoylation in turn decreases CBS activity by similar to 28% in the absence of hPc2 and by 70% in its presence. Based on these results, we conclude that hPc2 serves as a SUMO E3 ligase for CBS, increasing the efficiency of sumoylation. We also demonstrate that gamma-cystathionase, the second enzyme in the transsulfuration pathway is a substrate for sumoylation under in vitro conditions. We speculate that the role of this modification may be for nuclear localization of the cysteine-generating pathway under conditions where nuclear glutathione demand is high.	[Banerjee, Ruma] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Agrawal, N (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	AGRAWAL, NITISH/H-6186-2011; AGRAWAL, NITISH/E-3468-2013	AGRAWAL, NITISH/0000-0003-0823-7355; 	National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee R, 2005, ARCH BIOCHEM BIOPHYS, V433, P144, DOI 10.1016/j.abb.2004.08.037; Borras C, 2004, J BIOL CHEM, V279, P34332, DOI 10.1074/jbc.M402425200; Chen XL, 2004, J BIOL CHEM, V279, P52082, DOI 10.1074/jbc.C400481200; Cmarko D, 2003, J CELL SCI, V116, P335, DOI 10.1242/jcs.00225; Evande R, 2002, BIOCHEMISTRY-US, V41, P11832, DOI 10.1021/bi026248d; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gregoire S, 2005, MOL CELL BIOL, V25, P2273, DOI 10.1128/MCB.25.6.2273-2287.2005; Hilgarth RS, 2004, J BIOL CHEM, V279, P53899, DOI 10.1074/jbc.R400021200; Ho Y.F., 1994, TOXICOLOGIST, V14, P178; Jacobs JJL, 2002, BBA-REV CANCER, V1602, P151, DOI 10.1016/S0304-419X(02)00052-5; Janosik M, 2001, BIOCHEMISTRY-US, V40, P10625, DOI 10.1021/bi010711p; Kabil O, 2006, BIOCHEMISTRY-US, V45, P13528, DOI 10.1021/bi0615644; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Kraus JP, 1999, HUM MUTAT, V13, P362; Li B, 2007, BIOCHEM J, V405, P369, DOI 10.1042/BJ20061873; Long JY, 2005, J BIOL CHEM, V280, P35477, DOI 10.1074/jbc.M504477200; Maclean KN, 2002, J CELL PHYSIOL, V192, P81, DOI 10.1002/jcp.10118; Markovic J, 2007, J BIOL CHEM, V282, P20416, DOI 10.1074/jbc.M609582200; Martin S, 2007, NAT REV NEUROSCI, V8, P948, DOI 10.1038/nrn2276; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Miles EW, 2004, J BIOL CHEM, V279, P29871, DOI 10.1074/jbc.R400005200; Mudd S., 2001, METABOLIC MOL BASES, P2007; Owerbach D, 2005, BIOCHEM BIOPH RES CO, V337, P517, DOI 10.1016/j.bbrc.2005.09.090; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Prudova A, 2006, P NATL ACAD SCI USA, V103, P6489, DOI 10.1073/pnas.0509531103; Rajan S, 2005, CELL, V121, P37, DOI 10.1016/j.cell.2005.01.019; Ringrose L, 2007, CURR OPIN CELL BIOL, V19, P290, DOI 10.1016/j.ceb.2007.04.010; Roscic A, 2006, MOL CELL, V24, P77, DOI 10.1016/j.molcel.2006.08.004; Satijn DPE, 1997, MOL CELL BIOL, V17, P6076, DOI 10.1128/MCB.17.10.6076; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Sen S, 2007, BIOCHEMISTRY-US, V46, P4110, DOI 10.1021/bi602617f; Sewalt RGAB, 1999, MOL CELL BIOL, V19, P777; Taoka S, 1999, BIOCHEMISTRY-US, V38, P2738, DOI 10.1021/bi9826052; Taoka S, 1998, J BIOL CHEM, V273, P25179, DOI 10.1074/jbc.273.39.25179; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Vertegaal ACO, 2007, BIOCHEM SOC T, V35, P1422, DOI 10.1042/BST0351422; Woeller CF, 2007, J BIOL CHEM, V282, P17623, DOI 10.1074/jbc.M702526200; Wotton D, 2007, BIOCHEM SOC T, V35, P1401, DOI 10.1042/BST0351401; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Zhu WD, 2008, BIOCHEMISTRY-US, V47, P6226, DOI 10.1021/bi800351a	41	50	51	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4032	10.1371/journal.pone.0004032	http://dx.doi.org/10.1371/journal.pone.0004032			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107218	Green Submitted, Green Published, gold			2022-12-25	WOS:000265463000024
J	Miller, MW; Swanson, HM; Wolfe, LL; Quartarone, FG; Huwer, SL; Southwick, CH; Lukacs, PM				Miller, Michael W.; Swanson, Heather M.; Wolfe, Lisa L.; Quartarone, Fred G.; Huwer, Sherri L.; Southwick, Charles H.; Lukacs, Paul M.			Lions and Prions and Deer Demise	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; RANGING MULE DEER; PREDATION; PREVALENCE; COLORADO; EPIDEMIOLOGY; TRANSMISSION; INFECTION; DYNAMICS	Background: Contagious prion diseases - scrapie of sheep and chronic wasting disease of several species in the deer family - give rise to epidemics that seem capable of compromising host population viability. Despite this prospect, the ecological consequences of prion disease epidemics in natural populations have received little consideration. Methodology/Principal Findings: Using a cohort study design, we found that prion infection dramatically lowered survival of free-ranging adult (>2-year-old) mule deer (Odocoileus hemionus): estimated average life expectancy was 5.2 additional years for uninfected deer but only 1.6 additional years for infected deer. Prion infection also increased nearly fourfold the rate of mountain lions (Puma concolor) preying on deer, suggesting that epidemics may alter predator-prey dynamics by facilitating hunting success. Despite selective predation, about one fourth of the adult deer we sampled were infected. High prevalence and low survival of infected deer provided a plausible explanation for the marked decline in this deer population since the 1980s. Conclusion: Remarkably high infection rates sustained in the face of intense predation show that even seemingly complete ecosystems may offer little resistance to the spread and persistence of contagious prion diseases. Moreover, the depression of infected populations may lead to local imbalances in food webs and nutrient cycling in ecosystems in which deer are important herbivores.	[Miller, Michael W.; Wolfe, Lisa L.; Quartarone, Fred G.; Huwer, Sherri L.; Lukacs, Paul M.] Wildlife Res Ctr, Colorado Div Wildlife, Ft Collins, CO USA; [Swanson, Heather M.] City Boulder Open Space & Mt Parks, Boulder, CO USA; [Southwick, Charles H.] Univ Colorado, Dept Ecol & Evolut Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Miller, MW (corresponding author), Wildlife Res Ctr, Colorado Div Wildlife, Ft Collins, CO USA.	mike.miller@state.co.us			Colorado Division of Wildlife; City of Boulder; US Department of Agriculture; Animal&Plant Health Inspection Service, Veterinary Services	Colorado Division of Wildlife; City of Boulder; US Department of Agriculture(United States Department of Agriculture (USDA)); Animal&Plant Health Inspection Service, Veterinary Services	Our funding came from the Colorado Division of Wildlife, the City of Boulder, and the US Department of Agriculture, Animal&Plant Health Inspection Service, Veterinary Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; BOWDEN DC, 1995, J WILDLIFE MANAGE, V59, P840, DOI 10.2307/3801965; Detwiler LA, 2003, REV SCI TECH OIE, V22, P121, DOI 10.20506/rst.22.1.1386; Duffy MA, 2007, OECOLOGIA, V153, P453, DOI 10.1007/s00442-007-0742-y; Fox KA, 2006, J GEN VIROL, V87, P3451, DOI 10.1099/vir.0.81999-0; Fryxell JM, 2007, NATURE, V449, P1041, DOI 10.1038/nature06177; Gross JE, 2001, J WILDLIFE MANAGE, V65, P205, DOI 10.2307/3802899; Holt RD, 2007, AM NAT, V169, P690, DOI 10.1086/513188; Hornlimann B, 2007, PRIONS IN HUMANS AND ANIMALS, P1, DOI 10.1515/9783110200171; HOSMER DW, 2000, WILEY PS TX, P1; HUDSON PJ, 1992, J ANIM ECOL, V61, P681, DOI 10.2307/5623; Jewell JE, 2005, J GEN VIROL, V86, P2127, DOI 10.1099/vir.0.81077-0; Johnson PTJ, 2006, ECOLOGY, V87, P1973, DOI 10.1890/0012-9658(2006)87[1973:DODHIB]2.0.CO;2; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; MCCLINTOCK BT, 2008, BIOMETRICS IN PRESS; Miller MW, 2006, ECOL APPL, V16, P2208, DOI 10.1890/1051-0761(2006)016[2208:DOPDTI]2.0.CO;2; Miller MW, 2005, J WILDLIFE DIS, V41, P275, DOI 10.7589/0090-3558-41.2.275; Miller MW, 2000, J WILDLIFE DIS, V36, P676, DOI 10.7589/0090-3558-36.4.676; Miller MW, 2002, VET REC, V151, P610, DOI 10.1136/vr.151.20.610; Miller MW, 2003, NATURE, V425, P35, DOI 10.1038/425035a; Ostfeld RS, 2004, FRONT ECOL ENVIRON, V2, P13, DOI 10.1890/1540-9295(2004)002[0013:APGFYH]2.0.CO;2; Packer C, 2003, ECOL LETT, V6, P797, DOI 10.1046/j.1461-0248.2003.00500.x; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Unsworth JW, 1999, J WILDLIFE MANAGE, V63, P315, DOI 10.2307/3802515; Williams ES, 2005, VET PATHOL, V42, P530, DOI 10.1354/vp.42-5-530; WILLIAMS ES, 1980, J WILDLIFE DIS, V16, P89, DOI 10.7589/0090-3558-16.1.89; Wolfe LL, 2004, WILDLIFE SOC B, V32, P500, DOI 10.2193/0091-7648(2004)32[500:FOTFMC]2.0.CO;2; Wolfe LL, 2002, J WILDLIFE MANAGE, V66, P564, DOI 10.2307/3803124	28	89	91	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4019	10.1371/journal.pone.0004019	http://dx.doi.org/10.1371/journal.pone.0004019			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107193	Green Submitted, Green Published, gold			2022-12-25	WOS:000265463000014
J	Beaufays, J; Adam, B; Decrem, Y; Prevot, PP; Santini, S; Brasseur, R; Brossard, M; Lins, L; Vanhamme, L; Godfroid, E				Beaufays, Jerome; Adam, Benoit; Decrem, Yves; Prevot, Pierre-Paul; Santini, Sebastien; Brasseur, Robert; Brossard, Michel; Lins, Laurence; Vanhamme, Luc; Godfroid, Edmond			Ixodes ricinus Tick Lipocalins: Identification, Cloning, Phylogenetic Analysis and Biochemical Characterization	PLOS ONE			English	Article							SOFT TICK; BINDING PROTEINS; FAMILY; INHIBITOR; MECHANISM; EVOLUTION; MOUBATIN; CLADE; SHARE	Background: During their blood meal, ticks secrete a wide variety of proteins that interfere with their host's defense mechanisms. Among these proteins, lipocalins play a major role in the modulation of the inflammatory response. Methodology/Principal Findings: Screening a cDNA library in association with RT-PCR and RACE methodologies allowed us to identify 14 new lipocalin genes in the salivary glands of the Ixodes ricinus hard tick. A computational in-depth structural analysis confirmed that LIRs belong to the lipocalin family. These proteins were called LIR for ``Lipocalin from I. ricinus'' and numbered from 1 to 14 (LIR1 to LIR14). According to their percentage identity/similarity, LIR proteins may be assigned to 6 distinct phylogenetic groups. The mature proteins have calculated pM and pI varying from 21.8 kDa to 37.2 kDa and from 4.45 to 9.57 respectively. In a western blot analysis, all recombinant LIRs appeared as a series of thin bands at 50-70 kDa, suggesting extensive glycosylation, which was experimentally confirmed by treatment with N-glycosidase F. In addition, the in vivo expression analysis of LIRs in I. ricinus, examined by RT-PCR, showed homogeneous expression profiles for certain phylogenetic groups and relatively heterogeneous profiles for other groups. Finally, we demonstrated that LIR6 codes for a protein that specifically binds leukotriene B4. Conclusions/Significance: This work confirms that, regarding their biochemical properties, expression profile, and sequence signature, lipocalins in Ixodes hard tick genus, and more specifically in the Ixodes ricinus species, are segregated into distinct phylogenetic groups suggesting potential distinct function. This was particularly demonstrated by the ability of LIR6 to scavenge leukotriene B4. The other LIRs did not bind any of the ligands tested, such as 5-hydroxytryptamine, ADP, norepinephrine, platelet activating factor, prostaglandins D2 and E2, and finally leukotrienes B4 and C4.	[Beaufays, Jerome; Decrem, Yves; Prevot, Pierre-Paul; Vanhamme, Luc; Godfroid, Edmond] Free Univ Brussels, IBMM, Lab Mol Biol Ectoparasites, Gosselies, Belgium; [Adam, Benoit; Santini, Sebastien; Brasseur, Robert; Lins, Laurence] Gembloux Agr Univ, Ctr Biophys Mol Numer, Gembloux, Belgium; [Brossard, Michel] Univ Neuchatel, Inst Zool, CH-2000 Neuchatel, Switzerland; [Vanhamme, Luc] Free Univ Brussels, IBMM, Lab Mol Parasitol, B-1050 Gosselies, Belgium	Universite Libre de Bruxelles; University of Liege; University of Neuchatel; Universite Libre de Bruxelles	Beaufays, J (corresponding author), Free Univ Brussels, IBMM, Lab Mol Biol Ectoparasites, Gosselies, Belgium.	edmond.godfroid@ulb.ac.be	LINS, LAURENCE/Y-1661-2019	LINS, LAURENCE/0000-0001-7772-6748; Santini, Sebastien/0000-0001-7087-1950	Belgian National Fund for Scientific Research [Senior Research Associate]; Ministere de la Region Wallonne in Belgium [215107, 415702]	Belgian National Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS); Ministere de la Region Wallonne in Belgium	LVH is a Senior Research Associate at the Belgian National Fund for Scientific Research. This work was supported by contracts 215107 and 415702 from the Ministere de la Region Wallonne in Belgium.	Adam B, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-1; Clarke J, 1999, STRUCT FOLD DES, V7, P1145, DOI 10.1016/S0969-2126(99)80181-6; Couvreur B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001400; FLOWER DR, 1993, PROTEIN SCI, V2, P753, DOI 10.1002/pro.5560020507; Flower DR, 1996, BIOCHEM J, V318, P1; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; KELLER PM, 1993, J BIOL CHEM, V268, P5450; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leboulle G, 2002, AM J TROP MED HYG, V66, P225, DOI 10.4269/ajtmh.2002.66.225; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P862, DOI 10.1016/j.ibmb.2008.06.002; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P841, DOI 10.1016/j.ibmb.2008.06.007; Mans BJ, 2008, J BIOL CHEM, V283, P18721, DOI 10.1074/jbc.M800188200; Mans BJ, 2003, MOL BIOL EVOL, V20, P1158, DOI 10.1093/molbev/msg126; Mans BJ, 2002, TOXICON, V40, P1007, DOI 10.1016/S0041-0101(02)00098-3; Mans BJ, 2001, ELECTROPHORESIS, V22, P1739, DOI 10.1002/1522-2683(200105)22:9&lt;1739::AID-ELPS1739&gt;3.0.CO;2-7; MANS BJ, INSECT BIOCH MOL BIO, V34, P1; Nunn MA, 2005, J IMMUNOL, V174, P2084, DOI 10.4049/jimmunol.174.4.2084; Paesen GC, 1999, MOL CELL, V3, P661, DOI 10.1016/S1097-2765(00)80359-7; PERUTZ MF, 1965, J MOL BIOL, V13, P669, DOI 10.1016/S0022-2836(65)80134-6; Ribeiro JMC, 2006, INSECT BIOCHEM MOLEC, V36, P111, DOI 10.1016/j.ibmb.2005.11.005; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sangamnatdej S, 2002, INSECT MOL BIOL, V11, P79, DOI 10.1046/j.0962-1075.2001.00311.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WARLOW RS, 1987, MOL IMMUNOL, V24, P27, DOI 10.1016/0161-5890(87)90108-8	29	39	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2008	3	12							e3941	10.1371/journal.pone.0003941	http://dx.doi.org/10.1371/journal.pone.0003941			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AV	19096708	Green Published, gold, Green Submitted			2022-12-25	WOS:000265458800001
J	Dotson, CD; Zhang, L; Xu, H; Shin, YK; Vigues, S; Ott, SH; Elson, AET; Choi, HJ; Shaw, H; Egan, JM; Mitchell, BD; Li, XD; Steinle, NI; Munger, SD				Dotson, Cedrick D.; Zhang, Lan; Xu, Hong; Shin, Yu-Kyong; Vigues, Stephan; Ott, Sandra H.; Elson, Amanda E. T.; Choi, Hyun Jin; Shaw, Hillary; Egan, Josephine M.; Mitchell, Braxton D.; Li, Xiaodong; Steinle, Nanette I.; Munger, Steven D.			Bitter Taste Receptors Influence Glucose Homeostasis	PLOS ONE			English	Article								TAS1R- and TAS2R-type taste receptors are expressed in the gustatory system, where they detect sweet- and bitter-tasting stimuli, respectively. These receptors are also expressed in subsets of cells within the mammalian gastrointestinal tract, where they mediate nutrient assimilation and endocrine responses. For example, sweeteners stimulate taste receptors on the surface of gut enteroendocrine L cells to elicit an increase in intracellular Ca2+ and secretion of the incretin hormone glucagon-like peptide-1 (GLP-1), an important modulator of insulin biosynthesis and secretion. Because of the importance of taste receptors in the regulation of food intake and the alimentary responses to chemostimuli, we hypothesized that differences in taste receptor efficacy may impact glucose homeostasis. To address this issue, we initiated a candidate gene study within the Amish Family Diabetes Study and assessed the association of taste receptor variants with indicators of glucose dysregulation, including a diagnosis of type 2 diabetes mellitus and high levels of blood glucose and insulin during an oral glucose tolerance test. We report that a TAS2R haplotype is associated with altered glucose and insulin homeostasis. We also found that one SNP within this haplotype disrupts normal responses of a single receptor, TAS2R9, to its cognate ligands ofloxacin, procainamide and pirenzapine. Together, these findings suggest that a functionally compromised TAS2R receptor negatively impacts glucose homeostasis, providing an important link between alimentary chemosensation and metabolic disease.	[Dotson, Cedrick D.; Vigues, Stephan; Elson, Amanda E. T.; Choi, Hyun Jin; Munger, Steven D.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Zhang, Lan; Xu, Hong; Li, Xiaodong] Senomyx Inc, San Diego, CA USA; [Shin, Yu-Kyong; Egan, Josephine M.] NIA, NIH, Baltimore, MD USA; [Ott, Sandra H.; Shaw, Hillary; Mitchell, Braxton D.; Steinle, Nanette I.] Univ Maryland, Sch Med, Dept Med, Div Endocrinol, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University System of Maryland; University of Maryland Baltimore	Dotson, CD (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA.	smung001@umaryland.edu	vigues, stephan/AAG-3390-2020; Mitchell, Braxton/CAF-0876-2022	Elson, Amanda/0000-0002-5744-5954; Dotson, Cedrick/0000-0003-0992-1191; Mitchell, Braxton/0000-0003-4920-4744	NIDCD [DC005786, DC007317]; NHLBI [HL076768]; University of Maryland School of Medicine, the Clinical Nutrition Research Unit of Maryland [DK072488]; Intramural Research Program of the NIH/National Institute on Aging; NIDCR; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC007317, R01DC005786] Funding Source: NIH RePORTER	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Maryland School of Medicine, the Clinical Nutrition Research Unit of Maryland; Intramural Research Program of the NIH/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the NIDCD (DC005786 to S.D.M.; DC007317 to S.V.), NHLBI (HL076768 to N.I.S.), the University of Maryland School of Medicine, the Clinical Nutrition Research Unit of Maryland (DK072488), and the Intramural Research Program of the NIH/National Institute on Aging (Y.-K.S. and J.M.E.). C.D.D. was supported by NIDCD and NIDCR training grants. L.Z., H.X. and X.L. are employees of Senomyx, Inc. The funders had no role in decision to publish or preparation of the manuscript. With the exception of studies performed at, and funded by, Senomyx, Inc., the funders had no role in the study design, data collection or analysis. For experiments performed at and funded by Senomyx, Inc. (these are restricted to the receptor deorphaning experiments reported in Figure 2), study design, data collection and analysis was performed according to good scientific practices. Analysis and interpretation of these (Figure 2) experiments were also performed by authors CDD and SDM (University of Maryland School of Medicine).	Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Assadi-Porter FM, 2008, J AM CHEM SOC, V130, P7212, DOI 10.1021/ja8016939; Bachmanov AA, 2007, ANNU REV NUTR, V27, P389, DOI 10.1146/annurev.nutr.26.061505.111329; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bartoshuk LM, 2006, PHILOS T R SOC B, V361, P1137, DOI 10.1098/rstb.2006.1853; Behrens M, 2006, CELL MOL LIFE SCI, V63, P1501, DOI 10.1007/s00018-006-6113-8; Bezencon C, 2007, CHEM SENSES, V32, P41, DOI 10.1093/chemse/bjl034; Breslin PAS, 2008, CURR BIOL, V18, pR148, DOI 10.1016/j.cub.2007.12.017; Brockhoff A, 2007, J AGR FOOD CHEM, V55, P6236, DOI 10.1021/jf070503p; Bufe B, 2002, NAT GENET, V32, P397, DOI 10.1038/ng1014; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Cannon DS, 2005, NICOTINE TOB RES, V7, P853, DOI 10.1080/14622200500330209; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Conneely KN, 2007, AM J HUM GENET, V81, P1158, DOI 10.1086/522036; Damak S, 2003, SCIENCE, V301, P850, DOI 10.1126/science.1087155; Damcott CM, 2006, DIABETES, V55, P2654, DOI 10.2337/db06-0338; DeFronzo RA, 2004, MED CLIN N AM, V88, P787, DOI 10.1016/j.mcna.2004.04.013; Duffy VB, 2007, CURR OPIN GASTROEN, V23, P171, DOI 10.1097/MOG.0b013e3280147d50; Duffy VB, 2004, ALCOHOL CLIN EXP RES, V28, P1629, DOI 10.1097/01.ALC.0000145789.55183.D4; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Glendinning JI, 2008, PHYSIOL BEHAV, V93, P757, DOI 10.1016/j.physbeh.2007.11.029; Hansen JL, 2006, CHEM SENSES, V31, P403, DOI 10.1093/chemse/bjj044; Hinrichs AL, 2006, AM J HUM GENET, V78, P103, DOI 10.1086/499253; Hsueh WC, 2000, DIABETES CARE, V23, P595, DOI 10.2337/diacare.23.5.595; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Kim U, 2005, HUM MUTAT, V26, P199, DOI 10.1002/humu.20203; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; Kim UK, 2006, CHEM SENSES, V31, P599, DOI 10.1093/chemse/bjj065; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Mace OJ, 2007, J PHYSIOL-LONDON, V582, P379, DOI 10.1113/jphysiol.2007.130906; Maehashi K, 2008, BIOCHEM BIOPH RES CO, V365, P851, DOI 10.1016/j.bbrc.2007.11.070; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; Mattes R. D., 2003, Handbook of olfaction and gustation, P881; Nie Y, 2005, CURR BIOL, V15, P1948, DOI 10.1016/j.cub.2005.09.037; Nie YL, 2006, CHEM SENSES, V31, P505, DOI 10.1093/chemse/bjj053; Park-Wyllie LY, 2006, NEW ENGL J MED, V354, P1352, DOI 10.1056/NEJMoa055191; Pronin AN, 2007, CURR BIOL, V17, P1403, DOI 10.1016/j.cub.2007.07.046; Pronin AN, 2004, CHEM SENSES, V29, P583, DOI 10.1093/chemse/bjh064; Rampersaud E, 2007, DIABETES, V56, P3053, DOI 10.2337/db07-0457; Reed DR, 2004, J NEUROSCI, V24, P938, DOI 10.1523/JNEUROSCI.1374-03.2004; Rozengurt E, 2007, CURR OPIN PHARMACOL, V7, P557, DOI 10.1016/j.coph.2007.10.002; Rozengurt E, 2006, AM J PHYSIOL-GASTR L, V291, pG171, DOI 10.1152/ajpgi.00073.2006; Rozengurt N, 2006, AM J PHYSIOL-GASTR L, V291, pG792, DOI 10.1152/ajpgi.00074.2006; Salonen JT, 2007, AM J HUM GENET, V81, P338, DOI 10.1086/520599; Sandell MA, 2006, CURR BIOL, V16, pR792, DOI 10.1016/j.cub.2006.08.049; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Sclafani A, 2006, PHYSIOL BEHAV, V89, P525, DOI 10.1016/j.physbeh.2006.03.021; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinle NI, 2002, AM J CLIN NUTR, V75, P1098, DOI 10.1093/ajcn/75.6.1098; Sugita M, 2006, CELL MOL LIFE SCI, V63, P2000, DOI 10.1007/s00018-006-6100-0; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Ueda T, 2003, J NEUROSCI, V23, P7376; Wang JC, 2007, ALCOHOL CLIN EXP RES, V31, P209, DOI 10.1111/j.1530-0277.2006.00297.x; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; Wooding S, 2006, GENETICS, V172, P2015; Wu SV, 2002, P NATL ACAD SCI USA, V99, P2392, DOI 10.1073/pnas.042617699; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	63	181	187	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2008	3	12							e3974	10.1371/journal.pone.0003974	http://dx.doi.org/10.1371/journal.pone.0003974			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AT	19092995	gold, Green Submitted, Green Published			2022-12-25	WOS:000265458600009
J	Horne, AW; Phillips, JA; Kane, N; Lourenco, PC; McDonald, SE; Williams, ARW; Simon, C; Dey, SK; Critchley, HOD				Horne, Andrew W.; Phillips, John A., III; Kane, Nicole; Lourenco, Paula C.; McDonald, Sarah E.; Williams, Alistair R. W.; Simon, Carlos; Dey, Sudhansu K.; Critchley, Hilary O. D.			CB1 Expression Is Attenuated in Fallopian Tube and Decidua of Women with Ectopic Pregnancy	PLOS ONE			English	Article							CANNABINOID RECEPTOR; GENE; CNR1; IMPLANTATION; NICOTINE; OVIDUCT; SYSTEM; SPERM; BRAIN	Background: Embryo retention in the Fallopian tube (FT) is thought to lead to ectopic pregnancy (EP), a considerable cause of morbidity. In mice, genetic/pharmacological silencing of cannabinoid receptor Cnr1, encoding CB1, causes retention of embryos in the oviduct. The role of the endocannabinoids in tubal implantation in humans is not known. Methods and Findings: Timed FT biopsies (n = 18) were collected from women undergoing gynecological procedures for benign conditions. Endometrial biopsies and whole blood were collected from women undergoing surgery for EP (n = 11); management of miscarriage (n = 6), and termination of pregnancy (n = 8). Using RT-PCR and immunohistochemistry, CB1 mRNA and protein expression levels/patterns were examined in FT and endometrial biopsies. The distribution of two polymorphisms of CNR1 was examined by TaqMan analysis of genomic DNA from the whole blood samples. In normal FT, CB1 mRNA was higher in luteal compared to follicular-phase (p<0.05). CB1 protein was located in smooth muscle of the wall and of endothelial vessels, and luminal epithelium of FT. In FT from women with EP, CB1 mRNA expression was low. CB1 mRNA expression was also significantly lower (p<0.05) in endometrium of women with EP compared to intrauterine pregnancies (IUP). Although of 1359G/A (rs1049353) polymorphisms of CNR1 gene suggests differential distribution of genotypes between the small, available cohorts of women with EP and those with IUP, results were not statistically significant. Conclusions: CB1 mRNA shows temporal variation in expression in human FT, likely regulated by progesterone. CB1 mRNA is expressed in low levels in both the FT and endometrium of women with EP. We propose that aberrant endocannabinoid-signaling in human FT leads to EP. Furthermore, our finding of reduced mRNA expression along with a possible association between polymorphism genotypes of the CNR1 gene and EP, suggests a possible genetic predisposition to EP that warrants replication in a larger sample pool.	[Horne, Andrew W.; Kane, Nicole; Lourenco, Paula C.; McDonald, Sarah E.; Critchley, Hilary O. D.] Univ Edinburgh, Ctr Reprod Biol, Dept Reprod & Dev Sci, Queens Med Res Inst, Edinburgh EH3 9EW, Midlothian, Scotland; [Phillips, John A., III] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN USA; [Williams, Alistair R. W.] Univ Edinburgh, Roy Infirmary Edinburgh, Dept Pathol, Edinburgh EH8 9YL, Midlothian, Scotland; [Simon, Carlos] Univ Valencia, Inst Univ IVI, FIVI, E-46003 Valencia, Spain; [Dey, Sudhansu K.] Cincinnati Childrens Res Fdn, Div Reprod Sci, Cincinnati, OH USA	University of Edinburgh; Vanderbilt University; University of Edinburgh; University of Valencia; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation	Horne, AW (corresponding author), Univ Edinburgh, Ctr Reprod Biol, Dept Reprod & Dev Sci, Queens Med Res Inst, Edinburgh EH3 9EW, Midlothian, Scotland.	hilary.critchley@ed.ac.uk	Simon, Carlos/G-2186-2014	Simon, Carlos/0000-0003-0902-9531; CRITCHLEY, HILARY/0000-0003-1913-4044; Horne, Andrew/0000-0002-9656-493X; McDonald, Sarah/0000-0003-2776-7415	Tenovus Scotland [E06/7]; The Barbour Watson Trust; NHS Lothian Research and Development [SPG2006/7]; NIDA/NIH [DA06668]; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA006668, R01DA006668] Funding Source: NIH RePORTER	Tenovus Scotland; The Barbour Watson Trust; NHS Lothian Research and Development; NIDA/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by Tenovus Scotland (E06/7) (AWH), The Barbour Watson Trust (AWH and HODC), and NHS Lothian Research and Development (SPG2006/7) (AWH) and an NIDA/NIH grant (DA06668) (SKD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball E, 2006, J PATHOL, V208, P535, DOI 10.1002/path.1927; BLOCH E, 1978, VITAM HORM, V36, P203; Catalano RD, 2007, MOL HUM REPROD, V13, P641, DOI 10.1093/molehr/gam021; CHANG MC, 1993, MOL REPROD DEV, V36, P507, DOI 10.1002/mrd.1080360416; Farquhar CM, 2005, LANCET, V366, P583, DOI 10.1016/S0140-6736(05)67103-6; Gadzicki D, 1999, MOL CELL PROBE, V13, P321, DOI 10.1006/mcpr.1999.0249; Gonzalez S, 2002, BRAIN RES, V954, P73, DOI 10.1016/S0006-8993(02)03344-9; Hamdani N, 2008, EUR NEUROPSYCHOPHARM, V18, P34, DOI 10.1016/j.euroneuro.2007.05.005; HEILMAN RD, 1976, FERTIL STERIL, V27, P426; HELM G, 1982, ACTA PHYSIOL SCAND, V114, P425, DOI 10.1111/j.1748-1716.1982.tb07005.x; HOWE GR, 1973, J REPROD FERTIL, V33, P425; Kane N, 2008, MOL ENDOCRINOL, V22, P716, DOI 10.1210/me.2007-0316; Kao LC, 2002, ENDOCRINOLOGY, V143, P2119, DOI 10.1210/en.143.6.2119; Maccarrone M, 2000, EUR J BIOCHEM, V267, P2991; Mukul LV, 2007, OBSTET GYN CLIN N AM, V34, P403, DOI 10.1016/j.ogc.2007.07.001; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Paria BC, 2001, J BIOL CHEM, V276, P20523, DOI 10.1074/jbc.M100679200; Russo P, 2007, J CLIN ENDOCR METAB, V92, P2382, DOI 10.1210/jc.2006-2523; SAMUELSON UE, 1986, ACTA PHYSIOL SCAND, V126, P355, DOI 10.1111/j.1748-1716.1986.tb07827.x; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; SCHUEL H, 1994, P NATL ACAD SCI USA, V91, P7678, DOI 10.1073/pnas.91.16.7678; SMITH CG, 1987, FERTIL STERIL, V48, P355; Sun XF, 2008, MOL CELL ENDOCRINOL, V286, pS3, DOI 10.1016/j.mce.2008.01.002; Taylor AH, 2007, HUM REPROD UPDATE, V13, P501, DOI 10.1093/humupd/dmm018; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wang HB, 2004, NAT MED, V10, P1074, DOI 10.1038/nm1104; Wang HB, 2003, P NATL ACAD SCI USA, V100, P14914, DOI 10.1073/pnas.2436379100; WILHELMSSON L, 1980, FERTIL STERIL, V33, P280; YOSHINAGA K, 1979, BIOL REPROD, V20, P294, DOI 10.1095/biolreprod20.2.294; 2003, SAVING MOTHERS LIVES	30	56	59	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2008	3	12							e3969	10.1371/journal.pone.0003969	http://dx.doi.org/10.1371/journal.pone.0003969			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AT	19093002	gold, Green Published, Green Submitted			2022-12-25	WOS:000265458600006
J	Throsby, M; van den Brink, E; Jongeneelen, M; Poon, LLM; Alard, P; Cornelissen, L; Bakker, A; Cox, F; van Deventer, E; Guan, Y; Cinatl, J; ter Meulen, J; Lasters, I; Carsetti, R; Peiris, M; de Kruif, J; Goudsmit, J				Throsby, Mark; van den Brink, Edward; Jongeneelen, Mandy; Poon, Leo L. M.; Alard, Philippe; Cornelissen, Lisette; Bakker, Arjen; Cox, Freek; van Deventer, Els; Guan, Yi; Cinatl, Jindrich; ter Meulen, Jan; Lasters, Ignace; Carsetti, Rita; Peiris, Malik; de Kruif, John; Goudsmit, Jaap			Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM(+) Memory B Cells	PLOS ONE			English	Article								Background: The hemagglutinin (HA) glycoprotein is the principal target of protective humoral immune responses to influenza virus infections but such antibody responses only provide efficient protection against a narrow spectrum of HA antigenic variants within a given virus subtype. Avian influenza viruses such as H5N1 are currently panzootic and pose a pandemic threat. These viruses are antigenically diverse and protective strategies need to cross protect against diverse viral clades. Furthermore, there are 16 different HA subtypes and no certainty the next pandemic will be caused by an H5 subtype, thus it is important to develop prophylactic and therapeutic interventions that provide heterosubtypic protection. Methods and Findings: Here we describe a panel of 13 monoclonal antibodies (mAbs) recovered from combinatorial display libraries that were constructed from human IgM(+) memory B cells of recent (seasonal) influenza vaccinees. The mAbs have broad heterosubtypic neutralizing activity against antigenically diverse H1, H2, H5, H6, H8 and H9 influenza subtypes. Restriction to variable heavy chain gene IGHV1-69 in the high affinity mAb panel was associated with binding to a conserved hydrophobic pocket in the stem domain of HA. The most potent antibody (CR6261) was protective in mice when given before and after lethal H5N1 or H1N1 challenge. Conclusions: The human monoclonal CR6261 described in this study could be developed for use as a broad spectrum agent for prophylaxis or treatment of human or avian influenza infections without prior strain characterization. Moreover, the CR6261 epitope could be applied in targeted vaccine strategies or in the design of novel antivirals. Finally our approach of screening the IgM+ memory repertoire could be applied to identify conserved and functionally relevant targets on other rapidly evolving pathogens.	[Throsby, Mark; van den Brink, Edward; Jongeneelen, Mandy; Bakker, Arjen; Cox, Freek; van Deventer, Els; ter Meulen, Jan; de Kruif, John; Goudsmit, Jaap] Crucell Holland BV, Leiden, Netherlands; [Poon, Leo L. M.; Guan, Yi; Peiris, Malik] Univ Hong Kong, Queen Mary Hosp, Hong Kong Special Admin Region, Dept Microbiol, Hong Kong, Peoples R China; [Alard, Philippe; Lasters, Ignace] Algonom NV, Ghent, Belgium; [Cornelissen, Lisette] Wageningen Univ, Cent Vet Inst, Lelystad, Netherlands; [Cinatl, Jindrich] Goethe Univ Frankfurt, Inst Med Virol, D-6000 Frankfurt, Germany; [Carsetti, Rita] Bambino Gesu Childrens Res Hosp, Lab Cell Biol, Rome, Italy	Johnson & Johnson; University of Hong Kong; Wageningen University & Research; Goethe University Frankfurt; IRCCS Bambino Gesu	Throsby, M (corresponding author), Merus BV, Utrecht, Netherlands.	j.goudsmit@crucell.com	Poon, Leo Lit Man/C-4382-2009; Poon, Leo/AAP-6887-2020; Carsetti, Rita/K-7616-2016; Peiris, Joseph Sriyal Malik/C-4380-2009	Poon, Leo Lit Man/0000-0002-9101-7953; Carsetti, Rita/0000-0002-2632-1078; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; Guan, Yi/0000-0001-6057-9243	SenterNovem [IS055026]; Area of Excellence Scheme of the University Grants Committee, Hong Kong [AoE/M-12/06]	SenterNovem; Area of Excellence Scheme of the University Grants Committee, Hong Kong	This work was supported through grant IS055026 from SenterNovem. LLMP, YG and JSMP are supported by an Area of Excellence Scheme of the University Grants Committee, Hong Kong (Grant AoE/M-12/06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIR GM, 1981, P NATL ACAD SCI-BIOL, V78, P7639, DOI 10.1073/pnas.78.12.7639; Baumgarth N, 2000, J EXP MED, V192, P271, DOI 10.1084/jem.192.2.271; Boel E, 2000, J IMMUNOL METHODS, V239, P153, DOI 10.1016/S0022-1759(00)00170-8; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; CDC, 1997, MMWR-MORBID MORTAL W, V46, P1204; Chin PS, 2002, J VIROL, V76, P507, DOI 10.1128/JVI.76.2.507-516.2002; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Desmet J, 2002, PROTEINS, V48, P31, DOI 10.1002/prot.10131; Eliasson DG, 2008, VACCINE, V26, P1243, DOI 10.1016/j.vaccine.2007.12.027; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; GERHARD W, 1981, NATURE, V290, P713, DOI 10.1038/290713a0; Gerhard W, 2001, CURR TOP MICROBIOL, V260, P171; Gocnik M, 2008, J GEN VIROL, V89, P958, DOI 10.1099/vir.0.83524-0; GRAVES PN, 1983, VIROLOGY, V126, P106, DOI 10.1016/0042-6822(83)90465-8; Hanson BJ, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-126; Harada Y, 2003, J EXP MED, V197, P1779, DOI 10.1084/jem.20021457; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062; Jayasekera JP, 2007, J VIROL, V81, P3487, DOI 10.1128/JVI.02128-06; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Kramer RA, 2005, EUR J IMMUNOL, V35, P2131, DOI 10.1002/eji.200526134; Kramer RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng058; Kruetzmann S, 2003, J EXP MED, V197, P939, DOI 10.1084/jem.20022020; Luftig MA, 2006, NAT STRUCT MOL BIOL, V13, P740, DOI 10.1038/nsmb1127; Luke TC, 2006, ANN INTERN MED, V145, P599, DOI 10.7326/0003-4819-145-8-200610170-00139; Ma W, 2007, P NATL ACAD SCI USA, V104, P20949, DOI 10.1073/pnas.0710286104; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; OKUNO Y, 1994, J VIROL, V68, P517, DOI 10.1128/JVI.68.1.517-520.1994; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Russell RJ, 2004, VIROLOGY, V325, P287, DOI 10.1016/j.virol.2004.04.040; Simmons CP, 2007, PLOS MED, V4, P928, DOI 10.1371/journal.pmed.0040178; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Smirnov YA, 2000, ARCH VIROL, V145, P1733, DOI 10.1007/s007050070088; Subbarao K, 2006, IMMUNITY, V24, P5, DOI 10.1016/j.immuni.2005.12.005; Tangye SG, 2007, J IMMUNOL, V179, P13, DOI 10.4049/jimmunol.179.1.13; WANG ML, 1986, J VIROL, V57, P124, DOI 10.1128/JVI.57.1.124-128.1986; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; WHO, 2021, CUM NUMB CONF HUM CA; *WHO ECDC, 2008, FREQ ASK QUEST OS RE; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Xu KM, 2007, J VIROL, V81, P10389, DOI 10.1128/JVI.00979-07; Zhou BP, 2007, NEW ENGL J MED, V357, P1450, DOI 10.1056/NEJMc070359	49	582	690	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2008	3	12							e3942	10.1371/journal.pone.0003942	http://dx.doi.org/10.1371/journal.pone.0003942			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AR	19079604	gold, Green Published			2022-12-25	WOS:000265458400003
J	Hurtado-Guerrero, R; Schuttelkopf, AW; Mouyna, I; Ibrahim, AFM; Shepherd, S; Fontaine, T; Latge, JP; van Aalten, DMF				Hurtado-Guerrero, Ramon; Schuettelkopf, Alexander W.; Mouyna, Isabelle; Ibrahim, Adel F. M.; Shepherd, Sharon; Fontaine, Thierry; Latge, Jean-Paul; van Aalten, Daan M. F.			Molecular Mechanisms of Yeast Cell Wall Glucan Remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULES; PH-REGULATED GENE; SACCHAROMYCES-CEREVISIAE; XYLOGLUCAN ENDOTRANSGLYCOSYLASE; ASPERGILLUS-FUMIGATUS; CANDIDA-ALBICANS; OLIVE POLLEN; FUNGAL CELL; SCHIZOSACCHAROMYCES-POMBE; PROTEIN STRUCTURES	Yeast cell wall remodeling is controlled by the equilibrium between glycoside hydrolases, glycosyltransferases, and transglycosylases. Family 72 glycoside hydrolases (GH72) are ubiquitous in fungal organisms and are known to possess significant transglycosylase activity, producing elongated beta(1-3) glucan chains. However, the molecular mechanisms that control the balance between hydrolysis and transglycosylation in these enzymes are not understood. Here we present the first crystal structure of a glucan transglycosylase, Saccharomyces cerevisiae Gas2 (ScGas2), revealing a multidomain fold, with a (beta alpha)(8) catalytic core and a separate glucan binding domain with an elongated, conserved glucan binding groove. Structures of ScGas2 complexes with different beta-glucan substrate/product oligosaccharides provide "snapshots" of substrate binding and hydrolysis/transglycosylation giving the first insights into the mechanisms these enzymes employ to drive beta(1-3) glucan elongation. Together with mutagenesis and analysis of reaction products, the structures suggest a "base occlusion" mechanism through which these enzymes protect the covalent protein-enzyme intermediate from a water nucleophile, thus controlling the balance between hydrolysis and transglycosylation and driving the elongation of beta(1-3) glucan chains in the yeast cell wall.	[Hurtado-Guerrero, Ramon; Schuettelkopf, Alexander W.; Shepherd, Sharon; van Aalten, Daan M. F.] Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee DD1 5EH, Scotland; [Ibrahim, Adel F. M.] Univ Dundee, Coll Life Sci, Div Signal Transduct Therapy, CLS DNA Manipulat Team, Dundee DD1 5EH, Scotland; [Mouyna, Isabelle; Fontaine, Thierry; Latge, Jean-Paul] Inst Pasteur, Unite Aspergillus, F-75724 Paris, France	University of Dundee; University of Dundee; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Hurtado-Guerrero, R (corresponding author), Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee DD1 5EH, Scotland.	R.Hurtadoguerrero@dundee.ac.uk; dmfvanaalten@dundee.ac.uk	Ibrahim, Adel FM/E-5273-2012; Fontaine, Thierry/F-8227-2011; mouyna, isabelle/F-3578-2011; Latge, Jean Paul/C-9846-2014; Mouyna, Isabelle/O-7697-2018; Fontaine, thierry/Q-2201-2018	Mouyna, Isabelle/0000-0003-3140-5927; Fontaine, thierry/0000-0002-8184-789X; Hurtado-Guerrero, Ramon/0000-0002-3122-9401; van Aalten, Daan/0000-0002-1499-6908	Wellcome Trust senior research fellowship; European Union FP6 STREP Fungwall Programme	Wellcome Trust senior research fellowship(Wellcome Trust); European Union FP6 STREP Fungwall Programme(European Commission)	This work was supported by a Wellcome Trust senior research fellowship ( to D. M. F. v. A.) and European Union FP6 STREP Fungwall Programme. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. The atomic coordinates and structure factors ( codes 2W61, 2W62, and 2W63) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ ( http:// www. rcsb. org/).	Adams DJ, 2004, MICROBIOL-SGM, V150, P2029, DOI 10.1099/mic.0.26980-0; Andersen OA, 2008, CHEM BIOL, V15, P295, DOI 10.1016/j.chembiol.2008.02.015; Bahadur RP, 2003, PROTEINS, V53, P708, DOI 10.1002/prot.10461; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barral P, 2005, BIOCHEM J, V390, P77, DOI 10.1042/BJ20050456; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Cabib E, 2007, MOL MICROBIOL, V63, P921, DOI 10.1111/j.1365-2958.2006.05565.x; Coutinho PM, 1999, ROY SOC CH, P3; de Medina-Redondo M, 2008, MOL MICROBIOL, V68, P1283, DOI 10.1111/j.1365-2958.2008.06233.x; Dias FMV, 2004, J BIOL CHEM, V279, P25517, DOI 10.1074/jbc.M401647200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fleet G.H., 1991, YEASTS, VVol. 4, P199, DOI [10.1002/jobm.19720120411, DOI 10.1002/JOBM.19720120411]; Fontaine T, 2000, J BIOL CHEM, V275, P41528; Fontaine T, 2000, J BIOL CHEM, V275, P27594; GHANNOUM MA, 1995, INFECT IMMUN, V63, P4528, DOI 10.1128/IAI.63.11.4528-4530.1995; Hartland RP, 1996, J BIOL CHEM, V271, P26843, DOI 10.1074/jbc.271.43.26843; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Hurtado-Guerrero R, 2007, CHEM BIOL, V14, P589, DOI 10.1016/j.chembiol.2007.03.015; Jain S, 1996, NAT STRUCT BIOL, V3, P375, DOI 10.1038/nsb0496-375; Johansson P, 2004, PLANT CELL, V16, P874, DOI 10.1105/tpc.020065; Kauffman CA, 2008, SEMIN RESP CRIT CARE, V29, P211, DOI 10.1055/s-2008-1063859; Kitagaki H, 2002, MOL MICROBIOL, V46, P1011, DOI 10.1046/j.1365-2958.2002.03244.x; KOLLAR R, 1995, J BIOL CHEM, V270, P1170, DOI 10.1074/jbc.270.3.1170; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; Mouyna I, 2005, MOL MICROBIOL, V56, P1675, DOI 10.1111/j.1365-2958.2005.04654.x; Mouyna I, 2000, J BIOL CHEM, V275, P14882, DOI 10.1074/jbc.275.20.14882; Mouyna I, 2000, BIOCHEM J, V347, P741, DOI 10.1042/0264-6021:3470741; Muhlschlegel FA, 1997, MOL CELL BIOL, V17, P5960; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape D, 2004, ORTHOP CLIN N AM, V35, P293, DOI 10.1016/j.ocl.2004.04.001; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; POPOLO L, 1993, J BACTERIOL, V175, P1879, DOI 10.1128/JB.175.7.1879-1885.1993; Popolo L, 2008, J BIOL CHEM, V283, P18553, DOI 10.1074/jbc.M801562200; Ragni E, 2007, YEAST, V24, P297, DOI 10.1002/yea.1473; Ragni E, 2007, EUKARYOT CELL, V6, P302, DOI 10.1128/EC.00321-06; Ram AFJ, 1998, J BACTERIOL, V180, P1418, DOI 10.1128/JB.180.6.1418-1424.1998; Rodriguez R, 2007, J INVEST ALLERG CLIN, V17, P4; Rodriguez-Pena JM, 2000, MOL CELL BIOL, V20, P3245, DOI 10.1128/MCB.20.9.3245-3255.2000; Rye CS, 2000, CURR OPIN CHEM BIOL, V4, P573, DOI 10.1016/S1367-5931(00)00135-6; SAPORITOIRWIN SM, 1995, MOL CELL BIOL, V15, P601; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shoseyov O, 2006, MICROBIOL MOL BIOL R, V70, P283, DOI 10.1128/MMBR.00028-05; Sulova Z, 1998, BIOCHEM J, V330, P1475, DOI 10.1042/bj3301475; Sulova Z, 2001, PLANT PHYSIOL BIOCH, V39, P927, DOI 10.1016/S0981-9428(01)01313-4; Tougan T, 2002, GENES CELLS, V7, P217, DOI 10.1046/j.1356-9597.2001.00511.x; Trevino MA, 2008, PROTEIN SCI, V17, P371, DOI 10.1110/ps.073230008; Wierenga RK, 2001, FEBS LETT, V492, P193, DOI 10.1016/S0014-5793(01)02236-0	51	61	63	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8461	8469		10.1074/jbc.M807990200	http://dx.doi.org/10.1074/jbc.M807990200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19097997	Green Published, hybrid			2022-12-25	WOS:000264397800030
J	Tourand, Y; Deneke, J; Moriarty, TJ; Chaconas, G				Tourand, Yvonne; Deneke, Jan; Moriarty, Tara J.; Chaconas, George			Characterization and in Vitro Reaction Properties of 19 Unique Hairpin Telomeres from the Linear Plasmids of the Lyme Disease Spirochete	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BORRELIA-BURGDORFERI; RESOLVASE REST; STRAIN B31; SEQUENCE; GENOME; INFECTIVITY; RESOLUTION; EXCHANGE; DISTINCT; CYCLE	The genome of the Lyme disease pathogen Borrelia burgdorferi contains about a dozen linear DNA molecules that carry covalently closed hairpin telomeres as a specialized mechanism for dealing with the end-replication problem. The hairpin telomeres are generated from replicative intermediates through a two-step transesterification promoted by the telomere resolvase ResT. Although the genome of B. burgdorferi has been sequenced, the sequence of most telomeres has remained unknown because of difficulties in recovering and completely sequencing the covalently closed hairpin ends. In this study we report a new approach for the direct sequencing Borrelia telomeres and report the sequence, characterization, and in vitro reaction properties of 19 unique telomeres. Surprisingly, a variation of greater than 160-fold in the initial reaction rates of in vitro ResT-mediated telomere resolution was observed between the most active and least active telomeres. Moreover, three of the hairpin telomeres were completely inactive in vitro, but their in vivo functionality was demonstrated. Our results provide important new information on the structure and function of the B. burgdorferi telomeres and suggest the possibility that factors besides the telomere resolvase ResT may influence the reaction in vivo and rescue those telomeres that are not functional in vitro with ResT alone.	Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary	Chaconas, G (corresponding author), 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	chaconas@ucalgary.ca	Moriarty, Tara J./K-1684-2016	Moriarty, Tara J./0000-0002-1751-5145	Canadian Institutes of Health [MOP-53086]; Canada Research Chairs Program; Alberta Heritage Fund for Medical Research	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); Alberta Heritage Fund for Medical Research(Alberta Heritage Foundation for Medical Research)	This research was supported in part by the Canadian Institutes of Health Research Grant MOP-53086, the Canada Research Chairs Program, and the Alberta Heritage Fund for Medical Research. The costs of publication of this article were defrayed in part by the payment of page charges.	Aihara H, 2007, MOL CELL, V27, P901, DOI 10.1016/j.molcel.2007.07.026; Bankhead T, 2004, P NATL ACAD SCI USA, V101, P13768, DOI 10.1073/pnas.0405762101; Bankhead T, 2006, MOL MICROBIOL, V62, P895, DOI 10.1111/j.1365-2958.2006.05423.x; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; BARBOUR AG, 1987, SCIENCE, V237, P409, DOI 10.1126/science.3603026; Barbour AG, 1997, NATURE, V390, P553, DOI 10.1038/37475; Beaurepaire C, 2005, MOL MICROBIOL, V57, P132, DOI 10.1111/j.1365-2958.2005.04688.x; Bono JL, 2000, J BACTERIOL, V182, P2445, DOI 10.1128/JB.182.9.2445-2452.2000; Byram R, 2004, J BACTERIOL, V186, P3561, DOI 10.1128/JB.186.11.3561-3569.2004; Casjens S, 1997, MOL MICROBIOL, V26, P581, DOI 10.1046/j.1365-2958.1997.6051963.x; Casjens S, 2000, J MOL MICROB BIOTECH, V2, P401; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Chaconas G, 2005, MOL MICROBIOL, V58, P625, DOI 10.1111/j.1365-2958.2005.04872.x; Chaconas G, 2001, EMBO J, V20, P3229, DOI 10.1093/emboj/20.12.3229; Deneke J, 2004, J BIOL CHEM, V279, P53699, DOI 10.1074/jbc.M409001200; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Grimm D, 2005, J MED ENTOMOL, V42, P676, DOI 10.1603/0022-2585(2005)042[0676:DPRBBB]2.0.CO;2; Grimm D, 2004, INFECT IMMUN, V72, P5938, DOI 10.1128/IAI.72.10.5938-5946.2004; HINNEBUSCH J, 1991, J BACTERIOL, V173, P7233, DOI 10.1128/jb.173.22.7233-7239.1991; HINNEBUSCH J, 1990, MOL MICROBIOL, V4, P811, DOI 10.1111/j.1365-2958.1990.tb00651.x; Huang WM, 2004, J BACTERIOL, V186, P4134, DOI 10.1128/JB.186.13.4134-4141.2004; Jewett MW, 2007, MOL MICROBIOL, V66, P975, DOI 10.1111/j.1365-2958.2007.05969.x; Jewett MW, 2007, MOL MICROBIOL, V64, P1358, DOI 10.1111/j.1365-2958.2007.05746.x; Kobryn K, 2005, J BIOL CHEM, V280, P26788, DOI 10.1074/jbc.M504530200; Kobryn K, 2005, MOL CELL, V17, P783, DOI 10.1016/j.molcel.2005.02.025; Kobryn K, 2002, MOL CELL, V9, P195, DOI 10.1016/S1097-2765(01)00433-6; Labandeira-Rey M, 2001, INFECT IMMUN, V69, P446, DOI 10.1128/IAI.69.1.446-455.2001; Lawrenz MB, 2002, INFECT IMMUN, V70, P4798, DOI 10.1128/IAI.70.9.4798-4804.2002; Miller JC, 2000, J BACTERIOL, V182, P6254, DOI 10.1128/JB.182.21.6254-6258.2000; Pal U, 2004, J CLIN INVEST, V113, P220, DOI 10.1172/JCI200419894; Picardeau M, 2000, MICROBIOL-UK, V146, P305, DOI 10.1099/00221287-146-2-305; Purser JE, 2003, MOL MICROBIOL, V48, P753, DOI 10.1046/j.1365-2958.2003.03452.x; Purser JE, 2000, P NATL ACAD SCI USA, V97, P13865, DOI 10.1073/pnas.97.25.13865; Revel AT, 2005, P NATL ACAD SCI USA, V102, P6972, DOI 10.1073/pnas.0502565102; Stewart PE, 2005, PLASMID, V53, P1, DOI 10.1016/j.plasmid.2004.10.006; Strother KO, 2005, VECTOR-BORNE ZOONOT, V5, P237, DOI 10.1089/vbz.2005.5.237; Tourand Y, 2003, MOL MICROBIOL, V48, P901, DOI 10.1046/j.1365-2958.2003.03485.x; Tourand Y, 2007, MOL MICROBIOL, V64, P580, DOI 10.1111/j.1365-2958.2007.05691.x; Tourand Y, 2006, J BACTERIOL, V188, P7378, DOI 10.1128/JB.00760-06; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; Yang XFF, 2004, J EXP MED, V199, P641, DOI 10.1084/jem.20031960; Zhang JR, 1997, CELL, V89, P275, DOI 10.1016/S0092-8674(00)80206-8	42	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7264	7272		10.1074/jbc.M808918200	http://dx.doi.org/10.1074/jbc.M808918200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19122193	Green Published, hybrid			2022-12-25	WOS:000263919000073
J	AbdAlla, S; Lother, H; el Missiry, A; Sergeev, P; Langer, A; el Faramawy, Y; Quitterer, U				AbdAlla, Said; Lother, Heinz; el Missiry, Ahmed; Sergeev, Pavel; Langer, Andreas; el Faramawy, Yasser; Quitterer, Ursula			Dominant Negative AT(2) Receptor Oligomers Induce G-protein Arrest and Symptoms of Neurodegeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE BRAIN; PHOSPHOINOSITIDE HYDROLYSIS; MUSCARINIC RECEPTOR; OXIDATIVE STRESS; TRANSGENIC MICE; KINASE-C; TRANSGLUTAMINASE; HETERODIMERS; G(Q)/G(11); SECRETION	Neurodegeneration in Alzheimer's disease ( AD) correlates with dysfunction of signaling mediated by G alpha(q/11). Nondissociable angiotensin II AT(2) receptor oligomers are linked to the impaired G alpha(q/11)-stimulated signaling of AD patients and transgenic mice with AD-like symptoms. To further analyze the role of AT(2) receptor oligomers, we induced the formation of AT(2) oligomers in an in vitro cell system. Similarly as in vivo, sequential oxidative and transglutaminase-dependent cross-linking steps triggered the formation of AT(2) oligomers in vitro. Elevated reactive oxygen species mediated oxidative cross-linking of AT(2) monomers to dimers involving tyrosine residues located at putative interreceptor contact sites of the cytoplasmic loop connecting transmembrane helices III/IV. Cross-linked AT(2) dimers were subsequently a substrate of activated transglutaminase-2, which targeted the carboxyl terminus of AT(2) dimers, as assessed by truncated and chimeric AT(2) receptors, respectively. AT(2) oligomers acted as dominant negative receptors in vitro by mediating G alpha(q/11) protein sequestration and G alpha(q/11) protein arrest. The formation of AT(2) oligomers and G-protein dysfunction could be suppressed in vitro and in vivo by an AT(2) receptor mutant. Inhibition of AT(2) oligomerization upon stereotactic expression of the AT(2) receptor mutant revealed that G alpha(q/11) sequestering AT(2) oligomers enhanced the development of neurodegenerative symptoms in the hippocampus of transgenic mice with AD-like pathology. Thus, AT(2) oligomers inducing G alpha(q/11) arrest are causally involved in inducing symptoms of neurodegeneration.	[AbdAlla, Said; Lother, Heinz; el Faramawy, Yasser] Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, D-20251 Hamburg, Germany; [el Missiry, Ahmed] Ain Shams Univ Hosp, Med Res Ctr, Cairo, Egypt; [Sergeev, Pavel; Langer, Andreas; Quitterer, Ursula] Swiss Fed Inst Technol, Dept Mol Pharmacol, CH-8057 Zurich, Switzerland; [Sergeev, Pavel; Langer, Andreas; Quitterer, Ursula] Univ Zurich, CH-8057 Zurich, Switzerland	Heinrich Pette Institute; University of Hamburg; Egyptian Knowledge Bank (EKB); Ain Shams University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Quitterer, U (corresponding author), Y17M70,Winterthurerstr 190, CH-8057 Zurich, Switzerland.	ursula.quitterer@pharma.ethz.ch						AbdAlla S, 2004, CELL, V119, P343, DOI 10.1016/j.cell.2004.10.006; AbdAlla S, 2001, J BIOL CHEM, V276, P39721, DOI 10.1074/jbc.M105253200; AbdAlla S, 2000, NATURE, V407, P94, DOI 10.1038/35024095; AbdAlla S, 2001, NAT MED, V7, P1003, DOI 10.1038/nm0901-1003; AbdAlla S, 2009, J BIOL CHEM, V284, P6554, DOI 10.1074/jbc.M807746200; Bonelli RM, 2002, NEUROBIOL DIS, V11, P106, DOI 10.1006/nbdi.2002.0535; Butterfield DA, 2004, BRAIN PATHOL, V14, P426; BUXBAUM JD, 1992, P NATL ACAD SCI USA, V89, P10075, DOI 10.1073/pnas.89.21.10075; Caccamo A, 2006, NEURON, V49, P671, DOI 10.1016/j.neuron.2006.01.020; de la Monte SM, 2006, J ALZHEIMERS DIS, V9, P167; FERRARIDILEO G, 1993, LIFE SCI, V53, pPL439, DOI 10.1016/0024-3205(93)90037-4; Fotiadis D, 2004, FEBS LETT, V564, P281, DOI 10.1016/S0014-5793(04)00194-2; FOWLER CJ, 1995, MOL CELL BIOCHEM, V149, P287, DOI 10.1007/BF01076590; GREENWOOD AF, 1995, NEUROSCIENCE, V69, P125, DOI 10.1016/0306-4522(95)00220-D; Haring R, 1998, J NEUROCHEM, V71, P2094; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Johnson GVW, 1997, BRAIN RES, V751, P323, DOI 10.1016/S0006-8993(96)01431-X; JOPE RS, 1994, NEUROBIOL AGING, V15, P221, DOI 10.1016/0197-4580(94)90116-3; King DL, 2002, PHYSIOL BEHAV, V75, P627, DOI 10.1016/S0031-9384(02)00639-X; Miura M, 2002, J NEUROSCI, V22, P8379; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nurnberg A, 2008, J BIOL CHEM, V283, P35526, DOI 10.1074/jbc.M804972200; Sayas CL, 1999, J BIOL CHEM, V274, P37046, DOI 10.1074/jbc.274.52.37046; Tsang SWY, 2006, NEUROBIOL AGING, V27, P1216, DOI 10.1016/j.neurobiolaging.2005.07.010; Wess J, 2007, NAT REV DRUG DISCOV, V6, P721, DOI 10.1038/nrd2379; Wettschureck N, 2006, MOL CELL BIOL, V26, P5888, DOI 10.1128/MCB.00397-06	26	36	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6566	6574		10.1074/jbc.M808277200	http://dx.doi.org/10.1074/jbc.M808277200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19074439	hybrid, Green Accepted			2022-12-25	WOS:000263742700059
J	Urban, A; Behm-Ansmant, I; Branlant, C; Motorin, Y				Urban, Alan; Behm-Ansmant, Isabelle; Branlant, Christiane; Motorin, Yuri			RNA Sequence and Two-dimensional Structure Features Required for Efficient Substrate Modification by the Saccharomyces cerevisiae RNA:Psi-Synthase Pus7p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASMIC TRANSFER-RNAS; SMALL NUCLEAR RNAS; 5S RIBOSOMAL-RNA; PSEUDOURIDINE-SYNTHASE; U2 SNRNA; SUBCELLULAR-LOCALIZATION; CONSERVED PSEUDOURIDINE; TRANSFER RNA(TYR); YEAST; RECOGNITION	The RNA: pseudouridine (Psi) synthase Pus7p of Saccharomyces cerevisiae is a multisite-specific enzyme that is able to modify U-13 in several yeast tRNAs, U-35 in the pre-tRNA(Tyr) (G Psi A), U-35 in U2 small nuclear RNA, and U-50 in 5 S rRNA. Pus7p belongs to the universally conserved TruD-like family of RNA: Psi-synthases found in bacteria, archaea, and eukarya. Although several RNA substrates for yeast Pus7p have been identified, specificity of their recognition and modification has not been studied. However, conservation of a 7-nt-long sequence, including the modified U residue, in all natural Pus7p substrates suggested the importance of these nucleotides for Pus7p recognition and/or catalysis. Using site-directed mutagenesis, we designed a set of RNA variants derived from the yeast tRNA(Asp)(GUC), pre- tRNA(Tyr)(G Psi A), and U2 small nuclear RNA and tested their ability to be modified by Pus7p in vitro. We demonstrated that the highly conserved U-2 and A (+1) residues (nucleotide numbers refer to target U-0) are crucial identity elements for efficient modification by Pus7p. Nucleotide substitutions at other surrounding positions (-4, -3, -2, -3) have only a moderate effect. Surprisingly, the identity of the nucleotide immediately 5' to the target U-0 residue (position-1) is not important for efficient modification. Alteration of tRNA three-dimensional structure had no detectable effect on Pus7p activity at position 13. However, our results suggest that the presence of at least one stem-loop structure including or close to the target U nucleotide is required for Pus7p-catalyzed modification.	[Motorin, Yuri] Nancy Univ, Lab Maturat ARN & Enzymol Mol, UMR 7567, CNRS UHP Nancy 1,Fac Sci, F-54506 Vandoeuvre Les Nancy, France	Universite de Lorraine	Motorin, Y (corresponding author), Nancy Univ, Lab Maturat ARN & Enzymol Mol, UMR 7567, CNRS UHP Nancy 1,Fac Sci, BP 239, F-54506 Vandoeuvre Les Nancy, France.	Yuri.Motorin@maem.uhp-nancy.fr	MOTORIN, Yuri/E-2499-2011; MOTORIN, Yuri/AAQ-9527-2020; BEHM-ANSMANT, Isabelle/B-1406-2012	MOTORIN, Yuri/0000-0002-8018-334X; URBAN, Alan/0000-0002-6460-2364; Branlant, Christiane/0000-0003-4728-5499; Behm-Ansmant, Isabelle/0000-0001-8909-0660; Motorin, Alexandr/0000-0001-9622-4591	CNRS; Ministere de la Jeunesse; de l'Education Nationale et de la Recherche	CNRS(Centre National de la Recherche Scientifique (CNRS)); Ministere de la Jeunesse; de l'Education Nationale et de la Recherche	This work was supported by laboratory funds from the CNRS and the Ministere de la Jeunesse, de l'Education Nationale et de la Recherche."	Ansmant I, 2000, NUCLEIC ACIDS RES, V28, P1941, DOI 10.1093/nar/28.9.1941; Ansmant I, 2001, J BIOL CHEM, V276, P34934, DOI 10.1074/jbc.M103131200; ARES M, 1986, CELL, V47, P49, DOI 10.1016/0092-8674(86)90365-X; Auffinger P, 1998, J BIOMOL STRUCT DYN, V16, P693, DOI 10.1080/07391102.1998.10508281; Auffinger P, 2001, RNA, V7, P334, DOI 10.1017/S1355838201002382; Becker HF, 1997, J MOL BIOL, V274, P505, DOI 10.1006/jmbi.1997.1417; Becker HF, 1997, NUCLEIC ACIDS RES, V25, P4493, DOI 10.1093/nar/25.22.4493; Behm-Ansmant I, 2004, J BIOL CHEM, V279, P52998, DOI 10.1074/jbc.M409581200; Behm-Ansmant I, 2003, RNA, V9, P1371, DOI 10.1261/rna.5520403; Behm-Ansmant I, 2006, RNA, V12, P1583, DOI 10.1261/rna.100806; Bhasin M, 2004, NUCLEIC ACIDS RES, V32, pW414, DOI 10.1093/nar/gkh350; BRANLANT C, 1982, EMBO J, V1, P1259, DOI 10.1002/j.1460-2075.1982.tb00022.x; CHOFFAT Y, 1988, MOL CELL BIOL, V8, P3332, DOI 10.1128/MCB.8.8.3332; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Decatur WA, 2008, MOL CELL BIOL, V28, P3089, DOI 10.1128/MCB.01574-07; Drawid A, 2000, J MOL BIOL, V301, P1059, DOI 10.1006/jmbi.2000.3968; Ericsson UB, 2004, FEBS LETT, V565, P59, DOI 10.1016/j.febslet.2004.03.085; Gu XR, 1998, BIOCHEMISTRY-US, V37, P339, DOI 10.1021/bi971590p; Hua SJ, 2001, BIOINFORMATICS, V17, P721, DOI 10.1093/bioinformatics/17.8.721; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Hur S, 2006, J BIOL CHEM, V281, P38969, DOI 10.1074/jbc.R600034200; Ishitani R, 2003, CELL, V113, P383, DOI 10.1016/S0092-8674(03)00280-0; Jiang HQ, 1997, NUCLEIC ACIDS RES, V25, P2694, DOI 10.1093/nar/25.14.2694; JOHNSON PF, 1983, NATURE, V302, P681, DOI 10.1038/302681a0; Kaya Y, 2003, RNA, V9, P711, DOI 10.1261/rna.5230603; KEITH G, 1995, BIOCHIMIE, V77, P142, DOI 10.1016/0300-9084(96)88118-1; Kiparisov S, 2005, MOL GENET GENOMICS, V274, P235, DOI 10.1007/s00438-005-0020-9; Koonin EV, 1996, NUCLEIC ACIDS RES, V24, P2411, DOI 10.1093/nar/24.12.2411; Lin Y, 2008, BIOCHEMISTRY-US, V47, P5503, DOI 10.1021/bi7022392; Ma XJ, 2003, EMBO J, V22, P1889, DOI 10.1093/emboj/cdg191; Massenet S, 1999, MOL CELL BIOL, V19, P2142; MORAS D, 1980, NATURE, V288, P669, DOI 10.1038/288669a0; Motorin Y, 1998, RNA, V4, P856, DOI 10.1017/S1355838298980396; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Newby MI, 2002, NAT STRUCT BIOL, V9, P958, DOI 10.1038/nsb873; NISHIKAW.K, 1974, FEBS LETT, V40, P106, DOI 10.1016/0014-5793(74)80904-X; Pienkowska J, 2002, BBA-GENE STRUCT EXPR, V1574, P137, DOI 10.1016/S0167-4781(01)00355-4; QUIGLEY GJ, 1976, SCIENCE, V194, P796, DOI 10.1126/science.790568; Roovers M, 2006, NUCLEIC ACIDS RES, V34, P4293, DOI 10.1093/nar/gkl530; Smith MW, 2001, MOL CELL BIOL, V21, P8264, DOI 10.1128/MCB.21.24.8264-8275.2001; Sprinzl M, 2005, NUCLEIC ACIDS RES, V33, pD139, DOI 10.1093/nar/gki012; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; SWERDLOW H, 1984, J BIOL CHEM, V259, P5197; SZWEYKOWSKAKULINSKA Z, 1992, EMBO J, V11, P1907, DOI 10.1002/j.1460-2075.1992.tb05243.x; Szymanski M, 2002, NUCLEIC ACIDS RES, V30, P176, DOI 10.1093/nar/30.1.176; VANTOL H, 1988, NUCLEIC ACIDS RES, V16, P1951, DOI 10.1093/nar/16.5.1951; Yang CX, 2005, J BIOL CHEM, V280, P6655, DOI 10.1074/jbc.M413288200; ZERFASS K, 1992, NUCLEIC ACIDS RES, V20, P5911, DOI 10.1093/nar/20.22.5911	48	23	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5845	5858		10.1074/jbc.M807986200	http://dx.doi.org/10.1074/jbc.M807986200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19114708	hybrid, Green Published			2022-12-25	WOS:000263560600048
J	Huo, YL; McConnell, SC; Yang, SRLR; Zhang, TT; Sun, CW; Wu, LC; Ryan, TM				Huo, Yongliang; McConnell, Sean C.; Yang, Shan-Run Liu Rui; Zhang, Ting-Ting; Sun, Chiao-Wang; Wu, Li-Chen; Ryan, Thomas M.			Humanized Mouse Model of Cooley's Anemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GLOBIN GENE; SICKLE-CELL-DISEASE; HUMAN GAMMA-GLOBIN; YEAST ARTIFICIAL CHROMOSOME; EMBRYONIC STEM-CELLS; TRANSGENIC MICE; DEVELOPMENTAL REGULATION; INEFFECTIVE ERYTHROPOIESIS; SPLICING MUTATION; THALASSEMIA	A novel humanized mouse model of Cooley's Anemia (CA) was generated by targeted gene replacement in embryonic stem (ES) cells. Because the mouse does not have a true fetal hemoglobin, a delayed switching human gamma to beta(0) globin gene cassette (gamma beta(0)) was inserted directly into the murine beta globin locus replacing both adult mouse beta globin genes. The inserted human beta(0) globin allele has a mutation in the splice donor site that produces the same aberrant transcripts in mice as described in human cells. No functional human beta globin polypeptide chains are produced. Heterozygous gamma beta(0) mice suffer from microcytic anemia. Unlike previously described animal models of beta thalassemia major, homozygous gamma beta(0) mice switch from mouse embryonic globin chains to human fetal gamma globin during fetal life. When bred with human alpha globin knockin mice, homozygous CA mice survive solely upon human fetal hemoglobin at birth. This preclinical animal model of CA can be utilized to study the regulation of globin gene expression, synthesis, and switching; the reactivation of human fetal globin gene expression; and the testing of genetic and cell-based therapies for the correction of thalassemia.	[Huo, Yongliang; McConnell, Sean C.; Yang, Shan-Run Liu Rui; Zhang, Ting-Ting; Sun, Chiao-Wang; Wu, Li-Chen; Ryan, Thomas M.] Univ Alabama, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Ryan, TM (corresponding author), 1918 Univ Blvd,MCLM 566A, Birmingham, AL 35294 USA.	tryan@uab.edu	McConnell, Sean/E-6775-2011	Ryan, Thomas/0000-0002-8982-0253; McConnell, Sean/0000-0002-0988-5373	National Institutes of Health [R01 HL072351, R01 HL073440]; UAB CMB Training [T32 GM008111]; Carmichael Scholarship; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073440, R01HL072351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008111] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UAB CMB Training; Carmichael Scholarship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL072351 (to T. M. R.) and R01 HL073440 (to T. M. R.); UAB CMB Training Grant T32 GM008111 (to S. C. M.); and the Carmichael Scholarship (to S. C. M. and T.-T. Z.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bank A, 1985, Curr Top Hematol, V5, P1; BEHRINGER RR, 1990, GENE DEV, V4, P380, DOI 10.1101/gad.4.3.380; BEHRINGER RR, 1989, SCIENCE, V245, P971, DOI 10.1126/science.2772649; BUNN HF, 1986, HEMOGLOBIN MOL GENET, P333; CIAVATTA DJ, 1995, P NATL ACAD SCI USA, V92, P9259, DOI 10.1073/pnas.92.20.9259; ENVER T, 1990, NATURE, V344, P309, DOI 10.1038/344309a0; FERGUSON DJ, 1990, AM J HEMATOL, V33, P13, DOI 10.1002/ajh.2830330104; FORGET BG, 1975, ANNU REV MED, V26, P345, DOI 10.1146/annurev.me.26.020175.002021; FORRESTER WC, 1986, P NATL ACAD SCI USA, V83, P1359, DOI 10.1073/pnas.83.5.1359; GAENSLER KML, 1993, P NATL ACAD SCI USA, V90, P11381, DOI 10.1073/pnas.90.23.11381; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Jamsai D, 2005, GENOMICS, V85, P453, DOI 10.1016/j.ygeno.2004.11.016; Kaufman RM, 1999, BLOOD, V94, P3178, DOI 10.1182/blood.V94.9.3178.421k23_3178_3184; KAZAZIAN HH, 1975, P NATL ACAD SCI USA, V72, P567, DOI 10.1073/pnas.72.2.567; Kean LS, 2002, EXP HEMATOL, V30, P394, DOI 10.1016/S0301-472X(02)00780-4; Kingsley PD, 2006, BLOOD, V107, P1665, DOI 10.1182/blood-2005-08-3097; Kollia P, 1992, Gene Geogr, V6, P59; Lewis J, 1998, BLOOD, V91, P2152, DOI 10.1182/blood.V91.6.2152.2152_2152_2156; Mathias LA, 2000, EXP HEMATOL, V28, P1343, DOI 10.1016/S0301-472X(00)00555-5; NIENHUIS AW, 1978, CELL, V15, P307, DOI 10.1016/0092-8674(78)90106-X; Nishino T, 2006, BRIT J HAEMATOL, V134, P100, DOI 10.1111/j.1365-2141.2006.06102.x; Nozaki M, 1999, LAB INVEST, V79, P293; PETERSON KR, 1993, P NATL ACAD SCI USA, V90, P7593, DOI 10.1073/pnas.90.16.7593; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rivella S, 2003, BLOOD, V101, P2932, DOI 10.1182/blood-2002-10-3305; Ryan TM, 1997, SCIENCE, V278, P873, DOI 10.1126/science.278.5339.873; RYAN TM, 1989, P NATL ACAD SCI USA, V86, P37, DOI 10.1073/pnas.86.1.37; Ryan TM, 2000, NUCLEIC ACIDS RES, V28, P2736, DOI 10.1093/nar/28.14.2736; RYAN TM, 1990, SCIENCE, V247, P566, DOI 10.1126/science.2154033; RYAN TM, 1989, GENE DEV, V3, P314, DOI 10.1101/gad.3.3.314; SHEHEE WR, 1993, P NATL ACAD SCI USA, V90, P3177, DOI 10.1073/pnas.90.8.3177; SKOW LC, 1983, CELL, V34, P1043, DOI 10.1016/0092-8674(83)90562-7; STEINBERG MH, 1988, AM J MED SCI, V296, P308, DOI 10.1097/00000441-198811000-00004; STROUBOULIS J, 1992, GENE DEV, V6, P1857, DOI 10.1101/gad.6.10.1857; TREISMAN R, 1983, NATURE, V302, P591, DOI 10.1038/302591a0; TUAN D, 1984, P NATL ACAD SCI-BIOL, V81, P2718, DOI 10.1073/pnas.81.9.2718; Vadolas J, 2006, J BIOL CHEM, V281, P7399, DOI 10.1074/jbc.M512931200; WHITELAW E, 1990, MOL CELL BIOL, V10, P6596, DOI 10.1128/MCB.10.12.6596; Wu LC, 2006, BLOOD, V108, P1183, DOI 10.1182/blood-2006-02-004812; YANG BL, 1995, P NATL ACAD SCI USA, V92, P11608, DOI 10.1073/pnas.92.25.11608; YUAN J, 1993, BLOOD, V82, P374, DOI 10.1182/blood.V82.2.374.bloodjournal822374	41	17	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4889	4896		10.1074/jbc.M805681200	http://dx.doi.org/10.1074/jbc.M805681200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19098001	Green Published, hybrid			2022-12-25	WOS:000263416600018
J	Jennings, TA; Mackintosh, SG; Harrison, MK; Sikora, D; Sikora, B; Dave, B; Tackett, AJ; Cameron, CE; Raney, KD				Jennings, Thomas A.; Mackintosh, Samuel G.; Harrison, Melody K.; Sikora, Deniz; Sikora, Bartek; Dave, Bhuvanesh; Tackett, Alan J.; Cameron, Craig E.; Raney, Kevin D.			NS3 Helicase from the Hepatitis C Virus Can Function as a Monomer or Oligomer Depending on Enzyme and Substrate Concentrations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIOPHAGE-T4 DDA HELICASE; SINGLE-STRANDED-DNA; PROTEIN-PROTEIN INTERACTIONS; IN-VITRO; NONSTRUCTURAL PROTEIN-3; MACROMOLECULAR MACHINES; REPLICATION COMPLEX; UNWINDING ACTIVITY; CRYSTAL-STRUCTURE; HCVNS3 HELICASE	Hepatitis C virus NS3 helicase can unwind double-stranded DNA and RNA and has been proposed to form oligomeric structures. Here we examine the DNA unwinding activity of monomeric NS3. Oligomerization was measured by preparing a fluorescently labeled form of NS3, which was titrated with unlabeled NS3, resulting in a hyperbolic increase in fluorescence anisotropy and providing an apparent equilibrium dissociation constant of 236 nM. To evaluate the DNA binding activity of individual subunits within NS3 oligomers, two oligonucleotides were labeled with fluorescent donor or acceptor molecules and then titrated with NS3. Upon the addition of increasing concentrations of NS3, fluorescence energy transfer was observed, which reached a plateau at a 1: 1 ratio of NS3 to oligonucleotides, indicating that each subunit within the oligomeric form of NS3 binds to DNA. DNA unwinding was measured under multiple turnover conditions with increasing concentrations of NS3; however, no increase in specific activity was observed, even at enzyme concentrations greater than the apparent dissociation constant for oligomerization. An ATPase-deficient form of NS3, NS3(D290A), was prepared to explore the functional consequences of oligomerization. Under single turnover conditions in the presence of excess concentration of NS3 relative to DNA, NS3(D290A) exhibited a dominant negative effect. However, under multiple turnover conditions in which DNA concentration was in excess to enzyme concentration, NS3(D290A) did not exhibit a dominant negative effect. Taken together, these data support a model in which monomeric forms of NS3 are active. Oligomerization of NS3 occurs, but subunits can function independently or cooperatively, dependent upon the relative concentration of the DNA.	[Jennings, Thomas A.; Mackintosh, Samuel G.; Harrison, Melody K.; Sikora, Deniz; Sikora, Bartek; Dave, Bhuvanesh; Tackett, Alan J.; Raney, Kevin D.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [Cameron, Craig E.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	University of Arkansas System; University of Arkansas Medical Sciences; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Raney, KD (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.	raneykevind@uams.edu			National Institutes of Health [AI060563]; Arkansas IDeA Networkof Biomedical Research Excellence Research [P20RR016460]; Arkansas Biosciences Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI060563, R01AI060563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arkansas IDeA Networkof Biomedical Research Excellence Research; Arkansas Biosciences Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (AI060563 to K. D. R. and C. E. C.), Arkansas IDeA Networkof Biomedical Research Excellence Research Grant (P20RR016460), and the Arkansas Biosciences Institute. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Beran RKF, 2008, J BIOL CHEM, V283, P29929, DOI 10.1074/jbc.M804065200; Byrd AK, 2005, BIOCHEMISTRY-US, V44, P12990, DOI 10.1021/bi050703z; Cheng W, 2001, J MOL BIOL, V310, P327, DOI 10.1006/jmbi.2001.4758; Delagoutte E, 2002, Q REV BIOPHYS, V35, P431, DOI 10.1017/S0033583502003852; Dillingham MS, 2002, BIOCHEMISTRY-US, V41, P643, DOI 10.1021/bi011137k; Dimitrova M, 2003, J VIROL, V77, P5401, DOI 10.1128/JVI.77.9.5401-5414.2003; DONG F, 1995, J BIOL CHEM, V270, P7462, DOI 10.1074/jbc.270.13.7462; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; FAILLA C, 1995, J VIROL, V69, P1769, DOI 10.1128/JVI.69.3.1769-1777.1995; Fischer CJ, 2004, J MOL BIOL, V344, P1287, DOI 10.1016/j.jmb.2004.10.005; Gallinari P, 1999, BIOCHEMISTRY-US, V38, P5620, DOI 10.1021/bi982892+; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; Griffin BA, 2000, METHOD ENZYMOL, V327, P565; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Gwack Y, 1997, EUR J BIOCHEM, V250, P47, DOI 10.1111/j.1432-1033.1997.00047.x; Gwack Y, 1996, BIOCHEM BIOPH RES CO, V225, P654, DOI 10.1006/bbrc.1996.1225; Ishido S, 1998, BIOCHEM BIOPH RES CO, V244, P35, DOI 10.1006/bbrc.1998.8202; Jennings TA, 2008, BIOCHEMISTRY-US, V47, P1126, DOI 10.1021/bi701048a; Jezewska MJ, 1998, J BIOL CHEM, V273, P10515, DOI 10.1074/jbc.273.17.10515; Kang LW, 1998, ACTA CRYSTALLOGR D, V54, P121, DOI 10.1107/S0907444997008883; Khu YL, 2001, J VIROL, V75, P205, DOI 10.1128/JVI.75.1.205-214.2001; KIM DW, 1995, BIOCHEM BIOPH RES CO, V215, P160, DOI 10.1006/bbrc.1995.2447; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Kolykhalov AA, 2000, J VIROL, V74, P2046, DOI 10.1128/JVI.74.4.2046-2051.2000; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Levin MK, 1999, J BIOL CHEM, V274, P31839, DOI 10.1074/jbc.274.45.31839; Levin MK, 2004, J BIOL CHEM, V279, P26005, DOI 10.1074/jbc.M403257200; Locatelli GA, 2002, BIOCHEMISTRY-US, V41, P10332, DOI 10.1021/bi026082g; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Lundblad JR, 1996, MOL ENDOCRINOL, V10, P607, DOI 10.1210/me.10.6.607; Maluf NK, 2003, J MOL BIOL, V325, P913, DOI 10.1016/S0022-2836(02)01277-9; Mechanic LE, 1999, J BIOL CHEM, V274, P12488, DOI 10.1074/jbc.274.18.12488; Morris PD, 2001, J BIOL CHEM, V276, P19691, DOI 10.1074/jbc.M010928200; Morris PD, 2001, METHODS, V23, P149, DOI 10.1006/meth.2000.1116; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; Nanduri B, 2002, P NATL ACAD SCI USA, V99, P14722, DOI 10.1073/pnas.232401899; Pang PS, 2002, EMBO J, V21, P1168, DOI 10.1093/emboj/21.5.1168; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Piccininni S, 2002, J BIOL CHEM, V277, P45670, DOI 10.1074/jbc.M204124200; Porter DJT, 1998, J BIOL CHEM, V273, P18906, DOI 10.1074/jbc.273.30.18906; Preugschat F, 2000, BIOCHEMISTRY-US, V39, P5174, DOI 10.1021/bi9923860; Quinkert D, 2005, J VIROL, V79, P13594, DOI 10.1128/JVI.79.21.13594-13605.2005; Rajagopal V, 2008, J MOL BIOL, V376, P69, DOI 10.1016/j.jmb.2007.10.070; Rasnik I, 2004, J MOL BIOL, V336, P395, DOI 10.1016/j.jmb.2003.12.031; RestrepoHartwig MA, 1996, J VIROL, V70, P8908, DOI 10.1128/JVI.70.12.8908-8916.1996; Serebrov V, 2004, NATURE, V430, P476, DOI 10.1038/nature02704; Sikora B, 2008, J BIOL CHEM, V283, P11516, DOI 10.1074/jbc.M708125200; Soultanas P, 2001, TRENDS BIOCHEM SCI, V26, P47, DOI 10.1016/S0968-0004(00)01734-5; Stano NM, 2005, NATURE, V435, P370, DOI 10.1038/nature03615; Tackett AJ, 2005, J BIOL CHEM, V280, P10797, DOI 10.1074/jbc.M407971200; Tackett AJ, 2001, NUCLEIC ACIDS RES, V29, P565, DOI 10.1093/nar/29.2.565; Tai CL, 1996, J VIROL, V70, P8477, DOI 10.1128/JVI.70.12.8477-8484.1996; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; von Hippel PH, 2001, CELL, V104, P177, DOI 10.1016/S0092-8674(01)00203-3; Wolk B, 2000, J VIROL, V74, P2293, DOI 10.1128/JVI.74.5.2293-2304.2000; Yang Q, 2007, MOL CELL, V28, P253, DOI 10.1016/j.molcel.2007.08.016; Yao NH, 1999, STRUCTURE, V7, P1353, DOI 10.1016/S0969-2126(00)80025-8; Yao NH, 1997, NAT STRUCT BIOL, V4, P463, DOI 10.1038/nsb0697-463; Zhang C, 2005, J VIROL, V79, P8687, DOI 10.1128/JVI.79.14.8687-8697.2005	59	36	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4806	4814		10.1074/jbc.M805540200	http://dx.doi.org/10.1074/jbc.M805540200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19088075	Green Published, hybrid			2022-12-25	WOS:000263416600008
J	Liu, J; Weiss, HL; Rychahou, P; Jackson, LN; Evers, BM; Gao, T				Liu, J.; Weiss, H. L.; Rychahou, P.; Jackson, L. N.; Evers, B. M.; Gao, T.			Loss of PHLPP expression in colon cancer: role in proliferation and tumorigenesis	ONCOGENE			English	Article						PHLPP; colon cancer cells; Akt; protein kinase C; tumorigenesis	PROTEIN-KINASE-C; BREAST-CANCER; CELLS; GENE; AKT; GROWTH; CARCINOGENESIS; PHOSPHATASE; INVASION; P27	PHLPP (PH domain leucine-rich repeats protein phosphatase) represents a family of novel Ser/Thr protein phosphatases. Two highly related isoforms in this family, PHLPP1 and PHLPP2, have been identified to serve as negative regulators of Akt and protein kinase C by dephosphorylating the kinases directly. In this study, we examined the expression pattern of both PHLPP isoforms in colorectal cancer specimens and the adjacent normal mucosa using immunohistochemical staining. We found that the expression of PHLPP1 or PHLPP2 isoform was lost or decreased in 78 and 86% of tumor tissues, respectively. Stable overexpression of either PHLPP isoform in colon cancer cells decreased the rate of cell proliferation and sensitized the cells to growth inhibition induced by the phosphoinositide-3 kinase inhibitor, LY294002, whereas knockdown of either PHLPP isoform by shRNA promoted the proliferation of DLD1 cells. In addition, we demonstrated that the PHLPP-mediated growth inhibition in colon cancer cells was largely rescued by overexpression of a constitutively active Akt. Moreover, reexpression of either PHLPP isoform in HCT116 cells inhibited tumor growth in vivo. Taken together, our results strongly support a tumor suppressor role of PHLPP in colon cancer.	[Gao, T.] Univ Texas Galveston, Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; [Liu, J.] Sichuan Univ, W China Med Sch Preclin & Forens Med, Dept Biochem & Mol Biol, Chengdu 610064, Sichuan, Peoples R China; [Liu, J.; Weiss, H. L.; Evers, B. M.; Gao, T.] Univ Texas Galveston, Med Branch, Sealy Ctr Canc Cell Biol, Galveston, TX 77555 USA; [Weiss, H. L.] Univ Texas Galveston, Med Branch, Dept Prevent Med & Community Hlth, Galveston, TX 77555 USA; [Rychahou, P.; Jackson, L. N.; Evers, B. M.] Univ Texas Galveston, Med Branch, Dept Surg, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; Sichuan University; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Gao, T (corresponding author), Univ Texas Galveston, Med Branch, Dept Pharmacol & Toxicol, 301 Univ Blvd, Galveston, TX 77555 USA.	tigao@utmb.edu		Rychahou, Piotr/0000-0001-7352-9122	NIH [K01 CA10209-05]; American Cancer Society [RSG0822001TBE, R01CA104748]; NATIONAL CANCER INSTITUTE [R01CA104748, K01CA102098] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank UTMB. ow cytometry core for assistance with the. ow cytometry analysis, and Dr Alexandra Newton at University of California San Diego for providing the wild- type and mutant Akt and PKC bII expression constructs. This work was supported by NIH K01 CA10209-05(TG), American Cancer Society RSG0822001TBE (TG) and R01CA104748 (BME).	Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gokmen-Polar Y, 2001, CANCER RES, V61, P1375; Hershko DD, 2006, CANCER-AM CANCER SOC, V107, P668, DOI 10.1002/cncr.22073; Kosinski C, 2007, P NATL ACAD SCI USA, V104, P15418, DOI 10.1073/pnas.0707210104; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Manning BD, 2005, GENE DEV, V19, P1773, DOI 10.1101/gad.1314605; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Maroulakou IG, 2007, CANCER RES, V67, P167, DOI 10.1158/0008-5472.CAN-06-3782; Murray NR, 1999, J CELL BIOL, V145, P699, DOI 10.1083/jcb.145.4.699; Nakayama K, 2004, DEV CELL, V6, P661, DOI 10.1016/S1534-5807(04)00131-5; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Qiao M, 2007, CANCER RES, V67, P5293, DOI 10.1158/0008-5472.CAN-07-0877; REINER A, 1990, CANCER RES, V50, P7057; Rosner M, 2006, MUTAT RES-REV MUTAT, V613, P10, DOI 10.1016/j.mrrev.2006.03.001; Saaf AM, 2007, MOL BIOL CELL, V18, P4245, DOI 10.1091/mbc.E07-04-0309; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Yoeli-Lerner M, 2005, MOL CELL, V20, P539, DOI 10.1016/j.molcel.2005.10.033	21	126	137	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 19	2009	28	7					994	1004		10.1038/onc.2008.450	http://dx.doi.org/10.1038/onc.2008.450			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	408TH	19079341	Green Accepted			2022-12-25	WOS:000263457400006
J	Danielsen, JMR; Larsen, DH; Schou, KB; Freire, R; Falck, J; Bartek, J; Lukas, J				Danielsen, Jannie M. Rendtlew; Larsen, Dorthe Helena; Schou, Kenneth Bodtker; Freire, Raimundo; Falck, Jacob; Bartek, Jiri; Lukas, Jiri			HCLK2 Is Required for Activity of the DNA Damage Response Kinase ATR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE CHECKPOINTS; DOUBLE-STRAND BREAKS; S-PHASE CHECKPOINT; CAENORHABDITIS-ELEGANS; IONIZING-RADIATION; ACTIVATION; CHK1; PROTEIN; TOPBP1; PHOSPHORYLATION	ATR is a protein kinase that orchestrates the cellular response to replication problems and DNA damage. HCLK2 has previously been reported to stabilize ATR and Chk1. Here we provide evidence that human HCLK2 acts at an early step in the ATR signaling pathway and contributes to full-scale activation of ATR kinase activity. We show that HCLK2 forms a complex with ATR-ATRIP and the ATR activator TopBP1. We demonstrate that HCLK2-induced ATR kinase activity toward substrates requires TopBP1 and vice versa and provides evidence that HCLK2 facilitates efficient ATR-TopBP1 association. Consistent with its role in ATR activation, HCLK2 depletion severely impaired phosphorylation of multiple ATR targets including Chk1, Nbs1, and Smc1 after DNA damage. We show that HCLK2 is required for and stimulates ATR autophosphorylation and activity toward different substrates in vitro. Furthermore, HCLK2 depletion abrogated the G(2) checkpoint and decreased survival of cells after exposure to DNA damaging agents and replicative stress. Overall, our data suggest that HCLK2 facilitates ATR activation and, therefore, contributes to ATR-mediated checkpoint signaling. Importantly, our results suggest that HCLK2 functions in the same pathway as TopBP1 but that the two proteins regulate different steps in ATR activation.	[Danielsen, Jannie M. Rendtlew; Larsen, Dorthe Helena; Schou, Kenneth Bodtker; Bartek, Jiri; Lukas, Jiri] Danish Canc Soc, Inst Canc Biol, DK-2100 Copenhagen, Denmark; [Danielsen, Jannie M. Rendtlew; Larsen, Dorthe Helena; Schou, Kenneth Bodtker; Bartek, Jiri; Lukas, Jiri] Danish Canc Soc, Ctr Genotox Stress Res, DK-2100 Copenhagen, Denmark; [Freire, Raimundo] Hosp Univ Canarias, Unidad Investigac, Tenerife 38320, Spain; [Falck, Jacob] Novo Nordisk AS, DK-2880 Bagsvaerd, Denmark	Danish Cancer Society; Danish Cancer Society; Universidad de la Laguna; Novo Nordisk	Bartek, J (corresponding author), Danish Canc Soc, Inst Canc Biol, Strandboulevarden 49, DK-2100 Copenhagen, Denmark.	jb@cancer.dk; jil@cancer.dk	Larsen, Dorthe Helena/E-9771-2010; Freire, Raimundo/Q-7660-2019; Bartek, Jiri/G-5870-2014; Larsen, Dorthe Helena/Z-6206-2019	Larsen, Dorthe Helena/0000-0002-8280-1252; Freire, Raimundo/0000-0003-4473-8894; Larsen, Dorthe Helena/0000-0002-8280-1252; Lukas, Jiri/0000-0001-9087-506X	Danish Cancer Society, Danish National Research Foundation; Danish Medical Research Council and European Union ( DNA Repair)	Danish Cancer Society, Danish National Research Foundation(Danish Cancer SocietyDanmarks Grundforskningsfond); Danish Medical Research Council and European Union ( DNA Repair)	This work was supported by the Danish Cancer Society, Danish National Research Foundation, and Danish Medical Research Council and European Union ( DNA Repair). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Ahmed S, 2001, CURR BIOL, V11, P1934, DOI 10.1016/S0960-9822(01)00604-2; Anderson CM, 2008, GENE DEV, V22, P854, DOI 10.1101/gad.1646208; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Benard C, 2001, DEVELOPMENT, V128, P4045; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; Collis SJ, 2007, NAT CELL BIOL, V9, P391, DOI 10.1038/ncb1555; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Falck J, 2002, NAT GENET, V30, P290, DOI 10.1038/ng845; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Garcia V, 2005, DNA REPAIR, V4, P1227, DOI 10.1016/j.dnarep.2005.04.001; Garcia-Muse T, 2005, EMBO J, V24, P4345, DOI 10.1038/sj.emboj.7600896; Hall-Jackson CA, 1999, ONCOGENE, V18, P6707, DOI 10.1038/sj.onc.1203077; HARTMAN PS, 1982, GENETICS, V102, P159; Hayashi T, 2007, GENES CELLS, V12, P1357, DOI 10.1111/j.1365-2443.2007.01141.x; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Kumagai A, 2004, J BIOL CHEM, V279, P49599, DOI 10.1074/jbc.M408353200; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Liu QH, 2000, GENE DEV, V14, P1448; Liu S, 2006, MOL CELL BIOL, V26, P6056, DOI 10.1128/MCB.00492-06; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Shikata M, 2007, J BIOL CHEM, V282, P5346, DOI 10.1074/jbc.M607432200; Syljuasen RG, 2004, CANCER RES, V64, P9035, DOI 10.1158/0008-5472.CAN-04-2434; Takai H, 2007, CELL, V131, P1248, DOI 10.1016/j.cell.2007.10.052; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	36	36	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4140	4147		10.1074/jbc.M808174200	http://dx.doi.org/10.1074/jbc.M808174200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19097996	hybrid			2022-12-25	WOS:000263134400011
J	Mollicone, R; Moore, SEH; Bovin, N; Garcia-Rosasco, M; Candelier, JJ; Martinez-Duncker, I; Oriol, R				Mollicone, Rosella; Moore, Stuart E. H.; Bovin, Nicolai; Garcia-Rosasco, Marcela; Candelier, Jean-Jacques; Martinez-Duncker, Ivan; Oriol, Rafael			Activity, Splice Variants, Conserved Peptide Motifs, and Phylogeny of Two New alpha 1,3-Fucosyltransferase Families (FUT10 and FUT11)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUCOSYL-TRANSFERASE GENES; GROWTH FACTOR-LIKE; DROSOPHILA-MELANOGASTER; N-GLYCANS; SUBSTRATE-SPECIFICITY; SEQUENCE ALIGNMENT; MOLECULAR-CLONING; O-FUCOSYLATION; CDNA CLONING; AMINO-ACID	We report the cloning of three splice variants of the FUT10 gene, encoding for active alpha-L-fucosyltransferase-isoforms of 391, 419, and 479 amino acids, and two splice variants of the FUT11 gene, encoding for two related alpha-L-fucosyltransferases of 476 and 492 amino acids. The FUT10 and FUT11 appeared 830 million years ago, whereas the other alpha 1,3-fucosyltransferases emerged 450 million years ago. FUT10-391 and FUT10-419 were expressed in human embryos, whereas FUT10-479 was cloned from adult brain and was not found in embryos. Recombinant FUT10-419 and FUT10-479 have a type II trans-membrane topology and are retained in the endoplasmic reticulum (ER) by a membrane retention signal at their NH2 termini. The FUT10-479 has, in addition, a COOH-ER membrane retention signal. The FUT10-391 is a soluble protein without a transmembrane domain or ER retention signal that transiently localizes to the Golgi and then is routed to the lysosome. After transfection in COS7 cells, the three FUT10s and at least one FUT11, link alpha-L-fucose onto conalbumin glycopeptides and biantennary N-glycan acceptors but not onto short lactosaminyl acceptor substrates as do classical monoexonic alpha 1,3-fucosyltransferases. Modifications of the innermost core GlcNAc of the N-glycan, by substitution with ManNAc or with an opened GlcNAc ring or by the addition of an alpha 1,6-fucose, suggest that the FUT10 transfer is performed on the innermost GlcNAc of the core chitobiose. We can exclude alpha 1,3-fucosylation of the two peripheral GlcNAcs linked to the trimannosyl core of the acceptor, because the FUT10 fucosylated biantennary N-glycan product loses both terminal GlcNAc residues after digestion with human placenta alpha-N-acetylglucosaminidase.	[Mollicone, Rosella; Garcia-Rosasco, Marcela; Candelier, Jean-Jacques; Martinez-Duncker, Ivan; Oriol, Rafael] Univ Paris 11, INSERM, U602, F-94807 Villejuif, France; [Moore, Stuart E. H.] Univ Paris 07, INSERM, U773, CRB3, F-75018 Paris, France; [Bovin, Nicolai] Russian Acad Sci, MM Shemyakin Bioorgan Chem Inst, Moscow 117997, Russia	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Mollicone, R (corresponding author), Univ Paris 11, INSERM, U602, 16 Ave Paul Vaillant Couturier, F-94807 Villejuif, France.	rosella.mollicone@inserm.fr	Bovin, Nicolai/P-2948-2017; Duncker, Ivan Martinez/AAE-6105-2020; Moore, Stuart/AAF-3920-2021	Bovin, Nicolai/0000-0001-8669-4477; Duncker, Ivan Martinez/0000-0001-5626-2892; Moore, Stuart/0000-0002-1020-2242	INSERM; CNRS Groupement de Recherche 2590; Association de la Recherche contre le Cancer [RM-3611]; Fonds National pour la Science [ACI 0693]; EUROGLYCANET; Contract Interface	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS Groupement de Recherche 2590; Association de la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Fonds National pour la Science; EUROGLYCANET; Contract Interface	This work was supported in part by INSERM, CNRS Groupement de Recherche 2590, Association de la Recherche contre le Cancer Grant RM-3611, Fonds National pour la Science (ACI 0693 Biologie Cellulaire, Moleculaire et Structurale BMCS152 2004), EUROGLYCANET, and a Contract Interface (INSERM/AP) (to S. E. H. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aebi M, 2001, TRENDS CELL BIOL, V11, P136, DOI 10.1016/S0962-8924(01)01925-0; Altmann F, 2007, INT ARCH ALLERGY IMM, V142, P99, DOI 10.1159/000096114; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baboval T, 2002, MAMM GENOME, V13, P538, DOI 10.1007/s00335-001-2152-5; Bardor M, 2003, GLYCOBIOLOGY, V13, P427, DOI 10.1093/glycob/cwg024; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Blair JE, 2005, MOL BIOL EVOL, V22, P2275, DOI 10.1093/molbev/msi225; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; Breton C, 1998, GLYCOBIOLOGY, V8, P87, DOI 10.1093/glycob/8.1.87; Britten CJ, 1998, GLYCOBIOLOGY, V8, P321, DOI 10.1093/glycob/8.4.321; Cailleau-Thomas A, 2000, GLYCOBIOLOGY, V10, P789, DOI 10.1093/glycob/10.8.789; Candelier JJ, 2000, HISTOCHEM CELL BIOL, V114, P113; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Clarke JL, 1996, J BIOL CHEM, V271, P10317, DOI 10.1074/jbc.271.17.10317; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Costache M, 1997, J BIOL CHEM, V272, P29721, DOI 10.1074/jbc.272.47.29721; Costache M, 1997, TRANSFUS CLIN BIOL, V4, P367, DOI 10.1016/S1246-7820(97)80042-0; Coullin P, 2003, CYTOGENET GENOME RES, V103, P111, DOI 10.1159/000076298; Dupuy F, 1999, J BIOL CHEM, V274, P12257, DOI 10.1074/jbc.274.18.12257; Dupuy F, 2004, GLYCOBIOLOGY, V14, P347, DOI 10.1093/glycob/cwh053; Dupuy F, 2002, MOL BIOL EVOL, V19, P815, DOI 10.1093/oxfordjournals.molbev.a004138; Fabini G, 2001, J BIOL CHEM, V276, P28058, DOI 10.1074/jbc.M100573200; Faveeuw C, 2003, EUR J IMMUNOL, V33, P1271, DOI 10.1002/eji.200323717; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GABORIAUD C, 1987, FEBS LETT, V224, P149, DOI 10.1016/0014-5793(87)80439-8; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Harduin-Lepers A, 2005, GLYCOBIOLOGY, V15, P805, DOI 10.1093/glycob/cwi063; Hedges SB, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-2; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Javaud C, 2003, GENETICA, V118, P157, DOI 10.1023/A:1024101625214; Kageyama N, 1999, J BIOCHEM-TOKYO, V125, P838, DOI 10.1093/oxfordjournals.jbchem.a022357; KORCHAGINA EY, 1992, BIOORG KHIM+, V18, P283; LEGAULT DJ, 1995, J BIOL CHEM, V270, P20987, DOI 10.1074/jbc.270.36.20987; Leiter H, 1999, J BIOL CHEM, V274, P21830, DOI 10.1074/jbc.274.31.21830; LEMESLEVARLOOT L, 1990, BIOCHIMIE, V72, P555, DOI 10.1016/0300-9084(90)90120-6; LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679, DOI 10.1091/mbc.4.7.679; Loriol C, 2006, GLYCOBIOLOGY, V16, P736, DOI 10.1093/glycob/cwj124; Lowe JB, 2001, CELL, V104, P809, DOI 10.1016/S0092-8674(01)00277-X; Luo Y, 2005, J BIOL CHEM, V280, P11289, DOI 10.1074/jbc.M414574200; Luo Y, 2006, J BIOL CHEM, V281, P9385, DOI 10.1074/jbc.M511974200; Luo Y, 2006, J BIOL CHEM, V281, P9393, DOI 10.1074/jbc.M511975200; Martinez-Duncker I, 2004, GLYCOBIOLOGY, V14, P13, DOI 10.1093/glycob/cwh006; Martinez-Duncker I, 2003, GLYCOBIOLOGY, V13, p1C, DOI 10.1093/glycob/cwg113; MOLLICONE R, 1992, CARBOHYD RES, V228, P265, DOI 10.1016/S0008-6215(00)90564-0; MOORE SEH, 1994, J BIOL CHEM, V269, P12715; Natunen J, 2001, GLYCOBIOLOGY, V11, P209, DOI 10.1093/glycob/11.3.209; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Oriol R, 1999, GLYCOBIOLOGY, V9, P323, DOI 10.1093/glycob/9.4.323; Oriol R., 1995, BLOOD CEL B, P37; PALCIC MM, 1988, GLYCOCONJUGATE J, V5, P49, DOI 10.1007/BF01048331; Paschinger K, 2005, GLYCOBIOLOGY, V15, P463, DOI 10.1093/glycob/cwi028; Petit D, 2006, J MOL EVOL, V63, P353, DOI 10.1007/s00239-005-0189-x; Rendic D, 2006, J BIOL CHEM, V281, P3343, DOI 10.1074/jbc.M508334200; Rendic D, 2007, BIOCHEM J, V402, P105, DOI 10.1042/BJ20060964; Roos C, 2002, J BIOL CHEM, V277, P3168, DOI 10.1074/jbc.m107927200; Saint-Pol A, 1999, J BIOL CHEM, V274, P13547, DOI 10.1074/jbc.274.19.13547; Saunier K, 2001, MOL BIOL EVOL, V18, P2083, DOI 10.1093/oxfordjournals.molbev.a003749; Staudacher E, 1999, BBA-GEN SUBJECTS, V1473, P216, DOI 10.1016/S0304-4165(99)00181-6; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TRETTER V, 1993, INT ARCH ALLERGY IMM, V102, P259, DOI 10.1159/000236534; van Tetering A, 1999, FEBS LETT, V461, P311, DOI 10.1016/S0014-5793(99)01489-1; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200; Wierinckx A, 1999, MOL BIOL EVOL, V16, P1535, DOI 10.1093/oxfordjournals.molbev.a026066; Wilson IBH, 2001, GLYCOBIOLOGY, V11, P261, DOI 10.1093/glycob/11.4.261; Wilson IBH, 2001, BBA-GEN SUBJECTS, V1527, P88, DOI 10.1016/S0304-4165(01)00151-9; Yanagidani S, 1997, J BIOCHEM-TOKYO, V121, P626	66	48	48	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4723	4738		10.1074/jbc.M809312200	http://dx.doi.org/10.1074/jbc.M809312200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19088067	hybrid			2022-12-25	WOS:000263134400072
J	Vetrivel, KS; Meckler, X; Chen, Y; Nguyen, PD; Seidah, NG; Vassar, R; Wong, PC; Fukata, M; Kounnas, MZ; Thinakaran, G				Vetrivel, Kulandaivelu S.; Meckler, Xavier; Chen, Ying; Nguyen, Phuong D.; Seidah, Nabil G.; Vassar, Robert; Wong, Philip C.; Fukata, Masaki; Kounnas, Maria Z.; Thinakaran, Gopal			Alzheimer Disease A beta Production in the Absence of S-Palmitoylation-dependent Targeting of BACE1 to Lipid Rafts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-PRECURSOR-PROTEIN; TRANS-GOLGI NETWORK; GAMMA-SECRETASE; CHOLESTEROL DEPLETION; CLEAVING ENZYME; GGA PROTEINS; ASPARTYL PROTEASE; HUMAN BRAIN; VHS DOMAIN; CLEAVAGE	Alzheimer disease beta-amyloid (A beta) peptides are generated via sequential proteolysis of amyloid precursor protein (APP) by BACE1 and gamma-secretase. A subset of BACE1 localizes to cholesterol-rich membrane microdomains, termed lipid rafts. BACE1 processing in raft microdomains of cultured cells and neurons was characterized in previous studies by disrupting the integrity of lipid rafts by cholesterol depletion. These studies found either inhibition or elevation of A beta production depending on the extent of cholesterol depletion, generating controversy. The intricate interplay between cholesterol levels, APP trafficking, and BACE1 processing is not clearly understood because cholesterol depletion has pleiotropic effects on Golgi morphology, vesicular trafficking, and membrane bulk fluidity. In this study, we used an alternate strategy to explore the function of BACE1 in membrane microdomains without altering the cellular cholesterol level. We demonstrate that BACE1 undergoes S-palmitoylation at four Cys residues at the junction of transmembrane and cytosolic domains, and Ala substitution at these four residues is sufficient to displace BACE1 from lipid rafts. Analysis of wild type and mutant BACE1 expressed in BACE1 null fibroblasts and neuroblastoma cells revealed that S-palmitoylation neither contributes to protein stability nor subcellular localization of BACE1. Surprisingly, non-raft localization of palmitoylation-deficient BACE1 did not have discernible influence on BACE1 processing of APP or secretion of A beta. These results indicate that post-translational S-palmitoylation of BACE1 is not required for APP processing, and that BACE1 can efficiently cleave APP in both raft and non-raft microdomains.	[Vetrivel, Kulandaivelu S.; Meckler, Xavier; Chen, Ying; Thinakaran, Gopal] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Vetrivel, Kulandaivelu S.; Meckler, Xavier; Chen, Ying; Thinakaran, Gopal] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA; [Vetrivel, Kulandaivelu S.; Meckler, Xavier; Chen, Ying; Thinakaran, Gopal] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Nguyen, Phuong D.; Kounnas, Maria Z.] TorreyPines Therapeut Inc, La Jolla, CA 92037 USA; [Seidah, Nabil G.] Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada; [Vassar, Robert] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Wong, Philip C.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Fukata, Masaki] Natl Inst Nat Sci, Natl Inst Physiol Sci, Div Membrane Physiol, Okazaki, Aichi 4448787, Japan	University of Chicago; University of Chicago; University of Chicago; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Northwestern University; Feinberg School of Medicine; Johns Hopkins University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Thinakaran, G (corresponding author), Knapp R212,924 E 57th St, Chicago, IL 60637 USA.	gopal@uchicago.edu	Fukata, Masaki/AAZ-2476-2021; Seidah, Nabil/I-3596-2013	Fukata, Masaki/0000-0001-5200-9806; Seidah, Nabil/0000-0001-6503-9342	National Institutes of Health [AG021495, AG019070]; Alzheimer's Association [IIRG, NIRG]; Canadian Institutes of Health Research [MOP 44363]; American Federation for Aging Research Fellowship; NATIONAL INSTITUTE ON AGING [R01AG021495, R01AG019070] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); American Federation for Aging Research Fellowship; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG021495 and AG019070 (to G. T.). This work was also supported by Alzheimer's Association Grants IIRG (to G. T.) and NIRG (to K. S. V.), Canadian Institutes of Health Research Grant MOP 44363 (to N. G. S.), and an American Federation for Aging Research Fellowship (to X. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abad-Rodriguez J, 2004, J CELL BIOL, V167, P953, DOI 10.1083/jcb.200404149; Abbal C, 2006, BLOOD, V108, P3352, DOI 10.1182/blood-2006-04-013912; Benjannet S, 2001, J BIOL CHEM, V276, P10879, DOI 10.1074/jbc.M009899200; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Capell A, 2000, J BIOL CHEM, V275, P30849, DOI 10.1074/jbc.M003202200; Cheng HP, 2007, NAT CLIN PRACT NEURO, V3, P374, DOI 10.1038/ncpneuro0549; Cheng HP, 2009, J BIOL CHEM, V284, P1373, DOI 10.1074/jbc.M806380200; Cole SL, 2008, J BIOL CHEM, V283, P29621, DOI 10.1074/jbc.R800015200; Cordy JM, 2003, P NATL ACAD SCI USA, V100, P11735, DOI 10.1073/pnas.1635130100; Cordy JM, 2006, MOL MEMBR BIOL, V23, P111, DOI 10.1080/09687860500496417; Costantini C, 2007, BIOCHEM J, V407, P383, DOI 10.1042/BJ20070040; Creemers JWM, 2001, J BIOL CHEM, V276, P4211, DOI 10.1074/jbc.M006947200; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Hansen GH, 2000, J BIOL CHEM, V275, P5136, DOI 10.1074/jbc.275.7.5136; Hao MM, 2004, J BIOL CHEM, V279, P14171, DOI 10.1074/jbc.M309793200; Harder T, 1997, CURR OPIN CELL BIOL, V9, P534, DOI 10.1016/S0955-0674(97)80030-0; Hayashi T, 2005, J CEREBR BLOOD F MET, V25, P41, DOI 10.1038/sj.jcbfm.9600005; He XY, 2005, J BIOL CHEM, V280, P11696, DOI 10.1074/jbc.M411296200; He XY, 2003, BIOCHEMISTRY-US, V42, P12174, DOI 10.1021/bi035199h; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Huang K, 2005, CURR OPIN NEUROBIOL, V15, P527, DOI 10.1016/j.conb.2005.08.001; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Iwatsubo T, 2004, CURR OPIN NEUROBIOL, V14, P379, DOI 10.1016/j.conb.2004.05.010; Jonas MC, 2008, EMBO REP, V9, P916, DOI 10.1038/embor.2008.132; Kirsch C, 2003, BIOCHEM PHARMACOL, V65, P843, DOI 10.1016/S0006-2952(02)01654-4; Kitazume S, 2001, P NATL ACAD SCI USA, V98, P13554, DOI 10.1073/pnas.241509198; Koh YH, 2005, J BIOL CHEM, V280, P32499, DOI 10.1074/jbc.M506199200; Koo EH, 1996, J CELL SCI, V109, P991; KOO EH, 1994, J BIOL CHEM, V269, P17386; Lamb BT, 1999, NAT NEUROSCI, V2, P695, DOI 10.1038/11154; Lee EB, 2005, J CELL BIOL, V168, P291, DOI 10.1083/jcb.200407070; Li QM, 2004, J BIOL CHEM, V279, P10542, DOI 10.1074/jbc.M310001200; Li T, 2003, J NEUROSCI, V23, P3272; Lichtenthaler SF, 2003, J BIOL CHEM, V278, P48713, DOI 10.1074/jbc.M303861200; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; McCormick PJ, 2008, TRAFFIC, V9, P1984, DOI 10.1111/j.1600-0854.2008.00814.x; Melkonian KA, 1999, J BIOL CHEM, V274, P3910, DOI 10.1074/jbc.274.6.3910; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Onishi M, 1996, EXP HEMATOL, V24, P324; Riddell DR, 2001, CURR BIOL, V11, P1288, DOI 10.1016/S0960-9822(01)00394-3; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Sakurai T, 2008, J CELL BIOL, V183, P339, DOI 10.1083/jcb.200804075; Shiba T, 2004, TRAFFIC, V5, P437, DOI 10.1111/j.1600-0854.2004.00188.x; Shvartsman DE, 2006, TRAFFIC, V7, P917, DOI 10.1111/j.1600-0854.2006.00437.x; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Thinakaran G, 1998, NEUROBIOL DIS, V4, P438, DOI 10.1006/nbdi.1998.0171; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vetrivel KS, 2006, NEUROLOGY, V66, pS69, DOI 10.1212/01.wnl.0000192107.17175.39; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Vetrivel KS, 2005, J BIOL CHEM, V280, P25892, DOI 10.1074/jbc.M503570200; Vetrivel KS, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-4; Wahle T, 2005, MOL CELL NEUROSCI, V29, P453, DOI 10.1016/j.mcn.2005.03.014; Wahle T, 2006, J NEUROSCI, V26, P12838, DOI 10.1523/JNEUROSCI.1982-06.2006; Walter J, 2001, J BIOL CHEM, V276, P14634, DOI 10.1074/jbc.M011116200; Wang YZ, 2000, TRAFFIC, V1, P952, DOI 10.1034/j.1600-0854.2000.011205.x; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Won JS, 2008, J NEUROCHEM, V105, P1536, DOI 10.1111/j.1471-4159.2008.05283.x; Wong HK, 2005, J BIOL CHEM, V280, P23009, DOI 10.1074/jbc.M414648200; Xiu J, 2005, J NEUROSCI RES, V82, P531, DOI 10.1002/jnr.20658; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yan RQ, 2001, J BIOL CHEM, V276, P36788, DOI 10.1074/jbc.M104350200; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007	72	119	123	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3793	3803		10.1074/jbc.M808920200	http://dx.doi.org/10.1074/jbc.M808920200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19074428	hybrid, Green Published			2022-12-25	WOS:000262872500048
J	Mamiya, A; Beshel, J; Xu, CS; Zhong, Y				Mamiya, Akira; Beshel, Jennifer; Xu, Chunsu; Zhong, Yi			Neural Representations of Airflow in Drosophila Mushroom Body	PLOS ONE			English	Article							MEMORY TRACE; OLFACTORY REPRESENTATIONS; TERM-MEMORY; BODIES; MELANOGASTER; NEURONS; CA2+; LOCALIZATION; ORGANIZATION; INTEGRATION	The Drosophila mushroom body (MB) is a higher olfactory center where olfactory and other sensory information are thought to be associated. However, how MB neurons of Drosophila respond to sensory stimuli other than odor is not known. Here, we characterized the responses of MB neurons to a change in airflow, a stimulus associated with odor perception. In vivo calcium imaging from MB neurons revealed surprisingly strong and dynamic responses to an airflow stimulus. This response was dependent on the movement of the 3(rd) antennal segment, suggesting that Johnston's organ may be detecting the airflow. The calyx, the input region of the MB, responded homogeneously to airflow on. However, in the output lobes of the MB, different types of MB neurons responded with different patterns of activity to airflow on and off. Furthermore, detailed spatial analysis of the responses revealed that even within a lobe that is composed of a single type of MB neuron, there are subdivisions that respond differently to airflow on and off. These subdivisions within a single lobe were organized in a stereotypic manner across flies. For the first time, we show that changes in airflow affect MB neurons significantly and these effects are spatially organized into divisions smaller than previously defined MB neuron types.	[Mamiya, Akira; Beshel, Jennifer; Xu, Chunsu; Zhong, Yi] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Xu, Chunsu] SUNY Stony Brook, Stony Brook, NY USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Mamiya, A (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	zhongyi@cshl.edu		Zhong, Yi/0000-0002-7927-5976; Mamiya, Akira/0000-0002-3199-5341; Zhong, Yi/0000-0001-7810-9899	US National Institutes of Health [5RO1DC005784-05]; DART Neuroscience Inc; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005784] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DART Neuroscience Inc; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding was provided by a grant from the US National Institutes of Health (5RO1DC005784-05) and DART Neuroscience Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; Armstrong JD, 1998, LEARN MEMORY, V5, P102; Budick SA, 2007, J EXP BIOL, V210, P4092, DOI 10.1242/jeb.006502; Budick SA, 2006, J EXP BIOL, V209, P3001, DOI 10.1242/jeb.02305; Bulkin DA, 2006, CURR OPIN NEUROBIOL, V16, P415, DOI 10.1016/j.conb.2006.06.008; Calvert G., 2004, HDB MULTISENSORY PRO, P915; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; Gerber B, 2004, CURR OPIN NEUROBIOL, V14, P737, DOI 10.1016/j.conb.2004.10.014; Gopfert MC, 2002, J EXP BIOL, V205, P1199; Grosmaitre X, 2007, NAT NEUROSCI, V10, P348, DOI 10.1038/nn1856; Gupta A.P., 1987, ARTHROPOD BRAIN ITS; Han Q, 2005, J COMP PHYSIOL A, V191, P521, DOI 10.1007/s00359-005-0618-8; Jeffery KJ, 2007, HIPPOCAMPUS, V17, P775, DOI 10.1002/hipo.20322; Kamikouchi A, 2006, J COMP NEUROL, V499, P317, DOI 10.1002/cne.21075; Kayser C, 2007, BRAIN STRUCT FUNCT, V212, P121, DOI 10.1007/s00429-007-0154-0; Kepecs A, 2007, J NEUROPHYSIOL, V98, P205, DOI 10.1152/jn.00071.2007; Koehl MAR, 2006, CHEM SENSES, V31, P93, DOI 10.1093/chemse/bjj009; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; Lin HH, 2007, CELL, V128, P1205, DOI 10.1016/j.cell.2007.03.006; Liu X, 2007, NEURON, V56, P1090, DOI 10.1016/j.neuron.2007.10.036; Mainland J, 2006, CHEM SENSES, V31, P181, DOI 10.1093/chemse/bjj012; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Mellon DF, 2005, J EXP BIOL, V208, P3711, DOI 10.1242/jeb.01827; Menzel R, 2001, LEARN MEMORY, V8, P53, DOI 10.1101/lm.38801; MURLIS J, 1992, ANNU REV ENTOMOL, V37, P505, DOI 10.1146/annurev.en.37.010192.002445; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Olsen SR, 2007, NEURON, V54, P89, DOI 10.1016/j.neuron.2007.03.010; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Pologruto TA, 2004, J NEUROSCI, V24, P9572, DOI 10.1523/JNEUROSCI.2854-04.2004; Reiff DF, 2005, J NEUROSCI, V25, P4766, DOI 10.1523/JNEUROSCI.4900-04.2005; Strausfeld NJ, 2003, MICROSC RES TECHNIQ, V62, P151, DOI 10.1002/jemt.10368; Strausfeld NJ, 1998, LEARN MEMORY, V5, P11; Taube JS, 2007, ANNU REV NEUROSCI, V30, P181, DOI 10.1146/annurev.neuro.29.051605.112854; Technau GM, 1984, J NEUROGENET, V1, P113, DOI 10.3109/01677068409107077; Todi SV, 2004, MICROSC RES TECHNIQ, V63, P388, DOI 10.1002/jemt.20053; Turner GC, 2008, J NEUROPHYSIOL, V99, P734, DOI 10.1152/jn.01283.2007; Vickers NJ, 2001, NATURE, V410, P466, DOI 10.1038/35068559; Wang YL, 2008, J NEUROSCI, V28, P4368, DOI 10.1523/JNEUROSCI.2958-07.2008; Wang YL, 2004, J NEUROSCI, V24, P6507, DOI 10.1523/JNEUROSCI.3727-03.2004; Wang YL, 2001, NEURON, V29, P267, DOI 10.1016/S0896-6273(01)00196-9; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Yu DH, 2006, NEURON, V52, P845, DOI 10.1016/j.neuron.2006.10.030; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672; Zhu SJ, 2003, DEVELOPMENT, V130, P2603, DOI 10.1242/dev.00466	47	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2008	3	12							e4063	10.1371/journal.pone.0004063	http://dx.doi.org/10.1371/journal.pone.0004063			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437DL	19115002	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000265466300006
J	Eckmeier, D; Geurten, BRH; Kress, D; Mertes, M; Kern, R; Egelhaaf, M; Bischof, HJ				Eckmeier, Dennis; Geurten, Bart R. H.; Kress, Daniel; Mertes, Marcel; Kern, Roland; Egelhaaf, Martin; Bischof, Hans-Joachim			Gaze Strategy in the Free Flying Zebra Finch (Taeniopygia guttata)	PLOS ONE			English	Article								Fast moving animals depend on cues derived from the optic flow on their retina. Optic flow from translational locomotion includes information about the three-dimensional composition of the environment, while optic flow experienced during a rotational self motion does not. Thus, a saccadic gaze strategy that segregates rotations from translational movements during locomotion will facilitate extraction of spatial information from the visual input. We analysed whether birds use such a strategy by highspeed video recording zebra finches from two directions during an obstacle avoidance task. Each frame of the recording was examined to derive position and orientation of the beak in three-dimensional space. The data show that in all flights the head orientation was shifted in a saccadic fashion and was kept straight between saccades. Therefore, birds use a gaze strategy that actively stabilizes their gaze during translation to simplify optic flow based navigation. This is the first evidence of birds actively optimizing optic flow during flight.	[Eckmeier, Dennis; Kress, Daniel; Mertes, Marcel; Bischof, Hans-Joachim] Univ Bielefeld, Lehrstuhl Verhaltensforsch, Bielefeld, Germany; [Geurten, Bart R. H.; Kress, Daniel; Mertes, Marcel; Kern, Roland; Egelhaaf, Martin] Univ Bielefeld, Lehrstuhl Neurobiol & Ctr Excellence, D-4800 Bielefeld, Germany	University of Bielefeld; University of Bielefeld	Eckmeier, D (corresponding author), Univ Bielefeld, Lehrstuhl Verhaltensforsch, Bielefeld, Germany.	dennis.eckmeier@uni-bielefeld.de	Eckmeier, Dennis/AAE-7886-2020; Egelhaaf, Martin/A-9824-2010; Geurten, Bart/I-2037-2019	Eckmeier, Dennis/0000-0002-7818-8993; Egelhaaf, Martin/0000-0002-9336-4270; Geurten, Bart/0000-0002-1816-3241; Kern, Roland/0000-0002-7258-9956	DFG - Deutsche Forschungsgemeinschaft, Germany [Ke 645/2-1]	DFG - Deutsche Forschungsgemeinschaft, Germany(German Research Foundation (DFG))	This study was supported by the DFG - Deutsche Forschungsgemeinschaft, Germany (Ke 645/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUGUET JY, 1998, 6 INT C COMP VIS ICC; Bredenkotter M, 1996, BRAIN BEHAV EVOLUT, V47, P23, DOI 10.1159/000113226; DAVIES MNO, 1991, ZOOL JAHRB ALLG ZOOL, V95, P331; DAVIES MNO, 1990, NATURWISSENSCHAFTEN, V77, P142, DOI 10.1007/BF01134481; Eckmeier D, 2008, J COMP PHYSIOL A, V194, P871, DOI 10.1007/s00359-008-0358-7; ENGELAGE J, 1988, EXP BRAIN RES, V70, P79; GIBSON JJ, 1950, AM J PSYCHOL, V63, P367, DOI 10.2307/1418003; GIOANNI H, 1988, EXP BRAIN RES, V69, P583, DOI 10.1007/BF00247311; GIOANNI H, 1988, EXP BRAIN RES, V69, P567, DOI 10.1007/BF00247310; Kern R, 2006, J EXP BIOL, V209, P1251, DOI 10.1242/jeb.02127; KOENDERINK JJ, 1986, VISION RES, V26, P161, DOI 10.1016/0042-6989(86)90078-7; LEE DN, 1993, J EXP BIOL, V180, P85; Lindemann J., 2005, VISUAL NAVIGATION VI; Martin GR, 2007, J ORNITHOL, V148, pS547, DOI 10.1007/s10336-007-0213-6; MARTINOYA C, 1980, 28 INT C PHYS SCI, P477; McFadden Sally A., 1993, P47; Schilstra C, 1998, NATURE, V395, P654, DOI 10.1038/27114; Schilstra C, 1999, J EXP BIOL, V202, P1481; Vaina L. M., 2004, OPTIC FLOW; Van Hateren JH, 1999, J EXP BIOL, V202, P1491; Voss J, 2003, J COMP PHYSIOL A, V189, P545, DOI 10.1007/s00359-003-0430-2; Wylie DRW, 1997, J COMP NEUROL, V384, P517, DOI 10.1002/(SICI)1096-9861(19970811)384:4<517::AID-CNE3>3.0.CO;2-5	22	50	51	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e3956	10.1371/journal.pone.0003956	http://dx.doi.org/10.1371/journal.pone.0003956			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107185	Green Published, Green Submitted, gold			2022-12-25	WOS:000265463000003
J	Vitorino, LR; Margos, G; Feil, EJ; Collares-Pereira, M; Ze-Ze, L; Kurtenbach, K				Vitorino, Liliana R.; Margos, Gabriele; Feil, Edward J.; Collares-Pereira, Margarida; Ze-Ze, Libia; Kurtenbach, Klaus			Fine-Scale Phylogeographic Structure of Borrelia lusitaniae Revealed by Multilocus Sequence Typing	PLOS ONE			English	Article							BURGDORFERI SENSU-LATO; IXODES-RICINUS TICKS; LYME-DISEASE; GENETIC DIVERSITY; QUESTING TICKS; GENOMIC GROUPS; RECOMBINATION; POLYMORPHISM; POPULATIONS; PREVALENCE	Borrelia lusitaniae is an Old World species of the Lyme borreliosis (LB) group of tick-borne spirochetes and prevails mainly in countries around the Mediterranean Basin. Lizards of the family Lacertidae have been identified as reservoir hosts of B. lusitaniae. These reptiles are highly structured geographically, indicating limited migration. In order to examine whether host geographic structure shapes the evolution and epidemiology of B. lusitaniae, we analyzed the phylogeographic population structure of this tick-borne bacterium using a recently developed multilocus sequence typing (MLST) scheme based on chromosomal housekeeping genes. A total of 2,099 questing nymphal and adult Ixodes ricinus ticks were collected in two climatically different regions of Portugal, being similar to 130 km apart. All ticks were screened for spirochetes by direct PCR. Attempts to isolate strains yielded 16 cultures of B. lusitaniae in total. Uncontaminated cultures as well as infected ticks were included in this study. The results using MLST show that the regional B. lusitaniae populations constitute genetically distinct populations. In contrast, no clear phylogeographic signals were detected in sequences of the commonly used molecular markers ospA and ospC. The pronounced population structure of B. lusitaniae over a short geographic distance as captured by MLST of the housekeeping genes suggests that the migration rates of B. lusitaniae are rather low, most likely because the distribution of mediterranean lizard populations is highly parapatric. The study underlines the importance of vertebrate hosts in the geographic spread of tick-borne microparasites.	[Ze-Ze, Libia] Univ Lisbon, Fac Ciencias, Dept Biol Vegetal, Ctr Genet & Biol Mol, P-1200 Lisbon, Portugal; [Vitorino, Liliana R.; Margos, Gabriele; Feil, Edward J.; Kurtenbach, Klaus] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Vitorino, Liliana R.; Collares-Pereira, Margarida] Univ Nova Lisboa, Inst Higiene Med Trop, Unidade Leptospirose Borreliose Lyme, Lisbon, Portugal; [Ze-Ze, Libia] Inst Nacl Saude Dr Ricardo Jorge, Ctr Estud Vectores Doencas Infecciosas, Lisbon, Portugal	Universidade de Lisboa; University of Bath; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Instituto Nacional de Saude Dr. Ricardo Jorge	Vitorino, LR (corresponding author), Univ Lisbon, Fac Ciencias, Dept Biol Vegetal, Ctr Genet & Biol Mol, Campo Grande, P-1200 Lisbon, Portugal.	kk221@bath.ac.uk	Zé-Zé, Líbia Maria Marques/U-5730-2017	Zé-Zé, Líbia Maria Marques/0000-0001-7258-1439; MARGOS, Gabriele/0000-0001-5304-9615	The Wellcome Trust, London, United Kingdom [074322]; Science Foundation Portugal	The Wellcome Trust, London, United Kingdom(Wellcome Trust); Science Foundation Portugal	The study was funded by grant 074322 of The Wellcome Trust, London, United Kingdom (to K.K.) and the Science Foundation Portugal (to L.R.V.). The sponsors did not have a role in study design and decision to submit it for publication.	Baptista S, 2004, INT J MED MICROBIOL, V293, P109, DOI 10.1016/S1433-1128(04)80016-0; Barral M, 2002, J MED ENTOMOL, V39, P177, DOI 10.1603/0022-2585-39.1.177; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Bunikis J, 2004, MICROBIOL-SGM, V150, P1741, DOI 10.1099/mic.0.26944-0; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; Collares-Pereira M, 2004, J CLIN MICROBIOL, V42, P1316, DOI 10.1128/JCM.42.3.1316-1318.2004; Cooper JE, 2004, TRENDS MICROBIOL, V12, P373, DOI 10.1016/j.tim.2004.06.003; Crowley T. J., 1991, PALAEOCLIMATOLOGY; De Michelis S, 2000, J CLIN MICROBIOL, V38, P2128; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Dsouli N, 2006, J MED ENTOMOL, V43, P737, DOI 10.1603/0022-2585(2006)43[737:RROLPA]2.0.CO;2; Escudero R, 2000, J CLIN MICROBIOL, V38, P4026, DOI 10.1128/JCM.38.11.4026-4033.2000; Etti S, 2003, APPL ENVIRON MICROB, V69, P3008, DOI 10.1128/AEM.69.5.3008-3010.2003; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Godinho R, 2006, MOL ECOL, V15, P731, DOI 10.1111/j.1365-294X.2006.02813.x; Godinho R, 2005, AMPHIBIA-REPTILIA, V26, P271, DOI 10.1163/156853805774408667; Grego E, 2007, J MOL EVOL, V65, P512, DOI 10.1007/s00239-007-9029-5; Holmes EC, 1999, MOL BIOL EVOL, V16, P405, DOI 10.1093/oxfordjournals.molbev.a026121; Hubalek Z, 1997, EUR J EPIDEMIOL, V13, P951, DOI 10.1023/A:1007426304900; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jouda F, 2004, J MED ENTOMOL, V41, P162, DOI 10.1603/0022-2585-41.2.162; Kurtenbach K, 2002, TRENDS MICROBIOL, V10, P74, DOI 10.1016/S0966-842X(01)02298-3; Kurtenbach K, 2001, APPL ENVIRON MICROB, V67, P4926, DOI 10.1128/AEM.67.10.4926-4929.2001; Kurtenbach K, 2006, NAT REV MICROBIOL, V4, P660, DOI 10.1038/nrmicro1475; LeFleche A, 1997, INT J SYST BACTERIOL, V47, P921; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Margos G, 2008, P NATL ACAD SCI USA, V105, P8730, DOI 10.1073/pnas.0800323105; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Paulo OS, 2008, MOL ECOL, V17, P1535, DOI 10.1111/j.1365-294X.2008.03706.x; Paulo OS, 2002, MOL ECOL, V11, P809, DOI 10.1046/j.1365-294X.2002.01484.x; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; POSTIC D, 1994, INT J SYST BACTERIOL, V44, P743, DOI 10.1099/00207713-44-4-743; Postic D, 2007, INT J MED MICROBIOL, V297, P263, DOI 10.1016/j.ijmm.2007.01.006; Qiu WG, 2002, GENETICS, V160, P833; Qui W, 1997, HEREDITAS, V127, P203; Richter D, 2006, APPL ENVIRON MICROB, V72, P4627, DOI 10.1128/AEM.00285-06; RIJPKEMA SGT, 1995, J CLIN MICROBIOL, V33, P3091, DOI 10.1128/JCM.33.12.3091-3095.1995; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SMITH JM, 1992, J MOL EVOL, V34, P126; Spratt BG, 1999, CURR OPIN MICROBIOL, V2, P312, DOI 10.1016/S1369-5274(99)80054-X; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Urwin R, 2003, TRENDS MICROBIOL, V11, P479, DOI 10.1016/j.tim.2003.08.006; VOS M, 2008, COMP HOMOLOGOUS RECO, P1; Wang IN, 1999, GENETICS, V151, P15; WILL G, 1995, MED MICROBIOL IMMUN, V184, P73, DOI 10.1007/BF00221390; Younsi H, 2005, J CLIN MICROBIOL, V43, P1587, DOI 10.1128/JCM.43.4.1587-1593.2005; Younsi H, 2001, EUR J EPIDEMIOL, V17, P53, DOI 10.1023/A:1010928731281; Zeidner NS, 2001, J MED MICROBIOL, V50, P1055, DOI 10.1099/0022-1317-50-12-1055	52	33	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2008	3	12							e4002	10.1371/journal.pone.0004002	http://dx.doi.org/10.1371/journal.pone.0004002			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CB	19104655	Green Published, Green Submitted, gold			2022-12-25	WOS:000265462400003
J	Castro, FAV; Mariani, D; Panek, AD; Eleutherio, ECA; Pereira, MD				Vieira Castro, Frederico Augusto; Mariani, Diana; Panek, Anita Dolly; Araujo Eleutherio, Elis Cristina; Pereira, Marcos Dias			Cytotoxicity Mechanism of Two Naphthoquinones (Menadione and Plumbagin) in Saccharomyces cerevisiae	PLOS ONE			English	Article								Background: Quinones are compounds extensively used in studies of oxidative stress due to their role in plants as chemicals for defense. These compounds are of great interest for pharmacologists and scientists, in general, because several cancer chemotherapeutic agents contain the quinone nucleus. However, due to differences in structures and diverse pharmacological effects, the exact toxicity mechanisms exerted by quinones are far from elucidatation. Methodology/Principal Findings: Using Saccharomyces cerevisiae, we evaluated the main mechanisms of toxicity of two naphthoquinones, menadione and plumbagin, by determining tolerance and oxidative stress biomarkers such as GSH and GSSG, lipid peroxidation levels, as well as aconitase activity. The importance of glutathione transferases (GST) in quinone detoxification was also addressed. The GSSG/GSH ratio showed that menadione seemed to exert its toxicity mainly through the generation of ROS while plumbagin acted as an electrophile reacting with GSH. However, the results showed that, even by different pathways, both drugs were capable of generating oxidative stress through their toxic effects. Our results showed that the control strain, BY4741, and the glutathione transferase deficient strains (gtt1 Delta and gtt2 Delta) were sensitive to both compounds. With respect to the role of GST isoforms in cellular protection against quinone toxicity, we observed that the Gtt2 deficient strain was unable to overcome lipid peroxidation, even after a plumbagin pre-treatment, indicating that this treatment did not improve tolerance when compared with the wild type strain. Cross-tolerance experiments confirmed distinct cytotoxicity mechanisms for these naphthoquinones since only a pre-treatment with menadione was able to induce acquisition of tolerance against stress with plumbagin. Conclusions/Significance: These results suggest different responses to menadione and plumbagin which could be due to the fact that these compounds use different mechanisms to exert their toxicity. In addition, the Gtt2 isoform seemed to act as a general protective factor involved in quinone detoxification.	[Vieira Castro, Frederico Augusto; Mariani, Diana; Panek, Anita Dolly; Araujo Eleutherio, Elis Cristina; Pereira, Marcos Dias] Univ Fed Rio de Janeiro, Inst Quim, Dept Bioquim, LIFE, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro	Castro, FAV (corresponding author), Univ Fed Rio de Janeiro, Inst Quim, Dept Bioquim, LIFE, Rio De Janeiro, Brazil.	fredcastro@iq.ufrj.br	Pereira, Marcos Dias/D-8982-2014; Panek, Anita D/J-5821-2013; Eleutherio, Elis C A/J-5468-2013	Pereira, Marcos Dias/0000-0001-5594-2255; Eleutherio, Elis C A/0000-0001-5842-2714	FAPERJ; CNPq; CAPES (PROCAD/MES); FAPESP [04-10067/6]; FINEP	FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (PROCAD/MES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FINEP(Financiadora de Inovacao e Pesquisa (Finep))	FAPERJ, CNPq, CAPES (PROCAD/MES), FAPESP (04-10067/6) and FINEP. These funders contributed to this manuscript by providing financial support.	Adamis PDB, 2004, TOXICOL LETT, V154, P81, DOI 10.1016/j.toxlet.2004.07.003; Adamis PDB, 2004, J BIOCHEM MOL TOXIC, V18, P12, DOI 10.1002/jbt.20000; Azevedo D, 2003, FREE RADICAL BIO MED, V35, P889, DOI 10.1016/S0891-5849(03)00434-9; Barreto L, 2006, EUKARYOT CELL, V5, P1748, DOI 10.1128/EC.00216-06; Bernt E., 1974, METHODS ENZYMATIC AN, V4, P1643; Castro FAV, 2007, BBA-GEN SUBJECTS, V1770, P213, DOI 10.1016/j.bbagen.2006.10.013; Chiou TJ, 2000, TOXICOLOGY, V154, P75, DOI 10.1016/S0300-483X(00)00321-8; Choi JH, 1998, J BIOL CHEM, V273, P29915, DOI 10.1074/jbc.273.45.29915; Chung SH, 1999, FEBS LETT, V449, P235, DOI 10.1016/S0014-5793(99)00452-4; Circu ML, 2008, FREE RADICAL BIO MED, V44, P768, DOI 10.1016/j.freeradbiomed.2007.09.011; Costa Vitor, 2001, Molecular Aspects of Medicine, V22, P217, DOI 10.1016/S0098-2997(01)00012-7; De Paivai SR, 2004, AN ACAD BRAS CIENC, V76, P499, DOI 10.1590/S0001-37652004000300004; Fernandes PN, 2007, REDOX REP, V12, P236, DOI 10.1179/135100007X200344; Garcera A, 2006, BIOCHEM J, V398, P187, DOI 10.1042/BJ20060034; GARDNER PR, 1995, J BIOL CHEM, V270, P13399, DOI 10.1074/jbc.270.22.13399; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Inbaraj JJ, 2004, CHEM RES TOXICOL, V17, P55, DOI 10.1021/tx034132s; Mager WH, 2005, TRENDS PHARMACOL SCI, V26, P265, DOI 10.1016/j.tips.2005.03.004; Masella R, 2005, J NUTR BIOCHEM, V16, P577, DOI 10.1016/j.jnutbio.2005.05.013; Monks Terrence J, 2002, Curr Drug Metab, V3, P425, DOI 10.2174/1389200023337388; Monks TJ, 1998, ANNU REV PHARMACOL, V38, P229, DOI 10.1146/annurev.pharmtox.38.1.229; POWOLNY AA, 2008, PHARM RES; Rodriguez CE, 2004, TOXICOLOGY, V201, P185, DOI 10.1016/j.tox.2004.04.016; Seung SA, 1998, CHEM-BIOL INTERACT, V113, P133, DOI 10.1016/S0009-2797(98)00024-6; Shapira M, 2004, MOL BIOL CELL, V15, P5659, DOI 10.1091/mbc.E04-04-0340; STEELS EL, 1994, MICROBIOL-SGM, V140, P569, DOI 10.1099/00221287-140-3-569; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Wallace MA, 2005, CHEM RES TOXICOL, V18, P1279, DOI 10.1021/tx050050n	28	99	100	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2008	3	12							e3999	10.1371/journal.pone.0003999	http://dx.doi.org/10.1371/journal.pone.0003999			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CA	19098979	Green Submitted, Green Published, gold			2022-12-25	WOS:000265462300010
J	Morand, S; Ueyama, T; Tsujibe, S; Saito, N; Korzeniowska, A; Leto, TL				Morand, Stanislas; Ueyama, Takehiko; Tsujibe, Satoshi; Saito, Naoaki; Korzeniowska, Agnieszka; Leto, Thomas L.			Duox maturation factors form cell surface complexes with Duox affecting the specificity of reactive oxygen species generation	FASEB JOURNAL			English	Article						Dual oxidase; NADPH oxidase; Nox; NIP	HYDROGEN-PEROXIDE PRODUCTION; NADPH OXIDASE; DUAL OXIDASE; GENE; IDENTIFICATION; ACTIVATION; MUTATIONS; PROTEINS; SUPEROXIDE; EXPRESSION	Dual oxidases (Duox1 and Duox2) are plasma membrane-targeted hydrogen peroxide generators that support extracellular hemoperoxidases. Duox activator 2 (Duoxa2), initially described as an endoplasmic reticulum resident protein, functions as a maturation factor needed to deliver active Duox2 to the cell surface. However, less is known about the Duox1/Duoxa1 homologues. We identified four alternatively spliced Duoxa1 variants and explored their roles in Duox subcellular targeting and reconstitution. Duox1 and Duox2 are functionally rescued by Duoxa2 or the Duoxa1 variants that contain the third coding exon. All active maturation factors are cotransported to the cell surface when coexpressed with either Duox1 or Duox2, consistent with detection of endogenous Duoxa1 on apical plasma membranes of the airway epithelium. In contrast, the Duoxa proteins are retained in the endoplasmic reticulum when expressed without Duox. Duox1/Duoxa1 alpha and Duox2/Duoxa2 pairs produce the highest levels of hydrogen peroxide, as they undergo Golgi-based carbohydrate modifications and form stable cell surface complexes. Cross-functioning pairs that do not form stable complexes produce less hydrogen peroxide and leak superoxide. These findings suggest Duox activators not only promote Duox maturation, but they function as part of the hydrogen peroxide-generating enzyme.-Morand, S., Ueyama, T., Tsujibe, S., Saito, N., Korzeniowska, A., Leto, T. L. Duox maturation factors form cell surface complexes with Duox affecting the specificity of reactive oxygen species generation. FASEB J. 23, 1205-1218 (2009)	[Morand, Stanislas; Korzeniowska, Agnieszka; Leto, Thomas L.] NIAID, Host Def Lab, NIH, Rockville, MD 20852 USA; [Ueyama, Takehiko; Tsujibe, Satoshi; Saito, Naoaki] Kobe Univ, Biosignal Res Ctr, Mol Pharmacol Lab, Kobe, Hyogo 657, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Kobe University	Leto, TL (corresponding author), NIAID, Host Def Lab, NIH, 12441 Parklawn Dr, Rockville, MD 20852 USA.	tleto@nih.gov			U.S. National Institutes of Health Intramural Research Program, National Institute of Allergy and Infectious Diseases; KAKENHI on Priority Areas and on the GlobalCOE Program in Japan; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000614, Z01AI000614] Funding Source: NIH RePORTER	U.S. National Institutes of Health Intramural Research Program, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); KAKENHI on Priority Areas and on the GlobalCOE Program in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are thankful to Dr. F. Borrego (NIAID/LIG) and Dr. J. Kabat (NIAID/RTB) for their technical assistance in flow cytometry and imaging experiments. This work was supported by the U.S. National Institutes of Health Intramural Research Program, National Institute of Allergy and Infectious Diseases, and KAKENHI on Priority Areas and on the GlobalCOE Program in Japan.	Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Ameziane-El-Hassani R, 2005, J BIOL CHEM, V280, P30046, DOI 10.1074/jbc.M500516200; BENARD B, 1971, UNION MED CAN, V100, P701; Caillou B, 2001, J CLIN ENDOCR METAB, V86, P3351, DOI 10.1210/jc.86.7.3351; Cross AR, 2004, BBA-BIOENERGETICS, V1657, P1, DOI 10.1016/j.bbabio.2004.03.008; CROSS AR, 1986, BIOCHEM J, V237, P111, DOI 10.1042/bj2370111; DE D, 2002, EXP CELL RES, V273, P187; De Deken X, 2000, J BIOL CHEM, V275, P23227, DOI 10.1074/jbc.M000916200; Donko A, 2005, PHILOS T R SOC B, V360, P2301, DOI 10.1098/rstb.2005.1767; Dupuy C, 2000, BIOCHEM BIOPH RES CO, V277, P287, DOI 10.1006/bbrc.2000.3671; Dupuy C, 1999, J BIOL CHEM, V274, P37265, DOI 10.1074/jbc.274.52.37265; DUPUY C, 1991, J BIOL CHEM, V266, P3739; Edens WA, 2001, J CELL BIOL, V154, P879, DOI 10.1083/jcb.200103132; El Hassani RA, 2005, AM J PHYSIOL-GASTR L, V288, pG933, DOI 10.1152/ajpgi.00198.2004; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Forteza R, 2005, AM J RESP CELL MOL, V32, P462, DOI 10.1165/rcmb.2004-0302OC; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897; Grasberger H, 2007, MOL ENDOCRINOL, V21, P1408, DOI 10.1210/me.2007-0018; Grasberger H, 2006, J BIOL CHEM, V281, P18269, DOI 10.1074/jbc.C600095200; Harper RW, 2006, FEBS LETT, V580, P5150, DOI 10.1016/j.febslet.2006.08.048; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; KOZAK M, 1992, ANNU REV CELL BIOL, V8, P197, DOI 10.1146/annurev.cb.08.110192.001213; Luxen S, 2008, CANCER RES, V68, P1037, DOI 10.1158/0008-5472.CAN-07-5782; Moreno JC, 2002, NEW ENGL J MED, V347, P95, DOI 10.1056/NEJMoa012752; Nakano Y, 2007, BIOCHEM J, V403, P97, DOI 10.1042/BJ20060819; PICK E, 1981, J IMMUNOL METHODS, V46, P211, DOI 10.1016/0022-1759(81)90138-1; Qin HJ, 2004, J BIOL CHEM, V279, P11304, DOI 10.1074/jbc.M311733200; Schwarzer C, 2004, J BIOL CHEM, V279, P36454, DOI 10.1074/jbc.M404983200; Song Y, 2007, J CLIN ENDOCR METAB, V92, P3764, DOI 10.1210/jc.2007-0660; Sugawara M, 2002, EXP BIOL MED, V227, P141, DOI 10.1177/153537020222700209; Ueyama T, 2006, MOL CELL BIOL, V26, P2160, DOI 10.1128/MCB.26.6.2160-2174.2006; Varela V, 2006, CLIN CHEM, V52, P182, DOI 10.1373/clinchem.2005.058321; Vigone Maria Cristina, 2005, Hum Mutat, V26, P395; Wesley UV, 2007, J BIOL CHEM, V282, P3213, DOI 10.1074/jbc.M606533200; Wong JL, 2004, DEV CELL, V7, P801, DOI 10.1016/j.devcel.2004.10.014; Zamproni I, 2008, J CLIN ENDOCR METAB, V93, P605, DOI 10.1210/jc.2007-2020; ZENG J, 1992, J MOL BIOL, V226, P185, DOI 10.1016/0022-2836(92)90133-5; Zhu YM, 2006, J BIOL CHEM, V281, P30336, DOI 10.1074/jbc.M607191200	39	126	127	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2009	23	4					1205	1218		10.1096/fj.08-120006	http://dx.doi.org/10.1096/fj.08-120006			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZO	19074510	Green Published			2022-12-25	WOS:000266651600025
J	Elliott, JM; Rouge, L; Wiesmann, C; Scheer, JM				Elliott, J. Michael; Rouge, Lionel; Wiesmann, Christian; Scheer, Justin M.			Crystal Structure of Procaspase-1 Zymogen Domain Reveals Insight into Inflammatory Caspase Autoactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERLEUKIN-1-BETA CONVERTING-ENZYME; ACTIVATION MECHANISM; INITIATOR CASPASES; ALLOSTERIC SITE; PROTEIN; GENERATION; DRONC; PURIFICATION; SPECIFICITY; INHIBITOR	One key event in inflammatory signaling is the activation of the initiator caspase, procaspase-1. Presented here is the crystal structure of the procaspase-1 zymogen without its caspase recruitment domain solved to 2.05 angstrom. Although the isolated domain is monomeric in solution, the protein appeared dimeric in crystals. The loop arrangements in the dimer provide insight into the first autoproteolytic events that occur during activation by oligomerization. Additionally, in contrast to other caspases, we demonstrate that autoproteolysis at the second cleavage site, Asp(316), is necessary for conversion to a stable dimer in solution. Critical elements of secondary structure are revealed in the crystal structure that explain why a dimeric protein is favored after proteolysis at this aspartic acid. Dimer stabilization is concurrent with a 130-fold increase in k(cat), the sole contributing kinetic factor to an activated and efficient mediator of inflammation.	[Elliott, J. Michael; Scheer, Justin M.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Rouge, Lionel; Wiesmann, Christian] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Scheer, JM (corresponding author), Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA.	scheer.justin@gene.com		Wiesmann, Christian/0000-0002-4092-9880	Office of Science, Office of Basic Energy Sciences, Materials Sciences Division, United States Department of Energy [DE-AC03-76SF00098]	Office of Science, Office of Basic Energy Sciences, Materials Sciences Division, United States Department of Energy(United States Department of Energy (DOE))	We acknowledge the Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, Materials Sciences Division, United States Department of Energy under Contract DE-AC03-76SF00098 at Lawrence Berkeley National Laboratory. We thank Richard Vandlen for support, guidance, and manuscript review; Jiansheng Wu and Katrina Nicholes for advice and suggestions; and Hok Seon Kim, Dan Yansura, Cecelia Brown, and Art Huang for providing materials.	Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Bao Q, 2007, CELL DEATH DIFFER, V14, P56, DOI 10.1038/sj.cdd.4402028; BLACK RA, 1989, J BIOL CHEM, V264, P5323; Chai JJ, 2001, CELL, V107, P399, DOI 10.1016/S0092-8674(01)00544-X; Chang DW, 2003, EMBO J, V22, P4132, DOI 10.1093/emboj/cdg414; Chao Y, 2005, PLOS BIOL, V3, P1079, DOI 10.1371/journal.pbio.0030183; Chen M, 2002, J BIOL CHEM, V277, P50761, DOI 10.1074/jbc.M210356200; Cornelis S, 2007, CURR PHARM DESIGN, V13, P367, DOI 10.2174/138161207780163006; Dorstyn L, 2008, CELL DEATH DIFFER, V15, P461, DOI 10.1038/sj.cdd.4402288; Druilhe A, 2001, CELL DEATH DIFFER, V8, P649, DOI 10.1038/sj.cdd.4400881; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fahr BT, 2006, BIOORG MED CHEM LETT, V16, P559, DOI 10.1016/j.bmcl.2005.10.048; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Garcia-Calvo M, 1999, CELL DEATH DIFFER, V6, P362, DOI 10.1038/sj.cdd.4400497; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Hardy JA, 2004, CURR OPIN STRUC BIOL, V14, P706, DOI 10.1016/j.sbi.2004.10.009; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; Humke EW, 2000, CELL, V103, P99, DOI 10.1016/S0092-8674(00)00108-2; Joshi VD, 2002, INFECT IMMUN, V70, P6896, DOI 10.1128/IAI.70.12.6896-6903.2002; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lamkanfi M, 2004, J BIOL CHEM, V279, P51729, DOI 10.1074/jbc.M407891200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee SH, 2001, J BIOL CHEM, V276, P34495, DOI 10.1074/jbc.M101415200; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petrilli V, 2005, CURR BIOL, V15, pR581, DOI 10.1016/j.cub.2005.07.049; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Piana S, 2003, BIOCHEMISTRY-US, V42, P8720, DOI 10.1021/bi034032l; Razmara M, 2002, J BIOL CHEM, V277, P13952, DOI 10.1074/jbc.M107811200; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Riedl SJ, 2001, P NATL ACAD SCI USA, V98, P14790, DOI 10.1073/pnas.221580098; Romanowski MJ, 2004, STRUCTURE, V12, P1361, DOI 10.1016/j.str.2004.05.010; Scheer JM, 2005, PROTEIN EXPRES PURIF, V41, P148, DOI 10.1016/j.pep.2005.01.008; Scheer JM, 2006, P NATL ACAD SCI USA, V103, P7595, DOI 10.1073/pnas.0602571103; Scheer JM, 2009, CRC ENZYM INHIB SER, P225; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Simmons LC, 2002, J IMMUNOL METHODS, V263, P133, DOI 10.1016/S0022-1759(02)00036-4; Snipas SJ, 2008, CELL DEATH DIFFER, V15, P938, DOI 10.1038/cdd.2008.23; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Tsuji NM, 2004, INT IMMUNOL, V16, P335, DOI 10.1093/intimm/dxh041; WILSON KP, 1994, NATURE, V370, P270, DOI 10.1038/370270a0; Yamin TT, 1996, J BIOL CHEM, V271, P13273, DOI 10.1074/jbc.271.22.13273; Yan N, 2006, J BIOL CHEM, V281, P8667, DOI 10.1074/jbc.M513232200	48	60	60	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6546	6553		10.1074/jbc.M806121200	http://dx.doi.org/10.1074/jbc.M806121200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19117953	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000263742700057
J	Bogachev, AV; Belevich, NP; Bertsova, YV; Verkhovsky, MI				Bogachev, Alexander V.; Belevich, Nikolai P.; Bertsova, Yulia V.; Verkhovsky, Michael I.			Primary Steps of the Na+-translocating NADH: Ubiquinone Oxidoreductase Catalytic Cycle Resolved by the Ultrafast Freeze-Quench Approach	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUINONE OXIDOREDUCTASE; VIBRIO-ALGINOLYTICUS; ELECTRON-TRANSFER; NQRC SUBUNITS; CHOLERAE; HARVEYI; REDUCTASE; PURIFICATION; RIBOFLAVIN; COMPLEX	The Na+-translocating NADH: ubiquinone oxidoreductase (Na+ - NQR) is a component of respiratory chain of various bacteria, and it generates a redox-driven transmembrane electrochemical Na+ potential. Primary steps of the catalytic cycle of Na+ - NQR from Vibrio harveyi were followed by the ultrafast freeze-quench approach in combination with conventional stopped-flow technique. The obtained sequence of events includes NADH binding (similar to 1.5 x 10(7) M-1 s(-1)), hydride ion transfer from NADH to FAD (similar to 3.5 x 10(3) s(-1)), and partial electron separation and formation of equivalent fractions of reduced 2Fe-2S cluster and neutral semiquinone of FAD (similar to 0.97 x 10(3) s(-1)). In the last step, a quasi-equilibrium is approached between the two states of FAD: two-electron reduced (50%) and one-electron reduced (the other 50%) species. The latter, neutral semiquinone of FAD, shares the second electron with the 2Fe-2S center. The transient midpoint redox potentials for the cofactors obtained during the fast kinetics measurements are very different from ones achieved during equilibrium redox titration and show that the functional states of the enzyme realized during its turning over cannot be modeled by the equilibrium approach.	[Bogachev, Alexander V.; Bertsova, Yulia V.] Moscow MV Lomonosov State Univ, Dept Mol Energet Microorganisms, Belozersky Inst Physicochem Biol, Moscow 119992, Russia; [Belevich, Nikolai P.; Verkhovsky, Michael I.] Univ Helsinki, Inst Biotechnol, Helsinki Bioenerget Grp, Helsinki 00014, Finland	Lomonosov Moscow State University; University of Helsinki	Verkhovsky, MI (corresponding author), Moscow MV Lomonosov State Univ, Dept Mol Energet Microorganisms, Belozersky Inst Physicochem Biol, Moscow 119992, Russia.	michael.verkhovsky@helsinki.fi	Bogachev, Alexander V/E-5844-2012; Bertsova, Yulia V./B-5505-2014	Bogachev, Alexander V/0000-0003-3035-4494; 	Biocentrum Helsinki [7919028]; Sigrid Juselius Foundation [4700827]; Academy of Finland [115108]; Russian Foundation for Basic Research [07-04-00619]	Biocentrum Helsinki; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by grants from the Biocentrum Helsinki (Project Number 7919028), the Sigrid Juselius Foundation (Project Number 4700827), the Academy of Finland (Project Number 115108), and the Russian Foundation for Basic Research (Project Number 07-04-00619).	Barquera B, 2002, P NATL ACAD SCI USA, V99, P10322, DOI 10.1073/pnas.162361299; Barquera B, 2004, BIOCHEMISTRY-US, V43, P12322, DOI 10.1021/bi048689y; Barquera B, 2002, BIOCHEMISTRY-US, V41, P3781, DOI 10.1021/bi011873o; BATIE CJ, 1984, J BIOL CHEM, V259, P1976; Bogachev AV, 2001, BIOCHEMISTRY-US, V40, P7318, DOI 10.1021/bi002545b; Bogachev AV, 2005, BIOCHEMISTRY-MOSCOW+, V70, P143, DOI 10.1007/s10541-005-0093-4; Bogachev AV, 2002, BBA-BIOENERGETICS, V1556, P113, DOI 10.1016/S0005-2728(02)00342-0; Bogachev AV, 2006, BIOCHEMISTRY-US, V45, P3421, DOI 10.1021/bi052422x; Bogachev AV, 1997, FEBS LETT, V409, P475, DOI 10.1016/S0014-5793(97)00536-X; Cherepanov AV, 2004, BBA-BIOENERGETICS, V1656, P1, DOI 10.1016/j.bbabio.2004.02.006; Fadeeva MS, 2008, FEMS MICROBIOL LETT, V279, P116, DOI 10.1111/j.1574-6968.2007.01015.x; Hase CC, 2001, MICROBIOL MOL BIOL R, V65, P353, DOI 10.1128/MMBR.65.3.353-370.2001; Hayashi M, 2001, FEBS LETT, V488, P5, DOI 10.1016/S0014-5793(00)02404-2; Juarez O, 2008, J BIOL CHEM, V283, P33162, DOI 10.1074/jbc.M806913200; Konas DW, 2006, BIOCHEMISTRY-US, V45, P12596, DOI 10.1021/bi061011t; Lin Y, 2003, ANAL CHEM, V75, P5381, DOI 10.1021/ac0346205; MORGAN JE, 1995, BIOCHEMISTRY-US, V34, P15633, DOI 10.1021/bi00048a005; Nakayama Y, 2000, FEBS LETT, V474, P165, DOI 10.1016/S0014-5793(00)01595-7; Palmer G., 1971, FLAVINS FLAVOPROTEIN, P123; PfenningerLi XD, 1996, BIOCHEMISTRY-US, V35, P6233, DOI 10.1021/bi953032l; RICH PR, 1995, FEBS LETT, V375, P5, DOI 10.1016/0014-5793(95)01164-A; Tanaka M, 2003, BIOPHYS J, V84, P1998, DOI 10.1016/S0006-3495(03)75008-5; Turk K, 2004, J BIOL CHEM, V279, P21349, DOI 10.1074/jbc.M311692200; Verkhovskaya ML, 2008, P NATL ACAD SCI USA, V105, P3763, DOI 10.1073/pnas.0711249105; Zhou WD, 1999, BIOCHEMISTRY-US, V38, P16246, DOI 10.1021/bi991664s	25	19	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5533	5538		10.1074/jbc.M808984200	http://dx.doi.org/10.1074/jbc.M808984200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19117949	hybrid			2022-12-25	WOS:000263560600016
J	Carra, S; Brunsting, JF; Lambert, H; Landry, J; Kampinga, HH				Carra, Serena; Brunsting, Jeanette F.; Lambert, Herman; Landry, Jacques; Kampinga, Harm H.			HspB8 Participates in Protein Quality Control by a Non-chaperone-like Mechanism That Requires eIF2 alpha Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; INITIATION-FACTOR 2-ALPHA; ENDOPLASMIC-RETICULUM; ALPHA-SUBUNIT; HSP22 HSPB8; IN-VIVO; HUNTINGTIN FRAGMENTS; MAMMALIAN HOMOLOG; UBIQUITIN LIGASE; FACTOR EIF-2	Aggregation of mutated proteins is a hallmark of many neurodegenerative disorders, including Huntington disease. We previously reported that overexpression of the HspB8 . Bag3 chaperone complex suppresses mutated huntingtin aggregation via autophagy. Classically, HspB proteins are thought to act as ATP-independent molecular chaperones that can bind unfolded proteins and facilitate their processing via the help of ATP-dependent chaperones such as the Hsp70 machine, in which Bag3 may act as a molecular link between HspB, Hsp70, and the ubiquitin ligases. However, here we show that HspB8 and Bag3 act in a non-canonical manner unrelated to the classical chaperone model. Rather, HspB8 and Bag3 induce the phosphorylation of the alpha-subunit of the translation initiator factor eIF2, which in turn causes a translational shut-down and stimulates autophagy. This function of HspB8 . Bag3 does not require Hsp70 and also targets fully folded substrates. HspB8 . Bag3 activity was independent of the endoplasmic reticulum (ER) stress kinase PERK, demonstrating that its action is unrelated to ER stress and suggesting that it activates stress-mediated translational arrest and autophagy through a novel pathway.	[Carra, Serena; Brunsting, Jeanette F.; Kampinga, Harm H.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiat & Stress Cell Biol, NL-9713 AV Groningen, Netherlands; [Lambert, Herman; Landry, Jacques] Univ Laval, Ctr Rech Cancerol, Hotel Dieu, Quebec City, PQ G1R 2J6, Canada	University of Groningen; Laval University	Carra, S (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Radiat & Stress Cell Biol, Deusinglaan 1, NL-9713 AV Groningen, Netherlands.	s.carra@med.umcg.nl	Carra, Serena/O-2835-2015	Carra, Serena/0000-0003-0939-0140; Kampinga, Harm/0000-0002-8966-8466	Senter (Innovatiegerichte Onderzoeksprogramma Genomics [IGE07004]; Prinses Beatrix Foundation [WAR05-0129]	Senter (Innovatiegerichte Onderzoeksprogramma Genomics; Prinses Beatrix Foundation	This work was supported in part by Senter (Innovatiegerichte Onderzoeksprogramma Genomics Grant IGE07004) and by Prinses Beatrix Foundation Grant WAR05-0129.	Alberti S, 2002, J BIOL CHEM, V277, P45920, DOI 10.1074/jbc.M204196200; Arndt V, 2005, MOL BIOL CELL, V16, P5891, DOI 10.1091/mbc.E05-07-0660; Benndorf R, 2001, J BIOL CHEM, V276, P26753, DOI 10.1074/jbc.M103001200; Berger Z, 2006, HUM MOL GENET, V15, P433, DOI 10.1093/hmg/ddi458; Berlanga JJ, 1999, EUR J BIOCHEM, V265, P754, DOI 10.1046/j.1432-1327.1999.00780.x; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Brush MH, 2003, MOL CELL BIOL, V23, P1292, DOI 10.1128/MCB.23.4.1292-1303.2003; Carra S, 2005, HUM MOL GENET, V14, P1659, DOI 10.1093/hmg/ddi174; Carra S, 2008, AUTOPHAGY, V4, P237, DOI 10.4161/auto.5407; Carra S, 2008, J BIOL CHEM, V283, P1437, DOI 10.1074/jbc.M706304200; Chen SM, 2002, BIOCHEMISTRY-US, V41, P7391, DOI 10.1021/bi011772q; Chowdary TK, 2004, BIOCHEM J, V381, P379, DOI 10.1042/BJ20031958; COLTHURST DR, 1987, EUR J BIOCHEM, V166, P357, DOI 10.1111/j.1432-1033.1987.tb13523.x; Cummings CJ, 2000, ANNU REV GENOM HUM G, V1, P281, DOI 10.1146/annurev.genom.1.1.281; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; Depre C, 2002, CIRC RES, V91, P1007, DOI 10.1161/01.RES.0000044380.54893.4B; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Doong H, 2002, CANCER LETT, V188, P25, DOI 10.1016/S0304-3835(02)00456-1; Doong H, 2003, J BIOL CHEM, V278, P28490, DOI 10.1074/jbc.M209682200; Doong H, 2000, ONCOGENE, V19, P4385, DOI 10.1038/sj.onc.1203797; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; Fontaine JM, 2005, BIOCHEM BIOPH RES CO, V337, P1006, DOI 10.1016/j.bbrc.2005.09.148; Giese KC, 2002, J BIOL CHEM, V277, P46310, DOI 10.1074/jbc.M208926200; Gober MD, 2004, BIOCHEM BIOPH RES CO, V321, P267, DOI 10.1016/j.bbrc.2004.06.103; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Haslbeck M, 2004, EMBO J, V23, P638, DOI 10.1038/sj.emboj.7600080; Irobi J, 2004, NAT GENET, V36, P597, DOI 10.1038/ng1328; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Kalia SK, 2004, NEURON, V44, P931, DOI 10.1016/j.neuron.2004.11.026; Kim MV, 2004, BIOCHEM BIOPH RES CO, V325, P649, DOI 10.1016/j.bbrc.2004.10.074; Kim MV, 2004, BIOCHEM BIOPH RES CO, V315, P796, DOI 10.1016/j.bbrc.2004.01.130; King MA, 2008, MOL PHARMACOL, V73, P1052, DOI 10.1124/mol.107.043398; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Kubota H, 2003, J BIOL CHEM, V278, P20457, DOI 10.1074/jbc.C300133200; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; LEROUX A, 1982, P NATL ACAD SCI-BIOL, V79, P2147, DOI 10.1073/pnas.79.7.2147; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li H, 2007, MOL CELL BIOL, V27, P5296, DOI 10.1128/MCB.01667-06; Luders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Magnifico A, 2003, J BIOL CHEM, V278, P43169, DOI 10.1074/jbc.M308009200; Moren A, 2005, J BIOL CHEM, V280, P22115, DOI 10.1074/jbc.M414027200; Narasimhan J, 2004, J BIOL CHEM, V279, P22820, DOI 10.1074/jbc.M402228200; Nollen EAA, 1999, MOL CELL BIOL, V19, P2069; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Pagliuca MG, 2003, FEBS LETT, V541, P11, DOI 10.1016/S0014-5793(03)00274-6; PATHAK VK, 1988, MOL CELL BIOL, V8, P993, DOI 10.1128/MCB.8.2.993; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Rosas H D, 2004, NeuroRx, V1, P263, DOI 10.1602/neurorx.1.2.263; Rosati A, 2007, J CELL PHYSIOL, V210, P676, DOI 10.1002/jcp.20865; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sanbe A, 2007, J BIOL CHEM, V282, P555, DOI 10.1074/jbc.M605481200; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Smith CC, 2000, J BIOL CHEM, V275, P25690, DOI 10.1074/jbc.M002140200; Sood R, 2000, GENETICS, V154, P787; Sun X, 2007, CELL STRESS CHAPERON, V12, P307, DOI 10.1379/CSC-276.1; Sun XK, 2004, J BIOL CHEM, V279, P2394, DOI 10.1074/jbc.M311324200; Takayama S, 1999, J BIOL CHEM, V274, P781, DOI 10.1074/jbc.274.2.781; Takayama S, 2001, NAT CELL BIOL, V3, pE237, DOI 10.1038/ncb1001-e237; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Tang BS, 2005, HUM GENET, V116, P222, DOI 10.1007/s00439-004-1218-3; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Wyttenbach A, 2000, P NATL ACAD SCI USA, V97, P2898, DOI 10.1073/pnas.97.6.2898; Young P, 2008, J GEN VIROL, V89, P866, DOI 10.1099/vir.0.83414-0	73	105	105	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5523	5532		10.1074/jbc.M807440200	http://dx.doi.org/10.1074/jbc.M807440200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19114712	hybrid			2022-12-25	WOS:000263560600015
J	Knezevic, II; Predescu, SA; Neamu, RF; Gorovoy, MS; Knezevic, NM; Easington, C; Malik, AB; Predescu, DN				Knezevic, Ivana I.; Predescu, Sanda A.; Neamu, Radu F.; Gorovoy, Matvey S.; Knezevic, Nebojsa M.; Easington, Cordus; Malik, Asrar B.; Predescu, Dan N.			Tiam1 and Rac1 Are Required for Platelet-activating Factor-induced Endothelial Junctional Disassembly and Increase in Vascular Permeability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCERYL ETHER PHOSPHORYLCHOLINE; LIGHT-CHAIN PHOSPHORYLATION; ACTIN-FILAMENT INTEGRITY; SMOOTH-MUSCLE-CELLS; BOTULINUM C2 TOXIN; PROTEIN-KINASE-C; MICROVASCULAR PERMEABILITY; GROWTH-FACTOR; BARRIER DYSFUNCTION; PHOSPHOLIPASE-C	It is known that platelet-activating factor (PAF) induces severe endothelial barrier leakiness, but the signaling mechanisms remain unclear. Here, using a wide range of biochemical and morphological approaches applied in both mouse models and cultured endothelial cells, we addressed the mechanisms of PAF-induced disruption of interendothelial junctions (IEJs) and of increased endothelial permeability. The formation of interendothelial gaps filled with filopodia and lamellipodia is the cellular event responsible for the disruption of endothelial barrier. We observed that PAF ligation of its receptor induced the activation of the Rho GTPase Rac1. Following PAF exposure, both Rac1 and its guanine nucleotide exchange factor Tiam1 were found associated with a membrane fraction from which they co-immunoprecipitated with PAF receptor. In the same time frame with Tiam1-Rac1 translocation, the junctional proteins ZO-1 and VE-cadherin were relocated from the IEJs, and formation of numerous interendothelial gaps was recorded. Notably, the response was independent of myosin light chain phosphorylation and thus distinct from other mediators, such as histamine and thrombin. The changes in actin status are driven by the PAF-induced localized actin polymerization as a consequence of Rac1 translocation and activation. Tiam1 was required for the activation of Rac1, actin polymerization, relocation of junctional associated proteins, and disruption of IEJs. Thus, PAF-induced IEJ disruption and increased endothelial permeability requires the activation of a Tiam1-Rac1 signaling module, suggesting a novel therapeutic target against increased vascular permeability associated with inflammatory diseases.	[Knezevic, Ivana I.; Predescu, Sanda A.; Easington, Cordus; Predescu, Dan N.] Rush Univ, Med Ctr, Dept Pharmacol, Chicago, IL 60612 USA; [Neamu, Radu F.; Gorovoy, Matvey S.; Knezevic, Nebojsa M.; Malik, Asrar B.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA	Rush University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Predescu, DN (corresponding author), 1735 W Harrison St,Jelke S Bldg,Rm 1415A, Chicago, IL 60612 USA.	Dan_Predescu@rush.edu	Knezevic, Nebojsa Nick/H-9921-2019	Knezevic, Nebojsa Nick/0000-0001-8028-1495; Malik, Asrar/0000-0002-8205-7128; Predescu, Sanda/0000-0002-9386-6756	National Institutes of Health [RO1-HLO89462, PO1-HL60678]; American Heart Association [SDG0635175N]; RUMC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084153, R01HL089462, P01HL060678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056159] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); RUMC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-HLO89462 ( to S. P.) and PO1-HL60678 ( to A. B. M.). This work was also supported by American Heart Association Grant SDG0635175N, and start-up funds from RUMC ( to D. N. P.).	Adamson RH, 2003, AM J PHYSIOL-HEART C, V285, pH406, DOI 10.1152/ajpheart.00021.2003; Adamson RH, 2002, J PHYSIOL-LONDON, V539, P295, DOI 10.1113/jphysiol.2001.013117; Aktories K, 2004, ANAEROBE, V10, P101, DOI 10.1016/j.anaerobe.2003.10.003; AKTORIES K, 1986, NATURE, V322, P390, DOI 10.1038/322390a0; Axelrad TW, 2004, FASEB J, V18, P568, DOI 10.1096/fj.03-0479fje; Baisden JM, 2001, ONCOGENE, V20, P6607, DOI 10.1038/sj.onc.1204802; Baldwin AL, 2001, CRIT REV BIOMED ENG, V29, P247, DOI 10.1615/CritRevBiomedEng.v29.i2.20; BALDWIN AL, 1995, AM J PHYSIOL-HEART C, V269, pH1528, DOI 10.1152/ajpheart.1995.269.5.H1528; BENVENISTE J, 1989, ADV PROSTAG THROMB L, V19, P355; BJORK J, 1983, EUR J PHARMACOL, V96, P87, DOI 10.1016/0014-2999(83)90532-0; Bogatcheva NV, 2002, BIOCHEMISTRY-MOSCOW+, V67, P75, DOI 10.1023/A:1013904231324; BRAQUET P, 1991, MED RES REV, V11, P295, DOI 10.1002/med.2610110303; BURHOP KE, 1986, AM REV RESPIR DIS, V134, P548; BUSSOLINO F, 1994, J BIOL CHEM, V269, P2877; BUSSOLINO F, 1987, J IMMUNOL, V139, P2439; CAMUSSI G, 1983, INT ARCH ALLER A IMM, V70, P245, DOI 10.1159/000233331; CAMUSSI G, 1983, J IMMUNOL, V131, P2397; CHIGNARD M, 1979, NATURE, V279, P799, DOI 10.1038/279799a0; Cicchetti G, 2002, CRIT REV ORAL BIOL M, V13, P220, DOI 10.1177/154411130201300302; Cohen AW, 1999, AM J PHYSIOL-HEART C, V277, pH2038, DOI 10.1152/ajpheart.1999.277.5.H2038; Cook JA, 2003, J BIOL CHEM, V278, P35812, DOI 10.1074/jbc.M302878200; Dejana E, 1996, J CLIN INVEST, V98, P1949, DOI 10.1172/JCI118997; Deo DD, 2004, J BIOL CHEM, V279, P3497, DOI 10.1074/jbc.M304497200; DRENCKHAHN D, 1997, ENDOTHELIAL CONTRACT; DVORAK HF, 1995, AM J PATHOL, V146, P1029; FANNING AS, 2001, TIGHT JUNCTIONS, P265; Fleming IN, 2004, BIOCHEM J, V382, P857, DOI 10.1042/BJ20040916; Fleming IN, 1998, FEBS LETT, V429, P229, DOI 10.1016/S0014-5793(98)00566-3; GARCIA JGN, 1995, J CELL PHYSIOL, V163, P510, DOI 10.1002/jcp.1041630311; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Garrett TA, 2007, EXP CELL RES, V313, P3285, DOI 10.1016/j.yexcr.2007.05.027; GOTTLIEB AI, 1991, LAB INVEST, V65, P123; HALONEN M, 1980, AM REV RESPIR DIS, V122, P915; HUMPHREY DM, 1984, LAB INVEST, V50, P16; Lee TYJ, 2003, MICROSC RES TECHNIQ, V60, P115, DOI 10.1002/jemt.10250; LU ZP, 1993, CIRC SHOCK, V41, P8; Lum H, 1996, CAN J PHYSIOL PHARM, V74, P787, DOI 10.1139/cjpp-74-7-787; MADARA JL, 1987, AM J PHYSIOL, V253, pC854, DOI 10.1152/ajpcell.1987.253.6.C854; MAJNO G, 1961, J BIOPHYS BIOCHEM CY, V11, P571, DOI 10.1083/jcb.11.3.571; Marrache AM, 2002, J IMMUNOL, V169, P6474, DOI 10.4049/jimmunol.169.11.6474; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Meng WX, 2004, EMBO J, V23, P760, DOI 10.1038/sj.emboj.7600095; Michel CC, 1999, PHYSIOL REV, V79, P703, DOI 10.1152/physrev.1999.79.3.703; Michiels F, 1997, J CELL BIOL, V137, P387, DOI 10.1083/jcb.137.2.387; Nicholson-Dykstra S, 2005, CURR BIOL, V15, pR346, DOI 10.1016/j.cub.2005.04.029; Patterson RL, 1999, CELL, V98, P487, DOI 10.1016/S0092-8674(00)81977-7; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; PINCKARD RN, 1980, J RETICULOENDOTH SOC, V28, pS95; PIROTZKY E, 1984, MICROCIRC ENDOTH LYM, V1, P107; PORTER K, 1972, P 5 ANN STER SCANN E, P1244; Predescu D, 1996, EUR J CELL BIOL, V69, P86; Predescu SA, 2001, MOL BIOL CELL, V12, P1019, DOI 10.1091/mbc.12.4.1019; Predescu SA, 2007, J BIOL CHEM, V282, P17166, DOI 10.1074/jbc.M608996200; Qian Y, 1998, ONCOGENE, V16, P2185, DOI 10.1038/sj.onc.1201753; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Ridley A J, 1999, Prog Mol Subcell Biol, V22, P1; Ridley AJ, 1999, BIOCHEM SOC SYMP, V65, P111; Robert EG, 2001, CURR PHARM DESIGN, V7, P1615, DOI 10.2174/1381612013397203; ROBERTS WG, 1995, J CELL SCI, V108, P2369; Rousseau S, 2000, TRENDS CARDIOVAS MED, V10, P321, DOI 10.1016/S1050-1738(01)00072-X; Ryu Y, 2002, CIRC RES, V90, P325, DOI 10.1161/hh0302.104455; Schirenbeck A, 2005, NAT CELL BIOL, V7, P619, DOI 10.1038/ncb1266; Simionescu M, 2002, MICROSC RES TECHNIQ, V57, P269, DOI 10.1002/jemt.10086; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SNYDER F, 1995, BIOCHEM J, V305, P689, DOI 10.1042/bj3050689; Stafforini DM, 2003, CRIT REV CL LAB SCI, V40, P643, DOI 10.1080/714037693; Surks HK, 2005, J BIOL CHEM, V280, P42543, DOI 10.1074/jbc.M506863200; SVENSJO E, 1986, FASEB J, V45, P89; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Taylor SJ, 1996, CURR BIOL, V6, P1621, DOI 10.1016/S0960-9822(02)70785-9; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANDEKERCKHOVE J, 1988, J BIOL CHEM, V263, P696; VERIN AD, 1995, AM J PHYSIOL-LUNG C, V269, pL99, DOI 10.1152/ajplung.1995.269.1.L99; WALSH CT, 2008, FASEB J IN PRESS; Waschke J, 2004, AM J PHYSIOL-HEART C, V286, pH394, DOI 10.1152/ajpheart.00221.2003; WEGNER A, 1988, J BIOL CHEM, V263, P13739; Weiner OD, 1999, NAT CELL BIOL, V1, P75, DOI 10.1038/10042	77	68	72	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5381	5394		10.1074/jbc.M808958200	http://dx.doi.org/10.1074/jbc.M808958200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19095647	Green Published, hybrid			2022-12-25	WOS:000263416600068
J	Liu, LF; Ishihara, K; Ichimura, T; Fujita, N; Hino, S; Tomita, S; Watanabe, S; Saitoh, N; Ito, T; Nakao, M				Liu, Lifeng; Ishihara, Ko; Ichimura, Takaya; Fujita, Naoyuki; Hino, Shinjiro; Tomita, Saori; Watanabe, Sugiko; Saitoh, Noriko; Ito, Takaaki; Nakao, Mitsuyoshi			MCAF1/AM Is Involved in Sp1-mediated Maintenance of Cancer-associated Telomerase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMORTAL HUMAN-CELLS; REVERSE-TRANSCRIPTASE GENE; HTERT GENE; HETEROCHROMATIN FORMATION; PROMOTER SEQUENCES; DNA METHYLATION; FACTOR FAMILY; RNA; ACTIVATION; REPRESSION	Telomerase maintains telomere length and is implicated in senescence and immortalization of mammalian cells. Two essential components for this enzyme are telomerase reverse transcriptase (TERT) and the telomerase RNA component (encoded by the TERC gene). These telomerase subunit genes are known to be mainly expressed by specificity protein 1 (Sp1). MBD1-containing chromatin-associated factor 1 (MCAF1), also known as ATFa-associated modulator (AM) and activating transcription factor 7-interacting protein (ATF7IP), mediates gene regulation, although the precise function of MCAF1 remains to be elucidated. Here, we report that MCAF1 is involved in Sp1-dependent maintenance of telomerase activity in cancer cells. Two evolutionarily conserved domains of MCAF1 directly interact with Sp1 and the general transcriptional apparatus. Selective depletion of MCAF1 or Sp1 down-regulates TERT and TERC genes in cultured cells, which results in decreased telomerase activity. The transcriptionally active form of RNA polymerase II and the general transcription factor ERCC3 decreased in the TERT promoter under the loss of MCAF1 or Sp1. Consistently, MCAF1 is found to be frequently overexpressed in naturally occurring cancers that originate in different tissues. Our data suggest that transcriptional function of MCAF1 facilitates telomerase expression by Sp1, which may be a common mechanism in proliferative cancer cells.	[Liu, Lifeng; Ishihara, Ko; Hino, Shinjiro; Tomita, Saori; Watanabe, Sugiko; Saitoh, Noriko; Nakao, Mitsuyoshi] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Regenerat Med, Kumamoto 8600811, Japan; [Ichimura, Takaya; Ito, Takaaki] Kumamoto Univ, Grad Sch Med Sci, Dept Pathol & Expt Med, Kumamoto 8608556, Japan; [Fujita, Naoyuki] Kumamoto Univ, Grad Sch Med Sci, Dept Mol Pharmacol, Kumamoto 8608556, Japan	Kumamoto University; Kumamoto University; Kumamoto University	Nakao, M (corresponding author), Kumamoto Univ, Inst Mol Embryol & Genet, Dept Regenerat Med, 2-2-1 Honjo, Kumamoto 8600811, Japan.	mnakao@gpo.kumamoto-u.ac.jp	Watanabe, Sugiko/Q-6201-2019	Watanabe, Sugiko/0000-0002-2120-9546	Ministry of Education, Culture, Sports, Science and Technology; Global COE (Center of Excellence) "Cell Fate Regulation Research and Education Unit," Kumamoto University	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE (Center of Excellence) "Cell Fate Regulation Research and Education Unit," Kumamoto University(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology (to M. N.) and a Grant-in-aid for Global COE (Center of Excellence) "Cell Fate Regulation Research and Education Unit," Kumamoto University. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; Aoto T, 2006, DEV BIOL, V298, P354, DOI 10.1016/j.ydbio.2006.04.450; Avilion AA, 1996, CANCER RES, V56, P645; Bellon M, 2008, JNCI-J NATL CANCER I, V100, P98, DOI 10.1093/jnci/djm269; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Cairney CJ, 2008, BIOCHIMIE, V90, P13, DOI 10.1016/j.biochi.2007.07.025; Cao Y, 2008, CANCER SCI, V99, P1092, DOI 10.1111/j.1349-7006.2008.00815.x; Chang LK, 2005, NUCLEIC ACIDS RES, V33, P6528, DOI 10.1093/nar/gki956; Colgin LM, 1999, CURR OPIN GENET DEV, V9, P97, DOI 10.1016/S0959-437X(99)80014-8; Cong YS, 2002, MICROBIOL MOL BIOL R, V66, P407, DOI 10.1128/MMBR.66.3.407-425.2002; Cristofari G, 2006, EMBO J, V25, P565, DOI 10.1038/sj.emboj.7600952; De Graeve F, 2000, ONCOGENE, V19, P1807, DOI 10.1038/sj.onc.1203492; Devereux TR, 1999, CANCER RES, V59, P6087; Fujita N, 2003, MOL CELL BIOL, V23, P2834, DOI 10.1128/MCB.23.8.2834-2843.2003; Guilleret I, 2002, INT J CANCER, V101, P335, DOI 10.1002/ijc.10593; Gunther M, 2000, MOL CELL BIOCHEM, V210, P131, DOI 10.1023/A:1007177623283; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Herbert BS, 1999, P NATL ACAD SCI USA, V96, P14276, DOI 10.1073/pnas.96.25.14276; Horikawa I, 1999, CANCER RES, V59, P826; Ichimura T, 2005, J BIOL CHEM, V280, P13928, DOI 10.1074/jbc.M413654200; Janknecht R, 2004, FEBS LETT, V564, P9, DOI 10.1016/S0014-5793(04)00356-4; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kumakura S, 2005, CANCER RES, V65, P2778, DOI 10.1158/0008-5472.CAN-04-1819; Kyo S, 2002, ONCOGENE, V21, P688, DOI 10.1038/sj.onc.1205163; Kyo S, 2000, NUCLEIC ACIDS RES, V28, P669, DOI 10.1093/nar/28.3.669; Myers LC, 2000, ANNU REV BIOCHEM, V69, P729, DOI 10.1146/annurev.biochem.69.1.729; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Nugent CI, 1998, GENE DEV, V12, P1073, DOI 10.1101/gad.12.8.1073; PUGH BF, 1991, GENE DEV, V5, P1935, DOI 10.1101/gad.5.11.1935; Renaud S, 2007, NUCLEIC ACIDS RES, V35, P1245, DOI 10.1093/nar/gkl1125; Rooney PH, 1999, BRIT J CANCER, V80, P862, DOI 10.1038/sj.bjc.6690433; Safe S, 2005, EUR J CANCER, V41, P2438, DOI 10.1016/j.ejca.2005.08.006; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Smale ST, 1997, BBA-GENE STRUCT EXPR, V1351, P73, DOI 10.1016/S0167-4781(96)00206-0; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Takakura M, 1999, CANCER RES, V59, P551; Uchimura Y, 2006, J BIOL CHEM, V281, P23180, DOI 10.1074/jbc.M602280200; Wang HB, 2003, MOL CELL, V12, P475, DOI 10.1016/j.molcel.2003.08.007; Wang X, 2008, ONCOGENE, V27, P1894, DOI 10.1038/sj.onc.1210821; Wege H, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng003; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Woychik NA, 2002, CELL, V108, P453, DOI 10.1016/S0092-8674(02)00646-3; Yang JW, 1999, J BIOL CHEM, V274, P26141, DOI 10.1074/jbc.274.37.26141; Yi XM, 1999, MOL CELL BIOL, V19, P3989; Yi XM, 2001, NUCLEIC ACIDS RES, V29, P4818, DOI 10.1093/nar/29.23.4818; Zhao JQ, 1998, ONCOGENE, V16, P1345, DOI 10.1038/sj.onc.1201892; Zhao JQ, 2000, NEOPLASIA, V2, P531, DOI 10.1038/sj.neo.7900114	50	42	53	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5165	5174		10.1074/jbc.M807098200	http://dx.doi.org/10.1074/jbc.M807098200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19106100	hybrid			2022-12-25	WOS:000263416600047
J	Shelton, MD; Distler, AM; Kern, TS; Mieyal, JJ				Shelton, Melissa D.; Distler, Anne M.; Kern, Timothy S.; Mieyal, John J.			Glutaredoxin Regulates Autocrine and Paracrine Proinflammatory Responses in Retinal Glial (Muller) Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B KINASE; PROTEIN S-GLUTATHIONYLATION; NECROSIS-FACTOR-ALPHA; DIABETIC-RETINOPATHY; OXIDATIVE STRESS; GROWTH-FACTOR; INTERLEUKIN-6; EXPRESSION; RAT; MECHANISMS	Protein S-glutathionylation is a reversible redox-dependent post-translational modification. Many cellular functions and signal transduction pathways involve proteins whose cysteine-dependent activities are modulated by glutathionylation. Glutaredoxin (Grx1) plays a key role in such regulation because it is a specific and efficient catalyst of deglutathionylation. We recently reported an increase in Grx1 in retinae of diabetic rats and in rat retinal Muller glial cells (rMC-1) cultured in high glucose. This up-regulation of Grx1 was concomitant with NF kappa B activation and induction of intercellular adhesion molecule-1 (ICAM-1). This proinflammatory response was replicated by adenoviral-directed up-regulation of Grx1 in cells in normal glucose. The site of regulation of NF kappa B was localized to the cytoplasm, where I kappa B kinase (IKK) is a master regulator of NF kappa B activation. In the current study, inhibition of IKK activity abrogated the increase in ICAM-1 induced by high glucose or by adenoviral-directed up-regulation of Grx1. Conditioned medium from the Muller cells overexpressing Grx1 was added to fresh cultures of Muller or endothelial cells and elicited increases in the Grx1 and ICAM-1 proteins in these cells. These effects correlate with a novel finding that secretion of interleukin-6 was elevated in the cultures of Grx overexpressing cells. Also, pure interleukin-6 increased Grx1 and ICAM-1 in the rMC-1 cells. Thus, Grx1 appears to play an important role in both autocrine and paracrine proinflammatory responses. Furthermore, IKK beta isolated from Muller cells in normal glucose medium was found to be glutathionylated on Cys-179. Hence Grx-mediated activation of IKK via deglutathionylation may play a central role in diabetic complications in vivo where Grx1 is increased.	[Shelton, Melissa D.; Distler, Anne M.; Kern, Timothy S.; Mieyal, John J.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Kern, Timothy S.] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; [Shelton, Melissa D.; Kern, Timothy S.; Mieyal, John J.] Louis Stokes Cleveland Vet Affairs Med Res Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Mieyal, JJ (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 2109 Adelbert Rd,WRT300-9, Cleveland, OH 44106 USA.	jjm5@cwru.edu			NEI NIH HHS [5 T32 EY07157, T32 EY007157] Funding Source: Medline; NIA NIH HHS [R01 AG024413, P01 AG 15885] Funding Source: Medline; NATIONAL EYE INSTITUTE [T32EY007157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG015885, R01AG024413] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Cameron NE, 2008, CURR DRUG TARGETS, V9, P60, DOI 10.2174/138945008783431718; Chrestensen CA, 2000, J BIOL CHEM, V275, P26556, DOI 10.1074/jbc.M004097200; ELASRAR AM, 1992, AM J OPHTHALMOL, V114, P731, DOI 10.1016/S0002-9394(14)74052-8; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; GRAVINA SA, 1993, BIOCHEMISTRY-US, V32, P3368, DOI 10.1021/bi00064a021; GRAVINA SA, 1993, THESIS CASE W RESERV; Gustavsson C, 2008, RETINA-J RET VIT DIS, V28, P645, DOI 10.1097/IAE.0b013e31815ec32d; Hosoya K, 2001, EXP EYE RES, V72, P163, DOI 10.1006/exer.2000.0941; Jeon KI, 2003, EXP MOL MED, V35, P61, DOI 10.1038/emm.2003.9; KAUFFMANN DJH, 1994, INVEST OPHTH VIS SCI, V35, P900; Li X, 2005, AM J PHYSIOL-HEART C, V288, pH1417, DOI 10.1152/ajpheart.00559.2004; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Mukherjee TK, 2007, J IMMUNOL, V178, P1835, DOI 10.4049/jimmunol.178.3.1835; Murugeswari P, 2008, RETINA-J RET VIT DIS, V28, P817, DOI 10.1097/IAE.0b013e31816576d5; Mysliwiec M, 2008, DIABETES RES CLIN PR, V79, P141, DOI 10.1016/j.diabres.2007.07.011; Pan S, 2007, CIRC RES, V100, P213, DOI 10.1161/01.RES.0000256089.30318.20; Peltoniemi M, 2004, HUM PATHOL, V35, P1000, DOI 10.1016/j.humpath.2004.04.009; Pineda-Molina E, 2001, BIOCHEMISTRY-US, V40, P14134, DOI 10.1021/bi011459o; Qanungo S, 2007, J BIOL CHEM, V282, P18427, DOI 10.1074/jbc.M610934200; Reynaert NL, 2007, AM J RESP CELL MOL, V36, P147, DOI 10.1165/rcmb.2006-0259RC; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Sanchez RN, 2003, INVEST OPHTH VIS SCI, V44, P4006, DOI 10.1167/iovs.03-0040; Sappington RM, 2006, INVEST OPHTH VIS SCI, V47, P3860, DOI 10.1167/iovs.05-1408; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Seki T, 2006, ANN NY ACAD SCI, V1070, P535, DOI 10.1196/annals.1317.043; Shelton MD, 2005, ANTIOXID REDOX SIGN, V7, P348, DOI 10.1089/ars.2005.7.348; Shelton MD, 2007, J BIOL CHEM, V282, P12467, DOI 10.1074/jbc.M610863200; Shoelson SE, 2003, INT J OBESITY, V27, pS49, DOI 10.1038/sj.ijo.0802501; Srinivasan S, 2004, ARTERIOSCL THROM VAS, V24, P851, DOI 10.1161/01.ATV.zhq0504.2260; Takashima Y, 1999, IMMUNOL LETT, V68, P397, DOI 10.1016/S0165-2478(99)00087-5	31	44	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4759	4766		10.1074/jbc.M805464200	http://dx.doi.org/10.1074/jbc.M805464200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19074435	hybrid, Green Published			2022-12-25	WOS:000263416600003
J	Broca, C; Quoyer, J; Costes, S; Linck, N; Varrault, A; Deffayet, PM; Bockaert, J; Dalle, S; Bertrand, G				Broca, Christophe; Quoyer, Julie; Costes, Safia; Linck, Nathalie; Varrault, Annie; Deffayet, Pierre-Marie; Bockaert, Joeel; Dalle, Stephane; Bertrand, Gyslaine			beta-Arrestin 1 Is Required for PAC(1) Receptor-mediated Potentiation of Long-lasting ERK1/2 Activation by Glucose in Pancreatic beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCAGON-LIKE PEPTIDE-1; ELEMENT-BINDING PROTEIN; ADENYLATE-CYCLASE; INSULIN-SECRETION; INTESTINAL POLYPEPTIDE; REGULATED KINASE; ISLETS; PACAP; SRC; LINE	In pancreatic beta-cells, the pituitary adenylate cyclase-activating polypeptide (PACAP) exerts a potent insulin secretory effect via PAC(1) and VPAC receptors (Rs) through the G alpha(s)/cAMP/protein kinase A pathway. Here, we investigated the mechanisms linking PAC(1)R to ERK1/2 activation in INS-1E beta-cells and pancreatic islets. PACAP caused a transient (5 min) increase in ERK1/2 phosphorylation via PAC(1)Rs and promoted nuclear translocation of a fraction of cytosolic p-ERK1/2. Both protein kinase A- and Src-dependent pathways mediated this transient ERK1/2 activation. Moreover, PACAP potentiated glucose-induced long-lasting ERK1/2 activation. Blocking Ca2+ influx abolished glucose-induced ERK1/2 activation and PACAP potentiating effect. Glucose stimulation during KC1 depolarization showed that, in addition to the triggering signal (rise in cytosolic [Ca2+]), the amplifying pathway was also involved in glucose-induced sustained ERK1/2 activation and was required for PACAP potentiation. The finding that at 30 min glucose-induced p-ERK1/2 was detected in both cytosol and nucleus while the potentiating effect of PACAP was only observed in the cytosol, suggested the involvement of the scaffold protein beta-arrestin. Indeed, beta-arrestin 1 (beta-arr1) depletion (in beta-arr1 knockout mouse islets or in INS-1E cells by siRNA) completely abolished PACAP potentiation of long-lasting ERK1/2 activation by glucose. Finally, PACAP potentiated glucose-induced CREB transcriptional activity and IRS-2 mRNA expression mainly via the ERK1/2 signaling pathway, and likewise, beta-arr1 depletion reduced the PACAP potentiating effect on IRS-2 expression. These results establish for the first time that PACAP potentiates glucose-induced long-lasting ERK1/2 activation via a beta-arr1-dependent pathway and thus provide new insights concerning the mechanisms of PACAP and glucose actions in pancreatic beta-cells.	[Bertrand, Gyslaine] Univ Montpellier I, Inst Genom Fonct, CNRS, INSERM,U661,Unite Mixte Rech 5203, F-34094 Montpellier 5, France; Univ Montpellier 2, F-34094 Montpellier 5, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier	Bertrand, G (corresponding author), Univ Montpellier I, Inst Genom Fonct, CNRS, INSERM,U661,Unite Mixte Rech 5203, F-34094 Montpellier 5, France.	gyslaine.bertrand@igf.cnrs.fr	, Costes/AAC-2820-2020; bertrand, gyslaine/AAC-6716-2020	, Costes/0000-0001-8323-1207; Linck, Nathalie/0000-0002-2218-239X; Broca, Christophe/0000-0002-7715-8231	INSERM; Region Languedoc-Roussillon	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region Languedoc-Roussillon(Region OccitanieRegion Ile-de-France)	Supported by INSERM and the Region Languedoc-Roussillon.	Ackermann AM, 2007, J MOL ENDOCRINOL, V38, P193, DOI 10.1677/JME-06-0053; AfKlinteberg K, 1996, ENDOCRINOLOGY, V137, P2791, DOI 10.1210/en.137.7.2791; Arnette D, 2003, J BIOL CHEM, V278, P32517, DOI 10.1074/jbc.M301174200; Barki-Harrington L, 2008, PHYSIOLOGY, V23, P17, DOI 10.1152/physiol.00042.2007; Barthet G, 2007, MOL BIOL CELL, V18, P1979, DOI 10.1091/mbc.E06-12-1080; Benes C, 1998, J BIOL CHEM, V273, P15507, DOI 10.1074/jbc.273.25.15507; Bertrand G, 1996, BRIT J PHARMACOL, V117, P764, DOI 10.1111/j.1476-5381.1996.tb15256.x; Bertrand G, 2002, J BIOL CHEM, V277, P32883, DOI 10.1074/jbc.M205326200; Borboni P, 1999, ENDOCRINOLOGY, V140, P5530, DOI 10.1210/en.140.12.5530; Botia B, 2007, PEPTIDES, V28, P1746, DOI 10.1016/j.peptides.2007.04.013; Briaud I, 2003, DIABETES, V52, P974, DOI 10.2337/diabetes.52.4.974; Cantley J, 2007, DIABETOLOGIA, V50, P1248, DOI 10.1007/s00125-007-0637-9; Cao WH, 2000, J BIOL CHEM, V275, P38131, DOI 10.1074/jbc.C000592200; Caunt CJ, 2006, TRENDS ENDOCRIN MET, V17, P276, DOI 10.1016/j.tem.2006.07.008; Conner DA, 1997, CIRC RES, V81, P1021; Costes S, 2006, DIABETES, V55, P2220, DOI 10.2337/db05-1618; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Dalle S, 2004, J BIOL CHEM, V279, P20345, DOI 10.1074/jbc.M312483200; Defea K, 2008, BRIT J PHARMACOL, V153, pS298, DOI 10.1038/sj.bjp.0707508; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Doyle ME, 2007, PHARMACOL THERAPEUT, V113, P546, DOI 10.1016/j.pharmthera.2006.11.007; Ehses JA, 2002, J BIOL CHEM, V277, P37088, DOI 10.1074/jbc.M205055200; Filipsson K, 1997, J CLIN ENDOCR METAB, V82, P3093, DOI 10.1210/jc.82.9.3093; FRIDOLF T, 1992, CELL TISSUE RES, V269, P275, DOI 10.1007/BF00319618; FRODIN M, 1995, J BIOL CHEM, V270, P7882, DOI 10.1074/jbc.270.14.7882; Gibson TB, 2006, DIABETES, V55, P1066, DOI 10.2337/diabetes.55.04.06.db05-1266; Gomez E, 2002, J BIOL CHEM, V277, P48146, DOI 10.1074/jbc.M209165200; Harmar AJ, 2001, GENOME BIOL, V2; He Y, 2003, ELECTROPHORESIS, V24, P101, DOI 10.1002/elps.200390000; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Henquin JC, 2003, EUR J CLIN INVEST, V33, P742, DOI 10.1046/j.1365-2362.2003.01207.x; Jamen F, 2000, J CLIN INVEST, V105, P1307, DOI 10.1172/JCI9387; Jamen F, 2002, ENDOCRINOLOGY, V143, P1253, DOI 10.1210/en.143.4.1253; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Khoo S, 1997, P NATL ACAD SCI USA, V94, P5599, DOI 10.1073/pnas.94.11.5599; Khoo S, 2004, CELL BIOCHEM BIOPHYS, P191; Khoo S, 2003, J BIOL CHEM, V278, P32969, DOI 10.1074/jbc.M301198200; Lawrence M, 2008, ACTA PHYSIOL, V192, P11, DOI 10.1111/j.1748-1716.2007.01785.x; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Longuet C, 2005, ENDOCRINOLOGY, V146, P643, DOI 10.1210/en.2004-0841; Luttrell LM, 2005, J MOL NEUROSCI, V26, P253, DOI 10.1385/JMN:26:2-3:253; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Sonoda N, 2008, P NATL ACAD SCI USA, V105, P6614, DOI 10.1073/pnas.0710402105; Straub SG, 1996, J BIOL CHEM, V271, P1660, DOI 10.1074/jbc.271.3.1660; Tomimoto S, 2004, J PHARMACOL EXP THER, V309, P796, DOI 10.1124/jpet.103.062919; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vaudry D, 2000, PHARMACOL REV, V52, P269; Werry TD, 2005, TRENDS ENDOCRIN MET, V16, P26, DOI 10.1016/j.tem.2004.11.008; Winzell MS, 2007, PEPTIDES, V28, P1805, DOI 10.1016/j.peptides.2007.04.024; YADA T, 1994, J BIOL CHEM, V269, P1290; Yamamoto K, 2003, DIABETES, V52, P1155, DOI 10.2337/diabetes.52.5.1155	55	34	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4332	4342		10.1074/jbc.M807595200	http://dx.doi.org/10.1074/jbc.M807595200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19074139	hybrid			2022-12-25	WOS:000263134400032
J	Schnitzler, MMY; Rinne, S; Skrobek, L; Renigunta, V; Schlichthorl, G; Derst, C; Gudermann, T; Daut, J; Preisig-Muller, R				Mederos y Schnitzler, Michael; Rinne, Susanne; Skrobek, Lennart; Renigunta, Vijay; Schlichthoerl, Guenter; Derst, Christian; Gudermann, Thomas; Daut, Juergen; Preisig-Mueller, Regina			Mutation of Histidine 105 in the T1 Domain of the Potassium Channel Kv2.1 Disrupts Heteromerization with Kv6.3 and Kv6.4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED K+ CHANNELS; ALPHA-SUBUNITS; MOLECULAR DIVERSITY; SHAB; SHAKER; DETERMINANTS; EXCITABILITY; MODULATION; ACTIVATION; INTERFACE	The voltage-activated K+ channel subunit Kv2.1 can form heterotetramers with members of the Kv6 subfamily, generating channels with biophysical properties different from homomeric Kv2.1 channels. The N-terminal tetramerization domain (T1) has been shown previously to play a role in Kv channel assembly, but the mechanisms controlling specific heteromeric assembly are still unclear. In Kv6. x channels the histidine residue of the zinc ion-coordinating C3H1 motif of Kv2.1 is replaced by arginine or valine. Using a yeast two-hybrid assay, we found that substitution of the corresponding histidine 105 in Kv2.1 by valine (H105V) or arginine (H105R) disrupted the interaction of the T1 domain of Kv2.1 with the T1 domains of both Kv6.3 and Kv6.4, whereas interaction of the T1 domain of Kv2.1 with itself was unaffected by this mutation. Using fluorescence resonance energy transfer (FRET), interaction could be detected between the subunits Kv2.1/Kv2.1, Kv2.1/Kv6.3, and Kv2.1/Kv6.4. Reduced FRET signals were obtained after co-expression of Kv2.1(H105V) or Kv2.1(H105R) with Kv6.3 or Kv6.4. Wild-type Kv2.1 but not Kv2.1(H105V) could be co-immunoprecipitated with Kv6.4. Co-expression of dominant-negative mutants of Kv6.3 reduced the current produced Kv2.1, but not of Kv2.1(H105)R mutants. Co-expression of Kv6.3 or Kv6.4 with wt Kv2.1 but not with Kv2.1(H105V) or Kv2.1(H105R) changed the voltage dependence of activation of the channels. Our results suggest that His-105 in the T1 domain of Kv2.1 is required for functional heteromerization with members of the Kv6 subfamily. We conclude from our findings that Kv2.1 and Kv6. x subunits have complementary T1 domains that control selective heteromerization.	[Rinne, Susanne; Renigunta, Vijay; Schlichthoerl, Guenter; Derst, Christian; Daut, Juergen; Preisig-Mueller, Regina] Univ Marburg, Inst Physiol, D-35032 Marburg, Germany; [Mederos y Schnitzler, Michael; Skrobek, Lennart; Gudermann, Thomas] Univ Marburg, Inst Pharmacol & Toxicol, D-35037 Marburg, Germany; [Rinne, Susanne; Renigunta, Vijay; Schlichthoerl, Guenter; Derst, Christian; Daut, Juergen; Preisig-Mueller, Regina] Univ Marburg, Inst Physiol, D-35037 Marburg, Germany	Philipps University Marburg; Philipps University Marburg; Philipps University Marburg	Daut, J (corresponding author), Univ Marburg, Inst Physiol, Deutschhausstr 2, D-35037 Marburg, Germany.	jdaut@staff.uni-marburg.de			Medizinstiftung; P. E.-Kempkes-Stiftung; SFB593	Medizinstiftung; P. E.-Kempkes-Stiftung; SFB593(German Research Foundation (DFG))	This study was supported by the Medizinstiftung (to M. M. S. and R. P. M.), P. E.-Kempkes-Stiftung (to R. P. M.), and SFB593 (TP A3, to T. G.; TP A4, to J. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barry DM, 1996, ANNU REV PHYSIOL, V58, P363, DOI 10.1146/annurev.ph.58.030196.002051; Bixby KA, 1999, NAT STRUCT BIOL, V6, P38; Chiara MD, 1999, J NEUROSCI, V19, P6865, DOI 10.1523/JNEUROSCI.19-16-06865.1999; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; COVARRUBIAS M, 1991, NEURON, V7, P763, DOI 10.1016/0896-6273(91)90279-9; Cushman SJ, 2000, NAT STRUCT BIOL, V7, P403; Deutsch C, 2002, ANNU REV PHYSIOL, V64, P19, DOI 10.1146/annurev.physiol.64.081501.155934; Du J, 2000, J PHYSIOL-LONDON, V522, P19, DOI 10.1111/j.1469-7793.2000.t01-2-00019.xm; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Hille B., 2001, ION CHANNELS EXCITAB, P131; Hugnot JP, 1996, EMBO J, V15, P3322, DOI 10.1002/j.1460-2075.1996.tb00697.x; Jahng AW, 2002, J BIOL CHEM, V277, P47885, DOI 10.1074/jbc.M208416200; Jan LY, 1997, J PHYSIOL-LONDON, V505, P267, DOI 10.1111/j.1469-7793.1997.267bb.x; Ju M, 2003, J BIOL CHEM, V278, P12769, DOI 10.1074/jbc.M212973200; Kramer JW, 1998, AM J PHYSIOL-CELL PH, V274, pC1501, DOI 10.1152/ajpcell.1998.274.6.C1501; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lu JL, 2001, BIOCHEMISTRY-US, V40, P10934, DOI 10.1021/bi010763e; Malin SA, 2002, J NEUROSCI, V22, P10094; Minor DL, 2000, CELL, V102, P657, DOI 10.1016/S0092-8674(00)00088-X; Misonou H, 2005, NEUROTOXICOLOGY, V26, P743, DOI 10.1016/j.neuro.2005.02.003; Misonou H, 2005, J NEUROSCI METH, V144, P165, DOI 10.1016/j.jneumeth.2004.11.007; Misonou H, 2008, J NEUROSCI, V28, P8529, DOI 10.1523/JNEUROSCI.1417-08.2008; Mohapatra DP, 2008, J NEUROSCI, V28, P4982, DOI 10.1523/JNEUROSCI.0186-08.2008; Ottschytsch N, 2002, P NATL ACAD SCI USA, V99, P7986, DOI 10.1073/pnas.122617999; Patel AJ, 1997, EMBO J, V16, P6615, DOI 10.1093/emboj/16.22.6615; Pioletti M, 2006, NAT STRUCT MOL BIOL, V13, P987, DOI 10.1038/nsmb1164; Post MA, 1996, FEBS LETT, V399, P177, DOI 10.1016/S0014-5793(96)01316-6; RAINEY WE, 1994, MOL CELL ENDOCRINOL, V100, P45, DOI 10.1016/0303-7207(94)90277-1; Robinson JM, 2005, NEURON, V45, P223, DOI 10.1016/j.neuron.2004.12.043; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; Salinas M, 1997, J BIOL CHEM, V272, P24371, DOI 10.1074/jbc.272.39.24371; Salinas M, 1997, J BIOL CHEM, V272, P8774, DOI 10.1074/jbc.272.13.8774; Sano Y, 2002, FEBS LETT, V512, P230, DOI 10.1016/S0014-5793(02)02267-6; SHEN NV, 1993, NEURON, V11, P67; Strang C, 2003, J BIOL CHEM, V278, P31361, DOI 10.1074/jbc.M304268200; Tu LW, 1996, J BIOL CHEM, V271, P18904, DOI 10.1074/jbc.271.31.18904; Vacher H, 2008, PHYSIOL REV, V88, P1407, DOI 10.1152/physrev.00002.2008; Vega-Saenz de Miera E, 2004, MOL BRAIN RES, V123, P91, DOI 10.1016/j.molbrainres.2004.01.004; Wang GY, 2006, J GEN PHYSIOL, V127, P391, DOI 10.1085/jgp.200509442; Wang GY, 2005, J GEN PHYSIOL, V126, P55, DOI 10.1085/jgp.200509288; XU J, 1995, J BIOL CHEM, V270, P24761, DOI 10.1074/jbc.270.42.24761; Zhu XR, 1999, RECEPTOR CHANNEL, V6, P337	43	13	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4695	4704		10.1074/jbc.M808786200	http://dx.doi.org/10.1074/jbc.M808786200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19074135	hybrid			2022-12-25	WOS:000263134400069
J	Yerbury, JJ; Kumita, JR; Meehan, S; Dobson, CM; Wilson, MR				Yerbury, Justin J.; Kumita, Janet R.; Meehan, Sarah; Dobson, Christopher M.; Wilson, Mark R.			alpha(2)-Macroglobulin and Haptoglobin Suppress Amyloid Formation by Interacting with Prefibrillar Protein Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONE-LIKE ACTIVITY; EXTRACELLULAR CHAPERONE; ALZHEIMERS-DISEASE; CLUSTERIN; BETA; PEPTIDE; CLEARANCE; BINDING; ALPHA-2-MACROGLOBULIN; SPECIFICITY	alpha(2)-Macroglobulin (alpha M-2) and haptoglobin ( Hp) are both abundant secreted glycoproteins that are best known for their protease trapping and hemoglobin binding activities, respectively. Like the small heat shock proteins, both these glycoproteins have in common the ability to protect a range of proteins from stress-induced amorphous aggregation and have been described as extracellular chaperones. Using an array of biophysical techniques, this study establishes that in vitro at substoichiometric levels and under physiological conditions alpha M-2 and Hp both inhibit the formation of amyloid fibrils from a range of proteins. We also provide evidence that both alpha M-2 and Hp interact with prefibrillar species to maintain the solubility of amyloidogenic proteins. These findings suggest that both alpha M-2 and Hp are likely to play an important role in controlling the inappropriate aggregation of proteins in the extracellular environment.	[Yerbury, Justin J.; Wilson, Mark R.] Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia; [Kumita, Janet R.; Meehan, Sarah; Dobson, Christopher M.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Wollongong; University of Cambridge	Wilson, MR (corresponding author), Univ Wollongong, Sch Biol Sci, Northfields Ave, Wollongong, NSW 2522, Australia.	mrw@uow.edu.au	Yerbury, Justin/AAC-7054-2022; Kumita, Janet/AAO-5254-2021; Wilson, Mark R/B-3254-2018	Yerbury, Justin/0000-0003-2528-7039; Wilson, Mark R/0000-0002-9551-7445	Rosemary Foundation Loader; Alzheimer's Australia Research; Biotechnology and Biological Sciences Research Council [BB/E019927/1] Funding Source: researchfish	Rosemary Foundation Loader; Alzheimer's Australia Research; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by a Rosemary Foundation Loader research grant through Alzheimer's Australia Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adler V, 2007, NEUROCHEM J+, V1, P43, DOI 10.1134/S1819712407010060; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; BARRETT AJ, 1981, METHOD ENZYMOL, V80, P737; Bell RD, 2007, J CEREBR BLOOD F MET, V27, P909, DOI 10.1038/sj.jcbfm.9600419; BOWMAN BH, 1982, ADV HUM GENET, V12, P189; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Dobryszycka W, 1997, EUR J CLIN CHEM CLIN, V35, P647; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Du YS, 1997, J NEUROCHEM, V69, P299; El-Ghmati SM, 2002, SCAND J IMMUNOL, V55, P352, DOI 10.1046/j.1365-3083.2002.01067.x; Ettrich R, 2002, BIOL CHEM, V383, P1667, DOI 10.1515/BC.2002.187; Fabrizi C, 2001, J NEUROCHEM, V78, P406, DOI 10.1046/j.1471-4159.2001.00419.x; French K, 2008, BIOCHEMISTRY-US, V47, P1176, DOI 10.1021/bi701976f; Graversen JH, 2002, INT J BIOCHEM CELL B, V34, P309, DOI 10.1016/S1357-2725(01)00144-3; Hatters DM, 2002, EUR J BIOCHEM, V269, P2789, DOI 10.1046/j.1432-1033.2002.02957.x; Hughes SR, 1998, P NATL ACAD SCI USA, V95, P3275, DOI 10.1073/pnas.95.6.3275; Humphreys DT, 1999, J BIOL CHEM, V274, P6875, DOI 10.1074/jbc.274.11.6875; IMBER MJ, 1981, J BIOL CHEM, V256, P8134; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kumita JR, 2007, J MOL BIOL, V369, P157, DOI 10.1016/j.jmb.2007.02.095; Kumita JR, 2006, FEBS J, V273, P711, DOI 10.1111/j.1742-4658.2005.05099.x; LOUAGIE H, 1993, VACCINE, V11, P1188, DOI 10.1016/0264-410X(93)90041-U; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Mettenburg JM, 2002, J BIOL CHEM, V277, P13338, DOI 10.1074/jbc.M106792200; Motomiya Y, 2003, KIDNEY INT, V64, P2244, DOI 10.1046/j.1523-1755.2003.00315.x; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Narita M, 1997, J NEUROCHEM, V69, P1904; Pavlicek Z, 1999, COLLECT CZECH CHEM C, V64, P717, DOI 10.1135/cccc19990717; Poon S, 2002, FEBS LETT, V513, P259, DOI 10.1016/S0014-5793(02)02326-8; Poon S, 2000, BIOCHEMISTRY-US, V39, P15953, DOI 10.1021/bi002189x; POWERS JM, 1981, J NEUROPATH EXP NEUR, V40, P592, DOI 10.1097/00005072-198111000-00002; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; SNELLMAN O, 1967, NATURE, V216, P1033, DOI 10.1038/2161033a0; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P11539; Starkey P. M., 1977, PROTEINASES MAMMALIA, P663; Strausak D, 2001, BRAIN RES BULL, V55, P175, DOI 10.1016/S0361-9230(01)00454-3; Yerbury JJ, 2005, EMBO REP, V6, P1131, DOI 10.1038/sj.embor.7400586; Yerbury JJ, 2005, BIOCHEMISTRY-US, V44, P10914, DOI 10.1021/bi050764x; Yerbury JJ, 2007, FASEB J, V21, P2312, DOI 10.1096/fj.06-7986com	39	79	79	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4246	4254		10.1074/jbc.M807242200	http://dx.doi.org/10.1074/jbc.M807242200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19074141	hybrid			2022-12-25	WOS:000263134400022
J	Champagne, K; Shishido, A; Root, MJ				Champagne, Kelly; Shishido, Akira; Root, Michael J.			Interactions of HIV-1 Inhibitory Peptide T20 with the gp41 N-HR Coiled Coil	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 FUSION; MEMBRANE-FUSION; POTENT INHIBITORS; TRANSMEMBRANE GLYCOPROTEIN; ENVELOPE GLYCOPROTEIN; ATOMIC-STRUCTURE; ENTRY INHIBITOR; HELICAL DOMAIN; 6-HELIX BUNDLE; BINDING-SITE	Cellular entry of human immunodeficiency virus type 1 (HIV-1) involves fusion of viral and cellular membranes and is mediated by structural transitions in viral glycoprotein gp41. The antiviral C-peptide T20 targets the gp41 N-terminal heptad repeat region (N-HR), blocking gp41 conformational changes essential for the entry process. To probe the T20 structure-activity relationship, we engineered a molecular mimic of the entire gp41 N-HR coiled coil using the 5-Helix design strategy. T20 bound this artificial protein (denoted 5H-ex) with nanomolar affinity (K-D = 30 nM), close to its IC50 concentration (similar to 3 nM) but much weaker than the affinity of a related inhibitory C-peptide C37 (K-D = 0.0007 nM). T20/C37 competitive binding assays confirmed that T20 interacts with the hydrophobic groove on the surface of the N-HR coiled coil outside of a deep pocket region crucial for C37 binding. We used 5H-ex to investigate how the T20 N and C termini contributed to the inhibitor binding activity. Mutating three aromatic residues at the T20 C terminus (WNWF -> ANAA) had no effect on affinity, suggesting that these amino acids do not participate in T20 binding to the gp41 N-HR. The results support recent evidence pointing to a different role for these residues in T20 inhibition (Peisajovich, S. G., Gallo, S. A., Blumenthal, R., and Shai, Y. (2003) J. Biol. Chem. 278, 21012-21017; Liu, S., Jing, W., Cheung, B., Lu, H., Sun, J., Yan, X., Niu, J., Farmar, J., Wu, S., and Jiang, S. (2007) J. Biol. Chem. 282, 9612-9620). By contrast, mutations near the T20 N terminus substantially influenced inhibitor binding strength. When Ile was substituted for Thr in the second T20 position, a 40-fold increase in binding affinity was measured (K-D = 0.75 nM). The effect of this affinity enhancement on T20 inhibitory potency varied among different viral strains. The original T20 and the higher affinity T20 variant had similar potency against wild type HIV-1. However, the higher affinity T20 variant was significantly more potent against T20-resistant virus. The findings suggest that other factors in addition to binding affinity play a role in limiting T20 potency. As a mimetic of the complete gp41 N-HR coiled coil region, 5H-ex will be a useful tool to further elucidate mechanistic profiles of C-peptide inhibitors.	[Champagne, Kelly; Shishido, Akira; Root, Michael J.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	Jefferson University	Root, MJ (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, 233 S 10th St,Rm 802, Philadelphia, PA 19107 USA.	mroot@mail.jci.tju.edu	Shishido, Akira/AAD-5818-2022	Shishido, Akira/0000-0002-2649-4139	National Institutes of Health [5-T32-DK0775, R01 GM66682]; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066682] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5-T32-DK0775 (to K. C.) and R01 GM66682 (to M. J. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abrahamyan LG, 2005, J VIROL, V79, P106, DOI 10.1128/JVI.79.1.106-115.2005; Bellamy-Mclntyre AK, 2007, J BIOL CHEM, V282, P23104, DOI 10.1074/jbc.M703485200; BLACKLOW SC, 1995, BIOCHEMISTRY-US, V34, P14955, DOI 10.1021/bi00046a001; Caffrey M, 1998, EMBO J, V17, P4572, DOI 10.1093/emboj/17.16.4572; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Doering DS, 1996, BIOCHEMISTRY-US, V35, P12677, DOI 10.1021/bi9615699; Eckert DM, 2001, P NATL ACAD SCI USA, V98, P11187, DOI 10.1073/pnas.201392898; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; FENOUILLET E, 1995, J GEN VIROL, V76, P1509, DOI 10.1099/0022-1317-76-6-1509; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Hamburger AE, 2005, J BIOL CHEM, V280, P12567, DOI 10.1074/jbc.M412770200; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; Kilgore NR, 2003, J VIROL, V77, P7669, DOI 10.1128/JVI.77.13.7669-7672.2003; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Lawless MK, 1996, BIOCHEMISTRY-US, V35, P13697, DOI 10.1021/bi9606962; Lazzarin A, 2003, NEW ENGL J MED, V348, P2186, DOI 10.1056/NEJMoa035211; Liu SW, 2007, J BIOL CHEM, V282, P9612, DOI 10.1074/jbc.M609148200; Liu SW, 2007, CURR PHARM DESIGN, V13, P143, DOI 10.2174/138161207779313722; Liu SW, 2005, J BIOL CHEM, V280, P11259, DOI 10.1074/jbc.M411141200; Lorizate M, 2006, BIOCHEMISTRY-US, V45, P14337, DOI 10.1021/bi0612521; Lorizate M, 2006, J MOL BIOL, V360, P45, DOI 10.1016/j.jmb.2006.04.056; Louis JM, 2003, J BIOL CHEM, V278, P20278, DOI 10.1074/jbc.M301627200; Louis JM, 2001, J BIOL CHEM, V276, P29485, DOI 10.1074/jbc.C100317200; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Luftig MA, 2006, NAT STRUCT MOL BIOL, V13, P740, DOI 10.1038/nsmb1127; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Munoz-Barroso I, 1998, J CELL BIOL, V140, P315, DOI 10.1083/jcb.140.2.315; Nameki D, 2005, J VIROL, V79, P764, DOI 10.1128/JVI.79.2.764-770.2005; Peisajovich SG, 2003, J BIOL CHEM, V278, P21012, DOI 10.1074/jbc.M212773200; Reeves JD, 2004, J VIROL, V78, P5476, DOI 10.1128/JVI.78.10.5476-5485.2004; Reeves JD, 2002, P NATL ACAD SCI USA, V99, P16249, DOI 10.1073/pnas.252469399; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; Root MJ, 2001, SCIENCE, V291, P884, DOI 10.1126/science.1057453; Root MJ, 2003, P NATL ACAD SCI USA, V100, P5016, DOI 10.1073/pnas.0936926100; Steger HK, 2006, J BIOL CHEM, V281, P25813, DOI 10.1074/jbc.M601457200; Tallarida R., 2000, DRUG SYNERGISM DOSE, P1; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; WANG ZX, 1995, FEBS LETT, V360, P111, DOI 10.1016/0014-5793(95)00062-E; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Wexler-Cohen Y, 2006, J BIOL CHEM, V281, P9005, DOI 10.1074/jbc.M512475200; Wexler-Cohen Y, 2007, FASEB J, V21, P3677, DOI 10.1096/fj.07-8582com; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770	46	46	50	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3619	3627		10.1074/jbc.M809269200	http://dx.doi.org/10.1074/jbc.M809269200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19073602	Green Published, hybrid			2022-12-25	WOS:000262872500030
J	El-Hage, N; Bruce-Keller, AJ; Yakovleva, T; Bazov, I; Bakalkin, G; Knapp, PE; Hauser, KF				El-Hage, Nazira; Bruce-Keller, Annadora J.; Yakovleva, Tatiana; Bazov, Igor; Bakalkin, Georgy; Knapp, Pamela E.; Hauser, Kurt F.			Morphine Exacerbates HIV-1 Tat-Induced Cytokine Production in Astrocytes through Convergent Effects on [Ca2+](i), NF-kappa B Trafficking and Transcription	PLOS ONE			English	Article								Astroglia are key cellular sites where opiate drug signals converge with the proinflammatory effects of HIV-1 Tat signals to exacerbate HIV encephalitis. Despite this understanding, the molecular sites of convergence driving opiate-accelerated neuropathogenesis have not been deciphered. We therefore explored potential points of interaction between the signaling pathways initiated by HIV-1 Tat and opioids in striatal astrocytes. Profiling studies screening 152 transcription factors indicated that the nuclear factor-kappa B (NF-kappa B) subunit, c-Rel, was a likely candidate for Tat or Tat plus opiate-induced increases in cytokine and chemokine production by astrocytes. Pretreatment with the NF-kappa B inhibitor parthenolide provided evidence that Tat +/- morphine-induced release of MCP-1, IL-6 and TNF-alpha by astrocytes is NF-kappa B dependent. The nuclear export inhibitor, leptomycin B, blocked the nucleocytoplasmic shuttling of NF-kappa B; causing p65 (RelA) accumulation in the nucleus, and significantly attenuated cytokine production in Tat +/- morphine exposed astrocytes. Similarly, chelating intracellular calcium ([Ca2+](i)) blocked Tat +/- morphine-evoked MCP-1 and IL-6 release, while artificially increasing the concentration of extracellular Ca2+ reversed this effect. Taken together, these results demonstrate that: 1) exposure to Tat +/- morphine is sufficient to activate NF-kappa B and cytokine production, 2) the release of MCP-1 and IL-6 by Tat +/- morphine are highly Ca2+ -dependent, while TNF-alpha appears to be less affected by the changes in [Ca2+](i), and 3) in the presence of Tat, exposure to opiates augments Tat-induced NF-kappa B activation and cytokine release through a Ca2+ -dependent pathway.	[El-Hage, Nazira; Knapp, Pamela E.; Hauser, Kurt F.] Virginia Commonwealth Univ, Sch Med, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA; [Bruce-Keller, Annadora J.] Louisiana State Univ, Pennington Biomed Res Ctr, Div Basic Res, Baton Rouge, LA 70803 USA; [Yakovleva, Tatiana; Bazov, Igor; Bakalkin, Georgy] Uppsala Univ, Dept Pharm Biosci, Div Biol Res Drug Dependence, Uppsala, Sweden; [Knapp, Pamela E.] Virginia Commonwealth Univ, Sch Med, Dept Anat & Neurobiol, Richmond, VA 23284 USA; [Knapp, Pamela E.; Hauser, Kurt F.] Virginia Commonwealth Univ, Inst Drug & Alcohol Stud, Richmond, VA 23284 USA	Virginia Commonwealth University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Uppsala University; Virginia Commonwealth University; Virginia Commonwealth University	El-Hage, N (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA.	nelhage@vcu.edu	Hauser, Kurt/AAX-8361-2020; Bruce-Keller, Annadora/N-1954-2017	Bakalkin, Georgy/0000-0002-8074-9833; Bazov, Igor/0000-0003-4388-1656; Hauser, Kurt/0000-0001-7886-0332	NIH [P01 DA19398, P20 RR012292]; AFA Forsakring; Swedish Alcohol Retail Monopoly; Swedish Research Council; Torsten och Ragnar Soderbergs stiftelser; Swedish National Drug Policy Coordinator; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA018633, K02DA027374, P01DA019398] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AFA Forsakring; Swedish Alcohol Retail Monopoly; Swedish Research Council(Swedish Research CouncilEuropean Commission); Torsten och Ragnar Soderbergs stiftelser; Swedish National Drug Policy Coordinator; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants P01 DA19398 to KH, PK, and AB-K, and P20 RR012292 to AB-K. This work was also funded by grants from AFA Forsakring, the Swedish Alcohol Retail Monopoly, the Swedish Research Council, Torsten och Ragnar Soderbergs stiftelser, and the Swedish National Drug Policy Coordinator to GB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2000, J CELL BIOL, V148, P849, DOI 10.1083/jcb.148.5.849; Allan SM, 2003, PHILOS T R SOC B, V358, P1669, DOI 10.1098/rstb.2003.1358; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; ARENZANASEISDEDOS F, 1995, MOL CELL BIOL, V15, P2689; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Bell JE, 1998, BRAIN, V121, P2043, DOI 10.1093/brain/121.11.2043; Bell JE, 2006, CURR HIV RES, V4, P249, DOI 10.2174/157016206777709401; Birbach A, 2002, J BIOL CHEM, V277, P10842, DOI 10.1074/jbc.M112475200; Camandola S, 2007, EXPERT OPIN THER TAR, V11, P123, DOI 10.1517/14728222.11.2.123; Choi S, 2006, J BIOL CHEM, V281, P12722, DOI 10.1074/jbc.M601018200; Conant K, 1998, P NATL ACAD SCI USA, V95, P3117, DOI 10.1073/pnas.95.6.3117; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; El-Hage N, 2006, GLIA, V53, P132, DOI 10.1002/glia.20262; El-Hage N, 2005, GLIA, V50, P91, DOI 10.1002/glia.20148; El-Hage N, 2008, J NEUROIMMUNE PHARM, V3, P275, DOI 10.1007/s11481-008-9127-1; El-Hage N, 2006, J NEUROIMMUNOL, V178, P9, DOI 10.1016/j.jneuroim.2006.05.027; Eugenin EA, 2006, J NEUROSCI, V26, P1098, DOI 10.1523/JNEUROSCI.3863-05.2006; Fiala M, 1996, J NEUROVIROL, V2, P158, DOI 10.3109/13550289609146878; Garcia-Segura LM, 1999, J NEUROBIOL, V40, P574, DOI 10.1002/(SICI)1097-4695(19990915)40:4<574::AID-NEU12>3.0.CO;2-8; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Haughey NJ, 1999, J NEUROCHEM, V73, P1363, DOI 10.1046/j.1471-4159.1999.0731363.x; Haughey NJ, 2002, JAIDS-J ACQ IMM DEF, V31, pS55, DOI 10.1097/00126334-200210012-00005; Hauser KF, 1998, PERSPECT DEV NEUROBI, V5, P437; Hauser KF, 2005, NEUROTOX RES, V8, P63, DOI 10.1007/BF03033820; Hauser KF, 1996, BRAIN RES, V720, P191, DOI 10.1016/0006-8993(96)00103-5; Hauser KF, 2007, J NEUROCHEM, V100, P567, DOI 10.1111/j.1471-4159.2006.04227.x; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hehner SP, 1999, J IMMUNOL, V163, P5617; Hua LWL, 2002, J NEUROIMMUNOL, V126, P180, DOI 10.1016/S0165-5728(02)00055-3; Israel A, 2000, TRENDS CELL BIOL, V10, P129, DOI 10.1016/S0962-8924(00)01729-3; Kim JM, 2005, CLIN EXP IMMUNOL, V140, P450, DOI 10.1111/j.1365-2249.2005.02804.x; KURIYAN J, 1995, STRUCTURE, V3, P135, DOI 10.1016/S0969-2126(01)00143-5; Kwok BHB, 2001, CHEM BIOL, V8, P759, DOI 10.1016/S1074-5521(01)00049-7; Lawrence DMP, 2006, GLIA, V53, P81, DOI 10.1002/glia.20261; Lilienbaum A, 2003, MOL CELL BIOL, V23, P2680, DOI 10.1128/MCB.23.8.2680-2698.2003; Luo Y, 2003, GLIA, V43, P119, DOI 10.1002/glia.10231; Luo Y, 2002, GLIA, V39, P19, DOI 10.1002/glia.10079; Mahajan SD, 2005, CLIN IMMUNOL, V115, P323, DOI 10.1016/j.clim.2005.02.004; Mahajan SD, 2002, J IMMUNOL, V169, P3589, DOI 10.4049/jimmunol.169.7.3589; Mankowski JL, 2004, J NEUROIMMUNOL, V157, P66, DOI 10.1016/j.jneuroim.2004.08.031; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; Mattson MP, 1998, INT REV NEUROBIOL, V42, P103, DOI 10.1016/S0074-7742(08)60609-1; Nath A, 2000, J PSYCHOPHARMACOL, V14, P222, DOI 10.1177/026988110001400305; Nath A, 2001, J NEUROVIROL, V7, P66; Nath A, 2002, JAIDS-J ACQ IMM DEF, V31, pS62, DOI 10.1097/00126334-200210012-00006; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; Prat A, 2001, GLIA, V36, P145, DOI 10.1002/glia.1104; Quinones MP, 2008, MOL CELL NEUROSCI, V37, P96, DOI 10.1016/j.mcn.2007.08.017; Roy S, 1998, BIOCHEM BIOPH RES CO, V245, P392, DOI 10.1006/bbrc.1998.8415; Sen CK, 1996, FEBS LETT, V385, P58, DOI 10.1016/0014-5793(96)00346-8; Sevigny JJ, 2004, NEUROLOGY, V63, P2084, DOI 10.1212/01.WNL.0000145763.68284.15; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Stiene-Martin A, 1998, GLIA, V22, P249, DOI 10.1002/(SICI)1098-1136(199803)22:3<249::AID-GLIA4>3.0.CO;2-0; Stylianou E, 1999, KIDNEY INT, V56, P873, DOI 10.1046/j.1523-1755.1999.00640.x; Swinney DC, 2002, J BIOL CHEM, V277, P23573, DOI 10.1074/jbc.M200842200; TYOR WR, 1992, ANN NEUROL, V31, P349, DOI 10.1002/ana.410310402; Wang D, 1998, J BIOL CHEM, V273, P29411, DOI 10.1074/jbc.273.45.29411; Wolff R, 1997, GENOME ANAL, V1, P1; Ye RD, 2001, J LEUKOCYTE BIOL, V70, P839; Zhai QW, 2004, GLIA, V48, P327, DOI 10.1002/glia.20087	60	92	93	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4093	10.1371/journal.pone.0004093	http://dx.doi.org/10.1371/journal.pone.0004093			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DO	19116667	Green Published, gold, Green Submitted			2022-12-25	WOS:000265466600014
J	Di Stefano, M; Calabro, ML; Di Gangi, IM; Cantatore, S; Barbierato, M; Bergamo, E; Kfutwah, AJ; Neri, M; Chieco-Bianchi, L; Greco, P; Gesualdo, L; Ayouba, A; Menu, E; Fiore, JR				Di Stefano, Mariantonietta; Calabro, Maria Luisa; Di Gangi, Iole Maria; Cantatore, Santina; Barbierato, Massimo; Bergamo, Elisa; Kfutwah, Anfumbom Jude; Neri, Margherita; Chieco-Bianchi, Luigi; Greco, Pantaleo; Gesualdo, Loreto; Ayouba, Ahidjo; Menu, Elisabeth; Fiore, Jose Ramon			In Vitro and In Vivo Human Herpesvirus 8 Infection of Placenta	PLOS ONE			English	Article							VARICELLA-ZOSTER-VIRUS; HERPES-SIMPLEX-VIRUS; HERPESVIRUS/HUMAN HERPESVIRUS-8; TRANSMISSION; PREGNANCY; DNA; CYTOMEGALOVIRUS; REPLICATION; APOPTOSIS; TYPE-1	Herpesvirus infection of placenta may be harmful in pregnancy leading to disorders in fetal growth, premature delivery, miscarriage, or major congenital abnormalities. Although a correlation between human herpesvirus 8 (HHV-8) infection and abortion or low birth weight in children has been suggested, and rare cases of in utero or perinatal HHV-8 transmission have been documented, no direct evidence of HHV-8 infection of placenta has yet been reported. The aim of this study was to evaluate the in vitro and in vivo susceptibility of placental cells to HHV-8 infection. Short-term infection assays were performed on placental chorionic villi isolated from term placentae. Qualitative and quantitative HHV-8 detection were performed by PCR and real-time PCR, and HHV-8 proteins were analyzed by immunohistochemistry. Term placenta samples from HHV-8-seropositive women were analyzed for the presence of HHV-8 DNA and antigens. In vitro infected histocultures showed increasing amounts of HHV-8 DNA in tissues and supernatants; cyto- and syncitiotrophoblasts, as well as endothelial cells, expressed latent and lytic viral antigens. Increased apoptotic phenomena were visualized by the terminal deoxynucleotidyl transferase-mediated deoxyuridine nick end-labeling method in infected histocultures. Ex vivo, HHV-8 DNA and a latent viral antigen were detected in placenta samples from HHV-8-seropositive women. These findings demonstrate that HHV-8, like other human herpesviruses, may infect placental cells in vitro and in vivo, thus providing evidence that this phenomenon might influence vertical transmission and pregnancy outcome in HHV-8-infected women.	[Gesualdo, Loreto] Univ Foggia, Mol Med Lab, Foggia, Italy; [Calabro, Maria Luisa; Di Gangi, Iole Maria; Bergamo, Elisa] IRCCS, Ist Oncol Veneto, Padua, Italy; [Cantatore, Santina] Univ Foggia, Sch Med, Lab Histol, Foggia, Italy; [Barbierato, Massimo; Chieco-Bianchi, Luigi] Univ Padua, Dept Oncol & Surg Sci, Oncol Sect, I-35100 Padua, Italy; [Kfutwah, Anfumbom Jude] Ctr Pasteur, Lab Virol, Yaounde, Cameroon; [Neri, Margherita; Greco, Pantaleo] Univ Foggia, Dept Surg Sci, Foggia, Italy; [Ayouba, Ahidjo] Inst Rech Dev, Unite Mixte Rech 145, Montpellier, France; [Menu, Elisabeth] Inst Pasteur, Unite Regulat Infect Retroviral, Paris, France; [Fiore, Jose Ramon] Univ Foggia, Dept Clin & Occupat Hlth, Foggia, Italy	University of Foggia; IRCCS Istituto Oncologico Veneto (IOV); University of Foggia; IRCCS Istituto Oncologico Veneto (IOV); University of Padua; University of Foggia; Institut de Recherche pour le Developpement (IRD); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Foggia	Di Stefano, M (corresponding author), Univ Foggia, Mol Med Lab, Foggia, Italy.	j.fiore@unifg.it	Gesualdo, Loreto/K-7751-2016; Neri, Margherita/AAD-4521-2022; MENU, Elisabeth/B-2886-2010; Calabrò, Maria Luisa/H-6015-2016; Greco, Pantaleo/AAC-5173-2022; Ayouba, Ahidjo/G-8775-2017	Gesualdo, Loreto/0000-0002-4861-0911; MENU, Elisabeth/0000-0001-8844-9328; Calabrò, Maria Luisa/0000-0001-9401-6182; Ayouba, Ahidjo/0000-0002-5081-1632; di stefano, mariantonietta/0000-0001-8814-0953; NERI, Margherita/0000-0002-6459-1669; di gangi, iole maria/0000-0001-6192-5451; GRECO, Pantaleo/0000-0003-2461-6777; fiore, jose ramon/0000-0002-3079-5866	Istituto Superiore di Sanita [50G.3, 50G.29]; Associazione Italiana per la Ricerca sul Cancro [fellowship]; Associazione Italiana per la Lotta contro le Leucemie, Linfomi e Mieloma; Istituto Oncologico Veneto, IRCCS [fellowship]	Istituto Superiore di Sanita; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana per la Lotta contro le Leucemie, Linfomi e Mieloma(Fondazione AIRC per la ricerca sul cancro); Istituto Oncologico Veneto, IRCCS	This work was supported by grants from Istituto Superiore di Sanita (grant n. 50G.3, MLC; grant n. 50G.29, JRF) and from Associazione Italiana per la Ricerca sul Cancro (MLC). MB was the recipient of a fellowship from Associazione Italiana per la Lotta contro le Leucemie, Linfomi e Mieloma (AIL). IMDG was the recipient of a fellowship from Istituto Oncologico Veneto, IRCCS; EB was the recipient of a fellowship from Associazione Italiana per la Ricerca sul Cancro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akula SM, 2002, CELL, V108, P407, DOI 10.1016/S0092-8674(02)00628-1; Akula SM, 2001, VIROLOGY, V282, P245, DOI 10.1006/viro.2000.0851; Arechavaleta-Velasco F, 2002, J REPROD IMMUNOL, V55, P113, DOI 10.1016/S0165-0378(01)00143-7; Avgil M, 2006, REPROD TOXICOL, V21, P436, DOI 10.1016/j.reprotox.2004.11.014; Bestetti G, 1998, AIDS, V12, P541; Brayfield BP, 2004, J INFECT DIS, V189, P2260, DOI 10.1086/421119; Brayfield BP, 2003, J INFECT DIS, V187, P559, DOI 10.1086/367985; CALABRESE EJ, 1999, BELLE NEWSLETTER, V8, P1; Carbone A, 2000, LEUKEMIA LYMPHOMA, V36, P447, DOI 10.3109/10428190009148391; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chow SSW, 2006, J MED VIROL, V78, P747, DOI 10.1002/jmv.20618; Csoma E, 2002, J MED VIROL, V67, P67, DOI 10.1002/jmv.2194; Dedicoat M, 2004, J INFECT DIS, V190, P1068, DOI 10.1086/423326; Du MQ, 2007, J CLIN PATHOL, V60, P1350, DOI 10.1136/jcp.2007.047969; Enright AM, 2004, PEDIATR CLIN N AM, V51, P889, DOI 10.1016/j.pcl.2004.03.005; Faye A, 2005, PLACENTA, V26, P262, DOI 10.1016/j.placenta.2004.08.005; Fisher S, 2000, J VIROL, V74, P6808, DOI 10.1128/JVI.74.15.6808-6820.2000; Ganem D, 2006, ANNU REV PATHOL-MECH, V1, P273, DOI 10.1146/annurev.pathol.1.110304.100133; Gasperini P, 2005, J CLIN MICROBIOL, V43, P2866, DOI 10.1128/JCM.43.6.2866-2875.2005; Gaye-Diallo A, 2001, B SOC PATHOL EXOT, V94, P231; Kawana K, 1996, INT J GYNECOL OBSTET, V55, P165, DOI 10.1016/S0020-7292(96)02732-4; Lisco A, 2006, J CLIN MICROBIOL, V44, P3863, DOI 10.1128/JCM.00791-06; Mantina H, 2001, INT J CANCER, V94, P749, DOI 10.1002/ijc.1529; Mbulaiteye SM, 2005, JAIDS-J ACQ IMM DEF, V38, P474, DOI 10.1097/01.qai.0000132495.89162.c0; Nikkels AF, 2005, J INFECT DIS, V191, P540, DOI 10.1086/426942; Pica F, 2007, CURR OPIN INFECT DIS, V20, P152, DOI 10.1097/QCO.0b013e3280143919; Plancoulaine S, 2004, CANCER RES, V64, P8782, DOI 10.1158/0008-5472.CAN-04-2000; Rezza G, 2000, SEX TRANSM DIS, V27, P159, DOI 10.1097/00007435-200003000-00008; Sarmati L, 2003, J INFECT DIS, V188, P173, DOI 10.1086/375830; Sarmati Loredana, 2004, Herpes, V11, P50; Schleiss Mark R, 2003, Herpes, V10, P4; Smith SC, 1997, AM J OBSTET GYNECOL, V177, P1395, DOI 10.1016/S0002-9378(97)70081-4; Smith SC, 1997, AM J OBSTET GYNECOL, V177, P57, DOI 10.1016/S0002-9378(97)70438-1; Toth FD, 1997, VIROLOGY, V229, P400, DOI 10.1006/viro.1997.8449; Vieira J, 1997, J VIROL, V71, P7083, DOI 10.1128/JVI.71.9.7083-7087.1997; Weck RL, 2008, CLIN OBSTET GYNECOL, V51, P349, DOI 10.1097/GRF.0b013e31816f276e; Wojcicki JM, 2004, EPIDEMIOL INFECT, V132, P1191, DOI 10.1017/S0950268804002845	37	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2008	3	12							e4073	10.1371/journal.pone.0004073	http://dx.doi.org/10.1371/journal.pone.0004073			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DL	19115001	Green Published, Green Submitted, gold			2022-12-25	WOS:000265466300013
J	Canepari, M; Vogt, KE				Canepari, Marco; Vogt, Kaspar E.			Dendritic Spike Saturation of Endogenous Calcium Buffer and Induction of Postsynaptic Cerebellar LTP	PLOS ONE			English	Article								The architecture of parallel fiber axons contacting cerebellar Purkinje neurons retains spatial information over long distances. Parallel fiber synapses can trigger local dendritic calcium spikes, but whether and how this calcium signal leads to plastic changes that decode the parallel fiber input organization is unknown. By combining voltage and calcium imaging, we show that calcium signals, elicited by parallel fiber stimulation and mediated by voltage-gated calcium channels, increase non-linearly during high-frequency bursts of electrically constant calcium spikes, because they locally and transiently saturate the endogenous buffer. We demonstrate that these non-linear calcium signals, independently of NMDA or metabotropic glutamate receptor activation, can induce parallel fiber long-term potentiation. Two-photon imaging in coronal slices revealed that calcium signals inducing long-term potentiation can be observed by stimulating either the parallel fiber or the ascending fiber pathway. We propose that local dendritic calcium spikes, evoked by synaptic potentials, provide a unique mechanism to spatially decode parallel fiber signals into cerebellar circuitry changes.	[Canepari, Marco; Vogt, Kaspar E.] Univ Basel, Biozentrum, Div Pharmacol & Neurobiol, Basel, Switzerland	University of Basel	Canepari, M (corresponding author), Univ Basel, Biozentrum, Div Pharmacol & Neurobiol, Basel, Switzerland.	marco.canepari@unibas.ch	Canepari, Marco/AAJ-6709-2021; Canepari, Marco/H-6772-2012	Canepari, Marco/0000-0001-9759-2388; Canepari, Marco/0000-0001-9759-2388; Vogt, Kaspar/0000-0002-0859-876X	University of Basel	University of Basel	This work was supported by the University of Basel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blatow M, 2003, NEURON, V38, P79, DOI 10.1016/S0896-6273(03)00196-X; Brenowitz SD, 2005, NEURON, V45, P419, DOI 10.1016/j.neuron.2004.12.045; Canepari M, 2007, J PHYSIOL-LONDON, V580, P463, DOI 10.1113/jphysiol.2006.125005; Canepari M, 2006, J PHYSIOL-LONDON, V573, P65, DOI 10.1113/jphysiol.2005.103770; Canepari M, 2008, CELL MOL NEUROBIOL, V28, P1079, DOI 10.1007/s10571-008-9285-y; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; Coesmans M, 2004, NEURON, V44, P691, DOI 10.1016/j.neuron.2004.10.031; Coutinho V, 2004, EUR J NEUROSCI, V20, P740, DOI 10.1111/j.1460-9568.2004.03533.x; Dittman JS, 1998, J NEUROSCI, V18, P6147; EBERHARD M, 1994, EUR J BIOCHEM, V222, P21, DOI 10.1111/j.1432-1033.1994.tb18836.x; Fierro L, 1996, J PHYSIOL-LONDON, V496, P617, DOI 10.1113/jphysiol.1996.sp021713; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Gundappa-Sulur G, 1999, J COMP NEUROL, V408, P580, DOI 10.1002/(SICI)1096-9861(19990614)408:4<580::AID-CNE11>3.0.CO;2-O; Holthoff K, 2006, CELL TISSUE RES, V326, P369, DOI 10.1007/s00441-006-0263-8; Jorntell H, 2006, NEURON, V52, P227, DOI 10.1016/j.neuron.2006.09.032; Kuruma A, 2003, EUR J NEUROSCI, V18, P2677, DOI 10.1111/j.1460-9568.2003.02977.x; Lee SH, 2000, J PHYSIOL-LONDON, V525, P419, DOI 10.1111/j.1469-7793.2000.t01-2-00419.x; Lev-Ram V, 2002, P NATL ACAD SCI USA, V99, P8389, DOI 10.1073/pnas.122206399; Maeda H, 1999, NEURON, V24, P989, DOI 10.1016/S0896-6273(00)81045-4; Marcaggi P, 2005, NAT NEUROSCI, V8, P776, DOI 10.1038/nn1458; Marcaggi P, 2007, J PHYSIOL-LONDON, V578, P545, DOI 10.1113/jphysiol.2006.115014; MIYAKAWA H, 1992, J NEUROPHYSIOL, V68, P1178, DOI 10.1152/jn.1992.68.4.1178; Nagerl UV, 2000, BIOPHYS J, V79, P3009, DOI 10.1016/S0006-3495(00)76537-4; Neher E, 1998, CELL CALCIUM, V24, P345, DOI 10.1016/S0143-4160(98)90058-6; Rancz EA, 2006, J NEUROSCI, V26, P5428, DOI 10.1523/JNEUROSCI.5284-05.2006; Renzi M, 2007, J PHYSIOL-LONDON, V585, P91, DOI 10.1113/jphysiol.2007.141531; Safo PK, 2005, NEURON, V48, P647, DOI 10.1016/j.neuron.2005.09.020; Sarkisov DV, 2008, J NEUROSCI, V28, P133, DOI 10.1523/JNEUROSCI.1729-07.2008; Schmidt H, 2003, J PHYSIOL-LONDON, V551, P13, DOI 10.1113/jphysiol.2002.035824; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Sims RE, 2005, J NEUROSCI, V25, P3246, DOI 10.1523/JNEUROSCI.0073-05.2005; Sims RE, 2006, J NEUROSCI, V26, P5153, DOI 10.1523/JNEUROSCI.4121-05.2006; STUART G, 1994, NEURON, V13, P703, DOI 10.1016/0896-6273(94)90037-X; Tanaka K, 2007, NEURON, V54, P787, DOI 10.1016/j.neuron.2007.05.014; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Womack MD, 2004, J NEUROSCI, V24, P3511, DOI 10.1523/JNEUROSCI.0290-04.2004; Womack MD, 2004, J NEUROSCI, V24, P8818, DOI 10.1523/JNEUROSCI.2915-04.2004; Xu-Friedman MA, 1999, BIOPHYS J, V76, P2029, DOI 10.1016/S0006-3495(99)77360-1	39	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2008	3	12							e4011	10.1371/journal.pone.0004011	http://dx.doi.org/10.1371/journal.pone.0004011			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CB	19104665	Green Published, gold			2022-12-25	WOS:000265462400012
J	Ren, YZR; Pan, F; Parvez, S; Fleig, A; Chong, CR; Xu, J; Dang, YJ; Zhang, J; Jiang, HS; Penner, R; Liu, JO				Ren, Yunzhao R.; Pan, Fan; Parvez, Suhel; Fleig, Andrea; Chong, Curtis R.; Xu, Jing; Dang, Yongjun; Zhang, Jin; Jiang, Hongsi; Penner, Reinhold; Liu, Jun O.			Clofazimine Inhibits Human Kv1.3 Potassium Channel by Perturbing Calcium Oscillation in T Lymphocytes	PLOS ONE			English	Article								The Kv1.3 potassium channel plays an essential role in effector memory T cells and has been implicated in several important autoimmune diseases including multiple sclerosis, psoriasis and type 1 diabetes. A number of potent small molecule inhibitors of Kv1.3 channel have been reported, some of which were found to be effective in various animal models of autoimmune diseases. We report herein the identification of clofazimine, a known anti-mycobacterial drug, as a novel inhibitor of human Kv1.3. Clofazimine was initially identified as an inhibitor of intracellular T cell receptor-mediated signaling leading to the transcriptional activation of human interleukin-2 gene in T cells from a screen of the Johns Hopkins Drug Library. A systematic mechanistic deconvolution revealed that clofazimine selectively blocked the Kv1.3 channel activity, perturbing the oscillation frequency of the calcium-release activated calcium channel, which in turn led to the inhibition of the calcineurin-NFAT signaling pathway. These effects of clofazimine provide the first line of experimental evidence in support of a causal relationship between Kv1.3 and calcium oscillation in human T cells. Furthermore, clofazimine was found to be effective in blocking human T cell-mediated skin graft rejection in an animal model in vivo. Together, these results suggest that clofazimine is a promising immunomodulatory drug candidate for treating a variety of autoimmune disorders.	[Pan, Fan; Chong, Curtis R.; Xu, Jing; Dang, Yongjun; Zhang, Jin; Liu, Jun O.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Ren, Yunzhao R.; Liu, Jun O.] Johns Hopkins Univ, Sch Med, Program Biochem Cellular & Mol Biol, Baltimore, MD 21218 USA; [Parvez, Suhel; Fleig, Andrea; Penner, Reinhold; Liu, Jun O.] Queens Med Ctr, Ctr Biomed Res, Honolulu, HI USA; [Parvez, Suhel; Fleig, Andrea] Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96822 USA; [Jiang, Hongsi] Northwestern Univ, Feinberg Sch Med, Dept Med, Evanston, IL 60208 USA; [Liu, Jun O.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; The Queen's Medical Center; University of Hawaii System; Northwestern University; Feinberg School of Medicine; Johns Hopkins University	Ren, YZR (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	joliu@jhu.edu	dang, yongjun/A-8095-2011; dang, yongjun/M-6531-2016; Parvez, Suhel/E-6778-2010	dang, yongjun/0000-0001-7237-1132; Parvez, Suhel/0000-0002-6318-6506; Penner, Reinhold/0000-0002-5366-1537; Fleig, Andrea/0000-0001-8396-7249; Xu, Jing/0000-0002-3307-2719	Department of Pharmacology, Johns Hopkins School of Medicine; Keck Foundation; Flight Attendant Medical Research Institute Fund; Fund for Medical Discovery from Johns Hopkins; Johns Hopkins Malaria Research Institute; National Center for Research Resources (NCRR) [UL1 RR 025005]; National Institutes of Health (NIH) [RO1 GM080555, PO1 GM078195]; NIH Roadmap for Medical Research; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080555, P01GM078195] Funding Source: NIH RePORTER	Department of Pharmacology, Johns Hopkins School of Medicine; Keck Foundation(W.M. Keck Foundation); Flight Attendant Medical Research Institute Fund; Fund for Medical Discovery from Johns Hopkins; Johns Hopkins Malaria Research Institute; National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Department of Pharmacology, Johns Hopkins School of Medicine, the Keck Foundation, the Flight Attendant Medical Research Institute Fund, the Fund for Medical Discovery from Johns Hopkins and the Johns Hopkins Malaria Research Institute (for initial funding of the library). The project was also supported in part by Grant Number UL1 RR 025005 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) and NIH Roadmap for Medical Research. RP was supported by NIH RO1 GM080555 and AF by NIH PO1 GM078195.	AFDHAL NH, 1991, DIGEST DIS SCI, V36, P449, DOI 10.1007/BF01298873; BARRY VC, 1957, NATURE, V179, P1013, DOI 10.1038/1791013a0; Beeton C, 2001, P NATL ACAD SCI USA, V98, P13942, DOI 10.1073/pnas.241497298; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; Bezerra ELM, 2005, ARTHRITIS RHEUM-US, V52, P3073, DOI 10.1002/art.21358; BROWNE SG, 1977, LEPROSY REV, V48, P283; BURRES NS, 1995, J ANTIBIOT, V48, P380, DOI 10.7164/antibiotics.48.380; Byrne ST, 2007, ANTIMICROB AGENTS CH, V51, P4495, DOI 10.1128/AAC.00753-07; Cahalan MD, 2001, J CLIN IMMUNOL, V21, P235, DOI 10.1023/A:1010958907271; Chandy KG, 2004, TRENDS PHARMACOL SCI, V25, P280, DOI 10.1016/j.tips.2004.03.010; CHANDY KG, 1984, J EXP MED, V160, P369, DOI 10.1084/jem.160.2.369; Chong CR, 2006, J MED CHEM, V49, P2677, DOI 10.1021/jm051225t; Chong CR, 2007, ACS CHEM BIOL, V2, P263, DOI 10.1021/cb600362d; Chong CR, 2006, NAT CHEM BIOL, V2, P415, DOI 10.1038/nchembio806; CHUAPRAPAISILP T, 1978, BRIT J DERMATOL, V99, P303, DOI 10.1111/j.1365-2133.1978.tb02001.x; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.biochem.63.1.1045; DECOURSEY TE, 1984, NATURE, V307, P465, DOI 10.1038/307465a0; Deps PD, 2007, LEPROSY REV, V78, P216; DOLMETSCH RE, 1994, J GEN PHYSIOL, V103, P365, DOI 10.1085/jgp.103.3.365; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Fanger CM, 2001, J BIOL CHEM, V276, P12249, DOI 10.1074/jbc.M011342200; Felix JP, 1999, BIOCHEMISTRY-US, V38, P4922, DOI 10.1021/bi982954w; GOTO T, 1987, TRANSPLANT P, V19, P4; Griffith EC, 1997, CHEM BIOL, V4, P461, DOI 10.1016/S1074-5521(97)90198-8; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; Hanson DC, 1999, BRIT J PHARMACOL, V126, P1707, DOI 10.1038/sj.bjp.0702480; HILL RJ, 1995, MOL PHARMACOL, V48, P98; KAHAN BD, 1989, NEW ENGL J MED, V321, P1725; Koo GC, 1999, CELL IMMUNOL, V197, P99, DOI 10.1006/cimm.1999.1569; KROP LC, 1993, NEW ENGL J MED, V329, P1582; Launay P, 2004, SCIENCE, V306, P1374, DOI 10.1126/science.1098845; Lee BSJ, 1997, BLOOD, V89, P2298, DOI 10.1182/blood.V89.7.2298; LIU J, 1993, IMMUNOL TODAY, V14, P290, DOI 10.1016/0167-5699(93)90048-P; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; MACKEY JP, 1974, BRIT J DERMATOL, V91, P93, DOI 10.1111/j.1365-2133.1974.tb06723.x; MATTESON DR, 1984, NATURE, V307, P468, DOI 10.1038/307468a0; MENSING H, 1988, DERMATOLOGICA, V177, P232, DOI 10.1159/000248569; MURRAY AG, 1994, P NATL ACAD SCI USA, V91, P9146, DOI 10.1073/pnas.91.19.9146; Nguyen A, 1996, MOL PHARMACOL, V50, P1672; Pan F, 2004, J BIOL CHEM, V279, P14477, DOI 10.1074/jbc.C300487200; Panyi G, 2004, P NATL ACAD SCI USA, V101, P1285, DOI 10.1073/pnas.0307421100; Peyrin-Biroulet L, 2007, GASTROENTEROLOGY, V132, P2594, DOI 10.1053/j.gastro.2007.04.027; Ramu G, 1976, Lepr India, V48, P722; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rus H, 2005, P NATL ACAD SCI USA, V102, P11094, DOI 10.1073/pnas.0501770102; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Selby W, 2007, GASTROENTEROLOGY, V132, P2313, DOI 10.1053/j.gastro.2007.03.031; SIGAL NH, 1991, J EXP MED, V173, P619, DOI 10.1084/jem.173.3.619; SMITH EH, 1984, S AFR MED J, V66, P341; Spencer RH, 1997, J BIOL CHEM, V272, P2389; THOMSON AW, 1993, IMMUNOL REV, V136, P71, DOI 10.1111/j.1600-065X.1993.tb00655.x; Trevillyan JM, 2001, J BIOL CHEM, V276, P48118, DOI 10.1074/jbc.M107919200; Vennekamp J, 2004, MOL PHARMACOL, V65, P1364, DOI 10.1124/mol.65.6.1364; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921; Wulff H, 2007, CURR OPIN DRUG DISC, V10, P438; Xu JC, 2003, HUM MOL GENET, V12, P551, DOI 10.1093/hmg/ddg049	56	85	90	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2008	3	12							e4009	10.1371/journal.pone.0004009	http://dx.doi.org/10.1371/journal.pone.0004009			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CB	19104661	Green Published, gold, Green Submitted			2022-12-25	WOS:000265462400010
J	Ikegaya, Y; Matsumoto, W; Chiou, HY; Yuste, R; Aaron, G				Ikegaya, Yuji; Matsumoto, Wataru; Chiou, Huei-Yu; Yuste, Rafael; Aaron, Gloster			Statistical Significance of Precisely Repeated Intracellular Synaptic Patterns	PLOS ONE			English	Article								Can neuronal networks produce patterns of activity with millisecond accuracy? It may seem unlikely, considering the probabilistic nature of synaptic transmission. However, some theories of brain function predict that such precision is feasible and can emerge from the non-linearity of the action potential generation in circuits of connected neurons. Several studies have presented evidence for and against this hypothesis. Our earlier work supported the precision hypothesis, based on results demonstrating that precise patterns of synaptic inputs could be found in intracellular recordings from neurons in brain slices and in vivo. To test this hypothesis, we devised a method for finding precise repeats of activity and compared repeats found in the data to those found in surrogate datasets made by shuffling the original data. Because more repeats were found in the original data than in the surrogate data sets, we argued that repeats were not due to chance occurrence. Mokeichev et al. (2007) challenged these conclusions, arguing that the generation of surrogate data was insufficiently rigorous. We have now reanalyzed our previous data with the methods introduced from Mokeichev et al. (2007). Our reanalysis reveals that repeats are statistically significant, thus supporting our earlier conclusions, while also supporting many conclusions that Mokeichev et al. (2007) drew from their recent in vivo recordings. Moreover, we also show that the conditions under which the membrane potential is recorded contributes significantly to the ability to detect repeats and may explain conflicting results. In conclusion, our reevaluation resolves the methodological contradictions between Ikegaya et al. (2004) and Mokeichev et al. (2007), but demonstrates the validity of our previous conclusion that spontaneous network activity is non-randomly organized.	[Matsumoto, Wataru; Chiou, Huei-Yu] Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Tokyo, Japan; [Ikegaya, Yuji] Japan Sci & Technol Agcy, Tokyo, Japan; [Yuste, Rafael] Columbia Univ, Howard Hughes Med Inst, Dept Biol Sci, New York, NY 10027 USA; [Aaron, Gloster] Wesleyan Univ, Hall Atwater & Shanklin Labs, Dept Biol, Neurosci & Behav Program, Middletown, CT 06459 USA	University of Tokyo; Japan Science & Technology Agency (JST); Columbia University; Howard Hughes Medical Institute; Wesleyan University	Ikegaya, Y (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Tokyo, Japan.	gaaron@wesleyan.edu		Ikegaya, Yuji/0000-0003-2260-8191	KAKENHI [20019014, 19659013]; NSF [CNS-0619508]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NSF(National Science Foundation (NSF))	Mouse in vivo experiments were supported in part by a Grant-in-Aid for Science Research on Priority Areas (Elucidation of neural network function in the brain: KAKENHI#20019014) and a Grant-in-Aid for Science Research (KAKENHI# 19659013). Computer time on Wesleyan University's cluster computer was supported by the NSF under grant number CNS-0619508. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES M, 1991, CAMBRIDGE U PRESS; Baker SN, 2000, J NEUROPHYSIOL, V84, P1770, DOI 10.1152/jn.2000.84.4.1770; Beggs JM, 2004, J NEUROSCI, V24, P5216, DOI 10.1523/JNEUROSCI.0540-04.2004; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; Contreras D, 2001, J NEUROSCI, V21, P9403, DOI 10.1523/JNEUROSCI.21-23-09403.2001; Douglas R., 2004, SYNAPTIC ORG BRAIN, DOI [10.1093/ACPROF:OSO/9780195159561.003.0012, DOI 10.1093/ACPROF:OSO/9780195159561.003]; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; IZHIKEVICH EM, 2004, SPIKE TIMING DYNAMIC; Kang S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000022; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Lestienne R, 1996, BIOL CYBERN, V74, P55, DOI 10.1007/BF00199137; Llinas RR, 2002, P NATL ACAD SCI USA, V99, P449, DOI 10.1073/pnas.012604899; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; Madhavan R, 2007, PHYS BIOL, V4, P181, DOI 10.1088/1478-3975/4/3/005; Mao BQ, 2001, NEURON, V32, P883, DOI 10.1016/S0896-6273(01)00518-9; Mokeichev A, 2007, NEURON, V53, P413, DOI 10.1016/j.neuron.2007.01.017; Molnar G, 2008, PLOS BIOL, V6, P1842, DOI 10.1371/journal.pbio.0060222; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Oram MW, 1999, J NEUROPHYSIOL, V81, P3021, DOI 10.1152/jn.1999.81.6.3021; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Prut Y, 1998, J NEUROPHYSIOL, V79, P2857, DOI 10.1152/jn.1998.79.6.2857; Raichman N, 2008, J NEUROSCI METH, V170, P96, DOI 10.1016/j.jneumeth.2007.12.020; Rolston JD, 2007, NEUROSCIENCE, V148, P294, DOI 10.1016/j.neuroscience.2007.05.025; Roxin A, 2008, J NEUROSCI, V28, P10734, DOI 10.1523/JNEUROSCI.1016-08.2008; Shmiel T, 2006, J NEUROPHYSIOL, V96, P2645, DOI 10.1152/jn.00798.2005	27	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2008	3	12							e3983	10.1371/journal.pone.0003983	http://dx.doi.org/10.1371/journal.pone.0003983			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AV	19096523	Green Published, gold, Green Submitted			2022-12-25	WOS:000265458800005
J	Lahoute, C; Sotiropoulos, A; Favier, M; Guillet-Deniau, I; Charvet, C; Ferry, A; Butler-Browne, G; Metzger, D; Tuil, D; Daegelen, D				Lahoute, Charlotte; Sotiropoulos, Athanassia; Favier, Marilyne; Guillet-Deniau, Isabelle; Charvet, Claude; Ferry, Arnaud; Butler-Browne, Gillian; Metzger, Daniel; Tuil, David; Daegelen, Dominique			Premature Aging in Skeletal Muscle Lacking Serum Response Factor	PLOS ONE			English	Article								Aging is associated with a progressive loss of muscle mass, increased adiposity and fibrosis that leads to sarcopenia. At the molecular level, muscle aging is known to alter the expression of a variety of genes but very little is known about the molecular effectors involved. SRF (Serum Response Factor) is a crucial transcription factor for muscle-specific gene expression and for post-natal skeletal muscle growth. To assess its role in adult skeletal muscle physiology, we developed a post-mitotic myofiber-specific and tamoxifen-inducible SRF knockout model. Five months after SRF loss, no obvious muscle phenotype was observed suggesting that SRF is not crucial for myofiber maintenance. However, mutant mice progressively developed IIB myofiber-specific atrophy accompanied by a metabolic switch towards a more oxidative phenotype, muscular lipid accumulation, sarcomere disorganization and fibrosis. After injury, mutant muscles exhibited an altered regeneration process, showing smaller regenerated fibers and persistent fibrosis. All of these features are strongly reminiscent of abnormalities encountered in aging skeletal muscle. Interestingly, we also observed an important age associated decrease in SRF expression in mice and human muscles. Altogether, these results suggest that a naturally occurring SRF down-regulation precedes and contributes to the muscle aging process. Indeed, triggering SRF loss in the muscles of mutant mice results in an accelerated aging process.	[Lahoute, Charlotte; Sotiropoulos, Athanassia; Favier, Marilyne; Guillet-Deniau, Isabelle; Tuil, David; Daegelen, Dominique] Univ Paris 05, CNRS, UMR 8104, Inst Cochin, Paris, France; [Lahoute, Charlotte; Sotiropoulos, Athanassia; Favier, Marilyne; Guillet-Deniau, Isabelle; Tuil, David; Daegelen, Dominique] Inserm, U567, Paris, France; [Charvet, Claude] INRA, UR1282, Infectiol Animal Sante Publ, Nouzilly, France; [Ferry, Arnaud; Butler-Browne, Gillian] UPMC Paris 6, Inserm, UMR S787, Inst Myol, Paris, France; [Ferry, Arnaud] Univ Paris 05, Paris, France; [Metzger, Daniel] Univ Louis Pasteur, Coll France, IGBMC, Dept Funct Genom, Inserm, F-67070 Strasbourg, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Lahoute, C (corresponding author), Univ Paris 05, CNRS, UMR 8104, Inst Cochin, Paris, France.	david.tuil@inserm.fr; dominique.daegelen@inserm.fr	Sotiropoulos, Athanassia/P-4269-2017; ferry, arnaud/D-2816-2019; Charvet, Claude/X-3751-2019; Mouly, Gillian/G-6595-2017	ferry, arnaud/0000-0002-6050-4556; Charvet, Claude/0000-0002-0596-6598; butler-browne, gillian/0000-0002-3431-242X; Sotiropoulos, Athanassia/0000-0002-7265-1473; Metzger, Daniel/0000-0002-5555-046X	Association Francaise contre les Myopathies (AFM) [fellowship]; European 6th Framework Program Network of Excellence MYORES; Agence Nationale de la Recherche; French Ministry of Research	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); European 6th Framework Program Network of Excellence MYORES; Agence Nationale de la Recherche(French National Research Agency (ANR)); French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This work was funded by grants from the Association Francaise contre les Myopathies (AFM), by the European 6th Framework Program Network of Excellence MYORES, and by the Agence Nationale de la Recherche (ANR GENOPAT 2008- INAFIB). We also thank Region Ile de France for contributing to the Cochin Institute animal care facility. Lahoute held a grant from the French Ministry of Research and an AFM fellowship. Those funders played no role in the study design, experimentation, decision to publish or writing the paper.	Adamo ML, 2006, AGEING RES REV, V5, P310, DOI 10.1016/j.arr.2006.05.001; Akimoto T, 2005, BIOCHEM BIOPH RES CO, V329, P381, DOI 10.1016/j.bbrc.2005.01.136; Allen DL, 2005, J BIOL CHEM, V280, P17126, DOI 10.1074/jbc.M501207200; Azhar G, 2007, BASIC RES CARDIOL, V102, P233, DOI 10.1007/s00395-006-0634-z; Bertrand A, 2003, AM J PHYSIOL-CELL PH, V285, pC1071, DOI 10.1152/ajpcell.00104.2003; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Carson JA, 2000, J APPL PHYSIOL, V88, P337, DOI 10.1152/jappl.2000.88.1.337; Charvet C, 2006, MOL CELL BIOL, V26, P6664, DOI 10.1128/MCB.00138-06; Chevessier F, 2004, NEUROMUSCULAR DISORD, V14, P208, DOI 10.1016/j.nmd.2003.11.007; Chow N, 2007, P NATL ACAD SCI USA, V104, P823, DOI 10.1073/pnas.0608251104; Crawford K, 2002, MOL CELL BIOL, V22, P5887, DOI 10.1128/MCB.22.16.5887-5896.2002; Dennis RA, 2008, PHYSIOL GENOMICS, V32, P393, DOI 10.1152/physiolgenomics.00191.2007; Ding W, 2001, J CELL SCI, V114, P1011; Edstrom E, 2005, AGING CELL, V4, P65, DOI 10.1111/j.1474-9728.2005.00145.x; Favier FB, 2008, PFLUG ARCH EUR J PHY, V456, P587, DOI 10.1007/s00424-007-0423-z; Fluck M, 1999, J APPL PHYSIOL, V86, P1793, DOI 10.1152/jappl.1999.86.6.1793; Giresi PG, 2005, PHYSIOL GENOMICS, V21, P253, DOI 10.1152/physiolgenomics.00249.2004; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; GOPINATH SD, 2008, AGING CELL; Gordon SE, 2001, J APPL PHYSIOL, V90, P1174, DOI 10.1152/jappl.2001.90.3.1174; Grounds MD, 1998, ANN NY ACAD SCI, V854, P78, DOI 10.1111/j.1749-6632.1998.tb09894.x; Guillet-Deniau I, 2004, J CELL SCI, V117, P1937, DOI 10.1242/jcs.01069; Hayes A, 1996, J APPL PHYSIOL, V80, P670, DOI 10.1152/jappl.1996.80.2.670; JAISWAL YK, 1990, BIOCHEM BIOPH RES CO, V168, P71, DOI 10.1016/0006-291X(90)91676-J; Koopman R, 2001, HISTOCHEM CELL BIOL, V116, P63; LEXELL J, 1995, J GERONTOL A-BIOL, V50, P11; Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102; Lu XG, 1998, J GERONTOL A-BIOL, V53, pB3, DOI 10.1093/gerona/53A.1.B3; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; MUSCAT GE, 1988, MOL CELL BIOL, V8, P4120, DOI 10.1128/MCB.8.10.4120; Nicole S, 2003, J CELL BIOL, V161, P571, DOI 10.1083/jcb.200210117; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; Owino V, 2001, FEBS LETT, V505, P259, DOI 10.1016/S0014-5793(01)02825-3; Pahor M, 1998, J Nutr Health Aging, V2, P97; Parise G, 2000, Curr Opin Clin Nutr Metab Care, V3, P489, DOI 10.1097/00075197-200011000-00012; Park SK, 2005, CARDIOVASC RES, V66, P205, DOI 10.1016/j.cardiores.2005.01.005; Parlakian A, 2005, CIRCULATION, V112, P2930, DOI 10.1161/CIRCULATIONAHA.105.533778; Parlakian A, 2004, MOL CELL BIOL, V24, P5281, DOI 10.1128/MCB.24.12.5281-5289.2004; Pedersen BK, 2007, TRENDS PHARMACOL SCI, V28, P152, DOI 10.1016/j.tips.2007.02.002; Piec I, 2005, FASEB J, V19, P1143, DOI 10.1096/fj.04-3084fje; REGGIANI C, 1992, MUSCLE NERVE, V15, P199, DOI 10.1002/mus.880150212; Sakuma K, 2004, ACTA NEUROPATHOL, V108, P241, DOI 10.1007/s00401-004-0884-5; Sakuma K, 2008, BBA-MOL BASIS DIS, V1782, P453, DOI 10.1016/j.bbadis.2008.03.008; Schiaffino S, 2007, PHYSIOLOGY, V22, P269, DOI 10.1152/physiol.00009.2007; Schmitt A, 2001, EXP HEMATOL, V29, P1295, DOI 10.1016/S0301-472X(01)00733-0; Schuler M, 2005, GENESIS, V41, P165, DOI 10.1002/gene.20107; Taylor A, 1997, MOL CELL BIOCHEM, V169, P61, DOI 10.1023/A:1006898812618; Yamamoto M, 2005, J BIOL CHEM, V280, P38029, DOI 10.1074/jbc.M509039200	48	51	53	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2008	3	12							e3910	10.1371/journal.pone.0003910	http://dx.doi.org/10.1371/journal.pone.0003910			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZU	19079548	Green Published, gold, Green Submitted			2022-12-25	WOS:000265455900004
J	Pacheco-Lopez, G; Riether, C; Doenlen, R; Engler, H; Niemi, MB; Engler, A; Kavelaars, A; Heijnen, CJ; Schedlowski, M				Pacheco-Lopez, Gustavo; Riether, Carsten; Doenlen, Raphael; Engler, Harald; Niemi, Maj-Britt; Engler, Andrea; Kavelaars, Annemieke; Heijnen, Cobi J.; Schedlowski, Manfred			Calcineurin inhibition in splenocytes induced by pavlovian conditioning	FASEB JOURNAL			English	Article						cyclosporin A; immunosuppression; associative learning; placebo; taste	CYCLOSPORINE-A; SPLENIC INNERVATION; TASTE-AVERSION; IL-2 PRODUCTION; INSULAR CORTEX; IN-VIVO; IMMUNE; IMMUNOSUPPRESSION; RAT; PLACEBO	Pavlovian conditioning is one of the major neurobiological mechanisms of placebo effects, potentially influencing the course of specific diseases and the response to a pharmacological therapy, such as immunosuppression. In our study with behaviorally conditioned rats, a relevant taste (0.2% saccharin) preceded the application of the immunosuppressive drug cyclosporin A (CsA), a specific calcineurin (CaN) inhibitor. Our results demonstrate that through pavlovian conditioning the particular pharmacological properties of CsA can be transferred to a neutral taste, i.e., CaN activity was inhibited in splenocytes from conditioned rats after reexposure to the gustatory stimulus. Concomitant immune consequences were observed on ex vivo mitogenic challenge (anti-CD3). Particularly, Th1-cytokine, but not Th2-cytokine, production and cell proliferation were impeded. Appropriate pharmacological and behavioral controls certify that all these changes in T-lymphocyte reactivity are attributable to mere taste reexposure. Furthermore, the underlying sympathetic-lymphocyte interaction was revealed modeling the conditioned response in vitro. CaN activity in CD4(+) T lymphocytes is reduced by beta-adrenergic stimulation (terbutaline), with these effects antagonized by the beta-adrenoreceptor antagonist nadolol. In summary, CaN was identified as the intracellular target for inducing conditioned immunosuppression by CsA, contributing to our understanding of the intracellular mechanisms behind "learned placebo effects."-Pacheco-Lopez, G., Riether, C., Doenlen, R., Engler, H., Niemi, M.-B., Engler, A., Kavelaars, A., Heijnen, C. J., Schedlowski, M. Calcineurin inhibition in splenocytes induced by pavlovian conditioning. FASEB J. 23, 1161-1167 (2009)	[Pacheco-Lopez, Gustavo; Riether, Carsten; Doenlen, Raphael; Engler, Harald; Niemi, Maj-Britt; Engler, Andrea] ETH, Inst Behav Sci, Dept Psychol & Behav Immunobiol, Zurich, Switzerland; [Engler, Harald; Schedlowski, Manfred] Univ Duisburg Essen, Fac Med, Div Med Psychol & Behav Immunobiol, Essen, Germany; [Kavelaars, Annemieke; Heijnen, Cobi J.] Univ Med Ctr Utrecht, Lab Psychoneuroimmunol, Utrecht, Netherlands	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Duisburg Essen; Utrecht University; Utrecht University Medical Center	Pacheco-Lopez, G (corresponding author), Inst Behav Sci Psychol & Behav Immunobiol, TUR B21-1,Turnerstr 1, CH-8092 Zurich, Switzerland.	pacheco@ifv.gess.ethz.ch	Pacheco-Lopez, Gustavo/AAH-3215-2019; Riether, Carsten/ABC-7699-2021; Riether, Carsten/K-8603-2013; Engler, Harald/H-8773-2017; Pacheco-Lopez, Gustavo/E-8795-2016	Pacheco-Lopez, Gustavo/0000-0002-3458-197X; Riether, Carsten/0000-0001-7512-513X; Riether, Carsten/0000-0001-7512-513X; Engler, Harald/0000-0001-6329-1990; Pacheco-Lopez, Gustavo/0000-0002-3458-197X	ETH Fund [0-20297-05]; Dr. Donald C. Cooper Fund	ETH Fund; Dr. Donald C. Cooper Fund	This work was supported by ETH Fund grant 0-20297-05 and by the Dr. Donald C. Cooper Fund (ETH Zurich).	ADER R, 1982, SCIENCE, V215, P1534, DOI 10.1126/science.7063864; Ader R, 2001, PSYCHONEUROIMMUNOLOG, P3; Amaro S, 1996, PHYSIOL BEHAV, V60, P71, DOI 10.1016/0031-9384(95)02250-3; Barten MJ, 2006, CYTOM PART A, V69A, P155, DOI 10.1002/cyto.a.20215; Batiuk TD, 1997, TRANSPL P, V29, P1239, DOI 10.1016/S0041-1345(96)00481-2; Benedetti F, 2008, ANNU REV PHARMACOL, V48, P33, DOI 10.1146/annurev.pharmtox.48.113006.094711; BLANCK A, 1991, J STEROID BIOCHEM, V39, P33, DOI 10.1016/0960-0760(91)90009-T; Bovbjerg DH, 2003, BRAIN BEHAV IMMUN, V17, pS58; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cano G, 2001, J COMP NEUROL, V439, P1, DOI 10.1002/cne.1331; CECHETTO DF, 1990, AM J PHYSIOL, V258, pR245, DOI 10.1152/ajpregu.1990.258.1.R245; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; de la Fuente-Fernandez R, 2002, LANCET NEUROL, V1, P85, DOI 10.1016/S1474-4422(02)00038-8; Downing JEG, 2000, IMMUNOL TODAY, V21, P281, DOI 10.1016/S0167-5699(00)01635-2; Enck P, 2008, NEURON, V59, P195, DOI 10.1016/j.neuron.2008.06.030; Exton MS, 1998, PHYSIOL BEHAV, V63, P241, DOI 10.1016/S0031-9384(97)00432-0; Exton MS, 2002, J NEUROIMMUNOL, V131, P21, DOI 10.1016/S0165-5728(02)00249-7; Exton MS, 2001, IMMUNOL REV, V184, P226, DOI 10.1034/j.1600-065x.2001.1840120.x; Exton MS, 1998, J NEUROIMMUNOL, V88, P182, DOI 10.1016/S0165-5728(98)00122-2; Exton MS, 1999, AM J PHYSIOL-REG I, V276, pR1710, DOI 10.1152/ajpregu.1999.276.6.R1710; Exton MS, 2000, AM J PHYSIOL-REG I, V279, pR1310, DOI 10.1152/ajpregu.2000.279.4.R1310; Giang DW, 1996, J NEUROPSYCH CLIN N, V8, P194; Goebel MU, 2002, FASEB J, V16, P1869, DOI 10.1096/fj.02-0389com; Goehler LE, 2000, AUTON NEUROSCI-BASIC, V85, P49, DOI 10.1016/S1566-0702(00)00219-8; GROSSMAN Z, 1992, INT J NEUROSCI, V64, P275, DOI 10.3109/00207459209000555; Halloran PF, 1999, TRANSPLANTATION, V68, P1356, DOI 10.1097/00007890-199911150-00023; Ho S, 1996, CLIN IMMUNOL IMMUNOP, V80, pS40, DOI 10.1006/clin.1996.0140; Janz LJ, 1996, PHYSIOL BEHAV, V59, P1103, DOI 10.1016/0031-9384(95)02171-X; KLOSTERHALFEN S, 1990, BEHAV NEUROSCI, V104, P716, DOI 10.1037/0735-7044.104.5.716; LYSON T, 1994, HYPERTENSION, V23, P667, DOI 10.1161/01.HYP.23.5.667; MARTIN B, 1985, J BIOL CHEM, V260, P4932; MCCAFFREY PG, 1993, SCIENCE, V262, P750, DOI 10.1126/science.8235597; Niemi MB, 2007, J NEUROIMMUNOL, V188, P74, DOI 10.1016/j.jneuroim.2007.05.016; Niemi MB, 2006, BRAIN BEHAV IMMUN, V20, P527, DOI 10.1016/j.bbi.2006.02.004; OPPENHEIMER SM, 1992, BRAIN RES, V569, P221, DOI 10.1016/0006-8993(92)90633-K; Pacheco-Lopez G, 2005, J NEUROSCI, V25, P2330, DOI 10.1523/JNEUROSCI.4230-04.2005; Pacheco-Lopez G, 2006, BRAIN BEHAV IMMUN, V20, P430, DOI 10.1016/j.bbi.2006.05.003; Pacheco-Lopez G, 2007, PSYCHONEUROIMMUNOLOGY, VOLS I AND II, 4TH EDITION, P631; Price DD, 2008, ANNU REV PSYCHOL, V59, P565, DOI 10.1146/annurev.psych.59.113006.095941; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Ramer-Quinn DS, 2000, BRAIN BEHAV IMMUN, V14, P239, DOI 10.1006/brbi.2000.0603; Riether C, 2008, REV NEUROSCIENCE, V19, P1; Sanders VM, 2002, BRAIN BEHAV IMMUN, V16, P290, DOI 10.1006/brbi.2001.0639; SCHMIDT J, 1994, IMMUNOPHARMACOLOGY, V27, P173, DOI 10.1016/0162-3109(94)90013-2; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Steinman L, 2004, NAT IMMUNOL, V5, P575, DOI 10.1038/ni1078; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Wrona D, 2006, J NEUROIMMUNOL, V172, P38, DOI 10.1016/j.jneuroim.2005.10.017; Xie YF, 2002, IMMUNOBIOLOGY, V206, P345, DOI 10.1078/0171-2985-00185; Zhang WG, 2000, P NATL ACAD SCI USA, V97, P9765, DOI 10.1073/pnas.170160397	51	34	34	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2009	23	4					1161	1167		10.1096/fj.08-115683	http://dx.doi.org/10.1096/fj.08-115683			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZO	19103649				2022-12-25	WOS:000266651600020
J	Blount, AL; Schmidt, K; Justice, NJ; Vale, WW; Fischer, WH; Bilezikjian, LM				Blount, Amy L.; Schmidt, Karsten; Justice, Nicholas J.; Vale, Wylie W.; Fischer, Wolfgang H.; Bilezikjian, Louise M.			FoxL2 and Smad3 Coordinately Regulate Follistatin Gene Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVIN-BINDING PROTEIN; GONADOTROPIN-RELEASING-HORMONE; SIGNAL-TRANSDUCTION; OVARIAN DEVELOPMENT; PITUITARY ACTIVIN; PROSTATE-CANCER; GRANULOSA-CELL; EXPRESSION; TISSUES; LOCALIZATION	Follistatin is a transcriptional target and a modulator of activin action. Through an autocrine/paracrine loop, activin controls follistatin levels and thus regulates its own bioavailability. In gonadotropic alpha T3-1 cells, activin induces follistatin transcription primarily through the action of Smad3 at an intronic Smad-binding element (SBE1). Using a proteomics approach, we searched for endogenous alpha T3-1 proteins that participate in SBE1-mediated transcription. We identified FoxL2, a member of the forkhead family, as a candidate modulator of SBE1 function. Mutations of FoxL2 are associated with the blepharophimosis/ptosis/epicanthus inversus syndrome characterized with craniofacial defects and premature ovarian failure. FoxL2 localizes to alpha-glycoprotein subunit-and follicle-stimulating hormone beta-positive cells of the adult mouse pituitary and is present in alpha T3-1 and L beta T2 cells, but its pituitary actions remain largely unknown. We have determined that FoxL2 binds to a forkhead-binding element (FKHB) located just downstream of the SBE1 site of the follistatin gene and functions as a Smad3 partner to drive SBE1-mediated transcription in alpha T3-1 cells treated with activin. Chromatin immunoprecipitation assays confirm that endogenous FoxL2 and Smad3 are recruited to the intronic enhancer of the follistatin gene where the SBE1 and FKHB sites are located. Exogenous FoxL2 enhances SBE1-mediated transcription, and short hairpin RNA-mediated knockdown of endogenous FoxL2 protein compromises this effect in alpha T3-1 cells. FoxL2 directly associates with Smad3 but not Smad2 or Smad4. This association between Smad3 and FoxL2 is mediated by the MH2 domain of Smad3 and is dependent on an intact forkhead domain in FoxL2. Altogether, these observations highlight a novel role for FoxL2 and suggest that it may function as a transcriptional regulator and a coordinator of Smad3 targets.	[Blount, Amy L.; Schmidt, Karsten; Justice, Nicholas J.; Vale, Wylie W.; Fischer, Wolfgang H.; Bilezikjian, Louise M.] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA	Salk Institute	Bilezikjian, LM (corresponding author), Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	bilezikjian@salk.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046941] Funding Source: NIH RePORTER; NICHD NIH HHS [5R01HD046941-05, R01 HD046941] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Bartholin L, 2002, ONCOGENE, V21, P2227, DOI 10.1038/sj.onc.1205294; BENAYOUN BA, 2009, HUM MOL GEN IN PRESS; Besecke LM, 1996, ENDOCRINOLOGY, V137, P3667, DOI 10.1210/en.137.9.3667; Beysen D, 2008, HUM MUTAT, V29, pE205, DOI 10.1002/humu.20819; Bilezikjian LM, 2004, MOL CELL ENDOCRINOL, V225, P29, DOI 10.1016/j.mce.2004.02.010; Bilezikjian LM, 2003, ENDOCRINOLOGY, V144, P732, DOI 10.1210/en.2002-220703; BILEZIKJIAN LM, 1993, ENDOCRINOLOGY, V133, P2554, DOI 10.1210/en.133.6.2554; Blount AL, 2008, J BIOL CHEM, V283, P7016, DOI 10.1074/jbc.M709502200; Burger LL, 2004, J MOL ENDOCRINOL, V33, P559, DOI 10.1677/jme.1.01600; Burger LL, 2002, ENDOCRINOLOGY, V143, P3243, DOI 10.1210/en.2002-220216; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Cocquet J, 2002, J MED GENET, V39, P916, DOI 10.1136/jmg.39.12.916; CORRIGAN AZ, 1991, ENDOCRINOLOGY, V128, P1682, DOI 10.1210/endo-128-3-1682; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; Dalkin AC, 1996, ENDOCRINOLOGY, V137, P548, DOI 10.1210/en.137.2.548; Danila DC, 2000, J CLIN ENDOCR METAB, V85, P1009, DOI 10.1210/jc.85.3.1009; De Baere E, 2001, HUM MOL GENET, V10, P1591, DOI 10.1093/hmg/10.15.1591; DEPAOLO LV, 1993, ENDOCRINOLOGY, V132, P2221, DOI 10.1210/en.132.5.2221; Ding Y, 2005, RNA, V11, P1157, DOI 10.1261/rna.2500605; Ding Y, 2004, NUCLEIC ACIDS RES, V32, pW135, DOI 10.1093/nar/gkh449; Ellsworth BS, 2003, MOL CELL ENDOCRINOL, V206, P93, DOI 10.1016/S0303-7207(03)00235-1; Ellsworth BS, 2006, MOL ENDOCRINOL, V20, P2796, DOI 10.1210/me.2005-0303; ESCH FS, 1987, MOL ENDOCRINOL, V1, P849, DOI 10.1210/mend-1-11-849; Ethier JF, 2001, REPRODUCTION, V121, P667, DOI 10.1530/rep.0.1210667; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Guo QX, 1998, MOL ENDOCRINOL, V12, P96, DOI 10.1210/mend.12.1.0053; Harrington AE, 2006, EMBO J, V25, P1035, DOI 10.1038/sj.emboj.7601000; Harrison CA, 2005, TRENDS ENDOCRIN MET, V16, P73, DOI 10.1016/j.tem.2005.01.003; HORN F, 1991, MOL ENDOCRINOL, V5, P347, DOI 10.1210/mend-5-3-347; KAISER UB, 1992, ENDOCRINOLOGY, V130, P3048, DOI 10.1210/en.130.5.3048; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; KOGAWA K, 1991, ENDOCRINOLOGY, V128, P1434, DOI 10.1210/endo-128-3-1434; KOGAWA K, 1991, ENDOCRINOL JAPON, V38, P383; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; LEBRUN JJ, 1997, INHIBIN ACTIVIN FOLL, P1; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; MATZUK MM, 1995, NATURE, V374, P360, DOI 10.1038/374360a0; MICHEL U, 1992, J MOL ENDOCRINOL, V9, P147, DOI 10.1677/jme.0.0090147; NAKAMURA T, 1990, SCIENCE, V247, P836, DOI 10.1126/science.2106159; Nallathambi Jeyabalan, 2008, Hum Mutat, V29, pE123, DOI 10.1002/humu.20809; Ogino H, 2008, CLIN CANCER RES, V14, P660, DOI 10.1158/1078-0432.CCR-07-1221; Pannetier M, 2006, J MOL ENDOCRINOL, V36, P399, DOI 10.1677/jme.1.01947; Phillips DJ, 1998, FRONT NEUROENDOCRIN, V19, P287, DOI 10.1006/frne.1998.0169; Pisarska MD, 2004, ENDOCRINOLOGY, V145, P3424, DOI 10.1210/en.2003-1141; Qian WJ, 2005, J PROTEOME RES, V4, P53, DOI 10.1021/pr0498638; Randall RA, 2004, MOL CELL BIOL, V24, P1106, DOI 10.1128/MCB.24.3.1106-1121.2004; ROBERTSON DM, 1987, BIOCHEM BIOPH RES CO, V149, P744, DOI 10.1016/0006-291X(87)90430-X; Sardana G, 2008, J PROTEOME RES, V7, P3329, DOI 10.1021/pr8003216; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SHIMASAKI S, 1989, MOL ENDOCRINOL, V3, P651, DOI 10.1210/mend-3-4-651; SHIMASAKI S, 1988, P NATL ACAD SCI USA, V85, P4218, DOI 10.1073/pnas.85.12.4218; SHIMONAKA M, 1991, ENDOCRINOLOGY, V128, P3313, DOI 10.1210/endo-128-6-3313; Sidis Y, 2006, ENDOCRINOLOGY, V147, P3586, DOI 10.1210/en.2006-0089; SUGINO K, 1993, J BIOL CHEM, V268, P15579; Thomas TZ, 1997, J CLIN ENDOCR METAB, V82, P3851, DOI 10.1210/jc.82.11.3851; Thompson TB, 2005, DEV CELL, V9, P535, DOI 10.1016/j.devcel.2005.09.008; Tiscornia G, 2006, NAT PROTOC, V1, P234, DOI 10.1038/nprot.2006.36; Treier M, 1998, GENE DEV, V12, P1691, DOI 10.1101/gad.12.11.1691; Uda M, 2004, HUM MOL GENET, V13, P1171, DOI 10.1093/hmg/ddh124; Uhlenhaut NH, 2006, MOL GENET METAB, V88, P225, DOI 10.1016/j.ymgme.2006.03.005; Vale W., 1990, HDB EXPT PHARM, P211; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Welt C, 2002, EXP BIOL MED, V227, P724, DOI 10.1177/153537020222700905; WIATER E, 2008, BIOL TGFSS FAMILY, P79; Winters SJ, 1997, ENDOCRINOLOGY, V138, P4324, DOI 10.1210/en.138.10.4324; Yeo CY, 1999, J BIOL CHEM, V274, P26584, DOI 10.1074/jbc.274.37.26584	70	90	93	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7631	7645		10.1074/jbc.M806676200	http://dx.doi.org/10.1074/jbc.M806676200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19106105	Green Published, hybrid			2022-12-25	WOS:000264195600025
J	Raschle, T; Speziga, D; Kress, W; Moccand, C; Gehrig, P; Amrhein, N; Weber-Ban, E; Fitzpatrick, TB				Raschle, Thomas; Speziga, Davide; Kress, Wolfgang; Moccand, Cyril; Gehrig, Peter; Amrhein, Nikolaus; Weber-Ban, Eilika; Fitzpatrick, Teresa B.			Intersubunit Cross-talk in Pyridoxal 5 '-Phosphate Synthase, Coordinated by the C Terminus of the Synthase Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS; STRUCTURAL INSIGHTS; ESCHERICHIA-COLI; PLP SYNTHASE; AMINO-ACID; BIOSYNTHESIS; VITAMIN-B-6; SPECTROSCOPY; MUTAGENESIS; MECHANISM	Vitamin B-6 is essential in all organisms, due to its requirement as a cofactor in the form of pyridoxal 5 '-phosphate (PLP) for key metabolic enzymes. It can be synthesized de novo by either of two pathways known as deoxyxylulose 5-phosphate (DXP)-dependent and DXP-independent. The DXP-independent pathway is the predominant pathway and is found in most microorganisms and plants. A glutamine amidotransferase consisting of the synthase Pdx1 and its glutaminase partner, Pdx2, form a complex that directly synthesizes PLP from ribose 5-phosphate, glyceraldehyde 3-phosphate, and glutamine. The protein complex displays an ornate architecture consisting of 24 subunits, two hexameric rings of 12 Pdx1 subunits to which 12 Pdx2 subunits attach, with the glutaminase and synthase active sites remote from each other. The multiple catalytic ability of Pdx1, the remote glutaminase and synthase active sites, and the elaborate structure suggest regulation of activity on several levels. A missing piece in deciphering this intricate puzzle has been information on the Pdx1 C-terminal region that has thus far eluded structural characterization. Here we use fluorescence spectrophotometry and protein chemistry to demonstrate that the Pdx1 C terminus is indispensable for PLP synthase activity and mediates intersubunit cross-talk within the enzyme complex. We provide evidence that the C terminus can act as a flexible lid, bridging as well as shielding the active site of an adjacent protomer in Pdx1. We show that ribose 5-phosphate binding triggers strong cooperativity in Pdx1, and the affinity for this substrate is substantially enhanced upon interaction with the Michaelis complex of Pdx2 and glutamine.	[Moccand, Cyril; Fitzpatrick, Teresa B.] Univ Geneva, Dept Bot & Plant Biol, CH-1211 Geneva, Switzerland; [Raschle, Thomas; Speziga, Davide; Amrhein, Nikolaus; Fitzpatrick, Teresa B.] ETH, Inst Plant Sci, CH-8092 Zurich, Switzerland; [Kress, Wolfgang; Weber-Ban, Eilika] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Gehrig, Peter] Funct Genom Ctr Zurich, CH-8057 Zurich, Switzerland	University of Geneva; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Fitzpatrick, TB (corresponding author), Univ Geneva, Dept Bot & Plant Biol, CH-1211 Geneva, Switzerland.	theresa.fitzpatrick@unige.ch		Weber-Ban, Eilika/0000-0002-5773-9274	Swiss National Science Foundation [3100A0-107975/1, PP00A_119186]; Novartis International	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis International	This work was supported by Swiss National Science Foundation Grants 3100A0-107975/1 (to N.A. and T. B. F.) and Grant PP00A_119186 (to T. B. F.) and a grant from Novartis International A. G. (to Duilio Arigoni, ETH Zurich). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Bauer JA, 2004, J BIOL CHEM, V279, P2704, DOI 10.1074/jbc.M310311200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRZOVIC PS, 1993, BIOCHEMISTRY-US, V32, P10404, DOI 10.1021/bi00090a016; Burns KE, 2005, J AM CHEM SOC, V127, P3682, DOI 10.1021/ja042792t; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Chin JW, 2002, CHEMBIOCHEM, V3, P1135, DOI 10.1002/1439-7633(20021104)3:11<1135::AID-CBIC1135>3.0.CO;2-M; DeLano W, 2002, PYMOL 0 99; Desamero R, 2003, BIOCHEMISTRY-US, V42, P2941, DOI 10.1021/bi026994i; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; Drewke C, 2001, VITAM HORM, V61, P121; Fitzpatrick TB, 2007, BIOCHEM J, V407, P1, DOI 10.1042/BJ20070765; Garrido-Franco M, 2003, BBA-PROTEINS PROTEOM, V1647, P92, DOI 10.1016/S1570-9639(03)00065-7; Garrido-Franco M, 2002, J MOL BIOL, V321, P601, DOI 10.1016/S0022-2836(02)00695-2; GARRIDOFRANCO M, 2001, STRUCTURE, V9, P245; Gengenbacher M, 2006, J BIOL CHEM, V281, P3633, DOI 10.1074/jbc.M508696200; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; Mittenhuber G, 2001, J MOL MICROB BIOTECH, V3, P1; Neuwirth M, 2007, BIOCHEMISTRY-US, V46, P5131, DOI 10.1021/bi602602x; Raschle T, 2005, J BIOL CHEM, V280, P32291, DOI 10.1074/jbc.M501356200; Raschle T, 2007, J BIOL CHEM, V282, P6098, DOI 10.1074/jbc.M610614200; Ryu YH, 2006, NAT METHODS, V3, P263, DOI 10.1038/NMETH864; Singh SK, 1999, BIOCHEMISTRY-US, V38, P14906, DOI 10.1021/bi991615f; Strohmeier M, 2006, P NATL ACAD SCI USA, V103, P19284, DOI 10.1073/pnas.0604950103; Zein F, 2006, BIOCHEMISTRY-US, V45, P14609, DOI 10.1021/bi061464y; Zhu JH, 2005, J BIOL CHEM, V280, P27914, DOI 10.1074/jbc.M503642200	25	19	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7706	7718		10.1074/jbc.M804728200	http://dx.doi.org/10.1074/jbc.M804728200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19074821	hybrid, Green Published			2022-12-25	WOS:000264195600033
J	Tang, GQ; Paratkar, S; Patel, SS				Tang, Guo-Qing; Paratkar, Swaroopa; Patel, Smita S.			Fluorescence Mapping of the Open Complex of Yeast Mitochondrial RNA Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RATE-LIMITING STEP; DNA COPY NUMBER; SPECIFICITY FACTOR; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; PROMOTER DNA; SCHNEIDER CELLS; SIGMA-FACTORS; SC-MTTFB; INITIATION	The mitochondrial RNA polymerase (mtRNAP) of Saccharomyces cerevisiae, consisting of a complex of Rpo41 and Mtf1, is homologous to the phage single polypeptide T7/T3 RNA polymerases. The yeast mtRNAP recognizes a conserved nonanucleotide sequence to initiate specific transcription. In this work, we have defined the region of the nonanucleotide that is melted by the mtRNAP using 2-aminopurine (2AP) fluorescence that is sensitive to changes in base stacking interactions. We show that mtRNAP spontaneously melts the promoter from -4 to +2 forming a bubble around the transcription start site at +1. The location and size of the DNA bubble in this open complex of the mtRNAP closely resembles that of the T7 RNA polymerase. We show that DNA melting requires the simultaneous presence of Rpo41 and Mtf1. Adding the initiating nucleotide ATP does not expand the size of the initially melted DNA, but the initiating nucleotide differentially affects base stacking interactions at -1 and -2. Thus, the promoter structure upstream of the transcription start site is slightly rearranged during early initiation from its structure in the pre-initiation stage. Unlike on the duplex promoter, Rpo41 alone was able to form a competent open complex on a pre-melted promoter. The results indicate that Rpo41 contains the elements for recognizing the melted promoter through interactions with the template strand. We propose that Mtf1 plays a role in base pair disruption during the early stages of open complex formation.	[Tang, Guo-Qing; Paratkar, Swaroopa; Patel, Smita S.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Patel, SS (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA.	patelss@umdnj.edu			National Institutes of Health [GM51966]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM051966, R01GM051966] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM51966 (to S. S. P.).	Amiott EA, 2006, J BIOL CHEM, V281, P34982, DOI 10.1074/jbc.M608638200; Amiott EA, 2006, MOL CELL, V22, P329, DOI 10.1016/j.molcel.2006.03.031; Bandwar RP, 2001, J BIOL CHEM, V276, P14075, DOI 10.1074/jbc.M011289200; Biswas TK, 1998, GENE, V212, P305, DOI 10.1016/S0378-1119(98)00133-4; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; Carrodeguas JA, 1996, GENE EXPRESSION, V6, P219; Cermakian N, 1996, NUCLEIC ACIDS RES, V24, P648, DOI 10.1093/nar/24.4.648; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Clayton D A, 2000, Hum Reprod, V15 Suppl 2, P11; Cliften PF, 1997, GENE DEV, V11, P2897, DOI 10.1101/gad.11.21.2897; Cliften PF, 2000, MOL CELL BIOL, V20, P7013, DOI 10.1128/MCB.20.18.7013-7023.2000; Cotney J, 2007, NUCLEIC ACIDS RES, V35, P4042, DOI 10.1093/nar/gkm424; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Fedoriw AM, 1998, BIOCHEMISTRY-US, V37, P11971, DOI 10.1021/bi980980o; Gaspari M, 2004, BBA-BIOENERGETICS, V1659, P148, DOI 10.1016/j.bbabio.2004.10.003; Helmann JD, 1999, BIOCHEMISTRY-US, V38, P5959, DOI 10.1021/bi990206g; JANG SH, 1991, J BIOL CHEM, V266, P22671; Jean JM, 2001, P NATL ACAD SCI USA, V98, P37, DOI 10.1073/pnas.011442198; Jia YP, 1996, J BIOL CHEM, V271, P30451, DOI 10.1074/jbc.271.48.30451; Kashkina E, 2007, J BIOL CHEM, V282, P21578, DOI 10.1074/jbc.C700098200; Kravchenko JE, 2005, NATURE, V436, P735, DOI 10.1038/nature03848; Liu CH, 2002, J BIOL CHEM, V277, P2725, DOI 10.1074/jbc.M108856200; Liu CH, 2001, J MOL BIOL, V308, P465, DOI 10.1006/jmbi.2001.4601; MANGUS DA, 1994, J BIOL CHEM, V269, P26568; MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4; Matsunaga M, 2004, J BIOL CHEM, V279, P44239, DOI 10.1074/jbc.C400384200; Matsunaga M, 2004, PROTEIN EXPRES PURIF, V35, P126, DOI 10.1016/j.pep.2003.12.022; Matsunaga M, 2004, J BIOL CHEM, V279, P2012, DOI 10.1074/jbc.M307819200; Matsushima Y, 2005, J BIOL CHEM, V280, P16815, DOI 10.1074/jbc.M500569200; Matsushima Y, 2004, J BIOL CHEM, V279, P26900, DOI 10.1074/jbc.M401643200; OSINGA KA, 1982, NUCLEIC ACIDS RES, V10, P7993, DOI 10.1093/nar/10.24.7993; Roy S, 2004, EMBO J, V23, P869, DOI 10.1038/sj.emboj.7600098; Saluz Hans Peter, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P1; SCHINKEL AH, 1987, J BIOL CHEM, V262, P12785; SCHINKEL AH, 1986, EMBO J, V5, P1041, DOI 10.1002/j.1460-2075.1986.tb04320.x; SCHINKEL AH, 1988, EMBO J, V7, P3255, DOI 10.1002/j.1460-2075.1988.tb03192.x; Schroeder LA, 2007, NUCLEIC ACIDS RES, V35, P4141, DOI 10.1093/nar/gkm431; Schubot FD, 2001, PROTEIN SCI, V10, P1980, DOI 10.1110/ps.11201; SHADEL GS, 1995, MOL CELL BIOL, V15, P2101; Tang GQ, 2006, BIOCHEMISTRY-US, V45, P4936, DOI 10.1021/bi0522910; Tang GQ, 2006, BIOCHEMISTRY-US, V45, P4947, DOI 10.1021/bi052292s; Ujvari A, 1996, BIOCHEMISTRY-US, V35, P14574, DOI 10.1021/bi961165g; WINKLEY CS, 1985, J BIOL CHEM, V260, P4214; Young BA, 2002, CELL, V109, P417, DOI 10.1016/S0092-8674(02)00752-3	44	26	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5514	5522		10.1074/jbc.M807880200	http://dx.doi.org/10.1074/jbc.M807880200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19116203	Green Published, hybrid			2022-12-25	WOS:000263560600014
J	Tongaonkar, P; Selsted, ME				Tongaonkar, Prasad; Selsted, Michael E.			SDF2L1, a Component of the Endoplasmic Reticulum Chaperone Complex, Differentially Interacts with alpha-, beta-, and theta-Defensin Propeptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-DISULFIDE-ISOMERASE; SWISS-MODEL; INFECTION; CELLS; IDENTIFICATION; THYROGLOBULIN; MATURATION; IMMUNITY; ERP72	Mammalian defensins are cationic antimicrobial peptides that play a central role in host innate immunity and as regulators of acquired immunity. In animals, three structural defensin subfamilies, designated as alpha, beta, and theta, have been characterized, each possessing a distinctive tridisulfide motif. Mature alpha- and beta-defensins are produced by simple proteolytic processing of their prepropeptide precursors. In contrast, the macrocyclic beta-defensins are formed by the head-to-tail splicing of nonapeptides excised from a pair of prepropeptide precursors. Thus, elucidation of the theta-defensin biosynthetic pathway provides an opportunity to identify novel factors involved in this unique process. We incorporated the theta-defensin precursor, proRTD1a, into a bait construct for a yeast two-hybrid screen that identified rhesus macaque stromal cell-derived factor 2-like protein 1 (SDF2L1), as an interactor. SDF2L1 is a component of the endoplasmic reticulum (ER) chaperone complex, which we found to also interact with alpha- and beta-defensins. However, analysis of the SDF2L1 domain requirements for binding of representative alpha-, beta-, and theta-defensins revealed that alpha- and beta-defensins bind SDF2L1 similarly, but differently from the interactions that mediate binding of SDF2L1 to pro-theta-defensins. Thus, SDF2L1 is a factor involved in processing and/or sorting of all three defensin subfamilies.	[Tongaonkar, Prasad; Selsted, Michael E.] Univ Calif Irvine, Sch Med, Dept Pathol & Lab Med, Irvine, CA 92697 USA; [Selsted, Michael E.] Univ Calif Irvine, Sch Med, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Tongaonkar, P (corresponding author), Univ Calif Irvine, Sch Med, Dept Pathol & Lab Med, Irvine, CA 92697 USA.	ptongaon@uci.edu			National Institutes of Health [AI058129, AI022931, DE015517]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058129, R01AI022931, R37AI022931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015517] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants AI058129, AI022931, and DE015517. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALEY SB, 1994, INFECT IMMUN, V62, P5397, DOI 10.1128/IAI.62.12.5397-5403.1994; BANIAHMAD C, 1994, BIOTECHNIQUES, V16, P194; Bastian A, 2001, REGUL PEPTIDES, V101, P157, DOI 10.1016/S0167-0115(01)00282-8; Bies C, 2004, BIOL CHEM, V385, P389, DOI 10.1515/BC.2004.043; Chertov O, 1996, J BIOL CHEM, V271, P2935, DOI 10.1074/jbc.271.6.2935; DAHER KA, 1986, J VIROL, V60, P1068, DOI 10.1128/JVI.60.3.1068-1074.1986; Di Jeso B, 2005, MOL CELL BIOL, V25, P9793, DOI 10.1128/MCB.25.22.9793-9805.2005; Ericksen B, 2005, ANTIMICROB AGENTS CH, V49, P269, DOI 10.1128/AAC.49.1.269-275.2005; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Fukuda S, 2001, BIOCHEM BIOPH RES CO, V280, P407, DOI 10.1006/bbrc.2000.4111; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; Gruber CW, 2007, J BIOL CHEM, V282, P20435, DOI 10.1074/jbc.M700018200; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Herwig S, 1996, BLOOD, V87, P350, DOI 10.1182/blood.V87.1.350.bloodjournal871350; Hiratsuka T, 2000, NEPHRON, V85, P34, DOI 10.1159/000045627; KUZNETSOV G, 1994, J BIOL CHEM, V269, P22990; Lillard JW, 1999, P NATL ACAD SCI USA, V96, P651, DOI 10.1073/pnas.96.2.651; Linnik KM, 1998, J BIOL CHEM, V273, P21368, DOI 10.1074/jbc.273.33.21368; LIU L, 1995, BLOOD, V85, P1095, DOI 10.1182/blood.V85.4.1095.bloodjournal8541095; MADURA K, 1993, J BIOL CHEM, V268, P12046; Mambula SS, 2000, INFECT IMMUN, V68, P6257, DOI 10.1128/IAI.68.11.6257-6264.2000; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Newman SL, 2000, INFECT IMMUN, V68, P5668, DOI 10.1128/IAI.68.10.5668-5672.2000; Ponting CP, 2000, TRENDS BIOCHEM SCI, V25, P48; Quinones-Mateu ME, 2003, AIDS, V17, pF39, DOI [10.1097/00002030-200311070-00001, 10.1097/01.aids.0000096878.73209.4f]; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; Tani K, 2000, INT IMMUNOL, V12, P691, DOI 10.1093/intimm/12.5.691; VALORE EV, 1992, BLOOD, V79, P1538; WIMLEY WC, 1994, PROTEIN SCI, V3, P1362, DOI 10.1002/pro.5560030902; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yasin B, 2004, J VIROL, V78, P5147, DOI 10.1128/JVI.78.10.5147-5156.2004; Yoshikawa F, 1996, J BIOL CHEM, V271, P18277, DOI 10.1074/jbc.271.30.18277	34	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5602	5609		10.1074/jbc.M806664200	http://dx.doi.org/10.1074/jbc.M806664200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19109254	Green Published, hybrid			2022-12-25	WOS:000263560600023
J	Yang, YW; Wang, XX; Hawkins, CA; Chen, K; Vaynberg, J; Mao, X; Tu, YZ; Zuo, XB; Wang, JB; Wang, YX; Wu, CY; Tjandra, N; Qin, J				Yang, Yanwu; Wang, Xiaoxia; Hawkins, Cheryl A.; Chen, Kan; Vaynberg, Julia; Mao, Xian; Tu, Yizeng; Zuo, Xiaobing; Wang, Jinbu; Wang, Yun-xing; Wu, Chuanyue; Tjandra, Nico; Qin, Jun			Structural Basis of Focal Adhesion Localization of LIM-only Adaptor PINCH by Integrin-linked Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; RESIDUAL DIPOLAR COUPLINGS; CELL-SHAPE MODULATION; KAPPA-B COMPLEX; ANKYRIN REPEAT; MOLECULAR DISSECTION; ILK; MATRIX; SURVIVAL; DOMAIN	The LIM-only adaptor PINCH (the particularly interesting cysteine- and histidine-rich protein) plays a pivotal role in the assembly of focal adhesions (FAs), supramolecular complexes that transmit mechanical and biochemical information between extracellular matrix and actin cytoskeleton, regulating diverse cell adhesive processes such as cell migration, cell spreading, and survival. A key step for the PINCH function is its localization to FAs, which depends critically on the tight binding of PINCH to integrin-linked kinase (ILK). Here we report the solution NMR structure of the core ILK.PINCH complex (28 kDa, K-D similar to 68 nM) involving the N-terminal ankyrin repeat domain (ARD) of ILK and the first LIM domain (LIM1) of PINCH. We show that the ILK ARD exhibits five sequentially stacked ankyrin repeat units, which provide a large concave surface to grip the two contiguous zinc fingers of the PINCH LIM1. The highly electrostatic interface is evolutionally conserved but differs drastically from those of known ARD and LIM bound to other types of protein domains. Consistently mutation of a hot spot in LIM1, which is not conserved in other LIM domains, disrupted the PINCH binding to ILK and abolished the PINCH targeting to FAs. These data provide atomic insight into a novel modular recognition and demonstrate how PINCH is specifically recruited by ILK to mediate the FA assembly and cell-extracellular matrix communication.	[Yang, Yanwu; Wang, Xiaoxia; Vaynberg, Julia; Qin, Jun] Cleveland Clin, Dept Mol Cardiol, Lerner Res Inst, Cleveland, OH 44195 USA; [Yang, Yanwu; Qin, Jun] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44102 USA; [Hawkins, Cheryl A.; Tjandra, Nico] NHLBI, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA; [Chen, Kan; Tu, Yizeng; Wu, Chuanyue] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA; [Zuo, Xiaobing; Wang, Jinbu; Wang, Yun-xing] NCI, Prot Nucle Acid Interact Sect, Struct Biophys Lab, NIH, Frederick, MD 21702 USA; [Mao, Xian; Qin, Jun] Cleveland Ctr Struct Biol, Cleveland, OH 44102 USA	Cleveland Clinic Foundation; Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Qin, J (corresponding author), Cleveland Clin, Dept Mol Cardiol, Lerner Res Inst, NB20,9500 Euclid Ave, Cleveland, OH 44195 USA.	qinj@ccf.org	Zuo, Xiaobing/F-1469-2010; Qin, Jun/D-5559-2009	Qin, Jun/0000-0002-2647-9270	National Institutes of Health [HL58758, GM62823, DK54639, GM65188]; NHLBI; NCI; American Heart Association [0530067N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006064, R01HL058758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065188, R01GM062823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL58758 and GM62823 (to J.Q.) and DK54639 and GM65188 (to C. W.) and by the National Institutes of Health intramural research program of the NHLBI (to N.T.) and NCI (to Y.-X.W.). This work was also supported by American Heart Association Grant 0530067N (to Y.Y.).	Batchelor AH, 1998, SCIENCE, V279, P1037, DOI 10.1126/science.279.5353.1037; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Brakebusch C, 2003, EMBO J, V22, P2324, DOI 10.1093/emboj/cdg245; Braun A, 2003, EXP CELL RES, V284, P239, DOI 10.1016/S0014-4827(02)00039-3; Chen H, 2005, LAB INVEST, V85, P1342, DOI 10.1038/labinvest.3700345; Clore GM, 1998, J MAGN RESON, V133, P216, DOI 10.1006/jmre.1998.1419; Clore GM, 1998, J MAGN RESON, V131, P159, DOI 10.1006/jmre.1997.1345; Clore GM, 2003, J AM CHEM SOC, V125, P2902, DOI 10.1021/ja028893d; Clore GM, 1998, CURR OPIN CHEM BIOL, V2, P564, DOI 10.1016/S1367-5931(98)80084-7; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; de Alba E, 2002, PROG NUCL MAG RES SP, V40, P175, DOI 10.1016/S0079-6565(01)00042-5; Deane JE, 2003, EMBO J, V22, P2224, DOI 10.1093/emboj/cdg196; Fukuda T, 2003, J BIOL CHEM, V278, P51324, DOI 10.1074/jbc.M309122200; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Huang HC, 2007, ONCOGENE, V26, P2781, DOI 10.1038/sj.onc.1210078; Huxford T, 1998, CELL, V95, P759, DOI 10.1016/S0092-8674(00)81699-2; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Li FG, 1999, J CELL SCI, V112, P4589; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Li SH, 2005, J CELL SCI, V118, P2913, DOI 10.1242/jcs.02422; Liang XQ, 2005, MOL CELL BIOL, V25, P3056, DOI 10.1128/MCB.25.8.3056-3062.2005; Nikolopoulos SN, 2002, J BIOL CHEM, V277, P1568, DOI 10.1074/jbc.M108612200; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Russo AA, 1998, NATURE, V395, P237, DOI 10.1038/26155; Sakai T, 2003, GENE DEV, V17, P926, DOI 10.1101/gad.255603; Srivastava D, 2006, GENE DEV, V20, P2327, DOI 10.1101/gad.1472506; Stanchi F, 2005, J CELL SCI, V118, P5899, DOI 10.1242/jcs.02686; Tu YZ, 1999, MOL CELL BIOL, V19, P2425; Vaynberg J, 2005, MOL CELL, V17, P513, DOI 10.1016/j.molcel.2004.12.031; Velyvis A, 2001, J BIOL CHEM, V276, P4932, DOI 10.1074/jbc.M007632200; Wu CY, 2005, TRENDS CELL BIOL, V15, P460, DOI 10.1016/j.tcb.2005.07.002; Wu CY, 2004, BBA-MOL CELL RES, V1692, P55, DOI 10.1016/j.bbamcr.2004.01.006; Xu Z, 2005, J BIOL CHEM, V280, P27631, DOI 10.1074/jbc.M504189200; Zhang YJ, 2002, J CELL SCI, V115, P4777, DOI 10.1242/jcs.00166	39	29	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5836	5844		10.1074/jbc.M805319200	http://dx.doi.org/10.1074/jbc.M805319200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19117955	hybrid, Green Published			2022-12-25	WOS:000263560600047
J	Endo, M; Antonyak, MA; Cerione, RA				Endo, Makoto; Antonyak, Marc A.; Cerione, Richard A.			Cdc42-mTOR Signaling Pathway Controls Hes5 and Pax6 Expression in Retinoic Acid-dependent Neural Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONAL CARCINOMA-CELLS; CENTRAL-NERVOUS-SYSTEM; RHO-GTPASES; IN-VITRO; SKELETAL MYOGENESIS; RADIAL GLIA; P19 CELLS; NEURONS; STEM; ACTIVATION	The conditional knockout of the small GTPase Cdc42 from neuroepithelial (NE) and radial glial (RG) cells in the mouse telencephalon has been shown to have a significant impact on brain development by causing these neural progenitor cells to detach from the apical/ventricular surface and to lose their cell identity. This has been attributed to the requirement for Cdc42 in establishing properapical/basal cell polarity and cell-cell adhesions. In the present study, we provide new insights into the role played by Cdc42 in the maintenance of neural progenitor cells, using the mouse embryonal carcinoma P19 cell line as a model system. We show that the ability of P19 cells to undergo the transition from an Oct3/4-positive, undifferentiated status to microtubule-associated protein 2-positive neurons and glial fibrillary acidic protein-positive astrocytes, upon treatment with retinoic acid (RA), requires RA-induced activation of Cdc42 during the neural cell lineage specification phase. Experiments using chemical inhibitors and RNA interference suggest that the actions of Cdc42 are mediated through signaling pathways that start with fibroblast growth factors and Delta/Notch proteins and lead to Cdc42-dependent mTOR activation, culminating in the up-regulation of Hes5 and Pax6, two transcription factors that are essential for the maintenance of NE and RG cells. The constitutively active Cdc42(F28L) mutant was sufficient to up-regulate Hes5 and Pax6 in P19 cells, even in the absence of RA treatment, ultimately promoting their transition to neural progenitor cells. The ectopic Cdc42 expression also significantly augmented the RA-dependent up-regulation of these transcription factors, resulting in P19 cells maintaining their neural progenitor status but being unable to undergo terminal differentiation. These findings shed new light on how Cdc42 influences neural progenitor cell fate by regulating gene expression.	[Endo, Makoto; Antonyak, Marc A.; Cerione, Richard A.] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA; [Cerione, Richard A.] Cornell Univ, Dept Chem & Chem Biol, Baker Lab, Ithaca, NY 14853 USA	Cornell University; Cornell University	Cerione, RA (corresponding author), Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA.	rac1@cornell.edu		Endo, Makoto/0000-0002-2055-5471	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047458] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM047458] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ameerun RF, 1996, CELL GROWTH DIFFER, V7, P1679; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Armour C, 1999, EXP CELL RES, V251, P79, DOI 10.1006/excr.1999.4567; BAIN G, 1994, BIOESSAYS, V16, P343, DOI 10.1002/bies.950160509; Cappello S, 2006, NAT NEUROSCI, V9, P1099, DOI 10.1038/nn1744; Cerione RA, 2004, TRENDS CELL BIOL, V14, P127, DOI 10.1016/j.tcb.2004.01.008; Chen F, 2000, CURR BIOL, V10, P758, DOI 10.1016/S0960-9822(00)00571-6; Chen L, 2006, P NATL ACAD SCI USA, V103, P16520, DOI 10.1073/pnas.0603533103; Chou MM, 1996, CELL, V85, P573, DOI 10.1016/S0092-8674(00)81257-X; Dono R, 2003, AM J PHYSIOL-REG I, V284, pR867, DOI 10.1152/ajpregu.00533.2002; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fang YM, 2003, CURR BIOL, V13, P2037, DOI 10.1016/j.cub.2003.11.021; Farah MH, 2000, DEVELOPMENT, V127, P693; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hiratochi M, 2007, NUCLEIC ACIDS RES, V35, P912, DOI 10.1093/nar/gkl1128; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Ma QH, 2008, NAT CELL BIOL, V10, P283, DOI 10.1038/ncb1690; MCBURNEY MW, 1993, INT J DEV BIOL, V37, P135; MCBURNEY MW, 1982, NATURE, V299, P165, DOI 10.1038/299165a0; McCormick MB, 1996, MOL CELL BIOL, V16, P5792; Murray RC, 2000, DEV DYNAM, V218, P189, DOI 10.1002/(SICI)1097-0177(200005)218:1<189::AID-DVDY16>3.0.CO;2-4; Okada Y, 2004, DEV BIOL, V275, P124, DOI 10.1016/j.ydbio.2004.07.038; Quinn JC, 2007, DEV BIOL, V302, P50, DOI 10.1016/j.ydbio.2006.08.035; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; SKERJANC IS, 1994, MOL CELL BIOL, V14, P8451, DOI 10.1128/MCB.14.12.8451; Skerjanc IS, 1999, TRENDS CARDIOVAS MED, V9, P139, DOI 10.1016/S1050-1738(99)00017-1; Staines WA, 1996, NEUROSCIENCE, V71, P845, DOI 10.1016/0306-4522(95)00494-7; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tu S, 2003, J BIOL CHEM, V278, P49293, DOI 10.1074/jbc.M307021200; van der Heyden MAG, 2003, CARDIOVASC RES, V58, P292, DOI 10.1016/S0008-6363(02)00771-X; Wang C, 2006, MOL BIOL CELL, V17, P3075, DOI 10.1091/mbc.E05-11-1087; Wang LY, 2008, J NEUROSCI RES, V86, P1254, DOI 10.1002/jnr.21578; Wu WJ, 2003, CELL, V114, P715, DOI 10.1016/S0092-8674(03)00688-3; Wu XW, 2007, DEV DYNAM, V236, P2767, DOI 10.1002/dvdy.21309; Wu XW, 2006, GENE DEV, V20, P571, DOI 10.1101/gad.361406; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475	44	43	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5107	5118		10.1074/jbc.M807745200	http://dx.doi.org/10.1074/jbc.M807745200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19097998	Green Published, hybrid			2022-12-25	WOS:000263416600041
J	Kurabe, N; Arai, S; Nishijima, A; Kubota, N; Suizu, F; Mori, M; Kurokawa, J; Kondo-Miyazaki, M; Ide, T; Murakami, K; Miyake, K; Ueki, K; Koga, H; Yatomi, Y; Tashiro, F; Noguchi, M; Kadowaki, T; Miyazaki, T				Kurabe, Nobuya; Arai, Satoko; Nishijima, Akemi; Kubota, Naoto; Suizu, Futoshi; Mori, Mayumi; Kurokawa, Jun; Kondo-Miyazaki, Miki; Ide, Tomohiro; Murakami, Kouji; Miyake, Katsuhisa; Ueki, Kohjiro; Koga, Hisashi; Yatomi, Yutaka; Tashiro, Fumio; Noguchi, Masayuki; Kadowaki, Takashi; Miyazaki, Toru			The Death Effector Domain-containing DEDD Supports S6K1 Activity via Preventing Cdk1-dependent Inhibitory Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-GROWTH; INSULIN-RESISTANCE; CONTAINING PROTEIN; SIZE CONTROL; KINASE; MTOR; CANCER; NUTRIENT; DIVISION; TARGET	Cell cycle regulation and biochemical responses upon nutrients and growth factors are the major regulatory mechanisms for cell sizing in mammals. Recently, we identified that the death effector domain-containing DEDD impedes mitotic progression by inhibiting Cdk1 (cyclin-dependent kinase 1) and thus maintains an increase of cell size during the mitotic phase. Here we found that DEDD also associates with S6 kinase 1 (S6K1), downstream of phosphatidylinositol 3-kinase, and supports its activity by preventing inhibitory phosphorylation of S6K1 brought about by Cdk1 during the mitotic phase. DEDD-/- cells showed reduced S6K1 activity, consistently demonstrating decreased levels in activating phosphorylation at the Thr-389 site. In addition, levels of Cdk1-dependent inhibitory phosphorylation at the C terminus of S6K1 were enhanced in DEDD-/- cells and tissues. Consequently, as in S6K1(-/-) mice, the insulin mass within pancreatic islets was reduced in DEDD-/- mice, resulting in glucose intolerance. These findings suggest a novel cell sizing mechanism achieved by DEDD through the maintenance of S6K1 activity prior to cell division. Our results also suggest that DEDD may harbor important roles in glucose homeostasis and that its deficiency might be involved in the pathogenesis of type 2 diabetes mellitus.	[Kurabe, Nobuya; Arai, Satoko; Nishijima, Akemi; Mori, Mayumi; Kurokawa, Jun; Kondo-Miyazaki, Miki; Miyazaki, Toru] Univ Tokyo, Div Mol Biomed Pathogenesis, Ctr Dis Biol & Integrat Med, Tokyo 1130033, Japan; [Kubota, Naoto; Ueki, Kohjiro; Yatomi, Yutaka; Kadowaki, Takashi] Univ Tokyo, Fac Med, Dept Internal Med, Tokyo 1130033, Japan; [Suizu, Futoshi; Noguchi, Masayuki] Hokkaido Univ, Div Canc Biol, Inst Med Genet, Sapporo, Hokkaido 060, Japan; [Ide, Tomohiro; Murakami, Kouji] Kyorin Pharmaceut Co Ltd, Metab Discovery Res Labs, Biosci Div, Tochigi 3290114, Japan; [Miyake, Katsuhisa] Fukuoka Univ, Sch Med, Dept Internal Med, Div Nephrol & Rheumatol, Fukuoka 8128581, Japan; [Koga, Hisashi] Kazusa DNA Res Inst, Dept Human Genome Res, Chiba 2920818, Japan; [Tashiro, Fumio] Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Chiba 2788510, Japan	University of Tokyo; University of Tokyo; Hokkaido University; Kyorin Pharmaceutical Co Ltd; Fukuoka University; Kazusa DNA Research Institute; Tokyo University of Science	Miyazaki, T (corresponding author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1130033, Japan.	tm@m.u-tokyo.ac.jp	Kubota, Naoto/N-7892-2015; Suizu, Futoshi/G-3530-2019	Suizu, Futoshi/0000-0003-0206-4289; Yatomi, Yutaka/0000-0003-1719-4297; Miyazaki, Toru/0000-0003-3842-4362; Mori, Mayumi/0000-0001-6190-9785; Arai, Satoko/0000-0002-6145-8686	National Institutes of Health [5RO1AI50948-05]; Ministry of Education, Sports, Culture, Science, and Technology, Japan; Takeda Science Foundation; Mitsubishi Pharma Research Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Danone Institute of Nutrition for Health; Uehara Memorial Foundation; Kanae Foundation for the Promotion of Medical Science; Kanzawa Medical Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050948] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Sports, Culture, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsubishi Pharma Research Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Danone Institute of Nutrition for Health(Danone Nutricia); Uehara Memorial Foundation(Uehara Memorial Foundation); Kanae Foundation for the Promotion of Medical Science; Kanzawa Medical Research Foundation(Kanzawa Medical Research Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 5RO1AI50948-05. This work was also supported by grants-in-aid from the Ministry of Education, Sports, Culture, Science, and Technology, Japan, the Takeda Science Foundation (to T. M. and S. A.), the Mitsubishi Pharma Research Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Danone Institute of Nutrition for Health, the Uehara Memorial Foundation (to T. M.), the Kanae Foundation for the Promotion of Medical Science, and the Kanzawa Medical Research Foundation (to S. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Arai S, 2007, P NATL ACAD SCI USA, V104, P2289, DOI 10.1073/pnas.0611167104; Arechiga AF, 2007, J IMMUNOL, V179, P5291, DOI 10.4049/jimmunol.179.8.5291; Boyer D, 2008, MOL CELL BIOCHEM, V307, P59, DOI 10.1007/s11010-007-9584-5; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Cooper S, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-35; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; De Virgilio C, 2006, ONCOGENE, V25, P6392, DOI 10.1038/sj.onc.1209884; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Hou ZB, 2007, J BIOL CHEM, V282, P6922, DOI 10.1074/jbc.M607836200; Huang S, 2003, CURR OPIN PHARMACOL, V3, P371, DOI 10.1016/S1471-4892(03)00071-7; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kellogg DR, 2003, J CELL SCI, V116, P4883, DOI 10.1242/jcs.00908; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; McMullen JR, 2004, MOL CELL BIOL, V24, P6231, DOI 10.1128/MCB.24.14.6231-6240.2004; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Miyazaki T, 2007, CELL CYCLE, V6, P1419; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Montagne Jacques, 2000, Molecular Cell Biology Research Communications, V4, P195, DOI 10.1006/mcbr.2001.0284; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Papst PJ, 1998, J BIOL CHEM, V273, P15077, DOI 10.1074/jbc.273.24.15077; Park S, 2008, EMBO REP, V9, P766, DOI 10.1038/embor.2008.102; PEARSON RB, 1995, EMBO J, V14, P5279, DOI 10.1002/j.1460-2075.1995.tb00212.x; Pende M, 2000, NATURE, V408, P994, DOI 10.1038/35050135; Pullen N, 1997, FEBS LETT, V410, P78, DOI 10.1016/S0014-5793(97)00323-2; Rupes I, 2002, TRENDS GENET, V18, P479, DOI 10.1016/S0168-9525(02)02745-2; Schmidt T, 2007, HISTOCHEM CELL BIOL, V127, P123, DOI 10.1007/s00418-006-0255-5; Schumann DM, 2007, P NATL ACAD SCI USA, V104, P2861, DOI 10.1073/pnas.0611487104; Shah OJ, 2003, J BIOL CHEM, V278, P16433, DOI 10.1074/jbc.M300435200; Shamji AF, 2003, MOL CELL, V12, P271, DOI 10.1016/j.molcel.2003.08.016; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Stegh AH, 1998, EMBO J, V17, P5974, DOI 10.1093/emboj/17.20.5974; Tibbetts MD, 2003, NAT IMMUNOL, V4, P404, DOI 10.1038/ni0503-404; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Valentinis B, 2001, J CLIN PATHOL-MOL PA, V54, P133, DOI 10.1136/mp.54.3.133; VALMIKI MG, CELL MOL LI IN PRESS; Vogt PK, 2001, TRENDS MOL MED, V7, P482, DOI 10.1016/S1471-4914(01)02161-X; Yang Q, 2006, P NATL ACAD SCI USA, V103, P6811, DOI 10.1073/pnas.0602282103	41	8	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5050	5055		10.1074/jbc.M808598200	http://dx.doi.org/10.1074/jbc.M808598200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19106089	hybrid, Green Published			2022-12-25	WOS:000263416600035
J	Hinson, ER; Cresswell, P				Hinson, Ella R.; Cresswell, Peter			The N-terminal Amphipathic alpha-Helix of Viperin Mediates Localization to the Cytosolic Face of the Endoplasmic Reticulum and Inhibits Protein Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE CURVATURE; GOLGI TRANSPORT; INTERFERON; REPLICATION; VIRUS; EXPRESSION; CELLS; IDENTIFICATION; TRIGGER; SAR1P	Viperin is an evolutionarily conserved interferon-inducible protein that localizes to the endoplasmic reticulum (ER) and inhibits a number of DNA and RNA viruses. In this study, we report that viperin specifically localizes to the cytoplasmic face of the ER and that an amphipathic alpha-helix at its N terminus is necessary for the ER localization of viperin and sufficient to promote ER localization of a reporter protein, dsRed. Overexpression of intact viperin but not the amphipathic alpha-helix fused to dsRed induced crystalloid ER. Consistent with other proteins that induce crystalloid ER, viperin self-associates, and it does so independently of the amphipathic alpha-helix. Viperin expression also affected the transport of soluble but not membrane-associated proteins. Expression of intact viperin or an N-terminal alpha-helix-dsRed fusion protein significantly reduced secretion of soluble alkaline phosphatase and reduced its rate of ER-to-Golgi trafficking. Similarly, viperin expression inhibited bulk protein secretion and secretion of endogenous alpha(1)-antitrypsin and serum albumin from HepG2 cells. Converting hydrophobic residues in the N-terminal alpha-helix to acidic residues partially or completely restored normal transport of soluble alkaline phosphatase, suggesting that the extended amphipathic nature of the N-terminal alpha-helical domain is essential for inhibiting protein secretion.	[Cresswell, Peter] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Hinson, Ella R.] Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT 06520 USA; [Cresswell, Peter] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Cresswell, P (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 300 Cedar St,TAC S670, New Haven, CT 06520 USA.	peter.cresswell@yale.edu			Ellison Foundation; Howard Hughes Medical Institute	Ellison Foundation(Lawrence Ellison Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	The work was supported by the Ellison Foundation and the Howard Hughes Medical Institute. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Antonny B, 2006, CURR OPIN CELL BIOL, V18, P386, DOI 10.1016/j.ceb.2006.06.003; BERGER J, 1988, GENE, V66, P1, DOI 10.1016/0378-1119(88)90219-3; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chin KC, 2001, P NATL ACAD SCI USA, V98, P15125, DOI 10.1073/pnas.011593298; DASCHER C, 1994, J BIOL CHEM, V269, P1437; Folsch H, 2003, J CELL BIOL, V163, P351, DOI 10.1083/jcb.200309020; Fukuda M, 2001, J BIOL CHEM, V276, P41112, DOI 10.1074/jbc.M106209200; Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024; Helbig KJ, 2005, HEPATOLOGY, V42, P702, DOI 10.1002/hep.20844; Jiang D, 2008, J VIROL, V82, P1665, DOI 10.1128/JVI.02113-07; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Mackenzie J, 2005, TRAFFIC, V6, P967, DOI 10.1111/j.1600-0854.2005.00339.x; Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890; ORCI L, 1984, CELL, V36, P835, DOI 10.1016/0092-8674(84)90033-3; Peaper DR, 2005, EMBO J, V24, P3613, DOI 10.1038/sj.emboj.7600814; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Rivieccio MA, 2006, J IMMUNOL, V177, P4735, DOI 10.4049/jimmunol.177.7.4735; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; Stephens DJ, 2004, J CELL SCI, V117, P3635, DOI 10.1242/jcs.01269; Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009; Yamamoto A, 1996, J CELL SCI, V109, P1727; Zhang YG, 2007, J VIROL, V81, P11246, DOI 10.1128/JVI.01282-07; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	24	115	120	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4705	4712		10.1074/jbc.M807261200	http://dx.doi.org/10.1074/jbc.M807261200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19074433	Green Published, hybrid			2022-12-25	WOS:000263134400070
J	Hizume, M; Kobayashi, A; Teruya, K; Ohashi, H; Ironside, JW; Mohri, S; Kitamoto, T				Hizume, Masaki; Kobayashi, Atsushi; Teruya, Kenta; Ohashi, Hiroaki; Ironside, James W.; Mohri, Shirou; Kitamoto, Tetsuyuki			Human Prion Protein (PrP) 219K Is Converted to PrPSc but Shows Heterozygous Inhibition in Variant Creutzfeldt-Jakob Disease Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCRAPIE; MICE; PRNP; SUSCEPTIBILITY; AMPLIFICATION; TRANSMISSION; CODON-219; INSERTION; SEQUENCE; KURU	Prion protein gene (PRNP) E219K is a human polymorphism commonly occurring in Asian populations but is rarely found in patients with sporadic Creutzfeldt-Jakob disease (CJD). Thus the polymorphism E219K has been considered protective against sporadic CJD. The corresponding mouse prion protein (PrP) polymorphism variant (mouse PrP 218K) is not converted to the abnormal isoform (PrPSc) and shows a dominant negative effect on wild-type PrP conversion. To define the conversion activity of this human molecule, we herein established knock-in mice with human PrP 219K and performed a series of transmission experiments with human prions. Surprisingly, the human PrP 219K molecule was converted to PrPSc in variant CJD infection, and the conversion occurred more efficiently than PrP 219E molecule. Notably the knock-in mice with PRNP codon 219E/K showed the least efficient conversion compared with their hemizygotes with PRNP codon 219E/0 or codon 219K/0, or homozygotes with PRNP codon 219E/E or codon 219K/K. This phenomenon indicated heterozygous inhibition. This heterozygous inhibition was observed also in knock-in mice with PRNP codon 129M/V genotype. In addition to variant CJD infection, the human PrP 219K molecule is conversion-competent in transmission experiments with sporadic CJD prions. Therefore, the protective effect of PRNP E219K against sporadic CJD might be due to heterozygous inhibition.	[Hizume, Masaki; Kobayashi, Atsushi; Kitamoto, Tetsuyuki] Tohoku Univ, Grad Sch Med, Dept Prion Res, Div CJD Sci & Technol, Sendai, Miyagi 9808575, Japan; [Teruya, Kenta] Tohoku Univ, Grad Sch Med, Dept Prion Res, Div Prion Biol, Sendai, Miyagi 9808575, Japan; [Ohashi, Hiroaki] Cent Inst Expt Anim, Kawasaki, Kanagawa 2160011, Japan; [Ironside, James W.] Western Gen Hosp, Natl CJD Surveillance Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Mohri, Shirou] Natl Inst Anim Hlth, Prion Dis Res Ctr, Tsukuba, Ibaraki 3050856, Japan; [Hizume, Masaki] Tokyo Med & Dent Univ, Grad Sch, Dept Neurol & Neurol Sci, Bunkyo Ku, Tokyo 1138519, Japan	Tohoku University; Tohoku University; University of Edinburgh; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Tokyo Medical & Dental University (TMDU)	Kitamoto, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Prion Res, Div CJD Sci & Technol, 2-1 Seiryo, Sendai, Miyagi 9808575, Japan.	kitamoto@mail.tain.tohoku.ac.jp	Mohri, Shirou/AAK-1281-2020; Teruya, Kenta/L-1530-2019	Ironside, James/0000-0001-5869-2108	National Institute of Biomedical Innovation; Ministry of Health, Labor, and Welfare; Ministry of Education, Culture, Sports, Science and Technology; Medical Research Council [G0600953, G0900580] Funding Source: researchfish; MRC [G0600953, G0900580] Funding Source: UKRI	National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Promotion of Fundamental Studies in Health Science of National Institute of Biomedical Innovation (to H. O., S. M., and T. K.), a grant from the Ministry of Health, Labor, and Welfare (to A. K., S. M., and T. K.), and a Grant-in Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (to A. K. and T. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Asano M, 2006, BIOCHEM BIOPH RES CO, V342, P293, DOI 10.1016/j.bbrc.2006.01.149; Asante EA, 2006, P NATL ACAD SCI USA, V103, P10759, DOI 10.1073/pnas.0604292103; Bartz JC, 2007, J VIROL, V81, P689, DOI 10.1128/JVI.01751-06; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; BELLINGERKAWAHARA CG, 1988, VIROLOGY, V164, P537, DOI 10.1016/0042-6822(88)90569-7; Bishop MT, 2006, LANCET NEUROL, V5, P393, DOI 10.1016/S1474-4422(06)70413-6; Brown P, 2006, NEUROLOGY, V67, P389, DOI 10.1212/01.wnl.0000231528.65069.3f; COLLINGE J, 1991, LANCET, V337, P1441, DOI 10.1016/0140-6736(91)93128-V; FURUKAWA H, 1995, MOL BRAIN RES, V30, P385, DOI 10.1016/0169-328X(95)00034-P; GAJDUSEK DC, 1957, NEW ENGL J MED, V257, P974, DOI 10.1056/NEJM195711142572005; Grathwohl KUD, 1996, ARCH VIROL, V141, P1863, DOI 10.1007/BF01718200; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Jeong BH, 2005, NEUROGENETICS, V6, P229, DOI 10.1007/s10048-005-0016-y; Jones M, 2007, J PATHOL, V213, P21, DOI 10.1002/path.2204; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; KITAMOTO T, 1994, PHILOS T R SOC B, V343, P391, DOI 10.1098/rstb.1994.0034; KITAMOTO T, 1993, BIOCHEM BIOPH RES CO, V191, P709, DOI 10.1006/bbrc.1993.1275; Kitamoto T, 2002, BIOCHEM BIOPH RES CO, V294, P280, DOI 10.1016/S0006-291X(02)00476-X; KITAMOTO T, 1991, BRAIN RES, V545, P319, DOI 10.1016/0006-8993(91)91306-L; KITAMOTO T, 1991, J VIROL, V65, P6292, DOI 10.1128/JVI.65.11.6292-6295.1991; Kobayashi A, 2007, J BIOL CHEM, V282, P30022, DOI 10.1074/jbc.M704597200; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Korth C, 2003, P NATL ACAD SCI USA, V100, P4784, DOI 10.1073/pnas.2627989100; Lee CI, 2007, PROTEIN SCI, V16, P2166, DOI 10.1110/ps.072954607; Manuelidis L, 1998, P NATL ACAD SCI USA, V95, P2520, DOI 10.1073/pnas.95.5.2520; Mead S, 2003, SCIENCE, V300, P640, DOI 10.1126/science.1083320; Meier P, 2003, CELL, V113, P49, DOI 10.1016/S0092-8674(03)00201-0; Nishida Y, 2004, NEUROLOGY, V63, P1978, DOI 10.1212/01.WNL.0000144196.43430.E1; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; Perrier V, 2002, P NATL ACAD SCI USA, V99, P13079, DOI 10.1073/pnas.182425299; Pocchiari M, 2004, BRAIN, V127, P2348, DOI 10.1093/brain/awh249; PRUSINER SB, 1994, PHILOS T ROY SOC B, V343, P447, DOI 10.1098/rstb.1994.0043; Prusiner SB, 1998, BRAIN PATHOL, V8, P499; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Shibuya S, 1998, ANN NEUROL, V43, P826, DOI 10.1002/ana.410430618; Taguchi Y, 2003, AM J PATHOL, V163, P2585, DOI 10.1016/S0002-9440(10)63613-9; Tahiri-Alaoui A, 2006, J BIOL CHEM, V281, P34171, DOI 10.1074/jbc.M606606200; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Yamada M, 2006, LANCET, V367, P874, DOI 10.1016/S0140-6736(06)68344-X; Yu SL, 2004, EUR J HUM GENET, V12, P867, DOI 10.1038/sj.ejhg.5201245	40	51	51	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3603	3609		10.1074/jbc.M809254200	http://dx.doi.org/10.1074/jbc.M809254200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19074151	hybrid			2022-12-25	WOS:000262872500028
J	Pfister, JA; Ma, C; Morrison, BE; D'Mello, SR				Pfister, Jason A.; Ma, Chi; Morrison, Brad E.; D'Mello, Santosh R.			Opposing Effects of Sirtuins on Neuronal Survival: SIRT1-Mediated Neuroprotection Is Independent of Its Deacetylase Activity	PLOS ONE			English	Article							CEREBELLAR GRANULE NEURONS; NF-KAPPA-B; TRANSCRIPTION FACTORS; HISTONE DEACETYLASE; NEGATIVE REGULATOR; THERAPEUTIC ROLE; YEAST SIR2; RESVERATROL; INHIBITION; PROTEIN	Background: Growing evidence suggests that sirtuins, a family of seven distinct NAD-dependent enzymes, are involved in the regulation of neuronal survival. Indeed, SIRT1 has been reported to protect against neuronal death, while SIRT2 promotes neurodegeneration. The effect of SIRTs 3-7 on the regulation of neuronal survival, if any, has yet to be reported. Methodology and Principal Findings: We examined the effect of expressing each of the seven SIRT proteins in healthy cerebellar granule neurons (CGNs) or in neurons induced to die by low potassium (LK) treatment. We report that SIRT1 protects neurons from LK-induced apoptosis, while SIRT2, SIRT3 and SIRT6 induce apoptosis in otherwise healthy neurons. SIRT5 is generally localized to both the nucleus and cytoplasm of CGNs and exerts a protective effect. In a subset of neurons, however, SIRT5 localizes to the mitochondria and in this case it promotes neuronal death. Interestingly, the protective effect of SIRT1 in neurons is not reduced by treatments with nicotinamide or sirtinol, two pharmacological inhibitors of SIRT1. Neuroprotection was also observed with two separate mutant forms of SIRT1, H363Y and H355A, both of which lack deacetylase activity. Furthermore, LK-induced neuronal death was not prevented by resveratrol, a pharmacological activator of SIRT1, at concentrations at which it activates SIRT1. We extended our analysis to HT-22 neuroblastoma cells which can be induced to die by homocysteic acid treatment. While the effects of most of the SIRT proteins were similar to that observed in CGNs, SIRT6 was modestly protective against homocysteic acid toxicity in HT-22 cells. SIRT5 was generally localized in the mitochondria of HT-22 cells and was apoptotic. Conclusions/Significance: Overall, our study makes three contributions -(a) it represents the first analysis of SIRT3-7 in the regulation of neuronal survival, (b) it shows that neuroprotection by SIRT1 can be mediated by a novel, non-catalytic mechanism, and (c) that subcellular localization may be an important determinant in the effect of SIRT5 on neuronal viability.	[Pfister, Jason A.; Ma, Chi; Morrison, Brad E.; D'Mello, Santosh R.] Univ Texas Dallas, Dept Mol & Cell Biol, Richardson, TX 75083 USA	University of Texas System; University of Texas Dallas	Pfister, JA (corresponding author), Univ Texas Dallas, Dept Mol & Cell Biol, Richardson, TX 75083 USA.	dmello@utdallas.edu	D'Mello, Santosh/AAM-3644-2020; D'Mello, Santosh/AAO-7192-2020; Waldvogel, Henry/D-6691-2012	D'Mello, Santosh/0000-0002-7652-1334; , Chi/0000-0002-4171-0813; Morrison, Brad/0000-0002-6356-7149; Waldvogel, Henry/0000-0003-2165-8568	NIH [NS40408, NS058462]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS066404, R21NS058462, R01NS040408] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants NS40408 and NS058462 to SRD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja N, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705488200; Alvira D, 2007, NEUROSCIENCE, V147, P746, DOI 10.1016/j.neuroscience.2007.04.029; Anekonda TS, 2006, BRAIN RES REV, V52, P316, DOI 10.1016/j.brainresrev.2006.04.004; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; Bastianetto S, 2000, BRIT J PHARMACOL, V131, P711, DOI 10.1038/sj.bjp.0703626; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Biacsi R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000017; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cao C, 2019, J CELL MOL MED, V23, P7342, DOI 10.1111/jcmm.14593; CHEN HMW, EUR J NEURO IN PRESS; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Dey S, 2008, CARCINOGENESIS, V29, P1920, DOI 10.1093/carcin/bgn175; Feige JN, 2008, CURR OPIN CELL BIOL, V20, P303, DOI 10.1016/j.ceb.2008.03.012; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Gan L, 2008, NEURON, V58, P10, DOI 10.1016/j.neuron.2008.03.015; Gao ZG, 2008, BIOCHEM BIOPH RES CO, V376, P793, DOI 10.1016/j.bbrc.2008.09.079; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; Han YS, 2004, BRIT J PHARMACOL, V141, P997, DOI 10.1038/sj.bjp.0705688; Hisahara S, 2008, P NATL ACAD SCI USA, V105, P15599, DOI 10.1073/pnas.0800612105; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Huang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001710; Jin QH, 2007, J CELL PHYSIOL, V213, P88, DOI 10.1002/jcp.21091; Jin YH, 2008, BIOCHEM BIOPH RES CO, V368, P690, DOI 10.1016/j.bbrc.2008.01.114; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kim EJ, 2007, MOL CELL, V28, P277, DOI 10.1016/j.molcel.2007.08.030; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Knutson MD, 2008, NUTR REV, V66, P591, DOI 10.1111/j.1753-4887.2008.00109.x; Kojima K, 2008, BIOCHEM BIOPH RES CO, V373, P423, DOI 10.1016/j.bbrc.2008.06.045; Koulich E, 2001, J NEUROCHEM, V76, P1188, DOI 10.1046/j.1471-4159.2001.00134.x; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Langley B, 2008, J NEUROSCI, V28, P163, DOI 10.1523/JNEUROSCI.3200-07.2008; Li Y, 2007, CELL DEATH DIFFER, V14, P2058, DOI 10.1038/sj.cdd.4402219; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Manna SK, 2000, J IMMUNOL, V164, P6509, DOI 10.4049/jimmunol.164.12.6509; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Milne JC, 2008, CURR OPIN CHEM BIOL, V12, P11, DOI 10.1016/j.cbpa.2008.01.019; Morozova N, 2007, GENES CELLS, V12, P561, DOI 10.1111/j.1365-2443.2007.01074.x; Nakamura Y, 2008, BIOCHEM BIOPH RES CO, V366, P174, DOI 10.1016/j.bbrc.2007.11.122; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Neugebauer RC, 2008, J MED CHEM, V51, P1203, DOI 10.1021/jm700972e; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Okawara M, 2007, BIOCHEM PHARMACOL, V73, P550, DOI 10.1016/j.bcp.2006.11.003; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; Ota H, 2007, J MOL CELL CARDIOL, V43, P571, DOI 10.1016/j.yjmcc.2007.08.008; Outeiro TF, 2008, BBA-MOL BASIS DIS, V1782, P363, DOI 10.1016/j.bbadis.2008.02.010; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Parker JA, 2005, NAT GENET, V37, P349, DOI 10.1038/ng1534; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sanders BD, 2007, MOL CELL, V25, P463, DOI 10.1016/j.molcel.2006.12.022; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Shindler KS, 2007, INVEST OPHTH VIS SCI, V48, P3602, DOI 10.1167/iovs.07-0131; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Vaquero A, 2006, GENE DEV, V20, P1256, DOI 10.1101/gad.1412706; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Venkatesan B, 2008, FASEB J, V22, P3469, DOI 10.1096/fj.08-109488; Verdin E, 2007, MOL CELL, V28, P354, DOI 10.1016/j.molcel.2007.10.013; Westphal CH, 2007, TRENDS BIOCHEM SCI, V32, P555, DOI 10.1016/j.tibs.2007.09.008; Yalcin A, 2003, J NEUROCHEM, V84, P397, DOI 10.1046/j.1471-4159.2003.01540.x; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515	68	150	164	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4090	10.1371/journal.pone.0004090	http://dx.doi.org/10.1371/journal.pone.0004090			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DO	19116652	gold, Green Submitted, Green Published			2022-12-25	WOS:000265466600011
J	Brechot, N; Gomez, E; Bignon, M; Khallou-Laschet, J; Dussiot, M; Cazes, A; Alanio-Brechot, C; Durand, M; Philippe, J; Silvestre, JS; Van Rooijen, N; Corvol, P; Nicoletti, A; Chazaud, B; Germain, S				Brechot, Nicolas; Gomez, Elisa; Bignon, Marine; Khallou-Laschet, Jamila; Dussiot, Michael; Cazes, Aurelie; Alanio-Brechot, Cecile; Durand, Melanie; Philippe, Josette; Silvestre, Jean-Sebastien; Van Rooijen, Nico; Corvol, Pierre; Nicoletti, Antonino; Chazaud, Benedicte; Germain, Stephane			Modulation of Macrophage Activation State Protects Tissue from Necrosis during Critical Limb Ischemia in Thrombospondin-1-Deficient Mice	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; ENDOTHELIAL GROWTH-FACTOR; SKELETAL-MUSCLE; ALTERNATIVE ACTIVATION; ALTERED INFLAMMATION; NEGATIVE REGULATOR; NECROTIC CELLS; RECEPTOR-GAMMA; CCR2-/-MICE; PHAGOCYTOSIS	Background: Macrophages, key regulators of healing/regeneration processes, strongly infiltrate ischemic tissues from patients suffering from critical limb ischemia (CLI). However pro-inflammatory markers correlate with disease progression and risk of amputation, suggesting that modulating macrophage activation state might be beneficial. We previously reported that thrombospondin-1 (TSP-1) is highly expressed in ischemic tissues during CLI in humans. TSP-1 is a matricellular protein that displays well-known angiostatic properties in cancer, and regulates inflammation in vivo and macrophages properties in vitro. We therefore sought to investigate its function in a mouse model of CLI. Methods and Findings: Using a genetic model of tsp-1(-/-) mice subjected to femoral artery excision, we report that tsp-1(-/-) mice were clinically and histologically protected from necrosis compared to controls. Tissue protection was associated with increased postischemic angiogenesis and muscle regeneration. We next showed that macrophages present in ischemic tissues exhibited distinct phenotypes in tsp-1(-/-) and wt mice. A strong reduction of necrotic myofibers phagocytosis was observed in tsp-1(-/-) mice. We next demonstrated that phagocytosis of muscle cell debris is a potent pro-inflammatory signal for macrophages in vitro. Consistently with these findings, macrophages that infiltrated ischemic tissues exhibited a reduced postischemic pro-inflammatory activation state in tsp-1(-/-) mice, characterized by a reduced Ly-6C expression and a less pro-inflammatory cytokine expression profile. Finally, we showed that monocyte depletion reversed clinical and histological protection from necrosis observed in tsp-1(-/-) mice, thereby demonstrating that macrophages mediated tissue protection in these mice. Conclusion: This study defines targeting postischemic macrophage activation state as a new potential therapeutic approach to protect tissues from necrosis and promote tissue repair during CLI. Furthermore, our data suggest that phagocytosis plays a crucial role in promoting a deleterious intra-tissular pro-inflammatory macrophage activation state during critical injuries. Finally, our results describe TSP-1 as a new relevant physiological target during critical leg ischemia.	[Brechot, Nicolas; Gomez, Elisa; Bignon, Marine; Cazes, Aurelie; Durand, Melanie; Philippe, Josette; Corvol, Pierre; Germain, Stephane] INSERM, U833, Paris, France; [Brechot, Nicolas; Gomez, Elisa; Bignon, Marine; Cazes, Aurelie; Durand, Melanie; Philippe, Josette; Corvol, Pierre; Germain, Stephane] Coll France, Lab Angiogenese Embryonnaire Pathol, Paris, France; [Khallou-Laschet, Jamila; Dussiot, Michael; Nicoletti, Antonino] INSERM, U872, Paris, France; [Khallou-Laschet, Jamila; Dussiot, Michael; Nicoletti, Antonino] Univ Paris 06, Ctr Rech Cordeliers, F-75252 Paris, France; [Alanio-Brechot, Cecile] AP HP, Hop Bicetre, LabHematol, Le Kremlin Bicetre, France; [Silvestre, Jean-Sebastien] INSERM, U689, Paris, France; [Silvestre, Jean-Sebastien] Univ Paris 07, Ctr Rech Cardiovasc Lariboisiere, Paris, France; [Van Rooijen, Nico] Free Univ Amsterdam, Med Ctr, Dept Mol Cell Biol, Amsterdam, Netherlands; [Chazaud, Benedicte] INSERM, U 567, CNRS, UMR 8104, Paris, France; [Chazaud, Benedicte] Univ Paris 05, Inst Cochin, F-75270 Paris, France; [Germain, Stephane] AP HP, Hop Europeen Georges Pompidou, Serv Hematol Biol A, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Vrije Universiteit Amsterdam; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Brechot, N (corresponding author), INSERM, U833, Paris, France.	stephane.germain@college-de-france.fr	Germain, Stephane/E-2301-2016; Nicoletti, Antonino/A-9460-2015; Perdiguero, Elisa Gomez/U-2120-2018; Van Rooijen, Nico/Z-1578-2019; Bréchot, Nicolas/AAM-7412-2021; Chazaud, Benedicte/N-9291-2017; Silvestre, Jean-Sebastien/K-7695-2017	Germain, Stephane/0000-0001-5992-1275; Nicoletti, Antonino/0000-0002-2623-0897; Perdiguero, Elisa Gomez/0000-0002-7717-7897; Bréchot, Nicolas/0000-0002-7536-287X; Chazaud, Benedicte/0000-0002-1262-502X; Silvestre, Jean-Sebastien/0000-0003-3962-2205; Laschet, Jamila/0000-0002-5090-4417; Alanio, Cecile/0000-0003-2785-7445	European Vascular Genomics Network [LSHMCT-2003-503254]; Agence Nationale de la recherche [ANR-06-JCJC-0160]; Fondation pour la Recherche Medicale	European Vascular Genomics Network; Agence Nationale de la recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work emanates from the European Vascular Genomics Network (http://www.evgn.org) (contract LSHMCT-2003-503254) and is supported by a grant from Agence Nationale de la recherche (ANR-06-JCJC-0160). NB is supported by Fondation pour la Recherche Medicale.	Agah A, 2002, AM J PATHOL, V161, P831, DOI 10.1016/S0002-9440(10)64243-5; Alleva DG, 2002, J LEUKOCYTE BIOL, V71, P677; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Barani J, 2005, J VASC SURG, V42, P75, DOI 10.1016/j.jvs.2005.03.025; Baumgartner I, 1998, CIRCULATION, V97, P1114, DOI 10.1161/01.CIR.97.12.1114; Bottcher A, 2006, ARTHRITIS RHEUM-US, V54, P927, DOI 10.1002/art.21660; Brouckaert G, 2004, MOL BIOL CELL, V15, P1089, DOI 10.1091/mbc.E03-09-0668; Chan G, 2008, J IMMUNOL, V181, P698, DOI 10.4049/jimmunol.181.1.698; Contreras-Shannon V, 2007, AM J PHYSIOL-CELL PH, V292, pC953, DOI 10.1152/ajpcell.00154.2006; Couffinhal T, 1998, AM J PATHOL, V152, P1667; Demeure CE, 2000, J IMMUNOL, V164, P2193, DOI 10.4049/jimmunol.164.4.2193; Dewald O, 2005, CIRC RES, V96, P881, DOI 10.1161/01.RES.0000163017.13772.3a; Dimitrijevic OB, 2007, STROKE, V38, P1345, DOI 10.1161/01.STR.0000259709.16654.8f; Dirkx AEM, 2006, J LEUKOCYTE BIOL, V80, P1183, DOI 10.1189/jlb.0905495; Doyen V, 2003, J EXP MED, V198, P1277, DOI 10.1084/jem.20030705; Engstrom G, 2004, J VASC SURG, V40, P1101, DOI 10.1016/j.jvs.2004.09.017; Esemuede N, 2004, J SURG RES, V122, P135, DOI 10.1016/j.jss.2004.05.015; Fadok VA, 2001, J IMMUNOL, V166, P6847, DOI 10.4049/jimmunol.166.11.6847; Favier J, 2005, J PATHOL, V207, P358, DOI 10.1002/path.1833; Frangogiannis NG, 2005, CIRCULATION, V111, P2935, DOI 10.1161/CIRCULATIONAHA.104.510354; Furuichi K, 2003, J AM SOC NEPHROL, V14, P2503, DOI 10.1097/01.ASN.0000089563.63641.A8; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Grimbert P, 2006, J IMMUNOL, V177, P3534, DOI 10.4049/jimmunol.177.6.3534; Hayasaki T, 2006, CIRC J, V70, P342, DOI 10.1253/circj.70.342; Heil M, 2006, J CELL MOL MED, V10, P45, DOI 10.1111/j.1582-4934.2006.tb00290.x; Isenberg JS, 2007, BLOOD, V109, P1945, DOI 10.1182/blood-2006-08-041368; Lamy L, 2007, J IMMUNOL, V178, P5930, DOI 10.4049/jimmunol.178.9.5930; Lawler J, 2004, INT J BIOCHEM CELL B, V36, P1038, DOI 10.1016/j.biocel.2004.01.008; Lawler J, 1998, J CLIN INVEST, V101, P982, DOI 10.1172/JCI1684; Lawler J, 2002, J CELL MOL MED, V6, P1, DOI 10.1111/j.1582-4934.2002.tb00307.x; Le Jan S, 2003, AM J PATHOL, V162, P1521, DOI 10.1016/S0002-9440(10)64285-X; Lederman RJ, 2002, LANCET, V359, P2053, DOI 10.1016/S0140-6736(02)08937-7; Lucas M, 2006, J IMMUNOL, V177, P4047, DOI 10.4049/jimmunol.177.6.4047; MANSFIELD PJ, 1994, J IMMUNOL, V153, P4219; Michalik L, 2006, J CLIN INVEST, V116, P598, DOI 10.1172/JCI27958; Moodley Y, 2003, AM J PATHOL, V162, P771, DOI 10.1016/S0002-9440(10)63874-6; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Ochoa O, 2007, AM J PHYSIOL-REG I, V293, pR651, DOI 10.1152/ajpregu.00069.2007; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Rajagopalan S, 2003, AM HEART J, V145, P1114, DOI 10.1016/S0002-8703(03)00102-9; Ren Y, 2001, J IMMUNOL, V166, P4743, DOI 10.4049/jimmunol.166.7.4743; REN Y, 1995, J IMMUNOL, V154, P2366; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rissanen TT, 2002, AM J PATHOL, V160, P1393, DOI 10.1016/S0002-9440(10)62566-7; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Shirernan PK, 2007, J LEUKOCYTE BIOL, V81, P775, DOI 10.1189/jlb.0506356; Stern M, 1996, AM J PATHOL, V149, P911; Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342; Summan M, 2006, AM J PHYSIOL-REG I, V290, pR1488, DOI 10.1152/ajpregu.00465.2005; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; TASC Working Group, 2000, EUR J VASC ENDOVASC, V19, pS1; Tuomisto TT, 2004, ATHEROSCLEROSIS, V174, P111, DOI 10.1016/j.atherosclerosis.2004.01.015; van Amerongen MJ, 2007, AM J PATHOL, V170, P818, DOI 10.2353/ajpath.2007.060547; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Yamauchi Y, 2002, BIOCHEM BIOPH RES CO, V290, P1551, DOI 10.1006/bbrc.2002.6386	56	56	59	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2008	3	12							e3950	10.1371/journal.pone.0003950	http://dx.doi.org/10.1371/journal.pone.0003950			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AR	19079608	gold, Green Submitted, Green Published			2022-12-25	WOS:000265458400009
J	Jerga, A; Miller, DJ; White, SW; Rock, CO				Jerga, Agoston; Miller, Darcie J.; White, Stephen W.; Rock, Charles O.			Molecular Determinants for Interfacial Binding and Conformational Change in a Soluble Diacylglycerol Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSITION-STATE ANALOG; PHOSPHOLIPASE-C; CRYSTAL-STRUCTURE; VENOM PHOSPHOLIPASE-A2; STAPHYLOCOCCUS-AUREUS; ACTIVE-SITE; ACTIVATION; COMPLEX; ALPHA; MODULATION	DgkB is a soluble diacylglycerol (DAG) kinase that is essential for membrane lipid homeostasis in many Gram-positive pathogens. Anionic phospholipids, like phosphatidylglycerol (PtdGro), were required for DgkB to recognize diacylglycerol embedded in a phospholipid bilayer. An activity-independent vesicle binding assay was used to determine the role of specific residues in DgkB-PtdGro interactions. Lys15 and Lys165 were required for DgkB to dock with PtdGro vesicles and flank the entrance to the DgkB active site. Mg2+ was required for vesicle binding. The compromised vesicle binding by mutants in the key asparate residues forming the structural Mg2+-aspartate-water network within the substrate binding domain revealed that interfacial binding of DgkB required a Mg2+-dependent conformational change. DgkB interaction with phospholipid vesicles was not influenced by the presence of ATP, but anionic vesicles decreased the Km of the enzyme for ATP. Arg(100) and Lys15 are two surface residues in the ATP binding domain that were necessary for high affinity ATP binding. The key residues responsible for the structural Mg2+ binding site, the conformational changes that increase ATP affinity, and interfacial recognition of anionic phospholipids were identical in DgkB and the mammalian diacylglycerol kinase catalytic cores. This sequence conservation suggests that the mammalian enzymes also require a structural divalent cation and surface positively charged residues to bind phospholipid bilayers and trigger conformational changes that accelerate catalysis.	[Miller, Darcie J.; White, Stephen W.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Jerga, Agoston; Rock, Charles O.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Rock, CO (corresponding author), 262 Danny Thomas Pl, Memphis, TN 38105 USA.	charles.rock@stjude.org	White, Stephen W/N-8164-2018		National Institutes of Health [GM34496]; Cancer Center [CA21765]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034496, R37GM034496] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM34496. This work was also supported by Cancer Center Support Grant CA21765 and the American Lebanese Syrian Associated Charities. The costs of publication of this article were defrayed in part by the payment of page charges.	Abe T, 2003, BIOCHEM J, V375, P673, DOI 10.1042/BJ20031052; ANDERSON KS, 1988, BIOCHEMISTRY-US, V27, P1604, DOI 10.1021/bi00405a032; Boyer, 1970, ENZYMES, P341, DOI DOI 10.1016/S1874-6047(08)60170-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNIE S, 1985, J BIOL CHEM, V260, P9742; Fanani ML, 2004, BIOCHEMISTRY-US, V43, P14767, DOI 10.1021/bi049145z; Feng JW, 2003, J BIOL CHEM, V278, P24651, DOI 10.1074/jbc.M301207200; Feng JW, 2002, J BIOL CHEM, V277, P19867, DOI 10.1074/jbc.M200938200; Guo S, 2008, BIOCHEMISTRY-US, V47, P4201, DOI 10.1021/bi702269u; HEINZ DW, 1995, EMBO J, V14, P3855, DOI 10.1002/j.1460-2075.1995.tb00057.x; Jain MK, 2006, CURR OPIN CHEM BIOL, V10, P473, DOI 10.1016/j.cbpa.2006.08.015; Jerga A, 2007, J BIOL CHEM, V282, P21738, DOI 10.1074/jbc.M703536200; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; Liu JY, 2005, J MOL BIOL, V354, P289, DOI 10.1016/j.jmb.2005.09.026; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Miller DJ, 2008, STRUCTURE, V16, P1036, DOI 10.1016/j.str.2008.03.019; Nichols CE, 2007, PROTEINS, V68, P13, DOI 10.1002/prot.21386; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Royer CA, 2006, CHEM REV, V106, P1769, DOI 10.1021/cr0404390; Saccani J, 2004, LANGMUIR, V20, P9190, DOI 10.1021/la0489920; Sakane F, 1996, BIOCHEM J, V318, P583, DOI 10.1042/bj3180583; Sakane F, 2007, BBA-MOL CELL BIOL L, V1771, P793, DOI 10.1016/j.bbalip.2007.04.006; SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785; SCOTT DL, 1990, SCIENCE, V250, P1563, DOI 10.1126/science.2274788; Shao CH, 2007, J BIOL CHEM, V282, P9228, DOI 10.1074/jbc.M610918200; Stokka AJ, 2006, BIOCHEM J, V400, P493, DOI 10.1042/BJ20060962; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Tatulian SA, 1997, J MOL BIOL, V268, P809, DOI 10.1006/jmbi.1997.1014; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Thirugnanam S, 2001, BIOCHEMISTRY-US, V40, P10607, DOI 10.1021/bi010609s; Thomas WE, 1999, BIOCHEMISTRY-US, V38, P3320, DOI 10.1021/bi982567m; THUNNISSEN MMGM, 1990, NATURE, V347, P689, DOI 10.1038/347689a0; Tu-Sekine B, 2007, BIOCHEMISTRY-US, V46, P924, DOI 10.1021/bi061170c; ULLMAN EF, 1994, P NATL ACAD SCI USA, V91, P5426, DOI 10.1073/pnas.91.12.5426; Ullman EF, 1996, CLIN CHEM, V42, P1518; VANDENBERG B, 1995, NAT STRUCT BIOL, V2, P402, DOI 10.1038/nsb0595-402; WALSH JP, 1986, J BIOL CHEM, V261, P6239; WHITE DC, 1967, J BACTERIOL, V94, P1854, DOI 10.1128/JB.94.6.1854-1867.1967; WHITE SP, 1990, SCIENCE, V250, P1560, DOI 10.1126/science.2274787; Winget JM, 2006, BBA-MOL CELL BIOL L, V1761, P1260, DOI 10.1016/j.bbalip.2006.08.002; Zhang X, 2004, J BIOL CHEM, V279, P20490, DOI 10.1074/jbc.M401016200	41	9	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7246	7254		10.1074/jbc.M805962200	http://dx.doi.org/10.1074/jbc.M805962200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19112175	Green Published, hybrid			2022-12-25	WOS:000263919000071
J	AbdAlla, S; Lother, H; el Missiry, A; Langer, A; Sergeev, P; el Faramawy, Y; Quitterer, U				AbdAlla, Said; Lother, Heinz; el Missiry, Ahmed; Langer, Andreas; Sergeev, Pavel; el Faramawy, Yasser; Quitterer, Ursula			Angiotensin II AT(2) Receptor Oligomers Mediate G-protein Dysfunction in an Animal Model of Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; TRANSGENIC MICE; NEURONAL LOSS; PHOSPHOINOSITIDE HYDROLYSIS; MUSCARINIC RECEPTOR; TYPE-2 RECEPTOR; KINASE-C; BRAIN; STRESS; AGE	Progressive neurodegeneration and decline of cognitive functions are major hallmarks of Alzheimer disease (AD). Neurodegeneration in AD correlates with dysfunction of diverse signal transduction mechanisms, such as the G-protein-stimulated phosphoinositide hydrolysis mediated by G alpha(q/11). We report here that impaired G alpha(q/11)-stimulated signaling in brains of AD patients and mice correlated with the appearance of crosslinked oligomeric angiotensin II AT(2) receptors sequestering G alpha(q/11). Amyloid beta (A beta) was causal to AT(2) oligomerization, because cerebral microinjection of A beta triggered AT(2) oligomerization in the hippocampus of mice in a dose- dependent manner. A beta induced AT(2) oligomerization by a two-step process of oxidative and transglutaminase-dependent cross-linking. The induction of AT(2) oligomers in a transgenic mouse model with AD-like symptoms was associated with G alpha(q/11) dysfunction and enhanced neurodegeneration. Vice versa, stereotactic inhibition of AT(2) oligomers by RNA interference prevented the impairment of G alpha(q/11) and delayed Tau phosphorylation. Thus, A beta induces the formation of cross-linked AT(2) oligomers that contribute to the dysfunction of G alpha(q/11) in an animal model of Alzheimer disease.	[Langer, Andreas; Sergeev, Pavel; Quitterer, Ursula] Swiss Fed Inst Technol, Dept Mol Pharmacol, CH-8057 Zurich, Switzerland; [Langer, Andreas; Sergeev, Pavel; Quitterer, Ursula] Univ Zurich, CH-8057 Zurich, Switzerland; [AbdAlla, Said; Lother, Heinz; el Faramawy, Yasser] Heinrich Pette Inst Expt Virol & Immunol, D-20251 Hamburg, Germany; [el Missiry, Ahmed] Ain Shams Univ Hosp, Med Res Ctr, Cairo, Egypt	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Heinrich Pette Institute; Egyptian Knowledge Bank (EKB); Ain Shams University	Quitterer, U (corresponding author), Y17M70,Winterthurerstr 190, CH-8057 Zurich, Switzerland.	ursula.quitterer@pharma.ethz.ch						AbdAlla S, 2004, CELL, V119, P343, DOI 10.1016/j.cell.2004.10.006; AbdAlla S, 2001, J BIOL CHEM, V276, P39721, DOI 10.1074/jbc.M105253200; AbdAlla S, 2000, NATURE, V407, P94, DOI 10.1038/35024095; AbdAlla S, 2001, NAT MED, V7, P1003, DOI 10.1038/nm0901-1003; AbdAlla S, 2009, J BIOL CHEM, V284, P6566, DOI 10.1074/jbc.M808277200; Bonelli RM, 2002, NEUROBIOL DIS, V11, P106, DOI 10.1006/nbdi.2002.0535; Butterfield DA, 2004, BRAIN PATHOL, V14, P426; BUXBAUM JD, 1992, P NATL ACAD SCI USA, V89, P10075, DOI 10.1073/pnas.89.21.10075; Caccamo A, 2006, NEURON, V49, P671, DOI 10.1016/j.neuron.2006.01.020; Chen SH, 2000, EMBO J, V19, P4265, DOI 10.1093/emboj/19.16.4265; Dickstein DL, 2006, FASEB J, V20, P426, DOI 10.1096/fj.05-3956com; FERRARIDILEO G, 1993, LIFE SCI, V53, pPL439, DOI 10.1016/0024-3205(93)90037-4; FOWLER CJ, 1995, MOL CELL BIOCHEM, V149, P287, DOI 10.1007/BF01076590; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; GREENWOOD AF, 1995, NEUROSCIENCE, V69, P125, DOI 10.1016/0306-4522(95)00220-D; Haring R, 1998, J NEUROCHEM, V71, P2094; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; ICHIKI T, 1995, NATURE, V377, P748, DOI 10.1038/377748a0; Irizarry MC, 1997, J NEUROPATH EXP NEUR, V56, P965, DOI 10.1097/00005072-199709000-00002; Jeong YH, 2006, FASEB J, V20, P729, DOI 10.1096/fj.05-4265fje; Johnson GVW, 1997, BRAIN RES, V751, P323, DOI 10.1016/S0006-8993(96)01431-X; JOPE RS, 1994, NEUROBIOL AGING, V15, P221, DOI 10.1016/0197-4580(94)90116-3; King DL, 2002, PHYSIOL BEHAV, V75, P627, DOI 10.1016/S0031-9384(02)00639-X; KOWALL NW, 1991, P NATL ACAD SCI USA, V88, P7247, DOI 10.1073/pnas.88.16.7247; Miura M, 2002, J NEUROSCI, V22, P8379; MONLEON S, 1995, PSYCHOPHARMACOLOGY, V117, P453, DOI 10.1007/BF02246218; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nurnberg A, 2008, J BIOL CHEM, V283, P35526, DOI 10.1074/jbc.M804972200; Peavy GM, 2007, BIOL PSYCHIAT, V62, P472, DOI 10.1016/j.biopsych.2007.03.013; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; Price JL, 2001, ARCH NEUROL-CHICAGO, V58, P1395, DOI 10.1001/archneur.58.9.1395; Shenoy UV, 1999, ENDOCRINOLOGY, V140, P500, DOI 10.1210/en.140.1.500; Singer O, 2005, NAT NEUROSCI, V8, P1343, DOI 10.1038/nn1531; Thal DR, 2000, EXP NEUROL, V163, P98, DOI 10.1006/exnr.2000.7380; Tsang SWY, 2006, NEUROBIOL AGING, V27, P1216, DOI 10.1016/j.neurobiolaging.2005.07.010; Vervoort VS, 2002, SCIENCE, V296, P2401; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wess J, 2007, NAT REV DRUG DISCOV, V6, P721, DOI 10.1038/nrd2379; WEST MJ, 1994, LANCET, V344, P769, DOI 10.1016/S0140-6736(94)92338-8; Wettschureck N, 2006, MOL CELL BIOL, V26, P5888, DOI 10.1128/MCB.00397-06; Wilson RS, 2006, NEUROEPIDEMIOLOGY, V27, P143, DOI 10.1159/000095761	41	63	68	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6554	6565		10.1074/jbc.M807746200	http://dx.doi.org/10.1074/jbc.M807746200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19074441	Green Accepted, hybrid			2022-12-25	WOS:000263742700058
J	Chagot, B; Potet, F; Balser, JR; Chazin, WJ				Chagot, Benjamin; Potet, Franck; Balser, Jeffrey R.; Chazin, Walter J.			Solution NMR Structure of the C-terminal EF-hand Domain of Human Cardiac Sodium Channel Na(V)1.5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARRHYTHMOGENIC MECHANISM; BRUGADA-SYNDROME; LQT-3 MUTATION; ALPHA-SUBUNIT; CALCIUM; SIMULATION; PROTEINS; INSIGHTS; SITE	The voltage-gated sodium channel Na(V)1.5 is responsible for the initial upstroke of the action potential in cardiac tissue. Levels of intracellular calcium modulate inactivation gating of Na(V)1.5, in part through a C-terminal EF-hand calcium binding domain. The significance of this structure is underscored by the fact that mutations within this domain are associated with specific cardiac arrhythmia syndromes. In an effort to elucidate the molecular basis for calcium regulation of channel function, we have determined the solution structure of the C-terminal EF-hand domain using multidimensional heteronuclear NMR. The structure confirms the existence of the four-helix bundle common to EF-hand domain proteins. However, the location of this domain is shifted with respect to that predicted on the basis of a consensus 12-residue EF-hand calcium binding loop in the sequence. This finding is consistent with the weak calcium affinity reported for the isolated EF-hand domain; high affinity binding is observed only in a construct with an additional 60 residues C-terminal to the EF-hand domain, including the IQ motif that is central to the calcium regulatory apparatus. The binding of an IQ motif peptide to the EF-hand domain was characterized by isothermal titration calorimetry and nuclear magnetic resonance spectroscopy. The peptide binds between helices I and IV in the EF-hand domain, similar to the binding of target peptides to other EF-hand calcium-binding proteins. These results suggest a molecular basis for the coupling of the intrinsic (EF-hand domain) and extrinsic (calmodulin) components of the calcium-sensing apparatus of Na(V)1.5.	[Chagot, Benjamin; Chazin, Walter J.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA; [Potet, Franck; Balser, Jeffrey R.] Vanderbilt Univ, Dept Anesthesiol, Nashville, TN 37232 USA; [Chagot, Benjamin; Chazin, Walter J.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Chazin, Walter J.] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA; [Balser, Jeffrey R.] Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA; [Balser, Jeffrey R.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Chazin, WJ (corresponding author), Vanderbilt Univ, Struct Biol Ctr, 5140 BIOSCI MRBIII, Nashville, TN 37232 USA.	walter.chazin@vanderbilt.edu	Chagot, Benjamin/AAC-6495-2019; Chagot, Benjamin/H-3258-2011	Chagot, Benjamin/0000-0002-9153-0060; 	National Institutes of Health [RO1GM56307]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1GM56307. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abriel H, 2000, CIRCULATION, V102, P921; Abriel H, 2001, CIRC RES, V88, P740, DOI 10.1161/hh0701.089668; An RH, 1998, CIRC RES, V83, P141, DOI 10.1161/01.RES.83.2.141; BABITCH J, 1990, NATURE, V346, P321, DOI 10.1038/346321b0; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berjanskii MV, 2006, NUCLEIC ACIDS RES, V34, pW63, DOI 10.1093/nar/gkl341; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Clancy CE, 2002, CIRCULATION, V105, P1208, DOI 10.1161/hc1002.105183; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fallon JL, 2005, STRUCTURE, V13, P1881, DOI 10.1016/j.str.2005.09.021; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Fujiwara T, 2003, BRAIN, V126, P531, DOI 10.1093/brain/awg053; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Glaaser IW, 2006, J BIOL CHEM, V281, P24015, DOI 10.1074/jbc.M605473200; Goddard T. D., 2006, SPARKY; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Hubbard S., 1992, NACCESS; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kim J, 2004, J BIOL CHEM, V279, P45004, DOI 10.1074/jbc.M407286200; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Maler L, 2002, J MOL BIOL, V317, P279, DOI 10.1006/jmbi.2002.5421; MINAMI Y, 1987, J BIOCHEM-TOKYO, V101, P889, DOI 10.1093/oxfordjournals.jbchem.a121956; MINAMI Y, 1988, J BIOCHEM-TOKYO, V104, P927, DOI 10.1093/oxfordjournals.jbchem.a122585; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; PALMER AG, 1998, CURVEFIT; Petitprez S, 2008, CARDIOVASC RES, V78, P494, DOI 10.1093/cvr/cvn023; Priori SG, 2002, CIRCULATION, V105, P1342, DOI 10.1161/hc1102.105288; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Schubert M, 2002, J BIOMOL NMR, V24, P149, DOI 10.1023/A:1020997118364; Shah VN, 2006, P NATL ACAD SCI USA, V103, P3592, DOI 10.1073/pnas.0507397103; Smits JPP, 2002, J AM COLL CARDIOL, V40, P350, DOI 10.1016/S0735-1097(02)01962-9; Tan HL, 2001, NATURE, V409, P1043, DOI 10.1038/35059090; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; Vatta M, 2002, MOL GENET METAB, V75, P317, DOI 10.1016/S1096-7192(02)00006-9; Voehler MW, 2006, J MAGN RESON, V183, P102, DOI 10.1016/j.jmr.2006.08.002; Wehrens XHT, 2000, CIRCULATION, V102, P584; Wingo TL, 2004, NAT STRUCT MOL BIOL, V11, P219, DOI 10.1038/nsmb737; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yu FH, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-207	49	58	62	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6436	6445		10.1074/jbc.M807747200	http://dx.doi.org/10.1074/jbc.M807747200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19074138	Green Published, hybrid			2022-12-25	WOS:000263742700046
J	Martin, L; Fluhrer, R; Haass, C				Martin, Lucas; Fluhrer, Regina; Haass, Christian			Substrate Requirements for SPPL2b-dependent Regulated Intramembrane Proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; SIGNAL PEPTIDE PEPTIDASE; DISEASE GAMMA-SECRETASE; TERMINAL PAL MOTIF; CATALYTIC PORE; C-TERMINUS; TNF-ALPHA; PRESENILIN; CLEAVAGE; IDENTIFICATION	Intramembrane proteolysis is now widely recognized as an important physiological pathway required for reverse signaling and membrane protein degradation. Aspartyl intramembrane cleaving proteases of the GXGD-type play an important regulatory role in health and disease. Besides gamma-secretase/presenilin, signal peptide peptidase (SPP) and SPP-like (SPPL) peptidases also belong to the family of GXGD-type aspartyl proteases. Although recently the first SPPL2a/b substrates have been identified, very little is known about substrate requirements, which allow them to be efficiently processed within the membrane. We demonstrate that similar to gamma-secretase substrates, intramembrane proteolysis of Bri2 (Itm2b) is greatly facilitated by an initial shedding event mediated by ADAM-10. Serial deletions revealed that the length of the ectodomain negatively correlates with efficient intramembrane proteolysis. Bri3 (Itm2c), which is highly homologous to Bri2, fails to be shed. Failure of shedding of Bri3 is accompanied by a lack of intramembrane proteolysis by SPPL2b. Surprisingly, a low molecular weight membrane-retained stub of Bri3 also fails to be processed by SPPL2b, indicating that shedding per se is not sufficient for subsequent intramembrane proteolysis. Extensive domain swapping analysis reveals that primary sequence determinants within the intracellular domain and the transmembrane domain together with short luminal juxtamembrane sequences are required for efficient intramembrane proteolysis.	[Fluhrer, Regina] Univ Munich, Ctr Integrated Prot Sci Munich, Dept Biochem, Lab Neurodegenerat Dis Res, D-80336 Munich, Germany; Univ Munich, Adolf Butenandt Inst, Dept Biochem, Lab Neurodegenerat Dis Res, D-80336 Munich, Germany	University of Munich; University of Munich	Fluhrer, R (corresponding author), Univ Munich, Ctr Integrated Prot Sci Munich, Dept Biochem, Lab Neurodegenerat Dis Res, D-80336 Munich, Germany.	rfluhrer@med.uni-muenchen.de; chaass@med.uni-muenchen.de	Fluhrer, Regina/F-2642-2011		Deutsche Forschungsgemeinschaft; Sonderforschungsbereich [SFB 596]; Center for Integrated Protein Science Munich; Boehringer Ingelheim Pharma GmbH Co.;  [HA1737-11-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sonderforschungsbereich(German Research Foundation (DFG)); Center for Integrated Protein Science Munich; Boehringer Ingelheim Pharma GmbH Co.(Boehringer Ingelheim); 	This work is supported by the Leibniz Award of the Deutsche Forschungsgemeinschaft ( to C. H.), the Deutsche Forschungsgemeinschaft Grant HA1737-11-1 ( to C. H. and R. F.), Sonderforschungsbereich Grant SFB 596 ( to C. H.), the Center for Integrated Protein Science Munich (CIPSM), and the Boehringer Ingelheim Pharma GmbH & Co. KG.	Chavez-Gutierrez L, 2008, J BIOL CHEM, V283, P20096, DOI 10.1074/jbc.M803040200; Choi SC, 2001, MOL CELLS, V12, P391; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Fluhrer R, 2006, NAT CELL BIOL, V8, P894, DOI 10.1038/ncb1450; Friedmann E, 2006, NAT CELL BIOL, V8, P843, DOI 10.1038/ncb1440; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Haass C, 2002, TRENDS CELL BIOL, V12, P556, DOI 10.1016/S0962-8924(02)02394-2; Hasegawa H, 2004, J BIOL CHEM, V279, P46455, DOI 10.1074/jbc.M406289200; Hemming ML, 2008, PLOS BIOL, V6, P2314, DOI 10.1371/journal.pbio.0060257; Kaden D, 2008, J BIOL CHEM, V283, P7271, DOI 10.1074/jbc.M708046200; Kaether C, 2004, EMBO J, V23, P4738, DOI 10.1038/sj.emboj.7600478; Kirkin V, 2007, CELL DEATH DIFFER, V14, P1678, DOI 10.1038/sj.cdd.4402175; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Krawitz P, 2005, J BIOL CHEM, V280, P39515, DOI 10.1074/jbc.M501645200; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lazarov VK, 2006, P NATL ACAD SCI USA, V103, P6889, DOI 10.1073/pnas.0602321103; Lemberg MK, 2002, MOL CELL, V10, P735, DOI 10.1016/S1097-2765(02)00655-X; Lichtenthaler SF, 1999, P NATL ACAD SCI USA, V96, P3053, DOI 10.1073/pnas.96.6.3053; Martin L, 2008, J BIOL CHEM, V283, P1644, DOI 10.1074/jbc.M706661200; Martoglio B, 2003, HUM MOL GENET, V12, pR201, DOI 10.1093/hmg/ddg303; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Narayanan S, 2007, J BIOL CHEM, V282, P20172, DOI 10.1074/jbc.M701536200; Okamoto T, 2008, J VIROL, V82, P3480, DOI 10.1128/JVI.02253-07; Osenkowski P, 2009, J MOL BIOL, V385, P642, DOI 10.1016/j.jmb.2008.10.078; Pittois K, 1998, GENE, V217, P141, DOI 10.1016/S0378-1119(98)00354-0; Ponting CP, 2002, HUM MOL GENET, V11, P1037, DOI 10.1093/hmg/11.9.1037; Prokop S, 2004, J BIOL CHEM, V279, P23255, DOI 10.1074/jbc.M401789200; Ren Z, 2007, J BIOL CHEM, V282, P35350, DOI 10.1074/jbc.M702739200; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Scheuermann S, 2001, J BIOL CHEM, V276, P33923, DOI 10.1074/jbc.M105410200; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Steiner H, 2008, J BIOL CHEM, V283, P29627, DOI 10.1074/jbc.R800010200; Steiner H, 2008, CURR ALZHEIMER RES, V5, P147, DOI 10.2174/156720508783954677; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Tolia A, 2008, J BIOL CHEM, V283, P19793, DOI 10.1074/jbc.M802461200; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Wang J, 2006, J NEUROCHEM, V96, P218, DOI 10.1111/j.1471-4159.2005.03548.x; Weihofen A, 2000, J BIOL CHEM, V275, P30951, DOI 10.1074/jbc.M005980200; Weihofen A, 2003, TRENDS CELL BIOL, V13, P71, DOI 10.1016/S0962-8924(02)00041-7; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wickham L, 2005, J NEUROCHEM, V92, P93, DOI 10.1111/j.1471-4159.2004.02840.x; Yamasaki A, 2006, J NEUROSCI, V26, P3821, DOI 10.1523/JNEUROSCI.5354-05.2006	46	42	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5662	5670		10.1074/jbc.M807485200	http://dx.doi.org/10.1074/jbc.M807485200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19114711	Green Published, hybrid			2022-12-25	WOS:000263560600030
J	Paulucci-Holthauzen, AA; Vergara, LA; Bellot, LJ; Canton, D; Scott, JD; O'Connor, KL				Paulucci-Holthauzen, Adriana A.; Vergara, Leoncio A.; Bellot, Larry J.; Canton, David; Scott, John D.; O'Connor, Kathleen L.			Spatial Distribution of Protein Kinase A Activity during Cell Migration Is Mediated by A-kinase Anchoring Protein AKAP Lbc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; CYCLIC-AMP; SIGNALING COMPLEX; CARDIAC MYOCYTES; ADENYLYL-CYCLASE; CARCINOMA-CELLS; ALPHA-6-BETA-4 INTEGRIN; LAMELLAE FORMATION; RHOA ACTIVATION; CAMP	Protein kinase A (PKA) has been suggested to be spatially regulated in migrating cells due to its ability to control signaling events that are critical for polarized actin cytoskeletal dynamics. Here, using the fluorescence resonance energy transfer-based A-kinase activity reporter (AKAR1), we find that PKA activity gradients form with the strongest activity at the leading edge and are restricted to the basal surface in migrating cells. The existence of these gradients was confirmed using immunocytochemistry using phospho-PKA substrate antibodies. This observation holds true for carcinoma cells migrating randomly on laminin-1 or stimulated to migrate on collagen I with lysophosphatidic acid. Phosphodiesterase inhibition allows the formation of PKA activity gradients; however, these gradients are no longer polarized. PKA activity gradients are not detected when a non-phosphorylatable mutant of AKAR1 is used, if PKA activity is inhibited with H-89 or protein kinase inhibitor, or when PKA anchoring is perturbed. We further find that a specific A-kinase anchoring protein, AKAP-Lbc, is a major contributor to the formation of these gradients. In summary, our data show that PKA activity gradients are generated at the leading edge of migrating cells and provide additional insight into the mechanisms of PKA regulation of cell motility.	[O'Connor, Kathleen L.] Univ Texas Med Branch, Dept Surg, Galveston, TX 77555 USA; [Vergara, Leoncio A.] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Paulucci-Holthauzen, Adriana A.; Bellot, Larry J.; O'Connor, Kathleen L.] Univ Texas Med Branch, Sealy Ctr Canc Cell Biol, Galveston, TX 77555 USA; [Canton, David; Scott, John D.] Univ Washington, Dept Pharmacol, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	O'Connor, KL (corresponding author), Univ Texas Med Branch, Dept Surg, 301 Univ Blvd, Galveston, TX 77555 USA.	kloconno@utmb.edu	Canton, David/N-7463-2015; O'Connor, Kathleen L/H-2569-2013	O'Connor, Kathleen L/0000-0002-1088-9734	National Institutes of Health [R21-GM071928, R01-CA109136, HL088366]; Fondation Leducq Transatlantic Network; NATIONAL CANCER INSTITUTE [R01CA109136] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM071928] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Leducq Transatlantic Network(Leducq Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R21-GM071928 and R01-CA109136. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. 1; Supported by National Institutes of Health Grant HL088366 and the Fondation Leducq Transatlantic Network.	Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; BOKOCH GM, 1994, J BIOL CHEM, V269, P31674; Borm B, 2005, EXP CELL RES, V302, P83, DOI 10.1016/j.yexcr.2004.08.034; Carnegie GK, 2004, MOL CELL, V15, P889, DOI 10.1016/j.molcel.2004.09.015; Carnegie GK, 2008, MOL CELL, V32, P169, DOI 10.1016/j.molcel.2008.08.030; CARR DW, 1992, J BIOL CHEM, V267, P13376; Chen M, 2005, ONCOGENE, V24, P5125, DOI 10.1038/sj.onc.1208729; Chen M, 2007, AM J PHYSIOL-CELL PH, V292, pC1927, DOI 10.1152/ajpcell.00400.2006; CORBIN JD, 1977, J BIOL CHEM, V252, P3854; Deming PB, 2008, J BIOL CHEM, V283, P35199, DOI 10.1074/jbc.M804448200; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; Diviani D, 2001, J BIOL CHEM, V276, P44247, DOI 10.1074/jbc.M106629200; Diviani D, 2004, EMBO J, V23, P2811, DOI 10.1038/sj.emboj.7600287; Diviani D, 2006, EUR J CELL BIOL, V85, P603, DOI 10.1016/j.ejcb.2006.01.001; Dodge KL, 2001, EMBO J, V20, P1921, DOI 10.1093/emboj/20.8.1921; Dong JM, 1998, J BIOL CHEM, V273, P22554, DOI 10.1074/jbc.273.35.22554; Dormond O, 2002, J BIOL CHEM, V277, P45838, DOI 10.1074/jbc.M209213200; Fleming YM, 2004, J CELL SCI, V117, P2377, DOI 10.1242/jcs.01096; Fukata Y, 1999, J CELL BIOL, V145, P347, DOI 10.1083/jcb.145.2.347; Goldfinger LE, 2003, J CELL BIOL, V162, P731, DOI 10.1083/jcb.200304031; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; HAYES JS, 1982, J CYCLIC NUCL PROT, V8, P1; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Howe AK, 2005, P NATL ACAD SCI USA, V102, P14320, DOI 10.1073/pnas.0507072102; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Iancu RV, 2007, BIOPHYS J, V92, P3317, DOI 10.1529/biophysj.106.095356; Iyengar R, 1996, SCIENCE, V271, P461, DOI 10.1126/science.271.5248.461; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Jurevicius J, 1996, P NATL ACAD SCI USA, V93, P295, DOI 10.1073/pnas.93.1.295; Kurokawa K, 2005, MOL BIOL CELL, V16, P4294, DOI 10.1091/mbc.E04-12-1076; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Laudanna C, 1997, J BIOL CHEM, V272, P24141, DOI 10.1074/jbc.272.39.24141; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lim CJ, 2008, MOL BIOL CELL, V19, P4930, DOI 10.1091/mbc.E08-06-0564; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; MEINKOTH JL, 1993, MOL CELL BIOCHEM, V128, P179, DOI 10.1007/BF01076769; Meyer CJ, 2000, NAT CELL BIOL, V2, P666, DOI 10.1038/35023621; Niggli V, 2008, INT J BIOCHEM CELL B, V40, P344, DOI 10.1016/j.biocel.2007.02.012; NISHIYAMA T, 1994, MOL CELL BIOL, V14, P2447, DOI 10.1128/MCB.14.4.2447; O'Connor KL, 2001, J BIOL CHEM, V276, P47895, DOI 10.1074/jbc.M107235200; O'Connor KL, 1998, J CELL BIOL, V143, P1749, DOI 10.1083/jcb.143.6.1749; O'Connor KL, 2000, J CELL BIOL, V148, P253, DOI 10.1083/jcb.148.2.253; Oliveria SF, 2003, J CELL BIOL, V160, P101, DOI 10.1083/jcb.200209127; Paulucci-Holthauzen AA, 2006, ANAL BIOCHEM, V355, P175, DOI 10.1016/j.ab.2006.06.002; Prag S, 2007, MOL BIOL CELL, V18, P2935, DOI 10.1091/mbc.E06-11-1031; Rabinovitz I, 1997, J CELL BIOL, V139, P1873, DOI 10.1083/jcb.139.7.1873; Rich TC, 2000, J GEN PHYSIOL, V116, P147, DOI 10.1085/jgp.116.2.147; Rich TC, 2001, P NATL ACAD SCI USA, V98, P13049, DOI 10.1073/pnas.221381398; Saucerman JJ, 2006, P NATL ACAD SCI USA, V103, P12923, DOI 10.1073/pnas.0600137103; Sayner SL, 2006, CIRC RES, V98, P675, DOI 10.1161/01.RES.0000209516.84815.3e; Takenawa T, 2001, J CELL SCI, V114, P1801; Tasken KA, 2001, J BIOL CHEM, V276, P21999, DOI 10.1074/jbc.C000911200; TAYLOR SS, 1992, FARADAY DISCUSS, V93, P143, DOI 10.1039/fd9929300143; TRON L, 1984, BIOPHYS J, V45, P939, DOI 10.1016/S0006-3495(84)84240-X; Valentin G, 2005, NAT METHODS, V2, P801, DOI 10.1038/nmeth1105-801; van Rheenen J, 2004, BIOPHYS J, V86, P2517, DOI 10.1016/S0006-3495(04)74307-6; Westphal RS, 2000, EMBO J, V19, P4589, DOI 10.1093/emboj/19.17.4589; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; Whittard JD, 2001, J CELL SCI, V114, P3265; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; YOUVAN DC, 1997, BIOTECHNOLOGY ALIA, V1, P1; Zaccolo M, 2002, CURR OPIN CELL BIOL, V14, P160, DOI 10.1016/S0955-0674(02)00316-2; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798	65	42	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5956	5967		10.1074/jbc.M805606200	http://dx.doi.org/10.1074/jbc.M805606200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19106088	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000263560600059
J	Scruggs, SB; Hinken, AC; Thawornkaiwong, A; Robbins, J; Walker, LA; de Tombe, PP; Geenen, DL; Buttrick, PM; Solaro, RJ				Scruggs, Sarah B.; Hinken, Aaron C.; Thawornkaiwong, Ariyaporn; Robbins, Jeffrey; Walker, Lori A.; de Tombe, Pieter P.; Geenen, David L.; Buttrick, Peter M.; Solaro, R. John			Ablation of Ventricular Myosin Regulatory Light Chain Phosphorylation in Mice Causes Cardiac Dysfunction in Situ and Affects Neighboring Myofilament Protein Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-A PHOSPHORYLATION; SKELETAL-MUSCLE FIBERS; PERFUSED RABBIT HEART; CANINE LEFT-VENTRICLE; TROPONIN-I; RAT HEARTS; INORGANIC-PHOSPHATE; FORCE DEVELOPMENT; CA2+ SENSITIVITY; ISOMETRIC FORCE	There is little direct evidence on the role of myosin regulatory light chain phosphorylation in ejecting hearts. In studies reported here we determined the effects of regulatory light chain (RLC) phosphorylation on in situ cardiac systolic mechanics and in vitro myofibrillar mechanics. We compared data obtained from control nontransgenic mice (NTG) with a transgenic mouse model expressing a cardiac specific nonphosphorylatable RLC (TG-RLC(P-). We also determined whether the depression in RLC phosphorylation affected phosphorylation of other sarcomeric proteins. TG-RLC(P-) demonstrated decreases in base-line load-independent measures of contractility and power and an increase in ejection duration together with a depression in phosphorylation of myosin-binding protein-C (MyBP-C) and troponin I (TnI). Although TG-RLC(P-) displayed a significantly reduced response to beta(1)-adrenergic stimulation, MyBP-C and TnI were phosphorylated to a similar level in TG-RLC(P-) and NTG, suggesting cAMP-dependent protein kinase signaling to these proteins was not disrupted. A major finding was that NTG controls were significantly phosphorylated at RLC serine 15 following beta(1)-adrenergic stimulation, a mechanism prevented in TG-RLC(P-), thus providing a biochemical difference in beta(1)-adrenergic responsiveness at the level of the sarcomere. Our measurements of Ca2+ tension and Ca2+-ATPase rate relations in detergent-extracted fiber bundles from LV trabeculae demonstrated a relative decrease in maximum Ca2+-activated tension and tension cost in TG-RLC(P-) fibers, with no change in Ca2+ sensitivity. Our data indicate that RLC phosphorylation is critical for normal ejection and response to beta(1)-adrenergic stimulation. Our data also indicate that the lack of RLC phosphorylation promotes compensatory changes in MyBP-C and TnI phosphorylation, which when normalized do not restore function.	[Scruggs, Sarah B.; Hinken, Aaron C.; Thawornkaiwong, Ariyaporn; de Tombe, Pieter P.; Geenen, David L.; Solaro, R. John] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA; [Scruggs, Sarah B.; Hinken, Aaron C.; Thawornkaiwong, Ariyaporn; de Tombe, Pieter P.; Geenen, David L.; Solaro, R. John] Univ Illinois, Cardiovasc Res Ctr, Chicago, IL 60612 USA; [Robbins, Jeffrey] Cincinnati Childrens Hosp, Dept Mol Cardiovasc Biol, Cincinnati, OH 45229 USA; [Walker, Lori A.; Buttrick, Peter M.] Univ Colorado, Div Cardiol, Aurora, CO 80045 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Cincinnati Children's Hospital Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus	Solaro, RJ (corresponding author), 835 S Wolcott Ave,M-C 901, Chicago, IL 60612 USA.	solarorj@uic.edu	Walker, Lori/J-7098-2013	Walker, Lori/0000-0003-2556-8076	National Institutes of Health [PO1 HL62426, RO1 HL22231, T32 HL07962, F32 HL086023]; American Heart Association [0710031Z]; Temple Hoyne Buell Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL086023, R01HL022231, T32HL007692, P01HL062426] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Temple Hoyne Buell Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 HL62426 (to R. J. S., P. P. D., and P. M. B.), RO1 HL22231 (to R. J. S.), T32 HL07962 (to S. B. S. and A. C. H.), and F32 HL086023 (to A. C. H.). This work was also supported by American Heart Association Grant 0710031Z (to S. B. S.) and funds from the Temple Hoyne Buell Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BAKER SP, 1980, MEMBRANE BIOCHEM, V3, P185, DOI 10.3109/09687688009063885; BARANY K, 1983, ELECTROPHORESIS, V4, P138, DOI 10.1002/elps.1150040207; Biesiadecki BJ, 2007, CIRC RES, V100, P1486, DOI 10.1161/01.RES.0000267744.92677.7f; Chan JY, 2008, CIRC RES, V102, P571, DOI 10.1161/CIRCRESAHA.107.161687; Chu GX, 2004, CIRC RES, V94, P184, DOI 10.1161/01.RES.0000107198.90218.21; CLEMENT O, 1992, BIOCHEM J, V285, P311, DOI 10.1042/bj2850311; Davis JS, 2002, COLD SPRING HARB SYM, V67, P345, DOI 10.1101/sqb.2002.67.345; Davis JS, 2002, BIOPHYS J, V83, P359, DOI 10.1016/S0006-3495(02)75175-8; Davis JS, 2001, CELL, V107, P631, DOI 10.1016/S0092-8674(01)00586-4; DETOMBE PP, 1995, CIRC RES, V76, P734, DOI 10.1161/01.RES.76.5.734; Epstein ND, 2006, CIRC RES, V98, P1110, DOI 10.1161/01.RES.0000223888.99864.3c; FREARSON N, 1975, BIOCHEM J, V151, P99, DOI 10.1042/bj1510099; FREARSON N, 1976, NATURE, V264, P801, DOI 10.1038/264801a0; FRITZ JD, 1989, ANAL BIOCHEM, V180, P205, DOI 10.1016/0003-2697(89)90116-4; Gruen M, 1999, FEBS LETT, V453, P254, DOI 10.1016/S0014-5793(99)00727-9; HIGH CW, 1980, AM J PHYSIOL, V239, pH756, DOI 10.1152/ajpheart.1980.239.6.H756; Hinken AC, 2007, PHYSIOLOGY, V22, P73, DOI 10.1152/physiol.00043.2006; Hinken AC, 2004, AM J PHYSIOL-CELL PH, V287, pC500, DOI 10.1152/ajpcell.00049.2004; HOFMANN PA, 1991, J PHYSIOL-LONDON, V439, P701, DOI 10.1113/jphysiol.1991.sp018689; HOLROYDE MJ, 1979, BIOCHIM BIOPHYS ACTA, V587, P628, DOI 10.1016/0304-4165(79)90014-X; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; JEACOCKE SA, 1980, BIOCHEM J, V188, P763, DOI 10.1042/bj1880763; Korte FS, 2003, CIRC RES, V93, P752, DOI 10.1161/01.RES.0000096363.85588.9A; Kunst G, 2000, CIRC RES, V86, P51, DOI 10.1161/01.RES.86.1.51; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; METZGER JM, 1989, J GEN PHYSIOL, V93, P855, DOI 10.1085/jgp.93.5.855; Montgomery DE, 2005, AM J PHYSIOL-HEART C, V289, pH1881, DOI 10.1152/ajpheart.00454.2005; Morano I, 1997, J MOL CELL CARDIOL, V29, P1177, DOI 10.1006/jmcc.1996.0353; MORANO I, 1986, BASIC RES CARDIOL, V81, P611, DOI 10.1007/BF02005185; MORANO I, 1988, BASIC RES CARDIOL, V83, P350, DOI 10.1007/BF02005820; Nagayama T, 2007, CIRCULATION, V116, P2399, DOI 10.1161/CIRCULATIONAHA.107.706523; Olsson MC, 2004, AM J PHYSIOL-HEART C, V287, pH2712, DOI 10.1152/ajpheart.01067.2003; Palmer BM, 2004, CIRC RES, V94, P1249, DOI 10.1161/01.RES.0000126898.95550.31; Pi YQ, 2003, J PHYSIOL-LONDON, V552, P845, DOI 10.1113/jphysiol.2003.045260; Poetter K, 1996, NAT GENET, V13, P63, DOI 10.1038/ng0596-63; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Sadayappan S, 2005, CIRC RES, V97, P1156, DOI 10.1161/01.RES.0000190605.79013.4d; Sanbe A, 1999, J BIOL CHEM, V274, P21085, DOI 10.1074/jbc.274.30.21085; Scruggs SB, 2006, J MOL CELL CARDIOL, V40, P465, DOI 10.1016/j.yjmcc.2005.12.009; SOLARO RJ, 1971, BIOCHIM BIOPHYS ACTA, V245, P259, DOI 10.1016/0005-2728(71)90033-8; Solaro RJ, 1998, CIRC RES, V83, P471, DOI 10.1161/01.RES.83.5.471; SOLARO RJ, 2001, HDB PHYSL 2, V1, P264; SOLARO RJ, 2001, HEART PHYSL PATHOPHY, P519; Stelzer JE, 2007, CIRC RES, V101, P503, DOI 10.1161/CIRCRESAHA.107.153650; Stelzer JE, 2006, J GEN PHYSIOL, V128, P261, DOI 10.1085/jgp.200609547; SUGA H, 1974, CIRC RES, V35, P117, DOI 10.1161/01.RES.35.1.117; SUGA H, 1973, CIRC RES, V32, P314, DOI 10.1161/01.RES.32.3.314; SWEENEY HL, 1986, AM J PHYSIOL, V250, pC657, DOI 10.1152/ajpcell.1986.250.4.C657; SWEENEY HL, 1993, AM J PHYSIOL, V264, pC1085, DOI 10.1152/ajpcell.1993.264.5.C1085; Thawornkaiwong A, 2003, LIFE SCI, V72, P1813, DOI 10.1016/S0024-3205(02)02473-6; van der Velden J, 2003, CARDIOVASC RES, V57, P505, DOI 10.1016/S0008-6363(02)00662-4; van der Velden J, 2003, CARDIOVASC RES, V57, P37, DOI 10.1016/S0008-6363(02)00606-5; van der Velden J, 2001, CIRCULATION, V104, P1140, DOI 10.1161/hc3501.095485; Wang XJ, 2001, CIRC RES, V89, P84, DOI 10.1161/hh1301.092688; Wang XJ, 2001, CIRCULATION, V103, P2402, DOI 10.1161/01.cir.103.19.2402; Weisberg A, 1996, P NATL ACAD SCI USA, V93, P8999, DOI 10.1073/pnas.93.17.8999; WESTWOOD SA, 1981, BIOCHEM J, V197, P185, DOI 10.1042/bj1970185; Yuan C, 2006, PROTEOMICS, V6, P4176, DOI 10.1002/pmic.200500894	59	86	87	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5097	5106		10.1074/jbc.M807414200	http://dx.doi.org/10.1074/jbc.M807414200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19106098	Green Published, hybrid			2022-12-25	WOS:000263416600040
J	Yan, J; Yang, Y; Zhang, H; King, C; Kan, HM; Cai, Y; Yuan, CX; Bloom, GS; Hua, X				Yan, J.; Yang, Y.; Zhang, H.; King, C.; Kan, H-M; Cai, Y.; Yuan, C-X; Bloom, G. S.; Hua, X.			Menin interacts with IQGAP1 to enhance intercellular adhesion of beta-cells	ONCOGENE			English	Article						menin; IQGAP1; intercellular adhesion; migration	MULTIPLE ENDOCRINE NEOPLASIA; E-CADHERIN; GENE; CDC42; PROTEIN; RAC1; SUPPRESSOR; EXPRESSION; MIGRATION; BINDING	Multiple endocrine neoplasia type 1 (MEN1) is a dominantly inherited tumor syndrome that results from the mutation of the MEN1 gene that encodes protein menin. Stable overexpression of MEN1 has been shown to partially suppress the Ras-mediated morphological changes of fibroblast cells. Little is known about the molecular mechanisms by which menin decreases the oncogenic effects on cell morphology and other phenotypes. Here we showed that ectopic expression of menin in pretumor beta-cells increases islet cell adhesion and reduces cell migration. Our further studies revealed that menin interacts with the scaffold protein, IQ motif containing GTPase activating protein 1 (IQGAP1), reduces GTP-Rac1 interaction with IQGAP1 but increases epithelial cadherin (E-cadherin)/beta-catenin interaction with IQGAP1. Consistent with an essential role for menin in regulating beta-cell adhesion in vivo, accumulations of beta-catenin and E-cadherin are reduced at cell junctions in the islets from Men1-excised mice. Together, these results de. ne a novel menin-IQGAP1 pathway that controls cell migration and cell-cell adhesion in endocrine cells.	[Yan, J.; Yang, Y.; Zhang, H.; King, C.; Hua, X.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA; [Zhang, H.] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Kan, H-M; Cai, Y.; Bloom, G. S.] Univ Virginia, Dept Biol, Charlottesville, VA USA; [Yuan, C-X] Univ Penn, Sch Med, Dept Prote Facil, Philadelphia, PA 19104 USA; [Bloom, G. S.] Univ Virginia, Dept Cell Biol, Charlottesville, VA USA	University of Pennsylvania; Pennsylvania Medicine; Sun Yat Sen University; University of Virginia; University of Pennsylvania; University of Virginia	Hua, X (corresponding author), Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Canc Biol, 421 Curie Blvd, Philadelphia, PA 19104 USA.	huax@mail.med.upenn.edu	Zhang, Hui/F-9253-2011	Yan, Jizhou/0000-0001-7482-7842	NIH [R01-CA-100912, R01-CA-113962, R01-NS051746]; American Diabetes Association [7-07-RA-60]; NATIONAL CANCER INSTITUTE [R01CA113962, R01CA100912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051746] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The parent clonal beta HC9 insulin-secreting cells (Radvanyi et al., 1993) were obtained from the cell repository of the Diabetes Research Center at the University of Pennsylvania, with permission of Dr FM Matschinsky. We thank Dr Faming Zhang for his gifts of purified MBP-tagged menin and nontagged menin, Dr Martin A Schwartz for mutant human Rac1 vectors and Dr Ruth Kroschewski for the IQGAP1 C-terminal constructs (C1-C4). All confocal images and quantitative analyses of fluorescent intensity were conducted at the Biomedical Imaging Core Facility at the University of Pennsylvania. We thank Peter Blessington, Alicia Nelson, Hai Shen, Mercy Gohil and Elena Blagoi for their technical assistance. A special thanks to Dr Claudia Andl and Dr Margaret Chou for their stimulating discussions. This work was supported in part from NIH grants (R01-CA-100912 and R01-CA-113962 to XH, and R01-NS051746 to GSB), and a grant from the American Diabetes Association (7-07-RA-60 to XH).	Andl CD, 2006, CANCER RES, V66, P9878, DOI 10.1158/0008-5472.CAN-05-4157; Bai F, 2007, MOL CELL BIOL, V27, P1495, DOI 10.1128/MCB.01764-06; Bashour AM, 1997, J CELL BIOL, V137, P1555, DOI 10.1083/jcb.137.7.1555; Bensenor LB, 2007, J CELL SCI, V120, P658, DOI 10.1242/jcs.03376; Bertolino P, 2003, CANCER RES, V63, P4836; Brandt DT, 2007, J CELL BIOL, V178, P193, DOI 10.1083/jcb.200612071; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Chen YX, 2006, P NATL ACAD SCI USA, V103, P1018, DOI 10.1073/pnas.0510347103; Crabtree JS, 2003, MOL CELL BIOL, V23, P6075, DOI 10.1128/MCB.23.17.6075-6085.2003; Crabtree JS, 2001, P NATL ACAD SCI USA, V98, P1118, DOI 10.1073/pnas.98.3.1118; DONNADIEU E, 1992, J IMMUNOL, V148, P2643; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Fukata M, 1999, J BIOL CHEM, V274, P26044, DOI 10.1074/jbc.274.37.26044; Fukata M, 2001, MOL CELL BIOL, V21, P2165, DOI 10.1128/MCB.21.6.2165-2183.2001; Grohmanova K, 2004, J BIOL CHEM, V279, P48495, DOI 10.1074/jbc.M408113200; Guru SC, 1999, MAMM GENOME, V10, P592, DOI 10.1007/s003359901051; Guru SC, 1998, P NATL ACAD SCI USA, V95, P1630, DOI 10.1073/pnas.95.4.1630; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Huang SC, 1999, LAB INVEST, V79, P301; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Jiang K, 2004, MOL CELL BIOL, V24, P5565, DOI 10.1128/MCB.24.12.5565-5576.2004; Kim YS, 1999, ONCOGENE, V18, P5936, DOI 10.1038/sj.onc.1203005; Kissil JL, 2007, CANCER RES, V67, P8089, DOI 10.1158/0008-5472.CAN-07-2300; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; La P, 2004, ENDOCRINOLOGY, V145, P3443, DOI 10.1210/en.2004-0124; Lakhani VT, 2007, ANNU REV MED, V58, P253, DOI 10.1146/annurev.med.58.100305.115303; Lambert M, 2002, J CELL BIOL, V157, P469, DOI 10.1083/jcb.200107104; Le Clainche C, 2007, J BIOL CHEM, V282, P426, DOI 10.1074/jbc.M607711200; Li SH, 2000, MOL CELL BIOL, V20, P697, DOI 10.1128/MCB.20.2.697-701.2000; Lopez-Egido JR, 2002, EXP CELL RES, V278, P175, DOI 10.1006/excr.2002.5575; Mataraza JM, 2007, CELL SIGNAL, V19, P1857, DOI 10.1016/j.cellsig.2007.04.011; Mataraza JM, 2003, J BIOL CHEM, V278, P41237, DOI 10.1074/jbc.M304838200; Mateer SC, 2002, J BIOL CHEM, V277, P12324, DOI 10.1074/jbc.M109535200; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Price LS, 2004, J BIOL CHEM, V279, P35127, DOI 10.1074/jbc.M404917200; RADVANYI F, 1993, MOL CELL BIOL, V13, P4223, DOI 10.1128/MCB.13.7.4223; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; Rittmeyer EN, 2008, J CELL SCI, V121, P391, DOI 10.1242/jcs.016881; Schnepp RW, 2006, CANCER RES, V66, P5707, DOI 10.1158/0008-5472.CAN-05-4518; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Taylor SJ, 1996, CURR BIOL, V6, P1621, DOI 10.1016/S0960-9822(02)70785-9; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Watanabe T, 2005, NOVART FDN SYMP, V269, P223; Watanabe T, 2005, NOVART FDN SYMP, V269, P101; Watanabe Takashi, 2005, Novartis Found Symp, V269, P92; Yan JZ, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000047; Yan JZ, 2006, MOL CELL BIOL, V26, P155, DOI 10.1128/MCB.26.1.155-168.2006; Yokoyama A, 2005, CELL, V123, P207, DOI 10.1016/j.cell.2005.09.025	50	40	46	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 19	2009	28	7					973	982		10.1038/onc.2008.435	http://dx.doi.org/10.1038/onc.2008.435			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	408TH	19079338	Green Accepted			2022-12-25	WOS:000263457400004
J	Joe, PA; Banerjee, A; Luduena, RF				Joe, Patrick A.; Banerjee, Asok; Luduena, Richard F.			Roles of beta-Tubulin Residues Ala(428) and Thr(429) in Microtubule Formation in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONTYROSINATED ALPHA-TUBULIN; CARBOXY-TERMINAL TAILS; POSTTRANSLATIONAL MODIFICATIONS; CYTOPLASMIC DYNEIN; BOVINE BRAIN; C-TERMINUS; GENES; ISOTYPES; SEQUENCE; KINESIN	The C termini of beta-tubulin isotypes are regions of high sequence variability that bind to microtubule-associated proteins and motors and undergo various post-translational modifications such as polyglutamylation and polyglycylation. Crystallographic analyses have been unsuccessful in resolving tubulin C termini. Here, we used a stepwise approach to study the role of this region in microtubule assembly. We generated a series of truncation mutants of human beta I and beta III tubulin. Transient transfection of HeLa cells with the mutants shows that mutants with deletions of up to 22 residues from beta III and 16 from beta I can assemble normally. Interestingly, removal of the next residue (Ala(428)) results in a complete loss of microtubule formation without affecting dimer formation. C-terminal tail switching of human beta I and beta III tubulin suggests that C-terminal tails are functionally equivalent. In short, residues outside of 1-429 of human beta-tubulins make no contribution to microtubule assembly. Ala(428), in the C-terminal sequence motif N-QQYQDA(428), lies at the end of helix H12 of beta-tubulin. We hypothesize that this residue is important for maintaining helix H12 structure. Deletion of Ala(428) may lead to unwinding of helix H12, resulting in tubulin dimers incapable of assembly. Thr(429) plays a more complex role. In the beta I isotype of tubulin, Thr(429) is not at all necessary for assembly; however, in the beta III isotype, its presence strongly favors assembly. This result is consistent with a likely more complex function of beta III as well as with the observation that evolutionary conservation is total for Ala(428) and frequent for Thr(429).	[Joe, Patrick A.; Banerjee, Asok; Luduena, Richard F.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Luduena, RF (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA.	luduena@uthscsa.edu			United States Army Breast Cancer Research Program [W81XWH-05-1-0238]; San Antonio Cancer Institute [P30 CA54174]; State of Texas Higher Coordinating Board, and Welch Foundation [AQ-0726]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER	United States Army Breast Cancer Research Program(United States Department of Defense); San Antonio Cancer Institute; State of Texas Higher Coordinating Board, and Welch Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by United States Army Breast Cancer Research Program Grant W81XWH-05-1-0238, San Antonio Cancer Institute Grant P30 CA54174, the State of Texas Higher Coordinating Board, and Welch Foundation Grant AQ-0726 (to R. F. L.).	AIZAWA H, 1991, J BIOL CHEM, V266, P9841; ALEXANDER JE, 1991, P NATL ACAD SCI USA, V88, P4685, DOI 10.1073/pnas.88.11.4685; AUDEBERT S, 1993, MOL BIOL CELL, V4, P615, DOI 10.1091/mbc.4.6.615; Banerjee A, 1999, BIOCHEMISTRY-US, V38, P5438, DOI 10.1021/bi981572n; Banerjee A, 2002, BIOCHEM BIOPH RES CO, V293, P598, DOI 10.1016/S0006-291X(02)00269-3; Banerjee A, 2002, J BIOL CHEM, V277, P46140, DOI 10.1074/jbc.M208065200; Bre MH, 1998, MOL BIOL CELL, V9, P2655, DOI 10.1091/mbc.9.9.2655; Brehm K, 2000, MOL BIOCHEM PARASIT, V107, P297, DOI 10.1016/S0166-6851(00)00178-X; Carre M, 2002, J BIOL CHEM, V277, P33664, DOI 10.1074/jbc.M203834200; CHAPIN SJ, 1991, J CELL SCI, V98, P27; DEANIN GG, 1980, EUR J BIOCHEM, V109, P207, DOI 10.1111/j.1432-1033.1980.tb04786.x; DeLano W, 2002, PYMOL 0 99; DETRICH HW, 1993, CELL MOTIL CYTOSKEL, V24, P156, DOI 10.1002/cm.970240303; DIAZNIDO J, 1990, J BIOL CHEM, V265, P13949; Dossou SJY, 2007, CELL MOTIL CYTOSKEL, V64, P847, DOI 10.1002/cm.20229; Duan JM, 2002, CURR BIOL, V12, P313, DOI 10.1016/S0960-9822(02)00651-6; DUPUIS P, 1992, EMBO J, V11, P3713, DOI 10.1002/j.1460-2075.1992.tb05456.x; Gagnon C, 1996, J CELL SCI, V109, P1545; Gerbod D, 2004, MOL PHYLOGENET EVOL, V31, P572, DOI 10.1016/j.ympev.2003.09.013; Gioio AE, 2004, EUR J NEUROSCI, V20, P865, DOI 10.1111/j.1460-9568.2004.03538.x; GOOD PJ, 1989, NUCLEIC ACIDS RES, V17, P8000, DOI 10.1093/nar/17.19.8000; GUNDERSEN GG, 1986, J CELL BIOL, V102, P1118, DOI 10.1083/jcb.102.3.1118; GUNDERSEN GG, 1984, CELL, V38, P779, DOI 10.1016/0092-8674(84)90273-3; HAGIWARA H, 1994, J BIOL CHEM, V269, P3581; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HARLOW P, 1988, J MOL EVOL, V27, P56, DOI 10.1007/BF02099730; HARPER DS, 1989, P NATL ACAD SCI USA, V86, P3252, DOI 10.1073/pnas.86.9.3252; Hartwig J, 2003, J THROMB HAEMOST, V1, P1580, DOI 10.1046/j.1538-7836.2003.00331.x; Henriquez JP, 1996, MOL CELL BIOCHEM, V158, P149, DOI 10.1007/BF00225841; Ikegami K, 2006, J BIOL CHEM, V281, P30707, DOI 10.1074/jbc.M603984200; Jensen-Smith HC, 2003, CELL MOTIL CYTOSKEL, V55, P213, DOI 10.1002/cm.10122; Ji SJ, 2002, BIOCHEM BIOPH RES CO, V296, P1245, DOI 10.1016/S0006-291X(02)02069-7; Jimenez MA, 1999, PROTEIN SCI, V8, P788; Jost W, 2004, GENE, V340, P151, DOI 10.1016/j.gene.2004.06.009; KIRKMASON KE, 1988, NUCLEIC ACIDS RES, V16, P2733, DOI 10.1093/nar/16.6.2733; Knipling L, 2006, BIOCHEM BIOPH RES CO, V341, P433, DOI 10.1016/j.bbrc.2005.12.201; LEWIS SA, 1987, CELL, V49, P539, DOI 10.1016/0092-8674(87)90456-9; LEWIS SA, 1985, J CELL BIOL, V101, P852, DOI 10.1083/jcb.101.3.852; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luchko T, 2008, BIOPHYS J, V94, P1971, DOI 10.1529/biophysj.107.115113; Luduena RF, 1998, INT REV CYTOL, V178, P207; LUDUENA RF, 1988, FEBS LETT, V230, P142, DOI 10.1016/0014-5793(88)80658-6; Moreno FJ, 1999, EUR J BIOCHEM, V262, P557, DOI 10.1046/j.1432-1327.1999.00408.x; Mukherjee M, 2003, J APPL MICROBIOL, V95, P861, DOI 10.1046/j.1365-2672.2003.02061.x; Njue AI, 2003, PARASITOLOGY, V127, P579, DOI 10.1017/S0031182003004086; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Nogales E, 1999, CELL MOL LIFE SCI, V56, P133, DOI 10.1007/s000180050012; Okamura S, 1999, CELL STRUCT FUNCT, V24, P117, DOI 10.1247/csf.24.117; Okamura S, 1997, CELL STRUCT FUNCT, V22, P291, DOI 10.1247/csf.22.291; Popodi EM, 2005, CELL MOTIL CYTOSKEL, V62, P48, DOI 10.1002/cm.20085; Priel A, 2005, EUR BIOPHYS J BIOPHY, V35, P40, DOI 10.1007/s00249-005-0003-0; REDEKER V, 1992, FEBS LETT, V313, P185, DOI 10.1016/0014-5793(92)81441-N; REDEKER V, 1994, SCIENCE, V266, P1688, DOI 10.1126/science.7992051; RUDIGER A, 1995, ANAL BIOCHEM, V224, P532, DOI 10.1006/abio.1995.1083; RUDIGER M, 1992, FEBS LETT, V308, P101, DOI 10.1016/0014-5793(92)81061-P; SACKETT DL, 1985, J BIOL CHEM, V260, P43; Schwarz PM, 1998, BIOCHEMISTRY-US, V37, P4687, DOI 10.1021/bi972763d; Schwer HD, 2001, CURR BIOL, V11, P579, DOI 10.1016/S0960-9822(01)00153-1; SERRANO L, 1985, EUR J BIOCHEM, V153, P595, DOI 10.1111/j.1432-1033.1985.tb09342.x; SERRANO L, 1984, P NATL ACAD SCI-BIOL, V81, P5989, DOI 10.1073/pnas.81.19.5989; SERRANO L, 1984, BIOCHEMISTRY-US, V23, P4675, DOI 10.1021/bi00315a024; SERRANO L, 1988, BIOCHEM J, V252, P683, DOI 10.1042/bj2520683; SHARMA J, 1994, J PROTEIN CHEM, V13, P165, DOI 10.1007/BF01891975; Skiniotis G, 2004, EMBO J, V23, P989, DOI 10.1038/sj.emboj.7600118; SULLIVAN KF, 1985, MOL CELL BIOL, V5, P2454, DOI 10.1128/MCB.5.9.2454; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TOMAREV SI, 1993, BIOCHIM BIOPHYS ACTA, V1216, P245, DOI 10.1016/0167-4781(93)90151-3; Tucker C, 1997, J BIOL CHEM, V272, P9481; VASSILEVSKAIA TD, 1993, PLANT MOL BIOL, V22, P715, DOI 10.1007/BF00047413; Wang ZH, 2000, BIOPHYS J, V78, P1955, DOI 10.1016/S0006-3495(00)76743-9; Yamamoto E, 1999, PLANT MOL BIOL, V39, P45, DOI 10.1023/A:1006108412801	72	21	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4283	4291		10.1074/jbc.M807491200	http://dx.doi.org/10.1074/jbc.M807491200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19074767	Green Published, hybrid			2022-12-25	WOS:000263134400026
J	Jurek, A; Amagasaki, K; Gembarska, A; Heldin, CH; Lennartsson, J				Jurek, Aleksandra; Amagasaki, Kenichi; Gembarska, Agnieszka; Heldin, Carl-Henrik; Lennartsson, Johan			Negative and Positive Regulation of MAPK Phosphatase 3 Controls Platelet-derived Growth Factor-induced Erk Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE PHOSPHATASE; FEEDBACK-REGULATION; IN-VIVO; SPECIFICITY; PATHWAYS; PHOSPHORYLATION; DEGRADATION; CASCADE; FAMILY; SITES	MAPK phosphatases (MKPs) are dual specificity phosphatases that dephosphorylate and thereby inactivate MAPKs. In the present study, we provide evidence that platelet-derived growth factor BB (PDGF-BB) regulates MKP3 (DUSP6), which is considered to be a phosphatase highly selective for Erk. Intriguingly, we observed that Mek is positively regulated by MKP3, whereas Erk itself is negatively regulated. In addition, we found that activation of PDGF receptor alpha or beta leads to a rapid proteasomal degradation of MKP3 in a manner that requires Mek activation; this feed-forward mechanism was found to be essential for efficient Erk phosphorylation. We could also demonstrate that PDGF-BB stimulation induces phosphorylation of MKP3 at Ser-174 and Ser-300; phosphorylation of Ser-174 is involved in PDGF-induced MKP3 degradation, since mutation of this site stabilized MKP3. Moreover, activated Erk induces mkp3 expression, leading to restoration of MKP3 levels after 1-2 h and a concomitant dephosphorylation of Erk in cells with activated PDGFR alpha. Reducing the MKP3 level by small interfering RNA leads to an increased Erk activation and mitogenic response to PDGF-BB. In conclusion, MKP3 is an important regulator of PDGF-induced Erk phosphorylation acting in both a rapid positive feed-forward and a later negative feed-back loop.	[Lennartsson, Johan] Uppsala Univ, Biomed Ctr, Ludwig Inst Canc Res, SE-75124 Uppsala, Sweden	Ludwig Institute for Cancer Research; Uppsala University	Lennartsson, J (corresponding author), Uppsala Univ, Biomed Ctr, Ludwig Inst Canc Res, Box 595, SE-75124 Uppsala, Sweden.	Johan.Lennartsson@LICR.uu.se			Swedish Research Council; TRANSFOG integrated European Union project	Swedish Research Council(Swedish Research CouncilEuropean Commission); TRANSFOG integrated European Union project	This work was supported by grants from the Swedish Research Council, Ake Wibergs stiftelse, Magnus Bergvalls stiftelse, and the TRANSFOG integrated European Union project. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bermudez O, 2008, ONCOGENE, V27, P3685, DOI 10.1038/sj.onc.1211040; BLUMEJENSEN P, 1995, J BIOL CHEM, V270, P14192, DOI 10.1074/jbc.270.23.14192; Brondello JM, 1997, J BIOL CHEM, V272, P1368, DOI 10.1074/jbc.272.2.1368; Brondello JM, 1999, SCIENCE, V286, P2514, DOI 10.1126/science.286.5449.2514; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Camps M, 1998, FEBS LETT, V425, P271, DOI 10.1016/S0014-5793(98)00250-6; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Cook SJ, 1996, BIOCHEM J, V320, P237, DOI 10.1042/bj3200237; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; Ekerot M, 2008, BIOCHEM J, V412, P287, DOI 10.1042/BJ20071512; Farooq A, 2004, CELL SIGNAL, V16, P769, DOI 10.1016/j.cellsig.2003.12.008; Fredriksson L, 2004, CYTOKINE GROWTH F R, V15, P197, DOI 10.1016/j.cytogfr.2004.03.007; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hirsch DD, 1997, J BIOL CHEM, V272, P4568, DOI 10.1074/jbc.272.7.4568; Hoshino R, 1999, ONCOGENE, V18, P813, DOI 10.1038/sj.onc.1202367; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Lin YW, 2006, J BIOL CHEM, V281, P915, DOI 10.1074/jbc.M508720200; Mandl M, 2005, MOL CELL BIOL, V25, P1830, DOI 10.1128/MCB.25.5.1830-1845.2005; Marchetti S, 2005, MOL CELL BIOL, V25, P854, DOI 10.1128/MCB.25.2.854-864.2005; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Marti F, 2001, J IMMUNOL, V166, P197, DOI 10.4049/jimmunol.166.1.197; MELOCHE S, 1992, MOL ENDOCRINOL, V6, P845, DOI 10.1210/me.6.5.845; MISRAPRESS A, 1995, J BIOL CHEM, V270, P14587, DOI 10.1074/jbc.270.24.14587; Muda M, 1996, J BIOL CHEM, V271, P4319; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Yamamoto T, 2006, CURR BIOL, V16, P1171, DOI 10.1016/j.cub.2006.04.044; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218	28	56	57	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4626	4634		10.1074/jbc.M808490200	http://dx.doi.org/10.1074/jbc.M808490200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19106095	hybrid			2022-12-25	WOS:000263134400062
J	Kuhn, FJP; Kuhn, C; Luckhoff, A				Kuehn, Frank J. P.; Kuehn, Cornelia; Lueckhoff, Andreas			Inhibition of TRPM8 by Icilin Distinct from Desensitization Induced by Menthol and Menthol Derivatives	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPSAICIN-RECEPTOR; PROSTATE-CANCER; COLD; CHANNEL; ACTIVATION; SENSITIVITY; REVEALS; IDENTIFICATION; MECHANISM; NEURONS	TRPM8 is a cation channel activated by cold temperatures and the chemical stimuli menthol and icilin. Both compounds use different mechanisms of current activation; amino acid residues within the S2-S3 linker have been identified critical for current activation by icilin but not by menthol. Current decline in the course of menthol stimulation reflects Ca2+-dependent desensitization attributed to phosphatidylinositol 4,5-bisphosphate depletion. Carboxyamide derivatives chemically resembling menthol have been described as activators of TRPM8 analogous to icilin. Our aim was a detailed analysis of whether differences exist between all these substances with respect to their activation and inactivation of currents. We studied wildtype TRPM8 as well as an s3-TRPM8 mutant with mutations in the S2-S3 linker region that could not be activated by icilin. Menthol and menthol derivatives behaved indistinguishable in evoking currents through both channels in a Ca2+-independent manner as well as inducing Ca2+-dependent desensitization. Icilin, in contrast, activated currents only in wild type TRPM8 and in the presence of Ca2+. Moreover, it completely reversed currents induced by menthol, menthol derivatives, and cold temperatures in wild type TRPM8 and s3-TRPM8; this current inhibition was independent of Ca2+. Finally, icilin suppressed current activation by the other agonists. None of the inhibiting effects of icilin occurred in the cation channel TRPA1 that is also stimulated by both menthol and icilin. Thus, icilin specifically inhibits TRPM8 independently of its interaction site within the S2-S3 linker through a process distinct from desensitization.	[Kuehn, Frank J. P.; Kuehn, Cornelia; Lueckhoff, Andreas] Rhein Westfal TH Aachen, Fac Med, Inst Physiol, D-52057 Aachen, Germany	RWTH Aachen University	Kuhn, FJP (corresponding author), Rhein Westfal TH Aachen, Fac Med, Inst Physiol, D-52057 Aachen, Germany.	fkuehn@physiology.rwth-aachen.de	Kuehn, Frank JP/H-5889-2018		Deutsche Forschungsgemeinschaft [2271/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was supported by the Deutsche Forschungsgemeinschaft Grant DFG KU 2271/1-1. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andersson DA, 2004, J NEUROSCI, V24, P5364, DOI 10.1523/JNEUROSCI.0890-04.2004; Bandell M, 2006, NAT NEUROSCI, V9, P493, DOI 10.1038/nn1665; Beck B, 2007, CELL CALCIUM, V41, P285, DOI 10.1016/j.ceca.2006.07.002; Bodding M, 2007, CELL CALCIUM, V42, P618, DOI 10.1016/j.ceca.2007.03.005; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; Doerner JF, 2007, J BIOL CHEM, V282, P13180, DOI 10.1074/jbc.M607849200; Gavva NR, 2004, J BIOL CHEM, V279, P20283, DOI 10.1074/jbc.M312577200; HENSEL H, 1951, ACTA PHYSIOL SCAND, V24, P27, DOI 10.1111/j.1748-1716.1951.tb00824.x; Hui KY, 2005, BIOCHEM BIOPH RES CO, V333, P374, DOI 10.1016/j.bbrc.2005.05.123; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Kim D, 2008, AM J PHYSIOL-CELL PH, V295, pC92, DOI 10.1152/ajpcell.00023.2008; Kuhn FJP, 2007, J BIOL CHEM, V282, P27598, DOI 10.1074/jbc.M702247200; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Reid G, 2002, J PHYSIOL-LONDON, V545, P595, DOI 10.1113/jphysiol.2002.024331; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Talavera K, 2005, NATURE, V438, P1022, DOI 10.1038/nature04248; Tsavaler L, 2001, CANCER RES, V61, P3760; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Voets T, 2007, NAT CHEM BIOL, V3, P174, DOI 10.1038/nchembio862; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; WEI ET, 1983, J PHARM PHARMACOL, V35, P110, DOI 10.1111/j.2042-7158.1983.tb04279.x; Xiao B, 2008, J NEUROSCI, V28, P9640, DOI 10.1523/JNEUROSCI.2772-08.2008; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Yamamura H, 2008, AM J PHYSIOL-CELL PH, V295, pC296, DOI 10.1152/ajpcell.00499.2007	30	38	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4102	4111		10.1074/jbc.M806651200	http://dx.doi.org/10.1074/jbc.M806651200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19095656	hybrid			2022-12-25	WOS:000263134400007
J	Merad, H; Porumb, H; Zargarian, L; Rene, B; Hobaika, Z; Maroun, RG; Mauffret, O; Fermandjian, S				Merad, Hayate; Porumb, Horea; Zargarian, Loussine; Rene, Brigitte; Hobaika, Zeina; Maroun, Richard G.; Mauffret, Olivier; Fermandjian, Serge			An Unusual Helix Turn Helix Motif in the Catalytic Core of HIV-1 Integrase Binds Viral DNA and LEDGF	PLOS ONE			English	Article								Background: Integrase (IN) of the type 1 human immunodeficiency virus (HIV-1) catalyzes the integration of viral DNA into host cellular DNA. We identified a bi-helix motif (residues 149-186) in the crystal structure of the catalytic core (CC) of the IN-Phe185Lys variant that consists of the alpha(4) and alpha(5) helices connected by a 3 to 5-residue turn. The motif is embedded in a large array of interactions that stabilize the monomer and the dimer. Principal Findings: We describe the conformational and binding properties of the corresponding synthetic peptide. This displays features of the protein motif structure thanks to the mutual intramolecular interactions of the alpha(4) and alpha(5) helices that maintain the fold. The main properties are the binding to: 1- the processing-attachment site at the LTR (long terminal repeat) ends of virus DNA with a K(d) (dissociation constant) in the sub-micromolar range; 2- the whole IN enzyme; and 3- the IN binding domain (IBD) but not the IBD-Asp366Asn variant of LEDGF (lens epidermal derived growth factor) lacking the essential Asp366 residue. In our motif, in contrast to the conventional HTH (helix-turn-helix), it is the N terminal helix (alpha(4)) which has the role of DNA recognition helix, while the C terminal helix (alpha(5)) would rather contribute to the motif stabilization by interactions with the alpha(4) helix. Conclusion: The motif, termed HTHi (i, for inverted) emerges as a central piece of the IN structure and function. It could therefore represent an attractive target in the search for inhibitors working at the DNA-IN, IN-IN and IN-LEDGF interfaces.	[Merad, Hayate; Porumb, Horea; Zargarian, Loussine; Rene, Brigitte; Hobaika, Zeina; Mauffret, Olivier; Fermandjian, Serge] Ecole Normale Super, CNRS, UMR 8113, LBPA, Cachan, France; [Maroun, Richard G.] Univ St Joseph, Fac Sci, Dept Sci Vie Terre, Beirut, Lebanon	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Saint Joseph University Beirut	Merad, H (corresponding author), Ecole Normale Super, CNRS, UMR 8113, LBPA, Cachan, France.	serge.fermandjian@lbpa.ens-cachan.fr	Maroun, Richard/ABG-6613-2020	Maroun, Richard/0000-0002-0697-2535	Centre National de la Recherche Scientifique (CNRS); French-Libanese program CEDRE [05 SF21/L14]; SIDACTION; National Agency for Research against AIDS (ANRS)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); French-Libanese program CEDRE; SIDACTION; National Agency for Research against AIDS (ANRS)(ANRS)	This work was supported by the Centre National de la Recherche Scientifique (CNRS), the French-Libanese program CEDRE (05 SF21/L14) and in part by grants from SIDACTION and the National Agency for Research against AIDS (ANRS) (to H. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armon-Omer A, 2004, J MOL BIOL, V336, P1117, DOI 10.1016/j.jmb.2003.11.057; Asante-Appiah E, 1999, ADV VIRUS RES, V52, P351, DOI 10.1016/S0065-3527(08)60306-1; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baranova S, 2007, NUCLEIC ACIDS RES, V35, P975, DOI 10.1093/nar/gkl1111; Bera S, 2005, BIOCHEMISTRY-US, V44, P15106, DOI 10.1021/bi0508340; Bouyac-Bertoia M, 2001, MOL CELL, V7, P1025, DOI 10.1016/S1097-2765(01)00240-4; Brown P. O., 1997, P161; Bujacz G, 1996, STRUCTURE, V4, P89, DOI 10.1016/S0969-2126(96)00012-3; Busschots K, 2007, J MOL BIOL, V365, P1480, DOI 10.1016/j.jmb.2006.10.094; Cai ML, 1997, NAT STRUCT BIOL, V4, P567, DOI 10.1038/nsb0797-567; Chen AP, 2006, J BIOL CHEM, V281, P4173, DOI 10.1074/jbc.M510628200; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Chen ZG, 2000, J MOL BIOL, V296, P521, DOI 10.1006/jmbi.1999.3451; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Cherepanov P, 2005, NAT STRUCT MOL BIOL, V12, P526, DOI 10.1038/nsmb937; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Craigie R, 2001, J BIOL CHEM, V276, P23213, DOI 10.1074/jbc.R100027200; Craigie R, 2002, MOBILE DNA, P613; Debyser Zeger, 2002, Antiviral Chemistry & Chemotherapy, V13, P1; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dvorin JD, 2002, J VIROL, V76, P12087, DOI 10.1128/JVI.76.23.12087-12096.2002; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; Eftink MR, 1997, METHOD ENZYMOL, V278, P221; Eijkelenboom APAM, 1997, CURR BIOL, V7, P739, DOI 10.1016/S0960-9822(06)00332-0; EIJKELENBOOM APAM, 1995, NAT STRUCT BIOL, V2, P807, DOI 10.1038/nsb0995-807; Emiliani S, 2005, J BIOL CHEM, V280, P25517, DOI 10.1074/jbc.M501378200; ENGELMAN A, 1991, CELL, V67, P1211, DOI 10.1016/0092-8674(91)90297-C; Esposito D, 1999, ADV VIRUS RES, V52, P319, DOI 10.1016/S0065-3527(08)60304-8; Esposito D, 1998, EMBO J, V17, P5832, DOI 10.1093/emboj/17.19.5832; Faure A, 2005, NUCLEIC ACIDS RES, V33, P977, DOI 10.1093/nar/gki241; Gao K, 2001, EMBO J, V20, P3565, DOI 10.1093/emboj/20.13.3565; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Gerton JL, 1997, J BIOL CHEM, V272, P25809, DOI 10.1074/jbc.272.41.25809; Goldgur Y, 1999, P NATL ACAD SCI USA, V96, P13040, DOI 10.1073/pnas.96.23.13040; Goldgur Y, 1998, P NATL ACAD SCI USA, V95, P9150, DOI 10.1073/pnas.95.16.9150; GOODARZI G, 1995, J VIROL, V69, P6090, DOI 10.1128/JVI.69.10.6090-6097.1995; Greenwald J, 1999, BIOCHEMISTRY-US, V38, P8892, DOI 10.1021/bi9907173; HARRISON SC, 1990, ANNU REV BIOCHEM, V59, P933, DOI 10.1146/annurev.bi.59.070190.004441; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Heuer TS, 1998, BIOCHEMISTRY-US, V37, P6667, DOI 10.1021/bi972949c; HEYDUK T, 1990, P NATL ACAD SCI USA, V87, P1744, DOI 10.1073/pnas.87.5.1744; Hill JJ, 1997, METHOD ENZYMOL, V278, P390; Jenkins TM, 1997, EMBO J, V16, P6849, DOI 10.1093/emboj/16.22.6849; Karki RG, 2004, J COMPUT AID MOL DES, V18, P739, DOI 10.1007/s10822-005-0365-5; Keenan RJ, 1998, CELL, V94, P181, DOI 10.1016/S0092-8674(00)81418-X; Krebs D, 1996, EUR J BIOCHEM, V235, P699, DOI 10.1111/j.1432-1033.1996.t01-1-00699.x; Leh H, 2000, BIOCHEMISTRY-US, V39, P9285, DOI 10.1021/bi000398b; Li HY, 2006, J MED CHEM, V49, P4477, DOI 10.1021/jm060307u; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Li M, 2005, J BIOL CHEM, V280, P29334, DOI 10.1074/jbc.M505367200; Limon A, 2002, J VIROL, V76, P10598, DOI 10.1128/JVI.76.21.10598-10607.2002; Llano M, 2006, SCIENCE; LODI PJ, 1995, BIOCHEMISTRY-US, V34, P9826, DOI 10.1021/bi00031a002; Lu R, 2005, J VIROL, V79, P2493, DOI 10.1128/JVI.79.4.2493-2505.2005; Maignan S, 1998, J MOL BIOL, V282, P359, DOI 10.1006/jmbi.1998.2002; Maroun RG, 1999, EUR J BIOCHEM, V260, P145, DOI 10.1046/j.1432-1327.1999.00130.x; Maroun RG, 2001, BIOCHEMISTRY-US, V40, P13840, DOI 10.1021/bi011328n; Maroun RG, 1999, J BIOL CHEM, V274, P34174, DOI 10.1074/jbc.274.48.34174; Melek M, 2002, P NATL ACAD SCI USA, V99, P134, DOI 10.1073/pnas.012610699; MIZUUCHI K, 1992, J BIOL CHEM, V267, P21273; MIZUUCHI K, 1992, ANNU REV BIOCHEM, V61, P1011; Mizuuchi K, 1997, GENES CELLS, V2, P1, DOI 10.1046/j.1365-2443.1997.970297.x; Morant-Lhomel A, 2006, BIOCHIMIE, V88, P253, DOI 10.1016/j.biochi.2005.08.003; Munoz V, 1997, BIOPOLYMERS, V41, P495, DOI 10.1002/(SICI)1097-0282(19970415)41:5<495::AID-BIP2>3.3.CO;2-6; Pandey KK, 2007, J VIROL, V81, P3969, DOI 10.1128/JVI.02322-06; Podtelezhnikov AA, 2003, BIOPOLYMERS, V68, P110, DOI 10.1002/bip.10217; Pommier Y, 2005, NAT REV DRUG DISCOV, V4, P236, DOI 10.1038/nrd1660; Porumb H, 2004, BBA-PROTEINS PROTEOM, V1699, P77, DOI 10.1016/j.bbapap.2004.01.005; ROTH MJ, 1989, CELL, V58, P47, DOI 10.1016/0092-8674(89)90401-7; VANGENT DC, 1992, P NATL ACAD SCI USA, V89, P9598, DOI 10.1073/pnas.89.20.9598; VANGENT DC, 1993, NUCLEIC ACIDS RES, V21, P3373, DOI 10.1093/nar/21.15.3373; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Wielens J, 2005, J COMPUT AID MOL DES, V19, P301, DOI 10.1007/s10822-005-5256-2; Zargarian L, 2003, J BIOL CHEM, V278, P19966, DOI 10.1074/jbc.M211711200; ZHONG LX, 1992, P NATL ACAD SCI USA, V89, P4462, DOI 10.1073/pnas.89.10.4462	75	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2009	4	1							e4081	10.1371/journal.pone.0004081	http://dx.doi.org/10.1371/journal.pone.0004081			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FR	19119323	Green Published, Green Submitted, gold			2022-12-25	WOS:000265472600002
J	Reibman, J; Marmor, M; Filner, J; Fernandez-Beros, ME; Rogers, L; Perez-Perez, GI; Blaser, MJ				Reibman, Joan; Marmor, Michael; Filner, Joshua; Fernandez-Beros, Maria-Elena; Rogers, Linda; Perez-Perez, Guillermo I.; Blaser, Martin J.			Asthma Is Inversely Associated with Helicobacter pylori Status in an Urban Population	PLOS ONE			English	Article							GASTRIC EPITHELIAL-CELLS; GASTROESOPHAGEAL-REFLUX; INTESTINAL MICROFLORA; T-CELLS; CAGA; INFECTION; PREVALENCE; ANTIBODIES; ADULTS; SEROPREVALENCE	Background: Microbial exposures have been suggested to confer protection from allergic disorders and reduced exposures to gastrointestinal microbiota have been proposed as an explanation for the increase in asthma prevalence. Since the general prevalence of Helicobacter pylori has been decreasing, we hypothesized that H. pylori serostatus would be inversely related to the presence of asthma. Methods: Adults were recruited to participate in the New York University (NYU)/Bellevue Asthma Registry in New York City. Adult asthma cases (N = 318) and controls (N = 208) were identified and serum IgG antibodies to H. pylori whole cell antigens or the immunodominant CagA antigen were measured. Results: As expected, the asthma cases and controls differed with respect to atopy and lung function. Seropositivity to H. pylori or CagA antigen was present in 47.1% of the total case and control study population. Asthma was inversely associated with CagA seropositivity (=OR = 0.57, 95% CI = 0.36-0.89). Median age of onset of asthma (doctor's diagnosis) was older ( 21 years) among individuals with CagA+ strains than among H. pylori-individuals (11 years) (p = 0.006). Conclusion: These data are consistent with the hypothesis that colonization with CagA+ H. pylori strains is inversely associated with asthma and is associated with an older age of asthma onset in an urban population. The data suggest H. pylori as a marker for protection.	[Marmor, Michael; Filner, Joshua; Fernandez-Beros, Maria-Elena; Rogers, Linda; Perez-Perez, Guillermo I.; Blaser, Martin J.] NYU, Sch Med, Dept Med, New York, NY 10003 USA; [Reibman, Joan; Marmor, Michael] NYU, Sch Med, Dept Environm Med, New York, NY USA	New York University; New York University	Reibman, J (corresponding author), NYU, Sch Med, Dept Med, New York, NY 10003 USA.	reibmj01@gcrc.med.nyu.edu	Marmor, Michael/L-9014-2015; Perez, Guillermo Perez/AAJ-3761-2020	Reibman, Joan/0000-0001-7878-1511; Perez Perez, Guillermo/0000-0002-0131-5798; Marmor, Michael/0000-0001-6605-2661	Colton Family Foundation; Diane Belfer Program in Human Microbial Ecology; Senior Scholar Award of the Ellison Medical Foundation;  [MO 1RR00096];  [ES 000260];  [RO1 GM63270]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063270] Funding Source: NIH RePORTER	Colton Family Foundation; Diane Belfer Program in Human Microbial Ecology; Senior Scholar Award of the Ellison Medical Foundation; ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	MO 1RR00096, ES 000260 (JR, MM), RO1 GM63270 (MB), Colton Family Foundation, The Diane Belfer Program in Human Microbial Ecology, Senior Scholar Award of the Ellison Medical Foundation (MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson HR, 2005, BRIT MED J, V330, P1037, DOI 10.1136/bmj.330.7499.1037; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; BANATVALA N, 1993, J INFECT DIS, V168, P219, DOI 10.1093/infdis/168.1.219; Bergman MP, 2004, J EXP MED, V200, P979, DOI 10.1084/jem.20041061; Beswick EJ, 2007, INFECT IMMUN, V75, P4334, DOI 10.1128/IAI.00553-07; Bjorksten B, 2004, SPRINGER SEMIN IMMUN, V25, P257, DOI 10.1007/s00281-003-0142-2; Blaser MJ, 2005, GASTROENTEROLOGY, V128, P1512, DOI 10.1053/j.gastro.2005.03.053; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; BLASER MJ, 1995, CANCER RES, V55, P2111; BURNEY PGJ, 1989, EUR RESPIR J, V2, P940; Cassino C, 2000, AM J RESP CRIT CARE, V162, P1423, DOI 10.1164/ajrccm.162.4.9912140; Chen Y, 2008, J INFECT DIS, V198, P553, DOI 10.1086/590158; Chen Y, 2007, ARCH INTERN MED, V167, P821, DOI 10.1001/archinte.167.8.821; DOOLEY CP, 1989, NEW ENGL J MED, V321, P1562, DOI 10.1056/NEJM198912073212302; Enright PL, 1999, CHEST, V116, P603, DOI 10.1378/chest.116.3.603; Everhart JE, 2000, GASTROENTEROL CLIN N, V29, P559, DOI 10.1016/S0889-8553(05)70130-8; Everhart JE, 2002, CLIN DIAGN LAB IMMUN, V9, P412, DOI 10.1128/CDLI.9.2.412-416.2002; Everhart JE, 2000, J INFECT DIS, V181, P1359, DOI 10.1086/315384; Garantziotis S, 2008, ANNU REV MED, V59, P343, DOI 10.1146/annurev.med.59.061206.112455; Guiney DG, 2003, INFECT IMMUN, V71, P4163, DOI 10.1128/IAI.71.7.4163-4166.2003; Hafsi N, 2004, J IMMUNOL, V173, P1249, DOI 10.4049/jimmunol.173.2.1249; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Harding SM, 2005, IMMUNOL ALLERGY CLIN, V25, P131, DOI 10.1016/j.iac.2004.09.006; Harding SM, 1997, CHEST, V111, P1389, DOI 10.1378/chest.111.5.1389; Ishihara S, 2004, J IMMUNOL, V173, P1406, DOI 10.4049/jimmunol.173.2.1406; Kiljander TO, 2004, CHEST, V126, P1490, DOI 10.1378/chest.126.5.1490; Kosunen TU, 1997, EPIDEMIOL INFECT, V119, P29, DOI 10.1017/S0950268897007565; KUIPERS EJ, 1995, J NATL CANCER I, V87, P1777, DOI 10.1093/jnci/87.23.1777; Linneberg A, 2003, J ALLERGY CLIN IMMUN, V111, P847, DOI 10.1067/mai.2003.1335; Lundgren A, 2005, INFECT IMMUN, V73, P523, DOI 10.1128/IAI.73.1.523-531.2005; MAI UEH, 1992, J EXP MED, V175, P517, DOI 10.1084/jem.175.2.517; Malaty HM, 2002, LANCET, V359, P931, DOI 10.1016/S0140-6736(02)08025-X; Matricardi PM, 2000, BMJ-BRIT MED J, V320, P412, DOI 10.1136/bmj.320.7232.412; Matricardi PM, 2002, J ALLERGY CLIN IMMUN, V110, P381, DOI 10.1067/mai.2002.126658; Matricardi PM, 1997, BRIT MED J, V314, P999, DOI 10.1136/bmj.314.7086.999; Moore WC, 2007, J ALLERGY CLIN IMMUN, V119, P405, DOI 10.1016/j.jaci.2006.11.639; O'Keeffe J, 2008, HELICOBACTER, V13, P1, DOI 10.1111/j.1523-5378.2008.00559.x; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Oderda G, 2007, J PEDIATR GASTR NUTR, V45, P301, DOI 10.1097/MPG.0b013e3180ca8960; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Perez-Perez GI, 2002, GUT, V50, P295, DOI 10.1136/gut.50.3.295; RAITALA A, 2005, MOL IMMUNOL; Ramsey CD, 2005, CURR OPIN PULM MED, V11, P14, DOI 10.1097/01.mcp.0000145791.13714.ae; Romero-Gallo J, 2002, CLIN DIAGN LAB IMMUN, V9, P1313, DOI 10.1128/CDLI.9.6.1313-1317.2002; Rowland M, 2006, GASTROENTEROLOGY, V130, P65, DOI 10.1053/j.gastro.2005.11.004; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; Sepp E, 1997, ACTA PAEDIATR, V86, P956, DOI 10.1111/j.1651-2227.1997.tb15178.x; Sorkness RL, 2008, J APPL PHYSIOL, V104, P394, DOI 10.1152/japplphysiol.00329.2007; Strachan David P., 2000, Thorax, V55, pS2, DOI 10.1136/thorax.55.suppl_1.S2; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Thjodleifsson B, 2007, SCAND J INFECT DIS, V39, P683, DOI 10.1080/00365540701225736; Wilson MS, 2005, J EXP MED, V202, P1199, DOI 10.1084/jem.20042572	54	137	145	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2008	3	12							e4060	10.1371/journal.pone.0004060	http://dx.doi.org/10.1371/journal.pone.0004060			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DI	19112508	Green Published, Green Submitted, gold			2022-12-25	WOS:000265466000018
J	Bordon, A; Bosco, N; Du Roure, C; Bartholdy, B; Kohler, H; Matthias, G; Rolink, AG; Matthias, P				Bordon, Alain; Bosco, Nabil; Du Roure, Camille; Bartholdy, Boris; Kohler, Hubertus; Matthias, Gabriele; Rolink, Antonius G.; Matthias, Patrick			Enforced Expression of the Transcriptional Coactivator OBF1 Impairs B Cell Differentiation at the Earliest Stage of Development	PLOS ONE			English	Article								OBF1, also known as Bob. 1 or OCA-B, is a B lymphocyte-specific transcription factor which coactivates Oct1 and Oct2 on B cell specific promoters. So far, the function of OBF1 has been mainly identified in late stage B cell populations. The central defect of OBF1 deficient mice is a severely reduced immune response to T cell-dependent antigens and a lack of germinal center formation in the spleen. Relatively little is known about a potential function of OBF1 in developing B cells. Here we have generated transgenic mice overexpressing OBF1 in B cells under the control of the immunoglobulin heavy chain promoter and enhancer. Surprisingly, these mice have greatly reduced numbers of follicular B cells in the periphery and have a compromised immune response. Furthermore, B cell differentiation is impaired at an early stage in the bone marrow: a first block is observed during B cell commitment and a second differentiation block is seen at the large preB2 cell stage. The cells that succeed to escape the block and to differentiate into mature B cells have post-translationally downregulated the expression of transgene, indicating that expression of OBF1 beyond the normal level early in B cell development is deleterious. Transcriptome analysis identified genes deregulated in these mice and Id2 and Id3, two known negative regulators of B cell differentiation, were found to be upregulated in the EPLM and preB cells of the transgenic mice. Furthermore, the Id2 and Id3 promoters contain octamer-like sites, to which OBF1 can bind. These results provide evidence that tight regulation of OBF1 expression in early B cells is essential to allow efficient B lymphocyte differentiation.	[Bordon, Alain; Du Roure, Camille; Bartholdy, Boris; Kohler, Hubertus; Matthias, Gabriele; Matthias, Patrick] Novartis Res Fdn, Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Bosco, Nabil; Rolink, Antonius G.] Univ Basel, Dept Biomed, Div Dev Mol Immunol, CH-4003 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; Novartis; University of Basel	Bordon, A (corresponding author), Novartis Res Fdn, Friedrich Miescher Inst Biomed Res, Basel, Switzerland.	patrick.matthias@fmi.ch	Bosco, Nabil/AAD-1579-2022		Novartis Research Foundation	Novartis Research Foundation	This work was supported by the Novartis Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balciunaite G, 2005, EUR J IMMUNOL, V35, P2019, DOI 10.1002/eji.200526318; BANERJI J, 1983, CELL, V33, P729, DOI 10.1016/0092-8674(83)90015-6; Bartholdy B, 2006, P NATL ACAD SCI USA, V103, P11665, DOI 10.1073/pnas.0509430103; Boehm J, 2001, EMBO J, V20, P4153, DOI 10.1093/emboj/20.15.4153; Brunner C, 2003, J BIOL CHEM, V278, P45231, DOI 10.1074/jbc.M302539200; Casellas R, 2002, CELL, V110, P575, DOI 10.1016/S0092-8674(02)00911-X; Ceredig R, 2006, BLOOD, V108, P1216, DOI 10.1182/blood-2005-10-006643; Corcoran LM, 2005, J EXP MED, V201, P1385, DOI 10.1084/jem.20042325; Cotta CV, 2003, BLOOD, V101, P4342, DOI 10.1182/blood-2002-10-3139; Deed RW, 1998, J BIOL CHEM, V273, P8278, DOI 10.1074/jbc.273.14.8278; DREYFUS M, 1987, EMBO J, V6, P1685, DOI 10.1002/j.1460-2075.1987.tb02418.x; Fuxa M, 2007, CURR OPIN IMMUNOL, V19, P129, DOI 10.1016/j.coi.2007.02.002; Greiner A, 2000, AM J PATHOL, V156, P501, DOI 10.1016/S0002-9440(10)64754-2; GROSSCHEDL R, 1985, CELL, V41, P885, DOI 10.1016/S0092-8674(85)80069-6; Harfst E, 2005, IMMUNOL LETT, V101, P173, DOI 10.1016/j.imlet.2005.05.013; Hess J, 2001, MOL CELL BIOL, V21, P1531, DOI 10.1128/MCB.21.5.1531-1539.2001; Jankovic M, 2003, INT IMMUNOL, V15, P1099, DOI 10.1093/intimm/dxg109; JENUWEIN T, 1991, GENE DEV, V5, P932, DOI 10.1101/gad.5.6.932; Ji M, 2008, BLOOD, V112, P1068, DOI 10.1182/blood-2008-01-133504; Karnowski A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003568; Kee BL, 2001, NAT IMMUNOL, V2, P242, DOI 10.1038/85303; Kim U, 1996, NATURE, V383, P542, DOI 10.1038/383542a0; LUO Y, 1992, CELL, V71, P231, DOI 10.1016/0092-8674(92)90352-D; MASON JO, 1985, CELL, V41, P479, DOI 10.1016/S0092-8674(85)80021-0; Massa S, 2003, EUR J IMMUNOL, V33, P2864, DOI 10.1002/eji.200323882; Matthias P, 2005, NAT REV IMMUNOL, V5, P497, DOI 10.1038/nri1633; Monroe JG, 2007, ADV IMMUNOL, V95, P1, DOI 10.1016/S0065-2776(07)95001-4; Moriuchi M, 2001, J BIOL CHEM, V276, P8639, DOI 10.1074/jbc.M008391200; Nielsen PJ, 1996, EUR J IMMUNOL, V26, P3214, DOI 10.1002/eji.1830261255; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; Qin XF, 1998, EMBO J, V17, P5066, DOI 10.1093/emboj/17.17.5066; Rolink AG, 2004, IMMUNOL REV, V197, P41, DOI 10.1111/j.0105-2896.2004.0101.x; SAMA G, 2002, ATLAS CERAMBYCIDAE E, V1, P1; Sauter P, 1997, IMMUNOBIOLOGY, V198, P207, DOI 10.1016/S0171-2985(97)80041-1; Schubart DB, 1996, NUCLEIC ACIDS RES, V24, P1913, DOI 10.1093/nar/24.10.1913; Schubart DB, 1996, NATURE, V383, P538, DOI 10.1038/383538a0; Schubart DB, 2000, J IMMUNOL, V164, P18, DOI 10.4049/jimmunol.164.1.18; Schubart K, 2001, NAT IMMUNOL, V2, P69, DOI 10.1038/83190; Siegel R, 2006, CELL, V125, P761, DOI 10.1016/j.cell.2006.03.036; Stevens S, 2000, J IMMUNOL, V164, P6372, DOI 10.4049/jimmunol.164.12.6372; STRUBIN M, 1995, CELL, V80, P497, DOI 10.1016/0092-8674(95)90500-6; Su GH, 1997, EMBO J, V16, P7118, DOI 10.1093/emboj/16.23.7118; Sun J, 2003, J IMMUNOL, V170, P1699, DOI 10.4049/jimmunol.170.4.1699; SUN XH, 1994, CELL, V79, P893, DOI 10.1016/0092-8674(94)90078-7; Tiedt R, 2001, EMBO J, V20, P4143, DOI 10.1093/emboj/20.15.4143; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Yu X, 2001, IMMUNITY, V14, P157, DOI 10.1016/S1074-7613(09)00090-9; Zandi S, 2008, J IMMUNOL, V181, P3364, DOI 10.4049/jimmunol.181.5.3364; Zandvoort A, 2002, CLIN EXP IMMUNOL, V130, P4, DOI 10.1046/j.1365-2249.2002.01953.x; Zhang M, 2004, CELL MOL IMMUNOL, V1, P89; Zhang Z, 2003, EMBO J, V22, P4759, DOI 10.1093/emboj/cdg464; Zwilling S, 1997, SCIENCE, V277, P221, DOI 10.1126/science.277.5323.221	52	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2008	3	12							e4007	10.1371/journal.pone.0004007	http://dx.doi.org/10.1371/journal.pone.0004007			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CB	19104664	Green Published, Green Submitted, gold			2022-12-25	WOS:000265462400008
J	Mullen, LM; Bosse, JT; Nair, SP; Ward, JM; Rycroft, AN; Robertson, G; Langford, PR; Henderson, B				Mullen, Lisa M.; Bosse, Janine T.; Nair, Sean P.; Ward, John M.; Rycroft, Andrew N.; Robertson, Giles; Langford, Paul R.; Henderson, Brian			Pasteurellaceae ComE1 Proteins Combine the Properties of Fibronectin Adhesins and DNA Binding Competence Proteins	PLOS ONE			English	Article								A novel fibronectin-binding protein from Pasteurella multocida (PM1665) that binds to the fibronectin type III(9-10) modules via two helix-hairpin-helix motifs has recently been described [1]. This protein shares homology with competence-related DNA-binding and uptake proteins (ComEA and ComE) from Gram-positive and Gram-negative bacteria. Here, we show that recombinant PM1665 (now designated ComE1) also binds to DNA through the same helix-hairpin-helix motifs required for fibronectin-binding. This binding to DNA is non sequence-specific and is confined to double-stranded DNA. We have cloned and expressed ComE1 proteins from five members of the Pasteurellaceae in order to further investigate the function(s) of these proteins. When expressed as recombinant GST-fusion proteins, all of the homologues bound both to fibronectin and to double-stranded DNA. Inactivation of the gene encoding the ComE1 homologue in Actinobacillus pleuropneumoniae indicates major roles for these proteins in at least two processes: natural transformation, and binding of bacteria to fibronectin.	[Nair, Sean P.; Henderson, Brian] UCL, Eastman Dent Inst, Div Microbial Dis, London, England; [Ward, John M.] UCL, Dept Biochem & Mol Biol, London, England; [Rycroft, Andrew N.] Roy Vet Coll, Dept Pathol & Infect Dis, Hertford, England; [Robertson, Giles] Univ London, Birkbeck Coll, Sch Crystallography, London WC1E 7HU, England; [Bosse, Janine T.; Langford, Paul R.] Imperial Coll London, Dept Paediat, Mol Infect Dis Grp, London, England	University of London; University College London; University of London; University College London; University of London; University of London Royal Veterinary College; University of London; Birkbeck University London; Imperial College London	Mullen, LM (corresponding author), UCL, Eastman Dent Inst, Div Microbial Dis, London, England.	l.mullen@eastman.ucl.ac.uk	Langford, Paul/AAU-4189-2020; Langford, Paul R/B-9092-2008	Langford, Paul/0000-0002-6368-4724; Langford, Paul R/0000-0002-6368-4724; Bosse, Janine/0000-0002-8491-4779; Ward, John/0000-0002-4415-5544; Mullen, Lisa/0000-0001-8278-2226	BBSRC [BBS/B03238, BBS/B/08132]; MRC [G0401038] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/B/08132, BB/C508193/1] Funding Source: researchfish; Medical Research Council [G0401038] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We acknowledge the financial support of the BBSRC (grant BBS/B03238) to BH, JMW, SPN and ANR for LM and BBSRC (BBS/B/08132) to PL and AR for JB.	Bosse JT, 2004, FEMS MICROBIOL LETT, V233, P277, DOI 10.1111/j.1574-6968.2004.tb09492.x; Chen I, 2001, J BACTERIOL, V183, P3160, DOI 10.1128/JB.183.10.3160-3168.2001; Doherty AJ, 1996, NUCLEIC ACIDS RES, V24, P2488, DOI 10.1093/nar/24.13.2488; DONACHIE W, 1995, HAEMOPHILUS ACTINOBA, V245; DUBNAU D, 1991, MICROBIOL REV, V55, P395, DOI 10.1128/MMBR.55.3.395-424.1991; Dubnau D, 1999, ANNU REV MICROBIOL, V53, P217, DOI 10.1146/annurev.micro.53.1.217; Finkel SE, 2001, J BACTERIOL, V183, P6288, DOI 10.1128/JB.183.21.6288-6293.2001; HYNES R, 1985, ANNU REV CELL BIOL, V1, P67, DOI 10.1146/annurev.cb.01.110185.000435; INAMINE GS, 1995, J BACTERIOL, V177, P3045, DOI 10.1128/jb.177.11.3045-3051.1995; Joh D, 1999, MATRIX BIOL, V18, P211, DOI 10.1016/S0945-053X(99)00025-6; LADBURY JE, 1995, P NATL ACAD SCI USA, V92, P3199, DOI 10.1073/pnas.92.8.3199; Lee PC, 2002, APPL MICROBIOL BIOT, V58, P663, DOI 10.1007/s00253-002-0935-6; Mullen LM, 2008, INFECT IMMUN, V76, P1093, DOI 10.1128/IAI.01349-07; Mullen LM, 2007, VET MICROBIOL, V122, P123, DOI 10.1016/j.vetmic.2006.12.022; Palchevskiy V, 2006, J BACTERIOL, V188, P3902, DOI 10.1128/JB.01974-05; Provvedi R, 1999, MOL MICROBIOL, V31, P271, DOI 10.1046/j.1365-2958.1999.01170.x; REDFIELD RJ, 1988, GENETICS, V119, P213; Redfield RJ, 1997, GENETICS, V146, P27; Redfield RJ, 2005, J MOL BIOL, V347, P735, DOI 10.1016/j.jmb.2005.01.012; Redfield RJ, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-82; Sheehan BJ, 2000, INFECT IMMUN, V68, P4778, DOI 10.1128/IAI.68.8.4778-4781.2000; SMITH HO, 1981, ANNU REV BIOCHEM, V50, P41, DOI 10.1146/annurev.bi.50.070181.000353; THAYER MM, 1995, EMBO J, V14, P4108, DOI 10.1002/j.1460-2075.1995.tb00083.x; van Vliet AHM, 1999, J BACTERIOL, V181, P6371, DOI 10.1128/JB.181.20.6371-6376.1999; Wang Y, 2002, J BACTERIOL, V184, P3442, DOI 10.1128/JB.184.13.3442-3449.2002; Webb SAR, 2001, METH MOLEC MED, V67, P663, DOI 10.1385/1-59259-149-3:663	26	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2008	3	12							e3991	10.1371/journal.pone.0003991	http://dx.doi.org/10.1371/journal.pone.0003991			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CA	19098981	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000265462300004
J	Rodriguez-Vita, J; Sanchez-Galan, E; Santamaria, B; Sanchez-Lopez, E; Rodrigues-Diez, R; Blanco-Colio, LM; Egido, J; Ortiz, A; Ruiz-Ortega, M				Rodriguez-Vita, Juan; Sanchez-Galan, Eva; Santamaria, Beatriz; Sanchez-Lopez, Elsa; Rodrigues-Diez, Raquel; Miguel Blanco-Colio, Luis; Egido, Jesus; Ortiz, Alberto; Ruiz-Ortega, Marta			Essential Role of TGF-beta/Smad Pathway on Statin Dependent Vascular Smooth Muscle Cell Regulation	PLOS ONE			English	Article								Background: The 3-hydroxy-3-methylglutaryl CoA reductase inhibitors (also called statins) exert proven beneficial effects on cardiovascular diseases. Recent data suggest a protective role for Transforming Growth Factor-beta (TGF-beta) in atherosclerosis by regulating the balance between inflammation and extracellular matrix accumulation. However, there are no studies about the effect of statins on TGF-beta/Smad pathway in atherosclerosis and vascular cells. Methodology: In cultured vascular smooth muscle cells (VSMCs) statins enhanced Smad pathway activation caused by TGF-beta. In addition, statins upregulated TGF-beta receptor type II (TRII), and increased TGF-beta synthesis and TGF-beta/Smad-dependent actions. In this sense, statins, through Smad activation, render VSMCs more susceptible to TGF-beta induced apoptosis and increased TGF-beta-mediated ECM production. It is well documented that high doses of statins induce apoptosis in cultured VSMC in the presence of serum; however the precise mechanism of this effect remains to be elucidated. We have found that statins-induced apoptosis was mediated by TGF-beta/Smad pathway. Finally, we have described that RhoA inhibition is a common intracellular mechanisms involved in statins effects. The in vivo relevance of these findings was assessed in an experimental model of atherosclerosis in apolipoprotein E deficient mice: Treatment with Atorvastatin increased Smad3 phosphorylation and TRII overexpression, associated to elevated ECM deposition in the VSMCs within atheroma plaques, while apoptosis was not detected. Conclusions: Statins enhance TGF-beta/Smad pathway, regulating ligand levels, receptor, main signaling pathway and cellular responses of VSMC, including apoptosis and ECM accumulation. Our findings show that TGF-beta/Smad pathway is essential for statins-dependent actions in VSMCs.	[Rodriguez-Vita, Juan; Sanchez-Lopez, Elsa; Rodrigues-Diez, Raquel; Ruiz-Ortega, Marta] Univ Autonoma Madrid, Cellular Biol Renal Dis Lab, Fdn Jimenez Diaz, E-28049 Madrid, Spain; [Sanchez-Galan, Eva; Miguel Blanco-Colio, Luis; Egido, Jesus] Univ Autonoma Madrid, Vasc Res Lab, Fdn Jimenez Diaz, Madrid, Spain; [Santamaria, Beatriz; Ortiz, Alberto] Univ Autonoma Madrid, Fdn Jimenez Diaz, Dialysis Unit, Madrid, Spain	Autonomous University of Madrid; Autonomous University of Madrid; Autonomous University of Madrid	Rodriguez-Vita, J (corresponding author), Univ Autonoma Madrid, Cellular Biol Renal Dis Lab, Fdn Jimenez Diaz, E-28049 Madrid, Spain.	mruizo@fjd.es	Ruiz-Ortega, Marta/D-3584-2012; Ortega, Marta Ruiz/AAN-2136-2020; Santamaria, Beatriz/B-3469-2015; Díez, Raquel Rodrigues/ABE-9703-2020; Blanco-Colio, Luis M./Z-2390-2019; ortiz, alberto/Y-7582-2018; Sanchez-Lopez, Elsa/A-7131-2017; Rodriguez-Vita, Juan/U-6337-2019; Rodriguez-Vita, Juan/K-2407-2014; ruiz-ortega, marta/D-3584-2012	Ruiz-Ortega, Marta/0000-0002-1495-6535; Ortega, Marta Ruiz/0000-0002-1495-6535; Santamaria, Beatriz/0000-0002-1990-2106; Díez, Raquel Rodrigues/0000-0002-6348-1505; ortiz, alberto/0000-0002-9805-9523; Sanchez-Lopez, Elsa/0000-0002-4236-1985; Rodriguez-Vita, Juan/0000-0001-9547-5508; Rodriguez-Vita, Juan/0000-0001-9547-5508; ruiz-ortega, marta/0000-0002-1403-2690; Blanco-Colio, Luis Miguel/0000-0002-1560-6609	Ministerio de Educacion y Ciencia [SAF 2005-03378]; Sociedad espanola de Cardiologia; Red tematica de Investigacion Renal, REDINREN [ISCIII-RETIC RD06/0016/0004, 06/0046]; Instituto de Salud Carlos III from Ministerio de Sanidad y Consumo [RD06/0014/0035, RD06/0014/0008]; EU project DIALOK [LSHB-CT-2007-036644]; Ministerio de Ciencia y Tecnologia [SAF2007/63648]	Ministerio de Educacion y Ciencia(Spanish Government); Sociedad espanola de Cardiologia(Instituto de Salud Carlos III); Red tematica de Investigacion Renal, REDINREN; Instituto de Salud Carlos III from Ministerio de Sanidad y Consumo(Instituto de Salud Carlos III); EU project DIALOK; Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work has been supported by grants from (SAF 2005-03378) the Ministerio de Educacion y Ciencia, Novartis grant form Sociedad espanola de Cardiologia, Red tematica de Investigacion Renal, REDINREN (ISCIII-RETIC RD06/0016/0004 and 06/0046) from the Instituto de Salud Carlos III from Ministerio de Sanidad y Consumo and the EU project DIALOK: LSHB-CT-2007-036644, Ministerio de Ciencia y Tecnologia (SAF2007/63648), Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, Redes RECAVA (RD06/0014/0035; RD06/0014/0008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boucher P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000448; CAJOT JF, 1990, P NATL ACAD SCI USA, V87, P6939, DOI 10.1073/pnas.87.18.6939; CARVAJAL G, 2008, KIDNEY INT; Chen CL, 2008, J CELL PHYSIOL, V215, P223, DOI 10.1002/jcp.21303; Chen CL, 2007, J CELL SCI, V120, P3509, DOI 10.1242/jcs.006916; Cicha I, 2005, ARTERIOSCL THROM VAS, V25, P1008, DOI 10.1161/01.ATV.0000162173.27682.7b; Cipollone F, 2004, STROKE, V35, P2253, DOI 10.1161/01.STR.0000140739.45472.9c; Clarke M, 2006, CELL CYCLE, V5, P2329, DOI 10.4161/cc.5.20.3383; Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459; Datta PK, 2000, J BIOL CHEM, V275, P40014, DOI 10.1074/jbc.C000508200; Dzau VJ, 2002, NAT MED, V8, P1249, DOI 10.1038/nm1102-1249; Ehrenstein MR, 2005, NEW ENGL J MED, V352, P73, DOI 10.1056/NEJMe048326; Erl Wolfgang, 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P135, DOI 10.2174/1568006043586134; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Grainger DJ, 2007, CARDIOVASC RES, V74, P213, DOI 10.1016/j.cardiores.2007.02.022; Guijarro C, 1998, CIRC RES, V83, P490, DOI 10.1161/01.RES.83.5.490; Guijarro C, 1999, KIDNEY INT, V56, pS88, DOI 10.1038/sj.ki.4495409; Leask A, 2003, J BIOL CHEM, V278, P13008, DOI 10.1074/jbc.M210366200; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Leblanc V, 1999, ONCOGENE, V18, P4884, DOI 10.1038/sj.onc.1202855; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Lutgens E, 2002, ARTERIOSCL THROM VAS, V22, P975, DOI 10.1161/01.ATV.0000019729.39500.2F; Mallat Z, 2001, CIRC RES, V89, P930, DOI 10.1161/hh2201.099415; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; McCaffrey TA, 1995, J CLIN INVEST, V96, P2667, DOI 10.1172/JCI118333; McCaffrey TA, 1999, J MOL CELL CARDIOL, V31, P1627, DOI 10.1006/jmcc.1999.0999; Morgan MA, 2001, BLOOD, V97, P1823, DOI 10.1182/blood.V97.6.1823; Nissen SE, 2006, JAMA-J AM MED ASSOC, V295, P1556, DOI 10.1001/jama.295.13.jpc60002; Nissen SE, 2004, JAMA-J AM MED ASSOC, V291, P1071, DOI 10.1001/jama.291.9.1071; Park HJ, 1999, P NATL ACAD SCI USA, V96, P11525, DOI 10.1073/pnas.96.20.11525; Porreca E, 2002, J AM COLL CARDIOL, V39, P1752, DOI 10.1016/S0735-1097(02)01857-0; Robertson AKL, 2003, J CLIN INVEST, V112, P1342, DOI 10.1172/JCI200318607; Rodriguez-Vita J, 2005, CIRCULATION, V111, P2509, DOI 10.1161/01.CIR.0000165133.84978.E2; Ruiz-Ortega M, 2000, CIRC RES, V86, P1266, DOI 10.1161/01.RES.86.12.1266; Ruiz-Ortega M, 2007, CARDIOVASC RES, V74, P196, DOI 10.1016/j.cardiores.2007.02.008; Ruperez M, 2007, HYPERTENSION, V50, P377, DOI 10.1161/HYPERTENSIONAHA.107.091264; Ryan ST, 2003, J VASC RES, V40, P37, DOI 10.1159/000068937; SEKINE A, 1989, J BIOL CHEM, V264, P8602; Smith JD, 1999, CIRC RES, V84, P1212, DOI 10.1161/01.RES.84.10.1212; Wang WS, 2006, CIRC RES, V98, P1032, DOI 10.1161/01.RES.0000218782.52610.dc; Yagi S, 2008, CIRC RES, V102, P68, DOI 10.1161/CIRCRESAHA.107.163493; Yano M, 2007, CIRC RES, V100, P1442, DOI 10.1161/01.RES.0000268411.49545.9c	42	48	53	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2008	3	12							e3959	10.1371/journal.pone.0003959	http://dx.doi.org/10.1371/journal.pone.0003959			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AS	19088845	gold, Green Published, Green Submitted			2022-12-25	WOS:000265458500006
J	Tan, LH; Schedl, P; Song, HJ; Garza, D; Konsolaki, M				Tan, Lihua; Schedl, Paul; Song, Ho-Juhn; Garza, Dan; Konsolaki, Mary			The Toll -> NF kappa B Signaling Pathway Mediates the Neuropathological Effects of the Human Alzheimer's A beta 42 Polypeptide in Drosophila	PLOS ONE			English	Article							NF-KAPPA-B; AMYLOID PRECURSOR PROTEIN; DORSAL-VENTRAL POLARITY; A-BETA; ANTIINFLAMMATORY AGENTS; MISSENSE MUTATIONS; IMMUNE-RESPONSE; SENILE-DEMENTIA; IMD PATHWAYS; MOUSE MODEL	Alzheimer's (AD) is a progressive neurodegenerative disease that afflicts a significant fraction of older individuals. Although a proteolytic product of the Amyloid precursor protein, the A beta 42 polypeptide, has been directly implicated in the disease, the genes and biological pathways that are deployed during the process of A beta 42 induced neurodegeneration are not well understood and remain controversial. To identify genes and pathways that mediated A beta 42 induced neurodegeneration we took advantage of a Drosophila model for AD disease in which ectopically expressed human A beta 42 polypeptide induces cell death and tissue degeneration in the compound eye. One of the genes identified in our genetic screen is Toll (Tl). It encodes the receptor for the highly conserved Tl -> NF kappa B innate immunity/inflammatory pathway and is a fly homolog of the mammalian Interleukin-1 (Ilk-1) receptor. We found that Tl loss-of-function mutations dominantly suppress the neuropathological effects of the A beta 42 polypeptide while gain-of-function mutations that increase receptor activity dominantly enhance them. Furthermore, we present evidence demonstrating that Tl and key downstream components of the innate immunity/inflammatory pathway play a central role in mediating the neuropathological activities of A beta 42. We show that the deleterious effects of A beta 42 can be suppressed by genetic manipulations of the Tl -> NF kappa B pathway that downregulate signal transduction. Conversely, manipulations that upregulate signal transduction exacerbate the deleterious effects of A beta 42. Since postmortem studies have shown that the Ilk-1 -> NF kappa B innate immunity pathway is substantially upregulated in the brains of AD patients, the demonstration that the Tl -> NF kappa B signaling actively promotes the process of A beta 42 induced cell death and tissue degeneration in flies points to possible therapeutic targets and strategies.	[Schedl, Paul] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Song, Ho-Juhn; Garza, Dan] Novartis Inst Biomed Res, Cambridge, MA USA; [Konsolaki, Mary] Rutgers, State Univ New Jersey, Dept Genet, Piscataway, NJ USA	Princeton University; Novartis; Rutgers State University New Brunswick	Tan, LH (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	pschedl@princeton.edu			Novartis	Novartis(Novartis)	Funds were provided by Novartis for a part time post-doctoral stipend for Lihua Tan. There was no other research support. Novartis had no role in the experimental design, in the analysis of the data, or in the preparation of the manuscript.	ANDERSON KV, 1985, CELL, V42, P779, DOI 10.1016/0092-8674(85)90274-0; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; Brennan CA, 2004, ANNU REV IMMUNOL, V22, P457, DOI 10.1146/annurev.immunol.22.012703.104626; BROUWERS N, 2008, ANN MED, V18, P1; Cao W, 2008, GENETICS, V178, P1457, DOI 10.1534/genetics.107.078394; Carter J., 2001, Current Molecular Medicine (Hilversum), V1, P733, DOI 10.2174/1566524013363177; Catalano SM, 2006, CURR TOP MED CHEM, V6, P597, DOI 10.2174/156802606776743066; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; Cruts M, 1998, ANN MED, V30, P560, DOI 10.3109/07853899809002605; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; DeLotto R, 2007, DEVELOPMENT, V134, P4233, DOI 10.1242/dev.010934; DREVETS WC, 1989, BIOL PSYCHIAT, V25, P39, DOI 10.1016/0006-3223(89)90145-5; Dudal S, 2004, NEUROBIOL AGING, V25, P861, DOI 10.1016/j.neurobiolaging.2003.08.008; FABERLANGENDOEN K, 1988, ANN NEUROL, V23, P365, DOI 10.1002/ana.410230409; Finelli A, 2004, MOL CELL NEUROSCI, V26, P365, DOI 10.1016/j.mcn.2004.03.001; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; Gahtan E, 1999, NEUROSCI BIOBEHAV R, V23, P615, DOI 10.1016/S0149-7634(98)00058-X; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Golde TE, 2002, NAT MED, V8, P936, DOI 10.1038/nm0902-936; Greeve I, 2004, J NEUROSCI, V24, P3899, DOI 10.1523/JNEUROSCI.0283-04.2004; Han ZS, 1999, J BIOL CHEM, V274, P21355, DOI 10.1074/jbc.274.30.21355; HASHIMOTO C, 1988, CELL, V52, P269, DOI 10.1016/0092-8674(88)90516-8; He P, 2007, J CELL BIOL, V178, P829, DOI 10.1083/jcb.200705042; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Imahori K, 1998, NEUROBIOL AGING, V19, pS93, DOI 10.1016/S0197-4580(98)00025-6; Imler J L, 2000, Rev Immunogenet, V2, P294; Ingelsson M, 2004, NEUROLOGY, V62, P925, DOI 10.1212/01.WNL.0000115115.98960.37; Jin JJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-23; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KOSIK KS, 1989, ANN MED, V21, P109, DOI 10.3109/07853898909149195; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; LEHMING N, 1994, NATURE, V371, P175, DOI 10.1038/371175a0; Leulier F, 2008, NAT REV GENET, V9, P165, DOI 10.1038/nrg2303; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Liang Y, 2004, CELL MOL IMMUNOL, V1, P343; Lim GP, 2000, J NEUROSCI, V20, P5709, DOI 10.1523/JNEUROSCI.20-15-05709.2000; McGeer PL, 2006, J ALZHEIMERS DIS, V9, P271; McGeer PL, 2006, NEUROBIOL AGING, V27, P1533, DOI 10.1016/j.neurobiolaging.2005.10.001; McGeer PL, 1996, NEUROLOGY, V47, P425, DOI 10.1212/WNL.47.2.425; MCGEER PL, 1990, LANCET, V335, P1037, DOI 10.1016/0140-6736(90)91101-F; Meng XJ, 1999, GENE DEV, V13, P792, DOI 10.1101/gad.13.7.792; Miotto B, 2006, GENE DEV, V20, P101, DOI 10.1101/gad.359506; Morisato D, 1995, ANNU REV GENET, V29, P371, DOI 10.1146/annurev.genet.29.1.371; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3; SCHNEIDER DS, 1991, GENE DEV, V5, P797, DOI 10.1101/gad.5.5.797; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Shulman JM, 2003, GENETICS, V165, P1233; SORBI S, 1995, LANCET, V346, P439, DOI 10.1016/S0140-6736(95)92809-X; Sorrentino G, 2007, NEUROL SCI, V28, P63, DOI 10.1007/s10072-007-0789-x; St George-Hyslop PH, 2000, ANN NY ACAD SCI, V924, P1; Stein D, 1998, DEVELOPMENT, V125, P2159; Steller H, 2008, CELL DEATH DIFFER, V15, P1132, DOI 10.1038/cdd.2008.50; STEWARD R, 1989, CELL, V59, P1179, DOI 10.1016/0092-8674(89)90773-3; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Tanji T, 2005, TRENDS IMMUNOL, V26, P193, DOI 10.1016/j.it.2005.02.006; Tuppo EE, 2005, INT J BIOCHEM CELL B, V37, P289, DOI 10.1016/j.biocel.2004.07.009; Walter S, 2007, CELL PHYSIOL BIOCHEM, V20, P947, DOI 10.1159/000110455; Watson DJ, 1999, BIOCHEM J, V340, P703, DOI 10.1042/0264-6021:3400703; WILCOCK GK, 1982, J NEUROL SCI, V56, P343, DOI 10.1016/0022-510X(82)90155-1; WISNIEWSKI T, 1991, BIOCHEM BIOPH RES CO, V179, P1247, DOI 10.1016/0006-291X(91)91706-I; Wu LP, 1998, NATURE, V392, P93, DOI 10.1038/32195; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Yoshida H, 2004, J NEUROCHEM, V90, P352, DOI 10.1111/j.1471-4159.2004.02479.x; YOSHIOKA K, 1991, BIOCHEM BIOPH RES CO, V178, P1141, DOI 10.1016/0006-291X(91)91011-Z	71	85	89	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2008	3	12							e3966	10.1371/journal.pone.0003966	http://dx.doi.org/10.1371/journal.pone.0003966			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AS	19088848	gold, Green Published, Green Submitted			2022-12-25	WOS:000265458500011
J	Cahu, J; Olichon, A; Hentrich, C; Schek, H; Drinjakovic, J; Zhang, CJ; Doherty-Kirby, A; Lajoie, G; Surrey, T				Cahu, Julie; Olichon, Aurelien; Hentrich, Christian; Schek, Henry; Drinjakovic, Jovana; Zhang, Cunjie; Doherty-Kirby, Amanda; Lajoie, Gilles; Surrey, Thomas			Phosphorylation by Cdk1 Increases the Binding of Eg5 to Microtubules In Vitro and in Xenopus Egg Extract Spindles	PLOS ONE			English	Article								Background: Motor proteins from the kinesin-5 subfamily play an essential role in spindle assembly during cell division of most organisms. These motors crosslink and slide microtubules in the spindle. Kinesin-5 motors are phosphorylated at a conserved site by Cyclin-dependent kinase 1 (Cdk1) during mitosis. Xenopus laevis kinesin-5 has also been reported to be phosphorylated by Aurora A in vitro. Methodology/Principal Findings: We investigate here the effect of these phosphorylations on kinesin-5 from Xenopus laevis, called Eg5. We find that phosphorylation at threonine 937 in the C-terminal tail of Eg5 by Cdk1 does not affect the velocity of Eg5, but strongly increases its binding to microtubules assembled in buffer. Likewise, this phosphorylation promotes binding of Eg5 to microtubules in Xenopus egg extract spindles. This enhancement of binding elevates the amount of Eg5 in spindles above a critical level required for bipolar spindle formation. We find furthermore that phosphorylation of Xenopus laevis Eg5 by Aurora A at serine 543 in the stalk is not required for spindle formation. Conclusions/Significance: These results show that phosphorylation of Eg5 by Cdk1 has a direct effect on the interaction of this motor with microtubules. In egg extract, phosphorylation of Eg5 by Cdk1 ensures that the amount of Eg5 in the spindle is above a level that is required for spindle formation. This enhanced targeting to the spindle appears therefore to be, at least in part, a direct consequence of the enhanced binding of Eg5 to microtubules upon phosphorylation by Cdk1. These findings advance our understanding of the regulation of this essential mitotic motor protein.	[Cahu, Julie; Olichon, Aurelien; Hentrich, Christian; Schek, Henry; Drinjakovic, Jovana; Doherty-Kirby, Amanda; Surrey, Thomas] European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Germany; [Zhang, Cunjie; Lajoie, Gilles] Univ Western Ontario, Schulich Sch Med, Don Rix Protein Identificat Facil, London, ON N6A 3K7, Canada	European Molecular Biology Laboratory (EMBL); Western University (University of Western Ontario)	Cahu, J (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Germany.	surrey@embl.de	Olichon, Aurelien/M-3115-2014; Olichon, Aurelien/Q-5425-2019; Holt, Janet E/B-2415-2013; Surrey, Thomas/AAC-4608-2021	Olichon, Aurelien/0000-0002-0821-3612; Hentrich, Christian/0000-0001-6697-5001; Surrey, Thomas/0000-0001-9082-1870	DFG; EU STREP Active Biomics; EU MCRTN Spindle Dynamics; EMBO; Ontario Research Development Challenge Fund (ORDCF)	DFG(German Research Foundation (DFG)); EU STREP Active Biomics; EU MCRTN Spindle Dynamics; EMBO(European Molecular Biology Organization (EMBO)); Ontario Research Development Challenge Fund (ORDCF)	T.S. acknowledges financial support from the DFG and the EU STREP Active Biomics, T.S. and A.O. from the DFG, and T.S. and C.H. from the EU MCRTN Spindle Dynamics, H.S. from EMBO, and G.L. from the Ontario Research Development Challenge Fund (ORDCF).	Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Blangy A, 1997, J BIOL CHEM, V272, P19418, DOI 10.1074/jbc.272.31.19418; Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Drummond DR, 1998, J CELL SCI, V111, P853; Ems-McClung SC, 2004, MOL BIOL CELL, V15, P46, DOI 10.1091/mbc.E03-07-0454; Funabiki H, 2000, CELL, V102, P411, DOI 10.1016/S0092-8674(00)00047-7; Giet R, 1999, J BIOL CHEM, V274, P15005, DOI 10.1074/jbc.274.21.15005; Goodman B, 2006, BIOCHEM SOC T, V34, P716, DOI 10.1042/BST0340716; Goshima G, 2005, CURR BIOL, V15, P1979, DOI 10.1016/j.cub.2005.09.054; Goshima G, 2005, MOL BIOL CELL, V16, P3896, DOI 10.1091/mbc.E05-02-0118; Gruss OJ, 2004, J CELL BIOL, V166, P949, DOI 10.1083/jcb.200312112; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; HAGAN I, 1992, NATURE, V356, P74, DOI 10.1038/356074a0; Hannak E, 2006, NAT PROTOC, V1, P2305, DOI 10.1038/nprot.2006.396; HECK MMS, 1993, J CELL BIOL, V123, P665, DOI 10.1083/jcb.123.3.665; Hildebrandt ER, 2000, BBA-MOL CELL RES, V1496, P99, DOI 10.1016/S0167-4889(00)00012-4; HOYT MA, 1992, J CELL BIOL, V118, P109, DOI 10.1083/jcb.118.1.109; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kapoor TM, 2001, J CELL BIOL, V154, P1125, DOI 10.1083/jcb.200106011; Kashina AS, 1996, NATURE, V379, P270, DOI 10.1038/379270a0; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Kwok BH, 2006, NAT CHEM BIOL, V2, P480, DOI 10.1038/nchembio812; Kwok BH, 2004, CURR BIOL, V14, P1783, DOI 10.1016/j.cub.2004.09.052; Malumbres M, 2007, CURR OPIN GENET DEV, V17, P60, DOI 10.1016/j.gde.2006.12.008; Mishima M, 2004, NATURE, V430, P908, DOI 10.1038/nature02767; Miyamoto DT, 2004, J CELL BIOL, V167, P813, DOI 10.1083/jcb.200407126; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Ohsugi M, 2003, EMBO J, V22, P2091, DOI 10.1093/emboj/cdg208; Roghi C, 1998, J CELL SCI, V111, P557; SAWIN KE, 1991, J CELL BIOL, V112, P925, DOI 10.1083/jcb.112.5.925; SAWIN KE, 1995, P NATL ACAD SCI USA, V92, P4289, DOI 10.1073/pnas.92.10.4289; SAWIN KE, 1992, NATURE, V359, P540, DOI 10.1038/359540a0; Seitz A, 2006, EMBO J, V25, P267, DOI 10.1038/sj.emboj.7600937; Sharp DJ, 2000, NATURE, V407, P41, DOI 10.1038/35024000; Sharp DJ, 1999, J CELL BIOL, V144, P125, DOI 10.1083/jcb.144.1.125; Trieselmann N, 2003, J CELL SCI, V116, P4791, DOI 10.1242/jcs.00798; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; UTENG M, 2008, J CELL BIOL; Varga V, 2006, NAT CELL BIOL, V8, P957, DOI 10.1038/ncb1462; Wilde A, 2001, NAT CELL BIOL, V3, P221, DOI 10.1038/35060000; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; Zhu CJ, 2006, P NATL ACAD SCI USA, V103, P6196, DOI 10.1073/pnas.0506926103	46	68	72	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2008	3	12							e3936	10.1371/journal.pone.0003936	http://dx.doi.org/10.1371/journal.pone.0003936			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AP	19079595	Green Submitted, gold, Green Published			2022-12-25	WOS:000265458200003
J	Coll, M; Libralato, S; Tudela, S; Palomera, I; Pranovi, F				Coll, Marta; Libralato, Simone; Tudela, Sergi; Palomera, Isabel; Pranovi, Fabio			Ecosystem Overfishing in the Ocean	PLOS ONE			English	Article							MARINE ECOSYSTEMS; FISHERIES MANAGEMENT; GLOBAL FISHERIES; WORLD FISHERIES; POPULATIONS; ATLANTIC; COLLAPSE; IMPACT; RECOVERY; INDEX	Fisheries catches represent a net export of mass and energy that can no longer be used by trophic levels higher than those fished. Thus, exploitation implies a depletion of secondary production of higher trophic levels (here the production of mass and energy by herbivores and carnivores in the ecosystem) due to the removal of prey. The depletion of secondary production due to the export of biomass and energy through catches was recently formulated as a proxy for evaluating the ecosystem impacts of fishing-i. e., the level of ecosystem overfishing. Here we evaluate the historical and current risk of ecosystem overfishing at a global scale by quantifying the depletion of secondary production using the best available fisheries and ecological data (i.e., catch and primary production). Our results highlight an increasing trend in the number of unsustainable fisheries (i.e., an increase in the risk of ecosystem overfishing) from the 1950s to the 2000s, and illustrate the worldwide geographic expansion of overfishing. These results enable to assess when and where fishing became unsustainable at the ecosystem level. At present, total catch per capita from Large Marine Ecosystems is at least twice the value estimated to ensure fishing at moderate sustainable levels.	[Palomera, Isabel] CSIC, ICM, Barcelona, Spain; [Coll, Marta] Dalhousie Univ, Dept Biol, Halifax, NS B3H 3J5, Canada; [Libralato, Simone] Ist Nazl Oceanograf Geofisica Speriment OGS, Sgonico Zgonik, Italy; [Tudela, Sergi] WWF, Mediterranean Programme Office, Barcelona, Spain; [Pranovi, Fabio] Univ Ca Foscari, Dipartimento Sci Ambientali, Venice, Italy	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Dalhousie University; Istituto Nazionale di Oceanografia e di Geofisica Sperimentale; World Wildlife Fund; Universita Ca Foscari Venezia	Coll, M (corresponding author), CSIC, ICM, Barcelona, Spain.	martacoll@dal.ca	Libralato, Simone/N-5668-2015; Palomera, Isabel/L-4769-2014; Libralato, Simone/AAR-2198-2020; Coll, Marta/A-9488-2012	Libralato, Simone/0000-0001-8112-1274; Palomera, Isabel/0000-0001-5708-168X; Libralato, Simone/0000-0001-8112-1274; Coll, Marta/0000-0001-6235-5868	Spanish Ministry of Education and Science [Predoctoral fellowship, postdoctoral fellowship]; Dalhousie University (Halifax, Canada)	Spanish Ministry of Education and Science(Spanish Government); Dalhousie University (Halifax, Canada)	MC was supported financially with a Predoctoral and a postdoctoral fellowship from the Spanish Ministry of Education and Science and additional support by Dalhousie University (Halifax, Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Bouvet M, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC001126; BRAY K, 2000, IUU20006 FAO; Christensen V, 2000, MAR FRESHWATER RES, V51, P447, DOI 10.1071/MF99085; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; Coleman FC, 2004, SCIENCE, V305, P1958, DOI 10.1126/science.1100397; DENNIS B, 1994, ECOL MONOGR, V64, P205, DOI 10.2307/2937041; Evans D., 2000, IUU200012 FAO; FAO, 2005, 457 FAO FISH; Fischer M, 2002, TRENDS ECOL EVOL, V17, P61, DOI 10.1016/S0169-5347(01)02419-3; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hilborn R, 2003, ANNU REV ENV RESOUR, V28, P359, DOI 10.1146/annurev.energy.28.050302.105509; Hoepffner N, 1999, INT J REMOTE SENS, V20, P1435, DOI 10.1080/014311699212812; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jennings S, 1998, ADV MAR BIOL, V34, P201, DOI 10.1016/S0065-2881(08)60212-6; KELLEHER K, 2005, 470 FAO FISH; Libralato S, 2008, MAR ECOL PROG SER, V355, P107, DOI 10.3354/meps07224; Link JS, 2002, CAN J FISH AQUAT SCI, V59, P1429, DOI 10.1139/F02-115; LONGHURST A, 1995, J PLANKTON RES, V17, P1245, DOI 10.1093/plankt/17.6.1245; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; MacArthur R.H., 1972, pvii; Murawski SA, 2000, ICES J MAR SCI, V57, P649, DOI 10.1006/jmsc.2000.0738; Myers RA, 1997, ECOL APPL, V7, P91, DOI 10.1890/1051-0761(1997)007[0091:WDFSCT]2.0.CO;2; Myers RA, 2005, PHILOS T R SOC B, V360, P13, DOI 10.1098/rstb.2004.1573; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pauly D, 2003, SCIENCE, V302, P1359, DOI 10.1126/science.1088667; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pitcher TJ, 2002, FISH FISH, V3, P317, DOI 10.1046/j.1467-2979.2002.00093.x; PLATT T, 1988, SCIENCE, V241, P1613, DOI 10.1126/science.241.4873.1613; Saltelli A., 2000, SENSITIVITY ANAL; Sherman K, 1999, MAR ECOL PROG SER, V190, P271, DOI 10.3354/meps190271; Tudela S, 2005, ICES J MAR SCI, V62, P585, DOI 10.1016/j.icesjms.2005.01.008; WALSH JJ, 1981, NATURE, V290, P300, DOI 10.1038/290300a0; Watson R, 2004, FISH FISH, V5, P168, DOI 10.1111/j.1467-2979.2004.00142.x; Watson R, 2001, NATURE, V414, P534, DOI 10.1038/35107050; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; [No title captured]; [No title captured]	39	156	161	17	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2008	3	12							e3881	10.1371/journal.pone.0003881	http://dx.doi.org/10.1371/journal.pone.0003881			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZS	19066624	gold, Green Published			2022-12-25	WOS:000265455700003
J	Inoue, T; Okino, N; Kakuta, Y; Hijikata, A; Okano, H; Goda, HM; Tani, M; Sueyoshi, N; Kambayashi, K; Matsumura, H; Kai, Y; Ito, M				Inoue, Tsuyoshi; Okino, Nozomu; Kakuta, Yoshimitsu; Hijikata, Atsushi; Okano, Hiroyuki; Goda, Hatsumi M.; Tani, Motohiro; Sueyoshi, Noriyuki; Kambayashi, Kouji; Matsumura, Hiroyoshi; Kai, Yasushi; Ito, Makoto			Mechanistic Insights into the Hydrolysis and Synthesis of Ceramide by Neutral Ceramidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; SPHINGOSINE 1-PHOSPHATE; ALKALINE CERAMIDASE; PURIFICATION; MEMBRANE; GENE; LOCALIZATION; METABOLISM; EXPRESSION; APOPTOSIS	Ceramidase (CDase; EC 3.5.1.23) hydrolyzes ceramide to generate sphingosine and fatty acid. The enzyme plays a regulatory role in a variety of physiological events in eukaryotes and also functions as an exotoxin in particular bacteria. The crystal structures of neutral CDase from Pseudomonas aeruginosa (PaCD) in the C2-ceramide-bound and -unbound forms were determined at 2.2 and 1.4 angstrom resolutions, respectively. PaCD consists of two domains, and the Zn2+- and Mg2+/Ca2+-binding sites are found within the center of the N-terminal domain and the interface between the domains, respectively. The structural comparison between the C2-ceramide-bound and unbound forms revealed an open-closed conformational change occurring to loop I upon binding of C2-ceramide. In the closed state, this loop sits above the Zn2+ coordination site and over the opening to the substrate binding site. Mutational analyses of residues surrounding the Zn2+ of PaCD and rat neutral CDase revealed that the cleavage or creation of the N-acyl linkage of ceramide follows a similar mechanism as observed for the Zn2+-dependent carboxypeptidases. The results provide an understanding of the molecular mechanism of hydrolysis and synthesis of ceramide	[Inoue, Tsuyoshi; Okano, Hiroyuki; Kambayashi, Kouji; Matsumura, Hiroyoshi; Kai, Yasushi] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan; [Okino, Nozomu; Kakuta, Yoshimitsu; Goda, Hatsumi M.; Tani, Motohiro; Sueyoshi, Noriyuki; Ito, Makoto] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Dept Biosci & Biotechnol, Higashi Ku, Fukuoka 8128581, Japan; [Hijikata, Atsushi] RIKEN, Res Ctr Allergy & Immunol, Lab Immunogen, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Okino, Nozomu; Ito, Makoto] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo 1020075, Japan	Osaka University; Kyushu University; RIKEN; Japan Science & Technology Agency (JST)	Inoue, T (corresponding author), Osaka Univ, Grad Sch Engn, Dept Appl Chem, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	inouet@chem.eng.osaka-u.ac.jp; makotoi@agr.kyushu-u.ac.jp	Ito, Makoto/Q-6164-2019; Okino, Nozomu/AAY-2635-2021	Matsumura, Hiroyoshi/0000-0003-0361-3796; Hijikata, Atsushi/0000-0003-4297-8368; ito, Makoto/0000-0003-3159-7818; Tani, Motohiro/0000-0003-4316-8260				Acharya JK, 2008, NEURON, V57, P69, DOI 10.1016/j.neuron.2007.10.041; Acharya U, 2004, P NATL ACAD SCI USA, V101, P1922, DOI 10.1073/pnas.0308693100; Acharya U, 2003, SCIENCE, V299, P1740, DOI 10.1126/science.1080549; Ancellin N, 2002, J BIOL CHEM, V277, P6667, DOI 10.1074/jbc.M102841200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; El Bawab S, 2000, J BIOL CHEM, V275, P21508, DOI 10.1074/jbc.M002522200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Galadari S, 2006, BIOCHEM J, V393, P687, DOI 10.1042/BJ20050682; GATT S, 1963, J BIOL CHEM, V238, P3131; Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007; Hamburger ZA, 1999, SCIENCE, V286, P291, DOI 10.1126/science.286.5438.291; HANNUN YA, 1987, SCIENCE, V235, P670, DOI 10.1126/science.3101176; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hwang YH, 2005, BIOCHEM BIOPH RES CO, V331, P37, DOI 10.1016/j.bbrc.2005.03.134; ITO M, 2002, MOL B INT U, V21, P41; KABSCH W, 1983, FEBS LETT, V155, P179, DOI 10.1016/0014-5793(82)80597-8; Kita K, 2000, BBA-MOL CELL BIOL L, V1485, P111, DOI 10.1016/S1388-1981(00)00029-9; Kono M, 2006, J BIOL CHEM, V281, P7324, DOI 10.1074/jbc.M508382200; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; MERRILL AH, 1986, J BIOL CHEM, V261, P3764; Mitsutake S, 2001, J BIOL CHEM, V276, P26249, DOI 10.1074/jbc.M102233200; Monjusho H, 2003, BIOCHEM J, V376, P473, DOI 10.1042/BJ20030652; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NILSSON A, 1969, BIOCHIM BIOPHYS ACTA, V176, P339, DOI 10.1016/0005-2760(69)90192-1; Ohlsson L, 2007, BIOCHIMIE, V89, P950, DOI 10.1016/j.biochi.2007.03.009; Okino N, 2003, J BIOL CHEM, V278, P29948, DOI 10.1074/jbc.M303310200; Okino N, 1998, J BIOL CHEM, V273, P14368, DOI 10.1074/jbc.273.23.14368; Okino N, 1999, J BIOL CHEM, V274, P36616, DOI 10.1074/jbc.274.51.36616; Okino N, 2007, J BIOL CHEM, V282, P6021, DOI 10.1074/jbc.M603088200; Olsson M, 2004, AM J PHYSIOL-GASTR L, V287, pG929, DOI 10.1152/ajpgi.00155.2004; Otwinowski Z., 1993, P CCP4 STUD WEEK DAT, P56; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pettus BJ, 2002, BBA-MOL CELL BIOL L, V1585, P114, DOI 10.1016/S1388-1981(02)00331-1; Rohrbough J, 2004, J NEUROSCI, V24, P7789, DOI 10.1523/JNEUROSCI.1146-04.2004; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shtraizent N, 2008, J BIOL CHEM, V283, P11253, DOI 10.1074/jbc.M709166200; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Tani M, 2005, J BIOL CHEM, V280, P36592, DOI 10.1074/jbc.M506827200; Tani M, 2004, J BIOL CHEM, V279, P29351, DOI 10.1074/jbc.M404012200; Tani M, 2000, J BIOL CHEM, V275, P11229, DOI 10.1074/jbc.275.15.11229; Tani M, 2003, J BIOL CHEM, V278, P10523, DOI 10.1074/jbc.M207932200; Tani M, 2000, J BIOL CHEM, V275, P3462, DOI 10.1074/jbc.275.5.3462; Tani M, 2007, CELL SIGNAL, V19, P229, DOI 10.1016/j.cellsig.2006.07.001; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Wu BX, 2007, J LIPID RES, V48, P600, DOI 10.1194/jlr.M600423-JLR200; Yoshimura Y, 2004, J BIOL CHEM, V279, P44012, DOI 10.1074/jbc.M405598200; Yoshimura Y, 2002, J BIOCHEM, V132, P229, DOI 10.1093/oxfordjournals.jbchem.a003215	56	20	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9566	9577		10.1074/jbc.M808232200	http://dx.doi.org/10.1074/jbc.M808232200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19088069	Green Published, hybrid			2022-12-25	WOS:000264669100063
J	Kim, SH; Shi, YL; Hanson, KA; Williams, LM; Sakasai, R; Bowler, MJ; Tibbetts, RS				Kim, Sang Hwa; Shi, Yuling; Hanson, Keith A.; Williams, Leah M.; Sakasai, Ryo; Bowler, Michael J.; Tibbetts, Randal S.			Potentiation of Amyotrophic Lateral Sclerosis (ALS)-associated TDP-43 Aggregation by the Proteasome-targeting Factor, Ubiquilin 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; SUPEROXIDE-DISMUTASE GENE; NUCLEAR FACTOR TDP-43; HUNTINGTONS-DISEASE; AXONAL-TRANSPORT; MOTOR-NEURONS; BINDING-PROPERTIES; RNA INTERFERENCE; PROTEIN; AUTOPHAGY	TDP-43 (43-kDa TAR DNA-binding domain protein) is a major constituent of ubiquitin-positive cytoplasmic aggregates present in neurons of patients with fronto-temporal lobular dementia and amyotrophic lateral sclerosis (ALS). The pathologic significance of TDP-43 aggregation is not known; however, dominant mutations in TDP-43 cause a subset of ALS cases, suggesting that misfolding and/or altered trafficking of TDP-43 is relevant to the disease process. Here, we show that the presenilin-binding protein ubiquilin 1 (UBQLN) plays a role in TDP-43 aggregation. TDP-43 interacted with UBQLN both in yeast and in vitro, and the carboxyl-terminal ubiquitin-associated domain of UBQLN was both necessary and sufficient for binding to polyubiquitylated forms of TDP-43. Overexpression of UBQLN recruited TDP-43 to detergent-resistant cytoplasmic aggregates that colocalized with the autophagosomal marker, LC3. UBQLN-dependent aggregation required the UBQLN UBA domain, was mediated by non-overlapping regions of TDP-43, and was abrogated by a mutation in UBQLN previously linked to Alzheimer disease. Four ALS-associated alleles of TDP-43 also coaggregated with UBQLN, and the extent of aggregation correlated with in vitro UBQLN binding affinity. Our findings suggest that UBQLN is a polyubiquitin-TDP-43 cochaperone that mediates the autophagosomal delivery and/or proteasome targeting of TDP-43 aggregates.	[Kim, Sang Hwa; Shi, Yuling; Hanson, Keith A.; Williams, Leah M.; Sakasai, Ryo; Bowler, Michael J.; Tibbetts, Randal S.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pharmacol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Tibbetts, RS (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Pharmacol, Madison, WI 53706 USA.	rstibbetts@wisc.edu		Tibbetts, Randal/0000-0003-2245-2297; Sakasai, Ryo/0000-0002-4495-5437	National Institutes of Health [CA124722]; American Cancer Society and a Shaw Scientist Award; Greater Milwaukee Foundation; NATIONAL CANCER INSTITUTE [R01CA124722] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society and a Shaw Scientist Award(American Cancer Society); Greater Milwaukee Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA124722. This work was also supported by the American Cancer Society and a Shaw Scientist Award (to R. S. T.) from the Greater Milwaukee Foundation.	Andersen PM, 2003, AMYOTROPH LATERAL SC, V4, P62, DOI 10.1080/14660820310011700; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Ayala YM, 2008, P NATL ACAD SCI USA, V105, P3785, DOI 10.1073/pnas.0800546105; Bedford FK, 2001, NAT NEUROSCI, V4, P908, DOI 10.1038/nn0901-908; Bertram L, 2005, NEW ENGL J MED, V352, P884, DOI 10.1056/NEJMoa042765; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Borchelt DR, 1998, NEUROBIOL DIS, V5, P27, DOI 10.1006/nbdi.1998.0178; Buratti E, 2004, AM J HUM GENET, V74, P1322, DOI 10.1086/420978; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Cairns NJ, 2007, AM J PATHOL, V171, P227, DOI 10.2353/ajpath.2007.070182; Cassina P, 2008, J NEUROSCI, V28, P4115, DOI 10.1523/JNEUROSCI.5308-07.2008; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Conklin D, 2000, GENE, V249, P91, DOI 10.1016/S0378-1119(00)00122-0; DAOUD H, 2009, J MED GENET IN PRESS; Davidson JD, 2000, HUM MOL GENET, V9, P2305, DOI 10.1093/oxfordjournals.hmg.a018922; DROSE S, 1993, BIOCHEMISTRY-US, V32, P3902, DOI 10.1021/bi00066a008; Feng PH, 2004, MOL CELL BIOL, V24, P3938, DOI 10.1128/MCB.24.9.3938-3948.2004; Ford DL, 2007, BIOCHEMISTRY-US, V46, P8827, DOI 10.1021/bi700604q; Ford DL, 2006, BIOCHEM J, V399, P397, DOI 10.1042/BJ20060441; Forman MS, 2007, CURR OPIN NEUROBIOL, V17, P548, DOI 10.1016/j.conb.2007.08.005; Funakoshi M, 2002, P NATL ACAD SCI USA, V99, P745, DOI 10.1073/pnas.012585199; Ganguly A, 2008, HUM MOL GENET, V17, P293, DOI 10.1093/hmg/ddm305; Gross GG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002495; Heir R, 2006, EMBO REP, V7, P1252, DOI 10.1038/sj.embor.7400823; Hosler BA, 2000, JAMA-J AM MED ASSOC, V284, P1664, DOI 10.1001/jama.284.13.1664; Ikeda K, 2004, NEUROPATHOLOGY, V24, P117, DOI 10.1111/j.1440-1789.2003.00537.x; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; KATAOKA T, 1994, J IMMUNOL, V153, P3938; Kim TY, 2008, BIOCHEM BIOPH RES CO, V369, P741, DOI 10.1016/j.bbrc.2008.02.086; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Ko HS, 2004, FEBS LETT, V566, P110, DOI 10.1016/j.febslet.2004.04.031; Kuehnlein P, 2008, ARCH NEUROL-CHICAGO, V65, P1185, DOI 10.1001/archneur.65.9.1185; Mah AL, 2000, J CELL BIOL, V151, P847, DOI 10.1083/jcb.151.4.847; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Massey LK, 2005, BIOCHEM J, V391, P513, DOI 10.1042/BJ20050491; Massey LK, 2004, J ALZHEIMERS DIS, V6, P79; Mitsumoto H., 1998, AMYOTROPHIC LATERAL; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Ralph GS, 2005, NAT MED, V11, P429, DOI 10.1038/nm1205; Rao H, 2002, J BIOL CHEM, V277, P11691, DOI 10.1074/jbc.M200245200; Raoul C, 2005, NAT MED, V11, P423, DOI 10.1038/nm1207; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Regan-Klapisz E, 2005, J CELL SCI, V118, P4437, DOI 10.1242/jcs.02571; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rubinsztein DC, 2007, NEURON, V54, P854, DOI 10.1016/j.neuron.2007.06.005; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; Sakasai R, 2008, J BIOL CHEM, V283, P13549, DOI 10.1074/jbc.M710197200; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Sasaki S, 2005, ACTA NEUROPATHOL, V110, P48, DOI 10.1007/s00401-005-1021-9; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Slifer MA, 2005, NEW ENGL J MED, V352, P2752; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Tanida I, 2008, AUTOPHAGY, V4, P131, DOI 10.4161/auto.5233; Towne C, 2008, MOL THER, V16, P1018, DOI 10.1038/mt.2008.73; Velde CV, 2004, NEUROMOL MED, V5, P193, DOI 10.1385/NMM:5:3:193; Walters KJ, 2002, BIOCHEMISTRY-US, V41, P1767, DOI 10.1021/bi011892y; Wang H, 2006, HUM MOL GENET, V15, P1025, DOI 10.1093/hmg/ddl017; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553; Winslow AR, 2008, BBA-MOL BASIS DIS, V1782, P723, DOI 10.1016/j.bbadis.2008.06.010; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065	67	95	99	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					8083	8092		10.1074/jbc.M808064200	http://dx.doi.org/10.1074/jbc.M808064200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19112176	Green Published, hybrid			2022-12-25	WOS:000264195600071
J	Henriques, BJ; Rodrigues, JV; Olsen, RK; Bross, P; Gomes, CM				Henriques, Barbara J.; Rodrigues, Joao V.; Olsen, Rikke K.; Bross, Peter; Gomes, Claudio M.			Role of Flavinylation in a Mild Variant of Multiple Acyl-CoA Dehydrogenation Deficiency A MOLECULAR RATIONALE FOR THE EFFECTS OF RIBOFLAVIN SUPPLEMENTATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-TRANSFER FLAVOPROTEIN; COENZYME-A DEHYDROGENASE; FATTY-ACID OXIDATION; TRANSFERRING-FLAVOPROTEIN; BETA-OXIDATION; GLUTARIC ACIDURIA; RESPIRATORY-CHAIN; FAD; MUTATIONS; MITOCHONDRIA	Mutations in the genes encoding the alpha-subunit and beta-subunit of the mitochondrial electron transfer flavoprotein (ETF) and the electron transfer flavoprotein: ubiquinone oxidoreductase ( ETF: QO) cause multiple acyl-CoA dehydrogenation deficiency ( MADD), a disorder of fatty acid and amino acid metabolism. Point mutations in ETF, which may compromise folding, and/or activity, are associated with both mild and severe forms of MADD. Here we report the investigation on the conformational and stability properties of the disease-causing variant ETF beta-D128N, and our findings on the effect of flavinylation in modulating protein conformational stability and activity. A combination of biochemical and biophysical methods including circular dichroism, visible absorption, flavin, and tryptophan fluorescence emission allowed the analysis of structural changes and of the FAD moiety. The ETF beta-D128N variant retains the overall fold of the wild type, but under stress conditions its flavin becomes less tightly bound. Flavinylation is shown to improve the conformational stability and biological activity of a destabilized D128N variant protein. Moreover, the presence of flavin prevented proteolytic digestion by avoiding protein destabilization. A patient homozygous for the ETF beta-D128N mutation developed severe disease symptoms in association with a viral infection and fever. In agreement, our results suggest that heat inactivation of the mutant may be more relevant at temperatures above 37 degrees C. To mimic a situation of fever in vitro, the flavinylation status was tested at 39 degrees C. FAD exerts the effect of a pharmacological chaperone, improving ETF conformation, and yielding a more stable and active enzyme. Our results provide a structural and functional framework that could help to elucidate the role that an increased cellular FAD content obtained from riboflavin supplementation may play in the molecular pathogenesis of not only MADD, but genetic disorders of flavoproteins in general.	[Henriques, Barbara J.; Rodrigues, Joao V.; Gomes, Claudio M.] UNL, ITQB, P-2780756 Oeiras, Portugal; [Olsen, Rikke K.; Bross, Peter] Aarhus Univ Hosp, Res Unit Mol Med, DK-8200 Skejby, Arhus N, Denmark	Universidade Nova de Lisboa; Aarhus University	Gomes, CM (corresponding author), UNL, ITQB, Av Republ 127, P-2780756 Oeiras, Portugal.	gomes@itqb.unl.pt	Rodrigues, Joao V/B-4877-2016; Rodrigues, João/GVU-7735-2022; Gomes, Cláudio M./A-8152-2008; Bross, Peter/B-7219-2013; Henriques, Bárbara J/A-1814-2016; Rodrigues, João/B-4235-2008	Rodrigues, Joao V/0000-0002-5605-656X; Gomes, Cláudio M./0000-0003-4662-6933; Bross, Peter/0000-0001-9526-8525; Henriques, Bárbara J/0000-0002-1724-9545; Rodrigues, João/0000-0002-5605-656X; Olsen, Rikke/0000-0003-3470-5589				AMENDT BA, 1986, J CLIN INVEST, V78, P205, DOI 10.1172/JCI112553; Ames BN, 2002, AM J CLIN NUTR, V75, P616, DOI 10.1093/ajcn/75.4.616; ANTOZZI C, 1994, NEUROLOGY, V44, P2153, DOI 10.1212/WNL.44.11.2153; Beresford MW, 2006, NEUROMUSCULAR DISORD, V16, P269, DOI 10.1016/j.nmd.2006.01.001; BRANDT NJ, 1979, J PEDIATR-US, V94, P669, DOI 10.1016/S0022-3476(79)80048-7; BROSS P, 1995, J BIOL CHEM, V270, P10284, DOI 10.1074/jbc.270.17.10284; DURAN M, 1992, PEDIATR RES, V31, P39, DOI 10.1203/00006450-199201000-00007; Ensenauer R, 2005, J BIOL CHEM, V280, P32309, DOI 10.1074/jbc.M504460200; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Frerman F. E., 2001, METABOLIC MOL BASES, P2357, DOI DOI 10.1036/OMMBID.131; Gempel K, 2007, BRAIN, V130, P2037, DOI 10.1093/brain/awm054; Gianazza E, 2006, ELECTROPHORESIS, V27, P1182, DOI 10.1002/elps.200500687; Goodman SI, 2002, MOL GENET METAB, V77, P86, DOI 10.1016/S1096-7192(02)00138-5; GREGERSEN N, 1982, PEDIATR RES, V16, P861, DOI 10.1203/00006450-198210000-00012; Gregersen N, 2004, EUR J BIOCHEM, V271, P470, DOI 10.1046/j.1432-1033.2003.03949.x; GREGERSEN N, 1985, J INHERIT METAB DIS, V8, P65, DOI 10.1007/BF01800662; Hansen J, 2005, BIOCHEM BIOPH RES CO, V333, P1160, DOI 10.1016/j.bbrc.2005.06.024; HERRICK KR, 1994, J BIOL CHEM, V269, P32239; KMOCH S, 1995, J INHERIT METAB DIS, V18, P227, DOI 10.1007/BF00711774; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lakshmi AV, 1998, INDIAN J MED RES, V108, P182; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pD266, DOI 10.1093/nar/gki001; Lundemose JB, 1997, J CLIN PATHOL-MOL PA, V50, P212, DOI 10.1136/mp.50.4.212; Manore MM, 2000, AM J CLIN NUTR, V72, p598S, DOI 10.1093/ajcn/72.2.598S; MCKEAN MC, 1983, J BIOL CHEM, V258, P1866; NAGAO M, 1992, J BIOL CHEM, V267, P17925; Olsen RKJ, 2007, BRAIN, V130, P2045, DOI 10.1093/brain/awm135; Olsen RKJ, 2003, HUM MUTAT, V22, P12, DOI 10.1002/humu.10226; Pallotta ML, 1998, FEBS LETT, V428, P245, DOI 10.1016/S0014-5793(98)00544-4; Powers HJ, 2003, AM J CLIN NUTR, V77, P1352; RHEAD W, 1993, PEDIATR RES, V33, P129, DOI 10.1203/00006450-199302000-00008; Roberts DL, 1996, P NATL ACAD SCI USA, V93, P14355, DOI 10.1073/pnas.93.25.14355; Royer C A, 1995, Methods Mol Biol, V40, P65; RUZICKA FJ, 1977, J BIOL CHEM, V252, P8440; SAIJO T, 1995, J BIOL CHEM, V270, P1899, DOI 10.1074/jbc.270.4.1899; Salazar D, 1997, J BIOL CHEM, V272, P26425, DOI 10.1074/jbc.272.42.26425; Sato K, 2003, J BIOCHEM, V134, P719, DOI 10.1093/jb/mvg199; Sato K, 1996, J BIOCHEM-TOKYO, V120, P276; Sato K, 1997, J BIOCHEM, V121, P477; Schiff M, 2006, MOL GENET METAB, V88, P153, DOI 10.1016/j.ymgme.2006.01.009; Shirley B A, 1995, Methods Mol Biol, V40, P177; Vergani L, 1999, BRAIN, V122, P2401, DOI 10.1093/brain/122.12.2401; WINDMUELLER HG, 1964, AM J CLIN NUTR, V15, P73, DOI 10.1093/ajcn/15.2.73; Yotsumoto Y, 2008, MOL GENET METAB, V94, P61, DOI 10.1016/j.ymgme.2008.01.002	44	62	69	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4222	4229		10.1074/jbc.M805719200	http://dx.doi.org/10.1074/jbc.M805719200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19088074	hybrid			2022-12-25	WOS:000263134400019
J	Paugh, BS; Bryan, L; Paugh, SW; Wilczynska, KM; Alvarez, SM; Singh, SK; Kapitonov, D; Rokita, H; Wright, S; Griswold-Prenner, I; Milstien, S; Spiegel, S; Kordula, T				Paugh, Barbara S.; Bryan, Lauren; Paugh, Steven W.; Wilczynska, Katarzyna M.; Alvarez, Silvina M.; Singh, Sandeep K.; Kapitonov, Dmitri; Rokita, Hanna; Wright, Sarah; Griswold-Prenner, Irene; Milstien, Sheldon; Spiegel, Sarah; Kordula, Tomasz			Interleukin-1 Regulates the Expression of Sphingosine Kinase 1 in Glioblastoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ASTROCYTE-SPECIFIC EXPRESSION; GENE-EXPRESSION; GROWTH-FACTOR; ALPHA(1)-ANTICHYMOTRYPSIN GENE; TUMOR INVASIVENESS; ACTIVATION; INHIBITOR; INVASION; LINE	Chronic inflammation and inflammatory cytokines have recently been implicated in the development and progression of various types of cancer. In the brain, neuroinflammatory cytokines affect the growth and differentiation of both normal and malignant glial cells, with interleukin 1 (IL-1) shown to be secreted by the majority of glioblastoma cells. Recently, elevated levels of sphingosine kinase 1 (SphK1), but not SphK2, were correlated with a shorter survival prognosis for patients with glioblastoma multiforme. SphK1 is a lipid kinase that produces the pro-growth, anti-apoptotic sphingosine 1-phosphate, which can induce invasion of glioblastoma cells. Here, we show that the expression of IL-1 correlates with the expression of SphK1 in glioblastoma cells, and neutralizing anti-IL-1 antibodies inhibit both the growth and invasion of glioblastoma cells. Furthermore, IL-1 up-regulates SphK1 mRNA levels, protein expression, and activity in both primary human astrocytes and various glioblastoma cell lines; however, it does not affect SphK2 expression. The IL-1-induced SphK1 up-regulation can be blocked by the inhibition of JNK, the overexpression of the dominant-negative c-Jun(TAM67), and the down-regulation of c-Jun expression by small interference RNA. Activation of SphK1 expression by IL-1 occurs on the level of transcription and is mediated via a novel AP-1 element located within the first intron of the sphk1 gene. In summary, our results suggest that SphK1 expression is transcriptionally regulated by IL-1 in glioblastoma cells, and this pathway may be important in regulating survival and invasiveness of glioblastoma cells.	[Paugh, Barbara S.; Bryan, Lauren; Paugh, Steven W.; Wilczynska, Katarzyna M.; Alvarez, Silvina M.; Singh, Sandeep K.; Kapitonov, Dmitri; Spiegel, Sarah; Kordula, Tomasz] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Paugh, Barbara S.; Bryan, Lauren; Paugh, Steven W.; Wilczynska, Katarzyna M.; Alvarez, Silvina M.; Singh, Sandeep K.; Kapitonov, Dmitri; Spiegel, Sarah; Kordula, Tomasz] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA; [Milstien, Sheldon] NIMH, Bethesda, MD 20892 USA; [Rokita, Hanna] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland; [Wright, Sarah; Griswold-Prenner, Irene] Elan Pharmaceut, San Francisco, CA 94080 USA	Virginia Commonwealth University; Virginia Commonwealth University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Jagiellonian University	Kordula, T (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Med Coll Virginia Campus, Richmond, VA 23298 USA.	tkordula@vcu.edu	Alvarez, Silvina Monica/GOE-5780-2022; Paugh, Barbara/B-3625-2009; Paugh, Steven/A-7739-2008	Paugh, Steven/0000-0001-5697-9228; Rokita, Hanna/0000-0003-2675-2393; Kapitonov, Dmitri/0000-0001-9177-5239; Wright, Sarah/0000-0002-3156-3792; Alvarez, Silvina/0000-0001-7522-7208	National Institutes of Health (NIH) [R21NS063283]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS063283, F31NS060433] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant R21NS063283 (to T. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Apte RN, 2006, EUR J CANCER, V42, P751, DOI 10.1016/j.ejca.2006.01.010; Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Basu A, 2004, J NEUROSCI RES, V78, P151, DOI 10.1002/jnr.20266; Bektas M, 2005, ONCOGENE, V24, P178, DOI 10.1038/sj.onc.1208019; Belda-Iniesta Cristobal, 2006, Clin Transl Oncol, V8, P635, DOI 10.1007/s12094-006-0033-9; Billich A, 2005, CELL SIGNAL, V17, P1203, DOI 10.1016/j.cellsig.2004.12.005; CINQUE S, 1992, IMMUNOL LETT, V34, P267, DOI 10.1016/0165-2478(92)90223-B; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Deb P, 2005, NEUROL INDIA, V53, P329; DELEGEANE AM, 1987, MOL CELL BIOL, V7, P3994, DOI 10.1128/MCB.7.11.3994; Doll F, 2005, BBA-MOL CELL BIOL L, V1738, P72, DOI 10.1016/j.bbalip.2005.12.001; Eberhardt W, 2000, J IMMUNOL, V165, P5788, DOI 10.4049/jimmunol.165.10.5788; Edsall LC, 1999, ANAL BIOCHEM, V272, P80, DOI 10.1006/abio.1999.4157; Francy JM, 2007, BBA-GENE STRUCT EXPR, V1769, P253, DOI 10.1016/j.bbaexp.2007.03.005; French KJ, 2003, CANCER RES, V63, P5962; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; GIULIAN D, 1988, J NEUROSCI, V8, P709; GIULIAN D, 1985, SCIENCE, V228, P497, DOI 10.1126/science.3872478; Gondi CS, 2004, NEURON GLIA BIOL, V1, P165, DOI 10.1017/S1740925X04000237; Gopalan S, 2005, J NEUROCHEM, V94, P763, DOI 10.1111/j.1471-4159.2005.03204.x; Gopalan SM, 2006, J BIOL CHEM, V281, P13126, DOI 10.1074/jbc.M601194200; Gopalan SM, 2006, J BIOL CHEM, V281, P1956, DOI 10.1074/jbc.M510935200; Hait NC, 2005, J BIOL CHEM, V280, P29462, DOI 10.1074/jbc.M502922200; Hill C, 2003, ADV ANAT PATHOL, V10, P212, DOI 10.1097/00125480-200307000-00004; Huwiler A, 2006, BBA-MOL CELL BIOL L, V1761, P367, DOI 10.1016/j.bbalip.2006.02.007; Imamura T, 2004, J VET MED SCI, V66, P1387, DOI 10.1292/jvms.66.1387; Imamura T, 2001, GENOMICS, V76, P117, DOI 10.1006/geno.2001.6607; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kiss DL, 2005, J NEUROCHEM, V92, P730, DOI 10.1111/j.1471-4159.2004.02900.x; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Kordula T, 2000, J NEUROSCI, V20, P7510; Laerum OD, 2001, J NEURO-ONCOL, V54, P1; Lakka SS, 2005, J BIOL CHEM, V280, P21882, DOI 10.1074/jbc.M408520200; Lu T, 2007, P NATL ACAD SCI USA, V104, P4365, DOI 10.1073/pnas.0700118104; Muracciole X, 2002, INT J RADIAT ONCOL, V52, P592, DOI 10.1016/S0360-3016(01)02699-2; Murakami M, 2007, J NEUROCHEM, V102, P1585, DOI 10.1111/j.1471-4159.2007.04673.x; Nakade Y, 2003, BBA-MOL CELL BIOL L, V1635, P104, DOI 10.1016/j.bbalip.2003.11.001; Paugh SW, 2008, BLOOD, V112, P1382, DOI 10.1182/blood-2008-02-138958; Paugh SW, 2003, FEBS LETT, V554, P189, DOI 10.1016/S0014-5793(03)01168-2; Saklatvala J, 1999, BIOCHEM SOC SYMP, P63; Sanchez T, 2004, J CELL BIOCHEM, V92, P913, DOI 10.1002/jcb.20127; SAWADOGO M, 1988, J BIOL CHEM, V263, P11985; Schichor C, 2005, J NEURO-ONCOL, V73, P9, DOI 10.1007/s11060-004-3341-3; SEED B, 1988, GENE, V67, P271, DOI 10.1016/0378-1119(88)90403-9; Sobue S, 2005, J NEUROCHEM, V95, P940, DOI 10.1111/j.1471-4159.2005.03399.x; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Sukocheva OA, 2003, MOL ENDOCRINOL, V17, P2002, DOI 10.1210/me.2003-0119; TADA M, 1993, J NEURO-ONCOL, V17, P261, DOI 10.1007/BF01049981; Van Brocklyn JR, 2005, J NEUROPATH EXP NEUR, V64, P695, DOI 10.1097/01.jnen.0000175329.59092.2c; Van Brocklyn JR, 2003, CANCER LETT, V199, P53, DOI 10.1016/S0304-3835(03)00334-3; Van Brocklyn JR, 2002, CANCER LETT, V181, P195, DOI 10.1016/S0304-3835(02)00050-2; Venkataraman K, 2006, BIOCHEM J, V397, P461, DOI 10.1042/BJ20060251; Visentin B, 2006, CANCER CELL, V9, P225, DOI 10.1016/j.ccr.2006.02.023; Wilczynska KM, 2006, J BIOL CHEM, V281, P34955, DOI 10.1074/jbc.M604616200; Yao JH, 2007, J BIOL CHEM, V282, P6075, DOI 10.1074/jbc.M609039200	56	75	80	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3408	3417		10.1074/jbc.M807170200	http://dx.doi.org/10.1074/jbc.M807170200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19074142	Green Published, hybrid			2022-12-25	WOS:000262872500006
J	Taylor, RP; Geisler, TS; Chambers, JH; McClain, DA				Taylor, Rodrick P.; Geisler, Taylor S.; Chambers, Jefferson H.; McClain, Donald A.			Up-regulation of O-GlcNAc Transferase with Glucose Deprivation in HepG2 Cells Is Mediated by Decreased Hexosamine Pathway Flux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED N-ACETYLGLUCOSAMINE; RNA-POLYMERASE-II; TETRATRICOPEPTIDE REPEATS; INSULIN-RESISTANCE; SKELETAL-MUSCLE; PROTEINS; GLYCOSYLATION; GLCNACYLATION; NUCLEAR; DOMAIN	O-Linked N-acetylglucosamine (O-GlcNAc) is a post-translational modification of proteins that functions as a nutrient sensing mechanism. We have previously shown a significant induction of O-GlcNAc modification under conditions of glucose deprivation. Increased O-GlcNAc modification was mediated by increased mRNA for nucleocytoplasmic O-linked N-acetylglucosaminyltransferase (ncOGT). We have investigated the mechanism mediating ncOGT induction with glucose deprivation. The signal does not appear to be general energy depletion because no differences in AMP-dependent kinase protein levels or phosphorylation were observed between glucose-deprived and normal glucose-treated cells. However, treatment of glucose-deprived cells with a small dose (1 mM) of glucosamine blocked the induction of ncOGT mRNA and subsequent increase in O-GlcNAc protein modification, suggesting that decreased hexosamine flux is the signal for ncOGT up-regulation. Consistent with this, treatment of glucose-deprived cells with an inhibitor of O-GlcNAcase (O-(2-acetamido-2-deoxy-D-glucopyranosylidene) amino N-phenyl carbamat) completely prevented the subsequent up-regulation of ncOGT. Glucosamine treatment also resulted in a 40% rescue of the down-regulation of glycogen synthase activity normally seen after glucose deprivation. We conclude that deglycosylation of proteins within the first few hours of glucose deprivation promotes ncOGT induction. These findings suggest a novel negative feedback regulatory loop for OGT and O-GlcNAc regulation.	[McClain, Donald A.] Univ Utah, Sch Med, Div Endocrinol, Dept Biochem, Salt Lake City, UT 84132 USA; [Taylor, Rodrick P.; Geisler, Taylor S.; Chambers, Jefferson H.; McClain, Donald A.] Univ Utah, Sch Med, Dept Med, Salt Lake City, UT 84132 USA; [McClain, Donald A.] Vet Affairs Med Ctr, Res Serv, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Veterans Health Administration (VHA)	McClain, DA (corresponding author), Univ Utah, Sch Med, Div Endocrinol, Dept Biochem, 30 N 2030 East, Salt Lake City, UT 84132 USA.	donald.mcclain@hsc.utah.edu		McClain, Don/0000-0002-3310-2359	National Institutes of Health Grant [RO1-DK43526]; Research Service of the Veterans Administration; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043526] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Service of the Veterans Administration; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1-DK43526. This work was also supported by the Research Service of the Veterans Administration. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Cheung WD, 2008, J BIOL CHEM, V283, P13009, DOI 10.1074/jbc.M801222200; Comer FI, 1999, BBA-GEN SUBJECTS, V1473, P161, DOI 10.1016/S0304-4165(99)00176-2; Dauphinee SM, 2005, J CELL BIOCHEM, V96, P579, DOI 10.1002/jcb.20508; Gao Y, 2003, ARCH BIOCHEM BIOPHYS, V415, P155, DOI 10.1016/S0003-9861(03)00234-0; Gazdag AC, 2000, AM J PHYSIOL-REG I, V278, pR504, DOI 10.1152/ajpregu.2000.278.2.R504; Gewinner C, 2004, J BIOL CHEM, V279, P3563, DOI 10.1074/jbc.M306449200; Han I, 1997, MOL CELL BIOL, V17, P2550, DOI 10.1128/MCB.17.5.2550; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hebert LF, 1996, J CLIN INVEST, V98, P930, DOI 10.1172/JCI118876; Hiromura M, 2003, J BIOL CHEM, V278, P14046, DOI 10.1074/jbc.M300789200; KELLY WG, 1989, CELL, V57, P243, DOI 10.1016/0092-8674(89)90962-8; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Love, 2005, SCI STKE, V2005, DOI DOI 10.1126/STKE.3122005RE13; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Marshall S, 2004, J BIOL CHEM, V279, P35313, DOI 10.1074/jbc.M404133200; Nelson BA, 1997, AM J PHYSIOL-ENDOC M, V272, pE848, DOI 10.1152/ajpendo.1997.272.5.E848; Nolte D, 2002, MAMM GENOME, V13, P62, DOI 10.1007/s00335-001-2108-9; Parker GJ, 2003, J BIOL CHEM, V278, P10022, DOI 10.1074/jbc.M207787200; ROBINSON KA, 1995, DIABETES, V44, P1438, DOI 10.2337/diabetes.44.12.1438; Steinmetz EJ, 1997, CELL, V89, P491, DOI 10.1016/S0092-8674(00)80230-5; Taylor RP, 2008, J BIOL CHEM, V283, P6050, DOI 10.1074/jbc.M707328200; Toleman C, 2004, J BIOL CHEM, V279, P53665, DOI 10.1074/jbc.M410406200; Wells L, 2004, J BIOL CHEM, V279, P38466, DOI 10.1074/jbc.M406481200; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yki-Jarvinen H, 1998, METABOLISM, V47, P449, DOI 10.1016/S0026-0495(98)90058-0; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007	28	73	75	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3425	3432		10.1074/jbc.M803198200	http://dx.doi.org/10.1074/jbc.M803198200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19073609	Green Published, hybrid			2022-12-25	WOS:000262872500008
J	Morino, S; Kondo, T; Sasaki, K; Adachi, H; Suico, MA; Sekimoto, E; Matsuda, T; Shuto, T; Araki, E; Kai, H				Morino, Saori; Kondo, Tatsuya; Sasaki, Kazunari; Adachi, Hironori; Suico, Mary Ann; Sekimoto, Erika; Matsuda, Tomoko; Shuto, Tsuyoshi; Araki, Eiichi; Kai, Hirofumi			Mild Electrical Stimulation with Heat Shock Ameliorates Insulin Resistance via Enhanced Insulin Signaling	PLOS ONE			English	Article								Low-intensity electrical current (or mild electrical stimulation; MES) influences signal transduction and activates phosphatidylinositol-3 kinase (PI3K)/Akt pathway. Because insulin resistance is characterized by a marked reduction in insulin-stimulated PI3K-mediated activation of Akt, we asked whether MES could increase Akt phosphorylation and ameliorate insulin resistance. In addition, it was also previously reported that heat shock protein 72 (Hsp72) alleviates hyperglycemia. Thus, we applied MES in combination with heat shock (HS) to in vitro and in vivo models of insulin resistance. Here we show that 10-min treatment with MES at 5 V (0.1 ms pulse duration) together with HS at 42 degrees C increased the phosphorylation of insulin signaling molecules such as insulin receptor substrate (IRS) and Akt in HepG2 cells maintained in high-glucose medium. MES (12 V)+mild HS treatment of high fat-fed mice also increased the phosphorylation of insulin receptor beta subunit (IR beta) and Akt in mice liver. In high fat-fed mice and db/db mice, MES+HS treatment for 10 min applied twice a week for 12-15 weeks significantly decreased fasting blood glucose and insulin levels and improved insulin sensitivity. The treated mice showed significantly lower weight of visceral and subcutaneous fat, a markedly improved fatty liver and decreased size of adipocytes. Our findings indicated that the combination of MES and HS alleviated insulin resistance and improved fat metabolism in diabetes mouse models, in part, by enhancing the insulin signaling pathway.	[Morino, Saori; Suico, Mary Ann; Sekimoto, Erika; Matsuda, Tomoko; Shuto, Tsuyoshi; Kai, Hirofumi] Kumamoto Univ, Dept Mol Med, Fac Med & Pharmaceut Sci, Global COE Cell Fate Regulat Res & Educ Unit, Kumamoto, Japan; [Kondo, Tatsuya; Sasaki, Kazunari; Adachi, Hironori; Araki, Eiichi] Kumamoto Univ, Fac Med & Pharm Sci, Dept Metabol Med, Kumamoto 860, Japan	Kumamoto University; Kumamoto University	Morino, S (corresponding author), Kumamoto Univ, Dept Mol Med, Fac Med & Pharmaceut Sci, Global COE Cell Fate Regulat Res & Educ Unit, Kumamoto, Japan.	earaki@gpo.kumamoto-u.ac.jp; hirokai@gpo.kumamoto-u.ac.jp	Kazunari, Sasaki/ABF-2853-2020	Kazunari, Sasaki/0000-0003-2514-5778; Suico, Mary Ann/0000-0002-6751-8352; Kondo, Tatsuya/0000-0003-4830-8955	Ministry of Education, Science, Sports and Culture (MEXT) of Japan [19390045, 20390259, 19591058]; JSPS [Fellows]; Global COE Program (Cell Fate Regulation Research and Education Unit), MEXT, Japan; Foundation of Medical Innovation of Kumamoto University; Suzuken Memorial Foundation	Ministry of Education, Science, Sports and Culture (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global COE Program (Cell Fate Regulation Research and Education Unit), MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Foundation of Medical Innovation of Kumamoto University; Suzuken Memorial Foundation	This work is supported by grants from the Ministry of Education, Science, Sports and Culture (MEXT) of Japan to H. Kai (#19390045), E. Araki (#20390259) and T. Kondo (#19591058), by Grant-in-Aid for JSPS Fellows (to S. Morino), and from the Global COE Program (Cell Fate Regulation Research and Education Unit), MEXT, Japan (to H. Kai), a grant from the Foundation of Medical Innovation of Kumamoto University (to T. Kondo) and a grant from Suzuken Memorial Foundation (to T. Kondo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Ainsworth L, 2006, PAIN, V120, P182, DOI 10.1016/j.pain.2005.10.030; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Cha DR, 2007, DIABETES, V56, P2036, DOI 10.2337/db06-1134; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Chung J, 2008, P NATL ACAD SCI USA, V105, P1739, DOI 10.1073/pnas.0705799105; Daitoku H, 2003, DIABETES, V52, P642, DOI 10.2337/diabetes.52.3.642; Ducluzeau PH, 2002, J CELL SCI, V115, P2857; Farese RV, 2005, EXP BIOL MED, V230, P593; Gabai VL, 2000, J BIOL CHEM, V275, P38088, DOI 10.1074/jbc.M006632200; Gabbay RA, 1996, J BIOL CHEM, V271, P1890, DOI 10.1074/jbc.271.4.1890; Hilder TL, 2003, FEBS LETT, V553, P63, DOI 10.1016/S0014-5793(03)00972-4; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kirson ED, 2004, CANCER RES, V64, P3288, DOI 10.1158/0008-5472.CAN-04-0083; Kirson ED, 2007, P NATL ACAD SCI USA, V104, P10152, DOI 10.1073/pnas.0702916104; Klover PJ, 2004, INT J BIOCHEM CELL B, V36, P753, DOI 10.1016/j.biocel.2003.10.002; Kobayashi T, 2005, BIOCHEM BIOPH RES CO, V331, P1301, DOI 10.1016/j.bbrc.2005.04.096; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004; McCarty MF, 2006, MED HYPOTHESES, V66, P527, DOI 10.1016/j.mehy.2004.08.033; Mobbs RJ, 2007, J CLIN NEUROSCI, V14, P216, DOI 10.1016/j.jocn.2005.11.007; MORINO S, 2008, J PHARM SCI IN PRESS; Nelson Fred R T, 2003, J Am Acad Orthop Surg, V11, P344; Okamoto H, 2003, J BIOL CHEM, V278, P28359, DOI 10.1074/jbc.R300009200; Okiyoneda T, 2004, MOL BIOL CELL, V15, P563, DOI 10.1091/mbc.E03-06-0379; Pagano G, 2002, HEPATOLOGY, V35, P367, DOI 10.1053/jhep.2002.30690; Park HS, 2001, EMBO J, V20, P446, DOI 10.1093/emboj/20.3.446; PETHIG R, 1987, PHYS MED BIOL, V32, P933, DOI 10.1088/0031-9155/32/8/001; ROBINSON KR, 1985, J CELL BIOL, V101, P2023, DOI 10.1083/jcb.101.6.2023; Schinner S, 2005, DIABETIC MED, V22, P674, DOI 10.1111/j.1464-5491.2005.01566.x; Schinner S, 2005, J BIOL CHEM, V280, P7369, DOI 10.1074/jbc.M408560200; Seegers JC, 2001, MED HYPOTHESES, V57, P224, DOI 10.1054/mehy.2001.1292; Sekino M, 2003, J APPL PHYS, V94, P5359, DOI 10.1063/1.1607517; Shimizu H, 2006, DIABETIC MED, V23, P253, DOI 10.1111/j.1464-5491.2006.01776.x; Shimohara S, 2005, INT J ONCOL, V27, P1527; STOY RD, 1982, PHYS MED BIOL, V27, P501, DOI 10.1088/0031-9155/27/4/002; Syed NA, 2000, MOL CELL BIOCHEM, V211, P123, DOI 10.1023/A:1007159422667; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Taniguchi CM, 2006, P NATL ACAD SCI USA, V103, P12093, DOI 10.1073/pnas.0604628103; Tremblay F, 2005, ENDOCRINOLOGY, V146, P1328, DOI 10.1210/en.2004-0777; Volloch V, 1998, CELL STRESS CHAPERON, V3, P265, DOI 10.1054/csac.1998.0120; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Wust P, 2002, LANCET ONCOL, V3, P487, DOI 10.1016/S1470-2045(02)00818-5; Zang MW, 2004, J BIOL CHEM, V279, P47898, DOI 10.1074/jbc.M408149200; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925	50	62	65	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2008	3	12							e4068	10.1371/journal.pone.0004068	http://dx.doi.org/10.1371/journal.pone.0004068			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DL	19114996	Green Published, gold, Green Submitted			2022-12-25	WOS:000265466300009
J	Murray, LA; Hackett, TL; Warner, SM; Shaheen, F; Argentieri, RL; Dudas, P; Farrell, FX; Knight, DA				Murray, Lynne A.; Hackett, Tillie L.; Warner, Stephanie M.; Shaheen, Furquan; Argentieri, Rochelle L.; Dudas, Paul; Farrell, Francis X.; Knight, Darryl A.			BMP-7 Does Not Protect against Bleomycin-Induced Lung or Skin Fibrosis	PLOS ONE			English	Article								Bone morphogenic protein (BMP)-7 is a member of the BMP family which are structurally and functionally related, and part of the TGF beta super family of growth factors. BMP-7 has been reported to inhibit renal fibrosis and TGF beta 1-induced epithelial-mesenchymal transition (EMT), in part through negative interactions with TGF beta 1 induced Smad 2/3 activation. We utilized in vivo bleomycin-induced fibrosis models in the skin and lung to determine the potential therapeutic effect of BMP-7. We then determined the effect of BMP-7 on TGF beta 1-induced EMT in lung epithelial cells and collagen production by human lung fibroblasts. We show that BMP-7 did not affect bleomycin-induced fibrosis in either the lung or skin in vivo; had no effect on expression of pro-fibrotic genes by human lung fibroblasts, either at rest or following exposure to TGF beta 1; and did not modulate TGF beta 1-induced EMT in human lung epithelial cells. Taken together our data indicates that BMP-7 has no antifibrotic effect in lung or skin fibrosis either in vivo or in vitro. This suggests that the therapeutic options for BMP-7 may be confined to the renal compartment.	[Murray, Lynne A.; Argentieri, Rochelle L.; Dudas, Paul; Farrell, Francis X.] Centocor Inc, Tissue Remodeling & Metabol Dept, Immunobiol Dept, Radnor, PA USA; [Hackett, Tillie L.; Warner, Stephanie M.; Shaheen, Furquan; Knight, Darryl A.] St Pauls Hosp, James Hogg iCapture Ctr Cardiovasc & Pulmon Res, Vancouver, BC, Canada; [Hackett, Tillie L.; Warner, Stephanie M.; Shaheen, Furquan; Knight, Darryl A.] Univ British Columbia, Dept Anesthesiol, Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada	Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; St. Paul's Hospital; University of Saskatchewan; University of British Columbia	Murray, LA (corresponding author), Promedior Inc, Malvern, PA USA.	lmurray@promedior.com	Murray, Lynne/AAB-1793-2020	Murray, Lynne/0000-0003-4879-966X	Centocor, Inc; Canadian Institutes for Health Research; Wolfe and Gita Churg Foundation	Centocor, Inc(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Wolfe and Gita Churg Foundation	The work in this manuscript was supported by Centocor, Inc and operating funds from the Canadian Institutes for Health Research; the Wolfe and Gita Churg Foundation and an endowment from the Rashpal Dhillon family to DAK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blease K, 2002, AM J PATHOL, V160, P481, DOI 10.1016/S0002-9440(10)64867-5; Burdick MD, 2005, AM J RESP CRIT CARE, V171, P261, DOI 10.1164/rccm.200409-1164OC; Cutroneo KR, 2007, J CELL PHYSIOL, V211, P585, DOI 10.1002/jcp.20972; Derynck R, 1997, BBA-REV CANCER, V1333, pF105, DOI 10.1016/S0304-419X(97)00017-6; Eickelberg O, 2007, TRENDS CARDIOVAS MED, V17, P263, DOI 10.1016/j.tcm.2007.09.003; Evans RA, 2003, EXP CELL RES, V282, P90, DOI 10.1016/S0014-4827(02)00015-0; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gauldie J, 2007, BIOCHEM SOC T, V35, P661, DOI 10.1042/BST0350661; Gu L, 2007, ACTA PHARMACOL SIN, V28, P382, DOI 10.1111/j.1745-7254.2007.00468.x; Higashiyama H, 2007, J CLIN PATHOL, V60, P283, DOI 10.1136/jcp.2006.037606; Hogaboam GM, 1999, J IMMUNOL, V163, P2193; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Jain R, 2007, AM J RESP CELL MOL, V37, P38, DOI 10.1165/rcmb.2006-0353OC; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Karsenty G, 1996, ANN NY ACAD SCI, V785, P98, DOI 10.1111/j.1749-6632.1996.tb56247.x; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Keane MP, 1999, J IMMUNOL, V163, P5686; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Lakos G, 2004, AM J PATHOL, V165, P203, DOI 10.1016/S0002-9440(10)63289-0; Lakos G, 2006, PATHOBIOLOGY, V73, P224, DOI 10.1159/000098208; Maric I, 2003, J CELL PHYSIOL, V196, P258, DOI 10.1002/jcp.10275; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Matsushita M, 2004, INT ARCH ALLERGY IMM, V135, P348, DOI 10.1159/000082331; Okada H, 1997, AM J PHYSIOL-RENAL, V273, pF563, DOI 10.1152/ajprenal.1997.273.4.F563; OZKAYNAK E, 1991, BIOCHEM BIOPH RES CO, V179, P116, DOI 10.1016/0006-291X(91)91342-A; Saika S, 2004, AM J PATHOL, V164, P651, DOI 10.1016/S0002-9440(10)63153-7; Tacke F, 2007, DIGEST DIS SCI, V52, P3404, DOI 10.1007/s10620-007-9758-8; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Vallance BA, 2005, AM J PHYSIOL-GASTR L, V289, pG116, DOI 10.1152/ajpgi.00051.2005; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Willis BC, 2007, AM J PHYSL LUNG CELL; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Wordinger RJ, 2007, EXP BIOL MED, V232, P979, DOI 10.3181/0510-MR-345; Wrana JL, 2000, CELL, V100, P189, DOI 10.1016/S0092-8674(00)81556-1; Wu Z, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-1; Yamamoto T, 2000, ARCH DERMATOL RES, V292, P556, DOI 10.1007/s004030000180; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg M, 2005, J BIOL CHEM, V280, P8094, DOI 10.1074/jbc.M413102200; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200; Zhang HY, 1996, AM J PATHOL, V148, P527	41	49	52	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2008	3	12							e4039	10.1371/journal.pone.0004039	http://dx.doi.org/10.1371/journal.pone.0004039			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DI	19112509	Green Published, Green Submitted, gold			2022-12-25	WOS:000265466000008
J	Mercatelli, N; Coppola, V; Bonci, D; Miele, F; Costantini, A; Guadagnoli, M; Bonanno, E; Muto, G; Frajese, GV; De Maria, R; Spagnoli, LG; Farace, MG; Ciafre, SA				Mercatelli, Neri; Coppola, Valeria; Bonci, Desiree; Miele, Francesca; Costantini, Arianna; Guadagnoli, Marco; Bonanno, Elena; Muto, Giovanni; Frajese, Giovanni Vanni; De Maria, Ruggero; Spagnoli, Luigi Giusto; Farace, Maria Giulia; Ciafre, Silvia Anna			The Inhibition of the Highly Expressed Mir-221 and Mir-222 Impairs the Growth of Prostate Carcinoma Xenografts in Mice	PLOS ONE			English	Article								Background: MiR-221 and miR-222 are two highly homologous microRNAs whose upregulation has been recently described in several types of human tumors, for some of which their oncogenic role was explained by the discovery of their target p27, a key cell cycle regulator. We previously showed this regulatory relationship in prostate carcinoma cell lines in vitro, underlying the role of miR-221/222 as inducers of proliferation and tumorigenicity. Methodology/Principal Findings: Here we describe a number of in vivo approaches confirming our previous data. The ectopic overexpression of miR-221 is able, per se, to confer a high growth advantage to LNCaP-derived tumors in SCID mice. Consistently, the anti-miR-221/222 antagomir treatment of established subcutaneous tumors derived from the highly aggressive PC3 cell line, naturally expressing high levels of miR-221/222, reduces tumor growth by increasing intratumoral p27 amount; this effect is long lasting, as it is detectable as long as 25 days after the treatment. Furthermore, we provide evidence in favour of a clinical relevance of the role of miR-221/222 in prostate carcinoma, by showing their general upregulation in patient-derived primary cell lines, where we find a significant inverse correlation with p27 expression. Conclusions/Significance: These findings suggest that modulating miR-221/222 levels may have a therapeutic potential in prostate carcinoma.	[Mercatelli, Neri; Miele, Francesca; Guadagnoli, Marco; Farace, Maria Giulia; Ciafre, Silvia Anna] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00173 Rome, Italy; [Coppola, Valeria; Bonci, Desiree; De Maria, Ruggero] Ist Superiore Sanita, Dept Hematol, Oncol & Mol Med, Rome, Italy; [Costantini, Arianna; Bonanno, Elena; Spagnoli, Luigi Giusto] Univ Roma Tor Vergata, Dept Biopathol, I-00173 Rome, Italy; [Muto, Giovanni] S Giovanni Bosco Hosp, Dept Urol, Turin, Italy; [Frajese, Giovanni Vanni] Univ Roma Tor Vergata, Dept Internal Med, Rome, Italy; [De Maria, Ruggero] Mediterranean Inst Oncol, Catania, Italy	University of Rome Tor Vergata; Istituto Superiore di Sanita (ISS); University of Rome Tor Vergata; University of Rome Tor Vergata; Mediterranean Institute of Oncology	Mercatelli, N (corresponding author), Inst Andre Lwoff, CNRS, FRE 2944 EPIGENET & CANC, Villejuif, France.	ciafre@uniroma2.it	Coppola, Valeria/K-5120-2016; De Maria, Ruggero/S-6385-2019; Bonci, Desiree/K-6488-2016; ciafrè, silvia anna/G-1783-2012	Coppola, Valeria/0000-0002-5745-2572; De Maria, Ruggero/0000-0003-2255-0583; Bonci, Desiree/0000-0002-2472-5140; ciafrè, silvia anna/0000-0001-6467-8396; bonanno, elena/0000-0002-0222-0141; Spagnoli, Luigi Giusto/0000-0002-0684-5501; Muto, Giovanni/0000-0003-3593-6450	Italian Ministry of Instruction, University and Scientific Research (MIUR); Ministry of Health, FIRB [RBNE01MBEC]; PRIN [20077YZTL8_002]; University of Rome Tor Vergata [PhD fellowship in Endocrinology]	Italian Ministry of Instruction, University and Scientific Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Ministry of Health, FIRB; PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); University of Rome Tor Vergata	This study was funded in part by grants from the Italian Ministry of Instruction, University and Scientific Research (MIUR) to SAC and MGF, and from the Ministry of Health, FIRB # RBNE01MBEC and PRIN # 20077YZTL8_002 to MGF. NM was a recipient of a PhD fellowship in Endocrinology, University of Rome "Tor Vergata". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-60; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Dalmay T, 2008, J INTERN MED, V263, P366, DOI 10.1111/j.1365-2796.2008.01926.x; Felicetti F, 2008, CANCER RES, V68, P2745, DOI 10.1158/0008-5472.CAN-07-2538; Fernandez PL, 2002, PATHOBIOLOGY, V70, P1, DOI 10.1159/000065998; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; Fornari F, 2008, ONCOGENE, V27, P5651, DOI 10.1038/onc.2008.178; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Garofalo M, 2008, ONCOGENE, V27, P3845, DOI 10.1038/onc.2008.6; Gillies JK, 2007, CELL CYCLE, V6, P2005, DOI 10.4161/cc.6.16.4526; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Krutzfeldt J, 2007, NUCLEIC ACIDS RES, V35, P2885, DOI 10.1093/nar/gkm024; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24; Medina R, 2008, CANCER RES, V68, P2773, DOI 10.1158/0008-5472.CAN-07-6754; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Musiyenko A, 2008, J MOL MED, V86, P313, DOI 10.1007/s00109-007-0296-9; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Prueitt RL, 2008, PROSTATE, V68, P1152, DOI 10.1002/pros.20786; Said J, 2005, BIOMARKERS, V10, pS83, DOI 10.1080/13547500500215050; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Sylvestre Y, 2007, J BIOL CHEM, V282, P2135, DOI 10.1074/jbc.M608939200; Visone R, 2007, ENDOCR-RELAT CANCER, V14, P791, DOI 10.1677/ERC-07-0129; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008	32	202	211	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4029	10.1371/journal.pone.0004029	http://dx.doi.org/10.1371/journal.pone.0004029			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107213	gold, Green Published, Green Submitted			2022-12-25	WOS:000265463000022
J	Krejci, P; Salazar, L; Kashiwada, TA; Chlebova, K; Salasova, A; Thompson, LM; Bryja, V; Kozubik, A; Wilcox, WR				Krejci, Pavel; Salazar, Lisa; Kashiwada, Tamara A.; Chlebova, Katarina; Salasova, Alena; Thompson, Leslie Michels; Bryja, Vitezslav; Kozubik, Alois; Wilcox, William R.			Analysis of STAT1 Activation by Six FGFR3 Mutants Associated with Skeletal Dysplasia Undermines Dominant Role of STAT1 in FGFR3 Signaling in Cartilage	PLOS ONE			English	Article								Activating mutations in FGFR3 tyrosine kinase cause several forms of human skeletal dysplasia. Although the mechanisms of FGFR3 action in cartilage are not completely understood, it is believed that the STAT1 transcription factor plays a central role in pathogenic FGFR3 signaling. Here, we analyzed STAT1 activation by the N540K, G380R, R248C, Y373C, K650M and K650E-FGFR3 mutants associated with skeletal dysplasias. In a cell-free kinase assay, only K650M and K650E-FGFR3 caused activatory STAT1(Y701) phosphorylation. Similarly, in RCS chondrocytes, HeLa, and 293T cellular environments, only K650M and K650E-FGFR3 caused strong STAT1 activation. Other FGFR3 mutants caused weak (HeLa) or no activation (293T and RCS). This contrasted with ERK MAP kinase activation, which was strongly induced by all six mutants and correlated with the inhibition of proliferation in RCS chondrocytes. Thus the ability to activate STAT1 appears restricted to the K650M and K650E-FGFR3 mutants, which however account for only a small minority of the FGFR3-related skeletal dysplasia cases. Other pathways such as ERK should therefore be considered as central to pathological FGFR3 signaling in cartilage.	[Chlebova, Katarina; Salasova, Alena; Bryja, Vitezslav; Kozubik, Alois] Masaryk Univ, Dept Anim Physiol & Immunol, Inst Expt Biol, Brno, Czech Republic; [Krejci, Pavel; Bryja, Vitezslav; Kozubik, Alois] ASCR, Inst Biophys, Dept Cytokinet, Brno, Czech Republic; [Krejci, Pavel; Wilcox, William R.] Cedars Sinai Med Ctr, Med Genet Inst, Los Angeles, CA USA; [Salazar, Lisa; Kashiwada, Tamara A.; Thompson, Leslie Michels] Univ Calif Irvine, Dept Psychiat & Human Behavior, Irvine, CA 92717 USA; [Wilcox, William R.] Univ Calif Los Angeles, Sch Med, Dept Pediat, Los Angeles, CA 90024 USA	Masaryk University Brno; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Cedars Sinai Medical Center; University of California System; University of California Irvine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Krejci, P (corresponding author), Masaryk Univ, Dept Anim Physiol & Immunol, Inst Expt Biol, Brno, Czech Republic.	pavel.krejci@cshs.org	Bryja, Vít?zslav/H-1925-2014; Kozubík, Alois/H-1954-2014; Bryja, Vítězslav/P-4217-2019; Krejčí, Pavel/I-4285-2014	Bryja, Vít?zslav/0000-0002-9136-5085; Bryja, Vítězslav/0000-0002-9136-5085; Salasova, Alena/0000-0001-9246-6956; Krejci, Pavel/0000-0003-0618-9134	National Institutes of Health [5P01-HD22657]; Ministry of Education, Youth and Sports of the Czech Republic [MSM0021622430]; Academy of Sciences of the Czech Republic [AVOZ50040507, AVOZ50040702]; EMBO Installation grant; Winnick Family Research Scholars award	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); EMBO Installation grant; Winnick Family Research Scholars award	This work was supported by National Institutes of Health (5P01-HD22657), Ministry of Education, Youth and Sports of the Czech Republic (MSM0021622430), Academy of Sciences of the Czech Republic (AVOZ50040507, AVOZ50040702), EMBO Installation grant (VB), and a Winnick Family Research Scholars award (WRW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Aikawa T, 2001, J BIOL CHEM, V276, P29347, DOI 10.1074/jbc.M101859200; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; d'Avis PY, 1998, CELL GROWTH DIFFER, V9, P71; Dailey L, 2003, J CELL BIOL, V161, P1053, DOI 10.1083/jcb.200302075; Harada D, 2007, BONE, V41, P273, DOI 10.1016/j.bone.2006.11.030; Hart KC, 2000, ONCOGENE, V19, P3309, DOI 10.1038/sj.onc.1203650; Hart KC, 2001, MOL BIOL CELL, V12, P931, DOI 10.1091/mbc.12.4.931; Horton WA, 2007, LANCET, V370, P162, DOI 10.1016/S0140-6736(07)61090-3; Krejci P, 2005, J CELL SCI, V118, P5089, DOI 10.1242/jcs.02618; Krejci P, 2004, EXP CELL RES, V297, P152, DOI 10.1016/j.yexcr.2004.03.011; Krejci P, 2008, J CELL SCI, V121, P272, DOI 10.1242/jcs.017160; Krejci P, 2007, J BIOL CHEM, V282, P2929, DOI 10.1074/jbc.M606144200; L'Hote CGM, 2005, EXP CELL RES, V304, P417, DOI 10.1016/j.yexcr.2004.11.012; Legeai-Mallet L, 1998, J BIOL CHEM, V273, P13007, DOI 10.1074/jbc.273.21.13007; Legeai-Mallet L, 2004, BONE, V34, P26, DOI 10.1016/j.bone.2003.09.002; Li CL, 1999, HUM MOL GENET, V8, P35, DOI 10.1093/hmg/8.1.35; Lievens PMJ, 2004, J BIOL CHEM, V279, P43254, DOI 10.1074/jbc.M405247200; Lievens PMJ, 2003, J BIOL CHEM, V278, P17344, DOI 10.1074/jbc.M212710200; MATSUSHITA T, 2008, HUM MOL GEN IN PRESS; Murakami S, 2004, GENE DEV, V18, P290, DOI 10.1101/gad.1179104; Nowroozi N, 2005, HUM MOL GENET, V14, P1529, DOI 10.1093/hmg/ddi161; Ornitz DM, 2005, CYTOKINE GROWTH F R, V16, P205, DOI 10.1016/j.cytogfr.2005.02.003; Passos-Bueno MR, 1999, HUM MUTAT, V14, P115; Plowright EE, 2000, BLOOD, V95, P992, DOI 10.1182/blood.V95.3.992.003k29_992_998; Raucci A, 2004, J BIOL CHEM, V279, P1747, DOI 10.1074/jbc.M310384200; Ronchetti D, 2001, ONCOGENE, V20, P3553, DOI 10.1038/sj.onc.1204465; Rozenblatt-Rosen O, 2002, J CELL SCI, V115, P553; Sahni M, 1999, GENE DEV, V13, P1361, DOI 10.1101/gad.13.11.1361; Sahni M, 2001, DEVELOPMENT, V128, P2119; Su WCS, 1997, NATURE, V386, P288, DOI 10.1038/386288a0; Webster MK, 1996, MOL CELL BIOL, V16, P4081; Yasoda A, 2004, NAT MED, V10, P80, DOI 10.1038/nm971	33	34	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2008	3	12							e3961	10.1371/journal.pone.0003961	http://dx.doi.org/10.1371/journal.pone.0003961			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AS	19088846	Green Published, gold			2022-12-25	WOS:000265458500007
J	Eller, LA; Eller, MA; Ouma, B; Kataaha, P; Kyabaggu, D; Tumusiime, R; Wandege, J; Sanya, R; Sateren, WB; Wabwire-Mangen, F; Kibuuka, H; Robb, ML; Michael, NL; de Souza, MS				Eller, Leigh Anne; Eller, Michael A.; Ouma, Benson; Kataaha, Peter; Kyabaggu, Denis; Tumusiime, Richard; Wandege, Joseph; Sanya, Ronald; Sateren, Warren B.; Wabwire-Mangen, Fred; Kibuuka, Hannah; Robb, Merlin L.; Michael, Nelson L.; de Souza, Mark S.			Reference Intervals in Healthy Adult Ugandan Blood Donors and Their Impact on Conducting International Vaccine Trials	PLOS ONE			English	Article								Background: Clinical trials are increasingly being conducted internationally. In order to ensure enrollment of healthy participants and proper safety evaluation of vaccine candidates, established reference intervals for clinical tests are required in the target population. Methodology/Principal Findings: We report a reference range study conducted in Ugandan adult blood bank donors establishing reference intervals for hematology and clinical chemistry parameters. Several differences were observed when compared to previously established values from the United States, most notably in neutrophils and eosinophils. Conclusions/Significance: In a recently conducted vaccine trial in Uganda, 31 percent (n = 69) of volunteers screened (n = 223) were excluded due to hematologic abnormalities. If local reference ranges had been employed, 83% of those screened out due to these abnormalities could have been included in the study, drastically reducing workload and cost associated with the screening process. In addition, toxicity tables used in vaccine and drug trial safety evaluations may need adjustment as some clinical reference ranges determined in this study overlap with grade 1 and grade 2 adverse events.	[Eller, Michael A.; Sateren, Warren B.; Robb, Merlin L.; de Souza, Mark S.] US Mil HIV Res Program, Rockville, MD USA; [Eller, Leigh Anne; Eller, Michael A.; Ouma, Benson; Kyabaggu, Denis; Tumusiime, Richard; Wandege, Joseph; Sanya, Ronald; Wabwire-Mangen, Fred; Kibuuka, Hannah] Makerere Univ, Walter Reed Project, Kampala, Uganda; [Kataaha, Peter] Uganda Natl Blood Transfus Serv, Kampala, Uganda; [Michael, Nelson L.] Walter Reed Army Inst Res, Rockville, MD USA; [de Souza, Mark S.] Armed Forces Res Inst Med Sci, Bangkok, Thailand	Walter Reed Army Institute of Research (WRAIR); Makerere University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS)	Eller, LA (corresponding author), US Mil HIV Res Program, Rockville, MD USA.	leller@muwrp.org	Eller, Michael A./I-2156-2019	Eller, Michael A./0000-0003-3905-4877	U.S. Army Medical Research and Materiel Command [W81XWH-04-02-0005]; Henry M. Jackson Foundation for the Advancement of Military Medicine; DAIDS [1Y-A1-26-42-07]	U.S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Henry M. Jackson Foundation for the Advancement of Military Medicine; DAIDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the U.S. Army Medical Research and Materiel Command and its Cooperative Agreement (W81XWH-04-02-0005) with the Henry M. Jackson Foundation for the Advancement of Military Medicine and with an Inter Agency Agreement (1Y-A1-26-42-07) with DAIDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BADENHORST CJ, 1995, E AFR MED J, V72, P19; Bain BJ, 1996, J CLIN PATHOL, V49, P664, DOI 10.1136/jcp.49.8.664; BLACK HR, 1986, AM J MED, V81, P479, DOI 10.1016/0002-9343(86)90303-7; *DIAGN R, 2007, INSTR US; Eller MA, 2007, VACCINE, V25, P7737, DOI 10.1016/j.vaccine.2007.08.056; Ezeilo G C, 1974, East Afr Med J, V51, P936; EZEILO GC, 1971, TROP GEOGR MED, V23, P264; EZEILO GC, 1972, LANCET, V2, P1003; Kratz A, 2004, NEW ENGL J MED, V351, P1548, DOI 10.1056/NEJMcpc049016; Lugada ES, 2004, CLIN DIAGN LAB IMMUN, V11, P29, DOI 10.1128/CDLI.11.1.29-34.2004; Menard D, 2003, J VIROL METHODS, V111, P129, DOI 10.1016/S0166-0934(03)00169-1; Menard D, 2003, CLIN DIAGN LAB IMMUN, V10, P443, DOI 10.1128/CDLI.10.3.443-445.2003; NCCLS, 2000, DEF DET REF INT CLIN, V20; PILIS W, 1988, INT J SPORTS MED, V9, P102, DOI 10.1055/s-2007-1024987; Saathoff E, 2008, TROP MED INT HEALTH, V13, P612, DOI 10.1111/j.1365-3156.2008.02047.x; SHAPER AG, 1971, LANCET, V2, P1021; Tsegaye A, 1999, CLIN DIAGN LAB IMMUN, V6, P410, DOI 10.1128/CDLI.6.3.410-414.1999; TUGUME SB, 1995, CLIN DIAGN LAB IMMUN, V2, P233, DOI 10.1128/CDLI.2.2.233-235.1995	18	54	54	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2008	3	12							e3919	10.1371/journal.pone.0003919	http://dx.doi.org/10.1371/journal.pone.0003919			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZU	19079547	Green Published, Green Submitted, gold			2022-12-25	WOS:000265455900006
J	Parachoniak, CA; Park, M				Parachoniak, Christine A.; Park, Morag			Distinct Recruitment of Eps15 via Its Coiled-coil Domain Is Required For Efficient Down-regulation of the Met Receptor Tyrosine Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; CLATHRIN-MEDIATED ENDOCYTOSIS; UBIQUITIN-INTERACTING MOTIF; GRB2 BINDING-SITE; EGF RECEPTORS; JUXTAMEMBRANE DOMAIN; PLASMA-MEMBRANE; COATED PITS; CBL; INTERNALIZATION	Down-regulation of receptor tyrosine kinases (RTK) through receptor internalization and degradation is critical for appropriate biological responses. The hepatocyte growth factor RTK (also known as Met) regulates epithelial remodeling, dispersal, and invasion and is deregulated in human cancers. Impaired down-regulation of the Met RTK leads to sustained signaling, cell transformation, and tumorigenesis, hence understanding mechanisms that regulate this process is crucial. Here we report that, following Met activation, the endocytic adaptor protein, Eps15, is recruited to the plasma membrane and becomes both tyrosine-phosphorylated and ubiquitinated. Recruitment of Eps15 requires Met receptor kinase activity and involves two distinct Eps15 domains. Unlike previous reports for the EGF RTK, which requires the Eps15 ubiquitin interacting motif, recruitment of Eps15 to Met involves the coiled-coil domain of Eps15 and the signaling adaptor molecule, Grb2, which binds through a proline-rich motif in the third domain of Eps15. Expression of the coiled-coil domain is sufficient to displace the wild-type Eps15 protein complex from Met, resulting in loss of tyrosine phosphorylation of Eps15. Knockdown of Eps15 results in delayed Met degradation, which can be rescued by expression of Eps15 WT but not an Eps15 mutant lacking the coiled-coil domain, identifying a role for this domain in Eps15-mediated Met down-modulation. This study demonstrates a new mechanism of recruitment for Eps15 downstream of the Met receptor, involving the coiled- coil domain of Eps15 as well as interaction of Eps15 with Grb2. This highlights distinct regulation of Eps15 recruitment and the diversity and adaptability of endocytic molecules in promoting RTK trafficking.	[Parachoniak, Christine A.; Park, Morag] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Park, Morag] McGill Univ, Dept Med, Montreal, PQ H3G 1Y6, Canada; [Park, Morag] McGill Univ, Dept Oncol, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University; McGill University	Park, M (corresponding author), Goodman Canc Ctr, 1160 Ave Pins Ouest,Canc Pavil,Room 511, Montreal, PQ H3G 1Y6, Canada.	morag.park@mcgill.ca			Canadian Institutes of Health Research (CIHR); Canada Graduate Scholarship Doctoral Award	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Graduate Scholarship Doctoral Award	This work was supported in part by a fellowship ( to C. P.) from the Canadian Institutes of Health Research (CIHR) Canada Graduate Scholarship Doctoral Award and by an operating grant ( to M. P.) from CIHR.	Abella JV, 2005, MOL CELL BIOL, V25, P9632, DOI 10.1128/MCB.25.21.9632-9645.2005; Aguilar RC, 2005, P NATL ACAD SCI USA, V102, P2679, DOI 10.1073/pnas.0500213102; Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Barriere H, 2006, TRAFFIC, V7, P282, DOI 10.1111/j.1600-0854.2006.00384.x; Bean AJ, 2000, J BIOL CHEM, V275, P15271, DOI 10.1074/jbc.275.20.15271; Belleudi F, 2003, FEBS LETT, V553, P262, DOI 10.1016/S0014-5793(03)01020-2; Benmerah A, 1999, J CELL SCI, V112, P1303; Benmerah A, 1996, J BIOL CHEM, V271, P12111, DOI 10.1074/jbc.271.20.12111; Benmerah A, 1995, J CELL BIOL, V131, P1831, DOI 10.1083/jcb.131.6.1831; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Borowiak M, 2004, P NATL ACAD SCI USA, V101, P10608, DOI 10.1073/pnas.0403412101; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Confalonieri S, 2000, J CELL BIOL, V150, P905, DOI 10.1083/jcb.150.4.905; Cupers P, 1997, J BIOL CHEM, V272, P33430, DOI 10.1074/jbc.272.52.33430; de Melker AA, 2004, J BIOL CHEM, V279, P55465, DOI 10.1074/jbc.M409765200; de Melker AA, 2004, J CELL SCI, V117, P5001, DOI 10.1242/jcs.01354; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; FAZIOLI F, 1993, MOL CELL BIOL, V13, P5814, DOI 10.1128/MCB.13.9.5814; Fixman ED, 1997, J BIOL CHEM, V272, P20167, DOI 10.1074/jbc.272.32.20167; Fourier TM, 1996, J BIOL CHEM, V271, P22211, DOI 10.1074/jbc.271.36.22211; Funakoshi H, 2003, CLIN CHIM ACTA, V327, P1, DOI 10.1016/S0009-8981(02)00302-9; GORDEN P, 1978, P NATL ACAD SCI USA, V75, P5025, DOI 10.1073/pnas.75.10.5025; Hammond DE, 2003, MOL BIOL CELL, V14, P1346, DOI 10.1091/mbc.E02-09-0578; Hammond DE, 2001, ONCOGENE, V20, P2761, DOI 10.1038/sj.onc.1204475; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hicke L, 2001, CELL, V106, P527, DOI 10.1016/S0092-8674(01)00485-8; HILLMAN GM, 1982, BIOCHEMISTRY-US, V21, P1667, DOI 10.1021/bi00536a030; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Jeffers M, 1997, MOL CELL BIOL, V17, P799, DOI 10.1128/MCB.17.2.799; Jeffers M, 1996, J MOL MED-JMM, V74, P505, DOI 10.1007/BF00204976; Jiang XJ, 2003, MOL BIOL CELL, V14, P858, DOI 10.1091/mbc.E02-08-0532; Klapisz E, 2002, J BIOL CHEM, V277, P30746, DOI 10.1074/jbc.M203004200; Kong-Beltran M, 2006, CANCER RES, V66, P283, DOI 10.1158/0008-5472.CAN-05-2749; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Lee JH, 2000, ONCOGENE, V19, P4947, DOI 10.1038/sj.onc.1203874; Li N, 2005, TRAFFIC, V6, P459, DOI 10.1111/j.1600-0854.2005.00290.x; Li N, 2007, J BIOL CHEM, V282, P16764, DOI 10.1074/jbc.M610835200; Lock LS, 2002, MOL BIOL CELL, V13, P2132, DOI 10.1091/mbc.02-02-0031; Ma PC, 2003, CANCER RES, V63, P6272; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Naslavsky N, 2007, J BIOL CHEM, V282, P16612, DOI 10.1074/jbc.M609493200; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Peschard P, 2007, ONCOGENE, V26, P1276, DOI 10.1038/sj.onc.1210201; Peschard P, 2004, J BIOL CHEM, V279, P29565, DOI 10.1074/jbc.M403954200; Peschard P, 2001, MOL CELL, V8, P995, DOI 10.1016/S1097-2765(01)00378-1; Peschard P, 2003, CANCER CELL, V3, P519, DOI 10.1016/S1535-6108(03)00136-3; Peschard P, 2007, MOL CELL, V27, P474, DOI 10.1016/j.molcel.2007.06.023; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2; Riezman H, 2002, NATURE, V416, P381, DOI 10.1038/416381a; RODRIGUES GA, 1991, MOL CELL BIOL, V11, P2962, DOI 10.1128/MCB.11.6.2962; Roxrud I, 2008, J CELL BIOL, V180, P1205, DOI 10.1083/jcb.200708115; Schmidt PR, 1997, J ANTHROPOL ARCHAEOL, V16, P73, DOI 10.1006/jaar.1997.0305; SCHUMACHER C, 1995, J BIOL CHEM, V270, P15341, DOI 10.1074/jbc.270.25.15341; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Sorkina T, 2002, J BIOL CHEM, V277, P27433, DOI 10.1074/jbc.M201595200; Stang E, 2004, MOL BIOL CELL, V15, P3591, DOI 10.1091/mbc.E04-01-0041; Tebar F, 1996, J BIOL CHEM, V271, P28727, DOI 10.1074/jbc.271.46.28727; Torrisi MR, 1999, MOL BIOL CELL, V10, P417, DOI 10.1091/mbc.10.2.417; vanDelft S, 1997, J CELL BIOL, V136, P811, DOI 10.1083/jcb.136.4.811; Veiga E, 2005, NAT CELL BIOL, V7, P894, DOI 10.1038/ncb1292	67	24	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8382	8394		10.1074/jbc.M807607200	http://dx.doi.org/10.1074/jbc.M807607200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19109251	hybrid, Green Published			2022-12-25	WOS:000264397800022
J	Sasaki-Suzuki, N; Arai, K; Ogata, T; Kasahara, K; Sakoda, H; Chida, K; Asano, T; Pessin, JE; Hakuno, F; Takahashi, SI				Sasaki-Suzuki, Naoko; Arai, Kiyoshi; Ogata, Tomomi; Kasahara, Kouhei; Sakoda, Hideyuki; Chida, Kazuhiro; Asano, Tomoichiro; Pessin, Jeffrey E.; Hakuno, Fumihiko; Takahashi, Shin-Ichiro			Growth Hormone Inhibition of Glucose Uptake in Adipocytes Occurs without Affecting GLUT4 Translocation through an Insulin Receptor Substrate-2-Phosphatidylinositol 3-Kinase-dependent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AKT/PROTEIN KINASE-B; PHOSPHATIDYLINOSITOL 3-KINASE ACTIVATION; 3T3-L1 ADIPOCYTES; PHOSPHOINOSITIDE 3-KINASE; TYROSINE KINASE; FACTOR-I; RAT ADIPOCYTES; SIGNAL-TRANSDUCTION; FRTL-5 CELLS; TRANSPORT	Growth hormone (GH) pretreatment of 3T3-L1 adipocytes resulted in a concentration- and time-dependent inhibition of insulin-stimulated glucose uptake. Surprisingly, this occurred without significant effect on insulin-stimulated glucose transporter (GLUT)4 translocation or fusion with the plasma membrane. In parallel, the inhibitory actions of chronic GH pretreatment also impaired insulin-dependent activation of phosphatidylinositol (PI) 3-kinase bound to insulin receptor substrate (IRS)-2 but not to IRS-1. In addition, insulin-stimulated Akt phosphorylation was inhibited by GH pretreatment. In contrast, overexpression of IRS-2 or expression of a constitutively active Akt mutant prevented the GH-induced insulin resistance of glucose uptake. Moreover, small interfering RNA-mediated IRS-2 knockdown also inhibited insulin-stimulated Akt activation and glucose uptake without affecting GLUT4 translocation and plasma membrane fusion. Together, these data support a model in which chronic GH stimulation inhibits insulin-dependent activation of phosphatidylinositol 3-kinase through a specific interaction of phosphatidylinositol 3-kinase bound to IRS-2. This inhibition leads to suppression of Akt activation coupled to glucose transport activity but not translocation or plasma membrane fusion of GLUT4.	[Sasaki-Suzuki, Naoko; Arai, Kiyoshi; Ogata, Tomomi; Kasahara, Kouhei; Chida, Kazuhiro; Hakuno, Fumihiko; Takahashi, Shin-Ichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Dept Anim Sci, Tokyo 1138657, Japan; [Sasaki-Suzuki, Naoko; Arai, Kiyoshi; Ogata, Tomomi; Kasahara, Kouhei; Chida, Kazuhiro; Hakuno, Fumihiko; Takahashi, Shin-Ichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Dept Appl Biol Chem, Tokyo 1138657, Japan; [Sasaki-Suzuki, Naoko; Pessin, Jeffrey E.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Sakoda, Hideyuki; Asano, Tomoichiro] Univ Tokyo, Grad Sch Med, Dept Internal Med, Bunkyo Ku, Tokyo 1138655, Japan; [Asano, Tomoichiro] Hiroshima Univ, Grad Sch Biomed Sci, Div Mol Med Sci, Minami Ku, Hiroshima 7348553, Japan; [Pessin, Jeffrey E.] Yeshiva Univ Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Pessin, Jeffrey E.] Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	University of Tokyo; University of Tokyo; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Tokyo; Hiroshima University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Takahashi, SI (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Dept Anim Sci, 1-1-1 Yayoi, Tokyo 1138657, Japan.	atkshin@mail.ecc.u-tokyo.ac.jp		Hakuno, Fumihiko/0000-0002-4447-6225; Takahashi, Shin-Ichiro/0000-0002-2323-2010	National Institutes of Health grant; Japan Society for the Promotion of Science [11460126]; Ministry of Education, Science and Culture of Japan [15658080, 16208028]; Program for Promotion of Basic Research Activities for Innovative Biosciences	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Basic Research Activities for Innovative Biosciences	This work was supported, in whole or in part, by a National Institutes of Health grant ( to J. E. P.). This work was also supported by a grant-in-aid for international joint research ( to S.-I.T.) from Japan Society for the Promotion of Science, Grants-in-aid for Scientific Research ( B)( 2) 11460126, Exploratory Research 15658080, and Scientific Research ( A)( 2) 16208028) from the Ministry of Education, Science and Culture of Japan ( to S.- I. T.), and by the Program for Promotion of Basic Research Activities for Innovative Biosciences ( to F. H.).	Ariga M, 2000, BIOCHEM J, V348, P409, DOI 10.1042/0264-6021:3480409; BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; BECK P, 1965, J LAB CLIN MED, V66, P366; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; CERASI E, 1964, LANCET, V2, P769; CHEATHAM B, 1994, MOL CELL BIOL, V14, P4902, DOI 10.1128/MCB.14.7.4902; Cho Y, 2006, ENDOCRINOLOGY, V147, P5374, DOI 10.1210/en.2006-0518; CLARKE JF, 1994, BIOCHEM J, V300, P631, DOI 10.1042/bj3000631; Ducluzeau PH, 2002, DIABETES METAB, V28, P85; Elmendorf JS, 1998, J BIOL CHEM, V273, P13289, DOI 10.1074/jbc.273.21.13289; Funaki M, 2004, MOL CELL BIOL, V24, P7567, DOI 10.1128/MCB.24.17.7567-7577.2004; Galetic I, 1999, PHARMACOL THERAPEUT, V82, P409, DOI 10.1016/S0163-7258(98)00071-0; GRONBORG M, 1993, J BIOL CHEM, V268, P23435; Guilherme A, 1998, J BIOL CHEM, V273, P33119, DOI 10.1074/jbc.273.50.33119; Hakuno F, 2007, J BIOL CHEM, V282, P37747, DOI 10.1074/jbc.M702472200; HARE JF, 1989, BIOCHEMISTRY-US, V28, P574, DOI 10.1021/bi00428a024; Huang C, 2005, J BIOL CHEM, V280, P19426, DOI 10.1074/jbc.M412317200; Jiang T, 1998, J BIOL CHEM, V273, P11017, DOI 10.1074/jbc.273.18.11017; Kabuta T, 2002, J BIOL CHEM, V277, P6846, DOI 10.1074/jbc.M107058200; Kim YB, 1999, J CLIN INVEST, V104, P733, DOI 10.1172/JCI6928; KOTANI K, 1995, BIOCHEM BIOPH RES CO, V209, P343, DOI 10.1006/bbrc.1995.1509; Martin SS, 1996, J BIOL CHEM, V271, P17605, DOI 10.1074/jbc.271.30.17605; Miyake S, 1996, P NATL ACAD SCI USA, V93, P1320, DOI 10.1073/pnas.93.3.1320; Nedachi T, 2000, ENDOCRINOLOGY, V141, P2429, DOI 10.1210/en.141.7.2429; Nelson BA, 2000, DIABETES, V49, P981, DOI 10.2337/diabetes.49.6.981; OKADA T, 1994, J BIOL CHEM, V269, P3568; Ross SA, 1996, J BIOL CHEM, V271, P3328, DOI 10.1074/jbc.271.6.3328; Sakoda H, 2000, DIABETES, V49, P1700, DOI 10.2337/diabetes.49.10.1700; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Sasson S, 1997, DIABETOLOGIA, V40, P30, DOI 10.1007/s001250050639; Scheepers A, 2004, JPEN-PARENTER ENTER, V28, P364, DOI 10.1177/0148607104028005364; Sharma PM, 1998, J BIOL CHEM, V273, P18528, DOI 10.1074/jbc.273.29.18528; SKOLNIK EY, 1993, EMBO J, V12, P1929, DOI 10.1002/j.1460-2075.1993.tb05842.x; SMITH RM, 1993, ARCH BIOCHEM BIOPHYS, V300, P238, DOI 10.1006/abbi.1993.1033; Sweeney G, 2001, ENDOCRINOLOGY, V142, P4806, DOI 10.1210/en.142.11.4806; Takano A, 2001, DIABETES, V50, P1891, DOI 10.2337/diabetes.50.8.1891; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Venable CL, 2000, J BIOL CHEM, V275, P18318, DOI 10.1074/jbc.M908392199; Watson RT, 2004, ENDOCR REV, V25, P177, DOI 10.1210/er.2003-0011; Watson RT, 2001, RECENT PROG HORM RES, V56, P175, DOI 10.1210/rp.56.1.175; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; WHITE MF, 1997, DIABETOLOGIA, V40, P2; Yuen K, 2002, CLIN ENDOCRINOL, V57, P333, DOI 10.1046/j.1365-2265.2002.01601.x	44	24	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6061	6070		10.1074/jbc.M808282200	http://dx.doi.org/10.1074/jbc.M808282200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19122000	Green Published, hybrid			2022-12-25	WOS:000263742700008
J	Stewart, AK; Kurschat, CE; Vaughan-Jones, RD; Alper, SL				Stewart, Andrew K.; Kurschat, Christine E.; Vaughan-Jones, Richard D.; Alper, Seth L.			Putative Re-entrant Loop 1 of AE2 Transmembrane Domain Has a Major Role in Acute Regulation of Anion Exchange by pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-RESIDUES; COEXPRESSED FRAGMENTS; CL-/HCO3-EXCHANGER; INTRACELLULAR PH; BAND-3; PROTEIN; TOPOLOGY; TRANSPORT; REGION; COMPLEMENTATION	Normal pH sensitivity of the SLC4A2/AE2 anion exchanger requires transmembrane domain (TMD) amino acid (aa) residues not conserved in the homologous but relatively pH-insensitive SLC4A1/AE1 polypeptide. We tested the hypothesis that the nonconserved aa cluster (DKPK1078)-D-1075 within the first putative re-entrant loop (RL1) of AE2 TMD contributes to pH sensor function by studying anion exchange function of AE2 mutants in which these and other RL1 aa were systematically substituted with corresponding RL1 aa from AE1. Regulation of Cl-/Cl- and Cl-/HCO3- exchange by intracellular pH (pH(i)) or extracellular pH (pH(o)) was measured as 4,4'-di-isothiocyanatostilbene-2,2' disulfonic acid- sensitive Cl-36(-) efflux from Xenopus oocytes. AE2 RL1 mutants (1075)AAAQ(1078) and (1075)AAAQN(1079) showed reduced pHi sensitivity and pHo sensitivity was acid- shifted by similar to 1 pH unit. Individual mutants D1075A and P1077A exhibited moderately altered pH sensitivity, whereas a range of substitutions at conserved AE2 Ile-1079 substantially altered sensitivity to pH(o) and/or pH(i). Substitution of the complete AE1 RL1 with AE2 RL1 failed to confer AE2-like pH sensitivity onto AE1. Replacement, however, of AE1 RL1 (763)SGPGAAAQ(770) with AE2 (1071)VAPGDKPK(1078) restored pHi sensitivity to the chimera AE2((1-920))/AE1((613-929)) without affecting its low sensitivity to pHo. The results show that acute regulation of AE2 by pH requires RL1 of the TMD. We propose that critical segments of RL1 constitute part of an AE2 pH sensor that, together with residues within the N-terminal half of the TMD, constrain the AE2 polypeptide in a conformation required for regulation of anion exchange by pHi.	[Stewart, Andrew K.; Kurschat, Christine E.; Alper, Seth L.] Beth Israel Deaconess Med Ctr, Mol & Vasc Med Unit, Boston, MA 02215 USA; [Stewart, Andrew K.; Kurschat, Christine E.; Alper, Seth L.] Beth Israel Deaconess Med Ctr, Renal Unit, Boston, MA 02215 USA; [Stewart, Andrew K.; Kurschat, Christine E.; Alper, Seth L.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; [Vaughan-Jones, Richard D.] Univ Oxford, Univ Lab Physiol, Burdon Sanderson Cardiac Sci Ctr, Oxford OX1 3PT, England	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Oxford	Alper, SL (corresponding author), Beth Israel Deaconess Med Ctr, Mol & Vasc Med Unit, RW763 E Campus,330 Brookline Ave, Boston, MA 02215 USA.	salper@caregroup.harvard.edu			National Institutes of Health [DK43495]; Beth Israel Deaconess Medical Center [RR017927]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043495, R37DK043495] Funding Source: NIH RePORTER; British Heart Foundation [RG/08/016/26423] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beth Israel Deaconess Medical Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); British Heart Foundation(British Heart Foundation)	This work was supported, in whole or in part, by National Institutes of Health Grants DK43495 ( to S. L. A.) and RR017927 ( Shared Instrument Grant) to Beth Israel Deaconess Medical Center.	BROSIUS FC, 1989, J BIOL CHEM, V264, P7784; Chernova MN, 2003, AM J PHYSIOL-CELL PH, V284, pC1235, DOI 10.1152/ajpcell.00522.2002; Fujinaga J, 1999, J BIOL CHEM, V274, P6626, DOI 10.1074/jbc.274.10.6626; Gawenis LR, 2004, J BIOL CHEM, V279, P30531, DOI 10.1074/jbc.M403779200; GRINSTEIN S, 1978, BIOCHIM BIOPHYS ACTA, V507, P294, DOI 10.1016/0005-2736(78)90424-8; Groves JD, 1998, BIOCHEM J, V332, P161, DOI 10.1042/bj3320161; Groves JD, 1999, BIOCHEM J, V344, P687, DOI 10.1042/0264-6021:3440687; Hackel M, 1999, BIOPHYS CHEM, V82, P35, DOI 10.1016/S0301-4622(99)00104-0; JEAN T, 1985, J BIOL CHEM, V260, P9678; Kanki T, 2002, BIOCHEMISTRY-US, V41, P13973, DOI 10.1021/bi026619q; KOPITO RR, 1989, CELL, V59, P927, DOI 10.1016/0092-8674(89)90615-6; Kuma H, 2002, BIOCHEMISTRY-US, V41, P3380, DOI 10.1021/bi015879p; Kurschat CE, 2006, J BIOL CHEM, V281, P1885, DOI 10.1074/jbc.M509734200; LINN SC, 1992, J BIOL CHEM, V267, P7927; Matta CF, 2003, PROTEINS, V52, P360, DOI 10.1002/prot.10414; McAlear SD, 2006, J BIOL CHEM, V281, P32417, DOI 10.1074/jbc.M607253200; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; Niederer SA, 2008, BIOPHYS J, V94, P2385, DOI 10.1529/biophysj.107.118885; Popov M, 1999, BIOCHEM J, V339, P269, DOI 10.1042/0264-6021:3390269; Sackin H, 2006, BIOPHYS J, V90, P3582, DOI 10.1529/biophysj.105.076653; Stewart AK, 2007, J PHYSIOL-LONDON, V584, P59, DOI 10.1113/jphysiol.2007.136119; Stewart AK, 2007, PFLUG ARCH EUR J PHY, V454, P373, DOI 10.1007/s00424-007-0220-8; Stewart AK, 2007, AM J PHYSIOL-CELL PH, V292, pC909, DOI 10.1152/ajpcell.00265.2006; Stewart AK, 2004, J BIOL CHEM, V279, P52664, DOI 10.1074/jbc.M408108200; Stewart AK, 2002, J GEN PHYSIOL, V120, P707, DOI 10.1085/jgp.20028641; Stewart AK, 2001, AM J PHYSIOL-CELL PH, V281, pC1344, DOI 10.1152/ajpcell.2001.281.4.C1344; STEWART AK, 2007, KIDNEY, V2, P1499; Tang XB, 1998, J BIOL CHEM, V273, P22545, DOI 10.1074/jbc.273.35.22545; Tang XB, 1999, J BIOL CHEM, V274, P3557, DOI 10.1074/jbc.274.6.3557; VAUGHANJONES RD, 1990, J PHYSIOL-LONDON, V428, P441, DOI 10.1113/jphysiol.1990.sp018221; Wang L, 1997, J BIOL CHEM, V272, P10631; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; WOOD PG, 1992, PROGR CELL RES, V2, P325; Zhang Y, 1996, J BIOL CHEM, V271, P5741, DOI 10.1074/jbc.271.10.5741; Zhu QS, 2004, J BIOL CHEM, V279, P23565, DOI 10.1074/jbc.M401380200; Zhu QS, 2003, J BIOL CHEM, V278, P3112, DOI 10.1074/jbc.M207797200	36	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6126	6139		10.1074/jbc.M802051200	http://dx.doi.org/10.1074/jbc.M802051200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19103596	hybrid, Green Published			2022-12-25	WOS:000263742700015
J	Herbert, SP; Odell, AF; Ponnambalam, S; Walker, JH				Herbert, Shane P.; Odell, Adam F.; Ponnambalam, Sreenivasan; Walker, John H.			Activation of Cytosolic Phospholipase A(2)-alpha as a Novel Mechanism Regulating Endothelial Cell Cycle Progression and Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID RELEASE; PROLIFERATING CELLS; DNA-REPLICATION; ANTIBODY KI-67; IN-VITRO; A(2); EXPRESSION; MEMBRANE; PATHWAY; ANTIGEN	Release of endothelial cells from contact-inhibition and cell cycle re-entry is required for the induction of new blood vessel formation by angiogenesis. Using a combination of chemical inhibition, loss of function, and gain of function approaches, we demonstrate that endothelial cell cycle re-entry, S phase progression, and subsequent angiogenic tubule formation are dependent upon the activity of cytosolic phospholipase A(2)-alpha (cPLA(2)alpha). Inhibition of cPLA(2)alpha activity and small interfering RNA (siRNA)-mediated knockdown of endogenous cPLA(2)alpha reduced endothelial cell proliferation. In the absence of cPLA(2)alpha activity, endothelial cells exhibited retarded progression from G(1) through S phase, displayed reduced cyclin A/cdk2 expression, and generated less arachidonic acid. In quiescent endothelial cells, cPLA(2)alpha is inactivated upon its sequestration at the Golgi apparatus. Upon the stimulation of endothelial cell proliferation, activation of cPLA(2)alpha by release from the Golgi apparatus was critical to the induction of cyclin A expression and efficient cell cycle progression. Consequently, inhibition of cPLA(2)alpha was sufficient to block angiogenic tubule formation in vitro. Furthermore, the siRNA-mediated retardation of endothelial cell cycle re-entry and proliferation was reversed upon overexpression of an siRNA-resistant form of cPLA(2)alpha. Thus, activation of cPLA(2)alpha acts as a novel mechanism for the regulation of endothelial cell cycle re-entry, cell cycle progression, and angiogenesis.	[Herbert, Shane P.; Odell, Adam F.; Ponnambalam, Sreenivasan; Walker, John H.] Univ Leeds, Endothelial Cell Biol Unit, Inst Mol & Cell Biol, Leeds Inst Genet Hlth & Therapeut, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Walker, JH (corresponding author), Univ Leeds, Endothelial Cell Biol Unit, Inst Mol & Cell Biol, Leeds Inst Genet Hlth & Therapeut, Leeds LS2 9JT, W Yorkshire, England.	j.h.walker@leeds.ac.uk	Odell, Adam/J-1386-2012	Herbert, Shane/0000-0003-2517-1845; Ponnambalam, Sreenivasan/0000-0002-4452-7619	Biotechnology and Biological Sciences Research Council; Yorkshire Cancer Research; British Heart Foundation; Wellcome Trust	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Yorkshire Cancer Research; British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Biotechnology and Biological Sciences Research Council Ph. D. studentship ( to S. P. H.), a Yorkshire Cancer Research pump priming grant ( to S. P. H. and J.H.W.), a British Heart Foundation project grant ( to S. P. and J.H.W.), a Wellcome Trust project grant ( to S. P. and J.H.W.), and a Wellcome Trust equipment award to the Leeds Bioimaging Facility ( to S. P.).	ACKERMANN EJ, 1995, J BIOL CHEM, V270, P445, DOI 10.1074/jbc.270.1.445; Akiba S, 2004, BIOL PHARM BULL, V27, P1174, DOI 10.1248/bpb.27.1174; Baburina I, 1999, J BIOL CHEM, V274, P9400, DOI 10.1074/jbc.274.14.9400; Boonstra Johannes, 2003, Prog Cell Cycle Res, V5, P181; BREM H, 1993, J PEDIATR SURG, V28, P1253, DOI 10.1016/S0022-3468(05)80308-2; Brown DC, 2002, HISTOPATHOLOGY, V40, P2, DOI 10.1046/j.1365-2559.2002.01343.x; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; CHANNON JY, 1990, J BIOL CHEM, V265, P5409; Coverley D, 2002, NAT CELL BIOL, V4, P523, DOI 10.1038/ncb813; Dennis EA, 1997, TRENDS BIOCHEM SCI, V22, P1, DOI 10.1016/S0968-0004(96)20031-3; Dormond O, 2002, ANTICANCER RES, V22, P3159; EVANS CE, 1984, PROSTA LEUKOTR MED, V14, P255, DOI 10.1016/0262-1746(84)90209-9; Evans JH, 2001, J BIOL CHEM, V276, P30150, DOI 10.1074/jbc.M100943200; Ezan J, 2004, CARDIOVASC RES, V63, P731, DOI 10.1016/j.cardiores.2004.05.006; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; GERDES J, 1984, J IMMUNOL, V133, P1710; Ghomashchi F, 2001, BBA-BIOMEMBRANES, V1513, P160, DOI 10.1016/S0005-2736(01)00349-2; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; Herbert SP, 2007, J BIOL CHEM, V282, P34468, DOI 10.1074/jbc.M701541200; Herbert SP, 2006, J BIOL CHEM, V281, P35709, DOI 10.1074/jbc.M600699200; Herbert SP, 2005, MOL BIOL CELL, V16, P3800, DOI 10.1091/mbc.E05-02-0164; Howell GJ, 2004, MOL MEMBR BIOL, V21, P413, DOI 10.1080/09687860400011571; JACKOWSKI S, 1994, J BIOL CHEM, V269, P3858; Jackowski S, 1996, J BIOL CHEM, V271, P20219, DOI 10.1074/jbc.271.34.20219; Jackowski S, 2000, BBA-MOL CELL BIOL L, V1483, P301, DOI 10.1016/S1388-1981(99)00203-6; Jaffe EA, 1984, BIOL ENDOTHELIAL CEL, P1; Jiang YJ, 2003, MOL CELL BIOCHEM, V246, P31, DOI 10.1023/A:1023495626568; Kramer RM, 1997, FEBS LETT, V410, P49, DOI 10.1016/S0014-5793(97)00322-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mariggio S, 2006, FASEB J, V20, P2567, DOI 10.1096/fj.05-5397fje; Murakami M, 2000, BBA-MOL CELL BIOL L, V1488, P159, DOI 10.1016/S1388-1981(00)00118-9; NALEFSKI EA, 1994, J BIOL CHEM, V269, P18239; Ni Z, 2006, J BIOL CHEM, V281, P16245, DOI 10.1074/jbc.M513874200; Paunesku T, 2001, INT J RADIAT BIOL, V77, P1007, DOI 10.1080/09553000110069335; Sauane M, 2000, BIOCHEM BIOPH RES CO, V270, P11, DOI 10.1006/bbrc.2000.2383; SCHLUTER C, 1993, J CELL BIOL, V123, P513, DOI 10.1083/jcb.123.3.513; Scott KF, 1999, J LEUKOCYTE BIOL, V66, P535, DOI 10.1002/jlb.66.4.535; Shappell SB, 2001, CANCER RES, V61, P497; Staton CA, 2004, INT J EXP PATHOL, V85, P233, DOI 10.1111/j.0959-9673.2004.00396.x; TAKAHASHI T, 1993, J NEUROCYTOL, V22, P1096, DOI 10.1007/BF01235751; Tian W, 2008, J BIOL CHEM, V283, P3960, DOI 10.1074/jbc.M707345200; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; van Rossum GSAT, 2002, CELL MOL LIFE SCI, V59, P181, DOI 10.1007/s00018-002-8414-x; WHATLEY RE, 1994, J CLIN INVEST, V94, P1889, DOI 10.1172/JCI117539; Yazlovitskaya EM, 2008, CELL DEATH DIFFER, V15, P1641, DOI 10.1038/cdd.2008.93; Zhang XH, 2006, J CELL SCI, V119, P1005, DOI 10.1242/jcs.02821; Zhang XH, 2007, J CELL SCI, V120, P4134, DOI 10.1242/jcs.015834	50	33	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5784	5796		10.1074/jbc.M807282200	http://dx.doi.org/10.1074/jbc.M807282200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19119141	Green Published, hybrid			2022-12-25	WOS:000263560600042
J	Miki, T; Okawa, K; Sekimoto, T; Yoneda, Y; Watanabe, S; Ishizaki, T; Narumiya, S				Miki, Takashi; Okawa, Katsuya; Sekimoto, Toshihiro; Yoneda, Yoshihiro; Watanabe, Sadanori; Ishizaki, Toshimasa; Narumiya, Shuh			mDia2 Shuttles between the Nucleus and the Cytoplasm through the Importin-alpha/beta- and CRM1-mediated Nuclear Transport Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOREGULATORY DOMAIN; RIBOSOMAL-SUBUNITS; EXPORT SIGNALS; FORMIN MDIA1; ACTIN; PROTEIN; LOCALIZATION; BINDING; TRANSCRIPTION; PROFILIN	Mammalian homolog of Drosophila diaphanous (mDia) consisting of three isoforms, mDia1, mDia2, and mDia3, is an effector of Rho GTPases that catalyzes actin nucleation and polymerization. Although the mDia actions on actin dynamics in the cytoplasm have been well studied, whether mDia accumulates and functions in the nucleus remains largely unknown. Given the presence of actin and actin-associated proteins in the nucleus, we have examined nuclear localization of mDia isoforms. We expressed each of mDia isoforms as a green fluorescent protein fusion protein and examined their localization. Although all the mDia isoforms were localized predominantly in the cytoplasm under the steady-state conditions, mDia2 and not mDia1 or mDia3 accumulated extensively in the nucleus upon treatment with leptomycin B (LMB), an inhibitor of CRM1-dependent nuclear export. The LMB-inducednuclear accumulation was confirmed for endogenous mDia2 by using an antibody specific to mDia2. Studies using green fluorescent protein fusions of various truncation mDia2 mutants and point mutants of some of these proteins identified a functional nuclear localization signal in the N terminus of mDia2 and at least one functional nuclear export signal in the C terminus. The nuclear localization signal of mDia2 bound to importin-alpha and was imported into the nucleus by importin-alpha/beta complex in an in vitro transport assay. Consistently, depletion of importin-beta with RNA interference suppressed the LMB-induced nuclear localization of endogenous mDia2. These results suggest that mDia2 continuously shuttles between the nucleus and the cytoplasm using specific nuclear transport machinery composing of importin-alpha/beta and CRM1.	[Miki, Takashi; Watanabe, Sadanori; Ishizaki, Toshimasa; Narumiya, Shuh] Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto 6068501, Japan; [Okawa, Katsuya] Kyoto Univ, Fac Med, Frontier Technol Ctr, Kyoto 6068501, Japan; [Sekimoto, Toshihiro; Yoneda, Yoshihiro] Osaka Univ, Dept Biochem, Grad Sch Med, Suita, Osaka 5650871, Japan; [Yoneda, Yoshihiro] Osaka Univ, Labs Biomol Networks, Dept Frontier Biosci, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Yoneda, Yoshihiro] CREST, JST, Suita, Osaka 5650871, Japan	Kyoto University; Kyoto University; Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Narumiya, S (corresponding author), Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto 6068501, Japan.	snaru@mfour.med.kyoto-u.ac.jp	Miki, Takashi/AGV-9237-2022; Miki, Takashi/S-7569-2018	Miki, Takashi/0000-0003-3715-7039; Miki, Takashi/0000-0003-3715-7039	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for Specially Promoted Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Alberts AS, 1998, J BIOL CHEM, V273, P8616, DOI 10.1074/jbc.273.15.8616; Bione S, 1998, AM J HUM GENET, V62, P533, DOI 10.1086/301761; Copeland JW, 2002, MOL BIOL CELL, V13, P4088, DOI 10.1091/mbc.02-06-0092; Copeland SJ, 2007, J BIOL CHEM, V282, P30120, DOI 10.1074/jbc.M703834200; Dundr M, 2007, J CELL BIOL, V179, P1095, DOI 10.1083/jcb.200710058; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Ji P, 2008, NAT CELL BIOL, V10, P314, DOI 10.1038/ncb1693; Johnson AW, 2002, TRENDS BIOCHEM SCI, V27, P580, DOI 10.1016/S0968-0004(02)02208-9; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Keminer O, 1999, BIOPHYS J, V77, P217, DOI 10.1016/S0006-3495(99)76883-9; Kiseleva E, 2004, J CELL SCI, V117, P2481, DOI 10.1242/jcs.01098; Kovar DR, 2006, CURR OPIN CELL BIOL, V18, P11, DOI 10.1016/J.CEB.2005.12.011; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Macchi P, 2004, J BIOL CHEM, V279, P31440, DOI 10.1074/jbc.C400226200; McDonald D, 2006, J CELL BIOL, V172, P541, DOI 10.1083/jcb.200507101; Menard I, 2006, APOPTOSIS, V11, P1863, DOI 10.1007/s10495-006-0087-8; Michaelson D, 2008, J CELL BIOL, V181, P485, DOI 10.1083/jcb.200801047; Miki T, 2004, J BIOL CHEM, V279, P47473, DOI 10.1074/jbc.M407883200; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Nagoshi E, 1999, MOL BIOL CELL, V10, P2221, DOI 10.1091/mbc.10.7.2221; Olave IA, 2002, ANNU REV BIOCHEM, V71, P755, DOI 10.1146/annurev.biochem.71.110601.135507; Pederson T, 2005, MOL BIOL CELL, V16, P5055, DOI 10.1091/mbc.E05-07-0656; Pederson T, 2008, J CELL BIOL, V180, P1061, DOI 10.1083/jcb.200709082; Pellegrin S, 2005, CURR BIOL, V15, P129, DOI 10.1016/j.cub.2005.01.011; Peng J, 2003, CURR BIOL, V13, P534, DOI 10.1016/S0960-9822(03)00170-2; Percipalle P, 2006, J CELL BIOL, V172, P967, DOI 10.1083/jcb.200512083; Sekimoto T, 2004, EMBO J, V23, P1934, DOI 10.1038/sj.emboj.7600198; SIOMI H, 1995, J CELL BIOL, V129, P551, DOI 10.1083/jcb.129.3.551; Skare P, 2003, EXP CELL RES, V286, P12, DOI 10.1016/S0014-4827(03)00102-2; Stuven T, 2003, EMBO J, V22, P5928, DOI 10.1093/emboj/cdg565; Suetsugu S, 2003, J BIOL CHEM, V278, P42515, DOI 10.1074/jbc.M302177200; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Wallar BJ, 2006, J BIOL CHEM, V281, P4300, DOI 10.1074/jbc.M510277200; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Watanabe S, 2008, MOL BIOL CELL, V19, P2328, DOI 10.1091/mbc.E07-10-1086; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Yasuda S, 2004, NATURE, V428, P767, DOI 10.1038/nature02452; Ye J, 2008, GENE DEV, V22, P322, DOI 10.1101/gad.455908; Zemp I, 2007, FEBS LETT, V581, P2783, DOI 10.1016/j.febslet.2007.05.013; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	49	38	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5753	5762		10.1074/jbc.M806191200	http://dx.doi.org/10.1074/jbc.M806191200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19117945	hybrid			2022-12-25	WOS:000263560600039
J	Tang, TD; Zheng, B; Chen, SH; Murphy, AN; Kudlicka, K; Zhou, HL; Farquhar, MG				Tang, Tingdong; Zheng, Bin; Chen, Sheng-Hong; Murphy, Anne N.; Kudlicka, Krystyna; Zhou, Huilin; Farquhar, Marilyn G.			hNOA1 Interacts with Complex I and DAP3 and Regulates Mitochondrial Respiration and Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; CELL-DEATH; ENDOPLASMIC-RETICULUM; PROTEIN; FISSION; IDENTIFICATION; MUTATIONS; MEDIATOR; BINDING; FUSION	Mitochondria are dynamic organelles that play key roles in metabolism, energy production, and apoptosis. Coordination of these processes is essential to maintain normal cellular functions. Here we characterized hNOA1, the human homologue of AtNOA1 (Arabidopsis thaliana nitric oxide-associated protein 1), a large mitochondrial GTPase. By immunofluorescence, immunoelectron microscopy, and mitochondrial subfractionation, endogenous hNOA1 is localized within mitochondria where it is peripherally associated with the inner mitochondrial membrane facing the mitochondrial matrix. Overexpression and knockdown of hNOA1 led to changes in mitochondrial shape implying effects on mitochondrial dynamics. To identify the interaction partners of hNOA1 and to further understand its cellular functions, we performed immunoprecipitation-mass spectrometry analysis of endogenous hNOA1 from enriched mitochondrial fractions and found that hNOA1 interacts with both Complex I of the electron transport chain and DAP3 (death-associated protein 3), a positive regulator of apoptosis. Knockdown of hNOA1 reduces mitochondrial O-2 consumption similar to 20% in a Complex I-dependent manner, supporting a functional link between hNOA1 and Complex I. Moreover, knockdown of hNOA1 renders cells more resistant to apoptotic stimuli such as gamma-interferon and staurosporine, supporting a role for hNOA1 in regulating apoptosis. Thus, based on its interactions with both Complex I and DAP3, hNOA1 may play a role in mitochondrial respiration and apoptosis.	[Farquhar, Marilyn G.] Univ Calif San Diego, Dept Cellular & Mol Med, George Palade Labs Cellular & Mol Med, La Jolla, CA 92093 USA; [Murphy, Anne N.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Chen, Sheng-Hong; Zhou, Huilin] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Farquhar, MG (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, George Palade Labs Cellular & Mol Med, Rm 210,9500 Gilman Dr, La Jolla, CA 92093 USA.	mfarquhar@ucsd.edu	Chen, Sheng-hong/AAU-4018-2021; Murphy, Anne N/H-3217-2016	Chen, Sheng-hong/0000-0002-7722-2221; Murphy, Anne N/0000-0002-5222-9902; Zheng, Bin/0000-0002-0998-7177; Zhou, Huilin/0000-0002-1350-4430	National Institutes of Health [CA100768, DKI7780]; NATIONAL CANCER INSTITUTE [R01CA100768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080469] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA100768 and DKI7780 ( to M. G. F.).	ALBERTS B, 2008, MOL BIOL CELL, V5, P827; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Berger T, 2000, J CELL SCI, V113, P3603; Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014; Bossy-Wetzel E, 2003, CURR OPIN CELL BIOL, V15, P706, DOI 10.1016/j.ceb.2003.10.015; Cardol P, 2002, J MOL BIOL, V319, P1211, DOI 10.1016/S0022-2836(02)00407-2; CAVDAR KE, 2001, FEBS LETT, V492, P166; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; CORTESE JD, 1995, BBA-BIOENERGETICS, V1228, P216, DOI 10.1016/0005-2728(94)00178-8; Crawford NM, 2006, TRENDS PLANT SCI, V11, P526, DOI 10.1016/j.tplants.2006.09.007; DiMauro S, 2001, SEMIN CELL DEV BIOL, V12, P397, DOI 10.1006/scdb.2001.0277; Eskelinen EL, 2004, MOL BIOL CELL, V15, P3132, DOI 10.1091/mbc.E04-02-0103; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Fukushima NH, 2001, MOL BIOL CELL, V12, P2756, DOI 10.1091/mbc.12.9.2756; Guo FQ, 2003, SCIENCE, V302, P100, DOI 10.1126/science.1086770; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.bi.54.070185.005055; Hobman TC, 1998, MOL BIOL CELL, V9, P1265, DOI 10.1091/mbc.9.6.1265; Huang S, 1997, J NEUROCHEM, V69, P2516; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Jofuku A, 2005, BIOCHEM BIOPH RES CO, V333, P650, DOI 10.1016/j.bbrc.2005.05.154; Kim HR, 2007, FASEB J, V21, P188, DOI 10.1096/fj.06-6283com; Kim R, 2006, CANCER CHEMOTH PHARM, V57, P545, DOI 10.1007/s00280-005-0111-7; KISSIL JL, 1995, J BIOL CHEM, V270, P27932, DOI 10.1074/jbc.270.46.27932; Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V289, pC881, DOI 10.1152/ajpcell.00104.2005; LAPIDUS RG, 1993, ARCH BIOCHEM BIOPHYS, V306, P246, DOI 10.1006/abbi.1993.1507; Le-Niculescu H, 2005, J BIOL CHEM, V280, P22012, DOI 10.1074/jbc.M501833200; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Lehtonen S, 2008, MOL BIOL CELL, V19, P2949, DOI 10.1091/mbc.E07-05-0521; Lenaz G, 2006, BBA-BIOENERGETICS, V1757, P1406, DOI 10.1016/j.bbabio.2006.05.007; Lin P, 1998, J CELL BIOL, V141, P1515, DOI 10.1083/jcb.141.7.1515; Malfatti E, 2007, BRAIN, V130, P1894, DOI 10.1093/brain/awm114; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Meeusen S, 2006, CELL, V127, P383, DOI 10.1016/j.cell.2006.09.021; Moreau M, 2008, J BIOL CHEM, V283, P32957, DOI 10.1074/jbc.M804838200; Morimoto T, 2002, MICROBIOL-SGM, V148, P3539, DOI 10.1099/00221287-148-11-3539; Mukamel Z, 2004, J BIOL CHEM, V279, P36732, DOI 10.1074/jbc.M400041200; Murphy AN, 1996, P NATL ACAD SCI USA, V93, P9893, DOI 10.1073/pnas.93.18.9893; Nagai M, 2003, MOL BIOL CELL, V14, P4984, DOI 10.1091/mbc.E03-06-0385; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Pagliarini DJ, 2005, MOL CELL, V19, P197, DOI 10.1016/j.molcel.2005.06.008; Parihar A, 2008, LIFE SCI, V82, P1077, DOI 10.1016/j.lfs.2008.03.019; Parihar MS, 2008, BBA-GEN SUBJECTS, V1780, P921, DOI 10.1016/j.bbagen.2008.02.006; Parihar MS, 2008, BIOCHEM BIOPH RES CO, V367, P761, DOI 10.1016/j.bbrc.2008.01.015; Parihar MS, 2008, BIOCHEM BIOPH RES CO, V366, P23, DOI 10.1016/j.bbrc.2007.11.056; Santel A, 2001, J CELL SCI, V114, P867; Satoh M, 2003, BIOCHEM BIOPH RES CO, V300, P482, DOI 10.1016/S0006-291X(02)02874-7; Sudhamsu J, 2008, J BIOL CHEM, V283, P32968, DOI 10.1074/jbc.M804837200; Suzuki T, 2001, J BIOL CHEM, V276, P33181, DOI 10.1074/jbc.M103236200; Tondera D, 2005, J CELL SCI, V118, P3049, DOI 10.1242/jcs.02415; Venkatakrishnan P, 2008, FASEB J, V22; Vrbacky M, 2003, PHYSIOL RES, V52, P545; Wiley SE, 2007, P NATL ACAD SCI USA, V104, P5318, DOI 10.1073/pnas.0701078104; Zemojtel T, 2006, FEBS LETT, V580, P455, DOI 10.1016/j.febslet.2005.12.038; Zemojtel T, 2006, TRENDS PLANT SCI, V11, P524, DOI 10.1016/j.tplants.2006.09.008; Zheng B, 2004, MOL BIOL CELL, V15, p322A, DOI 10.1091/mbc.e04-06-0446; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200	57	32	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5414	5424		10.1074/jbc.M807797200	http://dx.doi.org/10.1074/jbc.M807797200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19103604	Green Published, hybrid			2022-12-25	WOS:000263416600071
J	Stein, CM; Zalwango, S; Malone, LL; Won, SH; Mayanja-Kizza, H; Mugerwa, RD; Leontiev, DV; Thompson, CL; Cartier, KC; Elston, RC; Iyengar, SK; Boom, WH; Whalen, CC				Stein, Catherine M.; Zalwango, Sarah; Malone, LaShaunda L.; Won, Sungho; Mayanja-Kizza, Harriet; Mugerwa, Roy D.; Leontiev, Dmitry V.; Thompson, Cheryl L.; Cartier, Kevin C.; Elston, Robert C.; Iyengar, Sudha K.; Boom, W. Henry; Whalen, Christopher C.			Genome Scan of M-tuberculosis Infection and Disease in Ugandans	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; INTERFERON-GAMMA RECEPTOR; QUANTITATIVE-TRAIT; ASSOCIATION ANALYSIS; LINKAGE ANALYSIS; IMMUNE-RESPONSE; IFN-GAMMA; SUSCEPTIBILITY; POLYMORPHISM; GENES	Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), is an enduring public health problem globally, particularly in sub-Saharan Africa. Several studies have suggested a role for host genetic susceptibility in increased risk for TB but results across studies have been equivocal. As part of a household contact study of Mtb infection and disease in Kampala, Uganda, we have taken a unique approach to the study of genetic susceptibility to TB, by studying three phenotypes. First, we analyzed culture confirmed TB disease compared to latent Mtb infection (LTBI) or lack of Mtb infection. Second, we analyzed resistance to Mtb infection in the face of continuous exposure, defined by a persistently negative tuberculin skin test (PTST-); this outcome was contrasted to LTBI. Third, we analyzed an intermediate phenotype, tumor necrosis factor-alpha (TNF alpha) expression in response to soluble Mtb ligands enriched with molecules secreted from Mtb (culture filtrate). We conducted a full microsatellite genome scan, using genotypes generated by the Center for Medical Genetics at Marshfield. Multipoint model-free linkage analysis was conducted using an extension of the Haseman-Elston regression model that includes half sibling pairs, and HIV status was included as a covariate in the model. The analysis included 803 individuals from 193 pedigrees, comprising 258 full sibling pairs and 175 half sibling pairs. Suggestive linkage (p, 10 23) was observed on chromosomes 2q21-2q24 and 5p13-5q22 for PTST-, and on chromosome 7p22-7p21 for TB; these findings for PTST-are novel and the chromosome 7 region contains the IL6 gene. In addition, we replicated recent linkage findings on chromosome 20q13 for TB (p = 0.002). We also observed linkage at the nominal a = 0.05 threshold to a number of promising candidate genes, SLC11A1 (PTST-p = 0.02), IL-1 complex (TB p = 0.01), IL12BR2 (TNF alpha p = 0.006), IL12A (TB p = 0.02) and IFNGR2 (TNF alpha p = 0.002). These results confirm not only that genetic factors influence the interaction between humans and Mtb but more importantly that they differ according to the outcome of that interaction: exposure but no infection, infection without progression to disease, or progression of infection to disease. Many of the genetic factors for each of these stages are part of the innate immune system.	[Stein, Catherine M.; Won, Sungho; Leontiev, Dmitry V.; Cartier, Kevin C.; Elston, Robert C.; Iyengar, Sudha K.; Whalen, Christopher C.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Stein, Catherine M.; Malone, LaShaunda L.; Boom, W. Henry; Whalen, Christopher C.] Case Western Reserve Univ, Dept Med, TB Res Unit, Cleveland, OH 44106 USA; [Thompson, Cheryl L.] Case Western Reserve Univ, Dept Family Med, Cleveland, OH 44106 USA; [Stein, Catherine M.; Zalwango, Sarah; Mayanja-Kizza, Harriet; Mugerwa, Roy D.; Boom, W. Henry; Whalen, Christopher C.] Case Western Reserve Univ, Uganda Res Collaborat, Kampala, Uganda; [Mayanja-Kizza, Harriet; Mugerwa, Roy D.] Makerere Univ, Sch Med, Mulago Hosp, Kampala, Uganda	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Makerere University; Mulago National Referral Hospital	Stein, CM (corresponding author), Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA.	kasia@darwin.cwru.edu	Mayanja-Kizza, Harriet/AAM-5372-2020; /S-1190-2019; Stein, Catherine/P-9498-2019	Mayanja-Kizza, Harriet/0000-0002-9297-6208; /0000-0001-7488-250X; Stein, Catherine/0000-0002-9763-5023	National Institutes of Health, National Center for Research Resources (NCRR) Multidisciplinary Clinical Research Career Development [KL2RR024990]; Tuberculosis Research Unit [N01-AI95383, HHSN266200700022C]; NIAID [N01-AI70022]; STERIS Corporation; Gene Expression and Genotyping Facility of the Comprehensive Cancer Center of Case Western Reserve University; University Hospitals of Cleveland [P30 CA43703]; NHLBI Mammalian Genotyping Service [HV48141]; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024990, P41RR003655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI095383] Funding Source: NIH RePORTER	National Institutes of Health, National Center for Research Resources (NCRR) Multidisciplinary Clinical Research Career Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Tuberculosis Research Unit; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); STERIS Corporation; Gene Expression and Genotyping Facility of the Comprehensive Cancer Center of Case Western Reserve University; University Hospitals of Cleveland; NHLBI Mammalian Genotyping Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported in part by the National Institutes of Health, National Center for Research Resources (NCRR) Multidisciplinary Clinical Research Career Development Programs Grant (KL2RR024990), Tuberculosis Research Unit (grant N01-AI95383 and HHSN266200700022C/ N01-AI70022 from the NIAID), a developmental grant from the STERIS Corporation, the Gene Expression and Genotyping Facility of the Comprehensive Cancer Center of Case Western Reserve University and University Hospitals of Cleveland (P30 CA43703), and the NHLBI Mammalian Genotyping Service (Contract Number HV48141). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; Awomoyi AA, 2005, J ENDOTOXIN RES, V11, P281, DOI 10.1179/096805105X58706; BARNES PF, 1990, J IMMUNOL, V145, P149; Bellamy R., 1998, Tubercle and Lung Disease, V79, P83, DOI 10.1054/tuld.1998.0009; Bellamy R, 2000, P NATL ACAD SCI USA, V97, P8005, DOI 10.1073/pnas.140201897; Berrington WR, 2007, IMMUNOL REV, V219, P167, DOI 10.1111/j.1600-065X.2007.00545.x; Burl S, 2007, CLIN EXP IMMUNOL, V149, P117, DOI 10.1111/j.1365-2249.2007.03399.x; COMSTOCK GW, 1982, AM REV RESPIR DIS, V125, P8; Cooke GS, 2006, AM J RESP CRIT CARE, V174, P339, DOI 10.1164/rccm.200601-088OC; Cooke GS, 2008, AM J RESP CRIT CARE, V178, P203, DOI 10.1164/rccm.200710-1554OC; Cordell HJ, 2001, ANN HUM GENET, V65, P491, DOI 10.1017/S0003480001008831; CROWLE AJ, 1990, INFECT IMMUN, V58, P632, DOI 10.1128/IAI.58.3.632-638.1990; Doffinger R, 2000, J INFECT DIS, V181, P379, DOI 10.1086/315197; Dorman SE, 1998, J CLIN INVEST, V101, P2364, DOI 10.1172/JCI2901; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; El Baghdadi J, 2006, J EXP MED, V203, P1679, DOI 10.1084/jem.20060269; Elston RC, 2000, GENET EPIDEMIOL, V19, P1, DOI 10.1002/1098-2272(200007)19:1<1::AID-GEPI1>3.0.CO;2-E; Epstein MP, 2000, AM J HUM GENET, V67, P1219, DOI 10.1016/S0002-9297(07)62952-8; Fisher R., 1950, STAT METHODS RES WOR; Gomez LM, 2006, TISSUE ANTIGENS, V67, P290, DOI 10.1111/j.1399-0039.2006.00566.x; Guwatudde D, 2003, B WORLD HEALTH ORGAN, V81, P799; Guwatudde D, 2003, AM J EPIDEMIOL, V158, P887, DOI 10.1093/aje/kwg227; Hall MA, 2002, AM J HUM GENET, V70, P1172, DOI 10.1086/340090; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Jamieson SE, 2004, GENES IMMUN, V5, P46, DOI 10.1038/sj.gene.6364029; Jorgenson E, 2005, AM J HUM GENET, V76, P276, DOI 10.1086/427926; Kaufmann SHE, 2006, INT J TUBERC LUNG D, V10, P1068; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kusuhara K, 2007, INT J IMMUNOGENET, V34, P35, DOI 10.1111/j.1744-313X.2007.00653.x; Ladel CH, 1997, INFECT IMMUN, V65, P4843, DOI 10.1128/IAI.65.11.4843-4849.1997; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Li HT, 2006, INT J TUBERC LUNG D, V10, P3; McKinney JD, 1998, BIOMED RES REP, P51; Miller EN, 2004, GENES IMMUN, V5, P63, DOI 10.1038/sj.gene.6364031; Montoya-Delgado LE, 2001, GENETICS, V158, P875; Ohyama H, 2005, J CLIN PATHOL, V58, P740, DOI 10.1136/jcp.2004.023903; Olson JM, 2004, HUM HERED, V58, P49, DOI 10.1159/000081456; Oral HB, 2006, CYTOKINE, V35, P143, DOI 10.1016/j.cyto.2006.07.015; Pritchard JK, 2000, GENETICS, V155, P945; RAVIGLIONE MC, 1995, JAMA-J AM MED ASSOC, V273, P220, DOI 10.1001/jama.273.3.220; RICE J, 1978, AM J HUM GENET, V30, P618; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Roach DR, 2002, J IMMUNOL, V168, P4620, DOI 10.4049/jimmunol.168.9.4620; Schaid DJ, 2000, GENET EPIDEMIOL, V19, P30, DOI 10.1002/1098-2272(200007)19:1<30::AID-GEPI3>3.3.CO;2-O; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Shete S, 2003, HUM HERED, V55, P79, DOI 10.1159/000072312; Sinha R, 2008, HUM HERED, V65, P66, DOI 10.1159/000108938; STEAD WW, 1992, ANN INTERN MED, V116, P937, DOI 10.7326/0003-4819-116-11-937; STEAD WW, 1990, NEW ENGL J MED, V322, P422, DOI 10.1056/NEJM199002153220702; Stein CM, 2007, HUM GENET, V121, P663, DOI 10.1007/s00439-007-0357-8; Stein CM, 2005, HUM HERED, V60, P109, DOI 10.1159/000088913; Stein CM, 2003, J INFECT DIS, V187, P1679, DOI 10.1086/375249; Thompson CL, 2006, AM J HUM GENET, V79, P606, DOI 10.1086/507847; van Crevel R, 2002, CLIN MICROBIOL REV, V15, P294, DOI 10.1128/CMR.15.2.294-309.2002; van de Vosse E, 2004, LANCET INFECT DIS, V4, P739, DOI 10.1016/S1473-3099(04)01203-4; Wheeler E, 2006, ANN HUM GENET, V70, P78, DOI 10.1111/j.1529-8817.2005.00223.x; Wilkinson RJ, 1999, J EXP MED, V189, P1863, DOI 10.1084/jem.189.12.1863; Zhang YM, 2003, NAT GENET, V34, P181, DOI 10.1038/ng1166	59	89	92	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4094	10.1371/journal.pone.0004094	http://dx.doi.org/10.1371/journal.pone.0004094			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DO	19116662	gold, Green Published, Green Submitted			2022-12-25	WOS:000265466600015
J	Zhou, YC; Zheng, M; Shi, QX; Zhang, L; Zhen, W; Chen, WY; Zhang, YL				Zhou, Yuchuan; Zheng, Min; Shi, Qixian; Zhang, Li; Zhen, Wei; Chen, Wenying; Zhang, Yonglian			An Epididymis-Specific Secretory Protein HongrES1 Critically Regulates Sperm Capacitation and Male Fertility	PLOS ONE			English	Article								Mammalian sperm capacitation is an essential prerequisite to fertilizion. Although progress had been made in understanding the physiology and biochemistry of capacitation, little is known about the potential roles of epididymal proteins during this process. Here we report that HongrES1, a new member of the SERPIN ( serine proteinase inhibitor) family exclusively expressed in the rat cauda epididymis and up-regulated by androgen, is secreted into the lumen and covers the sperm head. Co-culture of caudal sperms with HongrES1 antibody in vitro resulted in a significant increase in the percentage of capacitated spermatozoa. Furthermore, the percentage of capacitated spermatozoa clearly increased in rats when HongrES1 was down-regulated by RNAi in vivo. Remarkably, knockdown of HongrES1 in vivo led to reduced fertility accompanied with deformed appearance of fetuses and pups. These results identify HongrES1 as a novel and critical molecule in the regulation of sperm capacitation and male fertility.	[Zhou, Yuchuan; Zheng, Min; Zhang, Li; Zhen, Wei; Zhang, Yonglian] Chinese Acad Sci, Shanghai Key Lab Mol Androl, Inst Biochem & Cell Biol, State Key Lab Mol Biol,Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Shi, Qixian; Chen, Wenying] Zhejiang Acad Med Sci, Unit Reproduct Physiol, Hangzhou, Peoples R China; [Zhang, Yonglian] Shanghai Inst Planned Parenthood Res, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Zhejiang Academy of Medical Sciences	Zhou, YC (corresponding author), Chinese Acad Sci, Shanghai Key Lab Mol Androl, Inst Biochem & Cell Biol, State Key Lab Mol Biol,Shanghai Inst Biol Sci, Shanghai, Peoples R China.	ylzhang@sibs.ac.cn	zhou, yuchuan/AAF-6202-2019		973 program [2006CB504002, 2006CB944002]; National Natural Science Foundation of China [30400072]; Chinese Post Doctoral Science Foundation [2005037519]; Shanghai Science and Technology [06JC14075]; Chinese Academy of Sciences (CAS) Knowledge Creative Program [KSCX1-YW-R-54]	973 program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Post Doctoral Science Foundation(China Postdoctoral Science Foundation); Shanghai Science and Technology(Shanghai Science & Technology Committee); Chinese Academy of Sciences (CAS) Knowledge Creative Program(Chinese Academy of Sciences)	This research was supported by following grants: The 973 program (2006CB504002 and 2006CB944002), the National Natural Science Foundation of China (30400072), Chinese Post Doctoral Science Foundation (2005037519), Shanghai Science and Technology funding (06JC14075), the Chinese Academy of Sciences (CAS) Knowledge Creative Program (KSCX1-YW-R-54).	Ajduk A, 2006, BIOL REPROD, V75, P442, DOI 10.1095/biolreprod.106.053223; Araki Y, 2002, J ANDROL, V23, P854; AUSTIN CR, 1951, AUST J SCI RES SER B, V4, P581, DOI 10.1071/BI9510581; AUSTIN CR, 1952, NATURE, V170, P326, DOI 10.1038/170326a0; Brewis Ian A, 2005, Hum Fertil (Camb), V8, P253, DOI 10.1080/14647270500420178; CHANG MC, 1955, NATURE, V175, P1036, DOI 10.1038/1751036a0; CHANG MC, 1951, NATURE, V168, P997; Chauvin TR, 2004, BIOL REPROD, V71, P560, DOI 10.1095/biolreprod.103.026302; Cross NL, 1998, BIOL REPROD, V59, P7, DOI 10.1095/biolreprod59.1.7; DAVIS BK, 1980, P NATL ACAD SCI-BIOL, V77, P1546, DOI 10.1073/pnas.77.3.1546; DAVIS BK, 1981, P NATL ACAD SCI-BIOL, V78, P7560, DOI 10.1073/pnas.78.12.7560; deLamirande E, 1997, MOL HUM REPROD, V3, P175, DOI 10.1093/molehr/3.3.175; DOW MPD, 1989, GAMETE RES, V23, P171, DOI 10.1002/mrd.1120230204; FRASER LR, 1993, J REPROD FERTIL, V97, P539, DOI 10.1530/jrf.0.0970539; Gomendio M, 2006, P NATL ACAD SCI USA, V103, P15113, DOI 10.1073/pnas.0605795103; Harrison RAP, 1996, MOL REPROD DEV, V45, P378, DOI 10.1002/(SICI)1098-2795(199611)45:3&lt;378::AID-MRD16&gt;3.0.CO;2-V; Hinton BT, 1995, REPROD FERT DEVELOP, V7, P731, DOI 10.1071/RD9950731; Hu YX, 2002, CELL RES, V12, P157, DOI 10.1038/sj.cr.7290122; Hu ZH, 2002, CELL RES, V12, P407, DOI 10.1038/sj.cr.7290143; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kirby JL, 2004, BIOL REPROD, V71, P613, DOI 10.1095/biolreprod.103.025635; KOHANE AC, 1980, BIOL REPROD, V23, P737, DOI 10.1095/biolreprod23.4.737; Kumar P, 2007, NATURE, V448, P39, DOI 10.1038/nature05901; Li P, 2001, SCIENCE, V291, P1783, DOI 10.1126/science.1056545; Luconi M, 1998, BIOL REPROD, V58, P1476, DOI 10.1095/biolreprod58.6.1476; Luconi M, 1996, BIOL REPROD, V55, P207, DOI 10.1095/biolreprod55.1.207; Mittal V, 2004, NAT REV GENET, V5, P355, DOI 10.1038/nrg1323; Oberlander G, 1996, J REPROD FERTIL, V106, P231, DOI 10.1530/jrf.0.1060231; ORGEBINCRIST MC, 1967, NATURE, V216, P816, DOI 10.1038/216816a0; Pilch B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r40; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Roberts KP, 2003, BIOL REPROD, V69, P572, DOI 10.1095/biolreprod.102.013771; ROCHWERGER L, 1992, MOL REPROD DEV, V31, P34, DOI 10.1002/mrd.1080310107; ROYERE D, 1991, MOL REPROD DEV, V28, P177, DOI 10.1002/mrd.1080280211; Saxena DK, 2004, BIOL REPROD, V70, P993, DOI 10.1095/biolreprod.103.021667; Seli E, 2004, FERTIL STERIL, V82, P378, DOI 10.1016/j.fertnstert.2003.12.039; Shoji M, 2005, DEV BIOL, V282, P524, DOI 10.1016/j.ydbio.2005.03.030; Suarez SS, 2006, HUM REPROD UPDATE, V12, P23, DOI 10.1093/humupd/dmi047; Suarez SS, 1998, BIOL REPROD, V58, P1105, DOI 10.1095/biolreprod58.5.1105; Syntin P, 1996, BIOL REPROD, V55, P956, DOI 10.1095/biolreprod55.5.956; TAFT R, 1992, Journal of Animal Science, V70, P256; TOYODA Y, 1974, J REPROD FERTIL, V36, P125, DOI 10.1530/jrf.0.0360125; Tulsiani DRP, 2004, BIOESSAYS, V26, P281, DOI 10.1002/bies.20003; Visconti PE, 2002, J REPROD IMMUNOL, V53, P133, DOI 10.1016/S0165-0378(01)00103-6; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; Visconti PE, 1999, DEV BIOL, V214, P429, DOI 10.1006/dbio.1999.9428; Wassarman PM, 1999, CELL, V96, P175, DOI 10.1016/S0092-8674(00)80558-9; Wassarman PM, 2001, NAT CELL BIOL, V3, pE59, DOI 10.1038/35055178; WATSON PF, 1995, REPROD FERT DEVELOP, V7, P891; Yanagimachi R., 1994, P189; Zhou CX, 2004, NAT CELL BIOL, V6, P458, DOI 10.1038/ncb1127; Zhu CF, 2007, BIOL REPROD, V76, P63, DOI 10.1095/biolreprod.106.054635	52	68	74	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4106	10.1371/journal.pone.0004106	http://dx.doi.org/10.1371/journal.pone.0004106			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DO	19116669	Green Published, gold, Green Submitted			2022-12-25	WOS:000265466600023
J	Lee, S; Kasif, S; Weng, ZP; Cantor, CR				Lee, Soohyun; Kasif, Simon; Weng, Zhiping; Cantor, Charles R.			Quantitative Analysis of Single Nucleotide Polymorphisms within Copy Number Variation	PLOS ONE			English	Article							HARDY-WEINBERG EQUILIBRIUM; SEGMENTAL DUPLICATIONS; SEQUENCE VARIATION; GENOTYPING ERRORS; GENE CONVERSION; DEVIATIONS; ADMIXTURE; DETECT; MAP	Background: Single nucleotide polymorphisms (SNPs) have been used extensively in genetics and epidemiology studies. Traditionally, SNPs that did not pass the Hardy-Weinberg equilibrium (HWE) test were excluded from these analyses. Many investigators have addressed possible causes for departure from HWE, including genotyping errors, population admixture and segmental duplication. Recent large-scale surveys have revealed abundant structural variations in the human genome, including copy number variations (CNVs). This suggests that a significant number of SNPs must be within these regions, which may cause deviation from HWE. Results: We performed a Bayesian analysis on the potential effect of copy number variation, segmental duplication and genotyping errors on the behavior of SNPs. Our results suggest that copy number variation is a major factor of HWE violation for SNPs with a small minor allele frequency, when the sample size is large and the genotyping error rate is 0 similar to 1%. Conclusions: Our study provides the posterior probability that a SNP falls in a CNV or a segmental duplication, given the observed allele frequency of the SNP, sample size and the significance level of HWE testing.	[Lee, Soohyun; Kasif, Simon; Weng, Zhiping; Cantor, Charles R.] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Kasif, Simon; Weng, Zhiping; Cantor, Charles R.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Kasif, Simon] Harvard Univ, MIT Hlth Sci & Technol, Childrens Hosp Informat Program, Boston, MA USA; [Cantor, Charles R.] Sequenom Inc, San Diego, CA USA; [Weng, Zhiping] Univ Massachusetts, Worcester, MA USA	Boston University; Boston University; Harvard University; Boston Children's Hospital; Sequenom; University of Massachusetts System; University of Massachusetts Worcester	Lee, S (corresponding author), Boston Univ, Bioinformat Program, Boston, MA 02215 USA.	zhiping@umassmed.edu; ccantor@sequenom.com		Lee, Soohyun/0000-0002-3594-6213	Sequenom [R01 GM080625]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080625] Funding Source: NIH RePORTER	Sequenom; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	R01 GM080625 & Sequenom Support	Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Council N. R., 1996, EV FOR DNA EV; Cox DG, 2006, HUM HERED, V61, P10, DOI 10.1159/000091787; Deng HW, 2001, GENETICS, V157, P885; EMIGH TH, 1980, BIOMETRICS, V36, P627, DOI 10.2307/2556115; Fredman D, 2004, NAT GENET, V36, P861, DOI 10.1038/ng1401; Halder I, 2008, HUM MUTAT, V29, P648, DOI 10.1002/humu.20695; Hardy GH, 1908, SCIENCE, V28, P49, DOI 10.1126/science.28.706.49; HERNANDEZ JL, 1989, BIOMETRICS, V45, P53, DOI 10.2307/2532034; Hosking L, 2004, EUR J HUM GENET, V12, P395, DOI 10.1038/sj.ejhg.5201164; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jeffreys AJ, 2004, NAT GENET, V36, P151, DOI 10.1038/ng1287; Korbel JO, 2007, P NATL ACAD SCI USA, V104, P10110, DOI 10.1073/pnas.0703834104; Leal SM, 2005, GENET EPIDEMIOL, V29, P204, DOI 10.1002/gepi.20086; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Olson JM, 1996, BIOMETRICS, V52, P971, DOI 10.2307/2533058; Ragoussis J, 2006, PLOS GENET, V2, P920, DOI 10.1371/journal.pgen.0020100; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Shoemaker J, 1998, GENETICS, V149, P2079; Trikalinos TA, 2006, AM J EPIDEMIOL, V163, P300, DOI 10.1093/aje/kwj046; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Weinberg W., 1908, JAHRESHEFTE VEREINS, V64, P369; Weir BS., 1996, GENETIC DATA ANAL; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; ZOGOPOULOS G, 2007, HUM GENET	33	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2008	3	12							e3906	10.1371/journal.pone.0003906	http://dx.doi.org/10.1371/journal.pone.0003906			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AT	19093001	Green Published, gold, Green Submitted			2022-12-25	WOS:000265458600001
J	Beyrouthy, MJ; Alexander, KE; Baldwin, A; Whitfield, ML; Bass, HW; McGee, D; Hurt, MM				Beyrouthy, Maroun J.; Alexander, Karen E.; Baldwin, Amy; Whitfield, Michael L.; Bass, Hank W.; McGee, Dan; Hurt, Myra M.			Identification of G1-Regulated Genes in Normally Cycling Human Cells	PLOS ONE			English	Article								Background: Obtaining synchronous cell populations is essential for cell-cycle studies. Methods such as serum withdrawal or use of drugs which block cells at specific points in the cell cycle alter cellular events upon re-entry into the cell cycle. Regulatory events occurring in early G1 phase of a new cell cycle could have been overlooked. Methodology and Findings: We used a robotic mitotic shake-off apparatus to select cells in late mitosis for genome-wide gene expression studies. Two separate microarray experiments were conducted, one which involved isolation of RNA hourly for several hours from synchronous cell populations, and one experiment which examined gene activity every 15 minutes from late telophase of mitosis into G1 phase. To verify synchrony of the cell populations under study, we utilized methods including BrdU uptake, FACS, and microarray analyses of histone gene activity. We also examined stress response gene activity. Our analysis enabled identification of 200 early G1-regulated genes, many of which currently have unknown functions. We also confirmed the expression of a set of genes candidates (fos, atf3 and tceb) by qPCR to further validate the newly identified genes. Conclusion and Significance: Genome-scale expression analyses of the first two hours of G1 in naturally cycling cells enabled the discovery of a unique set of G1-regulated genes, many of which currently have unknown functions, in cells progressing normally through the cell division cycle. This group of genes may contain future targets for drug development and treatment of human disease.	[Alexander, Karen E.; Hurt, Myra M.] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Baldwin, Amy] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Baldwin, Amy] Brigham and Womens Hosp, Channing Lab, Boston, MA USA; [Whitfield, Michael L.] Dartmouth Med Sch, Norris Cotton Canc Ctr, Dept Genet, Hanover, NH USA; [Beyrouthy, Maroun J.; Bass, Hank W.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Beyrouthy, Maroun J.] Dartmouth Med Sch, Dept Pharmacol & Toxicol, Hanover, NH USA; [McGee, Dan] Florida State Univ, Dept Stat, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; Harvard University; Harvard Medical School; Dartmouth College; Norris Cotton Cancer Center; State University System of Florida; Florida State University; Dartmouth College; State University System of Florida; Florida State University	Beyrouthy, MJ (corresponding author), Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA.	myra.hurt@med.fsu.edu	Bass, Hank W./I-4962-2012; Whitfield, Michael/AAC-5010-2020	Bass, Hank W./0000-0003-0522-0881; 	HHMI; V Foundation for Cancer Research; Scleroderma Research Foundation; Florida Division of the American Cancer Society; NATIONAL CANCER INSTITUTE [R01CA130795] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); V Foundation for Cancer Research; Scleroderma Research Foundation; Florida Division of the American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	MLW has been supported by HHMI, and by grants from the V Foundation for Cancer Research and the Scleroderma Research Foundation. This work was supported in part by a grant to MMH from the Florida Division of the American Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseev OM, 2003, J BIOL CHEM, V278, P8846, DOI 10.1074/jbc.M210352200; Ashihara T, 1979, Methods Enzymol, V58, P248; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; BECKER JF, 1979, CHEM-BIOL INTERACT, V26, P257, DOI 10.1016/0009-2797(79)90029-2; Blanchard JM, 2000, BIOCHEM PHARMACOL, V60, P1179, DOI 10.1016/S0006-2952(00)00384-1; BOWMAN TL, 1995, NUCLEIC ACIDS RES, V23, P3083, DOI 10.1093/nar/23.16.3083; Bravo R, 1990, Semin Cancer Biol, V1, P37; BRUSH D, 1985, MOL CELL BIOL, V5, P1307, DOI 10.1128/MCB.5.6.1307; CAMPISI J, 1984, EXP CELL RES, V152, P459, DOI 10.1016/0014-4827(84)90647-5; Cui WC, 2001, MOL BIOL REP, V28, P123, DOI 10.1023/A:1015288412047; de Belle I, 1999, ONCOGENE, V18, P3633, DOI 10.1038/sj.onc.1202696; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; EICHENLAUBRITTER U, 1989, CYTOGENET CELL GENET, V52, P170, DOI 10.1159/000132871; Eliassen KA, 1998, MOL CELL BIOL, V18, P7106, DOI 10.1128/MCB.18.12.7106; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; GRAVES RA, 1985, P NATL ACAD SCI USA, V82, P5685, DOI 10.1073/pnas.82.17.5685; HATCH CL, 1990, J BIOL CHEM, V265, P15211; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; HURT MM, 1991, MOL CELL BIOL, V11, P2929, DOI 10.1128/MCB.11.6.2929; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Ji C, 1997, ONCOGENE, V15, P2749, DOI 10.1038/sj.onc.1201441; Kaarniranta K, 2003, BIORHEOLOGY, V40, P87; Kaludov NK, 1996, P NATL ACAD SCI USA, V93, P4465, DOI 10.1073/pnas.93.9.4465; Kaysen JH, 1999, J MEMBRANE BIOL, V168, P77; Kireeva ML, 1996, MOL CELL BIOL, V16, P1326; Kothapalli D, 2000, J CELL PHYSIOL, V182, P119, DOI 10.1002/(SICI)1097-4652(200001)182:1<119::AID-JCP13>3.0.CO;2-4; Liu BC, 2006, NEPHRON EXP NEPHROL, V103, P16, DOI 10.1159/000090504; LONGIARU M, 1979, NUCLEIC ACIDS RES, V6, P3369, DOI 10.1093/nar/6.10.3369; Lu D, 2007, BIOCHEM J, V401, P559, DOI 10.1042/BJ20061081; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; MANNIRONI C, 1989, NUCLEIC ACIDS RES, V17, P9113, DOI 10.1093/nar/17.22.9113; Marzluff WF, 2002, GENOMICS, V80, P487, DOI 10.1006/geno.2002.6850; MIRONESCU S, 1977, J CELL PHYSIOL, V90, P281, DOI 10.1002/jcp.1040900214; Myokai F, 2003, J PERIODONTAL RES, V38, P255, DOI 10.1034/j.1600-0765.2003.00602.x; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Palko L, 2004, J CELL SCI, V117, P465, DOI 10.1242/jcs.00870; PEHRSON JR, 1982, BIOCHEMISTRY-US, V21, P456, DOI 10.1021/bi00532a006; Peng D, 1996, CANCER RES, V56, P3666; PICKERING SJ, 1987, HUM REPROD, V2, P207, DOI 10.1093/oxfordjournals.humrep.a136516; SCHEFFNER M, 1991, P NATL ACAD SCI USA, V88, P5523, DOI 10.1073/pnas.88.13.5523; SCHNEIDERMAN MH, 1972, EXP CELL RES, V74, P430, DOI 10.1016/0014-4827(72)90398-9; Sene KH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-85; SEYFERT VL, 1990, J IMMUNOL, V145, P3647; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Shin HY, 2002, PHYSIOL GENOMICS, V11, P245, DOI 10.1152/physiolgenomics.00068.2002; STEIN G, HISTONE GENES STRUCT, P281; Takita M, 2003, CYTOM PART A, V55A, P24, DOI 10.1002/cyto.a.10066; TERASIMA T, 1963, SCIENCE, V140, P490, DOI 10.1126/science.140.3566.490; TERASIMA T, 1963, BIOPHYS J, V3, P11, DOI 10.1016/S0006-3495(63)86801-0; Tessema M, 2004, VIRCHOWS ARCH, V444, P313, DOI 10.1007/s00428-003-0971-3; Wahab NA, 2002, J AM SOC NEPHROL, V13, P2437, DOI 10.1097/01.ASN.0000031828.58276.02; WELLS D, 1985, P NATL ACAD SCI USA, V82, P2834, DOI 10.1073/pnas.82.9.2834; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; WU RS, 1981, CELL, V27, P321, DOI 10.1016/0092-8674(81)90415-3; Yamazaki K, 2002, J BIOL CHEM, V277, P26444, DOI 10.1074/jbc.M202859200; YARBRO JW, 1992, SEMIN ONCOL, V19, P1; ZIMMERMAN RJ, 1981, CARCINOGENESIS, V2, P1303, DOI 10.1093/carcin/2.12.1303	57	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2008	3	12							e3943	10.1371/journal.pone.0003943	http://dx.doi.org/10.1371/journal.pone.0003943			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AP	19079774	Green Published, gold			2022-12-25	WOS:000265458200007
J	Ullrich, RT; Zander, T; Neumaier, B; Koker, M; Shimamura, T; Waerzeggers, Y; Borgman, CL; Tawadros, S; Li, HF; Sos, ML; Backes, H; Shapiro, GI; Wolf, J; Jacobs, AH; Thomas, RK; Winkeler, A				Ullrich, Roland T.; Zander, Thomas; Neumaier, Bernd; Koker, Mirjam; Shimamura, Takeshi; Waerzeggers, Yannic; Borgman, Christa L.; Tawadros, Samir; Li, Hongfeng; Sos, Martin L.; Backes, Heiko; Shapiro, Geoffrey I.; Wolf, Juergen; Jacobs, Andreas H.; Thomas, Roman K.; Winkeler, Alexandra			Early Detection of Erlotinib Treatment Response in NSCLC by 3 '-Deoxy-3 '-[F-18]-Fluoro-L-Thymidine ([F-18]FLT) Positron Emission Tomography (PET)	PLOS ONE			English	Article								Background: Inhibition of the epidermal growth factor receptor ( EGFR) has shown clinical success in patients with advanced non-small cell lung cancer (NSCLC). Somatic mutations of EGFR were found in lung adenocarcinoma that lead to exquisite dependency on EGFR signaling; thus patients with EGFR-mutant tumors are at high chance of response to EGFR inhibitors. However, imaging approaches affording early identification of tumor response in EGFR-dependent carcinomas have so far been lacking. Methodology/Principal Findings: We performed a systematic comparison of 39-Deoxy-39-[18F]-fluoro-L-thymidine ([F-18]FLT) and 2-[F-18]-fluoro-2-deoxy-D-glucose ([F-18]FDG) positron emission tomography (PET) for their potential to identify response to EGFR inhibitors in a model of EGFR-dependent lung cancer early after treatment initiation. While erlotinib-sensitive tumors exhibited a striking and reproducible decrease in [F-18]FLT uptake after only two days of treatment, [F-18]FDG PET based imaging revealed no consistent reduction in tumor glucose uptake. In sensitive tumors, a decrease in [F-18]FLT PET but not [F-18]FDG PET uptake correlated with cell cycle arrest and induction of apoptosis. The reduction in [F-18]FLT PET signal at day 2 translated into dramatic tumor shrinkage four days later. Furthermore, the specificity of our results is confirmed by the complete lack of [F-18]FLT PET response of tumors expressing the T790M erlotinib resistance mutation of EGFR. Conclusions: [F-18]FLT PET enables robust identification of erlotinib response in EGFR-dependent tumors at a very early stage. [F-18]FLT PET imaging may represent an appropriate method for early prediction of response to EGFR TKI treatment in patients with NSCLC.	[Neumaier, Bernd; Koker, Mirjam; Waerzeggers, Yannic; Li, Hongfeng; Sos, Martin L.; Backes, Heiko; Jacobs, Andreas H.; Thomas, Roman K.; Winkeler, Alexandra] Univ Cologne, Max Planck Inst Neurol Res, Max Planck Soc, Fac Med,Klaus Joachim Zulch Labs, Cologne, Germany; [Ullrich, Roland T.; Jacobs, Andreas H.; Winkeler, Alexandra] Ctr Mol Med Cologne CMMC, Cologne, Germany; [Jacobs, Andreas H.] Klin Fulda, Fulda, Germany; [Shimamura, Takeshi; Borgman, Christa L.; Shapiro, Geoffrey I.] Harvard Univ, Med Sch, Dana Farber Canc Inst, Brigham & Womens Hosp, Dept Med Oncol, Boston, MA USA; [Shimamura, Takeshi; Borgman, Christa L.; Shapiro, Geoffrey I.] Harvard Univ, Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA USA; [Zander, Thomas; Tawadros, Samir; Wolf, Juergen; Thomas, Roman K.] Univ Cologne, Ctr Integrated Oncol Koln Bonn, Dept Internal Med I, D-5000 Cologne, Germany; [Thomas, Roman K.] Max Planck Soc, Chem Genom Ctr, Dortmund, Germany	Max Planck Society; University of Cologne; University of Cologne; Klinikum Fulda; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Cologne; Max Planck Society	Ullrich, RT (corresponding author), Univ Cologne, Max Planck Inst Neurol Res, Max Planck Soc, Fac Med,Klaus Joachim Zulch Labs, Cologne, Germany.	nini@nf.mpg.de	Sos, Martin L/I-1852-2014; Winkeler, Alexandra/B-7436-2014; Jacobs, Andreas H./AAA-6794-2020; Neumaier, Bernd/G-7058-2019	Winkeler, Alexandra/0000-0003-3397-2570; Neumaier, Bernd/0000-0001-5425-3116	Koeln Fortune Program, University of Cologne; International Association for the Study of Lung Cancer (IASLC) [fellow]; Deutsche Krebshilfe [107954]; German Ministry of Science and Education as part of the German National Genome Research Network (NGFNplus) program; 6th FW EU grant EMIL [LSHC-CT-2004-503569]; EC-FP6-Project DiMI [LSHB-CT-2005-512146]; EC-FP6-Clinigene [LSBH-CT-06-018933]	Koeln Fortune Program, University of Cologne; International Association for the Study of Lung Cancer (IASLC); Deutsche Krebshilfe(Deutsche Krebshilfe); German Ministry of Science and Education as part of the German National Genome Research Network (NGFNplus) program; 6th FW EU grant EMIL; EC-FP6-Project DiMI(European Commission); EC-FP6-Clinigene	RTU is supported by the Koeln Fortune Program, University of Cologne. RTK is a fellow of the International Association for the Study of Lung Cancer (IASLC). This work was supported by the Deutsche Krebshilfe through grant 107954 to RTK and by the German Ministry of Science and Education as part of the German National Genome Research Network (NGFNplus) program. YW, AHJ and AW are supported by the 6th FW EU grant EMIL (LSHC-CT-2004-503569), EC-FP6-Project DiMI (LSHB-CT-2005-512146) and EC-FP6-Clinigene (LSBH-CT-06-018933). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buck AK, 2002, CANCER RES, V62, P3331; Fueger BJ, 2006, J NUCL MED, V47, P999; HAMACHER K, 1986, J NUCL MED, V27, P235; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Machulla HJ, 2000, J RADIOANAL NUCL CH, V243, P843, DOI 10.1023/A:1010684101509; Moyer JD, 1997, CANCER RES, V57, P4838; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pieterman RM, 2000, NEW ENGL J MED, V343, P254, DOI 10.1056/NEJM200007273430404; Schiffer WK, 2007, J NUCL MED, V48, P277; Shields AF, 1998, NAT MED, V4, P1334, DOI 10.1038/3337; Solit DB, 2007, CANCER RES, V67, P11463, DOI 10.1158/0008-5472.CAN-07-2976; Su H, 2006, CLIN CANCER RES, V12, P5659, DOI 10.1158/1078-0432.CCR-06-0368; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; THOMAS RK, 2007, NAT GENET; Thomas RK, 2006, NAT MED, V12, P852, DOI 10.1038/nm1437; Toyohara J, 2002, NUCL MED BIOL, V29, P281, DOI 10.1016/S0969-8051(02)00286-X; Ullrich R, 2008, CLIN CANCER RES, V14, P2049, DOI 10.1158/1078-0432.CCR-07-1553; Weber WA, 2003, J CLIN ONCOL, V21, P2651, DOI 10.1200/JCO.2003.12.004; Weber WA, 2003, NUKLEARMED-NUCL MED, V42, P135	20	78	79	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2008	3	12							e3908	10.1371/journal.pone.0003908	http://dx.doi.org/10.1371/journal.pone.0003908			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZW	19079597	gold, Green Published, Green Submitted			2022-12-25	WOS:000265456300001
J	Figueredo, SM; Weeks, CS; Young, SK; Ouellette, AJ				Figueredo, Sharel M.; Weeks, Colby S.; Young, Steven K.; Ouellette, Andre J.			Anionic Amino Acids near the Pro-alpha-defensin N Terminus Mediate Inhibition of Bactericidal Activity in Mouse Pro-cryptdin-4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANETH CELL; ANTIMICROBIAL PEPTIDES; MATRIX METALLOPROTEINASE-7; INNATE IMMUNITY; SMALL-INTESTINE; CRYPTDIN-4; ACTIVATION; MEMBRANE; DETERMINANTS; RECOGNITION	In mouse Paneth cells, alpha-defensins, termed cryptdins (Crps), are activated by matrix metalloproteinase-7-mediated proteolysis of inactive precursors (pro-Crps) to bactericidal forms. The activating cleavage step at Ser(43) down arrow Ile(44) in mouse pro-Crp4-(20-92) removes nine acidic amino acids that collectively block the membrane-disruptive behavior of the Crp4 moiety of the proform. This inhibitory mechanism has been investigated further to identify whether specific cluster(s) of electronegative amino acids in pro-Crp4-(20-43) are responsible for blocking bactericidal activity and membrane disruption. To test whether specific cluster(s) of electronegative amino acids in pro-Crp4-(20 43) have specific positional effects that block bactericidal peptide activity and membrane disruption, acidic residues positioned at the distal (Asp(20), Asp(26), Glu(27), and Glu(28)), mid (Glu(32) and Glu(33)), and proximal (Glu(37), Glu(38), and Asp(39)) clusters in pro-Crp4-(20-92) were mutagenized, and variants were assayed for differential effects of mutagenesis on bactericidal peptide activity. Substitution of the mid and proximal Asp and Glu clusters with Gly produced additive effects with respect to the induction of both bactericidal activity and membrane permeabilization of live Escherichia coli ML35 cells. In contrast, substitution of distal Glu and Asp residues with Gly or their deletion resulted in pro-Crp4-(20-92) variants with bactericidal and membrane-disruptive activities equal to or greater than that of fully mature Crp4. These findings support the conclusion that the most distal N-terminal anionic residues of pro-Crp4-(20-92) are primarily responsible for blocking Crp4-mediated membrane disruption in the precursor.	[Ouellette, Andre J.] Univ Calif Irvine, Coll Hlth Sci, Sch Med, Dept Pathol & Lab Med, Irvine, CA 92697 USA; [Ouellette, Andre J.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA; [Ouellette, Andre J.] Univ Calif Irvine, Ctr Immunol, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Ouellette, AJ (corresponding author), Univ Calif Irvine, Coll Hlth Sci, Sch Med, Dept Pathol & Lab Med, Med Sci I D440, Irvine, CA 92697 USA.	aouellet@uci.edu		Young, Steven/0000-0002-1586-5651	NIAID NIH HHS [AI059346] Funding Source: Medline; NIDDK NIH HHS [DK044632] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R55DK044632, R01DK044632] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ayabe T, 2002, J BIOL CHEM, V277, P3793, DOI 10.1074/jbc.M107507200; Ayabe T, 2002, J BIOL CHEM, V277, P5219, DOI 10.1074/jbc.M109410200; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; GANZ T, 1993, BLOOD, V82, P641; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Ganz T, 2004, CR BIOL, V327, P539, DOI 10.1016/j.crvi.2003.12.007; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; Hristova K, 1997, J BIOL CHEM, V272, P24224, DOI 10.1074/jbc.272.39.24224; Jing WG, 2004, BIOCHEMISTRY-US, V43, P15759, DOI 10.1021/bi048645p; Kamdar K, 2008, J BIOL CHEM, V283, P32361, DOI 10.1074/jbc.M805296200; KULIAWAT R, 1992, J CELL BIOL, V118, P521, DOI 10.1083/jcb.118.3.521; LIU L, 1995, BLOOD, V85, P1095, DOI 10.1182/blood.V85.4.1095.bloodjournal8541095; Maemoto A, 2004, J BIOL CHEM, V279, P44188, DOI 10.1074/jbc.M406154200; Matsuzaki K, 1998, BIOCHEMISTRY-US, V37, P15144, DOI 10.1021/bi9811617; MICHAELSON D, 1992, J LEUKOCYTE BIOL, V51, P634, DOI 10.1002/jlb.51.6.634; Ouellette AJ, 2005, SPRINGER SEMIN IMMUN, V27, P133, DOI 10.1007/s00281-005-0202-x; Ouellette AJ, 1999, AM J PHYSIOL-GASTR L, V277, pG257, DOI 10.1152/ajpgi.1999.277.2.G257; Ouellette Andre J., 2005, P175; Porter EM, 2002, CELL MOL LIFE SCI, V59, P156, DOI 10.1007/s00018-002-8412-z; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Satchell DP, 2003, PEPTIDES, V24, P1795, DOI 10.1016/j.peptides.2003.08.020; Satchell DP, 2003, J BIOL CHEM, V278, P13838, DOI 10.1074/jbc.M212115200; Selsted M E, 1993, Genet Eng (N Y), V15, P131; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Shirafuji Y, 2003, J BIOL CHEM, V278, P7910, DOI 10.1074/jbc.M210600200; Tanabe H, 2004, J BIOL CHEM, V279, P11976, DOI 10.1074/jbc.M310251200; Traub LM, 1997, CURR OPIN CELL BIOL, V9, P527, DOI 10.1016/S0955-0674(97)80029-4; VALORE EV, 1992, BLOOD, V79, P1538; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; Weeks CS, 2006, J BIOL CHEM, V281, P28932, DOI 10.1074/jbc.M602041200; WHITE SH, 1995, CURR OPIN STRUC BIOL, V5, P521, DOI 10.1016/0959-440X(95)80038-7; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Wu ZB, 2007, J MOL BIOL, V368, P537, DOI 10.1016/j.jmb.2007.02.040; Zanetti M, 1997, ANN NY ACAD SCI, V832, P147, DOI 10.1111/j.1749-6632.1997.tb46244.x; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zou GZ, 2008, J MOL BIOL, V381, P1281, DOI 10.1016/j.jmb.2008.06.066	36	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6826	6831		10.1074/jbc.M807024200	http://dx.doi.org/10.1074/jbc.M807024200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19106102	Green Published, hybrid			2022-12-25	WOS:000263919000028
J	Palmer, SM; Playford, MP; Craig, SW; Schaller, MD; Campbell, SL				Palmer, Sean M.; Playford, Martin P.; Craig, Susan W.; Schaller, Michael D.; Campbell, Sharon L.			Lipid Binding to the Tail Domain of Vinculin SPECIFICITY AND THE ROLE OF THE N AND C TERMINI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; INTRAMOLECULAR ASSOCIATION; ACTIN-FILAMENTS; HYPERTROPHIC CARDIOMYOPATHY; DILATED CARDIOMYOPATHY; ACIDIC PHOSPHOLIPIDS; MISSENSE MUTATION; CRYSTAL-STRUCTURE; CELL-MIGRATION; TALIN-BINDING	Vinculin is a highly conserved and abundant cytoskeletal protein involved in linking the actin cytoskeleton to the cell membrane at sites of cellular adhesion. At these sites of adhesion, vinculin plays a role in physiological processes such as cell motility, migration, development, and wound healing. Loss of normal vinculin function has been associated with cancer phenotypes, cardiovascular disease, and lethal errors in embryogenesis. The tail domain of vinculin (Vt) binds to acidic phospholipids and has been proposed to play a role in vinculin activation and focal adhesion turnover. To better characterize Vt-lipid specificity, we conducted a series of lipid co-sedimentation experiments and find that Vt shows specific association with phosphatidylinositol 4,5-bisphosphate (PIP2), compared with phosphatidylethanolamine (PE), phosphatidylcholine (PC), phosphatidylserine (PS), or phosphatidylinositol (PI) in the context of mixed lipid vesicles. The C terminus of Vt has been proposed to be important for PIP2 association, as various mutations and deletions within the C-terminal reduce PIP2 association. Lipid co-sedimentation and NMR analyses indicate that removal of the hydrophobic hairpin does not alter Vt structure or PIP2 association. However, more extensive deletions within the C-terminal introduce Vt structural perturbations and reduce PIP2 binding. Intriguingly, a significant increase in PIP2 binding was observed for multiple Vt variants that perturb interactions between the N-terminal strap and helix bundle, suggesting that a rearrangement of this N-terminal strap may be required for PIP2 binding.	[Palmer, Sean M.; Campbell, Sharon L.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Playford, Martin P.; Schaller, Michael D.] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; [Schaller, Michael D.; Campbell, Sharon L.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Playford, Martin P.] NHLBI, NIH, Bethesda, MD 20892 USA; [Craig, Susan W.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Johns Hopkins University	Campbell, SL (corresponding author), Univ N Carolina, Dept Biochem & Biophys, CB 7260, Chapel Hill, NC 27599 USA.	sharon_campbell@med.unc.edu	, UNC Biomolecular NMR Facility/AAD-7901-2022	campbell, sharon/0000-0003-0311-409X	NIGMS NIH HHS [R01 GM080568-01A1, R01 GM080568] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080568] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bakolitsa C, 1999, CELL, V99, P603, DOI 10.1016/S0092-8674(00)81549-4; Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; BARSTEAD RJ, 1991, J CELL BIOL, V114, P715, DOI 10.1083/jcb.114.4.715; BELKIN AM, 1988, J BIOL CHEM, V263, P6631; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Borgon RA, 2004, STRUCTURE, V12, P1189, DOI 10.1016/j.str.2004.05.009; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; Chandrasekar I, 2005, J CELL SCI, V118, P1461, DOI 10.1242/jcs.01734; Chen H, 2005, J CELL BIOL, V169, P459, DOI 10.1083/jcb.200410100; Chen H, 2006, J BIOL CHEM, V281, P40389, DOI 10.1074/jbc.M607324200; Cohen DM, 2005, J BIOL CHEM, V280, P17109, DOI 10.1074/jbc.M414704200; COLL JL, 1995, P NATL ACAD SCI USA, V92, P9161, DOI 10.1073/pnas.92.20.9161; Cullen PJ, 2001, CURR BIOL, V11, pR882, DOI 10.1016/S0960-9822(01)00523-1; Danen EHJ, 2003, J PATHOL, V201, P632, DOI 10.1002/path.1472; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delon I, 2007, CURR OPIN CELL BIOL, V19, P43, DOI 10.1016/j.ceb.2006.12.013; FERNANDEZ JLR, 1992, J CELL BIOL, V119, P427, DOI 10.1083/jcb.119.2.427; FERNANDEZ JLR, 1993, J CELL BIOL, V122, P1285, DOI 10.1083/jcb.122.6.1285; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; GEIGER B, 1980, P NATL ACAD SCI-BIOL, V77, P4127, DOI 10.1073/pnas.77.7.4127; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; Goldmann WH, 2002, BIOCHEM BIOPH RES CO, V290, P749, DOI 10.1006/bbrc.2001.6243; GROESCH ME, 1990, CELL MOTIL CYTOSKEL, V15, P41, DOI 10.1002/cm.970150107; Holz RW, 2000, J BIOL CHEM, V275, P17878, DOI 10.1074/jbc.M000925200; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; Janssen MEW, 2006, MOL CELL, V21, P271, DOI 10.1016/j.molcel.2005.11.020; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Johnson RP, 1998, BIOCHEMISTRY-US, V37, P10211, DOI 10.1021/bi9727242; Johnson RP, 2000, J BIOL CHEM, V275, P95, DOI 10.1074/jbc.275.1.95; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; JOHNSON RP, 1995, BIOCHEM BIOPH RES CO, V210, P159, DOI 10.1006/bbrc.1995.1641; JOHNSON RP, 1994, J BIOL CHEM, V269, P12611; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kedrin D, 2007, J MAMMARY GLAND BIOL, V12, P143, DOI 10.1007/s10911-007-9046-4; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Miller GJ, 2001, J BIOL CHEM, V276, P28829, DOI 10.1074/jbc.M102561200; Moissoglu K, 2006, BIOL CELL, V98, P547, DOI 10.1042/BC20060025; MOLONY L, 1985, J CELL BIOCHEM, V29, P31, DOI 10.1002/jcb.240290104; Palmer SM, 2008, BIOMOL NMR ASSIGM, V2, P69, DOI 10.1007/s12104-008-9087-7; PARDO JV, 1983, P NATL ACAD SCI-BIOL, V80, P1008, DOI 10.1073/pnas.80.4.1008; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; RASBAND WS, 2006, IMAGE J VERSION 1 37; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Saunders RM, 2006, EUR J CELL BIOL, V85, P487, DOI 10.1016/j.ejcb.2006.01.014; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Steimle PA, 1999, J BIOL CHEM, V274, P18414, DOI 10.1074/jbc.274.26.18414; Subauste MC, 2004, J CELL BIOL, V165, P371, DOI 10.1083/jcb.200308011; Vasile VC, 2006, MOL GENET METAB, V87, P169, DOI 10.1016/j.ymgme.2005.08.006; Vasile VC, 2006, BIOCHEM BIOPH RES CO, V349, P709, DOI 10.1016/j.bbrc.2006.08.106; Vasile VC, 2006, BIOCHEM BIOPH RES CO, V345, P998, DOI 10.1016/j.bbrc.2006.04.151; Weekes J, 1996, BIOCHEM J, V314, P827, DOI 10.1042/bj3140827; Winkler J, 1996, J STRUCT BIOL, V116, P270, DOI 10.1006/jsbi.1996.0042; Xu WM, 1998, DEVELOPMENT, V125, P327; Xu WM, 1998, J CELL SCI, V111, P1535; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; Zemljic-Harpf AE, 2004, AM J PATHOL, V165, P1033, DOI 10.1016/S0002-9440(10)63364-0; Zemljic-Harpf AE, 2007, MOL CELL BIOL, V27, P7522, DOI 10.1128/MCB.00728-07; Ziegler WH, 2002, J BIOL CHEM, V277, P7396, DOI 10.1074/jbc.M110008200; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004	61	48	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7223	7231		10.1074/jbc.M807842200	http://dx.doi.org/10.1074/jbc.M807842200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19110481	Green Published, hybrid			2022-12-25	WOS:000263919000069
J	Volonte, D; Kahkonen, B; Shapiro, S; Di, YP; Galbiati, F				Volonte, Daniela; Kahkonen, Beth; Shapiro, Steven; Di, YuanPu; Galbiati, Ferruccio			Caveolin-1 Expression Is Required for the Development of Pulmonary Emphysema through Activation of the ATM-p53-p21 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOKE-INDUCED EMPHYSEMA; CIGARETTE-SMOKE; CELLULAR SENESCENCE; LUNG FIBROBLASTS; OXIDATIVE STRESS; PREMATURE SENESCENCE; PLASMA-MEMBRANE; CELLS; GROWTH; MICE	Free radicals play a role in aging and age-related human diseases, including pulmonary emphysema. Cigarette smoke represents a source of oxidants and is considered an environmental hazard that causes pulmonary emphysema. Here, we show that caveolin-1 activates ataxia telangiectasia-mutated (ATM) after oxidative stress by sequestering the ATM inhibitor, the catalytic subunit of protein phosphatase 2A, into caveolar membranes. We demonstrate that cigarette smoke extracts promote stress-induced premature senescence in wild type but not caveolin-1 null lung fibroblasts and that caveolin-1 expression is required for activation of the ATM-p53-p21(Waf1/Cip1) pathway following stimulation with cigarette smoke extracts in vitro. In vivo studies show that caveolin-1 expression is necessary for cigarette smoking-induced senescence of lung fibroblasts and pulmonary emphysema. These findings bring new insights into the molecular mechanism underlying free radical activation of the ATM-p53 pathway and indicate that caveolin-1 is a novel therapeutic target for the treatment and/or prevention of pulmonary emphysema.	[Volonte, Daniela; Galbiati, Ferruccio] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Kahkonen, Beth; Di, YuanPu] Univ Pittsburgh, Sch Med, Dept Environm & Occupat Hlth, Pittsburgh, PA 15261 USA; [Shapiro, Steven] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Galbiati, F (corresponding author), 200 Lothrop St, Pittsburgh, PA 15261 USA.	feg5@pitt.edu	Di, Yuanpu Peter/H-4191-2016; Galbiati, Ferruccio/AAF-3527-2020	Di, Yuanpu Peter/0000-0003-2028-2087; 	National Institutes of Health [AG022548]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K22ES011033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG022548] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG022548 (to F. G.).	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bernhard D, 2007, EXP GERONTOL, V42, P160, DOI 10.1016/j.exger.2006.09.016; Boren E, 2004, AUTOIMMUN REV, V3, P401, DOI 10.1016/j.autrev.2004.03.004; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chen K, 2003, J BIOL CHEM, V278, P39527, DOI 10.1074/jbc.M304423200; Chen QM, 1998, BIOCHEM J, V332, P43, DOI 10.1042/bj3320043; Chung HY, 2002, MICROSC RES TECHNIQ, V59, P264, DOI 10.1002/jemt.10203; Cohen PTW, 2002, J CELL SCI, V115, P241; Dasari A, 2006, CANCER RES, V66, P10805, DOI 10.1158/0008-5472.CAN-06-1236; Frippiat C, 2001, J BIOL CHEM, V276, P2531, DOI 10.1074/jbc.M006809200; Galbiati F, 2001, MOL BIOL CELL, V12, P2229, DOI 10.1091/mbc.12.8.2229; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; Goodarzi AA, 2004, EMBO J, V23, P4451, DOI 10.1038/sj.emboj.7600455; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Holz O, 2004, EUR RESPIR J, V24, P575, DOI 10.1183/09031936.04.00143703; Honkanen RE, 2002, CURR MED CHEM, V9, P2055, DOI 10.2174/0929867023368836; Houghton AM, 2006, J CLIN INVEST, V116, P753, DOI 10.1172/JCI25617; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Lundberg AS, 2000, CURR OPIN CELL BIOL, V12, P705, DOI 10.1016/S0955-0674(00)00155-1; MacNee W, 1999, AM J RESP CRIT CARE, V160, pS58, DOI 10.1164/ajrccm.160.supplement_1.15; MacNee William, 2005, Proc Am Thorac Soc, V2, P50, DOI 10.1513/pats.200411-056SF; Maeno T, 2007, J IMMUNOL, V178, P8090, DOI 10.4049/jimmunol.178.12.8090; Moiseeva O, 2006, MOL BIOL CELL, V17, P1583, DOI 10.1091/mbc.E05-09-0858; MOLDOVAN NI, 1995, EXP CELL RES, V219, P309, DOI 10.1006/excr.1995.1233; Muller KC, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-32; Nobukuni S, 2002, RESPIROLOGY, V7, P217, DOI 10.1046/j.1440-1843.2002.00400.x; Noordhoek JA, 2003, EXP LUNG RES, V29, P291, DOI 10.1080/01902140303789; Nyunoya T, 2006, AM J RESP CELL MOL, V35, P681, DOI 10.1165/rcmb.2006-0169OC; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; SARGIACOMO M, 1995, P NATL ACAD SCI USA, V92, P9407, DOI 10.1073/pnas.92.20.9407; SCHNITZER JE, 1995, J BIOL CHEM, V270, P14399, DOI 10.1074/jbc.270.24.14399; Shackelford RE, 2001, J BIOL CHEM, V276, P21951, DOI 10.1074/jbc.M011303200; Shapiro SD, 2003, AM J PATHOL, V163, P2329, DOI 10.1016/S0002-9440(10)63589-4; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; SMART EJ, 1994, J CELL BIOL, V127, P1185, DOI 10.1083/jcb.127.5.1185; SNIDER GL, 1992, AM REV RESPIR DIS, V146, P1615, DOI 10.1164/ajrccm/146.6.1615; Tsuji T, 2004, AM J RESP CELL MOL, V31, P643, DOI 10.1165/rcmb.2003-0290OC; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Volonte D, 2002, MOL BIOL CELL, V13, P2502, DOI 10.1091/mbc.01-11-0529	40	55	56	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5462	5466		10.1074/jbc.C800225200	http://dx.doi.org/10.1074/jbc.C800225200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19103597	hybrid, Green Published			2022-12-25	WOS:000263560600008
J	Xie, P; Guo, SB; Fan, YN; Zhang, H; Gu, DF; Li, HH				Xie, Ping; Guo, Shubin; Fan, Yongna; Zhang, Hua; Gu, Dongfeng; Li, Huihua			Atrogin-1/MAFbx Enhances Simulated Ischemia/Reperfusion-induced Apoptosis in Cardiomyocytes through Degradation of MAPK Phosphatase-1 and Sustained JNK Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE ATROPHY; DEPENDENT CARDIAC-HYPERTROPHY; FOXO TRANSCRIPTION FACTORS; JUN NH2-TERMINAL KINASE; INDUCED CELL-DEATH; N-TERMINAL KINASE; PROTEIN-KINASE; MYOCARDIAL-ISCHEMIA; INFARCT SIZE; P38 MAPK	Atrogin-1/MAFbx is a major atrophy-related E3 ubiquitin ligase that is expressed specifically in striated muscle. Although the contribution of atrogin-1 to cardiac and muscle hypertrophy/atrophy has been examined extensively, it remains unclear whether atrogin-1 plays an essential role in the simulated ischemia/reperfusion-induced apoptosis of primary cardiomyocytes. Here we showed that atrogin-1 markedly enhanced ischemia/reperfusion-induced apoptosis in cardiomyocytes via activation of JNK signaling. Overexpression of atrogin-1 increased phosphorylation of JNK and c-Jun and decreased phosphorylation of Foxo3a. In addition, atrogin-1 decreased Bcl-2, increased Bax, and enhanced the activation of caspases. Furthermore, JNK inhibitor SP600125 markedly blocked the effect of atrogin-1 on cell apoptosis and the expression of apoptotic-related proteins and caspases. Importantly, atrogin-1 induced sustained activation of JNK through a mechanism that involved degradation of MAPK phosphatase-1 (MKP-1) protein. Atrogin-1 interacted with and triggered MKP-1 for ubiquitin-mediated degradation. In contrast, proteasome inhibitors markedly blocked the degradation of MKP-1. Taken together, these results demonstrate that atrogin-1 promotes degradation of MKP-1 through the ubiquitin-proteasome pathway, thereby leading to persistent activation of JNK signaling and further cardiomyocyte apoptosis following ischemia/reperfusion injury.	[Xie, Ping; Fan, Yongna; Zhang, Hua; Li, Huihua] Peking Union Med Coll, Dept Pathol, Beijing 100005, Peoples R China; [Xie, Ping; Fan, Yongna; Zhang, Hua; Li, Huihua] Peking Union Med Coll, Natl Lab Med Mol Biol, Inst Basic Med Sci, Beijing 100005, Peoples R China; [Guo, Shubin] Peking Union Med Coll, Dept Acute Med, Peking Union Med Hosp, Chinese Acad Med Sci, Beijing 100005, Peoples R China; [Gu, Dongfeng] Chinese Acad Med Sci, Peking Union Med Coll, Div Populat Genet & Prevent, Cardiovasc Inst, Beijing 100037, Peoples R China; [Gu, Dongfeng] Chinese Acad Med Sci, Peking Union Med Coll, Div Populat Genet & Prevent, Fuwai Hosp, Beijing 100037, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College	Li, HH (corresponding author), Peking Union Med Coll, Dept Pathol, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.	hhli1995@yahoo.com			China Natural Science Foundation [2006CB503805, 2006CB910306, 30670860]; Ministry of Education of China [20060023051, 20070023022]	China Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China)	This work was supported by China Natural Science Foundation Grants 2006CB503805, 2006CB910306, and 30670860 (to H. L.) and The Ph.D. Programs Foundation of Ministry of Education of China Grants 20060023051 and 20070023022 (to H. L.).	Adams V, 2007, CARDIOVASC RES, V73, P120, DOI 10.1016/j.cardiores.2006.10.026; Aoki H, 2002, J BIOL CHEM, V277, P10244, DOI 10.1074/jbc.M112355200; Armstrong SC, 2004, CARDIOVASC RES, V61, P427, DOI 10.1016/j.cardiores.2003.09.031; Assimakopoulou M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-202; Baines CP, 2005, J MOL CELL CARDIOL, V38, P47, DOI 10.1016/j.yjmcc.2004.11.004; Bhat NR, 1999, J NEUROCHEM, V72, P112, DOI 10.1046/j.1471-4159.1999.0720112.x; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Brondello JM, 1999, SCIENCE, V286, P2514, DOI 10.1126/science.286.5449.2514; Capano M, 2006, BIOCHEM J, V395, P57, DOI 10.1042/BJ20051654; CHARLES CH, 1992, ONCOGENE, V7, P187; CHEN QL, 1995, J BIOL CHEM, V270, P28499, DOI 10.1074/jbc.270.48.28499; Choi BH, 2006, J CELL SCI, V119, P1329, DOI 10.1242/jcs.02837; Das A, 2006, J BIOL CHEM, V281, P38644, DOI 10.1074/jbc.M606142200; Dickinson RJ, 2006, J CELL SCI, V119, P4607, DOI 10.1242/jcs.03266; EMSLIE EA, 1994, HUM GENET, V93, P513; Engelbrecht A-M, 2004, BASIC RES CARDIOL, V99, P338, DOI 10.1007/s00395-004-0478-3; Ferrandi C, 2004, BRIT J PHARMACOL, V142, P953, DOI 10.1038/sj.bjp.0705873; Franklin CC, 1997, J BIOL CHEM, V272, P16917, DOI 10.1074/jbc.272.27.16917; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; Hanai JI, 2007, J CLIN INVEST, V117, P3940, DOI 10.1172/JCI32741; He HP, 1999, CELL DEATH DIFFER, V6, P987, DOI 10.1038/sj.cdd.4400572; Hreniuk D, 2001, MOL PHARMACOL, V59, P867, DOI 10.1124/mol.59.4.867; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; KEYSE SM, 1992, NATURE, V359, P644, DOI 10.1038/359644a0; Keyse SM, 2008, CANCER METAST REV, V27, P253, DOI 10.1007/s10555-008-9123-1; LAU LF, 1985, EMBO J, V4, P3145, DOI 10.1002/j.1460-2075.1985.tb04057.x; Le-Niculescu H, 1999, MOL CELL BIOL, V19, P751; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Li HH, 2004, J CLIN INVEST, V114, P1058, DOI 10.1172/JCl200422220; Li HH, 2007, J CLIN INVEST, V117, P3211, DOI 10.1172/JCI31757; Li J, 2001, MOL CELL BIOL, V21, P8213, DOI 10.1128/MCB.21.23.8213-8224.2001; Li YP, 2005, FASEB J, V19, P362, DOI 10.1096/fj.04-2364com; Lin YW, 2006, J BIOL CHEM, V281, P915, DOI 10.1074/jbc.M508720200; Michel MC, 2001, N-S ARCH PHARMACOL, V363, P245, DOI 10.1007/s002100000363; Milano G, 2007, AM J PHYSIOL-HEART C, V292, pH1828, DOI 10.1152/ajpheart.01117.2006; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Sanchez-Perez I, 2000, ONCOGENE, V19, P5142, DOI 10.1038/sj.onc.1203887; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Thompson SJ, 2008, CURR OPIN PHARMACOL, V8, P90, DOI 10.1016/j.coph.2007.09.010; Venugopal SK, 2007, J BIOL CHEM, V282, P31900, DOI 10.1074/jbc.M703729200; Wu JJ, 2005, J BIOL CHEM, V280, P16461, DOI 10.1074/jbc.M501762200; Xifro X, 2006, J BIOL CHEM, V281, P6801, DOI 10.1074/jbc.M504571200; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Zhang L, 2007, CELL CYCLE, V6, P1479; Zhou JY, 2006, CANCER RES, V66, P4888, DOI 10.1158/0008-5472.CAN-05-4229	48	76	79	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5488	5496		10.1074/jbc.M806487200	http://dx.doi.org/10.1074/jbc.M806487200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19117950	hybrid			2022-12-25	WOS:000263560600011
J	Ahuja, N; Korkin, D; Chaba, R; Cezairliyan, BO; Sauer, RT; Kim, KK; Gross, CA				Ahuja, Nidhi; Korkin, Dmitry; Chaba, Rachna; Cezairliyan, Brent O.; Sauer, Robert T.; Kim, Kyeong Kyu; Gross, Carol A.			Analyzing the Interaction of RseA and RseB, the Two Negative Regulators of the sigma(E) Envelope Stress Response, Using a Combined Bioinformatic and Experimental Strategy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI SIGMA(E); MULTIPLE SEQUENCE ALIGNMENT; EXTRACYTOPLASMIC STRESS; CRYSTAL-STRUCTURE; PERIPLASMIC STRESS; PDZ DOMAIN; PROTEIN; PROTEOLYSIS; BINDING; RPOE	The Escherichia coli envelope stress response is controlled by the alternative sigma factor, sigma(E), and is induced when unfolded outer membrane proteins accumulate in the periplasm. The response is initiated by sequential cleavage of the membrane-spanning anti-sigma factor, RseA. RseB is an important negative regulator of envelope stress response that exerts its negative effects on sigma(E) activity through its binding to RseA. In this study, we analyze the interaction between RseA and RseB. We found that tight binding of RseB to RseA required intact RseB. Using programs that performed global and local sequence alignment of RseB and RseA, we found regions of high similarity and performed alanine substitution mutagenesis to test the hypothesis that these regions were functionally important. This protocol is based on the hypothesis that functionally dependent regions of two proteins co-evolve and therefore are likely to be sequentially conserved. This procedure allowed us to identify both an N-terminal and C-terminal region in RseB important for binding to RseA. We extensively analyzed the C-terminal region, which aligns with a region of RseA coincident with the major RseB binding determinant in RseA. Both allele-specific suppression analysis and cysteine-mediated disulfide bond formation indicated that this C-terminal region of similarity of RseA and RseB identifies a contact site between the two proteins. We suggest a similar protocol can be successfully applied to pairs of non-homologous but functionally linked proteins to find specific regions of the protein sequences that are important for establishing functional linkage.	[Ahuja, Nidhi; Chaba, Rachna; Gross, Carol A.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Gross, Carol A.] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94158 USA; [Korkin, Dmitry] Univ Missouri, Inst Informat, Columbia, MO 65211 USA; [Korkin, Dmitry] Univ Missouri, Dept Comp Sci, Columbia, MO 65211 USA; [Cezairliyan, Brent O.; Sauer, Robert T.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Kim, Kyeong Kyu] Sungkyunkwan Univ, Samsung Biomed Res Inst, Dept Mol Cell Biol, Suwon 440746, South Korea	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Massachusetts Institute of Technology (MIT); Sungkyunkwan University (SKKU)	Gross, CA (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, GH S376,600 16th St, San Francisco, CA 94158 USA.	cgross@cgl.ucsf.edu	Kim, Kyeong Kyu/ABH-1988-2020	Kim, Kyeong Kyu/0000-0003-2515-8894; Sauer, Robert/0000-0002-1719-5399	National Institutes of Health [GM-32678, AI-16892]; Korean Ministry of Education, Science, and Technology [FPR08B2-270]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI016892] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korean Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants GM-32678 ( to C. A. G.) and AI-16892 ( to R. T. S.). This work was also supported by FPR08B2-270 of the 21C Frontier Functional Proteomics Project ( to K. K. K.) from the Korean Ministry of Education, Science, and Technology.	Adams PD, 1996, MOL CELL BIOL, V16, P6623; Ades SE, 1999, GENE DEV, V13, P2449, DOI 10.1101/gad.13.18.2449; Alba BM, 2004, MOL MICROBIOL, V52, P613, DOI 10.1111/j.1365-2958.2003.03982.x; Alba BM, 2002, GENE DEV, V16, P2156, DOI 10.1101/gad.1008902; Beck BJ, 1997, J BACTERIOL, V179, P6504, DOI 10.1128/jb.179.21.6862-6864.1997; Campbell EA, 2003, MOL CELL, V11, P1067, DOI 10.1016/S1097-2765(03)00148-5; Cezairliyan BO, 2007, P NATL ACAD SCI USA, V104, P3771, DOI 10.1073/pnas.0611567104; Chaba R, 2007, GENE DEV, V21, P124, DOI 10.1101/gad.1496707; Collinet B, 2000, J BIOL CHEM, V275, P33898, DOI 10.1074/jbc.M006214200; Connolly L, 1997, GENE DEV, V11, P2012, DOI 10.1101/gad.11.15.2012; CUNNINGHAM MW, 1989, J IMMUNOL, V143, P2677; Dartigalongue C, 2001, J BIOL CHEM, V276, P20866, DOI 10.1074/jbc.M100464200; DeLasPenas A, 1997, MOL MICROBIOL, V24, P373, DOI 10.1046/j.1365-2958.1997.3611718.x; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Grigorova IL, 2004, GENE DEV, V18, P2686, DOI 10.1101/gad.1238604; Hannenhalli SS, 2000, J MOL BIOL, V303, P61, DOI 10.1006/jmbi.2000.4036; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Kanehara K, 2002, GENE DEV, V16, P2147, DOI 10.1101/gad.1002302; Kim DY, 2007, P NATL ACAD SCI USA, V104, P8779, DOI 10.1073/pnas.0703117104; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; MECSAS J, 1993, GENE DEV, V7, P2618, DOI 10.1101/gad.7.12b.2618; Miller JH., 1972, EXPT MOL GENETICS; Missiakas D, 1997, MOL MICROBIOL, V24, P355, DOI 10.1046/j.1365-2958.1997.3601713.x; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; RAINA S, 1995, EMBO J, V14, P1043, DOI 10.1002/j.1460-2075.1995.tb07085.x; Raivio TL, 2001, ANNU REV MICROBIOL, V55, P591, DOI 10.1146/annurev.micro.55.1.591; Rezuchova B, 2003, FEMS MICROBIOL LETT, V225, P1, DOI 10.1016/S0378-1097(03)00480-4; Rhodius VA, 2006, PLOS BIOL, V4, P43, DOI 10.1371/journal.pbio.0040002; ROUVIERE PE, 1995, EMBO J, V14, P1032, DOI 10.1002/j.1460-2075.1995.tb07084.x; Sambrook J, 2001, MOL CLONING LAB MANU; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; Wilken C, 2004, CELL, V117, P483, DOI 10.1016/S0092-8674(04)00454-4; Wollmann P, 2007, J MOL BIOL, V372, P927, DOI 10.1016/j.jmb.2007.06.039	36	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5403	5413		10.1074/jbc.M806012200	http://dx.doi.org/10.1074/jbc.M806012200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19103591	hybrid, Green Published			2022-12-25	WOS:000263416600070
J	Ji, CH; Kopetzki, E; Jekle, A; Stubenrauch, KG; Liu, XR; Zhang, J; Rao, E; Schlothauer, T; Fischer, S; Cammack, N; Heilek, G; Ries, S; Sankuratri, S				Ji, Changhua; Kopetzki, Erhard; Jekle, Andreas; Stubenrauch, Kay-Gunnar; Liu, Xingrong; Zhang, Jun; Rao, Eileen; Schlothauer, Tilman; Fischer, Stephan; Cammack, Nick; Heilek, Gabrielle; Ries, Stefan; Sankuratri, Surya			CD4-anchoring HIV-1 Fusion Inhibitor with Enhanced Potency and in Vivo Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ENTRY INHIBITORS; ANTIRETROVIRAL ACTIVITY; RESISTANCE MUTATIONS; ANTI-CD4 ANTIBODY; RHESUS-MONKEYS; ENFUVIRTIDE; INFECTION; TYPE-1; GP41	In this study, we describe a novel CD4-targeting bifunctional human immunodeficiency virus (HIV-1) fusion inhibitor (CD4-BFFI) that blocks HIV-1 entry by inhibiting both HIV-1 attachment and fusion and is highly potent against both R5 and X4 HIV-1 viruses in various antiviral assays, including peripheral blood mononuclear cell (PBMC) infection assays. Previously, we have reported a CCR5 antibody-based bifunctional HIV-1 fusion inhibitor (BFFI) that was highly active in blocking R5 HIV-1 infection but was ineffective against X4 viruses infecting human PBMCs (Kopetzki, E., Jekle, A., Ji, C., Rao, E., Zhang, J., Fischer, S., Cammack, N., Sankuratri, S., and Heilek, G.(2008) Virology J. 5,56-65). CD4-BFFI, which consists of two HIV-1 fusion inhibitor (FI) T-651 variant peptides recombinantly fused to the Fc end of a humanized anti-CD4 monoclonal antibody, has demonstrated more than 100-fold greater antiviral activity than T-651 variant or the parental CD4 monoclonal antibody. Mechanistic studies revealed that CD4-BFFI primarily blocks the HIV-1-cell fusion step through its FI peptide moieties. The enhanced antiviral activity of CD4-BFFI is most likely due to avid binding of the bivalent FI peptides as well as the increased local concentration of CD4-BFFI via attachment to the target cell surface receptor CD4. In vivo pharmacokinetic studies demonstrated that CD4-BFFI was stable in monkey blood, and a dose of 10 mg/kg maintained serum concentrations greater than 2,000-fold over the IC90 value for 7 days postdosing. This novel bifunctional inhibitor with improved potency and favorable pharmacokinetic properties may offer a novel approach for HIV-1 therapy.	[Ji, Changhua; Jekle, Andreas; Zhang, Jun; Rao, Eileen; Cammack, Nick; Heilek, Gabrielle; Sankuratri, Surya] Roche Palo Alto, Virol Dis Area, Palo Alto, CA 94304 USA; [Liu, Xingrong] Roche Palo Alto, Nonclin Safety, Palo Alto, CA 94304 USA; [Kopetzki, Erhard; Stubenrauch, Kay-Gunnar; Schlothauer, Tilman; Fischer, Stephan; Ries, Stefan] Roche Penzberg, Div Pharmaceut, D-82377 Penzberg, Germany	Roche Holding; Roche Holding; Roche Holding	Ji, CH (corresponding author), Roche Palo Alto, Virol Dis Area, 3431 Hillview Ave, Palo Alto, CA 94304 USA.	changhua.ji@roche.com		Jekle, Andreas/0000-0001-9416-2622				Boon L, 2002, TOXICOLOGY, V172, P191, DOI 10.1016/S0300-483X(02)00002-1; Borkow G., 2005, Current Drug Targets - Infectious Disorders, V5, P3, DOI 10.2174/1568005053174645; Carter NJ, 2007, DRUGS, V67, P2277, DOI 10.2165/00003495-200767150-00010; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Coakley E, 2005, CURR OPIN INFECT DIS, V18, P9, DOI 10.1097/00001432-200502000-00003; Dimitrov A, 2007, CURR OPIN INVEST DR, V8, P653; DUENSING T, 2006, 13 C RETR OPP INF DE; Dwyer JJ, 2007, P NATL ACAD SCI USA, V104, P12772, DOI 10.1073/pnas.0701478104; Goethals O, 2008, J VIROL, V82, P10366, DOI 10.1128/JVI.00470-08; Ji CH, 2006, J BIOMOL SCREEN, V11, P65, DOI 10.1177/1087057105282959; Ji C, 2007, MOL PHARMACOL, V72, P18, DOI 10.1124/mol.107.035055; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; Kopetzki E, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-56; Kuritzkes DR, 2004, J INFECT DIS, V189, P286, DOI 10.1086/380802; Lazzarin A, 2005, EXPERT OPIN PHARMACO, V6, P453, DOI 10.1517/14656566.6.3.453; Lee B, 1999, P NATL ACAD SCI USA, V96, P5215, DOI 10.1073/pnas.96.9.5215; Liu SW, 2007, CURR PHARM DESIGN, V13, P143, DOI 10.2174/138161207779313722; Marr P, 2008, EXPERT OPIN PHARMACO, V9, P2349, DOI 10.1517/14656566.9.13.2349 ; Platt EJ, 2005, J VIROL, V79, P4347, DOI 10.1128/JVI.79.7.4347-4356.2005; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; Reeves JD, 2002, P NATL ACAD SCI USA, V99, P16249, DOI 10.1073/pnas.252469399; Reimann KA, 2002, AIDS RES HUM RETROV, V18, P747, DOI 10.1089/08892220260139486; Reimann KA, 1997, AIDS RES HUM RETROV, V13, P933, DOI 10.1089/aid.1997.13.933; Rusconi S, 2007, CURR TOP MED CHEM, V7, P1273; Shafer RW, 2008, AIDS REV, V10, P67; Walter BL, 2005, J VIROL, V79, P4828, DOI 10.1128/JVI.79.8.4828-4837.2005; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Zhang XQ, 2006, ANTIMICROB AGENTS CH, V50, P2231, DOI 10.1128/AAC.00761-05	28	23	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5175	5185		10.1074/jbc.M808745200	http://dx.doi.org/10.1074/jbc.M808745200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19097993	hybrid			2022-12-25	WOS:000263416600048
J	Fleming, YM; Ferguson, GJ; Spender, LC; Larsson, J; Karlsson, S; Ozanne, BW; Grosse, R; Inman, GJ				Fleming, Y. M.; Ferguson, G. J.; Spender, L. C.; Larsson, J.; Karlsson, S.; Ozanne, B. W.; Grosse, R.; Inman, G. J.			TGF-beta-mediated activation of RhoA signalling is required for efficient (V12)HaRas and (V600E)BRAF transformation	ONCOGENE			English	Article						TGF-beta; RhoA; Ras; Raf; transformation	GROWTH-FACTOR-BETA; TRANSCRIPTION FACTORS; TUMOR-SUPPRESSOR; GTPASES; PATHWAYS; CANCER; RAS; REORGANIZATION; PROLIFERATION; KINASE	Transforming growth factor beta-1 (TGF-beta) acts as both a tumour suppressor and a tumour promoter in a context-dependent manner. The tumour-promoting activities of TGF-beta are likely to result from a combination of Smad and non-Smad signalling pathways but remain poorly understood. Here we show that TGF-beta-mediated activation of RhoA is dependent on the kinase activity of ALK5 and that continuous ALK5 activity maintains basal RhoA-ROCK signalling, cell morphology and actin dynamics in serum-starved rodent fibroblasts independently of Smad2, Smad3 and Smad4. In immortalized human diploid. broblasts, we show that oncogenic rewiring by transduction of (V12)HaRas instigates regulation of RhoA-ROCK signalling through an autocrine TGF-beta 1-ALK5 pathway. Furthermore, we show that ALK5-mediated activation of RhoA is required for efficient (V12)HaRas, V-Raf and (V600E)BRAF transformation and (V12)HaRas-mediated anchorage-independent growth. These findings identify a new pro-oncogenic activity of TGF-beta and indicate that tumours harbouring (V12)HaRas and (V600E)BRAF mutations may be susceptible to TGF-beta signalling inhibitors.	[Fleming, Y. M.; Ferguson, G. J.; Spender, L. C.; Inman, G. J.] Beatson Inst Canc Res, Growth Factor Signalling Lab, Glasgow G61 1BD, Lanark, Scotland; [Larsson, J.; Karlsson, S.] Univ Lund Hosp, Inst Lab Med, Lund, Sweden; [Larsson, J.; Karlsson, S.] Univ Lund Hosp, Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, Lund, Sweden; [Ozanne, B. W.] Beatson Inst Canc Res, Invas & Metastasis Lab, Glasgow G61 1BD, Lanark, Scotland; [Grosse, R.] Univ Heidelberg, Inst Pharmacol, D-6900 Heidelberg, Germany	Beatson Institute; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Beatson Institute; Ruprecht Karls University Heidelberg	Inman, GJ (corresponding author), Beatson Inst Canc Res, Growth Factor Signalling Lab, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	g.inman@beatson.gla.ac.uk		Inman, Gareth/0000-0002-6264-4253; Grosse, Robert/0000-0002-3380-5273	Association for International Cancer Research; Cancer Research UK	Association for International Cancer Research; Cancer Research UK(Cancer Research UK)	We thank P ten-Dijke, R Treisman, C Hill, T Crook, X-F Wang, R Derynck, A Hall and M Olson for valuable reagents. We thank J Wyke and M Olson for critically reading the paper and for discussions during the course of this work. This work was supported by an Association for International Cancer Research fellowship to GJI (GJI, YMF, GJF and LCS) and Cancer Research UK (YMF, GJI, GJF, LCS, and BWO).	Bhowmick NA, 2003, P NATL ACAD SCI USA, V100, P15548, DOI 10.1073/pnas.2536483100; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chen SY, 2006, J BIOL CHEM, V281, P1765, DOI 10.1074/jbc.M507771200; CROOK T, 1994, CELL, V79, P817, DOI 10.1016/0092-8674(94)90071-X; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Edlund S, 2002, MOL BIOL CELL, V13, P902, DOI 10.1091/mbc.01-08-0398; Goulimari P, 2005, J BIOL CHEM, V280, P42242, DOI 10.1074/jbc.M508690200; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kang YB, 2005, P NATL ACAD SCI USA, V102, P13909, DOI 10.1073/pnas.0506517102; Larsson J, 2001, EMBO J, V20, P1663, DOI 10.1093/emboj/20.7.1663; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Olson MF, 1998, NATURE, V394, P295, DOI 10.1038/28425; Ozanne BW, 2006, CURR OPIN GENET DEV, V16, P65, DOI 10.1016/j.gde.2005.12.012; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; QIU RG, 1995, P NATL ACAD SCI USA, V92, P11781, DOI 10.1073/pnas.92.25.11781; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Sahai E, 1998, EMBO J, V17, P1350, DOI 10.1093/emboj/17.5.1350; Sahai E, 2001, EMBO J, V20, P755, DOI 10.1093/emboj/20.4.755; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sahai E, 1999, CURR BIOL, V9, P136, DOI 10.1016/S0960-9822(99)80067-0; Shen X, 2001, J BIOL CHEM, V276, P15362, DOI 10.1074/jbc.M009534200; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Vardouli L, 2005, J BIOL CHEM, V280, P11448, DOI 10.1074/jbc.M402651200; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3; ZHENG Y, 1995, J BIOL CHEM, V270, P9031, DOI 10.1074/jbc.270.16.9031	30	35	35	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB 19	2009	28	7					983	993		10.1038/onc.2008.449	http://dx.doi.org/10.1038/onc.2008.449			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	408TH	19079344				2022-12-25	WOS:000263457400005
J	Samadi, N; Gaetano, C; Goping, IS; Brindley, DN				Samadi, N.; Gaetano, C.; Goping, I. S.; Brindley, D. N.			Autotaxin protects MCF-7 breast cancer and MDA-MB-435 melanoma cells against Taxol-induced apoptosis	ONCOGENE			English	Article						ceramides; chemotherapy; chemoresistance; lysophosphatidate; lysophosphatidylcholine; phosphatidylinositol 3-kinase	LYSOPHOSPHATIDIC ACID RECEPTOR; RETRACTED ARTICLE. SEE; COUPLED RECEPTOR; PREVENTS APOPTOSIS; SURVIVAL FACTOR; OVARIAN; TUMOR; GROWTH; ACTIVATION; PACLITAXEL	Autotaxin (ATX) promotes cancer cell survival, growth, migration, invasion and metastasis. ATX converts extracellular lysophosphatidylcholine (LPC) into lysophosphatidate (LPA). As these lipids have been reported to affect cell signaling through their own G-protein-coupled receptors, ATX could modify the balance of this signaling. Also, ATX affects cell adhesion independently of its catalytic activity. We investigated the interactions of ATX, LPC and LPA on the apoptotic effects of Taxol, which is commonly used in breast cancer treatment. LPC had no significant effect on Taxol-induced apoptosis in MCF-7 breast cancer cells, which do not secrete significant ATX. Addition of incubation medium from MDA-MB-435 melanoma cells, which secrete ATX, or recombinat ATX enabled LPC to inhibit Taxol-induced apoptosis of MCF-7 cells. Inhibiting ATX activity blocked this protection against apoptosis. We conclude that LPC has no significant effect in protecting MCF-7 cells against Taxol treatment unless it is converted to LPA by ATX. LPA strongly antagonized Taxol-induced apoptosis through stimulating phosphatidylinositol 3-kinase and inhibiting ceramide formation. LPA also partially reversed the Taxol-induced arrest in the G2/M phase of the cell cycle. Our results support the hypothesis that therapeutic inhibition of ATX activity could improve the efficacy of Taxol as a chemotherapeutic agent for cancer treatment.	[Gaetano, C.; Goping, I. S.; Brindley, D. N.] Univ Alberta, Dept Biochem, Signal Transduct Res Grp, Edmonton, AB T6G 2S2, Canada; [Samadi, N.] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB T6G 2S2, Canada	University of Alberta; University of Alberta	Brindley, DN (corresponding author), Univ Alberta, Dept Biochem, Signal Transduct Res Grp, Edmonton, AB T6G 2S2, Canada.	david.brindley@ualberta.ca	Gaetano, Carlo/P-9997-2019	Gaetano, Carlo/0000-0002-5238-1832; samadi, nasser/0000-0001-7960-6432				Aoki J, 2002, J BIOL CHEM, V277, P48737, DOI 10.1074/jbc.M206812200; Asakuma J, 2003, CANCER RES, V63, P1365; Baudhuin LM, 2002, MOL PHARMACOL, V62, P660, DOI 10.1124/mol.62.3.660; Bergstralh DT, 2006, CANCER TREAT REV, V32, P166, DOI 10.1016/j.ctrv.2006.01.004; Brindley DN, 2004, J CELL BIOCHEM, V92, P900, DOI 10.1002/jcb.20126; BRINDLEY DN, 1993, J NUTR BIOCHEM, V4, P442, DOI 10.1016/0955-2863(93)90061-Z; Chappell J, 2001, J BIOL CHEM, V276, P38023; Charles AG, 2001, CANCER CHEMOTH PHARM, V47, P444, DOI 10.1007/s002800000265; Chen M, 2007, AM J PHYSIOL-CELL PH, V292, pC1927, DOI 10.1152/ajpcell.00400.2006; Clair T, 2003, CANCER RES, V63, P5446; Contos JJA, 2000, P NATL ACAD SCI USA, V97, P13384, DOI 10.1073/pnas.97.24.13384; Croset M, 2000, BIOCHEM J, V345, P61, DOI 10.1042/0264-6021:3450061; Cui P, 2007, BIOORG MED CHEM LETT, V17, P1634, DOI 10.1016/j.bmcl.2006.12.114; Demidenko ZN, 2008, ONCOGENE, V27, P4402, DOI 10.1038/onc.2008.82; Dennis J, 2005, J NEUROSCI RES, V82, P737, DOI 10.1002/jnr.20686; Dufour G, 2004, J BIOL CHEM, V279, P44113, DOI 10.1074/jbc.M405323200; Fang XJ, 2000, BIOCHEM J, V352, P135, DOI 10.1042/0264-6021:3520135; Fang XJ, 2002, BBA-MOL CELL BIOL L, V1582, P257, DOI 10.1016/S1388-1981(02)00179-8; Ferry G, 2008, J PHARMACOL EXP THER, V327, P809, DOI 10.1124/jpet.108.141911; Fox MA, 2004, MOL CELL NEUROSCI, V27, P140, DOI 10.1016/j.mcn.2004.06.002; Frankel A, 1996, CLIN CANCER RES, V2, P1307; Furui T, 1999, CLIN CANCER RES, V5, P4308; Gauthier R, 2001, AM J PHYSIOL-CELL PH, V280, pC1540, DOI 10.1152/ajpcell.2001.280.6.C1540; Goetzl EJ, 1999, CANCER RES, V59, P5370; Goetzl EJ, 1999, J IMMUNOL, V162, P2049; Hama K, 2004, J BIOL CHEM, V279, P17634, DOI 10.1074/jbc.M313927200; Harnois C, 2004, J CELL PHYSIOL, V198, P209, DOI 10.1002/jcp.10399; Hu XJ, 2005, J BIOL CHEM, V280, P9498, DOI 10.1074/jbc.M410455200; Inoue CN, 2001, CLIN SCI, V101, P11, DOI 10.1042/CS20000293; Jasinska R, 1999, BIOCHEM J, V340, P677, DOI 10.1042/0264-6021:3400677; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Kabarowski JHS, 2001, SCIENCE, V293, P702, DOI 10.1126/science.1061781; Kim K, 2005, FASEB J, V19, P819, DOI 10.1096/fj.04-2988fje; Koh JS, 1998, J CLIN INVEST, V102, P716, DOI 10.1172/JCI1002; Krajewski S, 1999, ENDOCR-RELAT CANCER, V6, P29, DOI 10.1677/erc.0.0060029; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Levine JS, 1997, AM J PHYSIOL-RENAL, V273, pF575, DOI 10.1152/ajprenal.1997.273.4.F575; Lin P, 2003, J BIOL CHEM, V278, P14379, DOI 10.1074/jbc.M209101200; Marchetti P, 2002, CRIT REV ONCOL HEMAT, V44, pS3; Martin A, 1997, ONCOGENE, V14, P1571, DOI 10.1038/sj.onc.1200987; McGrogan BT, 2008, BBA-REV CANCER, V1785, P96, DOI 10.1016/j.bbcan.2007.10.004; Melet A, 2008, ADV EXP MED BIOL, V615, P47, DOI 10.1007/978-1-4020-6554-5_4; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Murph MM, 2007, MOL CANCER RES, V5, P1201, DOI 10.1158/1541-7786.MCR-06-0338; Nam SW, 2000, ONCOGENE, V19, P241, DOI 10.1038/sj.onc.1203263; Nam SW, 2001, CANCER RES, V61, P6938; Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84; Pilquil C, 2006, J BIOL CHEM, V281, P38418, DOI 10.1074/jbc.M601670200; Radeff-Huang J, 2004, J CELL BIOCHEM, V92, P949, DOI 10.1002/jcb.20094; Radu CG, 2004, P NATL ACAD SCI USA, V101, P245, DOI 10.1073/pnas.2536801100; Ramjaun AR, 2007, ONCOGENE, V26, P970, DOI 10.1038/sj.onc.1209852; Rikitake Y, 2002, ARTERIOSCL THROM VAS, V22, P2049, DOI 10.1161/01.ATV.0000040598.18570.54; Rusovici R, 2007, BBA-GEN SUBJECTS, V1770, P1194, DOI 10.1016/j.bbagen.2007.04.008; Sakashita F, 2008, CANCER CHEMOTH PHARM, V62, P379, DOI 10.1007/s00280-007-0614-5; Saunders DE, 1997, INT J CANCER, V70, P214, DOI 10.1002/(SICI)1097-0215(19970117)70:2<214::AID-IJC13>3.0.CO;2-I; Sietsma H, 2002, NEUROCHEM RES, V27, P665, DOI 10.1023/A:1020228117739; Snyder JP, 2001, P NATL ACAD SCI USA, V98, P5312, DOI 10.1073/pnas.051309398; So J, 2005, GYNECOL ONCOL, V97, P870, DOI 10.1016/j.ygyno.2005.03.004; Spankuch B, 2007, ONCOGENE, V26, P5793, DOI 10.1038/sj.onc.1210355; STRACKE ML, 1992, J BIOL CHEM, V267, P2524; Sun BL, 2003, INT J MOL MED, V12, P633; Swanton C, 2007, CANCER CELL, V11, P498, DOI 10.1016/j.ccr.2007.04.011; Tigyi G, 2003, PROG LIPID RES, V42, P498, DOI 10.1016/S0163-7827(03)00035-3; Tomura H, 2005, CELL SIGNAL, V17, P1466, DOI 10.1016/j.cellsig.2005.06.002; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; Weiner JA, 1999, P NATL ACAD SCI USA, V96, P5233, DOI 10.1073/pnas.96.9.5233; Xu Y, 1998, JAMA-J AM MED ASSOC, V280, P719, DOI 10.1001/jama.280.8.719; Yang SY, 2002, CLIN EXP METASTAS, V19, P603, DOI 10.1023/A:1020950420196; Ye XQ, 2002, BBA-MOL CELL BIOL L, V1585, P108, DOI 10.1016/S1388-1981(02)00330-X; Yue JM, 2004, CELL SIGNAL, V16, P385, DOI 10.1016/j.cellsig.2003.08.012; Zhu K, 2001, J BIOL CHEM, V276, P41325, DOI 10.1074/jbc.M008057200	72	73	79	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 19	2009	28	7					1028	1039		10.1038/onc.2008.442	http://dx.doi.org/10.1038/onc.2008.442			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	408TH	19079345				2022-12-25	WOS:000263457400009
J	Schiewer, MJ; Morey, LM; Burd, CJ; Liu, Y; Merry, DE; Ho, SM; Knudsen, KE				Schiewer, M. J.; Morey, L. M.; Burd, C. J.; Liu, Y.; Merry, D. E.; Ho, S-M; Knudsen, K. E.			Cyclin D1 repressor domain mediates proliferation and survival in prostate cancer	ONCOGENE			English	Article						androgen receptor; testosterone; prostatic adenocarcinoma; cell cycle	ANDROGEN-RECEPTOR REGULATION; D-DEPENDENT KINASE; INDEPENDENT MECHANISM; CELL-PROLIFERATION; ESTROGEN-RECEPTOR; GENE-EXPRESSION; CARCINOMA-CELLS; CO-REPRESSOR; DNA-BINDING; ACTIVATION	Regulation of the androgen receptor (AR) is critical to prostate cancer (PCa) development; therefore, AR is the first line therapeutic target for disseminated tumors. Cell cycle-dependent accumulation of cyclin D1 negatively modulates the transcriptional regulation of AR through discrete, CDK4-independent mechanisms. The transcriptional corepressor function of cyclin D1 resides within a defined motif termed repressor domain (RD), and it was hypothesized that this motif could be utilized as a platform to develop new strategies for blocking AR function. Here, we demonstrate that expression of the RD peptide is sufficient to disrupt AR transcriptional activation of multiple, prostate-specific AR target genes. Importantly, these actions are sufficient to specifically inhibit S-phase progression in AR-positive PCa cells, but not in AR-negative cells or tested AR-positive cells of other lineages. As expected, impaired cell cycle progression resulted in a suppression of cell doubling. Additionally, cell death was observed in AR-positive cells that maintain androgen dependence and in a subset of castrate-resistant PCa cells, dependent on Akt activation status. Lastly, the ability of RD to cooperate with existing hormone therapies was examined, which revealed that RD enhanced the cellular response to an AR antagonist. Together, these data demonstrate that RD is sufficient to disrupt AR-dependent transcriptional and proliferative responses in PCa, and can enhance efficacy of AR antagonists, thus establishing the impetus for development of RD-based mimetics.	[Merry, D. E.; Knudsen, K. E.] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Schiewer, M. J.; Knudsen, K. E.] Thomas Jefferson Univ, Dept Canc Biol, Philadelphia, PA 19107 USA; [Morey, L. M.; Ho, S-M] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Burd, C. J.] NIEHS, Mol Carcinogenesis Lab, Res Triangle Pk, NC 27709 USA; [Liu, Y.; Merry, D. E.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Ho, S-M] Univ Cincinnati, Coll Med, Cter Environm Genet, Cincinnati, OH USA; [Ho, S-M] Univ Cincinnati, Coll Med, UC Barrett Canc Ctr, Cincinnati, OH USA; [Knudsen, K. E.] Thomas Jefferson Univ, Dept Urol, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University; University System of Ohio; University of Cincinnati; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Jefferson University; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Jefferson University	Knudsen, KE (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, Bluemle Life Sci Bldg,233 S 10th St,Room 1008A, Philadelphia, PA 19107 USA.	karen.knudsen@kimmelcancercenter.org		Schiewer, Matthew/0000-0002-2325-4228; Burd, Craig/0000-0002-6899-6751; Knudsen, Karen/0000-0002-1301-890X	NIH [CA099996, CA116777, CA015776, CA062269, CA112532];  [T32-CA117846]; NATIONAL CANCER INSTITUTE [T32CA117846, R01CA112532, R01CA099996, R01CA015776, R01CA116777, R01CA062269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank the K Knudsen lab for critical input, especially SM Godoy Tundidor; S Schwemberger, S Fox and M Faradaugh for technical assistance, and the E Knudsen laboratory for commentary. This work was supported by NIH grants CA099996 and CA116777 (to KEK); CA015776, CA062269, CA112532 (to SMH). LMM was supported by training grant T32-CA117846.	Agus DB, 1999, J NATL CANCER I, V91, P1869, DOI 10.1093/jnci/91.21.1869; Balk SP, 2008, NUCL RECEPT SIGNAL, V6; Bienvenu F, 2001, J BIOL CHEM, V276, P16840, DOI 10.1074/jbc.M100795200; BIRRELL SN, 1995, J STEROID BIOCHEM, V52, P459, DOI 10.1016/0960-0760(95)00005-K; Burd CJ, 2005, MOL ENDOCRINOL, V19, P607, DOI 10.1210/me.2004-0266; Burnstein KL, 2005, J CELL BIOCHEM, V95, P657, DOI 10.1002/jcb.20460; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Cheng H, 2006, CANCER RES, V66, P10613, DOI 10.1158/0008-5472.CAN-06-0028; Cheng MG, 1998, P NATL ACAD SCI USA, V95, P1091, DOI 10.1073/pnas.95.3.1091; Chmelar R, 2007, INT J CANCER, V120, P719, DOI 10.1002/ijc.22365; Coqueret O, 2002, GENE, V299, P35, DOI 10.1016/S0378-1119(02)01055-7; Davies MA, 1999, CANCER RES, V59, P2551; ESQUENET M, 1995, MOL CELL ENDOCRINOL, V109, P105, DOI 10.1016/0303-7207(95)03490-X; Ewen ME, 2004, TRENDS MOL MED, V10, P158, DOI 10.1016/j.molmed.2004.02.005; EWEN ME, 1993, CELL, V73, P487, DOI 10.1016/0092-8674(93)90136-E; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Fu MF, 2005, J BIOL CHEM, V280, P16934, DOI 10.1074/jbc.M500403200; Ganter B, 1998, EMBO J, V17, P255, DOI 10.1093/emboj/17.1.255; Ghosh PM, 2005, ENDOCR-RELAT CANCER, V12, P119, DOI 10.1677/erc.1.00835; Gottschalk AR, 2005, INT J RADIAT ONCOL, V61, P1183, DOI 10.1016/j.ijrobp.2004.12.024; Gregory CW, 2001, CANCER RES, V61, P2892; Hadaschik BA, 2007, UROL ONCOL-SEMIN ORI, V25, P413, DOI 10.1016/j.urolonc.2007.05.010; Hess-Wilson JK, 2006, CANCER RES, V66, P11998, DOI 10.1158/0008-5472.CAN-06-2249; Hu B, 2007, CANCER RES, V67, P8810, DOI 10.1158/0008-5472.CAN-07-1140; Inoue K, 1998, MOL CELL BIOL, V18, P1590, DOI 10.1128/MCB.18.3.1590; James MK, 2008, MOL CELL BIOL, V28, P498, DOI 10.1128/MCB.02171-06; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kato A, 1998, BIOCHEM BIOPH RES CO, V245, P70, DOI 10.1006/bbrc.1998.8377; Knudsen KE, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-15; Knudsen KE, 1999, CANCER RES, V59, P2297; Knudsen KE, 1998, J BIOL CHEM, V273, P20213, DOI 10.1074/jbc.273.32.20213; Li JW, 2006, MOL ENDOCRINOL, V20, P776, DOI 10.1210/me.2005-0298; Li JW, 2002, GENE DEV, V16, P687, DOI 10.1101/gad.962502; Lilja H, 2008, NAT REV CANCER, V8, P268, DOI 10.1038/nrc2351; Lin HM, 2002, J BIOL CHEM, V277, P28733, DOI 10.1074/jbc.M203380200; Locke JA, 2008, CANCER RES, V68, P6407, DOI 10.1158/0008-5472.CAN-07-5997; MATSUSHIME H, 1992, CELL, V71, P323, DOI 10.1016/0092-8674(92)90360-O; MAUCHER A, 1993, J CANCER RES CLIN, V119, P669, DOI 10.1007/BF01215986; McMenamin ME, 1999, CANCER RES, V59, P4291; Mehra R, 2007, CANCER RES, V67, P7991, DOI 10.1158/0008-5472.CAN-07-2043; Mehra R, 2007, MODERN PATHOL, V20, P538, DOI 10.1038/modpathol.3800769; Minamiguchi K, 2004, MOL CELL ENDOCRINOL, V214, P175, DOI 10.1016/j.mce.2003.10.060; Montgomery RB, 2008, CANCER RES, V68, P4447, DOI 10.1158/0008-5472.CAN-08-0249; Mullany LK, 2008, CELL CYCLE, V7, P2215, DOI 10.4161/cc.7.14.6274; Neuman E, 1997, MOL CELL BIOL, V17, P5338, DOI 10.1128/MCB.17.9.5338; Olshavsky NA, 2008, ONCOGENE, V27, P3111, DOI 10.1038/sj.onc.1210981; Parry D, 1999, MOL CELL BIOL, V19, P1775; Perner S, 2007, AM J SURG PATHOL, V31, P882, DOI 10.1097/01.pas.0000213424.38503.aa; Petre CE, 2002, J BIOL CHEM, V277, P2207, DOI 10.1074/jbc.M106399200; Petre-Draviam CE, 2005, ONCOGENE, V24, P431, DOI 10.1038/sj.onc.1208200; Petre-Draviam CE, 2003, CANCER RES, V63, P4903; Petrylak DP, 2005, UROLOGY, V65, P3, DOI 10.1016/j.urology.2005.03.053; Pienta KJ, 2006, CLIN CANCER RES, V12, P1665, DOI 10.1158/1078-0432.CCR-06-0067; Quayle SN, 2007, P NATL ACAD SCI USA, V104, P1331, DOI 10.1073/pnas.0606718104; Quayle SN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-32; QUELLE DE, 1993, GENE DEV, V7, P1559, DOI 10.1101/gad.7.8.1559; Reutens AT, 2001, MOL ENDOCRINOL, V15, P797, DOI 10.1210/me.15.5.797; RUNDLETT SE, 1990, MOL ENDOCRINOL, V4, P708, DOI 10.1210/mend-4-5-708; Salesi N, 2005, J EXP CLIN CANC RES, V24, P175; Shand RL, 2006, CURR OPIN UROL, V16, P123, DOI 10.1097/01.mou.0000193384.39351.64; Sharifi N, 2005, JAMA-J AM MED ASSOC, V294, P238, DOI 10.1001/jama.294.2.238; Sharifi N, 2002, J MOL MED, V80, P219, DOI 10.1007/s00109-001-0305-3; Shen MM, 2007, CANCER RES, V67, P6535, DOI 10.1158/0008-5472.CAN-07-1271; SKAPEK SX, 1995, SCIENCE, V267, P1022, DOI 10.1126/science.7863328; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; Subbarayan V, 2005, NEOPLASIA, V7, P280, DOI 10.1593/neo.04457; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Walcott JL, 2002, J BIOL CHEM, V277, P50855, DOI 10.1074/jbc.M209466200; Wang CG, 2003, MOL CELL BIOL, V23, P6159, DOI 10.1128/MCB.23.17.6159-6173.2003; Wang CG, 2006, P NATL ACAD SCI USA, V103, P11567, DOI 10.1073/pnas.0603363103; Wilson S, 2005, BIOCHEM J, V388, P967, DOI 10.1042/BJ20041066; WONG CI, 1993, J BIOL CHEM, V268, P19004; Xu YY, 2006, CANCER RES, V66, P7783, DOI 10.1158/0008-5472.CAN-05-4472; Zhu P, 2006, CELL, V124, P615, DOI 10.1016/j.cell.2005.12.032; Zwijsen RML, 1998, GENE DEV, V12, P3488, DOI 10.1101/gad.12.22.3488	78	19	19	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 19	2009	28	7					1016	1027		10.1038/onc.2008.446	http://dx.doi.org/10.1038/onc.2008.446			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	408TH	19079343	Green Accepted			2022-12-25	WOS:000263457400008
J	Chiang, YJ; Jordan, MS; Horai, R; Schwartzberg, PL; Koretzky, GA; Hodes, RJ				Chiang, Y. Jeffrey; Jordan, Martha S.; Horai, Reiko; Schwartzberg, Pamela L.; Koretzky, Gary A.; Hodes, Richard J.			Cbl Enforces an SLP76-dependent Signaling Pathway for T Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADAPTER PROTEIN SLP-76; C-CBL; NEGATIVE REGULATION; ANTIGEN RECEPTOR; TYROSINE PHOSPHORYLATION; THYMOCYTE DEVELOPMENT; POSITIVE SELECTION; ACTIVATION; TCR; MICE	A signaling pathway involving ZAP-70, LAT, and SLP76 has been regarded as essential for receptor-driven T cell development and activation. Consistent with this model, mice deficient in SLP76 have a complete block at the double negative 3 stage of T cell development. Recently, however, it has been reported that inactivation of Cbl, a ubiquitin-protein isopeptide ligase, partially rescues T cell development in SLP76-deficient mice. To probe the influence of Cbl on domain-specific SLP76 functions, we reconstituted SLP76(-/-) Cbl(-/-) mice with Slp76 transgenes bearing mutations in each of three functional domains of SLP76 as follows: Y3F, in which the amino-terminal tyrosine residues of SLP76 were mutated, eliminating sites of SLP76 interaction with Vav, Nck, and Itk; Delta 20, in which 20 amino acids in the proline-rich region of SLP76 were deleted, removing a binding site for Gads; and RK, in which arginine 448 of SLP76 was replaced by lysine, abolishing function of the Src homology 2 domain. Although each of these transgenes has been shown to partially rescue T cell development in SLP76(-/-) mice, we report here that Cbl inactivation completely reverses the severe double negative 3 developmental block that occurs in SLP76-deficient mice expressing the Y3F transgene (Y3F mice) and partially rescues the defect in positive selection in T cell receptor transgenic Y3F mice, but in contrast fails to rescue thymic development of SLP76-deficient mice expressing the Delta 20 or RK transgene. Rescue in SLP76(-/-) Cbl(-/-) Y3F double-positive thymocytes is associated with enhanced tyrosine phosphorylation of signaling molecules, including Lck, Vav, PLC-gamma 1, and ERKs, but not Itk, in response to T cell receptor stimulation. Thus, our data demonstrate that Cbl suppresses activation of a bypass signaling pathway and thereby enforces SLP76 dependence of early T cell development.	[Chiang, Y. Jeffrey; Hodes, Richard J.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Chiang, Y. Jeffrey; Hodes, Richard J.] NIA, NIH, Bethesda, MD 20892 USA; [Jordan, Martha S.; Koretzky, Gary A.] Univ Penn, Signal Transduct Program, Abramson Family Canc Res Inst, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Horai, Reiko; Schwartzberg, Pamela L.] NHGRI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Pennsylvania; Pennsylvania Medicine; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Chiang, YJ (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10,4B36, Bethesda, MD 20892 USA.	chiangj@mail.nih.gov	Koretzky, Gary/AAU-5381-2021		National Institutes of Health grant (NCI Intramural Research Program); NATIONAL CANCER INSTITUTE [ZIABC009281, Z01BC009255, ZICBC009255] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000123, Z01HG000123] Funding Source: NIH RePORTER	National Institutes of Health grant (NCI Intramural Research Program)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported, in whole or in part, by a National Institutes of Health grant (NCI Intramural Research Program).	Alonso A, 2004, J BIOL CHEM, V279, P4922, DOI 10.1074/jbc.M308978200; Balagopalan L, 2007, MOL CELL BIOL, V27, P8622, DOI 10.1128/MCB.00467-07; Bogin Y, 2007, P NATL ACAD SCI USA, V104, P6638, DOI 10.1073/pnas.0609771104; Bunnell SC, 2006, MOL CELL BIOL, V26, P7155, DOI 10.1128/MCB.00507-06; Chiang YJ, 2004, J EXP MED, V200, P25, DOI 10.1084/jem.20040262; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; Fagerholm S, 2002, EUR J IMMUNOL, V32, P1670, DOI 10.1002/1521-4141(200206)32:6<1670::AID-IMMU1670>3.0.CO;2-M; GRIFFITHS EK, 2002, SCI STKE, pRE3; Han JW, 1997, MOL CELL BIOL, V17, P1346, DOI 10.1128/MCB.17.3.1346; Hawash IY, 2002, J BIOL CHEM, V277, P5683, DOI 10.1074/jbc.M110002200; Jordan MS, 2008, IMMUNITY, V28, P359, DOI 10.1016/j.immuni.2008.01.010; Jordan MS, 2006, J IMMUNOL, V176, P2430, DOI 10.4049/jimmunol.176.4.2430; Kadlecek TA, 1998, J IMMUNOL, V161, P4688; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Koretzky GA, 2006, NAT REV IMMUNOL, V6, P67, DOI 10.1038/nri1750; Koretzky GA, 2001, NAT REV IMMUNOL, V1, P95, DOI 10.1038/35100523; Kumar L, 2002, P NATL ACAD SCI USA, V99, P884, DOI 10.1073/pnas.022619199; Laky K, 2006, IMMUNOL REV, V209, P274, DOI 10.1111/j.0105-2896.2006.00358.x; Lucas JA, 2002, J IMMUNOL, V168, P6142, DOI 10.4049/jimmunol.168.12.6142; Manetz TS, 2001, MOL CELL BIOL, V21, P3763, DOI 10.1128/MCB.21.11.3763-3774.2001; Mazza C, 2007, SEMIN IMMUNOL, V19, P225, DOI 10.1016/j.smim.2007.03.003; Myers MD, 2005, J CELL BIOL, V170, P285, DOI 10.1083/jcb.200501164; Myung PS, 2001, IMMUNITY, V15, P1011, DOI 10.1016/S1074-7613(01)00253-9; NAKAYAMA T, 1989, NATURE, V341, P651, DOI 10.1038/341651a0; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Rao NV, 2002, P NATL ACAD SCI USA, V99, P3794, DOI 10.1073/pnas.062055999; Seet BT, 2007, EMBO J, V26, P678, DOI 10.1038/sj.emboj.7601535; SHORTMAN K, 1988, IMMUNOL CELL BIOL, V66, P423, DOI 10.1038/icb.1988.54; Thien CBF, 2005, BIOCHEM J, V391, P153, DOI 10.1042/BJ20050892; Thien CBF, 1999, J IMMUNOL, V162, P7133; Yamasaki S, 2007, TRENDS IMMUNOL, V28, P39, DOI 10.1016/j.it.2006.11.006; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1	34	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4429	4438		10.1074/jbc.M808679200	http://dx.doi.org/10.1074/jbc.M808679200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19074136	Green Published, hybrid			2022-12-25	WOS:000263134400043
J	Davidge, KS; Sanguinetti, G; Yee, CH; Cox, AG; McLeod, CW; Monk, CE; Mann, BE; Motterlini, R; Poole, RK				Davidge, Kelly S.; Sanguinetti, Guido; Yee, Chu Hoi; Cox, Alan G.; McLeod, Cameron W.; Monk, Claire E.; Mann, Brian E.; Motterlini, Roberto; Poole, Robert K.			Carbon Monoxide-releasing Antibacterial Molecules Target Respiration and Global Transcriptional Regulators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; NITRIC-OXIDE; GENE-EXPRESSION; METAL-BINDING; ZINC; PROTEIN; SYSTEM; SIGNAL; COMPLEXES; MEMBRANE	Carbon monoxide, a classical respiratory inhibitor, also exerts vasodilatory, anti-inflammatory, and antiapoptotic effects. CO-releasing molecules have therapeutic value, increasing phagocytosis and reducing sepsis-induced lethality. Here we identify for the first time the bacterial targets of Ru(CO)(3)Cl(glycinate) (CORM-3), a ruthenium-based carbonyl that liberates CO rapidly under physiological conditions. Contrary to the expectation that CO would be preferentially inhibitory at low oxygen tensions or anaerobically, Escherichia coli cultures were also sensitive to CORM-3 at concentrations equimolar with oxygen. CORM-3, assayed as ruthenium, was taken up by bacteria and rapidly delivered CO intracellularly to terminal oxidases. Microarray analysis of CORM-3-treated cells revealed extensively modified gene expression, notably down-regulation of genes encoding key aerobic respiratory complexes. Genes involved in metal metabolism, homeostasis, or transport were also differentially expressed, and free intracellular zinc levels were elevated. Probabilistic modeling of transcriptomic data identified the global transcription regulators ArcA, CRP, Fis, FNR, Fur, BaeR, CpxR, and IHF as targets and potential CO sensors. Our discovery that CORM-3 is an effective inhibitor and global regulator of gene expression, especially under aerobic conditions, has important implications for administration of CO-releasing agents in sepsis and inflammation.	[Davidge, Kelly S.; Yee, Chu Hoi; Monk, Claire E.; Poole, Robert K.] Univ Sheffield, Dept Mol Biol & Biotechnol, Western Bank, Sheffield S10 2TN, S Yorkshire, England; [Sanguinetti, Guido] Univ Sheffield, Dept Comp Sci, Western Bank, Sheffield S10 2TN, S Yorkshire, England; [Cox, Alan G.; McLeod, Cameron W.] Univ Sheffield, Ctr Analyt Sci, Western Bank, Sheffield S10 2TN, S Yorkshire, England; [Mann, Brian E.] Univ Sheffield, Dept Chem, Western Bank, Sheffield S10 2TN, S Yorkshire, England; [Motterlini, Roberto] Italian Inst Technol, Dept Drug Discovery & Dev, I-16163 Genoa, Italy	University of Sheffield; University of Sheffield; University of Sheffield; University of Sheffield; Istituto Italiano di Tecnologia - IIT	Poole, RK (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Western Bank, Sheffield S10 2TN, S Yorkshire, England.	r.poole@sheffield.ac.uk	Motterlini, Roberto/Q-1890-2019; Motterlini, Roberto/G-2489-2013	Motterlini, Roberto/0000-0003-2684-2612; Motterlini, Roberto/0000-0003-2684-2612; Davidge, Sandra/0000-0002-5559-4905	Biotechnology and Biological Sciences Research Council (UK); Society for General Microbiology; Biotechnology and Biological Sciences Research Council [BB/E015883/1] Funding Source: researchfish; BBSRC [BB/E015883/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Society for General Microbiology; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (UK) and a Vacation Studentship from the Society for General Microbiology (to R. K. P. and C. H. Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALANI FT, 1988, J CHEM SOC DA, V9, P2329; Barbe JM, 2004, DALTON T, P1208, DOI 10.1039/b316706b; Beard SJ, 1997, MOL MICROBIOL, V25, P883, DOI 10.1111/j.1365-2958.1997.mmi518.x; Binet MRB, 2000, FEBS LETT, V473, P67, DOI 10.1016/S0014-5793(00)01509-X; Binet MRB, 2002, FEMS MICROBIOL LETT, V213, P121, DOI 10.1016/S0378-1097(02)00803-0; Boczkowski J, 2006, TRENDS BIOCHEM SCI, V31, P614, DOI 10.1016/j.tibs.2006.09.001; Borisov VB, 2001, J BIOL CHEM, V276, P22095, DOI 10.1074/jbc.M011542200; Chung SW, 2008, J CLIN INVEST, V118, P239, DOI 10.1172/JCI32730; Clark JE, 2003, CIRC RES, V93, pE2, DOI 10.1161/01.RES.0000084381.86567.08; Crack JC, 2007, P NATL ACAD SCI USA, V104, P2092, DOI 10.1073/pnas.0609514104; Cruz-Ramos H, 2002, EMBO J, V21, P3235, DOI 10.1093/emboj/cdf339; David G, 2003, J BIOL CHEM, V278, P43728, DOI 10.1074/jbc.M304484200; Desmard M, 2005, CELL MOL BIOL, V51, P403, DOI 10.1170/T644; Desmard M, 2009, FASEB J, V23, P1023, DOI 10.1096/fj.08-122804; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Flatley J, 2005, J BIOL CHEM, V280, P10065, DOI 10.1074/jbc.M410393200; Foresti R, 2005, CELL MOL BIOL, V51, P409, DOI 10.1170/T645; Georgellis D, 2001, SCIENCE, V292, P2314, DOI 10.1126/science.1059361; GIBSON JF, 1986, ARCH ENVIRON CON TOX, V15, P519, DOI 10.1007/BF01056564; GIBSON JF, 1984, ARCH MICROBIOL, V139, P265, DOI 10.1007/BF00402012; Gilberthorpe NJ, 2008, J BIOL CHEM, V283, P11146, DOI 10.1074/jbc.M708019200; Guo YR, 2004, AM J PHYSIOL-HEART C, V286, pH1649, DOI 10.1152/ajpheart.00971.2003; Husain M, 2008, J BIOL CHEM, V283, P7682, DOI 10.1074/jbc.M708845200; IUCHI S, 1990, J BACTERIOL, V172, P6020, DOI 10.1128/jb.172.10.6020-6025.1990; Jung WS, 2008, FEMS MICROBIOL LETT, V284, P109, DOI 10.1111/j.1574-6968.2008.01187.x; Kalnenieks U, 1998, FEMS MICROBIOL LETT, V168, P91; Keilin D., 1966, HIST CELL RESP CYTOC, P252; Kershaw CJ, 2007, BIOCHEM BIOPH RES CO, V364, P66, DOI 10.1016/j.bbrc.2007.09.094; Lee LJ, 2005, J BACTERIOL, V187, P1124, DOI 10.1128/JB.187.3.1124-1134.2005; Li H, 2007, J MOL BIOL, V368, P1358, DOI 10.1016/j.jmb.2007.02.107; LOMIS TJ, 1989, INORG CHEM, V28, P2369, DOI 10.1021/ic00311a023; MARKS GS, 1991, TRENDS PHARMACOL SCI, V12, P185, DOI 10.1016/0165-6147(91)90544-3; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Motterlini R, 2007, BIOCHEM SOC T, V35, P1142, DOI 10.1042/BST0351142; Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530; Neidhardt FC, 1990, PHYSL BACTERIAL CELL, P1; Nobre LS, 2007, ANTIMICROB AGENTS CH, V51, P4303, DOI 10.1128/AAC.00802-07; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Overhaus M, 2006, AM J PHYSIOL-GASTR L, V290, pG695, DOI 10.1152/ajpgi.00152.2005; Partridge JD, 2007, J BIOL CHEM, V282, P11230, DOI 10.1074/jbc.M700728200; Patzer SI, 1998, MOL MICROBIOL, V28, P1199, DOI 10.1046/j.1365-2958.1998.00883.x; Poole RK, 1996, J BACTERIOL, V178, P5487, DOI 10.1128/jb.178.18.5487-5492.1996; POOLE RK, 1979, BIOCHEM J, V184, P379, DOI 10.1042/bj1840379; Puskarova A, 2002, MICROBIOL-SGM, V148, P3801, DOI 10.1099/00221287-148-12-3801; Raffa RG, 2002, MOL MICROBIOL, V45, P1599, DOI 10.1046/j.1365-2958.2002.03112.x; Ragsdale SW, 2004, CRIT REV BIOCHEM MOL, V39, P165, DOI 10.1080/10409230490496577; Raivio TL, 2000, MOL MICROBIOL, V37, P1186, DOI 10.1046/j.1365-2958.2000.02074.x; Roberts GP, 2004, MICROBIOL MOL BIOL R, V68, P453, DOI 10.1128/MMBR.68.3.453-473.2004; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Sawle P, 2005, BRIT J PHARMACOL, V145, P800, DOI 10.1038/sj.bjp.0706241; SCHUBERT MP, 1933, J AM CHEM SOC, V55, P4563; Scragg JL, 2008, J BIOL CHEM, V283, P24412, DOI 10.1074/jbc.M803037200; Taille C, 2005, J BIOL CHEM, V280, P25350, DOI 10.1074/jbc.M503512200; Velayudhan J, 2007, MOL MICROBIOL, V63, P1495, DOI 10.1111/j.1365-2958.2007.05600.x; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; WOOD PM, 1984, BIOCHIM BIOPHYS ACTA, V768, P293, DOI 10.1016/0304-4173(84)90020-X; Yamamoto K, 2008, J BIOTECHNOL, V133, P196, DOI 10.1016/j.jbiotec.2007.08.002; Yatsunyk LA, 2008, J BIOL INORG CHEM, V13, P271, DOI 10.1007/s00775-007-0320-0; Yoshimura-Suzuki T, 2005, J BACTERIOL, V187, P6678, DOI 10.1128/JB.187.19.6678-6682.2005	60	120	120	3	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4516	4524		10.1074/jbc.M808210200	http://dx.doi.org/10.1074/jbc.M808210200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19091747	hybrid, Green Accepted			2022-12-25	WOS:000263134400052
J	Schmidt, BZ; Watts, RJ; Aridor, M; Frizzell, RA				Schmidt, Bela Z.; Watts, Rebecca J.; Aridor, Meir; Frizzell, Raymond A.			Cysteine String Protein Promotes Proteasomal Degradation of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) by Increasing Its Interaction with the C Terminus of Hsp70-interacting Protein and Promoting CFTR Ubiquitylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE; EPITHELIAL-CELLS; ATPASE ACTIVITY; LATE STEPS; CHAPERONE; HSP70; DROSOPHILA; CHIP; P97; BIOGENESIS	Cysteine string protein (Csp) is a J-domain-containing protein whose overexpression blocks the exit of cystic fibrosis transmembrane conductance regulator ( CFTR) from the endoplasmic reticulum ( ER). Another method of blocking ER exit, the overexpression of Sar1-GTP, however, yielded twice as much immature CFTR compared with Csp overexpression. This finding suggested that Csp not only inhibits CFTR ER exit but also facilitates the degradation of immature CFTR. This was confirmed by treatment with a proteasome inhibitor, which returned the level of immature CFTR to that found in cells expressing Sar1-GTP only. CspH43Q, which does not interact with Hsc70/Hsp70 efficiently, did not promote CFTR degradation, suggesting that the pro-degradative effect of Csp requires Hsc70/Hsp70 binding/activation. In agreement with this, Csp overexpression increased the amount of Hsc70/Hsp70 co-immunoprecipitated with CFTR, whereas overexpression of CspH43Q did not. The Hsc70/Hsp70 binding partner C terminus of Hsp70-interacting protein ( CHIP) can target CFTR for proteasome-mediated degradation. Csp overexpression also increased the amount of CHIP co-immunoprecipitated with CFTR. In addition, CHIP interacted directly with Csp, which was confirmed by in vitro binding experiments. Csp overexpression also increased CFTR ubiquitylation and reduced the half-life of immature CFTR. These findings indicate that Csp not only regulates the exit of CFTR from the ER, but that this action is accompanied by Hsc70/Hsp70 and CHIP-mediated CFTR degradation.	[Schmidt, Bela Z.; Watts, Rebecca J.; Aridor, Meir; Frizzell, Raymond A.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Frizzell, RA (corresponding author), S362 BST,3500 Terrace St, Pittsburgh, PA 15261 USA.	Frizzell@pitt.edu		Watters, Rebecca/0000-0001-7486-7510; Schmidt, Bela Z/0000-0003-1085-9372	National Institutes of Health [DK68196, DK72506,, DK62318]; Cystic Fibrosis Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072506, R56DK062318, R01DK062318, R01DK068196] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK68196, DK72506, and DK62318. This work was also supported by the Cystic Fibrosis Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alberti S, 2004, MOL BIOL CELL, V15, P4003, DOI 10.1091/mbc.E04-04-0293; Aridor M, 1998, J CELL BIOL, V141, P61, DOI 10.1083/jcb.141.1.61; Arndt V, 2005, MOL BIOL CELL, V16, P5891, DOI 10.1091/mbc.E05-07-0660; Bielli A, 2005, J CELL BIOL, V171, P919, DOI 10.1083/jcb.200509095; Brown H, 1998, EMBO J, V17, P5048, DOI 10.1093/emboj/17.17.5048; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Chamberlain LH, 1997, BIOCHEM J, V322, P853, DOI 10.1042/bj3220853; Chamberlain LH, 1996, J BIOL CHEM, V271, P19514, DOI 10.1074/jbc.271.32.19514; Chamberlain LH, 1996, J BIOL CHEM, V271, P7320, DOI 10.1074/jbc.271.13.7320; Chamberlain LH, 2000, J NEUROCHEM, V74, P1781, DOI 10.1046/j.1471-4159.2000.0741781.x; Chamberlain LH, 1997, J BIOL CHEM, V272, P31420, DOI 10.1074/jbc.272.50.31420; Evans GJO, 2002, BIOCHEM J, V364, P343, DOI 10.1042/BJ20020123; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; Graham ME, 2000, J NEUROSCI, V20, P1281; GUNDERSEN CB, 1994, J BIOL CHEM, V269, P19197; Halawani D, 2006, MOL CELL, V22, P713, DOI 10.1016/j.molcel.2006.06.003; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Lei DC, 1996, GENE THER, V3, P427; Leveque C, 1998, J BIOL CHEM, V273, P13488, DOI 10.1074/jbc.273.22.13488; Magga JM, 2000, NEURON, V28, P195, DOI 10.1016/S0896-6273(00)00096-9; MASTROGIACOMO A, 1994, SCIENCE, V263, P981, DOI 10.1126/science.7906056; Meacham GC, 1999, EMBO J, V18, P1492, DOI 10.1093/emboj/18.6.1492; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Natochin M, 2005, J BIOL CHEM, V280, P30236, DOI 10.1074/jbc.M500722200; Nie ZP, 1999, J NEUROSCI, V19, P10270; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Ranjan R, 1998, J NEUROSCI, V18, P956; Sakisaka T, 2002, EMBO J, V21, P6125, DOI 10.1093/emboj/cdf603; Swiatecka-Urban A, 2005, J BIOL CHEM, V280, P36762, DOI 10.1074/jbc.M508944200; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tobaben S, 2001, NEURON, V31, P987, DOI 10.1016/S0896-6273(01)00427-5; Tsai J, 1996, J BIOL CHEM, V271, P9347, DOI 10.1074/jbc.271.16.9347; Uchiyama K, 2006, DEV CELL, V11, P803, DOI 10.1016/j.devcel.2006.10.016; Wang XD, 2004, J CELL BIOL, V167, P65, DOI 10.1083/jcb.200401035; Westhoff B, 2005, CURR BIOL, V15, P1058, DOI 10.1016/j.cub.2005.04.058; YANG YP, 1993, P NATL ACAD SCI USA, V90, P9480, DOI 10.1073/pnas.90.20.9480; Younger JM, 2004, J CELL BIOL, V167, P1075, DOI 10.1083/jcb.200410065; Zhang H, 1999, J CELL SCI, V112, P1345; Zhang H, 2006, J BIOL CHEM, V281, P11312, DOI 10.1074/jbc.M512013200; Zhang H, 2002, J BIOL CHEM, V277, P28948, DOI 10.1074/jbc.M111706200; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297; ZINSMAIER KE, 1990, J NEUROGENET, V7, P15, DOI 10.3109/01677069009084150	45	38	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4168	4178		10.1074/jbc.M806485200	http://dx.doi.org/10.1074/jbc.M806485200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19098309	Green Published, hybrid			2022-12-25	WOS:000263134400014
J	Zhao, RB; Min, SH; Wang, YH; Campanella, E; Low, PS; Goldman, ID				Zhao, Rongbao; Min, Sang Hee; Wang, Yanhua; Campanella, Estela; Low, Philip S.; Goldman, I. David			A Role for the Proton-coupled Folate Transporter (PCFT-SLC46A1) in Folate Receptor-mediated Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOROID-PLEXUS; FUNCTIONAL-CHARACTERIZATION; BINDING PROTEIN; TUMOR-CELLS; CARRIER; RAT; DEFICIENCY; IMPACT; PH; IDENTIFICATION	Recently, this laboratory identified a proton-coupled folate transporter (PCFT), with optimal activity at low pH. PCFT is critical to intestinal folate absorption and transport into the central nervous system because there are loss-of-function mutations in this gene in the autosomal recessive disorder, hereditary folate malabsorption. The current study addresses the role PCFT might play in another transport pathway, folate receptor (FR)-mediated endocytosis. FR alpha cDNA was transfected into novel PCFT+ and PCFT- HeLa sublines. FR alpha was shown to bind and trap folates in vesicles but with minimal export into the cytosol in PCFT- cells. Cotransfection of FR alpha and PCFT resulted in enhanced folate transport into cytosol as compared with transfection of FR alpha alone. Probenecid did not inhibit folate binding to FR, but inhibited PCFT- mediated transport at endosomal pH, and blocked FR alpha-mediated transport into the cytosol. FR alpha and PCFT co-localized to the endosomal compartment. These observations (i) indicate that PCFT plays a role in FR alpha-mediated endocytosis by serving as a route of export of folates from acidified endosomes and (ii) provide a functional role for PCFT in tissues in which it is expressed, such as the choroid plexus, where the extracellular milieu is at neutral pH.	[Zhao, Rongbao; Min, Sang Hee; Goldman, I. David] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Zhao, Rongbao; Min, Sang Hee; Goldman, I. David] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Wang, Yanhua] Med Coll Penn & Hahnemann Univ, Dept Pathol, Philadelphia, PA 19129 USA; [Campanella, Estela; Low, Philip S.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Drexel University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Goldman, ID (corresponding author), Chanin 2,1300 Morris Pk Ave, Bronx, NY 10461 USA.	igoldman@aecom.yu.edu		Puchulu-Campanella, Estela/0000-0002-3951-3925; Low, Philip/0000-0001-9042-5528	National Institutes of Health [CA-82621]; Mesothelioma Applied Research Foundation; NATIONAL CANCER INSTITUTE [R01CA082621, P30CA013330, P30CA023168] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mesothelioma Applied Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA-82621 from the NCI. This work was also supported by a grant from the Mesothelioma Applied Research Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ANDERSON RGW, 1992, SCIENCE, V255, P410, DOI 10.1126/science.1310359; Andrews NC, 2007, ANNU REV PHYSIOL, V69, P69, DOI 10.1146/annurev.physiol.69.031905.164337; Andrews NC, 2007, CELL METAB, V5, P5, DOI 10.1016/j.cmet.2006.12.004; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; Fleming MD, 1998, P NATL ACAD SCI USA, V95, P1148, DOI 10.1073/pnas.95.3.1148; GARRICK MD, 1993, J BIOL CHEM, V268, P14867; Geller J, 2002, MEDICINE, V81, P51, DOI 10.1097/00005792-200201000-00004; Gunshin H, 2005, J CLIN INVEST, V115, P1258, DOI [10.1172/JCI200524356, 10.1172/JCI24356]; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; He W, 2007, P NATL ACAD SCI USA, V104, P11760, DOI 10.1073/pnas.0703875104; Inoue K, 2008, AM J PHYSIOL-GASTR L, V294, pG660, DOI 10.1152/ajpgi.00309.2007; Kamen BA, 2004, ADV DRUG DELIVER REV, V56, P1085, DOI 10.1016/j.addr.2004.01.002; KAMEN BA, 1988, J BIOL CHEM, V263, P13602; KAMEN BA, 1991, J CLIN INVEST, V87, P1442, DOI 10.1172/JCI115150; Kennedy MD, 2003, PHARM RES-DORDR, V20, P714, DOI 10.1023/A:1023421232689; Lasry I, 2008, BLOOD, V112, P2055, DOI 10.1182/blood-2008-04-150276; LEAMON CP, 1992, J BIOL CHEM, V267, P24966; LEAMON CP, 1993, J BIOL CHEM, V268, P24847; MASON JB, 1994, PHYSL GASTROINTESTIN; MCEWAN GTA, 1990, J MED ENG TECHNOL, V14, P16, DOI 10.3109/03091909009028758; Min SH, 2008, J PEDIATR-US, V153, P435, DOI 10.1016/j.jpeds.2008.04.009; Moretti P, 2008, J AUTISM DEV DISORD, V38, P1170, DOI 10.1007/s10803-007-0492-z; Patrick TA, 1997, J NEURO-ONCOL, V32, P111, DOI 10.1023/A:1005713115147; Piedrahita JA, 1999, NAT GENET, V23, P228, DOI 10.1038/13861; PRASAD PD, 1994, BBA-MOL CELL RES, V1222, P309, DOI 10.1016/0167-4889(94)90184-8; Qiu A, 2007, AM J PHYSIOL-CELL PH, V293, pC1669, DOI 10.1152/ajpcell.00202.2007; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Ramaekers VT, 2007, NEUROPEDIATRICS, V38, P276, DOI 10.1055/s-2008-1065354; Ramaekers VT, 2005, NEW ENGL J MED, V352, P1985, DOI 10.1056/NEJMoa043160; Ramaekers VT, 2004, DEV MED CHILD NEUROL, V46, P843, DOI 10.1017/S0012162204001471; Schaer CA, 2008, J LEUKOCYTE BIOL, V83, P325, DOI 10.1189/jlb.0407226; Schwartz RS, 2005, NEW ENGL J MED, V352, P1948, DOI 10.1056/NEJMp058034; Segal MB, 2000, CELL MOL NEUROBIOL, V20, P183, DOI 10.1023/A:1007045605751; SELHUB J, 1984, J BIOL CHEM, V259, P6601; Shayeghi M, 2005, CELL, V122, P789, DOI 10.1016/j.cell.2005.06.025; SPECTOR R, 1975, SCIENCE, V187, P540, DOI 10.1126/science.1167256; SPECTOR R, 1975, AM J PHYSIOL, V229, P777, DOI 10.1152/ajplegacy.1975.229.3.777; Subramanian VS, 2008, AM J PHYSIOL-CELL PH, V295, pC828, DOI 10.1152/ajpcell.00249.2008; Umapathy NS, 2007, INVEST OPHTH VIS SCI, V48, P5299, DOI 10.1167/iovs.07-0288; Unal ES, 2008, BBA-BIOMEMBRANES, V1778, P1407, DOI 10.1016/j.bbamem.2008.03.009; Wang YH, 2001, BBA-BIOMEMBRANES, V1513, P49, DOI 10.1016/S0005-2736(01)00340-6; WEITMAN SD, 1992, CANCER RES, V52, P3396; WEITMAN SD, 1992, CANCER RES, V52, P6708; Wollack JB, 2008, J NEUROCHEM, V104, P1494, DOI 10.1111/j.1471-4159.2007.05095.x; Yang J, 2007, J PHARMACOL EXP THER, V321, P462, DOI 10.1124/jpet.106.117648; Zhao RB, 2004, CLIN CANCER RES, V10, P8735, DOI 10.1158/1078-0432.CCR-04-0932; Zhao RB, 2004, CLIN CANCER RES, V10, P718, DOI 10.1158/1078-0432.CCR-1066-03; Zhao RB, 1997, J BIOL CHEM, V272, P21207, DOI 10.1074/jbc.272.34.21207; Zhao RB, 2008, MOL PHARMACOL, V74, P854, DOI 10.1124/mol.108.045443; Zhao R, 2007, BLOOD, V110, P1147, DOI 10.1182/blood-2007-02-077099; Zhao RB, 2007, CANCER METAST REV, V26, P129, DOI 10.1007/s10555-007-9047-1	51	112	117	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4267	4274		10.1074/jbc.M807665200	http://dx.doi.org/10.1074/jbc.M807665200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19074442	hybrid, Green Published			2022-12-25	WOS:000263134400024
J	Brockmeier, A; Brockmeier, U; Williams, DB				Brockmeier, Achim; Brockmeier, Ulf; Williams, David B.			Distinct Contributions of the Lectin and Arm Domains of Calnexin to Its Molecular Chaperone Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM CHAPERONE; I HISTOCOMPATIBILITY MOLECULES; PEPTIDE-BINDING-SPECIFICITY; CALRETICULIN P-DOMAIN; HEAT-SHOCK-PROTEIN; CIRCULAR-DICHROISM; QUALITY-CONTROL; SUBSTRATE-BINDING; ESCHERICHIA-COLI; CONFORMATIONAL STATES	Calnexin is a Ca2+-binding transmembrane chaperone of the endoplasmic reticulum that recognizes Glc(1)Man(5-9)GlcNAc(2) oligosaccharides on folding glycoproteins as well as non-native elements of the polypeptide backbone. This latter mode of recognition enables calnexin to suppress the aggregation of both glycosylated and nonglycosylated substrates. The luminal portion of calnexin (S-Cnx) consists of two domains, a globular lectin domain and an extended arm domain. To understand the function of these domains during the interaction of calnexin with non-native protein conformers, we tested deletion mutants of S-Cnx for their abilities to suppress the aggregation of nonglycosylated firefly luciferase. The arm domain alone exhibited no capacity to suppress aggregation. However, stepwise truncation of the arm domain in S-Cnx resulted in a progressive reduction in aggregation suppression potency to the point where the globular domain alone exhibited 25% potency. To characterize the polypeptide-binding site, we used hydrophobic peptides that were competitors of the ability of S-Cnx to suppress luciferase aggregation. Direct binding experiments revealed a single site of peptide binding in the globular domain (K-d = 0.9 mu M) at a location distinct from the lectin site. Progressive truncation of the arm domain in S-Cnx had no effect on the binding of small peptides but reduced the binding affinity of S-Cnx for large, non-native protein substrates. Because protein substrates exhibited no binding to the isolated arm domain, our findings support a model in which calnexin suppresses aggregation through a polypeptide-binding site in its globular domain, with the arm domain enhancing aggregation suppression by sterically constraining large substrates.	[Williams, David B.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Williams, DB (corresponding author), Univ Toronto, Dept Biochem, Med Sci Bldg, Toronto, ON M5S 1A8, Canada.	david.williams@utoronto.ca			Canadian Institutes of Health Research; Canadian Cancer Society	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS))	This work was supported by grants from the Canadian Institutes of Health Research and the Canadian Cancer Society (to D. B. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arnaud N, 1997, ANALYST, V122, P143, DOI 10.1039/a605279g; BAKSH S, 1991, J BIOL CHEM, V266, P21458; Bosl B, 2005, J BIOL CHEM, V280, P38170, DOI 10.1074/jbc.M506149200; Brockmeier A, 2006, BIOCHEMISTRY-US, V45, P12906, DOI 10.1021/bi0614378; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Caramelo JJ, 2004, J BIOL CHEM, V279, P46280, DOI 10.1074/jbc.M408404200; Culina S, 2004, J BIOL CHEM, V279, P54210, DOI 10.1074/jbc.M410841200; Davis DP, 1999, J IMMUNOL, V163, P3842; Duus K, 2008, PROTEIN PEPTIDE LETT, V15, P103; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Ellgaard L, 2001, P NATL ACAD SCI USA, V98, P3133, DOI 10.1073/pnas.051630098; FLYNN GC, 1991, NATURE, V353, P726, DOI 10.1038/353726a0; FOURIE AM, 1994, J BIOL CHEM, V269, P30470; FRESKGARD PO, 1994, BIOCHEMISTRY-US, V33, P14281, DOI 10.1021/bi00251a041; Frickel EM, 2002, P NATL ACAD SCI USA, V99, P1954, DOI 10.1073/pnas.042699099; GRAGEROV A, 1994, J MOL BIOL, V235, P848, DOI 10.1006/jmbi.1994.1043; GREENE LE, 1995, J BIOL CHEM, V270, P2967, DOI 10.1074/jbc.270.7.2967; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; HEBERT DN, 1995, CELL, V81, P425, DOI 10.1016/0092-8674(95)90395-X; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; High S, 2000, FEBS LETT, V476, P38, DOI 10.1016/S0014-5793(00)01666-5; HIRST JD, 1994, J MOL BIOL, V243, P173, DOI 10.1006/jmbi.1994.1644; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Ihara Y, 1999, MOL CELL, V4, P331, DOI 10.1016/S1097-2765(00)80335-4; Ireland BS, 2008, MOL BIOL CELL, V19, P2413, DOI 10.1091/mbc.E07-10-1055; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; Kapoor M, 2004, BIOCHEMISTRY-US, V43, P97, DOI 10.1021/bi0355286; Kapoor M, 2003, J BIOL CHEM, V278, P6194, DOI 10.1074/jbc.M209132200; KOSEN PA, 1981, BIOCHEMISTRY-US, V20, P5744, DOI 10.1021/bi00523a017; Leach MR, 2004, J BIOL CHEM, V279, P9072, DOI 10.1074/jbc.M310788200; Leach MR, 2002, J BIOL CHEM, V277, P29686, DOI 10.1074/jbc.M202405200; Lentze N, 2004, BIOCHEM BIOPH RES CO, V325, P401, DOI 10.1016/j.bbrc.2004.10.043; Li Jingzhi, 2004, Biol Proced Online, V6, P204, DOI 10.1251/bpo90; Li JZ, 2005, BIOCHEM J, V386, P453, DOI 10.1042/BJ20041050; Li ZJ, 2001, BIOCHEMISTRY-US, V40, P11193, DOI 10.1021/bi010948l; Meacock SL, 2000, ESSAYS BIOCHEM, V36, P1; NUNNARI J, 1992, Current Opinion in Cell Biology, V4, P573, DOI 10.1016/0955-0674(92)90074-M; OKAZAKI A, 1994, NAT STRUCT BIOL, V1, P439, DOI 10.1038/nsb0794-439; Patil AR, 2000, J BIOL CHEM, V275, P24348, DOI 10.1074/jbc.M003102200; Pollock S, 2004, EMBO J, V23, P1020, DOI 10.1038/sj.emboj.7600119; RICHARME G, 1993, J BIOL CHEM, V268, P24074; RICHARME G, 1994, J BIOL CHEM, V269, P7095; Ritter C, 2005, EMBO J, V24, P1730, DOI 10.1038/sj.emboj.7600645; Rizvi SM, 2004, MOL CELL, V15, P913, DOI 10.1016/j.molcel.2004.09.001; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Saito Y, 1999, EMBO J, V18, P6718, DOI 10.1093/emboj/18.23.6718; Sandhu N, 2007, BBA-PROTEINS PROTEOM, V1774, P701, DOI 10.1016/j.bbapap.2007.03.019; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; Singh J., 1992, ATLAS PROTEIN SIDE C; Stronge VS, 2001, J BIOL CHEM, V276, P39779, DOI 10.1074/jbc.M107091200; Tan Y, 2006, BBA-GEN SUBJECTS, V1760, P745, DOI 10.1016/j.bbagen.2006.02.003; Taylor SC, 2004, NAT STRUCT MOL BIOL, V11, P128, DOI 10.1038/nsmb715; Thammavongsa V, 2005, J BIOL CHEM, V280, P33497, DOI 10.1074/jbc.M503648200; Thomson SP, 2005, CELL STRESS CHAPERON, V10, P242, DOI 10.1379/CSC-126.1; TJOELKER LW, 1994, BIOCHEMISTRY-US, V33, P3229, DOI 10.1021/bi00177a013; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Urbanova N, 2008, ANAL SCI, V24, P727, DOI 10.2116/analsci.24.727; Vassilakos A, 1998, BIOCHEMISTRY-US, V37, P3480, DOI 10.1021/bi972465g; WARE FE, 1995, J BIOL CHEM, V270, P4697, DOI 10.1074/jbc.270.9.4697; WOODY RW, 1994, EUR BIOPHYS J BIOPHY, V23, P253, DOI 10.1007/BF00213575; WOODY RW, 1995, METHOD ENZYMOL, V246, P34; Xu XH, 2004, FEBS LETT, V570, P155, DOI 10.1016/j.febslet.2004.06.039; Zapun A, 1998, J BIOL CHEM, V273, P6009, DOI 10.1074/jbc.273.11.6009; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	65	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3433	3444		10.1074/jbc.M804866200	http://dx.doi.org/10.1074/jbc.M804866200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19074423	hybrid			2022-12-25	WOS:000262872500009
J	Okech, BA; Mwobobia, IK; Kamau, A; Muiruri, S; Mutiso, N; Nyambura, J; Mwatele, C; Amano, T; Mwandawiro, CS				Okech, Bernard A.; Mwobobia, Isaac K.; Kamau, Anthony; Muiruri, Samuel; Mutiso, Noah; Nyambura, Joyce; Mwatele, Cassian; Amano, Teruaki; Mwandawiro, Charles S.			Use of Integrated Malaria Management Reduces Malaria in Kenya	PLOS ONE			English	Article								Background: During an entomological survey in preparation for malaria control interventions in Mwea division, the number of malaria cases at the Kimbimbi sub-district hospital was in a steady decline. The underlying factors for this reduction were unknown and needed to be identified before any malaria intervention tools were deployed in the area. We therefore set out to investigate the potential factors that could have contributed to the decline of malaria cases in the hospital by analyzing the malaria control knowledge, attitudes and practices (KAP) that the residents in Mwea applied in an integrated fashion, also known as integrated malaria management (IMM). Methods: Integrated Malaria Management was assessed among community members of Mwea division, central Kenya using KAP survey. The KAP study evaluated community members' malaria disease management practices at the home and hospitals, personal protection measures used at the household level and malaria transmission prevention methods relating to vector control. Concurrently, we also passively examined the prevalence of malaria parasite infection via outpatient admission records at the major referral hospital in the area. In addition we studied the mosquito vector population dynamics, the malaria sporozoite infection status and entomological inoculation rates (EIR) over an 8 month period in 6 villages to determine the risk of malaria transmission in the entire division. Results: A total of 389 households in Mwea division were interviewed in the KAP study while 90 houses were surveyed in the entomological study. Ninety eight percent of the households knew about malaria disease while approximately 70% of households knew its symptoms and methods to manage it. Ninety seven percent of the interviewed households went to a health center for malaria diagnosis and treatment. Similarly a higher proportion (81%) used anti-malarial medicines bought from local pharmacies. Almost 90% of households reported owning and using an insecticide treated bed net and 81% reported buying the nets within the last 5 years. The community also used mosquito reduction measures including, in order of preference, environmental management (35%), mosquito repellent and smoke (31%) insecticide canister sprays (11%), and window and door screens (6%). These methods used by the community comprise an integrated malaria management (IMM) package. Over the last 4 years prior to this study, the malaria cases in the community hospital reduced from about 40% in 2000 to less than 10% by 2004 and by the year 2007 malaria cases decreased to zero. In addition, a one time cross-sectional malaria parasite survey detected no Plasmodium infection in 300 primary school children in the area. Mosquito vector populations were variable in the six villages but were generally lower in villages that did not engage in irrigation activities. The malaria risk as estimated by EIR remained low and varied by village and proximity to irrigation areas. The average EIR in the area was estimated at 0.011 infectious bites per person per day. Conclusions: The usage of a combination of malaria control tools in an integrated fashion by residents of Mwea division might have influenced the decreased malaria cases in the district hospital and in the school children. A vigorous campaign emphasizing IMM should be adopted and expanded in Mwea division and in other areas with different eco-epidemiological patterns of malaria transmission. With sustained implementation and support from community members integrated malaria management can reduce malaria significantly in affected communities in Africa.	[Mwobobia, Isaac K.; Nyambura, Joyce; Mwatele, Cassian; Amano, Teruaki; Mwandawiro, Charles S.] KEMRI, ESACIPAC, Nairobi, Kenya; [Okech, Bernard A.] KEMRI, CBRD, Nairobi, Kenya; [Kamau, Anthony] Minist Hlth, AMREF, Nairobi, Kenya; [Muiruri, Samuel; Mutiso, Noah] Minist Hlth, DVBD, Nairobi, Kenya; [Okech, Bernard A.] Univ Florida, Environm Hlth Program, Dept Epidemiol & Biostat, St Augustine, FL USA; [Okech, Bernard A.] Univ Florida, Emerging Pathogens Inst, St Augustine, FL USA; [Okech, Bernard A.] Univ Florida, Whitney Lab Marine Biosci, St Augustine, FL USA	African Medical & Research Foundation (AMREF); State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Okech, BA (corresponding author), KEMRI, ESACIPAC, Nairobi, Kenya.	Okech@whitney.ufl.edu			Japanese International Cooperation Agency; Government of Kenya	Japanese International Cooperation Agency; Government of Kenya	This study was supported by the Japanese International Cooperation Agency and the Government of Kenya. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuya TO, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-57; Beier JC, 1999, AM J TROP MED HYG, V61, P109, DOI 10.4269/ajtmh.1999.61.109; BEIER JC, 1991, J MED ENTOMOL, V28, P533, DOI 10.1093/jmedent/28.4.533; Geerligs PDP, 2003, B WORLD HEALTH ORGAN, V81, P205; IJUMBA JN, 1990, MED VET ENTOMOL, V4, P425, DOI 10.1111/j.1365-2915.1990.tb00461.x; Kamau L, 2003, J AM MOSQUITO CONTR, V19, P130; Kibe Lydiah W, 2006, Afr Health Sci, V6, P240; Kitua AY, 2008, SCIENCE, V319, P900, DOI 10.1126/science.319.5865.900c; Lengeler C, 2007, LANCET, V370, P1009, DOI 10.1016/S0140-6736(07)61454-8; Mabaso MLH, 2004, TROP MED INT HEALTH, V9, P846, DOI 10.1111/j.1365-3156.2004.01263.x; MUKIAMA TK, 1989, ACTA TROP, V46, P181, DOI 10.1016/0001-706X(89)90035-1; Mutero CM, 2000, ACTA TROP, V76, P253, DOI 10.1016/S0001-706X(00)00109-1; Mutero CM, 2004, ACTA TROP, V89, P171, DOI 10.1016/j.actatropica.2003.07.003; Muturi EJ, 2008, AM J TROP MED HYG, V78, P270, DOI 10.4269/ajtmh.2008.78.270; Nahlen BL, 2003, AM J TROP MED HYG, V68, P1; Noor AM, 2007, PLOS MED, V4, P1341, DOI 10.1371/journal.pmed.0040255; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Phillips-Howard PA, 2003, AM J TROP MED HYG, V68, P23, DOI 10.4269/ajtmh.2003.68.23; Utzinger J, 2002, NATURE, V419, P431, DOI 10.1038/419431a; Winstanley P, 2006, ADV PARASIT, V61, P47, DOI 10.1016/S0065-308X(05)61002-0; 2003, TROP MED INT HLTH, V8, P860	21	43	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2008	3	12							e4050	10.1371/journal.pone.0004050	http://dx.doi.org/10.1371/journal.pone.0004050			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DL	19115000	Green Submitted, gold, Green Published			2022-12-25	WOS:000265466300002
J	Reiner, R; Krasnov-Yoeli, N; Dehtiar, Y; Jarrous, N				Reiner, Robert; Krasnov-Yoeli, Natalie; Dehtiar, Yana; Jarrous, Nayef			Function and Assembly of a Chromatin-Associated RNase P that Is Required for Efficient Transcription by RNA Polymerase I	PLOS ONE			English	Article								Background: Human RNase P has been initially described as a tRNA processing enzyme, consisting of H1 RNA and at least ten distinct protein subunits. Recent findings, however, indicate that this catalytic ribonucleoprotein is also required for transcription of small noncoding RNA genes by RNA polymerase III (Pol III). Notably, subunits of human RNase P are localized in the nucleolus, thus raising the possibility that this ribonucleoprotein complex is implicated in transcription of rRNA genes by Pol I. Methodology/Principal Findings: By using biochemical and reverse genetic means we show here that human RNase P is required for efficient transcription of rDNA by Pol I. Thus, inactivation of RNase P by targeting its protein subunits for destruction by RNA interference or its H1 RNA moiety for specific cleavage causes marked reduction in transcription of rDNA by Pol I. However, RNase P restores Pol I transcription in a defined reconstitution system. Nuclear run on assays reveal that inactivation of RNase P reduces the level of nascent transcription by Pol I, and more considerably that of Pol III. Moreover, RNase P copurifies and associates with components of Pol I and its transcription factors and binds to chromatin of the promoter and coding region of rDNA. Strikingly, RNase P detaches from transcriptionally inactive rDNA in mitosis and reassociates with it at G1 phase through a dynamic and stepwise assembly process that is correlated with renewal of transcription. Conclusions/Significance: Our findings reveal that RNase P activates transcription of rDNA by Pol I through a novel assembly process and that this catalytic ribonucleoprotein determines the transcription output of Pol I and Pol III, two functionally coordinated transcription machineries.	[Reiner, Robert; Krasnov-Yoeli, Natalie; Dehtiar, Yana; Jarrous, Nayef] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Mol Biol, IL-91010 Jerusalem, Israel	Hebrew University of Jerusalem	Reiner, R (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Mol Biol, IL-91010 Jerusalem, Israel.	jarrous@md.huji.ac.il	Jarrous, Nayef/S-6825-2019		United States-Israel Binational Science Foundation [2005/009]; Israel Science Foundation [673/06]	United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation)	This research is supported by the United States-Israel Binational Science Foundation (grant no. 2005/009) and the Israel Science Foundation (grant no. 673/06) to N. J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Aravind L, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r64; Barrandon C, 2007, MOL CELL BIOL, V27, P6996, DOI 10.1128/MCB.00975-07; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Chen DY, 2001, J CELL BIOL, V153, P169, DOI 10.1083/jcb.153.1.169; Dieci G, 2000, J MOL BIOL, V299, P601, DOI 10.1006/jmbi.2000.3783; Dieci G, 2007, TRENDS GENET, V23, P614, DOI 10.1016/j.tig.2007.09.001; Dundr M, 2002, SCIENCE, V298, P1623, DOI 10.1126/science.1076164; Fath S, 2000, J CELL BIOL, V149, P575, DOI 10.1083/jcb.149.3.575; Ferrari R, 2008, CELL MOL BIOL LETT, V13, P112, DOI 10.2478/s11658-007-0041-y; Gallagher JEG, 2004, GENE DEV, V18, P2506, DOI 10.1101/gad.1226604; Goodrich JA, 2006, NAT REV MOL CELL BIO, V7, P612, DOI 10.1038/nrm1946; Gorski SA, 2008, MOL CELL, V30, P486, DOI 10.1016/j.molcel.2008.04.021; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Granneman S, 2005, CURR OPIN CELL BIOL, V17, P281, DOI 10.1016/j.ceb.2005.04.001; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Heix J, 1998, EMBO J, V17, P7373, DOI 10.1093/emboj/17.24.7373; Hu P, 2003, MOL CELL, V12, P699, DOI 10.1016/j.molcel.2003.08.011; Jarrous N, 2002, RNA, V8, P1, DOI 10.1017/S1355838202011184; Jarrous N, 2001, METHOD ENZYMOL, V342, P93, DOI 10.1016/S0076-6879(01)42538-9; Jarrous N, 2007, NUCLEIC ACIDS RES, V35, P3519, DOI 10.1093/nar/gkm071; KASSAVETIS GA, 1990, CELL, V60, P235, DOI 10.1016/0092-8674(90)90739-2; Kettenberger H, 2006, NAT STRUCT MOL BIOL, V13, P44, DOI 10.1038/nsmb1032; Kikovska E, 2007, P NATL ACAD SCI USA, V104, P2062, DOI 10.1073/pnas.0607326104; Klein J, 1999, P NATL ACAD SCI USA, V96, P6096, DOI 10.1073/pnas.96.11.6096; Kopp K, 2007, MOL BIOL CELL, V18, P394, DOI 10.1091/mbc.E06-03-0249; Kovrigina E, 2003, P NATL ACAD SCI USA, V100, P1598, DOI 10.1073/pnas.0337661100; Kwek KY, 2002, NAT STRUCT BIOL, V9, P800, DOI 10.1038/nsb862; Li Y, 2001, P NATL ACAD SCI USA, V98, P441, DOI 10.1073/pnas.021555498; Lunyak VV, 2008, CURR OPIN CELL BIOL, V20, P281, DOI 10.1016/j.ceb.2008.03.018; Mann H, 2003, MOL CELL, V12, P925, DOI 10.1016/S1097-2765(03)00357-5; Mariner PD, 2008, MOL CELL, V29, P499, DOI 10.1016/j.molcel.2007.12.013; Mayer C, 2006, MOL CELL, V22, P351, DOI 10.1016/j.molcel.2006.03.028; Moss T, 2002, CELL, V109, P545, DOI 10.1016/S0092-8674(02)00761-4; Philimonenko VV, 2004, NAT CELL BIOL, V6, P1165, DOI 10.1038/ncb1190; Prasanth KV, 2007, GENE DEV, V21, P11, DOI 10.1101/gad.1484207; Preuss S, 2007, BBA-GENE STRUCT EXPR, V1769, P383, DOI 10.1016/j.bbaexp.2007.02.005; Prieto JL, 2007, GENE DEV, V21, P2041, DOI 10.1101/gad.436707; Raska I, 2006, INT REV CYTOL, V255, P177, DOI 10.1016/S0074-7696(06)55004-1; Reiner R, 2006, GENE DEV, V20, P1621, DOI 10.1101/gad.386706; SCHMITT ME, 1993, MOL CELL BIOL, V13, P7935, DOI 10.1128/MCB.13.12.7935; Schnapp A, 1996, METHOD ENZYMOL, V273, P233; Schneider DA, 2007, MOL CELL, V26, P217, DOI 10.1016/j.molcel.2007.04.007; Seither P, 1998, J MOL BIOL, V275, P43, DOI 10.1006/jmbi.1997.1434; Storz G, 2005, ANNU REV BIOCHEM, V74, P199, DOI 10.1146/annurev.biochem.74.082803.133136; Thompson M, 2003, SCIENCE, V302, P1399, DOI 10.1126/science.1089814; Van Herreweghe E, 2007, EMBO J, V26, P3570, DOI 10.1038/sj.emboj.7601783; Wassarman KM, 2004, NAT STRUCT MOL BIOL, V11, P803, DOI 10.1038/nsmb0904-803; Welting TJM, 2006, RNA, V12, P1373, DOI 10.1261/rna.2293906; WHITE RJ, 1995, MOL CELL BIOL, V15, P6653; Zhang HF, 2004, J MOL BIOL, V342, P1077, DOI 10.1016/j.jmb.2004.06.006	51	38	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2008	3	12							e4072	10.1371/journal.pone.0004072	http://dx.doi.org/10.1371/journal.pone.0004072			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DL	19115013	Green Published, gold, Green Submitted			2022-12-25	WOS:000265466300012
J	Choi, YH; Cowan, DB; Nathan, M; Poutias, D; Stamm, C; del Nido, PJ; McGowan, FX				Choi, Yeong-Hoon; Cowan, Douglas B.; Nathan, Meena; Poutias, Dimitrios; Stamm, Christof; del Nido, Pedro J.; McGowan, Francis X., Jr.			Myocardial Hypertrophy Overrides the Angiogenic Response to Hypoxia	PLOS ONE			English	Article							GROWTH-FACTOR; SIGNAL-TRANSDUCTION; TYROSINE KINASE; TARGET GENES; HIF-2-ALPHA; ACTIVATION; HIF-1-ALPHA; EXPRESSION; ISCHEMIA; RECEPTOR	Background: Cyanosis and myocardial hypertrophy frequently occur in combination. Hypoxia or cyanosis can be potent inducers of angiogenesis, regulating the expression of hypoxia-inducible factors (HIF), vascular endothelial growth factors (VEGF), and VEGF receptors (VEGFR-1 and 2); in contrast, pressure overload hypertrophy is often associated with impaired pro-angiogenic signaling and decreased myocardial capillary density. We hypothesized that the physiological pro-angiogenic response to cyanosis in the hypertrophied myocardium is blunted through differential HIF and VEGF-associated signaling. Methods and Results: Newborn rabbits underwent aortic banding and, together with sham-operated littermates, were transferred into a hypoxic chamber (FiO(2) = 0.12) at 3 weeks of age. Control banded or sham-operated rabbits were housed in normoxia. Systemic cyanosis was confirmed (hematocrit, arterial oxygen saturation, and serum erythropoietin). Myocardial tissue was assayed for low oxygen concentrations using a pimonidazole adduct. At 4 weeks of age, HIF-1 alpha and HIF-2 alpha protein levels, HIF-1 alpha DNA-binding activity, and expression of VEGFR-1, VEGFR-2, and VEGF were determined in hypoxic and normoxic rabbits. At 6 weeks of age, left-ventricular capillary density was assessed by immunohistochemistry. Under normoxia, capillary density was decreased in the banded rabbits compared to non-banded littermates. As expected, non-hypertrophied hearts responded to hypoxia with increased capillary density; however, banded hypoxic rabbits demonstrated no increase in angiogenesis. This blunted pro-angiogenic response to hypoxia in the hypertrophied myocardium was associated with lower HIF-2 alpha and VEGFR-2 levels and increased HIF-1 alpha activity and VEGFR-1 expression. In contrast, non-hypertrophied hearts responded to hypoxia with increased HIF-2 alpha and VEGFR-2 expression with lower VEGFR-1 expression. Conclusion: The participation of HIF-2 alpha and VEGFR-2 appear to be required for hypoxia-stimulated myocardial angiogenesis. In infant rabbit hearts with pressure overload hypertrophy, this pro-angiogenic response to hypoxia is effectively uncoupled, apparently in part due to altered HIF-mediated signaling and VEGFR subtype expression.	[Choi, Yeong-Hoon; Nathan, Meena; Stamm, Christof; del Nido, Pedro J.] Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Cardiac Surg, Boston, MA USA; [Cowan, Douglas B.; Poutias, Dimitrios; McGowan, Francis X., Jr.] Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Anesthesiol, Perioperat & Pain Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Choi, YH (corresponding author), Heartctr Univ Cologne, Dept Cardiothorac Surg, Ctr Mol Med Cologne, Cologne, Germany.	yh.choi@uk-koeln.de	Stamm, Christof/J-5719-2014	Cowan, Douglas/0000-0002-6309-2737	National Institutes of Health [HL074734, HL066186, HL63095, HL068915]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063095, R01HL066186, P50HL074734, R01HL068915, R01HL088206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by the National Institutes of Health (grants HL074734, HL066186, HL63095, and HL068915). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2004, CIRC RES, V95, P884, DOI 10.1161/01.RES.0000147365.86159.f5; ALLARD MF, 1994, J MOL CELL CARDIOL, V26, P1551, DOI 10.1006/jmcc.1994.1175; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Aprelikova O, 2006, CANCER RES, V66, P5641, DOI 10.1158/0008-5472.CAN-05-3345; Arteel GE, 1998, EUR J BIOCHEM, V253, P743, DOI 10.1046/j.1432-1327.1998.2530743.x; BAKER EJ, 1995, AM J PHYSIOL-HEART C, V268, pH1165, DOI 10.1152/ajpheart.1995.268.3.H1165; Baker JE, 1997, CIRCULATION, V95, P1278; Baker JE, 1997, J MOL CELL CARDIOL, V29, P845, DOI 10.1006/jmcc.1996.0361; Carroll VA, 2006, CANCER RES, V66, P6264, DOI 10.1158/0008-5472.CAN-05-2519; Cowan DB, 2000, AM J PHYSIOL-HEART C, V279, pH619, DOI 10.1152/ajpheart.2000.279.2.H619; COWAN DB, 1993, J BIOL CHEM, V268, P26904; del Nido PJ, 1998, AM J PHYSIOL-HEART C, V274, pH728, DOI 10.1152/ajpheart.1998.274.2.H728; DEVRIES C, 1992, SCIENCE, V255, P989, DOI 10.1126/science.1312256; Dutta D, 2008, J BIOL CHEM, V283, P25404, DOI 10.1074/jbc.M804349200; Elvert G, 2003, J BIOL CHEM, V278, P7520, DOI 10.1074/jbc.M211298200; Friehs I, 1999, CIRCULATION, V100, P187; Friehs I, 2004, ANN THORAC SURG, V77, P2004, DOI 10.1016/j.athoracsur.2003.11.003; Friehs I, 2003, ANN THORAC SURG, V75, pS678, DOI 10.1016/S0003-4975(02)04692-1; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Kendall RL, 1996, BIOCHEM BIOPH RES CO, V226, P324, DOI 10.1006/bbrc.1996.1355; Kim CH, 2002, CIRC RES, V90, pE25, DOI 10.1161/hh0202.104923; Lisy K, 2008, CELL DEATH DIFFER, V15, P642, DOI 10.1038/sj.cdd.4402315; Maxwell PH, 2001, CURR OPIN GENET DEV, V11, P293, DOI 10.1016/S0959-437X(00)00193-3; Maynard MA, 2003, J BIOL CHEM, V278, P11032, DOI 10.1074/jbc.M208681200; PARK JE, 1994, J BIOL CHEM, V269, P25646; Petrova TV, 1999, EXP CELL RES, V253, P117, DOI 10.1006/excr.1999.4707; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Rivard A, 2000, J BIOL CHEM, V275, P29643, DOI 10.1074/jbc.M001029200; Roskoski R, 2008, BIOCHEM BIOPH RES CO, V375, P287, DOI 10.1016/j.bbrc.2008.07.121; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; SEETHARAM L, 1995, ONCOGENE, V10, P135; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Shohet RV, 2007, J MOL MED, V85, P1309, DOI 10.1007/s00109-007-0279-x; SINK JD, 1981, J THORAC CARDIOV SUR, V81, P865; Stamm C, 2002, CIRCULATION, V106, pI290, DOI 10.1161/01.cir.0000032896.55215.a0; Takeuchi K, 1998, CIRCULATION, V98, pII234; Uchida T, 2004, J BIOL CHEM, V279, P14871, DOI 10.1074/jbc.M400461200; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988	41	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2008	3	12							e4042	10.1371/journal.pone.0004042	http://dx.doi.org/10.1371/journal.pone.0004042			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DI	19112498	gold, Green Published, Green Submitted			2022-12-25	WOS:000265466000009
J	Sharma, TS; Hughes, J; Murillo, A; Riley, J; Soares, A; Little, F; Mitchell, CD; Hanekom, WA				Sharma, Tanvi S.; Hughes, Jane; Murillo, Amarylis; Riley, Joanne; Soares, Andreia; Little, Francesca; Mitchell, Charles D.; Hanekom, Willem A.			CD8+T-Cell Interleukin-7 Receptor Alpha Expression as a Potential Indicator of Disease Status in HIV-Infected Children	PLOS ONE			English	Article								Background: Initiation and modification of antiretroviral therapy in HIV-infected children depend on viral load and CD4+ T-cell count. However, these surrogates have limitations, and complementary immunological markers to assess therapeutic response are needed. Our aim was to evaluate CD8+ T-cell expression of CD127 as a marker of disease status in HIV-infected children, based on adult data suggesting its usefulness. We hypothesized that CD127 expression on CD8+ T-cells is lower in children with more advanced disease. Methods: In a cross-sectional evaluation, we used flow cytometry to measure CD127+ expression on CD8+ T-cells in whole blood from HIV-infected children with varying disease status. This was compared with expression of CD38 on this subset, currently used in clinical practice as a marker of disease status. Results: 51 HIV-infected children were enrolled. There was a strong positive correlation between CD127 expression on CD8+ T-cells and CD4+ T-cell count, and height and weight z-scores, and a strong negative correlation between CD127 expression and viral load. In contrast, we found no association between CD38 expression and these disease status markers. Conclusions: CD8+ T-cell CD127 expression is significantly higher in children with better HIV disease control, and may have a role as an immunologic indicator of disease status. Longitudinal studies are needed to determine the utility of this marker as a potential indicator of HIV disease progression.	Harvard Univ, Childrens Hosp, Sch Med, Div Pediat Infect Dis, Boston, MA 02115 USA; [Hughes, Jane; Riley, Joanne; Soares, Andreia; Hanekom, Willem A.] Sch Child & Adolescent Hlth, S African Tuberculosis Vaccine Initiative, Cape Town, South Africa; [Murillo, Amarylis; Mitchell, Charles D.] Univ Miami, Miller Sch Med, Div Pediat Infect Dis, Miami, FL USA; [Little, Francesca] Univ Cape Town, Dept Stat Sci, Cape Town, South Africa	Harvard University; Boston Children's Hospital; Harvard Medical School; University of Miami; University of Cape Town	Sharma, TS (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Div Pediat Infect Dis, Boston, MA 02115 USA.	Willem.hanekom@uct.ac.za		Hanekom, Willem/0000-0003-3070-6154; Little, Francesca/0000-0002-5917-9928	University of Miami Comprehensive AIDS Program; Green Family Foundation; NIH [D43-TW01280, UO1-AI27560, RO1-AI065653, NO1-A195383]; FOGARTY INTERNATIONAL CENTER [D43TW001280] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065653, U01AI027560] Funding Source: NIH RePORTER	University of Miami Comprehensive AIDS Program; Green Family Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	University of Miami Comprehensive AIDS Program (WH); Green Family Foundation (TS, WH); NIH (D43-TW01280 and UO1-AI27560 to CM, RO1-AI065653 and NO1-A195383 to WH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2005, CURR HIV RES, V3, P261, DOI 10.2174/1570162054368093; Alpdogan O, 2005, TRENDS IMMUNOL, V26, P56, DOI 10.1016/j.it.2004.11.002; [Anonymous], 1994, MMWR Recomm Rep, V43, P1; Arpadi SM, 2000, J ACQ IMMUN DEF SYND, V25, pS37, DOI 10.1097/00126334-200010001-00006; Beq S, 2005, EUR CYTOKINE NETW, V16, P293; Boettler T, 2006, J VIROL, V80, P3532, DOI 10.1128/JVI.80.7.3532-3540.2006; Bohler T, 1999, AIDS, V13, P779, DOI 10.1097/00002030-199905070-00006; Borkowsky W, 2000, J INFECT DIS, V182, P96, DOI 10.1086/315672; Bradley LM, 2005, TRENDS IMMUNOL, V26, P172, DOI 10.1016/j.it.2005.01.004; Chiappini E, 2003, JAIDS-J ACQ IMM DEF, V33, P601, DOI 10.1097/00126334-200308150-00008; Colle JH, 2006, JAIDS-J ACQ IMM DEF, V42, P277, DOI 10.1097/01.qai.0000214823.11034.4e; Colle JH, 2006, CLIN EXP IMMUNOL, V143, P398, DOI 10.1111/j.1365-2249.2006.03022.x; Dunham RM, 2008, J IMMUNOL, V180, P5582, DOI 10.4049/jimmunol.180.8.5582; Essajee SM, 1999, AIDS, V13, P2523, DOI 10.1097/00002030-199912240-00005; Fry TJ, 2005, J IMMUNOL, V174, P6571, DOI 10.4049/jimmunol.174.11.6571; Golden-Mason L, 2006, HEPATOLOGY, V44, P1098, DOI 10.1002/hep.21365; Harari A, 2004, BLOOD, V103, P966, DOI 10.1182/blood-2003-04-1203; Koesters SA, 2006, EUR J IMMUNOL, V36, P336, DOI 10.1002/eji.200535111; MacPherson PA, 2001, J ACQ IMMUN DEF SYND, V28, P454, DOI 10.1097/00042560-200112150-00008; Marrack P, 2004, ANNU REV IMMUNOL, V22, P765, DOI 10.1146/annurev.immunol.22.012703.104554; Mercier F, 2008, CLIN EXP IMMUNOL, V152, P72, DOI 10.1111/j.1365-2249.2008.03610.x; Mocroft A, 1997, J ACQ IMMUN DEF SYND, V14, P158, DOI 10.1097/00042560-199702010-00009; Mussini C, 2002, AIDS, V16, P1609, DOI 10.1097/00002030-200208160-00006; Nunnari G, 2005, EXPERT OPIN BIOL TH, V5, P1421, DOI 10.1517/14712598.5.11.1421; Pahwa R, 2006, J INFECT DIS, V193, P879, DOI 10.1086/500471; Paiardini M, 2005, J IMMUNOL, V174, P2900, DOI 10.4049/jimmunol.174.5.2900; Pett Sarah L, 2003, Expert Rev Anti Infect Ther, V1, P83, DOI 10.1586/14787210.1.1.83; Read SW, 2006, JAIDS-J ACQ IMM DEF, V42, P537, DOI 10.1097/01.qai.0000223027.47456.d0; Resino S, 2005, ACTA PAEDIATR, V94, P170, DOI 10.1080/08035250410020208; Resino S, 2004, CLIN EXP IMMUNOL, V137, P570, DOI 10.1111/j.1365-2249.2004.02583.x; Rethi B, 2005, AIDS, V19, P2077, DOI 10.1097/01.aids.0000189848.75699.0f; Romero P, 2007, J IMMUNOL, V178, P4112, DOI 10.4049/jimmunol.178.7.4112; Rosenblatt HM, 2005, J INFECT DIS, V192, P445, DOI 10.1086/431597; Sasson SC, 2006, J INFECT DIS, V193, P505, DOI 10.1086/499309; SCHLESINGER M, 1995, PEDIATR RES, V38, P390, DOI 10.1203/00006450-199509000-00020; Sportes C, 2008, J EXP MED, V205, P1701, DOI 10.1084/jem.20071681; Verweel G, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e25; Vigano A, 2000, CHEM IMMUNOL, V75, P207; Wherry EJ, 2006, VIROLOGY, V353, P366, DOI 10.1016/j.virol.2006.06.017	39	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2008	3	12							e3986	10.1371/journal.pone.0003986	http://dx.doi.org/10.1371/journal.pone.0003986			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AV	19096522	Green Published, Green Submitted, gold			2022-12-25	WOS:000265458800008
J	Desmard, M; Davidge, KS; Bouvet, O; Morin, D; Roux, D; Foresti, R; Ricard, JD; Denamur, E; Poole, RK; Montravers, P; Motterlini, R; Boczkowski, J				Desmard, Mathieu; Davidge, Kelly S.; Bouvet, Odile; Morin, Didier; Roux, Damien; Foresti, Roberta; Ricard, Jean D.; Denamur, Erick; Poole, Robert K.; Montravers, Philippe; Motterlini, Roberto; Boczkowski, Jorge			A carbon monoxide-releasing molecule (CORM-3) exerts bactericidal activity against Pseudomonas aeruginosa and improves survival in an animal model of bacteraemia	FASEB JOURNAL			English	Article						pharmacology; anti-infective agents; sepsis; microbiology	THERAPEUTIC APPLICATIONS; MITOCHONDRIAL; CO; SENSITIVITY; INFECTIONS; OXIDASE; TARGETS	The search for new molecules to fight Pseudomonas aeruginosa is of paramount importance. Carbon monoxide (CO) is known to act as an effective inhibitor of the respiratory chain in P. aeruginosa, but the practical use of this gas as an antibacterial molecule is hampered by its toxicity and difficulty to manipulate. Here, we show that a water-soluble CO releaser (CORM-3) possesses bactericidal properties against laboratory and antibiotic-resistant P. aeruginosa. CORM-3 reduced the bacterial count by 4 logs 180 min after in vitro treatment. CORM-3-treated bacteria had a lower O-2 consumption than vehicle-treated bacteria, and the decrease in O-2 consumption temporally preceded the bactericidal action of CORM-3. These results support the hypothesis that the antimicrobial effect of CORM-3 is mediated by an interaction of CO liberated by the carrier with the bacterial respiratory chain. The antibacterial effect occurred at concentrations of CORM-3 that are 50-fold lower than toxic concentrations for eukaryotic cells. CORM-3 treatment compared to vehicle treatment decreased bacterial counts in the spleen and increased survival in immunocompetent and immunosuppressed mice following P. aeruginosa bacteremia. Our results suggest that CORMs could form the basis for developing a new therapeutic strategy against P. aeruginosa-induced infection.-Desmard, M., Davidge, K. S., Bouvet, O., Morin, D., Roux, D., Foresti, R., Ricard, J. D., Denamur, E., Poole, R. K., Montravers, P., Motterlini, R., Boczkowski, J. A carbon monoxide-releasing molecule (CORM-3) exerts bactericidal activity against Pseudomonas aeruginosa and improves survival in an animal model of bacteraemia. FASEB J. 23, 1023-1031 (2009)	[Desmard, Mathieu; Boczkowski, Jorge] Univ Paris 07, Fac Med, INSERM, U700, Paris, France; [Desmard, Mathieu; Boczkowski, Jorge] Univ Paris 07, Fac Med, INSERM, U722, Paris, France; [Davidge, Kelly S.; Poole, Robert K.] Univ Sheffield, Dept Mol Biol & Biotechnol, Western Bank, Sheffield S10 2TN, S Yorkshire, England; [Morin, Didier] Univ Paris 12, Fac Med, INSERM, U841 Equipe 3, Creteil, France; [Ricard, Jean D.] Hop Louis Mourier, AP HP, F-92701 Colombes, France; [Desmard, Mathieu; Montravers, Philippe] Hop Bichat Claude Bernard, AP HP, Dept Anesthesie Reanimat Chirurg, F-75877 Paris 18, France; [Boczkowski, Jorge] Hop Bichat Claude Bernard, AP HP, Ctr Invest Clin 07, F-75877 Paris 18, France; [Foresti, Roberta; Motterlini, Roberto] Northwick Pk Inst Med Res, Dept Surg Res, Harrow, Middx, England; [Foresti, Roberta; Motterlini, Roberto] Italian Inst Technol, Dept Drug Discovery & Dev, Genoa, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Sheffield; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Imperial College London; Istituto Italiano di Tecnologia - IIT	Desmard, M (corresponding author), Fac Med Paris 7, INSERM, U700, Site X Bichat,BP416, F-75870 Paris 18, France.	desmardmathieu@yahoo.fr	Roux, Damien/C-5618-2014; Motterlini, Roberto/Q-1890-2019; Boczkowski, Jorge/S-7474-2018; Motterlini, Roberto/G-2489-2013; Roux, Damien/L-3671-2014	Roux, Damien/0000-0002-6103-6416; Motterlini, Roberto/0000-0003-2684-2612; Boczkowski, Jorge/0000-0001-6619-5785; Motterlini, Roberto/0000-0003-2684-2612; Roux, Damien/0000-0002-6103-6416; foresti, roberta/0000-0002-0836-7937; didier, MORIN/0000-0002-0967-1850; Davidge, Sandra/0000-0002-5559-4905	Assistance Publique-Hopitaux de Paris, France; French Cystic Fibrosis Association Vaincre La Mucoviscidose; BBSRC [BB/E015883/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E015883/1] Funding Source: researchfish	Assistance Publique-Hopitaux de Paris, France; French Cystic Fibrosis Association Vaincre La Mucoviscidose; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The study was performed under grants from Assistance Publique-Hopitaux de Paris, France (as a Contrat d'Interface to J. B.) and the French Cystic Fibrosis Association Vaincre La Mucoviscidose.	Alcaraz MJ, 2008, CURR PHARM DESIGN, V14, P465, DOI 10.2174/138161208783597362; Bedos JP, 2003, ANN FR ANESTH, V22, P534, DOI 10.1016/S0750-7658(03)00167-9; Boczkowski J, 2006, TRENDS BIOCHEM SCI, V31, P614, DOI 10.1016/j.tibs.2006.09.001; Chung SW, 2008, J CLIN INVEST, V118, P239, DOI 10.1172/JCI32730; Clark JE, 2003, CIRC RES, V93, pE2, DOI 10.1161/01.RES.0000084381.86567.08; Desmard M, 2007, ANTIOXID REDOX SIGN, V9, P2139, DOI 10.1089/ars.2007.1803; Ferrandiz ML, 2008, ANN RHEUM DIS, V67, P1211, DOI 10.1136/ard.2007.082412; Flamm RK, 2004, ANTIMICROB AGENTS CH, V48, P2431, DOI 10.1128/AAC.48.7.2431-2436.2004; Foresti R, 2004, BRIT J PHARMACOL, V142, P453, DOI 10.1038/sj.bjp.0705825; GIBSON JF, 1982, J GEN MICROBIOL, V128, P2211; Gorman D, 2003, TOXICOLOGY, V187, P25, DOI 10.1016/S0300-483X(03)00005-2; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; Hou SW, 2008, P NATL ACAD SCI USA, V105, P4039, DOI 10.1073/pnas.0800304105; Kaneko Y, 2007, J CLIN INVEST, V117, P877, DOI 10.1172/JCI30783; Motterlini R, 2004, FASEB J, V18, P284, DOI 10.1096/fj.04-2169fje; Motterlini R, 2005, EXPERT OPIN INV DRUG, V14, P1305, DOI 10.1517/13543784.14.11.1305; Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530; Nobre LS, 2007, ANTIMICROB AGENTS CH, V51, P4303, DOI 10.1128/AAC.00802-07; Otterbein LE, 2003, NAT MED, V9, P183, DOI 10.1038/nm817; Otterbein LE, 2002, ANTIOXID REDOX SIGN, V4, P309, DOI 10.1089/152308602753666361; PARR SR, 1975, BIOCHEM J, V151, P51, DOI 10.1042/bj1510051; Ryter SW, 2006, CURR OPIN PHARMACOL, V6, P257, DOI 10.1016/j.coph.2006.03.002; Suliman HB, 2007, J CELL SCI, V120, P299, DOI 10.1242/jcs.03318; Taille C, 2005, J BIOL CHEM, V280, P25350, DOI 10.1074/jbc.M503512200; Vera T, 2005, J AM SOC NEPHROL, V16, P950, DOI 10.1681/ASN.2004090736; VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639; Vincent JL, 2003, LANCET, V361, P2068, DOI 10.1016/S0140-6736(03)13644-6; Williams SE, 2008, PFLUG ARCH EUR J PHY, V456, P561, DOI 10.1007/s00424-007-0439-4; ZHANG J, 1992, J CLIN INVEST, V90, P1193, DOI 10.1172/JCI115980; Zuckerbraun BS, 2007, FASEB J, V21, P1099, DOI 10.1096/fj.06-6644com	30	122	131	2	48	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2009	23	4					1023	1031		10.1096/fj.08-122804	http://dx.doi.org/10.1096/fj.08-122804			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZO	19095732				2022-12-25	WOS:000266651600006
J	Dang, HX; Liu, Y; Pang, W; Li, CH; Wang, NP; Shyy, JYJ; Zhu, Y				Dang, Huaixin; Liu, Yan; Pang, Wei; Li, Chenghong; Wang, Nanping; Shyy, John Y. -J.; Zhu, Yi			Suppression of 2,3-Oxidosqualene Cyclase by High Fat Diet Contributes to Liver X Receptor-alpha-mediated Improvement of Hepatic Lipid Profile	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR ENDOTHELIAL-CELLS; CHOLESTEROL HOMEOSTASIS; LANOSTEROL CYCLASE; BINDING; LIGAND; ATHEROSCLEROSIS; TRANSCRIPTION; MACROPHAGES; INSULIN; PROTEIN	The liver X receptors (LXRs) sense oxysterols and regulate genes involved in cholesterol metabolism. Synthetic agonists of LXRs are potent stimulators of fatty acid synthesis, which is mediated largely by sterol regulatory element-binding protein-1c (SREBP-1c). Paradoxically, an improved hepatic lipid profile by LXR was observed in mice fed a Western high fat (HF) diet. To explore the underlying mechanism, we administered mice normal chow or an HF diet and overexpressed LXR alpha in the liver. The HF diet with tail-vein injection of adenovirus of LXR alpha increased the expression of LXR-targeted genes involved in cholesterol reverse transport but not those involved in fatty acid synthesis. A similar effect was also observed with the use of 22R-hydroxycholesterol, an LXR ligand, in cultured hepatocytes. Consequently, SREBP-1c maturation was inhibited by the HF diet, which resulted from the induction of Insig-2a. Importantly, increased cholesterol level suppressed the expression of 2,3-oxidosqualene cyclase (OSC), which led to an increase in endogenous LXR ligand(s). Furthermore, siRNA-mediated knockdown of OSC expression enhanced LXR activity and selectively up-regulated LXR-targeted genes involved in cholesterol reverse transport. Thus, down-regulation of OSC may account for a novel mechanism underlying the LXR-mediated lipid metabolism in the liver of mice fed an HF diet.	[Dang, Huaixin; Liu, Yan; Pang, Wei; Li, Chenghong; Zhu, Yi] Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Beijing 100083, Peoples R China; [Wang, Nanping] Peking Univ, Inst Cardiovasc Res, Beijing 100083, Peoples R China; [Shyy, John Y. -J.] Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA	Peking University; Peking University; University of California System; University of California Riverside	Zhu, Y (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Beijing 100083, Peoples R China.	zhuyi@hsc.pku.edu.cn	Liu, Yan/S-6650-2017; Liu, Yan/J-7597-2019; Wang, Nanping/G-1818-2011	Liu, Yan/0000-0002-3961-9172; Liu, Yan/0000-0002-3961-9172; Wang, Nanping/0000-0002-8528-8132	National Institutes of Health [HL77448]; National Natural Science Foundation of China [30570713, 30630032, 30890040]; Major National Basic Research Grant of China [2006BC503802]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major National Basic Research Grant of China; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL77448 ( to J. Y. S.). This study was also supported in part by grants from the National Natural Science Foundation of China (30570713, 30630032, 30890040), the "111" Project and the Major National Basic Research Grant of China ( 2006BC503802, to Y. Z.).	Arai S, 2005, CELL METAB, V1, P201, DOI 10.1016/j.cmet.2005.02.002; Beyea MM, 2007, J BIOL CHEM, V282, P5207, DOI 10.1074/jbc.M611063200; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Cao GQ, 2003, J BIOL CHEM, V278, P1131, DOI 10.1074/jbc.M210208200; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Chisholm JW, 2003, J LIPID RES, V44, P2039, DOI 10.1194/jlr.M300135-JLR200; Fu X, 2001, J BIOL CHEM, V276, P38378, DOI 10.1074/jbc.M105805200; Hegarty BD, 2005, P NATL ACAD SCI USA, V102, P791, DOI 10.1073/pnas.0405067102; Horton JD, 2002, BIOCHEM SOC T, V30, P1091, DOI 10.1042/bst0301091; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Kalaany NY, 2005, CELL METAB, V1, P231, DOI 10.1016/j.cmet.2005.03.001; Kennedy MA, 2005, CELL METAB, V1, P121, DOI 10.1016/j.cmet.2005.01.002; Lehrke M, 2005, CELL METAB, V1, P297, DOI 10.1016/j.cmet.2005.04.005; Lu M, 2006, AM J PHYSIOL-CELL PH, V290, pC1477, DOI 10.1152/ajpcell.00374.2005; McDonald JG, 2007, METHOD ENZYMOL, V432, P145, DOI 10.1016/S0076-6879(07)32006-5; Ory DS, 2004, CIRC RES, V95, P660, DOI 10.1161/01.RES.0000143422.83209.be; Peet DJ, 1998, CURR OPIN GENET DEV, V8, P571, DOI 10.1016/S0959-437X(98)80013-0; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; RIDDELL DR, 2007, MOL CELL NEUROSCI; Rowe AH, 2003, CIRC RES, V93, P717, DOI 10.1161/01.RES.0000097606.43659.F4; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Shimano H, 2000, TRENDS CARDIOVAS MED, V10, P275, DOI 10.1016/S1050-1738(00)00079-7; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828; Tangirala RK, 2002, P NATL ACAD SCI USA, V99, P11896, DOI 10.1073/pnas.182199799; Telford DE, 2005, ARTERIOSCL THROM VAS, V25, P2608, DOI 10.1161/01.ATV.0000189158.28455.94; Terasaka N, 2003, FEBS LETT, V536, P6, DOI 10.1016/S0014-5793(02)03578-0; Wagner BL, 2003, MOL CELL BIOL, V23, P5780, DOI 10.1128/MCB.23.16.5780-5789.2003; Wang NP, 2001, ARTERIOSCL THROM VAS, V21, P1414, DOI 10.1161/hq0901.095549; Wong J, 2004, ARTERIOSCL THROM VAS, V24, P2365, DOI 10.1161/01.ATV.0000148707.93054.7d; Wong J, 2008, J BIOL CHEM, V283, P700, DOI 10.1074/jbc.M706416200; Yabe D, 2003, P NATL ACAD SCI USA, V100, P3155, DOI 10.1073/pnas.0130116100; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Zeng LF, 2004, J BIOL CHEM, V279, P48801, DOI 10.1074/jbc.M407817200; Zhu MJ, 2008, ARTERIOSCL THROM VAS, V28, P527, DOI 10.1161/ATVBAHA.107.143487; Zhu Y, 2005, CARDIOVASC RES, V68, P425, DOI 10.1016/j.cardiores.2005.07.003	37	16	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6218	6226		10.1074/jbc.M803702200	http://dx.doi.org/10.1074/jbc.M803702200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19119143	hybrid, Green Published			2022-12-25	WOS:000263742700025
J	Li, ZZ; Berk, M; McIntyre, TM; Feldstein, AE				Li, Zheng Zheng; Berk, Michael; McIntyre, Thomas M.; Feldstein, Ariel E.			Hepatic Lipid Partitioning and Liver Damage in Nonalcoholic Fatty Liver Disease ROLE OF STEAROYL-CoA DESATURASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESISTANCE; METABOLIC SYNDROME; ANIMAL-MODELS; STEATOHEPATITIS; STEATOSIS; MICE; LIPOTOXICITY; EXPRESSION; PROTECTS; INJURY	Hepatic lipid overloading mainly in the form of triglycerides is considered a prerequisite for the development of nonalcoholic fatty liver disease (NAFLD). However, triglyceride accumulation in the liver in response to lipid overflow may represent a protective mechanism against lipotoxicity. Our aims were to assess the fundamental cellular mechanisms that link lipid compartmentation in hepatocytes to liver damage and disease progression in NAFLD by using both in vivo dietary models of NAFLD and in vitro cell models of lipid overloading. Exposure of murine or human hepatocytes to monounsaturated fatty acids (MUFAs) resulted in lipid accumulation without changes in cell viability. In contrast, cell incubation with saturated fatty acids (SFAs) significantly decreased cell viability and increased caspase activation and apoptosis, with only minor lipid droplet accumulation. Genetic or pharmacological inhibition of stearoyl-CoA desaturase-1 (SCD1), the enzyme that converts SFA to MUFA, sensitized cells to SFA-induced apoptosis. Hepatic SCD1 expression increased in experimental steatosis resulting from high fat diet and decreased in a methionine-choline-deficient (MCD) dietary model of steatohepatitis resulting in the latter situation in significantly increased hepatic SFA levels. SCD1(-/-) mice on the MCD diet had decreased steatosis and markedly increased hepatocellular apoptosis, liver injury, and fibrosis compared with the SCD1(+/+), whereas MUFA feeding prevents the MCD-induced injury. In conclusion, this study suggests hepatic SCD1 plays a key role in prevention of steatohepatitis by partitioning excess lipid into MUFA that can be safely stored. This concept has important implications for the development of novel treatment strategies for patients with this condition.	[Li, Zheng Zheng; Berk, Michael; McIntyre, Thomas M.; Feldstein, Ariel E.] Cleveland Clin, Dept Cell Biol, Cleveland, OH 44195 USA; [Feldstein, Ariel E.] Cleveland Clin, Dept Pediat Gastroenterol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Feldstein, AE (corresponding author), Cleveland Clin, Dept Pediat Gastroenterol & Cell Biol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	feldsta@ccf.org	Berk, Michael/M-7891-2013; Berk, Michael/M-3585-2019	Berk, Michael/0000-0002-5554-6946; Berk, Michael/0000-0002-5554-6946	National Institutes of Health [DK076852]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076852] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK076852. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Brunt EM, 2004, HUM PATHOL, V35, P1070, DOI 10.1016/j.humpath.2004.04.017; Canbay A, 2003, HEPATOLOGY, V38, P1188, DOI 10.1053/jhep.2003.50472; Canbay A, 2003, J CLIN INVEST, V112, P152, DOI 10.1172/JCI200317740; Chen C, 2008, CELL METAB, V7, P135, DOI 10.1016/j.cmet.2007.12.003; Clark JM, 2003, JAMA-J AM MED ASSOC, V289, P3000, DOI 10.1001/jama.289.22.3000; Clark JM, 2002, GASTROENTEROLOGY, V122, P1649, DOI 10.1053/gast.2002.33573; Dam-Larsen S, 2005, SCAND J GASTROENTERO, V40, P460, DOI 10.1080/00365520510012217; Dam-Larsen S, 2004, GUT, V53, P750, DOI 10.1136/gut.2003.019984; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Dela Pena A, 2005, GASTROENTEROLOGY, V129, P1663, DOI 10.1053/j.gastro.2005.09.004; den Boer M, 2004, ARTERIOSCL THROM VAS, V24, P644, DOI 10.1161/01.ATV.0000116217.57583.6e; Diehl AM, 2002, AM J PHYSIOL-GASTR L, V282, pG1, DOI 10.1152/ajpgi.00384.2001; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Feldstein AE, 2004, HEPATOLOGY, V40, P185, DOI 10.1002/hep.20283; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Feldstein AE, 2003, J HEPATOL, V39, P978, DOI 10.1016/S0168-8278(03)00460-4; Feldstein AE, 2006, AM J PHYSIOL-GASTR L, V290, pG1339, DOI 10.1152/ajpgi.00509.2005; Flowers JB, 2007, DIABETES, V56, P1228, DOI 10.2337/db06-1142; Gutierrez-Juarez R, 2006, J CLIN INVEST, V116, P1686, DOI 10.1172/JCI26991; Jiang GQ, 2005, J CLIN INVEST, V115, P1030, DOI 10.1172/JCI200523962; Koteish A, 2001, SEMIN LIVER DIS, V21, P89, DOI 10.1055/s-2001-12932; Li ZZ, 2008, HEPATOLOGY, V47, P1495, DOI 10.1002/hep.22183; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; London Roslyn M, 2007, Clin Liver Dis, V11, P55, DOI 10.1016/j.cld.2007.02.010; Mari M, 2006, CELL METAB, V4, P185, DOI 10.1016/j.cmet.2006.07.006; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; McClain CJ, 2007, HEPATOLOGY, V45, P1343, DOI 10.1002/hep.21788; Nanji Amin A, 2004, Clin Liver Dis, V8, P559, DOI 10.1016/j.cld.2004.04.002; Ntambi JM, 2002, CAN J APPL PHYSIOL, V27, P617, DOI 10.1139/h02-036; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Unger RH, 2003, TRENDS ENDOCRIN MET, V14, P398, DOI 10.1016/j.tem.2003.09.008; Wieckowska A, 2005, CURR OPIN PEDIATR, V17, P636, DOI 10.1097/01.mop.0000172816.79637.c5	39	295	304	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5637	5644		10.1074/jbc.M807616200	http://dx.doi.org/10.1074/jbc.M807616200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19119140	Green Published, hybrid			2022-12-25	WOS:000263560600027
J	Maestro, JL; Cobo, J; Belles, X				Maestro, Jose L.; Cobo, Juliana; Belles, Xavier			Target of Rapamycin (TOR) Mediates the Transduction of Nutritional Signals into Juvenile Hormone Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSECT BLATTELLA-GERMANICA; DEVELOPMENTAL PATTERN; TISSUE EXPRESSION; CORPORA ALLATA; CELL-GROWTH; COCKROACH; RHEB; DICTYOPTERA; DROSOPHILA; MOSQUITO	Anautogeny is a reproductive strategy by which females do not reproduce until they feed. Therefore, nutritional signals must inform the reproductive tissues, and cells that the organism has reached a nutritional status suitable for triggering reproductive processes. One of the possible pathways involved in anautogeny is the "target of rapamycin" (TOR) pathway, which has been described as connecting the nutritional status with growth, proliferation, and cancer. The German cockroach, Blattella germanica, is an anautogenous species whose vitellogenesis is governed by juvenile hormone. In the present report, we describe the cloning of TOR cDNA from B. germanica (BgTOR). Expression studies showed that BgTOR is expressed in adult female corpora allata and fat body. BgTOR knockdown using systemic RNAi in vivo produced a severe inhibition of juvenile hormone synthesis in adult female corpora allata, together with a reduction of mRNA levels corresponding to 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) synthase-1, HMG-CoA synthase-2, and HMG-CoA reductase. In addition, there was a reduction of vitellogenin mRNA in the fat body, and ovaries did not grow. Analysis of TOR expression in corpora allata of fed and starved females suggested that TOR is not regulated at the transcriptional level. Nevertheless, there was a reduction in HMG-CoA synthases and reductase mRNA in corpora allata (but not in the fat body) of starved females, together with a dramatic reduction of juvenile hormone production and ovary development. Taken together, our results indicate that TOR knockdown mimics starvation in terms of corpora allata activity, and suggest that nutritional signals that activate juvenile hormone biosynthesis and vitellogenin production are mediated by the TOR pathway.	[Maestro, Jose L.; Belles, Xavier] UPF, CSIC, Inst Biol Evolut, Barcelona 08003, Spain; [Cobo, Juliana] Univ Fed Uberlandia, Inst Genet & Bioquim, BR-38400902 Uberlandia, MG, Brazil	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; Universidade Federal de Uberlandia	Maestro, JL (corresponding author), UPF, CSIC, Inst Biol Evolut, Passeig Maritim Barceloneta 37-49, Barcelona 08003, Spain.	joseluis.maestro@ibe.upf-csic.es; xavier.belles@ibe.upf-csic.es	Belles, Xavier/G-2354-2015; Maestro, Jose/K-3708-2014	Belles, Xavier/0000-0002-1566-303X; Maestro, Jose/0000-0001-6117-0458	Spanish Ministry of Science and Technology [BFU2006-01090, AGL2005-00773, CGL2008-03517/BOS]	Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the Spanish Ministry of Science and Technology (Projects BFU2006-01090 (to J. L. M.) and AGL2005-00773 and CGL2008-03517/BOS (to X. B.).	Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; Belgacem YH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000187; Belles X, 2005, ANNU REV ENTOMOL, V50, P181, DOI 10.1146/annurev.ento.50.071803.130356; Belles X, 2005, REPRO BIOL, V12, P157; BUESA C, 1994, J BIOL CHEM, V269, P11707; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chiang AS, 1996, ARCH INSECT BIOCHEM, V32, P299, DOI 10.1002/(SICI)1520-6327(1996)32:3/4<299::AID-ARCH4>3.0.CO;2-O; Cruz J, 2006, DEV BIOL, V297, P158, DOI 10.1016/j.ydbio.2006.06.048; Grewal SS, 2007, J CELL BIOL, V179, P1105, DOI 10.1083/jcb.200709044; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAGEDORN HH, 1975, P NATL ACAD SCI USA, V72, P3255, DOI 10.1073/pnas.72.8.3255; Hansen IA, 2005, J BIOL CHEM, V280, P20565, DOI 10.1074/jbc.M500712200; Hansen IA, 2004, P NATL ACAD SCI USA, V101, P10626, DOI 10.1073/pnas.0403460101; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200; Maestro JL, 2006, ARCH INSECT BIOCHEM, V62, P73, DOI 10.1002/arch.20123; Maestro O, 2005, MOL CELL ENDOCRINOL, V238, P27, DOI 10.1016/j.mce.2005.04.004; Mane-Padros D, 2008, DEV BIOL, V315, P147, DOI 10.1016/j.ydbio.2007.12.015; Martin D, 1995, INVERTEBR REPROD DEV, V28, P171, DOI 10.1080/07924259.1995.9672479; MARTINEZGONZALEZ J, 1993, EUR J BIOCHEM, V213, P233, DOI 10.1111/j.1432-1033.1993.tb17753.x; MARTINEZGONZALEZ J, 1993, EUR J BIOCHEM, V217, P691, DOI 10.1111/j.1432-1033.1993.tb18295.x; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Osorio S, 1998, J INSECT PHYSIOL, V44, P31, DOI 10.1016/S0022-1910(97)00102-9; PIULACHS MD, 1992, J INSECT PHYSIOL, V38, P555, DOI 10.1016/0022-1910(92)90105-M; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Urano J, 2005, MOL MICROBIOL, V58, P1074, DOI 10.1111/j.1365-2958.2005.04877.x; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	29	76	80	2	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5506	5513		10.1074/jbc.M807042200	http://dx.doi.org/10.1074/jbc.M807042200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19106101	hybrid, Green Published			2022-12-25	WOS:000263560600013
J	Larbat, R; Hehn, A; Hans, J; Schneider, S; Jugde, H; Schneider, B; Matern, U; Bourgaud, F				Larbat, Romain; Hehn, Alain; Hans, Joachim; Schneider, Sarah; Jugde, Helene; Schneider, Bernd; Matern, Ulrich; Bourgaud, Frederic			Isolation and Functional Characterization of CYP71AJ4 Encoding for the First P450 Monooxygenase of Angular Furanocoumarin Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANISM-BASED INACTIVATION; AMMI-MAJUS L; MICROSOMAL CONVERSION; PSORALEN DERIVATIVES; PAPILIO-POLYXENES; RUTA-GRAVEOLENS; HIGH-EFFICIENCY; CYTOCHROME-P450; CLONING; PLANTS	The biosynthesis of linear and angular furanocoumarins is still poorly understood at the molecular level, with only psoralen synthase (CYP71AJ1) identified from Ammi majus. Using cDNA probes inferred from CYP71AJ1, three orthologs were isolated from Apium graveolens (CYP71AJ2) and Pastinaca sativa (CYP71AJ3 and -4) and functionally expressed in yeast cells. CYP71AJ2 and CYP71AJ3 displayed psoralen synthase activity, whereas CYP71AJ4 only catalyzed the conversion of (+)-columbianetin to angelicin and negligible amounts of a hydroxylated columbianetin by-product. CYP71AJ4 thus constitutes the first fully characterized P450 monooxygenase specific for the angular furanocoumarin pathway. The angelicin synthase exhibited an apparent K-m of 2.1 +/- 0.4 mu M for (+)-columbianetin and a k(cat) of 112 +/- 14 min(-1). Moreover, the use of 3'-deuterated (+)-columbianetin as substrate led to an almost complete "metabolic switch," resulting in the synthesis of anti-3'-hydroxy-3'-deuterated (+)-columbianetin. This confirms that angelicin synthase attacks columbianetin by syn-elimination of hydrogen from C-3'. Sequence comparison between psoralen synthase (CYP71AJ3) and angelicin synthase (CYP71AJ4) showed 70% identity, whereas the identity dropped to 40% in those regions thought to provide the substrate recognition sites. Accordingly, CYP71AJ3 and CYP71AJ4 might be derived from a common ancestor of unknown functionality by gene duplication and subsequent molecular evolution.	[Larbat, Romain; Hehn, Alain; Jugde, Helene; Bourgaud, Frederic] Nancy Univ, Inst Natl Rech Agron Agron Environm Nancy Colmar, UMR 1121, F-54505 Vandoeuvre Les Nancy, France; [Hans, Joachim; Schneider, Sarah; Matern, Ulrich] Univ Marburg, Inst Pharmazeut Biol, D-35037 Marburg, Germany; [Schneider, Bernd] Max Planck Inst Chem Ecol, D-07745 Jena, Germany	INRAE; Universite de Lorraine; Philipps University Marburg; Max Planck Society	Bourgaud, F (corresponding author), Nancy Univ, Inst Natl Rech Agron Agron Environm Nancy Colmar, UMR 1121, 2 Ave Foret Haye, F-54505 Vandoeuvre Les Nancy, France.	frederic.bourgaud@ensaia.inpl-nancy.fr	Larbat, Romain/GQZ-8786-2022; Larbat, Romain/C-8576-2013; Schneider, Bernd/A-3287-2014; Larbat, Romain/V-4270-2019	Schneider, Bernd/0000-0003-4788-1565; Larbat, Romain/0000-0002-9060-5040; Hehn, Alain/0000-0003-4507-8031; Bourgaud, Frederic/0000-0002-9898-2625	Region Lorraine; Deutsche Forschungsgemeinschaft; Fonds der Chemischen Industrie	Region Lorraine(Region Grand-Est); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by Region Lorraine (to F. B.), Deutsche Forschungsgemeinschaft, and Fonds der Chemischen Industrie (to U. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. 1 Both of these authors contributed equally to this work.	BASKIN JM, 1967, PHYTOCHEMISTRY, V6, P1209, DOI 10.1016/S0031-9422(00)86083-5; BEIER RC, 1983, PHYTOCHEMISTRY, V22, P2595, DOI 10.1016/0031-9422(83)80173-3; BERENBAUM M, 1981, SCIENCE, V212, P927, DOI 10.1126/science.212.4497.927; Berenbaum MR, 2006, ECOLOGY, V87, P3070, DOI 10.1890/0012-9658(2006)87[3070:PWAHPA]2.0.CO;2; Bourgaud F., 2006, Phytochemistry Reviews, V5, P293, DOI 10.1007/s11101-006-9040-2; BOURGAUD F, 1989, NATURAL SOURCES FURO, P219; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAPPELLETTI EM, 1998, BIOTECHNOLOGY AGR FO, V41, P238; DALLACQUA F, 1978, PHOTOCHEM PHOTOBIOL, V27, P33, DOI 10.1111/j.1751-1097.1978.tb07561.x; DHILLON DS, 1976, ARCH BIOCHEM BIOPHYS, V177, P74, DOI 10.1016/0003-9861(76)90417-3; Endler A, 2008, PLANT MOL BIOL, V67, P335, DOI 10.1007/s11103-008-9323-7; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GOTOH O, 1992, J BIOL CHEM, V267, P83; Gravot A, 2004, ARCH BIOCHEM BIOPHYS, V422, P71, DOI 10.1016/j.abb.2003.12.013; HAMERSKI D, 1988, EUR J BIOCHEM, V171, P369, DOI 10.1111/j.1432-1033.1988.tb13800.x; HAMERSKI D, 1988, FEBS LETT, V239, P263, DOI 10.1016/0014-5793(88)80930-X; Hehmann M, 2004, EUR J BIOCHEM, V271, P932, DOI 10.1111/j.1432-1033.2004.03995.x; Ito Y, 2005, J CHROMATOGR A, V1065, P145, DOI 10.1016/j.chroma.2004.12.044; Kai K, 2008, PLANT J, V55, P989, DOI 10.1111/j.1365-313X.2008.03568.x; Kawase M, 2005, IN VIVO, V19, P705; Koenigs LL, 1998, BIOCHEMISTRY-US, V37, P13184, DOI 10.1021/bi981198r; Larbat R, 2007, J BIOL CHEM, V282, P542, DOI 10.1074/jbc.M604762200; LETTERON P, 1986, J PHARMACOL EXP THER, V238, P685; Li WM, 2003, P NATL ACAD SCI USA, V100, P14593, DOI 10.1073/pnas.1934643100; Liu RM, 2005, J CHROMATOGR A, V1076, P127, DOI 10.1016/j.chroma.2005.04.041; MA RL, 1994, ARCH BIOCHEM BIOPHYS, V310, P332, DOI 10.1006/abbi.1994.1175; Murray R.D.H., 1982, NATURAL COUMARINS; Murray RDH, 2002, PROG CH ORG NAT PROD, V83, P1; NEAL JJ, 1994, PESTIC BIOCHEM PHYS, V50, P43, DOI 10.1006/pest.1994.1056; Ojala T, 2000, J ETHNOPHARMACOL, V73, P299, DOI 10.1016/S0378-8741(00)00279-8; OMURA T, 1964, J BIOL CHEM, V239, P2370; Pereira LE, 2007, EXP BIOL MED, V232, P1338, DOI 10.3181/0705-RM-148; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; Scott JG, 1996, INSECT BIOCHEM MOLEC, V26, P645, DOI 10.1016/S0965-1748(96)00008-2; Stanjek V, 1998, HELV CHIM ACTA, V81, P1596, DOI 10.1002/(SICI)1522-2675(19980909)81:9<1596::AID-HLCA1596>3.0.CO;2-F; Stanjek V, 1997, TETRAHEDRON, V53, P17699, DOI 10.1016/S0040-4020(97)10237-X; Stanjek V, 1999, PHYTOCHEMISTRY, V50, P1141, DOI 10.1016/S0031-9422(98)00650-5; Stanjek V, 1999, ANGEW CHEM INT EDIT, V38, P400, DOI 10.1002/(SICI)1521-3773(19990201)38:3<400::AID-ANIE400>3.0.CO;2-K; STANJEK V, 1998, THESIS U BONN GERMAN; STEMMER WPC, 1992, BIOTECHNIQUES, V13, P214; Stern RS, 2007, NEW ENGL J MED, V357, P682, DOI 10.1056/NEJMct072317; Takahashi S, 2005, J BIOL CHEM, V280, P3686, DOI 10.1074/jbc.M411870200; Takahashi S, 2007, J BIOL CHEM, V282, P31744, DOI 10.1074/jbc.M703378200; Wei Y, 2006, J CHROMATOGR A, V1115, P112, DOI 10.1016/j.chroma.2006.02.081; WENDORFF H, 1986, EUR J BIOCHEM, V161, P391, DOI 10.1111/j.1432-1033.1986.tb10458.x; Zschocke S, 1998, PHYTOCHEM ANALYSIS, V9, P283, DOI 10.1002/(SICI)1099-1565(199811/12)9:6&lt;283::AID-PCA419&gt;3.0.CO;2-9; ZUMWALT JG, 1993, COMP BIOCHEM PHYS C, V106, P111, DOI 10.1016/0742-8413(93)90261-I	47	49	55	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4776	4785		10.1074/jbc.M807351200	http://dx.doi.org/10.1074/jbc.M807351200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19098286	hybrid, Green Published			2022-12-25	WOS:000263416600005
J	Li, H; Mittal, A; Paul, PK; Kumar, M; Srivastava, DS; Tyagi, SC; Kumar, A				Li, Hong; Mittal, Ashwani; Paul, Pradyut K.; Kumar, Mukesh; Srivastava, Daya S.; Tyagi, Suresh C.; Kumar, Ashok			Tumor Necrosis Factor-related Weak Inducer of Apoptosis Augments Matrix Metalloproteinase 9 (MMP-9) Production in Skeletal Muscle through the Activation of Nuclear Factor-kappa B-inducing Kinase and p38 Mitogen-activated Protein Kinase A POTENTIAL ROLE OF MMP-9 IN MYOPATHY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX METALLOPROTEINASES; IKK-BETA; EXPRESSION; INHIBITION; PATHWAY; COMPLEX; DOMAIN; TWEAK; P65; STIMULATION	Destruction of skeletal muscle extracellular matrix is an important pathological consequence of many diseases involving muscle wasting. However, the underlying mechanisms leading to extracellular matrix breakdown in skeletal muscle tissues remain unknown. Using a microarray approach, we investigated the effect of tumor necrosis factor-related weak inducer of apoptosis (TWEAK), a recently identified muscle-wasting cytokine, on the expression of extracellular proteases in skeletal muscle. Among several other matrix metalloproteinases(MMPs), we found that the expression of MMP-9, a type IV collagenase, was drastically increased in myotubes in response to TWEAK. The level of MMP-9 was also higher in myofibers of TWEAK transgenic mice. TWEAK increased the activation of both classical and alternative nuclear factor-kappa B (NF-kappa B) signaling pathways. Inhibition of NF-kappa B activity blocked the TWEAK-induced production of MMP-9 in myotubes. TWEAK also increased the activation of AP-1, and its inhibition attenuated the TWEAK-induced MMP-9 production. Overexpression of a kinase-dead mutant of NF-kappa B-inducing kinase or I kappa B kinase-beta but not I kappa B kinase-alpha significantly inhibited the TWEAK-induced activation of MMP-9 promoter. The activation of MMP-9 also involved upstream recruitment of TRAF2 and cIAP2 proteins. TWEAK increased the activity of ERK1/2, JNK1, and p38 MAPK. However, the inhibition of only p38 MAPK blocked the TWEAK-induced expression of MMP-9 in myotubes. Furthermore the loss of body and skeletal muscle weights, inflammation, fiber necrosis, and degradation of basement membrane around muscle fibers were significantly attenuated in Mmp9 knock-out mice on chronic administration of TWEAK protein. The study unveils a novel mechanism of skeletal muscle tissue destruction in pathological conditions.	[Li, Hong; Mittal, Ashwani; Paul, Pradyut K.; Kumar, Mukesh; Srivastava, Daya S.; Kumar, Ashok] Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40202 USA; [Tyagi, Suresh C.] Univ Louisville, Sch Med, Dept Physiol & Biophys, Louisville, KY 40202 USA	University of Louisville; University of Louisville	Kumar, A (corresponding author), Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40202 USA.	ashok.kumar@louisville.edu	Mittal, Ashwani/J-2124-2012; LI, HONG/A-7133-2013	Mittal, Ashwani/0000-0002-6588-6194; Kumar, Ashok/0000-0002-2444-9529; Kumar, Ashok/0000-0001-8571-2848	National Institutes of Health [RO1 AG129623]; NATIONAL INSTITUTE ON AGING [R01AG029623] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AG129623 (to A. K.).	Acharyya S, 2007, J CLIN INVEST, V117, P889, DOI 10.1172/JCI30556; Brown SAN, 2003, BIOCHEM J, V371, P395, DOI 10.1042/BJ20021730; Cai BY, 2000, AM J PATHOL, V156, P1789, DOI 10.1016/S0002-9440(10)65050-X; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Carmeli E, 2004, MUSCLE NERVE, V29, P191, DOI 10.1002/mus.10529; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Chandler S, 1997, J NEUROIMMUNOL, V72, P155, DOI 10.1016/S0165-5728(96)00179-8; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chung JY, 2002, J CELL SCI, V115, P679; Das S, 2003, MOL CELL BIOCHEM, V253, P31, DOI 10.1023/A:1026093016148; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Dhawan P, 2002, J BIOL CHEM, V277, P7920, DOI 10.1074/jbc.M112210200; Dogra C, 2006, J BIOL CHEM, V281, P10327, DOI 10.1074/jbc.M511131200; Dogra C, 2007, FASEB J, V21, P1857, DOI 10.1096/fj.06-7537com; Fingleton B, 2007, CURR PHARM DESIGN, V13, P333, DOI 10.2174/138161207779313551; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; Gum R, 1996, J BIOL CHEM, V271, P10672, DOI 10.1074/jbc.271.18.10672; Gyrd-Hansen M, 2008, NAT CELL BIOL, V10, P1309, DOI 10.1038/ncb1789; Han SW, 2006, J BIOL CHEM, V281, P29614, DOI 10.1074/jbc.M604013200; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Heymans S, 2005, AM J PATHOL, V166, P15, DOI 10.1016/S0002-9440(10)62228-6; Hu WH, 2005, J BIOL CHEM, V280, P29233, DOI 10.1074/jbc.M501670200; Hunter RB, 2004, J CLIN INVEST, V114, P1504, DOI 10.1172/JCI200421696; Hunter RB, 2002, FASEB J, V16, P529, DOI 10.1096/fj.01-0866com; Jiang X, 2003, BIOCHEM BIOPH RES CO, V301, P583, DOI 10.1016/S0006-291X(03)00011-1; Jiang X, 2003, J BIOL CHEM, V278, P919, DOI 10.1074/jbc.M208696200; Jin BW, 2007, J CELL BIOCHEM, V100, P960, DOI 10.1002/jcb.21060; Kanagawa M, 2006, J HUM GENET, V51, P915, DOI 10.1007/s10038-006-0056-7; Kleiner DE, 1999, CANCER CHEMOTH PHARM, V43, pS42, DOI 10.1007/s002800051097; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; Kumar A, 2003, FASEB J, V17, P386, DOI 10.1096/fj.02-0542com; Kumar A, 2002, J BIOL CHEM, V277, P46493, DOI 10.1074/jbc.M203654200; Lewis MP, 2001, EUR J ORAL SCI, V109, P209, DOI 10.1034/j.1600-0722.2001.00021.x; Li H, 2008, J MOL MED, V86, P1113, DOI 10.1007/s00109-008-0373-8; Li YP, 2005, FASEB J, V19, P362, DOI 10.1096/fj.04-2364com; Luschen S, 2004, EXP CELL RES, V293, P196, DOI 10.1016/j.yexcr.2003.10.009; Mahoney DJ, 2008, P NATL ACAD SCI USA, V105, P11778, DOI 10.1073/pnas.0711122105; Michaluk P, 2007, J BIOL CHEM, V282, P16036, DOI 10.1074/jbc.M700641200; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Mujumdar VS, 2001, INT J CARDIOL, V79, P277, DOI 10.1016/S0167-5273(01)00449-1; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nair RR, 2005, BIOCHEM SOC T, V33, P1135, DOI 10.1042/BST0331135; Nho CW, 2004, J BIOL CHEM, V279, P26019, DOI 10.1074/jbc.M309022200; O'Mahony A, 2000, MOL CELL BIOL, V20, P1170, DOI 10.1128/MCB.20.4.1170-1178.2000; Park S, 1998, CANCER LETT, V127, P23, DOI 10.1016/S0304-3835(97)00543-0; Ram M, 2006, J CLIN IMMUNOL, V26, P299, DOI 10.1007/s10875-006-9022-6; Rangaswami H, 2004, J BIOL CHEM, V279, P38921, DOI 10.1074/jbc.M404674200; Saitoh T, 2003, J BIOL CHEM, V278, P36005, DOI 10.1074/jbc.M304266200; Shiao T, 2004, HUM MOL GENET, V13, P1873, DOI 10.1093/hmg/ddh204; Spate U, 2004, CURR OPIN CLIN NUTR, V7, P265, DOI 10.1097/01.mco.0000126344.88494.de; Srivastava AK, 2007, J BIOL CHEM, V282, P35113, DOI 10.1074/jbc.M705329200; Tanabe K, 2003, J NEUROSCI, V23, P9675; Tran NL, 2006, CANCER RES, V66, P9535, DOI 10.1158/0008-5472.CAN-06-0418; Vince JE, 2008, J CELL BIOL, V182, P171, DOI 10.1083/jcb.200801010; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Wittwer T, 2008, BIOCHEM BIOPH RES CO, V371, P294, DOI 10.1016/j.bbrc.2008.04.069; Zhong D, 2006, BIOCHEM BIOPH RES CO, V345, P867, DOI 10.1016/j.bbrc.2006.05.004	59	92	100	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4439	4450		10.1074/jbc.M805546200	http://dx.doi.org/10.1074/jbc.M805546200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19074147	hybrid, Green Published			2022-12-25	WOS:000263134400044
J	Zhang, XYZ; Goemaere, EL; Thome, R; Gavioli, M; Cascales, E; Lloubes, R				Zhang, Xiang Y. -Z.; Goemaere, Emilie L.; Thome, Remi; Gavioli, Marthe; Cascales, Eric; Lloubes, Roland			Mapping the Interactions between Escherichia coli Tol Subunits ROTATION OF THE TolR TRANSMEMBRANE HELIX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; BACTERIAL FLAGELLAR MOTOR; OUTER-MEMBRANE INTEGRITY; CONFORMATIONAL CHANGE; PERIPLASMIC DOMAIN; INNER MEMBRANE; CELL-ENVELOPE; PAL PROTEINS; KEY RESIDUES; COMPLEX	The TolQRA proteins of Escherichia coli form an inner membrane complex involved in the maintenance of the outer membrane stability and in the late stages of cell division. The TolQR complex uses the proton motive force to regulate TolA conformation and its interaction with the outer membrane Pal lipoprotein. It has been proposed that an ion channel forms at the TolQR transmembrane helix (TMH) interface. This complex assembles with a minimal TolQ: TolR ratio of 4-6:2 and therefore involves 14-20 TMHs. To define the organization of the transmembrane helices in the membrane within the TolQR complex, we initiated a cysteine scanning study. In this study, we report results for the systematic replacement of each residue of the TolR TMH. Phenotypic analyses first showed that most of the mutants are functional. Three mutants, TolR L22C, D23C, and V24C, were shown to affect TolQR functioning. Disulfide bond complex formation further showed that two TolR anchors are close enough to interact. Two substitutions, L22C and V24C, form high level of dimers, suggesting that the TolR helix rotates as molecular gears between these two positions and that disulfide bond formation between these residues blocked the rotary motion. Mutations of critical residues located within the TolQ TMH2 and TMH3 and the TolR TMH and proposed to form the ion pathway prevent rotation between these two residues. TolR anchors may form molecular gears that oscillate in response to proton motive force to regulate channel activity.	[Zhang, Xiang Y. -Z.; Goemaere, Emilie L.; Thome, Remi; Gavioli, Marthe; Cascales, Eric; Lloubes, Roland] CNRS, Inst Biol Struct & Microbiol, UPR 9027, Lab Ingn Syst Macromol, F-13402 Marseille 20, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Lloubes, R (corresponding author), CNRS, Inst Biol Struct & Microbiol, UPR 9027, Lab Ingn Syst Macromol, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	lloubes@ibsm.cnrs-mrs.fr	CASCALES, ERIC/G-7420-2011	CASCALES, ERIC/0000-0003-0611-9179; LLOUBES, Roland/0000-0002-9520-1053	Centre National de la Recherche Scientifique; Agence National de la Recherche Projet Blanc SODATOL; SODATOL; Fondation pour la Recherche Medicale fellowship	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence National de la Recherche Projet Blanc SODATOL(French National Research Agency (ANR)); SODATOL; Fondation pour la Recherche Medicale fellowship(Fondation pour la Recherche Medicale)	This work was supported by the Centre National de la Recherche Scientifique and a grant from Agence National de la Recherche Projet Blanc SODATOL. This work was also supported by funds from SODATOL ( to X. Y.-Z.Z.) and by a Fondation pour la Recherche Medicale fellowship ( to E. L. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ansaldi M, 1996, ANAL BIOCHEM, V234, P110, DOI 10.1006/abio.1996.0060; BLAIR DF, 1991, J BACTERIOL, V173, P4049, DOI 10.1128/jb.173.13.4049-4055.1991; BOUVERET E, 1995, J BIOL CHEM, V270, P11071, DOI 10.1074/jbc.270.19.11071; Braun TF, 2001, BIOCHEMISTRY-US, V40, P13051, DOI 10.1021/bi011264g; Braun TF, 2004, BIOCHEMISTRY-US, V43, P35, DOI 10.1021/bi035406d; Braun V, 1996, J BACTERIOL, V178, P2836, DOI 10.1128/jb.178.10.2836-2845.1996; Cascales E, 2002, J BACTERIOL, V184, P754, DOI 10.1128/JB.184.3.754-759.2002; Cascales E, 2001, MOL MICROBIOL, V42, P795, DOI 10.1046/j.1365-2958.2001.02673.x; Cascales E, 2004, MOL MICROBIOL, V51, P873, DOI 10.1046/j.1365-2958.2003.03881.x; Cascales E, 2000, MOL MICROBIOL, V38, P904, DOI 10.1046/j.1365-2958.2000.02190.x; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; DEROUICHE R, 1995, J BIOL CHEM, V270, P11078, DOI 10.1074/jbc.270.19.11078; DUCHE D, 1994, J BIOL CHEM, V269, P24820; Garcia-Herrero A, 2007, MOL MICROBIOL, V66, P872, DOI 10.1111/j.1365-2958.2007.05957.x; Gerding MA, 2007, MOL MICROBIOL, V63, P1008, DOI 10.1111/j.1365-2958.2006.05571.x; Germon P, 1998, J BACTERIOL, V180, P6433, DOI 10.1128/JB.180.24.6433-6439.1998; Germon P, 2001, J BACTERIOL, V183, P4110, DOI 10.1128/JB.183.14.4110-4114.2001; Goemaere EL, 2007, J BIOL CHEM, V282, P17749, DOI 10.1074/jbc.M701002200; Goemaere EL, 2007, J MOL BIOL, V366, P1424, DOI 10.1016/j.jmb.2006.12.020; GUIHARD G, 1994, J BIOL CHEM, V269, P5874; Higgs PI, 1998, J BACTERIOL, V180, P6031, DOI 10.1128/JB.180.22.6031-6038.1998; Higgs PI, 2002, MOL MICROBIOL, V44, P271, DOI 10.1046/j.1365-2958.2002.02880.x; Journet L, 2001, MOL MICROBIOL, V42, P331, DOI 10.1046/j.1365-2958.2001.02592.x; Journet L, 1999, J BACTERIOL, V181, P4476, DOI 10.1128/JB.181.15.4476-4484.1999; KAMPFENKEL K, 1993, J BACTERIOL, V175, P4485, DOI 10.1128/JB.175.14.4485-4491.1993; Kojima S, 2001, BIOCHEMISTRY-US, V40, P13041, DOI 10.1021/bi011263o; Kojima S, 2004, INT REV CYTOL, V233, P93, DOI 10.1016/S0074-7696(04)33003-2; Kojima S, 2000, J BACTERIOL, V182, P3314, DOI 10.1128/JB.182.11.3314-3318.2000; LAZZARONI JC, 1995, J MOL BIOL, V246, P1, DOI 10.1006/jmbi.1994.0058; Lloubes R, 2001, RES MICROBIOL, V152, P523, DOI 10.1016/S0923-2508(01)01226-8; MULLER MM, 1993, J BACTERIOL, V175, P6059, DOI 10.1128/JB.175.18.6059-6061.1993; Parsons LM, 2008, BIOCHEMISTRY-US, V47, P3131, DOI 10.1021/bi702283x; Saparov SM, 2007, MOL CELL, V26, P501, DOI 10.1016/j.molcel.2007.03.022; SUN TP, 1987, J BACTERIOL, V169, P2667, DOI 10.1128/jb.169.6.2667-2674.1987; VIEIRA J, 1991, GENE, V100, P189, DOI 10.1016/0378-1119(91)90365-I; Walburger A, 2002, MOL MICROBIOL, V44, P695, DOI 10.1046/j.1365-2958.2002.02895.x; WEBSTER RE, 1991, MOL MICROBIOL, V5, P1005, DOI 10.1111/j.1365-2958.1991.tb01873.x; Zhai YF, 2003, BBA-BIOMEMBRANES, V1614, P201, DOI 10.1016/S0005-2736(03)00176-7; Zhou JD, 1998, J BACTERIOL, V180, P2729, DOI 10.1128/JB.180.10.2729-2735.1998	39	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4275	4282		10.1074/jbc.M805257200	http://dx.doi.org/10.1074/jbc.M805257200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19075020	hybrid, Green Published			2022-12-25	WOS:000263134400025
J	Ohazama, A; Johnson, EB; Ota, MS; Choi, HJ; Porntaveetus, T; Oommen, S; Itoh, N; Eto, K; Gritli-Linde, A; Herz, J; Sharpe, PT				Ohazama, Atsushi; Johnson, Eric B.; Ota, Masato S.; Choi, Hong J.; Porntaveetus, Thantrira; Oommen, Shelly; Itoh, Nobuyuki; Eto, Kazuhiro; Gritli-Linde, Amel; Herz, Joachim; Sharpe, Paul T.			Lrp4 Modulates Extracellular Integration of Cell Signaling Pathways in Development	PLOS ONE			English	Article							TOOTH DEVELOPMENT; LIPOPROTEIN RECEPTORS; SYNAPTIC PLASTICITY; BMP ANTAGONIST; VASCULAR WALL; MOUSE; BONE; PROTEINS; REELIN; USAG-1	The extent to which cell signaling is integrated outside the cell is not currently appreciated. We show that a member of the low-density receptor-related protein family, Lrp4 modulates and integrates Bmp and canonical Wnt signalling during tooth morphogenesis by binding the secreted Bmp antagonist protein Wise. Mouse mutants of Lrp4 and Wise exhibit identical tooth phenotypes that include supernumerary incisors and molars, and fused molars. We propose that the Lrp4/Wise interaction acts as an extracellular integrator of epithelial-mesenchymal cell signaling. Wise, secreted from mesenchyme cells binds to BMP's and also to Lrp4 that is expressed on epithelial cells. This binding then results in the modulation of Wnt activity in the epithelial cells. Thus in this context Wise acts as an extracellular signaling molecule linking two signaling pathways. We further show that a downstream mediator of this integration is the Shh signaling pathway.	[Ohazama, Atsushi; Porntaveetus, Thantrira; Oommen, Shelly; Sharpe, Paul T.] Kings Coll London, Guys Hosp, Inst Dent, Dept Craniofacial Dev, London, England; [Johnson, Eric B.; Choi, Hong J.; Herz, Joachim] Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX USA; [Ota, Masato S.; Eto, Kazuhiro] Tokyo Med & Dent Univ, Grad Sch, Sect Mol Craniofacial Embryol, Tokyo, Japan; [Itoh, Nobuyuki] Kyoto Univ, Grad Sch Pharm Sci, Dept Genet Biochem, Kyoto, Japan; [Gritli-Linde, Amel] Gothenburg Univ, Sahlgrenska Acad, Dept Oral Biochem, Gothenburg, Sweden	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Tokyo Medical & Dental University (TMDU); Kyoto University; University of Gothenburg	Ohazama, A (corresponding author), Kings Coll London, Guys Hosp, Inst Dent, Dept Craniofacial Dev, London, England.	paul.sharpe@kcl.ac.uk	Porntaveetus, Thantrira/ABF-6854-2020	porntaveetus, thantrira/0000-0003-0145-9801; Sharpe, Paul/0000-0003-2116-9561	Wellcome Trust; MRC; RCUK [fellow]; NIH; Wolfgang Paul Award from the Alexander-von-Humboldt Foundation [HL20948, HL63762]; Swedish Research Council-Medicine [2789, 14100, 15181]; Faculty of Odontology; Biotechnology and Biological Sciences Research Council [BB/E01335X/1] Funding Source: researchfish; Medical Research Council [G0200709] Funding Source: researchfish; BBSRC [BB/E01335X/1] Funding Source: UKRI; MRC [G0200709] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948, R37HL063762, R01HL063762] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); RCUK(UK Research & Innovation (UKRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wolfgang Paul Award from the Alexander-von-Humboldt Foundation; Swedish Research Council-Medicine(Swedish Research Council); Faculty of Odontology; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Wellcome Trust and MRC. A.O. is an RCUK Fellow. J.H. is supported by grants from the NIH and is the recipient of a Wolfgang Paul Award from the Alexander-von-Humboldt Foundation (HL20948 and HL63762). A.G.L. is supported by the Swedish Research Council-Medicine (grants 2789, 14100 and 15181) and Faculty of Odontology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beffert U, 2005, NEURON, V47, P567, DOI 10.1016/j.neuron.2005.07.007; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Cobourne MT, 2004, DEVELOPMENT, V131, P2875, DOI 10.1242/dev.01163; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Dietrich S, 1997, DEVELOPMENT, V124, P3895; Drogemuller C, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-5; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gritli-Linde A, 2002, DEVELOPMENT, V129, P5323, DOI 10.1242/dev.00100; Herz J, 2002, ANNU REV BIOCHEM, V71, P405, DOI 10.1146/annurev.biochem.71.110601.135342; Herz J, 2004, CURR OPIN LIPIDOL, V15, P175, DOI 10.1097/00041433-200404000-00010; Herz J, 2006, NAT REV NEUROSCI, V7, P850, DOI 10.1038/nrn2009; Itasaki N, 2003, DEVELOPMENT, V130, P4295, DOI 10.1242/dev.00674; Johnson EB, 2005, HUM MOL GENET, V14, P3523, DOI 10.1093/hmg/ddi381; Johnson ML, 2004, J BONE MINER RES, V19, P1749, DOI 10.1359/JBMR.040816; Kassai Y, 2005, SCIENCE, V309, P2067, DOI 10.1126/science.1116848; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Klein OD, 2006, DEV CELL, V11, P181, DOI 10.1016/j.devcel.2006.05.014; Laurikkala J, 2003, DEV BIOL, V264, P91, DOI 10.1016/j.ydbio.2003.08.011; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; May P, 2007, ANN MED, V39, P219, DOI 10.1080/07853890701214881; McCarthy RA, 2002, J BIOL CHEM, V277, P25660, DOI 10.1074/jbc.M201933200; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; Murashima-Suginami A, 2007, BIOCHEM BIOPH RES CO, V359, P549, DOI 10.1016/j.bbrc.2007.05.148; Mustonen T, 2003, DEV BIOL, V259, P123, DOI 10.1016/S0012-1606(03)00157-X; Nam JS, 2006, J BIOL CHEM, V281, P13247, DOI 10.1074/jbc.M508324200; Nykjaer A, 2002, TRENDS CELL BIOL, V12, P273, DOI 10.1016/S0962-8924(02)02282-1; Ohazama A, 2004, CURR OPIN GENET DEV, V14, P513, DOI 10.1016/j.gde.2004.07.008; Peterkova R, 2002, CONNECT TISSUE RES, V43, P120, DOI 10.1080/03008200290000745; Peterkova R, 2006, J EXP ZOOL PART B, V306B, P234, DOI 10.1002/jez.b.21093; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Pownall ME, 1996, DEVELOPMENT, V122, P3881; Simon-Chazottes D, 2006, GENOMICS, V87, P673, DOI 10.1016/j.ygeno.2006.01.007; Spoelgen R, 2005, DEVELOPMENT, V132, P405, DOI 10.1242/dev.01580; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; TENCATE AR, 2003, TENCATES ORAL HISTOL, P79; Thesleff I, 1999, BONE, V25, P123, DOI 10.1016/S8756-3282(99)00119-2; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Tucker A, 2004, NAT REV GENET, V5, P499, DOI 10.1038/nrg1380; Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Wilkinson D.G, 1995, SITU HYBRIDISATION P; Yanagita M, 2006, J CLIN INVEST, V116, P70, DOI 10.1172/JCI25445; Yanagita M, 2004, BIOCHEM BIOPH RES CO, V316, P490, DOI 10.1016/j.bbrc.2004.02.075	45	143	147	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4092	10.1371/journal.pone.0004092	http://dx.doi.org/10.1371/journal.pone.0004092			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DO	19116665	Green Submitted, Green Published, gold			2022-12-25	WOS:000265466600013
J	Piao, S; Lee, SH; Kim, H; Yum, S; Stamos, JL; Xu, YB; Lee, SJ; Lee, J; Oh, S; Han, JK; Park, BJ; Weis, WI; Ha, NC				Piao, Shunfu; Lee, Sun-Hye; Kim, Hyunjoon; Yum, Soohwan; Stamos, Jennifer L.; Xu, Yongbin; Lee, Su-Jin; Lee, Jaewon; Oh, Sangtaek; Han, Jin-Kwan; Park, Bum-Joon; Weis, William I.; Ha, Nam-Chul			Direct Inhibition of GSK3 beta by the Phosphorylated Cytoplasmic Domain of LRP6 in Wnt/beta-Catenin Signaling	PLOS ONE			English	Article								Wnt/beta-catenin signaling plays a central role in development and is also involved in a diverse array of diseases. Binding of Wnts to the coreceptors Frizzled and LRP6/5 leads to phosphorylation of PPPSPxS motifs in the LRP6/5 intracellular region and the inhibition of GSK3 beta bound to the scaffold protein Axin. However, it remains unknown how GSK3 beta is specifically inhibited upon Wnt stimulation. Here, we show that overexpression of the intracellular region of LRP6 containing a Ser/Thr rich cluster and a PPPSPxS motif impairs the activity of GSK3 beta in cells. Synthetic peptides containing the PPPSPxS motif strongly inhibit GSK3b in vitro only when they are phosphorylated. Microinjection of these peptides into Xenopus embryos confirms that the phosphorylated PPPSPxS motif potentiates Wnt-induced second body axis formation. In addition, we show that the Ser/Thr rich cluster of LRP6 plays an important role in LRP6 binding to GSK3 beta. These observations demonstrate that phosphorylated LRP6/5 both recruits and directly inhibits GSK3 beta using two distinct portions of its cytoplasmic sequence, and suggest a novel mechanism of activation in this signaling pathway.	[Yum, Soohwan; Xu, Yongbin; Lee, Jaewon; Ha, Nam-Chul] Pusan Natl Univ, Coll Pharm, Pusan, South Korea; [Piao, Shunfu; Yum, Soohwan; Xu, Yongbin; Lee, Jaewon; Ha, Nam-Chul] Pusan Natl Univ, Res Inst Drug Dev, Pusan, South Korea; [Lee, Sun-Hye; Lee, Su-Jin; Park, Bum-Joon] Pusan Natl Univ, Coll Nat Sci, Dept Mol Biol, Pusan, South Korea; [Kim, Hyunjoon; Han, Jin-Kwan] POSTECH, Div Mol & Life Sci, Pohang, South Korea; [Stamos, Jennifer L.; Weis, William I.] Stanford Univ, Sch Med, Dept Struct Biol & Mol & Cellular Physiol, Stanford, CA 94305 USA; [Oh, Sangtaek] Inje Univ, PharmcoGenom Res Ctr, Pusan, South Korea	Pusan National University; Pusan National University; Pusan National University; Pohang University of Science & Technology (POSTECH); Stanford University; Inje University	Piao, S (corresponding author), Pusan Natl Univ, Coll Pharm, Pusan, South Korea.	hnc@pusan.ac.kr	Weis, William I/G-1437-2011; Lee, Jaewon/N-9064-2013	Weis, William I/0000-0002-5583-6150; Lee, Jaewon/0000-0003-3203-2130; Kim, Hyunjoon/0000-0002-0207-1190	Korea Research Foundation [KRF-2007-C00620]; U.S. National Institutes of Health [GM56169]; Basic Research Program of the Korea Science & Engineering Foundation [R01-2006-000-10521-0]; Advanced Basic Research Laboratory Program [R14-2002-012-01001-0]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056169] Funding Source: NIH RePORTER	Korea Research Foundation(National Research Foundation of Korea); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Basic Research Program of the Korea Science & Engineering Foundation(Korea Science and Engineering Foundation); Advanced Basic Research Laboratory Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by a Korea Research Foundation Grant (KRF-2007-C00620) to N-C.H. and by U.S. National Institutes of Health grant GM56169 to W.I.W. The Basic Research Program of the Korea Science & Engineering Foundation (R01-2006-000-10521-0), and The Advanced Basic Research Laboratory Program (R14-2002-012-01001-0) of KRF partly supported this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Bienz M, 2003, NAT CELL BIOL, V5, P179, DOI 10.1038/ncb0303-179; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Cliffe A, 2003, CURR BIOL, V13, P960, DOI 10.1016/S0960-9822(03)00370-1; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Cselenyi CS, 2008, P NATL ACAD SCI USA, V105, P8032, DOI 10.1073/pnas.0803025105; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Dajani R, 2003, EMBO J, V22, P494, DOI 10.1093/emboj/cdg068; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Dominguez I, 2000, DEVELOPMENT, V127, P861; Fraser E, 2002, J BIOL CHEM, V277, P2176, DOI 10.1074/jbc.M109462200; Ha NC, 2004, MOL CELL, V15, P511, DOI 10.1016/j.molcel.2004.08.010; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; Jho EH, 1999, BIOCHEM BIOPH RES CO, V266, P28, DOI 10.1006/bbrc.1999.1760; Julius MA, 2000, BIOCHEM BIOPH RES CO, V276, P1162, DOI 10.1006/bbrc.2000.3607; Kikuchi A, 2007, CELL SIGNAL, V19, P659, DOI 10.1016/j.cellsig.2006.11.001; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Mi KH, 2006, J BIOL CHEM, V281, P4787, DOI 10.1074/jbc.M508657200; Mi KH, 2005, J CELL BIOCHEM, V95, P328, DOI 10.1002/jcb.20400; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Pearl LH, 2002, CURR OPIN STRUC BIOL, V12, P761, DOI 10.1016/S0959-440X(02)00386-X; Takahashi R, 1998, J BIOL CHEM, V273, P7787, DOI 10.1074/jbc.273.14.7787; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Thomas GM, 1999, FEBS LETT, V458, P247, DOI 10.1016/S0014-5793(99)01161-8; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yanagawa SI, 1997, J BIOL CHEM, V272, P25243, DOI 10.1074/jbc.272.40.25243; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540; Zhou Q, 1997, J BIOL CHEM, V272, P7797, DOI 10.1074/jbc.272.12.7797	35	150	156	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4046	10.1371/journal.pone.0004046	http://dx.doi.org/10.1371/journal.pone.0004046			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19107203	Green Submitted, Green Published, gold			2022-12-25	WOS:000265463000032
J	Kuznetsov, S; Khokhlatchev, AV				Kuznetsov, Sergey; Khokhlatchev, Andrei V.			The Growth and Tumor Suppressors NORE1A and RASSF1A Are Targets for Calpain-Mediated Proteolysis	PLOS ONE			English	Article								Background: NORE1A and RASSF1A are growth and tumour suppressors inactivated in a variety of cancers. Methylation of NORE1A and RASSF1A promoters is the predominant mechanism for downregulation of these proteins; however, other mechanisms are likely to exist. Methodology/Principal Findings: Here we describe a proteolysis of NORE1A and RASSF1A by calpains as alternative mechanism of their downregulation. Extracts of H358 cell line, a human bronchoalveolar carcinoma, and H460, a large cell carcinoma, were capable of proteolysis of NORE1A protein in the calpain-dependent manner. Likewise, RASSF1A tumor suppressor was proteolyzed by the H358 cell extract. Addition of calpain inhibitor to H358 and H460 cells growing in tissue culture resulted in re-expression of endogenous NORE1A. A survey of 10 human lung tumours revealed that three of them contain an activity capable of inducing NORE1A degradation. Conclusions/Significance: Thus, degradation by calpains is a novel mechanism for downregulation of NORE1A and RASSF1A proteins and might be the mechanism allowing cancer cells to escape growth suppression.	Univ Rhode Isl, Dept Phys, Kingston, RI 02881 USA; [Khokhlatchev, Andrei V.] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA	University of Rhode Island; University of Virginia	Kuznetsov, S (corresponding author), Univ Rhode Isl, Dept Phys, East Hall, Kingston, RI 02881 USA.	ak9k@virginia.edu	Kuznetsov, Sergey B./GRX-6475-2022	Kuznetsov, Sergey B./0000-0003-4013-2991	University of Virginia Department of Pathology	University of Virginia Department of Pathology	University of Virginia Department of Pathology Startup funds, provided to AVK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama Y, 2004, ONCOGENE, V23, P3426, DOI 10.1038/sj.onc.1207486; Atencio IA, 2000, CELL GROWTH DIFFER, V11, P247; Burbee DG, 2001, JNCI-J NATL CANCER I, V93, P691, DOI 10.1093/jnci/93.9.691; Carragher NO, 2004, NEOPLASIA, V6, P53, DOI 10.1016/S1476-5586(04)80053-8; Carragher NO, 2002, INT J BIOCHEM CELL B, V34, P1539, DOI 10.1016/S1357-2725(02)00069-9; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; Dammann R, 2003, HISTOL HISTOPATHOL, V18, P665, DOI 10.14670/HH-18.665; Darnell GA, 2007, J BIOL CHEM, V282, P37492, DOI 10.1074/jbc.M706860200; Delmas C, 2003, J BIOL CHEM, V278, P12443, DOI 10.1074/jbc.M209523200; Demarchi F, 2007, CELL CYCLE, V6, P136; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; FOUKAKIS T, 2005, FUSION J CLIN ENDOCR; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Harjes E, 2006, STRUCTURE, V14, P881, DOI 10.1016/j.str.2006.03.008; Hesson L, 2003, ONCOGENE, V22, P947, DOI 10.1038/sj.onc.1206191; Hiwasa T, 2002, BIOCHEM BIOPH RES CO, V290, P510, DOI 10.1006/bbrc.2001.6197; Joy J, 2006, BIOL CHEM, V387, P329, DOI 10.1515/BC.2006.044; Khokhlatchev A, 2002, CURR BIOL, V12, P253, DOI 10.1016/S0960-9822(02)00683-8; Kimura Y, 2000, NEUROPATHOLOGY, V20, P153, DOI 10.1046/j.1440-1789.2000.00326.x; Kubbutat MHG, 1997, MOL CELL BIOL, V17, P460, DOI 10.1128/MCB.17.1.460; Liu LM, 2003, ONCOGENE, V22, P8125, DOI 10.1038/sj.onc.1206984; Moshnikova A, 2006, J BIOL CHEM, V281, P8143, DOI 10.1074/jbc.M511837200; Munarriz E, 2005, BIOCHEM BIOPH RES CO, V333, P954, DOI 10.1016/j.bbrc.2005.05.188; Pan ZG, 2005, CANCER BIOL THER, V4, P1116, DOI 10.4161/cbt.4.10.2023; Shiba, 1996, Breast Cancer, V3, P13, DOI 10.1007/BF02966957; Shiba E, 1996, ANTICANCER RES, V16, P773; Stieglitz B, 2008, EMBO J, V27, P1995, DOI 10.1038/emboj.2008.125; Tommasi S, 2005, CANCER RES, V65, P92; Tommasi S, 2002, ONCOGENE, V21, P2713, DOI 10.1038/sj.onc.1205365; Tonnetti L, 2008, CANCER RES, V68, P5648, DOI 10.1158/0008-5472.CAN-07-5850; van der Weyden L, 2005, MOL CELL BIOL, V25, P8356, DOI 10.1128/MCB.25.18.8356-8367.2005; van der Weyden L, 2007, BBA-REV CANCER, V1776, P58, DOI 10.1016/j.bbcan.2007.06.003; Vavvas D, 1998, J BIOL CHEM, V273, P5439, DOI 10.1074/jbc.273.10.5439; Vos MD, 2003, J BIOL CHEM, V278, P21938, DOI 10.1074/jbc.M211019200	34	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2008	3	12							e3997	10.1371/journal.pone.0003997	http://dx.doi.org/10.1371/journal.pone.0003997			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CA	19098985	Green Published, gold, Green Submitted			2022-12-25	WOS:000265462300008
J	Jeong, JH; Wang, ZX; Guimaraes, AS; Ouyang, X; Figueiredo, JL; Ding, ZH; Jiang, S; Guney, I; Kang, GH; Shin, E; Hahn, WC; Loda, MF; Abate-Shen, C; Weissleder, R; Chin, L				Jeong, Joseph H.; Wang, Zhenxiong; Guimaraes, Alexander S.; Ouyang, Xuesong; Figueiredo, Jose L.; Ding, Zhihu; Jiang, Shan; Guney, Isil; Kang, Gyeong Hoon; Shin, Eyoung; Hahn, William C.; Loda, Massimo F.; Abate-Shen, Cory; Weissleder, Ralph; Chin, Lynda			BRAF Activation Initiates but Does Not Maintain Invasive Prostate Adenocarcinoma	PLOS ONE			English	Article								Prostate cancer is the second leading cause of cancer-related deaths in men. Activation of MAP kinase signaling pathway has been implicated in advanced and androgen-independent prostate cancers, although formal genetic proof has been lacking. In the course of modeling malignant melanoma in a tyrosinase promoter transgenic system, we developed a genetically-engineered mouse (GEM) model of invasive prostate cancers, whereby an activating mutation of BRAF(V600E)-a mutation found in similar to 10% of human prostate tumors-was targeted to the epithelial compartment of the prostate gland on the background of Ink4a/Arf deficiency. These GEM mice developed prostate gland hyperplasia with progression to rapidly growing invasive adenocarcinoma without evidence of AKT activation, providing genetic proof that activation of MAP kinase signaling is sufficient to drive prostate tumorigenesis. Importantly, genetic extinction of BRAF(V600E) in established prostate tumors did not lead to tumor regression, indicating that while sufficient to initiate development of invasive prostate adenocarcinoma, BRAF(V600E) is not required for its maintenance.	[Jeong, Joseph H.; Wang, Zhenxiong; Ding, Zhihu; Jiang, Shan; Guney, Isil; Hahn, William C.; Loda, Massimo F.; Chin, Lynda] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Guimaraes, Alexander S.; Figueiredo, Jose L.; Weissleder, Ralph] Harvard Univ, Sch Med, Mass Gen Hosp, Ctr Syst Biol, Boston, MA 02115 USA; [Ouyang, Xuesong; Abate-Shen, Cory] Columbia Univ, Coll Physicians & Surgeons, Herbert Irving Comprehensive Canc Ctr, Dept Urol & Pathol, New York, NY 10027 USA; [Kang, Gyeong Hoon] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea; [Shin, Eyoung; Loda, Massimo F.] Harvard Univ, Sch Med, Brigham and Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Hahn, William C.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA USA; [Chin, Lynda] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Guney, Isil; Hahn, William C.; Loda, Massimo F.] MIT, Broad Inst Harvard, Cambridge, MA USA; [Guimaraes, Alexander S.; Figueiredo, Jose L.; Weissleder, Ralph] Harvard Univ, Sch Med, Mass Gen Hosp, Ctr Mol Imaging Res, Charlestown, MA USA; [Weissleder, Ralph] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Columbia University; Seoul National University (SNU); Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard Medical School	Jeong, JH (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	lynda_chin@dfci.harvard.edu	Abate-Shen, Cory/O-2520-2014; Kang, Gyeong Hoon/F-1051-2010	Abate-Shen, Cory/0000-0002-5021-0570; Kang, Gyeong Hoon/0000-0003-2380-6675; /0000-0003-0828-4143	Department of Defense (DOD) [Prostate Cancer Training Awards]; NIH [PO1 CA089021, RO1 CA109038, RO1 CA076501, UO1 CA084294, R24 CA92782, P50 CA86355, U54 CA119349, UO1 CA84313, RO1 CA93947]; Prostate Cancer Foundation (PCF) Award; DFCI-Novartis Investigator award; NATIONAL CANCER INSTITUTE [R01CA093947, P01CA089021, U01CA084294, R01CA076501, R24CA092782, R01CA109038, U01CA084313, P50CA086355, U54CA119349] Funding Source: NIH RePORTER	Department of Defense (DOD)(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Prostate Cancer Foundation (PCF) Award; DFCI-Novartis Investigator award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	J.H. Jeong and I. Guney are supported by Department of Defense (DOD) Prostate Cancer Training Awards. M.F. Loda is supported by NIH PO1 CA089021, Prostate Cancer Foundation (PCF) Award and DFCI-Novartis Investigator award. W.C. Hahn is supported by NIH RO1 CA109038 and the Prostate Cancer Foundation (PCF) Award. C. Abate-Shen is supported by NIH RO1 CA076501 and UO1 CA084294. R. Weissleder and all imaging studies are supported by NIH R24 CA92782, P50 CA86355, and U54 CA119349. This work is supported by grants from the NIH (UO1 CA84313; RO1 CA93947) to L. Chin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Abate-Shen Cory, 2002, Trends Genet, V18, pS1, DOI 10.1016/S0168-9525(02)02683-5; Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Bentel JM, 1996, J ENDOCRINOL, V151, P1, DOI 10.1677/joe.0.1510001; BOOKSTEIN R, 1993, CANCER RES, V53, P3369; Brewster SF, 1999, J UROLOGY, V161, P1238, DOI 10.1016/S0022-5347(01)61646-X; Byers RJ, 2007, J MOL DIAGN, V9, P20, DOI 10.2353/jmoldx.2007.060119; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Cho NY, 2006, INT J CANCER, V119, P1858, DOI 10.1002/ijc.22071; CUNHA GR, 1987, ENDOCR REV, V8, P338, DOI 10.1210/edrv-8-3-338; Di Cristofano A, 2001, NAT GENET, V27, P222, DOI 10.1038/84879; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Gao H, 2004, P NATL ACAD SCI USA, V101, P17204, DOI 10.1073/pnas.0407693101; Gao H, 2006, P NATL ACAD SCI USA, V103, P14477, DOI 10.1073/pnas.0606836103; Gioeli D, 1999, CANCER RES, V59, P279; Hill R, 2005, CANCER RES, V65, P10243, DOI 10.1158/0008-5472.CAN-05-1579; Hudson DL, 2004, PROSTATE CANCER P D, V7, P188, DOI 10.1038/sj.pcan.4500745; Ji HB, 2007, CANCER RES, V67, P4933, DOI 10.1158/0008-5472.CAN-06-4592; Kasper S, 2005, J CELL BIOCHEM, V94, P279, DOI 10.1002/jcb.20339; Kasper Susan, 2003, Methods Mol Med, V81, P113; Kim MJ, 2002, CANCER RES, V62, P2999; Konishi N, 1997, PROSTATE, V30, P53; Lin S, 2002, J BIOL CHEM, V277, P41725, DOI 10.1074/jbc.M203957200; Ma L, 2007, CANCER RES, V67, P7106, DOI 10.1158/0008-5472.CAN-06-4798; Majumder PK, 2003, P NATL ACAD SCI USA, V100, P7841, DOI 10.1073/pnas.1232229100; Mulholland DJ, 2006, ONCOGENE, V25, P329, DOI 10.1038/sj.onc.1209020; NAVONE NM, 1993, J NATL CANCER I, V85, P1657, DOI 10.1093/jnci/85.20.1657; Navone NM, 1999, J UROLOGY, V161, P304, DOI 10.1016/S0022-5347(01)62136-0; Regales L, 2003, PIGM CELL RES, V16, P685, DOI 10.1046/j.1600-0749.2003.00100.x; Sasaki Y, 2004, J INVEST DERMATOL, V123, P177, DOI 10.1111/j.0022-202X.2004.22722.x; Segawa N, 2001, PATHOL INT, V51, P452, DOI 10.1046/j.1440-1827.2001.01226.x; Shiraishi T, 1998, ANTICANCER RES, V18, P2789; Stackhouse GB, 1999, J UROLOGY, V162, P2040, DOI 10.1016/S0022-5347(05)68095-0; SUZUKI H, 1994, JPN J CANCER RES, V85, P847, DOI 10.1111/j.1349-7006.1994.tb02957.x; Theodorescu D, 1997, J UROLOGY, V158, P131, DOI 10.1097/00005392-199707000-00040; Tholouli E, 2006, BIOCHEM BIOPH RES CO, V348, P628, DOI 10.1016/j.bbrc.2006.07.122; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Tief K, 1997, PIGM CELL RES, V10, P153; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Uzgare AR, 2004, CANCER RES, V64, P6190, DOI 10.1158/0008-5472.CAN-04-0968; VERHAGEN APM, 1992, CANCER RES, V52, P6182; VOELLER HJ, 1991, MOL ENDOCRINOL, V5, P209, DOI 10.1210/mend-5-2-209; Wang L, 2003, CANCER RES, V63, P5209; Xin L, 2006, P NATL ACAD SCI USA, V103, P7789, DOI 10.1073/pnas.0602567103; Zhang BH, 2001, J BIOL CHEM, V276, P31620, DOI 10.1074/jbc.M102808200	47	38	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2008	3	12							e3949	10.1371/journal.pone.0003949	http://dx.doi.org/10.1371/journal.pone.0003949			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AR	19079609	Green Published, gold, Green Submitted			2022-12-25	WOS:000265458400008
J	Yu, DH; Macdonald, J; Liu, GH; Lee, AS; Ly, MM; Davis, T; Ke, N; Zhou, D; Wong-Staal, F; Li, QX				Yu, De-Hua; Macdonald, James; Liu, Guohong; Lee, Amy S.; Ly, Mimi; Davis, Timothy; Ke, Ning; Zhou, Demin; Wong-Staal, Flossie; Li, Qi-Xiang			Pyrvinium Targets the Unfolded Protein Response to Hypoglycemia and Its Anti-Tumor Activity Is Enhanced by Combination Therapy	PLOS ONE			English	Article							DRUG-RESISTANCE; GRP78 PROMOTER; TUMOR-CELLS; CANCER; STRESS; INDUCTION; KINASE; ACTIVATION; IDENTIFICATION; EXPRESSION	We identified pyrvinium pamoate, an old anthelminthic medicine, which preferentially inhibits anchorage-independent growth of cancer cells over anchorage-dependent growth (, 10 fold). It was also reported by others to have anti-tumor activity in vivo and selective toxicity against cancer cells under glucose starvation in vitro, but with unknown mechanism. Here, we provide evidence that pyrvinium suppresses the transcriptional activation of GRP78 and GRP94 induced by glucose deprivation or 2-deoxyglucose (2DG, a glycolysis inhibitor), but not by tunicamycin or A23187. Other UPR pathways induced by glucose starvation, e. g. XBP-1, ATF4, were also found suppressed by pyrvinium. Constitutive expression of GRP78 via transgene partially protected cells from pyrvinium induced cell death under glucose starvation, suggesting that suppression of the UPR is involved in pyrvinium mediated cytotoxicity under glucose starvation. Xenograft experiments showed rather marginal overall anti-tumor activity for pyrvinium as a monotherapy. However, the combination of pyrvinium and Doxorubicin demonstrated significantly enhanced efficacy in vivo, supporting a mechanistic treatment concept based on tumor hypoglycemia and UPR.	[Yu, De-Hua; Macdonald, James; Liu, Guohong; Lee, Amy S.; Ly, Mimi; Davis, Timothy; Ke, Ning; Zhou, Demin; Wong-Staal, Flossie; Li, Qi-Xiang] iTherX Pharmaceut Inc, San Diego, CA USA; [Lee, Amy S.] Univ So Calif, Keck Sch Med, Norris Comprehensive Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA USA	University of Southern California	Yu, DH (corresponding author), iTherX Pharmaceut Inc, San Diego, CA USA.	yu@itherx.com; hqxl@yahoo.com		Lee, Amy/0000-0002-0378-5443	NIH [1R43CA130386-01A1, CA27607]; NATIONAL CANCER INSTITUTE [R01CA027607, R37CA027607, R43CA130386] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	iTherX Pharmaceuticals, Inc. was the major study sponsor and responsible for decision for publication. Yu DH was partially supported by NIH grant 1R43CA130386-01A1. ASL was supported by NIH grant CA27607. NIH had no role in study design, data collection and analysis, desicion to publish, or preparation of the manuscript.	Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Brown JM, 1998, CANCER RES, V58, P1408; CLAASSEN G, 2004, PRECLINICA, V2, P435; El-Zawahry A, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-2; Esumi H, 2004, CANCER SCI, V95, P685, DOI 10.1111/j.1349-7006.2004.tb03330.x; Fels DR, 2006, CANCER BIOL THER, V5, P723, DOI 10.4161/cbt.5.7.2967; Fernandez PM, 2000, BREAST CANCER RES TR, V59, P15, DOI 10.1023/A:1006332011207; Fu Y, 2006, CANCER BIOL THER, V5, P741, DOI 10.4161/cbt.5.7.2970; Gazit G, 1999, BREAST CANCER RES TR, V54, P135, DOI 10.1023/A:1006102411439; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hensley ML, 1999, J CLIN ONCOL, V17, P3333, DOI 10.1200/JCO.1999.17.10.3333; Izuishi K, 2000, CANCER RES, V60, P6201; Ke N, 2004, BIOTECHNIQUES, V36, P826, DOI 10.2144/04365ST07; Ke N, 2006, EXP CELL RES, V312, P2726, DOI 10.1016/j.yexcr.2006.05.001; Koomagi R, 1999, ANTICANCER RES, V19, P4333; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; LI WWF, 1993, J BIOL CHEM, V268, P12003; Luo S, 2002, BIOCHEM J, V366, P787, DOI 10.1042/BJ20011802; Luo SZ, 2003, J BIOL CHEM, V278, P37375, DOI 10.1074/jbc.M303619200; Park HR, 2004, JNCI-J NATL CANCER I, V96, P1300, DOI 10.1093/jnci/djh243; Ranganathan AC, 2006, CANCER RES, V66, P1702, DOI 10.1158/0008-5472.CAN-05-3092; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Reddy RK, 1999, J BIOL CHEM, V274, P28476, DOI 10.1074/jbc.274.40.28476; RESENDEZ E, 1988, MOL CELL BIOL, V8, P4579, DOI 10.1128/MCB.8.10.4579; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Rutkowski DT, 2003, DEV CELL, V4, P442, DOI 10.1016/S1534-5807(03)00100-X; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Shuda M, 2003, J HEPATOL, V38, P605, DOI 10.1016/S0168-8278(03)00029-1; Song MS, 2001, CANCER RES, V61, P8322; Tsutsumi S, 2006, ONCOGENE, V25, P1018, DOI 10.1038/sj.onc.1209139; VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z; Yu DH, 2006, EXP CELL RES, V312, P865, DOI 10.1016/j.yexcr.2005.12.006; Yu DH, 2005, ASSAY DRUG DEV TECHN, V3, P401, DOI 10.1089/adt.2005.3.401	35	54	56	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2008	3	12							e3951	10.1371/journal.pone.0003951	http://dx.doi.org/10.1371/journal.pone.0003951			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AR	19079611	Green Published, Green Submitted, gold			2022-12-25	WOS:000265458400010
J	Gomez-Nunez, M; Haro, KJ; Dao, T; Chau, DM; Won, A; Escobar-Alvarez, S; Zakhaleva, V; Korontsvit, T; Gin, DY; Scheinberg, DA				Gomez-Nunez, Marta; Haro, Kurtis J.; Dao, Tao; Chau, Deming; Won, Annie; Escobar-Alvarez, Sindy; Zakhaleva, Victoriya; Korontsvit, Tatyana; Gin, David Y.; Scheinberg, David A.			Non-Natural and Photo-Reactive Amino Acids as Biochemical Probes of Immune Function	PLOS ONE			English	Article							WILMS-TUMOR GENE; CYTOTOXIC T-LYMPHOCYTES; SITE-SPECIFIC INCORPORATION; WT1 PEPTIDE; ANALOGS; EXPRESSION; VACCINE; BINDING; CELLS; EPITOPE	Wilms tumor protein (WT1) is a transcription factor selectively overexpressed in leukemias and cancers; clinical trials are underway that use altered WT1 peptide sequences as vaccines. Here we report a strategy to study peptide-MHC interactions by incorporating non-natural and photo-reactive amino acids into the sequence of WT1 peptides. Thirteen WT1 peptides sequences were synthesized with chemically modified amino acids (via fluorination and photo-reactive group additions) at MHC and T cell receptor binding positions. Certain new non-natural peptide analogs could stabilize MHC class I molecules better than the native sequences and were also able to elicit specific T-cell responses and sometimes cytotoxicity to leukemia cells. Two photo-reactive peptides, also modified with a biotin handle for pull-down studies, formed covalent interactions with MHC molecules on live cells and provided kinetic data showing the rapid clearance of the peptide-MHC complex. Despite "infinite affinity'' provided by the covalent peptide bonding to the MHC, immunogenicity was not enhanced by these peptides because the peptide presentation on the surface was dominated by catabolism of the complex and only a small percentage of peptide molecules covalently bound to the MHC molecules. This study shows that non-natural amino acids can be successfully incorporated into T cell epitopes to provide novel immunological, biochemical and kinetic information.	[Gomez-Nunez, Marta; Haro, Kurtis J.; Dao, Tao; Chau, Deming; Won, Annie; Escobar-Alvarez, Sindy; Zakhaleva, Victoriya; Korontsvit, Tatyana; Gin, David Y.; Scheinberg, David A.] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10021 USA; [Haro, Kurtis J.; Chau, Deming; Won, Annie; Escobar-Alvarez, Sindy] Weill Cornell, Grad Sch Med Sci, New York, NY USA	Memorial Sloan Kettering Cancer Center	Gomez-Nunez, M (corresponding author), Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, 1275 York Ave, New York, NY 10021 USA.	d-scheinberg@ski.mskcc.org		Escobar Alvarez, Sindy/0000-0002-8294-5918	NIH [PO1 23766, RO1 55349, RO1 58833]; Ellen and Sandy Levin fund; Lymphoma Foundation; The Glades fund; Experimental Therapeutics Center; Geoffrey Beene Center;  [GM73546]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM073546] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellen and Sandy Levin fund; Lymphoma Foundation; The Glades fund; Experimental Therapeutics Center; Geoffrey Beene Center; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH PO1 23766, RO1 55349, RO1 58833, the Ellen and Sandy Levin fund, the Lymphoma Foundation, The Glades fund, the Experimental Therapeutics Center, and the Geoffrey Beene Center. This work was further supported by training grant #GM73546. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAIN JD, 1989, J AM CHEM SOC, V111, P8013, DOI 10.1021/ja00202a052; Bellantuono I, 2002, BLOOD, V100, P3835, DOI 10.1182/blood.V100.10.3835; Brieger J, 1995, ANN ONCOL, V6, P811, DOI 10.1093/oxfordjournals.annonc.a059321; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; Cilloni D, 2003, J CLIN ONCOL, V21, P1988, DOI 10.1200/JCO.2003.10.503; Douat-Casassus C, 2007, J MED CHEM, V50, P1598, DOI 10.1021/jm0613368; Doubrovina ES, 2004, CLIN CANCER RES, V10, P7207, DOI 10.1158/1078-0432.CCR-04-1040; Gao LQ, 2000, BLOOD, V95, P2198, DOI 10.1182/blood.V95.7.2198.007k38_2198_2203; Gomez-Nunez M, 2006, LEUKEMIA RES, V30, P1293, DOI 10.1016/j.leukres.2006.02.010; Guichard G, 1996, J MED CHEM, V39, P2030, DOI 10.1021/jm9509511; Guichard G, 2000, J MED CHEM, V43, P3803, DOI 10.1021/jm000909s; Herr W, 1997, J IMMUNOL METHODS, V203, P141, DOI 10.1016/S0022-1759(97)00019-7; HUANG A, 1990, SCIENCE, V250, P991, DOI 10.1126/science.2173145; Inoue K, 1997, BLOOD, V89, P1405, DOI 10.1182/blood.V89.4.1405; Jones MA, 2006, ORG BIOMOL CHEM, V4, P3769, DOI 10.1039/b611170j; Kiick KL, 2002, P NATL ACAD SCI USA, V99, P19, DOI 10.1073/pnas.012583299; Krebs S, 1998, J PEPT SCI, V4, P378, DOI 10.1002/(SICI)1099-1387(199809)4:6<378::AID-PSC157>3.0.CO;2-B; Mailander V, 2004, LEUKEMIA, V18, P165, DOI 10.1038/sj.leu.2403186; Marastoni M, 2002, BIOORGAN MED CHEM, V10, P3061, DOI 10.1016/S0968-0896(02)00033-0; Marastoni M, 2001, J MED CHEM, V44, P2370, DOI 10.1021/jm001136a; Maurer U, 1997, EXP HEMATOL, V25, P945; Morita S, 2006, JPN J CLIN ONCOL, V36, P231, DOI 10.1093/jjco/hyl005; NOREN CJ, 1989, SCIENCE, V244, P182, DOI 10.1126/science.2649980; Ohminami H, 2000, BLOOD, V95, P286; Oji Y, 1999, JPN J CANCER RES, V90, P194, DOI 10.1111/j.1349-7006.1999.tb00733.x; Oka Y, 2000, IMMUNOGENETICS, V51, P99, DOI 10.1007/s002510050018; Oka Y, 2004, P NATL ACAD SCI USA, V101, P13885, DOI 10.1073/pnas.0405884101; PARK S, 1993, NAT GENET, V4, P415, DOI 10.1038/ng0893-415; PELLETIER J, 1991, GENE DEV, V5, P1345, DOI 10.1101/gad.5.8.1345; Pinilla-Ibarz J, 2006, LEUKEMIA, V20, P2025, DOI 10.1038/sj.leu.2404380; Poenaru S, 1999, J MED CHEM, V42, P2318, DOI 10.1021/jm981123l; PRITCHARDJONES K, 1990, NATURE, V346, P194, DOI 10.1038/346194a0; Quesnel A, 2001, J PEPT SCI, V7, P157, DOI 10.1002/psc.311; Tsuboi A, 2002, CANCER IMMUNOL IMMUN, V51, P614, DOI 10.1007/s00262-002-0328-9; Tsuboi A, 2004, MICROBIOL IMMUNOL, V48, P175, DOI 10.1111/j.1348-0421.2004.tb03503.x; Webb AI, 2004, J BIOL CHEM, V279, P23438, DOI 10.1074/jbc.M314066200; Webb AI, 2005, J IMMUNOL, V175, P3810, DOI 10.4049/jimmunol.175.6.3810; Weber PJA, 1997, J PEPT RES, V49, P375	38	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2008	3	12							e3938	10.1371/journal.pone.0003938	http://dx.doi.org/10.1371/journal.pone.0003938			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437AP	19079589	Green Submitted, Green Published, gold			2022-12-25	WOS:000265458200005
